PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Foster, KA; Recker, MJ; Lee, PS; Bell, MJ; Tyler-Kabara, EC				Foster, Kimberly A.; Recker, Matthew J.; Lee, Philip S.; Bell, Michael J.; Tyler-Kabara, Elizabeth C.			Factors Associated with Hemispheric Hypodensity after Subdural Hematoma following Abusive Head Trauma in Children	JOURNAL OF NEUROTRAUMA			English	Article						abusive head trauma; hemispheric hypodensity; intracranial hypertension; severe traumatic brain injury; subdural hematoma	SHAKEN BABY SYNDROME; NONTRAUMATIC INFANT DEATHS; HYPOXIC-ISCHEMIC INJURY; PERMANENT BRAIN-DAMAGE; GLASGOW COMA SCALE; YOUNG-CHILDREN; PREDICTIVE FACTORS; INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID; MENTAL-RETARDATION	Abusive head trauma (AHT) is a unique form of pediatric TBI with increased mortality and neurologic sequelae. Hemispheric hypodensity (HH) in association with subdural blood after AHT has been described. Though risk factors for HH are not understood, we hypothesized that risk factors could be identified. We retrospectively enrolled children under 5 years with TBI secondary to AHT (child advocacy diagnosis) who had undergone initial and interval brain imaging. Records were interrogated for prearrival and in-hospital physiologic and radiographic findings. HH was determined by a blinded observer. Twenty-four children were enrolled and 13 developed HH. HH was not significantly associated with age, initial Glascow Coma Scale, or mortality. Pediatric Intensity Level of Therapy (PILOT) scores (p = 0.01) and daily maximal intracranial pressure (ICPmax; p = 0.037) were higher in HH. Hypoxia, hypotension, cardiopulmonary arrest, need for blood transfusion, and daily blood glucoses tended to be greater in HH. Whereas all children with HH had acute subdural hematoma (SBH), many children without HH also had subdural blood; the presence of skull fracture was more likely in the children who did not develop HH (p = 0.04), but no other intracranial radiographic pattern of injury was associated with HH. Surgical intervention did not appear to protect against development of HH. A variety of insults associated with ischemia, including intracranial hypertension, ICP-directed therapies, hypoxia, hypotension, and cardiac arrest, occurred in the children who developed HH. Given the morbidity and mortality of this condition, larger studies to identify mechanisms leading to the development of HH and mitigating clinical approaches are warranted.	[Foster, Kimberly A.; Recker, Matthew J.; Lee, Philip S.; Bell, Michael J.; Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15224 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15224 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Bell, Michael J.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA		Foster, KA (corresponding author), Univ Pittsburgh, Dept Neurosurg, 4th Floor Fac Pavil 4401 Penn Ave, Pittsburgh, PA 15224 USA.	fosterka@upmc.edu	Tyler-Kabara, Elizabeth/H-4930-2013	Tyler-Kabara, Elizabeth/0000-0003-3286-1094	ADAPT [U01 NS08 1041]	This work received grant support from ADAPT (U01 NS08 1041; to M.J.B.).	Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; COHEN RA, 1986, AM J ROENTGENOL, V146, P97, DOI 10.2214/ajr.146.1.97; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Duhaime A.C., 1993, J NEUROTRAUMA S1, V10, pS59; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Duhaime AC, 2007, PROG BRAIN RES, V161, P293, DOI 10.1016/S0079-6123(06)61020-0; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Geddes JF, 2004, BMJ-BRIT MED J, V328, P719, DOI 10.1136/bmj.328.7442.719; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Graupman P, 2006, J NEUROSURG, V104, P245, DOI 10.3171/ped.2006.104.4.245; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Han Yong Y, 2002, Pediatr Crit Care Med, V3, P39, DOI 10.1097/00130478-200201000-00010; Harding B, 2004, BMJ-BRIT MED J, V328, P720, DOI 10.1136/bmj.328.7442.720; Hattori N, 2004, J NUCL MED, V45, P775; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; KURODA Y, 1992, NEUROSURGERY, V30, P687; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Matschke J, 2009, PEDIATRICS, V124, P1587, DOI 10.1542/peds.2008-3734; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miller M, 2004, PEDIATRICS, V114, P326, DOI 10.1542/peds.114.1.326; Muir ER, 2014, METHODS MOL BIOL, V1135, P205, DOI 10.1007/978-1-4939-0320-7_17; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Punt J, 2006, ARCH DIS CHILD, V91, P714; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; Ruppel RA, 2002, NEUROSURG CLIN N AM, V13, P169, DOI 10.1016/S1042-3680(01)00005-5; Scavarda D, 2010, CHILD NERV SYST, V26, P1555, DOI 10.1007/s00381-010-1150-x; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Shein SL, 2012, CRIT CARE MED, V40, P3115, DOI 10.1097/CCM.0b013e31826563c8; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Smith C, 2003, NEUROPATH APPL NEURO, V29, P411, DOI 10.1046/j.1365-2990.2003.00500.x; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	69	11	11	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2014	31	19					1625	1631		10.1089/neu.2014.3372			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AP5VI	WOS:000342146400004	24693985	Green Published			2022-02-06	
J	Hitosugi, M; Murayama, H; Motozawa, Y; Ishii, K; Ogino, M; Koyama, K				Hitosugi, Masahito; Murayama, Haruo; Motozawa, Yasuki; Ishii, Kanto; Ogino, Masahiro; Koyama, Katsuhiro			Biomechanical analysis of acute subdural hematoma resulting from judo	BIOMEDICAL RESEARCH-TOKYO			English	Article							INJURIES; HEAD; IMPACTS; CONCUSSION; FOOTBALL	This study investigated biomechanical mechanisms of acute subdural hematoma caused by judo and sought preventive measures to reduce injury. A Japanese judo expert repeatedly threw an anthropometric test device using two throwing techniques, Osoto-gari and Ouchi-gari. Linear and angular accelerations of the head were measured. Both throwing techniques resulted in the dummy falling backwards, with the occipital area of the head contacting the mat, and peak linear and angular accelerations being observed when the head contacted the mat. For linear acceleration, the posterior anterior direction showed the greatest force (41.0 +/- 2.6 G using Osoto-gari, and 86.5 +/- 4.3 G using Ouchi-gari). For angular acceleration, values for sagittal plane rotation were greatest among the three directions measured (3315 +/- 168 rad/s(2) using Osoto-gari, and 1328 +/- 201 rad/s(2) using Ouchi-gari). We concluded that occipital head contact produced the most forceful longitudinal linear and sagittal plane angular accelerations; subsequent stretches and ruptures of parasagittal bridging veins resulting in acute subdural hematoma. As severe head injuries can result if a person's head comes into contact with the mat, offensive throwing techniques should be restricted to participants able to sufficiently demonstrate the Ukemi technique.	[Hitosugi, Masahito] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan; [Murayama, Haruo] Dokkyo Med Univ, Sch Med, Dept Sports Sci, Shimotsuga, Tochigi, Japan; [Motozawa, Yasuki; Ishii, Kanto] Dokkyo Med Univ, Sch Med, Dept Legal Med, Shimotsuga, Tochigi, Japan; [Ogino, Masahiro] Dokkyo Med Univ, Sch Med, Dept Neurosurg, Shimotsuga, Tochigi, Japan; [Koyama, Katsuhiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Kofu, Yamanashi, Japan		Hitosugi, M (corresponding author), Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan.	hitosugi@belle.shiga-med.ac.jp		Hitosugi, Masahito/0000-0001-5243-8766	Honda R&D Centre in Tochigi; Ministry of Education, Culture, Sports, Science and Technology, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17689024]	The authors gratefully acknowledge Honda R&D Centre in Tochigi for their support. This study was funded in part by a Grant-in-Aid for Young Scientists (A) (No. 17689024) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Akiyama A., 2001, ESV PAP, V463, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Kamitani T, 2013, AM J SPORT MED, V41, P1915, DOI 10.1177/0363546513490662; Kerrigan J, 2005, P 19 C ENH SAF VEH E, P5; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Pocecco E, 2013, BRIT J SPORT MED, V47, P1139, DOI 10.1136/bjsports-2013-092886; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schmitt KU, 2010, TRAUMA BIOMECHANICS: ACCIDENTAL INJURY IN TRAFFIC AND SPORTS, THIRD EDITION, P1, DOI 10.1007/978-3-642-03713-9	12	11	11	0	13	BIOMEDICAL RESEARCH PRESS LTD	SAPPORO	HOKKAIDO UNIV, LAB HISTOLOGY & CYTOLOGY, C/O TOSHIHIKO IWANAGA, KITA 15-NISHI 7, SAPPORO, 060-8638, JAPAN	0388-6107	1880-313X		BIOMED RES-TOKYO	Biomed. Res.	OCT	2014	35	5					339	344		10.2220/biomedres.35.339			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AS4AU	WOS:000344216800006	25355441	Bronze			2022-02-06	
J	Patel, SK; Ross, P; Cuevas, M; Turk, A; Kim, H; Lo, TTY; Wong, LF; Bhatia, S				Patel, Sunita K.; Ross, Paula; Cuevas, Michelle; Turk, Anne; Kim, Heeyoung; Lo, Tracy T. Y.; Wong, Lennie F.; Bhatia, Smita			Parent-Directed Intervention for Children With Cancer-Related Neurobehavioral Late Effects: A Randomized Pilot Study	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						cancer and oncology; intervention outcome; neuropsychology; parenting; randomized controlled trial; rehabilitation	TRAUMATIC BRAIN-INJURY; PEDIATRIC CANCER; COGNITIVE REHABILITATION; CHILDHOOD-CANCER; ONCOLOGY GROUP; FOLLOW-UP; SURVIVORS; INVOLVEMENT; ACHIEVEMENT; SCHOOL	Objective To evaluate feasibility and preliminary efficacy of an intervention directed at parents of childhood cancer survivors (CCSs) with neurobehavioral late effects to improve targeted parenting skills, and thus to indirectly benefit the child's educational functioning. Methods 44 CCSs and their parents were randomized. Intervention-arm parents participated in eight individual training sessions augmented by a 3-month telephone support period. Pre- and postparent measures and child performance on Wechsler Individual Achievement Test-II and School Motivation and Learning Strategies Inventory assessed intervention effects. Results 90% of intervention parents completed the program with high adherence/perceived benefit. Between-group effect sizes ranged from d = 0.77 to d = 1.45 for parent knowledge, efficacy, frequency of pro-learning behaviors, and d = 0.21 to d = 0.76 for child academic scores. Parental time spent in intervention activities was associated with academic change. Conclusions A parent-directed intervention to indirectly promote academic functioning in CCSs appears feasible and effective in improving targeted parenting outcomes and for selected child academic outcomes.	[Patel, Sunita K.; Ross, Paula; Kim, Heeyoung; Lo, Tracy T. Y.; Wong, Lennie F.; Bhatia, Smita] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Cuevas, Michelle] South Cent Angeles Reg Ctr, Los Angeles, CA USA; [Turk, Anne] Fuller Theol Seminary, Pasadena, CA 91101 USA		Patel, SK (corresponding author), City Hope Natl Med Ctr, Dept Populat Sci, Room 105,Bldg 173,1500 E Duarte Rd, Duarte, CA 91010 USA.	spatel@coh.org	Patel, Sunita/AAD-4050-2019	Patel, Sunita/0000-0002-9023-8391	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R03 CA130731] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R03CA130731] Funding Source: NIH RePORTER		Abidin R, 1995, MANUAL PARENTING STR, V3rd; American Cancer Society, 2012, CANC FACTS FIG; BRADLEY RH, 1988, CHILD DEV, V59, P852, DOI 10.1111/j.1467-8624.1988.tb03239.x; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cohen J., 2013, STAT POWER ANAL BEHA; Conklin HM, 2010, J CLIN ONCOL, V28, P4465, DOI 10.1200/JCO.2010.28.4026; Gioia GA IP, 2000, BEHAV RATING INVENTO; GROLNICK WS, 1994, CHILD DEV, V65, P237, DOI 10.2307/1131378; Halligan P.W., 2005, EFFECTIVENESS REHABI; Hardy KK, 2013, PSYCHO-ONCOLOGY, V22, P1856, DOI 10.1002/pon.3222; Hill NE, 2004, CURR DIR PSYCHOL SCI, V13, P161, DOI 10.1111/j.0963-7214.2004.00298.x; Kesler SR, 2011, BRAIN INJURY, V25, P101, DOI 10.3109/02699052.2010.536194; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Miedel WT, 1999, J SCHOOL PSYCHOL, V37, P379, DOI 10.1016/S0022-4405(99)00023-0; Nathan PC, 2007, ARCH PEDIAT ADOL MED, V161, P798, DOI 10.1001/archpedi.161.8.798; Patel SK., 2014, J BEHAV HLTH, V3, P43, DOI DOI 10.5455/JBH.20131222084318; SOLBERG MM, 2001, COGNITIVE REHABILITA; Stroud K. C., 2006, SCH MOTIVATION LEARN; Switzer L. S., 1990, ELEMENTARY SCH GUIDA, V24, P200; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Van Voorhis FL, 2003, J EDUC RES, V96, P323, DOI 10.1080/00220670309596616; Verner J. A., 2005, THESIS SCH PSYCHOL F; Wechsler D., 2001, WECHSLER INDIVIDUAL; Werba BE, 2007, PEDIATR BLOOD CANCER, V48, P673, DOI 10.1002/pbc.21184; Wilson BA, 2003, NEUROPSYCHOLOG REHAB, P1; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	28	11	12	1	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	OCT	2014	39	9					1013	1027		10.1093/jpepsy/jsu045			15	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	AR2FI	WOS:000343398600006	24966398	Green Published, Bronze			2022-02-06	
J	Zheng, HB; Zhang, ZH; Luo, N; Liu, YY; Chen, QZ; Yan, H				Zheng, Huabin; Zhang, Zhuhong; Luo, Na; Liu, Yuanyuan; Chen, Qingzhong; Yan, Hua			Increased Th17 cells and IL-17 in rats with traumatic optic neuropathy	MOLECULAR MEDICINE REPORTS			English	Article						traumatic optic neuropathy; T helper 17 cells; interleukin-17; retina; optic nerve	REGULATORY T-CELLS; DISEASE; INJURY; AUTOIMMUNITY	T helper 17 (Th17) cells are strong inducers of numerous autoimmune diseases and inflammation. However, the role of Th17 cells and interleukin (IL)-17 in traumatic optic neuropathy (TON) are yet to be elucidated. In the present study, a rat model of TON was established using a fluid percussion brain injury device. Th17 cells were found to be upregulated in the spleens of rats in the TON group. In addition, the level of IL-17 in the retina of rats in the TON group was observed to increase with the upregulation of the Th17 cells. Furthermore, the expression of IL-17 in the optic nerve was found to be upregulated between one and seven days following injury in the rats in the TON group. These findings strongly suggest that the ratio of Th17 cells and the expression of IL-17 are upregulated in rats with TON. These findings also provide a rationale for developing therapeutic agents to treat TON.	[Zheng, Huabin; Zhang, Zhuhong; Liu, Yuanyuan; Chen, Qingzhong; Yan, Hua] Tianjin Med Univ, Gen Hosp, Dept Ophthalmol, Tianjin 300052, Peoples R China; [Luo, Na] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China		Yan, H (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Ophthalmol, 154 Anshan Rd, Tianjin 300052, Peoples R China.	phuayan2000@163.com			Tianjin application infrastructure and cutting-edge technology research program of China [10JCZDJC20300]	This study was supported by the Tianjin application infrastructure and cutting-edge technology research program of China (grant no. 10JCZDJC20300)	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bodanapally UK, 2013, J NEURO-OPHTHALMOL, V33, P128, DOI 10.1097/WNO.0b013e3182842553; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Dragon S, 2008, MOL IMMUNOL, V45, P160, DOI 10.1016/j.molimm.2007.04.027; Fisher J, 2001, J NEUROIMMUNOL, V119, P1, DOI 10.1016/S0165-5728(01)00342-3; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; Li Y, 2011, J NEUROIMMUNOL, V234, P155, DOI 10.1016/j.jneuroim.2011.03.009; Miliaras G, 2013, J NEUROL SURG PART A, V74, P168, DOI 10.1055/s-0032-1330115; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mosmann TR, 2005, J IMMUNOL, V175, P5; Negi Akira, 2013, Nippon Ganka Gakkai Zasshi, V117, P187; Ortega C, 2013, INT REV IMMUNOL, V32, P534, DOI 10.3109/08830185.2013.834898; Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251; Ropposch T, 2013, LARYNGOSCOPE, V123, P1082, DOI 10.1002/lary.23845; Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5; Shi W, 2013, CHINESE MED J-PEKING, V126, P1292, DOI 10.3760/cma.j.issn.0366-6999.20122854; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Yan H, 2012, CURR EYE RES, V37, P941, DOI 10.3109/02713683.2012.691599; Yu Wai Man P, 2013, COCHRANE DB SYST REV, V6; Yu Wai Man P, 2013, COCHRANE DB SYST REV, V6	23	11	11	0	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2014	10	4					1954	1958		10.3892/mmr.2014.2448			5	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	AQ4AQ	WOS:000342735000044	25110203	Bronze			2022-02-06	
J	Albert-Weissenberger, C; Mencl, S; Schuhmann, MK; Salur, I; Gob, E; Langhauser, F; Hopp, S; Hennig, N; Meuth, SG; Nolte, MW; Siren, AL; Kleinschnitz, C				Albert-Weissenberger, Christiane; Mencl, Stine; Schuhmann, Michael K.; Salur, Irmak; Goeb, Eva; Langhauser, Friederike; Hopp, Sarah; Hennig, Nelli; Meuth, Sven G.; Nolte, Marc W.; Siren, Anna-Leena; Kleinschnitz, Christoph			C1-Inhibitor protects from focal brain trauma in a cortical cryolesion mice model by reducing thrombo-inflammation	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						traumatic brain injury; edema; blood-brain barrier; C1-inhibitor; contact-kinin system; inflammation; thrombosis	KALLIKREIN-KININ SYSTEM; C1 ESTERASE INHIBITOR; RECEPTOR B1 PROTECTS; CLOSED-HEAD INJURY; HEREDITARY ANGIOEDEMA; C1-ESTERASE INHIBITOR; ISCHEMIC-STROKE; PLATELET ACTIVATION; LEUKOCYTE; RAT	Traumatic brain injury (TBI) induces a strong inflammatory response which includes blood-brain barrier damage, edema formation and infiltration of different immune cell subsets. More recently, microvascular thrombosis has been identified as another pathophysiological feature of TBI. The contact-kinin system represents an interface between inflammatory and thrombotic circuits and is activated in different neurological diseases. C1-Inhibitor counteracts activation of the contact-kinin system at multiple levels. We investigated the therapeutic potential of C1-Inhibitor in a model of TBI. Male and female C57BL/6 mice were subjected to cortical cryolesion and treated with C1-Inhibitor after 1 h. Lesion volumes were assessed between day 1 and day 5 and blood-brain barrier damage, thrombus formation as well as the local inflammatory response were determined post TBI. Treatment of male mice with 15.0 IU C1-Inhibitor, but not 7.5 IU, 1 h after cryolesion reduced lesion volumes by similar to 75% on day 1. This protective effect was preserved in female mice and at later stages of trauma. Mechanistically, C1-Inhibitor stabilized the blood-brain barrier and decreased the invasion of immune cells into the brain parenchyma. Moreover, C1-Inhibitor had strong antithrombotic effects. C1-Inhibitor represents a multifaceted anti-inflammatory and antithrombotic compound that prevents traumatic neurodegeneration in clinically meaningful settings.	[Albert-Weissenberger, Christiane; Mencl, Stine; Schuhmann, Michael K.; Goeb, Eva; Langhauser, Friederike; Hopp, Sarah; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; [Salur, Irmak; Hennig, Nelli; Siren, Anna-Leena] Univ Hosp Wurzburg, Dept Neurosurg, D-97080 Wurzburg, Germany; [Meuth, Sven G.] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Meuth, Sven G.] Univ Munster, Inst Physiol Neuropathophysiol 1, D-48149 Munster, Germany; [Nolte, Marc W.] CSL Behring GmbH, Marburg, Germany		Kleinschnitz, C (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Josef Schneider Str 1, D-97080 Wurzburg, Germany.	christoph.kleinschnitz@uni-wuerzburg.de	Siren, Anna-Leena/AAE-1374-2019	Siren, Anna-Leena/0000-0002-2217-0081; Kleinschnitz, Christoph/0000-0002-1650-8875	Else-Kroner-Fresenius Foundation; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [SFB 688, TP A13]; CSL Behring GmbH, Marburg, Germany	We thank Andrea Sauer, Sabrina Braunschweig, Melanie Glaser, Heike Menzel and Daniela Urlaub for excellent technical assistance. This work was supported by the Else-Kroner-Fresenius Foundation, the Deutsche Forschungsgemeinschaft (DFG, SFB 688, TP A13) and CSL Behring GmbH, Marburg, Germany.	Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; AUER LM, 1979, ACTA NEUROCHIR, V49, P219, DOI 10.1007/BF01808961; Banerji A, 2010, ALLERGY ASTHMA PROC, V31, P398, DOI 10.2500/aap.2010.31.3387; Begieneman MPV, 2012, J BURN CARE RES, V33, P544, DOI 10.1097/BCR.0b013e31823bc2fc; Bjorkqvist J, 2013, THROMB HAEMOSTASIS, V110, P399, DOI 10.1160/TH13-03-0258; Caccia S, 2011, BLOOD COAGUL FIBRIN, V22, P571, DOI 10.1097/MBC.0b013e3283494ba7; Cai SH, 2003, J IMMUNOL, V171, P4786, DOI 10.4049/jimmunol.171.9.4786; Caliezi C, 2000, PHARMACOL REV, V52, P91; CAMARGO ACM, 1973, BIOCHEMISTRY-US, V12, P1838, DOI 10.1021/bi00733a028; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coppola L, 2002, ARCH PATHOL LAB MED, V126, P842; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; Davis AE, 2008, MOL IMMUNOL, V45, P4057, DOI 10.1016/j.molimm.2008.06.028; de Jager SCA, 2013, ARTERIOSCL THROM VAS, V33, pE75, DOI 10.1161/ATVBAHA.112.300857; DICKNEITE G, 1993, BEHRING I MITT, V93, P299; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Duehrkop C, 2014, BIOCHEM PHARMACOL, V88, P12, DOI 10.1016/j.bcp.2013.12.013; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fiane AE, 1999, IMMUNOPHARMACOLOGY, V42, P231, DOI 10.1016/S0162-3109(99)00008-9; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; Horstick G, 1997, CIRCULATION, V95, P701, DOI 10.1161/01.CIR.95.3.701; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; KARIYA K, 1985, J NEUROCHEM, V44, P1892, DOI 10.1111/j.1471-4159.1985.tb07185.x; Keating GM, 2009, BIODRUGS, V23, P399, DOI 10.2165/11201100-000000000-00000; KIZUKI K, 1994, BRAIN RES, V634, P305, DOI 10.1016/0006-8993(94)91934-8; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Langhauser F, 2012, BLOOD, V120, P4082, DOI 10.1182/blood-2012-06-440057; Lehmann T G, 2000, Transpl Int, V13 Suppl 1, pS547, DOI 10.1111/j.1432-2277.2000.tb02101.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P381, DOI 10.1007/978-3-211-85578-2_73; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Magnus T, 2012, CURR OPIN NEUROL, V25, P334, DOI 10.1097/WCO.0b013e328352ede6; Martinez-Saguer I, 2014, TRANSFUSION, V54, P1552, DOI 10.1111/trf.12501; Mejia P, 2012, SHOCK, V38, P220, DOI 10.1097/SHK.0b013e31825bf40e; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; Prodan CI, 2014, J HEAD TRAUMA REHAB, V29, P522, DOI 10.1097/HTR.0000000000000010; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Raslan Furat, 2012, Exp Transl Stroke Med, V4, P6, DOI 10.1186/2040-7378-4-6; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reichel CA, 2012, BLOOD, V120, P880, DOI 10.1182/blood-2012-01-402164; Renne T, 2012, SEMIN IMMUNOPATHOL, V34, P31, DOI 10.1007/s00281-011-0288-2; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Tei R, 2008, NEUROL RES, V30, P761, DOI 10.1179/174313208X284241; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; van Buul JD, 2004, ARTERIOSCL THROM VAS, V24, P824, DOI 10.1161/01.ATV.0000122854.76267.5c; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD	62	11	11	0	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	SEP 9	2014	8								269	10.3389/fncel.2014.00269			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS7WK	WOS:000344462400001	25249935	Green Published, gold			2022-02-06	
J	de Lanerolle, NC; Hamid, H; Kulas, J; Pan, JW; Czlapinski, R; Rinaldi, A; Ling, G; Bandak, FA; Hetherington, HP				de Lanerolle, Nihal C.; Hamid, Hamada; Kulas, Joseph; Pan, Jullie W.; Czlapinski, Rebecca; Rinaldi, Anthony; Ling, Geoffrey; Bandak, Faris A.; Hetherington, Hoby P.			Concussive brain injury from explosive blast	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article								Objective: Explosive blast mild traumatic brain injury (mTBI) is associated with a variety of symptoms including memory impairment and posttraumatic stress disorder (PTSD). Explosive shock waves can cause hippocampal injury in a large animal model. We recently reported a method for detecting brain injury in soldiers with explosive blast mTBI using magnetic resonance spectroscopic imaging (MRSI). This method is applied in the study of veterans exposed to blast. Methods: The hippocampus of 25 veterans with explosive blast mTBI, 20 controls, and 12 subjects with PTSD but without exposure to explosive blast were studied using MRSI at 7 Tesla. Psychiatric and cognitive assessments were administered to characterize the neuropsychiatric deficits and compare with findings from MRSI. Results: Significant reductions in the ratio of N-acetyl aspartate to choline (NAA/Ch) and N-acetyl aspartate to creatine (NAA/Cr) (P < 0.05) were found in the anterior portions of the hippocampus with explosive blast mTBI in comparison to control subjects and were more pronounced in the right hippocampus, which was 15% smaller in volume (P < 0.05). Decreased NAA/Ch and NAA/Cr were not influenced by comorbidities - PTSD, depression, or anxiety. Subjects with PTSD without blast had lesser injury, which tended to be in the posterior hippocampus. Explosive blast mTBI subjects had a reduction in visual memory compared to PTSD without blast. Interpretation: The region of the hippocampus injured differentiates explosive blast mTBI from PTSD. MRSI is quite sensitive in detecting and localizing regions of neuronal injury from explosive blast associated with memory impairment.	[de Lanerolle, Nihal C.; Pan, Jullie W.; Hetherington, Hoby P.] Yale Univ, Dept Neurosurg, New Haven, CT 06520 USA; [Hamid, Hamada] Yale Univ, Dept Neurol, New Haven, CT 06520 USA; [Hamid, Hamada; Kulas, Joseph] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Hamid, Hamada; Czlapinski, Rebecca; Rinaldi, Anthony] West Haven VA, Dept Neurol, West Haven, CT 06516 USA; [Kulas, Joseph] West Haven VA, Dept Psychol, West Haven, CT 06516 USA; [Ling, Geoffrey; Bandak, Faris A.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Bandak, Faris A.] Integrated Serv Grp Inc, Potomac, MD 20854 USA		de Lanerolle, NC (corresponding author), Yale Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	Nihal.delanerolle@yale.edu	Altalib, Hamada/B-9656-2018	Altalib, Hamada/0000-0001-7154-1400	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB011639, R01 EB009871] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS081772] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB011639, R01EB009871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081772] Funding Source: NIH RePORTER		Avdievich NI, 2009, MAGN RESON MED, V62, P17, DOI 10.1002/mrm.21970; BEHAR KL, 1993, MAGNET RESON MED, V30, P38, DOI 10.1002/mrm.1910300107; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonne O, 2008, J CLIN PSYCHIAT, V69, P1087, DOI 10.4088/JCP.v69n0707; Bremner J Douglas, 2006, Dialogues Clin Neurosci, V8, P445; Cavus I, 2008, EPILEPSIA, V49, P1358, DOI 10.1111/j.1528-1167.2008.01603.x; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2; Flynn GF, 2010, CONTINUUM, V16, P79; Goldstein F, 1969, J BIOL CHEM, V244, P4; Greicius MD, 2005, NEURAL NETWORKS, V18, P225; Hetherington HP, 2007, NEUROLOGY, V69, P2256, DOI 10.1212/01.wnl.0000286945.21270.6d; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hetherington HP, 2010, MAGN RESON MED, V63, P9, DOI 10.1002/mrm.22182; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lee PL, 2008, TXB CLIN PSYCHOL NEW, P437; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Pan JW, 2005, ANN NEUROL, V57, P92, DOI 10.1002/ana.20317; Peskind ER, 2010, NEUROIMAGE, V27, P683; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; RAND, 2008, INVISIBLE WOUNDS WAR; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Strange BA, 2001, HIPPOCAMPUS, V11, P690, DOI 10.1002/hipo.1084; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Zola-Morgan S, 1991, Hippocampus, V1, P207, DOI 10.1002/hipo.450010208	38	11	11	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	SEP	2014	1	9					692	702		10.1002/acn3.98			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V45KL	WOS:000209815400007	25493283	Green Published, gold			2022-02-06	
J	Mast, JE; Antonini, TN; Raj, SP; Oberjohn, KS; Cassedy, A; Makoroff, KL; Wade, SL				Mast, Jennifer E.; Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Cassedy, Amy; Makoroff, Kathi L.; Wade, Shari L.			Web-based parenting skills to reduce behavior problems following abusive head trauma: A pilot study	CHILD ABUSE & NEGLECT			English	Article						Traumatic brain injury; Rehabilitation; Abusive head trauma; Pediatrics; Online intervention	BRAIN-INJURY; YOUNG-CHILDREN; INFANTS	Pediatric abusive head trauma causes significant cognitive and behavioral morbidity, yet very few post-acute interventions exist to facilitate long-term recovery. To meet the needs of this vulnerable population, we piloted a web-based intervention with live coaching designed to improve positive parenting and child behavior. The efficacy of this parenting skills intervention was compared with access to Internet resources on brain injury. Participants included seven families (four randomized to the parenting intervention and three randomized to receive Internet resources). Parenting skills were observed and child behavior was rated at baseline and intervention completion. At completion, parents who received the parenting skills intervention showed significantly more positive parenting behaviors and fewer undesirable behaviors during play than parents who received access to Internet resources. Additionally, during play, children in the parenting skills intervention group were more compliant following parent commands than children in the Internet resources group. Lastly, parents who received the parenting intervention reported less intense oppositional and conduct behavior problems in their children post-intervention than did parents in the Internet resources group. These findings provide preliminary evidence for the use of this web-based positive parenting skills intervention to improve parenting skills and child behavior following abusive head trauma. (C) 2014 Elsevier Ltd. All rights reserved.	[Mast, Jennifer E.; Antonini, Tanya N.; Raj, Stacey P.; Oberjohn, Karen S.; Cassedy, Amy; Makoroff, Kathi L.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Mast, Jennifer E.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Antonini, Tanya N.] Univ Cincinnati, Cincinnati, OH USA; [Raj, Stacey P.] Miami Univ, Oxford, OH 45056 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.						Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Antonini TN, 2012, J TELEMED TELECARE, V18, P333, DOI 10.1258/jtt.2012.120404; Barlow J, 2006, COCHRANE DATABASE SY, V3; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Carbaugh Suzanne Franklin, 2004, Adv Neonatal Care, V4, P105, DOI 10.1016/S1536-0903(04)00031-1; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006; Ewing-Cobbs L., 2013, J INT NEUROPSYCH SOC, V19, P1; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Eyberg S., 1988, CHILD FAMILY BEHAV T, V10, P33, DOI [10.1300/J019v10n01_04, DOI 10.1300/J019V10N01_04]; Eyberg S. M., 2005, MANUAL DYADIC PARENT; EYBERG SM, 1995, PSYCHOPHARMACOL BULL, V31, P83; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Glueckauf RL, 2011, CAREGIVING-RES PRACT, P85, DOI 10.1007/978-1-4419-8031-1_7; Huang MI, 2011, J NEUROSURG-PEDIATR, V8, P171, DOI 10.3171/2011.5.PEDS1139; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Pincus, 1999, EYBERG CHILD BEHAV I; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Starling SP, 2000, SOUTHERN MED J, V93, P463; Woodcock R., 2001, EXAMINERS MANUAL WOO	22	11	11	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	SEP	2014	38	9					1487	1495		10.1016/j.chiabu.2014.04.012			9	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	AP2IX	WOS:000341897000007	24844734				2022-02-06	
J	Mojtahedzadeh, M; Ahmadi, A; Mahmoodpoor, A; Beigmohammadi, MT; Abdollahi, M; Khazaeipour, Z; Shaki, F; Kuochaki, B; Hendouei, N				Mojtahedzadeh, Mojtaba; Ahmadi, Arezoo; Mahmoodpoor, Ata; Beigmohammadi, Mohammad Taghi; Abdollahi, Mohammad; Khazaeipour, Zahra; Shaki, Fatemeh; Kuochaki, Bizhan; Hendouei, Narjes			Hypertonic saline solution reduces the oxidative stress responses in traumatic brain injury patients	JOURNAL OF RESEARCH IN MEDICAL SCIENCES			English	Article						Hypertonic saline; mannitol; oxidative stress response; traumatic brain injury patients	INFLAMMATORY RESPONSE; HEAD-INJURY; RATS; PATHOPHYSIOLOGY; MANAGEMENT; THERAPY; SYSTEM; RESUSCITATION; MECHANISMS; PRESSURE	Background: Oxidative stress processes play an important role in the pathogenesis of secondary brain injury after traumatic brain injury (TBI). Hypertonic saline (HTS) has advantages as being preferred osmotic agent, but few studies investigated oxidant and antioxidant effects of HTS in TBI. This study was designed to compare two different regimens of HTS 5% with mannitol on TBI-induced oxidative stress. Materials and Methods: Thirty-three adult patients with TBI were recruited and have randomly received one of the three protocols: 125 cc of HTS 5% every 6 h as bolus, 500 cc of HTS 5% as infusion for 24 h or 1 g/kg mannitol of 20% as a bolus, repeated with a dose of 0.25-0.5 g/kg every 6 h based on patient's response for 3 days. Serum total antioxidant power (TAP), reactive oxygen species (ROS) and nitric oxide (NO) were measured at baseline and daily for 3 days. Results: Initial serum ROS and NO levels in patients were higher than control (6.86 +/- [3.2] vs. 1.57 +/- [0.5] picoM, P = 0.001, 14.6 +/- [1.6] vs. 7.8 +/- [3.9] mM, P = 0.001, respectively). Levels of ROS have decreased for all patients, but reduction was significantly after HTS infusion and mannitol (3.08 [+/- 3.1] to 1.07 [+/- 1.6], P = 0.001, 5.6 [+/- 3.4] to 2.5 [+/- 1.8], P = 0.003 respectively). During study, NO levels significantly decreased in HTS infusion but significantly increased in mannitol. TAP Levels had decreased in all patients during study especially in mannitol (P = 0.004). Conclusion: Hypertonic saline 5% has significant effects on the oxidant responses compared to mannitol following TBI that makes HTS as a perfect therapeutic intervention for reducing unfavorable outcomes in TBI patients.	[Mojtahedzadeh, Mojtaba; Hendouei, Narjes] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacotherapy, Tehran, Iran; [Abdollahi, Mohammad] Univ Tehran Med Sci, Dept Pharmacol & Toxicol, Fac Pharm, Toxicol Lab, Tehran, Iran; [Abdollahi, Mohammad] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran, Iran; [Khazaeipour, Zahra] Univ Tehran Med Sci, Inst Neurosci, Brain & Spinal Injury Res Ctr, Tehran, Iran; [Ahmadi, Arezoo; Beigmohammadi, Mohammad Taghi] Univ Tehran Med Sci, Sch Med, Dept Anesthesia & Crit Care, Tehran, Iran; [Ahmadi, Arezoo; Beigmohammadi, Mohammad Taghi] Univ Tehran Med Sci, Hlth Serv, Tehran, Iran; [Mahmoodpoor, Ata] Tabriz Univ Med Sci, Sch Med, Dept Anesthesia & Crit Care, Tabriz, Iran; [Mahmoodpoor, Ata] Tabriz Univ Med Sci, Hlth Serv, Tabriz, Iran; [Shaki, Fatemeh] Mazandaran Univ Med Sci, Dept Pharmacol & Toxicol, Sari, Iran; [Kuochaki, Bizhan; Hendouei, Narjes] Mazandaran Univ Med Sci, Fac Pharm, Dept Pharmacotherapy, Sari, Iran; [Kuochaki, Bizhan; Hendouei, Narjes] Mazandaran Univ Med Sci, Hlth Serv, Sari, Iran		Hendouei, N (corresponding author), Mazandaran Univ Med Sci, Addict Inst, Fac Pharm & Psychiat, Dept Pharmacotherapy, 20th Km Farahabad Rd, Sari, Iran.	hendoieen@yahoo.com	mahmoodpoor, ata/AAR-9972-2021; mahmoodpoor, Ata/AAD-6597-2021; Abdollahi, Mohammad/B-9232-2008	mahmoodpoor, Ata/0000-0002-4361-6230; Abdollahi, Mohammad/0000-0003-0123-1209; Shaki, Fatemeh/0000-0001-5861-656X	Tehran University of Medical SciencesTehran University of Medical Sciences [45861]	This research was financially supported by Tehran University of Medical Sciences (grant number: 45861).	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bratton S.L., 2007, J NEUROTRAUM, V24, pS, DOI [10.1089/neu.2007.9981, DOI 10.1089/NEU.2007.9981]; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hendoui N, 2013, EUR REV MED PHARMACO, V17, P477; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Madikians A, 2006, INDIAN J NEUROTRAUM, V3, P9; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mohammadi H, 2011, TOXICOL IND HEALTH, V27, P417, DOI 10.1177/0748233710387634; Mostafalou S, 2012, ADV PHARM BULL, V2, P79, DOI 10.5681/apb.2012.011; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Oh RC, 2011, AM FAM PHYSICIAN, V84, P1003; Palevsky PM, 2013, UP TO DATE      0911; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Sivonova M, 2008, CELL MOL NEUROBIOL, V28, P431, DOI 10.1007/s10571-007-9246-x; Sun YX, 2013, J SURG RES, V185, P477, DOI 10.1016/j.jss.2013.06.039; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Vosylius S, 2004, CROAT MED J, V45, P715; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Weant KA, 2008, ADV EMERG NURS J, V30, P17, DOI 10.1097/01.TME.0000311542.95656.92; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; Zeng HK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-153; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	36	11	13	0	5	ISFAHAN UNIV MED SCIENCES	ISFAHAN	HEZARJERIB AVE, PO BOX 81745-319, ISFAHAN, 00000, IRAN	1735-1995	1735-7136		J RES MED SCI	J. Res. Med. Sci.	SEP	2014	19	9					867	874					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY4LG	WOS:000347549000013	25535502				2022-02-06	
J	Newton, JD; White, PE; Ewing, MT; Makdissi, M; Davis, GA; Donaldson, A; Sullivan, SJ; Seward, H; Finch, CF				Newton, Joshua D.; White, Peta E.; Ewing, Michael T.; Makdissi, Michael; Davis, Gavin A.; Donaldson, Alex; Sullivan, S. John; Seward, Hugh; Finch, Caroline F.			Intention to use sport concussion guidelines among community-level coaches and sports trainers	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Football; Sports injury prevention; Decision making; Self-efficacy; Head injury; Sports safety	PLANNED BEHAVIOR; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; HEALTH BEHAVIOR; MODELS; ZURICH	Objectives: Sporting bodies have developed guidelines for managing community-level players with suspected concussion in response to international consensus statements on concussion in sport. The purpose of this study was to examine the factors that influence the intended use of concussion guidelines among community-level coaches and sports trainers from two popular football codes in Australia: Australian football and rugby league. Design: Cross-sectional survey. Methods: The survey, based on an extended theory of planned behaviour model, was completed by 183 Australian football coaches, 121 Australian football sports trainers, 171 rugby league coaches, and 142 rugby league sports trainers. Results: Personal norms and self-efficacy were significant predictors of intention to use concussion guidelines, although the relationship between self-efficacy and intention was stronger among Australian football coaches than rugby league coaches. Analysis of the salient beliefs that underpin self-efficacy found that coaches, irrespective of football code, felt less familiar (chi(2) = 25.70, p < 0.001) and less experienced (chi(2) = 31.56, p < 0.001) than sports trainers in using the concussion guidelines. At the same time, Australian football personnel, irrespective of their team role, felt that they had insufficient time (chi(2) = 8.04, p < 0.01) and resources (chi(2) = 12.31, p < 0.001) to implement the concussion guidelines relative to rugby league personnel. Conclusions: Programmes aimed at increasing the intended use of sport concussion guidelines should focus on enhancing self-efficacy and leveraging personal norms. Increasing coaches' familiarity and experience in using the concussion guidelines would also be warranted, as would finding ways to overcome the perceived time and resource constraints identified among Australian football personnel. (C) 2013 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Newton, Joshua D.; Ewing, Michael T.] Monash Univ, Dept Mkt, Frankston, Vic, Australia; [White, Peta E.; Donaldson, Alex; Finch, Caroline F.] Univ Ballarat, Ctr Hlth & Safe Sport, Ballarat, Vic 3353, Australia; [Makdissi, Michael; Davis, Gavin A.] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Sullivan, S. John] Univ Otago, Sch Physiotherapy, Ctr Hlth Act & Rehabil, Dunedin, New Zealand; [Seward, Hugh] AFL Med Officers Assoc, Melbourne, Vic, Australia		Newton, JD (corresponding author), Monash Univ, Dept Mkt, Peninsula Campus, Frankston, Vic, Australia.	joshua.newton@monash.edu		makdissi, michael/0000-0003-0334-7133; Ewing, Michael/0000-0002-2260-2761	Department of Planning and Community Development, Victoria, Australia; NHMRC Principal Research FellowshipNational Health and Medical Research Council of Australia [565900]	The research presented in this paper was part of the work undertaken for a Victorian Sports Injury Prevention Research Grant from the Department of Planning and Community Development, Victoria, Australia. That project's larger chief investigator team included all co-authors of this paper as well as Paul McCrory, Angela Clapperton, Willem Meeuwisse, and Carolyn Emery. PEW's salary was paid from this grant. CFF was supported by an NHMRC Principal Research Fellowship (ID: 565900). The funding agency was not involved in the collection, analysis, or interpretation of data, nor was it involved in any decisions regarding the publication of data.	AFL Medical Officers Association, 2013, MAN CONC AUSTR FOOTB; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Alla S, 2011, BRIT J SPORT MED, V45, P132, DOI 10.1136/bjsm.2010.074088; [Anonymous], 2013, NATL RUGBY LEAGUE MA; Armitage CJ, 2000, PSYCHOL HEALTH, V15, P173, DOI 10.1080/08870440008400299; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bandura A., 1997, SELF EFFICACY EXERCI; Conner M, 1998, J APPL SOC PSYCHOL, V28, P1429, DOI 10.1111/j.1559-1816.1998.tb01685.x; Dawson JF, 2006, J APPL PSYCHOL, V91, P917, DOI 10.1037/0021-9010.91.4.917; Donaldson A, 2012, BRIT J SPORT MED, V46, P759, DOI 10.1136/bjsports-2011-090073; Finch CF, 2010, BRIT J SPORT MED, V44, P973, DOI 10.1136/bjsm.2008.056069; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fishbein M., 2010, PREDICTING CHANGING, DOI DOI 10.4324/9780203838020; Grant AM, 2011, PSYCHOL SCI, V22, P1494, DOI 10.1177/0956797611419172; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; Newton JD, 2013, BRIT J SPORT MED, V47, P665, DOI 10.1136/bjsports-2011-090567; Newton JD, 2013, PSYCHOL HEALTH, V28, P495, DOI 10.1080/08870446.2012.745936; Newton JD, 2012, PSYCHOL HEALTH, V27, P588, DOI 10.1080/08870446.2011.611244; Painter JE, 2008, ANN BEHAV MED, V35, P358, DOI 10.1007/s12160-008-9042-y; Sheeran P., 2002, EUROPEAN REV SOCIAL, V12, DOI [https://doi.org/10.1080/14792772143000003, DOI 10.1080/14792772143000003]; van der Pligt J, 1998, J APPL SOC PSYCHOL, V28, P1339; West S. G., 1991, MULTIPLE REGRESSION; White PE, 2013, BR J SPORT IN PRESS	26	11	11	1	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	SEP	2014	17	5					469	473		10.1016/j.jsams.2013.10.240			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	AP9MZ	WOS:000342405200005	24252427	Green Published			2022-02-06	
J	Augustine, C; Cepinskas, G; Fraser, DD				Augustine, C.; Cepinskas, G.; Fraser, D. D.		Canadian Critical Care Translation	TRAUMATIC INJURY ELICITS JNK-MEDIATED HUMAN ASTROCYTE RETRACTION IN VITRO	NEUROSCIENCE			English	Article						trauma; human; astrocytes; brain microvascular endothelial cells; blood-brain barrier	BLOOD-BRAIN-BARRIER; STRETCH-INDUCED INJURY; ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; INHIBITION; CHILDREN; VIVO; SP600125	Brain injury causes dysfunction of the blood-brain barrier (BBB). The BBB is comprised of perivascular astrocytes whose end-feet ensheath brain microvascular endothelial cells. We investigated trauma-induced morphological changes of human astrocytes (HA) and human cerebral microvascular endothelial cells (hCMEC/D3) in vitro, including the potential role of mitogen-activated protein kinase (MAPK) signal-transduction pathways. HA or hCMEC/D3 were grown on flexible culture membranes and subjected to single traumatic injury normalized to 20%, 30% or 55% membrane deformation. Cells were assayed for morphological changes (i.e. retraction) and MAPK phosphorylation and/or expression (c-Jun NH2-terminal kinase (JNK) 1/2, extracellular signal-regulated kinase (ERK) 1/2, and p38). HA retraction was rapidly elicited with a single traumatic injury (55% membrane deformation; p < 0.01). Morphological recovery of HA was observed within 2 h (p < 0.05). Traumatic injuries increased phospho-JNK1/2 (p < 0.05) in HA, indicating MAPK activation. Pre-treatment of HA with structurally distinct JNK inhibitors (25 mu M), either SP600125 or SU3327, reduced JNK phosphorylation (p < 0.05) and trauma-induced HA retraction (P < 0.05). In contrast to HA, traumatic injury failed to induce either morphological changes or MAPK activation in hCMEC/D3. In summary, traumatic injury induces JNK-mediated HA retraction in vitro, while sparing morphological changes in cerebral microvascular endothelial cells. Astrocyte retraction from microvascular endothelial cells in vivo may occur after brain trauma, resulting in cellular uncoupling and BBB dysfunction. JNK may represent a potential therapeutic target for traumatic brain injuries. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Augustine, C.; Fraser, D. D.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Augustine, C.; Fraser, D. D.] Childrens Hlth Res Inst, London, ON, Canada; [Augustine, C.; Cepinskas, G.; Fraser, D. D.] Ctr Crit Illness Res, London, ON, Canada; [Cepinskas, G.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Cepinskas, G.] Univ Western Ontario, Dept Med, London, ON, Canada; [Fraser, D. D.] Univ Western Ontario, Dept Paediat, London, ON, Canada; [Fraser, D. D.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada		Fraser, DD (corresponding author), Childrens Hosp, LHSC, Room C2-C82,800,Commissioners Rd E, London, ON N6A 5W9, Canada.	douglas.fraser@lhsc.on.ca	Cepinskas, Gediminas/V-3810-2019	Cepinskas, Gediminas/0000-0002-0267-6659	Department of Pediatrics, Western University; Children's Health Foundation; PSI Foundation; Heart and Stroke FoundationHeart & Stroke Foundation of Canada [NA-6914]	We thank Drs. Jamie Hutchison and Greg Hare of the Canadian Critical Care Translational Biology Group for independent manuscript review, and Dr. Jamie Seabrook of the Children's Health Research Institute for an independent statistical review. CA received graduate student funding from the Department of Pediatrics, Western University, and the Children's Health Foundation. DDF is supported by the PSI Foundation and the Children's Health Foundation. GC is supported by the Heart and Stroke Foundation (NA-6914).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BRADBURY MWB, 1985, CIRC RES, V57, P213, DOI 10.1161/01.RES.57.2.213; Castejon OJ, 1998, BRAIN INJURY, V12, P409, DOI 10.1080/026990598122539; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Daoud H, 2013, NEUROCRIT CARE; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De SK, 2009, J MED CHEM, V52, P1943, DOI 10.1021/jm801503n; DeVries HE, 1997, PHARMACOL REV, V49, P143; Dhandapani KM, 2003, J BIOL CHEM, V278, P43329, DOI 10.1074/jbc.M305835200; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faul M, 2010, TRAUMATIC BRAIN INJU; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Jacobson J, 2002, J CELL SCI, V115, P1175; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Kramerov AA, 2012, J CELL BIOCHEM, V113, P2948, DOI 10.1002/jcb.24171; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; Lamb RG, 1997, J NEUROCHEM, V68, P1904; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Morrison Gavin, 2013, Pathophysiology, V20, P49, DOI 10.1016/j.pathophys.2012.02.006; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; PASCUCCI RC, 1988, INTENS CARE MED, V14, P185, DOI 10.1007/BF00717985; Rzigalinski BA, 1997, J NEUROCHEM, V68, P289; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Zhu DH, 2009, BIOCHEM J, V421, P201, DOI 10.1042/BJ20090356; Zurek J, 2011, J TRAUMA, V71, P854, DOI 10.1097/TA.0b013e3182140c8c	46	11	12	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 22	2014	274						1	10		10.1016/j.neuroscience.2014.05.009			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK8XO	WOS:000338712300001	24838066				2022-02-06	
J	Ghadiri, T; Sharifzadeh, M; Khodagholi, F; Mousavi, SMM; Hassanzadeh, G; Zarrindast, MR; Gorji, A				Ghadiri, Tahereh; Sharifzadeh, Mohammad; Khodagholi, Fariba; Mousavi, Sayed Mostafa Modarres; Hassanzadeh, Gholamreza; Zarrindast, Mohammad-Reza; Gorji, Ali			A novel traumatic brain injury model for induction of mild brain injury in rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Brain injury; Weight drop; Dark neurons; Head trauma; CNS	HEAD-INJURY; SPREADING DEPRESSION; CEREBROSPINAL-FLUID; NEURONAL DAMAGE; PATHOPHYSIOLOGY; EPIDEMIOLOGY; IMPAIRMENT; DEATH; BLOOD; MICE	Background: Due to the marked heterogeneity of human traumatic brain injury (TBI), none of the available animal model can reproduce the entire spectrum of TBI, especially mild focal TBI. This study was designed to develop a modified TBI weight drop model for induction of focal mild cerebral injury. New method: A stereotaxic coupled weight drop device was designed. Principle arm of device carries up to 500 g weights which their force was conveyed to animal skull through a thin nail like metal tip. To determine the optimal configuration of the device to induce mild TBI, six different trials were designed. The optimal configuration of the instrument was used for evaluation of behavioral, histopathological and molecular changes of mild TBI. Results: Neurologic and motor coordination deficits observed sharply within 24h post injury period. Histological studies revealed a remarkable increase in the number of dark neurons in trauma site. TBI increased the expression of apoptotic proteins, Bax, BCl2 and cleaved caspase-3 in the hippocampus. Comparison with existing methods: Our designed TBI device is capable to produce variable severity of TBI from mild to severe. The main advantage of the new TBI model is induction of mild local unilateral brain injury instead of traumatization of the whole brain. This model does not require craniotomy for induction of brain injury. Conclusion: This novel animal TBI model mimics human mild focal brain injury. This model is suitable for evaluation of pathophysiology. as well as screening of new therapies for mild TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Ghadiri, Tahereh; Sharifzadeh, Mohammad; Hassanzadeh, Gholamreza; Zarrindast, Mohammad-Reza] Univ Tehran Med Sci, Sch Adv Technol Med, Tehran, Iran; [Ghadiri, Tahereh; Mousavi, Sayed Mostafa Modarres; Gorji, Ali] Shefa Neurosci Res Ctr, Tehran, Iran; [Sharifzadeh, Mohammad] Univ Tehran Med Sci, Fac Pharm, Dept Toxicol, Tehran, Iran; [Khodagholi, Fariba] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Gorji, Ali] Univ Munster, Epilepsy Res Ctr, Dept Neurosurg, Inst Physiol 1, D-48149 Munster, Germany; [Gorji, Ali] Univ Munster, Epilepsy Res Ctr, Dept Neurol, Inst Physiol 1, D-48149 Munster, Germany		Gorji, A (corresponding author), Univ Munster, Epilepsy Res Ctr, Robert Koch Str 27a, D-48149 Munster, Germany.	gorjial@uni-muenster.de	Zarrindast, Mohammad-Reza/ABB-6610-2021; Mousapour Gorji, Ahmad/D-3670-2017; Khodagholi, Fariba/AAZ-4436-2020; Ghadiri, Tahereh/AAU-7811-2020	Zarrindast, Mohammad-Reza/0000-0002-0688-5378; Khodagholi, Fariba/0000-0002-4911-4530; Gorji, Ali/0000-0002-4557-3270; Ghadiri, Tahereh/0000-0002-3568-8699; sharifzadeh, mohammad/0000-0003-2991-7384	Shefa Neuroscience Center, Iran [25604]	Authors would like to thanks Thomas Westhoff, Ludger Sasse and Manfred Daweke for their technical assistance. This work was funded by the Shefa Neuroscience Center, Iran (grant related to Dr. Thesis 25604).	Aligholi H, 2014, J NEUROSCI METH, V225, P81, DOI 10.1016/j.jneumeth.2013.12.008; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Ishida K, 2004, NEUROSCIENCE, V125, P633, DOI 10.1016/j.neuroscience.2004.02.002; Jafarian M, 2010, NEUROSCIENCE, V169, P388, DOI 10.1016/j.neuroscience.2010.04.062; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Sadeghian H, 2012, EXP NEUROL, V233, P438, DOI 10.1016/j.expneurol.2011.11.017; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67	45	11	11	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	AUG 15	2014	233						18	27		10.1016/j.jneumeth.2014.05.035			10	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AM9TT	WOS:000340224600003	24906055				2022-02-06	
J	Liu, NK; Zhang, YP; Zou, J; Verhovshek, T; Chen, C; Lu, QB; Walker, CL; Shields, CB; Xu, XM				Liu, Nai-Kui; Zhang, Yi-Ping; Zou, Jian; Verhovshek, Toni; Chen, Chen; Lu, Qing-Bo; Walker, Chandler L.; Shields, Christopher B.; Xu, Xiao-Ming			A semicircular controlled cortical impact produces long-term motor and cognitive dysfunction that correlates well with damage to both the sensorimotor cortex and hippocampus	BRAIN RESEARCH			English	Article						Traumatic brain injury; Controlled cortical impact; Behavior; Histology; Mice	TRAUMATIC BRAIN-INJURY; BEHAVIORAL DEFICITS; MODEL; RECOVERY; IMPAIRMENT; MOUSE; RATS; MICE	Animal models of traumatic brain injury (TBI) are essential for testing novel hypotheses and therapeutic interventions. Unfortunately, due to the broad heterogeneity of TBI in humans, no single model has been able to reproduce the entire spectrum of these injuries. The controlled cortical impact (CCI) model is one of the most commonly used models of contusion TBI. However, behavioral evaluations have revealed transient impairment in motor function after CCI in rats and mice. Here we report a new semicircular CCI (S-CCI) model by increasing the impact tip area to cover both the motor cortex and hippocampal regions in adult mice. Mice were subjected to S-CCI or CCI using an electromagnetic impactor (Impactor One (TM), MyNeuroLab; semicircular tip: 3 mm radius; CCI tip diameter: 3 mm). We showed that S-CCI, at two injury severities, significantly decreased the neuroscore and produced deficits in performance on a rotarod device for the entire duration of the study. In contrast, the CCI induced motor deficits only at early stages after the injury, suggesting that the S-CCI model produces long-lasting motor deficits. Morris water maze test showed that both CCI and S-CCI produced persisting memory deficits. Furthermore, adhesive removal test showed significant somatosensoiy and motor deficits only in the S-CCI groups. Histological analysis showed a large extent of cortical contusion lesions, including both the sensory and motor cortex, and hippocampal damage in the S-CCI. These findings collectively suggest that the current model may offer sensitive, reliable, and clinically relevant outcomes for assessments of therapeutic strategies for TBI. (C) 2014 Published by Elsevier B.V.	[Liu, Nai-Kui; Zou, Jian; Verhovshek, Toni; Chen, Chen; Lu, Qing-Bo; Walker, Chandler L.; Xu, Xiao-Ming] Indiana Univ, Sch Med, Stark Neurosci Res Inst,Spinal Cord & Brain Injur, Dept Neurol Surg,Dept Anat & Cell Biol Goodman Ca, Indianapolis, IN 46202 USA; [Zhang, Yi-Ping; Shields, Christopher B.] Norton Healthcare, Norton Neurosci Inst, Louisville, KY 40202 USA		Xu, XM (corresponding author), Indiana Univ, Sch Med, Stark Neurosci Res Inst, 950 W Walnut St,R2 Bldg,Room 402, Indianapolis, IN 46202 USA.	xu26@iupui.edu	Zou, Jian/V-9067-2019; Walker, Chandler L./D-2256-2014	Walker, Chandler L./0000-0002-8616-8263; Xu, Xiao-ming/0000-0002-7229-0081	Indiana Spinal Cord and Brain Injury Research Foundation; Mari Hulman George Endowment; Indiana State Department of Health (ISDH) [A70-2-079609, A70-9-079138]	This work was supported by Indiana Spinal Cord and Brain Injury Research Foundation and Mari Hulman George Endowment (XMX), and by the Indiana State Department of Health (ISDH), Grant nos. A70-2-079609 and A70-9-079138) (NKL).	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Cai J, 2011, NEURAL REGEN RES, V6, P96, DOI 10.3969/j.issn.1673-5374.2011.02.003; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hillier SL, 1997, BRAIN INJURY, V11, P661; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Qiu X, 2011, NEURAL REGEN RES, V6, P645, DOI 10.3969/j.issn.1673-5374.2011.09.001; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244	41	11	12	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 12	2014	1576						18	26		10.1016/j.brainres.2014.05.042			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN1CC	WOS:000340319300002	24905625				2022-02-06	
J	Li, WC; Jiang, R; Jiang, DM; Zhu, FC; Su, B; Qiao, B; Qi, XT				Li, Wei-Chao; Jiang, Rong; Jiang, Dian-Ming; Zhu, Feng-Chen; Su, Bao; Qiao, Bo; Qi, Xiao-Tong			Lipopolysaccharide preconditioning attenuates apoptotic processes and improves neuropathologic changes after spinal cord injury in rats	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						lipopolysaccharide; preconditioning; neurotrauma; apoptosis; rat	TOLL-LIKE RECEPTOR-4; CELL-DEATH; ENDOTOXIN TOLERANCE; FUNCTIONAL RECOVERY; FLAVONOID WOGONIN; NITRIC-OXIDE; TNF-ALPHA; ACTIVATION; MECHANISMS; PROTECTS	We have shown earlier that administration of low-dose lipopolysaccharide (LPS) significantly contributed to recovery of motor function after traumatic spinal cord injury in the adult female rat. Using the same standardized animal model, we have now designed a set of experiments to test the hypothesis that LPS preconditioning attenuates stress-related apoptotic processes early after spinal cord trauma. The lower thoracic spinal cord injury in adult female Sprague-Dawley rats was caused by a 10 g weight rod drop from 25 mm on the dural surface of the exposed spinal cord at T10. The rats were randomly assigned to three groups: Sham injury, control (received normal saline alone), and LPS preconditioning (0.2 mg/kg, ip; 72 h prior to the injury). The animals were euthanized at 72 h postinjury. Neuropathologic changes were assessed using hematoxylin and eosin staining. SCI-induced apoptosis were observed by transmission electron microscopy. Caspase-3, cleaved caspase-3, Bax, and Bcl-2 were examined with immunohistochemistry or Western blotting. Compared with the control group, LPS preconditioning group showed significant improvement in the SCI-induced morphology changes. Furthermore, LPS preconditioning reduced the expressions of apoptotic markers caspase-3, cleaved caspase-3, and Bax, upregulated the expression of antiapoptotic marker Bcl-2 in the samples of spinal cord. Low-dose LPS attenuated the recruitment of inflammatory cells and the proliferation of glial cells in the site of injury. LPS preconditioning has neuroprotective effects against TSCI in rats due to its antiapoptosis properties as shown by the inhibition of caspase pathway and the upregulation of antiapoptotic protein.	[Li, Wei-Chao; Jiang, Dian-Ming; Su, Bao; Qiao, Bo; Qi, Xiao-Tong] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Chongqing 400016, Peoples R China; [Jiang, Rong] Chongqing Med Univ, Lab Stem Cell & Tissue Engn, Chongqing 400016, Peoples R China; [Zhu, Feng-Chen] Chongqing Med Univ, Yongchuan Hosp, Dept Orthoped Surg, Chongqing 400016, Peoples R China		Jiang, DM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, 1 Youyi Rd, Chongqing 400016, Peoples R China.	jdm571026@vip.163.com			University Development Program, Chongqing	This study was supported by a scholarship from the University Development Program, Chongqing.	AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Ambrozaitis Kazys Vytautas, 2006, Medicina (Kaunas), V42, P255; BEESON PB, 1946, P SOC EXP BIOL MED, V61, P248; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Cittelly DM, 2008, EXP NEUROL, V210, P295, DOI 10.1016/j.expneurol.2007.03.001; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cristante AF, 2012, CLINICS, V67, P1219, DOI 10.6061/clinics/2012(10)16; Davis AEM, 2005, EUR J NEUROSCI, V22, P2441, DOI 10.1111/j.1460-9568.2005.04447.x; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Dmowska M, 2010, NEUROCHEM RES, V35, P262, DOI 10.1007/s11064-009-0050-5; Esposito E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012170; Fan J, 2002, J IMMUNOL, V168, P5252, DOI 10.4049/jimmunol.168.10.5252; Faubel S., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P269, DOI 10.2174/1568008054863754; FREEDMAN HH, 1960, J EXP MED, V111, P453, DOI 10.1084/jem.111.4.453; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; GREISMAN SE, 1969, J CLIN INVEST, V48, P613, DOI 10.1172/JCI106020; GREISMAN SE, 1966, J EXP MED, V124, P983, DOI 10.1084/jem.124.5.983; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GUTH L, 1994, EXP NEUROL, V126, P76, DOI 10.1006/exnr.1994.1043; Kim H, 2001, NEUROSCI LETT, V309, P67, DOI 10.1016/S0304-3940(01)02028-6; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lastres-Becker I, 2006, J NEUROIMMUNOL, V173, P108, DOI 10.1016/j.jneuroim.2005.12.006; Lee H, 2003, FASEB J, V17, P1943, DOI 10.1096/fj.03-0057fje; Li WC, 2013, INT J NEUROSCI, V123, P240, DOI 10.3109/00207454.2012.755181; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Orio M, 2007, STROKE, V38, P2812, DOI 10.1161/STROKEAHA.107.486837; Pereira JE, 2009, EXP NEUROL, V220, P71, DOI 10.1016/j.expneurol.2009.07.030; Popovich PG, 2012, EXP NEUROL, V233, P677, DOI 10.1016/j.expneurol.2011.11.045; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Yune TY, 2009, J NEUROCHEM, V110, P1276, DOI 10.1111/j.1471-4159.2009.06214.x; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086	35	11	13	1	13	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	AUG	2014	124	8					585	592		10.3109/00207454.2013.864289			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AL4PK	WOS:000339114700006	24205811				2022-02-06	
J	Palmer, GA; Happe, MC; Paxson, JM; Jurek, BK; Graca, JJ; Olson, SA				Palmer, Glen A.; Happe, Maggie C.; Paxson, Janine M.; Jurek, Benjamin K.; Graca, Joseph J.; Olson, Stephen A.			Psychometric Properties of the Beck Depression Inventory-II for OEF/OIF Veterans in a Polytrauma Sample	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CONFIRMATORY FACTOR-ANALYSIS; POSTTRAUMATIC GROWTH INVENTORY; BDI-II; MANAGEMENT	Objective: The Beck Depression Inventory-II (BDI-II) is widely used as a screening instrument for depressive symptomatology in clinical settings. The factor structure has been researched in a variety of settings with results ranging from a single factor to a five-factor structure. The purpose of this study was to examine several identified factor structures when applied to a mixed polytrauma sample. Method: A sample of 310 veterans was used for this study. All subjects were administered the BDI-II screening measure as part of an evaluation in an outpatient polytrauma clinic. Confirmatory factor analysis was used to determine the best model. Results: Confirmatory factor analysis revealed that a three-factor model provided a best fit. A model previously identified for individuals in residential treatment for substance abuse provided a best fit for this sample. Conclusions: The BDI-II may provide additional information for clinicians when examining the three-factor model with veterans in polytrauma settings.	[Palmer, Glen A.; Happe, Maggie C.; Paxson, Janine M.; Jurek, Benjamin K.; Graca, Joseph J.; Olson, Stephen A.] St Cloud VA Hlth Care Syst, Dept Psychol, St Cloud, MN 56303 USA		Palmer, GA (corresponding author), St Cloud VA Hlth Care Syst, Dept Psychol, 4801 Vet Dr,EC-117, St Cloud, MN 56303 USA.			Palmer, Glen/0000-0001-8043-3487			Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brown TA., 2015, CONFIRMATORY FACTOR, V2; Buckley TC, 2001, J SUBST ABUSE TREAT, V20, P197, DOI 10.1016/S0740-5472(00)00169-0; Byrne B., 2012, MULTIVARIATE APPL SE; CHRISTENSEN BK, 1995, J INT NEUROPSYCH SOC, V1, P122; Cronbach L.J., 1984, ESSENTIALS PSYCHOL T, V4th Edn; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hoyle R.H., 1995, STRUCTURAL EQUATION; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Linley PA, 2007, J LOSS TRAUMA, V12, P321, DOI 10.1080/15325020601162823; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Palmer GA, 2012, J LOSS TRAUMA, V17, P545, DOI 10.1080/15325024.2012.678779; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Schinka JA, 2007, J TRAUMA STRESS, V20, P281, DOI 10.1002/jts.20202; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Siegert RJ, 2009, J INT NEUROPSYCH SOC, V15, P142, DOI 10.1017/S1355617708090048; United States Department of Veterans Affairs, 2011, UND TRAUM BRAIN INJ; United States Department of Veterans Affairs, 2008, PUTT POL CAR MAP	26	11	11	0	6	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2014	179	8					879	884		10.7205/MILMED-D-14-00048			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7UO	WOS:000340806700009	25102530	Bronze			2022-02-06	
J	Valle, EJ; Van Haren, RM; Allen, CJ; Jouria, JM; Bullock, MR; Schulman, CI; Namias, N; Livingstone, AS; Proctor, KG				Valle, Evan J.; Van Haren, Robert M.; Allen, Casey J.; Jouria, Jassin M.; Bullock, M. Ross; Schulman, Carl I.; Namias, Nicholas; Livingstone, Alan S.; Proctor, Kenneth G.			Does traumatic brain injury increase the risk for venous thromboembolism in polytrauma patients?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Thromboelastography; coagulopathy; heparin; intensive care unit	SECONDARY ISCHEMIC INSULTS; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; HYPERCOAGULABILITY; PROPHYLAXIS; PREVENTION; TRIAL	BACKGROUND: Trauma is a major risk factor for venous thromboembolism (VTE). Traumatic brain injury (TBI) is generally considered to further increase the VTE risk, which should prompt routine thromboprophylaxis. However, the associated risk for intracranial hemorrhage often delays anticoagulants. We test the hypothesis that TBI associated with polytrauma results in a higher rate of VTE than polytrauma without TBI. METHODS: From August 2011 to June 2013, a prospective observational trial with informed consent was performed in 148 intensive care unit (ICU) patients with a Greenfield Risk Assessment Profile score of 10 or greater. RESULTS: Demographics, Greenfield Risk Assessment Profile scores, the incidence of polytrauma, and mortality were similar, but TBI patients had worse Injury Severity Scores (ISS) (32 vs. 22), longer ICU lengths of stay (21 days vs. 12 days), more hypercoagulable thromboelastogram values on admission (94% vs. 79%), more received unfractionated heparin prophylaxis (65% vs. 36%), and the prophylaxis start date was more than a day later (all p < 0.05). Nevertheless, the VTE rate with TBI was similar to that without TBI (25% vs. 26%, p = 0.507). Furthermore, VTE occurred at similar time points after ICU admission with and without TBI. In both groups, about 30% of the VTEs were detected within 2 days of ICU admission and 50% of the VTEs occurred within 10 days of admission despite chemical and mechanical thromboprophylaxis. CONCLUSION: In complex polytrauma patients who survived to ICU admission and who were prescreened for high VTE risk, TBI did not further increase the risk for VTE. The most likely explanation is that no single risk factor is necessary or sufficient for VTE development, especially in those who routinely receive chemical and mechanical thromboprophylaxis. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Proctor, Kenneth G.] Univ Miami, Miller Sch Med, Ryder Trauma Ctr, Dewitt Daughtry Family Dept Surg,Div Trauma, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Ryder Trauma Ctr, Dewitt Daughtry Family Dept Surg,Div Surg Crit Ca, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Ryder Trauma Ctr, Dept Neurosurg, Miami, FL 33136 USA		Proctor, KG (corresponding author), Univ Miami, Miller Sch Med, Ryder Trauma Ctr, Dewitt Daughtry Family Dept Surg,Div Trauma, 1800 NW 10th Ave, Miami, FL 33136 USA.	kproctor@miami.edu	Van Haren, Robert/T-8218-2019; Proctor, Kenneth/AAA-2199-2022; Livingstone, Alan/AAA-4026-2019; Schulman, Carl/AAE-7448-2021	Proctor, Kenneth/0000-0003-1326-6628; Namias, Nicholas/0000-0001-7021-2250; Allen, Casey/0000-0001-9890-7417; Schulman, Carl/0000-0001-8899-4350	Office of Naval ResearchOffice of Naval Research [N140610670]; US Army Medical Research & Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [09078015]	This study was supported in part by Grants #N140610670 from the Office of Naval Research and #09078015 from the US Army Medical Research & Materiel Command.	Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; Bandle J, 2013, J TRAUMA ACUTE CARE, V74, P575, DOI 10.1097/TA.0b013e3182789330; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Brandt MM, 2007, AM J SURG, V193, P383; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 2007, J NEUROTRAUM, V24, pvii; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Faul M, 2010, TRAUMATIC BRAIN INJU; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginzburg E, 2003, BRIT J SURG, V90, P1338, DOI 10.1002/bjs.4309; Greenfield LJ, 1997, J TRAUMA, V42, P100, DOI 10.1097/00005373-199701000-00017; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harr JN, 2013, J TRAUMA ACUTE CARE, V74, P756, DOI 10.1097/TA.0b013e3182826d7e; Haut ER, 2009, J TRAUMA, V66, P994, DOI 10.1097/TA.0b013e3181991adc; Kahn SR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008201.pub2; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Mohseni Shahin, 2012, J Emerg Trauma Shock, V5, P11, DOI 10.4103/0974-2700.93102; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Robertson C, 2000, CRIT CARE MED, V28, P3358, DOI 10.1097/00003246-200009000-00046; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Ryan ML, 2014, J PEDIATR SURG, V49, P1295, DOI 10.1016/j.jpedsurg.2013.11.050; Ryan ML, 2012, J TRAUMA ACUTE CARE, V73, P385, DOI 10.1097/TA.0b013e31825a0519; Shackford SR, 2004, ANN SURG, V240, P496; Singh S, 2013, 13EHC0821 AG HEALTHC; Thorson CM, 2014, SURGERY, V155, P134, DOI 10.1016/j.surg.2013.06.053; Thorson CM, 2013, J AM COLL SURGEONS, V216, P580, DOI 10.1016/j.jamcollsurg.2012.12.006; Thorson CM, 2012, CRIT CARE MED, V40, P2967, DOI 10.1097/CCM.0b013e31825bcb60; Van Haren RM, 2014, J TRAUMA ACUTE CARE, V76, P443, DOI 10.1097/TA.0b013e3182a9d11d; Van Haren RM, 2013, J TRAUMA ACUTE CARE, V75, P37, DOI 10.1097/TA.0b013e3182984911; Van PY, 2009, J TRAUMA, V66, P1509, DOI 10.1097/TA.0b013e3181a51e33	37	11	13	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2014	77	2					243	250		10.1097/TA.0000000000000307			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AN0EJ	WOS:000340255700011	25058249				2022-02-06	
J	Crosby, SN; Kim, EJ; Koehler, DM; Rohmiller, MT; Mencio, GA; Green, NE; Lovejoy, SA; Schoenecker, JG; Martus, JE				Crosby, Samuel N., Jr.; Kim, Elliott J.; Koehler, Daniel M.; Rohmiller, Michael T.; Mencio, Gregory A.; Green, Neil E.; Lovejoy, Steven A.; Schoenecker, Jonathan G.; Martus, Jeffrey E.			Twenty-Year Experience with Rigid Intramedullary Nailing of Femoral Shaft Fractures in Skeletally Immature Patients	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							AVASCULAR NECROSIS; GREATER TROCHANTER; INTERNAL-FIXATION; FOLLOW-UP; ADOLESCENT; CHILDREN; FEMUR; HEAD; COMPLICATIONS; EPIPHYSIS	Background: Debate exists over the safety of rigid intramedullary nailing of femoral shaft fractures in skeletally immature patients. The goal of this study was to describe functional outcomes and complication rates of rigid intramedullary nailing in pediatric patients. Methods: A retrospective review was performed of femoral shaft fractures in skeletally immature patients treated with trochanteric rigid intramedullary nailing from 1987 to 2009. Radiographs made at initial injury, immediately postoperatively, and at the latest follow-up were reviewed. Patients were administered the Nonarthritic Hip Score and a survey. Results: The study population of 241 patients with 246 fractures was primarily male (75%) with a mean age of 12.9 years (range, eight to seventeen years). The majority of fractures were closed (92%) and associated injuries were common (45%). The mean operative time was 119 minutes, and the mean estimated blood loss was 202 mL. The mean clinical follow-up time was 16.2 months (range, three to seventy-nine months), and there were ninety-three patients with a minimum two-year clinical and radiographic follow-up. An increase of articulotrochanteric distance of >5 mm was noted in 15.1% (fourteen of ninety-three patients) at a minimum two-year follow-up; however, clinically relevant growth disturbance was only observed in two patients (2.2%) with the development of asymptomatic coxa valga. There was no femoral head osteonecrosis. Among the 246 fractures, twenty-four complications (9.8%) occurred. At the time of the latest follow-up, 1.7% (four of 241 patients) reported pain. The average Nonarthritic Hip Score was 92.4 points (range, 51 to 100 points), and 100% of patients reported satisfaction with their treatment. Conclusions: Rigid intramedullary nailing is an effective technique for treatment of femoral shaft fractures in pediatric patients with an acceptable rate of complications.	[Crosby, Samuel N., Jr.; Kim, Elliott J.; Koehler, Daniel M.; Rohmiller, Michael T.; Mencio, Gregory A.; Green, Neil E.; Lovejoy, Steven A.; Schoenecker, Jonathan G.; Martus, Jeffrey E.] Vanderbilt Univ, Dept Orthopaed Surg, Med Ctr, Monroe Carell Jr Childrens Hosp, Nashville, TN 37232 USA		Crosby, SN (corresponding author), Vanderbilt Univ, Dept Orthopaed Surg, Med Ctr, Monroe Carell Jr Childrens Hosp, 4202 DOT,2200 Childrens Way, Nashville, TN 37232 USA.	jeff.martus@vanderbilt.edu	Martus, Jeffrey E/L-7555-2015; Martus, Jeff/L-2688-2019; Martus, Jeffrey/N-4071-2019	Martus, Jeffrey E/0000-0002-5768-6715; Martus, Jeffrey/0000-0002-5768-6715			Archdeacon M, 2008, J ORTHOP TRAUMA, V22, P3, DOI 10.1097/BOT.0b013e31816073b6; ASTION DJ, 1995, J BONE JOINT SURG AM, V77A, P1092, DOI 10.2106/00004623-199507000-00018; Barlas Khurram, 2006, Acta Orthop Belg, V72, P159; Beaty, 1995, J Am Acad Orthop Surg, V3, P207; BEATY JH, 1994, J PEDIATR ORTHOPED, V14, P178, DOI 10.1097/01241398-199403000-00009; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Buford D, 1998, CLIN ORTHOP RELAT R, P85; Christensen CP, 2003, CLIN ORTHOP RELAT R, P75, DOI 10.1097/01.blo.0000043047.84315.4b; GAGE JR, 1980, J BONE JOINT SURG AM, V62, P785, DOI 10.2106/00004623-198062050-00013; GALPIN RD, 1994, J PEDIATR ORTHOPED, V14, P184, DOI 10.1097/01241398-199403000-00010; GONZALEZHERRANZ P, 1995, J BONE JOINT SURG BR, V77B, P262, DOI 10.1302/0301-620X.77B2.7706343; Gordon JE, 2004, J ORTHOP TRAUMA, V18, P416, DOI 10.1097/00005131-200408000-00004; Gordon JE, 2003, J BONE JOINT SURG AM, V85A, P1295, DOI 10.2106/00004623-200307000-00016; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; Helmy N, 2008, J ORTHOP TRAUMA, V22, P10, DOI 10.1097/BOT.0b013e31815f5357; HERNDON WA, 1989, J PEDIATR ORTHOPED, V9, P29, DOI 10.1097/01241398-198901000-00006; Kanellopoulos AD, 2006, J TRAUMA, V60, P217, DOI 10.1097/01.ta.0000199913.02341.d6; Keeler KA, 2009, J PEDIATR ORTHOPED, V29, P345, DOI 10.1097/BPO.0b013e3181a53b59; KEMPF I, 1985, J BONE JOINT SURG AM, V67A, P709, DOI 10.2106/00004623-198567050-00005; KIRBY RM, 1981, J PEDIATR ORTHOPED, V1, P193, DOI 10.1097/01241398-198110000-00010; Larson AN, 2012, J BONE JOINT SURG AM, V94A, P584, DOI 10.2106/JBJS.J.01073; Letts M, 2002, J TRAUMA, V52, P504, DOI 10.1097/00005373-200203000-00015; MacNeil JAM, 2011, J PEDIATR ORTHOPED, V31, P377, DOI 10.1097/BPO.0b013e3182172613; MILESKI RA, 1994, J BONE JOINT SURG AM, V76A, P1706, DOI 10.2106/00004623-199411000-00014; MILESKI RA, 1995, J PEDIATR ORTHOPED, V15, P24, DOI 10.1097/01241398-199501000-00006; Momberger N, 2000, J PEDIATR ORTHOPED, V20, P482, DOI 10.1097/00004694-200007000-00011; Moroz LA, 2006, J BONE JOINT SURG BR, V88B, P1361, DOI 10.1302/0301-620X.88B10.17517; OMALLEY DE, 1995, J PEDIATR ORTHOPED, V15, P21, DOI 10.1097/01241398-199501000-00005; Park KC, 2012, INJURY, V43, P870, DOI 10.1016/j.injury.2011.10.032; Peskun C, 2008, J ORTHOP TRAUMA, V22, P102, DOI 10.1097/BOT.0b013e318162a0d2; REEVES RB, 1990, J PEDIATR ORTHOPED, V10, P592, DOI 10.1097/01241398-199009000-00004; Sanders DW, 2008, CAN J SURG, V51, P366; Sanders JO, 2001, J PEDIATR ORTHOPED, V21, P436, DOI 10.1097/00004694-200107000-00004; Sink EL, 2006, J PEDIATR ORTHOPED, V26, P177, DOI 10.1097/01.bpo.0000218524.90620.34; Skak SV, 1996, J PEDIATR ORTHOP B, V5, P195, DOI 10.1097/01202412-199605030-00011; Stans AA, 1999, J PEDIATR ORTHOPED, V19, P222, DOI 10.1097/00004694-199903000-00017; THOMETZ JG, 1995, J BONE JOINT SURG AM, V77, P1423, DOI 10.2106/00004623-199509000-00019; Townsend DR, 2000, CLIN ORTHOP RELAT R, P113	38	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	JUL 2	2014	96A	13					1080	1089		10.2106/JBJS.M.01128			10	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	AR8AT	WOS:000343798700016	24990973				2022-02-06	
J	Chatterji, B; Dickhut, C; Mielke, S; Kruger, J; Just, I; Glage, S; Meier, M; Wedekind, D; Pich, A				Chatterji, Bijon; Dickhut, Clarissa; Mielke, Svenja; Krueger, Jonas; Just, Ingo; Glage, Silke; Meier, Martin; Wedekind, Dirk; Pich, Andreas			MALDI imaging mass spectrometry to investigate endogenous peptides in an animal model of Usher's disease	PROTEOMICS			English	Article						Animal proteomics; Endogenous peptides; MALDI imaging; Rat brain; Usher's disease	TRAUMATIC BRAIN-INJURY; RETINITIS-PIGMENTOSA; SCAFFOLDING PROTEIN; RAT-BRAIN; GENE; DYSTROPHY; PRECURSOR; DEAFNESS; PROSAAS; WHIRLIN	Imaging MS (MSI) has emerged as a valuable tool to study the spatial distribution of biomolecules in the brain. Herein, MALDI-MSI was used to determine the distribution of endogenous peptides in a rat model of Usher's disease. This rare disease is considered as a leading cause of deaf-blindness in humans worldwide. Cryosections of brain tissue were analyzed by MALDI-MSI to differentiate between healthy and diseased rats. MSI results were highly reproducible. Tissue-specific peptides were identified by MS/MS using LC-Orbitrap and MALDI-TOF/TOF analyses. These peptides were proposed for histological classification due to their particular spatial distribution in the brain, for example, substantia nigra, corpus callosum, and hippocampus. Several endogenous peptides showed significantly increased ion densities, particularly in the colliculi superiores and in the substantia nigra of diseased rats, including peptides derived from Fsd1, dystrobrevin-beta, and ProSAAS. Furthermore, several proteolytic degradation products of the myelin basic protein were identified, of which one peptide is most likely mediated by calpain-2. Our findings contribute to the characterization of this animal model and include possible peptide markers of disease.	[Chatterji, Bijon; Dickhut, Clarissa; Mielke, Svenja; Krueger, Jonas; Just, Ingo; Pich, Andreas] Hannover Med Sch, Inst Toxicol, D-30625 Hannover, Germany; [Glage, Silke; Meier, Martin; Wedekind, Dirk] Hannover Med Sch, Inst Lab Anim Sci, D-30625 Hannover, Germany		Pich, A (corresponding author), Hannover Med Sch, Core Unit Mass Spectrometry Prote, Inst Toxicol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	chatterji.bijon@mh-hannover.de; pich.andreas@mh-hannover.de		Meier, Martin/0000-0001-8642-0409			Aller E, 2010, MOL VIS, V16, P495; Battacharya G, 2005, BIOCHEMISTRY-US, V44, P11518, DOI 10.1021/bi050245u; Blake DJ, 1998, P NATL ACAD SCI USA, V95, P241, DOI 10.1073/pnas.95.1.241; Bonnel D, 2013, ANAL BIOCHEM, V434, P187, DOI 10.1016/j.ab.2012.10.035; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Bora A, 2008, J PROTEOME RES, V7, P4992, DOI 10.1021/pr800394e; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Calligaris D, 2013, ANAL CHEM, V85, P2117, DOI 10.1021/ac302746t; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Carim-Todd L, 2001, BBA-GENE STRUCT EXPR, V1518, P200, DOI 10.1016/S0167-4781(01)00178-6; Chance MR, 2010, HUM MOL GENET, V19, P1515, DOI 10.1093/hmg/ddq025; Chatterji B, 2013, EXPERT REV PROTEOMIC, V10, P381, DOI 10.1586/14789450.2013.814939; CROSS GS, 1987, EMBO J, V6, P3277, DOI 10.1002/j.1460-2075.1987.tb02646.x; Debois D, 2010, ANAL CHEM, V82, P4036, DOI 10.1021/ac902875q; Deininger SO, 2011, ANAL BIOANAL CHEM, V401, P167, DOI 10.1007/s00216-011-4929-z; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Deutskens F, 2011, J MASS SPECTROM, V46, P568, DOI 10.1002/jms.1926; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Eikel D, 2011, RAPID COMMUN MASS SP, V25, P3587, DOI 10.1002/rcm.5274; Feng Yun, 2002, Brain Res Gene Expr Patterns, V1, P135; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; FUJIYOSHI T, 1994, ANN OTO RHINOL LARYN, V103, P449, DOI 10.1177/000348949410300606; Grati M, 2012, J NEUROSCI, V32, P14288, DOI 10.1523/JNEUROSCI.3071-12.2012; Green JA, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-96; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hatcher NG, 2008, P NATL ACAD SCI USA, V105, P12527, DOI 10.1073/pnas.0804340105; Held N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015669; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; Kellner U, 1998, BRIT J OPHTHALMOL, V82, P650, DOI 10.1136/bjo.82.6.650; Kuramoto T, 2001, P NATL ACAD SCI USA, V98, P559, DOI 10.1073/pnas.98.2.559; LECHAN RM, 1986, SCIENCE, V231, P159, DOI 10.1126/science.3079917; Lee JE, 2010, MOL CELL PROTEOMICS, V9, P285, DOI 10.1074/mcp.M900362-MCP200; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; MAYER P, 1903, Z WISSENSCHAFTLICHE, V20, P409; Monroe EB, 2008, PROTEOMICS, V8, P3746, DOI 10.1002/pmic.200800127; Murga-Zamalloa CA, 2011, J BIOL CHEM, V286, P28276, DOI 10.1074/jbc.M111.237560; Nirmalan NJ, 2011, J PROTEOME RES, V10, P896, DOI 10.1021/pr100812d; NUDEL U, 1988, NATURE, V331, P635, DOI 10.1038/331635a0; Ojika K, 2000, PROG NEUROBIOL, V60, P37, DOI 10.1016/S0301-0082(99)00021-0; Palomero-Gallagher N, 2010, NEUROSCIENCE, V170, P542, DOI 10.1016/j.neuroscience.2010.07.043; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Qian YM, 2000, J BIOL CHEM, V275, P23596, DOI 10.1074/jbc.M001583200; Schober Y, 2012, RAPID COMMUN MASS SP, V26, P1141, DOI 10.1002/rcm.6192; Sloane JA, 2003, J NEUROCHEM, V84, P157, DOI 10.1046/j.1471-4159.2003.01541.x; Taban IM, 2007, J AM SOC MASS SPECTR, V18, P145, DOI 10.1016/j.jasms.2006.09.017; Tavel L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036187; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Wada M, 2004, NEUROSCI LETT, V356, P49, DOI 10.1016/j.neulet.2003.11.028; Whailova A, 2008, J SEP SCI, V31, P468, DOI 10.1002/jssc.200700269; Zeiser J, 2013, J PROTEOME RES, V12, P1604, DOI 10.1021/pr300973q	50	11	11	1	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	JUL	2014	14	13-14					1674	1687		10.1002/pmic.201300558			14	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AM0RM	WOS:000339553900011	24841751				2022-02-06	
J	Donaldson, LD				Donaldson, Laurie D.			Spondylolysis in Elite Junior-Level Ice Hockey Players	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						spondylolysis; low back pain; spine; pars interarticularis; hockey; adolescent athlete	PARS INTERARTICULARIS; INJURIES; SPINE; CONCUSSIONS; DEFECTS	Background: Spondylolysis is a common cause of low back pain and significant loss of play in the young athlete. Its incidence in hockey players has not been reported. This study reviewed the incidence and potential causative factors of low back pain and spondylolysis in an elite junior-level ice hockey program over a 15-year period. Hypothesis: Because of the repetitive movements of the lower spine required by the sport, spondylolysis was expected to be a frequent cause of low back pain in hockey players. Study Design: Retrospective case review. Methods: The medical and athletic trainer records of male ice hockey players, ages 15 to 18 years, who presented with the complaint of low back pain were reviewed. This elite program consisted of 2 rosters. There were approximately 44 players total per year representing these 2 teams. For players diagnosed with spondylolysis, the following factors were reviewed: year in the program, age at presentation, symptoms and duration, studies performed, level of spondylolysis, presence of spondylolisthesis, affected side to shooting side, player position, treatment, and current level of play. Results: Over 9 hockey seasons, 25 players presented to medical staff with low back pain. Of those, 44% were confirmed to have lumbar spondylolysis. The majority of these cases presented in the first year of the program without clear history of trauma but rather vague pain with weight lifting or hockey. Less than half of spondylolysis cases were diagnosed on plain films. There were no cases of spondylolisthesis. Spondylolysis occurred on the shooting side in 73% of players. Sixty-four percent of players with spondylolysis were forwards. The treatment for most included rest from lifting and hockey and physical therapy. Average return to play was 8 weeks. Ninety-six percent of players continued to play at an elite level. Conclusion: Spondylolysis should be strongly considered in the differential of low back pain in ice hockey players with consideration for advanced imaging. Considerable loss of play occurs with spondylolysis, but with proper treatment, excellent outcomes occur.	[Donaldson, Laurie D.] Univ Michigan, Dept Orthopaed Surg, MedSport, Ann Arbor, MI 48109 USA		Donaldson, LD (corresponding author), Univ Michigan, MedSport, Lobby A,24 Frank Lloyd Wright Dr, Ann Arbor, MI 48106 USA.	lddonald@med.umich.edu					Agel J, J ATHL TRAIN; AMATO M, 1984, RADIOLOGY, V153, P627, DOI 10.1148/radiology.153.3.6494460; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; BLANDA J, 1993, J SPINAL DISORD, V6, P406, DOI 10.1097/00002517-199306050-00007; Campbell RSD, 2005, SKELETAL RADIOL, V34, P63, DOI 10.1007/s00256-004-0878-3; Congeni J, 2000, J MUSCULOSKELET MED, V17, P123; d'Hemecourt PA, 2000, CLIN SPORT MED, V19, P663, DOI 10.1016/S0278-5919(05)70231-3; d'Hemecourt PA, 2002, ORTHOPEDICS, V25, P653; Eddy D, 2005, CLIN J SPORT MED, V15, P453, DOI 10.1097/01.jsm.0000186681.13416.0c; El Rassi G, 2005, AM J SPORT MED, V33, P1688, DOI 10.1177/0363546505275645; JACKSON DW, 1981, AM J SPORT MED, V9, P304, DOI 10.1177/036354658100900504; LETTS M, 1986, J PEDIATR ORTHOPED, V6, P40, DOI 10.1097/01241398-198601000-00009; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MAZUR LJ, 1993, SPORTS MED, V16, P57, DOI 10.2165/00007256-199316010-00005; Micheli LJ, 2006, CLIN SPORT MED, V25, P75, DOI 10.1016/j.csm.2005.08.001; MICHELI LJ, 1995, ARCH PEDIAT ADOL MED, V149, P15, DOI 10.1001/archpedi.1995.02170130017004; Miller SF, 2004, AM J SPORT MED, V32, P928, DOI 10.1177/0363546503262194; Ruiz-Cotorro A, 2006, BRIT J SPORT MED, V40, P441, DOI 10.1136/bjsm.2005.023960; STEINER ME, 1985, SPINE, V10, P937, DOI 10.1097/00007632-198512000-00013; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Sys J, 2001, EUR SPINE J, V10, P498, DOI 10.1007/s005860100326; Ward CV, 2007, SPINE, V32, pE85, DOI 10.1097/01.brs.0000252200.66545.43; WILTSE LL, 1976, CLIN ORTHOP RELAT R, P23	23	11	11	0	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2014	6	4					356	359		10.1177/1941738113519958			4	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V20FK	WOS:000214872300012	24982710	Green Published			2022-02-06	
J	Huang, YN; Lai, CC; Chiu, CT; Lin, JJ; Wang, JY				Huang, Ya-Ni; Lai, Chien-Cheng; Chiu, Chien-Tsai; Lin, Jhen-Jhe; Wang, Jia-Yi			L-Ascorbate Attenuates the Endotoxin-Induced Production of Inflammatory Mediators by Inhibiting MAPK Activation and NF-kappa B Translocation in Cortical Neurons/Glia Cocultures	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; VITAMIN-C; OXIDATIVE STRESS; PROINFLAMMATORY CYTOKINES; DEHYDROASCORBIC ACID; CEREBROSPINAL-FLUID; NEUROINFLAMMATION; INDUCTION; DIFFERENTIATION	In response to acute insults to the central nervous system, such as pathogen invasion or neuronal injuries, glial cells become activated and secrete inflammatory mediators such as nitric oxide (NO), cytokines, and chemokines. This neuroinflammation plays a crucial role in the pathophysiology of chronic neurodegenerative diseases. Endogenous ascorbate levels are significantly decreased among patients with septic encephalopathy. Using the bacterial endotoxin lipopolysaccharide (LPS) to induce neuroinflammation in primary neuron/glia cocultures, we investigated how L-ascorbate (vitamin C; Vit. C) affected neuroinflammation. LPS (100 ng/ml) induced the expression of inducible NO synthase (iNOS) and the production of NO, interleukin (IL)-6, and macrophage inflammatory protein-2 (MIP-2/CXCL2) in a time-dependent manner; however, cotreatment with Vit. C (5 or 10 mM) attenuated the LPS-induced iNOS expression and production of NO, IL-6, and MIP-2 production. The morphological features revealed after immunocytochemical staining confirmed that Vit. C suppressed LPS-induced astrocytic and microglial activation. Because Vit. C can be transported into neurons and glia via the sodium-dependent Vit. C transporter-2, we examined how Vit. C affected LPS-activated intracellular signaling in neuron/glia cocultures. The results indicated the increased activation (caused by phosphorylation) of mitogen-activated protein kinases (MAPKs), such as p38 at 30 min and extracellular signal-regulated kinases (ERKs) at 180 min after LPS treatment. The inhibition of p38 and ERK MAPK suppressed the LPS-induced production of inflammatory mediators. Vit. C also inhibited the LPS-induced activation of p38 and ERK. Combined treatments of Vit. C and the inhibitors of p38 and ERK yielded no additional inhibition compared with using the inhibitors alone, suggesting that Vit. C functions through the same signaling pathway (i.e., MAPK) as these inhibitors. Vit. C also reduced LPS-induced I kappa B-alpha degradation and NF-kappa B translocation. Thus, Vit. C suppressed the LPS-stimulated production of inflammatory mediators in neuron/glia cocultures by inhibiting the MAPK and NF-kappa B signaling pathways.	[Huang, Ya-Ni] Hsin Sheng Jr Coll Med Care & Management, Dept Nursing, Taoyuan, Taiwan; [Lai, Chien-Cheng] Far Eastern Mem Hosp, Dept Surg, Div Orthoped, New Taipei City, Taiwan; [Chiu, Chien-Tsai] En Chu Kong Hosp, Dept Neurosurg, New Taipei City, Taiwan; [Lin, Jhen-Jhe; Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Jhen-Jhe; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Dept Physiol, Taipei, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.	jywang2010@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351	Hsin Sheng College of Medical Care and Management, Taiwan [HSC-102-005]; National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC99-2320-B-038-006-MY3, NSC 101-2321-B-038-003]	This work was supported in part by a grant (HSC-102-005) to YNH from the Hsin Sheng College of Medical Care and Management, Taiwan; and grants (NSC99-2320-B-038-006-MY3 and NSC 101-2321-B-038-003 to JYW) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Becker JC, 2003, BIOCHEM BIOPH RES CO, V312, P507, DOI 10.1016/j.bbrc.2003.10.146; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Bowie AG, 2000, J IMMUNOL, V165, P7180, DOI 10.4049/jimmunol.165.12.7180; Carcamo JM, 2002, BLOOD, V99, P3205, DOI 10.1182/blood.V99.9.3205; Chiu CT, 2011, J INFECT DIS, V204, P1563, DOI 10.1093/infdis/jir608; Christen S, 2001, FREE RADICAL BIO MED, V31, P754, DOI 10.1016/S0891-5849(01)00642-6; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hediger MA, 2002, NAT MED, V8, P445, DOI 10.1038/nm0502-445; HORNIG D, 1975, ANN NY ACAD SCI, V258, P103, DOI 10.1111/j.1749-6632.1975.tb29271.x; Huang J, 2001, P NATL ACAD SCI USA, V98, P11720, DOI 10.1073/pnas.171325998; Huang YN, 2012, TOXICOL APPL PHARM, V265, P241, DOI 10.1016/j.taap.2012.08.036; Huang YN, 2009, TOXICOL APPL PHARM, V240, P315, DOI 10.1016/j.taap.2009.06.021; Kim BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055792; Kim WI, 2012, NEUROL RES; KINUTA Y, 1989, J NEUROSURG, V71, P421, DOI 10.3171/jns.1989.71.3.0421; Korcok J, 2002, J NEUROCHEM, V81, P185, DOI 10.1046/j.1471-4159.2002.00814.x; Lee JY, 2003, J NEUROSCI RES, V73, P156, DOI 10.1002/jnr.10647; Leow-Dyke S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-230; Lin CH, 2006, J NEUROSCI RES, V84, P1485, DOI 10.1002/jnr.21047; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173; Raza SS, 2013, NEUROSCIENCE, V230, P157, DOI 10.1016/j.neuroscience.2012.10.041; REBEC GV, 1994, PROG NEUROBIOL, V43, P537, DOI 10.1016/0301-0082(94)90052-3; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Rosales-Corral S, 2003, J PINEAL RES, V35, P80, DOI 10.1034/j.1600-079X.2003.00057.x; Ryu JR, 2002, EXP BRAIN RES, V143, P257, DOI 10.1007/s00221-001-0991-7; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Shin DM, 2004, NEUROREPORT, V15, P1959, DOI 10.1097/00001756-200408260-00025; Sochocka M, 2013, CNS NEUROL DISORD DR; Son EW, 2004, ARCH PHARM RES, V27, P1073, DOI 10.1007/BF02975434; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Voigt K, 2002, FREE RADICAL RES, V36, P735, DOI 10.1080/10715760290032557; Wang JY, 1998, LIFE SCI, V63, P1571, DOI 10.1016/S0024-3205(98)00424-X; Wang YP, 2011, J IMMUNOL, V173, P5196; Wen LL, 2007, EXP NEUROL, V205, P270, DOI 10.1016/j.expneurol.2007.02.011; Wilson JX, 2009, BIOFACTORS, V35, P5, DOI 10.1002/biof.7; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xie Z, 2004, GLIA, V45, P170, DOI 10.1002/glia.10314; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043; Zhao SQ, 2011, INT IMMUNOPHARMACOL, V11, P468, DOI 10.1016/j.intimp.2010.12.017; Zhu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035125	47	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2014	9	7							e97276	10.1371/journal.pone.0097276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1UX	WOS:000339635000005	24983461	Green Submitted, gold, Green Published			2022-02-06	
J	Ping, XJ; Jiang, KW; Lee, SY; Cheng, JX; Jin, XM				Ping, Xingjie; Jiang, Kewen; Lee, Seung-Young; Cheng, Ji-Xing; Jin, Xiaoming			PEG-PDLLA Micelle Treatment Improves Axonal Function of the Corpus Callosum following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axon; CAP; cerebral cortex; micelles; TBI	CONTROLLED CORTICAL IMPACT; UNMYELINATED AXONS; FLUID PERCUSSION; SPINAL-CORD; INTRACRANIAL-PRESSURE; MEMBRANE PORATION; UNITED-STATES; PERMEABILITY; REPAIR; RAT	The initial pathological changes of diffuse axonal injury following traumatic brain injury (TBI) include membrane disruption and loss of ionic homeostasis, which further lead to dysfunction of axonal conduction and axon disconnection. Resealing the axolemma is therefore a potential therapeutic strategy for the early treatment of TBI. Monomethoxy poly (ethylene glycol)-poly (D, L-lactic acid) di-block copolymer micelles (mPEG-PDLLA) have been shown to restore depressed compound action potentials (CAPs) of spinal axons and promote functional recovery after spinal cord injury. Here, we evaluate the effect of the micelles on repairing the injured cortical axons following TBI. Adult mice subjected to controlled cortical impact (CCI) were treated with intravenous injection of the micelles at 0 h or 4 h after injury. Evoked CAPs were recorded from the corpus callosum of coronal cortical slices at 2 days after injury. The CCI caused significant decreases in the amplitudes of two CAP peaks that were respectively generated by the faster myelinated axons and slower unmyelinated axons. Micelle treatment at both 0 h and 4 h after CCI resulted in significant increases in both CAP peak amplitudes. Injection of fluorescent dye-labeled micelles revealed high fluorescent staining in cortical gray and white matters underneath the impact site. Labeling membrane-perforated neurons by injecting a membrane impermeable dye Texas Red-labeled dextran into lateral ventricles at 2 h post-CCI revealed that immediate micelle injection after CCI did not reduce the number of dye-stained cortical neurons and dentate granule cells of the hippocampus, indicating its ineffectiveness in repairing plasma membrane of neuronal somata. We conclude that intravenous administration of mPEG-PDLLA micelles immediately or at 4 h after TBI allows brain penetration via the compromised blood brain-barrier, and thereby improves the function of both myelinated and unmyelinated axons of the corpus callosum.	[Ping, Xingjie; Jiang, Kewen; Jin, Xiaoming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Anat & Cell Biol, Indiana Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA; [Jiang, Kewen] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Lee, Seung-Young; Cheng, Ji-Xing] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Lee, Seung-Young; Cheng, Ji-Xing] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA		Jin, XM (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, 980 W Walnut St R3,Room C426B, Indianapolis, IN 46202 USA.	xijin@iupui.edu	ping, xingjie/AAW-4597-2020; Jin, Xiaoming/AAH-3555-2020; Jin, Xiaoming/N-8545-2016	Jin, Xiaoming/0000-0002-8671-8640; Lee, Seung-Young/0000-0003-1349-3759	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS057940]; Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health [A70-0-079212]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99NS057940, R00NS057940] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health Grant NS057940 and by the Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health (A70-0-079212 to X.J.).	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chen HT, 2008, P NATL ACAD SCI USA, V105, P6596, DOI 10.1073/pnas.0707046105; Cho Y, 2012, EXP NEUROL, V233, P126, DOI 10.1016/j.expneurol.2011.09.028; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; GRAVEL C, 1990, J COMP NEUROL, V291, P147, DOI 10.1002/cne.902910110; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; KRAUSE TL, 1990, P NATL ACAD SCI USA, V87, P1471, DOI 10.1073/pnas.87.4.1471; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1996, ACT NEUR S, V66, P81; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Shi YZ, 2010, NAT NANOTECHNOL, V5, P80, DOI [10.1038/nnano.2009.303, 10.1038/NNANO.2009.303]; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Swanson TH, 1998, BRAIN RES, V784, P188, DOI 10.1016/S0006-8993(97)01323-1; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	42	11	11	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2014	31	13					1172	1179		10.1089/neu.2013.3147			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AL2VK	WOS:000338983500006	24579802	Green Published			2022-02-06	
J	Schwarzbold, ML; Diaz, AP; Nunes, JC; Sousa, DS; Hohl, A; Guarnieri, R; Linhares, MN; Walz, R				Schwarzbold, Marcelo L.; Diaz, Alexandre P.; Nunes, Jean C.; Sousa, Daniel S.; Hohl, Alexandre; Guarnieri, Ricardo; Linhares, Marcelo N.; Walz, Roger			Validity and screening properties of three depression rating scales in a prospective sample of patients with severe traumatic brain injury	REVISTA BRASILEIRA DE PSIQUIATRIA			English	Article						Traumatic brain injury; depression; ROC curve; screening	HOSPITAL ANXIETY; PSYCHIATRIC-DISORDERS; INVENTORY; MORTALITY; DIAGNOSIS; INTERVIEW; STROKE	Objective: To evaluate the validity and utility of the Hamilton Rating Scale for Depression (HAM-D), Beck Depression Inventory (BDI), and Hospital Anxiety and Depression Scale (HADS) as screening tools for depression after severe traumatic brain injury (TBI). Methods: Forty-six consecutive survivors of severe TBI were evaluated at a median of 15 months after injury. Receiver operating characteristic (ROC) analysis was performed using HAM-D, BDI, and HADS as predictors, and the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) as gold standard. Results: The area under the curve (AUC) for HAM-D was 0.89, and the optimal cutoff point was 7 (sensitivity 92.9%, specificity 78.1%); for the BDI, the AUC was 0.946 and the optimal cutoff point was 14 (sensitivity 92.3%, specificity 96.7%); for the HADS, the AUC was 0.947 and the optimal cutoff point was 9 (sensitivity 100%, specificity 80.7%); and for the HADS depression subscale, the AUC was 0.937 and the optimal cutoff point was 6 (sensitivity 92.9%, specificity 83.9%). There were no statistically significant differences among the AUCs. Conclusion: Our findings support a high validity and utility for the HAM-D, BDI, and HADS as screening tools for depression in patients with severe TBI, without major changes in standard cutoff points.	[Schwarzbold, Marcelo L.; Diaz, Alexandre P.; Nunes, Jean C.; Sousa, Daniel S.; Hohl, Alexandre; Guarnieri, Ricardo; Linhares, Marcelo N.; Walz, Roger] Univ Fed Santa Catarina, HU, Ctr Appl Neurosci CeNAp, Florianopolis, SC, Brazil; [Schwarzbold, Marcelo L.; Diaz, Alexandre P.; Sousa, Daniel S.; Guarnieri, Ricardo; Linhares, Marcelo N.] Hosp Governador Celso Ramos, Neurosurg Serv, Florianopolis, SC, Brazil; [Schwarzbold, Marcelo L.; Walz, Roger] Univ Fed Santa Catarina, Dept Clin Med, Univ Hosp, BR-88040970 Florianopolis, SC, Brazil		Schwarzbold, ML (corresponding author), Univ Fed Santa Catarina, Dept Clin Med, Univ Hosp, 3 Andar,Campus Univ, BR-88040970 Florianopolis, SC, Brazil.	schwlib@gmail.com	Diaz, Alexandre Paim/J-9042-2014; Schwarzbold, Marcelo Liborio/J-8960-2014; Diaz, Alexandre Paim/AAD-8323-2019; Hohl, Alexandre/R-9269-2019; Walz, Roger/K-9096-2013	Diaz, Alexandre Paim/0000-0002-6591-6648; Hohl, Alexandre/0000-0002-8073-5837; Walz, Roger/0000-0002-9875-6687	PRONEX Program (NENASC Project); PPSUS Program of Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC); National Science and Technology Institute for Translational Medicine (INCT-TM)	The authors thank Prof. Emil Kupek for statistical assistance. This work was supported by PRONEX Program (NENASC Project) and PPSUS Program of Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM).	Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Al-Adawi S, 2007, BRAIN INJURY, V21, P385, DOI 10.1080/02699050701311059; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berg A, 2009, STROKE, V40, P523, DOI 10.1161/STROKEAHA.108.527705; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Botega NJ, 1998, J BRAS PSIQUIAT, V47, P285; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Davydow DS, 2010, CRIT CARE, V14, DOI 10.1186/cc8867; Thais MERD, 2012, CNS NEUROSCI THER, V18, P606, DOI 10.1111/j.1755-5949.2012.00346.x; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; First M.B., 1996, STRUCTURED CLIN INTE; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Lecrubier Y, 2007, J CLIN PSYCHIAT, V68, P36; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Mojtabai R, 2013, PSYCHOTHER PSYCHOSOM, V82, P161, DOI 10.1159/000345968; Moreno DH, 1998, REV PSIQUIATR CLIN, P262; Naarding P, 2002, J NEUROPSYCH CLIN N, V14, P329, DOI 10.1176/appi.neuropsych.14.3.329; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9; Tavares M, 1996, ENTREVISTA CLIN ESTR; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	11	12	0	9	ASSOC BRASILEIRA PSIQUIATRIA	SAO PAULO	SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO, SP 04039-032  A, BRAZIL	1516-4446	1809-452X		REV BRAS PSIQUIATR	Rev. Bras. Psiquiatr.	JUL-SEP	2014	36	3					206	212		10.1590/1516-4446-2013-1308			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	AN2PD	WOS:000340426900005	24770656	gold, Green Submitted			2022-02-06	
J	Svoboda, T; Ramsay, JT				Svoboda, Tomislav; Ramsay, Jason T.			High rates of head injury among homeless and low-income housed men: a retrospective cohort study	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; CHRONIC SUBDURAL-HEMATOMA; SUBSTANCE-ABUSE; POPULATION; TORONTO; HEALTH	Objective To examine the predictors and temporal patterns of head injury (HI) presentation in the emergency department among cohorts of homeless and low-income housed men. Methods Retrospective review and logistic regression of HIs found in emergency department records for three groups of men, those: (1) who were chronically homeless with drinking problems (CHDP) (n=50), (2) in the general homeless population (GH) (n=60) and (3) in low-income housing (LIH) (n=59). Results The proportion of individuals with non-minimal HIs documented in the previous year were 28%, 3% and 5% with annual rates of 0.47, 0.017 and 0.037 among the CHDP, GH and LIH groups (p<0.0001). In the multivariate model, independent associations with having an HI included: an HI in the previous year (OR 11.8, 95% CI 3.83 to 36.4), drug dependence (OR 3.67, 95% CI 1.11 to 12.13) and seizures (OR 3.50, 95% CI 1.13 to 10.90), while mood-disorders were protective. Homelessness had a crude risk increase of HI (OR 3.15, 95% CI 1.21 to 8.23) but was not significant in the multivariate model. Among those with HIs, chronic homelessness with drinking problems was associated with a higher rate of HI. With each successive HI, the time interval to another HI was 12 days shorter (p=0.0004). The chronic subdural haematoma incidence in the under-65-year-old CHDP group was 11 per 1000 (95% CI 2.8 to 45). Conclusions Having an HI is better predicted by previous head injuries, drug dependence or a seizure disorder than a history of homelessness or alcohol dependence. HIs may become more frequent with time.	[Svoboda, Tomislav] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Svoboda, Tomislav] St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Ramsay, Jason T.] Univ Toronto Scarborough, Dept Anthropol, Hlth Studies Program, Toronto, ON, Canada		Svoboda, T (corresponding author), St Michaels Hosp, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	tomislav.svoboda@utoronto.ca			Central East Health Information Partnership; City of Toronto Shelter, Housing and Support Division; Physician Services Incorporated; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR)	Central East Health Information Partnership; the former City of Toronto Shelter, Housing and Support Division; Physician Services Incorporated; and the Canadian Institutes for Health Research.	Angus D. E., 1998, EC BURDEN UNINTENTIO; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cousseau D, 2001, REV NEUROLOGIA, V32, P821, DOI 10.33588/rn.3209.2000458; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Gelabert-Gonzalez M, 2001, NEUROCIRUGIA, V12, P325; Greene J, 2007, ANN EMERG MED, V49, P791, DOI 10.1016/j.annemergmed.2007.04.011; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kessler Ronald C., 1998, INT J METH PSYCH RES, V7, P171, DOI [DOI 10.1002/MPR.47, 10.1002/mpr.47]; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pickett W, 2001, CAN MED ASSOC J, V165, P288; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Svoboda T., 2006, HARM REDUCTION PROGR; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Wilton P, 2003, CAN MED ASSOC J, V168, P888; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	24	11	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUL	2014	31	7					571	575		10.1136/emermed-2012-201761			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AJ7XO	WOS:000337914800015	23625510				2022-02-06	
J	Yang, KC; Zhou, MJ; Sperry, JL; Rong, L; Zhu, XG; Geng, L; Wu, W; Zhao, G; Billiar, TR; Feng, QM				Yang, Kai-Chao; Zhou, Min-Jie; Sperry, Jason L.; Rong, Liu; Zhu, Xiao-Guang; Geng, Lei; Wu, Wei; Zhao, Gang; Billiar, Timothy R.; Feng, Qi-Ming			SIGNIFICANT SEX-BASED OUTCOME DIFFERENCES IN SEVERELY INJURED CHINESE TRAUMA PATIENTS	SHOCK			English	Article						Blunt trauma; sex; injury severity; sex hormone; nosocomial infection; mortality	IMMUNE-RESPONSES; GENDER-DIFFERENCES; INFLAMMATORY RESPONSE; TESTOSTERONE LEVELS; REPRODUCTIVE-CYCLE; HEMORRHAGIC-SHOCK; IMPROVED SURVIVAL; BRAIN-INJURY; FEMALE; DIMORPHISM	A body of experimental evidence suggests that the female sex is associated with a lower risk of mortality after trauma-hemorrhage. However, controversy remains regarding the mechanism responsible for these differences and if basic science findings correspond to clinical differences. Racial disparities in trauma outcomes have also been increasingly described. Until now, research on the association between sex and trauma patient outcomes mainly focused on patients in Europe and the United States. Our research attempted to determine whether the female sex is associated with a survival advantage among severely injured Chinese trauma patients. A retrospective analysis of data derived from the Emergency Intensive Care Unit of the Shanghai Sixth People';s Hospital Acute Trauma Center during 2010 to 2013 was performed to characterize differences in sex-based outcomes after severe blunt trauma. The patient study cohort (858 Asian subjects) was then stratified by age and injury severity (using the Injury Severity Score [ISS]). Crude and adjusted odds ratios (ORs) were calculated to evaluate the association between sex and nosocomial infection rate and hospitalized mortality, both overall and by age and ISS category subgroups. Among all trauma patients, females had a significantly lower risk of in-hospital mortality compared with males (OR, 0.41; 95% confidence interval [95% CI], 0.20 - 0.85). This difference was most apparent for patients younger than 50 years (OR, 0.31; 95% CI, 0.12 - 0.82) and the group with ISS scores of 25 or higher (OR, 0.39; 95% CI, 0.17 - 0.91). No differences in the development of nosocomial infections between sexes were seen among the overall patient group and subgroups. This study revealed a statistically significant association between sex and mortality among severe blunt trauma patients, particularly those patients younger than 50 years and with ISSs of 25 or higher. Women had significantly lower mortality than men after severe blunt trauma. These results highlight the important role of sex hormones and sex-based outcome differences after severe traumatic injury in the Chinese population.	[Yang, Kai-Chao; Zhou, Min-Jie; Rong, Liu; Zhu, Xiao-Guang; Geng, Lei; Wu, Wei; Zhao, Gang; Feng, Qi-Ming] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Emergency Med, Shanghai 200233, Peoples R China; [Sperry, Jason L.] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA USA		Feng, QM (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Emergency Med, 600 Yishan Rd, Shanghai 200233, Peoples R China.	fengqiming04@126.com			Shanghai Committee of Science and Technology, ChinaShanghai Science & Technology Committee [12410710700]	This study was supported by the Shanghai Committee of Science and Technology, China (grant no. 12410710700).	Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Angele MK, 2001, CYTOKINE, V16, P22, DOI 10.1006/cyto.2001.0945; Ba ZF, 2008, SHOCK, V30, P585, DOI 10.1097/SHK.0b013e31816f1a45; Bertoni AG, 2005, J NATL MED ASSOC, V97, P317; Bowles BJ, 2003, INJURY, V34, P27; Chaudry IH, 2003, J TRAUMA, V54, pS118, DOI 10.1097/01.TA.0000064511.14322.F1; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Combes A, 2009, CRIT CARE MED, V37, P2506, DOI 10.1097/CCM.0b013e3181a569df; Deitch EA, 2008, SHOCK, V29, P78, DOI 10.1097/shk.0b013e318063e98a; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Gannon CJ, 2004, SHOCK, V21, P410, DOI 10.1097/00024382-200405000-00003; Ghafoori B, 2012, J TRAUMA STRESS, V25, P106, DOI 10.1002/jts.21663; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Haider AH, 2010, J TRAUMA, V69, P537, DOI 10.1097/TA.0b013e3181efc67b; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Jarrar D, 2000, SURGERY, V128, P246, DOI 10.1067/msy.2000.107376; Jarrar D, 2000, AM J PHYSIOL-HEART C, V279, pH1015, DOI 10.1152/ajpheart.2000.279.3.H1015; JUDD H L, 1976, Clinical Obstetrics and Gynecology, V19, P775, DOI 10.1097/00003081-197612000-00005; Kher A, 2005, SHOCK, V23, P1, DOI 10.1097/01.shk.0000148055.12387.15; Knoferl MW, 2000, ARCH SURG-CHICAGO, V135, P425, DOI 10.1001/archsurg.135.4.425; Knoferl MW, 2002, ANN SURG, V235, P105, DOI 10.1097/00000658-200201000-00014; Knoferl MW, 2001, AM J PHYSIOL-CELL PH, V281, pC1131, DOI 10.1152/ajpcell.2001.281.4.C1131; Krausz MM, 2003, SHOCK, V20, P444, DOI 10.1097/01.shk.0000094560.76615.91; Leifke E, 2000, CLIN ENDOCRINOL, V53, P689, DOI 10.1046/j.1365-2265.2000.01159.x; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; Mizushima Y, 2000, ANN SURG, V232, P673, DOI 10.1097/00000658-200011000-00009; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Pathak EB, 2009, NEUROEPIDEMIOLOGY, V32, P302, DOI 10.1159/000208795; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Samy TSA, 2000, SHOCK, V14, P465; Schneider CP, 2000, SHOCK, V14, P347, DOI 10.1097/00024382-200014030-00019; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Sperry JL, 2012, J AM COLL SURGEONS, V214, P973, DOI 10.1016/j.jamcollsurg.2012.02.020; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Young MF, 2013, J EMERG MED, V45, P46, DOI 10.1016/j.jemermed.2012.07.088	43	11	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUL	2014	42	1					11	15		10.1097/SHK.0000000000000168			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	AJ5CZ	WOS:000337700600003	24667619				2022-02-06	
J	Eckroth, JR; Aas-Hansen, O; Sneddon, LU; Bichao, H; Doving, KB				Eckroth, Jared R.; Aas-Hansen, Oyvind; Sneddon, Lynne U.; Bichao, Helena; Doving, Kjell B.			Physiological and Behavioural Responses to Noxious Stimuli in the Atlantic Cod (Gadus morhua)	PLOS ONE			English	Article							RAINBOW-TROUT; COPING STYLES; TELEOST FISH; PAIN; CAPSAICIN; STRESS; NOCICEPTION; ANESTHESIA; MORPHINE; GOLDFISH	In the present study, our aim was to compare physiological and behavioural responses to different noxious stimuli to those of a standardized innocuous stimulus, to possibly identify aversive responses indicative of injury detection in a commercially important marine teleost fish, the Atlantic cod. Individual fish were administered with a noxious stimulus to the lip under short-term general anaesthesia (MS-222). The noxious treatments included injection of 0.1% or 2% acetic acid, 0.005% or 0.1% capsaicin, or piercing the lip with a commercial fishing hook. Counts of opercular beat rate (OBR) at 10, 30, 60, 90 and 120 min and observations of behaviour at 30 and 90 min post-treatment were compared with pre-treatment values and with control fish injected with physiological saline, an innocuous stimulus. Circulatory levels of physiological stress indicators were determined in all fish at 120 minutes post-treatment. All treatments evoked temporarily increased OBR that returned to pre-treatment levels at 60 minutes (saline, 0.005% capsaicin, hook), 90 minutes (0.1% acetic acid, 0.1% capsaicin), or 120 minutes (2% acetic acid), but with no significant differences from the control group at any time point. Fish treated with 0.1% and 2% acetic acid and 0.1% capsaicin displayed increased hovering close to the bottom of the aquaria and fish given 2% acetic acid and 0.1% capsaicin also displayed a reduced use of shelter. The only effect seen in hooked fish was brief episodes of lateral head shaking which were not seen pre-treatment or in the other groups, possibly reflecting a resiliency to tissue damage in the mouth area related to the tough nature of the Atlantic cod diet. There were no differences between groups in circulatory stress indicators two hours after treatment. This study provides novel data on behavioural indicators that could be used to assess potentially aversive events in Atlantic cod.	[Eckroth, Jared R.; Doving, Kjell B.] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Aas-Hansen, Oyvind; Bichao, Helena] Nofima, Norwegian Inst Food Fisheries & Aquaculture Res, Tromso, Norway; [Sneddon, Lynne U.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England		Aas-Hansen, O (corresponding author), Nofima, Norwegian Inst Food Fisheries & Aquaculture Res, Tromso, Norway.	oyvind.aas-hansen@nofima.no		Higgs, Dennis/0000-0002-0771-4642; Sneddon, Lynne/0000-0001-9787-3948	Norwegian Research Council, NRCResearch Council of Norway [18745/E40]; National Centre for the Replacement [NC/K000888/1] Funding Source: researchfish	This study was funded by the Norwegian Research Council (http://www.forskningsradet.no/) through the project "Nociception and potential pain perception in the Atlantic cod (Gadus morhua)", NRC project number 18745/E40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinghaus R, 2007, REV FISH SCI, V15, P75, DOI 10.1080/10641260601149432; Artigas ML, 2005, J FISH BIOL, V67, P384, DOI 10.1111/j.0022-1112.2005.00745.x; Ashley PJ, 2007, BRAIN RES, V1166, P47, DOI 10.1016/j.brainres.2007.07.011; Ashley PJ, 2009, ANIM BEHAV, V77, P403, DOI 10.1016/j.anbehav.2008.10.015; BEUKEMA J J, 1970, Netherlands Journal of Zoology, V20, P81; BEUKEMA JJ, 1970, J FISH BIOL, V2, P155, DOI 10.1111/j.1095-8649.1970.tb03268.x; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bossus M, 2011, COMP BIOCHEM PHYS A, V160, P43, DOI 10.1016/j.cbpa.2011.04.014; Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Brown JA, 2008, AQUACULTURE, V285, P135, DOI 10.1016/j.aquaculture.2008.08.027; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Chervova L.S, 1997, J ICHTHYOL+, V37, P98; Chung G, 2010, PHARM PAIN, P327; COSEWIC, 2003, ASS UPD REP GAD MORH; Council of the European Union, 1998, EUR CONV PROT VERT A; FERNO A, 1983, FISH RES, V2, P19, DOI 10.1016/0165-7836(83)90100-5; Foss A, 2006, AQUACULTURE, V256, P255, DOI 10.1016/j.aquaculture.2006.02.032; Gallagher AJ, 2010, J AQUAT ANIM HEALTH, V22, P229, DOI 10.1577/H10-012.1; Herbert NA, 2005, MAR BIOL, V147, P1403, DOI 10.1007/s00227-005-0003-8; HOLZER P, 1991, PHARMACOL REV, V43, P143; Huntingford FA, 2006, J FISH BIOL, V68, P332, DOI 10.1111/j.0022-1112.2006.001046.x; IASP, 2011, IASP TAX INT ASS STU; Johansen JL, 2006, J FISH BIOL, V68, P1918, DOI 10.1111/j.1095-8649.2006.01080.x; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karlsson A, 2011, FISH PHYSIOL BIOCHEM, p1 ; KAVALIERS M, 1988, BRAIN RES BULL, V21, P923, DOI 10.1016/0361-9230(88)90030-5; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Le Bars D, 2001, PHARMACOL REV, V53, P597; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Loeser J, 2008, KYOTO PROTOCOL IASP, V137, P5; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Mangos S, 2007, GENE EXPR PATTERNS, V7, P480, DOI 10.1016/j.modgep.2006.10.011; McMahon SB, 2006, INFLAMMATORY MEDIATO, P49; Melzack R., 2006, WALL MELZACKS TXB PA, P291; Mettam JJ, 2011, APPL ANIM BEHAV SCI, V133, P265, DOI 10.1016/j.applanim.2011.06.009; Meyer R.A., 2006, WALL MELZACKS TXB PA, P3; Molony V, 1997, J ANIM SCI, V75, P266; Newby NC, 2009, CAN J ZOOL, V87, P388, DOI 10.1139/Z09-023; Newby NC, 2008, APPL ANIM BEHAV SCI, V114, P260, DOI 10.1016/j.applanim.2007.12.006; Nilsson J, 2008, ANIM COGN, V11, P215, DOI 10.1007/s10071-007-0103-6; Nordgreen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092116; Nordgreen J, 2009, APPL ANIM BEHAV SCI, V119, P101, DOI 10.1016/j.applanim.2009.03.015; Olsen RE, 2010, NORWEGIAN SCI COMMIT, V09, P1; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; PARK KM, 1995, PAIN, V63, P163, DOI 10.1016/0304-3959(95)00029-R; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Roques JAC, 2010, PHYSIOL BEHAV, V101, P533, DOI 10.1016/j.physbeh.2010.08.001; Rose JD, 2007, DIS AQUAT ORGAN, V75, P139, DOI 10.3354/dao075139; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Rose JD, 2012, FISH FISH, P1; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P1, DOI 10.1002/9781444302264; Schjolden J, 2007, BRAIN BEHAV EVOLUT, V70, P227, DOI 10.1159/000105486; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; SCHULZ R, 1985, STEROIDS, V46, P717, DOI 10.1016/0039-128X(85)90051-0; Sherrington CS, 1903, J PHYSIOL-LONDON, V30, P39; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Sneddon LU, 2011, J CONSCIOUSNESS STUD, V18, P209; Tveiten H, 2010, J FISH BIOL, V76, P2318, DOI 10.1111/j.1095-8649.2010.02636.x; Zahl IH, 2010, FISH PHYSIOL BIOCHEM, V36, P719, DOI 10.1007/s10695-009-9346-2; Zahl IH, 2009, AQUACULTURE, V295, P52, DOI 10.1016/j.aquaculture.2009.06.019; Zimov S, 2004, J NEUROCYTOL, V33, P441, DOI 10.1023/B:NEUR.0000046574.72380.e8	69	11	11	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100150	10.1371/journal.pone.0100150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	WOS:000338503400082	24936652	Green Published, Green Submitted, gold			2022-02-06	
J	Edwards, JC; Bodle, JD				Edwards, Jonathan C.; Bodle, Jeffrey D.			Causes and Consequences of Sports Concussion	JOURNAL OF LAW MEDICINE & ETHICS			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; AMERICAN FOOTBALL; UNITED-STATES; RECOVERY; INJURIES; PLAYERS; IMPACT		[Edwards, Jonathan C.] Med Univ S Carolina, Charleston, SC 29425 USA; [Edwards, Jonathan C.] MUSC Comprehens Epilepsy Ctr, Charleston, SC USA; [Bodle, Jeffrey D.] Carolinas Med Ctr NorthEast, Concord, NC USA		Edwards, JC (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.						Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008	19	11	11	0	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	SUM	2014	42	2			SI		128	132		10.1111/jlme.12126			5	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	AM2XI	WOS:000339714400002	25040374				2022-02-06	
J	Russell, VA; Zigmond, MJ; Dimatelis, JJ; Daniels, WMU; Mabandla, MV				Russell, Vivienne A.; Zigmond, Michael J.; Dimatelis, Jacqueline J.; Daniels, William M. U.; Mabandla, Musa V.			The interaction between stress and exercise, and its impact on brain function	METABOLIC BRAIN DISEASE			English	Article						Voluntary running; Maternal separation; Stress exercise	PITUITARY-ADRENOCORTICAL AXIS; FRONTAL-CORTEX VOLUME; MATERNAL SEPARATION; VOLUNTARY EXERCISE; SYNAPTIC PLASTICITY; RAT MODEL; HIPPOCAMPUS; INCREASES; 6-HYDROXYDOPAMINE; MEMORY	In response to acute adversity, emotional signals shift the body into a state that permits rapid detection, identification, and appropriate response to a potential threat. The stress response involves the release of a variety of substances, including neurotransmitters, neurotrophic factors, hormones, and cytokines, that enable the body to deal with the challenges of daily life. The subsequent activation of various physiological systems can be both protective and damaging to the individual, depending on timing, intensity, and duration of the stressor. Successful recovery from stressful challenges during early life leads to strengthening of synaptic connections in health-promoting neural networks and reduced vulnerability to subsequent stressors that can be protective in later life. In contrast, chronic intense uncontrollable stress can be pathogenic and lead to disorders such as depression, anxiety, hypertension, Alzheimer's disease, Parkinson's disease, and an increased toxic response to additional stressors such as traumatic brain injury and stroke. This review briefly explores the interaction between stress experienced at different stages of development and exercise later in life.	[Russell, Vivienne A.; Dimatelis, Jacqueline J.] Univ Cape Town, Dept Human Biol, ZA-7925 Observatory, South Africa; [Zigmond, Michael J.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Daniels, William M. U.; Mabandla, Musa V.] Univ KwaZulu Natal, Div Human Physiol, ZA-4001 Durban, South Africa		Russell, VA (corresponding author), Univ Cape Town, Dept Human Biol, ZA-7925 Observatory, South Africa.	Vivienne.Russell@uct.ac.za					Aguiar AS, 2011, MECH AGEING DEV, V132, P560, DOI 10.1016/j.mad.2011.09.005; Akbarian S, 2010, NAT MED, V16, P1187, DOI 10.1038/nm1110-1187; Bechara RG, 2013, BEHAV BRAIN RES; Bick-Sander A, 2006, P NATL ACAD SCI USA, V103, P3852, DOI 10.1073/pnas.0502644103; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Camiletti-Moiron D, 2013, SCAND J MED SCI SPOR, V23, pe202, DOI 10.1111/sms.12065; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Chapman SB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00075; Choi JH, 2013, J EXERC REHABIL, V9, P457, DOI 10.12965/jer.130055; CHRISTENSEN NJ, 1983, ANNU REV PHYSIOL, V45, P139, DOI 10.1146/annurev.ph.45.030183.001035; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Daniels WMU, 2012, EXP PHYSIOL, V97, P239, DOI 10.1113/expphysiol.2011.061176; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dimatelis JJ, 2013, J MOL NEUROSCI; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Droste SK, 2007, NEUROENDOCRINOLOGY, V86, P26, DOI 10.1159/000104770; Fang ZH, 2013, NEUROSCI RES, V76, P187, DOI 10.1016/j.neures.2013.04.005; Farina N, 2013, INT PSYCHOGERIATR; Faure J, 2006, METAB BRAIN DIS, V21, P181, DOI 10.1007/s11011-006-9013-6; FREUND BJ, 1991, J APPL PHYSIOL, V70, P900, DOI 10.1152/jappl.1991.70.2.900; Gebara E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00145; Gutierrez-Santiago A, 2013, GAIT POSTURE; Hamacher-Dang TC, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00108; Howells FM, 2005, BEHAV BRAIN RES, V165, P210, DOI 10.1016/j.bbr.2005.06.044; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Jesse CR, 2013, NEUROSCIENCE; Kim TW, 2013, J EXERC REHABIL, V9, P451, DOI 10.12965/jer.130064; Kohman RA, 2012, BRAIN BEHAV IMMUN, V26, P803, DOI 10.1016/j.bbi.2011.10.006; Lai TJ, 2000, BIOL PSYCHIAT, V48, P971, DOI 10.1016/S0006-3223(00)01042-8; Mabandla M, 2004, METAB BRAIN DIS, V19, P43, DOI 10.1023/B:MEBR.0000027416.13070.c3; Mabandla MV, 2009, METAB BRAIN DIS, V24, P525, DOI 10.1007/s11011-009-9161-6; Mabandla MV, 2010, BEHAV BRAIN RES, V211, P16, DOI 10.1016/j.bbr.2010.02.045; Makena N, 2012, METAB BRAIN DIS, V27, P377, DOI 10.1007/s11011-012-9298-6; Marais L, 2008, NEUROSCI RES, V61, P106, DOI 10.1016/j.neures.2008.01.011; Marais L, 2009, METAB BRAIN DIS, V24, P587, DOI 10.1007/s11011-009-9157-2; MCKEEVER KH, 1987, MED SCI SPORT EXER, V19, P21, DOI 10.1249/00005768-198702000-00005; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Nadeau A, 2013, MED SCI SPORTS EXERC; Park CY, 2013, J EXERC REHABIL, V9, P406, DOI 10.12965/jer.130053; Patten AR, 2013, LEARN MEMORY, V20, P642, DOI 10.1101/lm.030635.113; Pienaar IS, 2008, STRESS, V11, P448, DOI 10.1080/10253890801890721; Piers t, 2013, BRAIN; Rothman SM, 2013, NEUROSCIENCE, V239, P228, DOI 10.1016/j.neuroscience.2012.10.014; Shih PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078163; Silveira PP, 2011, NEUROCHEM RES, V36, P2075, DOI 10.1007/s11064-011-0531-1; Steffens DC, 2003, NEUROPSYCHOPHARMACOL, V28, P2179, DOI 10.1038/sj.npp.1300285; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Sun HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081775; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Timmermans W, 2013, NEUROSCIENCE, V248, P626, DOI 10.1016/j.neuroscience.2013.05.043; Tse YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027215; Wang Q, 2013, BEHAV BRAIN RES, V256, P618, DOI 10.1016/j.bbr.2013.09.024; Wosiski-Kuhn M, 2012, SYNAPSE, V66, P661, DOI 10.1002/syn.21545; Yau SY, 2012, NEUROSCIENCE, V222, P289, DOI 10.1016/j.neuroscience.2012.07.019; Zhang H, 2013, MOL PSYCHIATR, V18, P471, DOI 10.1038/mp.2012.80; Zigmond MJ, 2009, PARKINSONISM RELAT D, V15, pS42, DOI 10.1016/S1353-8020(09)70778-3	57	11	11	3	41	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	JUN	2014	29	2			SI		255	260		10.1007/s11011-013-9479-y			6	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	AH7SU	WOS:000336335200006	24399497				2022-02-06	
J	Soldatovic-Stajic, B; Misic-Pavkov, G; Bozic, K; Novovic, Z; Gajic, Z				Soldatovic-Stajic, B.; Misic-Pavkov, G.; Bozic, K.; Novovic, Z.; Gajic, Z.			Neuropsychological and neurophysiological evaluation of cognitive deficits related to the severity of traumatic brain injury	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Traumatic brain injury; Cognitive disturbances; Neuropsychological testing; Event related potentials (P300)	EVENT-RELATED POTENTIALS; HEAD-INJURY; ATTENTION; RECOVERY; TESTS; P300; TASK; AGE	OBJECTIVES: Cognitive impairment is a common permanent sequela of traumatic brain injury (TBI). Its objectivization is based on neuropsychological and neurophysiological assessment. Neuropsychological evaluation requires a test battery, whereas for neurophysiological assessment the most significant is application of P300 Event-Related Potentials (ERPs). The aim of the study was to determine whether it is possible to differentiate between degrees of severity of TBI on the basis of neuropsychological and neurophysiological parameters. PATIENTS AND METHODS: A total of 90 patients with closed TBI were evaluated at least one year after trauma. Subjects were classified into three groups according to severity of TBI: mild, moderate and severe. In all subjects the Intelligence Test, the Wisconsin Card Sorting Test (WCST) and P300 ERPs were performed. RESULTS: General intelligence measures did not prove sensitivity enough to differentiate levels of severity of TBI, whereas the number of achieved categories on the WCST significantly discerned patients with mild and moderate TBI from patients with severe TBI. Perseverative errors significantly separated patients with mild TBI from patients with moderate and severe TBI. Non-perseverative errors significantly differentiated only patients with mild TBI from patients with severe TBI. Finally, P300 latency (EPLAT) significantly differentiated patients with mild TBI from patients with moderate and severe TBI. The results show that the applied test battery can discriminate between different levels of severity of TBI and emphasize the importance of P300 ERP in the evaluation of patients with brain injury. CONCLUSIONS: Our findings indicate that the WCST and ERP P300 latency have a significant role in the assessment of cognitive deficit related to TBI.	[Soldatovic-Stajic, B.; Misic-Pavkov, G.; Bozic, K.; Gajic, Z.] Univ Novi Sad, Fac Med, Clin Ctr Vojvodina, Novi Sad, Serbia; [Novovic, Z.] Univ Novi Sad, Fac Philosophy, Dept Psychol, Novi Sad, Serbia		Bozic, K (corresponding author), Univ Novi Sad, Fac Med, Clin Ctr Vojvodina, Novi Sad, Serbia.	bozick@eunet.rs		Gajic, Zoran/0000-0002-4798-2502			Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Berger J, 1994, PRIRU NIK VEKSLEROV; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cooper R, 1984, EVOKED POTENTIAL, VII, P446; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Heaton R.K., 1981, WISCONSIN CARD SORTI; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; Kirkby BS, 1996, NEUROPSYCHOLOGIA, V34, P689; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; Naito Yasuo, 2005, Kobe Journal of Medical Sciences, V51, P95; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; Rodriguez-Aranda C, 2006, J GENET PSYCHOL, V167, P269, DOI 10.3200/GNTP.167.3.269-287; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Spikman JM, 2004, J INT NEUROPSYCH SOC, V10, P851, DOI 10.1017/S1355617704106061; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	30	11	12	0	8	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	JUN	2014	18	11					1632	1637					6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AP3KM	WOS:000341974800011	24943974				2022-02-06	
J	Zhang, L; Zhao, MG; Fu, WH; Gao, XQ; Shen, J; Zhang, ZY; Xian, M; Jiao, YZ; Jiang, J; Wang, JQ; Gao, GM; Tang, B; Chen, L; Li, WM; Zhou, CH; Deng, SP; Gu, JW; Zhang, D; Zheng, Y; Chen, XM				Zhang, Li; Zhao, Minggang; Fu, Wenhao; Gao, Xinqiang; Shen, Ji; Zhang, Zuyun; Xian, Ming; Jiao, Yunzhi; Jiang, Jian; Wang, Jinqian; Gao, Guomin; Tang, Bin; Chen, Liang; Li, Weimin; Zhou, Changhua; Deng, Shaoping; Gu, Jianwen; Zhang, Dong; Zheng, Ying; Chen, Xiangmei			Epidemiological Analysis of Trauma Patients following the Lushan Earthquake	PLOS ONE			English	Article							2008 WENCHUAN EARTHQUAKE; 2010 YUSHU EARTHQUAKE; WOUND INFECTIONS; MANAGEMENT; DISASTER; VICTIMS; RESCUE; EVACUATION; CHINA; NEEDS	Background: A 7.0-magnitude earthquake hit Lushan County in China's Sichuan province on April 20, 2013, resulting in 196 deaths and 11,470 injured. This study was designed to analyze the characteristics of the injuries and the treatment of the seismic victims. Methods: After the earthquake, an epidemiological survey of injured patients was conducted by the Health Department of Sichuan Province. Epidemiological survey tools included paper-and-pencil questionnaires and a data management system based on the Access Database. Questionnaires were completed based on the medical records of inpatients with earthquake-related injuries. Outpatients or non-seismic injured inpatients were excluded. A total of 2010 patients from 140 hospitals were included. Results: The most common type of injuries involved bone fractures (58.3%). Children younger than 10 years of age suffered fewer fractures and chest injuries, but more skin and soft -tissue injuries. Patients older than 80 years were more likely to suffer hip and thigh fractures, pelvis fractures, and chest injuries, whereas adult patients suffered more ankle and foot fractures. A total of 207 cases of calcaneal fracture were due to high falling injuries related to extreme panic. The most common type of infection in hospitalized patients was pulmonary infections. A total of 70.5% patients had limb dysfunction, and 60.1% of this group received rehabilitation. Most patients received rehabilitation within 1 week, and the median duration of rehabilitation was 3 weeks. The cause of death of all seven hospitalized patients who died was severe traumatic brain injuries; five of this group died within 24 h after the earthquake. Conclusions: Injuries varied as a function of the age of the victim. As more injuries were indirectly caused by the Lushan earthquake, disaster education is urgently needed to avoid secondary injuries.	[Zhang, Li; Zhang, Dong; Zheng, Ying; Chen, Xiangmei] Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Zhang, Li; Zhang, Dong; Zheng, Ying; Chen, Xiangmei] Mil Med Coll, Beijing, Peoples R China; [Zhao, Minggang; Fu, Wenhao; Gao, Xinqiang] Natl Hlth & Family Planning Commiss Peoples Repub, Beijing, Peoples R China; [Shen, Ji; Zhang, Zuyun; Xian, Ming; Jiao, Yunzhi; Jiang, Jian; Wang, Jinqian] Hlth & Family Planning Commiss Sichuan Prov, Chengdu, Peoples R China; [Gao, Guomin; Tang, Bin; Chen, Liang] United Logist Minist, Dept Hlth, Chengdu, Chengdu Militar, Peoples R China; [Li, Weimin] Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China; [Zhou, Changhua] Publ Hlth Bur Yaan City, Yaan, Peoples R China; [Deng, Shaoping] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Gu, Jianwen] Chengdu Mil Command, Gen Hosp, Chengdu, Peoples R China		Chen, XM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	xmchen301@126.com		Zhang, Dong/0000-0002-6521-9586	Chinese PLA 12th FiveYear Plan for Medical Sciences [BWS11J027]; National Science & Technology Pillar Program [2011BAI10B00, 2013BAI09B05]	The study was funded by grants from Chinese PLA 12th FiveYear Plan for Medical Sciences (BWS11J027) and National Science & Technology Pillar Program (No. 2011BAI10B00, 2013BAI09B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardagh MW, 2012, LANCET, V379, P2109, DOI 10.1016/S0140-6736(12)60313-4; Bartels SA, 2012, LANCET, V379, P748, DOI 10.1016/S0140-6736(11)60887-8; Chen EQ, 2011, J HUAZHONG U SCI-MED, V31, P83, DOI 10.1007/s11596-011-0155-3; [陈锦 CHEN Jin], 2009, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V9, P1267; DEBRUYCKER M, 1983, B WORLD HEALTH ORGAN, V61, P1021; Emily YY., 2008, LANCET, V372, P359; Jiang Jie, 2012, J Evid Based Med, V5, P114, DOI 10.1111/j.1756-5391.2012.01186.x; Kang P, 2012, J TRAUMA ACUTE CARE, V72, P1626, DOI 10.1097/TA.0b013e3182479e07; Landry MD, 2010, PHYSIOTHER RES INT, V15, P123, DOI 10.1002/pri.488; Li SS, 2013, J REHABIL MED, V45, P603, DOI 10.2340/16501977-1176; Li Yuanfeng, 2009, J Evid Based Med, V2, P258, DOI 10.1111/j.1756-5391.2009.01045.x; Liu X, 2013, J EMERG MED, V45, P865, DOI 10.1016/j.jemermed.2013.05.054; Lushan earthquake medical expert team, 2013, CHINESE MED J, V93, P1527; Mace SE, 2007, AM J EMERG MED, V25, P762, DOI 10.1016/j.ajem.2006.12.011; Miskin IN, 2010, NEW ENGL J MED, V363, P2571, DOI 10.1056/NEJMc1005578; Oda J, 1997, J TRAUMA, V42, P470, DOI 10.1097/00005373-199703000-00015; Ouyang Y, 2013, LANCET, V381, P1801, DOI 10.1016/S0140-6736(13)61105-8; Raissi GR, 2007, J SPINAL CORD MED, V30, P369, DOI 10.1080/10790268.2007.11753954; Ran YC, 2010, SCAND J INFECT DIS, V42, P347, DOI 10.3109/00365540903510682; Sever MS, 2001, KIDNEY INT, V60, P1114, DOI 10.1046/j.1523-1755.2001.0600031114.x; Shen Ji, 2012, J Evid Based Med, V5, P75, DOI 10.1111/j.1756-5391.2012.01176.x; Sugihara G, 2011, LANCET, V378, P485, DOI 10.1016/S0140-6736(11)61250-6; Tang BH, 2013, LANCET, V381, P1984, DOI 10.1016/S0140-6736(13)61201-5; Tao C, 2009, DIAGN MICR INFEC DIS, V63, P268, DOI 10.1016/j.diagmicrobio.2008.11.009; van der Tol A, 2009, NEPHROL DIAL TRANSPL, V24, P907, DOI 10.1093/ndt/gfn557; Wang Y, 2010, EMERG INFECT DIS, V16, P974, DOI 10.3201/eid1606.091523; Zhang H, 2013, CHIN J TRAUMATOL, V16, P10, DOI 10.3760/cma.j.issn.1008-1275.2013.01.002; Zhang L, 2014, CHINESE MED J-PEKING, V127, P995, DOI 10.3760/cma.j.issn.0366-6999.20131708; Zhang L, 2012, INJURY, V43, P1470, DOI 10.1016/j.injury.2010.11.036; Zhang LL, 2012, LANCET, V379, P853, DOI 10.1016/S0140-6736(11)61876-X	30	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2014	9	5							e97416	10.1371/journal.pone.0097416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0UW	WOS:000339563400027	24846207	Green Published, Green Submitted, gold			2022-02-06	
J	Hameed, MQ; Goodrich, GS; Dhamne, SC; Amandusson, A; Hsieh, TH; Mou, D; Wang, YP; Rotenberg, A				Hameed, Mustafa Q.; Goodrich, Grant S.; Dhamne, Sameer C.; Amandusson, Asa; Hsieh, Tsung-Hsun; Mou, Danlei; Wang, Yingpeng; Rotenberg, Alexander			A rapid lateral fluid percussion injury rodent model of traumatic brain injury and post-traumatic epilepsy	NEUROREPORT			English	Article						lateral fluid percussion; post-traumatic epilepsy; traumatic brain injury	NEURONAL DEGENERATION; BEHAVIORAL DEFICITS; CELL-DEATH; RAT; HYPOTHERMIA; CONSEQUENCES; PROTECTION; SEIZURES; AGENTS	Traumatic brain injury is a leading cause of acquired epilepsy. Initially described in 1989, lateral fluid percussion injury (LFPI) has since become the most extensively used and well-characterized rodent traumatic brain injury and post-traumatic epilepsy model. Universal findings, particularly seizures that reliably develop after an initial latent period, are evident across studies from multiple laboratories. However, the LFPI procedure is a two-stage process, requiring initial surgical attachment of a skull fluid cannula and then reanesthesia for delivery of the epidural fluid pressure wave. We now describe a modification of the original technique, termed 'rapid lateral fluid percussion injury' (rLFPI), which allows for a one-stage procedure and thus shorter operating time and reduced anesthesia exposure. Anesthetized male Long-Evans rats were subjected to rLFPI through a length of plastic tubing fitted with a pipette tip cannula with a 4-mm aperture. The cannula opening was positioned over a craniectomy of slightly smaller diameter and exposed dura such that the edges of the cannula fit tightly when pressed to the skull with a micromanipulator. Fluid percussion was then delivered immediately thereafter, in the same surgery session. rLFPI resulted in nonlethal focal cortical injury in all animals. We previously demonstrated that the rLFPI procedure resulted in post-traumatic seizures and regional gliosis, but had not examined other histopathologic elements. Now, we show apoptotic cell death confined to the perilesional cortex and chronic pathologic changes such as ipsilesional ventriculomegaly that are seen in the classic model. We conclude that the rLFPI method is a viable alternative to classic LFPI, and - being a one-stage procedure - has the advantage of shorter experiment turnaround and reduced exposure to anesthetics.	[Hameed, Mustafa Q.; Goodrich, Grant S.; Dhamne, Sameer C.; Rotenberg, Alexander] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Hameed, Mustafa Q.] Harvard Univ, Sch Med, Dept Neurosurg, Boston Childrens Hosp, Boston, MA 02115 USA; [Amandusson, Asa] Uppsala Univ, Div Clin Neurophysiol, Dept Neurosci, Uppsala, Sweden; [Hsieh, Tsung-Hsun] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei, Taiwan; [Mou, Danlei] Capital Med Univ, Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Wang, Yingpeng] Beijing Aerosp Gen Hosp, Dept Neurol, Beijing, Peoples R China		Rotenberg, A (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02215 USA.	alexander.rotenberg@childrens.harvard.edu	Hameed, Mustafa/G-3677-2014; Hsieh, Tung-Hsun/AAZ-5010-2020	Hameed, Mustafa/0000-0003-4004-5564; Hsieh, Tung-Hsun/0000-0002-1794-7941	DoD Defense Medical Research and Development Program Basic Research Award [PT090716]; CURE	This work was supported by DoD Defense Medical Research and Development Program Basic Research Award PT090716 (A. R.) and CURE (A. R.).	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Conti AC, 1998, J NEUROSCI, V18, P5663; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Loscher W, 2002, EPILEPSY RES, V50, P3, DOI 10.1016/S0920-1211(02)00063-3; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ozden S, 2004, J NEUROTRAUM, V21, P73, DOI 10.1089/089771504772695968; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Temkin N R, 1995, New Horiz, V3, P518; Temkin NR, 2001, DRUGS, V61, P1045, DOI 10.2165/00003495-200161080-00002	25	11	11	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	MAY 7	2014	25	7					532	536		10.1097/WNR.0000000000000132			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF1GR	WOS:000334462900017	24553065				2022-02-06	
J	Auner, B; Marzi, I				Auner, B.; Marzi, I.			Pediatric multiple trauma	CHIRURG			German	Article						Multiple trauma; Injury pattern; Traumatic brain injury; Emergency room; Child	CHILDREN; INJURIES; MANAGEMENT; CHILDHOOD	Multiple trauma in children is rare so that even large trauma centers will only treat a small number of cases. Nevertheless, accidents are the most common cause of death in childhood whereby the causes are mostly traffic accidents and falls. Head trauma is the most common form of injury and the degree of severity is mostly decisive for the prognosis. Knowledge on possible causes of injury and injury patterns as well as consideration of anatomical and physiological characteristics are of great importance for treatment. The differences compared to adults are greater the younger the child is. Decompression and stopping bleeding are the main priorities before surgical fracture stabilization. The treatment of a severely injured child should be carried out by an interdisciplinary team in an approved trauma center with expertise in pediatrics. An inadequate primary assessment involves a high risk of early mortality. On the other hand children have a better prognosis than adults with comparable injuries.	[Auner, B.; Marzi, I.] Klinikum Johann Wolfgang Goethe Univ Frankfurt, Klin Unfall Hand & Wiederherstellungschirurg, D-60590 Frankfurt, Germany		Auner, B (corresponding author), Klinikum Johann Wolfgang Goethe Univ Frankfurt, Klin Unfall Hand & Wiederherstellungschirurg, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	birgit.auner@kgu.de					Bouillon B, 2004, UNFALLCHIRURG, V107, P844, DOI 10.1007/s00113-004-0847-2; Bundesamt S, JAHRESSTATISTIK; Debus F, 2013, UNFALLCHIRURG; Jagannathan J, 2007, OUTCOME FOLLOWING DE; Jakob H, 2013, TRAUMA BERUFSKRANKH, V15, P67, DOI 10.1007/s10039-012-1905-6; Jakob H, 2009, UNFALLCHIRURG, V112, P951, DOI 10.1007/s00113-009-1682-2; Landau A, 2006, INJURY, V37, P66, DOI 10.1016/j.injury.2005.07.013; Laurer H, 2009, UNFALLCHIRURG, V112, P771, DOI 10.1007/s00113-009-1589-y; Marzi I, 2012, PRAXISBUCH POLYTRAUM, pS1; Marzi I, 2009, KINDERTRAUMATOLOGIE, pS 1; Moore HB, 2013, J TRAUMA ACUTE CARE, V75, P995, DOI 10.1097/TA.0b013e3182ab065b; NAU C, 2010, ORTHOPADIE UNFALLCHI, V5, P23; Patel Neil, 2013, Surg Neurol Int, V4, P128, DOI 10.4103/2152-7806.119055; Schmittenbecher PP, 2013, MONATSSCHR KINDERH, V161, P122, DOI 10.1007/s00112-012-2759-5; Schneidmueller D, 2011, UNFALLCHIRURG, V114, P396, DOI 10.1007/s00113-011-1969-y; SHARPLES PM, 1990, BRIT MED J, V301, P1193, DOI 10.1136/bmj.301.6762.1193; Slongo TF, 2013, UNFALLCHIRURG, V116, P1076, DOI 10.1007/s00113-013-2462-6; Strohm PC, 2011, UNFALLCHIRURG, V114, P323, DOI 10.1007/s00113-011-1967-0; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Unfallchirurgie DGF, 2011, S3 LEITL POL SCHWERV, pS1; Unfallchirurgie DGF, 2014, WEISSB SCHWERV; Unfallversicherung DG, 2014, ANF GES UNF VERS NAC; Voth M, 2013, UNFALLCHIRURG, V116, P1062, DOI 10.1007/s00113-013-2460-8; Walcher F, 2006, BRIT J SURG, V93, P238, DOI 10.1002/bjs.5213; Walcher F, 2009, ANAESTHESIST, V58, P375, DOI 10.1007/s00101-009-1513-4; Wyen H, 2010, EUR J TRAUMA EMERG S, V36, P300, DOI 10.1007/s00068-010-1124-4	26	11	13	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-4722	1433-0385		CHIRURG	Chirurg	MAY	2014	85	5					451	461		10.1007/s00104-013-2680-z			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AG8LJ	WOS:000335669600017	24811223				2022-02-06	
J	Egea-Guerrero, JJ; Murillo-Cabezas, F; Rodriguez-Rodriguez, A; Gordillo-Escobar, E; Revuelto-Rey, J; Munoz-Sanchez, MA; Leon-Justel, A; Vilches-Arenas, A				Egea-Guerrero, J. J.; Murillo-Cabezas, F.; Rodriguez-Rodriguez, A.; Gordillo-Escobar, E.; Revuelto-Rey, J.; Munoz-Sanchez, M. A.; Leon-Justel, A.; Vilches-Arenas, A.			An experimental model of mass-type brain damage in the rat: Expression of brain damage based on neurospecific enolase and protein S100B	MEDICINA INTENSIVA			Spanish	Article						S100B protein; Neurospecifie enolase; Traumatic brain injury; Experimental model; Rat	NEURON-SPECIFIC ENOLASE; FLUID-PERCUSSION INJURY; SUBARACHNOID HEMORRHAGE; MODERATE HYPOTHERMIA; COGNITIVE RECOVERY; S100-BETA PROTEIN; CEREBRAL-ISCHEMIA; MARKER; RODENTS; LESION	Objective: To determine whether a model of transient mass-type brain damage (MTBD) in the rat produces early release of neurospecific enolase (NSE) and protein S100B in peripheral blood, as an expression of the induced brain injury. Design: An experimental study with a control group. Setting: Experimental operating room of the Institute of Biomedicine (IBiS) of Virgen del Rocio University Hospital (Seville, Spain). Participants: Fourteen adult Wistar rats. Interventions: Blood was sampled at baseline, followed by: MTBD group, a trephine perforation was used to insert and inflate the balloon of a catheter at a rate of 500 mu l/20 sec, followed by 4 blood extractions every 20 min. Control group, the same procedure as before was carried out, though without trephine perforation. Primary study variables: Weight, early mortality, serum NSE and S100B concentration. Results: Differences in NSE and S100B concentration were observed over time within the MTBD group (P < .001), though not so in the control group. With the exception of the baseline determination, differences were observed between the two groups in terms of the mean NSE and S100B values. Following MTBD, NSE and S100B progressively increased at all measurement time-points, with r = 0.765; P= .001 and r = 0.628; P= .001, respectively. In contrast, the control group showed no such correlation for either biomarker. Conclusions: Serum NSE and S100B concentrations offer an early indication of brain injury affecting the gray and white matter in an experimental model of mass-type MTBD in the rat. (C) 2013 Elsevier Espana, S.L. and SEMICYUC. All rights reserved.	[Egea-Guerrero, J. J.; Murillo-Cabezas, F.; Gordillo-Escobar, E.; Revuelto-Rey, J.; Munoz-Sanchez, M. A.] Univ Seville, IBiS CSIC, HU Virgen Rocio, Unidad Neurocrit, Seville, Spain; [Rodriguez-Rodriguez, A.; Leon-Justel, A.] Univ Seville, IBiS CSIC, HU Virgen Rocio, Dept Bioquim Clin, Seville, Spain; [Vilches-Arenas, A.] Univ Seville, IBiS CSIC Univ Sevilla, Dept Med Prevent & Salud Publ, Seville, Spain		Egea-Guerrero, JJ (corresponding author), Univ Seville, IBiS CSIC, HU Virgen Rocio, Unidad Neurocrit, Seville, Spain.	juanjoegea@hotmail.com	IBIS, NEUROINMUNO/O-9306-2015; Murillo-Cabezas, Francisco/AAO-3348-2021; Rodriguez-Rodriguez, Ana/F-4718-2016; Vilches-Arenas, Angel/C-1167-2015; IBIS, NEUROCRITICOS/C-1805-2016; Egea-Guerrero, Juan Jose JJ/P-5080-2014	Rodriguez-Rodriguez, Ana/0000-0002-6854-9695; Vilches-Arenas, Angel/0000-0003-2197-3760; Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; Revuelto-Rey, Jaume/0000-0001-8350-9555			Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Burger R, 2003, J NEUROTRAUM, V20, P543, DOI 10.1089/089771503767168474; Burger R, 2002, J NEUROSURG, V97, P1410, DOI 10.3171/jns.2002.97.6.1410; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; DAY INM, 1984, CLIN CHIM ACTA, V136, P219, DOI 10.1016/0009-8981(84)90295-X; Donato Rosario, 2010, Cardiovasc Psychiatry Neurol, V2010, P929712, DOI 10.1155/2010/929712; Egea-Guerrero JJ, 2012, TRANSPL P, V44, P2050, DOI 10.1016/j.transproceed.2012.07.070; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Bernal EF, 2013, MED INTENSIVA, V37, P327, DOI 10.1016/j.medin.2012.05.015; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; HARDEMARK HG, 1988, STROKE, V19, P1140, DOI 10.1161/01.STR.19.9.1140; HATFIELD RH, 1992, BRAIN RES, V577, P249, DOI 10.1016/0006-8993(92)90280-M; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; KAISER E, 1989, CLIN CHIM ACTA, V183, P13, DOI 10.1016/0009-8981(89)90268-4; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; MARANGOS PJ, 1980, J NEUROCHEM, V34, P1254, DOI 10.1111/j.1471-4159.1980.tb09967.x; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Munoz-Sanchez MA, 2012, J NEUROSCI METH, V211, P88, DOI 10.1016/j.jneumeth.2012.08.010; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; Revuelto-Rey J, 2012, MED INTENSIVA, V36, P213, DOI 10.1016/j.medin.2011.08.002; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Warnat Jan, 2012, Acta Neurochir Suppl, V114, P393, DOI 10.1007/978-3-7091-0956-4_76; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752	39	11	12	0	11	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	MAY	2014	38	4					218	225		10.1016/j.medin.2013.03.015			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG9CH	WOS:000335715800004	23786666				2022-02-06	
J	Juengst, SB; Arenth, PM; Whyte, EM; Skidmore, ER				Juengst, Shannon B.; Arenth, Patricia M.; Whyte, Ellen M.; Skidmore, Elizabeth R.			Brief Report of Affective State and Depression Status After Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						positive affect; negative affect; depression; brain injury	MINOR DEPRESSION; MAJOR DEPRESSION; NATURAL-HISTORY; NEGATIVE AFFECT; PRIMARY-CARE; DISORDERS; MODEL; PREDICTORS; DISABILITY; VALIDITY	Objective: To examine the relationship between affective state (positive and negative affect) and depression status among adults with chronic traumatic brain injury (TBI). Research Method: This is a cross-sectional cohort study of community-dwelling adults with chronic TBI (n = 64) that assesses the relationship between affective state (positive and negative affect), using the Positive and Negative Affect Schedule (PANAS), and depression status, categorized as no depression, history of depressive episode, and current depressive episode, using the Primary Care Evaluation of Mental Disorders (PRIME-MD). Results: Affective state differed significantly across depression status groups for both positive affect (F (2, 61) = 5.10, p = .009) and negative affect (F (2, 61) = 8.19, p = .001). Participants with no depression reported higher positive affect (M = 35.67, SD = 9.08) than those with a current depressive episode (M = 27.64, SD = 8.59, p = .007) and lower negative affect (M = 14.52, SD = 5.08) than those with a history of a depressive episode (M = 20.21, SD = 5.08, p = .006) and those with a current depressive episode (M = 22.29, SD = 6.21, p = .001). Conclusions: Poor affective state, including both low positive affect and high negative affect, is associated with depression diagnosis. High negative affect is present, even in the absence of a current depressive episode, after TBI. These data highlight the need to assess affective state in addition to screening for mood disorders among adults with chronic TBI.	[Juengst, Shannon B.; Skidmore, Elizabeth R.] Univ Pittsburgh, Dept Occupat Therapy, Sch Hlth & Rehabil Sci, Pittsburgh, PA 15213 USA; [Juengst, Shannon B.; Arenth, Patricia M.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Whyte, Ellen M.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; [Skidmore, Elizabeth R.] Univ Pittsburgh, Pittsburgh, PA 15213 USA		Juengst, SB (corresponding author), Univ Pittsburgh, 3471 Fifth Ave,Kaufmann Med Bldg,Suite 202, Pittsburgh, PA 15213 USA.	sbj7@pitt.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD055931] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055931] Funding Source: NIH RePORTER		Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Beekman ATF, 2002, ARCH GEN PSYCHIAT, V59, P605, DOI 10.1001/archpsyc.59.7.605; Beekman ATF, 1997, PSYCHOL MED, V27, P1397, DOI 10.1017/S0033291797005734; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Gray E.K., 2001, EMOTION MOOD TEMPERA, P21; Harkness KL, 2002, EUR J PERSONALITY, V16, P271, DOI 10.1002/per.441; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoofien D, 2001, BRAIN INJURY, V15, P189; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Lyness JM, 1999, J AM GERIATR SOC, V47, P647, DOI 10.1111/j.1532-5415.1999.tb01584.x; Malec J., 2005, MAYO PORTLAND ADAPTA; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nutt D, 2007, J PSYCHOPHARMACOL, V21, P461, DOI 10.1177/0269881106069938; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; TEASDALE G, 1974, LANCET, V2, P81; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346	33	11	11	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2014	59	2					242	246		10.1037/a0036294			5	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AJ7SQ	WOS:000337897800016	24708234	Green Accepted			2022-02-06	
J	McCabe, JT; Moratz, C; Liu, YB; Burton, E; Morgan, A; Budinich, C; Lowe, D; Rosenberger, J; Chen, HZ; Liu, J; Myers, M				McCabe, Joseph T.; Moratz, Chantal; Liu, Yunbo; Burton, Ellen; Morgan, Amy; Budinich, Craig; Lowe, Dennell; Rosenberger, John; Chen, HuaZhen; Liu, Jiong; Myers, Matthew			APPLICATION OF HIGH-INTENSITY FOCUSED ULTRASOUND TO THE STUDY OF MILD TRAUMATIC BRAIN INJURY	ULTRASOUND IN MEDICINE AND BIOLOGY			English	Article						Animal models; Blast injury; Blood-brain barrier; Mouse; High-intensity focused ultrasound; Traumatic brain injury	BLAST OVERPRESSURE; MICROGLIA; OUTCOMES; TISSUE; LOCALIZATION; MECHANISMS; MORTALITY; PRESSURE; MODEL; RATS	Though intrinsically of much higher frequency than open-field blast overpressures, high-intensity focused ultrasound (HIFU) pulse trains can be frequency modulated to produce a radiation pressure having a similar form. In this study, 1.5-MHz HIFU pulse trains of 1-ms duration were applied to intact skulls of mice in vivo and resulted in blood-brain barrier disruption and immune responses (astrocyte reactivity and microglial activation). Analyses of variance indicated that 24 h after HIFU exposure, staining density for glial fibrillary acidic protein was elevated in the parietal and temporal regions of the cerebral cortex, corpus callosum and hippocampus, and staining density for the microglial marker, ionized calcium binding adaptor molecule, was elevated 2 and 24 h after exposure in the corpus callosum and hippocampus (all statistical test results, p < 0.05). HIFU shows promise for the study of some bio-effect aspects of blast-related, non-impact mild traumatic brain injuries in animals. (E-mail: Joseph.McCabe@usuhs.edu) Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology.	[McCabe, Joseph T.; Lowe, Dennell; Rosenberger, John; Chen, HuaZhen; Liu, Jiong] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [McCabe, Joseph T.; Moratz, Chantal; Budinich, Craig] Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA; [McCabe, Joseph T.; Moratz, Chantal; Burton, Ellen; Morgan, Amy] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Moratz, Chantal; Burton, Ellen; Morgan, Amy] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Liu, Yunbo; Myers, Matthew] US FDA, Ctr Devices & Radiol Hlth, White Oak, MD USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Joseph.McCabe@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442	U.S. Army Medical Research and Materiel Command GrantU.S. Army Medical Research & Materiel Command (USAMRMC) [W81 XWH-09-2-0147]; Translational Research Grant Opportunities of the Blast Lethality Injury and Research Program Grant [600-070-00000-00-106108]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G183 YL]	This work was supported by U.S. Army Medical Research and Materiel Command Grant W81 XWH-09-2-0147 and Translational Research Grant Opportunities of the Blast Lethality Injury and Research Program Grant 600-070-00000-00-106108 to J.T.M., and Project G183 YL from The Center for Neuroscience and Regenerative Medicine to C. M.-The experiments were conducted according to the principles set forth in the Guide for Care and Use of Laboratory Animals, ILAR, National Research Council, DHEW Publication (NIH) 73-23. The opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army, Department of Defense, U.S. government or Uniformed Services University of the Health Sciences. The use of trade names does not constitute an official endorsement or approval of the use of such reagents or commercial hardware or software. This document may not be cited for purposes of advertisement.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Aschkenasy-Steuer G, 2005, CRIT CARE, V9, P490, DOI 10.1186/cc3762; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Chavko M, 2008, J TRAUMA, V65, P1140, DOI 10.1097/TA.0b013e3181870a8c; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Duck F.A., 1990, PHYS PROPERTIES TISS; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; FRY FJ, 1995, ULTRASOUND MED BIOL, V21, P1227, DOI 10.1016/0301-5629(96)89519-6; Gateau J, 2011, PHYS MED BIOL, V56, P7001, DOI 10.1088/0031-9155/56/22/001; Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3; Gorbunov NK, 2008, EXPLOSION BLAST RELA, P298; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; International Commission on Radiation Units and Measurements (ICRU), 1998, 61 ICRU; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kulik L, 2009, J IMMUNOL, V182, P5363, DOI 10.4049/jimmunol.0803980; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; Min BK, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-23; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Myers MR, 2009, J ACOUST SOC AM, V126, P425, DOI 10.1121/1.3148204; NYBORG WL, 1988, PHYS MED BIOL, V33, P785, DOI 10.1088/0031-9155/33/7/002; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Parker KJ, 2011, PHYS MED BIOL, V56, pR1, DOI 10.1088/0031-9155/56/1/R01; Rao LVM, 2012, J THROMB HAEMOST, V10, P2242, DOI 10.1111/jth.12003; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Samiotaki G, 2012, MAGN RESON MED, V67, P769, DOI 10.1002/mrm.23063; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T, 2008, RAND CORPORATION MON; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Wahab RA, 2012, MED PHYS, V39, P4274, DOI 10.1118/1.4729712; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9	57	11	14	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0301-5629	1879-291X		ULTRASOUND MED BIOL	Ultrasound Med. Biol.	MAY	2014	40	5					965	978		10.1016/j.ultrasmedbio.2013.11.023			14	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	AE1TR	WOS:000333753600014	24462152	Green Published			2022-02-06	
J	Murphy, MP; Carmine, H; Kolakowsky-Hayner, S				Murphy, Mary P.; Carmine, Helen; Kolakowsky-Hayner, Stephanie			Modifiable and Nonmodifiable Risk Factors for Falls After Traumatic Brain Injury: An Exploratory Investigation With Implications for Medication Use	REHABILITATION NURSING			English	Article						falls; Brain injury; research: quantitative	ANTICHOLINERGIC PROPERTIES; PREVENTING FALLS; OLDER-PEOPLE; STROKE; REHABILITATION; HOME; EPIDEMIOLOGY; POPULATION; DISEASE; HEALTH	Purpose Falls are a challenge for rehabilitation nurses, facilities, families, and individuals. Studies related to the causes of falls and potential strategies for risk management have been conducted across disability groups and with the elderly. Still, a focus on individuals with traumatic brain injuries (TBI), specifically, has been limited. This paper presents a brief review of relevant research and the results of a preliminary investigation. Methods This study was a retrospective study of 125 individuals with TBI in residential treatment. Specific risk factors for falls in this population were identified. Findings Results indicate that age, injury severity, medical complications, specific medications and polypharmacy are significantly linked to falls in individuals with brain injuries. Specifically, the use of anticholinergic medications was associated with falls in this study. Conclusions The results of this study are limited both by the use of a convenience sample and the fact that it is an initial exploratory step to future multicenter research. Still, the resulting fall risk profile that emerged is an important consideration for rehabilitation practitioners working in brain injury. Clinical Relevance Identifying those individuals with TBI most at risk for falling and taking appropriate measures to prevent falling, including consideration of both number and type of medication used, are important measures for rehabilitation teams working with this population to take.	[Murphy, Mary P.; Carmine, Helen] ReMed, Paoli, PA 19301 USA; [Kolakowsky-Hayner, Stephanie] Santa Clara Med Ctr, Rehabil Res Ctr, San Jose, CA USA		Murphy, MP (corresponding author), ReMed, Paoli, PA 19301 USA.	mmurphy@remed.com	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909			Arciniegas DB, 2011, J HEAD TRAUMA REHAB, V26, P319, DOI 10.1097/HTR.0b013e31821ebfb3; Ashburn A, 2001, AGE AGEING, V30, P47, DOI 10.1093/ageing/30.1.47; Bulat T, 2008, J AM ACAD NURSE PRAC, V20, P181, DOI 10.1111/j.1745-7599.2008.00311.x; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Carmine H, 2005, BRAIN INJ PROFESS, V2, P26; Centers for Disease Control, 2006, MMWR-MORBID MORTAL W, V57, P225; Connell BR, 1997, ARCH PHYS MED REHAB, V78, P179, DOI 10.1016/S0003-9993(97)90261-6; Cumming RG, 1999, J AM GERIATR SOC, V47, P1397, DOI 10.1111/j.1532-5415.1999.tb01556.x; de Carle AJ, 2001, INT J GERIATR PSYCH, V16, P762, DOI 10.1002/gps.407.abs; Dennison AC, 2007, AM J PHYS MED REHAB, V86, P621, DOI 10.1097/PHM.0b013e311611583; Felicetti T, 2009, PROF CASE MANAG, V14, P158, DOI 10.1097/01.PCAMA.0000352529.94964.27; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Gerretsen P, 2011, EXPERT OPIN DRUG SAF, V10, P751, DOI 10.1517/14740338.2011.579899; Gostynski M, 2001, SOZ PRAVENTIV MED, V46, P123, DOI 10.1007/BF01299729; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Gray SL, 1999, ANN PHARMACOTHER, V33, P1147, DOI 10.1345/aph.19036; Hauer K, 2002, ARCH PHYS MED REHAB, V83, P217, DOI 10.1053/apmr.2002.29613; Haumschild MJ, 2003, AM J HEALTH-SYST PH, V60, P1029, DOI 10.1093/ajhp/60.10.1029; Huang ES, 2010, J GEN INTERN MED, V25, P141, DOI 10.1007/s11606-009-1179-2; Hyndman D, 2004, J NEUROL NEUROSUR PS, V75, P994, DOI 10.1136/jnnp.2003.016014; Kelly KD, 2003, AGE AGEING, V32, P503, DOI 10.1093/ageing/afg081; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Lamb SE, 2003, STROKE, V34, P494, DOI 10.1161/01.STR.0000053444.00582.B7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mackintosh SF, 2006, ARCH PHYS MED REHAB, V87, P1583, DOI 10.1016/j.apmr.2006.09.004; McGrath JC, 2008, CLIN REHABIL, V22, P635, DOI 10.1177/0269215507086432; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; NYBERG L, 1995, STROKE, V26, P838, DOI 10.1161/01.STR.26.5.838; Peterson EW, 2007, MULT SCLER J, V13, P1168, DOI 10.1177/1352458507079260; Protas EJ, 2005, NEUROREHABILITATION, V20, P183; Quigley PA, 2007, REHABIL NURS, V32, P120, DOI 10.1002/j.2048-7940.2007.tb00163.x; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Slattum P., 2009, ANTICHOLINERGIC ACH; Stapleton T, 2001, CLIN REHABIL, V15, P437, DOI 10.1191/026921501678310243; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stevens M, 2001, J AM GERIATR SOC, V49, P1448, DOI 10.1046/j.1532-5415.2001.4911236.x; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; Tutuarima JA, 1997, STROKE, V28, P297, DOI 10.1161/01.STR.28.2.297; Ugur C, 2000, J NEUROL NEUROSUR PS, V69, P649, DOI 10.1136/jnnp.69.5.649; Wawruch M, 2012, PHARMACOEPIDEM DR S, V21, P170, DOI 10.1002/pds.2169; Wilson NM, 2011, J AM GERIATR SOC, V59, P875, DOI 10.1111/j.1532-5415.2011.03386.x	45	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	MAY	2014	39	3					113	122		10.1002/rnj.89			10	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	AG7ET	WOS:000335581600002	23720011				2022-02-06	
J	Ferreira, APO; Rodrigues, FS; Della-Pace, ID; Mota, BC; Oliveira, SM; Gewehr, CDV; Bobinski, F; de Oliveira, CV; Brum, JS; Oliveira, MS; Furian, AF; de Barros, CSL; dos Santos, ARS; Ferreira, J; Fighera, MR; Royes, LFF				Oliveira Ferreira, Ana Paula; Rodrigues, Fernanda Silva; Della-Pace, Iuri Domingues; Mota, Bibiana Castagna; Oliveira, Sara Marchesan; Velho Gewehr, Camila de Campos; Bobinski, Franciane; de Oliveira, Clarissa Vasconcelos; Brum, Juliana Sperotto; Oliveira, Mauro Schneider; Furian, Ana Flavia; Lombardo de Barros, Claudio Severo; Soares dos Santos, Adair Roberto; Ferreira, Juliano; Fighera, Michele Rechia; Freire Royes, Luiz Fernando			HOE-140, an antagonist of B2 receptor, protects against memory deficits and brain damage induced by moderate lateral fluid percussion injury in mice	PSYCHOPHARMACOLOGY			English	Article						Traumatic brain injury; Bradykinin; Inflammation; Object recognition task; Oxidative stress	BRADYKININ B-2 RECEPTOR; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD TRAUMA; PENTYLENETETRAZOL-INDUCED SEIZURES; KALLIKREIN-KININ SYSTEM; FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; K+-ATPASE ACTIVITY; OXIDATIVE STRESS; CELL-DEATH	There are evidences indicating the role of kinins in pathophysiology of traumatic brain injury, but little is known about their action on memory deficits. Our aim was to establish the role of bradykinin receptors B-1 (B1R) and B-2 (B2R) on the behavioral, biochemical, and histologic features elicited by moderate lateral fluid percussion injury (mLFPI) in mice. The role of kinin B-1 and B-2 receptors in brain damage, neuromotor, and cognitive deficits induced by mLFPI, was evaluated by means of subcutaneous injection of B2R antagonist (HOE-140; 1 or 10 nmol/kg) or B1R antagonist (des-Arg9-[Leu8]-bradykinin (DAL-Bk; 1 or 10 nmol/kg) 30 min and 24 h after brain injury. Brain damage was evaluated in the cortex, being considered as lesion volume, inflammatory, and oxidative damage. The open field and elevated plus maze tests were performed to exclude the nonspecific effects on object recognition memory test. Our data revealed that HOE-140 (10 nmol/kg) protected against memory impairment. This treatment attenuated the brain edema, interleukin-1 beta, tumor necrosis factor-alpha, and nitric oxide metabolites content elicited by mLFPI. Accordingly, HOE-140 administration protected against the increase of nicotinamide adenine dinucleotide phosphate oxidase activity, thiobarbituric-acid-reactive species, protein carbonylation generation, and Na+ K+ ATPase inhibition induced by trauma. Histologic analysis showed that HOE-140 reduced lesion volume when analyzed 7 days after brain injury. This study suggests the involvement of the B-2 receptor in memory deficits and brain damage caused by mLFPI in mice.	[Oliveira Ferreira, Ana Paula; Rodrigues, Fernanda Silva; Della-Pace, Iuri Domingues; Mota, Bibiana Castagna; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Dept Metodos & Tecn Desport, Lab Bioquim Exercicio, BR-97105900 Santa Maria, RS, Brazil; [Oliveira Ferreira, Ana Paula; Rodrigues, Fernanda Silva; Della-Pace, Iuri Domingues; Mota, Bibiana Castagna; Oliveira, Sara Marchesan; Velho Gewehr, Camila de Campos; Ferreira, Juliano; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol Bioquim Toxicol, BR-97105900 Santa Maria, RS, Brazil; [Bobinski, Franciane; Soares dos Santos, Adair Roberto] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Ciencias Fisiol, Florianolpolis, SC, Brazil; [de Oliveira, Clarissa Vasconcelos; Oliveira, Mauro Schneider] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Fisiol & Farmacol, BR-97105900 Santa Maria, RS, Brazil; [Brum, Juliana Sperotto; Lombardo de Barros, Claudio Severo] Univ Fed Santa Maria, Ctr Ciencias Rurais, Dept Patol, BR-97105900 Santa Maria, RS, Brazil; [Furian, Ana Flavia] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Ciencia & Tecnol Alimentos, BR-97105900 Santa Maria, RS, Brazil; [Fighera, Michele Rechia] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Neuropsiquiatria, BR-97105900 Santa Maria, RS, Brazil		Royes, LFF (corresponding author), Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Dept Metodos & Tecn Desport, Lab Bioquim Exercicio, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Oliveira, Mauro Schneider/G-3437-2012; Fighera, Michele R/J-9576-2014; Santos, Adair/C-5565-2013; royes, luiz/T-3581-2019; Ferreira, Juliano/A-9803-2013; Bobinski, Franciane/AAV-8234-2020; Bobinski, Franciane/ABB-5476-2021	Oliveira, Mauro Schneider/0000-0002-5381-1208; Santos, Adair/0000-0002-6435-4698; Ferreira, Juliano/0000-0002-9562-0602; Bobinski, Franciane/0000-0002-3537-1712; Fighera, Michele/0000-0002-3111-7530; oliveira, sara/0000-0003-2960-5284; royes, luiz/0000-0003-4045-4827	Conselho Nacional de Desenvolvimento Cientifico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES; Brazil)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [301552/2007-0]; CNPq/FAPERGSConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [11/2082-4]	The presente study was supported by Conselho Nacional de Desenvolvimento Cientifico (CNPq) and by Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES; Brazil). Ferreira J is the recipient of CNPq fellowships, grant numbers 301552/2007-0. Royes L. F. F is recipient of CNPq/FAPERGS fellowships, grant numbers 11/2082-4. The funding sources had no involvement in study design, in the collection, analysis, interpretation of data, and in the writing of the report. We also attest that all the experimentswere performed in compliance with Brazilian (law no. 6638 of 1979-Standards for the Practice Teaching-scientific Animal use) law currently in force, and that experiments were previously approved by the Committee on the Use and Care of Laboratory Animals of the Federal University of the Santa Maria (process number: 113/2010).	Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Ayer R, 2011, ACTA NEUROCHIR SUPPL, V111, P145, DOI 10.1007/978-3-7091-0693-8_24; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bay E, 2012, ARCH PSYCHIAT NURS, V26, P477, DOI 10.1016/j.apnu.2012.06.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CHAO J, 1983, J BIOL CHEM, V258, P5173; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; CORREA FMA, 1979, P NATL ACAD SCI USA, V76, P1489, DOI 10.1073/pnas.76.3.1489; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Gorlach C, 2001, J NEUROTRAUM, V18, P833, DOI 10.1089/089771501316919193; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Hsieh HL, 2010, ANTIOXID REDOX SIGN, V13, P1829, DOI 10.1089/ars.2009.2957; Ivashkova Y, 2006, J TRAUMA, V61, P879, DOI 10.1097/01.ta.0000234722.98537.01; Jamme I, 1995, NEUROREPORT, V7, P333; Kaplanski J, 2003, RESUSCITATION, V56, P207, DOI 10.1016/S0300-9572(02)00371-4; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; Klasner B, 2006, NEUROCHEM INT, V49, P442, DOI 10.1016/j.neuint.2006.02.010; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Lee YJ, 2002, MOL CELL NEUROSCI, V19, P186, DOI 10.1006/mcne.2001.1073; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Lin CC, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-35; Liu HT, 2009, J PHYSIOL-LONDON, V587, P2197, DOI 10.1113/jphysiol.2008.165084; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Marceau F, 2004, NAT REV DRUG DISCOV, V3, P845, DOI 10.1038/nrd1522; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Noda M, 2003, LIFE SCI, V72, P1573, DOI 10.1016/S0024-3205(02)02449-9; Noda M, 2007, J NEUROCHEM, V101, P397, DOI 10.1111/j.1471-4159.2006.04339.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira MS, 2004, NEUROSCIENCE, V128, P721, DOI 10.1016/j.neuroscience.2004.07.012; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Potts Mathew B, 2006, NeuroRx, V3, P143; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Raidoo DM, 1998, PHARMACOL THERAPEUT, V79, P105, DOI 10.1016/S0163-7258(98)00011-4; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Su JJ, 2009, BIOCHEM BIOPH RES CO, V388, P205, DOI 10.1016/j.bbrc.2009.07.135; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Theodoros D G, 1998, Pediatr Rehabil, V2, P107; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Yang CM, 2013, MOL NEUROBIOL, V47, P1020, DOI 10.1007/s12035-013-8402-1; Zhan H, 2004, NEUROL RES, V26, P35, DOI 10.1179/016164104773026507; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	71	11	11	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	MAY	2014	231	9					1935	1948		10.1007/s00213-013-3336-x			14	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AF2AE	WOS:000334514200006	24202114				2022-02-06	
J	Kim, B; Kim, JH; Kim, MK; Lee, KS; Kim, Y; Choi, TK; Kim, YT; Lee, SH				Kim, Borah; Kim, Jeong Hoon; Kim, Min-Kyoung; Lee, Kang Soo; Kim, Youngki; Choi, Tai Kiu; Kim, Yun Tai; Lee, Sang-Hyuk			Frontal White Matter Alterations in Short-Term Medicated Panic Disorder Patients without Comorbid Conditions: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							SOCIAL ANXIETY DISORDER; CEREBRAL-BLOOD-FLOW; OBSESSIVE-COMPULSIVE DISORDER; TRAUMATIC BRAIN-INJURY; 1ST 6 MONTHS; BENZODIAZEPINE-RECEPTOR; STRUCTURAL CONNECTIVITY; OCCIPITAL FASCICULUS; MAJOR DEPRESSION; CORPUS-CALLOSUM	The frontal cortex might play an important role in the fear network, and white matter (WM) integrity could be related to the pathophysiology of panic disorder (PD). A few studies have investigated alterations of WM integrity in PD. The aim of this study was to determine frontal WM integrity differences between patients with PD without comorbid conditions and healthy control (HC) subjects by using diffusion tensor imaging. Thirty-six patients with PD who had used medication within 1 week and 27 age-and sex-matched HC subjects participated in this study. Structural brain magnetic resonance imaging was performed on all participants. Panic Disorder Severity Scale and Beck Anxiety Inventory (BAI) scores were assessed. Tract-based spatial statistics (TBSS) was used for image analysis. TBSS analysis showed decreased fractional anisotropy (FA) in frontal WM and WM around the frontal lobe, including the corpus callosum of both hemispheres, in patients with PD compared to HC subjects. Moreover, voxel-wise correlation analysis revealed that the BAI scores for patients with PD were positively correlated with their FA values for regions showing group differences in the FA of frontal WM of both hemispheres. Altered integrity in frontal WM of patients with PD without comorbid conditions might represent the structural pathophysiology in these patients, and these changes could be related to clinical symptoms of PD.	[Kim, Borah; Kim, Min-Kyoung; Choi, Tai Kiu; Lee, Sang-Hyuk] CHA Univ, Dept Psychiat, CHA Bundang Med Ctr, Songnam, Gyeonggi Do, South Korea; [Kim, Jeong Hoon] Bundang Jaesaeng Hosp, Dept Psychiat, Songnam, Gyeonggi Do, South Korea; [Lee, Kang Soo] CHA Univ, Dept Psychiat, CHA Gangnam Med Ctr, Seoul, South Korea; [Kim, Youngki] Sujiyonsei Psychiat Clin, Yongin, Gyeonggi Do, South Korea; [Kim, Yun Tai] CHA Univ, Coll Life Sci, Dept Appl Biosci, Pocheon Si, Gyeonggi Do, South Korea		Kim, YT (corresponding author), CHA Univ, Coll Life Sci, Dept Appl Biosci, Pocheon Si, Gyeonggi Do, South Korea.	ytkim@cha.ac.kr; leesanghyuk@yahoo.com			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2011-0023359]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0023359) to S. H. Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; Asami T, 2009, PSYCHIAT RES-NEUROIM, V173, P128, DOI 10.1016/j.pscychresns.2008.10.004; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Baur V, 2011, J PSYCHIATR RES, V45, P1366, DOI 10.1016/j.jpsychires.2011.05.007; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bremner JD, 2000, BIOL PSYCHIAT, V47, P96, DOI 10.1016/S0006-3223(99)00188-2; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Compton RJ, 2008, EMOTION, V8, P684, DOI 10.1037/a0012910; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; de Carvalho MR, 2010, EXPERT REV NEUROTHER, V10, P291, DOI 10.1586/ERN.09.161; Dresler T, 2012, J PSYCHIATR RES, V46, P1627, DOI 10.1016/j.jpsychires.2012.09.004; EDMONSTONE Y, 1994, ACTA PSYCHIAT SCAND, V90, P298, DOI 10.1111/j.1600-0447.1994.tb01597.x; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; First M.B., 1996, STRUCTURED CLIN INTE; Fischer H, 1998, NEUROSCI LETT, V251, P137, DOI 10.1016/S0304-3940(98)00503-5; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Han DH, 2008, J PSYCHIATR RES, V42, P399, DOI 10.1016/j.jpsychires.2007.03.002; Hasler G, 2008, ARCH GEN PSYCHIAT, V65, P1166, DOI 10.1001/archpsyc.65.10.1166; Kaasinen V, 2001, P NATL ACAD SCI USA, V98, P13272, DOI 10.1073/pnas.231313198; Kang EH, 2012, NEUROPSYCHOBIOLOGY, V66, P106, DOI 10.1159/000337740; Kent JM, 2005, AM J PSYCHIAT, V162, P1379, DOI 10.1176/appi.ajp.162.7.1379; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P415, DOI 10.1001/archpsyc.63.4.415; Kim B, 2013, PROG NEURO-PSYCHOPH, V43, P188, DOI 10.1016/j.pnpbp.2012.12.022; Kim B, 2013, J AFFECT DISORDERS, V147, P64, DOI 10.1016/j.jad.2012.10.009; Lai CH, 2013, J AFFECT DISORDERS, V150, P330, DOI 10.1016/j.jad.2013.04.014; Lai CH, 2013, J AFFECT DISORDERS, V146, P378, DOI 10.1016/j.jad.2012.09.022; Lai CH, 2012, J AFFECT DISORDERS, V140, P285, DOI 10.1016/j.jad.2012.01.049; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Lim YJ, 2007, DEPRESS ANXIETY, V24, P95, DOI 10.1002/da.20206; Maddock RJ, 2003, NEUROREPORT, V14, P325, DOI 10.1097/01.wnr.0000059776.23521.25; MARKOWITZ JS, 1989, ARCH GEN PSYCHIAT, V46, P984; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Miao W, 2012, AJNR AM J NEURORADIO; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Ohta H, 2008, DEPRESS ANXIETY, V25, P1053, DOI 10.1002/da.20463; Parraga HC, 2003, INT J PSYCHIAT MED, V33, P107, DOI 10.2190/D4Y1-WNBX-HQW8-HDPL; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Roy-Byrne PP, 1999, J CLIN PSYCHIAT; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shear MK, 2001, J PSYCHIAT RES, V35, P293, DOI 10.1016/S0022-3956(01)00028-0; Shergill SS, 2007, AM J PSYCHIAT, V164, P467, DOI 10.1176/appi.ajp.164.3.467; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sobanski T, 2010, PSYCHOL MED, V40, P1879, DOI 10.1017/S0033291709991930; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; STEWART RS, 1988, AM J PSYCHIAT, V145, P442; Tromp DPM, 2012, ARCH GEN PSYCHIAT, V69, P925, DOI 10.1001/archgenpsychiatry.2011.2178; Uhlmann C., 2013, PSYCHOL MED, P1; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P922, DOI 10.1001/archpsyc.62.8.922; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Walterfang M, 2009, J AFFECT DISORDERS, V115, P411, DOI 10.1016/j.jad.2008.10.010; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; WOODS SW, 1988, LANCET, V2, P678; Yook SP, 1997, KOREAN J CLIN PSYCHO, V16, P185	63	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95279	10.1371/journal.pone.0095279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	WOS:000338917300010	24788587	Green Published, Green Submitted, gold			2022-02-06	
J	Tajiri, N; Hernandez, D; Acosta, S; Shinozuka, K; Ishikawa, H; Ehrhart, J; Diamandis, T; Gonzales-Portillo, C; Borlongan, MC; Tan, J; Kaneko, Y; Borlongan, CV				Tajiri, Naoki; Hernandez, Diana; Acosta, Sandra; Shinozuka, Kazutaka; Ishikawa, Hiroto; Ehrhart, Jared; Diamandis, Theo; Gonzales-Portillo, Chiara; Borlongan, Mia C.; Tan, Jun; Kaneko, Yuji; Borlongan, Cesar V.			Suppressed cytokine expression immediatey following traumatic brain injury in neonatal rats indicates an expeditious endogenous anti-inflammatory response	BRAIN RESEARCH			English	Article						Traumatic brain injury; Neonatal traumatic brain injury; Cytokine expression; Neuroinflammation	SHAKEN-BABY-SYNDROME; INFLAMMATION; OUTCOMES; INFANTS	The timing of therapeutic intervention in traumatic brain injury (TBI) is critical. Although immediate cell death cascades have become established in adult TBI, the pathophysiology underlying neonatal TBI is poorly understood. The objective of the present study was to determine the role of cytokine regulation following TBI in neonatal rats. Seven-day-old Sprague-Dawley rats were subjected to TBI using the controlled cortical impact (CCI) injury model. Age-matched littermates that did not receive TBI served as the controls. Immediately following TBI, rats were euthanized, and the brains were divided into the ipsilateral and contralateral hemispheres then flash frozen. A BioRad 23-Flex panel was used to measure cytokine levels. Surprisingly, the data revealed that 18 of the 23 cytokines analyzed were significantly downregulated in the hemisphere contralateral to the TBI impacted hemisphere. IL-5, IL-6 and MIP-3a were significantly suppressed in both ipsilateral and contralateral hemispheres of neonatal TBI rats compared to the control rats. A parallel study processing the plasma of the same cohort of neonatal rats revealed no difference in the same cytokines analyzed in the brain tissue, suggesting highly localized cytokine suppression in the brain during early injury. In stark contrast to the reported early pro-inflammatory response exhibited in adult TBI, the present neonatal TBI study demonstrated a reversed cytokine profile of downregulation. These results suggest a robust, immediate anti-inflammatory response mounted by the contralateral hemisphere of the young brain. (C) 2014 Elsevier B.V. All rights reserved.	[Tajiri, Naoki; Hernandez, Diana; Acosta, Sandra; Shinozuka, Kazutaka; Ishikawa, Hiroto; Ehrhart, Jared; Diamandis, Theo; Gonzales-Portillo, Chiara; Borlongan, Mia C.; Tan, Jun; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA; [Ehrhart, Jared; Tan, Jun] Univ S Florida, Coll Med, Dept Psychiat & Behav Med, Rashid Lab Dev Neurobiol,Silver Child Dev Ctr, Tampa, FL 33612 USA		Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782; Shinozuka, Kazutaka/0000-0002-6435-4460; Borlongan, Mia/0000-0003-3223-8374; Ishikawa, Hiroto/0000-0003-0760-7203	Department of Neurosurgery and Brain Repair funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	This research was supported by the Department of Neurosurgery and Brain Repair funds.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Altimier L, 2008, J PERINAT NEONAT NUR, V22, P68, DOI 10.1097/01.JPN.0000311877.32614.69; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Ashton R, 2010, J CHILD PSYCHOL PSYC, V51, P967, DOI 10.1111/j.1469-7610.2010.02272.x; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Case Mary E., 2007, Legal Medicine, V9, P83, DOI 10.1016/j.legalmed.2006.11.017; Chung C.S., 2013, COCHRANE DB SYST REV, P30; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Faul M, 2010, TRAUMATIC BRAIN INJU; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Kaneko Y, 2012, CELL MED, V4, P55, DOI 10.3727/215517912X639306; Karasu A, 2009, ULUS TRAVMA ACIL CER, V15, P159; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; Niedzwecki CM, 2008, J HEAD TRAUMA REHAB, V23, P209, DOI 10.1097/01.HTR.0000327253.61751.29; Pabon MM, 2013, FUTUR NEUROL, V8, P193, DOI 10.2217/FNL.12.85; Paiva WS, 2011, ACTA MEDICA PORT, V 24, P805; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Shrivastava K, 2013, DEV NEUROSCI-BASEL, V35, P212, DOI 10.1159/000348432; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Waters R.J., 2013, J NEUROTRAUMA; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	34	11	12	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 22	2014	1559						65	71		10.1016/j.brainres.2014.02.041			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG0NU	WOS:000335113000007	24602693	Green Accepted			2022-02-06	
J	Nenadovic, V; Velazquez, JLP; Hutchison, JS				Nenadovic, Vera; Velazquez, Jose Luis Perez; Hutchison, James Saunders			Phase Synchronization in Electroencephalographic Recordings Prognosticates Outcome in Paediatric Coma	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SOMATOSENSORY-EVOKED POTENTIALS; INTENSIVE-CARE-UNIT; VOLUME CONDUCTION; SPLINE-LAPLACIAN; EEG COHERENCE; CHILDREN; VARIABILITY; COMPLEXITY; MORTALITY	Brain injury from trauma, cardiac arrest or stroke is the most important cause of death and acquired disability in the paediatric population. Due to the lifetime impact of brain injury, there is a need for methods to stratify patient risk and ultimately predict outcome. Early prognosis is fundamental to the implementation of interventions to improve recovery, but no clinical model as yet exists. Healthy physiology is associated with a relative high variability of physiologic signals in organ systems. This was first evaluated in heart rate variability research. Brain variability can be quantified through electroencephalographic (EEG) phase synchrony. We hypothesised that variability in brain signals from EEG recordings would correlate with patient outcome after brain injury. Lower variability in EEG phase synchronization, would be associated with poor patient prognosis. A retrospective study, spanning 10 years (2000-2010) analysed the scalp EEGs of children aged 1 month to 17 years in coma (Glasgow Coma Scale, GCS, < 8) admitted to the paediatric critical care unit (PCCU) following brain injury from TBI, cardiac arrest or stroke. Phase synchrony of the EEGs was evaluated using the Hilbert transform and the variability of the phase synchrony calculated. Outcome was evaluated using the 6 point Paediatric Performance Category Score (PCPC) based on chart review at the time of hospital discharge. Outcome was dichotomized to good outcome (PCPC score 1 to 3) and poor outcome (PCPC score 4 to 6). Children who had a poor outcome following brain injury secondary to cardiac arrest, TBI or stroke, had a higher magnitude of synchrony (R index), a lower spatial complexity of the synchrony patterns and a lower temporal variability of the synchrony index values at 15 Hz when compared to those patients with a good outcome.	[Nenadovic, Vera; Hutchison, James Saunders] Div Neurol Sick Kids, Toronto, ON, Canada; [Hutchison, James Saunders] Dept Crit Care Med Sick Kids, Toronto, ON, Canada; [Velazquez, Jose Luis Perez; Hutchison, James Saunders] Univ Toronto, Inst Med Sci, Toronto, ON, Canada		Nenadovic, V (corresponding author), Div Neurol Sick Kids, Toronto, ON, Canada.	Vera.nenadovic@sickkids.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	This work was supported in part by Dr. Nenadovic's CIHR Banting and Best Doctoral Fellowship to, and by Dr. Perez Velazquez's Discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Avner JR, 2006, PEDIATR REV, V27, P331, DOI 10.1542/pir.27-9-331; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Babiloni F, 1996, ELECTROEN CLIN NEURO, V98, P363, DOI 10.1016/0013-4694(96)00284-2; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Bricolo A, 1990, HDB CLIN NEUROLOGY, V13, P181; Buchman TG, 1996, J TRAUMA, V41, P599, DOI 10.1097/00005373-199610000-00002; Carrai R, 2010, INTENS CARE MED, V36, P1112, DOI 10.1007/s00134-010-1884-7; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Catroppa C, 2009, FUTUR NEUROL, V4, P811, DOI 10.2217/FNL.09.52; Cimponeriu L, 2002, P ANN INT IEEE EMBS, P2029, DOI 10.1109/IEMBS.2002.1053151; Daubin C, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-35; Davey MP, 2000, CLIN NEUROPHYSIOL, V111, P1949, DOI 10.1016/S1388-2457(00)00435-1; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Dominguez LG, 2008, INT J BIFURCAT CHAOS, V18, P429; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Farrell CA, 2013, PAED CHILD HEALT-CAN, V18, P253, DOI 10.1093/pch/18.5.253; Feurra M, 2011, J NEUROSCI, V31, P12165, DOI 10.1523/JNEUROSCI.0978-11.2011; Fischer J, 2001, Crit Care Nurs Q, V23, P52; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Flohr H, 1995, BEHAV BRAIN RES, V71, P157, DOI 10.1016/0166-4328(95)00033-X; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P554, DOI 10.1136/adc.2009.161083; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Jones KE, 2009, LEVETIRACETAM VERSUS; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kirton A, 2007, NEUROREHABILITATION, V22, P371; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le Van Quyen M, 2007, TRENDS NEUROSCI, V30, P365, DOI 10.1016/j.tins.2007.05.006; Lerma C, 2008, MED BIOL ENG COMPUT, V46, P715, DOI 10.1007/s11517-008-0326-y; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Mandel R, 2002, J PEDIATR-US, V141, P45, DOI 10.1067/mpd.2002.125005; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mewasingh LD, 2003, PEDIATR NEUROL, V28, P178, DOI 10.1016/S0887-8994(02)00509-X; Moorman JR, 2011, J PEDIATR-US, V159, P900, DOI 10.1016/j.jpeds.2011.06.044; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nelson LP, 2012, PEDIATR CRIT CARE ME, V13, P338, DOI 10.1097/PCC.0b013e3182196a8f; Nenadovic V, 2008, J NEUROTRAUM, V25, P615, DOI 10.1089/neu.2007.0474; Noirhomme A, 2010, FRONTIERS SYS NEUROS, V4, P1; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Peliowski-Davidovich A, 2012, PAED CHILD HEALT-CAN, V17, P41, DOI 10.1093/pch/17.1.41; Perez Velazquez JL, 2011, BRAIN BEHAV CONTINUU; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Raja Beharelle A, 2012, NEUROIMAGE, V60, P1528, DOI 10.1016/j.neuroimage.2012.01.037; Scheuer ML, 2004, J CLIN NEUROPHYSIOL, V21, P353; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff Nicholas D, 2010, Cleve Clin J Med, V77 Suppl 3, pS27, DOI 10.3949/ccjm.77.s3.05; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shields DC, 2007, SURG NEUROL, V67, P354, DOI 10.1016/j.surneu.2006.09.036; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1; Turgeon AF, 2012, CRIT CARE ROUNDS, V8; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Van CA, 2003, CURRENT PRACTICE CLI, P463; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Velazquez JLP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00098; Vet NJ, 2013, INTENS CARE MED, V39, P1524, DOI 10.1007/s00134-013-2971-3; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; Winter WR, 2007, STAT MED, V26, P3946, DOI 10.1002/sim.2978; Wittman JJ, 2005, NEUROCRIT CARE, V2, P330, DOI 10.1385/NCC:2:3:330; Wu WQ, 2011, CLIN NEUROPHYSIOL, V122, P21, DOI 10.1016/j.clinph.2010.06.003; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077325; Young GB, 2009, CAN J NEUROL SCI, V36, pS9; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH	92	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e94942	10.1371/journal.pone.0094942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	WOS:000335227400021	24752289	gold, Green Submitted, Green Published			2022-02-06	
J	Iatridou, K; Mandalidis, D; Chronopoulos, E; Vagenas, G; Athanasopoulos, S				Iatridou, Katerina; Mandalidis, Dimitris; Chronopoulos, Efstathios; Vagenas, George; Athanasopoulos, Spyros			Static and dynamic body balance following provocation of the visual and vestibular systems in females with and without joint hypermobility syndrome	JOURNAL OF BODYWORK AND MOVEMENT THERAPIES			English	Article						Joint hypermobility syndrome; Static body balance; Dynamic body balance; Proprioception; Visual system; Vestibular system		Objectives: Joint hypermobility syndrome (JHS) is a heritable disorder of the connective tissue characterized by excessive joint movement, musculoskeletal pain and neurophysiological deficits (i.e. decreased proprioceptive acuity, altered neuromuscular reflexes). Such deficits may affect body balance thus increasing the risk of injury. The present study aimed at examining static and dynamic body balance following challenge of the visual and vestibular systems in individuals with JHS. Methods: The sample consisted of 21 females with JHS and 20 controls without signs of JHS. Static body balance was assessed by the degree of anteroposterior and mediolateral deviation of the center of pressure, during 20-sec single-leg stances with eyes opened (EO), eyes closed (EC) and eyes opened with head extension (EO-HE) using a foot pressure platform. Dynamicbody balance was assessed by the number of landing and balance errors committed during a multiple single-leg-hop-stabilization test. Results: Nonparametric analysis showed that the JHS-group demonstrated significantly greater (a) mediolateral deviation during single-leg-stance with EO (p < 0.01), (b) mediolateral and anteroposterior deviation during single-leg-stance with EO-HE (p < 0.05), and (c) number of landing errors (p < 0.05) compared to the control group. Conclusions: Poor static balance following challenge of the vestibular system may be justified by vestibular deficiency and/or insufficient proprioceptive capabilities of the neck. Impairments of dynamic balance in individuals with JHS may be attributed to proprioceptive deficits, which can alter feedforward and feedback mechanisms. (C) 2013 Published by Elsevier Ltd.	[Iatridou, Katerina; Mandalidis, Dimitris; Athanasopoulos, Spyros] Univ Athens, Fac Phys Educ & Sport Sci, Lab Athlet Phys Therapy, Athens, Greece; [Chronopoulos, Efstathios] Univ Athens, Orthopaed Dept 2, Athens, Greece; [Vagenas, George] Univ Athens, Fac Phys Educ & Sport Sci, Lab Quantitat Anal & Kinesiol Res, Athens, Greece		Iatridou, K (corresponding author), Papagou 44,15343 Agia Paraskevi, Attiki, Greece.	kiatridou@phed.uoa.gr; dmndlds@hotmail.com; stathi24@yahoo.gr; gvagenas@phed.uoa.gr; spathana@phed.uoa.gr	Mandalidis, Dimitris/K-4940-2019	Mandalidis, Dimitris/0000-0002-8358-7438			Aoki M, 2012, EXP BRAIN RES, V217, P251, DOI 10.1007/s00221-011-2989-0; Asseman FB, 2008, GAIT POSTURE, V27, P76, DOI 10.1016/j.gaitpost.2007.01.004; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; BRANDT T, 1981, ANN NY ACAD SCI, V374, P636, DOI 10.1111/j.1749-6632.1981.tb30907.x; Chappell JD, 2007, AM J SPORT MED, V35, P235, DOI 10.1177/0363546506294077; Everman D B, 1998, Pediatr Rev, V19, P111, DOI 10.1542/pir.19-4-111; Ferrell WR, 2007, ARTHRIT RHEUM-ARTHR, V57, P1329, DOI 10.1002/art.22992; Ferrell WR, 2004, ARTHRITIS RHEUM-US, V50, P3323, DOI 10.1002/art.20582; FORLEO LHA, 1993, J RHEUMATOL, V20, P916; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; Gazit Y, 2003, AM J MED, V115, P33, DOI 10.1016/S0002-9343(03)00235-3; Grahame R, 2000, J RHEUMATOL, V27, P1777; Grahame R, 2004, RHEUMATOLOGY, V43, P90; HALL MG, 1995, BRIT J RHEUMATOL, V34, P121; Hansson EE, 2010, ACTA OTO-LARYNGOL, V130, P1358, DOI 10.3109/00016489.2010.498024; Hassan BS, 2001, ANN RHEUM DIS, V60, P612, DOI 10.1136/ard.60.6.612; Hodges PW, 1997, EXP BRAIN RES, V114, P362, DOI 10.1007/PL00005644; Hodges PW, 1997, PHYS THER, V77, P132, DOI 10.1093/ptj/77.2.132; HORAK FB, 1987, PHYS THER, V67, P1881, DOI 10.1093/ptj/67.12.1881; Hrysomallis C, 2007, SPORTS MED, V37, P547, DOI 10.2165/00007256-200737060-00007; Juul-Kristensen B, 2007, RHEUMATOLOGY, V46, P1835, DOI 10.1093/rheumatology/kem290; KESHNER EA, 1989, AM J OCCUP THER, V43, P320, DOI 10.5014/ajot.43.5.320; MALLIK AK, 1994, BRIT J RHEUMATOL, V33, P631; Mebes C, 2008, ARTHRIT RHEUM-ARTHR, V59, P1665, DOI 10.1002/art.24196; Page P, 2006, J BODYW MOV THER, V10, P77, DOI 10.1016/j.jbmt.2005.04.006; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; Riemann BL, 1999, J SPORT REHABIL, V8, P171, DOI 10.1123/jsr.8.3.171; Rombaut L, 2011, ARTHRIT CARE RES, V63, P1432, DOI 10.1002/acr.20557; Sahin N, 2008, RHEUMATOL INT, V28, P995, DOI 10.1007/s00296-008-0566-z; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Slmmonds JV, 2007, MANUAL THER, V12, P298, DOI 10.1016/j.math.2007.05.001; Solomonow M, 1998, SPINE, V23, P2552, DOI 10.1097/00007632-199812010-00010; Yasuda T, 1999, EUR ARCH OTO-RHINO-L, V256, pS27, DOI 10.1007/PL00014149; YATES BJ, 1992, BRAIN RES REV, V17, P51, DOI 10.1016/0165-0173(92)90006-8	35	11	13	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1360-8592	1532-9283		J BODYW MOV THER	J.Bodyw. Mov. Ther.	APR	2014	18	2					159	164		10.1016/j.jbmt.2013.10.003			6	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V02TK	WOS:000213691900003	24725781				2022-02-06	
J	Melcer, T; Walker, J; Sechriest, VF; Lebedda, M; Quinn, K; Galarneau, M				Melcer, Ted; Walker, Jay; Sechriest, V. Franklin, II; Lebedda, Martin; Quinn, Kimberly; Galarneau, Michael			Glasgow Coma Scores, Early Opioids, and Posttraumatic Stress Disorder Among Combat Amputees	JOURNAL OF TRAUMATIC STRESS			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOMS; MORPHINE; IRAQ; PTSD	A recent study found that combat amputees had a reduced prevalence of posttraumatic stress disorder (PTSD) compared with nonamputees with serious extremity injuries. We hypothesized that an extended period of impaired consciousness or early treatment with morphine could prevent consolidation of traumatic memory and the development of PTSD. To examine this hypothesis, we retrospectively reviewed 258 combat casualty records from the Iraq or Afghanistan conflicts from 2001-2008 in the Expeditionary Medical Encounter Database, including medications and Glasgow Coma Scale (GCS) scores recorded at in-theater facilities within hours of the index injury. All patients sustained amputations from injuries. Psychological diagnoses were extracted from medical records for 24 months postinjury. None of 20 patients (0%) with GCS scores of 12 or lower had PTSD compared to 20% of patients with GCS scores of 12 or greater who did have PTSD. For patients with traumatic brain injury, those treated with intravenous morphine within hours of injury had a significantly lower prevalence of PTSD (6.3%) and mood disorders (15.6%) compared to patients treated with fentanyl only (prevalence of PTSD = 41.2%, prevalence of mood disorder = 47.1%). GCS scores and morphine and fentanyl treatments were not significantly associated with adjustment, anxiety, or substance abuse disorders.	[Melcer, Ted; Walker, Jay; Quinn, Kimberly; Galarneau, Michael] Naval Hlth Res Ctr, Dept Med Modeling & Simulat & Mission Support, San Diego, CA 92106 USA; [Sechriest, V. Franklin, II] Orthoped Med Grp, San Diego, CA USA; [Lebedda, Martin] Naval Med Ctr, San Diego, CA USA		Melcer, T (corresponding author), Naval Hlth Res Ctr, Med Modeling & Simulat Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	ted.melcer@med.navy.mil					AC Hart, 2008, ICD 9 CM PROFESSIONA; Andero R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005656; Armed Forces Health Surveillance Center, 2011, MED SURVEILLANCE MON, V18, P17; Benedek DM, 2007, MIL MED, V172, P681; Black IH, 2009, PREHOSP EMERG CARE, V13, P223, DOI 10.1080/10903120802290778; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; Centers for Disease Control and Prevention, 2012, BLAST INJ TRAUM BRAI; Centers for Disease Control and Prevention, 2012, TRAUM BRAIN INJ US R; Chiu KB, 2011, ACAD EMERG MED, V18, P1156, DOI 10.1111/j.1553-2712.2011.01206.x; Claxton AR, 1997, ANESTH ANALG, V84, P509, DOI 10.1097/00000539-199703000-00008; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Fox DJ, 1995, ANESTHESIA PERIOPERA, P211; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Hart AC, 2008, ICD 9 CM PROFESSIONA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Kacprowicz R. F., 2008, J SPEC OPER MED, V8, P48, DOI [10.1097/TA. 0b013e3182754674, DOI 10.1097/TA.0B013E3182754674]; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MacGregor AJ, 2009, MIL MED, V174, P224, DOI 10.7205/MILMED-D-03-9107; McGhee LL, 2011, J BURN CARE RES, V32, P46, DOI 10.1097/BCR.0b013e318204b359; Melcer T, 2013, J ORTHOP TRAUMA, V27, pE31, DOI 10.1097/BOT.0b013e3182517e1c; Pasternak GW, 2012, PAIN MED, V13, pS4, DOI 10.1111/j.1526-4637.2012.01335.x; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Stoddard FJ, 2009, J BURN CARE RES, V30, P836, DOI 10.1097/BCR.0b013e3181b48102; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; TEASDALE G, 1974, LANCET, V2, P81; Wain HJ, 2009, CARE COMBAT AMPUTEE, P265	33	11	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	APR	2014	27	2					152	159		10.1002/jts.21909			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	AF2II	WOS:000334535400005	24668780				2022-02-06	
J	Dai, YX; Sun, Q; Zhang, X; Hu, YC; Zhou, ML; Shi, JX				Dai, Yuxiang; Sun, Qing; Zhang, Xing; Hu, Yangchun; Zhou, Mengliang; Shi, Jixin			Cyclosporin A ameliorates early brain injury after subarachnoid hemorrhage through inhibition of a Nur77 dependent apoptosis pathway	BRAIN RESEARCH			English	Article						Cyclosporin A; Nur77; Apoptosis; Arly brain injury; Subarachnoid hemorrhage	ORPHAN STEROID-RECEPTOR; CEREBRAL-BLOOD-FLOW; MITOCHONDRIAL TRANSLOCATION; TRANSCRIPTION FACTORS; AKT PHOSPHORYLATES; CYTOCHROME-C; ACTIVATION; MODEL; MECHANISMS; VASOSPASM	Nur77 is a potent pro-apoptotic member of the orphan nuclear receptor superfamily. It has been demonstrated that can mediate apoptosis in many system cells in response to extracellular stimuli. Our previous study revealed Nur77-mediated apoptotic also involved in early brain injury (EBI) after experimental subarachnoid hemorrhage (SAH). CsA, a Nur77 inhibitor, can abolish DNA binding activity of Nur77, further inhibit the Nur77 dependent apoptosis pathway. CsA has the neuroprotective effects and has been demonstrated in ischemic stroke and traumatic brain injury. Hence, in this study was designed to explore the neuroprotective effects of CsA in EBI after SAH. Adult male SD rats were randomly assigned to four groups: (1) control group (n=24); (2) SAN (n=24); (3) SAH+DMSO group (n=24); and (4) SAH+CsA (n=24), 10 mg/kg of CsA or same volume of DMSO was administered by femoral vein injection at 15 min before SAN. CsA markedly decreased expressions of Nur77, p-Nur77, Bcl-2 and cyto C, and inhibited apoptosis. Improvement of neurological deficit, alleviation of brain edema and amelioration of EBI were obtained after prophylactic use of CsA. TUNEL-positive cells were reduced markedly in brain cortex by CsA. These findings suggest that neuroprotective effects of CsA during early peroid after SAH may be related to its inhibition of Nur77 dependent apoptosis pathway. (C) 2014 Elsevier B.V. All rights reserved.	[Dai, Yuxiang; Sun, Qing; Zhang, Xing; Hu, Yangchun; Zhou, Mengliang; Shi, Jixin] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China		Shi, JX (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	shijixinnj@hotmail.com		Zhou, Meng-liang/0000-0002-1165-5489			Ansar S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-107; Balasubramanian S, 2012, J AM SOC NEPHROL, V23, P674, DOI 10.1681/ASN.2011070646; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Chang LF, 2011, J SURG ONCOL, V103, P442, DOI 10.1002/jso.21809; Chen HZ, 2008, CARCINOGENESIS, V29, P2078, DOI 10.1093/carcin/bgn197; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Gao C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-7; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Guo ZD, 2010, NEUROL SCI, V31, P143, DOI 10.1007/s10072-009-0192-x; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; He ZH, 2012, STROKE, V43, P484, DOI 10.1161/STROKEAHA.111.626432; Huo JX, 2010, J BIOL CHEM, V285, P11827, DOI 10.1074/jbc.M109.072744; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu SJ, 2011, CANCER BIOL THER, V12, P1005, DOI 10.4161/cbt.12.11.18380; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Manno EM, 1997, NEUROSURGERY, V40, P289, DOI 10.1097/00006123-199702000-00010; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Pekarsky Y, 2001, P NATL ACAD SCI USA, V98, P3690, DOI 10.1073/pnas.051003198; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2002, NEUROREPORT, V13, P2553, DOI 10.1097/00001756-200212200-00034; Sabri M, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/394036; Schievink WI, 2004, NEUROEPIDEMIOLOGY, V23, P299, DOI 10.1159/000080096; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Wang AB, 2009, J IMMUNOL, V183, P3268, DOI 10.4049/jimmunol.0900894; Wang XX, 2012, STRESS, V15, P545, DOI 10.3109/10253890.2011.644603; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Xie ZY, 2012, BRAIN RES, V1472, P113, DOI 10.1016/j.brainres.2012.06.053; Yang H, 2011, HEPATOLOGY, V53, P865, DOI 10.1002/hep.24101; YAZDANBAKHSH K, 1995, P NATL ACAD SCI USA, V92, P437, DOI 10.1073/pnas.92.2.437; Yoon K, 2011, CARCINOGENESIS, V32, P836, DOI 10.1093/carcin/bgr040; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; Zhou L, 2013, LEUKEMIA, V27, P1358, DOI 10.1038/leu.2012.366; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	47	11	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 27	2014	1556						67	76		10.1016/j.brainres.2014.01.052			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AE5BK	WOS:000334002600008	24508908				2022-02-06	
J	Hoppe, IC; Kordahi, AM; Paik, AM; Lee, ES; Granick, MS				Hoppe, Ian C.; Kordahi, Anthony M.; Paik, Angie M.; Lee, Edward S.; Granick, Mark S.			Pediatric Facial Fractures as a Result of Gunshot Injuries: An Examination of Associated Injuries and Trends in Management	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						orbital fractures; mandibular fractures; maxillary fractures; skull fractures; zygomatic fractures; pediatrics; wounds; gunshot	SHOTGUN WOUNDS; RIGID FIXATION; FACE; RECONSTRUCTION; BONE; GROWTH; TRAUMA; HEAD	Introduction Facial fractures are relatively uncommon in the pediatric population, especially those inflicted as a result of interpersonal violence in the form of gunshot injuries. Few studies have examined the unique management of such high-energy injuries in the pediatric population. Oftentimes the resultant damage to soft tissue and bony structures is so great that it challenges the previously accepted standards in the management of pediatric facial fractures. This study will examine a level 1 trauma center's experience with these unique injuries. Methods A retrospective review of all facial fractures occurring in a pediatric population (those 18 years of age or younger) as a result of gunshot wounds in a level 1 trauma center in an urban environment was performed for the years 2000 to 2012. Descriptive information was collected regarding each case as well as information regarding concomitant injuries, treatment modalities, and selected outcomes. Results During this time period, there were 3147 facial fractures treated at our institution, 353 of which were in pediatric patients. Of these, 17 were the results of gunshot wounds. Three patients were excluded due to insufficient data, leaving a total of 14 patients. The average age of patients was 16.5 (range 14-18); all patients were African-American males. The most common fracture was that of the mandible (n = 10), with 2 of those patients exhibiting panfacial fractures. The average Glasgow Coma Scale on admission was 13.5 (range 3-15). Six of the patients were intubated in the emergency department. The most common concomitant injury was a skull fracture (n = 3), followed by cervical spine fractures (n = 2) and intracranial hemorrhages (n = 2). All patients were admitted to the hospital for reasons other than fracture management. Seven patients ultimately went to the operating room for fracture management. The treatment modalities employed were conservative management with closed techniques (n = 11), rigid internal fixation (n = 2), and the use of an external fixator device (n = 1). Minimal to no soft-tissue debridement was performed in 10 of the 14 patients, 2 of which presented between 6 months and 10 years post-injury with soft-tissue complications related to retained material. The mean hospital length of stay was 8.2 days (range 1-18 days). One patient expired. Discussion Pediatric facial fractures as a result of gunshot wounds represent a unique and fortunately rare entity that presents a challenge to all disciplines involved in treatment. In our patients, there was a tendency towards conservative management, with only 3 patients undergoing some form of fixation and only 7 undergoing some form of operative debridement. Concomitant injuries and the high-energy nature of gunshot wounds often preclude traditional management with rigid fixation to ensure adequate bony healing. However, it is important to adequately debride devitalized soft tissue and remove all foreign material to avoid future soft tissue-related complications.	[Hoppe, Ian C.; Kordahi, Anthony M.; Paik, Angie M.; Lee, Edward S.; Granick, Mark S.] Rutgers State Univ, New Jersey Med Sch, Div Plast Surg, Dept Surg, Newark, NJ 07103 USA		Hoppe, IC (corresponding author), Rutgers State Univ, New Jersey Med Sch, Div Plast Surg, Dept Surg, 140 Bergen St,E1620, Newark, NJ 07103 USA.	ianhoppe@gmail.com	Kordahi, Anthony/AAB-7641-2020	Granick, Mark/0000-0001-6507-1633			BROADBENT TR, 1972, J TRAUM, V12, P229, DOI 10.1097/00005373-197203000-00006; Clark N, 1996, PLAST RECONSTR SURG, V98, P583, DOI 10.1097/00006534-199609001-00001; COHEN RA, 1986, AM J ROENTGENOL, V146, P97, DOI 10.2214/ajr.146.1.97; EPPLEY BL, 1993, CLEFT PALATE-CRAN J, V30, P164, DOI 10.1597/1545-1569(1993)030<0164:EEOBPI>2.3.CO;2; FINCH DR, 1979, J TRAUMA, V19, P965, DOI 10.1097/00005373-197912000-00006; Glapa M, 2007, WORLD J SURG, V31, P2104, DOI 10.1007/s00268-007-9220-2; GOODSTEIN WA, 1979, J TRAUMA, V19, P961, DOI 10.1097/00005373-197912000-00005; GRUSS JS, 1985, PLAST RECONSTR SURG, V75, P17; GRUSS JS, 1991, PLAST RECONSTR SURG, V87, P436, DOI 10.1097/00006534-199103000-00008; GUSSACK GS, 1987, LARYNGOSCOPE, V97, P925; Hollier L, 2001, J ORAL MAXIL SURG, V59, P277, DOI 10.1053/joms.2001.20989; KABAN LB, 1977, PLAST RECONSTR SURG, V59, P15, DOI 10.1097/00006534-197701000-00002; LIN KY, 1991, PLAST RECONSTR SURG, V87, P229, DOI 10.1097/00006534-199102000-00003; Marschall M A, 1991, J Craniofac Surg, V2, P63, DOI 10.1097/00001665-199102020-00005; MAY M, 1973, ARCH OTOLARYNGOL, V98, P373; Robertson BC, 1999, SURG CLIN N AM, V79, P1489, DOI 10.1016/S0039-6109(05)70089-X; THORNE CH, 1992, CLIN PLAST SURG, V19, P233; WONG L, 1991, PLAST RECONSTR SURG, V88, P395, DOI 10.1097/00006534-199109000-00003; Wong L, 1993, J Craniofac Surg, V4, P234; ZIDE MF, 1979, J ORAL SURG, V37, P319; Zun LS, 2005, PEDIATR EMERG CARE, V21, P568, DOI 10.1097/01.pec.0000177195.45537.95	21	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR	2014	25	2					400	405		10.1097/SCS.0000000000000657			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AG4IB	WOS:000335381800063	24561367				2022-02-06	
J	Kuhl, HN; Ritchie, D; Taveira-Dick, AC; Hoefling, KA; Russo, SA				Kuhl, Heather N.; Ritchie, David; Taveira-Dick, Angela C.; Hoefling, Katie A.; Russo, Stephen A.			Concussion History and Knowledge Base in Competitive Equestrian Athletes	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; equestrian sports; head injuries; education		Background: Head injuries are responsible for the majority of serious equestrian sports injuries and deaths. Because of significant health risks to equestrians, education regarding the prevention of head and brain injuries is essential. Hypothesis: A significant number of riders have experienced a concussion, and few have knowledge of concussion. Study Design: Cross-sectional study. Methods: Ninety-four riders competing, riding, or attending equestrian events at the Palm Beach International Equestrian Center in Wellington, Florida, from January to April 2010 were surveyed. Measures of central tendency were utilized to evaluate response patterns. Results: Almost half of equestrian riders (44%) experienced concussions during their careers. Those riders who suffered a brain injury were likely to return to riding without seeking medical clearance. Almost 40% of riders were never educated regarding concussions, while 15% received education from their trainers. Conclusion: Education of riders, parents, and horse trainers is needed to raise awareness of concussions and reduce the likelihood of subsequent injuries.	[Kuhl, Heather N.; Taveira-Dick, Angela C.; Hoefling, Katie A.; Russo, Stephen A.] Nova Southeastern Univ, 3301 Coll Ave, Ft Lauderdale, FL 33314 USA; [Ritchie, David] Univ Colorado, Sch Med, Denver, CO USA		Taveira-Dick, AC (corresponding author), Nova Southeastern Univ, 3301 Coll Ave, Ft Lauderdale, FL 33314 USA.	angelataveira79@gmail.com					Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Bixby-Hammet DM, 2008, EQUESTRIAN MED SAFET, V22, P1; BIXBYHAMMETT D, 1990, SPORTS MED, V9, P36, DOI 10.2165/00007256-199009010-00004; Broshek DK, 2001, AM MED EQUESTRIAN AS, V12, P1; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; CONDIE C, 1993, PUBLIC HEALTH REP, V108, P121; Frankel HL, 1998, AM SURGEON, V64, P151; Hobbs Gregory D., 1994, Journal of Emergency Medicine, V12, P143, DOI 10.1016/0736-4679(94)90690-4; Jagodzinski Tanya, 2005, WMJ, V104, P50; Kriss TC, 1997, J TRAUMA, V43, P97, DOI 10.1097/00005373-199707000-00022; LINDSAY KW, 1980, BRIT MED J, V281, P789, DOI 10.1136/bmj.281.6243.789; Lloyd R G, 1987, Br J Sports Med, V21, P22; MASTERS RG, 1991, CLIN J SPORT MED, V1, P123; McCrory P, 2005, MED SPORT SCI, V48, P8, DOI 10.1159/000084280; Moss PS, 2002, EMERG MED J, V19, P412, DOI 10.1136/emj.19.5.412; NELSON DE, 1992, AM J DIS CHILD, V146, P611, DOI 10.1001/archpedi.1992.02160170091022; NELSON DE, 1994, AM J PREV MED, V10, P15, DOI 10.1016/S0749-3797(18)30641-X; NELSON DE, 1994, PHYSICIAN SPORTSMED, V22, P53, DOI 10.1080/00913847.1994.11710501; Watt GM, 1996, SPORTS MED, V22, P187, DOI 10.2165/00007256-199622030-00005; Whitlock M R, 1987, Br J Sports Med, V21, P25	20	11	11	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2014	6	2					136	138		10.1177/1941738113508073			3	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V20EK	WOS:000214869700007	24587863	Green Published			2022-02-06	
J	Labbe, DR; Vance, DE; Wadley, V; Novack, TA				Labbe, Donald R.; Vance, David E.; Wadley, Virginia; Novack, Thomas A.			Predictors of Driving Avoidance and Exposure Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						driving; structural equation modeling; traumatic brain injury	FUNCTIONAL INDEPENDENCE MEASURE; COMMUNITY INTEGRATION; DEPRESSIVE SYMPTOMS; SELF-REGULATION; ABILITY; REHABILITATION; PATTERNS; OUTCOMES; DRIVERS; AMNESIA	Background: An estimated 40% to 60% of individuals who experience a moderate to severe traumatic brain injury (TBI) return to driving. However, little is known about driving behavior post-TBI and how this may be related to demographic, injury, and outcome factors. Methods: A total of 184 participants who experienced moderate to severe TBI were included in this study. Participants completed a telephone survey regarding return to driving and current driving behavior. Structural equation modeling was used to analyze predicted relationships between demographic and injury-related variables with driving exposure and avoidance within 5 years of injury. Results: The model indicated that participants who were older and female tended to avoid a greater number of challenging everyday driving scenarios. Participants who had more severe injuries and those with poorer performance on cognitive measures at the time of rehabilitation discharge were likely to drive less frequently and over less distances at follow-up, though they did not avoid challenging driving situations. Conclusions: Young men and those with more severe injuries may require additional attention regarding their driving behavior following TBI.	[Labbe, Donald R.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Vance, David E.] Univ Alabama Birmingham, Dept Nursing, Edward R Roybal Ctr Translat Res Aging & Mobil, Birmingham, AL USA; [Wadley, Virginia] Univ Alabama Birmingham, Dept Med, Edward R Roybal Ctr Translat Res Aging & Mobil, Birmingham, AL USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Labbe, DR (corresponding author), Brown Univ, Alpert Med Sch, 830 Chalkstone Ave, Providence, RI 02912 USA.	dlabbe@uab.edu	Vance, David/AAE-6047-2020	Vance, David/0000-0002-0498-6263	National Institute on Disability and Rehabilitation Research [H133A070039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042687] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025777] Funding Source: NIH RePORTER	The current study was funded by the National Institute on Disability and Rehabilitation Research Grant No. H133A070039.	Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Baldock MRJ, 2006, ACCIDENT ANAL PREV, V38, P1038, DOI 10.1016/j.aap.2006.04.016; Ball K, 1998, ACCIDENT ANAL PREV, V30, P313, DOI 10.1016/S0001-4575(97)00102-4; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343, DOI 10.1093/geronb/56.6.S343; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P52, DOI 10.1016/S0003-9993(98)90208-8; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Haselkorn JK, 1998, ARCH PHYS MED REHAB, V79, P738, DOI 10.1016/S0003-9993(98)90349-5; Heaton R. K., 2004, REVISED COMPREHENSIV; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; JORESKOG K, 1993, LISREL 8 SIMPLIS COM; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Lyman JM, 2001, ACCIDENT ANAL PREV, V33, P413, DOI 10.1016/S0001-4575(00)00055-5; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Neese LE, 2000, BRAIN INJURY, V14, P719; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Rhodes N, 2011, ACCIDENT ANAL PREV, V43, P923, DOI 10.1016/j.aap.2010.11.015; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Rudman DL, 2006, CAN J AGING, V25, P65, DOI 10.1353/cja.2006.0031; Schanke AK, 2008, J REHABIL MED, V40, P733, DOI 10.2340/16501977-0256; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); TEASDALE G, 1974, LANCET, V2, P81; Vance DE, 2006, ACCIDENT ANAL PREV, V38, P823, DOI 10.1016/j.aap.2006.02.008; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Windsor TD, 2007, GERONTOLOGIST, V47, P215, DOI 10.1093/geront/47.2.215; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	40	11	11	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2014	29	2					185	192		10.1097/HTR.0b013e3182795211			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9ZH	WOS:000336504600012	23474877	Green Accepted			2022-02-06	
J	Velmurugan, J; Sinha, S; Satishchandra, P				Velmurugan, Jayabal; Sinha, Sanjib; Satishchandra, Parthasarathy			Magnetoencephalography recording and analysis	ANNALS OF INDIAN ACADEMY OF NEUROLOGY			English	Article						Epilepsy analysis; head and source model; Magnetoencephalography (MEG); MEG acquisition	HUMAN BRAIN; MEG; LOCALIZATION; EEG; IDENTIFICATION; SCHIZOPHRENIA; EPILEPSY; NETWORK; MODELS; SPIKE	Magnetoencephalography (MEG) non-invasively measures the magnetic field generated due to the excitatory postsynaptic electrical activity of the apical dendritic pyramidal cells. Such a tiny magnetic field is measured with the help of the biomagnetometer sensors coupled with the Super Conducting Quantum Interference Device (SQUID) inside the magnetically shielded room (MSR). The subjects are usually screened for the presence of ferromagnetic materials, and then the head position indicator coils, electroencephalography (EEG) electrodes (if measured simultaneously), and fiducials are digitized using a 3D digitizer, which aids in movement correction and also in transferring the MEG data from the head coordinates to the device and voxel coordinates, thereby enabling more accurate co-registration and localization. MEG data pre-processing involves filtering the data for environmental and subject interferences, artefact identification, and rejection. Magnetic resonance Imaging (MRI) is processed for correction and identifying fiducials. After choosing and computing for the appropriate head models (spherical or realistic; boundary/finite element model), the interictal/ictal epileptiform discharges are selected and modeled by an appropriate source modeling technique (clinically and commonly used - single equivalent current dipole - ECD model). The equivalent current dipole (ECD) source localization of the modeled interictal epileptiform discharge (IED) is considered physiologically valid or acceptable based on waveform morphology, isofield pattern, and dipole parameters (localization, dipole moment, confidence volume, goodness of fit). Thus, MEG source localization can aid clinicians in sublobar localization, lateralization, and grid placement, by evoking the irritative/seizure onset zone. It also accurately localizes the eloquent cortex-like visual, language areas. MEG also aids in diagnosing and delineating multiple novel findings in other neuropsychiatric disorders, including Alzheimers disease, Parkinsonism, Traumatic brain injury, autistic disorders, and so oon.	[Velmurugan, Jayabal; Sinha, Sanjib; Satishchandra, Parthasarathy] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India		Sinha, S (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Hosur Rd, Bangalore 560029, Karnataka, India.	sanjib_sinha2004@yahoo.co.in	jayabal, velmurugan/E-4011-2014	Jayabal, Velmurugan/0000-0002-5479-7786			AHONEN AI, 1993, PHYS SCRIPTA, VT49A, P198, DOI 10.1088/0031-8949/1993/T49A/033; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anninos R, 2007, ACTA NEUROL BELG, V107, P5; Bagic A, 2009, J CLIN NEUROPHYSIOL, V26, P290, DOI 10.1097/WNP.0b013e3181b49d50; Bagic AI, 2011, J CLIN NEUROPHYSIOL, V28, P362, DOI 10.1097/WNO.0b013e3181cde4ad; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Ebersole JS, 2007, J CLIN NEUROPHYSIOL, V24, P120, DOI 10.1097/WNP.0b013e31803ece13; Fehr T, 2003, SCHIZOPHR RES, V63, P63, DOI 10.1016/S0920-9964(02)00213-X; Fernandes JM, 2005, J CLIN NEUROPHYSIOL, V22, P68, DOI 10.1097/01.WNP.0000150999.67749.6D; Fuchs M, 2007, J CLIN NEUROPHYSIOL, V24, P101, DOI 10.1097/WNP.0b013e318038fb3e; Guide MU, 2005, EL NEUR OY; Hansen P.C., 2010, MEG INTRO METHODS; Hoechstetter K, 2010, BESA RES TUTORIAL, P1; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Martino J, 2011, ANN NEUROL, V69, P521, DOI 10.1002/ana.22167; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mosher JC, 1999, J CLIN NEUROPHYSIOL, V16, P225, DOI 10.1097/00004691-199905000-00004; Ochi A, 2008, INT J PSYCHOPHYSIOL, V68, P104, DOI 10.1016/j.ijpsycho.2007.12.008; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Rockstroh BS, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-44; SATO S, 1991, J CLIN NEUROPHYSIOL, V8, P144, DOI 10.1097/00004691-199104000-00003; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; Schwartz D, 1996, BRAIN TOPOGR, V9, P101, DOI 10.1007/BF01200710; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Toga AW, 2006, NAT REV NEUROSCI, V7, P952, DOI 10.1038/nrn2012; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Zijlmans M, 2002, J CLIN NEUROPHYSIOL, V19, P183, DOI 10.1097/00004691-200206000-00001; [No title captured]	28	11	11	0	14	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0972-2327	1998-3549		ANN INDIAN ACAD NEUR	Ann. Indian Acad. Neurol.	MAR	2014	17			1			S113	S119		10.4103/0972-2327.128678			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF6PE	WOS:000334836200019	24791077	Green Published, gold			2022-02-06	
J	Xu, W; Cao, MH; Zheng, HY; Tan, X; Li, L; Cui, G; Xu, J; Cao, JH; Ke, KF; Wu, QY				Xu, Wei; Cao, Maohong; Zheng, Heyi; Tan, Xiang; Li, Lei; Cui, Gang; Xu, Jian; Cao, Jianhua; Ke, Kaifu; Wu, Qiyun			Upregulation of SYF2 Is Associated With Neuronal Apoptosis Caused by Reactive Astrogliosis to Neuroinflammation	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						SYF2; cyclin D1; astrocyte proliferation; neuronal apoptosis; neuroinflammation; rat	CELL-CYCLE PROGRESSION; TRAUMATIC BRAIN-INJURY; DNA-DAMAGE RESPONSES; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; PROTEIN; LIPOPOLYSACCHARIDE; INFLAMMATION	SYF2, known as CCNDBP1-interactor or p29, is likely involved in pre-mRNA splicing and cell cycle progression. The present study was designed to elucidate dynamic changes in SYF2 expression and distribution in the cerebral cortex in a lipopolysaccharide (LPS)-induced neuroinflammation rat model. It was found that SYF2 expression was induced strongly in active astrocytes after LPS injection. In vitro studies showed that the upregulation of SYF2 might be involved in the activation of C6 cells after LPS challenge and the neuronal apoptosis after conditioned media challenge. In addition, with silencing of SYF2 in C6 and PC12 cells by siRNA, the results indicated that SYF2 was required for astrocyte activation and neuronal apoptosis induced by LPS. Our findings on the cellular signaling pathway may provide a new therapeutic strategy against neuroinflammation in the CNS. (c) 2013 Wiley Periodicals, Inc.	[Xu, Wei; Cao, Maohong; Zheng, Heyi; Tan, Xiang; Li, Lei; Xu, Jian; Cao, Jianhua; Ke, Kaifu; Wu, Qiyun] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, JS, Peoples R China; [Cui, Gang] Soochow Univ, Dept Neurol, Affiliated Hosp, Suzhou, Peoples R China		Ke, KF (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, JS, Peoples R China.	kekaifu1234@hotmail.com; wuqiyun-nt@hotmail.com					Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bamberger ME, 2002, NEUROSCIENTIST, V8, P276, DOI 10.1177/1073858402008003013; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bonda DJ, 2009, AGING-US, V1, P382, DOI 10.18632/aging.100044; Bonow RH, 2009, PHARMACOGENOMICS J, V9, P116, DOI 10.1038/tpj.2008.15; Chang MS, 2002, BIOCHEM BIOPH RES CO, V299, P241, DOI 10.1016/S0006-291X(02)02605-0; Chang MS, 2000, BIOCHEM BIOPH RES CO, V279, P732, DOI 10.1006/bbrc.2000.3992; Chen C., 2012, PLOS ONE, V7; Chu PC, 2006, CANCER RES, V66, P8484, DOI 10.1158/0008-5472.CAN-05-3229; Chu PC, 2009, CARCINOGENESIS, V30, P1710, DOI 10.1093/carcin/bgp204; Dahan O, 2002, NUCLEIC ACIDS RES, V30, P4361, DOI 10.1093/nar/gkf563; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Felts PA, 2005, BRAIN, V128, P1649, DOI 10.1093/brain/awh516; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hoozemans JJM, 2006, INT J DEV NEUROSCI, V24, P157, DOI 10.1016/j.ijdevneu.2005.11.001; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Koguchi K, 2002, GLIA, V37, P93, DOI 10.1002/glia.10017; Ledeboer A, 2002, AM J PHYSIOL-REG I, V282, pR1762, DOI 10.1152/ajpregu.00766.2001; Ma WB, 2007, J CELL BIOCHEM, V100, P1376, DOI 10.1002/jcb.21140; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Renton KW, 1999, BRAIN RES, V842, P139, DOI 10.1016/S0006-8993(99)01773-4; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Vincent K, 2003, GENETICS, V164, P895; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Zawadzka M, 2003, MOL CELL NEUROSCI, V22, P202, DOI 10.1016/S1044-7431(03)00036-8; Zhang ZH, 2010, J HYPERTENS, V28, P806, DOI 10.1097/HJH.0b013e3283358b6e; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	33	11	12	0	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAR	2014	92	3					318	328		10.1002/jnr.23312			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	289JA	WOS:000329677000005	24301298				2022-02-06	
J	Wahlstrom, MR; Olivecrona, M; Ahlm, C; Bengtsson, A; Koskinen, LOD; Naredi, S; Hultin, M				Wahlstrom, Marie Rodling; Olivecrona, Magnus; Ahlm, Clas; Bengtsson, Anders; Koskinen, Lars-Owe D.; Naredi, Silvana; Hultin, Magnus			Effects of prostacyclin on the early inflammatory response in patients with traumatic brain injury -a randomised clinical study	SPRINGERPLUS			English	Article						Traumatic brain injury; Epoprostenol; Systemic inflammatory response; Cytokines; Asymmetric dimethylarginine	ASYMMETRIC DIMETHYLARGININE; MICRODIALYSIS; SUBSTANCE; SEVERITY; DISEASE; SEPSIS; PLASMA; PGI(2); ROLES; SCORE	Objective and design: A prospective, randomised, double-blinded, clinical trial was performed at a level 1 trauma centre to determine if a prostacyclin analogue, epoprostenol (Flolan(R)), could attenuate systemic inflammatory response in patients with severe traumatic brain injury (TBI). Subjects: 46 patients with severe TBI, randomised to epoprostenol (n = 23) or placebo (n = 23). Treatment: Epoprostenol, 0.5 ng.kg(-1).min(-1), or placebo (saline) was given intravenously for 72 hours and then tapered off over the next 24 hours. Methods: Interleukin-6 (IL-6), interleukin-8 (IL-8), soluble intracellular adhesion molecule-1 (sICAM-1), C-reactive protein (CRP), and asymmetric dimethylarginine (ADMA) levels were measured over five days. Measurements were made at 24 h intervals <= 24 h after TBI to 97-120 h after TBI. Results: A significantly lower CRP level was detected in the epoprostenol group compared to the placebo group within 73-96 h (p = 0.04) and within 97-120 h (p = 0.008) after trauma. IL-6 within 73-96 h after TBI was significantly lower in the epoprostenol group compared to the placebo group (p = 0.04). ADMA was significantly increased within 49-72 h and remained elevated, but there was no effect of epoprostenol on ADMA levels. No significant differences between the epoprostenol and placebo groups were detected for IL-8 or sICAM-1. Conclusions: Administration of the prostacyclin analogue epoprostenol significantly decreased CRP and, to some extent, IL-6 levels in patients with severe TBI compared to placebo. These findings indicate an interesting option for treatment of TBI and warrants future larger studies.	[Wahlstrom, Marie Rodling; Naredi, Silvana; Hultin, Magnus] Umea Univ, Dept Surg & Perioperat Sci Anaesthesiol & Intens, S-90187 Umea, Sweden; [Olivecrona, Magnus; Koskinen, Lars-Owe D.] Umea Univ, Dept Pharmacol & Clin Neurosci, Neurosurg, S-90187 Umea, Sweden; [Ahlm, Clas] Umea Univ, Dept Clin Microbiol Infect Dis, S-90187 Umea, Sweden; [Bengtsson, Anders] Univ Gothenburg, Inst Clin Sci, Dept Anesthesiol & Intens Care, Sahlgrenska Acad, S-40530 Gothenburg, Sweden		Hultin, M (corresponding author), Umea Univ, Dept Surg & Perioperat Sci Anaesthesiol & Intens, S-90187 Umea, Sweden.	magnus.hultin@umu.se	Koskinen, Lars-Owe/AAQ-8957-2020; Hultin, Magnus/A-1321-2010	Hultin, Magnus/0000-0003-2935-7161; Naredi, Silvana/0000-0002-4409-6089; Olivecrona, Magnus/0000-0001-8457-4711; Koskinen, Lars-Owe/0000-0003-3528-8502	Department of Clinical Neurosciences at Umea University Hospital Research Foundation; Tore Nilsson Foundation; Kempe Foundation; Capio Research Foundation; Swedish Society of Medicine; Faculty of Medicine at Umea University; Department of Research and Development, Vasternorrland County Council, Sweden	This study was financially supported by grants from the Department of Clinical Neurosciences at Umea University Hospital Research Foundation, the Tore Nilsson Foundation, the Kempe Foundation, the Capio Research Foundation, the Swedish Society of Medicine, the Faculty of Medicine at Umea University, and the Department of Research and Development, Vasternorrland County Council, Sweden.	Andersson J, 2010, MENOPAUSE, V17, P365, DOI 10.1097/gme.0b013e3181c12b26; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boger RH, 2003, CLIN CHEM LAB MED, V41, P1467, DOI 10.1515/CCLM.2003.225; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chin KM, 2009, CHEST, V135, P130, DOI 10.1378/chest.08-1323; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Jawa Randeep S, 2011, J Intensive Care Med, V26, P73, DOI 10.1177/0885066610395679; JONES G, 1984, J PATHOL, V142, P51, DOI 10.1002/path.1711420110; Jungner M, 2009, J TRAUMA, V67, P1345, DOI 10.1097/TA.0b013e3181a5f211; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Neunaber C, 2011, RECENT PATENTS INFLA, V5, P17, DOI 10.2174/187221311794474892; Ohta S, 2005, LIVER INT, V25, P1061, DOI 10.1111/j.1478-3231.2005.01143.x; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; ORFEO T, 1994, J TRAUMA, V37, P347, DOI 10.1097/00005373-199409000-00003; Scheeren T, 1997, INTENS CARE MED, V23, P146, DOI 10.1007/s001340050309; Siekmeier R, 2008, J CARDIOVASC PHARM T, V13, P279, DOI 10.1177/1074248408326488; Stahel PF, 2007, INJURY, V38, P1409, DOI 10.1016/j.injury.2007.09.023; Stanisic M, 2012, INFLAMM RES, V61, P845, DOI 10.1007/s00011-012-0476-0; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	31	11	12	0	2	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	FEB 18	2014	3								98	10.1186/2193-1801-3-98			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1XW	WOS:000358950600004	24600548	Green Published, gold			2022-02-06	
J	Suehiro, E; Koizumi, H; Kunitsugu, I; Fujisawa, H; Suzuki, M				Suehiro, Eiichi; Koizumi, Hiroyasu; Kunitsugu, Ichiro; Fujisawa, Hirosuke; Suzuki, Michiyasu			Survey of Brain Temperature Management in Patients with Traumatic Brain Injury in the Japan Neurotrauma Data Bank	JOURNAL OF NEUROTRAUMA			English	Article						brain temperature management; CT classification (TCDB classification); severe traumatic brain injury; survey	HYPOTHERMIA THERAPY; SUBDURAL-HEMATOMA; MILD HYPOTHERMIA; HEAD-INJURY; INDUCTION; RAT	The goal of this study was to evaluate the clinical characteristics and effects of brain temperature management in patients with severe traumatic brain injury (TBI). A total of 1091 patients were registered from the Japan Neurotrauma Data Bank Project 2009. Those with a Glasgow Coma Scale (GCS) score of 9 or more, a GCS score of 3, bilateral dilated pupils, or cardiopulmonary arrest on arrival were excluded. This left a total of 401 patients. Patients were classified into three groups: no temperature management, with no intervention for brain temperature (225 patients, 56.1%), intensive normothermia (129 patients, 32.2%), and hypothermia (47 patients, 11.7%). Patient age, GCS score, pupillary abnormality, Injury Severity Score (ISS), intracranial pressure (ICP) monitoring, and outcome according to CT classification (Traumatic Coma Data Bank classification) on admission were examined. Patients were significantly older in the no temperature management group (average age 61.5 years) compared with normothermia (53.6 years) and hypothermia (46.9 years). ICP monitoring was significantly decreased in 85.1% of patients with hypothermia, 42.6% with normothermia, and 14.7% in no temperature management group. Favorable outcome rate was significantly higher with hypothermia (52.4%) compared with normothermia (26.9%) and no temperature management (20.7%) with evacuated mass lesions in contrast to diffuse injury. Multivariate analysis in patients with evacuated mass lesions showed that GCS (6pts), and hypothermia were independent factors related to a favorable outcome. Appropriate thermoregulation of the brain for individual patients with various types of TBI are important.	[Suehiro, Eiichi; Koizumi, Hiroyasu; Fujisawa, Hirosuke; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan; [Suehiro, Eiichi; Koizumi, Hiroyasu; Fujisawa, Hirosuke; Suzuki, Michiyasu] Japan Soc Neurotraumatol, Japan Neurotrauma Data Bank Comm, Tokyo, Japan; [Kunitsugu, Ichiro] Yamaguchi Univ, Sch Med, Dept Publ Hlth, Ube, Yamaguchi 7558505, Japan		Suehiro, E (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	suehiro-nsu@umin.ac.jp	Suehiro, Eiichi/I-5852-2019				Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Delbarre B, 1992, EXS, V62, P199; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; KURODA Y, 1992, NEUROSURGERY, V30, P687; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; Suehiro E, 2011, WORLD NEUROSURG, V75, P563, DOI 10.1016/j.wneu.2010.09.013; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725	16	11	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2014	31	4					315	320		10.1089/neu.2013.3057			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AA7PY	WOS:000331290600003	24047191				2022-02-06	
J	Aarnink, SH; Vos, SB; Leemans, A; Jernigan, TL; Madsen, KS; Baare, WFC				Aarnink, Saskia H.; Vos, Sjoerd B.; Leemans, Alexander; Jernigan, Terry L.; Madsen, Kathrine Skak; Baare, William F. C.			Automated longitudinal intra-subject analysis (ALISA) for diffusion MRI tractography	NEUROIMAGE			English	Article						Tractography; Diffusion; DTI; DTI Longitudinal data analyses	WHITE-MATTER TRACTS; TENSOR IMAGING TRACTOGRAPHY; TRAUMATIC BRAIN-INJURY; FRACTIONAL ANISOTROPY; AXONAL PROJECTIONS; MEAN DIFFUSIVITY; CORPUS-CALLOSUM; FIBER PATHWAYS; ATLAS; TRACKING	Fiber tractography (FT), which aims to reconstruct the three-dimensional trajectories of white matter (WM). fibers non-invasively, is one of the most popular approaches for analyzing diffusion tensor imaging (DTI) data given its high inter- and intra-rater reliability and scan-rescan reproducibility. The major disadvantage of manual FT segmentations, unfortunately, is that placing regions-of-interest for tract selection can be very labor-intensive and time-consuming. Although there are several methods that can identify specific WM fiber bundles in an automated way, manual FT segmentations across multiple subjects performed by a trained rater with neuroanatomical expertise are generally assumed to be more accurate. However, for longitudinal DTI analyses it may still be beneficial to automate the segmentation across multiple time points, but then for each individual subject separately. Both the inter-subject and intra-subject automation in this situation are intended for subjects without gross pathology. In this work, we propose such an automated longitudinal intra-subject analysis (dubbed ALISA) approach, and assessed whether ALISA could preserve the same level of reliability as obtained with manual FT segmentations. In addition, we compared ALISA with an automated inter-subject analysis. Based on DTI data sets from (i) ten healthy subjects that were scanned five times (six-month intervals, aged 7.6-8.6 years at the first scan) and (ii) one control subject that was scanned ten times (weekly intervals, 12.2 years at the first scan), we demonstrate that the increased efficiency provided by ALISA does not compromise the high degrees of precision and accuracy that can be achieved with manual FT segmentations. Further automation for inter-subject analyses, however, did not provide similarly accurate FT segmentations. (C) 2013 Elsevier Inc. All rights reserved.	[Aarnink, Saskia H.; Vos, Sjoerd B.; Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Heidelberglaan 100,Room QS4-300, NL-3584 CX Utrecht, Netherlands; [Aarnink, Saskia H.] Elkerliek Hosp, Helmond, Netherlands; [Jernigan, Terry L.; Madsen, Kathrine Skak; Baare, William F. C.] Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark; [Jernigan, Terry L.; Madsen, Kathrine Skak] Ctr Integrated Mol Brain Imaging, Copenhagen, Denmark; [Jernigan, Terry L.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jernigan, Terry L.] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92093 USA		Vos, SB (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Heidelberglaan 100,Room QS4-300, NL-3584 CX Utrecht, Netherlands.	Sjoerd@isi.uu.nl	Leemans, Alexander/A-1784-2011	Leemans, Alexander/0000-0002-9306-6126; Madsen, Kathrine Skak/0000-0001-8884-5902; Baare, William Frans Christiaan/0000-0002-1810-7266	Danish Medical Research CouncilDanish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Lundbeck FoundationLundbeckfonden	The HUBU project is supported by the Danish Medical Research Council, and the Lundbeck Foundation.	[Anonymous], 2011, FRONT NEUROINFORM, P5; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Cercignani M, 2010, DIFFUSION MRI THEORY, P485; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Clark KA, 2011, J PSYCHIATR RES, V45, P980, DOI 10.1016/j.jpsychires.2011.01.006; Clayden JD, 2007, IEEE T MED IMAGING, V26, P1555, DOI 10.1109/TMI.2007.905826; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Concha L, 2005, ANN NEUROL, V57, P188, DOI 10.1002/ana.20334; Concha L, 2009, J NEUROL NEUROSUR PS, V80, P312, DOI 10.1136/jnnp.2007.139287; Concha L, 2007, EPILEPSIA, V48, P931, DOI 10.1111/j.1528-1167.2007.01006.x; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; COOK PA, 2006, P INT SOC MAGN RESON, V14, P2759; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Deprez S, 2012, J CLIN ONCOL, V30, P274, DOI 10.1200/JCO.2011.36.8571; Deprez S, 2011, HUM BRAIN MAPP, V32, P480, DOI 10.1002/hbm.21033; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Emsell L, 2009, P 17 ANN M INT SOC M, P1224; Faria AV, 2011, NEUROIMAGE, V54, P1854, DOI 10.1016/j.neuroimage.2010.09.061; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Gong G, 2008, EPILEPSIA, V49, P1941, DOI 10.1111/j.1528-1167.2008.01666.x; Hagler DJ, 2009, HUM BRAIN MAPP, V30, P1535, DOI 10.1002/hbm.20619; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hasan KM, 2011, COMPUT BIOL MED, V41, P1062, DOI 10.1016/j.compbiomed.2010.10.008; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jernigan TL, 2011, PROG BRAIN RES, V189, P77, DOI 10.1016/B978-0-444-53884-0.00019-1; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Jones DK, 2005, MAGNET RESON MED, V53, P1462, DOI 10.1002/mrm.20484; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Karaus AHS, 2009, OPEN MED IMAGING J, V3, P21; Keller TA, 2009, NEURON, V64, P624, DOI 10.1016/j.neuron.2009.10.018; Kitchen CMR, 2009, AM J OPHTHALMOL, V147, P571, DOI 10.1016/j.ajo.2008.06.031; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Koch M, 2001, NEUROIMAGE, V13, pS176; Kristo G, 2013, MAGN RESON MED, V70, P1544, DOI 10.1002/mrm.24602; Kristo G, 2013, EUR RADIOL, V23, P28, DOI 10.1007/s00330-012-2589-9; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Leemans A, 2006, MAGN RESON MED, V55, P1414, DOI 10.1002/mrm.20898; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Madsen KS, 2011, NEUROIMAGE, V58, P1090, DOI 10.1016/j.neuroimage.2011.07.032; Madsen KS, 2010, NEUROPSYCHOLOGIA, V48, P854, DOI 10.1016/j.neuropsychologia.2009.11.001; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nimsky C, 2005, RADIOLOGY, V234, P218, DOI 10.1148/radiol.2341031984; Nimsky C, 2006, NEUROIMAGE, V30, P1219, DOI 10.1016/j.neuroimage.2005.11.001; O'Donnell LJ, 2009, NEUROIMAGE, V45, P832, DOI 10.1016/j.neuroimage.2008.12.023; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Price G, 2008, NEUROIMAGE, V39, P949, DOI 10.1016/j.neuroimage.2007.09.012; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reich DS, 2010, NEUROIMAGE, V49, P3047, DOI 10.1016/j.neuroimage.2009.11.043; Reijmer YD, 2013, NEUROLOGY, V80, P1370, DOI 10.1212/WNL.0b013e31828c2ee5; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sage CA, 2009, HUM BRAIN MAPP, V30, P3657, DOI 10.1002/hbm.20794; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Suarez RO, 2012, NEUROIMAGE, V59, P3690, DOI 10.1016/j.neuroimage.2011.11.043; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Sullivan EV, 2010, DEV NEUROPSYCHOL, V35, P233, DOI 10.1080/87565641003689556; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; van der Aa NE, 2011, STROKE, V42, P3410, DOI 10.1161/STROKEAHA.111.624858; Van Hecke W, 2008, NEUROIMAGE, V43, P69, DOI 10.1016/j.neuroimage.2008.07.006; Van Hecke W, 2007, IEEE T MED IMAGING, V26, P1598, DOI 10.1109/TMI.2007.906786; Van Hecke W, 2011, NEUROIMAGE, V55, P566, DOI 10.1016/j.neuroimage.2010.12.005; Van Hecke W, 2010, J MAGN RESON IMAGING, V31, P1492, DOI 10.1002/jmri.22198; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Van Hecke W, 2008, J MAGN RESON IMAGING, V27, P978, DOI 10.1002/jmri.21338; Van Hecke W, 2009, NEUROIMAGE, V46, P692, DOI 10.1016/j.neuroimage.2009.02.032; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Yogarajah M, 2008, NEUROIMAGE, V40, P1755, DOI 10.1016/j.neuroimage.2007.12.046; Yogarajah M, 2010, BRAIN, V133, P2348, DOI 10.1093/brain/awq175; Zhang JY, 2007, NEUROIMAGE, V38, P239, DOI 10.1016/j.neuroimage.2007.07.033; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	110	11	11	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	FEB 1	2014	86						404	416		10.1016/j.neuroimage.2013.10.026			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	298OZ	WOS:000330335300042	24157921	Green Published			2022-02-06	
J	Darwish, H; Mahmood, A; Schallert, T; Chopp, M; Therrien, B				Darwish, Hala; Mahmood, Asim; Schallert, Timothy; Chopp, Michael; Therrien, Barbara			Simvastatin and environmental enrichment effect on recognition and temporal order memory after mild-to-moderate traumatic brain injury	BRAIN INJURY			English	Article						Environmental enrichment; mild brain injury; recognition memory; simvastatin; TBI; temporal order memory	OBJECT RECOGNITION; PERIRHINAL CORTEX; DENTATE GYRUS; HIPPOCAMPAL-LESIONS; PREFRONTAL CORTEX; FEATURE AMBIGUITY; CHLORAL HYDRATE; RATS; NEUROGENESIS; ATORVASTATIN	Primary objective: The purpose of this study was to investigate the effect of mild-to-moderate (m-mod) traumatic brain injury (TBI) on spontaneous object (SO) recognition and temporal order (TO) memory in male Wistar rats and to compare the effects of environmental enrichment (EE) and simvastatin (Sim) on SO and TO memory post-injury. Research design: A randomized repeated measure experimental design was used. Methods and procedure: Seven days after arrival, animals received the injury or sham surgery. Using a Y-shaped maze, SO and TO memory was assessed in the two groups of animals at 6, 24, 48, 72 hours and 7, 14, 21 and 35 days post-surgery. Total time exploring each object and discrimination ratio were calculated and analysed. Then SO and TO memory were compared between two groups that received either Sim or EE for 2 hours daily starting 24 hours post-injury and a sham group that received saline for 14 days post-injury. Results: The results showed that the injury impaired SO and TO memory compared to the sham up to 35 days post-trauma. Injured animals exhibited familiarity preference, novelty aversion and impaired TO performance. EE improved the animals' SO recognition deficits 7 days post-injury after a shorter delay (1 minute) only and Sim reversed TO memory deficits 14 days post-injury after a longer delay (60 minutes). Conclusion: Persistent SO and TO memory deficits follow TBI in animals; Simv and EE seem to be promising therapies of TBI memory deficits.	[Darwish, Hala] Amer Univ Beirut, Fac Med, Sch Nursing, New York, NY 10017 USA; [Mahmood, Asim; Chopp, Michael] Henry Ford Hlth Syst, Detroit, MI USA; [Schallert, Timothy] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Therrien, Barbara] Univ Michigan, Med Surg Nursing Dept, Ann Arbor, MI 48109 USA		Darwish, H (corresponding author), Amer Univ Beirut, Fac Med, Sch Nursing, 3 Dag Hammerskjold Plaza,8th Floor, New York, NY 10017 USA.	hd30@aub.edu.lb		Darwish, Hala/0000-0001-5744-6466	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 NS042345, RO1 NS04225905, RO1 NS 05228001, T32 NR 007074, F31 NR009741]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS042345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007074, F31NR009741] Funding Source: NIH RePORTER	The research experiment was conducted at Henry Ford Health System Neurosurgery laboratory in collaboration with the University of Michigan. The authors report no conflicts of interest. This work was funded from the National Institutes of Health P01 NS042345, RO1 NS04225905, RO1 NS 05228001, T32 NR 007074 and F31 NR009741.	Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Bartko SJ, 2007, LEARN MEMORY, V14, P821, DOI 10.1101/lm.749207; Bartko SJ, 2007, J NEUROSCI, V27, P2548, DOI 10.1523/JNEUROSCI.5171-06.2007; Becker K, 2004, STROKE, V35, P2706, DOI 10.1161/01.STR.0000143215.61714.62; Beland FA, 1998, J TOXICOL ENV HEAL A, V54, P209; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Briones T L, 2000, Biol Res Nurs, V1, P299, DOI 10.1177/109980040000100406; Briones TL, 2006, BEHAV BRAIN RES, V171, P17, DOI 10.1016/j.bbr.2006.03.011; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Buffalo EA, 1998, HIPPOCAMPUS, V8, P330, DOI 10.1002/(SICI)1098-1063(1998)8:4<330::AID-HIPO3>3.0.CO;2-L; Buffalo EA, 2000, LEARN MEMORY, V7, P375, DOI 10.1101/lm.32100; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FIELD KJ, 1993, LAB ANIM, V27, P258, DOI 10.1258/002367793780745471; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Forwood SE, 2005, HIPPOCAMPUS, V15, P347, DOI 10.1002/hipo.20059; Hannesson DK, 2004, J NEUROSCI, V24, P4596, DOI 10.1523/JNEUROSCI.5517-03.2004; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Ludin A, 2006, BRAIN INJURY, V20, P799; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mitchell JB, 1998, BEHAV BRAIN RES, V97, P107, DOI 10.1016/S0166-4328(98)00032-1; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Norman G, 2004, BEHAV BRAIN RES, V148, P79, DOI 10.1016/S0166-4328(03)00176-1; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Skinner EI, 2007, NEUROPSYCHOLOGIA, V45, P2163, DOI 10.1016/j.neuropsychologia.2007.03.007; Umile EM, 1998, BRAIN INJURY, V12, P577; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wais PE, 2006, NEURON, V49, P459, DOI 10.1016/j.neuron.2005.12.020; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015	46	11	11	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2014	28	2					211	226		10.3109/02699052.2013.862737			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	302XR	WOS:000330638900011	24456059				2022-02-06	
J	Khan, SA; Shallwani, H; Shamim, MS; Murtaza, G; Enam, SA; Qureshi, RO; Tahir, MZ				Khan, Saad Akhtar; Shallwani, Hussain; Shamim, Muhammad Shahzad; Murtaza, Ghulam; Enam, Syed Ather; Qureshi, Reema Obaid; Tahir, Muhammad Zubair			Predictors of poor outcome of decompressive craniectomy in pediatric patients with severe traumatic brain injury: a retrospective single center study from Pakistan	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Decompressive craniectomy; Pediatric population	INTRACRANIAL HYPERTENSION; HEAD-INJURY; CHILDREN; MULTICENTER; IMPACT; TRIAL	This study aimed to determine the risk factors associated with poor outcome of decompressive craniectomy (DC) for severe traumatic brain injury (TBI) in pediatric patients. This retrospective study is conducted on pediatric population (age 1-15 years) presenting with TBI who underwent DC at our institute between January 2000 and 2010. Based on Glasgow outcome score (GOS) at a minimum follow-up of 5 months, patients were divided into two groups, namely poor outcome (GOS 1, 2, and 3) and good outcome (GOS 4 and 5). Records were reviewed and analyzed for preoperative and intraoperative predictors. We found 25 patients who were eligible as per selection criteria. Mean age at presentation was 6 +/- 4 years and there was male preponderance (84 %). Fall (60 %) was the most common mechanism of injury followed by gunshots and road traffic accident. On univariate analysis, presenting GCS a parts per thousand currency sign5 (p value = 0.009), delay in presentation of more than 150 min (p value = 0.010), DC performed after more than 4 h of arrival in hospital (p value = 0.042), and intraoperative blood loss exceeding 300 ml (p value = 0.001) were significant predictors of poor outcome. Our study suggests that DC in children is not only a life-saving procedure, but also leads to a good functional outcome after severe injury. However, patient selection still remains an important aspect, and the above-mentioned factors should be considered while deciding for DC to improve survival. Further prospective studies on larger sample size are warranted to validate our results.	[Khan, Saad Akhtar; Shallwani, Hussain; Shamim, Muhammad Shahzad; Murtaza, Ghulam; Enam, Syed Ather; Qureshi, Reema Obaid; Tahir, Muhammad Zubair] Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, Karachi, Pakistan		Shamim, MS (corresponding author), Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, Karachi, Pakistan.	shahzad.shamim@aku.edu		Khan, Saad Akhtar/0000-0002-2545-4020			ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bruce D A, 1990, Curr Probl Pediatr, V20, P61; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Irfan FB, 2010, CHILD NERV SYST, V26, P61, DOI 10.1007/s00381-009-0971-y; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Marion DW, 2006, NEUROSURGERY, V58, P655; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Shamim MS, 2011, INT J INJ CONTROL SA, V18, P213, DOI 10.1080/17457300.2011.555559; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Veen E, 2006, CRITICAL CARE, V10, P1; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; ZIMMERMAN RA, 1981, J NEURORADIOLOGY, V8, P257	25	11	12	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2014	30	2					277	281		10.1007/s00381-013-2225-2			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AA4NQ	WOS:000331073200010	23873518				2022-02-06	
J	Stone, JJ; Childs, S; Smith, LE; Battin, M; Papadakos, PJ; Huang, JH				Stone, Jonathan Jay; Childs, Sean; Smith, Lindsay Erin; Battin, Megan; Papadakos, Peter J.; Huang, Jason H.			Hourly neurologic assessments for traumatic brain injury in the ICU	NEUROLOGICAL RESEARCH			English	Article						Intensive care unit; Neurological assessments; Sleep; Traumatic brain injury	SEVERE HEAD-INJURIES; INTENSIVE-CARE-UNIT; WAKE-UP TEST; SLEEP DISRUPTION; RISK-FACTORS; HEMORRHAGE; PROGRESSION; HEMATOMA; SCAN	Objectives: Hourly neurologic assessments for traumatic brain injury (TBI) in the critical care setting are common practice but prolonged use may actually be harming patients through sleep deprivation. We reviewed practice patterns at our institution in order to gain insight into the role of frequent neurological assessments. Methods: A 6-month retrospective review was performed for patients who were admitted to an intensive care unit (ICU) with the diagnosis of TBI. Electronic medical records were reviewed based on billing codes. Variables collected included but were not limited to patient demographics, frequency of nursing neurologic evaluations, Glasgow coma scale (GCS), length of stay (LOS), and disposition. Results: A total of 124 patients were identified, 71% male with the average age of 52 years (range 19-96). Traumatic brain injury was classified as severe in 44, moderate in 18, and mild in 62 patients. A total of 89 (71.8%) patients underwent hourly nursing assessments for an average of 2.82 days. The median LOS for all patients was 7 days (range 0-109). There were 18 patients who remained on hourly neurological assessments for greater than 4 days and had a greater LOS (23 days vs 9 days, P = 0.001). Only two patients required surgery after 48 hours, both for chronic subdural hematomas. Discussion: Hourly neurologic checks are necessary in the acute period for patients with potentially expansible intracranial hemorrhages or malignant cerebral edema, but prolonged use may be harmful. Patients with a low probability of requiring neurosurgical intervention may benefit from reducing the total duration of hourly assessments.	[Stone, Jonathan Jay; Childs, Sean; Smith, Lindsay Erin; Battin, Megan; Papadakos, Peter J.; Huang, Jason H.] Univ Rochester, Rochester, NY USA		Huang, JH (corresponding author), Univ Rochester, Dept Neurosurg, 601 Elmwood Ave,Box 670, Rochester, NY 14627 USA.	Jason_Huang@urmc.rochester.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168			AURELL J, 1985, BRIT MED J, V290, P1029, DOI 10.1136/bmj.290.6474.1029; Brown CVR, 2011, J TRAUMA, V71, P37, DOI 10.1097/TA.0b013e31821e0c6e; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Faul M, 2010, TRAUMATIC BRAIN INJU; Freedman NS, 2001, AM J RESP CRIT CARE, V163, P451, DOI 10.1164/ajrccm.163.2.9912128; Freedman NS, 1999, AM J RESP CRIT CARE, V159, P1155, DOI 10.1164/ajrccm.159.4.9806141; Friese RS, 2008, CRIT CARE MED, V36, P697, DOI 10.1097/CCM.0B013E3181643F29; Kannus P, 2001, JAMA-J AM MED ASSOC, V286, P673, DOI 10.1001/jama.286.6.673; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; McGuire BE, 2000, ARCH INTERN MED, V160, P906, DOI 10.1001/archinte.160.7.906; National Collaborating Centre for Acute Care, 2007, HEAD INJ TRIAG ASS I; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pace MC, 2006, MINERVA ANESTESIOL, V72, P235; REILLY PL, 1975, LANCET, V2, P375; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Servadei F, 2000, EUROPEAN BRAIN INJUR, V46, P5; Skoglund K, 2012, CRIT CARE MED, V40, P216, DOI 10.1097/CCM.0b013e31822d7dbd; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; Weinhouse GL, 2009, CRIT CARE, V13, DOI 10.1186/cc8131; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516	26	11	11	3	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	FEB	2014	36	2					164	169		10.1179/1743132813Y.0000000285			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI7VK	WOS:000337108700012	24410060				2022-02-06	
J	Wei, XE; Li, YH; Zhao, H; Li, MH; Fu, M; Li, WB				Wei, Xiao-Er; Li, Yue-Hua; Zhao, Hui; Li, Ming-Hua; Fu, Min; Li, Wen-Bin			Quantitative evaluation of hyperbaric oxygen efficacy in experimental traumatic brain injury: an MRI study	NEUROLOGICAL SCIENCES			English	Article						Hyperbaric oxygen; Dynamic contrast-enhanced MRI; Diffusion-weighted imaging; Traumatic brain injury; Neuroprotection	FOCAL CEREBRAL-ISCHEMIA; INTRACRANIAL-PRESSURE; RAT MODEL; THERAPY; BARRIER; MECHANISMS; CONTUSION; EDEMA; AREA	To use DCE-magnetic resonance imaging (MRI) and diffusion-weighted imaging to evaluate the hyperbaric oxygen efficacy (HBO) in experimental traumatic brain injury (TBI). Forty-two rabbits were randomly divided into four groups: TBI, TBI + HBO, sham group, sham + HBO. The TBI + HBO and sham + HBO received a total of 10 HBO treatments within 7 days following TBI, and MRI was performed within a month after TBI. Functional assessments were performed pre-TBI, and at 1 and 30 days. In focal lesion area, K-trans in TBI + HBO group was lower than TBI group at both acute and subacute phase (p < 0.05). ADC was higher in TBI + HBO group than TBI group at acute phase (p < 0.01), but lower at subacute phase (p < 0.05). In perifocal area, K-trans were lower in TBI + HBO group than TBI group at acute phase (p < 0.01) after TBI. ADC was lower in the TBI + HBO group than in the TBI group at both acute and subacute phase (p < 0.01).The VCS was higher in TBI + HBO group than TBI group at 30 days (p < 0.05). HBO could improve the impaired BBB and cytotoxic edema after TBI and promote the recovery of neurofunction.	[Wei, Xiao-Er; Li, Yue-Hua; Li, Ming-Hua; Li, Wen-Bin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, Shanghai 200233, Peoples R China; [Zhao, Hui; Fu, Min] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Hyperbar Oxygen, Shanghai 200233, Peoples R China		Li, WB (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin_2003@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271540, 81000609]	This study is supported by the National Natural Science Foundation of China (Grant No. 81271540, No. 81000609).	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bennett M.H., 2004, COCHRANE DB SYST REV, V4; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gunther A, 2005, EUR J NEUROSCI, V21, P3189, DOI 10.1111/j.1460-9568.2005.04151.x; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Li YH, 2012, NEUROL SCI, V33, P731, DOI 10.1007/s10072-011-0768-0; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Masel BE, 2011, ARCH PHYS MED REHAB, V92, P1519, DOI 10.1016/j.apmr.2011.06.011; Matchett GA, 2009, NEUROL RES, V31, P114, DOI 10.1179/174313209X389857; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Sahni T, 2012, BRIT J NEUROSURG, V26, P202, DOI 10.3109/02688697.2011.626879; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Veltkamp R, 2006, BRAIN RES, V1076, P231, DOI 10.1016/j.brainres.2006.01.013; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	31	11	14	2	11	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	FEB	2014	35	2					295	302		10.1007/s10072-013-1514-6			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA3GE	WOS:000330980100022	23955096				2022-02-06	
J	Koutseff, A; Mittelhaeuser, C; Essabri, K; Auwerx, J; Meziane, H				Koutseff, Alexis; Mittelhaeuser, Christophe; Essabri, Karim; Auwerx, Johan; Meziane, Hamid			Impact of the apolipoprotein E polymorphism, age and sex on neurogenesis in mice: Pathophysiological relevance for Alzheimer's disease?	BRAIN RESEARCH			English	Article						Neurogenesis; Apolipoprotein E2; Apolipoprotein E3; Apolipoprotein E4; Knock-in mice; Age factor; Sex factor; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; TRANSGENIC MICE; OLD-AGE; NEURONS; PROLIFERATION	Apolipoprotein E (ApoE) is found in three different forms in humans (ApoE2, ApoE3 and ApoE4), and ApoE polymorphism is recognized as a major risk factor for Alzheimer's disease (AD). ApoE is involved in lipid and cholesterol transport, cell repair, and amyloid-13 deposition and certain studies suggest potential implications in neurogenesis. In this regard, we investigated the possible impact of the three different human ApoE isoforms on neurogenesis. We used ApoE knock-in mice of different ages and sex, and quantified newborn cells in the hippocampus by flow cytometry. Young adult ApoE4 mice (10-12 week-old) from both sexes displayed reduced neurogenesis compared with wild-types and the other genotypes. In addition, young adult ApoE2 female mice showed improved hippocampal progenitor cell proliferation. In older mice (1 year), hippocampal neurogenesis was globally decreased, particularly in females, and the difference between ApoE4 and the other genotypes observed in young animals disappeared for the two sexes, except for aged ApoE3 females. Indeed, a surprising protective effect of the ApoE3 genotype was observed in aged females. Our study highlights the role of ApoE in neurogenesis, and shows for the first time an early inequality between the ApoE genotypes. The reduced neurogenesis observed for the ApoE4 genotype and the improved results obtained in young ApoE2 females support the idea of a difference in the balance between neuronal birth and death modulated by the ApoE polymorphism in young animals. The maintenance of this balance and its modulation can influence pathophysiological mechanisms predisposing to neurodegenerative diseases like AD. (C) 2013 Elsevier B.V. All rights reserved.	[Koutseff, Alexis; Mittelhaeuser, Christophe; Essabri, Karim; Meziane, Hamid] ICS, Illkirch Graffenstaden, France; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol LISP NCEM, CH-1015 Lausanne, Switzerland		Meziane, H (corresponding author), ICS, Illkirch Graffenstaden, France.	meziane@igbmc.fr	Auwerx, Johan/ABE-9307-2021		Institut Clinique de la Souris (ICS); ICS	This work was supported by the Institut Clinique de la Souris (ICS). A. Koutseff was supported by a grant from the ICS.	Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Balu Darrick T., 2009, Journal of Pharmacological and Toxicological Methods, V59, P100, DOI 10.1016/j.vascn.2008.12.002; Bilsland JG, 2006, J NEUROSCI METH, V157, P54, DOI 10.1016/j.jneumeth.2006.03.026; Buttini M, 2002, J NEUROSCI, V22, P10539; Buttini M, 1999, J NEUROSCI, V19, P4867; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crews L, 2010, BRAIN STRUCT FUNCT, V214, P111, DOI 10.1007/s00429-009-0232-6; DAS GD, 1970, BRAIN RES, V21, P122, DOI 10.1016/0006-8993(70)90026-0; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Gould E, 1997, J NEUROSCI, V17, P2492; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Hauser P.S., 2010, PROG LIPID RES; Heine VM, 2004, NEUROBIOL AGING, V25, P361, DOI 10.1016/S0197-4580(03)00090-3; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Huang Y, 2006, CURR OPIN DRUG DISC, V9, P627; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Levi O, 2007, J NEUROCHEM, V100, P202, DOI 10.1111/j.1471-4159.2006.04189.x; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 1996, ANN NY ACAD SCI, V777, P139, DOI 10.1111/j.1749-6632.1996.tb34412.x; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Phillips W, 2006, STEM CELLS DEV, V15, P359, DOI 10.1089/scd.2006.15.359; Prickaerts J, 2004, NEUROCHEM INT, V45, P915, DOI 10.1016/j.neuint.2004.03.022; REED T, 1994, ARCH NEUROL-CHICAGO, V51, P1189, DOI 10.1001/archneur.1994.00540240033012; Riddle DR, 2007, BRAIN AGING MODELS M; Roses AD, 1998, ANN NY ACAD SCI, V855, P738, DOI 10.1111/j.1749-6632.1998.tb10653.x; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHIPPER HM, 2009, NEUROBIOL AGING; Simpson J.M., 2010, NEUROBIOL DIS; Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Struble RG, 2007, EXP GERONTOL, V42, P54, DOI 10.1016/j.exger.2006.05.013; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Tanzi R.E., 2012, COLD SPRING HARB PER, V2, DOI DOI 10.1101/CSHPEREPET.A006296; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thompson A, 2008, GENES BRAIN BEHAV, V7, P28, DOI 10.1111/j.1601-183X.2007.00379.x; Weisgraber Karl H., 1994, Current Opinion in Lipidology, V5, P110, DOI 10.1097/00041433-199404000-00007; WEISGRABER KH, 1994, CURR OPIN STRUC BIOL, V4, P507, DOI 10.1016/S0959-440X(94)90212-7; Zou LQ, 2010, INT J NEUROSCI, V120, P192, DOI 10.3109/00207450903464579	58	11	11	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 13	2014	1542						32	40		10.1016/j.brainres.2013.10.003			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	299UF	WOS:000330420500004	24140109				2022-02-06	
J	Li, LM; Menon, DK; Janowitz, T				Li, Lucia M.; Menon, David K.; Janowitz, Tobias			Cross-Sectional Analysis of Data from the US Clinical Trials Database Reveals Poor Translational Clinical Trial Effort for Traumatic Brain Injury, Compared with Stroke	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; FOLLOW-UP; TBI; CLINICALTRIALS.GOV; REHABILITATION; THROMBOLYSIS; DISABILITY; GUIDELINES; MODERATE; OUTCOMES	Traumatic brain injury (TBI) is an important public health problem, comparable to stroke in incidence and prevalence. Few interventions have proven efficacy in TBI, and clinical trials are, therefore, necessary to advance management in TBI. We describe the current clinical trial landscape in traumatic brain injury and compare it with the trial efforts for stroke. For this, we analysed all stroke and TBI studies registered on the US Clinical Trials (www.clinicaltrials.gov) database over a 10-year period (01/01/2000 to 01/31/2013). This methodology has been previously used to analyse clinical trial efforts in other specialties. We describe the research profile in each area: total number of studies, total number of participants and change in number of research studies over time. We also analysed key study characteristics, such as enrolment number and scope of recruitment. We found a mismatch between relative public health burden and relative research effort in each disease. Despite TBI having comparable prevalence and higher incidence than stroke, it has around one fifth of the number of clinical trials and participant recruitment. Both stroke and TBI have experienced an increase in the number of studies over the examined time period, but the rate of growth for TBI is one third that for stroke. Small-scale (< 1000 participants per trial) and single centre studies form the majority of clinical trials in both stroke and TBI, with TBI having significantly fewer studies with international recruitment. We discuss the consequences of these findings and how the situation might be improved. A sustained research effort, entailing increased international collaboration and rethinking the methodology of running clinical trials, is required in order to improve outcomes after traumatic brain injury.	[Li, Lucia M.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Menon, David K.] Cambridge Univ Hosp NHS Fdn Trust, Div Anaesthesia, Cambridge, England; [Janowitz, Tobias] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge, England		Li, LM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Med, London, England.	lml34@doctors.org.uk		Li, Lucia/0000-0001-7339-4854	NIHR Fellowship; Neuroscience Theme of the NIHR Cambridge Biomedical Research Centre; NIHRNational Institute for Health Research (NIHR); European Commission (TBIcare)European Commission; Wellcome Trust Translational Medicine and Therapeutics programme; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1000183B, G0001354, G0001354B] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090, ACF-2012-21-012, CL-2011-14-007] Funding Source: researchfish	LML is supported by an NIHR Fellowship. DKM is supported by the Neuroscience Theme of the NIHR Cambridge Biomedical Research Centre and an NIHR Senior Investigator awards, and by Framework Program 7 funding from the European Commission (TBIcare). TJ is supported by the Wellcome Trust Translational Medicine and Therapeutics programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; [Anonymous], 2012, LANCET NEUROL, V11, P1, DOI 10.1016/S1474-4422(11)70292-7; [Anonymous], 2012, BRIT HEART FDN ANN R; [Anonymous], 2012, CANC RES UK REP ACC; Barthel FMS, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-21; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Chan J, 2007, INT J REHABIL RES, V30, P137, DOI 10.1097/MRR.0b013e32813a2f11; Charles N, 2007, NEUROREHABILITATION, V22, P61; Chen ZM, 2000, STROKE, V31, P1240, DOI 10.1161/01.STR.31.6.1240; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Di Legge S, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/391538; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Foundation BT, 2007, J NEUROTRAUM, P106; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Hammell CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1683; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hirsch BR, 2013, JAMA INTERN MED, V173, P972, DOI 10.1001/jamainternmed.2013.627; Hoffmann B, 2002, ACT NEUR S, V79, P33; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hoofien D, 2001, BRAIN INJURY, V15, P189; Janowitz T, 2011, PROTEIN ENG DES SEL, V24, P105, DOI 10.1093/protein/gzq090; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Lecouturier Jan, 2008, BMC Med Ethics, V9, P9, DOI 10.1186/1472-6939-9-9; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; National Office of Statistics, 2011, DEATH REG SUMM TABL; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Rothwell PM, 2012, LANCET NEUROL, V11, P2, DOI 10.1016/S1474-4422(11)70283-6; Royston P, 2003, STAT MED, V22, P2239, DOI 10.1002/sim.1430; Royston P, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-81; Sandercock P, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000029; Tagliaferri T, 2006, ACTA NEUROCHIR, P225; Tate CM, 2013, J NEUROTRAUM; Union E, 2012, PROPOSAL REGULATION; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; von Wild KRH, 2008, ACT NEUR S, V101, P55; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; WARDLAW JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000213; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	60	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84336	10.1371/journal.pone.0084336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291WL	WOS:000329862500115	24416218	Green Published, Green Accepted, gold			2022-02-06	
J	Brunger, H; Ogden, J; Malia, K; Eldred, C; Terblanche, R; Mistlin, A				Brunger, Helen; Ogden, Jane; Malia, Kit; Eldred, Clare; Terblanche, Ronel; Mistlin, Alan			Adjusting to persistent post-concussive symptoms following mild traumatic brain injury and subsequent psycho-educational intervention: A qualitative analysis in military personnel	BRAIN INJURY			English	Article						Concussion; mild traumatic brain injury (mTBI); post-concussion symptoms (PCS); psycho-education; rehabilitation; thematic analysis	HEAD-INJURY; COLLABORATING-CENTER; TASK-FORCE; POSTTRAUMATIC GROWTH; RISK-FACTORS; IRAQ; AFGHANISTAN; GUIDELINES; NARRATIVES; SEQUELAE	Objective: Best practice guidelines outline ways in which mild traumatic brain injury (mTBI) and persistent post-concussive symptoms (PPCS) should be managed. In line with the existing evidence base, DMRC Headley Court established a treatment programme for UK servicemen and women with mTBI. This study explored the experiences of a sample of UK military personnel living with PPCS, who also received psycho-educational intervention (Phase 2) at this unit. Setting: DMRC Headley Court, Southeast England. Participants: Sixteen service personnel who had completed the intervention within 24 months prior to interview. Design: Semi-structured qualitative interview study, with purposive sampling and thematic analysis. Results: Participants described their mTBI in terms of: (1) onset; (2) subsequent symptom experience; (3) recovery; and (4) acceptance. All participants reported a significant degree of confusion and chaos in the aftermath of their traumatic event. These themes highlighted how, following enrolment onto the Phase 2 intervention at DMRC Headley Court, participants reported being (largely) able to manage PPCS. Further, many reported acceptance of their condition and described how they had managed to re-establish a sense of order. Conclusions: Following a flexible and tailored intervention for PPCS, patients report feeling empowered and describe having a renewed sense of stability.	[Brunger, Helen; Ogden, Jane] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England; [Malia, Kit; Eldred, Clare; Terblanche, Ronel; Mistlin, Alan] DMRC Headley Court, Ctr Mental & Cognit Hlth, Epsom, Surrey, England		Brunger, H (corresponding author), Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England.	h.brunger@surrey.ac.uk		Ogden, Jane/0000-0003-4271-5621	UK Military Charity, Help for Heroes	The authors wish to thank both the participants in this study for sharing their experiences and the two anonymous reviewers for their helpful comments on earlier versions of this manuscript. They would also like to thank the UK Military Charity, Help for Heroes, who funded this research project.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Barth JT, 1999, REHABILITATION ADULT, P471; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P387, DOI 10.1037/a0012998; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Defence Medical Services Department (DMSD), 2008, MILD TRAUM BRAIN INJ; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Management of Concussion/mTBI Working Group, 2009, CLIN PRACT GUID MAN; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCrea M., 2008, MILD TRAUMATIC BRAIN; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Smith J.A., 2003, QUALITATIVE PSYCHOL, P51; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03	77	11	11	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					71	80		10.3109/02699052.2013.857788			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700009	24328802				2022-02-06	
J	Carboncini, MC; Piarulli, A; Virgillito, A; Arrighi, P; Andre, P; Tomaiuolo, F; Frisoli, A; Bergamasco, M; Rossi, B; Bonfiglio, L				Carboncini, Maria Chiara; Piarulli, Andrea; Virgillito, Alessandra; Arrighi, Pieranna; Andre, Paolo; Tomaiuolo, Francesco; Frisoli, Antonio; Bergamasco, Massimo; Rossi, Bruno; Bonfiglio, Luca			A case of post-traumatic minimally conscious state reversed by midazolam: Clinical aspects and neurophysiological correlates	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Connectivity; catatonia; disorders of consciousness; EEG; GABAergic drugs; minimally conscious state; non-convulsive status epilepticus; theta rhythm	TRAUMATIC BRAIN-INJURY; NONCONVULSIVE STATUS EPILEPTICUS; REFRACTORY STATUS EPILEPTICUS; VEGETATIVE STATE; TRANSHEMISPHERIC DIASCHISIS; DIFFERENT REFERENCES; CATATONIC DISORDER; INFINITY REFERENCE; EEG-ANALYSIS; ZOLPIDEM	Purpose: We describe the case of a subject in a post-traumatic Minimally Conscious State (MCS) who retrieved full interaction with the environment after midazolam infusion. We studied EEG correlates of the "awakening reaction" in the different domains of frequency, time and cortical topography, along with the intrinsic connectivity within both the task-positive and the linguistic network. Methods: EEG recorded before and after midazolam administration has been submitted to spectral power analysis, sLORETA analysis and intrinsic connectivity analysis within both functional networks. Results: A critical change in the power spectrum profile was observed after midazolam: a) the power between 1 and 12 Hz decreased, reaching its maximum difference with respect to pre-infusion at about 7 Hz and b) the power between 12 and 30 Hz increased, with a maximum difference at about 15 Hz. At the same time, midazolam induced significant connectivity changes, especially for these two frequency bands, within both functional networks. Conclusions: We advance some hypotheses about certain aspects of the recovery from the MCS both in terms of anatomo-functional correlations and functional brain systems and we make inferences about the role that some kind of 'catatonic' symptoms might play in determining and/or maintaining this peculiar clinical state.	[Carboncini, Maria Chiara; Virgillito, Alessandra; Arrighi, Pieranna; Rossi, Bruno; Bonfiglio, Luca] Univ Pisa, Dept Neurosci, I-56126 Pisa, Italy; [Piarulli, Andrea; Frisoli, Antonio; Bergamasco, Massimo] PERCRO Perceptual Robot Lab, Scuola Super St Anna, Pisa, Italy; [Tomaiuolo, Francesco] Auxilium Vitae, Pisa, Italy; [Andre, Paolo] Univ Siena, Dept Med & Surg Sci & Neurosci, I-53100 Siena, Italy		Carboncini, MC (corresponding author), Univ Pisa, Dept Neurosci, Via Paradisa 2, I-56126 Pisa, Italy.	m.carboncini@ao-pisa.toscana.it	Tomaiuolo, Francesco/AAC-1534-2019; Virgillito, Alessandra/J-5457-2016; Carboncini, Maria Chiara/I-9445-2018	Virgillito, Alessandra/0000-0002-3416-8405; ROSSI, BRUNO/0000-0003-1914-8593; piarulli, andrea/0000-0003-4516-2671; Carboncini, Maria Chiara/0000-0002-3345-1524; Bonfiglio, Luca/0000-0001-5097-1014; BERGAMASCO, Massimo/0000-0002-7418-2332; Tomaiuolo, Fancesco/0000-0003-1230-2770			Alisky JM, 2009, SINGAP MED J, V50, P1117; ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bonfiglio L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093252; Bonfiglio L, 2013, HUM BRAIN MAPP, V34, P2178, DOI 10.1002/hbm.22056; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Canuet L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027863; CaradocDavies TH, 1996, DISABIL REHABIL, V18, P482, DOI 10.3109/09638289609165913; Caroff SN, 2004, CATATONIA PSYCHOPATH; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; Clauss P, 2001, SAMJ S AFR MED J, V91, P788; Clauss RP, 2004, ARZNEIMITTELFORSCH, V54, P641; Clauss RP, 2000, S AFR MED J, V90, P68; Clemens B, 2010, CLIN NEUROPHYSIOL, V121, P848, DOI 10.1016/j.clinph.2010.01.020; Daniels J, 2009, J NEUROPSYCH CLIN N, V21, P371, DOI 10.1176/appi.neuropsych.21.4.371; FARGE M, 1992, ANNU REV FLUID MECH, V24, P395, DOI 10.1146/annurev.fl.24.010192.002143; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gathwala G, 2012, INDIAN J PEDIATR, V79, P327, DOI 10.1007/s12098-011-0505-y; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GOLDENSOHN ES, 1960, NEUROLOGY, V10, P1; Grabenstatter HL, 2012, EPILEPSIA, V53, P71, DOI 10.1111/epi.12036; Hanley DF, 1998, CLIN THER, V20, P1093, DOI 10.1016/S0149-2918(98)80106-9; Hem E, 2005, NORD J PSYCHIAT, V59, P528, DOI 10.1080/08039480500360765; Hindriks R, 2013, NEUROIMAGE, V70, P150, DOI 10.1016/j.neuroimage.2012.12.018; Jones Gotman M., 1987, SURG TREATMENT EPILE, P203; Juhasz C, 1997, ACTA NEUROL SCAND, V96, P397; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kate MP, 2011, J NEUROPSYCH CLIN N, V23, pE2, DOI 10.1176/appi.neuropsych.23.3.E2; Kotchoubey B, 2013, RESTOR NEUROL NEUROS, V31, P473, DOI 10.3233/RNN-120307; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Lehembre R, 2012, ARCH ITAL BIOL, V150, P122, DOI 10.4449/aib.v150i2.1374; LIM J, 1986, J NEUROL NEUROSUR PS, V49, P833, DOI 10.1136/jnnp.49.7.833; LOUIS ED, 1995, EPILEPSIA, V36, P943, DOI 10.1111/j.1528-1157.1995.tb01639.x; Makeig S, 1996, ADV NEUR IN, V8, P145; Malur C, 2010, J NEUROPSYCH CLIN N, V22, pE17; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McDonald LV, 2011, JEFFERSON J PSYCHIAT, V10, P10; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Northoff G, 2004, SCHIZOPHRENIA BULL, V30, P405, DOI 10.1093/oxfordjournals.schbul.a007088; Nyakale NE, 2010, ARZNEIMITTELFORSCH, V60, P177, DOI 10.1055/s-0031-1296269; Olbrich S, 2009, NEUROIMAGE, V45, P319, DOI 10.1016/j.neuroimage.2008.11.014; Pascual-Marqui R.D., 2007, ARXIV07111455, V0711.1455; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Scheuerecker J, 2009, J PSYCHIATR RES, V43, P607, DOI 10.1016/j.jpsychires.2008.08.005; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff Nicholas D, 2010, Cleve Clin J Med, V77 Suppl 3, pS27, DOI 10.3949/ccjm.77.s3.05; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Smith JH, 2012, J NEUROPSYCH CLIN N, V24, P198, DOI 10.1176/appi.neuropsych.11060120; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taira T, 2007, ACTA NEUROCHIR SUPPL, V97, P227; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; TOWLE VL, 1993, ELECTROEN CLIN NEURO, V86, P1, DOI 10.1016/0013-4694(93)90061-Y; Valdes-Hernandez PA, 2009, J NEUROSCI METH, V185, P125, DOI 10.1016/j.jneumeth.2009.09.005; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Victor JD, 2011, P NATL ACAD SCI USA, V108, P15631, DOI 10.1073/pnas.1012168108; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157; Yao DZ, 2007, COMPUT BIOL MED, V37, P1529, DOI 10.1016/j.compbiomed.2007.02.002; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003	71	11	12	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2014	32	6					767	787		10.3233/RNN-140426			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AT9GS	WOS:000345236700004	25281612	Bronze			2022-02-06	
J	Fan, Y; Li, J; Zhang, YQ; Jiang, LH; Zhang, YN; Yan, CQ				Fan, Ying; Li, Jing; Zhang, Yan-Qiao; Jiang, Li-Hong; Zhang, Yi-Na; Yan, Chao-Qi			Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells	NEUROLOGICAL RESEARCH			English	Article						6-Hydroxydopamine; Protein kinase C; Subtype delta; Extracellular signal-regulated kinases (ERK); Parkinson's disease; Apoptosis; Rottlerin	DOPAMINERGIC NEURONAL CELLS; TRAUMATIC BRAIN INJURY; NF-KAPPA-B; PARKINSONS-DISEASE; PROTEOLYTIC ACTIVATION; PKC-DELTA; INDUCED APOPTOSIS; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; MOLECULAR PATHWAYS	Objectives: The incidence of Parkinson's disease (PD) is increasing as the global population ages. 6-hydroxydopamine (6-OHDA) can induce PD-like neuropathology and biochemical changes in both in vitro and in vivo models. Therefore, clarification of the molecular mechanism of 6-OHDA-induced cell death might contribute to the understanding of the pathogenesis of PD. Methods: With this goal in mind, we investigated the role of protein kinase C delta (PKC delta) in 6-OHDA-dependent death using the pheochromocytoma cell line, PC12. Cells were treated with 6-OHDA to induce toxicity with or without pretreatment using rottlerin (a PKC delta inhibitor), bisindolylmaleimide I (a general PKC inhibitor), Go "6976 (a PKC inhibitor selective for calcium-dependent PKC isoforms), or phorbol-12-myristate- 13-acetate (PMA, a PKC activator). Results: Phorbol-12-myristate-13-acetate decreased cell survival and increased the rate of apoptosis while rottlerin increased cell survival and decreased the rate of apoptosis. In contrast, neither bisindolylmaleimide I nor Go "6976 affected 6-OHDA-induced cell death. Western analysis demonstrated that phosphorylation of PKC delta on Thr 505 as well as extracellular signal-regulated kinase (ERK) phosphorylation increased after exposure to 6-OHDA. This increase in PKC delta phosphorylation was potentiated by PMA. However, rottlerin attenuated the 6-OHDA-stimulated increase in PKC delta and ERK phosphorylation. Conclusion: These data suggest that PKC delta, rather than classic-type PKC (alpha, beta1, beta2, gamma), participates in 6-OHDA-induced neurotoxicity in PC12 cells, and PKC delta activity is required for subsequent ERK activation during cell death.	[Fan, Ying; Li, Jing; Jiang, Li-Hong; Zhang, Yi-Na] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Peoples R China; [Zhang, Yan-Qiao] Harbin Med Univ, Affiliated Hosp 3, Dept Internal Med 8, Harbin, Peoples R China; [Yan, Chao-Qi] Harbin Med Univ, Affiliated Hosp 2, Dept Surg, Harbin, Peoples R China		Yan, CQ (corresponding author), 194 Xuefu Rd, Harbin 150081, Peoples R China.	yanchaoqi2002@163.com			International Cooperation Project of Science and Technology Department of Heilongjiang Province, China [WB08B05]; Science and Technology Foundation of Education Department of Heilongjiang Province, China [11521076]	This work was supported by the International Cooperation Project of Science and Technology Department of Heilongjiang Province, China (No. WB08B05), and the Science and Technology Foundation of Education Department of Heilongjiang Province, China (No. 11521076). We are grateful to Prof. Hulun Li and Dr Bo Sun (Neurobiology Department of Harbin Medical University), Prof. Baoliang Guo (Surgery Department of the Second Affiliated Hospital of Harbin Medical University), Dr Ryun Huang and Dr Xiangning Meng (Genetic and Molecular Biology Department of the Harbin Medical University) for their kind assistance. We thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Battaini F, 2001, PHARMACOL RES, V44, P353, DOI 10.1006/phrs.2001.0893; Benito-Leon J, 2004, NEUROLOGY, V62, P734, DOI 10.1212/01.WNL.0000113727.73153.68; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; COHEN G, 1974, J BIOL CHEM, V249, P2447; Collier TJ, 2003, ANN NY ACAD SCI, V991, P140; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Fan Y, 2009, NEUROSCI BULL, V25, P187, DOI 10.1007/s12264-009-0416-3; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Goldberg M, 1996, BIOCHEM PHARMACOL, V51, P1089, DOI 10.1016/0006-2952(96)00046-9; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; GSCHWENDT M, 1994, FEBS LETT, V338, P85, DOI 10.1016/0014-5793(94)80121-5; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hou ST, 2001, NEUROSCI LETT, V306, P153, DOI 10.1016/S0304-3940(01)01909-7; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V264, P696, DOI 10.1006/bbrc.1999.1542; Kanthasamy AG, 2003, ANTIOXID REDOX SIGN, V5, P609, DOI 10.1089/152308603770310275; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; Kaul S, 2003, EUR J NEUROSCI, V18, P1387, DOI 10.1046/j.1460-9568.2003.02864.x; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Kitazawa M, 2003, NEUROSCIENCE, V119, P945, DOI 10.1016/S0306-4522(03)00226-4; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kulich SM, 2007, FREE RADICAL BIO MED, V43, P372, DOI 10.1016/j.freeradbiomed.2007.04.028; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Kulich SM, 2003, J BIOSCIENCE, V28, P3; Kumar S, 2001, J BIOL CHEM, V276, P17281, DOI 10.1074/jbc.M101414200; Kuperstein F, 2002, EUR J NEUROSCI, V16, P44, DOI 10.1046/j.1460-9568.2002.02056.x; Lane EL, 2005, J PHARMACOL EXP THER, V312, P1124, DOI 10.1124/jpet.104.076554; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Latchoumycandane C, 2005, J PHARMACOL EXP THER, V313, P46, DOI 10.1124/jpet.104.078469; Lev N, 2003, PROG NEURO-PSYCHOPH, V27, P245, DOI 10.1016/S0278-5846(03)00019-8; Leverrier S, 2002, BIOCHEM J, V368, P905, DOI 10.1042/BJ20021253; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; MouattPrigent A, 1996, NEUROSCIENCE, V73, P979, DOI 10.1016/0306-4522(96)00100-5; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Seth K, 2002, NEUROSCI LETT, V330, P89, DOI 10.1016/S0304-3940(02)00714-0; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Tobon-Velasco JC, 2013, TOXICOLOGY, V304, P109, DOI 10.1016/j.tox.2012.12.011; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; WALKINSHAW G, 1994, NEUROSCIENCE, V63, P975, DOI 10.1016/0306-4522(94)90566-5; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang YJ, 2004, MOL CELL NEUROSCI, V25, P406, DOI 10.1016/j.mcn.2003.11.011; Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2; Zuch CL, 2000, J COMP NEUROL, V427, P440, DOI 10.1002/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7	55	11	11	0	5	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2014	36	1					53	64		10.1179/1743132813Y.0000000267			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI7VH	WOS:000337108300007	24107416				2022-02-06	
J	Fischerstrom, A; Nyholm, L; Lewen, A; Enblad, P				Fischerstrom, Ann; Nyholm, Lena; Lewen, Anders; Enblad, Per			Acute neurosurgery for traumatic brain injury by general surgeons in Swedish county hospitals: A regional study	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Acute subdural haematoma; Epidural haematoma; Acute neurosurgery; General surgeons; Local hospitals; Glasgow outcome score; Scandinavian guidelines	GLASGOW OUTCOME SCALE; REACTION-LEVEL-SCALE; HEAD-INJURY; PRACTICAL SCALE; COMA	Traditionally acute life-saving evacuations of extracerebral haematomas are performed by general surgeons on vital indication in county hospitals in the Uppsala-A-rebro health care region in Sweden, a region characterized by long distances and a sparsely distributed population. Recently, it was stated in the guidelines for prehospital care of traumatic brain injury from the Scandinavian Neurosurgical Society that acute neurosurgery should not be performed in smaller hospitals without neurosurgical expertise. The aim of this study was to investigate: how often does acute decompressive neurosurgery occur in county hospitals in the Uppsala-A-rebro region today, what is the indication for surgery, and what is the clinical outcome? Finally, the goal was to evaluate whether the current practice in the Uppsala-A-rebro region should be revised. Patients referred to the neurointensive care unit at the Department of Neurosurgery in Uppsala after acute evacuation of intracranial haematomas in the county hospitals 2005-2010 were included in the study. Data was collected retrospectively from the medical records following a predefined protocol. The presence of vital indication, radiological and clinical results, and long-term outcome were evaluated. A total of 49 patients (17 epidural haematomas and 32 acute subdural haematomas) were included in the study. The operation was judged to have been performed on vital indication in all cases. The postoperative CT scan was improved in 92 % of the patients. The reaction level and pupillary reactions were significantly improved after surgery. Long-term outcomes showed 51 % favourable outcome, 33 % unfavourable outcome, and in 16 % the outcome was unknown. Looking at the indication for acute neurosurgery, the postoperative clinical and radiological results, and the long-term outcome, it appears that our regional policy regarding life-saving decompressive neurosurgery in county hospitals by general surgeons should not be changed. We suggest a curriculum aimed at educating general surgeons in acute neurosurgery.	[Fischerstrom, Ann; Nyholm, Lena; Lewen, Anders; Enblad, Per] Uppsala Univ, Dept Neurosci, Neurosurg Sect, SE-75185 Uppsala, Sweden		Enblad, P (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg Sect, SE-75185 Uppsala, Sweden.	Per.Enblad@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348			Bellander Bo-Michael, 2008, Lakartidningen, V105, P1834; Carmont MR, 2005, POSTGRAD MED J, V81, P87, DOI 10.1136/pgmj.2004.021543; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; JENNETT B, 1975, LANCET, V1, P480; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sollid S, 2009, EMERG MED J, V26, P769, DOI 10.1136/emj.2008.061630; STALHAMMAR D, 1988, ACTA NEUROCHIR, V90, P73, DOI 10.1007/BF01560558; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wester T, 1999, J TRAUMA, V46, P914, DOI 10.1097/00005373-199905000-00023; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	15	11	11	1	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2014	156	1					177	185		10.1007/s00701-013-1932-5			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	281IE	WOS:000329093100027	24272412				2022-02-06	
J	Joseph, B; Aziz, H; Sadoun, M; Kulvatunyou, N; Pandit, V; Tang, A; Wynne, J; O' Keeffe, T; Friese, RS; Gruessner, RWG; Rhee, P				Joseph, Bellal; Aziz, Hassan; Sadoun, Moutamn; Kulvatunyou, Narong; Pandit, Viraj; Tang, Andrew; Wynne, Julie; O' Keeffe, Terence; Friese, Randall S.; Gruessner, Rainer W. G.; Rhee, Peter			Fatal gunshot wound to the head: the impact of aggressive management	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	98th Annual Clinical Congress of the American-College-of-Surgeons (ACS) / 67th Annual Sessions of the Owen H Wangensteen Forum on Fundamental Surgical Problems	SEP 30-OCT 04, 2012	Chicago, IL	Amer Coll Surg		GSW to the head; Organ donation; Aggressive management; T4 protocol	TRAUMATIC BRAIN-INJURY; ORGAN DONATION; DONOR; TRANSPLANTATION; OUTCOMES; NUMBER	BACKGROUND: Patients with fatal gunshot wounds (GSWs) to the head often have poor outcomes but are ideal candidates for organ donation. The purpose of this study was to evaluate the effects of aggressive management on organ donation in patient with fatal GSWs to the head. METHODS: A 5-year review of all patients at a trauma center with GSWs to the head was performed. The primary outcome was organ donation after fatal GSW to the head. RESULTS: A total of 98 patients with fatal GSWs to the head were identified. The rate of potential organ donation was 70%, of whom 49% eventually donated 72 solid organs. Twenty-five percent of patients were not considered eligible for donation as a result of disseminated intravascular coagulopathy. The T4 protocol lead to significant organ procurement rates (odds ratio, 3.6; 95% confidence interval, 1.3 to 9.6; P = .01). Failures to organ donation in eligible patients were due to lack of family consent and cardiac arrest. CONCLUSIONS: Organ donation after fatal GSW to the head is a legitimate goal. Management goals should focus on early aggressive resuscitation and correction of coagulopathy. Published by Elsevier Inc.	[Joseph, Bellal; Aziz, Hassan; Sadoun, Moutamn; Kulvatunyou, Narong; Pandit, Viraj; Tang, Andrew; Wynne, Julie; O' Keeffe, Terence; Friese, Randall S.; Gruessner, Rainer W. G.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ 85727 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu	Aziz, Hassan/ABA-5681-2021	Aziz, Hassan/0000-0003-0406-1946			Brody A, 2010, AM J SURG, V200, P728, DOI 10.1016/j.amjsurg.2010.09.002; Croezen DH, 2001, CLIN TRANSPLANT, V15, P11, DOI 10.1034/j.1399-0012.2001.00002.x; Ehrle R N, 1999, Crit Care Nurse, V19, P21; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P727; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; Lopez-Navidad A, 2002, TRANSPLANT P, V34, P20, DOI 10.1016/S0041-1345(01)02826-3; MACKENZIE DJ, 1993, AM SURGEON, V59, P764; MACOVIAK JA, 1987, TRANSPLANTATION, V43, P824, DOI 10.1097/00007890-198743060-00010; POLIN RS, 1995, NEUROSURG CLIN N AM, V6, P689; Raoof M, 2011, AM J SURG, V202, P701, DOI 10.1016/j.amjsurg.2011.06.028; Rostron AJ, 2007, TRANSPLANT REV, V21, P34, DOI [10.1016/j.trre.2007.01.003., DOI 10.1016/J.TRRE.2007.01.003]; Salim A, 2005, J TRAUMA, V58, P991, DOI 10.1097/01.TA.0000168708.78049.32; Salim A, 2007, CLIN TRANSPLANT, V21, P405, DOI 10.1111/j.1399-0012.2007.00659.x; Sung RS, 2008, AM J TRANSPLANT, V8, P922, DOI 10.1111/j.1600-6143.2008.02171.x; WHEELDON DR, 1995, J HEART LUNG TRANSPL, V14, P734; Zaroff Jonathan G., 2002, Circulation, V106, P836, DOI 10.1161/01.CIR.0000025587.40373.75	17	11	13	0	3	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JAN	2014	207	1					89	94		10.1016/j.amjsurg.2013.06.014			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	268VG	WOS:000328198100014	24119889				2022-02-06	
J	Kuipers, P; Doig, E; Kendall, M; Turner, B; Mitchell, M; Fleming, J				Kuipers, Pim; Doig, Emmah; Kendall, Melissa; Turner, Ben; Mitchell, Marion; Fleming, Jennifer			Hope: A further dimension for engaging family members of people with ABI	NEUROREHABILITATION			English	Article						Brain injury; rehabilitation; family relationships; hope	TRAUMATIC BRAIN-INJURY; REHABILITATION; PERSPECTIVES; INDIVIDUALS; TRANSITION; CAREGIVERS; HOME; EXPERIENCES; SUPPORT	BACKGROUND: Family member engagement is increasingly recognised as an influential factor in the rehabilitation continuum following Acquired Brain Injury, including the inpatient setting and longer-term community integration phases. OBJECTIVE: To explore the experiences of patients and family members about their involvement in brain injury rehabilitation. METHODS: This study comprised individual and group interviews with 14 ex-patients and family members. Interviews explored effects of inpatient rehabilitation on family relationships. Interview audio recordings were analysed using an interpretive approach by two independent researchers. RESULTS: Findings clearly confirmed the significance of engaging family members in inpatient rehabilitation, and specifically reinforced the importance of informational, emotional, practical and peer support. However, the key finding of the study was the importance of hope, and the need for rehabilitation professionals to foster hope. Despite not having included any questions on this topic, all interviewees noted the importance of hope, some saw it as fundamental to positive outcomes, and many were unconvinced of rehabilitation professionals' concern to avoid false hope. Various dimensions of hope are explored. CONCLUSIONS: The study notes that hope has been identified as highly important in many areas beyond brain injury rehabilitation. Based on this small preliminary study, the issue of hope is seen as a key focus for future research.	[Kuipers, Pim] Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Kuipers, Pim; Kendall, Melissa] Griffith Univ, Sch Human Serv, Ctr Community Sci, Brisbane, Qld 4111, Australia; [Doig, Emmah; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Kendall, Melissa] Metro South Hlth, Acquired Brain Injury Outreach Serv, Brisbane, Qld, Australia; [Kendall, Melissa] Metro South Hlth, Transit Rehabil Programme, Brisbane, Qld, Australia; [Turner, Ben] Princess Alexandra Hosp, Metro South Hlth, Acquired Brain Injury Outreach Serv, Brisbane, Qld 4102, Australia; [Mitchell, Marion] Griffith Univ, Griffith Hlth Inst, Ctr Hlth Practice Innovat, NHMRC Ctr Res Excellence Nursing NCREN, Brisbane, Qld 4111, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia		Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	e.doig@uq.edu.au	Doig, Emmah/AAG-6674-2021	Doig, Emmah/0000-0002-7020-053X; Kuipers, Pim/0000-0003-0340-2286			Bright FAS, 2013, APHASIOLOGY, V27, P41, DOI 10.1080/02687038.2012.718069; Bright FAS, 2011, TOP STROKE REHABIL, V18, P490, DOI 10.1310/tsr1805-490; Coco K, 2011, J NEUROSCI NURS, V43, P337, DOI 10.1097/JNN.0b013e318234ea0b; Degeneffe CE, 2010, BRAIN INJURY, V24, P1416, DOI 10.3109/02699052.2010.514317; DoHA, 2010, NAT PARTN AGR PREV H; Dorsett P, 2010, AUST SOC WORK, V63, P83, DOI 10.1080/03124070903464293; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Fleming J, 2012, SCAND J OCCUP THER, V19, P184, DOI 10.3109/11038128.2011.611531; Flick U., 2018, INTRO QUALITATIVE RE, V6; Gebhardt MC, 2011, REHABIL NURS, V36, P3, DOI 10.1002/j.2048-7940.2011.tb00059.x; Gill IJ, 2012, BRAIN INJURY, V26, P909, DOI 10.3109/02699052.2012.661118; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre Helene, 2012, J Trauma Nurs, V19, P197, DOI 10.1097/JTN.0b013e318275990d; Lucas MR, 2013, J NEUROSCI NURS, V45, P171, DOI 10.1097/JNN.0b013e31828a40f6; McGrath JC, 2011, BRAIN IMPAIR, V12, P82, DOI 10.1375/brim.12.2.82; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Strom TQ, 2007, BRAIN INJURY, V21, P1137, DOI 10.1080/02699050701687334; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257	23	11	11	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	3					475	480		10.3233/NRE-141139			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AS8UO	WOS:000344523600013	25248445				2022-02-06	
J	Lesko, MM; O'Brien, SJ; Childs, C; Bouamra, O; Rainey, T; Lecky, F				Lesko, Mehdi Moazzez; O'Brien, Sarah J.; Childs, Charmaine; Bouamra, Omar; Rainey, Timothy; Lecky, Fiona			Comparison of several prognostic tools in traumatic brain injury including S100B	BRAIN INJURY			English	Article						Outcome; prognosis; prognostic models; S100B; traumatic brain injury	RANDOMIZED CONTROLLED-TRIALS; POST-CONCUSSION SYMPTOMS; GLASGOW OUTCOME SCALE; PROTEIN-SERUM-LEVELS; SEVERE HEAD-INJURY; EXTERNAL VALIDATION; CLINICAL-TRIALS; COMPUTERIZED-TOMOGRAPHY; INTERNATIONAL MISSION; S-100-BETA PROTEIN	Primary objective: To identify which tool (a model, a biomarker or a combination of these) has better prognostic strength in traumatic brain injury (TBI). Design and methods: Data of 100 patients were analysed. TBI prognostic model B, constructed in Trauma Audit and Research Network (TARN), was run on the dataset and then S100B was added to this model. Another model was developed containing only S100B and, subsequently, other important predictors were added to assess the enhancement of the predictive power. The outcome measures were survival and favourable outcome. Results: No difference between performance of the prognostic model or S100B in isolation is observed. Addition of S100B to the prognostic model improves the performance (e. g. AUC, R-2 Nagelkerke and classification accuracy of TARN model B to predict survival increase respectively from 0.66, 0.11 and 70% to 0.77, 0.25 and 75%). Similarly, the predictive power of S100B increases by adding other predictors (e. g. AUC (0.69 vs. 0.79), R-2 Nagelkerke (0.15 vs. 0.30) and classification accuracy (73% vs. 77%) for survival prediction). Conclusion: A better prognostic tool than those currently available may be a combination of clinical predictors with a biomarker.	[Lesko, Mehdi Moazzez; Bouamra, Omar; Lecky, Fiona] Salford Royal Hosp, TARN, Salford M6 8HD, Lancs, England; [O'Brien, Sarah J.] Univ Liverpool, Natl Ctr Zoonosis Res, Inst Infect & Global Hlth, Neston, England; [Childs, Charmaine] Sheffield Hallam Univ, Ctr Hlth & Social Care Res, Sheffield S1 1WB, S Yorkshire, England; [Rainey, Timothy] Univ Manchester, Salford Royal Hosp, Sch Translat Med, Salford, Lancs, England; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, ScHARR, Hlth Serv Res Grp, Sheffield, S Yorkshire, England		Lesko, MM (corresponding author), Salford Royal Hosp, TARN, Clin Sci Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.	mehdimlesko@gmail.com		bouamra, omar/0000-0002-3155-4634; O'Brien, Sarah Jane/0000-0003-2896-8999			[Anonymous], 2008, PLOS MED, VLXII, P5; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285; David W.H., 2000, APPL LOGISTIC REGRES; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Homolkova H, 2012, NEUROENDOCRINOL LETT, V33, P207; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Kattan MW, 2003, J NATL CANCER I, V95, P634, DOI 10.1093/jnci/95.9.634; Lesko MM, 2013, J NEUROTRAUM, V30, P2778; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma H, 2010, J CLIN EPIDEMIOL, V63, P1391, DOI 10.1016/j.jclinepi.2010.05.003; Lingsma HF, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-201; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McMorran J, GEN PRACTICE NOTEBOO; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; NAT'L COUNCIL ON DISABILITY, 2009, CHIN STAT YB 2009, P12; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Qureshi AI, 2002, CRIT CARE MED, V30, P2778, DOI 10.1097/00003246-200212000-00029; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; SWETS JA, 1991, MED DECIS MAKING, V11, P9, DOI 10.1177/0272989X9101100102; Thelin EP, 2013, J NEUROTRAUM, V11, P9; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Turner EL, 2012, J CLIN EPIDEMIOL, V65, P474, DOI 10.1016/j.jclinepi.2011.08.012; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Workshop BE, 2011, BREAST CANC DIAGNO C, P5	60	11	11	0	9	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					987	994		10.3109/02699052.2014.890743			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600014	24655224				2022-02-06	
J	Lexell, EM; Flansbjer, UB; Lexell, J				Lexell, Eva Mansson; Flansbjer, Ulla-Britt; Lexell, Jan			Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation	DISABILITY AND REHABILITATION			English	Article						Activities of daily living; Canadian Occupational Performance Measure (COPM); multiple sclerosis; rehabilitation	TRAUMATIC BRAIN-INJURY; NEUROLOGICAL REHABILITATION; INPATIENT REHABILITATION; OCCUPATIONAL-THERAPY; IDENTIFIED GOALS; STROKE; ACHIEVEMENT; INDIVIDUALS; DISABILITY; VALIDITY	Purpose: To assess self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis (MS) on admission to and at discharge from interdisciplinary rehabilitation. Method: A retrospective study with a pre-post design. Twenty-seven women and 16 men with MS (mean age 51 years; median EDSS 6.5) participated in an individualised, goal-oriented, interdisciplinary, rehabilitation programme (average length 4 weeks). The Canadian Occupational Performance Measure (COPM) was used on admission to rehabilitation and at discharge. Results: On admission, the persons prioritised 216 activities that they perceived difficult to perform (mean number 3, range 2-8). Of these, 136 (63%) were in the COPM area of self-care, 52 (24%) in productivity and 28 (13%) in leisure. The lowest mean ratings of performance were found in the subgroups active recreation, community management and socialisation, and for satisfaction in the subgroup socialisation. For about 60% of the 216 prioritised activities, ratings of COPM performance as well as satisfaction were higher at discharge than on admission. For 18 (42%) and 24 (56%) persons, respectively, the mean change scores of performance and of satisfaction were equal to or greater than 2.0 at discharge, indicating a clinically significant change. Conclusions: Persons with MS can experience problems with all types of daily activities upon admission to rehabilitation, but also perceive improvements in their performance and satisfaction with performance in these activities at discharge from rehabilitation. Using patient-reported outcome measures, such as the COPM, may contribute to a broader understanding of the benefits of interdisciplinary rehabilitation in persons with MS.	[Lexell, Eva Mansson; Flansbjer, Ulla-Britt; Lexell, Jan] Lund Univ, Dept Hlth Sci, S-22100 Lund, Sweden; [Lexell, Eva Mansson; Flansbjer, Ulla-Britt; Lexell, Jan] Skane Univ Hosp, Dept Rehabil Med, Lund, Sweden		Lexell, EM (corresponding author), Lund Univ, Dept Hlth Sci, S-22100 Lund, Sweden.	eva.mansson_lexell@med.lu.se		Mansson Lexell, Eva/0000-0002-7243-4348; Lexell, Jan/0000-0001-5294-3332	Swedish Council for Working Life and Social ResearchSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)	The study was accomplished within the context of the Centre for Ageing and Supportive Environments (CASE), Lund University, Sweden, funded by the Swedish Council for Working Life and Social Research.	Bodiam C., 1999, BRIT J OCCUP THER, V62, P123, DOI [10.1177/030802269906200310, DOI 10.1177/030802269906200310]; Chenq Ya-Hsin, 2002, Occup Ther Int, V9, P167, DOI 10.1002/oti.163; Cup EHC, 2003, CLIN REHABIL, V17, P402, DOI 10.1191/0269215503cr635oa; Dedding C, 2004, CLIN REHABIL, V18, P660, DOI 10.1191/0269215504cr746oa; DOBLE SE, 1994, ARCH PHYS MED REHAB, V75, P843, DOI 10.1016/0003-9993(94)90107-4; Donnelly C, 2004, SPINAL CORD, V42, P302, DOI 10.1038/sj.sc.3101589; Eng JJ, 2003, MED SCI SPORT EXER, V35, P1271, DOI 10.1249/01.MSS.0000079079.58477.0B; Esnouf JE, 2010, MULT SCLER J, V16, P1141, DOI 10.1177/1352458510366013; Eyssen ICJM, 2005, CLIN REHABIL, V19, P888, DOI 10.1191/0269215505cr883oa; Eyssen ICJM, 2011, J REHABIL RES DEV, V48, P517, DOI 10.1682/JRRD.2010.06.0110; Finlayson M., 1998, CANADIAN J OCCUPATIO, V65, P299, DOI DOI 10.1177/000841749806500508; Finlayson M, 2012, MULTIPLE SCLEROSIS R, P355; Freeman JA, 1997, ANN NEUROL, V42, P236, DOI 10.1002/ana.410420216; Karhula ME, 2012, DISABIL REHABIL, P1; Kersten P, 2010, DISABIL REHABIL, V32, P1028, DOI 10.3109/09638281003775568; Khan F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006036.pub2; Khan F, 2008, ARCH PHYS MED REHAB, V89, P652, DOI 10.1016/j.apmr.2007.09.049; Kidd D., 1995, CLIN REHABIL, V9, P198, DOI [10.1177/026921559500900304, DOI 10.1177/026921559500900304]; Korner M, 2010, CLIN REHABIL, V24, P745, DOI 10.1177/0269215510367538; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Law M, 1994, Can J Occup Ther, V61, P191; Lexell Eva Mansson, 2006, Scand J Occup Ther, V13, P241; Mansson E, 2004, DISABIL REHABIL, V26, P576, DOI 10.1080/09638280410001684587; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Pollock N., 2005, CANADIAN OCCUPATIONA; Solari A, 1999, NEUROLOGY, V52, P57, DOI 10.1212/WNL.52.1.57; Thompson AJ, 2000, J REHABIL RES DEV, V37, P455; Trombly CA, 1998, AM J OCCUP THER, V52, P810, DOI 10.5014/ajot.52.10.810; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; World Health Organization, 2007, INT CLASS FUNCT DIS; Wressle E., 1999, SCAND J OCCUP THER, V6, P84, DOI [DOI 10.1080/110381299443771, 10.1080/110381299443771]	32	11	11	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2014	36	5					373	378		10.3109/09638288.2013.797506			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AC4HF	WOS:000332481100004	23735012	Green Submitted			2022-02-06	
J	Lin, YN; Chu, SF; Liang, WM; Chiu, WT; Lin, MR				Lin, Yen-Nung; Chu, Shu-Fen; Liang, Wen-Miin; Chiu, Wen-Ta; Lin, Mau-Roung			Validation of the Quality of Life After Brain Injury in Chinese Persons With Traumatic Brain Injury in Taiwan	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						quality of life; traumatic brain injury; Taiwan; psychometrics	SF-36 HEALTH SURVEY; MINI-MENTAL-STATE; VALIDITY; DEPRESSION; QOLIBRI; SCALE; REHABILITATION; EPIDEMIOLOGY; INDIVIDUALS; VERSION	Objective: To determine the psychometric properties of the Quality of Life After Brain Injury (QOLIBRI) in Chinese persons with traumatic brain injury (TBI) in Taiwan. Participants: Three hundred one patients with TBI were interviewed face-to-face at baseline; of these, 132 completed a follow-up assessment 1 year later. Settings: Neurosurgery clinics of 6 teaching hospitals in northern Taiwan. Measure: The 37-item QOLIBRI, including 6 domains of Cognition, Self, Daily Life and Autonomy, Social Relationships, Emotions, and Physical Problems. Results: A small percentage (<1%) of responses were missing, except the Sex Life item under the Social domain (5.9%). The QOLIBRI achieved adequate percentages for the floor value (0%-4%), ceiling value (1%-3.3%), internal consistency (0.79-0.95), and test-retest reliability (0.81-0.89). For construct validity, correlation coefficients (r(s)) for the QOLIBRI domains and selected clinical measures conceptually related to that domain were all 0.4 or more, except r(s) for QOLIBRI Cognition and Mini-Mental State Examination scores. A principal components analysis found that one item (Loneliness) of the Emotions domain did not converge with its corresponding domain of the original QOLIBRI (loading score <0.4). Effect sizes of responsiveness to changes in the Glasgow Outcome Scale-Extended over the 1-year period were clinically meaningful for all the QOLIBRI domains except the Emotions domain. Conclusion: With modifications to the Emotions domain, the QOLIBRI would be suitable for use with Chinese people in Taiwan who have TBI.	[Lin, Yen-Nung; Chu, Shu-Fen; Chiu, Wen-Ta; Lin, Mau-Roung] Taipei Med Univ, Inst Injury Prevent & Control, Coll Publ Hlth & Nutr, Taipei 11031, Taiwan; [Chu, Shu-Fen] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei 11031, Taiwan; Wan Fang Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Liang, Wen-Miin] China Med Univ, Dept Biostat, Coll Publ Hlth, Taichung, Taiwan; [Chiu, Wen-Ta] Shuang Ho Hosp, Dept Neurosurg, New Taipei City, Taiwan		Lin, MR (corresponding author), Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 11031, Taiwan.	mrlin@tmu.edu.tw	Lin, Yen-Nung/J-5278-2019	Lin, Yen-Nung/0000-0002-7350-503X	National Science CouncilMinistry of Science and Technology, Taiwan [NSC100-2314-B-038-025]; National Health Research Institute, Taiwan, Republic of ChinaNational Health Research Institutes - Taiwan [NHRI-EX101-9805PI]	This work was supported by the National Science Council (NSC100-2314-B-038-025) and the National Health Research Institute (NHRI-EX101-9805PI), Taiwan, Republic of China.	[Anonymous], 1999, JAMA, V282, P974; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuh JL, 2000, QUAL LIFE RES, V9, P675, DOI 10.1023/A:1008993821633; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Guo N.W., 1988, J REHABIL MED ASS, V16, P52, DOI DOI 10.1007/978-94-011-7973-7_3; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; Guyatt GH, 1997, PHARMACOECONOMICS, V12, P621, DOI 10.2165/00019053-199712060-00002; Guyatt GH, 1997, JAMA-J AM MED ASSOC, V277, P1232, DOI 10.1001/jama.277.15.1232; Hanwella R, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-137; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Kleinman A, 2004, NEW ENGL J MED, V351, P951, DOI 10.1056/NEJMp048078; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee S, 2009, PSYCHOL MED, V39, P735, DOI 10.1017/S0033291708004091; Leung C M, 1993, Int J Psychosom, V40, P29; Leung SOC, 2007, CLIN REHABIL, V21, P912, DOI 10.1177/0269215507077286; Liao S., 2001, INT JOINT C BIOM IJC, P1; Lin M-R, 1999, CHINESE J PUBLIC HLT, V18, P262; MAHONEY F I, 1965, Md State Med J, V14, P61; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Sartorius N., 1994, QUALITY LIFE ASSESSM, P3, DOI [DOI 10.1007/978-3-642-79123-9_1, 10.1007/978-3-642-79123-9_1.]; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sprangers MAG, 1996, CANCER TREAT REV, V22, P55, DOI 10.1016/S0305-7372(96)90064-X; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Truelle JL, 2008, ACTA NEUROCHIR SUPPL, V101, P125; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	11	11	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					E37	E47		10.1097/HTR.0b013e3182816363			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400009	23474879				2022-02-06	
J	Mantri, SS; Mantri, SP; Deogade, S; Bhasin, AS				Mantri, Sneha S.; Mantri, Shivkumar P.; Deogade, Suryakant; Bhasin, Abhilasha S.			Intra-oral Mouth-Guard In Sport Related Oro-Facial Injuries: Prevention is Better Than Cure!	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Orofacial injuries; Sports Dentistry; Custom Atheletic Mouthguard		India is rapidly assuming a more health-conscious posture. Olympic competition and professional sports have turned from mere dreams into goals. Many major professional sports leagues are expanding. Sports dentistry is a composite of skills for treatment, prevention, education and research in which dentistry and sports come together. Custom athletic mouth guards present additional health-care opportunities. They are designed to reduce the impact force of a direct blow to the jaw and create a gap between the condyle and skull thereby reducing the transference of the impact to the brain. The prevalence and severity of injuries to the teeth, jaws and intra-oral and peri-oral soft tissues, concussions and neck injuries are reduced when mouth guards are used. The dentist can play a proactive role in helping to deliver important expanded health care services.	[Mantri, Sneha S.; Deogade, Suryakant; Bhasin, Abhilasha S.] Hitkarini Dent Coll & Hosp, Dept Prosthodont, Jabalpur 482001, Madhya Pradesh, India; [Mantri, Shivkumar P.] Hitkarini Dent Coll & Hosp, Dept Conservat Dent, Jabalpur 482001, Madhya Pradesh, India		Mantri, SS (corresponding author), Gulmohar Duplex 8,Ivory Tower,Near Dalnik Bhaskar, Jabalpur 482001, MP, India.	snehamantri24@gmail.com	Mantri, Shivkumar/AAH-5961-2019	Mantri, Shivkumar/0000-0002-1952-0095			ADA, 2006, J AM DENT ASSOC, V137, P1712; Badel T., 2007, KINESIOL, V39, P97; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Canadian Dental Hygienists Association, 2005, CAN J DENT HYG, V39, P1; CHAPMAN PJ, 1989, AUST DENT J, V34, P36, DOI 10.1111/j.1834-7819.1989.tb03003.x; CHAPMAN PJ, 1983, SPORT HLTH, V1, P13; Chapman R, 1985, AUST J SCI MED SPORT, V3, P170; Ferrari CH, 2002, DENT TRAUMATOL, V18, P144, DOI 10.1034/j.1600-9657.2002.00017.x; Francis K T, 1991, Br J Sports Med, V25, P227; Fuchs CZ, 1981, THESIS; GARABEE W F JR, 1981, Basal Facts, V4, P77; Gelb H., 1977, CLIN MANAGEMENT HEAD, P73; HEINTZ WD, 1975, PHYSICIAN SPORTSMED, V3, P61; Hori N, 2004, J DENT RES, V83, P124, DOI 10.1177/154405910408300208; Jerolimov V., 2010, MED SCI, V34, P149; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Kumamoto David P, 2004, Gen Dent, V52, P270; Kvittem B, 1998, J PUBLIC HEALTH DENT, V58, P288, DOI 10.1111/j.1752-7325.1998.tb03011.x; Mellion MB, 2002, TEAM PHYS HDB; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; POWERS J M, 1984, Journal of the American Dental Association, V109, P84; Ranalli DN, 2002, DENT TRAUMATOL, V18, P231, DOI 10.1034/j.1600-9657.2002.00122.x; REED RV, 1994, BRIT DENT J, V176, P478, DOI 10.1038/sj.bdj.4808485; SCOTT J, 1994, BRIT DENT J, V176, P310, DOI 10.1038/sj.bdj.4808433; Smith S D, 1982, N Y State Dent J, V48, P298; Smith S D, 1978, N Y State Dent J, V44, P278; STENGER JM, 1964, J AM DENT ASSOC, V69, P273, DOI 10.14219/jada.archive.1964.0290; Tiep BL, 2007, J CARDIOPULM REHABIL, V27, P245; Torg JS, 1991, ATHLETIC INJURIES HE, Vsecond	30	11	11	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	JAN	2014	8	1					299	302		10.7860/JCDR/2014/6470.3872			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V9H9I	WOS:000422327700096	24596803	Green Published, gold			2022-02-06	
J	Nicholas, CR; McLaren, DG; Gawrysiak, MJ; Rogers, BP; Dougherty, JH; Nash, MR				Nicholas, Christopher R.; McLaren, Donald G.; Gawrysiak, Michael J.; Rogers, Baxter P.; Dougherty, John H.; Nash, Michael R.			Functional neuroimaging of personally-relevant stimuli in a paediatric case of impaired awareness	BRAIN INJURY			English	Article						Brain imaging; brain injury; cognition; consciousness; paediatric; neurology; self-referential	PERSISTENT VEGETATIVE STATE; MINIMALLY CONSCIOUS STATE; OWN NAME; BRAIN; SELF; LANGUAGE; FMRI; CHILDREN; PATIENT; SCALE	Background: Functional neuroimaging studies have observed preserved neural activation to personally relevant stimuli in patients within the disorders of consciousness (DOC) spectrum. As the majority of studies have focused on adult DOC patients, little is known about preserved activation in the developing brain of children with impaired consciousness. Case study: The aim of this study is to use fMRI to measure preserved neural activation to personally relevant stimuli (subject's own name and familiar voice) in a paediatric patient who sustained a traumatic brain injury and anoxic-ischaemia following a motor vehicle accident at 18 months of age rendering her probable for minimally conscious state. Contrasts revealed activation in the right middle frontal gyrus when hearing the subject's own name and the anterior supramarginal gyrus when hearing a familiar voice. Conclusion: This study provides preliminary support for fMRI as a method to measure preserved cognitive functioning in paediatric DOC patients.	[Nicholas, Christopher R.] William S Middleton Mem Vet Adm Med Ctr, GRECC, Madison, WI USA; [Nicholas, Christopher R.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53792 USA; [McLaren, Donald G.] ENRM VA Med Ctr, GRECC, Bedford, MA USA; [McLaren, Donald G.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [McLaren, Donald G.] Harvard Univ, Sch Med, Boston, MA USA; [Gawrysiak, Michael J.] Philadelphia Vet Med Ctr, MIRECC, Philadelphia, PA USA; [Rogers, Baxter P.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Rogers, Baxter P.] Vanderbilt Univ Sch Med, Dept Radiol & Radiol Sci, Nashville, TN USA; [Dougherty, John H.] Univ Tennessee, Med Ctr, Cole Neurosci Ctr, Knoxville, TN USA; [Nash, Michael R.] Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA		Nicholas, CR (corresponding author), Univ Wisconsin, Alzheimers Dis Res Ctr, 600 Highland Dr, Madison, WI 53792 USA.	psynich@gmail.com		McLaren, Donald/0000-0002-0566-4610; Rogers, Baxter/0000-0002-5666-2797	Cole Neuroscience Gift fund	This research would not have been possible without the generous financial support of the Cole Neuroscience Gift fund. The authors report no conflicts of interest.	Ahmad Z, 2003, NEUROLOGY, V60, P1598, DOI 10.1212/01.WNL.0000059865.32155.86; Balsamo LM, 2002, ARCH NEUROL-CHICAGO, V59, P1168, DOI 10.1001/archneur.59.7.1168; Bekinschtein T, 2004, J NEUROL NEUROSUR PS, V75, P788, DOI 10.1136/jnnp.2003.034876; BINDER JR, 1995, ARCH NEUROL-CHICAGO, V52, P593, DOI 10.1001/archneur.1995.00540300067015; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Crone JS, 2013, FRONT HUM NEUROSCI, V26, P504; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Eickhoff SB, 2008, EXP NEUROL, V214, P240, DOI 10.1016/j.expneurol.2008.08.007; FOX NA, 1994, DEV PSYCHOPATHOL, V6, P677, DOI 10.1017/S0954579400004739; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Huettel SA, 2001, NEUROREPORT, V12, P2411, DOI 10.1097/00001756-200108080-00025; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Machado C, 2007, CLIN EEG NEUROSCI, V38, P124, DOI 10.1177/155005940703800306; Machado C, 2011, CLIN NEUROPHYSIOL, V122, P1059, DOI 10.1016/j.clinph.2010.08.022; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; TEASDALE G, 1974, LANCET, V2, P81	23	11	11	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1135	1138		10.3109/02699052.2014.890745			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200017	24655307				2022-02-06	
J	Pang, L; Wu, Y; Dong, N; Xu, DH; Wang, DW; Wang, ZH; Li, XL; Bian, M; Zhao, HJ; Liu, XL; Zhang, N				Pang, Li; Wu, Yang; Dong, Ning; Xu, Da-hai; Wang, Da-wei; Wang, Zhi-hao; Li, Xing-Liang; Bian, Miao; Zhao, Hui-jie; Liu, Xiao-liang; Zhang, Nan			Elevated serum ubiquitin C-terminal hydrolase-L1 levels in patients with carbon monoxide poisoning	CLINICAL BIOCHEMISTRY			English	Article						Biomarkers; Brain damage; CO poisoning; Ubiquitin C-terminal hydrolase L1	TRAUMATIC BRAIN-INJURY; HYPERBARIC-OXYGEN; RISK-FACTORS; BIOMARKER; L1	Objective: Ubiquitin C-terminal hydrolase-L1 (UCH-L1) has been established as a reliable and potential biomarker of neuronal damage after acute neurologic insults, such as ischemic stroke, subarachnoid hemorrhage, and traumatic brain injury. However, the effect of serum UCH-L1 levels has not been investigated in carbon monoxide (CO)-poisoned patients. The aim of the present study was to evaluate whether serum UCH-L1 levels are a reliable marker of brain damage and the association of UCH-L1 with outcome. Design and methods: This case-control study enrolled 46 CO-poisoned subjects and 30 controls. Using an enzyme-linked immunosorbent assay (ELISA) kit, we studied the temporal profile of serum UCH-L1 levels at 6, 12, 24 and 48 h after acute CO poisoning. Poisoning severity was assessed using the Glasgow Coma Scale (GCS) score. Long-term outcome was assessed using the Glasgow Outcome Scale (GOS) at 6 months after poisoning. Results: Compared with controls, CO-poisoned patients had significantly elevated serum levels of UCH-L1 at each time point after poisoning. There were significantly higher levels of UCH-L1 in CO-poisoned patients with a lower GCS score as well as in those with a poor 6-month outcome dichotomized GOS. Conclusions: Serum levels of UCH-L1 appear to have potential clinical utility in providing valuable information about poisoning severity and outcome after CO poisoning. (C) 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Pang, Li; Wu, Yang; Dong, Ning; Xu, Da-hai; Wang, Da-wei; Wang, Zhi-hao; Li, Xing-Liang; Liu, Xiao-liang; Zhang, Nan] Jilin Univ, Affiliated Hosp 1, Dept Emergency, Changchun 130021, Jilin, Peoples R China; [Bian, Miao; Zhao, Hui-jie] Qianwei Hosp Jilin Prov, Dept Resp, Changchun, Jilin, Peoples R China		Liu, XL (corresponding author), Jilin Univ, Affiliated Hosp 1, Dept Emergency, 71 Xinmin Ave, Changchun 130021, Jilin, Peoples R China.	466634002@qq.com					Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Buckley Nicholas A, 2005, Toxicol Rev, V24, P75, DOI 10.2165/00139709-200524020-00002; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; Hampson NB, 2008, CRIT CARE MED, V36, P2523, DOI 10.1097/CCM.0b013e31818419d8; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Silver Shawna, 2006, CJEM, V8, P43; Stoller KP, 2007, NEUROL RES, V29, P146, DOI 10.1179/016164107X181770; Weaver LK, 2007, AM J RESP CRIT CARE, V176, P491, DOI 10.1164/rccm.200701-026OC; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Wolf SJ, 2008, ANN EMERG MED, V51, P138, DOI 10.1016/j.annemergmed.2007.10.012	15	11	11	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	JAN	2014	47	1-2					72	76		10.1016/j.clinbiochem.2013.09.015			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	285UX	WOS:000329421600014	24080464				2022-02-06	
J	Romero, K; Black, SE; Feinstein, A				Romero, Kristoffer; Black, Sandra E.; Feinstein, Anthony			Differences in cerebral perfusion deficits in mild traumatic brain injury and depression using single-photon emission computed tomography	FRONTIERS IN NEUROLOGY			English	Article						BI; depression; SPECT; neuropsychology; attention; partial least squares	BLOOD-FLOW; MAJOR DEPRESSION; NETWORKS; TBI; SYMPTOMS; NAIVE; FMRI	Background: Numerous studies have shown decreased perfusion in the prefrontal cortex following mild traumatic brain injury (mTBI). However, similar hypoperfusion can also be observed in depression. Given the high prevalence of depressive symptoms following mTBI, it is unclear to what extent depression influences hypoperfusion in TBI. Methods: Mild TB I patients without depressive symptoms (mTBI-noD, n = 39), TB I patients with depressive symptoms (mTBI-D, n=13), and 15 patients with major depressive disorder (MDD), but no TBI were given 99m T-ECD single-photon emission computed tomography (SPECT) scans within 2 weeks of injury. All subjects completed tests of information processing speed, complex attention, and executive functioning, and a self-report questionnaire measuring symptoms of psychological distress. Between-group comparisons of quantified SPECT perfusion were undertaken using univariate and multivariate (partial least squares) analyses. Results: mTBI-D and mTBI-noD groups did not differ in terms of cerebral perfusion. However, patients with MDD showed hypoperfusion compared to both TBI groups in several frontal (orbitofrontal, middle frontal, and superior frontal cortex), superior temporal, and posterior cingulate regions. The mTBI-D group showed poorer performance on a measure of complex attention and working memory compared to both the mTBI-noD and MDD groups. Conclusion: These results suggest that depressive symptoms do not affect SPECT perfusion in the sub-acute phase following a mild TBI. Conversely, MDD is associated with hypoperfusion primarily in frontal regions.	[Romero, Kristoffer; Feinstein, Anthony] SUNY Hlth Sci Ctr, Dept Psychiat, Room FG52,2075 Bayview Ave, Toronto, ON, Canada; [Black, Sandra E.] SUNY Hlth Sci Ctr, Heart & Stroke Fdn, Ctr Stroke Recovery, Toronto, ON, Canada; [Black, Sandra E.] SUNY Hlth Sci Ctr, LC Campbell Cognit Neurol Res Unit, Toronto, ON, Canada		Romero, K (corresponding author), SUNY Hlth Sci Ctr, Dept Psychiat, Room FG52,2075 Bayview Ave, Toronto, ON, Canada.	kris.romero@utoronto.ca		Romero, Kristoffer/0000-0002-3055-7112	CIHRCanadian Institutes of Health Research (CIHR) [36535]	We would like to acknowledge Nancy Lobaugh for her help with statistical analyses, Lisa Ehrlich for helping with collection and interpretation of SPECT scans, and Curtis Caldwell for helping with SPECT perfusion quantification. This work was supported by a CIHR grant (# 36535) to Anthony Feinstein.	Audenaert K., 2003, MED SCI MONITOR, V9, P112; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Davis PC, 2007, AM J NEURORADIOL, V28, P1619; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Fox WC, 2013, NEUROL RES, V35, P223, DOI 10.1179/1743132813Y.0000000162; Galynker II, 1998, J NUCL MED, V39, P608; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Graff-Guerrero A, 2004, J AFFECT DISORDERS, V80, P55, DOI 10.1016/S0165-0327(03)00049-1; Hamilton JP, 2013, NEUROBIOL DIS, V52, P4, DOI 10.1016/j.nbd.2012.01.015; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2011, TXB TRAUMATIC BRAIN, P173; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lapshin H, 2013, MULT SCLER J, V19, P1905, DOI 10.1177/1352458513488841; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lobaugh NJ, 2000, J NUCL MED, V41, P45; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 2011, TXB TRAUMATIC BRAIN, P239; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nagafusa Y, 2012, J AFFECT DISORDERS, V140, P296, DOI 10.1016/j.jad.2012.03.026; Nejad AB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00666; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Northoff G, 2011, NEUROSCI BIOBEHAV R, V35, P1929, DOI 10.1016/j.neubiorev.2010.12.007; Pagani M, 2004, EUR J NUCL MED MOL I, V31, P995, DOI 10.1007/s00259-004-1475-5; Perico CAM, 2005, NEUROSCI LETT, V384, P265, DOI 10.1016/j.neulet.2005.04.088; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Werneke U, 2000, PSYCHOL MED, V30, P823, DOI 10.1017/S0033291799002287; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	44	11	12	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								158	10.3389/fneur.2014.00158			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300151	25191305	Green Published, gold			2022-02-06	
J	Sullivan, KA; Edmed, SL; Kempe, C				Sullivan, Karen A.; Edmed, Shannon L.; Kempe, Chloe			The Effect of Injury Diagnosis on Illness Perceptions and Expected Postconcussion Syndrome and Posttraumatic Stress Disorder Symptoms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mild traumatic brain injury; acquired brain injury; head injury; neurocognitive disorder; postconcussion syndrome; neuropsychology; posttraumatic stress disorder	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; COGNITIVE PERFORMANCE; SERVICE MEMBERS; CONCUSSION; NEUROPSYCHOLOGY; RECOMMENDATIONS; INDIVIDUALS; TERMINOLOGY; EXPECTATION	Objective: To determine if systematic variation of diagnostic terminology (ie, concussion, minor head injury [MHI], mild traumatic brain injury [mTBI]) following a standardized injury description produced different expected symptoms and illness perceptions. We hypothesized that worse outcomes would be expected of mTBI, compared with other diagnoses, and that MHI would be perceived as worse than concussion. Method: 108 volunteers were randomly allocated to conditions in which they read a vignette describing a motor vehicle accident-related mTBI followed by a diagnosis of mTBI (n = 27), MHI (n = 24), concussion (n = 31), or, no diagnosis (n = 26). All groups rated (a) event "undesirability," (b) illness perception, and (c) expected postconcussion syndrome (PCS) and posttraumatic stress disorder (PTSD) symptoms 6 months after injury. Results: There was a statistically significant group effect on undesirability (mTBI > concussion and MHI), PTSD symptomatology (mTBI and no diagnosis > concussion), and negative illness perception (mTBI and no diagnosis > concussion). Conclusion: In general, diagnostic terminology did not affect anticipated PCS symptoms 6 months after injury, but other outcomes were affected. Given that these diagnostic terms are used interchangeably, this study suggests that changing terminology can influence known contributors to poor mTBI outcome.	[Sullivan, Karen A.; Edmed, Shannon L.; Kempe, Chloe] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Brisbane, Qld 4001, Australia; [Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, O Block,B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC 1000000311) approved this research. This project was granted an occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. Parts of this project were presented at the Australian Psychological Society, College of Clinical Neuropsychology Conference, Launceston Tasmania, November 22-25, 2012.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Ferrari R, 2011, J NEUROL NEUROSUR PS, V82, P826, DOI 10.1136/jnnp.2010.213520; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2011, LITTLE BLACK BOOK NE, P688; Iverson GL., 2012, PTSD MILD TRAUMATIC; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; King P A, 2011, PSYCHOMETRIC STUDY N; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; McCrae M., 2008, MILD TRAUMATIC BRAIN; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan KA, 2013, BRAIN INJURY, V27, P19, DOI 10.3109/02699052.2012.698360; Sullivan KA, 2012, CLIN NEUROPSYCHOL, V26, P1255, DOI 10.1080/13854046.2012.735254; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wills SM, 2001, BRAIN INJURY, V15, P645, DOI 10.1080/02699050010010502; World Health Organization, 2004, ICD 10 INT STAT CLAS	44	11	12	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					54	64		10.1097/HTR.0b013e31828c708a			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400011	23640540				2022-02-06	
J	White, PE; Shee, AW; Finch, CF				White, Peta E.; Shee, Anna Wong; Finch, Caroline F.			Independent appraiser assessment of the quality, methodological rigour and transparency of the development of the 2008 international consensus statement on concussion in sport	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Implementation; Injury Prevention; Concussion	CLINICAL GUIDELINE DEVELOPMENT; AGREE II; IMPLEMENTATION; ZURICH; RETURN	Aim In recent years, considerable effort has been devoted to the development and revisions to an international consensus statement on concussion in sport (ICSCS). The aim of this study was to obtain expert views on the methodological rigour and transparency with which the 2008 ICSCS was developed, as a precursor to the development of the 2012 update. Methods Delegates registered for the 2012 fourth International Conference on Concussion in Sport, selected local concussion researchers not involved in any prior international consensus meetings, and all authors of the 2008 ICSCS published paper were invited to assess the methodological rigour and transparency with which the 2008 ICSCS was developed. The online Appraisal of Guidelines for Research and Evaluation (AGREE) II assessment tool, with six quality domains, was used and domain scores were expressed as a percentage of the maximum possible score for that domain. Results 18 appraisers completed the online AGREE II assessment. Ten appraisers said they would recommend the 2008 ICSCS for use (without modification) and seven said they would recommend its use with some modification. The scope and purpose' and clarity of presentation' were rated highest, both scoring 78%. The lowest scoring domain was applicability' with a score of 55%. Conclusions The quality of the ICSCS is important because it is used to guide return-to-play decisions and the management of sport-related concussions. This appraisal of the 2008 ICSCS suggests that a greater focus is needed on the actual implementation of future ICSCS and the relationship between implementation and desired health outcomes.	[White, Peta E.; Shee, Anna Wong; Finch, Caroline F.] Univ Ballarat, Ctr Hlth & Safe Sport, Ballarat, Vic 3353, Australia		Finch, CF (corresponding author), Univ Ballarat, Ctr Hlth & Safe Sport, Ballarat, Vic 3353, Australia.	c.finch@ballarat.edu.au		Wong Shee, Anna/0000-0001-5095-218X	Victorian Sports Injury Prevention Research Grant from the Department of Planning and Community Development, Victoria, Australia; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [565900]	This work was supported by a Victorian Sports Injury Prevention Research Grant from the Department of Planning and Community Development, Victoria, Australia. CFF was supported by a National Health and Medical Research Council Principal Research Fellowship (ID: 565900).	AGREE Next Steps Consortium, 2009, AGR 2 INSTR; Alla S, 2011, BRIT J SPORT MED, V45, P132, DOI 10.1136/bjsm.2010.074088; Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Burgers JS, 2003, INT J TECHNOL ASSESS, V19, P148, DOI 10.1017/S026646230300014X; Burgers JS, 2003, INT J QUAL HEALTH C, V15, P31, DOI 10.1093/intqhc/15.1.31; Donaldson A, 2012, BRIT J SPORT MED, V46, P306, DOI 10.1136/bjsports-2011-090461; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Finch CF, 2010, BRIT J SPORT MED, V44, P913; Fretheim Atle, 2006, Health Res Policy Syst, V4, P15, DOI 10.1186/1478-4505-4-15; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Knai C, 2012, HEALTH POLICY, V107, P157, DOI 10.1016/j.healthpol.2012.06.004; Legido-Quigley H, 2012, HEALTH POLICY, V107, P146, DOI 10.1016/j.healthpol.2012.08.004; Lohr K N, 1990, J Dent Educ, V54, P699; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Health and Medical Research Council (NHMRC), 2000, PUT EV PRACT IMPL DI; Polus S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038891; Price J, 2012, BRIT J SPORT MED, V46, P1000, DOI 10.1136/bjsports-2011-090687; Van der Wees PJ, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-191	23	11	11	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	2					130	U139		10.1136/bjsports-2013-092720			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	276KK	WOS:000328749000015	24128756	Green Published, hybrid			2022-02-06	
J	Wilson, V; Mallipedhi, A; Stephens, JW; Redfern, RM; Price, DE				Wilson, V.; Mallipedhi, A.; Stephens, J. W.; Redfern, R. M.; Price, D. E.			The causes of hypopituitarism in the absence of abnormal pituitary imaging	QJM-AN INTERNATIONAL JOURNAL OF MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; IDIOPATHIC HYPOPITUITARISM; DIABETES-INSIPIDUS; HEMOCHROMATOSIS; INSUFFICIENCY; NEUROSARCOIDOSIS	Background: Hypopituitarism in the absence of a history of pituitary pathology or abnormal pituitary imaging is rare. Aim: To identify the cause of hypopituitarism in individuals in whom pituitary imaging was normal. Design: Retrospective analysis of electronic patient record. Method: A review of the pituitary function in the 506 patients on the Morriston Hospital pituitary database revealed 230 had some degree of hypopituitarism and of these, 21 (9%) had normal pituitary imaging. Results: Of this group, six patients had a past medical history of subarachnoid haemorrhage, head injury or meningitis, and mainly suffered from a deficiency of antidiuretic hormone. One patient had a stroke resulting in multiple anterior hormone deficiencies and six individuals had idiopathic cranial diabetes insipidus (DI). Subsequent investigations of the remaining eight patients with normal pituitary imaging revealed that two had neurosarcoidosis both of whom had panhypopituitarism. Four patients had haemochromatosis which resulted in gonadotropin deficiency in two, DI in one and panhypopituitarism in the other. There were two individuals with confirmed hypopituitarism and multiple hormone deficiencies in which no cause could be identified. Conclusion: These results show that hypopituitarism in the absence of pituitary pathology or an identifiable cause is rare. In patients with multiple anterior pituitary hormone deficiencies haemochromatosis and sarcoidosis should be considered.	[Wilson, V.; Mallipedhi, A.; Stephens, J. W.; Price, D. E.] Morriston Hosp, Dept Endocrinol & Diabet, Swansea SA6 6NL, W Glam, Wales; [Redfern, R. M.] Morriston Hosp, Dept Neurosurg, Swansea SA6 6NL, W Glam, Wales		Wilson, V (corresponding author), Morriston Hosp, Dept Endocrinol & Diabet, Swansea SA6 6NL, W Glam, Wales.	victoriawilson@doctors.org.uk					Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Al-Haddad S, 2011, ENDOCR PATHOL, V22, P6, DOI 10.1007/s12022-011-9148-9; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; CARDOSO ER, 1984, NEUROSURGERY, V14, P363, DOI 10.1227/00006123-198403000-00021; CHARBONNEL B, 1981, ACTA ENDOCRINOL-COP, V98, P178, DOI 10.1530/acta.0.0980178; de Graaff LCG, 2009, HORM RES, V71, P22, DOI 10.1159/000173738; GAMA R, 1995, POSTGRAD MED J, V71, P297, DOI 10.1136/pgmj.71.835.297; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Lamberts SWJ, 1998, LANCET, V352, P127; Lewis AS, 2009, PITUITARY, V12, P273, DOI 10.1007/s11102-008-0090-x; Marko NF, 2012, J CLIN NEUROSCI, V19, P1282, DOI 10.1016/j.jocn.2011.05.031; Murialdo G, 2002, J ENDOCRINOL INVEST, V25, P650, DOI 10.1007/BF03345093; STUART CA, 1978, ANN INTERN MED, V88, P589, DOI 10.7326/0003-4819-88-5-589; Tanaka K, 2012, INTERNAL MED, V51, P2175, DOI 10.2169/internalmedicine.51.6957; Tsiakalos A, 2010, J CLIN ENDOCR METAB, V95, P3277, DOI 10.1210/jc.2010-0144; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Young J, 2007, PRESSE MED, V36, P1319, DOI 10.1016/j.lpm.2007.01.041	19	11	12	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1460-2725	1460-2393		QJM-INT J MED	QJM-An Int. J. Med.	JAN	2014	107	1					21	24		10.1093/qjmed/hct193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280SM	WOS:000329051100005	24106315	Bronze			2022-02-06	
J	Wimalawansa, SJ				Wimalawansa, Sunil J.			Mechanisms of Developing Post-Traumatic Stress Disorder: New Targets for Drug Development and Other Potential Interventions	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Cytokines; homeostasis; hormones; neurons; psychiatry; stress; structure-function; trauma	CORTICOTROPIN-RELEASING-FACTOR; COGNITIVE ACTIVATION THEORY; BREATHING AWARENESS MEDITATION; AFRICAN-AMERICAN ADOLESCENTS; AMBULATORY BLOOD-PRESSURE; GRAY-MATTER DENSITY; MINDFULNESS MEDITATION; HIPPOCAMPAL VOLUME; RISK-FACTORS; ENDOCANNABINOID SYSTEM	The post-traumatic stress disorder (PTSD) is defined as a severe anxiety disorder that develops after exposure to an event with actual, threatened, or perceived death or serious injury, or a threat to the physical integrity of oneself or others that results in significant psychological trauma. Moreover, the ability of people to handle acute severe stress experiences varies among individuals. Depending on the underlying personality and resiliency, therefore, PTSD can occur in individuals exposed to exceedingly stressful incidences or those who have encountered seemingly less overwhelming stressors. In addition to severe stressful exposure, multiple other factors including genetic susceptibility; past experiences; cultural, spiritual, and personal beliefs; bullying and harassments; and lack of support at the workplace, social, and home environement may contribute to the development of PTSD. Author investigated multiple potential mechanisms for the development and sustenance of PTSD based on the recent literature and his own experiences and insight. Based on this search, author indicates that among other pathological and biochemical abnormalities, hormonal aberrations are most likely key mechanisms initiating and the maintenance of the PTSD. These pathophysiological neuro-hormonal changes instigate maladaptive learning processes caused by sustained high levels of anxiety and fear, through a hypo-responsive hypothalamic-pituitary axis and hyper-responsive catecholamine system (persistently elevated blood norepinephrine levels and lower than appropriate glucocorticoid levels). In addition to having inappropriately low serum cortisol levels and high epinephrine and norepinephrine levels, patients with PTSD also have mitochondrial dysfunctions and other hormonal abnormalities. Based on these data, author concluded that these pathological, biochemical and sustained neurohormonal abnormalities are likely to influence the structural brain changes, particularly in the amygdala and hippocampus, which are characteristics of patients with PTSD. Considering these abnormalities, neuroendocrine system needs to be considered as a key target for new drug development for prevention and treatment of PTSD.	Cardiometab Inst, Somerset, NJ 08873 USA		Wimalawansa, SJ (corresponding author), Cardiometab Inst, Somerset, NJ 08873 USA.	suniljw@hotmail.com		Wimalawansa, Prof. Sunil/0000-0003-1096-8595			Aardal-Eriksson E, 2001, BIOL PSYCHIAT, V50, P986, DOI 10.1016/S0006-3223(01)01253-7; Adeponle AB, 2012, PSYCHIAT SERV, V63, P147, DOI 10.1176/appi.ps.201100280; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P963; Bachynski KE, 2012, INJURY PREV, V18, P405, DOI 10.1136/injuryprev-2011-040112; Back SE, 2012, AM J PSYCHIAT, V169, P688, DOI 10.1176/appi.ajp.2011.11091433; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; Baker DG, 2001, NEUROIMMUNOMODULAT, V9, P209, DOI 10.1159/000049028; Balducci C, 2013, MED LAV, V104, P44; Ball CT, 2006, APPL COGNITIVE PSYCH, V20, P1167, DOI 10.1002/acp.1264; BANCROFT J, 1991, PSYCHOL MED, V21, P305, DOI 10.1017/S0033291700020407; Barnes VA, 2008, ETHNIC DIS, V18, P1; Beckerman NL, 2011, WOMEN HEALTH, V51, P497, DOI 10.1080/03630242.2011.584368; Belanoff JK, 2001, J PSYCHIATR RES, V35, P127, DOI 10.1016/S0022-3956(01)00018-8; BOHNEN N, 1991, J PSYCHOSOM RES, V35, P141, DOI 10.1016/0022-3999(91)90068-Y; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bonne O, 2011, J CLIN PSYCHIAT, V72, P1124, DOI 10.4088/JCP.09m05106blu; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; Brown ES, 2003, PSYCHOSOMATICS, V44, P204, DOI 10.1176/appi.psy.44.3.204; Brunello N, 2001, NEUROPSYCHOBIOLOGY, V43, P150, DOI 10.1159/000054884; Carlson LE, 2003, PSYCHOSOM MED, V65, P571, DOI 10.1097/01.PSY.0000074003.35911.41; Corvalan Juan C, 2011, Mo Med, V108, P296; Das A, 2011, ASIAN J PSYCHIATR, V4, P14, DOI 10.1016/j.ajp.2011.01.002; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; de Kloet CS, 2007, PROG BRAIN RES, V167, P287, DOI 10.1016/S0079-6123(07)67025-3; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; de la Espriella R, 2010, GLOBAL PUB HLTH, V19, P1; DELIMAR D, 1995, MIL MED, V160, P635, DOI 10.1093/milmed/160.12.635; Fang CY, 2010, J ALTERN COMPLEM MED, V16, P531, DOI 10.1089/acm.2009.0018; Franklin CL, 2002, J NERV MENT DIS, V190, P833, DOI 10.1097/00005053-200212000-00005; FRIEDMAN EH, 1994, BIOL PSYCHIAT, V35, P500, DOI 10.1016/0006-3223(94)90053-1; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; Giardino AE, 2009, FORDHAM LAW REV, V77, P2955; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Gregoski MJ, 2011, J ADOLESCENT HEALTH, V48, P59, DOI 10.1016/j.jadohealth.2010.05.019; Hajduczki A, 2011, ACS CHEM BIOL, V6, P301, DOI 10.1021/cb1001729; Hammack SE, 2012, NEUROPHARMACOLOGY, V62, P565, DOI 10.1016/j.neuropharm.2011.02.024; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Heim C, 1997, ANN NY ACAD SCI, V821, P194, DOI 10.1111/j.1749-6632.1997.tb48279.x; Heyman E, 2012, OBES REV, V13, P1110, DOI 10.1111/j.1467-789X.2012.01026.x; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Hu J, 2009, NEUROSCI BULL, V25, P153, DOI 10.1007/s12264-009-0112-3; Jain S, 2013, ASIAN J PSYCHIATR, V6, P269, DOI 10.1016/j.ajp.2013.04.003; Jatzko A, 2006, J AFFECT DISORDERS, V94, P121, DOI 10.1016/j.jad.2006.03.010; Jia M, 2012, J VISUAL EXP, P1327; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Julich Shirley, 2005, J Child Sex Abus, V14, P107, DOI 10.1300/J070v14n03_06; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Klaassens ER, 2012, PSYCHONEUROENDOCRINO, V37, P317, DOI 10.1016/j.psyneuen.2011.07.003; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Leung MK, 2012, SOCIAL COGN AFFECT N, V16, P21; Li XM, 2010, J CHEM NEUROANAT, V40, P248, DOI 10.1016/j.jchemneu.2010.07.001; Lindley SE, 2004, BIOL PSYCHIAT, V55, P940, DOI 10.1016/j.biopsych.2003.12.021; Lipov E, 2012, J AFFECT DISORDERS, V142, P1, DOI 10.1016/j.jad.2012.04.011; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 2002, PSYCHONEUROENDOCRINO, V27, P401, DOI 10.1016/S0306-4530(01)00061-0; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Maguen S, 2012, J AFFECT DISORDERS, V6; MASON JW, 1988, J NERV MENT DIS, V176, P498, DOI 10.1097/00005053-198808000-00008; McEwen BS, 1999, TRENDS ENDOCRIN MET, V10, P92, DOI 10.1016/S1043-2760(98)00122-2; McHugh T, 2012, CLIN PSYCHOL REV, V32, P93, DOI 10.1016/j.cpr.2011.07.013; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mironova V, 2013, ACTA PHYSIOL HUNG, V100, P395, DOI 10.1556/APhysiol.100.2013.4.4; Mograbi Gabriel Jose Correa, 2011, Mens Sana Monogr, V9, P276, DOI 10.4103/0973-1229.77444; Moore A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00018; Munhoz CD, 2008, BRAZ J MED BIOL RES, V41, P1037, DOI 10.1590/S0100-879X2008001200001; Najavits LM, 2012, J TRAUMA DISSOCIATIO, V13, P115, DOI 10.1080/15299732.2011.608781; Namnyak M, 2008, ACTA PSYCHIAT SCAND, V117, P4, DOI 10.1111/j.1600-0447.2007.01112.x; Nardo D, 2012, ACTA PSYCHIAT SCAND, V25, P1974; Naviaux RK, 2013, MITOCHONDRION, V24, P1085; Neria Y, 2011, AM PSYCHOL, V66, P429, DOI 10.1037/a0024791; Newport DJ, 2000, CURR OPIN NEUROBIOL, V10, P211, DOI 10.1016/S0959-4388(00)00080-5; North Carol S, 2004, Ann Clin Psychiatry, V16, P209, DOI 10.1080/10401230490522034; Ohayon MM, 2000, COMPR PSYCHIAT, V41, P469, DOI 10.1053/comp.2000.16568; Olszewski TM, 2005, J PSYCHOSOC NURS MEN, V43, P40; Oquendo M, 2005, AM J PSYCHIAT, V162, P560, DOI 10.1176/appi.ajp.162.3.560; Oquendo MA, 2003, AM J PSYCHIAT, V160, P580, DOI 10.1176/appi.ajp.160.3.580; Ospina MB, 2008, J ALTERN COMPLEM MED, V14, P1199, DOI 10.1089/acm.2008.0307; Otto MW, 2007, J ANXIETY DISORD, V21, P888, DOI 10.1016/j.janxdis.2006.10.008; Pearson DG, 2012, J BEHAV THER EXP PSY, V43, P1026, DOI 10.1016/j.jbtep.2012.04.002; Peiris-John R. J., 2006, Ceylon Medical Journal, V51, P42; Radley JJ, 2011, STRESS, V14, P481, DOI 10.3109/10253890.2011.604751; RADOSEVICH PM, 1989, BRAIN RES, V498, P89, DOI 10.1016/0006-8993(89)90402-2; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Rey J, 2010, AUSTRALAS PSYCHIATRY, V18, P309, DOI 10.3109/10398562.2010.498518; Ritsner MS, 2013, PSYCHIAT RES, V208, P1, DOI 10.1016/j.psychres.2013.02.029; Rubin DC, 2008, J EXP PSYCHOL GEN, V137, P591, DOI 10.1037/a0013165; Salvadori MC, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4793377; Sautter FJ, 2003, BIOL PSYCHIAT, V54, P1382, DOI 10.1016/S0006-3223(03)00571-7; Saylor C, 2006, PSYCHOL REP, V99, P581, DOI 10.2466/PR0.99.2.581-582; Schnurr PP, 2004, J TRAUMA STRESS, V17, P85, DOI 10.1023/B:JOTS.0000022614.21794.f4; Shucard JL, 2012, PSYCHIAT RES-NEUROIM, V204, P25, DOI 10.1016/j.pscychresns.2012.04.006; Skelton K, 2012, NEUROPHARMACOLOGY, V62, P628, DOI 10.1016/j.neuropharm.2011.02.013; Speca M, 2000, PSYCHOSOM MED, V62, P613, DOI 10.1097/00006842-200009000-00004; Spiegel D, 2010, J TRAUMA DISSOCIATIO, V11, P261, DOI 10.1080/15299731003780788; Steenkamp MM, 2012, BEHAV MODIF, V36, P857, DOI 10.1177/0145445512450908; Strawn JR, 2004, PSYCHOSOM MED, V66, P757, DOI 10.1097/01.psy.0000138133.72365.45; Su YA, 2008, INT J BIOL SCI, V4, P223; Suris A, 2010, ANN CLIN PSYCHIATRY, V22, P274; Tezcan E, 2003, EUR ARCH PSY CLIN N, V253, P89, DOI 10.1007/s00406-003-0413-x; Ursin H, 2004, PSYCHONEUROENDOCRINO, V29, P567, DOI 10.1016/S0306-4530(03)00091-X; Ursin H, 2010, NEUROSCI BIOBEHAV R, V34, P877, DOI 10.1016/j.neubiorev.2009.03.001; Ursin H, 2009, SCAND J PSYCHOL, V50, P639, DOI 10.1111/j.1467-9450.2009.00790.x; Utku F, 2006, BMJ-BRIT MED J, V333, P1123, DOI 10.1136/bmj.39037.702211.3A; van Praag HM, 2004, PROG NEURO-PSYCHOPH, V28, P923, DOI 10.1016/j.pnpbp.2004.05.011; van Zuiden M, 2013, BRAIN BEHAV IMMUN, V30, P12, DOI 10.1016/j.bbi.2012.08.015; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Wimalawansa SJ, 2012, BUDDHIST MEDITATION, P580; Wimalawansa SJ., 2013, ASIAN J MED SCI, V5, P29, DOI [10.3126/ajms.v5i2.85, DOI 10.3126/AJMS.V5I2.85]; Wimalawansa SJ., 2013, COMPR RES J MED MED, V1, P11; Wimalawansa SJ, 2012, MEDITATION EVERYONE; Xiao B, 2011, MOL MED REP, V4, P445, DOI 10.3892/mmr.2011.459; Xiao B, 2011, CELL MOL NEUROBIOL, V31, P37, DOI 10.1007/s10571-010-9550-8; YAU JLW, 1995, NEUROSCIENCE, V66, P571, DOI 10.1016/0306-4522(94)00612-9; Yehuda R, 2000, J CLIN PSYCHIAT, V61, P14; Yehuda R, 2002, PSYCHIAT QUART, V73, P123, DOI 10.1023/A:1015055711424; Yehuda R, 1998, BIOL PSYCHIAT, V44, P56, DOI 10.1016/S0006-3223(98)80007-3; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41; Zautra AJ, 2008, J CONSULT CLIN PSYCH, V76, P408, DOI 10.1037/0022-006X.76.3.408; Zhang L, 2006, MED HYPOTHESES, V66, P1205, DOI 10.1016/j.mehy.2005.11.041; Zohar J, 2008, CURR OPIN PSYCHIATR, V21, P74, DOI 10.1097/YCO.0b013e3282f269ee	121	11	12	0	55	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2014	13	5					807	816		10.2174/1871527313666140711091026			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy	AP1YJ	WOS:000341868000011	25012621				2022-02-06	
J	Zanca, JM; Dijkers, MP				Zanca, Jeanne M.; Dijkers, Marcel. P.			Describing What We Do: A Qualitative Study of Clinicians' Perspectives on Classifying Rehabilitation Interventions	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Classification; Focus groups; Health services research; Medical records; Rehabilitation	SCIREHAB PROJECT SERIES; THERAPY-PRACTICE-FRAMEWORK; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; STROKE REHABILITATION; OCCUPATIONAL-THERAPY; INPATIENT REHABILITATION; BLACK-BOX; PHYSICAL-THERAPY; TAXONOMY	Objective: To gain an understanding of clinical thought processes about treatment classification and description, and to identify desired characteristics of and challenges to be addressed by a future rehabilitation treatment taxonomy. Design: Qualitative analysis of data collected via focus groups and semistructured interviews. Setting: Inpatient rehabilitation programs. Participants: Clinicians (N=84) in 7 disciplines involved in data collection for practice-based evidence studies of spinal cord injury and traumatic brain injury rehabilitation. Interventions: Not applicable. Main Outcome Measure: Summary of themes reported by clinicians, determined by content analysis of focus group and interview transcripts. Results: The multifaceted nature of rehabilitation treatment was identified as a major challenge to the process of classifying interventions. Simultaneous delivery of multiple interventions, performance of integrated tasks that challenge multiple body systems, and conversation-based treatments were reported to be difficult to classify. Clinicians reported that treatment classifications that make reference to goals of treatment were clinically intuitive, but they also reported difficulties when attempting to classify activities that could address multiple goals. These rehabilitation practitioners considered the setting in which treatment occurs, equipment used, assistance or cueing provided, type of treatment participants, and specific tasks performed to be important descriptors of their interventions. They recommended creating a classification system that can be applied at greater or lesser levels of detail depending on the purpose for which it is being used. Conclusions: Treatment descriptors identified may be useful for differentiating classes of treatments or characterizing treatments within classes. Precise definition of the concept of the goal as it relates to treatment theory and definition of boundaries between treatments may aid classification of multifaceted treatment activities. A balance between detail and feasibility of use will facilitate successful clinical application of a future classification system. (C) 2014 by the American Congress of Rehabilitation Medicine	[Zanca, Jeanne M.; Dijkers, Marcel. P.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY USA		Zanca, JM (corresponding author), Kessler Fdn, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	jzanca@kesslerfoundation.org		Dijkers, Marcel/0000-0002-8362-5596	National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S Department of EducationUS Department of Education [H133A080053]	Supported by the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S Department of Education (grant no. H133A080053) to Icahn School of Medicine at Mount Sinai.	Abeyta N, 2009, J SPINAL CORD MED, V32, P336, DOI 10.1080/10790268.2009.11760787; Alexander H, 2001, CLIN REHABIL, V15, P207, DOI 10.1191/026921501666047564; American Physical Therapy Association, 2001, GUID PHYS THER PRACT; Ballinger C, 1999, CLIN REHABIL, V13, P301, DOI 10.1191/026921599673198490; Bernhardt J, 2007, J REHABIL MED, V39, P43, DOI 10.2340/16501977-0013; Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; Butts DS, 2007, AM J OCCUP THER, V61, P512, DOI 10.5014/ajot.61.5.512; Cahow C, 2009, J SPINAL CORD MED, V32, P298, DOI 10.1080/10790268.2009.11760783; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Dijkers MP, 2014, ARCH PHYS MED REHAB, V95, pS6, DOI 10.1016/j.apmr.2013.03.032; Dijkers MP, 2014, ARCH PHYS MED REHAB, V95, pS45, DOI 10.1016/j.apmr.2013.05.033; Gassaway J, 2005, ARCH PHYS MED REHAB, V86, pS16, DOI 10.1016/j.apmr.2005.08.114; Gassaway J, 2009, J SPINAL CORD MED, V32, P260, DOI 10.1080/10790268.2009.11760780; Gordan W, 2009, J SPINAL CORD MED, V32, P307, DOI 10.1080/10790268.2009.11760784; Gutman SA, 2007, AM J OCCUP THER, V61, P119, DOI 10.5014/ajot.61.1.119; Honaker D, 2007, AM J OCCUP THER, V61, P603, DOI 10.5014/ajot.61.5.603; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Johnson K, 2009, J SPINAL CORD MED, V32, P329, DOI 10.1080/10790268.2009.11760786; Natale A, 2009, J SPINAL CORD MED, V32, P270, DOI 10.1080/10790268.2009.11760781; Ozelie R, 2009, J SPINAL CORD MED, V32, P283, DOI 10.1080/10790268.2009.11760782; Pomeroy VM, 2001, CLIN REHABIL, V15, P67, DOI 10.1191/026921501675454995; Putman K, 2006, DISABIL REHABIL, V28, P1417, DOI 10.1080/09638280600638216; Stevens AB, 2007, J REHABIL RES DEV, V44, P537, DOI 10.1682/JRRD.2006.09.0120; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P10, DOI 10.1016/j.apmr.2007.08.127; Strasser DC, 2010, TOP STROKE REHABIL, V17, P282, DOI 10.1310/tsr1704-282; Strasser DC, 2005, ARCH PHYS MED REHAB, V86, P403, DOI 10.1016/j.apmr.2004.04.046; Sulch D, 2000, STROKE, V31, P1929, DOI 10.1161/01.STR.31.8.1929; van Langeveld SA, 2011, DISABIL REHABIL, V33, P412, DOI 10.3109/09638288.2010.498548; van Langeveld SA, 2011, PHYS THER, V91, P210, DOI 10.2522/ptj.20090417; van Langeveld SA, 2009, ARCH PHYS MED REHAB, V90, P1229, DOI 10.1016/j.apmr.2008.12.026; van Vliet PM, 2001, CLIN REHABIL, V15, P398, DOI 10.1191/026921501678310207; Whiteneck G, 2010, DISABIL REHABIL, V32, P1035, DOI 10.3109/09638281003775584; Whyte J, 2014, ARCH PHYS MED REHAB, V95, pS24, DOI 10.1016/j.apmr.2013.05.034; Whyte J, 2012, ARCH PHYS MED REHAB, V93, P394, DOI 10.1016/j.apmr.2011.11.016; Wilson C, 2009, J SPINAL CORD MED, V32, P319, DOI 10.1080/10790268.2009.11760785; 2002, AM J OCCUP THER, V56, P609	37	11	11	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2014	95	1		1			S55	S65		10.1016/j.apmr.2013.03.034			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	289KL	WOS:000329681300007	24370325				2022-02-06	
J	Zimmermann, N; Netto, TM; Amodeo, MT; Ska, B; Fonseca, RP				Zimmermann, Nicolle; Netto, Tania Maria; Amodeo, Maria Teresa; Ska, Bernadette; Fonseca, Rochele Paz			Working memory training and poetry-based stimulation programs: Are there differences in cognitive outcome in healthy older adults?	NEUROREHABILITATION			English	Article						Cognitive training; older adults; transfer; working memory	TRAUMATIC BRAIN-INJURY; EXECUTIVE COMPONENT; AGE-DIFFERENCES; WHITE-MATTER; REHABILITATION; PERFORMANCE; RETRIEVAL; CAPACITY	BACKGROUND: Neuropsychological interventions have been mainly applied with clinical populations, in spite of the need of preventing negative changes across life span. Among the few studies of cognitive stimulation in elderly, surprisingly there is no enough research comparing direct and indirect active stimulation programs. OBJECTIVE: This study aims to verify wheter there are differences between two cognitive interventions approaches in older adults: a structured Working Memory (WM) Training Program versus a Poetry-based Stimulation Program. METHODS: Fourteen older adults were randomly assigned to participate into one of the two intervention groups. The assessed neurocognitive components were attention, episodic and working memory, communicative and executive functions. WM Training activities were based on Baddeley's model; Poetry-based Stimulation Program was composed by general language activities. Data were analyzed with one-way ANCOVA with Delta scores and pre and post-training tests raw scores. RESULTS: WM group improved performance on WM, inhibition, and cognitive flexibility measures, while Poetry group improved on verbal fluency and narrative discourse tasks. DISCUSSION: Both approaches presented benefits; however WM Training improved its target function with transfer effects to executive functions, being useful for future studies with a variety of dementias. Poetry-based Stimulation also improved complex linguistic abilities. Both approaches may be helpful as strategies to prevent dysfunctional aging changes.	[Zimmermann, Nicolle; Amodeo, Maria Teresa; Fonseca, Rochele Paz] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Psychol, BR-90619900 Porto Alegre, RS, Brazil; [Zimmermann, Nicolle; Netto, Tania Maria] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil; [Ska, Bernadette] Univ Montreal, Geriatr Inst, Montreal, PQ, Canada; [Amodeo, Maria Teresa] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Language, BR-90619900 Porto Alegre, RS, Brazil		Fonseca, RP (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Psychol, Av Ipiranga 6681,Predio 11-9 Andar,Sala 932, BR-90619900 Porto Alegre, RS, Brazil.	rochele.fonseca@gmail.com		ZIMMERMANN, NICOLLE/0000-0003-4771-4070	Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Pontifical Catholic University of Rio Grande do Sul	We thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior for students scholarships; and Pontifical Catholic University of Rio Grande do Sul for grant and scholarships for this project. We express our special thanks to Michelle Bordin Bez for her distinct work during the groups interventions and data organization.	Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A., 2009, MEMORY; Bisiacchi PS, 2008, J CLIN EXP NEUROPSYC, V30, P723, DOI 10.1080/13803390701689587; Borella E, 2010, PSYCHOL AGING, V25, P767, DOI 10.1037/a0020683; Borella E, 2010, J LEARN DISABIL-US, V43, P541, DOI 10.1177/0022219410371676; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Burgess P.W., 1997, HAYLING BRIXTON TEST; Buschkuehl M, 2008, PSYCHOL AGING, V23, P743, DOI 10.1037/a0014342; Carretti B, 2007, EXP PSYCHOL, V54, P311, DOI 10.1027/1618-3169.54.4.311; Charlton RA, 2008, NEUROBIOL AGING, V29, P1547, DOI 10.1016/j.neurobiolaging.2007.03.017; Chaves M. L., 1992, ACTA NEUROL SCAND, V11, P412; Clare L, 2004, NEUROPSYCHOL REHABIL, V14, P385, DOI 10.1080/09602010443000074; Dahlin E, 2009, RESTOR NEUROL NEUROS, V27, P405, DOI 10.3233/RNN-2009-0492; DANEMAN M, 1983, J EXP PSYCHOL LEARN, V9, P561, DOI 10.1037/0278-7393.9.4.561; DOBBS AR, 1989, PSYCHOL AGING, V4, P500, DOI 10.1037/0882-7974.4.4.500; Duval J, 2008, NEUROPSYCHOL REHABIL, V18, P430, DOI 10.1080/09602010701573950; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; FINKE RA, 1988, MEM COGNITION, V16, P252, DOI 10.3758/BF03197758; Fonseca RP, 2008, BATERIA MONTREAL AVA; Fonseca RP, 2009, INSTRUMENTO AVALIACA; Joanette Y, 2004, PROTOCOLE MONTREAL E; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Klusmann V, 2010, J GERONTOL A-BIOL, V65, P680, DOI 10.1093/gerona/glq053; Matlin M. W., 2008, COGNITION, V7th; Moreland RL, 2000, ORGAN BEHAV HUM DEC, V82, P117, DOI 10.1006/obhd.2000.2891; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nessler D, 2006, NEUROIMAGE, V30, P299, DOI 10.1016/j.neuroimage.2005.09.005; Osaka M, 2012, BEHAV BRAIN RES, V233, P90, DOI 10.1016/j.bbr.2012.04.044; Rosen VM, 1997, J EXP PSYCHOL GEN, V126, P211, DOI 10.1037/0096-3445.126.3.211; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Van Dijk J. G., 2010, DISCOURSE CONTEXT SO; Wechsler D., 1945, WECHSLER MEMORY SCAL; Wegner D., 1985, COMPATIBLE INCOMPATI, DOI [10.1007/978-1-4612-5044-9, DOI 10.1007/978-1-4612-5044-9]; Wolfson, 1993, HALSTEAD REITAN NEUR; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	39	11	13	0	29	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	1					159	170		10.3233/NRE-141104			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP0PN	WOS:000341764700019	24990015				2022-02-06	
J	Hanley, DF; Chabot, R; Mould, WA; Morgan, T; Naunheim, R; Sheth, KN; Chiang, W; Prichep, LS				Hanley, Daniel F.; Chabot, Robert; Mould, W. Andrew; Morgan, Timothy; Naunheim, Rosanne; Sheth, Kevin N.; Chiang, William; Prichep, Leslie S.			Use of Brain Electrical Activity for the Identification of Hematomas in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						hematoma; mild traumatic brain injury; neuroimaging; quantitative EEG	NEAR-INFRARED SPECTROSCOPY; DEVICE	This study investigates the potential clinical utility in the emergency department (ED) of an index of brain electrical activity to identify intracranial hematomas. The relationship between this index and depth, size, and type of hematoma was explored. Ten minutes of brain electrical activity was recorded from a limited montage in 38 adult patients with traumatic hematomas (CT scan positive) and 38 mild head injured controls (CT scan negative) in the ED. The volume of blood and distance from recording electrodes were measured by blinded independent experts. Brain electrical activity data were submitted to a classification algorithm independently developed traumatic brain injury (TBI) index to identify the probability of a CT+traumatic event. There was no significant relationship between the TBI-Index and type of hematoma, or distance of the bleed from recording sites. A significant correlation was found between TBI-Index and blood volume. The sensitivity to hematomas was 100%, positive predictive value was 74.5%, and positive likelihood ratio was 2.92. The TBI-Index, derived from brain electrical activity, demonstrates high accuracy for identification of traumatic hematomas. Further, this was not influenced by distance of the bleed from the recording electrodes, blood volume, or type of hematoma. Distance and volume limitations noted with other methods, (such as that based on near-infrared spectroscopy) were not found, thus suggesting the TBI-Index to be a potentially important adjunct to acute assessment of head injury. Because of the life-threatening risk of undetected hematomas (false negatives), specificity was permitted to be lower, 66%, in exchange for extremely high sensitivity.	[Hanley, Daniel F.; Mould, W. Andrew] Johns Hopkins Univ, Sch Med, Div Brain Injury Outcomes, Baltimore, MD USA; [Chabot, Robert; Prichep, Leslie S.] NYU, Sch Med, Brain Res Labs, Dept Psychiat, New York, NY 10016 USA; [Morgan, Timothy] Johns Hopkins Univ, Dept Clin Res, Baltimore, MD USA; [Naunheim, Rosanne] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Sheth, Kevin N.] Univ Maryland, Sch Med, Div Neurocrit Care & Stroke, Baltimore, MD 21201 USA; [Sheth, Kevin N.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Chiang, William] NYU, Sch Med, Dept Emergency Med, New York, NY 10016 USA; [Chiang, William] Bellevue Hosp Ctr, New York, NY 10016 USA		Prichep, LS (corresponding author), NYU, Sch Med, Brain Res Labs, 462 1st Ave,OBV Room 885, New York, NY 10016 USA.	Leslie.prichep@nyumc.org		Chiang, William/0000-0003-3562-8896; Hanley, Daniel/0000-0002-9536-4258	BrainScope Co., Inc., Bethesda, MD	The authors acknowledge the contributions of those who made this research possible, including the primary investigators and research technicians at all the clinical sites and the patients who volunteered. This research was supported by BrainScope Co., Inc., Bethesda, MD, who granted expenses related to data acquisition.	DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kessel B, 2007, INJURY, V38, P1065, DOI 10.1016/j.injury.2007.05.009; Kohavi R., 1995, 14 INT JOINT C ART I; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; U. S. Food and Drug Administration Center for Devices and Radiological Health, 2011, FDA PERM MARK 1 HAND; United States Food and Drug Administration Center for Devices and Radiological Health, 2011, INFR MOD 1000 EV AUT	13	11	11	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2013	30	24					2051	2056		10.1089/neu.2013.3062			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	271QK	WOS:000328406500006	24040943	Green Submitted			2022-02-06	
J	Kieffer-Kristensen, R; Johansen, KLG				Kieffer-Kristensen, Rikke; Johansen, Karen Lise Gaardsvig			Hidden loss: A qualitative explorative study of children living with a parent with acquired brain injury	BRAIN INJURY			English	Article						Children; coping; distress; family; post-traumatic stress disorder; stress	POSTTRAUMATIC-STRESS; MARITAL RELATIONSHIPS; FAMILY; SYMPTOMS; CANCER; IMPACT	Primary objective: The purpose of this study was to listen to and learn from children showing high levels of post-traumatic stress symptoms after parental acquired brain injury (ABI), in order to achieve an in-depth understanding of the difficulties the children face in their everyday lives and identify possible trauma-related feelings and relational losses. Design: The study was qualitative, using a phenomenological approach. Methods and procedure: Fourteen children between 7-14 years of age were interviewed at home using a semi-structured interview guide. Siblings were also invited to participate. Results: All children were affected by their parents' ABI and the altered family situation. The children's expressions led the authors to identify six themes, including fear of losing the parent, distress and estrangement, chores and responsibilities, hidden loss, coping and support. The main finding indicates that the children experienced numerous losses, many of which were often suppressed or neglected by the children to protect the ill parents. Conclusions: The findings indicated that the children seemed to make a special effort to hide their feelings of loss and grief in order to protect the ill parent. These findings contribute to a deeper understanding of the traumatic process of parental ABI that some children experience and emphasize the importance of family-centred interventions that include the children.	[Kieffer-Kristensen, Rikke; Johansen, Karen Lise Gaardsvig] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark		Kieffer-Kristensen, R (corresponding author), Dept Psychol, Oster Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	rikke.kieffer@psy.ku.dk					Binderkrantz AS, 2009, GUIDE NVIVO 9; Boss P, 2002, J CLIN PSYCHOL, V58, P1351, DOI 10.1002/jclp.10083; Boszormenyi-Nagy I, 1973, INVISIBLE LOYALTIES; Brinkmann S., 2009, INTERVIEWS LEARNING; Bruce M, 2006, CLIN PSYCHOL REV, V26, P233, DOI 10.1016/j.cpr.2005.10.002; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Byng-Hall J, 2008, J FAM THER, V30, P147, DOI 10.1111/j.1467-6427.2008.00423.x; Camic P. M., 2004, QUALITATIVE RES PSYC; Cohen JA, 2004, J AM ACAD CHILD PSY, V43, P1225, DOI 10.1097/01.chi.0000135620.15522.38; Cohen JA, 2008, ARCH PEDIAT ADOL MED, V162, P447, DOI 10.1001/archpedi.162.5.447; Cohen Judith A, 2009, Dialogues Clin Neurosci, V11, P91; Copeland WE, 2010, AM J PSYCHIAT, V167, P1059, DOI 10.1176/appi.ajp.2010.09020178; Gosling J, 1999, BRAIN INJURY, V13, P785; Huizinga GA, 2005, EUR J CANCER, V41, P288, DOI 10.1016/j.ejca.2004.10.005; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Lazarus RS, 1992, STRESS APPRAISAL COP; LECLERE FB, 1994, J MARRIAGE FAM, V56, P457, DOI 10.2307/353112; McDermott BM, 2000, AUST NZ J PSYCHIAT, V34, P446, DOI 10.1080/j.1440-1614.2000.00753.x; Osborn T, 2007, PSYCHO-ONCOLOGY, V16, P101, DOI 10.1002/pon.1113; QSR International Pty Ltd, 2010, NVIVO QUAL DAT AN SO; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; Thastum Mikael, 2008, Clin Child Psychol Psychiatry, V13, P123, DOI 10.1177/1359104507086345; Webster G, 2007, CLIN REHABIL, V21, P1097, DOI 10.1177/0269215507079833	25	11	11	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1562	1569		10.3109/02699052.2013.841995			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400010	24111586				2022-02-06	
J	Skoglund, K; Enblad, P; Marklund, N				Skoglund, Karin; Enblad, Per; Marklund, Niklas			Monitoring and Sedation Differences in the Management of Severe Head Injury and Subarachnoid Hemorrhage Among Neurocritical Care Centers	JOURNAL OF NEUROSCIENCE NURSING			English	Article						monitoring; sedation; subarachnoid hemorrhage; traumatic brain injury; wake-up test	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; WAKE-UP TEST; INTENSIVE-CARE; CEREBRAL MICRODIALYSIS; DAILY INTERRUPTION; UNITED-KINGDOM; PROPOFOL; GUIDELINES	Background: The emergence of specialized neurocritical care (NCC) centers has been associated with an improved survival of patients with severe traumatic brain injury or subarachnoid hemorrhage. However, there are no established guidelines on sedation strategy or the frequency of evaluating the level of consciousness using the neurological wake-up test (NWT) in sedated NCC patients. Objectives: The aim was to compare the (1) monitoring techniques, (2) sedation principles, and (3) the use of the NWT in patients with severe traumatic brain injury or subarachnoid hemorrhage in 16 NCC centers. Method: A systematic survey of all 16 centers providing NCC in Scandinavia was performed using a questionnaire regarding the routine primary choice of sedative and analgesic compounds, monitoring techniques, and the frequency of the NWT, sent to the director of each center during 1999, 2004, and 2009. Results: The response rate was 100%. Except for one center in 1999, all included centers routinely used monitoring of intracranial and cerebral perfusion pressure. In contrast, newer monitoring techniques such as microdialysis, jugular bulb oximetry, and brain tissue oxygenation were infrequently used throughout the survey period. Approximately half of the NCC centers used propofol infusion as the primary sedative, whereas the remaining centers used midazolam infusion, and there was a marked variation in the choice of analgesia in each evaluated year. The NWT was never used in 50% of centers and six times daily in one center from 1999 to 2009. Most differences among the NCC centers remained unchanged over the evaluated 10-year period. Discussion: Although Scandinavian countries have similar healthcare systems, there were marked differences among the participating NCC centers in the choice of monitoring tools and sedatives and the routine use of the NWT. These differences likely reflect different clinical management traditions and a lack of evidence-based guidelines in routine NCC.	[Skoglund, Karin] Malardalen Univ, Sch Hlth Care & Social Welf, Eskilstuna, Sweden; [Enblad, Per; Marklund, Niklas] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden		Skoglund, K (corresponding author), Malardalen Univ, Sch Hlth Care & Social Welf, Eskilstuna, Sweden.	karin.skoglund@neuro.uu.se		Marklund, Niklas/0000-0002-9797-5626	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Uppsala University Hospital	This work was sponsored by the Swedish Research Council and funds from the Uppsala University Hospital.	Adembri C, 2007, CNS DRUG REV, V13, P333, DOI 10.1111/j.1527-3458.2007.00015.x; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Anifantaki S, 2009, J ADV NURS, V65, P1054, DOI 10.1111/j.1365-2648.2009.04967.x; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Beretta L, 2011, MINERVA ANESTESIOL, V77, P828; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Citerio Giuseppe, 2003, Curr Opin Crit Care, V9, P120, DOI 10.1097/00075198-200304000-00007; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; de Kruijk JR, 2001, BRAIN INJURY, V15, P117, DOI 10.1080/026990501458353; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Ferro JM, 2008, J NEUROL, V255, P465, DOI 10.1007/s00415-008-0606-3; Fudickar A, 2009, MINERVA ANESTESIOL, V75, P339; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Ghori Kamran A, 2007, Crit Care Resusc, V9, P166; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Haitsma IK, 2007, PROG BRAIN RES, V161, P207, DOI 10.1016/S0079-6123(06)61014-5; Helbok R, 2009, NEUROCRIT CARE, V11, P133, DOI 10.1007/s12028-009-9262-4; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Jacka MJ, 2007, CAN J NEUROL SCI, V34, P307, DOI 10.1017/S0317167100006727; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; Johnston NJ, 2006, RESUSCITATION, V70, P254, DOI 10.1016/j.resuscitation.2006.02.010; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Kramer AH, 2011, CRIT CARE, V15, DOI 10.1186/cc9977; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Rabinstein AA, 2010, LANCET NEUROL, V9, P504, DOI 10.1016/S1474-4422(10)70087-9; Rincon F, 2007, CURR OPIN CRIT CARE, V13, P115, DOI 10.1097/MCC.0b013e32808255c6; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Sakowitz OW, 2006, NEUROSURGERY, V58, P137, DOI 10.1227/01.NEU.0000194532.47239.7C; Samuelson Karin A, 2003, Intensive Crit Care Nurs, V19, P350; Samuelsson C, 2009, ACTA NEUROCHIR, V151, P437, DOI 10.1007/s00701-009-0265-x; Shafer A, 1998, CRIT CARE MED, V26, P947, DOI 10.1097/00003246-199805000-00034; Skoglund K, 2012, CRIT CARE MED, V40, P216, DOI 10.1097/CCM.0b013e31822d7dbd; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stevens RD, 2009, INTENS CARE MED, V35, P1556, DOI 10.1007/s00134-009-1533-1; Stevens Wendy J, 2004, J Neurosci Nurs, V36, P332; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanguy M, 2012, J NEUROTRAUM, V29, P1105, DOI 10.1089/neu.2011.1817; TEASDALE G, 1974, LANCET, V2, P81; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Walder B, 2001, ANESTH ANALG, V92, P975, DOI 10.1097/00000539-200104000-00033; Wittbrodt ET, 2005, PHARMACOTHERAPY, V25, p3S, DOI 10.1592/phco.2005.25.5_Part_2.3S; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73	61	11	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	DEC	2013	45	6					360	368		10.1097/JNN.0b013e3182a3cf4f			9	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	251XF	WOS:000326966300007	24217146				2022-02-06	
J	Byerley, AK; Donders, J				Byerley, Amy K.; Donders, Jacobus			Clinical Utility of the Behavior Rating Inventory of Executive Function-Self-Report (BRIEF-SR) in Adolescents With Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; executive functioning; assessment; construct validity; deficit awareness	GENDER-DIFFERENCES; NEUROPSYCHOLOGICAL ASSESSMENT; CHILDRENS KNOWLEDGE; WORKING-MEMORY; VALIDITY; AWARENESS; DEFICITS; AGREEMENT; DIAGNOSIS; SEVERITY	Objective: To evaluate the factor structure and correlates of the Behavior Rating Inventory of Executive Function-Self-Report (BRIEF-SR) in 118 adolescents with traumatic brain injury (TBI). Method: Cross-sectional study. Maximum-likelihood exploratory, as well as confirmatory, factor analysis. External correlates of factor scores were evaluated. Results: Two latent constructs were identified, with notable variation in scale loading pattern compared with standardization sample findings of the BRIEF-SR. These factors covaried inversely with severity of TBI; more severe injuries were associated with lower self-ratings of executive dysfunction, indicating a possible lack of deficit awareness in those with relatively severe injuries. Premorbid ADHD affected both factors, resulting in higher self-ratings of executive dysfunction, suggesting preserved awareness of preexisting difficulties in those with uncomplicated mild injuries. In addition, males reported less executive dysfunction than females. Conclusions/Implications: Findings suggest that the BRIEF-SR measures somewhat different latent constructs after TBI than in typically developing adolescents, and that BRIEF-SR scores need to be considered in concert with objective measures of injury severity and premorbid demographic and historical variables.	[Byerley, Amy K.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Alloway TP, 2009, CHILD PSYCHIAT HUM D, V40, P353, DOI 10.1007/s10578-009-0131-3; Anderson P. J., 2008, EXECUTIVE FUNCTIONS, P3; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colins O, 2008, J CLIN PSYCHIAT, V69, P141, DOI 10.4088/JCP.v69n0119; Culbertson W C, 2005, TOWER LONDON DREXEL; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Donders J, 2012, DEV NEUROPSYCHOL, V37, P333, DOI 10.1080/87565641.2011.646448; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Field A., 2017, DISCOVERING STAT USI, V5th; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fox J., 1991, REGRESSION DIAGNOSTI; Gioia, 2004, BRIEF SR BEHAV RATIN; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Grodzinsky GM, 1999, CLIN NEUROPSYCHOL, V13, P12, DOI 10.1076/clin.13.1.12.1983; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Klassen AF, 2006, CHILD CARE HLTH DEV, V32, P397, DOI 10.1111/j.1365-2214.2006.00609.x; Kuhn D, 2000, CURR DIR PSYCHOL SCI, V9, P178, DOI 10.1111/1467-8721.00088; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Morgan JE, 2008, TXB CLIN NEUROPSYCHO, P158; Murphy KR, 2004, STAT POWER ANAL; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Rucklidge JJ, 2010, PSYCHIAT CLIN N AM, V33, P357, DOI 10.1016/j.psc.2010.01.006; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schneider W, 2002, APPL METACOGNITION, P224, DOI DOI 10.1017/CBO9780511489976.011; Schneider W, 2008, MIND BRAIN EDUC, V2, P114, DOI 10.1111/j.1751-228X.2008.00041.x; SCHRAW G, 1995, EDUC PSYCHOL REV, V7, P351, DOI 10.1007/BF02212307; Sciberras E, 2011, J ATTEN DISORD, V15, P321, DOI 10.1177/1087054710361671; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Sperling RA, 2002, CONTEMP EDUC PSYCHOL, V27, P51, DOI 10.1006/ceps.2001.1091; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Thompson B., 2004, EXPLORATORY CONFIRMA; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Whitebread D, 2009, METACOGN LEARN, V4, P63, DOI 10.1007/s11409-008-9033-1; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112	50	11	12	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2013	58	4					412	421		10.1037/a0034228			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	296MQ	WOS:000330189600011	24041251				2022-02-06	
J	Chowdhury, T; Chowdhury, M; Schaller, B; Cappellani, RB; Daya, J				Chowdhury, Tumul; Chowdhury, Meenakshi; Schaller, Bernhard; Cappellani, Ronald B.; Daya, Jayesh			Perioperative considerations for neurosurgical procedures in the gravid patient: Continuing Professional Development	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							PREGNANT-WOMEN; BRAIN; ANESTHESIA; SURGERY; ANEURYSMS; RUPTURE; MODEL	The complexity of neurosurgical procedures and their interactions with maternal and fetal physiologies are key factors in determining the overall maternal and fetal outcome. The literature and guidelines provide only partial information regarding the standard of care in these cases. The purpose of this Continuing Professional Development module is to review the issues related to common neurosurgical conditions and their optimal anesthetic management. The most common neurosurgical conditions found in pregnancy include brain tumours, cerebrovascular diseases, spinal pathologies, and neurotrauma. Though rare, these conditions and related procedures may affect maternal and fetal outcome. Maternal considerations should be given priority in cases of emergent surgeries irrespective of trimester. In the early first trimester, risk of fetal loss and congenital malformation are substantial; hence, proper counselling should be given to the mother with special emphasis on therapeutic abortion. When indicated, anticonvulsants should be started as early as possible and continued throughout pregnancy. Surgical procedures can be performed with relative safety during the second trimester and early third trimester. After 34 weeks, delivery seems to be the first choice, and the role of regional anesthesia in this situation should be carefully planned after proper review of neurosurgical pathology and maternal condition. During acute neurological deterioration, however, Cesarean delivery under general anesthesia should be anticipated. A multidisciplinary approach with good communication amongst all team members certainly plays a crucial role for successful management of such cases.	[Chowdhury, Tumul; Cappellani, Ronald B.; Daya, Jayesh] Univ Manitoba, Dept Anesthesia & Perioperat Med, Winnipeg, MB R3A 1R9, Canada; [Chowdhury, Meenakshi] ESI Hosp, Dept OB&G, Gurgaon, India; [Schaller, Bernhard] Univ Southampton, Dept Res, Southampton, Hants, England; [Chowdhury, Tumul] Univ Manitoba, Dept Anesthesiol, Hlth Sci Ctr, Winnipeg, MB R3A 1R9, Canada		Chowdhury, T (corresponding author), Univ Manitoba, Dept Anesthesiol, Hlth Sci Ctr, 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.	tumulthunder@gmail.com	Schaller, Bernhard/AAA-4398-2019	Schaller, Bernhard/0000-0002-7710-8090			Adab N, 2006, CNS DRUGS, V20, P791, DOI 10.2165/00023210-200620100-00001; Afifi Y, 2003, CURR PHARM DESIGN, V9, P1745, DOI 10.2174/1381612033454487; [Anonymous], 2011, OBSTET GYNECOL, V117, P420; Armstrong S, 2011, ANESTH ANALG, V113, P318, DOI 10.1213/ANE.0b013e31821f125c; BASSO A, 1977, OBSTET GYNECOL, V49, P628; Berry C, 2011, AM J SURG, V201, P429, DOI 10.1016/j.amjsurg.2010.10.008; Brosh K, 2011, J POPUL THER CLIN PH, V18, pE89; Cole CD, 2007, NEUROSURGERY, V61, P369, DOI 10.1227/01.neu.0000303996.74526.30; Cowppli-Bony A, 2011, CANCER CAUSE CONTROL, V22, P697, DOI 10.1007/s10552-011-9742-7; Grocott HP, 1996, ANESTHESIOLOGY, V85, P1086, DOI 10.1097/00000542-199611000-00017; Harman F, 2012, CHILD NERV SYST, V28, P1055, DOI 10.1007/s00381-012-1782-0; Kilpatrick CC, 2010, SOUTH MED J, V103, P212, DOI 10.1097/SMJ.0b013e3181ce0e07; Kim YW, 2013, NEUROSURGERY, V72, P143, DOI 10.1227/NEU.0b013e3182796af9; Mazonakis M, 1999, BRIT J RADIOL, V72, P274, DOI 10.1259/bjr.72.855.10396218; Mirza FG, 2010, AM J PERINAT, V27, P579, DOI 10.1055/s-0030-1249358; Ng J, 2008, J NEUROL NEUROSUR PS, V79, P745, DOI 10.1136/jnnp.2007.117002; Nossek E, 2011, ACTA NEUROCHIR, V153, P1727, DOI 10.1007/s00701-011-1061-y; Qaiser R, 2007, SEMIN NEUROL, V27, P476, DOI 10.1055/s-2007-991129; Reitman E, 2011, BRIT J ANAESTH, V107, P72, DOI 10.1093/bja/aer343; ROELVINK NCA, 1987, ARCH NEUROL-CHICAGO, V44, P209, DOI 10.1001/archneur.1987.00520140069020; Roman H, 2004, ACTA OBSTET GYN SCAN, V83, P330, DOI 10.1111/j.0001-6349.2004.00281.x; Smith MW, 2008, OBSTET GYNECOL SURV, V63, P103, DOI 10.1097/OGX.0b013e318160161c; Tang SC, 2010, EXPERT REV NEUROTHER, V10, P205, DOI 10.1586/ERN.09.126; Tarnaris A, 2012, CLIN NEUROL NEUROSUR, V114, P703, DOI 10.1016/j.clineuro.2011.11.025; Tomimatsu T, 2012, REPROD SCI, V19, P1169, DOI 10.1177/1933719112443881; Tuncali Bahattin, 2006, J Anesth, V20, P40, DOI 10.1007/s00540-005-0359-4; Veering BT, 2009, CURR OPIN ANESTHESIO, V22, P634, DOI 10.1097/ACO.0b013e32832e7b09; Wang LP, 2008, ANESTH ANALG, V107, P193, DOI 10.1213/ane.0b013e31816c8888; Yoo KY, 2006, ANESTH ANALG, V103, P443, DOI 10.1213/01.ane.0000236785.17606.58	29	11	11	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	NOV	2013	60	11					1139	1155		10.1007/s12630-013-0031-7			17	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	239SB	WOS:000326044600011	24129743	Bronze			2022-02-06	
J	He, W; Wang, LS; Li, HZ; Cheng, LG; Zhang, M; Wladyka, CG				He, Wen; Wang, Li-Shu; Li, Hui-Zhan; Cheng, Ling-Gang; Zhang, Man; Wladyka, Christopher G.			Intraoperative contrast-enhanced ultrasound in traumatic brain surgery	CLINICAL IMAGING			English	Article						Traumatic brain injury; Contrast-enhance ultrasound; Intraoperative ultrasound		Objective: The objective was to assess intraoperative contrast-enhanced ultrasound (CEUS) in traumatic brain surgery. Methods: We prospectively performed intraoperative conventional ultrasound (IOUS) and CEUS in 32 patients who underwent emergency surgery for the treatment of traumatic brain injury (TBI). Sonographic appearance including echogenicity, border, and size of the traumatic lesion and adjacent brain tissue on CEUS were compared with those on IOUS using surgical results as the gold standard. The differences in the size and contrast enhancement parameters of the lesions between IOUS and CEUS were analyzed with a paired t test. Results: The accuracy of CEUS in assessing TBI was 100%, whereas IOUS was 51%. The absolute peak intensity (API) varied depending on the severity of brain injury. Lower API was observed in severely damaged brain tissue, whereas high API was seen in normal brain tissue or the brain tissue with mild injury. The border of the trauma lesion was more clearly defined on CEUS when compared to IOUS. The size of the lesions measured on CEUS was significantly larger than that on IOUS (P<.01). Importantly, small vessels supplying blood to the tissue in traumatic lesions, as an indication of possible brain vitality, were optimized on CEUS during the surgery. Based on the parameter of time intensity curve and appearances of the lesions on CEUS, the severity of lesions was reclassified and surgical intervention was redesigned in 21 (21/32, 66%) cases. Conclusion: Intraoperative CEUS improves accuracy in classification of traumatic brain injury, which helps neurosurgeons to effectively remove hematoma, preserve normal brain tissue, and prevent damaging the vessels during surgical intervention. (C) 2013 Elsevier Inc. All rights reserved.	[He, Wen; Wang, Li-Shu; Li, Hui-Zhan; Cheng, Ling-Gang] Capital Med Univ, Dept Ultrasound, Beijing Tiantan Hosp, Beijing 100050, Peoples R China; [Zhang, Man] Providence Hosp & Med Ctr, Dept Radiol, Southfield, MI USA; [Wladyka, Christopher G.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA		He, W (corresponding author), Capital Med Univ, Dept Ultrasound, Beijing Tiantan Hosp, 6 Tiantanxili, Beijing 100050, Peoples R China.	168hewen@sina.com			Capital Medical Development Grant	This study was supported by Capital Medical Development Grant (2005-2025).	ANDREWS BT, 1990, SURG NEUROL, V33, P291, DOI 10.1016/0090-3019(90)90052-Q; [Anonymous], 2012, OP STAND CONTR ENH U; Becker DP, 1990, NEUROLOGICAL SURG, P2079; ENZMANN DR, 1981, J NEUROSURG, V54, P304, DOI 10.3171/jns.1981.54.3.0304; Erdogan N, 2005, ACTA RADIOL, V46, P743, DOI 10.1080/02841850500223208; [郭志祥 Guo Zhixiang], 2010, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V19, P415; Guo ZX, 2009, CHIN J ULTRASOUND, V6, P1088; [何文 HE Wen], 2006, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V15, P755; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; LEKSELL L, 1956, Acta Chir Scand, V110, P301; Melada A, 2000, MINIM INVAS NEUROSUR, V43, P149, DOI 10.1055/s-2000-8335; ROTHMAN J, 1969, AMER J ROENTGENOL RA, V105, P413, DOI 10.2214/ajr.105.2.413; Tang YT, 2003, CHIN J NEUROMED, V2, P374; Tang YT, 2001, CHIN J MINIMALLY INV, V6, P173; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; W He, 2006, CHIN J MED ULTRASOUN, V3, P200; Wang HJ, 2007, J ULTRASOUND CLIN ME, V9, P368; Wang SJ, 2008, J SOOCHOW U MED SCI, V28, P829; Wang ZC, 2005, NEUROSURGERY, p[365, 436]; Yu DL, 2008, CHIN J MED ULTRASOUN, V5, P248	20	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0899-7071	1873-4499		CLIN IMAG	Clin. Imaging	NOV-DEC	2013	37	6					983	988		10.1016/j.clinimag.2013.08.001			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	250NE	WOS:000326858700002	24035526				2022-02-06	
J	Keatley, E; Ashman, T; Im, B; Rasmussen, A				Keatley, Eva; Ashman, Teresa; Im, Brian; Rasmussen, Andrew			Self-Reported Head Injury Among Refugee Survivors of Torture	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head injury; loss of consciousness; refugee; torture; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; HEALTH-STATUS; CHRONIC PAIN; DEPRESSION; CONCUSSION; SEQUELAE; RISK	Objective: To examine the prevalence of self-reported head injury among treatment-seeking refugee survivors of torture, a population at high risk for such injuries. Participants: A total of 488 survivors of torture accepted at a torture treatment clinic between January 1, 2008, and December 31, 2011. Main Measures: Harvard Trauma Questionnaire, incidence of head injury and resulting loss of consciousness (LOC), chief physical complaints, general health scale, indicators of torture severity (length of detention, sexual assault, and number of different persecution types). Results: Of the 488 cases reviewed, 335 (69%) patients reported sustaining a blow to the head. Of the 335 with head injury, 185 (55%) reported LOC following the injury. Those who reported sustaining a head injury were significantly more likely to be men, to have a greater number of types of torture experiences, and report sleep disturbances and headaches as their primary medical complaints. Conclusions: The high rates of head injury and head injury followed by LOC among treatment-seeking survivors of torture indicates the need for torture treatment centers to assess for possible brain injury. Our findings suggest that patients with possible traumatic brain injury (TBI) may be at a higher risk of negative physical outcomes than those without possible TBI.	[Keatley, Eva] NYU, Sch Med, Dept Internal Med, Bellevue Program Survivors Torture, New York, NY 10016 USA; [Ashman, Teresa] NYU, Langone Med Ctr, Rusk Inst Rehabil Med, New York, NY 10016 USA; [Im, Brian] NYU, Sch Med, Dept Rehabil Med, Bellevue Hosp, New York, NY 10016 USA; [Rasmussen, Andrew] Fordham Univ, Dept Psychol, New York, NY 10023 USA		Keatley, E (corresponding author), NYU, Sch Med, Dept Internal Med, Bellevue Program Survivors Torture, 462 1st Ave, New York, NY 10016 USA.	Eva.Keatley@nyumc.org		Rasmussen, Andrew/0000-0001-9149-4795			Aeschleman S. R., 1999, J RATION-EMOT COGN-B, V17, P51, DOI DOI 10.1023/A:1023073130972; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; BASOGLU M, 1995, J ANXIETY DISORD, V9, P339, DOI 10.1016/0887-6185(95)00014-F; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; BEGOVAC J, 1993, JAMA-J AM MED ASSOC, V270, P574, DOI 10.1001/jama.1993.03510050040011; Bradley Lloyd, 2006, Torture, V16, P41; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CDC, 2011, GET STATS TRAUM BRAI; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; Hooberman JB, 2007, J INTERPERS VIOLENCE, V22, P108, DOI 10.1177/0886260506294999; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kaminer D, 2008, SOC SCI MED, V67, P1589, DOI 10.1016/j.socscimed.2008.07.023; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Moreno A, 2002, SPINAL CORD, V40, P213, DOI 10.1038/sj.sc.3101284; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Palic S, 2009, TORTURE, V19, P23; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rasmussen A, 2006, C INN TRAUM RES LOS; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; ROBERTS RE, 1980, PSYCHIAT RES, V2, P125, DOI 10.1016/0165-1781(80)90069-4; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206	36	11	11	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					E8	E13		10.1097/HTR.0b013e3182776a70			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200002	23348404				2022-02-06	
J	Lequerica, AH; Chiaravalloti, ND; Sander, AM; Pappadis, MR; Arango-Lasprilla, JC; Hart, T; Banos, JH; De La Plata, CDM; Hammond, FM; Sherman, TE				Lequerica, Anthony H.; Chiaravalloti, Nancy D.; Sander, Angelle M.; Pappadis, Monique R.; Carlos Arango-Lasprilla, Juan; Hart, Tessa; Banos, James H.; De La Plata, Carlos D. Marquez; Hammond, Flora M.; Sherman, Tanya E.			The Community Integration Questionnaire: Factor Structure Across Racial/Ethnic Groups in Persons With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; community integration; ethnicity; rehabilitation; race	REHABILITATION; PARTICIPATION; ORIENTATION; OUTCOMES; RETURN; WORK; RACE	Objective: To examine the factor structure and construct validity of the Community Integration Questionnaire, a widely used measure of community participation among individuals with traumatic brain injury (TBI), among 3 racial/ethnic groups. Design: Prospective longitudinal cohort study. Setting: Enrollment in acute inpatient TBI rehabilitation with follow-up at 1 year after injury. Participants: A total of 1756 persons with TBI enrolled in the Traumatic Brain Injury Model Systems (TBIMS) national Database. Main Outcome Measure: Community Integration Questionnaire at 1 year after injury. Results: The goodness of fit for the factor structure of the Community Integration Questionnaire, separating items into Home Competency, Social Integration, and Productive Activity, was satisfactory for whites but not for blacks or Hispanics. Conclusions: Clinicians and researchers should take race/ethnicity into account when utilizing measures of community integration.	[Lequerica, Anthony H.; Chiaravalloti, Nancy D.] Kessler Fdn, Res Ctr, W Orange, NJ 07052 USA; [Lequerica, Anthony H.; Chiaravalloti, Nancy D.] UMDNJ New Jersey Med Sch, Newark, NJ USA; [Sander, Angelle M.; Pappadis, Monique R.] TIRR Mem Hermann, Houston, TX USA; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Hart, Tessa] Moss Rehabil Res Inst, Philadelphia, PA USA; [Banos, James H.] Univ Alabama Birmingham, Birmingham, AL USA; [De La Plata, Carlos D. Marquez] Univ Texas Dallas, Dallas, TX 75230 USA; [Hammond, Flora M.] Indiana Univ, Indianapolis, IN 46204 USA; [Sherman, Tanya E.] Wayne State Univ, Sch Med, Detroit, MI USA		Lequerica, AH (corresponding author), Kessler Fdn, Res Ctr, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	alequerica@kesslerfoundation.org	Pappadis, Monique/Q-8639-2016	Pappadis, Monique/0000-0003-4742-4380; Chiaravalloti, Nancy/0000-0003-2943-7567	National Institute on Disability and Rehabilitation Research [H133A070037, H133A070043, H133B090023, H133A070036, H133A070040, H133A070039, H133A070027, H133A070042, H133A080044]	This work was supported by the National Institute on Disability and Rehabilitation Research grants H133A070037, H133A070043, H133B090023, H133A070036, H133A070040, H133A070039, H133A070027, H133A070042, and H133A080044.	American Psychological Association, 2006, REP APA TASK FORC SO; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Garver M., 1999, J BUS LOGISTICS, V20, P33; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Keller SD, 1998, J CLIN EPIDEMIOL, V51, P1179, DOI 10.1016/S0895-4356(98)00110-3; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Phan HP, 2007, BRIT J EDUC PSYCHOL, V77, P719, DOI 10.1348/000709906X158339; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P158, DOI 10.1097/HTR.0b013e3181e7537e; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Smyth K, 1996, NURS RES, V45, P25, DOI 10.1097/00006199-199601000-00005; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Unger JB, 2007, J YOUTH ADOLESCENCE, V36, P555, DOI 10.1007/s10964-007-9184-4; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Zitnay GA, 2005, ACT NEUR S, V93, P131	38	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					E14	E22		10.1097/HTR.0b013e31826e3ca8			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200003	23249771				2022-02-06	
J	Sweet, JJ; Goldman, DJ; Breting, LMG				Sweet, Jerry J.; Goldman, Daniel J.; Breting, Leslie M. Guidotti			Traumatic Brain Injury: Guidance in a Forensic Context from Outcome, Dose-Response, and Response Bias Research	BEHAVIORAL SCIENCES & THE LAW			English	Article							MALINGERED NEUROCOGNITIVE DYSFUNCTION; SYMPTOM VALIDITY TEST; CLOSED-HEAD-INJURY; WORD MEMORY TEST; ADULT INTELLIGENCE SCALE; SPORT-RELATED CONCUSSION; RELIABLE DIGIT SPAN; OF-THE-LITERATURE; GOOD OLD DAYS; NEUROPSYCHOLOGICAL ASSESSMENT	Traumatic brain injury (TBI) occurs at a high incidence, involving millions of individuals in the U.S. alone. Related to this, there are large numbers of litigants and claimants who are referred annually for forensic evaluation. In formulating opinions regarding claimed injuries, the present review advises experts to rely on two sets of information: TBI outcome and neuropsychological dose-response studies of non-litigants and non-claimants, and response bias literature that has demonstrated the relatively high risk of invalid responding among examinees referred within a secondary gain context, which in turn has resulted in the development of specific assessment methods. Regarding prospective methods for detecting possible response bias, both symptom validity tests, for measuring over-reporting of symptoms on inventories and questionnaires, and performance validity tests, for measuring insufficient effort on ability tests, are considered essential. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Sweet, Jerry J.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Sweet, Jerry J.; Goldman, Daniel J.; Breting, Leslie M. Guidotti] NorthShore Univ HealthSyst, Evanston, IL 60201 USA		Sweet, JJ (corresponding author), NorthShore Univ HealthSyst, Dept Psychiat & Behav Sci, 909 Davis St,Suite 160, Evanston, IL 60201 USA.	jerrysweet@uchicago.edu					Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barsky AJ, 2002, ARCH INTERN MED, V162, P981, DOI 10.1001/archinte.162.9.981; Barth R. J., 2009, GUIDES NEWSLETTE SEP, P1; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Berry DTR, 2010, PSYCHOL INJ LAW, V3, P295, DOI 10.1007/s12207-010-9087-7; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P997, DOI 10.1016/j.acn.2005.06.003; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Carone D.A., 2013, MILD TRAUMATIC BRAIN; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Elhai J. D., 2011, PTSD MILD TRAUMATIC; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; Faul M, 2010, TRAUMATIC BRAIN INJU; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gioia GA., 2012, PEDIAT FORENSIC NEUR, P205; Gouse H, 2013, ARCH CLIN NEUROPSYCH, V28, P38, DOI 10.1093/arclin/acs100; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein MF, 2002, PSYCHOL ASSESSMENT, V14, P202, DOI 10.1037//1040-3590.14.2.202; Greve K., 2013, NEUROPSYCHOLOGY SCI, V1, P61; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Guidotti L. M., 2013, MILD TRAUMATIC BRAIN, P145; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kaufmann PM, 2009, CLIN NEUROPSYCHOL, V23, P1130, DOI 10.1080/13854040903107809; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Lamberty GJ, 2013, BEHAV SCI LAW, V31, P814, DOI 10.1002/bsl.2091; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Langeluddecke PM, 2005, J CLIN EXP NEUROPSYC, V27, P576, DOI 10.1080/13803390490918372; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Levin HS, 2001, NEUROPSYCHOLOGY, V15, P557, DOI 10.1037//0894-4105.15.4.557; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Lynch W, 2004, J HEAD TRAUMA REHAB, V19, P277, DOI 10.1097/00001199-200405000-00008; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Nelson N. W., 2013, MILD TRAUMATIC BRAIN; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ord JS, 2008, CLIN NEUROPSYCHOL, V22, P689, DOI 10.1080/13854040701425437; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Peck CP, 2013, CLIN NEUROPSYCHOL, V27, P693, DOI 10.1080/13854046.2013.779032; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schutte C., 2013, MILD TRAUMATIC BRAIN; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stein S. C., 1996, NEUROTRAUMA, P31; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Sweet J. J., 2011, CASEBOOK CLIN NEUROP, P200; Sweet JJ, 2013, J EXP PSYCHOPATHOL, V4, P6, DOI 10.5127/jep.022311; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; TEASDALE G, 1974, LANCET, V2, P81; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Warschausky S, 2005, NEUROPSYCHOLOGY, V19, P193, DOI 10.1037/0894-4105.19.2.193; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Williams CW, 1999, PROF PSYCHOL-RES PR, V30, P361, DOI 10.1037/0735-7028.30.4.361; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P239, DOI 10.1016/j.acn.2005.12.004; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Ylioja S, 2010, CLIN NEUROPSYCHOL, V24, P1097, DOI 10.1080/13854046.2010.516021; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	132	11	11	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		756	778		10.1002/bsl.2088			23	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	262KI	WOS:000327733400006	24019125				2022-02-06	
J	de Andrade, AF; Soares, MS; Patriota, GC; Belon, AR; Paiva, WS; Bor-Seng-Shu, E; Oliveira, MD; Nascimento, CN; Noleto, GS; Alves, AC; Figueiredo, EG; Otoch, JP; Teixeira, MJ				de Andrade, Almir Ferreira; Soares, Matheus Schmidt; Patriota, Gustavo Cartaxo; Belon, Alessandro Rodrigo; Paiva, Wellingson Silva; Bor-Seng-Shu, Edson; Oliveira, Marcelo de Lima; Nascimento, Clarissa Nobrega; Noleto, Gustavo Sousa; Alves Junior, Aderaldo Costa; Figueiredo, Eberval Gadelha; Otoch, Jose Pinhata; Teixeira, Manoel Jacobsen			Experimental rnodel of intracranial hypertension with continuous multiparametric monitoring in swine	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						experimental model; intracranial hypertension; transcranial doppler sonography	CRITICAL CLOSING PRESSURE; BRAIN; MODEL; HEMORRHAGE; BEHAVIOR; SENSORS; BLOOD	Objective: Intracranial hypertension (IN) develops in approximately 50% of all patients with severe traumatic brain injury (TBI). Therefore, it is very important to identify a suitable animal model to study and understand the pathophysiology of refractory IH to develop effective treatments. Methods: We describe a new experimental porcine model designed to simulate expansive brain hematoma causing IH. Under anesthesia, was simulated with a balloon insufflation. The IH variables were measured with intracranial pressure (ICP) parenchymal monitoring, epidural, cerebral oximetry, and transcranial Doppler (TCD). Results: None of the animals died during the experiment. The ICP epidural showed a slower rise compared with parenchymal ICP. We found a correlation between ICP and cerebral oximetry. Conclusion: The model described here seems useful to understand some of the pathophysiological characteristics of acute IH.	[de Andrade, Almir Ferreira; Soares, Matheus Schmidt; Paiva, Wellingson Silva; Bor-Seng-Shu, Edson; Oliveira, Marcelo de Lima; Nascimento, Clarissa Nobrega; Noleto, Gustavo Sousa; Figueiredo, Eberval Gadelha; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, Brazil; [Patriota, Gustavo Cartaxo; Belon, Alessandro Rodrigo; Alves Junior, Aderaldo Costa; Otoch, Jose Pinhata] Univ Sao Paulo, Sch Med, Expt Surg Lab, Sao Paulo, Brazil		Paiva, WS (corresponding author), Rua Eneas Aguiar 255-4080, BR-0543010 Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Figueiredo, Eberval Gadelha/H-3488-2012; Junior, Aderaldo C Alves/U-6958-2017; BOR-SENG-SHU, EDSON/AAC-9762-2019; Junior, Aderaldo Alves/Q-1682-2019; Belon, Alessandro Rodrigo/D-4260-2012; Noleto, Gustavo Sousa/ABB-7684-2021; Figueiredo, Eberval G/E-2071-2016; Paiva, Wellingson S/G-5517-2013	Junior, Aderaldo C Alves/0000-0001-5784-8625; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Junior, Aderaldo Alves/0000-0001-5784-8625; Belon, Alessandro Rodrigo/0000-0003-0010-8604; Noleto, Gustavo Sousa/0000-0002-1907-3774; Paiva, Wellingson S/0000-0002-5165-7040; de-Lima-Oliveira, Marcelo/0000-0002-7418-1516			ADAMS RD, 1985, PRINCIPLES NEUROLOGY; Bor-Seng-Shu E, 2012, ARQ NEURO-PSIQUIAT, V70, P357, DOI 10.1590/S0004-282X2012000500010; BRUDER N, 1995, INTENS CARE MED, V21, P850, DOI 10.1007/BF01700971; Dagal A, 2011, CURR OPIN ANESTHESIO, V24, P131, DOI 10.1097/ACO.0b013e3283445898; de Andrade AF, 2009, REV ASSOC MED BRAS, V55, P75, DOI 10.1590/S0104-42302009000100020; Eide PK, 2008, MED ENG PHYS, V30, P34, DOI 10.1016/j.medengphy.2007.01.005; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Kanter M J, 1991, Neurosurg Clin N Am, V2, P257; Kim DJ, 2012, J NEUROTRAUM, V29, P1354, DOI 10.1089/neu.2011.2018; MILLER JD, 1993, HEAD INJURY, P331; Paiva WS, 2009, REV NEUROLOGIA, V48, P134, DOI 10.33588/rn.4803.2008575; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; Pourcyrous M, 1997, PEDIATR RES, V42, P305, DOI 10.1203/00006450-199709000-00010; POWELL MP, 1985, J NEUROSURG, V63, P745, DOI 10.3171/jns.1985.63.5.0745; Raabe A, 1998, NEUROSURGERY, V43, P306, DOI 10.1097/00006123-199808000-00073; Ryska O, 2012, INT J ARTIF ORGANS, V35, P503, DOI 10.5301/ijao.5000099; Shi YY, 2010, TOHOKU J EXP MED, V220, P33, DOI 10.1620/tjem.220.33; Thees C, 2002, ANESTHESIOLOGY, V96, P595, DOI 10.1097/00000542-200203000-00014; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490	20	11	12	0	9	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	OCT	2013	71	10					802	806		10.1590/0004-282X20130126			5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	243KB	WOS:000326314200012	24212519	gold, Green Submitted			2022-02-06	
J	De Zani, D; Zani, DD; Binanti, D; Riccaboni, P; Rondena, M; Di Giancamillo, M				De Zani, D.; Zani, D. D.; Binanti, D.; Riccaboni, P.; Rondena, M.; Di Giancamillo, M.			Magnetic resonance features of closed head trauma in two foals	EQUINE VETERINARY EDUCATION			English	Article						horse; foal; MRI; brain; contusion; neurology	BRAIN-INJURY; FIELD MR; HORSES; TOMOGRAPHY; FRACTURES; DIAGNOSIS; CT	Two foals were admitted for neurological signs after trauma. Clinical and diagnostic investigations were performed that were suggestive of closed head trauma characterised by right parietal bone deviation (ping-pong fracture), cerebral contusion, haematoma and cerebellar contusion. The histopathological findings were consistent with areas of abnormal signal found on magnetic resonance investigations.	[De Zani, D.; Zani, D. D.; Di Giancamillo, M.] Univ Milan, Dipartimento Sci Clin Vet Reparto Radiol, Azienda Polo Vet Lodi, Lodi, Italy; [Binanti, D.; Riccaboni, P.] Univ Milan, Dipartimento Patol Igiene & Sanita Pubbl Vet, Fac Med Vet, Azienda Polo Vet Lodi, Lodi, Italy		De Zani, D (corresponding author), Univ Milan, Dipartimento Sci Clin Vet Reparto Radiol, Azienda Polo Vet Lodi, Lodi, Italy.	donatella.dezani@unimi.it	Di Giancamillo, Mauro/M-4877-2017; Riccaboni, Pietro/L-2707-2017; ZANI, DAVIDE DANILO/I-6027-2017	Di Giancamillo, Mauro/0000-0003-3128-4619; De Zani, Donatella/0000-0002-7032-2297; Riccaboni, Pietro/0000-0002-6783-7265; ZANI, DAVIDE DANILO/0000-0002-0444-2784			Arencibia A, 2001, VET RADIOL ULTRASOUN, V42, P405, DOI 10.1111/j.1740-8261.2001.tb00959.x; Audigie F, 2004, VET RADIOL ULTRASOUN, V45, P210, DOI 10.1111/j.1740-8261.2004.04035.x; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Brittain C., 2012, BMJ CASE REP, DOI 10.1136/bcr.01.2012.5631.; Chaffin MK, 1997, VET RADIOL ULTRASOUN, V38, P102, DOI 10.1111/j.1740-8261.1997.tb00823.x; Dupuis O, 2005, AM J OBSTET GYNECOL, V192, P165, DOI 10.1016/j.ajog.2004.06.035; Feary DJ, 2007, JAVMA-J AM VET MED A, V231, P259, DOI 10.2460/javma.231.2.259; Feige K, 2000, EQUINE VET EDUC, V12, P220, DOI 10.1111/j.2042-3292.2000.tb00044.x; Ferrell EA, 2002, VET RADIOL ULTRASOUN, V43, P510, DOI 10.1111/j.1740-8261.2002.tb01041.x; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Kara A, 2008, TURK NEUROSURG, V18, P1; MacKay RJ, 2004, VET CLIN N AM-EQUINE, V20, P199, DOI 10.1016/j.cveq.2003.11.006; Nakahara K, 2011, NEUROL MED-CHIR, V51, P272, DOI 10.2176/nmc.51.272; Rayner SG, 2005, AUST VET J, V83, P674, DOI 10.1111/j.1751-0813.2005.tb13045.x; Sanders SG, 2001, VET RADIOL ULTRASOUN, V42, P291, DOI 10.1111/j.1740-8261.2001.tb00942.x; Spoormakers TJR, 2003, EQUINE VET J, V35, P146, DOI 10.2746/042516403776114153; Tietje S, 1996, EQUINE VET J, V28, P98, DOI 10.1111/j.2042-3306.1996.tb01599.x; Tucker R., 2011, Equine MRI, P249; Tucker R., 2011, Equine MRI, P467; Vazquez JM, 2001, VET REC, V148, P229, DOI 10.1136/vr.148.8.229; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zia Z, 2007, EMERG MED J, V24, P731, DOI 10.1136/emj.2006.043570; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	28	11	11	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0957-7734			EQUINE VET EDUC	Equine Vet. Educ.	OCT	2013	25	10					493	498		10.1111/eve.12003			6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	212ZN	WOS:000324022400003					2022-02-06	
J	Koberda, JL; Moses, A; Koberda, P; Koberda, L				Koberda, J. Lucas; Moses, Andrew; Koberda, Paula; Koberda, Laura			Clinical Advantages of Quantitative Electroencephalogram (QEEG)-Electrical Neuroimaging Application in General Neurology Practice	CLINICAL EEG AND NEUROSCIENCE			English	Article						QEEG; electrical neuroimaging; neurology; neurofeedback	ELECTRICAL-ACTIVITY; EEG; QEEG; ABNORMALITIES; DISORDER; CHILDREN	QEEG-electrical neuroimaging has been underutilized in general neurology practice for uncertain reasons. Recent advances in computer technology have made this electrophysiological testing relatively inexpensive. Therefore, this study was conducted to evaluate the clinical usefulness of QEEG/electrical neuroimaging in neurological practice. Over the period of approximately 6 months, 100 consecutive QEEG recordings were analyzed for potential clinical benefits. The patients who completed QEEG were divided into 5 groups based on their initial clinical presentation. The main groups included patients with seizures, headaches, post-concussion syndrome, cognitive problems, and behavioral dysfunctions. Subsequently, cases were reviewed and a decision was made as to whether QEEG analysis contributed to the diagnosis and/or furthered patient's treatment. Selected and representative cases from each group are presented in more detail, including electrical neuroimaging with additional low-resolution electromagnetic tomography analysis or using computerized cognitive testing. Statistical analysis showed that QEEG analysis contributed to 95% of neurological cases, which indicates great potential for wider application of this modality in general neurology. Many patients also began neurotherapy, depending on the patient's desire to be involved in this treatment modality.	[Koberda, J. Lucas; Moses, Andrew; Koberda, Paula; Koberda, Laura] Tallahassee NeuroBalance Ctr, Tallahassee, FL 32317 USA; [Moses, Andrew; Koberda, Paula; Koberda, Laura] Florida State Univ, Tallahassee, FL 32306 USA		Koberda, JL (corresponding author), Tallahassee NeuroBalance Ctr, POB 13554, Tallahassee, FL 32317 USA.	JLKoberda@yahoo.com					Aminoff M. J., 1999, ELECTRODIAGNOSIS CLI; [Anonymous], 2001, NEUR SOFTW, P33708; Arns Martijn, 2008, Journal of Integrative Neuroscience, V7, P421, DOI 10.1142/S0219635208001897; Clark CR, 2009, CLIN EEG NEUROSCI, V40, P84, DOI 10.1177/155005940904000208; Coben R, 2008, CLIN NEUROPHYSIOL, V119, P1002, DOI 10.1016/j.clinph.2008.01.013; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; Deslandes A, 2004, ARQ NEURO-PSIQUIAT, V62, P44, DOI 10.1590/S0004-282X2004000100008; di Michele F, 2005, INT J PSYCHOPHYSIOL, V58, P81, DOI 10.1016/j.ijpsycho.2005.03.011; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; Fonseca LC, 2008, ARQ NEURO-PSIQUIAT, V66, P462, DOI 10.1590/S0004-282X2008000400004; Hargrove JB, 2010, CLIN EEG NEUROSCI, V41, P132, DOI 10.1177/155005941004100305; Lansbergen MM, 2011, PROG NEURO-PSYCHOPH, V35, P47, DOI 10.1016/j.pnpbp.2010.08.004; Michel CM., 2009, ELECT NEUROIMAGING; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Naunheim RS, 2010, BRAIN INJ; NeuroTrax Corporation, MINDSTR ASS; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Pascual-Marqui R.D., 1999, INT J BIOELECTROMAGN, V1, P75; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pop-Jordanova Nada, 2010, Nonlinear Biomed Phys, V4, P4, DOI 10.1186/1753-4631-4-4; Price J, 2009, INTRODUCTION TO QUANTITATIVE EEG AND NEUROFEEDBACK: ADVANCED THEORY AND APPLICATIONS, 2ND EDITION, P453, DOI 10.1016/B978-0-12-374534-7.00017-4; Rizzo M, 2004, BEHAV NEUROLOGY NEUR; Segrave RA, 2011, CLIN EEG NEUROSCI, V42, P45, DOI 10.1177/155005941104200110; Thatcher R.W., 2002, COMMUNICATION; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Walker JE, 2011, CLIN EEG NEUROSCI, V42, P59, DOI 10.1177/155005941104200112	26	11	11	0	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	OCT	2013	44	4					273	285		10.1177/1550059412475291			13	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	269WY	WOS:000328275400004	23536380				2022-02-06	
J	Kwon, HG; Kim, MS; Kim, SH; Jang, SH				Kwon, Hyeok Gyu; Kim, Min Su; Kim, Seong Ho; Jang, Sung Ho			Injury of the oculomotor nerve in a patient with traumatic brain injury: diffusion tensor tractography study	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						Eye Movements; Head Injury			[Kwon, Hyeok Gyu; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea; [Kim, Min Su; Kim, Seong Ho] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			DGIST R&D Programme of the Ministry of Education, Science and Technology of Korea [13-BD-0401]	The DGIST R&D Programme of the Ministry of Education, Science and Technology of Korea grant number: 13-BD-0401.	Hodaie M, 2010, NEUROSURGERY, V66, P788, DOI 10.1227/01.NEU.0000367613.09324.DA; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Yamada K, 2006, NEURORADIOLOGY, V48, P434, DOI 10.1007/s00234-006-0070-7	3	11	12	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	OCT	2013	84	10					1073	1074		10.1136/jnnp-2013-305111			2	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	209SH	WOS:000323779800007	23644532				2022-02-06	
J	Miyauchi, T; Wei, EP; Povlishock, JT				Miyauchi, Takashi; Wei, Enoch P.; Povlishock, John T.			Therapeutic Targeting of the Axonal and Microvascular Change Associated with Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						FK506; hypothermia; repetitive traumatic brain injury; therapeutic intervention	2ND IMPACT SYNDROME; POSTTRAUMATIC HYPOTHERMIA; HEAD-INJURY; HIGH-SCHOOL; CONCUSSION; FK506; VULNERABILITY; DAMAGE; RATS; ENCEPHALOPATHY	Recent interest in mild traumatic brain injury (mTBI) has increased the recognition that repetitive mTBI occurring within the sports and military settings can exacerbate the adverse consequences of the initial injury. While multiple studies have recently reported the pathological, metabolic, and functional changes associated with repetitive mTBI, no consideration has been given to the development of therapeutic approaches to attenuate these abnormalities. In this study, we used the model of repetitive impact acceleration insult previously reported by our laboratory to cause no initial structural and functional changes, yet evoke dramatic change following second insult of the same intensity. Using this model, we employed established neuroprotective agents including FK506 and hypothermia that were administered 1h after the second insult. Following either therapeutic intervention, changes of cerebral vascular reactivity to acetylcholine were assessed through a cranial window. Following the completion of the vascular studies, the animals were prepared to access the numbers of amyloid precursor protein (APP) positive axons, a marker of axonal damage. Following repetitive injury, cerebral vascular reactivity was dramatically preserved by either therapeutic intervention or the combination thereof compared to control group in which no intervention was employed. Similarly, APP density was significantly lower in the therapeutic intervention group compared in controls. Although the individual use of FK506 or hypothermia exerted significant protection, no additive benefit was found when both therapies were combined. In sum, the current study demonstrates that the exacerbated pathophysiological changes associated with repetitive mTBI can be therapeutically targeted.	[Miyauchi, Takashi; Wei, Enoch P.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Miyauchi, Takashi] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Ube, Yamaguchi, Japan		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077657, NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077657, P30NS047463, R01NS077675] Funding Source: NIH RePORTER	The authors would like to thank Ms. Lynn Davis and Mrs. Susan Walker for their technical assistance. This study was supported by NIH grants NS077657 and NS047463.	Allen GL, 2000, NETW COMPUT, V11, P18; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; Giza CC, 2001, J ATHL TRAINING, V36, P228; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KONTOS HA, 1988, AM J PHYSIOL, V255, pH1259, DOI 10.1152/ajpheart.1988.255.5.H1259; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mills JD, 2003, J BIOMED OPT, V8, P347, DOI 10.1117/1.1584443; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Sasakawa T, 2005, CYTOKINE, V29, P67, DOI 10.1016/j.cyto.2004.04.006; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Thomale UW, 2007, IMMUNOBIOLOGY, V212, P567, DOI 10.1016/j.imbio.2007.01.007; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	43	11	11	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2013	30	19					1664	1671		10.1089/neu.2013.2995			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	227WQ	WOS:000325146800007	23796228	Green Published, Green Submitted			2022-02-06	
J	Silk, T; Beare, R; Crossley, L; Rogers, K; Emsell, L; Catroppa, C; Beauchamp, M; Anderson, V				Silk, Timothy; Beare, Richard; Crossley, Louise; Rogers, Kirrily; Emsell, Louise; Catroppa, Cathy; Beauchamp, Miriam; Anderson, Vicki			Cavum septum pellucidum in pediatric traumatic brain injury	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Traumatic brain injury; Pediatric; Magnetic resonance imaging (MRI); Cavum septum pellucidum	ULTRA-HIGH-RISK; BIPOLAR DISORDER; SCHIZOPHRENIA; MRI; PREVALENCE; MODERATE; ATROPHY; SEGMENTATION; HIPPOCAMPUS; CHILDREN	The cavum septum pellucidum (CSP) is a fluid-filled cavity in the thin midline structure of the septum pellucidum. The CSP has been linked to several neurodevelopmental disorders, but it also occurs as a result of head injury. The aims were to assess the presence and characterization of the CSP in youth with traumatic brain injury (TBI), to assess whether injury severity or IQ measures were related to CSP size, and to examine brain morphometry changes associated with the CSP size. Ninety-eight survivors of TBI and 34 control children underwent magnetic resonance imaging (MRI). Numerous methods were used to define the presence and characterization of the CSP including length, classification of abnormally large CSP, rating of the CSP, and volume. There was no difference in presence of CSP between TBI patients and controls; however, there was larger and more severely graded CSP in the patient group. Size of the CSP correlated positively with injury severity, and regions that correlated most significantly with CSP size were the right entorhinal cortex and bilateral hippocampus. Characterizing the CSP and related brain changes may provide important information concerning disturbances seen after a TBI. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Silk, Timothy; Beare, Richard; Crossley, Louise; Rogers, Kirrily; Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Beauchamp, Miriam] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Emsell, Louise] Katholieke Univ Leuven, Dept Imaging & Pathol, Translat MRI, Louvain, Belgium; [Emsell, Louise] Katholieke Univ Leuven Hosp, Louvain, Belgium		Silk, T (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	tim.silk@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021; Silk, Tim/K-4295-2019; Emsell, Louise/ABA-8107-2020	Catroppa, Cathy/0000-0002-9750-0436; Beare, Richard/0000-0002-7530-5664; Emsell, Louise/0000-0003-0011-4158; Silk, Tim/0000-0002-7290-512X; Rogers, Kirrily/0000-0001-8282-537X	Victorian Neurotrauma Initiative; Victorian Government's Operational Infrastructure Support Program; NHMRC Career Development AwardNational Health and Medical Research Council of Australia	This work was supported by the Victorian Neurotrauma Initiative, by the Victorian Government's Operational Infrastructure Support Program and by the Royal Children's Hospital staff and patients. TS was supported by an NHMRC Career Development Award.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; [Anonymous], 1998, AM J PSYCHIAT, V155, P455, DOI 10.1176/ajp.155.8.1074; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; BODENSTEINER JB, 1990, PEDIATR NEUROL, V6, P391, DOI 10.1016/0887-8994(90)90007-N; Bodensteiner JB, 1998, J CHILD NEUROL, V13, P120, DOI 10.1177/088307389801300305; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Cabanis E A, 1986, Acta Radiol Suppl, V369, P365; Choi JS, 2008, PROG NEURO-PSYCHOPH, V32, P1326, DOI 10.1016/j.pnpbp.2008.04.011; Chon MW, 2010, EUR ARCH PSY CLIN N, V260, P337, DOI 10.1007/s00406-009-0081-6; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEGREEF G, 1992, PSYCHIAT RES-NEUROIM, V45, P1, DOI 10.1016/0925-4927(92)90009-S; DEGREEF G, 1992, AM J NEURORADIOL, V13, P835; DeLisi L., 1993, NEUROIMAGING, V45, P1; Dickey CC, 2007, SCHIZOPHR RES, V89, P49, DOI 10.1016/j.schres.2006.08.004; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Flashman LA, 2007, PSYCHIAT RES-NEUROIM, V154, P147, DOI 10.1016/j.pscychresns.2006.09.001; Fukuzako T, 1996, PSYCHIAT CLIN NEUROS, V50, P125, DOI 10.1111/j.1440-1819.1996.tb01675.x; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Handratta V, 2010, NEUROCASE, V16, P125, DOI 10.1080/13554790903329166; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kasai K, 2004, SCHIZOPHR RES, V71, P65, DOI 10.1016/j.schres.2003.12.010; Kim KJ, 2003, BIOL PSYCHIAT, V54, P76, DOI 10.1016/S0006-3223(02)01830-9; Kim MJ, 2007, BIPOLAR DISORD, V9, P274, DOI 10.1111/j.1399-5618.2007.00442.x; Kwon JS, 1998, AM J PSYCHIAT, V155, P509, DOI 10.1176/ajp.155.4.509; Li XD, 2012, PSYCHIAT CLIN NEUROS, V66, P587, DOI 10.1111/pcn.12002; McCrory P, 2002, BRIT J SPORT MED, V36, P157, DOI 10.1136/bjsm.36.3.157; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Nopoulos P, 1996, J NEUROPSYCH CLIN N, V8, P147; Nopoulos P, 2000, J NEUROPSYCH CLIN N, V12, P344, DOI 10.1176/appi.neuropsych.12.3.344; Nopoulos P, 1997, BIOL PSYCHIAT, V41, P1102, DOI 10.1016/S0006-3223(96)00209-0; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Pittella JEH, 2005, SURG NEUROL, V63, P30, DOI 10.1016/j.surneu.2004.09.012; Raine A, 2010, BRIT J PSYCHIAT, V197, P186, DOI 10.1192/bjp.bp.110.078485; RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103; ROSSI A, 1994, PSYCHIAT RES, V52, P43, DOI 10.1016/0165-1781(94)90119-8; SCHAEFER GB, 1994, DEV MED CHILD NEUROL, V36, P554; Shioiri T, 1996, PSYCHOL MED, V26, P431, DOI 10.1017/S0033291700034838; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Takahashi T, 2008, SCHIZOPHR RES, V105, P236, DOI 10.1016/j.schres.2008.06.021; Takahashi T, 2007, PROG NEURO-PSYCHOPH, V31, P1235, DOI 10.1016/j.pnpbp.2007.04.019; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; TEASDALE G, 1974, LANCET, V2, P81; Verger K, 2001, BRAIN INJURY, V15, P211; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x	52	11	12	1	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	SEP 30	2013	213	3					186	192		10.1016/j.pscychresns.2013.03.001			7	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	211TV	WOS:000323934800002	23816190				2022-02-06	
J	Amonette, WE; Mossberg, KA				Amonette, William E.; Mossberg, Kurt A.			Ventilatory Anaerobic Thresholds of Individuals Recovering From Traumatic Brain Injury Compared With Noninjured Controls	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						exercise prescription; exercise tolerance; fatigue; head injury rehabilitation	CHRONIC HEART-FAILURE; GAS-EXCHANGE; EXERCISE; FATIGUE; RELIABILITY; EFFICIENCY; RESPONSES; CAPACITY; VALIDITY; DEATH	Objective: The purpose of this study was to compare the peak aerobic capacities and ventilatory anaerobic thresholds (V-AT) of individuals with a traumatic brain injury (TBI) to age- and gender-matched controls. Methods: Nineteen participants that previously suffered a mild to moderate TBI and 19 apparently healthy controls volunteered as subjects. Traumatic brain injury and healthy controls were matched for age and gender and were similar in weight and body mass index. Volunteers performed a maximal graded treadmill test to volitional failure where oxygen consumption ((V) over dotO(2)), carbon dioxide production ((V) over dotCO(2)), ventilation ((V) over dot(E)), and heart rate were measured continuously. From metabolic and ventilatory data, V-AT was measured using a previously described method. V-AT and peak exercise responses of participants with a TBI were compared with healthy controls. Results: The (V) over dotO(2), and (V) over dotCO(2) at V-AT and peak exercise were lower for TBI compared with healthy controls. (V) over dot(E) was also lower for TBI at V-AT and peak exercise. Heart rate was lower for TBI at V-AT; however, TBI had similar heart rate to healthy controls at peak exercise. Conclusions: The V-AT and peak exercise capacities of participants with a TBI were below the metabolic demands of many routine daily activities. The data suggest that therapeutic interventions for individuals with a TBI should include targeted exercise prescriptions to improve cardiorespiratory fitness.	[Amonette, William E.; Mossberg, Kurt A.] Univ Texas Med Branch, Dept Phys Therapy, Rehabil Sci Div, Galveston, TX 77555 USA		Mossberg, KA (corresponding author), Univ Texas Med Branch, Dept Phys Therapy, 301 Univ Blvd, Galveston, TX 77555 USA.	kmossber@utmb.edu			Moody Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-HD046570]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD046570] Funding Source: NIH RePORTER	This work was supported, in part, by the Moody Foundation and NIH grant R01-HD046570 to Dr Mossberg. The authors thank P. Skinkis for technical assistance and Dr James Graham for his assistance with statistical analysis.	Amann M, 2004, MED SCI SPORT EXER, V36, P1716, DOI 10.1249/01.MSS.0000142305.18543.34; [Anonymous], 2001, NAT CTR INJ PREV CON; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Caviedes IR, 2012, RESP CARE, V57, P583, DOI 10.4187/respcare.01342; CHWALBINSKAMONETA J, 1989, J APPL PHYSIOL, V66, P2710, DOI 10.1152/jappl.1989.66.6.2710; Coucke W, 2012, CLIN CHIM ACTA, V413, P582, DOI 10.1016/j.cca.2011.11.030; Crouter SE, 2006, J APPL PHYSIOL, V100, P1324, DOI 10.1152/japplphysiol.00818.2005; Gaskill SE, 2001, MED SCI SPORT EXER, V33, P1841, DOI 10.1097/00005768-200111000-00007; Gitt AK, 2000, EUR HEART J, V21, P586; Gitt AK, 2002, CIRCULATION, V106, P3079, DOI 10.1161/01.CIR.0000041428.99427.06; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HAGBERG JM, 1981, MED SCI SPORT EXER, V13, P115, DOI 10.1249/00005768-198101320-00228; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOPKINS SR, 1994, J APPL PHYSIOL, V77, P912, DOI 10.1152/jappl.1994.77.2.912; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Malek MH, 2007, J STRENGTH COND RES, V21, P29, DOI 10.1519/00124278-200702000-00006; Midgley AW, 2007, CLIN PHYSIOL FUNCT I, V27, P122, DOI 10.1111/j.1475-097X.2007.00725.x; Mossberg K, 2010, REHABILITATION MOBIL, P276; Mossberg KA, 2005, AM J PHYS MED REHAB, V84, P492, DOI 10.1097/01.phm.0000166883.97562.cd; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Nanas SN, 2006, EUR J HEART FAIL, V8, P420, DOI 10.1016/j.ejheart.2005.10.003; Papazachou O, 2007, INT J CARDIOL, V118, P28, DOI 10.1016/j.ijcard.2006.04.091; Pollock ML, 1990, EXERCISE HLTH DIS; Riffenburgh RH, 2006, STATISTICS IN MEDICINE, 2ND EDITION, P1; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Thompson W R, 2010, ACSMS GUIDELINES EXE; Thurman DA, 1999, TRAUMATIC BRAIN INJU, P1; Valim V, 2002, J RHEUMATOL, V29, P353; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; WOLTHUIS RA, 1977, AM J CARDIOL, V39, P697, DOI 10.1016/S0002-9149(77)80131-8; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	37	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					E13	E20		10.1097/HTR.0b013e31826463a1			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600002	22935575	Green Accepted			2022-02-06	
J	Dahl, E; Emanuelson, I				Dahl, Ewa; Emanuelson, Ingrid			MOTOR PROFICIENCY IN CHILDREN WITH MILD TRAUMATIC BRAIN INJURY COMPARED WITH A CONTROL GROUP	JOURNAL OF REHABILITATION MEDICINE			English	Article						motor function; mild TBI; children; control study	POSTTRAUMATIC MOVEMENT-DISORDERS; HEAD-INJURY; RECOVERY; INFANTS; BALANCE	Objective: To assess motor proficiency and movement disorders in children with mild traumatic brain injury compared with an uninjured control group. Inclusion criteria were based on the definitions issued by the American Congress of Rehabilitation Medicine. Subjects: A group of 27 children with mild traumatic brain injury (age range 4-17 years) and a control group of 79 healthy children. Methods: Bruininks-Oseretsky Test of Motor Proficiency (BOTMP) was administered. This is a standardized comprehensive test of gross- and fine-motor function that produces standard scores for children in this age group. It is divided into 4 gross-motor tasks, 3 fine-motor tasks, 1 combined task, and a test of hand and foot dominance. Tremor was also evaluated. Results: The mean standard scores for both groups were within the normal range. For balance, the mild traumatic brain injury group had a significantly poorer performance than controls (p=0.03). Tremor was significantly more frequent in the mild traumatic brain injury group (p=0.004), and mixed-handedness was significantly over-represented in the mild traumatic brain injury group (p=0.02). Conclusion: In this study, children with mild traumatic brain injury did not differ from the norm in terms of fine-or gross-motor proficiency compared with a, control group of uninjured children, but a difference in balance skill (p=0.03), mixed-handedness (p=0.02) and tremor (p=0.004) was detected, to the injured children's detriment.	[Dahl, Ewa] Boras Hosp, Med Rehabil Clin, Boras, Sweden; [Emanuelson, Ingrid] Univ Gothenburg, Dept Paediat, Inst Clin Sci, Gothenburg, Sweden		Emanuelson, I (corresponding author), Habilitering & Halsa, Naverlursgatan 38, SE-42144 Vastra Frolunda, Sweden.	ingrid.emanuelson@vgregion.se			Alice Svensson's Memorial Fund at The Hospital of South Alvsborg, SAS, Sweden	This study was supported by grants from the Alice Svensson's Memorial Fund at The Hospital of South Alvsborg, SAS, Sweden. The authors are especially grateful to the parents and their children who participated in the study.	Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BIARY N, 1989, NEUROLOGY, V39, P103, DOI 10.1212/WNL.39.1.103; Bruininks R., 1978, BRUININKS OSERETSKY, P1401; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Coller WC, 1989, MOVEMENT DISORD, V4, P20; Croce RV, 2001, PERCEPT MOTOR SKILL, V93, P275, DOI 10.2466/pms.2001.93.1.275; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Domellof E, 2011, NEUROPSYCHOLOGIA, V49, P2299, DOI 10.1016/j.neuropsychologia.2011.04.033; Dumas HM, 2002, PHYS OCCUP THER PEDI, V22, P444; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 2001, J HEAD TRAUMA REHAB, V16, P595, DOI 10.1097/00001199-200112000-00007; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Krauss JK, 1997, MOVEMENT DISORD, V12, P428, DOI 10.1002/mds.870120326; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; O'Flaherty SJ, 2000, ARCH PHYS MED REHAB, V81, P723, DOI 10.1016/S0003-9993(00)90100-X; OCALLAGHAN MJ, 1993, CORTEX, V29, P617, DOI 10.1016/S0010-9452(13)80285-7; Quinn B, 2000, BRAIN INJURY, V14, P1063; Ronnqvist L, 2006, DEV PSYCHOBIOL, V48, P444, DOI 10.1002/dev.20160; Rosenblum Sara, 2003, Physical & Occupational Therapy in Pediatrics, V23, P47; Wong GF, 1989, MOVEMENT DISORD, V4, P20; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	29	11	11	0	14	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					729	733		10.2340/16501977-1188			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500006	24002307	gold, Green Submitted			2022-02-06	
J	Goldberg, Y; Danckert, J				Goldberg, Yael; Danckert, James			Traumatic Brain Injury, Boredom and Depression	BEHAVIORAL SCIENCES			English	Article						traumatic brain injury; boredom; depression		Traumatic brain injury (TBI) often presents with co-morbid depression and elevated levels of boredom. We explored the relationship between boredom and depression in a group of mild (n = 38), moderate-to-severe TBI patients (n = 14) and healthy controls (n = 88), who completed the Beck Depression Inventory and Boredom Proneness Scales as part of a larger study. Results showed that the relationship between boredom and depression was strongest in moderate-to-severe TBI patients. We explored two boredom proneness factors that index an individual` s need for external or internal stimulation. Results indicated that the need for external stimulation was the critical driver in the relation between boredom and depression. Once again, this relationship was strongest in the moderate-to-severe TBI group. These results suggest that one common factor underlying boredom and depression is the need for stimulation from the external environment and, presumably, a failure to satisfy that need-a disconnection felt most strongly in moderate-to-severe TBI.	[Goldberg, Yael; Danckert, James] Univ Waterloo, Dept Psychol, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada		Danckert, J (corresponding author), Univ Waterloo, Dept Psychol, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	ygoldber@uwaterloo.ca; jdancker@uwaterloo.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant awarded to JD.	Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Cuijpers P, 2013, J AFFECT DISORDERS, V144, P183, DOI 10.1016/j.jad.2012.06.025; DeCoster J., APPL LINEAR REGRESSI; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Eastwood JD, 2012, PERSPECT PSYCHOL SCI, V7, P482, DOI 10.1177/1745691612456044; FARMER R, 1986, J PERS ASSESS, V50, P4, DOI 10.1207/s15327752jpa5001_2; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Goldberg YK, 2011, J SOC CLIN PSYCHOL, V30, P647, DOI 10.1521/jscp.2011.30.6.647; Greenson R. R, 1951, PSYCHOANAL QUART, V20, P346; Gregorio G.W., 2013, J HEAD TRAU IN PRESS; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Jacobson NS, 2001, CLIN PSYCHOL-SCI PR, V8, P255, DOI 10.1093/clipsy/8.3.255; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Malkovsky E, 2012, EXP BRAIN RES, V221, P59, DOI 10.1007/s00221-012-3147-z; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Melton AMA, 2009, J PSYCHOL, V143, P493, DOI 10.3200/JRL.143.5.493-508; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; Pryce CR, 2011, PHARMACOL THERAPEUT, V132, P242, DOI 10.1016/j.pharmthera.2011.06.006; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Theobald Dale E, 2003, Palliat Support Care, V1, P71; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Vodanovich SJ, 2003, J PSYCHOL, V137, P569, DOI 10.1080/00223980309600636	29	11	11	0	3	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-328X			BEHAV SCI-BASEL	Behav. Sci.	SEP	2013	3	3					434	444		10.3390/bs3030434			11	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	V28HI	WOS:000215418100008	25379247	gold, Green Published, Green Submitted			2022-02-06	
J	Messinger, SD				Messinger, Seth D.			Vigilance and Attention among U.S. Service Members and Veterans After Combat	ANTHROPOLOGY OF CONSCIOUSNESS			English	Article						emotions; war rehabilitation; identity; military		In this article we explore the two emotional experiences of hypervigilance and attention. These emotions are associated with both military training and with posttraumatic stress among other disorders. We consider the way that these emotions can be experienced after exposure to combat as well as grievous bodily injury, and seek to untangle situations in which they are artifacts of military training and identity rather than symptoms. The data for this article are drawn from interviews and observations with former patients of the US Armed Forces Amputee Patient Care Program at the Walter Reed National Military Medical Center. An experience like hypervigilance is often treated as a symptom of posttraumatic stress disorder (PTSD) or mild traumatic brain injury. Some experts place the number of returning service members with either or both of these disorders in the hundreds of thousands. While some participants in our study have received diagnoses of either PTSD or mild traumatic brain injury, in many cases they experience emotions like hypervigilance, differently. Rather than being troubled by hypervigilance, they experience it as a valued legacy of their military training and an important characteristic that distinguishes them from civilians.	[Messinger, Seth D.] Univ Maryland, Uniformed Serv Univ Hlth Sci, Baltimore, MD 21201 USA		Messinger, SD (corresponding author), Univ Maryland, Uniformed Serv Univ Hlth Sci, Baltimore, MD 21201 USA.	Sethm@umbc.edu					Burke Carol, 2005, CAMP ALL AM HANOI JA; Csikszentmihalyi M., 2008, FLOW PSYCHOL OPTIMAL; Dao James, 2013, NEW YORK TIMES  0223, pA09; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Fani N, 2012, PSYCHOL MED, V42, P533, DOI 10.1017/S0033291711001565; Finley EP, 2011, FIELDS COMBAT UNDERS; Granville Robert, 2006, J AM ACAD ORTHOP SUR, V14, P5183; GROSSMAN DAVE, 2009, KILLING PSYCHOL COST; Gutmann M, 2010, BREAKING RANKS: IRAQ VETERANS SPEAK OUT AGAINST THE WAR, P1; Hochschild AR, 2012, MANAGED HEART: COMMERCIALIZATION OF HUMAN FEELING, P1; KLEINMAN A., 1998, TANNER LECT HUMAN VA; Kubrick Stanley, 1987, FULL METAL JACKET; Liman Doug, 2002, THE BOURNE IDENTITY; Luborsky M., 1994, QUALITATIVE METHODS; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; Lysack C., 2006, SCHOLARSHIP OCCUPATI; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; Messinger SD, 2007, QUAL HEALTH RES, V17, P353, DOI 10.1177/1049732306298803; Messinger SD, 2010, MED ANTHROPOL Q, V24, P281, DOI 10.1111/j.1548-1387.2010.01105.x; Mitka M, 2008, JAMA-J AM MED ASSOC, V299, P2138, DOI 10.1001/jama.299.18.2138; Pasquina Paul F, 2004, J REHABILITATION RES, V41, p3B; Reiner Rob, 1992, A FEW GOOD MEN; Rubinstein Robert L., 1995, QUALITATIVE RES RATI, V17, P89; RYBARCZYK B, 1995, REHABIL PSYCHOL, V40, P95; Shay, 2003, ODYSSEUS AM COMBAT T; Shay J., 1995, ACHILLES VIETNAM COM; Sobchack Vivian, 2004, CARNAL THOUGHTS EMBO; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teichman M, 2012, J SOC WORK PRACT ADD, V12, P163, DOI 10.1080/1533256X.2012.675270; Turner V., 1995, LEWIS HENRY MORGAN L; Wu W, 2011, PHILOS PHENOMEN RES, V82, P93, DOI 10.1111/j.1933-1592.2010.00457.x; Young A., 1997, HARMONY ILLUSIONS IN	32	11	11	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-4202	1556-3537		ANTHROPOL CONSCIOUS	Anthropol. Conscious.	SEP	2013	24	2					191	207		10.1111/anoc.12013			17	Anthropology	Emerging Sources Citation Index (ESCI)	Anthropology	V1V2O	WOS:000217266100007					2022-02-06	
J	Mounce, LTA; Williams, H; Jones, JM; Harris, A; Haslam, SA; Jetten, J				Mounce, Luke T. A.; Williams, Huw; Jones, Janelle M.; Harris, Adrian; Haslam, S. Alexander; Jetten, Jolanda			Neurogenic and Psychogenic Acute Postconcussion Symptoms Can Be Identified After Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; emergency medicine; mild traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; ROAD TRAFFIC ACCIDENT; HEAD-INJURY; EMERGENCY; QUESTIONNAIRE; RELIABILITY; POPULATION; PREDICTION; COMPLAINTS	Objectives: As provenance of postconcussion symptoms after mild traumatic brain injury (mTBI) is controversial, with similar rates found in other populations, we aimed to identify postconcussion symptoms specific to mTBI compared with controls. We also compared differences between complicated and uncomplicated mTBIs. Setting: Hospital emergency department. Participants: Adult individuals (34 individuals with complicated mTBI, 76 individuals with uncomplicated mTBI, and 47 orthopedic controls) who sought care in the emergency department and were consecutively recruited by post at 2 weeks postinjury. Main Measures: Rivermead Postconcussion Symptom Questionnaire. Preinjury factors were used as covariates. Results: Compared with orthopedic controls, complicated mTBI group reported greater severity of headaches, dizziness, and nausea, as well as concentration difficulties, suggesting that these are neurogenic. Severity of other symptoms measured on the Rivermead Postconcussion Symptom Questionnaire was not significantly different between these groups, suggesting that these are psychogenic. Differences were evident between the 2 mTBI samples on the items of dizziness, nausea, fatigue, sleep disturbance, and concentration difficulties. Conclusions: Neurogenic and psychogenic postconcussion symptoms were identified at the acute-phase postinjury. Findings suggest that treating persons with mTBI as a homogenous sample is not prudent. This should inform prognostic models and follow-up support offered after leaving the emergency department.	[Mounce, Luke T. A.; Williams, Huw; Haslam, S. Alexander] Univ Exeter, Ctr Clin Neuropsychol Res, Exeter EX4 4QG, Devon, England; [Harris, Adrian] Royal Devon & Exeter Fdn Trust, Emergency Dept, Exeter, Devon, England; [Jones, Janelle M.; Jetten, Jolanda] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia		Mounce, LTA (corresponding author), Univ Exeter, Dept Psychol, Coll Life & Environm Sci, Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	L.Mounce@exeter.ac.uk	Mounce, Luke/AAX-1911-2020; Jetten, Jolanda/H-3285-2014; Haslam, Alex/AAA-2512-2019	Mounce, Luke/0000-0002-6089-0661; Jetten, Jolanda/0000-0002-7588-5355; Haslam, Alex/0000-0001-9523-7921; Jones, Janelle/0000-0002-0910-2404; williams, huw/0000-0003-0670-2620	Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)	This study was funded by The Economic and Social Research Council.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus J, 1996, NEUROTRAUMA, P13; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tellier A, 1999, BRAIN INJURY, V13, P463; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	30	11	11	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					397	405		10.1097/HTR.0b013e318252dd75			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600087	22691962				2022-02-06	
J	Seng, EK; Driscoll, MA; Brandt, CA; Bathulapalli, H; Goulet, J; Silliker, N; Kerns, RD; Haskell, SG				Seng, Elizabeth K.; Driscoll, Mary A.; Brandt, Cynthia A.; Bathulapalli, Harini; Goulet, Joseph; Silliker, Norman; Kerns, Robert D.; Haskell, Sally G.			Prescription Headache Medication in OEF/OIF Veterans: Results From the Women Veterans Cohort Study	HEADACHE			English	Article						headache; veteran; gender; traumatic brain injury; trauma; posttraumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; GENDER-DIFFERENCES; HEALTH-CARE; ENDURING FREEDOM; MENTAL-HEALTH; MIGRAINE; PREVALENCE; EPIDEMIOLOGY; TRAUMA; COMBAT	Objective.-To examine differences in male and female veterans of Operations Enduring Freedom/Iraqi Freedom (OEF/OIF) period of service in taking prescription headache medication, and associations between taking prescription headache medication and mental health status, psychiatric symptoms, and rates of traumatic events. Background.-Headaches are common among active service members and are associated with impairment in quality of life. Little is known about headaches in OEF/OIF veterans. Methods.-Veterans participating in the Women Veterans Cohort Study responded to a cross-sectional survey to assess taking prescription headache medication, mental health status (Post Deployment Health Assessment), psychiatric symptoms (portions of the Brief Patient Health Questionnaire and the Posttraumatic Stress Disorder Checklist), and traumatic events (the Traumatic Life Events Questionnaire and queries regarding military trauma). Gender differences among taking prescription headache medication, health status, psychiatric symptoms, and traumatic events were examined. Regression analyses were used to examine the influence of gender on the associations between taking prescription headache medication and health status, psychiatric symptoms, and traumatic events. Results.-139/551 (25.2%) participants reported taking prescription headache medication in the past year. A higher proportion of women veterans (29.1%) reported taking prescription medication for headache in the last year compared with men (19.7%). Taking prescription headache medication was associated with poorer perceived mental health status, higher anxiety and posttraumatic stress disorder symptoms, and higher rates of traumatic events. The association between prescription headache medication use and perceived mental health status, and with the association between prescription headache medication use and posttraumatic stress disorder symptoms, was stronger for men than for women. Conclusions.-Among OEF/OIF veterans, the prevalence of clinically relevant headache is high, particularly among women veterans. Taking prescription headache medication is associated with poor mental health status, higher rates of psychiatric symptoms, and higher rates of traumatic events; however, these variables did not appear to meaningfully account for gender differences in prevalence of taking prescription headache medication. Future research should endeavor to identify factors that might account for the observed differences.	VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; Yale Univ, Sch Med, New Haven, CT USA		Seng, EK (corresponding author), VA Connecticut Healthcare Syst, Psychol Serv 116B, 950 Campbell Ave, West Haven, CT 06516 USA.	seng.elizabeth@gmail.com	Bathulapalli, Harini/B-7451-2015	Bathulapalli, Harini/0000-0002-2531-0238; Goulet, Joseph/0000-0002-0842-804X; Seng, Elizabeth/0000-0002-8938-4949	VA HSRD grant [DHI07-065]; REAP; Veterans AffairsUS Department of Veterans Affairs [I01HX000915] Funding Source: NIH RePORTER	This research was supported by the VA HSR&D grant #DHI07-065 (Haskell, Brandt) and REAP.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Bean-Mayberry B, 2011, WOMEN HEALTH ISS, V21, pS84, DOI 10.1016/j.whi.2011.04.022; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; CELENTANO DD, 1992, HEADACHE, V32, P223, DOI 10.1111/j.1526-4610.1992.hed3205223.x; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Cripe SM, 2011, HEADACHE, V51, P208, DOI 10.1111/j.1526-4610.2010.01777.x; Devine JW, 2005, HEADACHE, V45, P1171, DOI 10.1111/j.1526-4610.2005.00240.x; ENGEL CC, 1993, J NERV MENT DIS, V181, P683, DOI 10.1097/00005053-199311000-00006; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; Haskell SG, 2011, WOMEN HEALTH ISS, V21, P92, DOI 10.1016/j.whi.2010.08.001; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Haskell SG, 2009, PAIN MED, V10, P1167, DOI 10.1111/j.1526-4637.2009.00714.x; Krauthamer M., 2009, FEDERAL PRACTITIONER, V26, P8; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Leonardi Matilde, 2005, J Headache Pain, V6, P429, DOI 10.1007/s10194-005-0252-4; Lipton RB, 2002, NEUROLOGY, V58, P885, DOI 10.1212/WNL.58.6.885; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Mattocks KM, 2012, SOC SCI MED, V74, P537, DOI 10.1016/j.socscimed.2011.10.039; Meehan S, 2006, J GEN INTERN MED, V21, pS1, DOI 10.1111/j.1525-1497.2006.00382.x; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; National Academy of Sciences, 2012, URB MET FOR MON M US, P1; Nolen-Hoeksema S, 2012, PSYCHOL WOMEN Q, V3, P488; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Peterlin BL, 2011, HEADACHE, V51, P860, DOI 10.1111/j.1526-4610.2011.01907.x; Peterlin BL, 2009, HEADACHE, V49, P541, DOI 10.1111/j.1526-4610.2009.01368.x; Radat F, 2005, CEPHALALGIA, V25, P165, DOI 10.1111/j.1468-2982.2004.00839.x; Robbins MS, 2010, SEMIN NEUROL, V30, P107, DOI 10.1055/s-0030-1249220; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; SAS Institute Inc, 2010, SAS GRAPH 9 2 REF, V2; SILBERSTEIN SD, 2002, HEADACHE CLIN PRACTI; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Tietjen GE, 2010, HEADACHE, V50, P32, DOI 10.1111/j.1526-4610.2009.01557.x; Tietjen GE, 2010, HEADACHE, V50, P42, DOI 10.1111/j.1526-4610.2009.01558.x; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Weathers F., 1993, 9 ANN C ISTSS SAN AN	41	11	11	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	SEP	2013	53	8					1312	1322		10.1111/head.12155			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	213ZT	WOS:000324100100012	23808756				2022-02-06	
J	Wool, ZH				Wool, Zoe H.			On Movement: The Matter of US Soldiers' Being After Combat	ETHNOS			English	Article						War; the body; soldiers; movement; space; post-traumatic stress disorder; violence; America; Iraq war; Afghanistan war	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; UNITED-STATES; ADULTS; PTSD; HIPPOCAMPAL; REFLECTIONS; DIAGNOSIS; VETERANS; POLITICS	Using ethnographic vignettes of three American soldiers who served in Iraq and Afghanistan, this article proposes an analytics of movement through which to apprehend experiences of ontological transformation brought about by the many violences of service in a combat zone. I juxtapose a range of experiences of movement to explore the subjective experience of certain kinds of bodies as they move, see, and are seen to move in certain kinds of spaces. In the case of American soldiers who have been marked by their experiences in Iraq and Afghanistan, this approach is a displacement of post-traumatic stress disorder, the dominant frame for understanding soldiers' post-combat transformations. In its stead, the analytics of movement offers a sense of the vertiginous new worlds soldiers inhabit, which suggests ontology, rather than pathology, as the ground for understanding the matter of US soldiers' being after combat.	Rutgers State Univ, Piscataway, NJ 08855 USA		Wool, ZH (corresponding author), Rutgers State Univ, Piscataway, NJ 08855 USA.						Allen L, 2008, CULT ANTHROPOL, V23, P453, DOI 10.1111/j.1548-1360.2008.00015.x; American Psychiatric Association, 2010, PROP REV DSM 5 ENTR; [Anonymous], 2007, P BRIT ACAD, V151, P285, DOI DOI 10.5871/BACAD/9780197264249.003.0010; BEUTLER LE, 2002, RETHINKING DSM PSYCH; Boudreau Tyler E., 2009, BOSTON GLOBE; Bray Robert M., 2009, DEP DEFENSE SURVEY H; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Breslau J, 2004, CULT MED PSYCHIAT, V28, P113, DOI 10.1023/B:MEDI.0000034421.07612.c8; Butler J., 2009, FRAMES WAR IS LIFE G; Butler Judith, 2004, PRECARIOUS LIFE POWE; Butler Judith., 1993, BODIES MATTER DISCUR; Carey B., 2006, NY TIMES; Colvin Leonard E, 2003, NEW J GUIDE     1105; csordas thomas, 1994, EMBODIMENT EXPERIENC; Daniel E. Valentine, 1996, CHARRED LULLABIES CH; Das V, 2007, LIFE AND WORDS: VIOLENCE AND THE DESCENT INTO THE ORDINARY, P1; Das Veena, 1997, SOCIAL SUFFERING, P67; Defense Centers of Excellence for Psychological Health & Traumatic Brain Injury and the Department of Veterans Affairs, 2010, 2010 DOD VA SUIC PRE; Dieperink M, 2005, MIL MED, V170, P305, DOI 10.7205/MILMED.170.4.305; Dumit J, 2004, PICTURING PERSONHOOD; Fassin D., 2009, EMPIRE TRAUMA INQUIR; Finley EP, 2011, FIELDS COMBAT UNDERS; Finley EP, 2010, J FAMILY LIFE; Finley Erin, 2008, AM ANTHR ASS M SAN F; Foucault M, 1995, DISCIPLINE PUNISH; French L, 2004, CULT MED PSYCHIAT, V28, P211, DOI 10.1023/B:MEDI.0000034411.30611.a9; Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011; Goncalves OF, 2002, RETHINKING THE DSM: A PSYCHOLOGICAL PERSPECTIVE, P149, DOI 10.1037/10456-006; Grinker Lori, 2005, AFTERWAR VETERANS WO; Haberman Clyde, 2007, NY TIMES; Hacking Ian, 1995, REWRITING SOUL MULTI; HALL ET, 1968, CURR ANTHROPOL, V9, P83, DOI 10.1086/200975; Han C, 2004, CULT MED PSYCHIAT, V28, P169, DOI 10.1023/B:MEDI.0000034409.70790.66; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kienzler H, 2008, SOC SCI MED, V67, P218, DOI 10.1016/j.socscimed.2008.03.030; Killion TH, 2009, MIL PSYCHOL, V21, P9, DOI 10.1080/08995600802554540; Kirk Stuart, 1992, SELLING DSM RHEOTRIC; Kleinman Arthur, 1997, SOCIAL SUFFERING; Klima Alan, 2002, FUNEAL CASINO MEDIAT; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Krupa Gregg, 2005, DETROIT NEWS    1208; Lawrence-Zuniga, 2003, ANTHR SPACE PLACE LO; Leys R., 2000, TRAUMA GENEALOGY; Lingis A, 1986, PHENOMENOLOGICAL EXP; Linker B., 2011, WARS WASTE REHABILIT; Low Setha, 2003, GATES NEW AM DREAM; MacLeish Kenneth, 2010, AM ANTHR ASS ANN M N; MacLeish Kenneth, 2013, MAKING WAR FORT HOOD; Manning E., 2007, POLITICS TOUCH SENSE; Marshall RD, 1999, AM J PSYCHIAT, V156, P1677; Massumi B., 2002, PARABLES VIRTUAL MOV; Massumi Brian, 2003, MAKING ART DATABASES, P28; Merleau-Ponty M., 2002, PHENOMENOLOGY PERCEP; Messinger Seth, 2009, AAA M PHIL PA DEC 5; Mitchell WJT, 2001, PUBLIC CULTURE, V13, P391, DOI 10.1215/08992363-13-3-391; Mulvaney SW, 2010, PAIN PRACT, V10, P359, DOI 10.1111/j.1533-2500.2010.00373.x; Nordstrom C., 1997, DIFFERENT KIND WAR S; Norris FH, 2001, J ABNORM PSYCHOL, V110, P553, DOI 10.1037//0021-843X.110.4.553; Petryna A., 2002, LIFE EXPOSED; Povinelli E.A., 2006, EMPIRE LOVE THEORY I; Povinelli Elizabeth, 2011, EC ABANDONMENT SOCIA; Rosen GM, 2007, J ANXIETY DISORD, V21, P161, DOI 10.1016/j.janxdis.2006.09.007; Saunders Barry, 2008, CT SUITE WORK DIAGNO; Scarry Elaine, 1987, BODY PAIN; SCHEPER-HUGHES N, 1987, Medical Anthropology Quarterly, V1, P6, DOI 10.1525/maq.1987.1.1.02a00020; Scheper-Hughes N, 2008, ETHNOS, V73, P25, DOI 10.1080/00141840801927525; SCOTT WJ, 1990, SOC PROBL, V37, P294, DOI 10.1525/sp.1990.37.3.03a00020; Shevlin M, 2009, J ANXIETY DISORD, V23, P995, DOI 10.1016/j.janxdis.2009.07.001; Spencer J, 2005, DENVER POST; Spencer Jim, 2004, DENVER POST; St George Donna, 2006, WASHINGTON POST; Stewart K., 2007, ORDINARY AFFECTS; Stewart K, 2010, RUBRIC, V1, P1; Stoller P., 1997, SENSUOUS SCHOLARSHIP; Summerfield D, 2001, BRIT MED J, V322, P95, DOI 10.1136/bmj.322.7278.95; Taussig Michael, 1991, CULT ANTHROPOL, V6, P147; Taylor JS, 2005, ANNU REV ANTHROPOL, V34, P741, DOI 10.1146/annurev.anthro.33.070203.144004; Ticktin M, 2006, AM ETHNOL, V33, P33, DOI 10.1525/ae.2006.33.1.33; United Nations, 2008, EFF US ARM AMM CONT; Urry, 1999, SOCIOLOGY SOC MOBILI; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Wacquant L., 2008, URBAN OUTCASTS COMP; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Woon FL, 2009, J NEUROPSYCH CLIN N, V21, P5, DOI 10.1176/appi.neuropsych.21.1.5; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Young A., 1997, HARMONY ILLUSIONS IN; Young A, 2007, J ANXIETY DISORD, V21, P230, DOI 10.1016/j.janxdis.2006.09.001; Young Allan, 1995, DAEDALUS, V125, P215	89	11	11	1	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0014-1844	1469-588X		ETHNOS	Ethnos	SEP 1	2013	78	3					403	433		10.1080/00141844.2012.658428			31	Anthropology	Social Science Citation Index (SSCI)	Anthropology	225QS	WOS:000324978000005					2022-02-06	
J	Dean, PJA; Otaduy, MCG; Harris, LM; McNamara, A; Seiss, E; Sterr, A				Dean, Philip J. A.; Otaduy, Maria C. G.; Harris, Lisa M.; McNamara, Adam; Seiss, Ellen; Sterr, Annette			Monitoring long-term effects of mild traumatic brain injury with magnetic resonance spectroscopy: a pilot study	NEUROREPORT			English	Article						cognitive tasks; creatine; magnetic resonance spectroscopy; mild traumatic brain injury; persistent postconcussion syndrome	PROTON MR SPECTROSCOPY; CREATINE	This pilot study explores the metabolic changes associated with persistent postconcussion syndrome (PCS) after mild traumatic brain injury (mTBI; >12 months after injury) using magnetic resonance spectroscopy. We hypothesized that those mTBI participants with PCS will have larger metabolic differences than those without. Data were collected from mTBI participants with PCS, mTBI participants without PCS and non-head-injured participants (all groups: n=8). Magnetic resonance spectroscopy metabolite profiles within the dorsolateral prefrontal cortex showed a reduced creatine/choline ratio in mTBI patients compared with control participants. This data provides initial evidence for residual metabolic changes in chronic mTBI patients, but there was no conclusive relationship between these metabolic changes and PCS symptom report. Creatine is involved in maintaining energy levels in cells with high or fluctuating energy demand, suggesting that there may be some residual energy impairment in chronic mTBI.	[Dean, Philip J. A.; Harris, Lisa M.; McNamara, Adam; Seiss, Ellen; Sterr, Annette] Univ Surrey, Dept Psychol, Guildford GU2 7XH, Surrey, England; [Otaduy, Maria C. G.] Univ Sao Paulo FM USP, Sch Med, Dept Radiol, Lab Med Invest LIM 44, Sao Paulo, Brazil		Dean, PJA (corresponding author), Univ Surrey, Dept Psychol, Guildford GU2 7XH, Surrey, England.	p.dean@surrey.ac.uk	Otaduy, Maria/AAV-6070-2020; Seiss, Ellen/Y-6216-2019	Otaduy, Maria/0000-0003-2515-1131; Dean, Philip/0000-0002-2362-513X	Wingate Foundation Scholarship, UK	This work was supported by a Wingate Foundation Scholarship, UK.	Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Giza CC, 2001, J ATHL TRAINING, V36, P228; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Haga KK, 2009, NEUROBIOL AGING, V30, P353, DOI 10.1016/j.neurobiolaging.2007.07.005; Hattingen E, 2008, NEURORADIOLOGY, V50, P759, DOI 10.1007/s00234-008-0409-3; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Maniega SM, 2008, STROKE, V39, P2467, DOI 10.1161/STROKEAHA.107.507020; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Sakellaris G, 2008, ACTA PAEDIATR, V97, P31, DOI 10.1111/j.1651-2227.2007.00529.x; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; World Health Organization, 2004, ICD 10 INT STAT CLAS; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	25	11	11	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 21	2013	24	12					677	681		10.1097/WNR.0b013e3283637aa4			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202OE	WOS:000323226300007	23820737				2022-02-06	
J	Moon, Y; Kim, JY; Kim, WR; Kim, HJ; Jang, MJ; Nam, Y; Kim, K; Kim, H; Sun, W				Moon, Younghye; Kim, Joo Yeon; Kim, Woon Ryoung; Kim, Hyun Jung; Jang, Min Jee; Nam, Yoonkey; Kim, Kyungjin; Kim, Hyun; Sun, Woong			Function of Ezrin-Radixin-Moesin Proteins in Migration of Subventricular Zone-Derived Neuroblasts Following Traumatic Brain Injury	STEM CELLS			English	Article						ERM proteins; Phosphorylation; SDF1-CXCR4; Migration; Brain injury	NEURAL PROGENITOR CELLS; ERM PROTEINS; OLFACTORY-BULB; NEURONAL PRECURSORS; DIRECTED MIGRATION; CEREBRAL-CORTEX; ADULT BRAIN; STEM-CELLS; ACTIVATION; GROWTH	Throughout life, newly generated neuroblasts from the subventricular zone migrate toward the olfactory bulb through the rostral migratory stream. Upon brain injury, these migrating neuroblasts change their route and begin to migrate toward injured regions, which is one of the regenerative responses after brain damage. This injury-induced migration is triggered by stromal cell-derived factor 1 (SDF1) released from microglia near the damaged site; however, it is still unclear how these cells transduce SDF1 signals and change their direction. In this study, we found that SDF1 promotes the phosphorylation of ezrin-radixin-moesin (ERM) proteins, which are key molecules in organizing cell membrane and linking signals from the extracellular environment to the intracellular actin cytoskeleton. Blockade of ERM activation by overexpressing dominant-negative ERM (DN-ERM) efficiently perturbed the migration of neuroblasts. Considering that DN-ERM-expressing neuroblasts failed to maintain proper migratory cell morphology, it appears that ERM-dependent regulation of cell shape is required for the efficient migration of neuroblasts. These results suggest that ERM activation is an important step in the directional migration of neuroblasts in response to SDF1-CXCR4 signaling following brain injury. STEM CELLS 2013;31:1696-1705	[Moon, Younghye; Kim, Joo Yeon; Kim, Woon Ryoung; Kim, Hyun Jung; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Moon, Younghye; Kim, Joo Yeon; Kim, Woon Ryoung; Kim, Hyun Jung; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Div Brain Korea Biomed Sci 21, Seoul 136705, South Korea; [Moon, Younghye; Kim, Kyungjin] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Brain & Neuroendocrine Lab, Seoul 151742, South Korea; [Jang, Min Jee; Nam, Yoonkey] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea		Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Jang, Min Jee/AAO-2892-2020; Jang, Min Jee/F-1083-2014; Nam, Yoonkey/C-1662-2011	Nam, Yoonkey/0000-0003-4801-9547; sun, woong/0000-0003-1792-4894; Moon, Younghye/0000-0002-3737-0043; Kim, Hyun/0000-0002-7210-5798	Korean Ministry of Education, Science and Technology, via the Brain Research Center of the 21st Century Frontier Program in Neuroscience [2012K001108]; National Research Foundation of KoreaNational Research Foundation of Korea [20120006433, 20120005815, 2012049933, 2012014385]	This work was supported by grants from the Korean Ministry of Education, Science and Technology, via the Brain Research Center of the 21st Century Frontier Program in Neuroscience (2012K001108) and the National Research Foundation of Korea (20120006433, 20120005815, 2012049933, and 2012014385).	Alonso G, 2001, GLIA, V34, P253, DOI 10.1002/glia.1059; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Belvindrah R, 2011, J NEUROSCI, V31, P7551, DOI 10.1523/JNEUROSCI.6716-10.2011; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; CLARK P, 1993, J CELL SCI, V105, P203; Cleary MA, 2006, NEUROSCIENCE, V143, P851, DOI 10.1016/j.neuroscience.2006.08.028; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gatto CL, 2007, J CELL PHYSIOL, V210, P122, DOI 10.1002/jcp.20844; Gatto CL, 2003, J CELL BIOL, V162, P489, DOI 10.1083/jcb.200303039; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Haas MA, 2007, J NEUROSCI RES, V85, P34, DOI 10.1002/jnr.21102; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jang MJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046019; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; MARTIN M, 1995, J CELL BIOL, V128, P1081, DOI 10.1083/jcb.128.6.1081; Mintz CD, 2008, J COMP NEUROL, V510, P351, DOI 10.1002/cne.21799; Moon Y, 2013, HISTOCHEM CELL BIOL, V139, P403, DOI 10.1007/s00418-012-1048-7; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; Nam SC, 2007, J COMP NEUROL, V505, P190, DOI 10.1002/cne.21473; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Osman AM, 2011, STROKE, V42, P3559, DOI 10.1161/STROKEAHA.111.627802; Oudin MJ, 2011, J NEUROSCI, V31, P4000, DOI 10.1523/JNEUROSCI.5483-10.2011; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Wang K, 2004, BRAIN RES, V1024, P193, DOI 10.1016/j.brainres.2004.07.086; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zhou BB, 2010, LEUKEMIA RES, V34, P769, DOI 10.1016/j.leukres.2009.11.025	60	11	11	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	AUG	2013	31	8					1696	1705		10.1002/stem.1420			10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	205CM	WOS:000323418700022	23649635	Bronze			2022-02-06	
J	Soehle, M; Gies, B; Smielewski, P; Czosnyka, M				Soehle, Martin; Gies, Bernadette; Smielewski, Peter; Czosnyka, Marek			Reduced complexity of intracranial pressure observed in short time series of intracranial hypertension following traumatic brain injury in adults	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article; Proceedings Paper	SCAI 10th International Conference on Complexity in Acute Illness (ICCAI)	SEP, 2011	Bonn, GERMANY	Soc Complex Acute Illness (SCAI)		Intracranial pressure; Traumatic brain injury; Detrended fluctuation analysis; Scaling exponent; Sample entropy; Multiscale entropy	HEART-RATE-VARIABILITY; ARTERIAL-BLOOD PRESSURE; APPROXIMATE ENTROPY; PHYSIOLOGICAL SIGNALS; SAMPLE ENTROPY; MORTALITY; DYNAMICS; FAILURE; DISEASE; SYSTEM	Physiological parameters, such as intracranial pressure (ICP), are regulated by interconnected feedback loops, resulting in a complex time course. According to the decomplexification theory, disease is characterised by a loss of feedback loops resulting in a reduced complexity of the time course of physiological parameters. We hypothesized that complexity of the ICP time series is decreased during periods of intracranial hypertension (IHT) following adult traumatic brain injury. In an observational retrospective cohort study, ICP was continuously monitored using intraparenchymally implanted probes and stored using ICM + -software. Periods of IHT (ICP > 25 mmHg for at least 1,024 s), were compared with preceding periods of intracranial normotension (ICP < 20 mmHg) and analysed at 1 s-intervals. ICP data (length = 1,024 s) were normalised (mean = 0, SD = 1) and complexity was estimated using the scaling exponent alpha (as derived from detrended fluctuation analysis), sample entropy (SampEn, m = 1, r = 0.2 x SD) and multiscale entropy. 344 episodes were analysed in 22 patients. During IHT (ICP = 31.7 +/- A 7.8 mmHg, mean +/- A SD), alpha was significantly elevated (alpha A = 1.02 +/- A 0.22, p < 0.001) and SampEn significantly reduced (SampEn = 1.45 +/- A 0.46, p = 0.004) as compared to before IHT (ICP = 15.7 +/- A 3.2 mmHg, alpha = 0.81 +/- A 0.14, SampEn = 1.81 +/- A 0.24). In addition, MSE revealed a significantly (p < 0.05) decreased entropy at scaling factors ranging from 1 to 10. Both the increase in alpha as well as the decrease in SampEn and MSE indicate a loss of ICP complexity. Therefore following traumatic brain injury, periods of IHT seem to be characterised by a decreased complexity of the ICP waveform.	[Soehle, Martin; Gies, Bernadette] Univ Bonn, Dept Anaesthesiol & Intens Care Med, D-53105 Bonn, Germany; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 2QQ, England		Soehle, M (corresponding author), Univ Bonn, Dept Anaesthesiol & Intens Care Med, Sigmund Freud Str 25, D-53105 Bonn, Germany.	martin.soehle@ukb.uni-bonn.de		Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G9439390, G0600986] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237, G0600986] Funding Source: UKRI; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish		Angelini L, 2007, ARTIF INTELL MED, V41, P237, DOI 10.1016/j.artmed.2007.07.012; BEAUMONT A, 2000, NEUROSURGERY SCI BAS, V0001, P00460; Burr RL, 2008, IEEE T BIO-MED ENG, V55, P2509, DOI 10.1109/TBME.2008.2001286; Chandra FA, 2011, SCIENCE, V333, P187, DOI 10.1126/science.1200705; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldberger AL, 1997, PERSPECT BIOL MED, V40, P543; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Moorman JR, 2011, J PEDIATR-US, V159, P900, DOI 10.1016/j.jpeds.2011.06.044; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; RICH MW, 1988, AM J CARDIOL, V62, P714, DOI 10.1016/0002-9149(88)91208-8; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Soehle M, 2008, J CEREBR BLOOD F MET, V28, P64, DOI 10.1038/sj.jcbfm.9600506; Stadnitski T, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00127; Taqqu MS, 1995, SCI REP, V3, P785; TUININGA YS, 1994, BRIT HEART J, V72, P509; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256	36	11	11	0	17	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	AUG	2013	27	4			SI		395	403		10.1007/s10877-012-9427-0			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	175VJ	WOS:000321261400004	23306818				2022-02-06	
J	Darling, WG; Helle, N; Pizzimenti, MA; Rotella, DL; Hynes, SM; Ge, JZ; Stilwell-Morecraft, KS; Morecraft, RJ				Darling, Warren G.; Helle, Nicole; Pizzimenti, Marc A.; Rotella, Diane L.; Hynes, Stephanie M.; Ge, Jizhi; Stilwell-Morecraft, Kimberly S.; Morecraft, Robert J.			Laterality affects spontaneous recovery of contralateral hand motor function following motor cortex injury in rhesus monkeys	EXPERIMENTAL BRAIN RESEARCH			English	Article						Brain injury; Hand; Dexterity; Hemispheric dominance	TRAUMATIC BRAIN-INJURY; INTERHEMISPHERIC INHIBITION; CORTICAL CONNECTIONS; DEXTEROUS MOVEMENTS; NONHUMAN-PRIMATES; LEFT-HEMISPHERE; MACACA-MULATTA; HANDEDNESS; STROKE; CYTOARCHITECTURE	The purpose of this study was to test whether brain laterality influences spontaneous recovery of hand motor function after controlled brain injuries to arm areas of M1 and lateral premotor cortex (LPMC) of the hemisphere contralateral to the preferred hand in rhesus monkeys. We hypothesized that monkeys with stronger hand preference would exhibit poorer recovery of skilled hand use after such brain injury. Degree of handedness was assessed using a standard dexterity board task in which subjects could use either hand to retrieve small food pellets. Fine hand/digit motor function was assessed using a modified dexterity board before and after the M1 and LPMC lesions in ten monkeys. We found a strong negative relationship between the degree of handedness and the recovery of manipulation skill, demonstrating that higher hand preference was associated with poorer recovery of hand fine motor function. We also observed that monkeys with larger lesions within M1 and LPMC had greater initial impairment of manipulation and poorer recovery of reaching skill. We conclude that monkeys with a stronger hand preference are likely to show poorer recovery of contralesional hand fine motor skill after isolated brain lesions affecting the lateral frontal motor areas. These data may be extended to suggest that humans who exhibit weak hand dominance, and perhaps individuals who use both hands for fine motor tasks, may have a more favorable potential for recovery after a unilateral stroke or brain injury affecting the lateral cortical motor areas than individuals with a high degree of hand dominance.	[Darling, Warren G.; Helle, Nicole; Rotella, Diane L.; Hynes, Stephanie M.] Univ Iowa, Motor Control Labs, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA; [Pizzimenti, Marc A.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Ge, Jizhi; Stilwell-Morecraft, Kimberly S.; Morecraft, Robert J.] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Lab Neurol Sci, Vermillion, SD 57069 USA		Darling, WG (corresponding author), Univ Iowa, Motor Control Labs, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA.	warren-darling@uiowa.edu		Pizzimenti, Marc A/0000-0002-1309-6633	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 046367]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046367, R56NS046367] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant NS 046367.	Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Darling WG, 2011, EXP NEUROL, V231, P56, DOI 10.1016/j.expneurol.2011.05.015; Darling WG, 2009, EXP NEUROL, V220, P90, DOI 10.1016/j.expneurol.2009.07.034; Darling WG, 2006, J NEUROSCI METH, V154, P38, DOI 10.1016/j.jneumeth.2005.11.013; Dassonville P, 1997, P NATL ACAD SCI USA, V94, P14015, DOI 10.1073/pnas.94.25.14015; de Freitas PB, 2007, EXP BRAIN RES, V183, P487, DOI 10.1007/s00221-007-1064-3; Dragovic M, 2005, ACTA PSYCHIAT SCAND, V111, P410, DOI 10.1111/j.1600-0447.2005.00519.x; Duff SV, 2007, EXP BRAIN RES, V179, P551, DOI 10.1007/s00221-006-0811-1; Harris JE, 2006, NEUROREHAB NEURAL RE, V20, P380, DOI 10.1177/1545968305284528; HOPKINS WD, 1992, J COMP PSYCHOL, V106, P392, DOI 10.1037/0735-7036.106.4.392; HOPKINS WD, 1989, J COMP PSYCHOL, V103, P91; Hughes CML, 2007, J MOTOR BEHAV, V39, P3, DOI 10.3200/JMBR.39.1.3-8; Kaeser M, 2011, NEUROSURGERY, V68, P1405, DOI 10.1227/NEU.0b013e31820c02c0; KIMURA D, 1974, BRAIN, V97, P337, DOI 10.1093/brain/97.1.337; KIMURA D, 1977, BRAIN, V100, P527, DOI 10.1093/brain/100.3.527; Langan J, 2008, NEUROREHAB NEURAL RE, V22, P298, DOI 10.1177/1545968307307123; LEHMAN RAW, 1978, NEUROPSYCHOLOGIA, V16, P33, DOI 10.1016/0028-3932(78)90040-4; LEHMAN RAW, 1978, CORTEX, V14, P190, DOI 10.1016/S0010-9452(78)80044-6; LEHMAN RAW, 1980, CORTEX, V16, P197, DOI 10.1016/S0010-9452(80)80055-4; Liu Y, 1999, EXP BRAIN RES, V128, P149, DOI 10.1007/s002210050830; McNeal DW, 2010, J COMP NEUROL, V518, P586, DOI 10.1002/cne.22218; Morecraft RJ, 2012, BRAIN RES BULL, V87, P457, DOI 10.1016/j.brainresbull.2011.12.005; Morecraft RJ, 2004, J COMP NEUROL, V469, P37, DOI 10.1002/cne.10980; Morecraft RJ, 2002, BRAIN, V125, P176, DOI 10.1093/brain/awf011; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; Murata Y, 2008, J NEUROPHYSIOL, V99, P773, DOI 10.1152/jn.01001.2007; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Pal PK, 2005, J NEUROPHYSIOL, V94, P1668, DOI 10.1152/jn.01306.2004; Pizzimenti MA, 2007, J NEUROPHYSIOL, V98, P1015, DOI 10.1152/jn.00354.2007; Ridding MC, 2000, EXP BRAIN RES, V133, P249, DOI 10.1007/s002210000428; Schaefer SY, 2007, BRAIN, V130, P2146, DOI 10.1093/brain/awm145; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN; Schmitt V, 2008, LATERALITY, V13, P143, DOI 10.1080/13576500701757532; Spinozzi G, 2007, AM J PRIMATOL, V69, P336, DOI 10.1002/ajp.20352; Toole JF, 2007, ARCH NEUROL-CHICAGO, V64, P1184, DOI 10.1001/archneur.64.8.1184; Waller SM, 2005, CLIN REHABIL, V19, P544, DOI 10.1191/0269215505cr829oa; Walton A, 2008, NEUROBIOL AGING, V29, P1556, DOI 10.1016/j.neurobiolaging.2007.03.016; Wohrle Johannes C, 2007, Front Neurol Neurosci, V22, P193, DOI 10.1159/000102881; Zhang W, 2006, NEUROSCI LETT, V409, P200, DOI 10.1016/j.neulet.2006.09.048; Zhao DP, 2012, AM J PHYS ANTHROPOL, V148, P36, DOI 10.1002/ajpa.22038	44	11	11	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819			EXP BRAIN RES	Exp. Brain Res.	JUL	2013	228	1					9	24		10.1007/s00221-013-3533-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163CK	WOS:000320313000002	23652723	Green Accepted			2022-02-06	
J	El Ahmadieh, TY; Adel, JG; El Tecle, NE; Daou, MR; Aoun, SG; Nanney, AD; Bendok, BR				El Ahmadieh, Tarek Y.; Adel, Joseph G.; El Tecle, Najib E.; Daou, Marc R.; Aoun, Salah G.; Nanney, Allan D., III; Bendok, Bernard R.			Surgical Treatment of Elevated Intracranial Pressure: Decompressive Craniectomy and Intracranial Pressure Monitoring	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Elevated intracranial pressure; Decompressive craniectomy; Intraventricular catheter; Intracranial pressure monitoring; Intracranial mass; Intracranial hypertension hemicraniectomy	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE PATIENTS; SEVERE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; MALIGNANT INFARCTION; PERFUSION-PRESSURE; BACTERIAL-MENINGITIS; TERRITORY INFARCTION; CONTROLLED-TRIAL	Surgical techniques that address elevated intracranial pressure include (1) intraventricular catheter insertion and cerebrospinal fluid drainage, (2) removal of an intracranial space-occupying lesion, and (3) decompressive craniectomy. This review discusses the role of surgery in the management of elevated intracranial pressure, with special focus on intraventricular catheter placement and decompressive craniectomy. The techniques and potential complications of each procedure are described, and the existing evidence regarding the impact of these procedures on patient outcome is reviewed. Surgical management of mass lesions and ischemic or hemorrhagic stroke occurring in the posterior fossa is not discussed herein.	[El Ahmadieh, Tarek Y.; Adel, Joseph G.; El Tecle, Najib E.; Daou, Marc R.; Nanney, Allan D., III; Bendok, Bernard R.] Northwestern Univ, Dept Neurol Surg, Mcgaw Med Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Aoun, Salah G.] Univ Texas SW Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA		Bendok, BR (corresponding author), Northwestern Univ, Dept Neurol Surg, Mcgaw Med Ctr, Feinberg Sch Med, 676 North St Clair St,Suite 2210, Chicago, IL 60611 USA.	bbendok@nmff.org	AHMADIEH, TAREK Y. EL/K-5921-2019; Aoun, Salah G./J-2406-2019	AHMADIEH, TAREK Y. EL/0000-0002-7122-4349; Aoun, Salah G./0000-0003-3499-7569; el Tecle, Najib/0000-0002-5242-1646			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agrawal D, 2005, EUR J CLIN MICROBIOL, V24, P772, DOI 10.1007/s10096-005-0017-7; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Amantini A, 2008, EUR J ANAESTH, V25, P196, DOI 10.1017/S0265021507003183; Amantini A, 2009, NEUROPHYSIOL CLIN, V39, P85, DOI 10.1016/j.neucli.2009.01.006; Apuzzo MLJ, 2007, NEUROSURGERY, V61, P5, DOI 10.1227/01.NEU.0000255493.34063.7B; Arac A, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0958; Arnaout OM, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1160; Ausman J I, 1976, Surg Neurol, V6, P97; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Baussart B, 2006, ACTA ANAESTH SCAND, V50, P762, DOI 10.1111/j.1399-6576.2006.01038.x; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Broca P., 1867, B ACAD MED PARIS, V32, P866; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Carmel P W, 1999, Neurosurg Focus, V7, pe7; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Chen Jeff W, 2012, Surg Neurol Int, V3, P57, DOI 10.4103/2152-7806.96868; Chesler DA, 2011, MINIM INVAS NEUROSUR, V54, P243, DOI 10.1055/s-0031-1297249; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; Clower WT, 2001, NEUROSURGERY, V49, P1417, DOI 10.1097/00006123-200112000-00021; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 1998, STROKE, V29, P1573, DOI 10.1161/01.STR.29.8.1573; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Dandy WE, 1918, ANN SURG, V68, P5, DOI 10.1097/00000658-191807000-00002; Dasic D, 2006, BRIT J NEUROSURG, V20, P296, DOI 10.1080/02688690600999901; Dey M, 2012, CURR NEUROL NEUROSCI, V12, P24, DOI 10.1007/s11910-011-0231-x; DOCZI T, 1993, ACTA NEUROCHIR, V121, P1, DOI 10.1007/BF01405174; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Frank JI CD, 2003, 55 ANN M AM AC NEUR; Ghajar J, 1995, New Horiz, V3, P395; Gigante P, 2010, BRIT J NEUROSURG, V24, P625, DOI 10.3109/02688697.2010.505989; Gregson BA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-193; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; GUILLAUME J, 1951, PRESSE MED, V59, P953; GUILLAUME J, 1951, REV NEUROL, V84, P131; Gutierrez-Gonzalez R, 2010, J INFECTION, V61, P9, DOI 10.1016/j.jinf.2010.03.030; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hofmeijer J, 2004, STROKE, V35, P1476, DOI 10.1161/01.STR.0000128415.31274.3a; Hofmeijer J, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-29; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Jaffe J, 2012, NEUROSURGERY, V70, P1258, DOI 10.1227/NEU.0b013e31823f6571; Jamora R, 2004, 29 INT STROK C FEBR; Jantzen JPAH, 2007, BEST PRACT RES-CLIN, V21, P517, DOI 10.1016/j.bpa.2007.09.001; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; JENNETT B, 1976, LANCET, V1, P1031; Johnson RD, 2011, J CLIN NEUROSCI, V18, P1023, DOI 10.1016/j.jocn.2010.12.025; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Keen, 1890, LANCET, V136, P553, DOI DOI 10.1016/S0140-6736(00)48676-9; Keller E, 2005, ACTA NEUROCHIR SUPPL, V94, P177; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Kilincer C, 2005, ACTA NEUROCHIR, V147, P587, DOI 10.1007/s00701-005-0493-7; Kirkman Matthew A, 2012, Anesthesiol Clin, V30, P269, DOI 10.1016/j.anclin.2012.05.007; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Lang Shih-Shan, 2012, Anesthesiol Clin, V30, P289, DOI 10.1016/j.anclin.2012.05.008; Lee SC, 2013, J CLIN NEUROSCI, V20, P49, DOI 10.1016/j.jocn.2012.05.027; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Maira G, 2002, NEUROL RES, V24, P54, DOI 10.1179/016164102101199549; Mangat Halinder S, 2012, Continuum (Minneap Minn), V18, P532, DOI 10.1212/01.CON.0000415426.76524.e1; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; Marion DW, 2006, NEUROSURGERY, V58, P655; Mendelow AD, 2005, LANCET, V365, P387; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murthy JMK, 2005, NEUROCRIT CARE, V2, P258, DOI 10.1385/NCC:2:3:258; Naff NJ, 2000, STROKE, V31, P841, DOI 10.1161/01.STR.31.4.841; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Patton N, 2000, J ROY SOC MED, V93, P80, DOI 10.1177/014107680009300210; Pillai A, 2007, J NEUROSURG, V106, P59, DOI 10.3171/jns.2007.106.1.59; Pople I, 2012, NEUROSURGERY, V71, P6, DOI 10.1227/NEU.0b013e3182544e31; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Ronning P, 2008, ACTA NEUROL SCAND, V118, P347, DOI 10.1111/j.1600-0404.2008.01023.x; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Sankhyan N, 2010, INDIAN J PEDIATR, V77, P1409, DOI 10.1007/s12098-010-0190-2; Schade RP, 2005, J NEUROSURG, V102, P229, DOI 10.3171/jns.2005.102.2.0229; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Schwab S, 1997, NEUROLOGY, V48, P412, DOI 10.1212/WNL.48.2.412; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SELHORST JB, 1985, NEUROSURGERY, V16, P357, DOI 10.1227/00006123-198503000-00013; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; SPERRY B, 1979, J AM OSTEOPATH ASSOC, V78, P816; Spiotta AM, 2011, NEUROSURGERY, V69, P755, DOI 10.1227/NEU.0b013e31821d2b61; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suzuki M, 2000, NEUROSURGERY, V47, P1098, DOI 10.1097/00006123-200011000-00014; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Tyrrell P, 2008, STROKE NATL CLIN GUI; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vespa Paul, 2003, Neurosurg Focus, V15, pE4; von Bramann FG., 1908, MUNCHEN MED WCHNSCHR, V55, P1673; Wada Y, 2002, NEUROL MED-CHIR, V42, P414, DOI 10.2176/nmc.42.414; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wan WH, 2008, J CLIN NEUROSCI, V15, P223, DOI 10.1016/j.jocn.2007.05.025; Webb AJS, 2012, STROKE, V43, P1666, DOI 10.1161/STROKEAHA.112.650523; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Wolfe TJ, 2009, CURR NEUROL NEUROSCI, V9, P477, DOI 10.1007/s11910-009-0070-1; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005; ZUMKELLER M, 1992, NEUROSURG REV, V15, P33, DOI 10.1007/BF02352065	132	11	12	1	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					375	+		10.1016/j.nec.2013.03.003			18	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100007	23809032				2022-02-06	
J	Jungner, M; Lundblad, C; Bentzer, P				Jungner, M.; Lundblad, C.; Bentzer, P.			Rosuvastatin. in experimental brain trauma: Improved capillary patency but no effect on edema or cerebral blood flow	MICROVASCULAR RESEARCH			English	Article							CORTICAL IMPACT INJURY; NITRIC-OXIDE SYNTHASE; L-ARGININE; MICROVASCULAR PERMEABILITY; ENDOTHELIAL DYSFUNCTION; HEMODYNAMIC DEPRESSION; REDUCTASE INHIBITOR; IN-VIVO; ATORVASTATIN; RAT	Background: Microvascular dysfunction, characterized by edema formation secondary to increased blood-brain barrier (BBB) permeability and decreased blood flow, contributes to poor outcome following brain trauma. Recent studies have indicated that statins may counteract edema formation following brain trauma but little is known about other circulatory effects of statins in this setting. The objective of this study was to investigate whether statin treatment improves brain microcirculation early after traumatic brain injury, and whether microvascular effects are associated with altered production of nitric oxide and prostacyclin. Methods: After fluid percussion injury, rats were randomized to intravenous treatment with 20 mg/kg of rosuvastatin or vehicle. Brain edema (wet/dry weight), BBB integrity (Cr-51-EDTA blood to brain transfer), cerebral blood flow (C-14-iodoantipyrine autoradiography), and number of perfused cortical capillaries (FITC-albumin fluorescence microscopy), were measured at 4 and 24 h. NO and prostacyclin production was estimated from plasma concentration of the degradation products NO2- and NO3- (NOx) and 6-keto-PGF(1-alpha), respectively. Sham injured animals were treated with vehicle and analyzed at 4 h. Results: Trauma resulted in brain edema, BBB dysfunction, and reduced cortical blood flow, with no effect of statin treatment. Trauma also induced a reduction in the number of perfused capillaries, which was improved by statin treatment Stalin treatment led to increased NO levels and reduced mean arterial blood pressure. 6-Keto-PGF(1-alpha) levels tended to increase after trauma, and were significantly reduced by rosuvastatin. Conclusions: Rosuvastatin treatment may improve microcirculation after traumatic brain injury by preserved patency of cerebral capillaries. This effect is associated with increased NO and reduced prostacyclin production. No effect on brain edema or BBB integrity was found. (C) 2013 Elsevier Inc. All rights reserved.	[Jungner, M.; Lundblad, C.; Bentzer, P.] Lund Univ, Dept Anesthesiol & Intens Care, SE-22185 Lund, Sweden		Bentzer, P (corresponding author), Lund Univ, Dept Anesthesiol & Intens Care, SE-22185 Lund, Sweden.	marten.jungner@med.lu.se; cornelia.lundblad@med.lu.se; peter.bentzer@hotmail.com		Lundblad, Cornelia/0000-0001-9686-2112	Swedish Research CouncilSwedish Research CouncilEuropean Commission [11581]; Medical Faculty of Lund University, Region Skane (ALF); Anna and Edwin Berger Foundation	The study was supported by grants from the Swedish Research Council (11581), the Medical Faculty of Lund University, Region Skane (ALF), and the Anna and Edwin Berger Foundation.	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Bellia A, 2010, ATHEROSCLEROSIS, V210, P199, DOI 10.1016/j.atherosclerosis.2009.11.021; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Beretta S, 2011, NEUROPHARMACOLOGY, V60, P878, DOI 10.1016/j.neuropharm.2011.01.003; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Birnbaum Y, 2005, CARDIOVASC RES, V65, P345, DOI 10.1016/j.cardiores.2004.10.018; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P215, DOI 10.1038/jcbfm.1983.29; Bulhak A, 2007, AM J PHYSIOL-HEART C, V292, pH3158, DOI 10.1152/ajpheart.01354.2006; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; de Sotomayor MA, 2005, BRIT J PHARMACOL, V146, P1130, DOI 10.1038/sj.bjp.0706420; Degraeve F, 2001, J BIOL CHEM, V276, P46849, DOI 10.1074/jbc.M104197200; Engelhorn T, 2006, NEUROSCI LETT, V406, P92, DOI 10.1016/j.neulet.2006.07.022; Fenstermacher J.D., 1984, EDEMA, P384; FITZGERALD GA, 1983, CIRCULATION, V67, P1174, DOI 10.1161/01.CIR.67.6.1174; Fujita M, 2012, J NEUROTRAUM, V29, P1491, DOI 10.1089/neu.2011.2278; GOBEL U, 1989, J CEREBR BLOOD F MET, V9, P491, DOI 10.1038/jcbfm.1989.72; Golding EA, 2003, J CEREBR BLOOD F MET, V23, P210, DOI 10.1097/01.WCB.0000044739.64940.B5; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hernandez-Presa MA, 2002, ATHEROSCLEROSIS, V160, P49, DOI 10.1016/S0021-9150(01)00547-0; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Liuni A, 2010, J AM COLL CARDIOL, V55, P1002, DOI 10.1016/j.jacc.2009.11.046; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Lundblad C, 2007, MICROVASC RES, V74, P1, DOI 10.1016/j.mvr.2007.03.001; Lundblad C, 2004, J NEUROTRAUM, V21, P741, DOI 10.1089/0897715041269614; Lundblad C, 2008, J CEREBR BLOOD F MET, V28, P367, DOI 10.1038/sj.jcbfm.9600533; Maeda T, 1997, ACT NEUR S, V70, P102; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McTaggart F, 2001, AM J CARDIOL, V87, p28B; Miller J.D., 1978, JAMA-J AM MED ASSOC, V105, P770; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Naito Y, 2006, WORLD J GASTROENTERO, V12, P2024, DOI 10.3748/wjg.v12.i13.2024; Prinz V, 2008, STROKE, V39, P433, DOI 10.1161/STROKEAHA.107.492470; Prinz V, 2009, ANESTH ANALG, V109, P572, DOI 10.1213/ane.0b013e3181a85d0e; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; RIPPE B, 1994, PHYSIOL REV, V74, P163, DOI 10.1152/physrev.1994.74.1.163; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; WEST GB, 1977, INT ARCH ALLER A IMM, V55, P542, DOI 10.1159/000231969; WESTCOTT JY, 1987, PROSTAGLANDINS, V34, P877, DOI 10.1016/0090-6980(87)90068-2; Wood WG, 2010, ANN NY ACAD SCI, V1199, P69, DOI 10.1111/j.1749-6632.2009.05359.x	57	11	11	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0026-2862	1095-9319		MICROVASC RES	Microvasc. Res.	JUL	2013	88						48	55		10.1016/j.mvr.2013.03.004			8	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	239FI	WOS:000326007600007	23538316				2022-02-06	
J	King, T; Rosenberg, M; Braham, R; Ferguson, R; Dawson, B				King, Tyler; Rosenberg, Michael; Braham, Rebecca; Ferguson, Renee; Dawson, Brian			Life after the game - Injury profile of past elite Australian Football players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Australian football; Health and well-being; Injuries; Concussion; Retirement	SPORTS; CONSEQUENCES; CONCUSSION; RETIREMENT; LEAGUE	Objectives: To investigate the long-term health and well-being of past elite Australian Football League (AFL) players, with particular emphasis on the effect of playing injuries on current lifestyle. Design: Cross sectional survey. Methods: A health and well-being survey, completed by past AFL players (n=592) with mean (+/- SD) age of 55.1 y (+/- 15.8) and playing career of 7.7 y (+/- 4.1) sought information on demographics, education and employment, subjective well-being, lifestyle behaviours, physical health, disease prevalence, community and social structures, and playing history. Results: A majority of past players experienced serious injuries (76%) and concussion (73%) throughout their career, both increasing significantly with the number of games played. Of those who received injuries, 60% require on-going treatment, yet only 6% receive treatment costs covered by their club or the AFL Players' Association. A large proportion (64%) of respondents are affected in daily life from previous AFL injuries. Conclusions: AFL careers are compounded by high injury rates, including loss of consciousness with a high incidence of multiple concussions amongst those players reporting a serious injury. Greater number of injuries received will further the likelihood of requiring on-going treatment and being affected later in life. Additional research and planning may be important in assisting other improvements in the quality of life of past AFL players. (C) 2012 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[King, Tyler; Rosenberg, Michael; Braham, Rebecca; Ferguson, Renee; Dawson, Brian] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Nedlands, WA 6009, Australia		Braham, R (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Nedlands, WA 6009, Australia.	Rebecca.Braham@uwa.edu.au	Rosenberg, Michael/H-5748-2014		Australian Football Leagues Past Players Association	Funding for this research was received from The Australian Football Leagues Past Players Association. Past players are thanked for their involvement in this work.	AFL Medical Officers Association, 2011, MAN CONC AUSTR FOOTB; Australain Football League Players, 2012, LIV PLAYERS DAT; BAILLIE PHF, 1993, COUNS PSYCHOL, V21, P399, DOI 10.1177/0011000093213004; Braham R, 2004, J SCI MED SPORT, V7, P451, DOI 10.1016/S1440-2440(04)80263-9; Braham R, 2004, J SCI MED SPORT, V7, P96, DOI 10.1016/S1440-2440(04)80048-3; Deacon A, 1997, MED J AUSTRALIA, V166, P187, DOI 10.5694/j.1326-5377.1997.tb140072.x; Finch C, 1998, BRIT J SPORT MED, V32, P220, DOI 10.1136/bjsm.32.3.220; Fortunato V, 1999, J PERS INTERPERS LOS, V4, P269, DOI 10.1080/10811449908409735; Gabbe B, 2001, J SCI MED SPORT, V4, P386, DOI 10.1016/S1440-2440(01)80048-7; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hickey C, 2007, ED REGULATION MANAGI; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Meir RA, 1997, BRIT J SPORT MED, V31, P132, DOI 10.1136/bjsm.31.2.132; Meir RA, 2007, J SCI MED SPORT, V10, P187, DOI 10.1016/j.jsams.2006.06.002; Nicholas SJ, 2007, AM J SPORT MED, V35, P1674, DOI 10.1177/0363546507302219; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard J, 2012, 20 ANN AFL INJURY RE; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; The Australian Football League, 2010, 2010 RET DEL TRAD	19	11	11	0	25	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440			J SCI MED SPORT	J. Sci. Med. Sport	JUL	2013	16	4					302	306		10.1016/j.jsams.2012.09.003			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	174RP	WOS:000321173400004	23058879				2022-02-06	
J	Kurki, TJI; Laalo, JP; Oksaranta, OM				Kurki, Timo J. I.; Laalo, Jussi P.; Oksaranta, Olli M.			Diffusion tensor tractography of the uncinate fasciculus: Pitfalls in quantitative analysis due to traumatic volume changes	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						diffusion tensor imaging; tractography; traumatic brain injury	WHITE-MATTER INJURY; BRAIN-INJURY; AXONAL INJURY; DISTORTION CORRECTION; HEAD TRAUMA; MR; INTEGRITY; TRACTS; REPRODUCIBILITY; ASSOCIATION	Purpose: To demonstrate the sensitivity of quantitative diffusion tensor tractography to traumatic injury of the uncinate fasciculus (UF), and to evaluate the effect of volume changes on the accuracy of quantitative analysis. Materials and Methods: Diffusion tensor imaging (DTI) was performed at 3 T for 110 patients with traumatic brain injury (TBI) and 60 control subjects. Volume, mean diffusivity (MD), and mean fractional anisotropy (FA) of the UF were measured by means of tractography. The influence of FA threshold on mean FA values was determined and the values were further related to the tract volume. Results: In patients with TBI, 16% of the volumes and 29% of the FA values were decreased and 25% of the MD values were increased (> 2 SD from the mean of controls). Small tracts (6% of trajectories) often had normal mean FA, but low volume-related FA values. Large UFs often had decreased mean FA values, but normal volumerelated central values (3% of trajectories). Conclusion: Posttraumatic FA and MD changes and volume reductions are common in the tractography of UF. Trauma-induced volume changes can cause misleading whole-tract mean FA values. Therefore, additional volume- based analysis of the central part is beneficial for clinical assessment.	[Kurki, Timo J. I.; Oksaranta, Olli M.] Pulssi Med Ctr, FI-20100 Turku, Finland; [Kurki, Timo J. I.; Laalo, Jussi P.] Univ Turku, Dept Radiol, Turku, Finland		Kurki, TJI (corresponding author), Pulssi Med Ctr, MRI Unit, FI-20100 Turku, Finland.	timo.kurki@pulssi.fi		Kurki, Timo/0000-0001-5532-3534			Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bammer R, 2002, MAGNET RESON MED, V48, P128, DOI 10.1002/mrm.10184; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gale SD, 1995, J NEUROTRAUM, V12, P51; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jaermann T, 2004, MAGN RESON MED, V51, P230, DOI 10.1002/mrm.10707; Jahanshad N, 2010, NEUROIMAGE, V52, P455, DOI 10.1016/j.neuroimage.2010.04.236; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kier EL, 2002, AM J NEURORADIOL, V23, P677; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Stadlbauer A, 2008, RADIOLOGY, V247, P179, DOI 10.1148/radiol.2471070707; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yoshikawa T, 2008, RADIAT MED, V26, P481, DOI 10.1007/s11604-008-0262-7; Yu CS, 2008, NEUROIMAGE, V40, P1533, DOI 10.1016/j.neuroimage.2008.01.063	42	11	11	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807			J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUL	2013	38	1					46	53		10.1002/jmri.23901			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	180SA	WOS:000321614600006	23733545	Bronze			2022-02-06	
J	Michinaga, S; Ishida, A; Takeuchi, R; Koyama, Y				Michinaga, Shotaro; Ishida, Ayaka; Takeuchi, Risa; Koyama, Yutaka			Endothelin-1 stimulates cyclin D1 expression in rat cultured astrocytes via activation of Sp1	NEUROCHEMISTRY INTERNATIONAL			English	Article						Endothelin; Astrogliosis; Sp1; Cyclin D1; ETB receptor; Mitogen-activated protein kinase	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; REACTIVE ASTROCYTES; TRANSCRIPTIONAL REGULATION; GENE-TRANSCRIPTION; EPITHELIAL-CELLS; SCAR FORMATION; GLUCOSE-UPTAKE; D3 EXPRESSION; B RECEPTORS	Endothelins (ETs), a family of vasoconstrictor peptides, are up-regulated in several pathological conditions in the brain, and induce astrocytic proliferation. We previously observed that ET-1 increased the expression of cyclin D1 protein. Thus, we confirmed the intracellular up-regulation of cyclin D1 by ET-1 in rat cultured astrocytes. Real-time PCR analysis indicated that ET-1 (100 nM) and Ala(1,3,11,15)-ET-1 (100 nM), a selective agonist of the ETB receptor, induced a time-dependent and transient increase in cyclin D1 mRNA. The effect of ET-1 was diminished by an ETB antagonist (1 mu M BQ788) or inhibitors of Sp1 (500 nM mithramycin), ERK (50 mu M PD98059), p38 (20 mu M SB203580) and JNK (1 mu M SP600125), but not inhibitors of NF-kappa B (10 mu M SN50 and 100 mu M pyrrolidine dithiocarbamate). The binding assay for Sp1 indicated that ET-1 increased the binding activity of Sp1 to consensus sequences, and two oligonucleotides of the cyclin D1 promoter including the Sp1-binding sites diminished the effect of ET-1. Western blot analysis showed that ET-1 induced time-dependent and transient phosphorylation of Sp1 on Thr453 and Thr739 via the ETB receptor. ET-1-induced phosphorylation of Sp1 was attenuated by P098059 and SP600125. Additionally, ET-1 increased the incorporation of bromodeoxyuridine (BrdU) in cultured astrocytes and the number of BrdU-positive cells decreased in the presence of PD98059, SP600125 and mithramycin. These results suggest that ET-1 increases the expression of cyclin D1 via activation of Sp1 and induces astrocytic proliferation. (c) 2013 Elsevier Ltd. All rights reserved.	[Michinaga, Shotaro; Ishida, Ayaka; Takeuchi, Risa; Koyama, Yutaka] Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, Tonda Bayashi, Osaka 5848540, Japan		Koyama, Y (corresponding author), Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, 3-11-1 Nishikiori Kita, Tonda Bayashi, Osaka 5848540, Japan.	koyamay@osaka-ohtani.ac.jp			JPSP [21590108]	This work was supported by a Grant-in-Aid for Scientific Research (C) from the JPSP (21590108).	BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Dashwood MR, 2010, J CELL COMMUN SIGNAL, V4, P51, DOI 10.1007/s12079-009-0073-3; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gangoso E, 2012, GLIA, V60, P2040, DOI 10.1002/glia.22418; Goto K, 1996, JPN J PHARMACOL, V72, P261, DOI 10.1254/jjp.72.261; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Guo Y, 2002, ONCOGENE, V21, P7545, DOI 10.1038/sj.onc.1205907; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hama H, 1997, J NEUROSCI RES, V47, P590, DOI 10.1002/(SICI)1097-4547(19970315)47:6<590::AID-JNR4>3.0.CO;2-8; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Herrero-Gonzalez S, 2009, GLIA, V57, P222, DOI 10.1002/glia.20748; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Ishikawa N, 1997, EUR J NEUROSCI, V9, P895, DOI 10.1111/j.1460-9568.1997.tb01440.x; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kao YS, 2008, CELL SIGNAL, V20, P771, DOI 10.1016/j.cellsig.2007.12.012; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Koyama Y, 2004, J NEUROCHEM, V90, P904, DOI 10.1111/j.1471-4159.2004.02546.x; Koyama Y, 2003, EUR J NEUROSCI, V18, P887, DOI 10.1046/j.1460-9568.2003.02797.x; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Koyama Y, 2012, GLIA, V60, P1954, DOI 10.1002/glia.22411; Koyama Y, 2012, J PHARMACOL SCI, V118, P401, DOI 10.1254/jphs.11R13CP; Lin HM, 2002, ONCOGENE, V21, P8001, DOI 10.1038/sj.onc.1205820; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nie XJ, 1996, REV NEUROSCIENCE, V7, P177; Osada N, 2012, NEUROCHEM INT, V60, P47, DOI 10.1016/j.neuint.2011.11.001; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Ryu H, 2003, J NEUROSCI, V23, P3597; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Schinelli S, 2006, CURR MED CHEM, V13, P627, DOI 10.2174/092986706776055652; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; SUPATTAPONE S, 1989, BIOCHEM BIOPH RES CO, V165, P1115, DOI 10.1016/0006-291X(89)92718-6; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Teixeira A, 2000, J NEUROCHEM, V74, P1034, DOI 10.1046/j.1471-4159.2000.0741034.x; Tokumine J, 2003, J NEUROSCI RES, V74, P552, DOI 10.1002/jnr.10760; von Wichert T, 2005, ONCOGENE, V24, P1284, DOI 10.1038/sj.onc.1208264; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Yan GZ, 1997, J NEUROSCI, V17, P6122; Yeh SH, 2011, NUCLEIC ACIDS RES, V39, P5412, DOI 10.1093/nar/gkr161; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	56	11	12	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUL	2013	63	1					25	34		10.1016/j.neuint.2013.04.004			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	169BE	WOS:000320751100003	23619396				2022-02-06	
J	Moon, JH; Seo, BR; Jang, JW; Lee, JK; Moon, HS				Moon, Jung-Ho; Seo, Bo-Ra; Jang, Jae-Won; Lee, Jung-Kil; Moon, Hyung-Sik			Evaluation of Probability of Survival Using Trauma and Injury Severity Score Method in Severe Neurotrauma Patients	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; TRISS; Survival	STATISTICAL VALIDATION; TRISS METHOD; MORTALITY; ASCOT; CARE	Objective : Despite several limitations, the Trauma Injury Severity Score (TRISS) is normally used to evaluate trauma systems. The aim of this study was to evaluate the preventable trauma death rate using the TRISS method in severe trauma patients with traumatic brain injury using our emergency department data. Methods : The use of the TRISS formula has been suggested to consider definitively preventable death (DP); the deaths occurred with a probability of survival (Ps) higher than 0.50 and possible preventable death (PP); the deaths occurred with a Ps between 0.50 and 0.25. Deaths in patients with a calculated Ps of less than 0.25 is considered as non-preventable death (NP). A retrospective case review of deaths attributed to mechanical trauma occurring between January 1, 2011 and December 31, 2011 was conducted. Results : A total of 565 consecutive severe trauma patients with ISS>15 or Revised Trauma Score<7 were admitted in our institute. We excluded a total of 24 patients from our analysis : 22 patients younger than 15 years, and 2 patients with burned injury. Of these, 221 patients with head injury were analyzed in the final study. One hundred eighty-two patients were in DP, 13 in PP and 24 in NP. The calculated predicted mortality rates were 11.13%, 59.04%, and 90.09%. The actual mortality rates were 12.64%, 61.547%, and 91.67%, respectively. Conclusion : Although it needs to make some improvements, the present study showed that TRISS performed well in predicting survival of traumatic brain injured patients. Also, TRISS is relatively exact and acceptable compared with actual data, as a simple and time-saving method.	[Moon, Jung-Ho; Jang, Jae-Won; Lee, Jung-Kil] Chonnam Natl Univ Hosp & Med Sch, Dept Neurosurg, Kwangju, South Korea; [Seo, Bo-Ra; Moon, Hyung-Sik] Mokpo Hankook Hosp, Dept Neurosurg, Mokpo 530822, South Korea		Seo, BR (corresponding author), Mokpo Hankook Hosp, Dept Neurosurg, 483 Yeongsan Ro, Mokpo 530822, South Korea.	cd1379@naver.com					Al West T, 2000, J TRAUMA, V49, P530, DOI 10.1097/00005373-200009000-00022; Barmparas G, 2012, AM SURGEON, V78, P1166; CAYTEN CG, 1991, J TRAUMA, V31, P471, DOI 10.1097/00005373-199104000-00005; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Chiara Osvaldo, 2006, World J Emerg Surg, V1, P12, DOI 10.1186/1749-7922-1-12; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Gabbe BJ, 2004, ACAD EMERG MED, V11, P181, DOI 10.1197/j.aem.2003.08.019; HANNAN EL, 1995, J TRAUMA, V38, P83, DOI 10.1097/00005373-199501000-00022; Kilgo PD, 2006, J TRAUMA, V60, P1002, DOI 10.1097/01.ta.0000215827.54546.01; Kilgo PD, 2004, J TRAUMA, V57, P479, DOI 10.1097/01.TA.0000141024.96440.7C; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kirkham JJ, 2008, STAT MED, V27, P5725, DOI 10.1002/sim.3379; Millham FH, 2004, J TRAUMA, V56, P1090, DOI 10.1097/01.TA.0000119689.81910.06; Moore L, 2006, J TRAUMA, V60, P305, DOI 10.1097/01.ta.0000200840.89685.b0; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Moore L, 2010, J TRAUMA, V68, P698, DOI 10.1097/TA.0b013e3181aa093d; Schluter PJ, 2010, J TRAUMA, V68, P761, DOI 10.1097/TA.0b013e3181d3223b; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28	19	11	11	0	3	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	JUL	2013	54	1					42	46		10.3340/jkns.2013.54.1.42			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	211OB	WOS:000323916600009	24044080	gold, Green Published, Green Submitted			2022-02-06	
J	Recla, M; Bardoni, A; Galbiati, S; Pastore, V; Dominici, C; Tavano, A; Locatelli, F; Strazzer, S				Recla, Monica; Bardoni, Alessandra; Galbiati, Susanna; Pastore, Valentina; Dominici, Chiara; Tavano, Alessandro; Locatelli, Federica; Strazzer, Sandra			Cognitive and adaptive functioning after severe TBI in school-aged children	BRAIN INJURY			English	Article						Children; cognitive functioning; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CHILDHOOD HEAD-INJURY; SHORT-TERM; RECOVERY; ATTENTION; SIMILARITIES; PROFILES; DEFICITS; OUTCOMES; SCALE	Objective: Persistent cognitive and behavioural deficits have been documented in children suffering severe TBI. The aim of the present study was to examine the cognitive and adaptive profile of children of school age with severe TBI. Methods: This study selected 118 patients and divided them into three groups according to the severity of their clinical-functional picture. All the patients received a functional assessment using the Wee-FIM. Subjects with reduced responsiveness were evaluated by LOCFAS. Last, the cognitive profile children with a better recovery were described with WISC-III and Leiter-R and their adaptive behaviour with VABS. Results: Group 1 (n = 77) showed a borderline cognitive level with a disharmonious profile between VIQ and PIQ, significant deficits in the Processing Speed and Perceptual Organization Indices, lastly specific adaptive behavioural deficits. Length of coma correlated with their cognitive and adaptive profile. Group 2 (n = 14) included subjects with severe language and/or motor disabilities presenting with a partial cognitive functioning level moderately impaired. Group 3 (n = 27) included patients with reduced responsiveness (LOCFAS <= 3). Conclusions: In the first 12 months following severe TBI, 22.9% children stayed in minimal responsiveness, 11.9% showed debilitating language and motor deficits and 65.2% showed a more favourable cognitive recovery and could be assessed by WISC-III.	[Recla, Monica; Bardoni, Alessandra; Galbiati, Susanna; Pastore, Valentina; Dominici, Chiara; Tavano, Alessandro; Locatelli, Federica; Strazzer, Sandra] La Nostra Famiglia, IRCCS, E Medea, Bosisio Parini, Lecco, Italy		Strazzer, S (corresponding author), La Nostra Famiglia, IRCCS E Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, LC, Italy.	sandra.strazzer@bp.lnf.it	FEDERICA, LOCATELLI/AAA-5601-2020; BARDONI, ALESSANDRA/AAH-7233-2019; Recla, Monica/ABG-1905-2020; Galbiati, Susanna/AAH-6883-2019; Pastore, Valentina/AAH-6831-2019; Strazzer, Sandra/AAH-5712-2019	FEDERICA, LOCATELLI/0000-0002-8243-5483; BARDONI, ALESSANDRA/0000-0001-8404-3857; Recla, Monica/0000-0002-3001-8872; Galbiati, Susanna/0000-0001-7209-4251; Pastore, Valentina/0000-0002-3170-3070; Strazzer, Sandra/0000-0001-8414-6565; Tavano, Alessandro/0000-0002-2096-5542	Ministry of Health Research [56 L 289/2002]	The authors report no conflicts of interest. This work has been supported by two grants from the Ministry of Health Research: Project ex art. 56 L 289/2002. Fondi anno 2005. Scientific Institute 'E. Medea' awarded to Sandra Strazzer as Principal Investigator; and Ricerca Corrente 2010-2012. Scientific Institute 'E. Medea' awarded to Sandra Strazzer as Principal Investigator.	Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; ARAM DM, 1988, NEUROPSYCHOLOGIA, V26, P903, DOI 10.1016/0028-3932(88)90058-9; Bates E, 1999, CHANGING NERVOUS SYSTEM, P214; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Calhoun SL, 2005, PSYCHOL SCHOOLS, V42, P333, DOI 10.1002/pits.20067; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Donders J, 2005, J INT NEUROPSYCH SOC, V11, P386, DOI 10.1017/S1355617705050435; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 1997, Pediatr Rehabil, V1, P179; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Flannery J, 1995, J Nurs Meas, V3, P43; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kraus JF., 1995, TRAUMATIC HEAD INJUR, P117; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liscio M, 2008, DISABIL REHABIL, V30, P275, DOI 10.1080/09638280701257023; Mayes SD, 2004, CLIN NEUROPSYCHOL, V18, P559, DOI 10.1080/13854040490888530; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Pastore V, 2011, DISABIL REHABIL, V33, P675, DOI 10.3109/09638288.2010.506239; Radcliffe J, 2004, INT J DEV NEUROSCI, V12, P327; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Roid GH, 2002, LEITHER INT PERFORMA; ROVET JF, 1992, J PEDIATR PSYCHOL, V17, P187, DOI 10.1093/jpepsy/17.2.187; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TAYLOR HG, 1993, J CLIN CHILD PSYCHOL, V22, P196, DOI 10.1207/s15374424jccp2202_6; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	59	11	11	2	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					862	871		10.3109/02699052.2013.775499			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200013	23789863				2022-02-06	
J	Ueda, Y; Kitamoto, A; Willmore, LJ; Kojima, T				Ueda, Yuto; Kitamoto, Aya; Willmore, L. James; Kojima, Toshio			Hippocampal Gene Expression Profiling in a Rat Model of Posttraumatic Epilepsy Reveals Temporal Upregulation of Lipid Metabolism-Related Genes	NEUROCHEMICAL RESEARCH			English	Article						Amygdala; DNA microarray; Ferric chloride; Seizures	LOBE EPILEPSY; INJECTION	Traumatic brain injury occasionally causes posttraumatic epilepsy. To elucidate the molecular events responsible for posttraumatic epilepsy, we established a rodent model that involved the injection of microliter quantities of FeCl3 solution into the amygdalar nuclear complex. We previously compared hippocampal gene expression profiles in the traumatic epilepsy model and normal rats at 5 days after brain injury (acute phase) to determine the role of inflammation. In this study, we focused on later stages of epileptogenesis. We compared gene expression profiles at 5, 15 (sub-chronic phase), and 30 days (chronic phase) after brain injury to identify temporal changes in molecular networks involved in epileptogenesis. A total of 81 genes were significantly (at least twofold) up- or downregulated over the course of disease progression. We found that genes related to lipid metabolism, namely, Apoa1, Gh, Mc4r, Oprk1, and Pdk4, were temporarily upregulated in the sub-chronic phase. Changes in lipid metabolism regulation might be related to seizure propagation during epileptogenesis. This temporal description of hippocampal gene expression profiles throughout epileptogenesis provides clues to potential markers of disease phases and new therapeutic targets.	[Ueda, Yuto] Miyazaki Univ, Fac Med, Sect Psychiat, Dept Clin Neurosci, Miyazaki 8891692, Japan; [Kitamoto, Aya; Kojima, Toshio] RIKEN, Adv Sci Inst, Computat Syst Biol Res Grp, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Willmore, L. James] St Louis Univ, Sch Med, Dept Neurol, St Louis, MO 63104 USA; [Willmore, L. James] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63104 USA; [Kojima, Toshio] Hamamatsu Univ Sch Med, Res Equipment Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan		Kojima, T (corresponding author), Hamamatsu Univ Sch Med, Res Equipment Ctr, Higashi Ku, 1-20-1Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kojim.to@gmail.com		Kitamoto, Aya/0000-0002-0223-3874			Kato K, 2009, J NEUROCHEM, V110, P509, DOI 10.1111/j.1471-4159.2009.06132.x; Mulero JJ, 2002, IMMUNOGENETICS, V54, P293, DOI 10.1007/s00251-002-0467-3; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PAYAN H, 1970, EPILEPSIA, V11, P81, DOI 10.1111/j.1528-1157.1970.tb03869.x; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Ruiz N, 2011, BRAIN RES, V1426, P86, DOI 10.1016/j.brainres.2011.10.006; Ueda Y, 1998, EXP NEUROL, V153, P123, DOI 10.1006/exnr.1998.6869; Ueda Y, 2003, NEUROCHEM RES, V28, P1895, DOI 10.1023/A:1026136211759; Ueda Y, 2011, NEUROCHEM RES, V36, P1323, DOI 10.1007/s11064-010-0386-x; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; WILLMORE LJ, 1978, BRAIN RES, V152, P406, DOI 10.1016/0006-8993(78)90273-1; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x	12	11	14	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190			NEUROCHEM RES	Neurochem. Res.	JUL	2013	38	7					1399	1406		10.1007/s11064-013-1037-9			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	157HP	WOS:000319887300013	23585123				2022-02-06	
J	Garcia-Molina, A; Ensenat-Cantallops, A; Sanchez-Carrion, R; Rodriguez, P; Tormos, JM; Roig-Rovira, T				Garcia-Molina, Alberto; Ensenat-Cantallops, Antonia; Sanchez-Carrion, Rocio; Rodriguez, Pablo; Maria Tormos, Jose; Roig-Rovira, Teresa			Interindividual variability in recovery after traumatic brain injury: Effect of cognitive reserve	MEDICINA CLINICA			Spanish	Article						Cognitive reserve; Traumatic brain injury; Education; Occupational activity	COMPETENCE; COMPLEXITY; MODERATE; SCALE; WORK; SIZE	Background and objective: The aim of this study was to examine the effect of cognitive reserve in recovery after a moderate or severe traumatic brain injury (TBI). Different authors proposed that this construct might account for the mismatch between TBI severity, its clinical expression, and subsequent recovery. Patients and method: Eighty-four patients who sustained moderate-to-severe TBI participated in the study. Participants were divided into a high cognitive reserve group (n = 46) or low cognitive reserve group (n = 38) based on premorbid educational and occupational attainment. Patient's functional status was examined with the Patient Competency Rating Scale (PCRS). Results: There were no significant differences between groups in demographic and injury variables (sex, age, severity of injury, post-traumatic amnesia duration, and time since injury). The analysis revealed statistically significant differences between the 2 groups on the PCRS: The high cognitive reserve group scored better than the low cognitive reserve group. Conclusions: The results of this study suggest that cognitive reserve may mediate recovery after a moderate or severe TBI. Educational and occupational attainments provide a cognitive provision that would be associated with better functional status after injury. (c) 2012 Elsevier Espana, S.L. All rights reserved.	[Garcia-Molina, Alberto; Ensenat-Cantallops, Antonia; Sanchez-Carrion, Rocio; Rodriguez, Pablo; Maria Tormos, Jose; Roig-Rovira, Teresa] Univ Autonoma Barcelona, Inst Univ Neurorrehabil Guttmann, E-08193 Barcelona, Spain		Garcia-Molina, A (corresponding author), Univ Autonoma Barcelona, Inst Univ Neurorrehabil Guttmann, E-08193 Barcelona, Spain.	agarciam@guttmann.com		Tormos Munoz, Jose Maria/0000-0002-8764-2289			Andel R, 2007, J AGING HEALTH, V19, P397, DOI 10.1177/0898264307300171; [Anonymous], 2008, ACC COMPL AC FORM AM; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barnett JH, 2006, PSYCHOL MED, V36, P1053, DOI 10.1017/S0033291706007501; Bosma H, 2003, EXP AGING RES, V29, P33, DOI 10.1080/03610730303710; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Garcia-Molina A, 2010, PSICOTHEMA, V22, P430; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; HEILBRONNER RL, 1993, J CLIN EXP NEUROPSYC, V15, P67; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JUNQUE C, 1998, TRAUMATISMOS CRANEOE; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; KOHN ML, 1978, AM J SOCIOL, V84, P24, DOI 10.1086/226739; Leal-Cerro A, 2010, MED CLIN-BARCELONA, V134, P127, DOI 10.1016/j.medcli.2009.07.020; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Oyegbile TO, 2004, NEUROLOGY, V62, P1736, DOI 10.1212/01.WNL.0000125186.04867.34; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rodriguez M., 2004, ANALES PSICOLOGIA, V20, P175, DOI DOI 10.6018/ANALESPS.20.2.2730; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Perez PS, 2009, MED CLIN-BARCELONA, V132, P459, DOI 10.1016/j.medcli.2008.04.012; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schooler C., 2008, AGING EXERCISE COGNI, P15; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Stern Y, 2007, COGNITIVE RESERVE TH; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; TEASDALE G, 1974, LANCET, V2, P81; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Vargha A, 2000, J EDUC BEHAV STAT, V25, P101, DOI 10.3102/10769986025002101; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	32	11	12	0	9	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0025-7753	1578-8989		MED CLIN-BARCELONA	Med. Clin.	JUN 18	2013	140	12					527	531		10.1016/j.medcli.2012.09.047			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180LM	WOS:000321596700001	23481869				2022-02-06	
J	Yu, GF; Jie, YQ; Wu, A; Huang, Q; Dai, WM; Fan, XF				Yu, Guo-Feng; Jie, Yuan-Qing; Wu, An; Huang, Qiang; Dai, Wei-Min; Fan, Xiao-Feng			Increased plasma 8-iso-Prostaglandin F2 alpha concentration in severe human traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						8-lso-Prostaglandin F2 alpha; Biomarker; Traumatic brain injury; Outcome	OXIDATIVE STRESS; LIPID-PEROXIDATION; SYNAPTIC PROTEINS; BIOMARKERS; MARKER; DAMAGE	Background: 8-Iso-Prostaglandin F2a (8-iso-PGF2 alpha) is considered as a gold standard for measuring oxidative stress in vivo. The present study was undertaken to investigate plasma 8-iso-PGF2 alpha concentrations in severe human traumatic brain injury (TBI) and to analyze its correlation with disease outcome. Methods: One hundred six healthy subjects and 106 severe TBI patients were recruited. The correlations of plasma 8-iso-PGF2 alpha concentration with I-year mortality and unfavorable outcome (Glasgow Outcome Scale score of 1-3) were analyzed. Results: Thirty-one patients (29.2%) died and 48 patients (45.3%) had an unfavorable outcome at 1 year after TBI. Patients had significantly higher plasma 8-iso-PGF2 alpha levels compared to healthy controls (572.1 157.5 pg/ml vs. 843 +/- 18.9 pg/ml, P < 0.001). A multivariate analysis selected plasma 8-iso-PGF2 alpha level as an independent predictor for 1-year unfavorable outcome [odds ratio (OR) 1.401, 95% confidence interval (Cl) 1.107-2.371, P = 0.0051 and mortality (OR 1.609, 95% Cl 1.113-3.142, P = 0.003). A receiver operating characteristic curve analysis showed plasma 8-iso-PGF2 alpha level predicted 1-year unfavorable outcome [area under curve (AUC), 0.871; 95% Cl, 0.792-0.928] and mortality (AUC, 0.881; 95% Cl, 0.804-0.936) as statistically significantly. The prognostic value of 8-iso-PGF2 alpha was similar to that of Glasgow Coma Scale score for 1-year clinical outcomes (both P> 0.05). However, 8-iso-PGF2 alpha did not improve the prognostic value of Glasgow Coma Scale score for 1-year clinical outcomes (both P> 0.05). Conclusions: Plasma 8-iso-PGF2 alpha level is highly associated with 1-year clinical outcomes of TBI. (C) 2013 Elsevier B.V. All rights reserved.	[Yu, Guo-Feng; Jie, Yuan-Qing; Wu, An; Huang, Qiang; Dai, Wei-Min; Fan, Xiao-Feng] Quzhou Peoples Hosp, Dept Neurosurg, Kecheng District 324100, Quzhou, Peoples R China		Dai, WM (corresponding author), Quzhou Peoples Hosp, Dept Neurosurg, 2 Zhongloudi Rd, Kecheng District 324100, Quzhou, Peoples R China.	uanuenuau@163.com					Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Basu S, 2001, FEBS LETT, V508, P36, DOI 10.1016/S0014-5793(01)02998-2; Brunetti L, 2002, LIFE SCI, V71, P2447, DOI 10.1016/S0024-3205(02)02037-4; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Elesber AA, 2006, FREE RADICAL RES, V40, P385, DOI 10.1080/10715760500539154; Hoffman SW, 2000, J NEUROTRAUM, V17, P415, DOI 10.1089/neu.2000.17.415; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; JENNETT B, 1975, LANCET, V1, P480; Jimenez-Del-Rio M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/163913; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Milne GL, 2007, METHOD ENZYMOL, V433, P113, DOI 10.1016/S0076-6879(07)33006-1; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Owczarek D, 2010, INFLAMM BOWEL DIS, V16, P52, DOI 10.1002/ibd.20994; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Szuldrzynski K, 2010, POL ARCH MED WEWN, V120, P19; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wiswedel I, 2009, METHODS MOL BIOL, V580, P3, DOI 10.1007/978-1-60761-325-1_1; 施辉, 2005, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V23, P435	26	11	11	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JUN 5	2013	421						7	11		10.1016/j.cca.2013.02.030			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	161VH	WOS:000320220900002	23466601				2022-02-06	
J	Barwood, CHS; Murdoch, BE				Barwood, Caroline H. S.; Murdoch, Bruce E.			RETRACTED: Unravelling the influence of mild traumatic brain injury (MTBI) on cognitive-linguistic processing: A comparative group analysis (Retracted article. See vol. 31, pg. 1552, 2017)	BRAIN INJURY			English	Article; Retracted Publication						Cognition; high-level language; language; mild traumatic brain injury; TBI	CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; LANGUAGE; IMPAIRMENT; SUBSEQUENT; DISCOURSE; SEQUELAE	Background: Cognitive-linguistic deficits often accompany traumatic brain injury (TBI) and can negatively impact communicative competency. The linguistic sequelae underpinning mild TBI (MTBI) remain largely unexplored in contemporary literature. Objectives: The present research methods aim to provide group evidence pertaining to the influence of MTBI on linguistic and higher-level language processing. Extrapolating on the findings of recent case reports, it is hypothesized that performance of the MTBI patients will be significantly reduced compared to normal controls performance on the employed high-level linguistic tasks. Methods: Sixteen patients with MTBI and 16 age-and education-matched normal control participants were assessed using a comprehensive battery of cognitive-linguistic assessments. Results: The results demonstrated statistically significant differences between MTBI and normal control group performance across a number of higher-level linguistic, general cognitive and general language tasks. MTBI group performance was significantly lower than the normal control group on tasks requiring complex lexical semantic operations and memory demands, including: Recall, organization, making inferences, naming and perception/discrimination. Conclusions: These outcomes confer that post-MTBI, cognitive, high-level language and isolated general language performance (e. g. naming) is significantly reduced in MTBI patients, compared to normal controls. Furthermore, the detailed cognitive-linguistic profile offered provides a necessary direction for the identification of areas of linguistic decline in MTBI and targets for therapeutic intervention of impaired cognitive-linguistic processes to ultimately improve communicative outcomes in MTBI.	[Barwood, Caroline H. S.; Murdoch, Bruce E.] Univ Queensland, Ctr Neurogen Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia		Barwood, CHS (corresponding author), Univ Queensland, Ctr Neurogen Commun Disorders Res, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	c.barwood@uq.edu.au	Murdoch, Bruce E/C-1397-2012		Motor Accident Insurance Commission (MAIC) of Queensland	This research was funded by a grant from the Motor Accident Insurance Commission (MAIC) of Queensland. The authors report no conflicts of interest.	Adamovich B. B., 1992, SCALES COGNITIVE ABI; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Gronwall D, 1989, MILD HEAD INJURY, P153; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Hinchliffe FJ, 2001, TRAUMATIC BRAIN INJU, P199; Huisingh R, 1990, WORD TEST REVISED TE; Kaplan E., 2001, BOSTON NAMING TEST; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Levin H.S., 1989, MILD HEAD INJURY; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Parker RS, 1996, NEUROPSYCHOL REV, V6, P135, DOI 10.1007/BF01874895; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Spreen O., 1969, NEUROSENSORY CTR COM; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turkstra Lyn S, 2005, Semin Speech Lang, V26, P213, DOI 10.1055/s-2005-922100; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Whelan BM, 2003, J NEUROL NEUROSUR PS, V74, P1543, DOI 10.1136/jnnp.74.11.1543; Whelan BM, 2002, APHASIOLOGY, V16, P1213, DOI 10.1080/02687030244000446; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Wiig E. H., 1989, TEST LANGUAGE COMPET; WIIG EH, 1974, PERCEPT MOTOR SKILL, V38, P171, DOI 10.2466/pms.1974.38.1.171; Wong MN, 2010, APHASIOLOGY, V24, P1155, DOI 10.1080/02687030903168212	34	11	11	1	21	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					671	676		10.3109/02699052.2013.775500			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500005	23611468				2022-02-06	
J	Buschmann, C; Poloczek, S; Giesecke, MT; Kleber, C				Buschmann, C.; Poloczek, S.; Giesecke, M. T.; Kleber, C.			Preventable Trauma Deaths Epidemiology, Causes of Death, and Management Failures	NOTARZT			German	Article						trauma; trauma management; trauma mortality; injury pattern; emergency service; autopsy	POLYTRAUMATIZED PATIENTS; TRAFFIC FATALITIES; FOLEY CATHETER; HEALTH REGION; CARE; QUALITY; SYSTEM; MORTALITY; INJURY; AUDIT	Fatal trauma is one of the leading causes of death in Western industrialized countries. The aim of the present study was to determine the preventability of traumatic deaths, analyze the medical measures related to preventable deaths, detect management failures, and reveal specific injury patterns. All autopsied, direct trauma-related fatalities in Berlin in 2010 were included with systematic data acquisition, including police files, medical records, death certificates, and autopsy records. An interdisciplinary expert board judged the preventability of traumatic death according to the classification of non-preventable (NV), potentially preventable (PV), and definitively preventable (DV) fatalities. 85% were classified as NV, 10% as PV, and 5% as DV. The incidence of severe traumatic brain injury was significantly lower in PV/DV than in NV, and the incidence of fatal exsanguinations was significantly higher. Most PV and NV deaths occurred in the pre-hospital setting. Notably, no PV or DV was recorded for fatalities treated by airbound rescue service. Causes of DV deaths consisted of tension pneumothorax, unrecognized trauma, exsanguinations, and asphyxia. The overall trauma mortality in our study, compared to worldwide-published data, is low. Nevertheless, 15% of traumatic deaths were classified as preventable. Compulsory training in trauma management might further reduce trauma-related mortality. The main focus should remain on prevention programs, as the majority of the fatalities occurred as a result of non-survivable injuries.	[Buschmann, C.] Charite Univ Med Berlin, Inst Rechtsmed, D-10559 Berlin, Germany; [Poloczek, S.] Berliner Feuerwehr, Berlin, Germany; [Giesecke, M. T.; Kleber, C.] Charite Univ Med Berlin, Centrum Muskuloskeletale Chirurg, D-10559 Berlin, Germany		Buschmann, C (corresponding author), Charite Univ Med Berlin, Inst Rechtsmed, Turmstr 21, D-10559 Berlin, Germany.	claas.buschmann@charite.de					ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; Arnold JL, 1999, ANN EMERG MED, V33, P97, DOI 10.1016/S0196-0644(99)70424-5; Ashour A, 2007, EMERG MED AUSTRALAS, V19, P163, DOI 10.1111/j.1742-6723.2007.00948.x; Bakke HK, 2011, WORLD J SURG, V35, P1615, DOI 10.1007/s00268-011-1102-y; Buschmann C, 2011, FORENSIC SCI MED PAT, V7, P369, DOI 10.1007/s12024-011-9225-x; Buschmann CT, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-55; Chao BF, 2011, INJURY, V42, P958, DOI 10.1016/j.injury.2011.05.009; Davies GE, 2011, J TRAUMA, V70, pE75, DOI 10.1097/TA.0b013e3181f6f72f; DAVIS JW, 1992, J TRAUMA, V32, P660, DOI 10.1097/00005373-199205000-00020; Dick Wolfgang F, 2003, Prehosp Disaster Med, V18, P29; Doberentz Elke, 2010, Archiv fuer Kriminologie, V225, P1; Doll D, 2006, UNFALLCHIRURG, V109, P898, DOI 10.1007/s00113-006-1096-3; DRAAISMA JMT, 1989, J TRAUMA, V29, P1552; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Frink M, 2007, UNFALLCHIRURG, V110, P334, DOI 10.1007/s00113-006-1222-2; HAAS NP, 1995, CLIN ORTHOP RELAT R, P25; Helm M, 2012, ANAESTHESIST, V61, P106, DOI 10.1007/s00101-012-1981-9; Jat Afzal Ali, 2004, Asian J Surg, V27, P58, DOI 10.1016/S1015-9584(09)60247-5; Kessel N, 2008, GESCH RETTUNGSDIENST; Kirschner M, 1938, CHIRURG, V10, P713; Kleber C, 2013, UNFALLCHIRURG, V116, P345, DOI 10.1007/s00113-011-2132-5; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Kohler M, 2002, NJW, V12, P853; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Limb D, 1996, J ACCID EMERG MED, V13, P248; MACKENZIE EJ, 1992, J TRAUMA, V33, P292, DOI 10.1097/00005373-199208000-00021; Maio RF, 1996, J TRAUMA, V41, P83, DOI 10.1097/00005373-199607000-00013; McDermott FT, 2005, PREHOSP DISASTER MED, V20, P219, DOI 10.1017/S1049023X00002570; McDermott FT, 1996, J TRAUMA, V40, P520, DOI 10.1097/00005373-199604000-00003; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; OTTOSSON A, 1984, JAMA-J AM MED ASSOC, V251, P2668, DOI 10.1001/jama.251.20.2668; Papadopoulos IN, 1996, J TRAUMA, V41, P864, DOI 10.1097/00005373-199611000-00018; Perdekamp MG, 2009, RECHTSMEDIZIN, V19, P413, DOI 10.1007/s00194-009-0639-7; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Sanddal TL, 2011, J TRAUMA, V70, P970, DOI 10.1097/TA.0b013e3181fec9ba; Schlechtriemen I, 2002, UNFALLCHIRURG, V105, P974, DOI 10.1007/s00113-002-0515-3; SHACKFORD SR, 1987, J TRAUMA, V27, P866, DOI 10.1097/00005373-198708000-00004; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; Spohr F, 2012, NOTFALLMEDIZIN, P14; STOCCHETTI N, 1994, J TRAUMA, V36, P401, DOI 10.1097/00005373-199403000-00022; VAN WAGONER F H, 1961, J Trauma, V1, P401; Weninger P, 2005, UNFALLCHIRURG, V108, P559, DOI 10.1007/s00113-005-0949-5; WEST JG, 1979, ARCH SURG-CHICAGO, V114, P455; ZOLLINGER RW, 1955, ARCH SURG-CHICAGO, V70, P694, DOI 10.1001/archsurg.1955.01270110066010	45	11	11	0	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0177-2309	1438-8693		NOTARZT	Notarzt	JUN	2013	29	3					91	98		10.1055/s-0033-1343145			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	164XW	WOS:000320446800001					2022-02-06	
J	Hogan, NS; Coolican, M; Schmidt, LA				Hogan, Nancy S.; Coolican, Maggie; Schmidt, Lee A.			Making meaning in the legacy of tissue donation for donor families	PROGRESS IN TRANSPLANTATION			English	Article							PEDIATRIC ORGAN DONATION; BRAIN-DEATH; CONSENT; GRIEF; BEREAVEMENT; KNOWLEDGE; ATTITUDES; REFUSAL	Context-Individuals needing lifesaving (heart valves, skin grafts for repair of critical burn injuries) and life-enhancing (corneas, bone and tendon grafts, skin, and veins) tissue donations outnumber the tissues available for transplant. Objective-To describe the grief family members experienced 6 months after donation and to learn how family decision makers gained meaning from the decision to donate a loved one's tissues. This is phase 1 of a longitudinal study in which family decision makers will be surveyed again at 13 and 25 months after donation. Design-Qualitative descriptive. Participants-One hundred seven family decision makers whose family member died a traumatic sudden death and who authorized donating tissues for transplant. Data Collection and Analysis-Data were written responses to the questions, "If you could ask or tell your dead family member something, what would it be?" and "What meaning does donating tissue to others have for you?" Data were analyzed by using content analysis procedures. Results-Concepts derived from the first question represent the context of family members grieving the sudden death of a loved one. Concepts were (1) feeling empty, (2) missing and loving, (3) being grateful, and (4) having regrets. The concepts derived from the second question were (1) fulfilling their family member's wish, (2) doing the right thing, (3) believing something good came from the death, (4) helping others, and (5) living on. Reasons for donating were based, in part, on honoring the legacy of their loved ones who had given of themselves to others in life and now continued to give to others after death. Conclusion-The results of this study provide a basis for health professionals and donation staffs to better understand the context within which families grieve and give meaning to tissue donation. (C) 2013 NATCO, The Organization for Transplant Professionals	[Hogan, Nancy S.; Schmidt, Lee A.] Loyola Univ Chicago, Chicago, IL USA; [Coolican, Maggie] Musculoskeletal Transplant Fdn, East Hampton, CT USA		Hogan, NS (corresponding author), Loyola Univ Chicago, Marcella Niehoff Sch Nursing, 2160 South First Ave 105-2846, Maywood, IL 60153 USA.	nhogdn@luc.edu	Schmidt, Lee/AAY-4865-2021		Musculoskeletal Transplant Foundation	This study was partially supported by the Musculoskeletal Transplant Foundation.	Bellali T, 2007, Intensive Crit Care Nurs, V23, P216, DOI 10.1016/j.iccn.2007.01.002; Bellali T, 2006, DEATH STUD, V30, P883, DOI 10.1080/07481180600923257; Bredehorn T, 2002, TRANSPLANT P, V34, P2353, DOI 10.1016/S0041-1345(02)03284-0; Burnett P, 1997, PSYCHOL MED, V27, P49, DOI 10.1017/S0033291796004151; Burroughs TE, 1998, PSYCHOSOM MED, V60, P156, DOI 10.1097/00006842-199803000-00007; Cleiren MPHD, 2002, DEATH STUD, V26, P837, DOI 10.1080/07481180290106607; Core C, 2008, BEREAVEMENT CENTERED; Corr CA, 2011, PROG TRANSPLANT, V21, P220, DOI 10.7182/prtr.21.3.d33p21p72089213m; Corr CA, 2010, PROG TRANSPLANT, V20, P169, DOI 10.7182/prtr.20.2.w7727276m86241w4; DeSantis, 1992, QUALITATIVE HLTH RES, V2, P159, DOI 10.1177/104973239200200204; DOUGLASS GE, 1995, ANAESTH INTENS CARE, V23, P96, DOI 10.1177/0310057X9502300126; Gallup Organization, 1993, AM PUBLICS ATTITUDES; GORDON AK, 1995, CLIN TRANSPLANT, V9, P141; Gumbley E, 2006, Nurs Stand, V21, P51; Haire MC, 1996, MED J AUSTRALIA, V164, P28, DOI 10.5694/j.1326-5377.1996.tb94106.x; Hogan NS, 2002, DEATH STUD, V26, P615, DOI 10.1080/07481180290088338; Hogan NS, 2001, DEATH STUD, V25, P1, DOI 10.1080/074811801750058609; Jacobs J. E., 2005, DEV JUDGMENT DECISIO; Krippendorff K., 2018, CONTENT ANAL INTRO I; Lichtenthal WG, 2010, J CLIN PSYCHOL, V66, P791, DOI 10.1002/jclp.20700; Long T, 2008, SOC SCI MED, V67, P253, DOI 10.1016/j.socscimed.2008.03.039; Merchant SJ, 2008, CLIN TRANSPLANT, V22, P341, DOI 10.1111/j.1399-0012.2008.00790.x; Morse J M, 1995, Holist Nurs Pract, V9, P38; Nasrollahzadeh D, 2003, TRANSPL P, V35, P2545, DOI 10.1016/j.transproceed.2003.08.052; Neimeyer R., 2001, HDB BEREAVEMENT RES, P89, DOI DOI 10.1037/10436-004; Niday Patricia, 2007, Prog Transplant, V17, P289; Razek T, 2000, SURG CLIN N AM, V80, P1021, DOI 10.1016/S0039-6109(05)70111-0; Rodrigue JR, 2008, PEDIATR CRIT CARE ME, V9, P180, DOI 10.1097/PCC.0b013e3181668605; Saviozzi A, 2010, TRANSPL P, V42, P2195, DOI 10.1016/j.transproceed.2010.05.024; Sebach AM, 2012, J EMERG NURS, V38, P63, DOI 10.1016/j.jen.2011.01.013; Shabanzadeh AP, 2009, TRANSPL P, V41, P1480, DOI 10.1016/j.transproceed.2009.01.113; Shih FJ, 2001, PSYCHOSOM MED, V63, P69, DOI 10.1097/00006842-200101000-00009; Siminoff LA, 2010, J TRAUMA, V69, P956, DOI 10.1097/TA.0b013e3181d8924b; Siminoff LA, 2009, PROG TRANSPLANT, V19, P35, DOI 10.7182/prtr.19.1.9q02364408755h18; Sque M, 2005, TRANSPLANT P, V37, P543, DOI 10.1016/j.transproceed.2004.11.038; Sque M, 1996, SOC SCI MED, V43, P1359, DOI 10.1016/0277-9536(96)00002-0; Stouder DB, 2009, PROG TRANSPLANT, V19, P358; Tebourski Fethi, 2003, Tunis Med, V81, P482; WALKER JA, 1990, CAN MED ASSOC J, V142, P1383; Waters G, 2002, BEHAV BRAIN SCI, V25, P644, DOI 10.1017/S0140525X02480119; Wilson Penelope, 2006, Prog Transplant, V16, P52	41	11	11	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-9248	2164-6708		PROG TRANSPLANT	Prog. Transplant.	JUN	2013	23	2					180	187		10.7182/pit2013862			8	Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery; Transplantation	AT5KZ	WOS:000344983300012	23782667	Green Published			2022-02-06	
J	Lee, JK; Williams, M; Jennings, JM; Jamrogowicz, JL; Larson, AC; Jordan, LC; Heitmiller, ES; Hogue, CW; Ahn, ES				Lee, Jennifer K.; Williams, Monica; Jennings, Jacky M.; Jamrogowicz, Jessica L.; Larson, Abby C.; Jordan, Lori C.; Heitmiller, Eugenie S.; Hogue, Charles W.; Ahn, Edward S.			Cerebrovascular autoregulation in pediatric moyamoya disease	PEDIATRIC ANESTHESIA			English	Article						pediatric; neurosurgery; moyamoya; cerebrovascular; autoregulation	CEREBRAL-BLOOD-FLOW; NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; PERFUSION-PRESSURE; CARDIOPULMONARY BYPASS; PIAL SYNANGIOSIS; CARDIAC-ARREST; SWINE MODEL; CHILDREN; REVASCULARIZATION	Background Moyamoya syndrome carries a high risk of cerebral ischemia, and impaired cerebrovascular autoregulation may play a critical role. Autoregulation indices derived from near-infrared spectroscopy (NIRS) may clarify hemodynamic goals that conform to the limits of autoregulation. Objectives The aims of this pilot study were to determine whether the NIRS-derived indices could identify blood pressure ranges that optimize autoregulation and whether autoregulatory function differs between anatomic sides in patients with unilateral vasculopathy. Methods Pediatric patients undergoing indirect surgical revascularization for moyamoya were enrolled sequentially. NIRS-derived autoregulation indices, the cerebral oximetry index (COx) and the hemoglobin volume index (HVx), were calculated intraoperatively and postoperatively to measure autoregulatory function. The 5-mmHg ranges of optimal mean arterial blood pressure (MAPOPT) with best autoregulation and the lower limit of autoregulation (LLA) were identified. Results Of seven enrolled patients (aged 216years), six had intraoperative and postoperative autoregulation monitoring and one had only intraoperative monitoring. Intraoperative MAPOPT was identified in six (86%) of seven patients with median values of 6080mmHg. Intraoperative LLA was identified in three (43%) patients with median values of 5565mmHg. Postoperative MAPOPT was identified in six (100%) of six patients with median values of 7090mmHg. Patients with unilateral disease had higher intraoperative HVx (P=0.012) on side vasculopathy. Conclusions NIRS-derived indices may identify hemodynamic goals that optimize autoregulation in pediatric moyamoya.	[Lee, Jennifer K.; Williams, Monica; Heitmiller, Eugenie S.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Div Pediat Anesthesia, Baltimore, MD 21287 USA; [Jennings, Jacky M.] Johns Hopkins Univ, Sch Med, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; [Jennings, Jacky M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; [Jamrogowicz, Jessica L.; Larson, Abby C.; Hogue, Charles W.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Jordan, Lori C.] Vanderbilt Univ, Dept Neurol, Nashville, TN USA; [Ahn, Edward S.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21287 USA		Lee, JK (corresponding author), Johns Hopkins Univ, Div Pediat Anesthesia, Dept Anesthesiol & Crit Care Med, Charlotte R Bloomberg Childrens Ctr, 1800 Orleans St,Room 6321, Baltimore, MD 21287 USA.	jklee@jhmi.edu	Jordan, Lori/U-3167-2019	jennings, jacky/0000-0002-3789-5122; Larson, Abby/0000-0002-9106-993X	Covidien, Inc. (Boulder, CO); Somanetics; Covidien, Inc.; American Heart Association Scientist Development GrantAmerican Heart Association; International Anesthesia Research Society Clinical Scholars Award;  [NIH R01HL092259]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL092259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM075774] Funding Source: NIH RePORTER	Dr. Lee has received research support from Covidien, Inc. (Boulder, CO). Dr. Hogue received research funding from Somanetics and its parent company Covidien, Inc., and he served as a consultant to Covidien, Inc.; We would like to thank Claire Levine for her editorial assistance. Dr. Lee was supported by an American Heart Association Scientist Development Grant and The International Anesthesia Research Society Clinical Scholars Award. Dr. Hogue was supported by research grant NIH R01HL092259.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Easley RB, 2012, NEUROL RES IN PRESS; Gilmore MM, 2011, J PERINATOL, V31, P722, DOI 10.1038/jp.2011.17; Graham JF, 1997, CLIN NEUROL NEUROSUR, V99, pS31, DOI 10.1016/S0303-8467(97)00037-1; Gross BA, 2013, J CLIN NEUROSCI, V20, P44, DOI 10.1016/j.jocn.2012.08.002; Ibrahimi DM, 2010, CHILD NERV SYST, V26, P1297, DOI 10.1007/s00381-010-1209-8; Iwama T, 1996, NEUROSURGERY, V38, P1120, DOI 10.1097/00006123-199606000-00011; Joshi B, 2012, ANESTH ANALG, V114, P503, DOI 10.1213/ANE.0b013e31823d292a; Kawamata T, 2011, NEUROSURG REV, V34, P355, DOI 10.1007/s10143-011-0331-8; Khan N, 2012, NEUROSURGERY, V71, P587, DOI 10.1227/NEU.0b013e3182600b3c; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Lee JK, 2012, ANESTH ANALG, V114, P825, DOI 10.1213/ANE.0b013e31824762d5; Lee JK, 2011, CRIT CARE MED, V39, P2337, DOI 10.1097/CCM.0b013e318223b910; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Morisawa H, 2012, NEUROSURG REV; OGAWA A, 1990, ACTA NEUROCHIR, V105, P107, DOI 10.1007/BF01669991; OGAWA A, 1990, ACTA NEUROCHIR, V105, P30, DOI 10.1007/BF01664854; Oshima H, 2000, J NEUROSURG, V92, P949, DOI 10.3171/jns.2000.92.6.0949; Parray T, 2011, J NEUROSURG ANESTH, V23, P100, DOI 10.1097/ANA.0b013e3181f84fac; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Scott RM, 2004, J NEUROSURG, V100, P142, DOI 10.3171/ped.2004.100.2.0142; Smith ER, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.01.FOCUS08307; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Uchino H, 2012, STROKE, V43, P2610, DOI 10.1161/STROKEAHA.112.654723; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala MS, 2003, J NEUROSURG ANESTH, V15, P307, DOI 10.1097/00008506-200310000-00003; Vendrame M, 2011, PEDIATR NEUROL, V44, P427, DOI 10.1016/j.pediatrneurol.2011.01.004; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	33	11	12	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1155-5645			PEDIATR ANESTH	Pediatr. Anesth.	JUN	2013	23	6					547	556		10.1111/pan.12140			10	Anesthesiology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Pediatrics	137MV	WOS:000318440900011	23506446	Green Accepted			2022-02-06	
J	Yan, H; Zhang, HW; Fu, P; Liu, BL; Jin, WZ; Duan, SB; Xue, J; Liu, K; Sun, ZM; Zeng, XW				Yan, Hua; Zhang, Hong-Wei; Fu, Paul; Liu, Bao-Long; Jin, Wen-Zhe; Duan, Shi-Bo; Xue, Jing; Liu, Kui; Sun, Zhi-Ming; Zeng, Xian-Wei			Leptin's effect on accelerated fracture healing after traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						TBI; Fracture; leptin; GH; IGF-1	DEFICIENT OB/OB MICE; GROWTH-HORMONE; CALLUS FORMATION; HUMORAL-FACTORS; GENE-THERAPY; DOUBLE-BLIND; BONE; EXPRESSION; RATS; MASS	Objective: To investigate mechanisms behind the faster rehabilitation of limb fractures when associated with traumatic brain injury (TBI). Methods: New Zealand rabbits were divided into TBI group and sham-operation group for four studies as follows: (1) blood and cerebrospinal fluid (CSF) were drawn on days 1, 3, and 7 to demonstrate changes in serum leptin, growth hormone (GH), insulin-like growth factor 1 (IGF-1), and CSF leptin; (2) bone defection was created by drilling in the tibial bone and either leptin or normal saline was injected into rabbit's cerebellomedullary cistern. X-ray was taken at 1 days, 2 weeks, and 5 weeks and evaluated by criteria to determine rate of bone healing; (3) FITC-labeled rabbit leptin was injected into TBI and sham-operation groups, and frozen sections of rabbit brain were observed to identify differences in central nervous system (CNS) leptin by fluorescence; (4) polymerase chain reaction (PCR) was used to evaluate the expression of leptin production by brain tissue. Results: Serum and CSF leptin, GH, and IGF-1 concentrations were found to be higher in the TBI group than the sham-operation group at days 1, 3, and 7 (P<0.05). CSF leptin of the TBI group was positively correlated with serum leptin on day 1 (P<0.05), and positively correlated with GH and IGF-1 on days 3 and 7 (P<0.05). X-ray criteria demonstrated that leptin administration caused significantly faster healing calluses at 3 and 5 weeks as compared to control animals (P<0.05). FITC-labeled leptin study demonstrated that TBI animals had stronger expression of leptin in the brain than sham-operated animals. However, PCR of brain tissue leptin showed no significant differences between TBI and sham-operated animals in the expression of leptin. Conclusions: Our study suggests that increased CSF leptin, likely from blood-brain barrier breakdown, combined with elevated serum GH and IGF-1 after TBI, leads to accelerated fracture healing.	[Yan, Hua; Liu, Bao-Long; Xue, Jing; Sun, Zhi-Ming] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zhang, Hong-Wei] Tianjin Med Univ, Hosp 2, Dept Neurosurg, Tianjin, Peoples R China; [Fu, Paul] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI USA; [Jin, Wen-Zhe] Hebei Univ, Affiliated Hosp, Dept Neurosurg, Baoding, Peoples R China; [Duan, Shi-Bo] Cangzhou Cent Hosp, Dept Neurosurg, Cangzhou, Peoples R China; [Liu, Kui] Tianjin Peoples Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zeng, Xian-Wei] Weifang Med Coll, Affiliated Hosp, Dept Neurosurg, Weifang 261053, Peoples R China		Zeng, XW (corresponding author), Weifang Med Coll, Affiliated Hosp, Dept Neurosurg, Weifang 261053, Peoples R China.	szm618@yahoo.com.cn; zengxwei@163.com			Tianjin Public Health Bureau [2011KZ41, 10KG208]; Tianjin Municipal Science and Technology Commission [008ZCGYSF01600]	Hua Yan and Hong-Wei Zhang contributed equally to this study. This study was supported by grants from Tianjin Public Health Bureau (Nos. 2011KZ41 and 10KG208) and from Tianjin Municipal Science and Technology Commission (No. 008ZCGYSF01600).	Andreassen TT, 2003, CALCIFIED TISSUE INT, V73, P258, DOI 10.1007/S00223-002-2074-6; ANDREW JG, 1993, CALCIFIED TISSUE INT, V53, P97, DOI 10.1007/BF01321886; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Carro E, 1997, ENDOCRINOLOGY, V138, P2203, DOI 10.1210/en.138.5.2203; Cernak I, 1999, BRAIN INJURY, V13, P1005; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Dieguez C, 2011, NEUROENDOCRINOLOGY, V94, P1, DOI 10.1159/000328122; Dieter C, 2009, J BONE JOINT SURG AM, V91, P282; Federico G, 2003, HORM RES, V60, P46, DOI 10.1159/000071225; Frank SJ, 2007, ENDOCRINOLOGY, V148, P1486, DOI 10.1210/en.2007-0064; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; Hedstrom M, 2004, ACTA ORTHOP SCAND, V75, P394, DOI 10.1080/00016470410001141-1; Iwaniec UT, 2007, PEPTIDES, V28, P1012, DOI 10.1016/j.peptides.2007.02.001; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Raschke M, 2007, EUR J ENDOCRINOL, V156, P341, DOI 10.1530/EJE-06-0598; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Rosenbaum M, 1998, TRENDS ENDOCRIN MET, V9, P117, DOI 10.1016/S1043-2760(98)00028-9; Shenaq SM, 1996, CLIN PLAST SURG, V23, P157; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Takahashi MO, 1999, BIOCHEM BIOPH RES CO, V263, P100; Takeda Shu, 2011, Clin Calcium, V21, P691, DOI CliCa1105691696; Tena-Sempere M, 2001, J ENDOCRINOL, V170, P413, DOI 10.1677/joe.0.1700413; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Wlodarski Krzysztof, 2009, Ortop Traumatol Rehabil, V11, P1; Yi YS, 2000, DIAGNOSIS TREATMENT, P1; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	11	16	0	11	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	JUN	2013	35	5					537	544		10.1179/1743132813Y.0000000201			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	156IY	WOS:000319816500015	23594570				2022-02-06	
J	Yuan, Q; Liu, H; Wu, X; Sun, YR; Zhou, LF; Hu, J				Yuan, Qiang; Liu, Hua; Wu, Xing; Sun, Yirui; Zhou, Liangfu; Hu, Jin			Predictive value of initial intracranial pressure for refractory intracranial hypertension in persons with traumatic brain injury: A prospective observational study	BRAIN INJURY			English	Article						Brain injuries; intracranial pressure; prognosis; intracranial hypertension	CEREBRAL PERFUSION-PRESSURE; DECOMPRESSIVE CRANIECTOMY; BARBITURATE-COMA; GUIDELINES; MANAGEMENT; IMPACT	Objective: To prospectively investigate the predictive value of initial intracranial pressure (ICP) for refractory intracranial hypertension and outcomes in persons with diffuse traumatic brain injury (TBI). Methods: A prospective observational study was conducted in 107 adult persons with diffuse TBI (Marshall CT Class II-IV). Initial ICP was defined as the first ICP recorded in the operating room. Refractory intracranial hypertension was defined as ICP increases to more than 30mmHg and/or reduces in cerebral perfusion pressure to less than 60mmHg for a period longer than 15 minutes and failure to respond to the maximum medical treatment. Baseline demographics and injury-specific data were recorded. Multiple logistic regression models were used to determine independent risk factors for refractory intracranial hypertension and unfavourable outcomes. A receiver-operating characteristic (ROC) curve was then drawn. Results: The initial ICP allowed for a better refractory intracranial hypertension prediction (ROC area 0.868; 95% CI 0.799-0.937) than the Marshall Classification (ROC area 0.670; 95% CI 0.569-0.772) or Rotterdam Classification scores (ROC area 0.679; 95% CI 0.5770.780). An initial ICP value higher than 20mmHg had 83% sensitivity and 83% specificity, whereas an initial ICP value higher than 25mmHg had 64% sensitivity and 92% specificity for refractory intracranial hypertension. A multivariable logistic regression model showed that any 5mmHg pressure increase in a patient with initial ICP led to 2.884-times higher odds of refractory intracranial hypertension (95% CI 1.893-4.395; p<0.001). Head Abbreviated Injury Scale score, initial Glasgow Coma Scale (GCS) and initial GCS motor scores were not predictive of refractory intracranial hypertension (p>0.05). Conclusion: For persons with diffuse TBI, the initial ICP provides great prognostic discrimination and is an independent predictor of refractory intracranial hypertension.	[Yuan, Qiang; Wu, Xing; Sun, Yirui; Zhou, Liangfu; Hu, Jin] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China; [Liu, Hua] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China		Hu, J (corresponding author), Fudan Univ, Dept Neurosurg, Huashan Hosp, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	277089712@qq.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30371454, 81271375, 81171133]; Science and Technology Commission of Shanghai Municipality ProjectScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	This study was funded by the National Natural Science Foundation of China (NSFC Grants 30371454, 81271375 and 81171133), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300), Shanghai Nature Science Foundation (08411952000). The authors report no conflicts of interest.	Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 2000, MANAGEMENT PROGNOSIS; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Farahvar A, 2011, CURR OPIN ANESTHESIO, V24, P209, DOI 10.1097/ACO.0b013e328344016d; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; TEASDALE G, 1974, LANCET, V2, P81; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	23	11	12	2	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					664	670		10.3109/02699052.2013.775497			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500004	23611440				2022-02-06	
J	Armistead-Jehle, P; Buican, B				Armistead-Jehle, Patrick; Buican, Brett			Comparison of Select Advanced Clinical Solutions Embedded Effort Measures to the Word Memory Test in the Detection of Suboptimal Effort	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Suboptimal effort; Symptom Validity Tests; Word Memory Test; Advanced Clinical Solutions	SYMPTOM VALIDITY TESTS; NEUROPSYCHOLOGICAL TESTS; REPEATABLE BATTERY; MILITARY SAMPLE; EFFORT INDEX; PERFORMANCE; CLAIMANTS	This brief report sought to evaluate the classification statistics of the Advanced Clinical Solutions (ACS) embedded measures of symptom validity in relation to the Word Memory Test (WMT), a well-established standalone measure of effort in a sample of active duty military service members with a history of mild traumatic brain injury. Results demonstrated that relative to the WMT, the ACS embedded measures had adequate specificity, but lacked sensitivity. This result is in agreement with previous studies demonstrating poor sensitivity for embedded effort measures relative to standalone Symptom Validity Tests.	[Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Dept Behav Hlth, Ft Leavenworth, KS 66027 USA; [Buican, Brett] Ireland Army Community Hosp, Traumat Brain Injury Clin, Ft Knox, KY USA		Armistead-Jehle, P (corresponding author), Munson Army Hlth Ctr, Dept Behav Hlth, 550 Pope Ave, Ft Leavenworth, KS 66027 USA.	patrick.jehle@amedd.army.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2008, MANUAL FOR THE NONVE; Green P, 2004, GREENS MEDICAL SYMPT; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Pearson, 2009, ADVANCED CLINICAL SO; Randolph C, 1998, REPEATABLE BATTERY F; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Tombaugh T. N, 1996, THE TEST OF MEMORY M; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; [No title captured]	27	11	11	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2013	28	3					297	301		10.1093/arclin/act017			5	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	138YK	WOS:000318547600010	23535704	Bronze			2022-02-06	
J	Farrell, CA				Farrell, Catherine A.		Canadian Paediat Soc	Management of the paediatric patient with acute head trauma	PAEDIATRICS & CHILD HEALTH			English	Article						CT scan; Head trauma; Skull x-rays; Prevention; Traumatic brain injury	EARLY POSTTRAUMATIC SEIZURES; BRAIN-INJURY; COMPUTED-TOMOGRAPHY; SKULL FRACTURES; CHILDREN; PREDICTION; PREVENTION; PHENYTOIN; SCALE; COMA	Head trauma leading to brain injury is an important cause of morbidity and mortality in childhood. Injury severity is related to the mechanism of trauma, which itself varies with age. The vast majority of head trauma in paediatric patients is mild, requires no specific therapy and leaves no sequelae. However, it is important to identify individuals at risk of significant injury, and thus in need of specific evaluation. The purpose of this statement is to describe issues related to head trauma in infants, children and youth, including clinical manifestations, initial management priorities, guidelines for imaging, and subsequent observation and treatment. It addresses the evaluation of patients with acute trauma to the head at the time of initial assessment; it does not describe the subsequent management of such patients in the paediatric intensive care unit.	[Farrell, Catherine A.] Canadian Paediat Soc, 2305 St Laurent Blvd, Ottawa, ON K1G 4J8, Canada		Farrell, CA (corresponding author), Canadian Paediat Soc, 2305 St Laurent Blvd, Ottawa, ON K1G 4J8, Canada.	info@cps.ca					American College of Surgeons Committe on Trauma, 2008, ADV TRAUM LIF SUPP D; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Canadian Paediatric Society, 2012, AR WE DOING EN STAT; Canadian Paediatric Society Child and Youth Maltreatment Section Guidelines Working Group, 2007, MULT GUID ID INV MAN; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Erlichman DB, 2010, PEDIATR RADIOL, V40, P1375, DOI 10.1007/s00247-010-1555-4; Faul M, 2010, TRAUMATIC BRAIN INJU; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Friedman JN, 2011, PAED CHILD HEALT-CAN, V16, P91, DOI 10.1093/pch/16.2.91; Gordon Kevin E, 2006, Semin Pediatr Neurol, V13, P243, DOI 10.1016/j.spen.2006.09.005; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Guerguerian AM, 2009, CURR OPIN PEDIATR, V21, P737, DOI 10.1097/MOP.0b013e328332d11c; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mehta S, 2007, PAED CHILD HEALT-CAN, V12, P482, DOI 10.1093/pch/12.6.482; Meyer P, 2007, URGENCES SOINS INTEN, P901; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Parkin PC, 2009, LANCET, V374, P1127, DOI 10.1016/S0140-6736(09)61634-2; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Reed MJ, 2005, ARCH DIS CHILD, V90, P859, DOI 10.1136/adc.2004.053603; Sanford RA, 2010, J NEUROSURG-PEDIATR, V5, P213, DOI 10.3171/2009.9.PEDS09180; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; TEASDALE G, 1974, LANCET, V2, P81; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; YOUNG B, 1983, CHILD BRAIN, V10, P185; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016	38	11	13	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	MAY	2013	18	5					253	258		10.1093/pch/18.5.253			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	142HJ	WOS:000318787700008					2022-02-06	
J	Sears, JM; Graves, JM; Blanar, L; Bowman, SM				Sears, Jeanne M.; Graves, Janessa M.; Blanar, Laura; Bowman, Stephen M.			Case Identification of Work-Related Traumatic Brain Injury Using the Occupational Injury and Illness Classification System	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							CONSTRUCTION-INDUSTRY; EPIDEMIOLOGY; SURVEILLANCE; REGISTRY; RETURN; COSTS	Objectives: Traumatic brain injury (TBI) is one of the most common, costly, and disabling occupational injuries. Objectives included determining whether work-related TBI could be reliably identified using the Occupational Injury and Illness Classification System (OIICS) and describing challenges in developing an OIICS-based TBI case definition. Methods: Washington State trauma registry reports and workers' compensation claims were linked (1998 to 2008). Trauma registry diagnoses were used as the gold standard for six OIICS-based TBI case definitions. Results: The OIICS-based case definitions were highly specific but had low sensitivity, capturing less than a third of fatal and nonfatal TBI. Conclusion: The use of OIICS versus International Classification of Diseases-Ninth Revision-Clinical Modification codes underestimated TBI and changed the attributable cause distribution, with potential implications for prevention efforts. Surveillance methods that can more fully and accurately capture the impact of work-related TBI across the United States are needed.	[Sears, Jeanne M.; Blanar, Laura] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA; [Graves, Janessa M.] Univ Washington, Sch Med, Dept Pediat, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Bowman, Stephen M.] Natl Univ, Sch Hlth & Human Serv, Dept Community Hlth, San Diego, CA USA; [Bowman, Stephen M.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Dept Hlth Policy & Management, Baltimore, MD USA		Sears, JM (corresponding author), Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Box 354809, Seattle, WA 98195 USA.	jeannes@u.washington.edu	Bowman, Stephen/AAF-2154-2019; Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634	National Institute for Occupational Safety and Health (NIOSH)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [1R03OH009883]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [R03OH009883] Funding Source: NIH RePORTER	This study was funded in part by the National Institute for Occupational Safety and Health (NIOSH, 1R03OH009883). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIOSH. Dr Graves received fellowship support from the National Institute of Child Health and Human Development (T32HD057822).	Anderson NJ, 2010, AM J IND MED, V53, P693, DOI 10.1002/ajim.20815; Campbell Kevin M, 2008, Health Informatics J, V14, P5, DOI 10.1177/1460458208088855; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; Centers for Disease Control and Prevention, INJ PREV CONTR TAUM; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Faul M, 2010, TRAUMATIC BRAIN INJU; Forst LS, 1999, J OCCUP ENVIRON MED, V41, P514, DOI 10.1097/00043764-199906000-00019; Friedman LS, 2008, J OCCUP ENVIRON MED, V50, P350, DOI 10.1097/JOM.0b013e3181617324; Husberg BJ, 1998, AM J IND MED, V34, P493, DOI 10.1002/(SICI)1097-0274(199811)34:5&lt;493::AID-AJIM10&gt;3.0.CO;2-X; Kim H, 2006, NEUROREHABILITATION, V21, P269; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu M, 2011, WORK, V39, P283, DOI 10.3233/WOR-2011-1176; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; Mann NC, 2006, ACAD EMERG MED, V13, P946, DOI 10.1197/j.aem.2006.04.019; Marr A., 2004, CENTRAL NERVOUS SYST; National Institute for Occupational Safety and Health, OIICS; Office of Community Health Systems Health Systems Quality Assurance Washington State Department of Health, 1995, TRAUM WASH STAT CHAR; Sears JM, 2012, J OCCUP ENVIRON MED, V54, P356, DOI 10.1097/JOM.0b013e3182444fe7; Sears JM, 2011, J OCCUP ENVIRON MED, V53, P1243, DOI 10.1097/JOM.0b013e31822cff63; Sears JM, 2012, J OCCUP REHABIL; Seed PT, 2001, STATA TECH B, V59, P9; State of Washington, RCW TITL 51 EMPL OCC; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; *US DEP LAB, 2007, OCC INJ ILLN CLASS M; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Wei Chia, 2012, Minn Med, V95, P55; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	30	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1076-2752			J OCCUP ENVIRON MED	J. Occup. Environ. Med.	MAY	2013	55	5					507	513		10.1097/JOM.0b013e31827ee018			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	141UR	WOS:000318752500007	23618883	Green Accepted			2022-02-06	
J	Liedtke, W; Yeo, M; Zhang, HB; Wang, YD; Gignac, M; Miller, S; Berglund, K; Liu, J				Liedtke, Wolfgang; Yeo, Michele; Zhang, Hongbo; Wang, Yiding; Gignac, Michelle; Miller, Sara; Berglund, Ken; Liu, Jie			Highly Conductive Carbon Nanotube Matrix Accelerates Developmental Chloride Extrusion in Central Nervous System Neurons by Increased Expression of Chloride Transporter KCC2	SMALL			English	Article						carbon nanotubes; neuronal chloride; KCC2; chloride extrusion; central nervous system	IN-VITRO; CONTRIBUTES; PROMOTES; HYPEREXCITABILITY; DISRUPTION; RECOVERY; SWITCH	Exceptional mechanical and electrical properties of carbon nanotubes (CNT) have attracted neuroscientists and neural tissue engineers aiming to develop novel devices that interface with nervous tissues. In the central nervous system (CNS), the perinatal chloride shift represents a dynamic change that forms the basis for physiological actions of -aminobutyric acid (GABA) as an inhibitory neurotransmitter, a process of fundamental relevance for normal functioning of the CNS. Low intra-neuronal chloride concentrations are maintained by a chloride-extruding transporter, potassium chloride cotransporter 2 (KCC2). KCC2's increasing developmental expression underlies the chloride shift. In neural injury, repressed KCC2 expression plays a co-contributory role by corrupting inhibitory neurotransmission. Mechanisms of Kcc2 up-regulation are thus pertinent because of their medical relevance, yet they remain elusive. Here, it is shown that primary CNS neurons originating from the cerebral cortex, cultured on highly-conductive few-walled-CNT (fwCNT) have a strikingly accelerated chloride shift caused by increased KCC2 expression. KCC2 upregulation is dependent on neuronal voltage-gated calcium channels (VGCC) and, furthermore, on calcium/calmodulin-dependent kinase II, which is linked to VGCC-mediated calcium-influx. It is also demonstrated that accelerated Kcc2 transcription in brain-slices prepared from genetically-engineered reporter mice, in which Kcc2 promoter drives luciferase, when the cerebral cortex of these mice is exposed to fwCNT-coated devices. Based on these findings, whether fwCNT can enhance neural engineering devices for the benefit of neural injury conditions associated with elevated neuronal intracellular chloride concentrationsuch as pain, epilepsy, traumatic neural injury and ischemiacan now be addressed. Taken together, our novel insights illustrate how fwCNTs can promote low neuronal chloride in individual neurons and thus inhibitory transmission in neural circuits.	[Liedtke, Wolfgang; Yeo, Michele; Wang, Yiding; Berglund, Ken] Duke Univ, Dept Med Neurol, Durham, NC 27710 USA; [Liedtke, Wolfgang] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Liedtke, Wolfgang] Duke Univ, Ctr Neuroengn, Durham, NC 27710 USA; [Liedtke, Wolfgang] Duke Univ, Duke Clin Pain Care, Durham, NC 27710 USA; [Liedtke, Wolfgang] Duke Univ, Duke Clin Palliat Care, Durham, NC 27710 USA; [Zhang, Hongbo; Liu, Jie] Duke Univ, Dept Chem, Durham, NC 27710 USA; [Gignac, Michelle] Duke Univ, Dept Mech Engn, Durham, NC 27710 USA; [Miller, Sara] Duke Univ, Dept Pathol, Durham, NC 27710 USA		Liedtke, W (corresponding author), Duke Univ, Dept Med Neurol, Durham, NC 27710 USA.	wolfgang@neuro.duke.edu	Liu, Jie/B-4440-2010	Liu, Jie/0000-0003-0451-6111	Duke University; Klingenstein Fund, New York, NY; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS066307]; Center for the Environmental Implications of NanoTechnology, CEINT (NSF) [EF-0830093]; Unidym, Inc. (Sunnyvale CA); Duke University (PI JL); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS066307] Funding Source: NIH RePORTER	The authors wish to thank Dr. Sidney Simon, Duke University, for critical reading of the manuscript, and the late Dr. Timothy Olliver, also Duke University, for assistance with confocal microscopy. This study was supported by funding from Duke University, the Klingenstein Fund, New York, NY, and the NIH (R21NS066307) to WL, and by the Center for the Environmental Implications of NanoTechnology, CEINT (maintained by the NSF and the EPA; NSF Cooperative Agreement Number EF-0830093) to JL. In regards to the latter, any opinions, findings, conclusions or recommendations expressed in this article are those of the authors and do not necessarily reflect the views of the NSF or the EPA. This work has not been subjected to EPA review and no official endorsement should be inferred. HZ was partially supported by a contractual agreement between Unidym, Inc. (Sunnyvale CA) and Duke University (PI JL).	Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108; Bandyopadhyaya R, 2002, NANO LETT, V2, P25, DOI 10.1021/nl010065f; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Ciofani G, 2010, METHODS MOL BIOL, V625, P67, DOI 10.1007/978-1-60761-579-8_7; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; EGGERMONT J, 1993, EMBO J, V12, P2539, DOI 10.1002/j.1460-2075.1993.tb05909.x; Feng YY, 2008, ACS NANO, V2, P1634, DOI 10.1021/nn800388g; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Fiumelli H, 2007, CURR OPIN NEUROBIOL, V17, P81, DOI 10.1016/j.conb.2007.01.002; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gilmore JL, 2008, J NEUROIMMUNE PHARM, V3, P83, DOI 10.1007/s11481-007-9099-6; Higgins P, 2011, NAT NANOTECHNOL, V6, P83, DOI 10.1038/nnano.2011.5; Hou Y, 2009, ACS NANO, V3, P1057, DOI 10.1021/nn9000512; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lee HJ, 2011, NAT NANOTECHNOL, V6, P120, DOI 10.1038/nnano.2010.281; Lee W, 2009, PROG BRAIN RES, V180, P111, DOI 10.1016/S0079-6123(08)80006-4; Li JJ, 2011, ENVIRON HEALTH PERSP, V119, P784, DOI 10.1289/ehp.1002807; Lu J, 2008, NANO LETT, V8, P3325, DOI 10.1021/nl801744z; Malek SA, 2003, J NEUROSCI, V23, P3826; Moon SU, 2012, INT J NANOMED, V7, P2751, DOI 10.2147/IJN.S30273; Odom TW, 2002, ANN NY ACAD SCI, V960, P203, DOI 10.1111/j.1749-6632.2002.tb03035.x; Pellegrino C, 2011, J PHYSIOL-LONDON, V589, P2475, DOI 10.1113/jphysiol.2010.203703; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; Qi H, 2006, CHEM MATER, V18, P5691, DOI 10.1021/cm061528r; Qian C, 2006, J NANOSCI NANOTECHNO, V6, P1346, DOI 10.1166/jnn.2006.140; Rak K, 2011, J BIOMED MATER RES A, V97A, P158, DOI 10.1002/jbm.a.33042; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SCHILD D, 1995, J NEUROSCI METH, V59, P183, DOI 10.1016/0165-0270(94)00181-F; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Yeo M, 2009, J NEUROSCI, V29, P14652, DOI 10.1523/JNEUROSCI.2934-09.2009; Zheng B, 2002, ADV MATER, V14, P122, DOI 10.1002/1521-4095(20020116)14:2<122::AID-ADMA122>3.0.CO;2-V; Zhu L, 2008, EPILEPSY RES, V79, P201, DOI 10.1016/j.eplepsyres.2008.02.005	40	11	12	0	35	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1613-6810	1613-6829		SMALL	Small	APR 8	2013	9	7					1066	1075		10.1002/smll.201201994			10	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	118IT	WOS:000317019800017	23229576	Green Accepted			2022-02-06	
J	Hayden, ME; Plenger, P; Bison, K; Kowalske, K; Masel, B; Qualls, D				Hayden, Mary Ellen; Plenger, Patrick; Bison, Kier; Kowalske, Karen; Masel, Brent; Qualls, Devin			Treatment Effect Versus Pretreatment Recovery in Persons With Traumatic Brain Injury: A Study Regarding the Effectiveness of Postacute Rehabilitation	PM&R			English	Article							ENVIRONMENTAL ENRICHMENT; TACTILE STIMULATION; NEURAL PLASTICITY; LEARNED NONUSE; STROKE; EXPERIENCE; REORGANIZATION; MECHANISMS; OUTCOMES; CORTEX	Objective: To evaluate functional improvement following a traumatic brain injury (TBI) after admission to a postacute treatment facility, focusing on the time since injury and analysis of recovery by degree of impairment at admission. Design: A retrospective study of patients who received treatment at a postacute rehabilitation facility. Setting: Postacute rehabilitation for persons with acquired brain injury that involved transdisciplinary teams. Patients: Patients (n = 1274) were admitted for treatment less than 5 years after TBI and were assessed on our outcome measures at least 3 times. The patients were then grouped by the time since injury and the severity of impairment at admission. Methods: Patients received comprehensive multidisciplinary treatment 5 days per week, 6 hours per day. Main Outcome Measurements: Function was assessed by using the Pate Environmentally Relevant Program Outcome System (PERPOS) scale at admission, discharge, and approximately every 2 weeks during treatment. By using these assessment scores, the rate and degree of improvement were monitored. Results: Postacute rehabilitation yielded significant gains in functioning, with 69% of all patients who demonstrated clinically meaningful gains. The time since injury had a significant impact on gains made in rehabilitation (F-time (x) (time-since-treatment group) (interaction) = 17.75; P < .001), with the 0-3 months post injury group outperforming each other group (P < .001 for each comparison). This effect was statistically significant (P < .001) for each of the 3 severity-at-intake subgroups analyzed but was stronger for the severe (F-314 = 9.05) and moderate-to-severe (F-425 = 7.32) than for the mild-to-moderate (F-533 = 2.95) severity-at-intake groups. Conclusions: Postacute rehabilitation is associated with functional gains for individuals with TBI beyond what can be explained by undirected recovery. These findings provide evidence for postacute rehabilitation as effective care after TBI.	[Hayden, Mary Ellen] Pate Rehabil, Dallas, TX 75254 USA; [Plenger, Patrick] Pate Rehabil, Clin Res & Dev, Dallas, TX 75254 USA; [Bison, Kier] Pate Rehabil, Program Dev, Dallas, TX 75254 USA; [Kowalske, Karen] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Masel, Brent] Transit Learning Ctr Galveston, Galveston, TX USA; [Qualls, Devin] Pate Rehabil, Res & Therapy Dev, Dallas, TX 75254 USA		Hayden, ME (corresponding author), Pate Rehabil, 2655 Villa Creek Dr,Suite 140, Dallas, TX 75254 USA.	mehi@swbell.net			Pate Rehabilitation	Disclosures: board membership, founder, direct funds received, Pate Rehabilitation; consultancy, direct funds received, Pate Rehabilitation	Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bowers D., 1989, ARCH PHYS MED REHAB, V70, pA58; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carod-Artal FJ, 2005, BRAIN INJURY, V19, P667, DOI 10.1080/02699050400013626; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Cohen J., 2013, STAT POWER ANAL BEHA; Davis A E, 2000, Crit Care Nurs Clin North Am, V12, P447; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Faul M, 2010, TRAUMATIC BRAIN INJU; Friedman RM, 2004, P NATL ACAD SCI USA, V101, P12724, DOI 10.1073/pnas.0404884101; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Hayden ME, 2000, J HEAD TRAUMA REHAB, V15, P1000, DOI 10.1097/00001199-200008000-00004; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Jones TA, 2011, NEUROPLASTICITY REHA, P38; Khem JA, 2011, J COMMUN DISORD, V44, P521; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kolb B., 2011, NEUROPLASTICITY REHA, P13; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Lillie RA, 2011, NEUROPLASTICITY REHA, P257; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Micklewright JL, 2011, ARCH PHYS MED REHAB, V92, P1974, DOI 10.1016/j.apmr.2011.07.199; Morns DM, 2011, NEUROPLASTICITY REHA, P117; Munoz-Cespedes JM, 2005, NEUROPSYCHOL REV, V15, P169, DOI 10.1007/s11065-005-9178-5; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nudo RJ, 2011, NEUROPLASTICITY REHA, P65; Ratan RR, 2009, STROKE, V40, pS130, DOI 10.1161/STROKEAHA.108.534933; Rijntjes M, 2006, CURR OPIN NEUROL, V19, P76, DOI 10.1097/01.wco.0000203886.28068.38; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Seung S., 2012, CONNECTOME BRAINS WI; Slade A, 2002, J REHABIL MED, V34, P260, DOI 10.1080/165019702760390347; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Turner-Stokes L, 2004, CLIN MED, V4, P10, DOI 10.7861/clinmedicine.4-1-10; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Waehrens Eva Ejlersen, 2007, Scand J Occup Ther, V14, P250, DOI 10.1080/11038120601182974; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Will B, 1992, RECOVERY BRAIN DAMAG, P799; Wittenberg GF, 2010, NEUROBIOL DIS, V37, P252, DOI 10.1016/j.nbd.2009.09.007; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Zorowitz R, 2011, STROKE, V42, P294, DOI 10.1161/STROKEAHA.110.605063	50	11	12	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	APR	2013	5	4					319	327		10.1016/j.pmrj.2012.12.005			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	137VI	WOS:000318465900008	23375632				2022-02-06	
J	Letourneau-Guillon, L; Huynh, T; Jakobovic, R; Milwid, R; Symons, SP; Aviv, RI				Letourneau-Guillon, L.; Huynh, T.; Jakobovic, R.; Milwid, R.; Symons, S. P.; Aviv, R. I.			Traumatic Intracranial Hematomas: Prognostic Value of Contrast Extravasation	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							PRIMARY INTRACEREBRAL HEMORRHAGE; ANGIOGRAPHY SPOT SIGN; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; IN-HOSPITAL MORTALITY; ACUTE HEAD-INJURY; BRAIN-INJURY; CT ANGIOGRAPHY; IDENTIFIES PATIENTS; HIGHEST RISK; PROGRESSION	BACKGROUND AND PURPOSE: Contrast extravasation within spontaneous intracranial hemorrhage is a well-described predictor of hematoma growth, poor clinical outcome, and mortality. The purpose of this study was to assess the prognostic value of contrast extravasation in acute traumatic intracranial hematomas. MATERIALS AND METHODS: In our institution, CTA (including PCCT) is the primary screening technique for cervical vascular injuries. Sixty consecutive patients with at least 1 acute intracranial hematoma (ICH, subdural hematoma, and/or epidural hematoma) meeting pre-defined size criteria, with CTA/PCCT performed within 24 hours of admission and follow-up CT within 72 hours of admission, were retrospectively evaluated for CE by 2 observers. The predictive value of CE for a composite outcome (hematoma expansion, need for hematoma evacuation, in-hospital mortality) was evaluated on a per-patient basis. Interobserver agreement for CE and the association between baseline variables and outcome were also examined. Different patterns of extravasation were evaluated on a per-lesion basis, with outcomes including hematoma expansion and evacuation. RESULTS: CE was present in 30 (50%) patients with almost perfect interobserver agreement (kappa = 0.87; 95% CI, 0.74-0.99). The per-patient multivariate analysis showed independent association of midline shift (P = .020), Glasgow Coma Scale score <= 8 (P = .024), and CE (P = .017), with poor outcome and demonstrated a trend toward poor outcome prediction for age 65 years or older (P = .050). In the per-lesion analysis, only extravasation identified on CTA (active and contained extravasation) was associated with hematoma expansion and evacuation. CONCLUSIONS: Contrast extravasation within intracranial hematomas predicts poor in-hospital outcome in the setting of acute traumatic intracranial injuries.	[Letourneau-Guillon, L.; Huynh, T.; Jakobovic, R.; Milwid, R.; Symons, S. P.; Aviv, R. I.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada		Aviv, RI (corresponding author), Sunnybrook Hlth Sci Ctr, Room AG 31,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	richard.aviv@sunnybrook.ca	Letourneau-Guillon, Laurent/AAD-7324-2021	Letourneau-Guillon, Laurent/0000-0002-6325-7538; Huynh, Thien/0000-0001-9319-952X			Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Almandoz JED, 2012, J NEUROINTERV SURG, V4, P442, DOI 10.1136/neurintsurg-2011-010061; Almandoz JED, 2010, STROKE, V41, P54, DOI 10.1161/STROKEAHA.109.565382; Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; Becker KJ, 1999, STROKE, V30, P2025, DOI 10.1161/01.STR.30.10.2025; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; d'Esterre CD, 2011, AM J NEURORADIOL, V32, P1879, DOI 10.3174/ajnr.A2669; Divani AA, 2011, STROKE, V42, P1569, DOI 10.1161/STROKEAHA.110.607861; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; Ederies A, 2009, STROKE, V40, P1672, DOI 10.1161/STROKEAHA.108.541201; Gazzola S, 2008, STROKE, V39, P1177, DOI 10.1161/STROKEAHA.107.499442; Goldstein JN, 2007, NEUROLOGY, V68, P889, DOI 10.1212/01.wnl.0000257087.22852.21; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Hallevi H, 2010, CEREBROVASC DIS, V29, P217, DOI 10.1159/000267842; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; Kim J, 2008, AM J NEURORADIOL, V29, P520, DOI 10.3174/ajnr.A0859; Li N, 2011, STROKE, V42, P3441, DOI 10.1161/STROKEAHA.111.623405; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MAUSER HW, 1984, NEURORADIOLOGY, V26, P31, DOI 10.1007/BF00328200; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; Mnyusiwalla A, 2009, NEURORADIOLOGY, V51, P635, DOI 10.1007/s00234-009-0543-6; Murai Y, 1999, J NEUROSURG, V91, P424, DOI 10.3171/jns.1999.91.3.0424; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Park SY, 2010, J KOREAN NEUROSURG S, V48, P399, DOI 10.3340/jkns.2010.48.5.399; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Subramanian SK, 2002, NEUROL RES, V24, P125, DOI 10.1179/016164102101199657; Takanashi Y, 2001, J CLIN NEUROSCI, V8, P240, DOI 10.1054/jocn.2000.0804; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Thompson AL, 2009, CAN J NEUROL SCI, V36, P456, DOI 10.1017/S0317167100007782; Tomida M, 1998, NEUROSURGERY, V43, P66, DOI 10.1097/00006123-199807000-00040; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Tsuchida Y, 2001, MED PEDIATR ONCOL, V37, P1, DOI 10.1002/mpo.1154; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Wang YH, 2011, EUR NEUROL, V65, P150, DOI 10.1159/000324153; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729; 2006, NEUROSURGERY, V58, pS2	57	11	12	0	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2013	34	4					773	779		10.3174/ajnr.A3309			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	301MB	WOS:000330535300022	23079406	hybrid, Green Published			2022-02-06	
J	Liang, XY; Li, HN; Yang, XY; Zhou, WY; Niu, JG; Chen, BD				Liang, Xue-Yun; Li, Hai-Ning; Yang, Xiao-Yan; Zhou, Wen-Yan; Niu, Jian-Guo; Chen, Ben-Dong			Effect of Danshen aqueous extract on serum hs-CRP, IL-8, IL-10, TNF-alpha levels, and IL-10 mRNA, TNF-alpha mRNA expression levels, cerebral TGF-beta 1 positive expression level and its neuroprotective mechanisms in CIR rats	MOLECULAR BIOLOGY REPORTS			English	Article						Cerebral; Ischemia reperfusion; Danshen aqueous extract; Neuroprotection; IL-10 mRNA; TNF-alpha mRNA; RT-PCR	C-REACTIVE PROTEIN; ISCHEMIC-STROKE PATIENTS; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CORONARY-HEART-DISEASE; TUMOR-NECROSIS-FACTOR; CHINESE HERBAL DRUG; SALVIA-MILTIORRHIZA; PROSTATE-CANCER; OXIDATIVE STRESS	To observe the effects of Danshen aqueous extract (DSAE) on the cerebral tissue and nerve stem cells in cerebral ischemia reperfusion (CIR) rats. The model rats were prepared by occlusion of the middle cerebral artery for 2 h and then by reperfusion. They were randomly divided into five groups: a control group, an CIR group and three DSAE-treated groups. As compared with the sham control group, there was significant increase (P < 0.05, P < 0.01) in the serum high-sensitivity C-reactive protein (hs-CRP) and interleukin-8 (IL-8) levels, interleukin-10 (IL-10), tumor necrosis factor-alpha (TNF-alpha) levels, and IL-10 mRNA, TNF-alpha mRNA expression levels, function score, Infarct size, TUNEL + cell counts, cerebral transforming growth factor beta 1 (TGF-beta 1) positive expression and cerebral neuron specific enolase (NSE) levels, and decrease in fas-associated protein with death domain (FADD) and death-associated protein (Daxx) positive expression levels in the CIR group. Compared with CIR group, DSAE treatment dose-dependently significantly decreased serum hs-CRP, IL-8, IL-10, TNF-alpha levels, and IL-10 mRNA, TNF-alpha mRNA expression levels, function score, Infarct size, TUNEL + cell counts, cerebral TGF-beta 1 positive expression and cerebral NSE levels, and increase FADD and Daxx positive expression levels in the CIR + DSAE groups. Taken together, these results suggest that DSAE has a neuroprotective role in the CIR rats, which may be related to improvement of immunity function, proteins and genes expression.	[Liang, Xue-Yun; Yang, Xiao-Yan] Gen Hosp Ningxia Med Univ, Dept Lab Med, Yinchuan 750004, Peoples R China; [Li, Hai-Ning] Gen Hosp Ningxia Med Univ, Dept Neurol, Yinchuan 750004, Peoples R China; [Zhou, Wen-Yan] Gen Hosp Ningxia Med Univ, Dept ICU, Yinchuan 750004, Peoples R China; [Niu, Jian-Guo] Ningxia Med Univ, Sch Basic Med Sci, Dept Anat Histol & Embryol, Yinchuan 750004, Peoples R China; [Chen, Ben-Dong] Gen Hosp Ningxia Med Univ, Dept Hepatobiliary Surg, Yinchuan 750004, Peoples R China		Niu, JG (corresponding author), Ningxia Med Univ, Sch Basic Med Sci, Dept Anat Histol & Embryol, Yinchuan 750004, Peoples R China.	jguoniu@163.com; prbdchen@163.com					Albers GW, 2008, CHEST, V133, p630S, DOI 10.1378/chest.08-0720; Ata AK, 1997, ACTA NEUROPATHOL, V93, P326, DOI 10.1007/s004010050623; BARONE FC, 1992, STROKE, V23, P1337, DOI 10.1161/01.STR.23.9.1337; Bemeur C, 2005, NEUROCHEM INT, V46, P399, DOI 10.1016/j.neuint.2004.11.007; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145; Chan K, 2004, LIFE SCI, V75, P3157, DOI 10.1016/j.lfs.2004.06.010; Cheng TO, 2006, INT J CARDIOL, V110, P411, DOI 10.1016/j.ijcard.2005.08.069; Cheng TO, 2006, INT J CARDIOL, V113, P437, DOI 10.1016/j.ijcard.2005.10.026; Date I, 2006, NEUROSCI LETT, V407, P141, DOI 10.1016/j.neulet.2006.08.050; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Dietl M, 2009, FORTSCHR NEUROL PSYC, V77, P714, DOI 10.1055/s-0028-1109912; Dietrich WD, 1999, EXP NEUROL, V158, P444, DOI 10.1006/exnr.1999.7115; Dirnagl U, 2009, BRIT J PHARMACOL, V157, P1154, DOI 10.1111/j.1476-5381.2009.00211.x; Ellnain-Wojtaszek M, 2003, FITOTERAPIA, V74, P1, DOI 10.1016/S0367-326X(02)00306-4; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Guo BQ, 2004, ANTICANCER RES, V24, P1337; Hak AE, 1999, ARTERIOSCL THROM VAS, V19, P1986, DOI 10.1161/01.ATV.19.8.1986; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Huang JT, 2005, AM J PATHOL, V166, P1807, DOI 10.1016/S0002-9440(10)62490-X; Inoue K, 2000, CANCER RES, V60, P2290; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; Kang DG, 2002, AM J CHINESE MED, V30, P87, DOI 10.1142/S0192415X02000107; KEJI C, 1981, AM J CHINESE MED, V9, P193, DOI 10.1142/S0192415X81000251; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Krupinski J, 1998, NITRIC OXIDE-BIOL CH, V2, P442, DOI 10.1006/niox.1998.0204; Lee EJ, 2002, J NEUROSCI RES, V68, P636, DOI 10.1002/jnr.10251; Lee JC, 2005, GLIA, V50, P168, DOI 10.1002/glia.20164; Lee LF, 2004, ONCOGENE, V23, P2197, DOI 10.1038/sj.onc.1207344; Lehrer S, 2004, TECHNOL CANCER RES T, V3, P411, DOI 10.1177/153303460400300501; Li MH, 2008, J ETHNOPHARMACOL, V120, P419, DOI 10.1016/j.jep.2008.09.013; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu CS, 2006, ACTA PHARMACOL SIN, V27, P1137, DOI 10.1111/j.1745-7254.2006.00378.x; Liu LS, 2006, INT J STROKE, V1, P150, DOI 10.1111/j.1747-4949.2006.00041.x; Liu Nan, 2007, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V23, P498; Mendall MA, 1996, BRIT MED J, V312, P1061; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Mostaza JM, 2009, CEREBROVASC DIS, V27, P77, DOI 10.1159/000200443; Ormstad H, 2011, J NEUROL, V258, P677, DOI 10.1007/s00415-011-6006-0; Palmio J, 2010, PSYCHIAT RES, V177, P97, DOI 10.1016/j.psychres.2009.01.027; Patel BJ, 2000, J UROLOGY, V164, P1420, DOI 10.1016/S0022-5347(05)67210-2; Perini F, 2001, NEUROL SCI, V22, P289, DOI 10.1007/s10072-001-8170-y; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Qian SH, 2011, J ETHNOPHARMACOL, V137, P985, DOI 10.1016/j.jep.2011.07.018; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P3546, DOI 10.1128/AAC.49.8.3546-3549.2005; Reiland J, 1999, PROSTATE, V41, P78; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Song IU, 2010, EUR NEUROL, V64, P304, DOI 10.1159/000321415; Tam WY, 2009, J ALTERN COMPLEM MED, V15, P415, DOI 10.1089/acm.2008.0400; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Tian Xiao-hui, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P404; Veltri RW, 1999, UROLOGY, V53, P139, DOI 10.1016/S0090-4295(98)00455-5; Vila N, 2003, STROKE, V34, P671, DOI 10.1161/01.STR.0000057976.53301.69; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Wang Xue-feng, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P969; Wei Z M, 1996, Zhongguo Zhong Xi Yi Jie He Za Zhi, V16, P402; Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325; Wu WWP, 2010, PHYTOMEDICINE, V17, P219, DOI 10.1016/j.phymed.2009.05.005; Youn CS, 2012, AM J EMERG MED, V30, P124, DOI 10.1016/j.ajem.2010.11.006; Yue KKM, 2006, J ETHNOPHARMACOL, V106, P136, DOI 10.1016/j.jep.2005.12.026; Zhai QH, 1997, J NEUROL SCI, V152, P119, DOI 10.1016/S0022-510X(97)00154-8; Zhang Mei, 2003, Zhong Yao Cai, V26, P738; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	73	11	13	1	19	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	APR	2013	40	4					3419	3427		10.1007/s11033-012-2419-9			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	107MH	WOS:000316221100071	23378241				2022-02-06	
J	Uruma, G; Hashimoto, K; Abo, M				Uruma, Go; Hashimoto, Keiji; Abo, Masahiro			A new method for evaluation of mild traumatic brain injury with neuropsychological impairment using statistical imaging analysis for Tc-ECD SPECT	ANNALS OF NUCLEAR MEDICINE			English	Article						Mild traumatic brain injury; Neuropsychological impairments; Single photon emission computed tomography; Statistical imaging analysis	DIFFUSE AXONAL INJURY; CEREBRAL-BLOOD-FLOW; EMISSION-TOMOGRAPHY; GLUCOSE-METABOLISM; HEAD-INJURY; ACUTE STAGE; CORTEX; SUPPORTS; BEHAVIOR; DEFICITS	The objective of this study was to identify specific brain lesions with regional perfusion abnormalities possibly associated with neuropsychological impairments (NPI), as sequela after mild traumatic brain injury (MTBI), using 99mTc-ethylcysteinate dimer single photon emission computed tomography (Tc-99m ECD SPECT) and its novel analytic software. We studied 23 patients with diffuse axonal injury with NPI group (Impaired-DAI), 26 with MTBI with NPI group (Impaired-MTBI) and 24 with MTBI without NPI group (Healthy-MTBI). In each subject, Tc-99m ECD SPECT images were analyzed by easy Z score imaging system (eZIS) and voxel-based stereotactic extraction estimation (vbSEE). Segmented into lobule levels, ROIs were set in 140 areas in whole brain, and relative regional low Tc-99m ECD uptake was computed as "extent" (rate of coordinates with Z score > 2.0 in the ROI). Receiver operating characteristic analysis was performed using "extent" to discriminate the three groups. The highest area under the curve (AUC) value for data of Impaired-DAI and Healthy-MTBI groups was obtained in ROI on the left anterior cingulate gyrus (LtACG), with AUC of 0.93, optimal "extent" cutoff value of 10.9 %, sensitivity 87.0 %, specificity 83.3 %. The highest AUC value for data of Impaired-MTBI and Healthy-MTBI groups was also in the LtACG, with AUC of 0.87, optimal "extent" cutoff value of 9.2 %, sensitivity 73.1 %, specificity 83.3 %. Using two analytic software packages, eZIS and vbSEE, we identified specific lesions with low regional Tc-99m ECD uptake possibly associated with NPIs after MTBI. Especially, this trend was most marked in the left anterior cingulate gyrus in MTBI patients with NPIs and those with DAI. The optimal "extent" cutoff value, as a criterion for SPECT abnormality, might help the diagnosis of NPIs after MTBI.	[Uruma, Go; Hashimoto, Keiji; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, Tokyo, Japan; [Uruma, Go] Kanagawa Rehabil Hosp, Dept Rehabil Med, Atsugi, Kanagawa, Japan; [Hashimoto, Keiji] Natl Ctr Child Hlth & Dev, Div Rehabil Med, Tokyo, Japan		Uruma, G (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo, Japan.	uruma-jk@jikei.ac.jp		Hashimoto, Keiji/0000-0003-2412-860X; Abo, Masahiro/0000-0001-6701-4974	General Insurance Association of Japan	The authors appreciate the excellent technical support provided by Dr. M. Uchiyama and the radiological technologists at the Department of Radiology, Jikei University School of Medicine. This study was supported by a grant from The General Insurance Association of Japan. The authors declare that we have no conflict of interest.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Friston KJ, 1996, CEREB CORTEX, V6, P156, DOI 10.1093/cercor/6.2.156; Gardner RM, 2003, J HEAD TRAUMA REHAB, V18, P52, DOI 10.1097/00001199-200301000-00007; Gennarelli T A, 1984, Emerg Med Clin North Am, V2, P749; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; GRAHAM DI, 2000, HEAD INJURY, P176; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Katagi H, 2008, JIKEIKAI MED J, V123, P237; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Matsuda H, 2007, AM J NEURORADIOL, V28, P731; Matsuda H, 2004, NUCL MED COMMUN, V25, P67, DOI 10.1097/00006231-200401000-00010; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Mizumura S, 2003, ANN NUCL MED, V17, P289, DOI 10.1007/BF02988523; Momosaki R, 2012, EUR NEUROL, V67, P74, DOI 10.1159/000333778; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Okamoto T, 2007, EUR J NEUROL, V14, P540, DOI 10.1111/j.1468-1331.2007.01742.x; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Talairach J., 1988, COPLANAR STEREOTAXIC; Uruma G, 2010, EUR J NEUROL, V17, P461, DOI 10.1111/j.1468-1331.2009.02849.x; Uruma Go, 2006, Jikeikai Medical Journal, V53, P141; Van Laere KJ, 2002, J NUCL MED, V43, P458; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005	31	11	11	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	APR	2013	27	3					187	202		10.1007/s12149-012-0674-4			16	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	122FD	WOS:000317302500001	23255125				2022-02-06	
J	Valdez, M; Balachandran, B				Valdez, M.; Balachandran, B.			Longitudinal nonlinear wave propagation through soft tissue	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Brain fibers; Nonlinear viscoelasticity; Nonlinear wave propagation; Attenuation; Wave speed; Wave front steepening	TRAUMATIC BRAIN-INJURY; HUMAN HEAD; DEFORMATION; IMPACT; ATTENUATION; STRUTS; MODEL	In this paper, wave propagation through soft tissue is investigated. A primary aim of this investigation is to gain a fundamental understanding of the influence of soft tissue nonlinear material properties on the propagation characteristics of stress waves generated by transient loadings. Here, for computational modeling purposes, the soft tissue is modeled as a nonlinear visco-hyperelastic material, the geometry is assumed to be one-dimensional rod geometry, and uniaxial propagation of longitudinal waves is considered. By using the linearized model, a basic understanding of the characteristics of wave propagation is developed through the dispersion relation and in terms of the propagation speed and attenuation. In addition, it is illustrated as to how the linear system can be used to predict brain tissue material parameters through the use of available experimental ultrasonic attenuation curves. Furthermore, frequency thresholds for wave propagation along internal structures, such as axons in the white matter of the brain, are obtained through the linear analysis. With the nonlinear material model, the authors analyze cases in which one of the ends of the rods is fixed and the other end is subjected to a loading. Two variants of the nonlinear model are analyzed and the associated predictions are compared with the predictions of the corresponding linear model. The numerical results illustrate that one of the imprints of the nonlinearity on the wave propagation phenomenon is the steepening of the wave front, leading to jump-like variations in the stress wave profiles. This phenomenon is a consequence of the dependence of the local wave speed on the local deformation of the material. As per the predictions of the nonlinear material model, compressive waves in the structure travel faster than tensile waves. Furthermore, it is found that wave pulses with large amplitudes and small elapsed times are attenuated over shorter spans. This feature is due to the elevated strain-rates introduced at the end of the structure where the load is applied. In addition, it is shown that when steep wave fronts are generated in the nonlinear viscoelastic material, energy dissipation is focused in those wave fronts implying deposition of energy in a highly localized region of the material. Novel mechanisms for brain tissue damage are proposed based on the results obtained. The first mechanism is related to the dissipation of energy at steep wave fronts, while the second one is related to the interaction of steep wave fronts with axons encountered on its way through the structure. (C) 2013 Elsevier Ltd. All rights reserved.	[Valdez, M.; Balachandran, B.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA		Balachandran, B (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	mvaldez@umd.edu; balab@umd.edu		Valdez, Marcelo/0000-0001-5574-1461	Center for Energetic Concepts Development at University of Maryland	Partial support received for this work through the Center for Energetic Concepts Development at University of Maryland is gratefully acknowledged.	Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; CHIVERS RC, 1978, J ACOUST SOC AM, V63, P940, DOI 10.1121/1.381774; Clayton E., 2011, MECH BIOL SYSTEMS MA, V2, P57; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; ETOH A, 1994, JPN J APPL PHYS 1, V33, P2874, DOI 10.1143/JJAP.33.2874; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gao L, 1996, ULTRASOUND MED BIOL, V22, P959, DOI 10.1016/S0301-5629(96)00120-2; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Halabieh O, 2008, LECT NOTES COMPUT SC, V5104, P107, DOI 10.1007/978-3-540-70521-5_12; Haslach HW, 2011, MAXIMUM DISSIPATION NON-EQUILIBRIUM THERMODYNAMICS AND ITS GEOMETRIC STRUCTURE, P1; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060; Imielinska C, 2006, LECT NOTES COMPUT SC, V3994, P822; Kolsky H., 2003, STRESS WAVES SOLIDS; KREMKAU FW, 1981, J ACOUST SOC AM, V70, P29, DOI 10.1121/1.386578; Kumaresan S, 1996, MED BIOL ENG COMPUT, V34, P27, DOI 10.1007/BF02637019; Magrab E. B., 2009, VIBRATIONS; Mahapatra DR, 2001, SMART MATER STRUCT, V10, P1046, DOI 10.1088/0964-1726/10/5/321; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; NEWLAND DE, 1993, P ROY SOC LOND A MAT, V443, P203, DOI 10.1098/rspa.1993.0140; Nolte J., 2002, HUMAN BRAIN INTRO IT; Nyein M., 2008, TECHNICAL REPORT; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Pelinescu I, 2001, SMART MATER STRUCT, V10, P121, DOI 10.1088/0964-1726/10/1/312; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pinnoji PK, 2007, SADHANA-ACAD P ENG S, V32, P445, DOI 10.1007/s12046-007-0034-6; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Valdez M., 2011, SIMULATION BASED INN; Valdez MF, 2010, IFMBE PROC, V32, P13, DOI 10.1007/978-3-642-14998-6_4; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	37	11	11	0	34	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161			J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	APR	2013	20						192	208		10.1016/j.jmbbm.2013.01.002			17	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	137RP	WOS:000318455400020	23510921				2022-02-06	
J	Wu, ZL; Xu, HY; He, YL; Yang, GT; Liao, CH; Gao, W; Liang, M; He, XS				Wu, Zhongliang; Xu, Hongyu; He, Yalong; Yang, Guitao; Liao, Chunhua; Gao, Wei; Liang, Ming; He, Xiaosheng			Antisense oligodeoxynucleotides targeting connexin43 reduce cerebral astrocytosis and edema in a rat model of traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Traumatic brain injury; Reactive astrocytosis; Cerebral edema; Astrocytes; Connexin43	GAP-JUNCTIONAL COMMUNICATION; HEMICHANNELS; AQUAPORIN-4; EXPRESSION; RECEPTOR; ROLES	Objective: Brain injury induces an acute increase in the expression of gap junction protein connexin43 (Cx43). It also leads to cerebral edema, probably due to the swelling and proliferation of astrocytes reactive to the injury. Antisense oligodeoxynucleotides (AS-ODN) targeting Cx43 were tested for their ability to reduce reactive astrocytosis and cerebral edema in a rat model of traumatic brain injury (TBI). Methods: The brains of experimental animals were intraventricularly injected with these AS-ODNs, while sham rats and normal controls were administered saline in the same way. Controlled cortical impact (CCI) injury was induced in both experimental and sham rats, then the damaged brain tissue was stained for glial fibrillary acidic protein (GFAP) immunofluorescein, measured for water content using the wet-dry weight method, and examined for Cx43 protein expression by western blotting. Results: The brains of both experimental and sham groups were found to have a higher level of Cx43 expression, higher water content, and more swollen and proliferative astrocytes than the normal controls at 6 hours, 24 hours, and 48 hours post-trauma. But compared with the sham animals, brains of experimental rats showed less Cx43 expression, lower water content, and less swollen and proliferative astrocytes. These two brain-injured groups displayed a similar pattern of changes in these outcomes over the 48-hour time period studied. Discussion: Antisense oligodeoxynucleotides targeting Cx43 reduced reactive astrocytosis and cerebral edema following TBI, indicating that Cx43 might be involved in regulating the water imbalance between brain cells.	[Wu, Zhongliang; He, Yalong; Liao, Chunhua; Gao, Wei; Liang, Ming; He, Xiaosheng] Fourth Mil Med Univ, Inst Brain Dis, Xijing Hosp, Xian 710032, Peoples R China; [Wu, Zhongliang; Liao, Chunhua] Fourth Mil Med Univ, Dept Neurol, Xijing Hosp, Xian 710032, Peoples R China; [Xu, Hongyu; He, Yalong; Gao, Wei; Liang, Ming; He, Xiaosheng] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China; [Yang, Guitao] Fourth Mil Med Univ, Dept Med Teaching & Res Adm, Xijing Hosp, Xian 710032, Peoples R China		He, XS (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, 15 West Changle Rd, Xian 710032, Peoples R China.	hexiaos@fmmu.edu.cn		He, yalong/0000-0002-4669-5384	NSFCNational Natural Science Foundation of China (NSFC) [30971173]	The work was supported in part by an NSFC Grant (No. 30971173).	Alonso A, 2010, J CEREBR BLOOD F MET, V30, P1394, DOI 10.1038/jcbfm.2010.41; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Dihne M, 2001, BRAIN RES, V902, P178, DOI 10.1016/S0006-8993(01)02378-2; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Guttman JA, 2010, GUT, V59, P218, DOI 10.1136/gut.2008.170464; Kintsurashvili E, 2001, HYPERTENSION, V38, P1075, DOI 10.1161/hy1101.093426; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Maglione M, 2010, GLIA, V58, P1104, DOI 10.1002/glia.20991; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Rouach N, 2002, EUR J NEUROSCI, V15, P403, DOI 10.1046/j.0953-816x.2001.01868.x; Rouach N, 2000, J CELL BIOL, V149, P1513, DOI 10.1083/jcb.149.7.1513; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Suzukawa J, 2003, NEUROSCI LETT, V349, P21, DOI 10.1016/S0304-3940(03)00674-8; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; Yoon JJ, 2010, BRAIN RES, V1353, P194, DOI 10.1016/j.brainres.2010.07.005; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	22	11	11	2	11	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	APR	2013	35	3					255	262		10.1179/1743132813Y.0000000165			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	104QW	WOS:000316010700006	23485053				2022-02-06	
J	Frisina, PG; Kutlik, AM; Barrett, AM				Frisina, Pasquale G.; Kutlik, Ann M.; Barrett, Anna M.			Left-Sided Brain Injury Associated With More Hospital-Acquired Infections During Inpatient Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain; Infection; Injuries; Rehabilitation	TOLL-LIKE RECEPTORS; IMMUNE-RESPONSE; STIMULATION; PROBIOTICS; RISK; LATERALIZATION; MODULATION; NEOCORTEX	Objective: To test the hypothesis that a left-dominant brain immune network (LD-BIN) might affect the occurrence of infection during inpatient rehabilitation of stroke and traumatic brain injury (TBI). Design: A retrospective analysis was performed on electronic medical records between January 2009 and December 2010. All patients with left-or right-sided stroke or TBI were included into the study. The LD-BIN hypothesis was tested by comparing HAI rates depending on whether patients had left- or right-sided brain lesions. Setting: A large inpatient rehabilitation hospital. Participants: Among the patients (N=2236) with stroke or TBI who had either a left- or right-sided brain lesion, 163 patients were identified with HAIs. Intervention: Not applicable. Main Outcome Measure: Frequency of HAIs. Results: In the 163 patients identified with HAIs with a diagnosis of stroke or TBI, chi-square analysis revealed a significantly higher proportion of HAls among patients with left-sided (n=98; 60.1%) relative to right-sided (n=65; 39.9%) brain injuries (chi(2)=6.68, P<.01). These effects could not be attributed to either clinical or demographic factors. Conclusions: Our findings are consistent with the hypothesis that an LD-BIN may mediate vulnerability to infection during rehabilitation of patients with stroke or TBI. Further translational research investigating novel means of managing patients based on brain lesion location, and modulating the LD-BIN via behavioral and physiologic interventions, may result in neuroscience-based methods to improve infection resistance in brain-injured patients. Archives of Physical Medicine and Rehabilitation 2013;94:516-21 (C) 2013 by the American Congress of Rehabilitation Medicine	[Frisina, Pasquale G.; Kutlik, Ann M.; Barrett, Anna M.] Kessler Inst Rehabil, W Orange, NJ 07052 USA; [Barrett, Anna M.] Kessler Fdn Res Ctr, W Orange, NJ USA; [Barrett, Anna M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA		Frisina, PG (corresponding author), Kessler Inst Rehabil, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	pfrisina@kessler-rehab.com	Barrett, A.M./ABG-4475-2021	Barrett, A.M./0000-0002-0789-2887	Kessler Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS055808, K24HD062647]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD062647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055808] Funding Source: NIH RePORTER	Supported by the Kessler Foundation and the National Institutes of Health (grant nos. R01NS055808, K24HD062647).	American Medical Association, 2008, INT CLASS DIS 9 REV; BARDOS P, 1981, SCAND J IMMUNOL, V13, P609, DOI 10.1111/j.1365-3083.1981.tb00176.x; BARNEOUD P, 1987, PHYSIOL BEHAV, V41, P525, DOI 10.1016/0031-9384(87)90306-4; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Czlonkowska A, 1988, Ann N Y Acad Sci, V540, P608, DOI 10.1111/j.1749-6632.1988.tb27188.x; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2984; Diamond MC, 2001, COGNITIVE BRAIN RES, V12, P329, DOI 10.1016/S0926-6410(01)00059-3; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Fassbender K, 1997, J LAB CLIN MED, V130, P535, DOI 10.1016/S0022-2143(97)90131-1; Galletta EE, 2011, TOP STROKE REHABIL, V18, P87, DOI 10.1310/tsr1802-87; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Gruzelier J, 1996, INT J PSYCHOPHYSIOL, V23, P215, DOI 10.1016/S0167-8760(96)00064-5; Hamilton BB, 1987, REHABILITATION OUTCO; Harris AD, 2007, EMERG INFECT DIS, V13, P1144, DOI 10.3201/eid1308.070071; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hopkins PA, 2005, CLIN EXP IMMUNOL, V140, P395, DOI 10.1111/j.1365-2249.2005.02801.x; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jarchum I, 2011, INFECT IMMUN, V79, P1498, DOI 10.1128/IAI.01196-10; Kim AS, 2011, J CLIN GASTROENTEROL, V45, P844, DOI 10.1097/MCG.0b013e31823336cd; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Koch G, 2012, NEUROLOGY, V78, P24, DOI 10.1212/WNL.0b013e31823ed08f; Koch HJ, 2006, NEUROIMMUNOMODULAT, V13, P8, DOI 10.1159/000092108; Lan JG, 2005, WORLD J GASTROENTERO, V11, P3375, DOI 10.3748/wjg.v11.i22.3375; Meador KJ, 2004, ANN NEUROL, V55, P840, DOI 10.1002/ana.20105; Minnerup J, 2010, J NEUROL NEUROSUR PS, V81, P198, DOI 10.1136/jnnp.2009.182394; Mylotte JM, 2000, CLIN INFECT DIS, V30, P425, DOI 10.1086/313708; NEVEU PJ, 1989, J NEUROSCI RES, V22, P188, DOI 10.1002/jnr.490220212; Pochapin M, 2000, AM J GASTROENTEROL, V95, pS11, DOI 10.1016/S0002-9270(99)00809-6; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; RENOUX G, 1983, J NEUROIMMUNOL, V5, P227, DOI 10.1016/0165-5728(83)90043-7; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Sumner RC, 2011, J NEUROIMMUNOL, V240, P1, DOI 10.1016/j.jneuroim.2011.08.017; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vlajkovic S, 1994, Int J Neurosci, V78, P123	38	11	12	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2013	94	3					516	521		10.1016/j.apmr.2012.10.012			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	106PZ	WOS:000316158500016	23123439	Green Accepted			2022-02-06	
J	Fritz, NE; Basso, DM				Fritz, Nora E.; Basso, D. Michele			Dual-Task Training for Balance and Mobility in a Person With Severe Traumatic Brain Injury: A Case Study	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						balance; divided attention; dual-task; dual-task training; gait speed; severe traumatic brain injury; Walking While Talking Test (WWTT)	DIVIDED ATTENTION; WALKING SPEED; REHABILITATION; GAIT; RELIABILITY; PERFORMANCE; PREDICTION; STABILITY; VALIDITY; PROGRAM	Background and Purpose: Attentional impairments following severe traumatic brain injury (TBI) are common and can lead to decreased functional mobility and balance, as well as deficits in previously automatic movements such as walking and stair climbing. The purpose of this case study was to determine the feasibility and potential value of incorporating a cognitive-motor dual-task training program into physical therapy for a patient with a severe TBI. Case Description: The patient was a 26-year-old woman who sustained a severe TBI during a motor vehicle accident 46 days prior to physical therapy evaluation. On the 8-level Rancho Los Amigos Cognitive Function Scale, her functioning was classified as level IV. She had impairments in attention, functional mobility, and balance, all of which limited her ability to participate in activities of daily living. Intervention: Physical therapy was provided over 26 days within the inpatient rehabilitation setting. Interventions included mobility tasks such as walking, balancing, and stair climbing. Mobility training was paired with specific secondary cognitive and motor tasks. Outcomes: Dual-task trainingmay have contributed to improvements on outcome measures designed to test divided attention including the Walking While Talking Test and Trail Making Test and a greater rate of improvement in walking speed and time to descend stairs when compared to the baseline phase. Discussion: Addition of cognitive-motor dual-task training to standard physical therapy in the inpatient rehabilitation setting appears to be feasible and may have value for improving function in individuals with severe TBI.	[Fritz, Nora E.; Basso, D. Michele] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA		Fritz, NE (corresponding author), Ohio State Univ, Sch Hlth & Rehabil Sci, 453 W 10th Ave, Columbus, OH 43210 USA.	nora.fritz@osumc.edu	Basso, Michele/B-3817-2011; Fritz, Nora/ABG-6696-2020		Florence P. Kendall Doctoral Scholarship from the Foundation for Physical Therapy; Dodd Hall Inpatient Rehabilitation Hospital	This research was supported in part by a Florence P. Kendall Doctoral Scholarship from the Foundation for Physical Therapy.; We thank Sara Rismiller, MPT, NCS, for her mentorship and assistance in data collection, Dr Meredith Wilhelm for her thoughtful manuscript edits, and all of the providers on the traumatic brain injury service at Dodd Hall Inpatient Rehabilitation Hospital for their support.	Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Gentile A., 1987, MOVEMENT SCI FDN PHY, V1st Edn, P93; Hamilton F, 2009, MULT SCLER J, V15, P1215, DOI 10.1177/1352458509106712; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kraus MF, 2007, TRAUMATIC BRAIN INJU; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McDowd Joan M, 2007, J Neurol Phys Ther, V31, P98; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Mossberg KA, 2008, PHYS THER, V88, P77, DOI 10.2522/ptj.20070022; Mysiw WJ, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199612000-00003; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Pellecchia GL, 2005, J MOTOR BEHAV, V37, P239, DOI 10.3200/JMBR.37.3.239-246; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Rancho Los Amigos National Rehabilitation Center, FAM GUID RANCH LEV C; Roskell C, 1998, PHYSIOTHERAPY, V84, P118, DOI DOI 10.1016/S0031-9406(05)66508-X; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Silsupadol P, 2009, ARCH PHYS MED REHAB, V90, P381, DOI 10.1016/j.apmr.2008.09.559; Soukup V M, 1998, Appl Neuropsychol, V5, P65, DOI 10.1207/s15324826an0502_2; Tilson JK, 2010, PHYS THER, V90, P196, DOI 10.2522/ptj.20090079; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Verghese J, 2002, J AM GERIATR SOC, V50, P1572, DOI 10.1046/j.1532-5415.2002.50415.x; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yang YR, 2007, ARCH PHYS MED REHAB, V88, P1236, DOI 10.1016/j.apmr.2007.06.762; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Yogev-Seligmann G, 2012, ARCH PHYS MED REHAB, V93, P176, DOI 10.1016/j.apmr.2011.06.005	45	11	11	0	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	MAR	2013	37	1					37	43		10.1097/NPT.0b013e318282a20d			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	107LA	WOS:000316217200007	23364169				2022-02-06	
J	Kim, H; Kim, JH				Kim, Heejeong; Kim, Jee Hee			Evaluation of the Clinical Usefulness of Critical Patient Severity Classification System and Glasgow Coma Scale for Neurological Patients in Intensive Care Units	ASIAN NURSING RESEARCH			English	Article						critical illness; Glasgow Coma Scale; intensive care units; neurology	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; MORTALITY; PREDICTION; OUTCOMES	Purpose: The purpose of this study was to evaluate the clinical usefulness of the Critical Patient Severity Classification System (CPSCS) and Glasgow Coma Scale (GCS) for critically ill neurological patients and to determine the applicability of CPSCS and GCS in predicting their mortality. Methods: Data were collected from the medical records of 187 neurological patients who were admitted to the intensive care unit of C university hospital. The data were analyzed through chi-square test, t test, Mann-Whitney, Kruskal-Wallis, goodness-of-fit test, and receiver operating characteristic curve. Results: In accordance with patients' general and clinical characteristics, patient mortality turned out to be significantly different depending on intensive care unit stay, endotracheal intubation, central venous catheter, and severity by CPSCS. H1osmer-Lemeshow goodness-of-fit tests were applied to CPSCS and GCS. The results of the discrimination test using the receiver operating characteristic curve were CPSCS0, .743, GCS(0) .583, CPSCS24, .734, GCS(24) .612, CPSCS48, .591, GCS(48) .646, CPSCS72, .622, and GCS(72) .623. Logistic regression analysis showed that each point on the CPSCS score signifies a 1.034 higher likelihood of dying. Conclusion: Applied to neurologically ill patients, early CPSCS scores can be regarded as a useful tool. Copyright (C) 2013, Korean Society of Nursing Science. Published by Elsevier. All rights reserved.	[Kim, Heejeong] Namseoul Univ, Dept Nursing, Chungcheongnam Do, South Korea; [Kim, Jee Hee] Kangwon Natl Univ, Dept Emergency Med Technol, Samcheok Si 245907, Gangwon Do, South Korea		Kim, JH (corresponding author), Kangwon Natl Univ, Dept Emergency Med Technol, Samcheok Si 245907, Gangwon Do, South Korea.	kjh1962@hanmail.net			Namseoul University	This work was supported by the research grant provided by Namseoul University.	Carayon Pascale, 2005, Intensive Crit Care Nurs, V21, P284, DOI 10.1016/j.iccn.2004.12.003; Cavanagh Stephen J, 2002, J Neurosci Nurs, V34, P288; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Goncalves Leilane Andrade, 2007, Intensive Crit Care Nurs, V23, P355, DOI 10.1016/j.iccn.2007.04.009; Hospital Nurses Association, 1994, STUD EST NUMB NURS R; Kiekkas Panagiotis, 2007, Nurs Crit Care, V12, P34, DOI 10.1111/j.1478-5153.2006.00193.x; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; Lee S. H., 2006, THESIS KYUNGPOOK U D; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McNett Molly, 2007, J Neurosci Nurs, V39, P68; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Padilha KG, 2008, INTENS CRIT CARE NUR, V24, P197, DOI 10.1016/j.iccn.2007.09.004; Ross S., 1988, J TRAUMA, V45, P42; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Shin J. H., 2004, THESIS CHOSUN U GWAN; Shutter LA, 2008, ANN EMERG MED, V51, pS37, DOI 10.1016/j.annemergmed.2007.11.013; Siempos II, 2009, CRIT CARE MED, V37, P2283, DOI 10.1097/CCM.0b013e3181a02a67; Soo Oh， Hyun, 2009, [Korean Journal of Adult Nursing, 성인간호학회지], V21, P489; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; TAUNTON RL, 1994, J NURS ADMIN, V24, P48; TEASDALE G, 1974, LANCET, V2, P81; Vincent JL, 2000, INTENS CARE MED, V26, P1023, DOI 10.1007/s001340051313; Waterhouse C., 2005, NURSING STANDARD, V19, P56, DOI 10.7748/ns2005.04.19.33.56.c3857; Youn B. H., 2005, J KOREAN ACAD ADULT, V17, P464; 이동건, 2003, Infection and Chemotherapy, V35, P145	31	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1976-1317	2093-7482		ASIAN NURS RES	Asian Nurs. Res.	MAR	2013	7	1					8	15		10.1016/j.anr.2013.01.002			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	128VE	WOS:000317797000002	25031210	gold			2022-02-06	
J	Zepeda, A; Aguilar-Arredondo, A; Michel, G; Ramos-Languren, LE; Escobar, ML; Arias, C				Zepeda, Angelica; Aguilar-Arredondo, Andrea; Michel, Gabriela; Elisa Ramos-Languren, Laura; Escobar, Martha L.; Arias, Clorinda			Functional recovery of the dentate gyrus after a focal lesion is accompanied by structural reorganization in the adult rat	BRAIN STRUCTURE & FUNCTION			English	Article						Excitotoxicity; LTP; Damage; Contextual fear memory; Plasticity; Hippocampus	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC PLASTICITY; SUBVENTRICULAR ZONE; OPIOID RECEPTORS; GRANULE NEURONS; EXPRESSION; CORTEX; PROLIFERATION	The adult brain is highly plastic and tends to undergo substantial reorganization after injury to compensate for the lesion effects. It has been shown that such reorganization mainly relies on anatomical and biochemical modifications of the remaining cells which give rise to a network rewiring without reinstating the original morphology of the damaged region. However, few studies have analyzed the neurorepair potential of a neurogenic structure. Thus, the aim of this work was to analyze if the DG could restore its original morphology after a lesion and to establish if the structural reorganization is accompanied by behavioral and electrophysiological recovery. Using a subepileptogenic injection of kainic acid (KA), we induced a focal lesion in the DG and assessed in time (1) the loss and recovery of dependent and non dependent DG cognitive functions, (2) the anatomical reorganization of the DG using a stereological probe and immunohistochemical markers for different neuronal maturation stages and, (3) synaptic plasticity as assessed through the induction of in vivo long-term potentiation (LTP) in the mossy fiber pathway (CA3-DG). Our results show that a DG focal lesion with KA leads to a well delimited region of neuronal loss, disorganization of the structure, the loss of associated mnemonic functions and the impairment to elicit LTP. However, behavioral and synaptic plasticity expression occurs in a time dependent fashion and occurs along the morphological restoration of the DG. These results provide novel information on neural plasticity events associated to functional reorganization after damage.	[Zepeda, Angelica; Aguilar-Arredondo, Andrea; Michel, Gabriela; Arias, Clorinda] Univ Nacl Autonoma Mexico, Dept Med Genom & Toxicol Ambiental, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Zepeda, Angelica; Elisa Ramos-Languren, Laura; Escobar, Martha L.] Univ Nacl Autonoma Mexico, Div Invest & Estudios Posgrad, Fac Psicol, Mexico City 04510, DF, Mexico		Zepeda, A (corresponding author), Univ Nacl Autonoma Mexico, Dept Med Genom & Toxicol Ambiental, Inst Invest Biomed, AP 70-228, Mexico City 04510, DF, Mexico.	azepeda@biomedicas.unam.mx	Escobar, Martha L/AAH-4896-2020; /AAH-5629-2020	Zepeda, Angelica/0000-0003-0857-1652	DGAPA-PAPIITPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN215609, IN213210]; CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [60851]	We thank Pedro Medina, Miguel Tapia, Patricia Ferrera and Alicia Sampieri for technical assistance. We thank Verdon Taylor for providing facilities in the development of histochemical procedures. This project was supported by DGAPA-PAPIIT IN215609, IN213210 and CONACyT 60851.	Arias C, 1998, EXP NEUROL, V153, P242, DOI 10.1006/exnr.1998.6900; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ayala GX, 2008, NEUROPHARMACOLOGY, V55, P1383, DOI 10.1016/j.neuropharm.2008.08.035; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Calixto E, 2003, J NEUROSCI, V23, P4842; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Del Turco D, 2004, J COMP NEUROL, V477, P81, DOI 10.1002/cne.20239; DERRICK BE, 1991, BRAIN RES BULL, V27, P219, DOI 10.1016/0361-9230(91)90071-Q; DERRICK BE, 1992, J PHARMACOL EXP THER, V263, P725; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Dong HX, 2003, J NEUROSCI, V23, P1742; Duveau V, 2011, HIPPOCAMPUS, V21, P935, DOI 10.1002/hipo.20793; Eisch AJ, 2006, CONT NEUROS, P331, DOI 10.1007/978-1-59745-021-8_25; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Escobar ML, 2003, BRAIN RES, V991, P274, DOI 10.1016/j.brainres.2003.08.015; Escobar ML, 1997, BRAIN RES, V751, P330, DOI 10.1016/S0006-8993(96)01373-X; Schjetnan AGP, 2012, HIPPOCAMPUS, V22, P1, DOI 10.1002/hipo.20866; Gomez-Palacio-Schjetnan A, 2008, NEUROSCI LETT, V445, P62, DOI 10.1016/j.neulet.2008.08.069; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Gu PF, 2010, YAKUGAKU ZASSHI, V130, P1751, DOI 10.1248/yakushi.130.1751; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hernandez-Ortega K, 2007, J NEUROSCI RES, V85, P1744, DOI 10.1002/jnr.21301; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Ledergerber D, 2006, EXP NEUROL, V199, P130, DOI 10.1016/j.expneurol.2006.02.010; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nakagawa E, 2000, EPILEPSIA, V41, P10, DOI 10.1111/j.1528-1157.2000.tb01498.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Ogita K, 2005, J NEUROSCI RES, V82, P609, DOI 10.1002/jnr.20678; Okano H, 2008, PHILOS T R SOC B, V363, P2111, DOI 10.1098/rstb.2008.2264; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Sigler A, 2009, P NATL ACAD SCI USA, V106, P11759, DOI 10.1073/pnas.0812695106; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Wang S, 2005, EXP BRAIN RES, V165, P250, DOI 10.1007/s00221-005-2296-8; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Winship IR, 2008, J NEUROSCI, V28, P6592, DOI 10.1523/JNEUROSCI.0622-08.2008; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zepeda A, 2004, J NEUROSCI, V24, P1812, DOI 10.1523/JNEUROSCI.3213-03.2004; Zepeda A, 2003, J CEREBR BLOOD F MET, V23, P811, DOI 10.1097/01.WCB.0000075010.31477.1E; Zepeda A, 2009, CURR TRENDS NEUROL, V3, P33; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	68	11	11	0	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653	1863-2661		BRAIN STRUCT FUNCT	Brain Struct. Funct.	MAR	2013	218	2					437	453		10.1007/s00429-012-0407-4			17	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	096XL	WOS:000315438000007	22481229				2022-02-06	
J	Hendoui, N; Beigmohammadi, MT; Mahmoodpoor, A; Ahmadi, A; Abdollahi, M; Hasanpour, M; Hadi, F; Khazaeipour, Z; Mousavi, S; Mojtahedzadeh, M				Hendoui, N.; Beigmohammadi, M. T.; Mahmoodpoor, A.; Ahmadi, A.; Abdollahi, M.; Hasanpour, M.; Hadi, F.; Khazaeipour, Z.; Mousavi, S.; Mojtahedzadeh, M.			Reliability of calcium-binding protein S100B measurement toward optimization of hyperosmolal therapy in traumatic brain injury	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Traumatic brain injury; Hypertonic saline 5%; Mannitol; S100B; Osmotherapy; Intracranial hypertension	POSTTRAUMATIC INTRACRANIAL HYPERTENSION; 7.2-PERCENT HYPERTONIC SALINE; SODIUM-CHLORIDE; CEREBRAL EDEMA; HEAD-INJURY; PRESSURE; MANNITOL; DAMAGE; SERUM; PATHOPHYSIOLOGY	BACKGROUND: Osmotherapy is a cornerstone for the management of severe Traumatic Brain Injury (TBI). Hypertonic saline (HTS) has advantages as being preferred osmotic agent, but there is inadequte knowledge regarding dose and its saftey in comparison to mannitol. S100B, as a specific neuroinflammatory biomarker in TBI might be a reliable therapeutic index following osmotic therapy. AIM: To compare both administration ways of HTS 5% (bolus and infusion) with mannitol upon S100B as a therapeutic tool for monitoring treatment in TBI patients. METHOD: Adult patients wih modrate to severe TBI were recruited and have randomly received one of the three protocols: 125 cc of HTS 5% every 6 hrs (N: 11) as bolus; 500 cc of HTS 5% (N: 12) as infusion for 24 hrs; or 1 g/kg mannitol of 20% (N: 10) as a bolus, repeated with a dose of 0.25-0.5 g/kg every 6 hrs based on patient's response for 3 days. Serum S100B, blood pressure, serum sodium and osmolality and Glascow coma score (GCS) were measured at baseline and daily for 3 days. RESULTS: Initial serum S100B level in TBI patients was higher than control group (p < 0.0001). Levels of measured S100B have decreased for all treatment groups, but reduction wasn't significantly after hyperosmolal therapy. GCS level increased significantly in infusion group (p = 0.002) and there were negative and significant correlation between serum S100B level and GCS level in some days. Mean arterial pressure increased significantly in HTS groups (bolus: p = 0.002, infusion < 0.0001). CONCLUSIONS: S100B is closely related to the pathophysiological mechanism in TBI and may be useful as a therapeutic tool for treatment monitoring in TBI patients HTS is a safe and effective osmotic agent in TBI setting.	[Hendoui, N.] Mazandaran Univ Med Sci & Hlth Serv, Fac Pharm, Dept Pharmacotherapy, Sari, Iran; [Hendoui, N.; Mojtahedzadeh, M.] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacotherapy, Tehran, Iran; [Beigmohammadi, M. T.; Ahmadi, A.] Tehran Univ Med Sci & Hlth Serv, Sch Med, Anesthesiol & Intens Care Dept, Tehran, Iran; [Mahmoodpoor, A.] Tabriz Univ Med Sci & Hlth Serv, Anesthesiol & Intens Care Dept, Sch Med, Tabriz, Iran; [Abdollahi, M.] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacol & Toxicol, Toxicol Lab, Tehran, Iran; [Abdollahi, M.] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr, Tehran, Iran; [Hasanpour, M.] Tehran Univ Med Sci & Hlth Serv, Fac Pharm, Tehran, Iran; [Hadi, F.] Islamic Azad Univ, Pharmaceut Sci Branch, Tehran, Iran; [Khazaeipour, Z.] Univ Tehran Med Sci, Res Deputy Imam Khomeini Hosp Complex, Brain & Spinal Injury Repair Res Ctr, Tehran, Iran; [Mousavi, S.] Esfehan Univ Med Sci & Hlth Serv, Fac Pharm, Dept Pharmacotherapy, Esfehan, Iran		Mojtahedzadeh, M (corresponding author), Univ Tehran Med Sci, Fac Pharm, Dept Pharmacotherapy, Tehran, Iran.	mojtahed@sina.tums.ac.ir	mousavi, sarah/U-5014-2017; Hasanpour, Maede/ABG-9856-2021; mahmoodpoor, ata/AAR-9972-2021; Abdollahi, Mohammad/B-9232-2008; mahmoodpoor, Ata/AAD-6597-2021	mousavi, sarah/0000-0001-9792-1428; Hasanpour, Maede/0000-0002-8260-6123; Abdollahi, Mohammad/0000-0003-0123-1209; mahmoodpoor, Ata/0000-0002-4361-6230			Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bentsen G, 2006, CRIT CARE MED, V34, P2912, DOI 10.1097/01.CCM.0000245665.46789.7C; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Hu JR, 1997, J NEUROCHEM, V69, P2294; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lam AGM, 2001, NEUROBIOL AGING, V22, P765, DOI 10.1016/S0197-4580(01)00233-0; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Mori T, 2008, STROKE, V39, P2114, DOI 10.1161/STROKEAHA.107.503821; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 2002, CRIT CARE MED, V30, P2778, DOI 10.1097/00003246-200212000-00029; Reali C, 2005, J NEUROSCI RES, V81, P677, DOI 10.1002/jnr.20584; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Suarez Jose I, 2004, Cleve Clin J Med, V71 Suppl 1, pS9; Timmons SD, 2010, CRIT CARE MED, V38, pS431, DOI 10.1097/CCM.0b013e3181ec57ab; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Vosylius S, 2004, CROAT MED J, V45, P715; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weant KA, 2008, ADV EMERG NURS J, V30, P17, DOI 10.1097/01.TME.0000311542.95656.92; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005; Zornow M H, 1995, New Horiz, V3, P488	48	11	11	0	3	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	FEB	2013	17	4					477	485					9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	148EJ	WOS:000319225600008	23467946				2022-02-06	
J	Leitgeb, J; Mauritz, W; Brazinova, A; Majdan, M; Wilbacher, I				Leitgeb, Johannes; Mauritz, Walter; Brazinova, Alexandra; Majdan, Marek; Wilbacher, Ingrid			Outcome after severe brain trauma associated with epidural hematoma	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Traumatic brain injury, severe; Epidural hematoma, outcome; Prognostic scores	ACUTE SUBDURAL-HEMATOMA; EXTRADURAL HEMATOMA; PROGNOSTIC VALUE; HEAD-INJURIES; MORTALITY; IMPACT; COMA; EPIDEMIOLOGY; EXPERIENCE; MANAGEMENT	The aim of this study was to identify factors contributing to outcomes after severe traumatic brain injury (TBI) associated with epidural hematoma (EDH). Between 02/2002 and 4/2010 17 Austrian centers prospectively enrolled 863 patients with moderate and severe TBI into observational studies. Data on accident, treatment, and outcomes were collected. Data sets from patients who had severe TBI (=Glasgow Coma Scale score < 9) and EDH were selected. Six-month outcomes were classified as "favorable" if Glasgow Outcome Scale (GOS) scores were 5 or 4, and were classified as "unfavorable" if GOS scores were 3 or less. The Rotterdam score was used to classify computed tomography (CT) findings; the scores published by Hukkelhoven et al. (J Neurotrauma 22:1025-1039, 2005) were used to estimate predicted rates of death and of unfavorable outcomes. Univariate (Fisher's exact test, t test, Chi(2)-test) and multivariate (logistic regression) statistics were used to identify factors associated with hospital mortality and favorable outcome. Of the 738 patients with severe TBI 159 (21.5 %) had EDH. Of these, 49 (30.8 %) died in the hospital, 21 (13.2 %) survived with unfavorable outcome, 82 (51.6 %) with favorable outcome; long-term outcome was unknown in 7 survivors (4.4 %). Mortality rates predicted by the Rotterdam score showed good correlation with observed mortality rates. According to the Hukkelhoven scores, observed/predicted ratios for mortality and unfavorable outcome were 0.94 and 0.97, respectively. Age, severity of TBI, and neurological status were the main factors influencing outcomes after severe TBI associated with EDH. We were unable to demonstrate significant effects of treatment factors.	[Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Vienna, Austria; [Mauritz, Walter; Brazinova, Alexandra; Majdan, Marek; Wilbacher, Ingrid] INRO, Vienna, Austria; [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Dept Publ Hlth, Fac Hlth & Social Serv, Trnava, Slovakia		Leitgeb, J (corresponding author), Med Univ Vienna, Dept Traumatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	johannes.leitgeb@meduniwien.ac.at	Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X; Mauritz, Walter/0000-0001-9043-3712			Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; PARZHUBER A, 1994, UNFALLCHIRURG, V97, P615; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tallon JM, 2008, CAN J SURG, V51, P339; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	25	11	14	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	FEB	2013	133	2					199	207		10.1007/s00402-012-1652-y			9	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	075EK	WOS:000313866400008	23161150				2022-02-06	
J	Ozbay, G; Bakkal, M; Abbasoglu, Z; Demirel, S; Kargul, B; Welbury, R				Ozbay, G.; Bakkal, M.; Abbasoglu, Z.; Demirel, S.; Kargul, Betul; Welbury, R.			Incidence and prevention of traumatic injuries in paediatric handball players in Istanbul, Turkey	EUROPEAN ARCHIVES OF PAEDIATRIC DENTISTRY			English	Article						Handball player; Dental trauma; Children; Mouthguard	DENTAL TRAUMA; MOUTHGUARD USE; SPORTS; SWITZERLAND; AWARENESS	Aim To investigate the frequency of dental injuries in paediatric handball players. In addition, the players' habits with regard to mouthguard usage, as well as their general knowledge of the prevention of traumatic dental injuries (TDIs) were investigated. Data were collected by structured one-to-one interviews with children of 14 randomly selected handball teams in the amateur national league. Methods The questionnaire consisted of 15 questions. The age, gender, trauma experience and league status of each interviewee was recorded. The interviews took place mainly at national championships or tournaments. Results A total of 212 individuals, 74 girls and 138 boys, were interviewed. Forty-one of the 212 participants (19.3 %) had sustained a dental injury. The mean age of participants was 12 +/- 1.6 years. Concussion was the most frequent finding and the cause of injury was a blow from another player. The number of individuals that were aware of mouthguards was only 15.6 % and surprisingly no players used mouthguards. Conclusions The results show that handball players need more knowledge and education considering the prevention of TDIs from their sports clubs and dentists. The importance of adequate facial protection in contact sports should be endorsed by all sports clubs, and parents advised accordingly.	[Ozbay, G.; Bakkal, M.; Abbasoglu, Z.; Demirel, S.; Kargul, Betul] Marmara Univ, Fac Dent, Dept Pediat Dent, Buyukciftlik Sok 6, Istanbul, Turkey; [Welbury, R.] Univ Dent Sch & Hosp, Dept Paediat Dent, Glasgow, Lanark, Scotland		Kargul, B (corresponding author), Marmara Univ, Fac Dent, Dept Pediat Dent, Buyukciftlik Sok 6, Istanbul, Turkey.	bkargul@marmara.edu.tr	Kargul, Betul/AAA-3616-2021; Bakkal, Meltem/V-7366-2017	Kargul, Betul/0000-0002-3294-8846; Bakkal, Meltem/0000-0001-9863-130X; Abbasoglu, Zerrin/0000-0002-0077-5581; Welbury, Richard/0000-0002-9322-2440			Andreasen JO, 1994, TXB COLOR ATLAS TRAU, P719; Andreasen JO, 1970, SCAND J DENT RES, V78, P339; Beachy G, 2004, J ATHL TRAINING, V39, P310; Boffano P, 2012, DENT TRAUMATOL, V28, P210, DOI 10.1111/j.1600-9657.2011.01067.x; Caglar E, 2005, DENT TRAUMATOL, V21, P29, DOI 10.1111/j.1600-9657.2004.00271.x; Domey B., 1998, FDI WORLD, V7, P10; Farrington T, 2012, BRIT J ORAL MAX SURG, V50, P233, DOI 10.1016/j.bjoms.2010.11.020; *FDI, 1990, 7 FDI; Ferrari CH, 2002, DENT TRAUMATOL, V18, P144, DOI 10.1034/j.1600-9657.2002.00017.x; FLANDERS RA, 1995, J AM DENT ASSOC, V126, P491, DOI 10.14219/jada.archive.1995.0213; Francis K T, 1991, Br J Sports Med, V25, P227; Fux-Noy A, 2011, DENT TRAUMATOL, V27, P252, DOI 10.1111/j.1600-9657.2010.00970.x; HEINTZ WD, 1968, J AM DENT ASSOC, V77, P632; Hersberger S, 2012, DENT TRAUMATOL, V28, P287, DOI 10.1111/j.1600-9657.2011.01083.x; Jorgensen U, 1984, Br J Sports Med, V18, P59; Kececi AD, 2005, DENT TRAUMATOL, V21, P76, DOI 10.1111/j.1600-9657.2004.00302.x; KERR IL, 1986, SPORTS MED, V3, P415, DOI 10.2165/00007256-198603060-00003; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Knobloch K, 2005, SPORTVERLETZ SPORTSC, V19, P82, DOI 10.1055/s-2005-858142; Lang B, 2002, DENT TRAUMATOL, V18, P329, DOI 10.1034/j.1600-9657.2002.00123.x; Maxen M, 2011, DENT TRAUMATOL, V27, P95, DOI 10.1111/j.1600-9657.2010.00960.x; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Onyeaso CO, 2004, J NATL MED ASSOC, V96, P240; Persic R, 2006, DENT TRAUMATOL, V22, P231, DOI 10.1111/j.1600-9657.2006.00379.x; Quarrie KL, 2005, BRIT J SPORT MED, V39, P650, DOI 10.1136/bjsm.2004.016022; Ranalli DN, 2002, DENT TRAUMATOL, V18, P231, DOI 10.1034/j.1600-9657.2002.00122.x; SANE J, 1988, INT J ORAL MAX SURG, V17, P122, DOI 10.1016/S0901-5027(88)80165-6; Tulunoglu I, 2006, DENT TRAUMATOL, V22, P242, DOI 10.1111/j.1600-9657.2006.00386.x; Yde J, 1990, Br J Sports Med, V24, P51	29	11	12	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1818-6300	1996-9805		EUR ARCH PAEDIATR DE	Eur. Arch. Paediatr. Dent.	FEB	2013	14	1					41	45		10.1007/s40368-012-0005-4			5	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	V09CA	WOS:000214119900008	23532813				2022-02-06	
J	Reznik, JE; Gordon, SJ; Barker, RN; Keren, O; Arama, Y; Galea, MP				Reznik, Jacqueline E.; Gordon, Susan J.; Barker, Ruth N.; Keren, Ofer; Arama, Yuval; Galea, Mary P.			Extracorporeal Shock Wave Therapy (ESWT) as a treatment for recurrent Neurogenic Heterotopic Ossification (NHO)	BRAIN INJURY			English	Article						Brain injury; traumatic brain injury (TBI); neurogenic heterotopic ossification (NHO); extracorporeal shock wave therapy (ESWT)	BRAIN-INJURY; CHRONIC PAIN; RELIEF	Primary objective: To describe the effects of extracorporeal shock wave therapy (ESWT) on neurogenic heterotopic ossification (NHO). Research design: A single case study was considered the most appropriate methodology in this situation. Methods and procedures: The subject was a 43 year old female 10 years post-traumatic brain injury with recurring NHO around the hip joint. Baseline assessments of pain using a 10-point VAS, range of motion of the hip using a goniometer and walking ability (number of steps over a standard distance) were conducted. Four applications of ESWT using a Minispec (TM) Extracorporeal Shock Wave Lithotripsy machine (Medispec Int. USA) administered over 6 weeks to the anterolateral aspect of the right hip. Follow-up assessments were conducted weekly over the period of intervention and then monthly for 5 months. Main outcomes and results: Immediately following treatment, pain was reduced to 0 on the VAS scale; hip range of motion increased and the number of steps over a standard distance reduced, indicating increased step length. At 5-month follow-up, without further ESWT intervention, these results were maintained. Conclusion: This case study suggests that ESWT may be a non-invasive, low risk intervention for the management of NHO.	[Reznik, Jacqueline E.; Gordon, Susan J.; Barker, Ruth N.; Galea, Mary P.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Keren, Ofer] Chaim Sheba Med Ctr, Head Injury Dept, Ramat Gan, Israel; [Arama, Yuval] Assaf Harofe Med Ctr, Dept Orthopaed, Zerifin, Israel; [Galea, Mary P.] Univ Melbourne, Rehabil Sci Res Ctr, Melbourne, Vic, Australia		Reznik, JE (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia.	jackie.reznik@jcu.edu.au	Galea, Mary/F-4242-2010	Galea, Mary/0000-0003-0045-7978; Gordon, Susan/0000-0002-4760-1212; Barker, Ruth/0000-0002-2546-2581; Reznik, Jacqueline/0000-0002-7324-9531			Banovac K, 2000, J Spinal Cord Med, V23, P40; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Banovac K, 1997, J Spinal Cord Med, V20, P60; Banovac Kresimir, 2004, J Spinal Cord Med, V27, P376; Botte MJ, 1997, ORTHOPEDICS, V20, P335; Buselli P, 2010, ULTRASOUND MED BIOL, V36, P397, DOI 10.1016/j.ultrasmedbio.2009.11.007; Chauveau C, 2004, EXP MOL PATHOL, V76, P37, DOI 10.1016/j.yexmp.2003.10.001; Cipriano Cara, 2009, Orthopedics, V32, DOI 10.3928/01477447-20090728-33; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286, DOI 10.1302/0301-620X.43B2.286; Daud O, 1993, Disabil Rehabil, V15, P114; Dejerine, 1919, REV NEUROL-FRANCE, V35, P399; GARLAND DE, 1983, CLIN ORTHOP RELAT R, P197; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Goldman J, 1980, Physiotherapy, V66, P219; Haake M, 2002, ARCH ORTHOP TRAUM SU, V122, P222, DOI 10.1007/s00402-001-0362-7; Haake Michael, 2002, J Orthop Sci, V7, P97, DOI 10.1007/s776-002-8429-0; Helbig K, 2001, CLIN ORTHOP RELAT R, P68; Linan E, 2001, AM J PHYS MED REHAB, V80, P614, DOI 10.1097/00002060-200108000-00013; Maier M, 2003, CLIN ORTHOP RELAT R, P237, DOI 10.1097/01.blo.0000030173.56585.8f; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Mustafa M, 2011, UROL RES, V39, P223, DOI 10.1007/s00240-010-0339-5; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Ogden JA, 2001, CLIN ORTHOP RELAT R, P47, DOI 10.1097/00003086-200106000-00007; Rompe JD, 1996, J BONE JOINT SURG BR, V78B, P233, DOI 10.1302/0301-620X.78B2.0780233; Rompe JD, 2001, CLIN ORTHOP RELAT R, P102, DOI 10.1097/00003086-200106000-00014; Sator-Katzenschlager SM, 2003, ANESTH ANALG, V97, P791, DOI 10.1213/01.ANE.0000078584.03856.D3; Schaden W, 2001, CLIN ORTHOP RELAT R, P90; Silver J R, 1969, Paraplegia, V7, P220; SNOECX M, 1995, PARAPLEGIA, V33, P464, DOI 10.1038/sc.1995.101; Stover S L, 1976, Paraplegia, V14, P146; Takahashi N, 2003, AUTON NEUROSCI-BASIC, V107, P81, DOI 10.1016/S1566-0702(03)00134-6; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wang C, 2005, AM J SPORTS MED, V34, P592; Wang CJ, 2008, ARCH ORTHOP TRAUM SU, V128, P901, DOI 10.1007/s00402-007-0530-5; Wang CJ, 2003, J ORTHOP RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9; Wess OJ, 2008, UROL RES, V36, P327, DOI 10.1007/s00240-008-0156-2	40	11	13	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2013	27	2					242	247		10.3109/02699052.2012.729293			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500012	23384220	Green Accepted			2022-02-06	
J	Solomon, GS; Haase, RF; Kuhn, A				Solomon, Gary S.; Haase, Richard F.; Kuhn, Andrew			The Relationship among Neurocognitive Performances and Biopsychosocial Characteristics of Elite National Football League Draft Picks: An Exploratory Investigation	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						National Football League; Neurocognitive testing; Biopsychosocial characteristics; Draft picks; ImPACT; Concussion	TEST-RETEST RELIABILITY; CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALL; HIGH-SCHOOL; RECURRENT CONCUSSION; NCAA CONCUSSION; TEST BATTERY; PLAYERS; IMPACT; NFL	Sports neuropsychology has emerged as a specialty area within the field of clinical neuropsychology. The role of the sports neuropsychologist, rooted in baseline and post-concussion testing, has evolved to include other clinical domains, including the clinical assessment of potential draft picks. There is no published information on the neurocognitive characteristics of these draft picks. We sought to determine whether elite NFL draft picks differed from NFL roster athletes on neurocognitive (ImPACT) and biopsychosocial characteristics, and given that no published data exists for this population, adopted null hypotheses. Null hypotheses were rejected for two of the four ImPACT scores, as elite draft picks scored higher on measures of visual motor speed and reaction time than roster NFL athletes. Subtle but distinct neurocognitive differences are noted when comparing elite NFL draft picks with norms from a cumulative roster of a single NFL team.	[Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Haase, Richard F.] SUNY Albany, Albany, NY 12222 USA; [Kuhn, Andrew] Boston Univ, Boston, MA 02215 USA		Solomon, GS (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA.	garysolomon17@yahoo.com	Solomon, Gary/K-9011-2019; Kuhn, Andrew W/AAM-4820-2020	Kuhn, Andrew W/0000-0003-1836-7575			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Broglio S., 2008, BRIT J SPORT MED, V40, P802; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Casson Ira R, 2006, Neurosurgery, V59, pE1152; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DUCKRO PN, 1989, CEPHALALGIA, V9, P199, DOI 10.1046/j.1468-2982.1989.0903199.x; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gill A, 2012, J SPORT ECON, V13, P642, DOI 10.1177/1527002511429575; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson G., 2004, NAT ASS SCH PSYCH DA; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Kuzmits FE, 2008, J STRENGTH COND RES, V22, P1721, DOI 10.1519/JSC.0b013e318185f09d; Lovell M, 2007, IMPACT 2007 6 0 CLIN; Lovell M., 2002, IMPACT CONCUSSION MA; Lovell MR, 2011, APPL NEUROPSYCHOL, V18, P197, DOI 10.1080/09084282.2011.595446; Lyons BD, 2009, HUM PERFORM, V22, P225, DOI 10.1080/08959280902970401; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; National Institute of Mental Health (NIMH), 2012, STATISTICS; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Reider B, 2012, AM J SPORT MED, V40, P2197, DOI 10.1177/0363546512462362; Rencher Alvan C., 2002, METHODS MULTIVARIATE; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2012, ARCH CLIN NEUROPSYCH, V27, P622; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Wilens E, 2004, JAMA-J AM MED ASSOC, V292, P619, DOI 10.1001/jama.292.5.619; *WOND PERS TEST IN, 1992, WOND PERS TEST SCHOL; Wonderlic EF, 1939, J APPL PSYCHOL, V23, P685, DOI 10.1037/h0056432	49	11	11	0	23	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2013	28	1					9	20		10.1093/arclin/acs108			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	073EP	WOS:000313726600002	23220623	Bronze			2022-02-06	
J	Zhang, YM; Zhang, YQ; Cheng, SB; Chen, SX; Chen, AL; Tang, CZ				Zhang Yi-min; Zhang Yu-qing; Cheng Shao-bing; Chen Sheng-xin; Chen Ai-lian; Tang Chun-zhi			Effect of acupuncture on proliferation and differentiation of neural stem cells in brain tissues of rats with traumatic brain injury	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article						traumatic brain injury; acupuncture; neural stem cells; proliferation and differentiation; rats	PRECURSORS	To observe the effect of acupuncture on proliferation and differentiation of neural stem cells in brain tissues of rats with traumatic brain injuny. Thirty SD rats were randomly and equally allocated to the sham-operated, the model and the acupuncture groups. The traumatic brain injury model was established by the free drop method. For the rats in the acupuncture group, acupuncture was applied once a day for 7 days. Brain histotomy was carried out when treatments were completed. Immunohistochemical techniques were adopted to detect the cells that express nestin, neurofilament proteins (NF)-200 and glial fibrillary acidic proteins (GFAP), the markers of neural stem cells, neurons, astrocytes respectively. Compared to the sham-operated group, the number of nestin-positive cells and NF-200-positive cells in brain tissues was decreased significantly in the model group (P < 0.01), whereas the number of GFAP-positive cells was significantly increased P < 0.01). Compared to the model group, the positive cells of nestin, NF-200, GFAP in brain tissues in the acupuncture group were increased obviously (P < 0.01). Acupuncture can significantly increase the number of nestin-positive cells, NF-200-positive cells and GFAP-positive cells, indicating the significant increase of neural stem cells, neurons and astrocytes in number. Acupuncture can improve neuranagenesis by promoting the proliferation and differentiation of neural stem cells in brain tissues. This might be one of the mechanisms for acupuncture to treat traumatic brain injury and to promote the repair of nervous function.	[Zhang Yi-min; Zhang Yu-qing; Cheng Shao-bing; Chen Sheng-xin; Chen Ai-lian] Jinan Univ, Guangzhou 510632, Guangdong, Peoples R China; [Tang Chun-zhi] Guangzhou Univ Tradit Chinese Med, Guangzhou 510405, Guangdong, Peoples R China		Zhang, YM (corresponding author), Jinan Univ, Guangzhou 510632, Guangdong, Peoples R China.	jane-107@163.com			Natural Science Foundation of GuangdongNational Natural Science Foundation of Guangdong Province [9151063201000028]; Project of Science and Technology of Guangdong [2011B031800284]	Supported by Project of Natural Science Foundation of Guangdong (No. 9151063201000028) and Project of Science and Technology of Guangdong (No. 2011B031800284)	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Chen T, 2009, CHIN ORG ENG RES CLI, V13, P5367; Chen Y, 2007, BRAIN RES, V1166, P9, DOI 10.1016/j.brainres.2007.06.043; Ding Y, 2009, CHIN MAGAZINE MODERN, V11, P138; Li MJ, 2008, CHIN ORGAN ENG RES C, V12, P5709; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Tang Q, 2009, CHIN MAGAZINE REHABI, V24, P676; [田贵华 TIAN Guihua], 2011, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V26, P1197; Tu XH, 2011, WORLD J ACUPUNCT MOX, V21, P6; [邬巍 Wu Wei], 2008, [中国老年学杂志, Chinese Journal of Gerontology], V28, P238; Zhang XN, 2008, CHIN REHABIL THEORY, V14, P101; Zhang YM, 2006, CHIN CLIN REHABIL CH, V10, P135; Zhang YM, 2010, CHIN MED J CHIN, V51, P528; 黄艳君, 2007, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V22, P380	14	11	14	0	23	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0415			CHIN J INTEGR MED	Chin. J. Integr. Med.	FEB	2013	19	2					132	136		10.1007/s11655-013-1353-6			5	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	080WY	WOS:000314276000009	23371461				2022-02-06	
J	Zou, FH; Xu, J; Fu, HR; Cao, JH; Mao, H; Gong, MJ; Cui, G; Zhang, Y; Shi, W; Chen, J				Zou, Feihui; Xu, Jian; Fu, Hongran; Cao, Jianhua; Mao, Hui; Gong, Mingjie; Cui, Gang; Zhang, Yang; Shi, Wei; Chen, Jian			Different Functions of HIPK2 and CtBP2 in Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						HIPK2; CtBP2; Traumatic brain injury; Apoptosis; Proliferation; Rat	INTERACTING PROTEIN KINASE-2; TERMINAL BINDING-PROTEIN; SEVERE HEAD-INJURY; TRANSCRIPTIONAL COREPRESSOR; GROWTH-FACTOR; CELL-CYCLE; P53-INDEPENDENT APOPTOSIS; NEGATIVE MODULATION; GENE-EXPRESSION; CO-REPRESSORS	Traumatic brain injury (TBI) initiates a complex series of neurochemical and signaling changes that lead to neuronal dysfunction and over-reactive astrocytes. In our study, homeodomain interacting protein kinase 2 (HIPK2) can interact with C-terminal binding protein 2 (CtBP2) in rat brain, which is a component of Wnt-regulated transcription. Up to now, the functions of HIPK2 and CtBP2 in CNS are still with limited acquaintance. In our study, we found that the interaction between HIPK2 and CtBP2 was involved in central nervous system (CNS) injury and repair. We performed an acute TBI model in adult rats. Western blot and immunohistochemistry analysis revealed that both HIPK2 and CtBP2 significantly increased in the peritrauma brain cortex in comparison to contralateral cerebral cortex. And immunofluorescence double-labeling revealed that HIPK2 was mainly co-expressed with NeuN but less GFAP. Meanwhile, we also examined that the expression profiles of active-caspase-3 was correlated with the expression of HIPK2 and the expression profiles of the proliferating cell nuclear antigen (PCNA) was correlated with the expression of CtBP2. HIPK2 participated in apoptosis of neurons, but CtBP2 was associated with the activation and proliferation of astrocytes. Immunoprecipitation further showed that they enhanced the interaction with each other in the pathophysiology process. In conclusion, this was the first description that HIPK2 interacted with CtBP2 in traumatic brains. Our data suggest that HIPK2 and CtBP2 might play important roles in CNS pathophysiology after TBI, and might provide a basis for the further study on their roles in regulating the prognosis after TBI.	[Zou, Feihui; Fu, Hongran; Mao, Hui; Gong, Mingjie; Cui, Gang; Zhang, Yang; Shi, Wei; Chen, Jian] Nantong Univ, Affiliated Hosp, Surg Comprehens Lab, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Xu, Jian; Cao, Jianhua] Nantong Univ, Affiliated Hosp, Mental Hlth Ctr, Dept Psychiat, Nantong 226001, Jiangsu, Peoples R China		Shi, W (corresponding author), Nantong Univ, Affiliated Hosp, Surg Comprehens Lab, Dept Neurol, 19 Qi Xiu Rd, Nantong 226001, Jiangsu, Peoples R China.	ws740104@hotmail.com; chenjian9079@gmail.com					Al-Beiti MAM, 2008, AUST NZ J OBSTET GYN, V48, P329, DOI 10.1111/j.1479-828X.2008.00874.x; Birts CN, 2011, ONCOGENE, V30, P1272, DOI 10.1038/onc.2010.507; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; Engelhardt OG, 2003, EXP CELL RES, V283, P36, DOI 10.1016/S0014-4827(02)00025-3; Erhardt L, 1996, EUR HEART J, V17, P1781; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Kovi RC, 2010, CELL DEATH DIFFER, V17, P513, DOI 10.1038/cdd.2009.140; Lavra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020665; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; Li XH, 2005, J BIOL CHEM, V280, P15061, DOI 10.1074/jbc.M414262200; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; LOGAN A, 1992, J NEUROSCI, V12, P3828; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Moller A, 2003, CANCER RES, V63, P4310; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Paliwal S, 2006, MOL CELL BIOL, V26, P2360, DOI 10.1128/MCB.26.6.2360-2372.2006; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; SUBRAMANIAN T, 1989, ONCOGENE, V4, P415; Sung KS, 2005, FEBS LETT, V579, P3001, DOI 10.1016/j.febslet.2005.04.053; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; Wang SY, 2006, J BIOL CHEM, V281, P34810, DOI 10.1074/jbc.M607484200; Wang Y, 2001, BMC Mol Biol, V2, P8, DOI 10.1186/1471-2199-2-8; Wang Y, 2002, BIOCHEM BIOPH RES CO, V297, P148, DOI 10.1016/S0006-291X(02)02020-X; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang LP, 2005, BIOCHEM BIOPH RES CO, V330, P293, DOI 10.1016/j.bbrc.2005.02.156; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	57	11	12	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2013	49	2					395	408		10.1007/s12031-012-9906-2			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	070OW	WOS:000313519900018	23076816				2022-02-06	
J	Zou, XT; Wu, N; Tian, Y; Niezrecki, C; Chen, JL; Wang, XW				Zou, Xiaotian; Wu, Nan; Tian, Ye; Niezrecki, Christopher; Chen, Julie; Wang, Xingwei			Rapid miniature fiber optic pressure sensors for blast wave measurements	OPTICS AND LASERS IN ENGINEERING			English	Article						Fiber optic sensor; Fabry-Perot; Blast wave; Pressure sensor; Traumatic brain injury	INJURIES; BRAIN; DIAPHRAGM	Traumatic brain injury (TBI) is a serious potential threat to soldiers who are exposed to explosions. Since the pathophysiology of TBI associated with a blast wave is not clearly defined, it is crucial to have a sensing system to accurately quantify the blast wave dynamics. This paper presents an ultra-fast fiber optic pressure sensor based on Fabry-Perot (FP) interferometric principle that is capable of measuring the rapid pressure changes in a blast event. The blast event in the experiment was generated by a starter pistol blank firing at close range, which produced a more realistic wave profile compared to using compressed air driven shock tubes. To the authors' knowledge, it is also the first study to utilize fiber optic pressure sensors to measure the ballistics shock wave of a pistol firing. The results illustrated that the fiber optic pressure sensor has a rise time of 200 ns which demonstrated that the sensor has ability to capture the dynamic pressure transient during a blast event. Moreover, the resonant frequency of the sensor was determined to be 4.11 MHz, which agrees well with the specific designed value. Published by Elsevier Ltd.	[Zou, Xiaotian; Wang, Xingwei] Univ Massachusetts, Dept Biomed Engn & Biotechnol, Lowell, MA 01584 USA; [Wu, Nan; Tian, Ye; Wang, Xingwei] Univ Massachusetts, Dept Elect & Comp Engn, Lowell, MA 01584 USA; [Niezrecki, Christopher; Chen, Julie] Univ Massachusetts, Dept Mech Engn, Lowell, MA 01584 USA		Wang, XW (corresponding author), Univ Massachusetts, Dept Biomed Engn & Biotechnol, Lowell, MA 01584 USA.	xingwei_wang@uml.edu	Tian, Ye/A-1090-2014; Tian, Ye/C-4662-2013; Zou, Xiaotian/J-8657-2013	Tian, Ye/0000-0002-0785-1145; Tian, Ye/0000-0002-0785-1145; 	Army Research Laboratory (Nanomanufacturing of Multifunctional Sensors) [W911NF-07-2-0081]	The authors are grateful for the collaboration with Nanomanufacturing Center at University of Massachusetts Lowell. The authors also appreciate Army Research Laboratory for sponsoring this work (Nanomanufacturing of Multifunctional Sensors Ref. Award Number: W911NF-07-2-0081).	Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Eaton WP, 1997, SMART MATER STRUCT, V6, P530, DOI 10.1088/0964-1726/6/5/004; MacPherson WN, 2000, MEAS SCI TECHNOL, V11, P95, DOI 10.1088/0957-0233/11/2/302; Neff M, 1999, PROC GRAPH INTERF, P193; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parkes W, 2007, J MICROMECH MICROENG, V17, P1334, DOI 10.1088/0960-1317/17/7/016; Tian Y, 2011, SENSORS-BASEL, V11, P1078, DOI 10.3390/s110101078; Totsu K, 2003, 12 INT C TRANSD SOL, V1, P931; Wang WH, 2012, OPT COMMUN, V285, P3466, DOI 10.1016/j.optcom.2012.04.001; Wang WH, 2010, OPT EXPRESS, V18, P9006, DOI 10.1364/OE.18.009006; Wang WH, 2009, OPT EXPRESS, V17, P16613, DOI 10.1364/OE.17.016613; Watson S, 2006, MEAS SCI TECHNOL, V17, P1337, DOI 10.1088/0957-0233/17/6/008; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Wu N, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/5/055102; Wu N, 2011, OPT EXPRESS, V19, P10797, DOI 10.1364/OE.19.010797; Xu J, 2005, P SOC PHOTO-OPT INS, P5998; Xu JC, 2005, OPT LETT, V30, P3269, DOI 10.1364/OL.30.003269; Zou X, 2011, STUDY BLAST EVENT PR, P802809; Zou XT, 2012, MEASUREMENT, V45, P1077, DOI 10.1016/j.measurement.2012.01.034	21	11	13	2	54	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-8166			OPT LASER ENG	Opt. Lasers Eng.	FEB	2013	51	2					134	139		10.1016/j.optlaseng.2012.09.001			6	Optics	Science Citation Index Expanded (SCI-EXPANDED)	Optics	038OG	WOS:000311183400007					2022-02-06	
J	Gao, W; Xu, HY; Liang, M; Huang, JH; He, XS				Gao, Wei; Xu, Hongyu; Liang, Ming; Huang, Jason H.; He, Xiaosheng			Association between reduced expression of hippocampal glucocorticoid receptors and cognitive dysfunction in a rat model of traumatic brain injury due to lateral head acceleration	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury (TBI); Glucocorticoid receptors (GRs); Spatial memory; Hippocampus; Rats	DIFFUSE AXONAL INJURY; TRANSGENIC MICE; MEMORY	Expression of hippocampal glucocorticoid receptors (GRs) and spatial learning and memory were observed in rat model of diffuse traumatic brain injury (TBI) due to lateral head acceleration with an aim at investigating the relation between GRs expression and cognitive deficits. Immunohistochemical staining, Western blotting, and RT-PCR indicated that down-regulation of GRs expression occurred in the hippocampus among TBI-rats which demonstrated reduced performance of learning and memory in Morris water maze. As the GRs expression bounced up, the cognitive function approached to normal. It is concluded that reduced expression of hippocampal GRs was closely associated with learning and memory deficits in TBI-rats. Hippocampal GRs was involved in the biochemical mechanisms of cognitive deficits after TBI. (c) 2012 Elsevier Ireland Ltd. All rights reserved.	[Gao, Wei; Xu, Hongyu; Liang, Ming; He, Xiaosheng] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China; [Huang, Jason H.] Univ Rochester, Dept Neurosurg, Rochester, NY USA		He, XS (corresponding author), 15 W Changle Rd, Xian 710032, Peoples R China.	hexiaos@fmmu.edu.cn	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	NSFCNational Natural Science Foundation of China (NSFC) [30971173]	The present study was supported by the funds of 2010 NSFC proposal (Item No. 30971173).	DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; DEKLOET ER, 1988, NEUROENDOCRINOLOGY, V47, P109, DOI 10.1159/000124900; Douma BRK, 1998, PSYCHONEUROENDOCRINO, V23, P33, DOI 10.1016/S0306-4530(97)00091-7; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hwang IK, 2006, NEUROSCI RES, V54, P319, DOI 10.1016/j.neures.2005.12.012; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; MONTKOWSKI A, 1995, J NEUROENDOCRINOL, V7, P841, DOI 10.1111/j.1365-2826.1995.tb00724.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; PEPIN MC, 1992, NATURE, V355, P725, DOI 10.1038/355725a0; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Rohleder N, 2009, INT J PSYCHOPHYSIOL, V72, P74, DOI 10.1016/j.ijpsycho.2008.03.010; Rousse I, 1997, NEUROREPORT, V8, P841, DOI 10.1097/00001756-199703030-00007; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Taubenfeld SM, 2009, BIOL PSYCHIAT, V65, P249, DOI 10.1016/j.biopsych.2008.07.005; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008	19	11	12	1	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 15	2013	533						50	54		10.1016/j.neulet.2012.11.020			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	077GN	WOS:000314016000010	23200726				2022-02-06	
J	Phillips, KF; Deshpande, LS; DeLorenzo, RJ				Phillips, Kristin F.; Deshpande, Laxmikant S.; DeLorenzo, Robert J.			Hypothermia reduces calcium entry via the N-methyl-D-aspartate and ryanodine receptors in cultured hippocampal neurons	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Calcium; Hypothermia; Ryanodine receptor; NMDA receptor	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; RECURRENT EPILEPTIFORM DISCHARGES; GLUTAMATE NEUROTOXICITY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; HOMEOSTATIC MECHANISMS; CLINICAL-TRIALS; CARDIAC-ARREST; AMINO-ACIDS	Hypothermia is a powerful neuroprotective method when induced following cardiac arrest, stroke, and traumatic brain injury. The physiological effects of hypothermia are multifaceted and therefore a better knowledge of its therapeutic targets will be central to developing innovative combination therapies to augment the protective benefits of hypothermia. Altered neuronal calcium dynamics have been implicated following stroke, status epilepticus and traumatic brain injury. This study was therefore initiated to evaluate the effect of hypothermia on various modes of calcium entry into a neuron. Here, we utilized various pharmacological agents to stimulate major routes of calcium entry in primary cultured hippocampal neurons. Fluorescent calcium indicator Fura-2AM was used to compare calcium ratio under normothermic (37 degrees C) and hypothermic (31 degrees C) conditions. The results of this study indicate that hypothermia preferentially reduces calcium entry through N-methyl-D-aspartate receptors and ryanodine receptors. Hypothermia, on the other hand, did not have a significant effect on calcium entry through the voltage-dependent calcium channels or the inositol tri-phosphate receptors. The ability of hypothermia to selectively affect both N-methyl-D-aspartate receptors and ryanodine receptors-mediated calcium systems makes it an attractive intervention for alleviating calcium elevations that are present following many neurological injuries. (C) 2012 Elsevier B.V. All rights reserved.	[Phillips, Kristin F.; Deshpande, Laxmikant S.; DeLorenzo, Robert J.] Virginia Commonwealth Univ, Sch Med, Dept Neurol, Richmond, VA 23298 USA; [DeLorenzo, Robert J.] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA		DeLorenzo, RJ (corresponding author), Virginia Commonwealth Univ, Sch Med, POB 980599, Richmond, VA 23298 USA.	rdeloren@vcu.edu	Deshpande, Laxmikant S./B-7679-2013	Deshpande, Laxmikant S./0000-0003-1491-1561	CounterACT Program, National Institutes of Health Office of the Director (NIH OD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2U01NS058213-06, 1R21NS072061-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS058213, R21NS072061] Funding Source: NIH RePORTER	This research is supported by the CounterACT Program, National Institutes of Health Office of the Director (NIH OD), and the National Institute of Neurological Disorders and Stroke (NINDS), Grant Number 2U01NS058213-06 and 1R21NS072061-01A1 to RJD.	Adachi M, 2001, PEDIATR RES, V50, P590, DOI 10.1203/00006450-200111000-00010; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Angehagen M, 2003, NEUROREPORT, V14, P471, DOI 10.1097/01.wnr.0000059774.23521.b7; Asai S, 2000, BRAIN RES, V864, P60, DOI 10.1016/S0006-8993(00)02151-X; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, J NEUROSCI, V8, P185; deLorenzo RJ, 1998, P NATL ACAD SCI USA, V95, P14482, DOI 10.1073/pnas.95.24.14482; Deshpande LS, 2008, EUR J PHARMACOL, V583, P73, DOI 10.1016/j.ejphar.2008.01.025; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; GREENE RW, 1985, BRIT J PHARMACOL, V85, P163, DOI 10.1111/j.1476-5381.1985.tb08843.x; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; Hua Y, 2010, J ANESTH, V24, P726, DOI 10.1007/s00540-010-0999-x; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; ILLIEVICH UM, 1994, ANESTH ANALG, V78, P905; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; JENDEN DJ, 1969, PHARMACOL REV, V21, P1; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Koulen P, 2001, MOL NEUROBIOL, V24, P65, DOI 10.1385/MN:24:1-3:065; Kvrivishvili G, 2002, NEUROREPORT, V13, P1995, DOI 10.1097/00001756-200211150-00001; LEI SHZ, 1992, BRAIN RES, V598, P196, DOI 10.1016/0006-8993(92)90183-A; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MICHAELS RL, 1990, J NEUROSCI, V10, P283; MOUDY AM, 1994, NEUROPHARMACOLOGY, V33, P953, DOI 10.1016/0028-3908(94)90153-8; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nagarkatti N, 2010, EUR J NEUROSCI, V32, P80, DOI 10.1111/j.1460-9568.2010.07262.x; Niebauer M, 1999, NEUROPHARMACOLOGY, V38, P1343, DOI 10.1016/S0028-3908(99)00059-3; Ning XH, 2002, J APPL PHYSIOL, V92, P2200, DOI 10.1152/japplphysiol.01035.2001; OKUDA C, 1986, PHARMACOL BIOCHEM BE, V24, P79; Ooboshi H, 2000, BRAIN RES, V884, P23, DOI 10.1016/S0006-8993(00)02861-4; OSUGI T, 1986, BRAIN RES, V379, P84, DOI 10.1016/0006-8993(86)90258-1; Pal S, 2001, CELL CALCIUM, V30, P285, DOI 10.1054/ceca.2001.0236; Pal S, 1999, BRAIN RES, V851, P20, DOI 10.1016/S0006-8993(99)02035-1; Polderman KH, 2008, EUR J ANAESTH, V25, P23, DOI 10.1017/S026502150700333X; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rauck RL, 2006, J PAIN SYMPTOM MANAG, V31, P393, DOI 10.1016/j.jpainsymman.2005.10.003; Raza M, 2004, P NATL ACAD SCI USA, V101, P17522, DOI 10.1073/pnas.0408155101; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; ROTHMAN SM, 1987, NEUROSCIENCE, V22, P471, DOI 10.1016/0306-4522(87)90347-2; Sanz-Clemente A., 2012, NEUROSCIENTIST; Shorvon S, 2011, EPILEPSIA, V52, P53, DOI 10.1111/j.1528-1167.2011.03238.x; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706, DOI 10.1152/jn.1995.73.4.1706; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Sun DA, 2004, CELL CALCIUM, V35, P155, DOI 10.1016/j.ceca.2003.09.003; Sun DA, 2002, EPILEPSIA, V43, P1296, DOI 10.1046/j.1528-1157.2002.09702.x; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; UNEYAMA H, 1993, BRAIN RES, V604, P24, DOI 10.1016/0006-8993(93)90348-Q; Wenzel A, 1997, J NEUROCHEM, V68, P469; Winfree CJ, 1996, NEUROSURGERY, V38, P1216, DOI 10.1097/00006123-199606000-00034; WUIS EW, 1989, PHARMACOL TOXICOL, V64, P156, DOI 10.1111/j.1600-0773.1989.tb00621.x; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Yenari MA, 2010, STROKE, V41, pS72, DOI 10.1161/STROKEAHA.110.595371; Yoon KW, 1996, STROKE, V27, P122, DOI 10.1161/01.STR.27.1.122; Zeiner A, 2000, STROKE, V31, P86, DOI 10.1161/01.STR.31.1.86; ZHANG L, 1993, NEUROSCI LETT, V158, P105, DOI 10.1016/0304-3940(93)90623-S	67	11	13	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	JAN 5	2013	698	1-3					186	192		10.1016/j.ejphar.2012.10.010			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	085LL	WOS:000314616200022	23085028	Green Accepted			2022-02-06	
J	Asmaro, K; Fu, P; Ding, YC				Asmaro, Karam; Fu, Paul; Ding, Yuchuan			Neuroprotection & Mechanism of Ethanol in Stroke and Traumatic Brain Injury Therapy: New Prospects for an Ancient Drug	CURRENT DRUG TARGETS			English	Article						Ethanol; alcohol; stroke therapy; ischemia/reperfusion injury; traumatic brain injury therapy; neuroprotection	METHYL-D-ASPARTATE; INDUCED NEUROTOXICITY; ALCOHOL-CONSUMPTION; CEREBRAL-ISCHEMIA; DRINKING PATTERNS; CORTICAL-NEURONS; BLOOD-GLUCOSE; RAT; MODERATE; GLUTAMATE	Effective efforts to screen for agents that protect against the devastating effects of stroke have not produced viable results thus far. As a result this article reviews the possible role of ethanol as a neuroprotective agent in stroke and traumatic brain injury (TBI). Previous studies have associated ethanol consumption with a decreased risk of ischemic stroke, suggesting a neuroprotective mechanism. The translation of this clinical knowledge into basic science research with the goal of new therapy for acute stroke patients remains in its initial stages. In a recent study involving rats, we have shown that ethanol administration, in the correct dose after stroke onset, protects against ischemia-induced brain injury. The purpose of this paper is to discuss ethanol's neuroprotective properties in stroke when consumed as a preconditioning agent, in TBI with a positive blood alcohol content, and finally in stroke treatment, with the goal of using post-ischemia ethanol (PIE) therapy to ameliorate brain damage in the future.	[Asmaro, Karam; Fu, Paul; Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA		Ding, YC (corresponding author), Wayne State Univ, Sch Med, Dept Neurol Surg, 550 E Canfield Rd, Detroit, MI 48201 USA.	yding@med.wayne.edu		Asmaro, Karam/0000-0002-2084-4863	American Heart AssociationAmerican Heart Association; Wayne State University Neurosurgery Fund	This work was partially supported by the American Heart Association and the Wayne State University Neurosurgery Fund. We would like to also thank Ms. Lauren Kroll for proofreading the manuscript. The illustrations in Figure 2 were downloaded from http://www.vecteezy.com and produced by http://www.i-m-u.net.	Badaut J, 2007, METAB BRAIN DIS, V22, P251, DOI 10.1007/s11011-007-9057-2; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; BEGHI E, 1995, STROKE, V26, P1691, DOI 10.1161/01.STR.26.9.1691; Belmadani A, 2001, NEUROSCIENCE, V104, P769, DOI 10.1016/S0306-4522(01)00139-7; Belmadani A, 2004, NEUROREPORT, V15, P2093, DOI 10.1097/00001756-200409150-00019; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Berry C, 2011, AM SURGEON, V77, P1416; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Christensen H, 2002, EUR J NEUROL, V9, P297, DOI 10.1046/j.1468-1331.2002.00409.x; Collins MA, 1998, FASEB J, V12, P221, DOI 10.1096/fasebj.12.2.221; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dash PK, 2004, J NEUROTRAUM, V21, P1573, DOI 10.1089/0897715042441828; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; DILDYMAYFIELD JE, 1991, J NEUROCHEM, V56, P1536, DOI 10.1111/j.1471-4159.1991.tb02048.x; DONAHUE RP, 1986, JAMA-J AM MED ASSOC, V255, P2311, DOI 10.1001/jama.255.17.2311; DREJER J, 1985, J NEUROCHEM, V45, P145, DOI 10.1111/j.1471-4159.1985.tb05486.x; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Gentile NT, 2006, ACAD EMERG MED, V13, P174, DOI 10.1197/j.aem.2005.08.009; GILL JS, 1991, AM J MED, V90, P489, DOI 10.1016/0002-9343(91)80090-9; GILL JS, 1986, NEW ENGL J MED, V315, P1041, DOI 10.1056/NEJM198610233151701; Graffagnino C, 2010, NEUROCRIT CARE, V13, P307, DOI 10.1007/s12028-010-9469-4; GRUCHOW HW, 1982, ATHEROSCLEROSIS, V43, P393, DOI 10.1016/0021-9150(82)90038-7; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; HOJNACKI JL, 1991, ATHEROSCLEROSIS, V88, P49, DOI 10.1016/0021-9150(91)90256-3; JAMROZIK K, 1994, STROKE, V25, P51, DOI 10.1161/01.STR.25.1.51; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kett-White R, 2005, ACT NEUR S, V95, P83; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; KIRN TF, 1988, JAMA-J AM MED ASSOC, V260, P2480, DOI 10.1001/jama.1988.03410170018005; KLATSKY AL, 1989, STROKE, V20, P741, DOI 10.1161/01.STR.20.6.741; KOCHHAR A, 1988, ARCH NEUROL-CHICAGO, V45, P148, DOI 10.1001/archneur.1988.00520260034016; Kruyt ND, 2010, NAT REV NEUROL, V6, P145, DOI 10.1038/nrneurol.2009.231; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Louboutin JP, 2012, ALCOHOL, V46, P441, DOI 10.1016/j.alcohol.2012.02.001; Lucivero V, 2007, NEUROL SCI, V28, P165, DOI 10.1007/s10072-007-0814-0; LUSTIG HS, 1992, J NEUROCHEM, V59, P2193; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512; PALOMAKI H, 1993, STROKE, V24, P1828, DOI 10.1161/01.STR.24.12.1828; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Piironen K, 2012, STROKE, V43, P898, DOI 10.1161/STROKEAHA.111.631218; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Ritz MF, 2008, J NUTR, V138, P519, DOI 10.1093/jn/138.3.519; RUSSELL M, 1991, AM J PUBLIC HEALTH, V81, P452, DOI 10.2105/AJPH.81.4.452; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Sivaswamy S, 2010, EUR J NEUROSCI, V32, P1800, DOI 10.1111/j.1460-9568.2010.07451.x; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2; TAKADERA T, 1990, BRAIN RES, V537, P109, DOI 10.1016/0006-8993(90)90346-D; Thrift AG, 1999, EPIDEMIOLOGY, V10, P307, DOI 10.1097/00001648-199905000-00020; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; VOLKOW ND, 1990, PSYCHIAT RES-NEUROIM, V35, P39, DOI 10.1016/S0165-1781(06)80006-5; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Wang F, 2012, STROKE, V43, P205, DOI 10.1161/STROKEAHA.111.629576; Wang T, J NEUROSURG IN PRESS; Weir CJ, 1997, BMJ-BRIT MED J, V314, P1303, DOI 10.1136/bmj.314.7090.1303; WILKE N, 1994, EXS, V71, P49; Yuan Y, 2012, NEUROL RES, V34, P373, DOI 10.1179/1743132812Y.0000000030; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zeng XW, 2012, BRAIN RES, V1437, P127, DOI 10.1016/j.brainres.2011.12.012; Zhao YJ, 1998, ALCOHOL CLIN EXP RES, V22, P717, DOI 10.1097/00000374-199805000-00025	69	11	12	0	16	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1389-4501	1873-5592		CURR DRUG TARGETS	Curr. Drug Targets	JAN	2013	14	1					74	80		10.2174/138945013804806505			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	116GO	WOS:000316871200008	23170798				2022-02-06	
B	Corrigan, JD; Mysiw, WJ		Zasler, ND; Katz, DI; Zafonte, RD		Corrigan, John D.; Mysiw, W. Jerry			Substance Misuse Among Persons With Traumatic Brain Injury	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							ALCOHOL-USE PATTERNS; PSYCHIATRIC-DISORDERS; ABUSE TREATMENT; YOUNG-ADULTS; HEAD-INJURY; DRUG-USE; SYSTEMATIC BIAS; RISK-FACTORS; AXIS-I; OUTCOMES		[Corrigan, John D.] Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Mysiw, W. Jerry] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA		Corrigan, JD (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA.						Adams RS, 2011, EXAMINING ALCOHOL US; Adams RS, 2011, J SOCIAL WO IN PRESS; ALTERMAN AI, 1985, J STUD ALCOHOL, V46, P256, DOI 10.15288/jsa.1985.46.256; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Babor T.F., 2001, AUDIT THE ALCOHOL US; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Berry C, 2010, AM SURGEON, V76, P1067; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Blackerby W.F., 1990, J HEAD TRAUMA REHAB, V5, P47; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bogner JA, 1997, J HEAD TRAUMA REHAB, V12, P57, DOI 10.1097/00001199-199710000-00006; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Center for Substance Abuse Treatment, 1994, TREATM IMPR PROT TIP, V11; Committee on Trauma, SCREEN BRIEF INT QUI; Corrigan J. D., 1999, REHABILITATION ADULT; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Corrigan JD, DETECTING TRAUMATIC; Corrigan JD, 2009, 2009 ACRM ASNR JOINT; Corrigan JD, 2012, BRAIN INJ; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2007, BRAIN INJURY, V21, P343, DOI 10.1080/02699050701253103; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; *CTR SUBST AB TREA, 1998, TREATM IMPR PROT TIP, V29; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; De Reuck J, 2011, CLIN NEUROL NEUROSUR, V113, P469, DOI 10.1016/j.clineuro.2011.02.004; Dennis Michael, 2007, Addict Sci Clin Pract, V4, P45; Draus JM, 2008, J PEDIATR SURG, V43, P208, DOI 10.1016/j.jpedsurg.2007.09.046; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; Hensold TC, 2006, BRAIN INJURY, V20, P369, DOI 10.1080/02699050500487563; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HILLBOM M, 1986, J NEUROL NEUROSUR PS, V49, P1348, DOI 10.1136/jnnp.49.12.1348; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; HUNGERFORD DW, 2002, ALCOHOL PROBLEMS EME; IOM, 2009, GULF WAR HLTH, V7; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; LANGLEY M J, 1990, Brain Injury, V4, P77, DOI 10.3109/02699059009026151; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; MALLOY P, 1990, ADDICT BEHAV, V15, P431, DOI 10.1016/0306-4603(90)90029-W; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; National Institute on Alcoholism and Alcohol Abuse, HELP PAT WHO DRINK T; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; POKORNY AD, 1972, AM J PSYCHIAT, V129, P342, DOI 10.1176/ajp.129.3.342; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rona RJ, 2011, J HEAD TRAU IN PRESS; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P468, DOI 10.1097/HTR.0b013e3181c133d2; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Sherer M, 1999, BRAIN INJURY, V13, P973; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; SKINNER HA, 1993, ADDICTIVE BEHAVIORS ACROSS THE LIFE SPAN, P88; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; *SUBST AB MENT HLT, 2002, REP C PREV TREATM CO; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Turner AP, 2003, ARCH PHYS MED REHAB, V84, P358, DOI 10.1053/apmr.2003.50107; VERMA NP, 1992, CLIN ELECTROENCEPHAL, V23, P147, DOI 10.1177/155005949202300310; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whiteneck G, 2001, COLORADO TRAUMATIC B; Winqvist S, 2006, J ADOLESC HLTH, V39, p275e1, DOI DOI 10.1016/J.JADOHEALTH.2005.12.019; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221; Yen MH, 2006, ALCOHOL, V38, P117, DOI 10.1016/j.alcohol.2006.05.003	111	11	11	0	2	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							1315	1328					14	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100079					2022-02-06	
J	Drag, L; Renninger, C; King, R; Hoblyn, J				Drag, Lauren; Renninger, Christopher; King, Robert; Hoblyn, Jennifer			Predictors of Inpatient and Outpatient Healthcare Utilization in Veterans With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						healthcare; hospitalization; outpatients; traumatic brain injury; utilization; veterans	ILLNESS; HOSPITALIZATION; DIAGNOSES; SERVICES; COSTS; IRAQ	Objective: Traumatic brain injury (TBI) can place a significant financial and resource burden on healthcare systems. This study examined predictors of outpatient and inpatient healthcare utilization in veterans with a history of TBI. Methods: A secondary analysis was conducted on data from 1565 veterans with TBI and 1565 veterans without TBI seen for healthcare services at the VA Palo Alto Health Care System between 2000 and 2010. Patterns and predictors of outpatient and inpatient medical and psychiatric care were examined. Results: Veterans with TBI utilized significantly more services compared with the control group. The TBI group was seen for more than 160 000 outpatient services and was almost 9 times more likely to be hospitalized than the control group. Although psychiatric disorders were more prevalent in the TBI group and associated with increased medical and mental health utilization within the TBI group, they did not account fully for the significant group differences. Conclusions: Veterans with a history of TBI have much greater healthcare needs than veterans without TBI, likely because of non-TBI-related factors. Increased monitoring and early intervention treatments may be warranted for certain at-risk veterans with the goal of minimizing their need for long-term or extensive healthcare services in the future.	[Drag, Lauren] Palo Alto Univ, Palo Alto, CA USA; [Drag, Lauren] VA Palo Alto Hlth Care Syst, Res Serv, Palo Alto, CA 94304 USA; [King, Robert] VA Palo Alto Hlth Care Syst, Adm Serv, Palo Alto, CA 94304 USA; [Hoblyn, Jennifer] VA Palo Alto Hlth Care Syst, Psychiat Serv, Palo Alto, CA 94304 USA; [Renninger, Christopher; Hoblyn, Jennifer] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA		Drag, L (corresponding author), VA Palo Alto Hlth Care Syst, Res Serv, 3801 Miranda Ave 118J, Palo Alto, CA 94304 USA.	laurenldrag@gmail.com		Hoblyn MD, Jennifer/0000-0002-9393-4763			Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; Angelo C, 2011, EARLY INTERV PSYCHIA, V5, P203, DOI 10.1111/j.1751-7893.2011.00261.x; Armed Forces Health Surveillance Center, 2011, MMSR, V18, P8; Bauer MS, 1997, J AFFECT DISORDERS, V44, P159, DOI 10.1016/S0165-0327(97)00046-3; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Congressional Budget Office, 2010, POT COSTS VET HLTH C; Congressional Budget Office, 2009, EFF PROP INCR COST S; Defense and Veterans Brain Injury Center, FREQ ASK QUEST; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Ghose SS, 2005, MED CARE, V43, P1259, DOI 10.1097/01.mlr.0000185711.50480.13; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Hoofien D, 2000, J CLIN EXP NEUROPSYC, V22, P305, DOI 10.1076/1380-3395(200006)22:3;1-V;FT305; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Schnurr PP, 2000, J NERV MENT DIS, V188, P496, DOI 10.1097/00005053-200008000-00004; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sokal J, 2004, J NERV MENT DIS, V192, P421, DOI 10.1097/01.nmd.0000130135.78017.96; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Worley MJ, 2010, J SUBST ABUSE TREAT, V39, P124, DOI 10.1016/j.jsat.2010.05.009	27	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2013	28	1					39	47		10.1097/HTR.0b013e318263bb61			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	070ZW	WOS:000313555400005	22935573				2022-02-06	
J	Fife, GP; O'Sullivan, D; Pieter, W				Fife, G. P.; O'Sullivan, D.; Pieter, W.			BIOMECHNAICS OF HEAD INJURY IN OLYMPIC TAEKWONDO AND BOXING	BIOLOGY OF SPORT			English	Article						taelmondo; boxing injuries; head injury; biomechanics	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; IMPACTS; CONCUSSION; BIOMECHANICS	Objective: The purpose was to examine differences between taekwondo kicks and boxing punches in resultant linear head acceleration (RLA), head injury criterion (HIC15), peak head velocity, and peak foot and fist velocities. Data from two existing publications on boxing punches and taekwondo kicks were compared. Methods: For taekwondo head impacts a Hybrid II Crash Dummy (Hybrid II) head was instrumented with a tri-axial accelerometer mounted inside the Hybrid II head. The Hybrid II was fixed to a height-adjustable frame and fitted with a protective taekwondo helmet. For boxing testing, a Hybrid III Crash Dummy head was instrumented with an array of tri-axial accelerometers mounted at the head centre of gravity. Results: Differences in RLA between the roundhouse kick (130.11 +/- 51.67 g) and hook punch (71.23 +/- 32.19 g, d=1.39) and in HIC15 (clench axe kick: 162.63 +/- 104.10; uppercut: 24.10 +/- 12.54, d=2.29) were observed. Conclusions: Taekwondo kicks demonstrated significantly larger magnitudes than boxing punches for both RLA and HIC.	[Fife, G. P.] Yonsei Univ, Dept Phys Educ, Seoul 120749, South Korea; [Fife, G. P.; O'Sullivan, D.; Pieter, W.] Chung Ang Univ, Dept Phys Educ, Anseong 456756, Gyeonggido, South Korea; [Pieter, W.] Keimyung Univ, Dept Taekwondo, Taegu, South Korea		O'Sullivan, D (corresponding author), Chung Ang Univ, Coll Sport Sci, Dept Phys Educ, 72-1 Naeri Daedeokmyeon, Anseong 456756, Gyeonggido, South Korea.	tkd4@cau.ac.kr					Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cohen JE, 2010, ISR MED ASSOC J, V12, P509; Dun SC, 2007, J BIOMECH, V40, P265, DOI 10.1016/j.jbiomech.2006.01.008; El Ashker S, 2011, INT J PERF ANAL SPOR, V11, P356; Fife G, 2011, BRIT J SPORT MED, V45, P318, DOI [10.1136/bjsm.2011.084038.25, DOI 10.1136/BJSM.2011.084038.25]; Fife GP, 2012, ARCH BUDO, V8; Fife GP, 2013, INT SPORTMED J, V14, P53; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hanson O, 2011, P 3 INT S TAEKW STUD, P108; Hopkins GW, NEW VIEW STAT; Kazemi Mohsen, 2009, J Can Chiropr Assoc, V53, P144; Koh JO, 2011, P 3 INT S TAEKW STUD, P202; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Narvaez MA, 2011, THESIS MICHIGAN STAT; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; OLER M, 1991, J TRAUMA, V31, P251, DOI 10.1097/00005373-199131020-00017; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pieter W, 1998, JAMA-J AM MED ASSOC, V7, P10; PIETER W, 1998, KINESIOLOGY, V30, P22, DOI DOI 10.1589/JPTS.28.231; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; SCHWARTZ ML, 1986, J NEUROSURG, V64, P248, DOI 10.3171/jns.1986.64.2.0248; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; World Bank and International Finance Corporation, 2012, DUR CONT, P16; Young W, 2004, J SCI MED SPORT, V7, P23, DOI 10.1016/S1440-2440(04)80040-9; Zemper ED, 1989, BRIT J SPORT MED, V23, P161	31	11	11	0	25	INST SPORT	WARSAW 45	TRYLOGII 2, POB 30,, 01-892 WARSAW 45, POLAND	0860-021X	2083-1862		BIOL SPORT	Biol. Sport		2013	30	4					263	268		10.5604/20831862.1077551			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AB8OF	WOS:000332049200005	24744497				2022-02-06	
J	Gilbertson, S				Gilbertson, Simon			Improvisation and meaning	INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING			English	Article						Improvisation; music therapy; arts-based research; traumatic brain injury; long-term repeated-immersion; case study; therapeutic narrative analysis; musicological analysis	BRAIN	This article presents and discusses a long-term repeated-immersion research process that explores meaning allocated to an episode of 50 seconds of music improvisation in early neurosurgical rehabilitation by a teenage boy with severe traumatic brain injury and his music therapist. The process began with the original therapy session in August 1994 and extends to the current time of writing in 2013. A diverse selection of qualitative research methods were used during a repeated immersion and engagement with the selected episodes. The multiple methods used in this enquiry include therapeutic narrative analysis and musicological and video analysis during my doctoral research between 2002 and 2004, arts-based research in 2008 using expressive writing, and arts-based research in 2012 based on the creation of a body cast of my right hand as I used it to play the first note of my music improvising in the original therapy episode, which is accompanied by reflective journaling. The casting of my hand was done to explore and reconsider the role of my own body as an embodied and integral, but originally hidden, part of the therapy process. Put together, these investigations explore the potential meanings of the episode of music improvisation in therapy in an innovative and imaginative way. However, this article does not aim at this stage to present a model or theory for neurorehabilitation but offers an example of how a combination of diverse qualitative methods over an extended period of time can be instrumental in gaining innovative and rich insights into initially hidden perspectives on health, well-being, and human relating.	[Gilbertson, Simon] Univ Bergen, Grieg Acad, Inst Mus, GAMUT Grieg Acad Mus Therapy Res Ctr, Bergen, Norway		Gilbertson, S (corresponding author), Univ Bergen, Grieg Acad, Bergen, Norway.	simon.gilbertson@grieg.uib.no					Agrawal A., 2012, BRAIN INJURY FUNCTIO; AINSWORTH MDS, 1991, AM PSYCHOL, V46, P333, DOI 10.1037/0003-066X.46.4.333; Aldridge D, 1996, ART PSYCHOTHER, V23, P105, DOI 10.1016/0197-4556(95)00066-6; Aldridge D., 2002, MUSIC THERAPY TODAY; Allegranti B, 2011, EMBODIED PERFORMANCES: SEXUALITY, GENDER, BODIES, P1, DOI 10.1057/9780230306561; Baker FA, 2006, MUSIC THERAPY METHOD; Bradt J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub2; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; CACIOPPO JT, 2006, SOCIAL NEUROSCIENCE; Cozolino L., 2006, NEUROSCIENCE HUMAN R; Gilbertson S., 2008, VOICES WORLD FORUM M, V8; Gilbertson S., 2009, MUSIC MED, V1, P129; Gilbertson S., 2008, MUSIC THERAPY TRAUMA; GILBERTSON S, 1999, APPL MUSIC THERAPY D, P224; Gilbertson S., 2005, THESIS U WITTEN HERD; Gilbertson S. K., 2005, MUSIC THERAPY NEUROL, P83; Johnson M., 1990, MEANING BODY BODILY; Kelly G., 1955, PERSONAL CONSTRUCT P; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Ledger A, 2011, ART PSYCHOTHER, V38, P312, DOI 10.1016/j.aip.2011.09.001; Macpherson F., 2011, SENSES CLASSIC CONT; Malabou C., 2012, ONTOLOGY ACCIDENT ES; MENARY Richard, 2010, EXTENDED MIND; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schore A N, 2000, Attach Hum Dev, V2, P23; Shapiro L, 2011, NEW PROBL PHILOS, P1; Stern D.N., 2010, FORMS VITALITY EXPLO; Vygotsky LS., 1978, MIND SOC DEV HIGHER; WHO, 2004, WORLD REP ROAD TRAFF	31	11	11	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1748-2623	1748-2631		INT J QUAL STUD HEAL	Int. J. Qual. Stud. Health Well-Being		2013	8									10.3402/qhw.v8i0.20604			10	Public, Environmental & Occupational Health; Nursing; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Nursing; Biomedical Social Sciences	197YW	WOS:000322889800001		Green Published, gold			2022-02-06	
J	Godlewski, B; Pawelczyk, A; Pawelczyk, T; Ceranowicz, K; Wojdyn, M; Radek, M				Godlewski, Bartosz; Pawelczyk, Agnieszka; Pawelczyk, Tomasz; Ceranowicz, Katarzyna; Wojdyn, Maciej; Radek, Maciej			Retrospective Analysis of Operative Treatment of a Series of 100 Patients With Subdural Hematoma	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						subdural hematoma; treatment outcome; repeat surgery	CLOSED-SYSTEM DRAINAGE; ANTICOAGULANT-THERAPY; PRACTICAL SCALE; CRANIOSTOMY; MANAGEMENT; REDUCTION; SUBACUTE	This retrospective study of medical records, surgical protocols, patient observation cards, and imaging files of 100 patients treated for subdural hematoma analyzed the type of hematoma, patient age and sex, operative technique, neurological status, cause of injury, duration of hospital stay, mortality rate, and the number of and reasons for reoperations to determine the effects on treatment outcomes. The time between the head injury and onset of neurological symptoms was analyzed versus the type of hematoma determined from computed tomography (CT) scans. Acute hematomas accounted for 38% of the cases, with subacute hematomas representing 20%, and chronic ones accounting for 42%. In trauma patients, the mean time interval between the injury and onset of neurological symptoms was 0.38 days for acute hematomas, 13.8 days for subacute hematomas, and 23.75 days for chronic hematomas. Repeat surgery was carried out in 26% of the cases. Improvement was obtained in 44% of cases, deterioration in 20%, and no change in neurological status in 36%. Timing of the operations was between 15:00 and 23:00 in 45%, between 23:00 and 7:00 in 33%, and between 7:00 and 15:00 in 22%. The classification of hematomas based on CT presentation corresponds to the classification based on the time elapsed between injury and onset of symptoms, and appears to be appropriate and useful in everyday practice. No preceding injury was identified in 31.6% of acute hematomas, 50% of subacute hematomas, and 61.9% of chronic hematomas. Analysis of reoperations indicates that trepanation may be superior to craniotomy as primary surgery for subacute and chronic hematomas. Subdural hematoma surgeries take place at all times of the day, with most carried out outside the usual working hours.	[Godlewski, Bartosz; Ceranowicz, Katarzyna; Wojdyn, Maciej; Radek, Maciej] Med Univ Lodz, Dept Neurosurg & Peripheral Nerves Surg, WAM Univ Hosp Lodz, PL-90549 Lodz, Poland; [Pawelczyk, Agnieszka; Pawelczyk, Tomasz] Med Univ Lodz, Dept Affect & Psychot Disorders, PL-90549 Lodz, Poland		Godlewski, B (corresponding author), Med Univ Lodz, Dept Neurosurg & Peripheral Nerves Surg, WAM Univ Hosp Lodz, 113 Zeromskiego St, PL-90549 Lodz, Poland.	bartoszgodlewski@wp.pl	Radek, Maciej Jan/S-9227-2016; Pawelczyk, Tomasz/S-9266-2016; Pawelczyk, Agnieszka/S-9524-2016	Pawelczyk, Tomasz/0000-0002-1421-2050; Wojdyn, Maciej/0000-0002-4100-8514; Radek, Maciej/0000-0003-3544-1482; Pawelczyk, Agnieszka/0000-0003-1900-0214			Aoki N, 1996, NEUROL RES, V18, P145; Drapkin A J, 1991, Br J Neurosurg, V5, P467, DOI 10.3109/02688699108998475; Flannery T, 2001, BRIT J NEUROSURG, V15, P518, DOI 10.1080/02688690120097732; Greenberg MS, 2006, HDB NEUROSURGERY, P672; JENNETT B, 1975, LANCET, V1, P480; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Kaye AH, 2005, ESSENTIAL NEUROSURGE, P56; LABADIE EL, 1990, FIBRINOLYSIS CENTRAL, P141; Lee KS, 1998, BRAIN INJURY, V12, P901; Lee KS, 2004, BRAIN INJURY, V18, P351, DOI 10.1080/02699050310001645801; Lind CRP, 2003, J NEUROSURG, V99, P44, DOI 10.3171/jns.2003.99.1.0044; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Munro D, 1936, ARCH NEURO PSYCHIATR, V35, P64, DOI 10.1001/archneurpsyc.1936.02260010074005; Ogasawara K, 1999, NEUROSURGERY, V45, P484, DOI 10.1097/00006123-199909000-00014; ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263; Sambasivan M, 1997, SURG NEUROL, V47, P418, DOI 10.1016/S0090-3019(97)00188-2; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; TABADDOR K, 1977, J NEUROSURG, V46, P220, DOI 10.3171/jns.1977.46.2.0220; TEASDALE G, 1974, LANCET, V2, P81; Tybor Krzysztof, 2005, Neurol Neurochir Pol, V39, P220; Wakai S, 1990, J NEUROSURG, V26, P771; WINTZEN AR, 1982, ARCH NEUROL-CHICAGO, V39, P69, DOI 10.1001/archneur.1982.00510140003001	23	11	11	0	3	JAPAN NEUROSURGICAL SOC	TOKYO	7-3-1 HONGO BUNKYO-KU, TOKYO, 113-8655, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2013	53	1					26	33		10.2176/nmc.53.26			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	085NH	WOS:000314621000006	23358166	Bronze			2022-02-06	
J	Gunter, TD; Chibnall, JT; Antoniak, SK; Philibert, RA; Black, DW				Gunter, Tracy D.; Chibnall, John T.; Antoniak, Sandra K.; Philibert, Robert A.; Black, Donald W.			Childhood Trauma, Traumatic Brain Injury, and Mental Health Disorders Associated With Suicidal Ideation and Suicide-Related Behavior in a Community Corrections Sample	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							RECENTLY RELEASED PRISONERS; NATIONAL COMORBIDITY SURVEY; DELIBERATE SELF-HARM; RISK-FACTORS; MAJOR DEPRESSION; PSYCHOPATHY; MORTALITY; ABUSE; DEATH; POPULATION	Suicidal ideation and suicide-related behavior among community-supervised offenders are significant public health problems. In a sample of 418 subjects served by the community corrections office of Iowa's Sixth Judicial District, 56 percent of subjects denied suicidal ideation and suicide-related behavior (control group), 17 percent reported suicidal ideation without suicide-related behavior (ideator group), and 27 percent reported engaging in suicide-related behavior (actor group). A model comprising five independent variables differentiated the ideator and actor groups from the control group: Caucasian race, depressive symptom sum, brain injury, childhood trauma, and avoidant personality. These five factors, combined with the additional variables of PCL:SV Factor 2 (Psychopathy Checklist-Screening Version) score and lifetime anxiety disorder, differentiated the actor group from the control group.	[Gunter, Tracy D.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Gunter, Tracy D.] Indiana Univ, McKinney Sch Law, Bloomfield, NJ USA; [Chibnall, John T.] St Louis Univ, Dept Neurol & Psychiat, Sch Med, St Louis, MO USA; [Antoniak, Sandra K.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Philibert, Robert A.; Black, Donald W.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA		Gunter, TD (corresponding author), Indiana Univ Sch Med, Dept Psychiat, 355 West 16th St,Suite 2800, Indianapolis, IN 46202 USA.	tdgunter@iupui.edu	Gunter, Tracy/ABD-1754-2020	Gunter, Tracy/0000-0003-2122-8816; Black, Donald/0000-0001-8038-1971; Philibert, Robert/0000-0001-7822-4977			Achenbach TM., 2003, MANUAL ASEBA ADULT F; Allen J.P., 2003, ASSESSING ALCOHOL PR, V2nd ed.; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arboleda-Florez J, 2001, INT J LAW PSYCHIAT, V24, P357, DOI 10.1016/S0160-2527(01)00072-3; Bacskai E, 2009, PSYCHIAT RES, V165, P103, DOI 10.1016/j.psychres.2007.11.013; Baillargeon J, 2009, J AM ACAD PSYCHIATRY, V37, P188; Biles D., 1999, TRENDS ISSUES CRIME, V107; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Bjork Tabita, 2005, Crim Behav Ment Health, V15, P93, DOI 10.1002/cbm.41; Blaauw E, 2002, J TRAUMA STRESS, V15, P9, DOI 10.1023/A:1014323009493; Borges G, 2006, PSYCHOL MED, V36, P1747, DOI 10.1017/S0033291706008786; Brodsky BS, 2001, AM J PSYCHIAT, V158, P1871, DOI 10.1176/appi.ajp.158.11.1871; BUCHOLZ KK, 1994, ALCOHOL CLIN EXP RES, V18, P1091, DOI 10.1111/j.1530-0277.1994.tb00086.x; Chapman AL, 2005, SUICIDE LIFE-THREAT, V35, P558, DOI 10.1521/suli.2005.35.5.558; Clements-Nolle K, 2009, WOMEN HEALTH ISS, V19, P185, DOI 10.1016/j.whi.2009.02.002; Daigle MS, 2006, SUICIDE LIFE-THREAT, V36, P670, DOI 10.1521/suli.2006.36.6.670; Douglas KS, 2008, LAW HUMAN BEHAV, V32, P511, DOI 10.1007/s10979-007-9122-8; DOUGLAS KS, 2006, PSYCHOL SERV, V3, P97, DOI DOI 10.1037/1541-1559.3.2.97; Evren C, 2011, PSYCHIAT RES, V186, P91, DOI 10.1016/j.psychres.2010.07.045; Fagan Thomas J, 2010, J Correct Health Care, V16, P48, DOI 10.1177/1078345809348212; FARRINGTON DP, 1995, CRIM BEHAV MENT HEAL, V0005; Glaze L., 2010, 231681 NCJ US DEP JU; Glaze LE, 2009, 231680 NCJ US DEP JU; Grunebaum MF, 2010, J AFFECT DISORDERS, V123, P123, DOI 10.1016/j.jad.2009.09.010; Gunter TD, 2008, J AM ACAD PSYCHIATRY, V36, P27; Gunter TD, 2011, J CRIM JUST, V39, P238, DOI 10.1016/j.jcrimjus.2011.02.005; Gunter TD, 2009, BEHAV SCI LAW, V27, P695, DOI 10.1002/bsl.887; Guy LS, 2006, PSYCHOL ASSESSMENT, V18, P225, DOI 10.1037/1040-3590.18.2.225; Hare R. D, 1999, HARE PSYCHOPATHY CHE; Harpur T.J., 1989, PSYCHOL ASSESSMENT, V1, P6, DOI [10.1037/1040-3590.1.1.6, DOI 10.1037/1040-3590.1.1.6]; Harrison KS, 2007, ASSESSMENT, V14, P171, DOI 10.1177/1073191106296483; Hatton Diane C, 2008, Issues Ment Health Nurs, V29, P1304, DOI 10.1080/01612840802498599; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; Howard J, 2003, Crisis, V24, P98, DOI 10.1027//0227-5910.24.3.98; Jeglic EL, 2005, INT J OFFENDER THER, V49, P131, DOI 10.1177/0306624X04271130; Joukamaa M, 1998, FORENSIC SCI INT, V96, P11, DOI 10.1016/S0379-0738(98)00098-X; Kariminia A, 2007, MED J AUSTRALIA, V187, P387, DOI 10.5694/j.1326-5377.2007.tb01307.x; Kenny D, 2005, J FORENSIC PSYCHOL P, V8, P358; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Kishi Y, 2001, J NERV MENT DIS, V189, P623, DOI 10.1097/00005053-200109000-00009; Klonsky ED, 2003, AM J PSYCHIAT, V160, P1501, DOI 10.1176/appi.ajp.160.8.1501; Krinsky CS, 2009, AM J FOREN MED PATH, V30, P6, DOI 10.1097/PAF.0b013e3181873784; Lanes E, 2009, J FORENSIC SCI, V54, P692, DOI 10.1111/j.1556-4029.2009.01028.x; Lizardi D, 2011, ACTA PSYCHIAT SCAND, V124, P295, DOI 10.1111/j.1600-0447.2011.01724.x; MALT U, 1987, ACTA PSYCHIAT SCAND, V76, P261, DOI 10.1111/j.1600-0447.1987.tb02894.x; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; McGinnis JM, 1999, P ASSOC AM PHYSICIAN, V111, P109, DOI 10.1046/j.1525-1381.1999.09256.x; MILES CP, 1977, J NERV MENT DIS, V164, P231, DOI 10.1097/00005053-197704000-00002; Milligan RJ, 2005, LEGAL CRIMINOL PSYCH, V10, P13, DOI 10.1348/135532504X15439; Mumola C. J., 2005, 210036 NCJ US DEP JU; Nitkowski D, 2011, FORTSCHR NEUROL PSYC, V79, P9, DOI 10.1055/s-0029-1245772; Nock MK, 2007, J CONSULT CLIN PSYCH, V75, P707, DOI 10.1037/0022-006X.75.5.707; Nock MK, 2006, PSYCHIAT RES, V144, P65, DOI 10.1016/j.psychres.2006.05.010; Nock MK, 2006, J ABNORM PSYCHOL, V115, P616, DOI 10.1037/0021-843X.115.3.616; Nock MK, 2002, J CLIN CHILD ADOLESC, V31, P48, DOI 10.1207/153744202753441666; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Paanila J, 1999, FORENSIC SCI INT, V100, P187, DOI 10.1016/S0379-0738(98)00209-6; Pratt D, 2010, PSYCHOL MED, V40, P827, DOI 10.1017/S0033291709991048; Pritchard C, 1997, J ROY SOC HEALTH, V117, P180, DOI 10.1177/146642409711700310; Roe-Sepowitz Dominique, 2007, Crim Behav Ment Health, V17, P312, DOI 10.1002/cbm.665; Roy A, 2009, ARCH SUICIDE RES, V13, P46, DOI 10.1080/13811110802572130; Sarcbiapone M, 2009, PSYCHIAT RES, V165, P187, DOI 10.1016/j.psychres.2008.04.026; Sarchiapone A, 2009, EUR PSYCHIAT, V24, P57, DOI 10.1016/j.eurpsy.2008.07.005; Sarchiapone M, 2009, SUICIDE LIFE-THREAT, V39, P343, DOI 10.1521/suli.2009.39.3.343; Sattar Ghazala, 2003, Crisis, V24, P17, DOI 10.1027//0227-5910.24.1.17; Shepherd J, 2002, J ROY SOC MED, V95, P539, DOI 10.1258/jrsm.95.11.539; Shepherd JP, 2009, J PUBLIC HEALTH-UK, V31, P506, DOI 10.1093/pubmed/fdp054; Skeem JL, 2003, PSYCHOL ASSESSMENT, V15, P41, DOI 10.1037/1040-3590.15.1.41; Stanley B, 2001, AM J PSYCHIAT, V158, P427, DOI 10.1176/appi.ajp.158.3.427; Stewart LM, 2004, AUST NZ J PUBL HEAL, V28, P32, DOI 10.1111/j.1467-842X.2004.tb00629.x; Sullivan TP, 2005, PSYCHOL WOMEN QUART, V29, P290, DOI 10.1111/j.1471-6402.2005.00223.x; Suto I, 2010, PRISON J, V90, P288, DOI 10.1177/0032885510373499; Swogger MT, 2011, PSYCHIAT RES, V185, P363, DOI 10.1016/j.psychres.2010.07.036; Swogger MT, 2010, AGGRESSIVE BEHAV, V36, P45, DOI 10.1002/ab.20330; Swogger MT, 2009, J PERS DISORD, V23, P201, DOI 10.1521/pedi.2009.23.2.201; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Verona E, 2005, J CONSULT CLIN PSYCH, V73, P1065, DOI 10.1037/0022-006X.73.6.1065; Verona E, 2001, J ABNORM PSYCHOL, V110, P462, DOI 10.1037//0021-843X.110.3.462; Verona E, 2012, PERSONAL DISORD, V3, P247, DOI 10.1037/a0025945; Wessely S, 1996, J PUBLIC HEALTH MED, V18, P129, DOI 10.1093/oxfordjournals.pubmed.a024471; Wortzel HS, 2009, J AM ACAD PSYCHIATRY, V37, P82; Young MH, 2006, J FORENSIC SCI, V51, P156, DOI 10.1111/j.1556-4029.2005.00023.x; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; [No title captured]	86	11	11	0	19	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2013	41	2					245	255					11	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	185CJ	WOS:000321942500010	23771938				2022-02-06	
J	Huang, YH; Lee, TC; Lee, TH; Yang, KY; Liao, CC				Huang, Yu-Hua; Lee, Tao-Chen; Lee, Tsung-Han; Yang, Ka-Yen; Liao, Chen-Chieh			Remote Epidural Hemorrhage after Unilateral Decompressive Hemicraniectomy in Brain-Injured Patients	JOURNAL OF NEUROTRAUMA			English	Article						brain tamponade; decompressive craniectomy; TBI	ACUTE SUBDURAL-HEMATOMA; CONTRALATERAL EXTRADURAL HEMATOMA; CRANIECTOMY; EVACUATION; SURGERY	Epidural hemorrhage (EDH) that develops remote from the decompressed hemisphere can be associated with devastating morbidity after hemicraniectomy for traumatic brain injury (TBI). In this study, we investigated the incidence, risk factors, and outcome influence of post-craniectomy remote EDH. For this retrospective study, we enrolled 139 patients undergoing unilateral hemicraniectomy for TBI. The patients were subdivided into two groups based on whether EDH remote from the site of bone decompression was present (n = 11) or not (n = 128). We identified the intergroup differences in clinical parameters and outcomes. Multivariate odds regression was used to adjust for independent risk factors of the development of EDH. The incidence of remote EDH following decompressive hemicraniectomy for TBI was 7.9%. There were two independent risk factors for remote EDH, including absence of contusional hemorrhage (odds ratio, 95% confidence interval = 6.158, 1.090-34.802; p = 0.040) and presence of remote skull fracture (odds ratio, 95% confidence interval = 19.770, 2.194-178.152; p = 0.008) in preoperative computed tomography scans. The mean Glasgow Outcome Scale did not differ between the patients with and without EDH. In conclusion, remote EDH in patients undergoing unilateral decompressive hemicraniectomy for TBI is not uncommon. The absence of contusional hemorrhage and presence of remote skull fracture are independent risk factors. Although postcraniectomy remote EDH is devastating, timely computed tomography scanning and immediate hematoma evacuation are efficient and crucial for patient outcomes.	Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung, Taiwan		Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, 123 Ta Pei Rd, Niao Sung Hsiang, Kaohsiung Hsien, Taiwan.	newlupin2001@yahoo.com.tw					Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410	20	11	13	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2013	30	2					96	101		10.1089/neu.2012.2563			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	069NT	WOS:000313444000005	23013227				2022-02-06	
J	Kalayci, M; Aktunc, E; Gul, S; Hanci, V; Edebali, N; Cagavi, F; Acikgoz, B				Kalayci, Murat; Aktunc, Erol; Gul, Sanser; Hanci, Volkan; Edebali, Nurullah; Cagavi, Ferda; Acikgoz, Bektas			Decompressive craniectomy for acute subdural haematoma: An overview of current prognostic factors and a discussion about some novel prognostic parametres	JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION			English	Article						Acute subdural haematoma; Trauma; Decompressive craniectomy; Outcome	TRAUMATIC BRAIN-INJURY; CEREBRAL EDEMA; HEAD-INJURY; HEMICRANIECTOMY; MANAGEMENT; DAMAGE; COMPLICATIONS; HYPERGLYCEMIA; CRANIOTOMY; EVACUATION	Objective: To identify specific factors that can be used to predict functional outcome and to assess the value of decompressive craniectomy in patients with acute subdural haematoma. Methods: The retrospective study was done at the Zonguldak Karaelwas University Practice and Research Hospital, Turkey, and included 34 trauma patients who had undergone decompressive craniectomy for acute subdural haematoma from 2001 to 2009. At the 30th day of the operation, the patients were grouped as survivors and non-survivors. Besides, based on their Glasgow Outcome Scale, which was calculated 6 months post-operatively, the patients were divided into two functional groups: favourable outcomes (4-5 on the scale), and unfavourable outcomes (1-3 on the scale). The characteristics of the groups were compared using SPSS 15 for statistical analysis. Results: One-month mortality was 38.2% (n=13) and 6-month total mortality reached 47% (n=16). Patients with higher pre-operative revised trauma score, Glasgow coma scale, partial anterial pressure of carbon dioxide, arterial oxygen pressure, Charlson co-morbidity index score, blood glucose level, blood urea nitrogen, and lower age had a higher rate of survival and consequently a favourable outcome. Higher platelet values were only found to be a determinant of higher survival at the end of the first month without having any significant effect on the favourable outcome. Conclusion: In patients of traumatic acute subdural haematoma whose Glasgow coma scale on arrival was <= 8, a massive craniectomy along with the evacuation of the haematoma, may be considered as a treatment option for intra-operative and post-operative brain swelling. But in patients with a score of 3 on arrival and bilaterally fixed and dilated pupils, decompressive craniectomy is unnecessary.	[Kalayci, Murat; Gul, Sanser; Edebali, Nurullah; Acikgoz, Bektas] Zonguldak Karaelmas Univ, Sch Med, Dept Neurosurg, Zonguldak, Turkey; [Aktunc, Erol] Zonguldak Karaelmas Univ, Sch Med, Dept Family Med, Zonguldak, Turkey; [Hanci, Volkan] Zonguldak Karaelmas Univ, Sch Med, Dept Anesthesiol, Zonguldak, Turkey; [Cagavi, Ferda] Kocaeli Acibadem Hosp, Dept Neurosurg, Kocaeli, Turkey		Kalayci, M (corresponding author), Zonguldak Karaelmas Univ, Sch Med, Dept Neurosurg, Zonguldak, Turkey.	drkalayci@yahoo.com	Hanci, Volkan/Q-1573-2019; aktunc, erol/AAB-4950-2021	Hanci, Volkan/0000-0002-2227-194X; 			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bullock MR, 2006, NEUROSURGERY, V58, psi; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen-Roetling J, 2006, BIOCHEM BIOPH RES CO, V350, P233, DOI 10.1016/j.bbrc.2006.09.036; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Csokay A, 2001, NEUROSURG REV, V24, P209, DOI 10.1007/s101430100158; Csokay A, 2002, SURG NEUROL, V57, P126, DOI 10.1016/S0090-3019(01)00686-3; Csokay A, 2002, NEUROL RES, V24, P157, DOI 10.1179/016164102101199701; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FUJISAWA H, 1994, ACT NEUR S, V60, P193; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Hoff JT, 2003, ACT NEUR S, V86, P11; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; JENNETT B, 1975, LANCET, V1, P480; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Kreutziger J, 2009, J TRAUMA, V67, P704, DOI 10.1097/TA.0b013e3181b22e37; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Reinert M, 2002, NEUROL RES, V24, P601, DOI 10.1179/016164102101200438; RINALDI A, 1990, ACT NEUR S, V51, P394; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Sawauchi S, 2002, ACTA NEUROCHIR S, V81, P234; Schneider GH, 2002, ACT NEUR S, V81, P77; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; SHIGEMORI M, 1980, ACTA NEUROCHIR, V54, P61, DOI 10.1007/BF01401944; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Song EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; WONG CW, 1995, ACTA NEUROCHIR, V135, P38, DOI 10.1007/BF02307412; Wong CW, 1995, ACTA NEUROCHIR, V35, P100; Wong GKC, 2010, ACTA NEUROCHIR SUPPL, V106, P235, DOI 10.1007/978-3-211-98811-4_44; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	48	11	11	0	5	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0030-9982			J PAK MED ASSOC	J. Pak. Med. Assoc.	JAN	2013	63	1					38	49					12	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	059AX	WOS:000312677900010	23865130				2022-02-06	
J	Kaplan, Y; Myklebust, G; Nyska, M; Palmanovich, E; Victor, J; Witvrouw, E				Kaplan, Yonatan; Myklebust, Grethe; Nyska, Meir; Palmanovich, Ezequiel; Victor, Jan; Witvrouw, Erik			The Epidemiology of Injuries in Contact Flag Football	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						flag football; epidemiology; injuries	RANDOMIZED CONTROLLED-TRIAL; ANTERIOR CRUCIATE LIGAMENT; SURVEILLANCE SYSTEM; SOCCER INJURIES; RISK-FACTORS; PLAYERS; SPORTS; BRACES; BASKETBALL; CONCUSSION	Objective: To characterize the epidemiology of injuries in post-high school male and female athletes in the rapidly growing international sport of contact flag football. Design: Prospective injury-observational study. Setting: Kraft Stadium, Jerusalem, Israel. Participants: A total of 1492 players, consisting of men (n = 1252, mean age, 20.49 +/- 5.11) and women (n = 240, mean age, 21.32 +/- 8.95 years), participated in 1028 games over a 2-season period (2007-2009). Main Outcome Measures: All time-loss injuries sustained in game sessions were recorded by the off-the-field medical personnel and followed up by a more detailed phone injury surveillance questionnaire. Results: One hundred sixty-three injuries were reported, comprising 1 533 776 athletic exposures (AEs). The incidence rate was 0.11 [95% confidence interval (CI), 0.09-0.12] per 1000 AEs, and incidence proportion was 10.66% (95% CI, 9.10-12.22). Seventy-six percent of the injuries were extrinsic in nature. Thirty percent of the injuries were to the fingers, thumb, and wrist, 17% to the knee, 17% to the head/face, 13% to the ankle, and 11% to the shoulder. Conclusions: Contact flag football results in a significant amount of moderate to severe injuries. These data may be used in the development of a formal American flag football injury database and in the development and implementation of a high-quality, randomized, prospective injury prevention study. This study should include the enforcement of the no-pocket rule, appropriate headgear, self-fitting mouth guards, the use of ankle braces, and changing the blocking rules of the game.	[Kaplan, Yonatan; Witvrouw, Erik] Univ Ghent, Dept Rehabil Sci & Physiotherapy, B-9000 Ghent, Belgium; [Myklebust, Grethe] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Oslo, Norway; [Nyska, Meir; Palmanovich, Ezequiel] Meir Hosp, Dept Orthoped Surg, Kefar Sava, Israel; [Victor, Jan] Univ Ghent, Dept Phys Med & Orthopaed Surg, B-9000 Ghent, Belgium		Kaplan, Y (corresponding author), Hebrew Univ Jerusalem, Lerner Sports Ctr, Jerusalem Sports Med Ctr, IL-64460 Jerusalem, Israel.	sportmed@zahav.net.il		Palmanovich, Ezequiel/0000-0002-6068-9554			Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; [Anonymous], 2009, INT FLAG FOOTB 5 5 N; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Burnham BR, 2010, AM J PREV MED, V38, pS141, DOI 10.1016/j.amepre.2009.10.010; Chalmers D J, 1999, Inj Prev, V5, P72; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; COLLINS RK, 1987, AM J SPORT MED, V15, P238, DOI 10.1177/036354658701500308; Dick R, 2007, J ATHL TRAINING, V42, P221; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Handoll H.H., 2001, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD000018, DOI 10.1002/14651858.CD000018]; Harris DA, 2010, BRIT J SPORT MED, V44, P200, DOI 10.1136/bjsm.2008.047449; Karlsson Jon, 2002, Lakartidningen, V99, P3486; Kerr ZY, 2011, CLIN J SPORT MED, V21, P101, DOI 10.1097/JSM.0b013e31820bd1b6; Martinek V, 1999, ORTHOPADE, V28, P565; Myklebust Grethe, 2007, Instr Course Lect, V56, P407; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Olsen OE, 2005, BRIT MED J, V330, P449, DOI 10.1136/bmj.38330.632801.8F; Orchard J, 2001, AM J SPORT MED, V29, P196, DOI 10.1177/03635465010290021301; Orchard J., 1995, SPORT HLTH, V11, P39; Pasanen K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a295; Pietrosimone BG, 2008, J ATHL TRAINING, V43, P409, DOI 10.4085/1062-6050-43.4.409; QUINN K, 2000, COCHRANE DB SYST REV; Rishiraj N, 2009, SPORTS MED, V39, P937, DOI 10.2165/11317790-000000000-00000; Warden KB, 2009, J PREV INTERV COMMUN, V37, P209, DOI 10.1080/10852350902976155; Wikipedia the free encyclopedia, FLAG FOOTB; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Zebis MK, 2008, CLIN J SPORT MED, V18, P329, DOI 10.1097/JSM.0b013e31817f3e35	30	11	10	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2013	23	1					39	44		10.1097/JSM.0b013e3182694870			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	063VO	WOS:000313030300005	23006980	Green Submitted			2022-02-06	
J	Kong, LM; Lian, GP; Zheng, WB; Liu, HM; Zhang, HD; Chen, RW				Kong, Lingmei; Lian, Gengpeng; Zheng, Wenbin; Liu, Huimin; Zhang, Haidu; Chen, Ruowei			Effect of Alcohol on Diffuse Axonal Injury in Rat Brainstem: Diffusion Tensor Imaging and Aquaporin-4 Expression Study	BIOMED RESEARCH INTERNATIONAL			English	Article							EDEMA; MODEL; PATHOPHYSIOLOGY; MORTALITY; RECOVERY	The aim of this study is to assess the effects of alcohol on traumatic brain injury by using diffusion tensor imaging (DTI) and evaluate aquaporin-4(AQP4) expression changes in rat brainstems following acute alcohol intoxication with diffuse axonal injury (DAI). We further investigated the correlation between the AQP4 expression and DTI in the brain edema. Eighty-five rats were imaged before and after injury at various stages. DTI was used to measure brainstem apparent diffusion coefficient (ADC) and fractional anisotropy (FA), with immunostaining being used to determine AQP4 expression. After acute alcoholism with DAI, ADC values of the brainstem first decreased within 6 h and then elevated. FA values began to decline by 1 h, reaching a minimum at 24 h after trauma. There was a negative correlation between ADC values and brainstem AQP4 expression at 6 h and positive correlation at 6 h to 24 h. Changes of ADC and FA values in DAI with acute alcoholism indicate the effects of ethanol on brain edema and the severity of axonal injury. The correlations between ADC values and the brainstem AQP4 expression at different time points suggest that AQP4 expression follows an adaptative profile to the severity of brain edema.	[Kong, Lingmei; Zheng, Wenbin; Liu, Huimin; Zhang, Haidu; Chen, Ruowei] Shantou Univ, Affiliated Hosp 2, Dept Radiol, Coll Med, Shantou 515041, Peoples R China; [Lian, Gengpeng] Shantou Univ, Affiliated Hosp 1, Dept Radiol, Coll Med, Shantou 515041, Peoples R China		Zheng, WB (corresponding author), Shantou Univ, Affiliated Hosp 2, Dept Radiol, Coll Med, Dongxia North Rd, Shantou 515041, Peoples R China.	hwenb@126.com			Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [S2012010008974, 07008199]; Science and Technology Planning Project of Guangdong Province, China [2010B031600129]; Mental Health Center, Shantou University; Department of Forensic Medicine, Medical College of Shantou University	This study was supported by the Natural Science Foundation of Guangdong Province, China (Grants no. S2012010008974, no. 07008199), and the Science and Technology Planning Project of Guangdong Province, China (Grant no. 2010B031600129). The authors would also like to acknowledge the generous support by the Mental Health Center, Shantou University, and Professor Xiaojun Yu, the Department of Forensic Medicine, Medical College of Shantou University.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Aschner M, 2001, NEUROTOXICOLOGY, V22, P601, DOI 10.1016/S0161-813X(01)00039-0; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hirakawa K, 1994, Nihon Hoigaku Zasshi, V48, P63; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Katada R, 2009, J NEUROTRAUM, V26, P2015, DOI 10.1089/neu.2008.0552; Kong LM, 2012, AM J NEURORADIOL, V33, P928, DOI 10.3174/ajnr.A2873; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang HP, 2011, J TRAUMA, V70, pE6, DOI 10.1097/TA.0b013e3181cda3b9; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	27	11	11	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								798261	10.1155/2013/798261			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	249RV	WOS:000326795300001	24282821	Green Published, gold, Green Submitted			2022-02-06	
J	Martin, M; Conlon, LW				Martin, Matthew; Conlon, Lauren Weinberger			Does Platelet Transfusion Improve Outcomes in Patients With Spontaneous or Traumatic Intracerebral Hemorrhage?	ANNALS OF EMERGENCY MEDICINE			English	Article							PRIOR ANTIPLATELET THERAPY; CONTROLLED-TRIAL; BRAIN-INJURY; HEAD-INJURY; ANTICOAGULATION; REVERSAL; ASPIRIN; GROWTH; AGENTS; ADULTS	[Ann Emerg Med. 2013;61:58-61.] Editor's Note: Emergency physicians must often make decisions about patient management without clear-cut data of sufficient quality to support clinical guidelines or evidence-based reviews. Topics in the Best Available Evidence section must be relevant to emergency physicians, are formally peer reviewed, and must have a sufficient literature base to draw a reasonable conclusion but not such a large literature base that a traditional "evidence-based" review, meta-analysis, or systematic review can be performed.	[Martin, Matthew; Conlon, Lauren Weinberger] Univ Penn, Dept Emergency Med, Hosp Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Conlon, LW (corresponding author), Univ Penn, Dept Emergency Med, Hosp Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	lauren.conlon@uphs.upenn.edu					Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Beshay JE, 2010, J NEUROSURG, V112, P307, DOI 10.3171/2009.7.JNS0982; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Creutzfeldt CJ, 2009, J STROKE CEREBROVASC, V18, P221, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.007; de Gans K, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-19; Downey DM, 2009, AM SURGEON, V75, P1100; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; HARTWIGOTTO H, 1983, AM J MED, V75, P30, DOI 10.1016/0002-9343(83)90230-9; Karni A, 2001, AM SURGEON, V67, P1098; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e	24	11	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JAN	2013	61	1					58	61		10.1016/j.annemergmed.2012.03.025			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	069WY	WOS:000313469000012	22841709				2022-02-06	
J	Mathieu, A; Guillon, A; Leyre, S; Martin, F; Fusciardi, J; Laffon, M				Mathieu, Antoine; Guillon, Antoine; Leyre, Stephane; Martin, Frederique; Fusciardi, Jacques; Laffon, Marc			Aerosolized Lidocaine During Invasive Mechanical Ventilation: In Vitro Characterization and Clinical Efficiency to Prevent Systemic and Cerebral Hemodynamic Changes Induced by Endotracheal Suctioning in Head-injured Patients	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						endotracheal suctioning; lidocaine; vibrating plate nebulizer; intracranial pressure; cerebral perfusion pressure; neurosurgical intensive care unit	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; ULTRASONIC NEBULIZER; LOCAL-ANESTHESIA; BLOOD-PRESSURE; DEPOSITION; JET; STIMULATION; TRANSIENT; RESPONSES	Background: In patients with severe brain injury, endotracheal suctioning (ETS) can increase intracranial pressure (ICP) and reduce cerebral perfusion pressure (CPP). The aim of this prospective, blinded clinical trial was to assess the effectiveness of aerosolized lidocaine to prevent increase of ICP induced by ETS in mechanically ventilated head-injured patients. Methods: First, we measured the particle size of aerosolized lidocaine produced by a vibrating plate nebulizer. Second, we measured the cerebral hemodynamic response to tracheal suctioning in patients in a neurosurgical intensive care unit with and without pretreatment of aerosolized lidocaine. Results: Particle size distribution of aerosolized lidocaine was suitable to reach the bronchotracheal target during mechanical ventilation. In 15 patients included in this study, aerosolized lidocaine by itself did not induce significant changes in ICP. ETS caused an increase in ICP (variation: 6 +/- 2 mm Hg, P < 0.05) with a concomitant decrease in CPP (variation: 2 +/- 2 mm Hg, P < 0.05) that was maximal at 1 minute after NaCl aerosolization. This was prevented by aerosolization of lidocaine (variation of ICP: 1 +/- 1 mm Hg, and CPP: -1 +/- 1 mm Hg, P < 0.05). Conclusions: Aerosolized lidocaine (2 mg/kg) can prevent ETS-induced increases in ICP, without modifying systemic and cerebral hemodynamics in deeply sedated patients.	[Guillon, Antoine] CHRU Tours, Serv Reanimat Med, F-37044 Tours 09, France; [Mathieu, Antoine; Guillon, Antoine; Fusciardi, Jacques; Laffon, Marc] Univ Tours, Tours, France; [Mathieu, Antoine; Leyre, Stephane; Martin, Frederique; Fusciardi, Jacques; Laffon, Marc] Dept Anesthesiol & Intens Care, Tours, France; [Guillon, Antoine] Ctr Etud Pathol Resp, Tours, France		Mathieu, A (corresponding author), CHRU Tours, Serv Anesthesie Reanimat 1, F-37044 Tours 09, France.	mathieu.antoine37@gmail.com		guillon, antoine/0000-0002-4884-8620			Abdennour L, 2008, ANN FR ANESTH, V27, P596, DOI 10.1016/j.annfar.2008.04.012; [Anonymous], 1991, ANN FR ANESTH, V10, P313; BEDFORD RF, 1980, ANESTH ANALG, V59, P435; BERGER R, 1989, CHEST, V95, P299, DOI 10.1378/chest.95.2.299; Bilotta F, 2008, NEUROCRIT CARE, V8, P241, DOI 10.1007/s12028-007-9012-4; BRAIN JD, 1979, AM REV RESPIR DIS, V120, P1325; Brown B, 1992, HEART LUNG, V21, P286; Brucia J, 1996, HEART LUNG, V25, P295, DOI 10.1016/S0147-9563(96)80065-3; Carhuapoma JR, 1999, CRIT CARE MED, V27, P2843, DOI 10.1097/00003246-199912000-00049; COLEMAN RA, 1973, BRIT J PHARMACOL, V48, pP360; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; DONEGAN MF, 1980, ANESTHESIOLOGY, V52, P516, DOI 10.1097/00000542-198006000-00014; Ehrmann S, 2012, REANIMATION, V21, P42, DOI 10.1007/s13546-011-0338-8; Ersson U, 1990, ANESTHESIOLOGY, V34, P99; Fink JB, 1999, RESP CARE, V44, P53; FISHER DM, 1982, ANESTHESIOLOGY, V57, P416, DOI 10.1097/00000542-198211000-00013; Fok TF, 1997, PEDIATR RES, V42, P721, DOI 10.1203/00006450-199711000-00027; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; GRAF PD, 1979, AM REV RESPIR DIS, V120, P121; HAMILL JF, 1981, ANESTHESIOLOGY, V55, P578, DOI 10.1097/00000542-198111000-00016; HANOWELL LH, 1993, J NEUROSURG ANESTH, V5, P31; Harvey CJ, 1997, EUR RESPIR J, V10, P905; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Jee D, 2003, ANESTH ANALG, V96, P293, DOI 10.1097/00000539-200301000-00058; Kerr M E, 1998, Am J Crit Care, V7, P205; Kerr ME, 1999, CRIT CARE MED, V27, P2776, DOI 10.1097/00003246-199912000-00028; KIRKPATRICK MB, 1987, AM REV RESPIR DIS, V136, P447, DOI 10.1164/ajrccm/136.2.447; KORTTILA K, 1981, ACTA ANAESTH SCAND, V25, P161, DOI 10.1111/j.1399-6576.1981.tb01628.x; Leone M, 2004, ANESTH ANALG, V99, P1193, DOI 10.1213/01.ANE.0000132546.79769.91; Mercier E, 2008, REV MAL RESPIR, V25, P731, DOI 10.1016/S0761-8425(08)73802-6; Mercier E, 2004, AM J RESP CRIT CARE, V7, pA657; Miller DD, 2003, AM J RESP CRIT CARE, V168, P1205, DOI 10.1164/rccm.200210-1167OC; Newman SP, 1998, J AEROSOL MED, V11, pS97; Newman SP, 2007, J AEROSOL MED, V20, P7, DOI 10.1089/jamp.2007.0643; ORIORDAN TG, 1992, AM REV RESPIR DIS, V145, P1117, DOI 10.1164/ajrccm/145.5.1117; Parkes S, 1997, ANAESTH INTENSIVE CA, V25, P369; PARSONS LC, 1984, HEART LUNG, V13, P372; POULTON TJ, 1979, ANESTHESIOLOGY, V50, P470, DOI 10.1097/00000542-197905000-00018; RUDY EB, 1991, HEART LUNG, V20, P667; RUDY EB, 1986, HEART LUNG, V15, P488; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; TSEMENTZIS SA, 1982, ACTA NEUROCHIR, V65, P153, DOI 10.1007/BF01405841; VENUS B, 1984, CRIT CARE MED, V12, P391, DOI 10.1097/00003246-198404000-00011; Wainwright S P, 1996, Intensive Crit Care Nurs, V12, P303, DOI 10.1016/S0964-3397(96)80801-9; WHITE PF, 1982, ANESTHESIOLOGY, V56, P414, DOI 10.1097/00000542-198205000-00029; Williams KA, 2005, BRIT J ANAESTH, V95, P549, DOI 10.1093/bja/aei202; YANO M, 1986, ANESTHESIOLOGY, V64, P651, DOI 10.1097/00000542-198605000-00019; Young PJ, 1999, ANAESTHESIA, V54, P1183, DOI 10.1046/j.1365-2044.1999.01035.x; [No title captured]	51	11	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2013	25	1					8	15		10.1097/ANA.0b013e31826a75b1			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	057KJ	WOS:000312561800002	22990390				2022-02-06	
J	Oddy, M; Ramos, SD				Oddy, Michael; Ramos, Sara da Silva			Cost effective ways of facilitating home based rehabilitation and support	NEUROREHABILITATION			English	Article						Traumatic brain injury; neurobehavioural disorder; community based rehabilitation; cost-effectiveness; technology; review	TRAUMATIC BRAIN-INJURY; ASSISTIVE-TECHNOLOGY; CAREGIVER BURDEN; SELF-ESTEEM; DEFICITS; PEOPLE; MEMORY; INTERVENTION; INTEGRATION; ASSISTANCE	BACKGROUND: The long term support of people with neurobehavioural disorders following a severe traumatic brain injury (TBI) can amount to a lifetime cost of several million dollars. Such costs are often obtained from personal injury compensation. However, those not eligible for such awards often depend on their families to provide support and care at no direct financial cost, but with indirect financial and human costs in terms of loss of productivity, and increased stress and health problems. OBJECTIVES: The aim of this paper is to examine the role of support workers in the long-term care of those with neurobehavioural deficits following severe TBI and to discuss the feasibility of meeting some aspects of their role with technological solutions. METHODS: This critical review uses observational and cost-analysis methodologies to establish the roles and costs associated with staff supporting people with neurobehavioural disorders resulting from severe TBI. RESULTS: The role of support workers is varied and includes prompting to initiate and guide simple or complex activities, promoting social behaviour and managing emotional reactions. Some of these roles can be fulfilled by existing technology. CONCLUSIONS: Cost effective care of those with long-term neurobehavioural disorders can be provided by a combination of human support and existing technology.	[Oddy, Michael; Ramos, Sara da Silva] Brain Injury Rehabil Trust, Slinfold RH13 0TP, W Sussex, England		Oddy, M (corresponding author), Brain Injury Rehabil Trust, 5 Oaks Rd, Slinfold RH13 0TP, W Sussex, England.	michael.oddy@thedtgroup.org					Agree EM, 2005, J GERONTOL B-PSYCHOL, V60, pS272, DOI 10.1093/geronb/60.5.S272; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Antonucci T C, 1983, Fam Community Health, V6, P1; Au-Yeung KY, 2011, AM J MANAG CARE, V17, pE277; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; Berry E, 2007, NEUROPSYCHOL REHABIL, V17, P582, DOI 10.1080/09602010601029780; Boger J, 2011, NEUROREHABILITATION, V28, P271, DOI 10.3233/NRE-2011-0655; Brandt A, 2011, DISABIL REHABIL-ASSI, V6, P189, DOI 10.3109/17483107.2010.532286; Brown P., 2012, BRAIN IMPAIR, V13, P123, DOI [10.1017/BrImp.2012.12, DOI 10.1017/BRIMP.2012.12]; Craig A, 2005, MED SCI MONITOR, V11, pRA32; Croser R., 2001, AUSTR OCCUPATIONAL T, V48, P35; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; el Kaliouby R., 2005, Universal Access in the Information Society, V4, P121, DOI 10.1007/s10209-005-0119-0; Evans N, 2011, BRIT J OCCUP THER, V74, P249, DOI 10.4276/030802211X13046730116614; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Hamill M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-26; Hayes TL, 2009, TELEMED J E-HEALTH, V15, P770, DOI 10.1089/tmj.2009.0033; Higginson IJ, 2010, J CLIN EPIDEMIOL, V63, P535, DOI 10.1016/j.jclinepi.2009.06.014; Hoey J, 2010, COMPUT VIS IMAGE UND, V114, P503, DOI 10.1016/j.cviu.2009.06.008; Jackson H, 2001, NEUROREHABILITATION, V16, P27; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Jutai J, 2000, ASSIST TECHNOL, V12, P123, DOI 10.1080/10400435.2000.10132018; Kirsch NL, 2004, J HEAD TRAUMA REHAB, V19, P366, DOI 10.1097/00001199-200409000-00002; KIRSCH NL, 1987, J HEAD TRAUMA REHAB, V2, P77; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lamontagne ME, 2009, BRAIN INJURY, V23, P693, DOI 10.1080/02699050902970760; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Lopresti EF, 2008, IEEE ENG MED BIOL, V27, P29, DOI 10.1109/EMB.2007.907396; Marmot M, 2003, BRIT MED J, V327, P574, DOI 10.1136/bmj.327.7415.574; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McCluskey AE, 2000, BRAIN INJURY, V14, P943, DOI 10.1080/02699050050191896; McColl MA, 1999, BRAIN INJURY, V13, P311, DOI 10.1080/026990599121511; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McCrea J. D., 2009, REHABILITATION EXECU; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Mihailidis A, 2001, ASSIST TECHNOL, V13, P23, DOI 10.1080/10400435.2001.10132031; O'Neill B, 2010, NEUROPSYCHOL REHABIL, V20, P509, DOI 10.1080/09602010903519652; O'Neill B, 2008, J ASSIST TECHNOL, V2, P22, DOI 10.1108/17549450200800015; Orpwood R, 2008, J ASSIST TECHNOL, V2, P13, DOI 10.1108/17549450200800014; Redhead R., 2010, SOCIAL CARE NEURODIS, V1; Scherer MJ, 2005, DISABIL REHABIL, V27, P1321, DOI 10.1080/09638280500164800; Stinson DA, 2008, J PERS SOC PSYCHOL, V94, P412, DOI 10.1037/0022-3514.94.3.412; Svoboda E, 2010, NEUROPSYCHOL REHABIL, V20, P562, DOI 10.1080/09602011003669918; van Heugten CM, 2011, J REHABIL MED, V43, P647, DOI 10.2340/16501977-0818; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020; Whitlatch CJ, 1997, J AGING HEALTH, V9, P222; Wignall B., 2009, RAATE 2009 C COV UK; Wood RL, 1999, NEUROPSYCHOL REHABIL, V9, P505, DOI 10.1080/096020199389554	49	11	12	1	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	4					781	790		10.3233/NRE-130902			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	184QF	WOS:000321907100009	23867404				2022-02-06	
J	Rao, JS; Ma, MX; Zhao, C; Xi, Y; Yang, ZY; Liu, ZX; Li, XG				Rao, Jia-Sheng; Ma Manxiu; Zhao, Can; Xi, Yue; Yang, Zhao-Yang; Liu Zuxiang; Li, Xiao-Guang			Atrophy and Primary Somatosensory Cortical Reorganization after Unilateral Thoracic Spinal Cord Injury: A Longitudinal Functional Magnetic Resonance Imaging Study	BIOMED RESEARCH INTERNATIONAL			English	Article							AREAS 3B; MOTOR; PLASTICITY; BRAIN; CORTEX; MAP; DISABILITY; RESPONSES; CORRELATE; RECOVERY	The effects of traumatic spinal cord injury (SCI) on the changes in the central nervous system (CNS) over time may depend on the dynamic interaction between the structural integrity of the spinal cord and the capacity of the brain plasticity. Functional magnetic resonance imaging (fMRI) was used in a longitudinal study on five rhesus monkeys to observe cerebral activation during upper limb somatosensory tasks in healthy animals and after unilateral thoracic SCI. The changes in the spinal cord diameters were measured, and the correlations among time after the lesion, structural changes in the spinal cord, and primary somatosensory cortex (S1) reorganization were also determined. After SCI, activation of the upper limb in S1 shifted to the region which generally dominates the lower limb, and the rostral spinal cord transverse diameter adjacent to the lesion exhibited obvious atrophy, which reflects the SCI-induced changes in the CNS. A significant correlation was found among the time after the lesion, the spinal cord atrophy, and the degree of contralateral S1 reorganization. The results indicate the structural changes in the spinal cord and the dynamic reorganization of the cerebral activation following early SCI stage, which may help to further understand the neural plasticity in the CNS.	[Rao, Jia-Sheng; Zhao, Can; Xi, Yue; Yang, Zhao-Yang; Li, Xiao-Guang] Beihang Univ, Sch Biol Sci & Med Engn, Dept Biomed Engn, Beijing 100191, Peoples R China; [Ma Manxiu; Liu Zuxiang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Yang, Zhao-Yang; Li, Xiao-Guang] Capital Med Univ, Beijing Inst Neurosci, Beijing 100069, Peoples R China		Li, XG (corresponding author), Beihang Univ, Sch Biol Sci & Med Engn, Dept Biomed Engn, Beijing 100191, Peoples R China.	lxgchina@sina.com		Rao, Jia-Sheng/0000-0002-5196-0912; MA, MANXIU/0000-0003-1905-3615	State Key Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31130022, 31271037, 31320103903, 91132302]; National Science & Technology Pillar Program of China [2012BAI17B04]; National 863 ProjectNational High Technology Research and Development Program of China [2012AA020506]; National 973 ProjectNational Basic Research Program of China [2012CB825500]; Innovation Method Work Program [2012IM030100, 2010IM030800]; National Ministry of Education Special Fund for Excellent Doctoral Dissertation [201356]; Special Funds for Excellent Doctoral Dissertation of Beijing, China [20111000601]; Department of Science and Technology of Beijing, China [D090800046609004]	This work was supported by the State Key Program of National Natural Science Foundation of China (Grants nos. 31130022, 31271037, 31320103903, and 91132302), the National Science & Technology Pillar Program of China (Grant no. 2012BAI17B04), the National 863 Project (Grant no. 2012AA020506), the National 973 Project (Grant no. 2012CB825500), Innovation Method Work Program (Grants nos. 2012IM030100, 2010IM030800), the National Ministry of Education Special Fund for Excellent Doctoral Dissertation (Grant no. 201356), the Special Funds for Excellent Doctoral Dissertation of Beijing, China (Grant no. 20111000601), and the Key Project of Department of Science and Technology of Beijing, China (Grant no. D090800046609004). The authors would like to express heartfelt thanks to Ping Gao, Zhao-Long Tian, and Li-Ming Zhu for their kind help.	BIEDENBACH MA, 1980, BRAIN RES, V193, P1, DOI 10.1016/0006-8993(80)90941-5; Bjorkman A, 2009, EUR J NEUROSCI, V29, P837, DOI 10.1111/j.1460-9568.2009.06629.x; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Darian-Smith C, 2009, NEUROSCIENTIST, V15, P149, DOI 10.1177/1073858408331372; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Dong Y, 2008, J NEUROSURG-SPINE, V9, P538, DOI 10.3171/SPI.2008.10.0831; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Endo T, 2008, EXP NEUROL, V209, P155, DOI 10.1016/j.expneurol.2007.09.017; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; GARRAGHTY PE, 1990, J COMP NEUROL, V294, P583, DOI 10.1002/cne.902940406; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; Griffin KM, 2010, NEUROIMAGE, V51, P1395, DOI 10.1016/j.neuroimage.2010.03.024; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Holly LT, 2007, J NEUROSURG-SPINE, V6, P544, DOI 10.3171/spi.2007.6.6.5; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jones EG, 2000, ANNU REV NEUROSCI, V23, P1, DOI 10.1146/annurev.neuro.23.1.1; Kitamura K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027706; KUNZLE H, 1977, EXP BRAIN RES, V30, P481; Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063; Lundell H, 2011, SPINAL CORD, V49, P70, DOI 10.1038/sc.2010.87; Lundell H, 2011, NEUROIMAGE, V54, P1254, DOI 10.1016/j.neuroimage.2010.09.009; McLaren DG, 2010, METHODS, V50, P157, DOI 10.1016/j.ymeth.2009.10.003; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Padberg J, 2007, J NEUROSCI, V27, P10106, DOI 10.1523/JNEUROSCI.2632-07.2007; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Ramu J, 2007, EXP NEUROL, V204, P58, DOI 10.1016/j.expneurol.2006.09.015; Rao JS, 2013, J NEURORADIOLOGY, V40, P181, DOI 10.1016/j.neurad.2012.08.008; RAUSELL E, 1995, J NEUROSCI, V15, P4270; Scanley BE, 1997, MAGNET RESON MED, V37, P969, DOI 10.1002/mrm.1910370625; SUR M, 1982, J COMP NEUROL, V211, P177, DOI 10.1002/cne.902110207; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wey HY, 2010, NEUROIMAGE, V52, P1420, DOI 10.1016/j.neuroimage.2010.05.014; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072	50	11	13	1	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								753061	10.1155/2013/753061			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	289GU	WOS:000329670700001	24490171	gold, Green Published, Green Submitted			2022-02-06	
J	Ruff, R				Ruff, Ronald			Selecting the appropriate psychotherapies for individuals with traumatic brain injury: What works and what does not?	NEUROREHABILITATION			English	Article						Psychotherapy; emotional problems; traumatic brain injury; acquired brain damage; existential approach		BACKGROUND: When traditional psychotherapy is provided to patients with traumatic brain injuries (TBIs), the primary focus is on treating mood changes such as depression, anxiety or anger. However, traditional psychotherapeutic methods developed specifically for mood changes fall short when treating most TBI patients. In large part, this is because the psychological adjustment difficulties that most TBI patients face are linked to life-altering changes that are interwoven with permanent physical, cognitive, and social sequelae. In addition, mood changes in TBI patients are also caused by vocational and financial losses. OBJECTIVE: The sudden onset of these unfamiliar and interdependent problems necessitates a psychotherapeutic approach that acknowledges the inherent challenges of coping with multiple life-altering changes. For patients who experience a shattered sense of self, interventions need to be explored to make life meaningful following a TBI. METHODS: Anexistentially-oriented approach is introduced in the following steps: (1) identifying pre-injury future expectations, (2) examining how the TBI has altered these expectations, (3) grieving the loss of the expected future, and (4) developing a realistic future that is existentially meaningful. RESULTS: Pivotal gains are achieved when patients rebuild their lives according to their own core values. CONCLUSION: TBI patients can benefit from existential psychotherapy.	Univ Calif San Francisco, San Francisco Clin Neurosci, San Francisco, CA 94109 USA		Ruff, R (corresponding author), Univ Calif San Francisco, San Francisco Clin Neurosci, 909 Hyde St, San Francisco, CA 94109 USA.	ronruff@mindspring.com					Beck J.S., 1995, COGNITIVE THERAPY BA; Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Dobson KS, 2001, HDB COGNITIVE BEHAV; Doering B, 2011, CURR OPIN PSYCHIATR, V24, P156, DOI 10.1097/YCO.0b013e328343804e; Feiring C, 1984, Am J Psychoanal, V44, P197, DOI 10.1007/BF01248299; Frankl V.E., 1968, MANS SEARCH MEANING; Gomez L., 1997, INTRO OBJECT RELATIO; Heller W, 2006, J REHABIL, V72, P44; International Classification of Functioning and Disability; Beta 2 Draft, 1999, ASS CLASS EP GROUP W; Kabat-Zinn J, 1984, REVISION, V7, P71; Kbler-Ross E., 1969, DEATH DYING; Klein Melanie, 1975, ENVY GRATITUDE OTHER; Klonoff P. S., 2010, PSYCHOTHERAPY BRAIN; Maciejewski PK, 2007, JAMA-J AM MED ASSOC, V297, P716, DOI 10.1001/jama.297.7.716; Manchester D, 2001, BRAIN DAM B, P157; Mathiesen Birgit Bork, 2004, Cogn Neuropsychiatry, V9, P249, DOI 10.1080/13546800344000237; Ogden T. H., 1992, PROJECTIVE IDENTIFIC; Ogden T. H., 1977, PROJECTIVE IDENTIFIC; Ponsford J, 2012, PTSD MILD TRAUMATIC, P199; Prigatano G.P., 2010, STUDY ANOSOGNOSIA; Svanberg OG., 1998, J MENTAL HLTH, V7, P543, DOI DOI 10.1080/09638239817716; Weinberger J., 1999, EXPECTANCIES SHAPE E, P357, DOI DOI 10.1037/10332-015; Wood R. L1., 1990, NEUROBEHAVIOURAL SEQ; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1	25	11	12	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	4					771	779		10.3233/NRE-130901			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	184QF	WOS:000321907100008	23867403				2022-02-06	
J	Shih, CC; Lee, HH; Chen, TL; Tsai, CC; Lane, HL; Chiu, WT; Liao, CC				Shih, Chun-Chuan; Lee, Hsun-Hua; Chen, Ta-Liang; Tsai, Chin-Chuan; Lane, Hsin-Long; Chiu, Wen-Ta; Liao, Chien-Chang			Reduced Use of Emergency Care and Hospitalization in Patients with Traumatic Brain Injury Receiving Acupuncture Treatment	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							CHINESE MEDICINE; INCREASED RISK; POPULATION; PATTERNS; OUTCOMES; TAIWAN	Background. Little research exists on acupuncture treatment's effect on patients with traumatic brain injury (TBI). Methods. Using Taiwan's National Health Insurance Research Database, we conducted a cohort study to compare the use of emergency care and hospitalization in TBI patients with and without acupuncture treatment in the first year after TBI. The adjusted relative risks (RRs) and 95% confidence intervals (CIs) of high use of emergency care and hospitalization associated with acupuncture treatment were calculated in multivariate Poisson regression models with generalized estimating equation. Results. The means of medical visits of emergency care and hospitalization were lower in TBI patients with acupuncture treatment than in those without acupuncture treatment. After adjustment, acupuncture treatment was associated with decreased risk of high emergency care visits (beta = -0.0611, P = 0.0452) and hospitalization (beta = -0.0989, P < 0.0001). The RRs of high medical visits and expenditure for hospitalization associated with acupuncture treatment were 0.62 (95% CI = 0.50-0.76) and 0.66 (95% CI = 0.53-0.83), respectively. Conclusion. Patients with TBI who receive acupuncture treatment have reduced the use of emergency care and hospitalization in the first year after injury. The mechanisms of effects of acupuncture on TBI warrant further investigations.	[Shih, Chun-Chuan; Tsai, Chin-Chuan; Lane, Hsin-Long] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung 84001, Taiwan; [Lee, Hsun-Hua] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei 235, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei 110, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei 110, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Coll Med, Taipei 110, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 110, Taiwan		Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan.	jacky48863027@yahoo.com.tw			Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP98-RD-038, CCMP99-RD-035]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	This study is based (in part) on data from the National Health Insurance Research Database provided by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the National Health Research Institutes. This study is supported in part by a Grant from the Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan (Grants nos. CCMP98-RD-038 and CCMP99-RD-035) and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Bai LJ, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-73; Ballegaard S, 1999, J ALTERN COMPLEM MED, V5, P405, DOI 10.1089/acm.1999.5.405; Bonafede M, 2008, MED CARE, V46, P41, DOI 10.1097/MLR.0b013e3181589b7d; Chao MT, 2012, J ALTERN COMPLEM MED, V18, P561, DOI 10.1089/acm.2011.0128; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen FP, 2006, J ALTERN COMPLEM MED, V12, P379, DOI 10.1089/acm.2006.12.379; Chen YH, 2012, J NEUROTRAUM, V29, P1328, DOI 10.1089/neu.2011.2235; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Chen YH, 2011, PSYCHOL MED, V41, P1271, DOI 10.1017/S0033291710001819; Chi CH, 1996, SOC SCI MED, V43, P1329, DOI 10.1016/0277-9536(95)00429-7; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Guimaraes SB, 2008, J ACUPUNCT MERIDIAN, V1, P149, DOI 10.1016/S2005-2901(09)60036-4; Hsieh CW, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/951258; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Kung WM, 2011, INJURY, V42, P940, DOI 10.1016/j.injury.2010.09.019; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/387164; Liao CC, 2012, J TRAUMA ACUTE CARE, V73, P1327, DOI 10.1097/TA.0b013e31826fc87f; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Manheimer E, 2008, BMJ-BRIT MED J, V336, P545, DOI 10.1136/bmj.39471.430451.BE; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Quah-Smith I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012619; Robinson TW, 2012, J ALTERN COMPLEM MED, V18, P555, DOI 10.1089/acm.2010.0398; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Shih CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032540; Shih CC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-27; Shih CC, 2009, CHINESE MED J-PEKING, V122, P1544, DOI 10.3760/cma.j.issn.0366-6999.2009.13.013; Willich SN, 2006, PAIN, V125, P107, DOI 10.1016/j.pain.2006.06.006; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Yu WY, 2011, INT J EPIDEMIOL, V40, P794, DOI 10.1093/ije/dyr040; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397	38	11	11	0	11	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.		2013	2013								262039	10.1155/2013/262039			7	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Integrative & Complementary Medicine	192CT	WOS:000322462400001	23970929	Green Published, Green Submitted, gold			2022-02-06	
J	Yilmaz, ER; Kertmen, H; Gurer, B; Kanat, MA; Arikok, AT; Erguder, BI; Hasturk, AE; Ergil, J; Sekerci, Z				Yilmaz, Erdal Resit; Kertmen, Hayri; Gurer, Bora; Kanat, Mehmet Ali; Arikok, Ata Turker; Erguder, Berrin Imge; Hasturk, Askin Esen; Ergil, Julide; Sekerci, Zeki			The protective effect of 2-mercaptoethane sulfonate (MESNA) against traumatic brain injury in rats	ACTA NEUROCHIRURGICA			English	Article						Antioxidation; Antiapoptosis; 2-mercaptoethane sulfonate; Methylprednisolone; Neuroprotection; Traumatic brain injury	EXPERIMENTAL HEAD TRAUMA; SPINAL-CORD-INJURY; LIPID-PEROXIDATION; OXIDATIVE STRESS; FREE-RADICALS; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; XANTHINE-OXIDASE; DAMAGE; METABOLISM	The agent, 2-mercaptoethane sulfonate (MESNA), is a synthetic small molecule, widely used as a systemic protective agent against chemotherapy toxicity, but is primarily used to reduce hemorrhagic cystitis induced by cyclophosphamide. Because MESNA has potential antioxidant and cytoprotective effects, so we hypothesized that MESNA may protect the brain against traumatic injury. Thirty-two rats were randomized into four groups of eight animals each; Group 1 (sham), Group 2 (trauma), Group 3 (150 mg/kg MESNA), Group 4 (30 mg/kg methylprednisolone). Only skin incision was performed in the sham group. In all the other groups, the traumatic brain injury model was created by an object weighing 450 g falling freely from a height of 70 cm through a copper tube on to the metal disc over the skull. The drugs were administered immediately after the injury. The animals were killed 24 h later. Brain tissues were extracted for analysis, where levels of tissue malondialdehyde, caspase-3, glutathione peroxidase, superoxide dismutase, nitric oxide, nitric oxide synthetase and xanthine oxidase were analyzed. Also, histopathological evaluation of the tissues was performed. After head trauma, tissue malondialdehyde levels increased; these levels were significantly decreased by MESNA administration. Caspase-3 levels were increased after trauma, but no effect of MESNA was determined in caspase-3 activity. Following trauma, both glutathione peroxidase and superoxide dismutase levels were decreased; MESNA increased the activity of both these antioxidant enzymes. Also, after trauma, nitric oxide, nitric oxide synthetase and xanthine oxidase levels were increased; administration of MESNA significantly decreased the levels of nitric oxide, nitric oxide synthetase and xanthine oxidase, promising an antioxidant activity. Histopathological analysis showed that MESNA protected the brain tissues well from injury. Although further studies considering different dose regimens and time intervals are required, MESNA was shown to be at least as effective as methylprednisolone in the traumatic brain injury model.	[Gurer, Bora] SB Diskapi Yildirim Beyazit Egitim & Arastirma Ha, Ankara, Turkey; [Yilmaz, Erdal Resit; Kertmen, Hayri; Gurer, Bora; Sekerci, Zeki] Diskapi Yildirim Beyazit Educ & Res Hosp, Minist Hlth, Neurosurg Clin, Ankara, Turkey; [Kanat, Mehmet Ali] Refik Saydam Natl Publ Hlth Agcy, Minist Hlth, Ankara, Turkey; [Arikok, Ata Turker] Diskapi Yildirim Beyazit Educ & Res Hosp, Dept Pathol, Minist Hlth, Ankara, Turkey; [Erguder, Berrin Imge] Ankara Univ, Dept Biochem, TR-06100 Ankara, Turkey; [Hasturk, Askin Esen] Oncol Training & Res Hosp, Dept Neurosurg, Minist Hlth, Ankara, Turkey; [Ergil, Julide] Diskapi Yildirim Beyazit Educ & Res Hosp, Dept Anesthesiol, Minist Hlth, Ankara, Turkey		Gurer, B (corresponding author), SB Diskapi Yildirim Beyazit Egitim & Arastirma Ha, 1 Beyin Cerrahi Servisi, Ankara, Turkey.	boragurer@gmail.com	ali, mehmet/AAA-3233-2022; Gurer, Bora/K-1177-2012; Erguder, Imge/AAZ-5673-2020; KANAT, Mehmet Ali/ABG-9355-2021; HASTURK, ASKIN ESEN/AAE-5065-2019	Gurer, Bora/0000-0003-1500-6184; KANAT, Mehmet Ali/0000-0003-3494-4563; 			Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Aluise CD, 2011, FREE RADICAL BIO MED, V50, P1630, DOI 10.1016/j.freeradbiomed.2011.03.009; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BERRIGAN MJ, 1982, CANCER RES, V42, P3688; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Diaz-Ruiz A, 2000, NEUROREPORT, V11, P1765, DOI 10.1097/00001756-200006050-00033; Dolgun H, 2010, J CLIN NEUROSCI, V17, P486, DOI 10.1016/j.jocn.2009.07.108; Durak I, 2001, ACTA ANAESTH SCAND, V45, P119, DOI 10.1034/j.1399-6576.2001.450118.x; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; GRESSIER B, 1995, PHARM WORLD SCI, V17, P76, DOI 10.1007/BF01875435; GRESSIER B, 1994, PHARMAZIE, V49, P679; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; Lukacova N, 1996, NEUROCHEM RES, V21, P869, DOI 10.1007/BF02532334; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nishikawa A, 2003, CANCER LETT, V193, P11, DOI 10.1016/S0304-3835(02)00097-6; Nishio S, 1997, ACT NEUR S, V70, P84; Ozdemir D, 2005, PHYSIOL RES, V54, P631; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; PRAJDA N, 1975, FEBS LETT, V59, P245, DOI 10.1016/0014-5793(75)80385-1; Qian H, 1997, NEUROCHEM RES, V22, P1231, DOI 10.1023/A:1021980929422; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Schwerdt G, 2007, PEDIATR NEPHROL, V22, P798, DOI 10.1007/s00467-006-0414-x; Sener G, 2005, SURG TODAY, V35, P575, DOI 10.1007/s00595-004-2985-0; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9; SUN Y, 1988, CLIN CHEM, V34, P497; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Umemura T, 1996, JPN J CANCER RES, V87, P882, DOI 10.1111/j.1349-7006.1996.tb02115.x; Ustun ME, 2001, J TRAUMA, V51, P22, DOI 10.1097/00005373-200107000-00004; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Ypsilantis P, 2004, J SURG RES, V121, P84, DOI 10.1016/j.jss.2004.03.003	42	11	11	1	11	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JAN	2013	155	1					141	149		10.1007/s00701-012-1501-3			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	063QD	WOS:000313013900022	23053276				2022-02-06	
J	Agrawal, A; Kakani, A; Baisakhiya, N; Galwankar, S; Dwivedi, S; Pal, R				Agrawal, A.; Kakani, A.; Baisakhiya, N.; Galwankar, S.; Dwivedi, S.; Pal, Ranabir			Developing traumatic brain injury data bank: Prospective study to understand the pattern of documentation and presentation	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Traumatic brain injury; Documentation; Outcome; Registry; Trauma registry		Background: There are few published research reports from scattered studies on traumatic brain injuries (TBI) from the developing countries. Objectives: We attempted to identify the clinico-social correlates of TBI and to determine the efficiency of documentation to find out the pattern of presentation of TBI at a rural tertiary care teaching hospital. Materials and methods: A descriptive observational prospective study was performed from January to June 2010 at a tertiary care rural teaching hospital. Based on WHO guidelines "Standards for Surveillance of Neurotrauma" a data collection tool was designed. After validation by pilot study this data collection questionnaire was subjected to collect information on the participants with diagnosis of traumatic brain injury reported at the Emergency Department (ED). The collected data was entered into the TBI registry database based on Microsoft ( MS) excel that was developed for analytical conclusions. Results: Out of a total 414 TBI cases, the mean age was 33.47 years, 78.98 percent were male; half of all the victims were in the age 21-40 years; children (6-10 years) (6.76%) and adolescent (11-20 years) (10.39%) comprised a large group; 10.23 percent required resuscitation on admission; the mean duration of hospital stay was 5.42 days. The overall fatality was 7.75 percent; females contributed higher among fatal cases; 10.39 percent were below 10 years and nearly one- fourths (24.40%) less than 20 years is alarming. In the secular trend, highest number (33.57%) of TBI cases was reported in the month of June, followed by March (18.84%). Road traffic injuries were the commonest injury mechanism (56.76%) and mainly in the highways (57.25%). Minor associated injuries were bruises (40.10%) and abrasions (50.97%) and cuts (44.69%). Major associated injuries were few; ear, nose or throat (ENT) Bleeding (2.17%), Limb fracture (5.07%). Alcohol was risk factor in 9.42 percent cases. Of the life threatening computerized tomography (CT) scan findings subarachnoid hemorrhage was noted in 5.59 percent cases. Conclusions: Early analysis of a TBI data can lead to useful information but presently there are many lacunae to collect comprehensive information in TBI cases. There is further need to understand the number of variables required and many other requirements for userfriendly secure web-based database system to maintain, analyze and to update continuously for a national TBI registry. Copyright (C) 2012, Neurotrauma Society of India. All rights reserved.	[Agrawal, A.; Baisakhiya, N.; Dwivedi, S.] Narayana Med Coll & Hosp, Dept Neurosurg, Neurosurg, Nellore 524003, Andhra Pradesh, India; [Kakani, A.] MM Inst Med Sci & Res, Mullana Ambala, India; [Galwankar, S.] Univ S Florida, Fac Global Hlth & Emergency Med, Tampa, FL 33620 USA; [Pal, Ranabir] Sikkim Manipal Inst Med Sci, Gangtok, Sikkim, India		Agrawal, A (corresponding author), Narayana Med Coll & Hosp, Dept Neurosurg, Neurosurg, Nellore 524003, Andhra Pradesh, India.	dramitagrawal@gmail.com	Pal, Ranabir/M-6693-2013; Agrawal, Amit/C-1511-2011	Agrawal, Amit/0000-0002-3287-5448			Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Agrawal Amit, 2009, J Emerg Trauma Shock, V2, P56, DOI 10.4103/0974-2700.44687; Bhalla K, 2009, INJURY PREV, V15, P150, DOI 10.1136/ip.2008.020826; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; ESPOSITO TJ, 1992, ANN EMERG MED, V21, P351, DOI 10.1016/S0196-0644(05)82649-6; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GROSSMAN DC, 1995, J TRAUMA, V38, P14, DOI 10.1097/00005373-199501000-00006; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hill DA, 1996, J TRAUMA, V40, P351, DOI 10.1097/00005373-199603000-00004; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Lucas CE, 2001, J TRAUMA, V51, P1122, DOI 10.1097/00005373-200112000-00018; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Markogiannakis H, 2008, ULUS TRAVMA ACIL CER, V14, P125; McLellan BA, 1997, J TRAUMA, V42, P763, DOI 10.1097/00005373-199705000-00001; Moore L, 2008, INJURY, V39, P686, DOI 10.1016/j.injury.2008.02.023; Mullins RJ, 2001, J TRAUMA, V51, P1126; Nwomeh Benedict C, 2006, World J Emerg Surg, V1, P32; Peden M., 2004, WORLD REPORT ROAD TR; Probst C, 2006, EUR J TRAUMA, V32, P357; RUTLEDGE R, 1995, SURG CLIN N AM, V75, P305, DOI 10.1016/S0039-6109(16)46590-4; SAMPALIS JS, 1995, J TRAUMA, V39, P232, DOI 10.1097/00005373-199508000-00008; Sanidas E, 2003, EUR J SURG, V166, P13; Scheidler MG, 2000, J TRAUMA, V49, P864, DOI 10.1097/00005373-200011000-00012; Schultz CR, 2007, J TRAUMA, V63, P1143, DOI 10.1097/TA.0b013e31815688e3; Shaban Sami, 2009, World J Emerg Surg, V4, P42, DOI 10.1186/1749-7922-4-42; Shaban Sami, 2010, BMC Res Notes, V3, P187, DOI 10.1186/1756-0500-3-187; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; SWIERZEWSKI MJ, 1994, J TRAUMA, V37, P404, DOI 10.1097/00005373-199409000-00012; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Thurman DJ., 1995, STANDARDS SURVEILLAN; WEDDELL JM, 1973, INT J EPIDEMIOL, V2, P221, DOI 10.1093/ije/2.3.221; Wynn A, 2001, J TRAUMA, V51, P464, DOI 10.1097/00005373-200109000-00007	40	11	11	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2012	9	2					87	92		10.1016/j.ijnt.2012.11.001			6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M3Y	WOS:000218387700004					2022-02-06	
J	Blanie, A; Vigue, B; Benhamou, D; Duranteau, J; Geeraerts, T				Blanie, Antonia; Vigue, Bernard; Benhamou, Dan; Duranteau, Jacques; Geeraerts, Thomas			The Frontal Lobe and Thalamus Have Different Sensitivities to Hypoxia-Hypotension after Traumatic Brain Injury: A Microdialysis Study in Rats	JOURNAL OF NEUROTRAUMA			English	Article						energy metabolism; hypotension; hypoxia; traumatic brain injury; oxygenation	CLOSED-HEAD INJURY; CARDIAC-ARREST; MAGNETIC-RESONANCE; MODEL; DAMAGE; PATHOPHYSIOLOGY; RESUSCITATION; VULNERABILITY; EPIDEMIOLOGY; RESPONSES	After traumatic brain injury (TBI), lesions are anatomically heterogeneous, but the spatial heterogeneity of the post-traumatic brain's vulnerability to hypoxia-hypotension (HH) has been poorly studied. Our objective was to compare the effect of HH after TBI on brain energy metabolism into two regions: the frontal lobe and the thalamus. Twenty-eight Sprague-Dawley rats were randomized into four groups: sham, TBI (brain trauma alone, impact acceleration, 450-g weight drop from 1.8 m), HH (blood depletion to mean arterial pressure 40mm Hg, FiO(2) 10%, 15 min), and TBI-HH (TBI followed by HH, 45-min delay). Cerebral perfusion pressure (CPP) was continuously measured. Brain microdialysis and brain tissue oxygen partial pressure (PtiO(2)) probes were both inserted stereotaxically into the right thalamus and frontal lobe. Except during the HH period, CPP was always above 60mm Hg. During the hour following the HH period, significant increases in cerebral lactate-pyruvate ratio, glycerol, and glutamate were observed, and were always higher in the frontal lobe than in the thalamus (p < 0.001). In the TBI-HH group and in the frontal lobe, increases in glutamate and glycerol were significantly higher than in the HH group (p < 0.001). During the 30 min following the HH phase (reperfusion), an increase in PtiO(2) was observed. In the TBI-HH group, this increase was significantly lower in the frontal lobe than in the thalamus. These findings demonstrate that in the early post-traumatic period, the metabolic cerebral response to HH is higher in the frontal lobe than in the thalamus, and is worsened by TBI, suggesting a higher vulnerability for the frontal lobes.	[Blanie, Antonia; Vigue, Bernard; Benhamou, Dan; Duranteau, Jacques; Geeraerts, Thomas] Hop Bicetre, Dept Anesthesie Reanimat, Le Kremlin Bicetre, France		Blanie, A (corresponding author), CHU Bicetre, Dept Anesthesie Reanimat Chirurg, F-94275 Le Kremlin Bicetre, France.	Antonia.blanie@bct.aphp.fr	Benhamou, Dan/ABG-7935-2021				Arakawa S, 2006, STROKE, V37, P1211, DOI 10.1161/01.STR.0000217258.63925.6b; BLOMQVIST P, 1985, J CEREBR BLOOD F MET, V5, P420, DOI 10.1038/jcbfm.1985.57; Carre E, 2004, J NEUROSCI METH, V140, P23, DOI 10.1016/j.jneumeth.2004.04.037; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Geeraerts T, 2006, J NEUROTRAUM, V23, P1059, DOI 10.1089/neu.2006.23.1059; GRANHOLM L, 1968, ACTA PHYSIOL SCAND, V74, P398, DOI 10.1111/j.1748-1716.1968.tb04249.x; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Julien-Dolbec C, 2002, BRIT J ANAESTH, V89, P287, DOI 10.1093/bja/aef182; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; MAJOR O, 1990, ACT NEUR S, V51, P46; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Menon DK, 2003, ANESTHESIOLOGY, V98, P805, DOI 10.1097/00000542-200304000-00002; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; PAXINOS J, 1982, RAT BRAIN STEREOTAXI; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; Ract C, 2001, J NEUROTRAUM, V18, P1247, DOI 10.1089/089771501317095287; ROINE RO, 1993, STROKE, V24, P1005, DOI 10.1161/01.STR.24.7.1005; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taraszewska A, 2002, FOLIA NEUROPATHOL, V40, P133; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wijdicks EFM, 2001, AM J NEURORADIOL, V22, P1561	33	11	12	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2012	29	18					2782	2790		10.1089/neu.2012.2381			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	050ZE	WOS:000312092800007	22860603				2022-02-06	
J	Puljula, J; Cygnel, H; Makinen, E; Tuomivaara, V; Karttunen, V; Karttunen, A; Hillbom, M				Puljula, Jussi; Cygnel, Hanna; Makinen, Elina; Tuomivaara, Veli; Karttunen, Vesa; Karttunen, Ari; Hillbom, Matti			Mild traumatic brain injury diagnosis frequently remains unrecorded in subjects with craniofacial fractures	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Craniofacial fractures; Traumatic brain injury; Diagnostic accuracy; Alcohol; Guidelines	HEAD-INJURY; POSTCONCUSSION SYNDROME; EPIDEMIOLOGY; PERSPECTIVE; MANAGEMENT; DISABILITY; ACCURACY; PEOPLE; ADULTS; IMPACT	Background: Traumatic brain injuries (TBI) in subjects with craniofacial fractures are usually diagnosed by emergency room physicians. We investigated how often TBI remains unrecorded in these subjects, and whether diagnostic accuracy has improved after the implementation of new TBI guidelines. Methods: All subjects with craniofacial fractures admitted to Oulu University Hospital in 1999 and in 2007 were retrospectively identified. New guidelines for improving the diagnostic accuracy of TBI were implemented between 2000 and 2006. Clinical symptoms of TBI were gathered from notes on hospital charts and compared to the recorded diagnoses at discharge. Logistic regression was used to identify independent predictors for TBI to remain unrecorded. Results: Of 194 subjects with craniofacial fracture, 111(57%) had TBI, 40 in 1999 and 71 in 2007. Fifty-one TBIs (46%) remained unrecorded at discharge, 48 being mild and 3 moderate-to-severe. Subjects with unrecorded TBI were significantly less frequently referred to follow-up visits. Failures to record the TBI diagnosis were less frequent (29/71, 41%) in 2007 than in 1999 (22/40, 55%), but the difference was not statistically significant. The most significant independent predictor for this failure was the clinical specialty (other than neurology/neurosurgery) of the examining physician (p < 0.001). The subject's alcohol intoxication did not hamper the diagnosis of TBI. Conclusions: TBIs remain frequently unrecorded in subjects with craniofacial fractures. Recording of mild TBI slightly but insignificantly improved after the implementation of new guidelines. (C) 2012 Elsevier Ltd. All rights reserved.	[Puljula, Jussi; Cygnel, Hanna; Makinen, Elina; Tuomivaara, Veli; Karttunen, Vesa; Hillbom, Matti] Oulu Univ Hosp, Dept Neurol, Oys 90029, Finland; [Karttunen, Ari] Oulu Univ Hosp, Dept Diagnost Radiol, Oys 90029, Finland		Puljula, J (corresponding author), Oulu Univ Hosp, Dept Neurol, Box 20, Oys 90029, Finland.	jpuljula@paju.oulu.fi; jarvihan@paju.oulu.fi; elinakmakinen@gmail.com; veli.tuomivaara@oulu.fi; vesa.karttunen@ppshp.fi; ari.karttunen@ppshp.fi; matti.hillbom@oulu.fi					Batchelor J, 2002, EMERG MED J, V19, P515, DOI 10.1136/emj.19.6.515; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CONFORTI PJ, 1993, J ORAL MAXIL SURG, V51, P298, DOI 10.1016/S0278-2391(10)80179-X; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Swan MC, 2004, ALCOHOL RES, V9, P59; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298	30	11	11	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2100	2104		10.1016/j.injury.2012.04.010			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600023	22552039				2022-02-06	
J	Roe, WD; Gartrell, BD; Hunter, SA				Roe, W. D.; Gartrell, B. D.; Hunter, S. A.			Freezing and thawing of pinniped carcasses results in artefacts that resemble traumatic lesions	VETERINARY JOURNAL			English	Article						Pinniped; Marine mammal; Post-mortem examination; Freezing; Artefact; Trauma	RED-BLOOD-CELLS; CANINE TISSUES; FUR-SEAL; FROZEN; HEMORRHAGES; OTARIIDAE; BRUISES; INJURY	The objective of this study was to assess whether the freezing and thawing of pinniped carcasses prior to post-mortem examination could create artefacts that resembled lesions caused by trauma. Necropsy findings in New Zealand fur seals (Arctocephalus forsteri), captured incidental to commercial fishing, and either chilled (n = 5) or frozen (n = 5), were compared. Changes in frozen, but not in chilled, carcasses included: pseudo-bruising of subcutis; the accumulation of thick dark red fluid (resembling haemorrhage) in the thoracic cavity, pericardial sac and abdominal cavity; apparent subcapsular renal haemorrhage; pseudo-contusions of the brain; apparent haemorrhage from the nares; and blood-staining of the anterior ocular chamber. The processes of freezing and thawing were strongly associated with subcutaneous pseudo-bruises, the presence of thick, dark red abdominal fluid and renal subcapsular 'haemorrhage' (P = 0.004). These artefacts probably develop due to a combination of autolysis and 'freeze-thaw' effects including lysis of cell membranes, fluid shifts into the extracellular space, and disruption of blood vessel walls. The results of the study demonstrate that artefacts resembling traumatic lesions are created during freezing and thawing of pinniped bodies. Such changes must be taken into consideration at post-mortem examination of previously frozen carcasses. (C) 2012 Elsevier Ltd. All rights reserved.	[Roe, W. D.] Massey Univ, Inst Vet Anim & Biomed Sci, Pathobiol Grp, Palmerston North, New Zealand; [Gartrell, B. D.; Hunter, S. A.] Massey Univ, Inst Vet Anim & Biomed Sci, New Zealand Wildlife Hlth Ctr, Palmerston North, New Zealand		Roe, WD (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Pathobiol Grp, Palmerston North, New Zealand.	w.d.roe@massey.ac.nz	, Wendi/K-4110-2012	, Wendi/0000-0001-6832-5731; Gartrell, Brett/0000-0002-8062-9313	New Zealand Deepwater Group; New Zealand Ministry of Fisheries	All work was conducted under permit to the New Zealand Department of Conservation. This work was partly funded by the New Zealand Deepwater Group and the New Zealand Ministry of Fisheries. The authors would like to thank: Richard Wells and John Cleat for organisation of transport and other logistics; Laureline Meynier, Mike Hogan and Nicola Wallace for assistance in the post-mortem room; Evelyn Lupton and Eugene Ndeke for the processing of histology sections; Sandra Forsyth for clinical pathology expertise; and Professors I.G. Mayhew and R.D. Jolly for their useful comments.	BARAIBAR MA, 1985, J FORENSIC SCI, V30, P439; BARAIBAR MA, 1986, J FORENSIC SCI, V31, P283; Bockholdt B, 2005, FORENSIC SCI INT, V149, P133, DOI 10.1016/j.forsciint.2004.05.014; BRYDEN MM, 1978, ANAT RECORD, V191, P253, DOI 10.1002/ar.1091910210; Duignan P.J., 2007, DEP CONSERVATION RES, V280, P60; Dunn DG, 2002, J WILDLIFE DIS, V38, P505, DOI 10.7589/0090-3558-38.3.505; Evans D. L., 2001, JOINT INTERIM REPORT, V59; GILMARTIN W G, 1976, Journal of Wildlife Diseases, V12, P104; Grellner W, 2007, FORENSIC SCI INT, V165, P150, DOI 10.1016/j.forsciint.2006.05.029; ISHIGURO H, 1994, CRYOBIOLOGY, V31, P483, DOI 10.1006/cryo.1994.1059; Ketten D.R., 2005, WHOI200509, P36; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; MICOZZI MS, 1986, J FORENSIC SCI, V31, P953; Norman S.A., 2004, NMFSNWR34 NAT OC ATM, P120; PEGG DE, 1988, BIOPHYS J, V54, P471; Pollanen MS, 2009, AM J FOREN MED PATH, V30, P322, DOI 10.1097/PAF.0b013e3181c17ec2; PRINSLOO I, 1951, S Afr Med J, V25, P358; Roe W.D., 2009, 34 NZ AQ ENV BIOD, P36; Roe W.D., 2010, 47 NZ AQ ENV BIOD, P22; Saliki JT, 2006, J WILDLIFE DIS, V42, P142, DOI 10.7589/0090-3558-42.1.142; Saukko P., 2004, KNIGHTS FORENSIC PAT, V3rd, P267, DOI [10.1201/b13642, DOI 10.1201/B13642]; Schafer AT, 1999, FORENSIC SCI INT, V102, P149, DOI 10.1016/S0379-0738(99)00043-2; Scott KL, 2005, TRANSFUS MED REV, V19, P127, DOI 10.1016/j.tmrv.2004.11.004; SMITH A W, 1974, Journal of Wildlife Diseases, V10, P54; Stewardson CL, 1999, J ANAT, V195, P235, DOI 10.1046/j.1469-7580.1999.19520235.x; Tabata N, 2000, FORENSIC SCI INT, V108, P67, DOI 10.1016/S0379-0738(99)00199-1; THORNTON RN, 1986, FORENSIC SCI INT, V31, P225, DOI 10.1016/0379-0738(86)90161-1; Vanezis P, 2001, J CLIN PATHOL, V54, P348, DOI 10.1136/jcp.54.5.348; ZUGIBE FT, 1993, J FORENSIC SCI, V38, P1404	29	11	11	1	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233			VET J	Vet. J.	DEC	2012	194	3					326	331		10.1016/j.tvjl.2012.03.028			6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	066MG	WOS:000313224300016	22579416				2022-02-06	
J	Chang, YJ; Chen, SF; Chou, LD				Chang, Yao-Jen; Chen, Shu-Fang; Chou, Li-Der			A Feasibility Study of Enhancing Independent Task Performance for People with Cognitive Impairments Through the Use of a Handheld Location-Based Prompting System	IEEE TRANSACTIONS ON INFORMATION TECHNOLOGY IN BIOMEDICINE			English	Article						Cognitive impairments; ubiquitous computing; task prompting	DAILY LIVING SKILLS; VIDEO; MODERATE; ADULTS	An autonomous task-prompting system is presented to increase workplace and life independence for people with cognitive impairments such as traumatic brain injury, intellectual disability, schizophrenia, and down syndrome. This paper describes an approach to providing distributed cognition support of work engagement for persons with cognitive disabilities. In the pilot study, a prototype was built and tested in a community-based rehabilitation program involving preservice food preparation training of eight participants with cognitive impairments. The results show improvement in helping with task engagement is statistically significant compared to the oral-instruction method. A follow-up comparative study with two participants evaluated the shadow-team approach against the proposed system. Although the number of participants was few, the participants were studied in depth and the findings were very promising. The results in the autonomous task prompting without staff intervention indicate that the performance is statistically as good as the shadow-team approach. Our findings suggest that acquisition of job skills may be facilitated by the proposed system in conjunction with operant conditioning strategies.	[Chang, Yao-Jen] Chung Yuan Christian Univ, Dept Elect Engn, Chungli 32023, Taiwan; [Chen, Shu-Fang] Taipei Municipal Hosp, Ctr Occupat Therapy, Taipei 106, Taiwan; [Chou, Li-Der] Natl Cent Univ, Comp Sci & Informat Engn Dept, Tao Yuan 320, Taiwan		Chang, YJ (corresponding author), Chung Yuan Christian Univ, Dept Elect Engn, Chungli 32023, Taiwan.	yjchang@cycu.edu.tw; ab10721ziz@gmail.com; cld@csie.ncu.edu.tw			National Research Program for the Department of Industrial Technology (DoIT) of the Ministry of Economic Affairs, Taiwan [99-EC-17-A-19-S1-163]; National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 100-2221-E-033-062-053]	This work was supported in part by the National Research Program for the Department of Industrial Technology (DoIT) of the Ministry of Economic Affairs, Taiwan, under Grant 99-EC-17-A-19-S1-163 and in part by National Science Council, Taiwan, under Grant NSC 100-2221-E-033-062-053.	Bohonos S., 2007, P 1 ACM SIGMOBILE IN, P83, DOI [10.1145/1248054.1248080, DOI 10.1145/1248054.1248080]; Bond G. R., 1992, HDB PSYCHIAT REHABIL; Bond GR, 1997, PSYCHIATR SERV, V48, P335; Cannella-Malone H, 2006, EDUC TRAIN DEV DISAB, V41, P344; Carmien S., 2005, ACM Transactions on Computer-Human Interaction, V12, P233, DOI 10.1145/1067860.1067865; Chan Y K, 2008, Progress In Electromagnetics Research B, V2, P27, DOI 10.2528/PIERB07110101; Chang Y.-J., 2007, P 9 INT ACM SIGACCES; Chang YJ, 2010, PERS UBIQUIT COMPUT, V14, P737, DOI 10.1007/s00779-010-0285-9; Cihak DF, 2008, EDUC TRAIN DEV DISAB, V43, P102; Cihak DF, 2007, RES DEV DISABIL, V28, P397, DOI 10.1016/j.ridd.2006.05.003; Davies DK, 2002, EDUC TRAIN MENT RET, V37, P209; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Goodwin Simon, 1997, COMP MENTAL HLTH POL; Hoey J, 2010, COMPUT VIS IMAGE UND, V114, P503, DOI 10.1016/j.cviu.2009.06.008; Liu A. L., 2006, P 8 INT ACM SIGACCES, P95; Liu AL, 2008, DISABIL REHABIL-ASSI, V3, P69, DOI 10.1080/17483100701500173; Mechling LC, 2007, EDUC TRAIN DEV DISAB, V42, P24; Modayil J., 2008, AAAI FALL 2008 S AI; Pollack ME, 2006, GENERATIONS, V30, P67; Sohlberg MM, 2007, BRAIN INJURY, V21, P531, DOI 10.1080/02699050701311000; Taber-Doughty T, 2005, RES DEV DISABIL, V26, P411, DOI 10.1016/j.ridd.2004.07.006; Van Laarhoven T, 2006, EDUC TRAIN DEV DISAB, V41, P365; Wu M, 2005, P SIGCHI C HUM FACT, P511, DOI DOI 10.1145/1054972.1055043	23	11	11	0	12	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1089-7771	1558-0032		IEEE T INF TECHNOL B	IEEE T. Inf. Technol. Biomed.	NOV	2012	16	6					1157	1163		10.1109/TITB.2012.2198484			7	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematical & Computational Biology; Medical Informatics	053JT	WOS:000312268300020	22581142				2022-02-06	
J	Davceva, N; Janevska, V; Ilievski, B; Petrushevska, G; Popeska, Z				Davceva, N.; Janevska, V.; Ilievski, B.; Petrushevska, G.; Popeska, Z.			The occurrence of acute subdural haematoma and diffuse axonal injury as two typical acceleration injuries	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Diffuse axonal injury; Acute subdural haematoma; beta-Amyloid precursor protein	AMYLOID PRECURSOR PROTEIN; BETA-APP IMMUNOREACTIVITY; BRAIN-INJURY; HEAD-INJURY; FORENSIC NEUROPATHOLOGY; DIAGNOSIS; IMMUNOHISTOCHEMISTRY; MECHANISM; ASSAULT; ADULTS	Closed head injuries have already been classified into contact injuries and acceleration deceleration injuries. Two typical acceleration deceleration injuries and at the same time, the two worst head injuries are acute subdural haematoma (ASDH) and diffuse axonal injury (DAI), and that is where they got their medico-legal importance. Using experiments, it has been shown that acceleration with an impact time of more than 20-25 min (which occurs in traffic accidents in real life) causes DAI, whereas an impact time of 5-10 min is more likely to produce acute subdural haematoma. The aim of this research is to show that not all, but some types of traffic accidents are more typical for the occurrence of DAI, as well as that the ASDH is not a common feature for all types of fall. The analysis conveyed covered 80 cases of closed head injuries (traffic accidents, falls and assaults) where a complete forensic medical autopsy has been undertaken, followed by a complete forensic neuropathological examination. For the purpose of diagnosing DAI, immunohistochemistry using antibody against beta-amyloid precursor protein has been involved. Results show that ASDH is more likely to occur in cases of simple fall, assaults and cyclists and DAI is more typical for vehicular traffic accidents and cases of falling from a considerable height. The paper also comprises discussion about some open questions regarding the diagnosis of DAI in the medico-legal practice. (C) 2012 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Davceva, N.] Ss Cyril & Methodius Univ Skopje, Fac Med, Inst Forens Med Criminol & Med Deontol, Skopje 1000, Macedonia; [Janevska, V.; Ilievski, B.; Petrushevska, G.] Ss Cyril & Methodius Univ Skopje, Fac Med, Inst Pathol, Div 50, Skopje 1000, Macedonia; [Popeska, Z.] Ss Cyril & Methodius Univ Skopje, Fac Comp Sci & Engn, Skopje 1000, Macedonia		Davceva, N (corresponding author), Ss Cyril & Methodius Univ Skopje, Fac Med, Inst Forens Med Criminol & Med Deontol, Vodnjanska 19, Skopje 1000, Macedonia.	drdavcevamk@yahoo.com	Janevska, Vesna/AAG-4065-2021	Janevska, Vesna/0000-0001-6138-4448; Davceva, Natasha/0000-0001-8174-3145			Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Di Mayo VS, 2001, FORENSIC PATHOLOGY; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; Gusmao SNS, 2003, ARQ NEURO-PSIQUIAT, V61, P746, DOI 10.1590/S0004-282X2003000500008; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; IMAJO T, 1992, AM J FOREN MED PATH, V13, P169; Imajo T, 1996, AM J FOREN MED PATH, V17, P324, DOI 10.1097/00000433-199612000-00010; Kalimo H, 2004, FORENSIC SCI INT, V146, P71, DOI 10.1016/j.forsciint.2004.06.021; Kalimo H, 2004, FORENSIC SCI INT, V146, P73, DOI 10.1016/j.forsciint.2004.06.022; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Omalu BI, 2004, AM J FOREN MED PATH, V25, P270, DOI 10.1097/01.paf.0000136642.17300.8b; Raisanen J, 1999, AM J FOREN MED PATH, V20, P70, DOI 10.1097/00000433-199903000-00017; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; Sawauchi S, 2007, NEUROL SURG TOKYO, V35, P665; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shkrum M.J., 2007, FORENSIC PATHOLOGY T; Smith C, 2003, ACTA NEUROPATHOL, V106, P97, DOI 10.1007/s00401-003-0703-4; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	31	11	12	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X			J FORENSIC LEG MED	J. Forensic Leg. Med.	NOV	2012	19	8					480	484		10.1016/j.jflm.2012.04.022			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	038QK	WOS:000311189000009	23084313				2022-02-06	
J	Hoarau, X; Richer, E; Dehail, P; Cuny, E				Hoarau, Xavier; Richer, Edwidge; Dehail, Patrick; Cuny, Emmanuel			Comparison of long-term outcomes of patients with severe traumatic or hypoxic brain injuries treated with intrathecal baclofen therapy for dysautonomia	BRAIN INJURY			English	Article						Severe traumatic brain injury; hypoxia; dysautonomia; spasticity; hypertonia; intrathecal baclofen therapy; outcome	ALLEVIATES AUTONOMIC DYSFUNCTION; SUPRASPINAL SPASTICITY; VEGETATIVE STATE; DIENCEPHALIC SEIZURES; FUNCTIONAL OUTCOMES; HEAD-INJURY; INFUSION; RECOVERY; HYPERTONIA; SCALE	Primary objective: To compare the long-term outcome of patients with severe traumatic brain injury and patients with hypoxic brain injury with dysautonomia and hypertonia treated with intrathecal baclofen therapy. Methods and procedures: Fifty-three patients with severe traumatic (n = 43/53) or hypoxic (n = 10/53) brain injuries treated by intrathecal baclofen therapy were included to be evaluated with the Coma Recovery Scale-Revised, the Barthel Index, the Glasgow Outcome Scale, the Ashworth scale, the scores of hypertonic attacks, of sweating episode and of voluntary motor responses. A retrospective analysis highlighted patients' characteristics at admission and before surgery and their complications. Main outcomes and results: After a mean follow-up time of 9.6 years, 13/53 (24.5%) patients had died. Alive patients with traumatic brain injury had a higher level of consciousness recovery (p<0.02) and more abilities in activities of daily living (p<0.008) in the long-term. Their dysautonomia and limb hypertonia also significantly improved, contrary to patients with hypoxic brain injury who needed higher doses of baclofen (p<0.03). Conclusions: At long-term follow-up, patients with hypoxic brain injury had a poorer functional outcome than patients with traumatic brain injury with persistent symptoms of dysautonomia associated with uncontrolled hypertonia, despite the use of intrathecal baclofen.	[Hoarau, Xavier; Cuny, Emmanuel] Hop Pellegrin, Serv Neurochirurg, F-33076 Bordeaux, France; [Hoarau, Xavier; Dehail, Patrick; Cuny, Emmanuel] Univ Bordeaux Segalen, F-33076 Bordeaux, France; [Richer, Edwidge] Ctr Reeduc, Chateau Rauze, Cenac, France; [Dehail, Patrick] Hop Pellegrin, Serv Reeduc Fonct, F-33076 Bordeaux, France		Cuny, E (corresponding author), Univ Bordeaux Segalen, Hop Pellegrin, CHU Bordeaux, Serv Neurochirurg B, Pl Amelie Raba Leon, F-33076 Bordeaux, France.	emmanuel.cuny@chu-bordeaux.fr	Dehail, Patrick/T-5081-2019				Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Becker R, 1999, J NEUROL NEUROSUR PS, V66, P114, DOI 10.1136/jnnp.66.1.114; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; COHADON F, 1993, NEUROCHIRURGIE, V39, P281; Condouret JPM, 1988, HEMIPLEGIE VASCULAIR, P45; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Dario A, 2002, ACTA NEUROL SCAND, V105, P83, DOI 10.1034/j.1600-0404.2002.1o042.x; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; FitzGerald A, 2010, BRAIN INJURY, V24, P1311, DOI 10.3109/02699052.2010.506864; Francisco GE, 2005, BRAIN INJURY, V19, P359, DOI 10.1080/02699050400003999; Francois B, 2001, J TRAUMA, V50, P158, DOI 10.1097/00005373-200101000-00035; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MAHONEY F I, 1965, Md State Med J, V14, P61; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; PARKIN AJ, 1987, CORTEX, V23, P655, DOI 10.1016/S0010-9452(87)80055-2; PENN RD, 1995, MOVEMENT DISORD, V10, P675, DOI 10.1002/mds.870100524; PENN RD, 1984, LANCET, V1, P1078; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Rawicki B, 1999, J NEUROSURG, V91, P733, DOI 10.3171/jns.1999.91.5.0733; Richard I, 2007, ACTA NEUROCHIR SUPPL, V97, P213; Rifici C, 1994, Funct Neurol, V9, P29; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Taira T, 2009, PROG BRAIN RES, V177, P317, DOI 10.1016/S0079-6123(09)17721-X; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188	45	11	13	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1451	1463		10.3109/02699052.2012.694564			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400006	22725634				2022-02-06	
J	Kholodenko, IV; Yarygin, KN; Gubsky, LV; Konieva, AA; Tairova, RT; Povarova, OV; Kholodenko, RV; Burunova, VV; Yarygin, VN; Skvortsova, VI				Kholodenko, I. V.; Yarygin, K. N.; Gubsky, L. V.; Konieva, A. A.; Tairova, R. T.; Povarova, O. V.; Kholodenko, R. V.; Burunova, V. V.; Yarygin, V. N.; Skvortsova, V. I.			Intravenous Xenotransplantation of Human Placental Mesenchymal Stem Cells to Rats: Comparative Analysis of Homing in Rat Brain in Two Models of Experimental Ischemic Stroke	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						placental mesenchymal stem cells; ischemic stroke; middle cerebral artery occlusion; migration; homing		Mesenchymal stem cells from human placenta obtained after term natural delivery were cultured and labeled with vital dye Dil of magnetic fluorescing microparticles. The labeled cells were transplanted intravenously to rats with occlusion of the median cerebral artery. Penetration of cells through the brain-blood barrier and their distribution in the brain of experimental animals were studied on serial cryostat sections. Two models of cerebral artery occlusion associated with different traumatic consequences were used. The efficiency of crossing the blood-brain barrier by transplanted cells, the number of mesenchymal cells attaining the ischemic focus and neurogenic zones, and the time of death of transplanted cells largely depended on the degree and nature of injury to the central nervous system, which should be taken into account when planning the experiments for evaluation of the effects of cell therapy on the models of neurological diseases and in clinical studies in the field of regenerative neurology.	[Kholodenko, I. V.; Yarygin, K. N.; Burunova, V. V.] Russian Acad Med Sci, VN Orekhovich Res Inst Biomed Chem, Moscow, Russia; [Gubsky, L. V.; Konieva, A. A.; Tairova, R. T.; Povarova, O. V.; Yarygin, V. N.; Skvortsova, V. I.] NI Pirogov Russian State Med Univ, Moscow, Russia; [Konieva, A. A.] Minist Hlth & Social Dev, N Ossetian State Med Acad, Vladikavkaz, Russia; [Kholodenko, R. V.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow, Russia		Yarygin, KN (corresponding author), Russian Acad Med Sci, VN Orekhovich Res Inst Biomed Chem, Moscow, Russia.	kyarygin@yandex.ru	Yarygin, Konstantin N/C-4047-2009; Kovrazhkina, Elena/AAR-2425-2021; Povarova, O. V./R-3090-2016; Kholodenko, Irina V/F-7313-2017; Kholodenko, Roman/S-8412-2017	Yarygin, Konstantin N/0000-0002-2261-851X; Kholodenko, Irina V/0000-0002-4079-5210; Kholodenko, Roman/0000-0001-6083-6588; Povarova, Oxana/0000-0003-1820-299X			Burunova V. V., 2010, KLETOCH TEKHNOL BIOL, P63; Cheglakov I. B., 2008, KLETOCH TEKHNOL BIOL, P73; Konieva A. A., 2010, KLETOCH TEKHNOL BIOL, P147; Leu S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-63; Skvortsova VI, 2009, ZH NEVROL PSIKHIATR, V109, P62; SKVORTSOVA VI, 2008, KLETOCH TEKHNOL BIOL, P14; Stocum D. L, 2006, REGENERATIVE BIOL ME, P448; Takano K, 1997, J NEUROL SCI, V153, P8, DOI 10.1016/S0022-510X(97)00184-6; Yarygin KN, 2012, ZH NEVROL PSIKHIATR, V112, P4; Yarygin KN, 2009, B EXP BIOL MED+, V148, P862, DOI 10.1007/s10517-010-0837-z	10	11	12	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4888	1573-8221		B EXP BIOL MED+	Bull. Exp. Biol. Med.	NOV	2012	154	1					118	123		10.1007/s10517-012-1890-6			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	050QW	WOS:000312070100032	23330106				2022-02-06	
J	Liao, CC; Chang, HC; Yeh, CC; Chou, YC; Chiu, WT; Chen, TL				Liao, Chien-Chang; Chang, Huai-Chia; Yeh, Chun-Chieh; Chou, Yi-Chun; Chiu, Wen-Ta; Chen, Ta-Liang			Socioeconomic deprivation and associated risk factors of traumatic brain injury in children	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Socioeconomic deprivation; low income; traumatic brain injury; children; mental disorders; epilepsy	DELIBERATE SELF-HARM; BIRTH COHORT; HELMET LEGISLATION; MENTAL-DISORDERS; HEAD-INJURIES; FAMILY BURDEN; UNITED-STATES; YOUNG-ADULTS; VIOLENCE; EPIDEMIOLOGY	BACKGROUND: This study aimed to investigate the relative risks of low income (family socioeconomic deprivation) and associated factors for traumatic brain injury (TBI) in children. METHODS: Using Taiwan National Health Insurance Research Database and adjusting the covariates, we conducted a population-based case-control study analyzing 8,291 pediatric patients, aged 0 year to 17 years, diagnosed with TBI, and 33,164 sex- and age-matched controls to study the association of low income and TBI. The relative risks of TBI for socioeconomically deprived children with various coexisted medical conditions were evaluated. RESULTS: After adjustment, pediatric population with low income were at increased risk of TBI (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.52-1.92). Among the coexisting medical conditions, low-income pediatric population with mental disorders had significantly increased TBI risk when compared with matched controls (adjusted OR, 1.99; 95% CI, 1.51-2.63). Increased risk of TBI was also found in low-income children with epilepsy when compared with children of regular family income (adjusted OR, 3.11; 95% CI, 1.65-5.86). The adjusted OR of TBI for low-income children with mental disorders and epilepsy was as high as 4.45 (95% CI, 1.96-10.1). Among TBI patients, low-income children who had epilepsy were at significantly higher risk of post-TBI intracranial hemorrhage when compared with controls (OR, 10.6; 95% CI, 3.30-33.9). CONCLUSION: We found a significantly increased risk of TBI in socioeconomically deprived children, particularly among children with mental disorders, epilepsy, or both. Low-income children should be considered for special attention to reduce TBI risk and post-TBI morbidities. (J Trauma Acute Care Surg. 2012;73: 1327-1331. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Liao, Chien-Chang; Chang, Huai-Chia; Chen, Ta-Liang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chang; Chang, Huai-Chia; Chen, Ta-Liang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Liao, Chien-Chang; Chang, Huai-Chia; Chen, Ta-Liang] Taipei Med Univ, Sch Med, Taipei 11031, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Chou, Yi-Chun] China Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 11031, Taiwan		Chen, TL (corresponding author), Taipei Med Univ, Ctr Hlth Policy Res, 250 Wuxing St, Taipei 11031, Taiwan.	tlc@tmu.edu.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	Taipei Medical University Hospital's institutional and/or departmental sources	Taipei Medical University Hospital's institutional and/or departmental sources provided all the support for this study. No potential conflict of interest relevant to this article was reported.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Batty GD, 2009, AM J EPIDEMIOL, V169, P606, DOI 10.1093/aje/kwn381; Berger LM, 2005, CHILD ABUSE NEGLECT, V29, P107, DOI 10.1016/j.chiabu.2004.02.006; Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Heaney DC, 2002, BMJ-BRIT MED J, V325, P1013, DOI 10.1136/bmj.325.7371.1013; Howard L, 2007, BRIT J PSYCHIAT, V190, P129, DOI 10.1192/bjp.bp.106.023671; Joo JH, 2002, J CLIN PSYCHIAT, V63, P936, DOI 10.4088/JCP.v63n1012; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Liperoti R, 2007, J CLIN PSYCHIAT, V68, P929, DOI 10.4088/JCP.v68n0616; MacLean WE, 2010, J PEDIATR-US, V157, P979, DOI 10.1016/j.jpeds.2010.05.052; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; Max JE, 1998, BRAIN INJURY, V12, P41; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Olfson M, 2005, ARCH GEN PSYCHIAT, V62, P1122, DOI 10.1001/archpsyc.62.10.1122; Parkin PC, 2003, PEDIATRICS, V112, pE192, DOI 10.1542/peds.112.3.e192; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Scoliers G, 2009, SOC PSYCH PSYCH EPID, V44, P601, DOI 10.1007/s00127-008-0469-z; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Stratton G, 2007, OBESITY, V15, P1513, DOI 10.1038/oby.2007.179; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wu Q, 2010, OSTEOPOROSIS INT, V21, P1627, DOI 10.1007/s00198-010-1181-x; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	37	11	11	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2012	73	5					1327	1331		10.1097/TA.0b013e31826fc87f			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	043VF	WOS:000311577100053	23117388				2022-02-06	
J	Moriarity, JM; Pietrzak, RH; Kutcher, JS; Clausen, MH; McAward, K; Darby, DG				Moriarity, James M.; Pietrzak, Robert H.; Kutcher, Jeffrey S.; Clausen, Margaretha Helen; McAward, Kevin; Darby, David G.			Unrecognised ringside concussive injury in amateur boxers	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article								Objectives Concussion is common in contact sports such as boxing. Diagnosis of concussion depends on symptom report or recognition of clinical features, and true incidence may be underestimated. Persistent morbidity is a possible risk of repeated or unrecognised concussion. This study aimed to evaluate pre and postbout cognitive performance in motivated amateur boxers in order to detect objective evidence of unrecognised cognitive impairment suggestive of concussive injury. Methods The study employed a prospective and observational design. Participants were amateur boxers who won at least one bout in a single elimination competition. Optimal preparticipation performance using a computerised cognitive assessment tool (CCAT, Axon Sports) and no significant deterioration in cognitive performance within 24 h postbout were required to compete. All boxers were screened for clinical evidence of concussion by a ringside physician. Results Of approximately 200 competing boxers, 96 were eligible having won at least one of the total 160 bouts. Mean age was 21.3 (SD 1.9) years (range 18.5-29.7). Of these, 17 (10.6%) failed their first postbout CCAT, with 12 (71%) passing a repeat test. Of the five remaining boxers, there were two boxers (1.3% of bouts) not suspected of a concussion after their bouts, who showed evolving slowing in cognitive performance typical of a concussion. Conclusions Cognitive impairment, as detected by subtle deterioration in reaction time measures, can occur in amateur boxers postbout that is not recognised at ringside. Although the vast majority of bouts were conducted safely, unrecognised injury may occur and be detectable using objective computerised cognitive assessment.	[Darby, David G.] Univ Melbourne, Mental Hlth Res Inst, Natl Neurosci Facil, Parkville, Vic 3010, Australia; [Moriarity, James M.; McAward, Kevin] Univ Notre Dame, Athlet Dept, Notre Dame, IN 46556 USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Kutcher, Jeffrey S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Clausen, Margaretha Helen] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia		Darby, DG (corresponding author), Univ Melbourne, Mental Hlth Res Inst, Natl Neurosci Facil, Level 3,Alan Gilbert Bldg, Parkville, Vic 3010, Australia.	ddarby@unimelb.edu.au			Cogstate Ltd.	Dr Darby is a shareholder and consultant for CogState Ltd, and neurologist employed in academic and private practice. Dr Moriarity is a sports physician employed at the University of Notre Dame, and consultant for Axon Sports. Dr McCrory is a neurologist, and received research and educational funding from Cogstate Ltd. Dr Pietrzak is a neuropsychologist and consultant for CogState Ltd. Dr Kutcher is Sports Section Chair for the American Academy of Neurology. Dr Clausen is a neuropsychologist. Dr McAward is a sports physician employed at the University of Notre Dame.		0	11	11	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	NOV	2012	46	14					1011	1015		10.1136/bjsports-2011-090893			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	027MX	WOS:000310357900011	22547563				2022-02-06	
J	Hung, NN				Nguyen Ngoc Hung			Traumatic hip dislocation in children	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						femoral head necrosis; hip dislocation; hip fractures; multiple injuries; osteoarthritis	CHILDHOOD; NECROSIS; REDUCTION	The aim of this study was to evaluate the outcomes of reduction in the treatment of traumatic posterior hip dislocation in children. Data of 22 pediatric patients (22 hips) with traumatic hip dislocation from January 1995 to December 2007 were analyzed. The clinical evaluation focused on symptoms, physical findings, and range of motion. Radiographs identified the type of hip dislocation. The hip dislocation classification was based on Thompson and Epstein. The reduction procedure was performed according to three variants: variant 1, closed reduction; variant 2, release of the adductor longus, lengthening of the psoas tendon, and insertion of a Kirschner wire through the femoral head into the acetabulum; and variant 3, removal of the soft-tissue interposition of the hip. After reduction, radiography was used to determine whether the hip is concentric and to check whether any other injuries might have been caused after manipulation. There were six females (27.3%) and 16 males (72.7%) in this study. All had type I posterior dislocation of the hip. The ages of the patients at diagnosis ranged from 3 years, 2 months to 9 years, 10 months. The reduction procedure was performed according to variant 1 in 16, variant 2 in five, and variant 3 in one. We attained excellent results in eight hips (36.4%), good results in seven hips (31.8%), fair results in four hips (18.2%), and poor results in three hips (13.6%). There was avascular necrosis in three hips (13.6%), coxa magna in two hips (9.1%), deficient limb of 2 cm in two hips (9.1%), and a limp in two hips (9.1%). The hip scores were 82.4 points on average (range 62-100). Children with traumatic hip dislocation should undergo reduction as soon as possible. If the interval from injury to reduction exceeds 3 weeks, we suggest that the surgeon release the adductor longus, lengthen the psoas tendon, and insert a Kirschner wire. This simple and safe surgical procedure results in marked improvement in hip function and prevents complications later. J Pediatr Orthop B 21:542-551 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	Vietnam Natl Hosp Pediat, Hanoi, Vietnam		Hung, NN (corresponding author), Vietnam Natl Hosp Pediat, 18-879 La Thanh Rd, Hanoi, Vietnam.	ngocyenhung@gmail.com					AHMADI B, 1985, CLIN ORTHOP RELAT R, V175, P209; Banks SW, 1941, J BONE JOINT SURG, V23, P753; Banskota AK, 2007, J PEDIATR ORTHOPED, V27, P187, DOI 10.1097/BPO.0b013e31802c547e; BARQUET A, 1979, ACTA ORTHOP SCAND, V50, P549, DOI 10.3109/17453677908989803; BARQUET A, 1982, ACTA ORTHOP SCAND, V53, P815, DOI 10.3109/17453678208992299; BUCHANAN JJ, 1920, SURG GYNECOL OBSTET, V31, P462; BUNNELL WP, 1980, CLIN ORTHOP RELAT R, V147, P160; Choyce CC, 1924, BRIT J SURG, V12, P52, DOI 10.1002/bjs.1800124507; Dale BR, 2001, ROCKWOOD WILKIN FRAC, P929; El-Mowafi Hani, 2005, Acta Orthop Belg, V71, P686; EPSTEIN HC, 1974, J BONE JOINT SURG AM, VA 56, P1103, DOI 10.2106/00004623-197456060-00001; FREEMAN GE, 1961, J BONE JOINT SURG AM, V43, P401, DOI 10.2106/00004623-196143030-00007; GARRETT JC, 1979, J BONE JOINT SURG AM, V61, P2, DOI 10.2106/00004623-197961010-00002; GHORMLEY RK, 1953, AM J SURG, V85, P298, DOI 10.1016/0002-9610(53)90613-8; GLASS A, 1961, J BONE JOINT SURG BR, V43, P29; Hamilton PR, 1998, J PEDIATR ORTHOPED, V18, P691; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Huckstep RL, 1971, J BONE JOINT SURG BR, V53-B, P338; Kumar JN, 2009, ARCH ORTHOP TRAUM SU, V129, P823, DOI 10.1007/s00402-008-0735-2; Kumar S, 2005, CLIN ORTHOP RELAT R, P9, DOI 10.1097/01.blo.0000152366.58660.ea; Kumar S, 1999, ACTA ORTHOP SCAND, V70, P599, DOI 10.3109/17453679908997849; Mehlman CT, 2000, CLIN ORTHOP RELAT R, P68; Mirzatolooei F, 2009, ACTA ORTHOP TRAUMATO, V43, P532, DOI 10.3944/AOTT.2009.532; Nishino M, 1997, ARCH ORTHOP TRAUM SU, V116, P259, DOI 10.1007/BF00390048; OFFIERSKI CM, 1981, J BONE JOINT SURG BR, V63, P194, DOI 10.1302/0301-620X.63B2.7217141; PAI VS, 1992, INT ORTHOP, V16, P136, DOI 10.1007/BF00180204; PATERSON I, 1957, J BONE JOINT SURG BR, V39, P306, DOI 10.1302/0301-620X.39B2.306; PEARSON DE, 1973, CLIN ORTHOP RELAT R, P189; Pennsylvania Orthopedic Society, 1968, J BONE JOINT SURG AM, V50A, P79; RIEGER H, 1991, ARCH ORTHOP TRAUM SU, V110, P114, DOI 10.1007/BF00393886; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; Salcedo JD, 2010, ACTA ORTOP MEX, V24, P258; Salisbury RD, 2000, CLIN ORTHOP RELAT R, P106; SCHLONSKY J, 1973, J BONE JOINT SURG AM, VA 55, P1057, DOI 10.2106/00004623-197355050-00015; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; Varma BP, 1975, INDIAN J ORTHOP, V9, P69; YANG RS, 1991, CLIN ORTHOP RELAT R, P218; Yue JJ, 1996, J ORTHOP TRAUMA, V10, P447, DOI 10.1097/00005131-199610000-00001; Zrig M, 2009, ACTA ORTHOP BELG, V75, P328	39	11	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	NOV	2012	21	6					542	551		10.1097/BPB.0b013e328356371b			10	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	016IF	WOS:000309510500012	22751480				2022-02-06	
J	Zheng, ZL; Sanchez-Porras, R; Santos, E; Unterberg, AW; Sakowitz, OW				Zheng, Zelong; Sanchez-Porras, Renan; Santos, Edgar; Unterberg, Andreas W.; Sakowitz, Oliver W.			Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: From Vascular Spasm to Cortical Spreading Depolarizations	CURRENT NEUROVASCULAR RESEARCH			English	Article						Cerebral vasospasm; cortical spreading depolarization; delayed cerebral ischemia; spreading ischemia; subarachnoid hemorrhage; treatment	RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; ACUTE BRAIN-INJURY; TRIPLE-H THERAPY; BLOOD-FLOW; DOUBLE-BLIND; CLINICAL-TRIAL; CEREBROSPINAL-FLUID; MAGNESIUM-SULFATE; PERIINFARCT DEPOLARIZATIONS	Non-traumatic subarachnoid hemorrhage (SAH) represents about 5 to 6% of the overall incidence of stroke and is associated with high morbidity and mortality. Despite the substantial research and clinical efforts, delayed cerebral ischemia (DCI) is still the major complication after SAH and represents an important factor for severe neurological deficits. Cerebral vasospasm (VSP) has been recognised for a long time as an important underlying pathophysiologic cause of DCI, but it is now clearer that the mechanisms underlying DCI are multifactorial. Among other pathomechanisms proposed, ischemia-producing cortical spreading depolarizations (CSDs) are likely to be involved in DCI development. Understanding the plethora of different pathophysiological derangements after SAH is very important for the development of new therapies, in order to abolish secondary ischemic brain injuries early-on and improve patients' outcome. In this review, we strive to summarise the mechanisms and therapeutic developments of DCI.	[Zheng, Zelong; Sanchez-Porras, Renan; Santos, Edgar; Unterberg, Andreas W.; Sakowitz, Oliver W.] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany		Sanchez-Porras, R (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	renan.sanchez-porras@med.uni-heidelberg.de	Santos, Edgar/AAV-2506-2021	Santos, Edgar/0000-0002-8976-5549; Sakowitz, Oliver/0000-0003-3248-6335; Sanchez-Porras, Renan/0000-0002-9084-8114			ABE K, 1994, J CLIN ANESTH, V6, P99, DOI 10.1016/0952-8180(94)90004-3; Agrawal A, 2009, MINIM INVAS NEUROSUR, V52, P5, DOI 10.1055/s-0028-1085454; Al-Tamimi YZ, 2012, STROKE, V43, P677, DOI 10.1161/STROKEAHA.111.625731; ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; Bardutzky J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-203; Beaulieu C, 2000, MAGN RESON MED, V44, P110; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Birk S, 2004, J CEREBR BLOOD F MET, V24, P1352, DOI 10.1097/01.WCB.0000143536.22131.D7; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; BROUWERS PJAM, 1993, STROKE, V24, P809, DOI 10.1161/01.STR.24.6.809; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Castanares-Zapatero D, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-12; Choi HA, 2012, NEUROCRIT CARE, V16, P363, DOI 10.1007/s12028-012-9670-8; CLARK FL, 1989, J NEUROSURG, V70, P657; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dankbaar JW, 2010, CRIT CARE, V14, DOI 10.1186/cc8886; Dankbaar JW, 2009, NEURORADIOLOGY, V51, P813, DOI 10.1007/s00234-009-0575-y; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 2002, NEUROSURGERY, V51, P1457, DOI 10.1097/00006123-200212000-00017; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Egge A, 2001, NEUROSURGERY, V49, P593, DOI 10.1097/00006123-200109000-00012; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Fathi AR, 2011, J NEUROSURG, V115, P1213, DOI 10.3171/2011.7.JNS11390; Feigin VL, 1998, NEUROLOGY, V50, P876, DOI 10.1212/WNL.50.4.876; Frijns CJM, 2006, J NEUROL NEUROSUR PS, V77, P77, DOI 10.1136/jnnp.2005.064956; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Giller CA, 1998, NEUROSURGERY, V42, P490, DOI 10.1097/00006123-199803000-00010; GORELOVA NA, 1987, ELECTROEN CLIN NEURO, V66, P440, DOI 10.1016/0013-4694(87)90213-6; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Haghir H, 2009, NEUROSCIENCE, V163, P1340, DOI 10.1016/j.neuroscience.2009.07.067; HASHI K, 1972, J NEUROL SCI, V17, P15, DOI 10.1016/0022-510X(72)90017-2; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; HERZ DA, 1975, STROKE, V6, P417, DOI 10.1161/01.STR.6.4.417; Hirashima Y, 1997, NEUROCHEM RES, V22, P1249, DOI 10.1023/A:1021985030331; Hirashima Y, 1997, STROKE, V28, P1666, DOI 10.1161/01.STR.28.9.1666; HUBSCHMANN OR, 1980, J NEUROSURG, V52, P456, DOI 10.3171/jns.1980.52.4.0456; Huh PW, 1998, BRAIN RES, V804, P105, DOI 10.1016/S0006-8993(98)00674-X; Hui C, 2005, CLIN RADIOL, V60, P1030, DOI 10.1016/j.crad.2005.04.004; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; Jost SC, 2005, J NEUROSURG, V103, P25, DOI 10.3171/jns.2005.103.1.0025; KAMIYA K, 1983, J NEUROSURG, V59, P917, DOI 10.3171/jns.1983.59.6.0917; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KASUYA H, 2011, ACTA NEUROCHIR SUPPL, V2, P165, DOI DOI 10.1007/978-3-7091-0356-2_30; KAUBE H, 1994, EUR NEUROL, V34, P30, DOI 10.1159/000117004; Klimo P, 2004, J NEUROSURG, V100, P215, DOI 10.3171/jns.2004.100.2.0215; Koshimura K, 1999, J NEUROCHEM, V72, P2565, DOI 10.1046/j.1471-4159.1999.0722565.x; Kumral A, 2003, BIOL NEONATE, V83, P224, DOI 10.1159/000068926; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lee KH, 2006, NEUROCRIT CARE, V4, P68, DOI 10.1385/NCC:4:1:068; Lennihan L, 2000, STROKE, V31, P383, DOI 10.1161/01.STR.31.2.383; LEVITT P, 1971, J NEUROSURG, V35, P185, DOI 10.3171/jns.1971.35.2.0185; Liu GJ, 2012, EUR J CLIN PHARMACOL, V68, P131, DOI 10.1007/s00228-011-1100-x; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2012, STROKE, V43, P1463, DOI 10.1161/STROKEAHA.111.648980; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; MEE E, 1988, NEUROSURGERY, V22, P484, DOI 10.1227/00006123-198803000-00006; Muroi C, 2012, CURR OPIN CRIT CARE, V18, P119, DOI 10.1097/MCC.0b013e32835075ae; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Ohkuma H, 2000, STROKE, V31, P1621, DOI 10.1161/01.STR.31.7.1621; OKAMOTO S, 1984, STROKE, V15, P60, DOI 10.1161/01.STR.15.1.60; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; PETRUK KC, 1988, J NEUROSURG, V68, P505, DOI 10.3171/jns.1988.68.4.0505; PHILIPPON J, 1986, ACTA NEUROCHIR, V82, P110, DOI 10.1007/BF01456369; Pluta RM, 1998, J NEUROSURG, V88, P557, DOI 10.3171/jns.1998.88.3.0557; Rabinstein AA, 2005, STROKE, V36, P992, DOI 10.1161/01.STR.0000163090.59350.5a; Rabinstein AA, 2010, LANCET NEUROL, V9, P504, DOI 10.1016/S1474-4422(10)70087-9; Richter F, 2002, NEUROSCI LETT, V334, P123, DOI 10.1016/S0304-3940(02)01120-5; Sakowitz OW, 2006, CURR OPIN CRIT CARE, V12, P103, DOI 10.1097/01.ccx.0000216575.03815.ee; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Sakowitz OW, 2006, NEUROSURGERY, V58, P137, DOI 10.1227/01.NEU.0000194532.47239.7C; Sasaki T, 2009, NEUROSCI LETT, V449, P61, DOI 10.1016/j.neulet.2008.10.054; Schmidt U, 2010, ANESTH ANALG, V110, P895, DOI 10.1213/ANE.0b013e3181cc9ed8; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; SHIBUYA M, 1992, J NEUROSURG, V76, P571, DOI 10.3171/jns.1992.76.4.0571; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Siironen J, 2003, J NEUROSURG, V99, P953, DOI 10.3171/jns.2003.99.6.0953; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Springborg JB, 2007, ACTA NEUROCHIR, V149, P1089, DOI 10.1007/s00701-007-1284-z; Strong AJ, 2005, ADV TECH STAND NEUR, V30, P3, DOI 10.1007/3-211-27208-9_1; Strong AJ, 2007, CURR OPIN CRIT CARE, V13, P126, DOI 10.1097/MCC.0b013e32807faffb; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Suarez JI, 2004, J NEUROSURG, V100, P585, DOI 10.3171/jns.2004.100.4.0585; Suarez JI, 2012, STROKE, V43, P683, DOI 10.1161/STROKEAHA.111.633958; Suarez JI, 2011, NEUROCRIT CARE, V15, P302, DOI 10.1007/s12028-011-9603-y; Suzuki M, 1999, NEUROSURGERY, V44, P487, DOI 10.1097/00006123-199903000-00029; SUZUKI S, 1990, Neurologia Medico-Chirurgica, V30, P309, DOI 10.2176/nmc.30.309; TODA N, 1988, J CEREBR BLOOD F MET, V8, P46, DOI 10.1038/jcbfm.1988.7; Tseng MY, 2011, NEUROCRIT CARE, V15, P298, DOI 10.1007/s12028-011-9596-6; Tseng MY, 2009, J NEUROSURG, V111, P171, DOI 10.3171/2009.3.JNS081332; Uhl E, 2003, NEUROSURGERY, V52, P1307, DOI 10.1227/01.NEU.0000065154.04824.9E; van den Bergh WM, 2006, STROKE, V37, P2326, DOI 10.1161/01.STR.0000236841.16055.0f; van den Bergh WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57; van den Bergh WM, 2003, ACTA NEUROCHIR, V145, P195, DOI 10.1007/s00701-002-1064-9; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74; Vergouwen MDI, 2010, STROKE, V41, pE47, DOI 10.1161/STROKEAHA.109.556332; WELLUM GR, 1980, J NEUROSURG, V53, P486, DOI 10.3171/jns.1980.53.4.0486; Welters ID, 2010, ANESTH ANALG, V110, P934, DOI 10.1213/ANE.0b013e3181c95cfa; WIERNSPERGER N, 1981, STROKE, V12, P624, DOI 10.1161/01.STR.12.5.624; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169; Wong GKC, 2010, STROKE, V41, P921, DOI 10.1161/STROKEAHA.109.571125; Yamamoto S, 1998, BRAIN RES, V782, P194, DOI 10.1016/S0006-8993(97)01278-X; Zhang SH, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006778.pub2; Zwienenberg-Lee M, 2008, STROKE, V39, P1759, DOI 10.1161/STROKEAHA.107.502666	112	11	11	0	13	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026			CURR NEUROVASC RES	Curr. Neurovasc. Res.	NOV	2012	9	4					310	319		10.2174/156720212803530663			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022OG	WOS:000309968100011	22873726				2022-02-06	
J	Davceva, N; Janevska, V; Ilievski, B; Spasevska, L; Popeska, Z				Davceva, N.; Janevska, V.; Ilievski, B.; Spasevska, L.; Popeska, Z.			Dilemmas concerning the diffuse axonal injury as a clinicopathological entity in forensic medical practice	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Diffuse axonal injury; Closed head injuries; Traumatic brain damage; Diffuse brain damage	AMYLOID PRECURSOR PROTEIN; BETA-APP IMMUNOREACTIVITY; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; DIAGNOSIS; ASSAULT; IMMUNOHISTOCHEMISTRY; MARKER; ADULTS; DAMAGE	Dilemmas and discussions concerning the diffuse axonal injury (DAI) and still existing in forensic medical practice are as it follows: 1. Whether the occurrence of DAI can indicate the type of traumatic event that has caused the head trauma, 2. Whether the presence of axonal damage in cases of hypoxia, ischaemia and other pathological conditions casts a shadow on the post-mortem pathological diagnosis of DAI and totally negates it, or there are certain clues in the findings that can point to the aetiology of the axonal damage. This paper discusses our findings based on neuropathological examination of 60 forensic cases of closed head injury. The neuropathological examination included: a macroscopic examination of the coronal sections and a microscopic examination involving an immunohistochemical method with antibody against beta-amyloid precursor protein. Our findings indicate that DAI, as a clinicopathological entity, is undoubtedly an acceleration-deceleration injury, predominant in road traffic accidents as it is classically outlined, and cases of falling from a considerable height. Our findings point to a certain difference between the features of traumatic and ischaemic axonal damage. In this paper we also investigate the correlation between pathological grades of DAI and the impairment of the brain function before death. (C) 2012 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Davceva, N.] Fac Med, Inst Forens Med Criminol & Med Deontol, Skopje 1000, Macedonia; [Janevska, V.; Ilievski, B.; Spasevska, L.] Fac Med, Inst Pathol, Div 50, Skopje 1000, Macedonia; [Popeska, Z.] Fac Nat Sci, Inst Informat, Skopje 1000, Macedonia		Davceva, N (corresponding author), Fac Med, Inst Forens Med Criminol & Med Deontol, Vodnjanska 19, Skopje 1000, Macedonia.	drdavcevamk@yahoo.com	Janevska, Vesna/AAG-4065-2021	Janevska, Vesna/0000-0001-6138-4448; Davceva, Natasha/0000-0001-8174-3145			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; IMAJO T, 1992, AM J FOREN MED PATH, V13, P169; Imajo T, 1996, AM J FOREN MED PATH, V17, P324, DOI 10.1097/00000433-199612000-00010; IMAJO T, 1987, AM J FOREN MED PATH, V8, P217, DOI 10.1097/00000433-198708030-00004; Kalimo H, 2004, FORENSIC SCI INT, V146, P73, DOI 10.1016/j.forsciint.2004.06.022; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Niess C, 2002, ACTA NEUROPATHOL, V104, P79, DOI 10.1007/s00401-002-0525-9; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Smith C, 2003, ACTA NEUROPATHOL, V106, P97, DOI 10.1007/s00401-003-0703-4; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071	24	11	15	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X			J FORENSIC LEG MED	J. Forensic Leg. Med.	OCT	2012	19	7					413	418		10.1016/j.jflm.2012.04.011			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	000DM	WOS:000308366700009	22920765				2022-02-06	
J	Hammond, FM; Davis, CS; Cook, JR; Philbrick, P; Hirsch, MA				Hammond, Flora M.; Davis, Christine S.; Cook, James R.; Philbrick, Peggy; Hirsch, Mark A.			Relational dimension of irritability following traumatic brain injury: A qualitative analysis	BRAIN INJURY			English	Article						Irritability; behaviour; aggression; brain injury; relationship; marriage; family	CLOSED-HEAD-INJURY; MARITAL ADJUSTMENT; AGGRESSION; PERSONALITY; DEPRESSION; CARBAMAZEPINE; MANAGEMENT; SYMPTOMS; RECOVERY; SEQUELAE	Background: Irritability is a common long-term sequelae of traumatic brain injury (TBI). In a prior study on TBI irritability, relational interactions were one of four dimensions of irritability occurrence and precipitation. This present analysis examines these same data in greater detail. Methods: Fifty focus group transcripts from a study on irritability were re-analysed to examine: (1) irritability in spousal relationships following TBI, (2) retrospective accounts of spousal interactions contributing to irritability and (3) impact of irritability on marital relationships. Grounded Theory was used to develop themes, metacodes and theories. Results: Several theories emerged regarding irritability with respect to spousal relations, all based on the overarching theory that irritability in people with TBI has a strong relational component involved in triggering, experiencing and preventing irritability. Sub-theories supporting this include: (1) irritability breeds further irritability, (2) spousal responses can trigger irritability among persons with TBI and vice versa, (3) difficulties making emotional connections may incite negative interactions, (4) expectations of others may contribute to irritable behaviour, and (5) communication breakdowns may provoke irritability. Conclusions: Irritability associated with TBI resides in the family system as well as the individual. In treating irritability one should include comprehensive assessment and assistance to improve interpersonal interactions.	[Hammond, Flora M.; Philbrick, Peggy; Hirsch, Mark A.] Carolinas Healthcare Syst, Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Davis, Christine S.; Hirsch, Mark A.] Univ N Carolina, Dept Commun Studies, Charlotte, NC 28223 USA; [Cook, James R.] Univ N Carolina, Dept Psychol, Charlotte, NC 28223 USA		Hammond, FM (corresponding author), 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com	Hirsch, Mark A./D-2798-2016; Davis, Christine/K-4850-2019	Hirsch, Mark A./0000-0002-8997-7971; 	US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability Rehabilitation and Research [H133A20016]	This study was partially supported by US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability Rehabilitation and Research grant H133A20016.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arciniegas, 2000, Curr Treat Options Neurol, V2, P169; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Charmaz K, 2000, GROUNDED THEORY OBJE, P509; ChathamShowalter PE, 1996, J NEUROPSYCH CLIN N, V8, P96; CRONHOLM B, 1972, Scandinavian Journal of Rehabilitation Medicine, V4, P35; Davis C, 2010, BRAIN INJURY, V24, P210; Davis CS, 2010, STRAIGHT TALK COMMUN; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Foley D, 2000, CRITICAL ETHNOGRAPHY, P217; GALBRAITH S, 1985, BRIT MED J, V291, P1668, DOI 10.1136/bmj.291.6510.1668; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Glaser B., 1967, DISCOVERY GROUNDED T; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Greve KW, 2001, BRAIN INJURY, V15, P255; Gualtieri C T, 1990, J Child Adolesc Psychopharmacol, V1, P149, DOI 10.1089/cap.1990.1.149; Hammond F, 2006, J HEAD TRAUMA REHAB, V21, P412, DOI 10.1097/00001199-200609000-00014; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Harris JKJ, 2001, BRAIN INJURY, V15, P223; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; Hurley Robin A., 2002, Curr Treat Options Neurol, V4, P59, DOI 10.1007/s11940-002-0005-5; Kant R, 1998, BRAIN INJURY, V12, P661, DOI 10.1080/026990598122223; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Kim KY, 2001, PHARMACOTHERAPY, V21, P498, DOI 10.1592/phco.21.5.498.34504; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; LEWIN J, 1992, BRIT J PSYCHIAT, V161, P261, DOI 10.1192/bjp.161.2.261; Lindlof T.L., 2002, QUALITATIVE COMMUNIC; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; LISHMAN WA, 1978, IRISH MED J, V71, P306; Long CJ, 1995, P 27 SCI M ASS MAR L, P35; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McIntyre A., 2008, QUALITATIVE RES METH, V52, P15; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; MIDDELBOE T, 1992, J PERS DISORD, V6, P246, DOI 10.1521/pedi.1992.6.3.246; National Institute of Neurological Disorders and Stroke, 2002, NIH PUBL, V02-158; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Obonsawain MC, J NEUROLOGY NEUROSUR, V78, P1239; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; ROHRBAUGH RM, 1988, J AM GERIATR SOC, V36, P736, DOI 10.1111/j.1532-5415.1988.tb07177.x; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; SNAITH RP, 1985, BRIT J PSYCHIAT, V147, P127, DOI 10.1192/bjp.147.2.127; Stoep AV, 1991, J BEHAV HLTH SCI RES, V26, P329; Strauss A., 1990, BASICS QUALITATIVE R; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791	69	11	11	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2012	26	11					1287	1296		10.3109/02699052.2012.706352			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	005AQ	WOS:000308723100002	22897407				2022-02-06	
J	Lanier, WL				Lanier, William L.			The History of Neuroanesthesiology The People, Pursuits, and Practices	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						neuroanesthesiology; history; cerebral ischemia; cerebral physiology; general anesthesia; cerebral protection; SNACC; Society for Neuroscience in Anesthesiology and Critical Care	COMPLETE CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; VENOUS AIR-EMBOLISM; TRANS-ESOPHAGEAL ECHOCARDIOGRAPHY; INTRACRANIAL ANEURYSM SURGERY; HIGH-ENERGY PHOSPHATES; SPINAL-CORD ISCHEMIA; BLOOD-FLOW; CARDIAC-ARREST; NITROUS-OXIDE	Neuroanesthesiology has a rich history. Although advances in research and clinical practice were cornerstones for the development of this field, other equally critical factors came into play. These include the development of subspecialty societies, formal dissemination of information through textbooks and journal publications, and, most importantly, strong leadership. This article reviews important advances within the subspecialty and many individuals behind those advances. The analysis and speculative synthesis provide insights into the current status of neuroanesthesiology and possible directions for the subspecialty's future.	Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN 55905 USA		Lanier, WL (corresponding author), Mayo Clin, Coll Med, Dept Anesthesiol, 200 1st St SW, Rochester, MN 55905 USA.	lanier.william@mayo.edu					ABRAMSON NS, 1986, NEW ENGL J MED, V314, P397; Achrol AS, 2006, STROKE, V37, P231, DOI 10.1161/01.STR.0000195133.98378.4b; Aitken R R, 1974, Clin Neurosurg, V21, P107; Albin M S, 1989, J Neurosurg Anesthesiol, V1, P134, DOI 10.1097/00008506-198906000-00020; Albin MS, 1997, J NEUROSURG ANESTH, V9, P296, DOI 10.1097/00008506-199710000-00002; Albin MS, 1997, TXB NEUROANESTHESIA; ALBRECHT RF, 1987, STROKE, V18, P649, DOI 10.1161/01.STR.18.3.649; [Anonymous], 1957, ANESTHESIOLOGY, V18, P904; [Anonymous], J NEUROSURGICAL ANES; ARCHER DP, 1988, CAN J ANAESTH, V35, P338, DOI 10.1007/BF03010852; ARCHER DP, 1987, ANESTHESIOLOGY, V67, P642, DOI 10.1097/00000542-198711000-00005; ARTRU AA, 1993, J NEUROSURG ANESTH, V5, P178; Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; BAUGHMAN VL, 1989, ANESTHESIOLOGY, V70, P767, DOI 10.1097/00000542-198905000-00011; BLACK S, 1988, ANESTHESIOLOGY, V69, P49, DOI 10.1097/00000542-198807000-00008; BLACK S, 1989, ANESTHESIOLOGY, V71, P235, DOI 10.1097/00000542-198908000-00012; Bloom MJ, 1996, INT ANESTHESIOL CLIN, V34, P137, DOI 10.1097/00004311-199603430-00008; Brambrink AM, 2010, J NEUROSURG ANESTH, V22, P186, DOI 10.1097/ANA.0b013e3181e0bfb0; BUNEGIN L, 1994, STROKE, V25, P593, DOI 10.1161/01.STR.25.3.593; BUNEGIN L, 1981, ANESTHESIOLOGY, V55, P343, DOI 10.1097/00000542-198110000-00003; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CASCINO GD, 1993, J CLIN NEUROPHYSIOL, V10, P520, DOI 10.1097/00004691-199310000-00010; Cenic A, 2000, ANESTH ANALG, V90, P1376, DOI 10.1097/00000539-200006000-00021; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Cottrell J, 1989, J NEUROSURG ANESTHES, V1, P1; Cottrell JE, 2008, ANESTHESIOLOGY, V109, P377, DOI 10.1097/ALN.0b013e31818344da; COTTRELL JE, 1978, NEW ENGL J MED, V298, P809, DOI 10.1056/NEJM197804132981502; COTTRELL JE, 1993, J NEUROSURG ANESTH, V5, P69; COTTRELL JE, 1980, ANESTHESIA NEUROSURG; CUCCHIARA RF, 1984, ANESTHESIOLOGY, V60, P353, DOI 10.1097/00000542-198404000-00013; CUCCHIARA RF, 1985, ANESTHESIOLOGY, V63, P107, DOI 10.1097/00000542-198507000-00019; Cucchiara RF, 1990, CLIN NEUROANESTHESIA; DAWSON B, 1971, ANESTH ANAL CURR RES, V50, P443; de Haan P, 1998, J NEUROSURG ANESTH, V10, P86, DOI 10.1097/00008506-199804000-00004; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; DRUMMOND JC, 1995, NEUROSURGERY, V37, P742, DOI 10.1227/00006123-199510000-00019; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; Erickson KM, 2009, J NEUROSURG ANESTH, V21, P307, DOI 10.1097/ANA.0b013e3181aa03eb; FAULCONER A, 1949, ANESTHESIOLOGY, V10, P601; FAY T, 1959, J NEUROSURG, V16, P239, DOI 10.3171/jns.1959.16.3.0239; Fong JJ, 2008, CRIT CARE MED, V36, P2281, DOI 10.1097/CCM.0b013e318180c1eb; Fox AJ, 1999, AM J NEURORADIOL, V20, P358; Frost EAM, 1997, TXB NEUROANESTHESIA, P1; GIGNAC E, 1993, CAN J ANAESTH, V40, P421, DOI 10.1007/BF03009510; Gordon E, 1975, MONOGRAPHS ANAESTHES, P354; GRONQVIST Y K J, 1952, Ann Chir Gynaecol Fenn, V41, P149; GRUNDY BL, 1981, ANESTHESIOLOGY, V55, P462, DOI 10.1097/00000542-198110000-00025; Herrick IA, 1997, ANESTH ANALG, V84, P1280, DOI 10.1097/00000539-199706000-00020; HICKEY R, 1986, STROKE, V17, P1183, DOI 10.1161/01.STR.17.6.1183; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Hindman BJ, 2011, ANESTHESIOLOGY, V114, P782, DOI 10.1097/ALN.0b013e3182104859; HOFFMAN WE, 1990, ANESTHESIOLOGY, V72, P1045, DOI 10.1097/00000542-199006000-00015; HOFFMAN WE, 1991, J NEUROSURG ANESTH, V3, P96, DOI 10.1097/00008506-199106000-00003; Hoffman WE, 1998, ANESTHESIOLOGY, V88, P1188, DOI 10.1097/00000542-199805000-00008; Holmes JM, 1999, INVEST OPHTH VIS SCI, V40, P804; Howard-Lech VL, 1999, PHYSIOL MEAS, V20, P75, DOI 10.1088/0967-3334/20/1/006; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P554, DOI 10.1097/00000542-198910000-00013; KALKMAN CJ, 1993, ACTA ORTHOP SCAND, V64, P114, DOI 10.3109/17453679308994549; Kawaguchi M, 2004, ANESTH ANALG, V98, P798; KIERSEY DK, 1954, ANESTHESIOLOGY, V15, P356, DOI 10.1097/00000542-195407000-00004; Kofke WA, 2012, J NEUROSURG ANESTH, V24, P260, DOI 10.1097/ANA.0b013e318268005b; KOFKE WA, 1989, ANESTHESIOLOGY, V71, P653, DOI 10.1097/00000542-198911000-00005; KURODA Y, 1993, ANESTH ANALG, V76, P222, DOI 10.1213/00000539-199302000-00004; Lam A, 1995, ANESTHETIC MANAGEMEN; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LAM AM, 1983, ANESTH ANALG, V62, P742; Lanier WL, 2009, ANESTHESIOLOGY, V110, P456, DOI 10.1097/ALN.0b013e3181983f21; Lanier WL, 1996, ANESTHESIOLOGY, V84, P605, DOI 10.1097/00000542-199603000-00016; LANIER WL, 1995, J NEUROSURG ANESTH, V7, P216, DOI 10.1097/00008506-199507000-00021; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; Lanier WL, 1996, ANESTHESIOLOGY, V84, P917, DOI 10.1097/00000542-199604000-00020; LANIER WL, 1986, ANESTHESIOLOGY, V64, P551, DOI 10.1097/00000542-198605000-00003; LANIER WL, 1989, ANESTHESIOLOGY, V71, P87, DOI 10.1097/00000542-198907000-00016; Lee LA, 2006, ANESTHESIOLOGY, V105, P652, DOI 10.1097/00000542-200610000-00007; Lennarson PJ, 2001, J NEUROSURG, V94, P265, DOI 10.3171/spi.2001.94.2.0265; MARSHALL WK, 1980, ANESTHESIOLOGY, V52, P131; Mashour GA, 2012, ANESTH ANALG, V114, P715, DOI 10.1213/ANE.0b013e3182455c96; MATJASKO MJ, 1987, NEUROSURGERY, V21, P378; Matsumoto M, 1997, ANESTHESIOLOGY, V86, P1120, DOI 10.1097/00000542-199705000-00016; MATTA BF, 1995, BRIT J ANAESTH, V74, P159, DOI 10.1093/bja/74.2.159; Mayer SA, 2006, NEUROCRIT CARE, V5, P159, DOI 10.1385/NCC:5:2:159; McGregor DG, 2008, ANESTHESIOLOGY, V108, P568, DOI 10.1097/ALN.0b013e31816721fa; MICHENFE.JD, 1974, ANESTHESIOLOGY, V41, P231, DOI 10.1097/00000542-197409000-00004; MICHENFE.JD, 1969, J AMER MED ASSOC, V208, P1353; MICHENFELDER JD, 1972, ANESTHESIOLOGY, V36, P164, DOI 10.1097/00000542-197202000-00018; MICHENFELDER JD, 1968, J SURG RES, V8, P475, DOI 10.1016/0022-4804(68)90111-X; MICHENFELDER JD, 1989, ANESTHESIOLOGY, V70, P695, DOI 10.1097/00000542-198904000-00026; MICHENFELDER JD, 1969, ANESTHESIOLOGY, V30, P65, DOI 10.1097/00000542-196901000-00021; Michenfelder JD, 2000, ART SCI DEP ANESTHES, P51; Michenfelder JD, 1988, ANESTHESIA BRAIN CLI, P28; MINTON MD, 1986, ANESTHESIOLOGY, V65, P165, DOI 10.1097/00000542-198608000-00006; MODICA PA, 1990, ANESTH ANALG, V70, P433; MODICA PA, 1990, ANESTH ANALG, V70, P303; NATALE JE, 1989, STROKE, V20, P770, DOI 10.1161/01.STR.20.6.770; Newfield P, 2012, HDB NEUROANESTHESIA; Newfield P, 1973, HDB NEUROANESTHESIA; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Noppens RR, 2009, J CEREBR BLOOD F MET, V29, P277, DOI 10.1038/jcbfm.2008.116; NUSSMEIER NA, 1986, ANESTHESIOLOGY, V64, P165, DOI 10.1097/00000542-198602000-00006; Olney JW, 2004, ANESTHESIOLOGY, V101, P273, DOI 10.1097/00000542-200408000-00004; Pasternak JJ, 2008, MAYO CLIN PROC, V83, P406, DOI 10.4065/83.4.406; Pasternak JJ, 2012, J NEUROSURG ANESTH, V24, P300, DOI 10.1097/ANA.0b013e318266b20d; Pasternak JJ, 2009, ANESTHESIOLOGY, V110, P563, DOI 10.1097/ALN.0b013e318197ff81; PERKINS WJ, 1991, STROKE, V22, P902, DOI 10.1161/01.STR.22.7.902; Polis TZ, 1997, ANESTHESIOL CLIN N A, V15, P691; PROUGH DS, 1991, ANESTH ANALG, V72, P161, DOI 10.1213/00000539-199102000-00004; PUGSLEY W, 1994, STROKE, V25, P1393, DOI 10.1161/01.STR.25.7.1393; RAVUSSIN P, 1985, CAN ANAESTH SOC J, V32, P506, DOI 10.1007/BF03010801; ROSOMOFF HL, 1963, ANESTHESIOLOGY, V24, P640, DOI 10.1097/00000542-196309000-00011; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; SAFAR P, 1958, JAMA-J AM MED ASSOC, V166, P1459, DOI 10.1001/jama.1958.02990120051010; SAFAR P, 1961, JAMA-J AM MED ASSOC, V176, P574, DOI 10.1001/jama.1961.03040200010003; SANO T, 1992, ANESTHESIOLOGY, V76, P221, DOI 10.1097/00000542-199202000-00011; Sari A, 1971, Masui, V20, P68; Sawin PD, 1996, ANESTHESIOLOGY, V85, P26, DOI 10.1097/00000542-199607000-00005; SCHOTT GD, 1993, J NEUROL NEUROSUR PS, V56, P329, DOI 10.1136/jnnp.56.4.329; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; Sloan TB, 2002, J CLIN NEUROPHYSIOL, V19, P430, DOI 10.1097/00004691-200210000-00006; SMITH AL, 1974, STROKE, V5, P1; Smith M, 2011, PHILOS T R SOC A, V369, P4452, DOI 10.1098/rsta.2011.0242; Soriano Sulpicio G, 2002, Anesthesiol Clin North Am, V20, P389, DOI 10.1016/S0889-8537(01)00008-6; Sprung J, 2012, MAYO CLIN PROC, V87, P120, DOI 10.1016/j.mayocp.2011.11.008; STEEN PA, 1983, ANESTHESIOLOGY, V58, P527, DOI 10.1097/00000542-198306000-00009; STEEN PA, 1979, STROKE, V10, P522, DOI 10.1161/01.STR.10.5.522; STEEN PA, 1985, ANESTHESIOLOGY, V62, P406, DOI 10.1097/00000542-198504000-00007; STEEN PA, 1980, ANESTHESIOLOGY, V52, P224, DOI 10.1097/00000542-198003000-00007; STIRT JA, 1987, ANESTHESIOLOGY, V67, P50, DOI 10.1097/00000542-198707000-00009; Sviri GE, 2006, NEUROSURGERY, V59, P360, DOI 10.1227/01.NEU.0000223502.93013.6E; Takeshita H, 1997, Masui, V46 Suppl, pS1; TAKEUCHI K, 1989, Neurosurgical Review, V12, P265, DOI 10.1007/BF01790660; Talmor D, 1998, ANESTH ANALG, V87, P574, DOI 10.1097/00000539-199809000-00014; TATEISHI A, 1989, STROKE, V20, P1044, DOI 10.1161/01.STR.20.8.1044; TATEISHI A, 1991, RESUSCITATION, V21, P191, DOI 10.1016/0300-9572(91)90046-2; TERRY HR, 1962, ANESTH ANALG, V41, P241; TODD MM, 1992, ANESTHESIOLOGY, V76, P161; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala Monica S, 2002, Int Anesthesiol Clin, V40, P69; WAGNER SR, 1994, ANESTHESIOLOGY, V81, P1516, DOI 10.1097/00000542-199412000-00028; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021; Wang H, 2006, ACTA NEUROCHIR, V148, P565, DOI 10.1007/s00701-006-0747-z; Wang MC, 2009, SPINE, V34, P955, DOI 10.1097/BRS.0b013e31819e2fd5; Warner DS, 2004, ANESTH ANALG, V98, P563, DOI 10.1213/01.ANE.0000111213.71914.54; WARNER DS, 1993, ANESTHESIOLOGY, V79, P985, DOI 10.1097/00000542-199311000-00017; Warner DS, 1996, ANESTHESIOLOGY, V84, P1475, DOI 10.1097/00000542-199606000-00024; WARNER DS, 1995, STROKE, V26, P655, DOI 10.1161/01.STR.26.4.655; Wass CT, 1996, ANESTHESIOLOGY, V84, P644, DOI 10.1097/00000542-199603000-00020; Wass CT, 1996, INT ANESTHESIOL CLIN, V34, P95, DOI 10.1097/00004311-199603440-00008; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013; Wass CT, 1996, MAYO CLIN PROC, V71, P801; Werner C, 1998, Curr Opin Anaesthesiol, V11, P459, DOI 10.1097/00001503-199810000-00002; WHITE RJ, 1964, NATURE, V202, P1082, DOI 10.1038/2021082a0; WHITE RJ, 1963, SCIENCE, V141, P1060, DOI 10.1126/science.141.3585.1060; WHITE RJ, 1965, SCIENCE, V150, P779, DOI 10.1126/science.150.3697.779; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; WOLLMAN H, 1965, ANESTHESIOLOGY, V26, P329, DOI 10.1097/00000542-196505000-00009; YOUNG WL, 1994, NEUROSURGERY, V34, P601, DOI 10.1227/00006123-199404000-00006; ZAIDAN JR, 1991, ANESTHESIOLOGY, V74, P406, DOI 10.1097/00000542-199103000-00003; Zhang SC, 1999, INVEST OPHTH VIS SCI, V40, P1305; Zornow M H, 1995, New Horiz, V3, P488; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	165	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2012	24	4					281	299		10.1097/ANA.0b013e3182697743			19	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	013GR	WOS:000309294400003	22955191				2022-02-06	
J	Resnik, L; Borgia, M; Ni, PS; Pirraglia, PA; Jette, A				Resnik, Linda; Borgia, Matthew; Ni, Pensheng; Pirraglia, Paul A.; Jette, Alan			Reliability, validity and administrative burden of the community reintegration of injured service members computer adaptive test (CRIS-CAT)"	BMC MEDICAL RESEARCH METHODOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; AGGRESSIVE-BEHAVIOR; IRAQ	Background: The Computer Adaptive Test version of the Community Reintegration of Injured Service Members measure (CRIS-CAT) consists of three scales measuring Extent of, Perceived Limitations in, and Satisfaction with community integration. The CRIS-CAT was developed using item response theory methods. The purposes of this study were to assess the reliability, concurrent, known group and predictive validity and respondent burden of the CRIS-CAT. Methods: This was a three-part study that included a 1) a cross-sectional field study of 517 homeless, employed, and Operation Enduring Freedom / Operation Iraqi Freedom (OEF/OIF) Veterans; who completed all items in the CRIS item set, 2) a cohort study with one year follow-up study of 135 OEF/OIF Veterans, and 3) a 50-person study of CRIS-CAT administration. Conditional reliability of simulated CAT scores was calculated from the field study data, and concurrent validity and known group validity were examined using Pearson product correlations and ANOVAs. Data from the cohort were used to examine the ability of the CRIS-CAT to predict key one year outcomes. Data from the CRIS-CAT administration study were used to calculate ICC (2,1) minimum detectable change (MDC), and average number of items used during CAT administration. Results: Reliability scores for all scales were above 0.75, but decreased at both ends of the score continuum. CRIS-CAT scores were correlated with concurrent validity indicators and differed significantly between the three Veteran groups (P < .001). The odds of having any Emergency Room visits were reduced for Veterans with better CRIS-CAT scores (Extent, Perceived Satisfaction respectively: OR = 0.94, 0.93, 0.95; P < .05). CRIS-CAT scores were predictive of SF-12 physical and mental health related quality of life scores at the 1 year follow-up. Scales had ICCs >0.9. MDCs were 5.9, 6.2, and 3.6, respectively for Extent, Perceived and Satisfaction subscales. Number of items (mn, SD) administered at Visit 1 were 14.6 (3.8) 10.9 (2.7) and 10.4 (1.7) respectively for Extent, Perceived and Satisfaction subscales. Conclusion: The CRIS-CAT demonstrated sound measurement properties including reliability, construct, known group and predictive validity, and it was administered with minimal respondent burden. These findings support the use of this measure in assessing community reintegration.	[Resnik, Linda; Borgia, Matthew; Pirraglia, Paul A.] Providence VA Med Ctr, Providence, RI 02908 USA; [Resnik, Linda] Brown Univ, Dept Hlth Serv Policy & Practice, Providence, RI 02903 USA; [Jette, Alan] Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, Dept Hlth Policy & Management, Boston, MA 02118 USA		Resnik, L (corresponding author), Providence VA Med Ctr, 830 Chalkstone Ave, Providence, RI 02908 USA.	Linda.Resnik@va.gov		Jette, Alan/0000-0002-2117-9973	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development HSRDUS Department of Veterans Affairs [DHI-07-144]; NIH-NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1 R42HD065688-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065688] Funding Source: NIH RePORTER	This research was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development HSR&D DHI-07-144. The Administration Study reported in this paper was supported by NIH-NICHD 1 R42HD065688-01. The information in this manuscript does not necessarily reflect the position or policy of the government; no official endorsement should be inferred.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Brooks CA, 1992, CRAIG HAND ASS REP T; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; Cotton R, 2011, CLEAR HOLD BUILD STR; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P70; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Masters G.N.., 1997, HDB MODERN ITEM RESP, P101, DOI DOI 10.1007/978-1-4757-2691-6_6; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Resnik L, 2012, J REHABIL RES DEV, V49, P557, DOI 10.1682/JRRD.2011.04.0081; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; U.S. Department of Defense, 2011, US MIL CAS; Urbina S, 1997, PSYCHOL TESTING; Wainer H., 2000, COMPUTERIZED ADAPTIV; Walter OB, 2007, QUAL LIFE RES, V16, P143, DOI 10.1007/s11136-007-9191-7; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARM TA, 1989, PSYCHOMETRIKA, V54, P427, DOI 10.1007/BF02294627; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; World Health Organization, 2007, INT CLASS FUNCT DIS; Wounded Soldiers Get Help in Transition to VA, 2004, WOUND SOLD GET HELP; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2	34	11	11	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2288			BMC MED RES METHODOL	BMC Med. Res. Methodol.	SEP 17	2012	12								145	10.1186/1471-2288-12-145			17	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	060TL	WOS:000312800900002	22984850	Green Published, gold			2022-02-06	
J	Bilgin, S; Guclu-Gunduz, A; Oruckaptan, H; Kose, N; Celik, B				Bilgin, Sevil; Guclu-Gunduz, Arzu; Oruckaptan, Hakan; Kose, Nezire; Celik, Bulent			Gait and Glasgow Coma Scale scores can predict functional recovery in patients with traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						brain injury; traumatic brain injury; rehabilitation; early rehabilitation; function; prognosis; Glasgow Coma Scale; Glasgow Outcome Scale; functional level; neural regeneration	LENGTH-OF-STAY; INDEPENDENCE MEASURE; STROKE PATIENTS; REHABILITATION; CONSCIOUSNESS	Fifty-one patients with mild (n = 14), moderate (n = 10) and severe traumatic brain injury (n = 27) received early rehabilitation. Level of consciousness was evaluated using the Glasgow Coma Score. Functional level was determined using the Glasgow Outcome Score, whilst mobility was evaluated using the Mobility Scale for Acute Stroke. Activities of daily living were assessed using the Barthel Index. Following Bobath neurodevelopmental therapy, the level of consciousness was significantly improved in patients with moderate and severe traumatic brain injury, but was not greatly influenced in patients with mild traumatic brain injury. Mobility and functional level were significantly improved in patients with mild, moderate and severe traumatic brain injury. Gait recovery was more obvious in patients with mild traumatic brain injury than in patients with moderate and severe traumatic brain injury. Activities of daily living showed an improvement but this was insignificant except for patients with severe traumatic brain injury. Nevertheless, complete recovery was not acquired at discharge. Multiple regression analysis showed that gait and Glasgow Coma Scale scores can be considered predictors of functional outcomes following traumatic brain injury.	[Bilgin, Sevil; Kose, Nezire] Hacettepe Univ, Dept Physiotherapy & Rehabil, Fac Hlth Sci, Ankara, Turkey; [Guclu-Gunduz, Arzu] Gazi Univ, Dept Physiotherapy & Rehabil, Fac Hlth Sci, Ankara, Turkey; [Oruckaptan, Hakan] Hacettepe Univ, Fac Med, Dept Neurosurg, TR-06100 Ankara, Turkey; [Celik, Bulent] Gazi Univ, Dept Biostat, Fac Hlth Sci, Ankara, Turkey		Bilgin, S (corresponding author), Hacettepe Univ, Dept Physiotherapy & Rehabil, Fac Hlth Sci, TR-06100 Samanpazan Ankara, Turkey.	sevilcuvalci@yahoo.com	Celik, Bulent/A-7793-2017	Celik, Bulent/0000-0002-0481-4808			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Aygencel Gulbin, 2008, J Forensic Leg Med, V15, P1, DOI 10.1016/j.jflm.2007.05.005; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Dombovy Mary L, 2011, Continuum (Minneap Minn), V17, P584, DOI 10.1212/01.CON.0000399074.07686.76; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Houlden H, 2006, CLIN REHABIL, V20, P153, DOI 10.1191/0269215506cr917oa; Ilet PA, 2010, ARCH PHYS MED REHAB, V91, P788, DOI 10.1016/j.apmr.2009.11.028; JENNETT B, 1975, LANCET, V1, P480; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Kollen BJ, 2009, STROKE, V40, pE89, DOI 10.1161/STROKEAHA.108.533828; Lippert-Gruner M, 2010, NEUROL NEUROCHIR POL, V44, P475; Majdan M, EUR J PUBLI IN PRESS; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Miller KJ, 2005, J NEUROSURG, V103, P239, DOI 10.3171/jns.2005.103.2.0239; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/NEJM199512143332401; Navarrete-Navarro P, 2003, INTENS CARE MED, V29, P1237, DOI 10.1007/s00134-003-1755-6; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Simondson JA, 2003, CLIN REHABIL, V17, P558, DOI 10.1191/0269215503cr650oa; Wall G, NEUROCASE IN PRESS; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	31	11	11	0	11	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	SEP 5	2012	7	25					1978	1984		10.3969/j.issn.1673-5374.2012.25.009			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	018BT	WOS:000309635700009	25624828				2022-02-06	
J	Beasley, IG; Davies, LN				Beasley, Ian G.; Davies, Leon N.			Susceptibility to pattern glare following stroke	JOURNAL OF NEUROLOGY			English	Article						Stroke; Pattern glare; Cortical hyperexcitability	TRAUMATIC BRAIN-INJURY; VISUALLY SENSITIVE MIGRAINE; MEARES-IRLEN-SYNDROME; TINTED SPECTACLES; COLORED OVERLAYS; HEAD-INJURY; SYMPTOMS; LIGHT; DISCOMFORT; FREQUENCY	The aim of this work was to measure susceptibility to pattern glare within a stroke group, employing a direct method of assessment. Twenty stroke subjects, aged 38-85 years, were recruited, along with an age-matched control group (n = 20). Assessment of pattern glare susceptibility was undertaken using the pattern glare test. An abnormal degree of pattern glare is present when individuals score > 1 on the mid-high spatial frequency difference variable, a relative score that allows for normalization of the subject, or > 3 when viewing the mid spatial frequency grating. Stroke subjects demonstrate elevated levels of pattern glare compared to normative data values and a control population, as determined using the pattern glare test. This was most notable when considering the output measure for the mid-high difference variable. The mean score for the mid-high difference variable was 2.15 SD 1.27 for the stroke subjects versus 0.10 SD 1.12 for the control subjects. When considering the mid-high difference variable, 75% of the stroke group recorded an abnormal level of pattern glare compared to 5% in the control group. This study demonstrates an association between stroke subjects and elevated levels of pattern glare. Cortical hyperexcitability has been shown to present following stroke, and this has been proposed as a plausible explanation for the perceptual distortions experienced by individuals susceptible to pattern glare. Further work to assess the benefits of spectral filters in reducing perceptual distortions in stroke patients is currently underway.	[Beasley, Ian G.; Davies, Leon N.] Aston Univ, Ophthalm Res Grp, Birmingham B4 7ET, W Midlands, England; [Davies, Leon N.] Aston Univ, Aston Res Ctr Healthy Ageing, Birmingham B4 7ET, W Midlands, England		Davies, LN (corresponding author), Aston Univ, Ophthalm Res Grp, Birmingham B4 7ET, W Midlands, England.	l.n.davies@aston.ac.uk	Davies, Leon/H-4569-2012	/0000-0002-1554-0566			BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Braun C, 2001, CLIN NEUROPHYSIOL, V112, P336, DOI 10.1016/S1388-2457(00)00508-3; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Conlon E, 2001, PERCEPTION, V30, P571, DOI 10.1068/p2954; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Evans, 2010, PATTERN GLARE TEST I; Evans BJW, 2008, OPHTHAL PHYSL OPT, V28, P295, DOI 10.1111/j.1475-1313.2008.00578.x; Evans B. J. W., 1997, DYSLEXIA REV, V9, P18; Evans BJW, 2002, OPHTHAL PHYSL OPT, V22, P130, DOI 10.1046/j.1475-1313.2002.00017.x; Evans BJW, 2002, OPHTHAL PHYSL OPT, V22, P535, DOI 10.1046/j.1475-1313.2002.00071.x; EVANS BJW, 1991, OPHTHAL PHYSL OPT, V11, P206, DOI 10.1111/j.1475-1313.1991.tb00535.x; EVANS BJW, 1995, OPHTHAL PHYSL OPT, V15, P481, DOI 10.1046/j.1475-1313.1995.9500063j.x; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Harle DE, 2004, OPHTHAL PHYSL OPT, V24, P369, DOI 10.1111/j.1475-1313.2004.00212.x; Harle DE, 2006, HEADACHE, V46, P1431, DOI 10.1111/j.1526-4610.2006.00585.x; Hollis J, 2006, OPHTHAL PHYSL OPT, V26, P566, DOI 10.1111/j.1475-1313.2006.00401.x; Huang J, 2011, CEPHALALGIA, V31, P925, DOI 10.1177/0333102411409076; Jackowski MM, 1996, NEUROREHABILITATION, V6, P193, DOI 10.3233/NRE-1996-6305; Jeanes R, 1997, BRIT J PSYCHOL, V88, P531; Koerner C, 2004, NEUROSCI LETT, V361, P21, DOI 10.1016/j.neulet.2003.12.074; Kriss I, 2005, J RES READ, V28, P350, DOI 10.1111/j.1467-9817.2005.00274.x; Ludlow AK, 2006, J AUTISM DEV DISORD, V36, P507, DOI 10.1007/s10803-006-0090-5; NULTY DD, 1987, PSYCHOL MED, V17, P705, DOI 10.1017/S0033291700025940; Singleton C, 2005, J RES READ, V28, P365, DOI 10.1111/j.1467-9817.2005.00275.x; Tosta S, 2009, J HEAD TRAUMA REHAB, V24, P395; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wilkins A, 2004, J RES READ, V27, P152, DOI 10.1111/j.1467-9817.2004.00223.x; WILKINS A, 1984, BRAIN, V107, P989, DOI 10.1093/brain/107.4.989; Wilkins A.J., 1995, VISUAL STRESS; WILKINS AJ, 1987, ERGONOMICS, V30, P1705, DOI 10.1080/00140138708966059; Wilkins AJ, 2002, CEPHALALGIA, V22, P711, DOI 10.1046/j.1468-2982.2002.00362.x; Wilkins AJ, 1999, SEIZURE-EUR J EPILEP, V8, P444, DOI 10.1053/seiz.1999.0337; WILKINS AJ, 1984, OPHTHAL PHYSL OPT, V4, P53, DOI 10.1016/0275-5408(84)90052-8; Wilkins AJ, 1993, READING VISUAL DISCO; Wilkins AJ, 1991, OPHTHAL PHYSL OPT, V1, P163; Wright BN, 2007, J NEUROL, V254, P1729, DOI 10.1007/s00415-007-0648-y; YEKTA AA, 1989, OPHTHAL PHYSL OPT, V9, P115, DOI 10.1111/j.1475-1313.1989.tb00829.x	37	11	11	0	13	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354			J NEUROL	J. Neurol.	SEP	2012	259	9					1832	1839		10.1007/s00415-012-6418-5			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	999PT	WOS:000308327300009	22289968	hybrid, Green Published, Green Accepted			2022-02-06	
J	Christou, GA; Young, LR; Goel, R; Vechart, AP; Jerusalem, A				Christou, George A.; Young, Laurence R.; Goel, Rahul; Vechart, Andrew P.; Jerusalem, Antoine			Shock attenuation of PMMA sandwich panels filled with soda-lime glass beads: A fluid-structure interaction continuum model simulation	INTERNATIONAL JOURNAL OF IMPACT ENGINEERING			English	Article						Fluid-structure interaction; Shock propagation; Finite element method; Soda-lime glass; Foam	TRAUMATIC BRAIN-INJURY; BLAST; PROPAGATION; SUBJECT; PLATES	The dramatic increase of Improvised Explosive Device (IED) related injuries has stimulated many studies to reconsider the design of the current state-of-the-art vehicle and body protective equipment. Materials now need to be chosen not only to stop solid projectiles such as shrapnel or bullets but also to attenuate the injurious effects of incoming blast waves. New advanced computational models of such events have been proved to facilitate the access to information currently inaccessible to experiments. To this end, we developed a fluid structure interaction computational continuum model to investigate the attenuation properties of foam specimens containing filler materials under shock loading. Three test specimens were examined: a solid foam sample, and two other foam samples incorporating an intermediate layer of filler material: SiO2 aerogel and soda-lime glass beads. The model was then calibrated and the results compared to the corresponding shock tube experimental results [M.D. Alley, S.F. Son, G. Christou, R. Goel, L. Young, 2009]. In conclusion, the model shows good agreement with experiment values for the peak pressure of the transmitted wave as well as its propagation time. Complementing the existing experimental results, high density soda-lime glass beads filler material is shown to substantially decrease the peak magnitude of the transmitted wave and to decrease the spatial gradient of the pressure compared to the other lower density filler samples. However, the history of the sample reaction force suggests that the frame constraining the test specimen is being subjected to a higher impulse using the high density filler. Such a model paves the road to a new series of complex numerical models designed to accompany experimental testing by providing new insights on the mechanisms of fluid-structure interaction. (c) 2012 Elsevier Ltd. All rights reserved.	[Jerusalem, Antoine] IMDEA Mat Inst, Madrid 28040, Spain; [Christou, George A.; Young, Laurence R.; Goel, Rahul; Vechart, Andrew P.; Jerusalem, Antoine] MIT, Man Vehicle Lab, Cambridge, MA 02139 USA		Jerusalem, A (corresponding author), IMDEA Mat Inst, Madrid 28040, Spain.	antoine.jerusalem@imdea.org	Goel, Rahul/C-4480-2016	Goel, Rahul/0000-0002-3516-6938; Jerusalem, Antoine/0000-0001-5026-8038	Office of Naval ResearchOffice of Naval Research [N00014-08-1-0261]; Deshpande Fund (MIT); CIMIT [W81XWH-07-2-0011]; Spanish Ministry of Science and InnovationSpanish Government; European UnionEuropean Commission; Madrid Regional Government [ESTRUMAT-S2009/MAT-1585]	The authors gratefully acknowledge the fruitful discussions with Prof. Raul Radovitzky (MIT) and Prof. Ludovic Noels (Universite de Liege) and the financial support of the Office of Naval Research through contract No. N00014-08-1-0261. Support for the earlier model development was provided by the Deshpande Fund (MIT) and CIMIT contract No. W81XWH-07-2-0011. Dr. Antoine Jerusalem acknowledges support from the Juan de la Cierva grant from the Spanish Ministry of Science and Innovation, from the Amarout grant from the European Union and from the ESTRUMAT-S2009/MAT-1585 grant (Madrid Regional Government).	Allen RM, 2004, AIP CONF PROC, V706, P823; Alley M., 2009, EXPLOSIVE BLAST LOAD; Alley MD, 2009, AIP CONF PROC, V1195, P1135; Baker W. E., 1973, EXPLOSIONS IN AIR; Centers for Disease Control and Prevention, 2006, EXPL BLAST INJ PRIM; Christou G, 2010, THESIS MIT MASSACHUS; Courtney A, 2008, THORACIC MECH MILD T; Drumheller D. S., 1998, INTRO WAVE PROPAGATI; Grady D.E., 1996, SHOCK WAVE PROPERTIE; Hamada T, 2004, J PRESS VESS-T ASME, V126, P409, DOI 10.1115/1.1804201; Hartman W. F., 2006, SAND20060533 SAND NA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homae T, 2007, AIP CONF PROC, V955, P1289, DOI 10.1063/1.2832958; Jerusalem A, 2009, MODEL SIMUL MATER SC, V17, DOI 10.1088/0965-0393/17/2/025001; Jia X, 1999, PHYS REV LETT, V82, P1863, DOI 10.1103/PhysRevLett.82.1863; Kambouchev N, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349483; Kambouchev N., 2007, THESIS MIT CAMBRIDGE; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kitazawa Y, 1999, J GEOPHYS RES-PLANET, V104, P22035, DOI 10.1029/1998JE000554; Li QM, 2002, INT J IMPACT ENG, V27, P1049, DOI 10.1016/S0734-743X(02)00016-7; Mader C, 1968, EQUATION STATE SHOCK; Main JA, 2008, INT J SOLIDS STRUCT, V45, P2297, DOI 10.1016/j.ijsolstr.2007.11.019; MARSH SP, 1979, LASL SHOCK HUGONIOT; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Nesterenko V.F, 2003, P MAT RES SOC S, P759, DOI [10.1557/PROC-759-MM4.3., DOI 10.1557/PROC-759-MM4.3]; Qiu X, 2003, EUR J MECH A-SOLID, V22, P801, DOI 10.1016/j.euromechsol.2003.09.002; Rabczuk T, 2004, INT J NUMER METH ENG, V61, P1009, DOI 10.1002/nme.1100; Ruchelsman J., 2009, U.S. Patent, Patent No. [12/296,843, 12296843]; SALTER SH, 2002, P UK EXPL MIT WORKSH; Smith PD, 1994, BLAST BALLISTIC LOAD; Stewart D, 2010, J ASTM INT, P7; Stewart D, 2008, THESIS DUBLIN; Xue ZY, 2003, INT J MECH SCI, V45, P687, DOI 10.1016/S0020-7403(03)00108-5; Xue ZY, 2004, INT J IMPACT ENG, V30, P1283, DOI 10.1016/j.ijimpeng.2003.08.007; Zhuang SM, 2003, J MECH PHYS SOLIDS, V51, P245, DOI 10.1016/S0022-5096(02)00100-X	37	11	11	0	33	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0734-743X	1879-3509		INT J IMPACT ENG	Int. J. Impact Eng.	SEP	2012	47						48	59		10.1016/j.ijimpeng.2012.03.003			12	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	957NZ	WOS:000305171000005					2022-02-06	
J	Keshavarzi, Z; Khaksari, M; Razmi, Z; Hekmat, AS; Naderi, V; Rostami, S				Keshavarzi, Zakieh; Khaksari, Mohammad; Razmi, Zohre; Hekmat, Ava Soltani; Naderi, Vida; Rostami, Sima			The Effects of Cyclooxygenase Inhibitors on the Brain Inflammatory Response Following Traumatic Brain Injury in Rats	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Brain injury; Celecoxib; Ibuprofen; Interleukin-10	NEUROPROTECTION; ROFECOXIB; CELECOXIB; MODEL	Objective(s) Cytokines such as IL-1 beta are involved in inflammatory responses. This study evaluated the role of two different kinds of drugs (ibuprofen and celecoxib) on brain IL-10 and IL-1 beta after traumatic brain injury (TBI) in male rats. Materials and Methods Rats were assigned into 6 groups: intact, sham, TBI, and treated rats with vehicle, celecoxib or iboprophen. Cytokine concentrations were quantified by ELISA kits. Results Groups showed no significant difference in brain IL-10 either after TBI induction or after treatment with ibuprofen or celecoxib. Serum IL-10 in vehicle or ibuprofen treated animals was lower than in sham groups (P< 0.01). Brain IL-1 beta decreased after treatment by ibuprofen or celecoxib (P< 0.001). There was no statistical difference in serum IL-1 beta in TBI and intact. Serum IL-1 beta significantly decreased in rats that received celecoxib compared to TBI group (P< 0.01). Conclusion Based on our study IL-1 beta can decrease through both cyclooxygenase 1 (COX-1) and COX-2 pathway but serum IL-1 beta can decrease only by COX-2 pathway.	[Keshavarzi, Zakieh] N Khorasan Univ Med Sci, Bojnord, Iran; [Khaksari, Mohammad; Hekmat, Ava Soltani] Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran		Keshavarzi, Z (corresponding author), N Khorasan Univ Med Sci, Bojnord, Iran.	Zakieh_keshavarzi@yahoo.com	soltani, Ava/M-1217-2017; Keshavarzi, Zakieh/ABG-4268-2020; Haddad, Mohammad Khaksari/AAB-9025-2019; rostami, sima/N-2778-2018; naderi-boldaji, vida/AAZ-4291-2020	soltani, Ava/0000-0001-7949-3263; Haddad, Mohammad Khaksari/0000-0003-0770-4281; rostami, sima/0000-0003-3568-0192; naderi-boldaji, vida/0000-0001-9909-207X	physiology research center of Kerman University of Medical sciences, Kerman, Iran	The present study was financially supported by the physiology research center of Kerman University of Medical sciences, Kerman, Iran.	Blais V, 2005, J NEUROCHEM, V95, P1563, DOI 10.1111/j.1471-4159.2005.03480.x; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926, DOI 10.1097/01.WCB.0000130866.25040.7D; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Scali C, 2003, NEUROSCIENCE, V117, P909, DOI 10.1016/S0306-4522(02)00839-4; Sirota L, 2001, BIOL NEONATE, V79, P103, DOI 10.1159/000047075; Soltani Z., 2009, Iranian Journal of Endocrinology and Metabolism, V10, P629; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Zhao SZ, 2001, CLIN THER, V23, P1478, DOI 10.1016/S0149-2918(01)80121-1	12	11	12	0	0	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866			IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	SEP-OCT	2012	15	5					1102	1105					4	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	042XN	WOS:000311505600015	23492757				2022-02-06	
J	Li, YL; Li, LT; Yu, M; Wang, YZ; Ge, HY; Song, CQ				Li, Y. L.; Li, L. T.; Yu, M.; Wang, Y. Z.; Ge, H. Y.; Song, C. Q.			Beneficial Effects of the Herbal Medicine Di Huang Yin Zi in Patients with Spinal Cord Injury: a Randomized, Placebo-controlled Clinical Study	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Dr HUANG YIN ZI (DHYZ); CHINESE MEDICINE; COMPLEMENTARY MEDICINE; ALTERNATIVE MEDICINE; SPINAL CORD INJURY; FUNCTIONAL RECOVERY	GLYCYRRHIZAE-RADIX EXTRACT; NEUROLOGICAL FUNCTION; TIRILAZAD MESYLATE; GINSENG-RADIX; NITRIC-OXIDE; METHYLPREDNISOLONE; ANTIOXIDANT; APOPTOSIS; BRAIN; NALOXONE	OBJECTIVE: This study investigated the safety and therapeutic efficacy of Di Huang Yin Zi (DHYZ), a traditional Chinese decoction used to treat neurological disorders, in spinal cord injury (SCI). METHODS: In this double-blind, placebo-controlled study, patients with traumatic SCI and American Spinal Injury Association (ASIA) impairment grades B - D were randomized to receive DHYZ (n = 30) or placebo (n = 30) for 12 weeks. Both groups also received rehabilitation therapy during the study period. Motor and sensory function and activities of daily living (ADL) were assessed before treatment and at 4-week intervals. RESULTS: Significantly more patients in the DHYZ group showed an improved ASIA impairment grade during the treatment period (32.1%) compared with the placebo group (10.3%), and scores for sensory and motor function and ADL at the end of the treatment period were significantly higher in the DHYZ group than in the placebo group. No serious side-effects were reported. CONCLUSIONS: DHYZ was found to improve neurological function in patients with SCI and may be an effective adjuvant therapy to enhance functional recovery.	[Li, Y. L.; Wang, Y. Z.] Shandong Univ, Affiliated Hosp 2, Jinan 250100, Peoples R China; [Li, L. T.; Yu, M.; Song, C. Q.] Shandong Med Coll, Jinan, Peoples R China; [Ge, H. Y.] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Lab Expt Pain Res, Aalborg, Denmark		Li, YL (corresponding author), Shandong Univ, Affiliated Hosp 2, 247 Bei Yuan St, Jinan 250100, Peoples R China.	lyl.pro@163.com			Natural Science Foundation of Shandong Province, People's Republic of ChinaNatural Science Foundation of Shandong Province [30772695]	This study was supported by the Natural Science Foundation of Shandong Province, People's Republic of China (30772695). We thank Dr Shu-hua Wang for the randomization and coding procedures of the two groups. We also thank Dr Qing-Qiang Yu and nurses Xia-Yang and Lin Wang, who were responsible for distributing the medication and recording the times and doses of medication used each day in the study.	[Anonymous], 2000, PHARM PEOPL REP CHIN; Ao Q, 2006, SPINAL CORD, V44, P662, DOI 10.1038/sj.sc.3101900; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Botterell E H, 1975, Can J Neurol Sci, V2, P361; Bracken M B, 1991, J Neurotrauma, V8 Suppl 1, pS47; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.1984.03340250025015; BRACKEN MB, 1985, J NEUROSURG, V63, P704, DOI 10.3171/jns.1985.63.5.0704; BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; CHEN HC, 1990, AM J CHINESE MED, V18, P25, DOI 10.1142/S0192415X90000058; Chen HY, 2005, ANN NY ACAD SCI, V1042, P396, DOI 10.1196/annals.1338.062; COLLINS WF, 1983, PARAPLEGIA, V21, P204, DOI 10.1038/sc.1983.34; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dallmeijer AJ, 1999, MED SCI SPORT EXER, V31, P1330, DOI 10.1097/00005768-199909000-00015; DEJONG G, 1984, ARCH PHYS MED REHAB, V65, P66; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; Donovan WH, 1997, SPINAL CORD, V35, P275, DOI 10.1038/sj.sc.3100449; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Harkema SJ, 2001, NEUROSCIENTIST, V7, P455, DOI 10.1177/107385840100700514; Jian ZH, 2001, AM J CHINESE MED, V29, P509, DOI 10.1142/S0192415X01000538; Kim EH, 2003, BIOL PHARM BULL, V26, P1668, DOI 10.1248/bpb.26.1668; Kim SC, 2008, EVID-BASED COMPL ALT, V5, P165, DOI 10.1093/ecam/nem014; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Koo BS, 2004, PHYTOTHER RES, V18, P488, DOI 10.1002/ptr.1457; Kraus J.F., 1996, PRINCIPLES SPINE SUR, P41; KUBO M, 1994, BIOL PHARM BULL, V17, P1282, DOI 10.1248/bpb.17.1282; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li H, 2004, ANAL BIOANAL CHEM, V378, P1801, DOI 10.1007/s00216-004-2509-1; Li TJ, 2007, J PHARMACOL SCI, V105, P34, DOI 10.1254/jphs.FP0070450; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Lin ZH, 2005, J ETHNOPHARMACOL, V97, P477, DOI 10.1016/j.jep.2004.12.001; Nakajima S, 1998, AM J CHINESE MED, V26, P365, DOI 10.1142/S0192415X98000403; Park YH, 2009, PHARMAZIE, V64, P760, DOI 10.1691/ph.2009.9614; Peng QL, 1998, GEN PHARMACOL, V31, P221, DOI 10.1016/S0306-3623(97)00459-X; Peng QL, 1998, AM J CHINESE MED, V26, P291, DOI 10.1142/S0192415X98000336; Seo TB, 2006, ACTA PHARMACOL SIN, V27, P50, DOI 10.1111/j.1745-7254.2006.00252.x; Shimada Y, 2004, PHYTOMEDICINE, V11, P404, DOI 10.1016/j.phymed.2003.04.002; Shin HY, 2009, IMMUNOPHARM IMMUNOT, V31, P370, DOI 10.1080/08923970802698820; Staas W, 1998, REHABILITATION MED P, P1259; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Toda S, 2001, PHYTOTHER RES, V15, P541, DOI 10.1002/ptr.848; Tsai CC, 2003, AM J CHINESE MED, V31, P665, DOI 10.1142/S0192415X03001387; Wong AMK, 2003, AM J PHYS MED REHAB, V82, P21, DOI 10.1097/00002060-200301000-00004; Wong M K, 1981, Taiwan Yi Xue Hui Za Zhi, V80, P433; Wu SJ, 2004, PHYTOTHER RES, V18, P1008, DOI 10.1002/ptr.1617; Xia WJ, 2005, PEDIATR RES, V58, P784, DOI 10.1203/01.PDR.0000180550.99162.BC; Yanaga A, 2006, BIOL PHARM BULL, V29, P2415, DOI 10.1248/bpb.29.2415; Yokozawa T, 2000, PHYTOMEDICINE, V6, P439, DOI 10.1016/S0944-7113(00)80072-0; Yokozawa T, 2000, PHYTOMEDICINE, V6, P453, DOI 10.1016/S0944-7113(00)80074-4; Yu Y, 2008, EXP BRAIN RES, V184, P307, DOI 10.1007/s00221-007-1100-3; Yun YJ, 2007, BIOL PHARM BULL, V30, P337, DOI 10.1248/bpb.30.337; Zhang ZJ, 2007, J PSYCHIATR RES, V41, P360, DOI 10.1016/j.jpsychires.2005.06.002; Zheng SY, 2004, AM J CHINESE MED, V32, P209, DOI 10.1142/S0192415X04001874	59	11	11	1	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	SEP-OCT	2012	40	5					1715	1724		10.1177/030006051204000510			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	046JV	WOS:000311762200010	23206453	gold			2022-02-06	
J	Mehan, ND; Strauss, KI				Mehan, Neal D.; Strauss, Kenneth I.			Combined age- and trauma-related proteomic changes in rat neocortex: a basis for brain vulnerability	NEUROBIOLOGY OF AGING			English	Article						Age; Geriatric brain injury; Adult brain injury; Pediatric brain injury; Proteomics	RESPONSE MEDIATOR PROTEIN-2; HEAT-SHOCK-PROTEIN; DIHYDROPYRIMIDINASE-RELATED PROTEIN-2; CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE BRAIN; CAT VISUAL-CORTEX; APOLIPOPROTEIN-E; NERVOUS-SYSTEM; C-FOS; MITOCHONDRIAL DYSFUNCTION	This proteomic study investigates the widely observed clinical phenomenon, that after comparable brain injuries, geriatric patients fare worse and recover less cognitive and neurologic function than younger victims. Utilizing a rat traumatic brain injury model, sham surgery or a neocortical contusion was induced in 3 age groups. Geriatric (21 months) rats performed worse on behavioral measures than young adults (12-16 weeks) and juveniles (5-6 weeks). Motor coordination and certain cognitive deficits showed age-dependence both before and after injury. Brain proteins were analyzed using silver-stained two-dimensional electrophoresis gels. Spot volume changes (>2-fold change, p<0.01) were identified between age and injury groups using computer-assisted densitometry. Sequences were determined by mass spectrometry of tryptic peptides. The 19 spots identified represented 13 different genes that fell into 4 general age-and injury-dependent expression patterns. Fifteen isoforms changed differentially with respect to both age and injury (p<0.05). Further investigations into the nature and function of these isoforms may yield insights into the vulnerability of older patients and resilience of younger patients in recovery after brain injuries. (C) 2012 Elsevier Inc. All rights reserved.	[Mehan, Neal D.; Strauss, Kenneth I.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA		Strauss, KI (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA.	kenneth.strauss@hc.msu.edu			Greater Cincinnati Foundation; Elizabeth P. Lips Memorial Award; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS054890, R01-NS038654]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054890, R01NS038654] Funding Source: NIH RePORTER	This work was supported in part by the Greater Cincinnati Foundation, Elizabeth P. Lips Memorial Award and NINDS R01-NS054890, NINDS R01-NS038654. The authors wish to acknowledge the excellent technical assistance of Michael Wyder, Shawn Lewis, Aixiang Xue, Raquel Moore, Mingfu Zhou, Jason Dudley and Nathan Kuhn. Thanks also to Detlef Schumann and Kenneth Greis for valuable discussions on experimental design, and to Jack Lipton for suggestions on the manuscript.	Allen GV, 2001, NEUROSCIENCE, V102, P603, DOI 10.1016/S0306-4522(00)00519-4; Alvarez-Dolado M, 1999, J NEUROCHEM, V73, P2240, DOI 10.1046/j.1471-4159.1999.0732240.x; Arnaud P, 2002, DIABETES-METAB RES, V18, P311, DOI 10.1002/dmrr.315; BLUMENFELD KS, 1992, J CEREBR BLOOD F MET, V12, P987, DOI 10.1038/jcbfm.1992.136; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brown I R, 1991, Results Probl Cell Differ, V17, P217; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; BROWN WM, 1992, CELL, V68, P7, DOI 10.1016/0092-8674(92)90200-V; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Carrette O, 2006, J CHROMATOGR B, V840, P1, DOI 10.1016/j.jchromb.2006.05.019; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Cid C, 2007, PROTEOMICS, V7, P3207, DOI 10.1002/pmic.200700214; Cnops L, 2004, EUR J NEUROSCI, V19, P2345, DOI 10.1111/j.0953-816X.2004.03330.x; Cnops L, 2006, BRAIN RES, V1088, P109, DOI 10.1016/j.brainres.2006.03.028; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Eismann T, 2009, AM J PHYSIOL-GASTR L, V296, pG266, DOI 10.1152/ajpgi.90583.2008; Elwan O, 2003, J NEUROL SCI, V211, P15, DOI 10.1016/S0022-510X(03)00032-7; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; Fountoulakis M, 2000, ELECTROPHORESIS, V21, P673, DOI 10.1002/(SICI)1522-2683(20000201)21:3<673::AID-ELPS673>3.0.CO;2-Y; Fujisawa H, 2008, PROTEOMICS, V8, P1706, DOI 10.1002/pmic.200700928; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; FURUTOKATO S, 1985, J BIOL CHEM, V260, P2054; Gemma C, 2007, REV NEUROSCIENCE, V18, P137; Gennaro G, 2003, CIRCULATION, V107, P230, DOI 10.1161/01.CIR.0000050652.47145.4C; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; GOLDMAN H, 1992, NEUROBIOL AGING, V13, P57, DOI 10.1016/0197-4580(92)90009-M; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Greenbaum L M, 1992, Agents Actions Suppl, V36, P215; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hattori N, 2003, J NUCL MED, V44, P1709; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; Horvath AJ, 2004, J MOL EVOL, V59, P488, DOI 10.1007/s00239-004-2640-9; Iwazaki T, 2007, PROTEOMICS, V7, P1131, DOI 10.1002/pmic.200600595; KAGEYAMA R, 1985, J BIOL CHEM, V260, P2060; Kalabay L, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-15; KALMOVARIN N, 1991, INFLAMMATION, V15, P369, DOI 10.1007/BF00917353; KNOX CA, 1980, ACTA NEUROPATHOL, V51, P1, DOI 10.1007/BF00688844; Krueger-Naug A M R, 2002, Prog Mol Subcell Biol, V28, P235; Kuhla B, 2007, PROTEOMICS, V7, P3602, DOI 10.1002/pmic.200700248; Lanterna LAL, 2009, J STROKE CEREBROVASC, V18, P116, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.006; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Lin YL, 2008, BIOCHEM BIOPH RES CO, V369, P747, DOI 10.1016/j.bbrc.2008.02.095; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; Masseguin C, 2005, NEUROBIOL AGING, V26, P917, DOI 10.1016/j.neurobiolaging.2004.07.013; MAYHAN WG, 1990, AM J PHYSIOL, V258, pH1735; Mayhan WG, 2001, MICROCIRCULATION, V8, P89, DOI 10.1038/sj.mn.7300154; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Molvarec A, 2009, HYPERTENS RES, V32, P665, DOI 10.1038/hr.2009.79; Monaco C, 1997, GENOMICS, V46, P217, DOI 10.1006/geno.1997.5036; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; Ni MH, 2008, J CELL BIOCHEM, V103, P1833, DOI 10.1002/jcb.21575; OHKUBO K, 1991, J BIOCHEM-TOKYO, V109, P243; PAGES G, 1990, EUR J BIOCHEM, V190, P385, DOI 10.1111/j.1432-1033.1990.tb15587.x; Peeters RP, 2008, HORM-INT J ENDOCRINO, V7, P28, DOI 10.14310/horm.2002.1111035; Peila R, 2006, ACTA NEUROL SCAND, V114, P102, DOI 10.1111/j.1600-0404.2006.00693.x; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peters T., 1995, ALL ALBUMIN BIOCH GE; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Plumier JCL, 1997, J COMP NEUROL, V384, P409; Pola R, 2004, NEUROBIOL AGING, V25, P1361, DOI 10.1016/j.neurobiolaging.2004.02.028; Poon HF, 2006, NEUROBIOL AGING, V27, P1010, DOI 10.1016/j.neurobiolaging.2005.05.006; Poon HF, 2004, NEUROSCIENCE, V126, P915, DOI 10.1016/j.neuroscience.2004.04.046; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Putman CWMM, 1997, NEUROPEDIATRICS, V28, P106, DOI 10.1055/s-2007-973681; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; SANKAR R, 1983, NEUROBIOL AGING, V4, P65, DOI 10.1016/0197-4580(83)90056-8; Sironi L, 2001, STROKE, V32, P753, DOI 10.1161/01.STR.32.3.753; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Smith RG, 2005, ENDOCR REV, V26, P203, DOI 10.1210/er.2002-0017; Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Sultana R, 2007, J ALZHEIMERS DIS, V11, P153; Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021; Sun XC, 2008, CHIN J TRAUMATOL, V11, P247, DOI 10.1016/S1008-1275(08)60051-6; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Swift ME, 1999, LAB INVEST, V79, P1479; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; Tlaskowitz D, 2007, PHARMACOGENOMICS, V8, P959, DOI 10.2217/14E22416.8.8.959; Vaishnav RA, 2007, J NEUROSCI RES, V85, P373, DOI 10.1002/jnr.21130; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Vuaillat C, 2008, J NEUROIMMUNOL, V193, P38, DOI 10.1016/j.jneuroim.2007.09.033; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P95; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Wright GL, 2008, FASEB J, V22, P3264, DOI 10.1096/fj.08-106468; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; Yoshida K, 1999, BIOL CHEM, V380, P95, DOI 10.1515/BC.1999.013; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhao XZ, 2006, INT J NEUROPSYCHOPH, V9, P705, DOI 10.1017/S1461145705006267	109	11	11	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	SEP	2012	33	9					1857	1873		10.1016/j.neurobiolaging.2011.09.029			17	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	981TW	WOS:000306994600001	22088680	Green Accepted			2022-02-06	
J	Meunier, JM; Chang, WTW; Bluett, B; Wenker, E; Lindsell, CJ; Shaw, GJ				Meunier, Jason M.; Chang, Wan-Tsu W.; Bluett, Brent; Wenker, Evan; Lindsell, Christopher J.; Shaw, George J.			Temperature Affects Thrombolytic Efficacy Using rt-PA and Eptifibatide, an In Vitro Study	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; ULTRASOUND ENHANCED THROMBOLYSIS; TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; CLOT DISSOLUTION; SHORT-TERM; DEPENDENCE; THERAPY; LYSIS	The potential for hypothermia as a neuroprotectant during stroke has led to its increase in clinical use. At the same time, combination pharmaceutical therapies for ischemic stroke using recombinant tissue plasminogen activator (rt-PA), and GP IIb-IIIa inhibitors, such as Eptifibatide (Epf ), are under study. However, there is little data on how the reactions triggered by these agents are impacted by temperature. Here, clot lysis during exposure to the combination of rt-PA and Epf is measured in an in vitro human clot model at hypothermic temperatures. The hypothesis is that lytic efficacy of rt-PA and Epf decreases with decreasing temperature. Whole blood clots from 31 volunteers were exposed to rt-PA (0.5 mu g/mL) and Epf (0.63 mu g/mL) in human fresh-frozen plasma (rt-PA+Epf ), rt-PA alone in plasma (rt-PA Alone), or to plasma alone (Control), at temperatures from 30 degrees C to 37 degrees C, for 30 minutes. Clot lysis was measured using a microscopic imaging technique; the mean fractional clot loss (FCL) at 30 minutes was used to determine lytic efficacy. Temperature had a significant impact on FCL in clots exposed to rt-PA+Epf, with the FCL being lower at 30 degrees C to 36 degrees C than at 37 degrees C. The FCL remained significantly higher for rt-PA+Epf-treated clots than Controls regardless of temperature, with the exception of measurements made at 30 degrees C when no significant differences in the FCL were observed between groups. The use of hypothermia as a neuroprotectant may negatively impact the therapeutic benefit of thrombolytic agents.	[Meunier, Jason M.; Chang, Wan-Tsu W.; Wenker, Evan; Lindsell, Christopher J.; Shaw, George J.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Bluett, Brent] Univ Texas Southwestern Austin, Austin, TX USA		Meunier, JM (corresponding author), Univ Cincinnati, Dept Emergency Med, ML 0769, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	meuniejn@ucmail.uc.edu		Lindsell, Christopher/0000-0002-3297-2811	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02-NS056253, 3P50-NS044283-06S1]	This work was supported by NIH/NINDS through K02-NS056253 and 3P50-NS044283-06S1. The authors gratefully acknowledge useful conversations with Dr. Arthur Pancioli, Dr. Opeolu Adeoye, and Dr. William Knight of The Department of Emergency Medicine at The University of Cincinnati.	Abdullah JM, 2011, ACTA NEUROCHIR SUPPL, V111, P421, DOI 10.1007/978-3-7091-0693-8_72; Adams HP, 2008, STROKE, V39, P87, DOI 10.1161/STROKEAHA.106.476648; Adams HP, 1996, STROKE, V27, P1711; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Atar S, 2001, J THROMB THROMBOLYS, V11, P223, DOI 10.1023/A:1011912920777; Brekenfeld C, 2005, NEUROL RES, V27, pS29, DOI 10.1179/016164105X35549; Cannon CP, 2006, AM J CARDIOL, V98, p10Q, DOI 10.1016/j.amjcard.2006.09.026; Cheng J, 2005, ACOUST RES LETT ONL, V6, P25, DOI 10.1121/1.1815039; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cohen JE, 2012, J CLIN NEUROSCI, V19, P39, DOI 10.1016/j.jocn.2011.06.015; Collet JP, 2002, CIRC RES, V90, P428, DOI 10.1161/hh0402.105095; Connors John J 3rd, 2002, Rev Cardiovasc Med, V3 Suppl 2, pS92; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; Di Lazzaro V, 2012, NEUROL SCI, V33, P661, DOI 10.1007/s10072-011-0824-9; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; Donnan GA, 2011, NAT REV NEUROL, V7, P400, DOI 10.1038/nrneurol.2011.89; FRANCIS CW, 1995, THROMB HAEMOSTASIS, V73, P386; Granberg P O, 1991, Arctic Med Res, V50 Suppl 6, P23; Groysman LI, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.4.FOCUS1154; Hankey GJ, 2003, MED J AUSTRALIA, V178, P568, DOI 10.5694/j.1326-5377.2003.tb05361.x; Hardig BM, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-19; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Hitchcock KE, 2011, ULTRASOUND MED BIOL, V37, P1240, DOI 10.1016/j.ultrasmedbio.2011.05.011; Huh PW, 2000, J NEUROSURG, V92, P91, DOI 10.3171/jns.2000.92.1.0091; JAFFE GJ, 1989, AM J OPHTHALMOL, V108, P90, DOI 10.1016/S0002-9394(14)73272-6; Jahan Reza, 2009, Expert Rev Cardiovasc Ther, V7, P375, DOI 10.1586/erc.09.13; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Lebiedz P, 2012, RESUSCITATION, V83, P602, DOI 10.1016/j.resuscitation.2011.11.016; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; LOREN M, 1989, THROMB RES, V56, P67, DOI 10.1016/0049-3848(89)90009-1; Maas A, 2011, LANCET NEUROL, V10, P111, DOI 10.1016/S1474-4422(10)70312-4; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; MARINKOVIC SV, 1958, STROKE, V15, P1022; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin-Schild S, 2009, J STROKE CEREBROVASC, V18, P86, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.015; MEDEN P, 1994, ACTA NEUROL SCAND, V90, P91; Meunier JM, 2007, ULTRASOUND MED BIOL, V33, P576, DOI 10.1016/j.ultrasmedbio.2006.10.010; Meunier JM, 2011, CURR NEUROVASC RES, V8, P305; Meunier JM, 2009, THROMB RES, V123, P528, DOI 10.1016/j.thromres.2008.05.011; Nedelmann M, 2005, CEREBROVASC DIS, V20, P18, DOI 10.1159/000086122; Nielsen VG, 2011, BLOOD COAGUL FIBRIN, V22, P67, DOI 10.1097/MBC.0b013e3283423534; Pancioli AM, 2008, STROKE, V39, P3268, DOI 10.1161/STROKEAHA.108.517656; Patel SC, 1999, PROG CARDIOVASC DIS, V42, P217, DOI 10.1016/S0033-0620(99)70004-6; Polak JF, 2004, NEW ENGL J MED, V351, P2154, DOI 10.1056/NEJMp048249; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qureshi AI, 2006, NEUROSURGERY, V59, P789, DOI 10.1227/01.NEU.0000232862.06246.3D; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shaw GJ, 2008, ULTRASOUND MED BIOL, V34, P1783, DOI 10.1016/j.ultrasmedbio.2008.03.020; Shaw GJ, 2007, PHYS MED BIOL, V52, P2953, DOI 10.1088/0031-9155/52/11/002; Shaw GJ, 2010, THROMB RES, V126, pE305, DOI 10.1016/j.thromres.2010.07.020; Shaw George J, 2009, BMC Res Notes, V2, P117, DOI 10.1186/1756-0500-2-117; Shaw GJ, 2006, THROMB RES, V117, P603, DOI 10.1016/j.thromres.2005.05.005; Takeuchi S, 2011, LANCET NEUROL, V10, P404, DOI 10.1016/S1474-4422(11)70083-7; Tanne D, 1999, NEUROLOGY, V53, P424, DOI 10.1212/WNL.53.2.424; Tao X, 2006, SURG NEUROL, V65, P155, DOI 10.1016/j.surneu.2005.05.027; van der Pals J, 2011, J THROMB THROMBOLYS, V32, P72, DOI 10.1007/s11239-010-0541-x; Winter Patrick M, 2005, Acad Radiol, V12 Suppl 1, pS9, DOI 10.1016/j.acra.2005.02.016; WONG KC, 1983, WESTERN J MED, V138, P227; YENARI MA, 1995, THROMB RES, V77, P475, DOI 10.1016/0049-3848(95)93883-2; Yu X, 2000, MAGNET RESON MED, V44, P867, DOI 10.1002/1522-2594(200012)44:6<867::AID-MRM7>3.0.CO;2-P; Zgavc T, 2011, STROKE RES TREATMENT, V2011, P1; Zhao H, 2011, STROKE RES TREATMENT, V2011, P1; Zygun D, 2007, J CRIT CARE, V22, P235, DOI 10.1016/j.jcrc.2006.10.037	64	11	11	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	SEP 1	2012	2	3					112	118		10.1089/ther.2012.0007			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V38PH	WOS:000209354800004	23667777	Green Published			2022-02-06	
J	Rachubinski, AL; Maclean, KN; Evans, JR; Bjugstad, KB				Rachubinski, Angela L.; Maclean, Kenneth N.; Evans, Jeffrey R.; Bjugstad, Kimberly B.			Modulating cognitive deficits and tau accumulation in a mouse model of aging Down syndrome through neonatal implantation of neural progenitor cells	EXPERIMENTAL GERONTOLOGY			English	Article						Down syndrome; Alzheimer's disease; Neural progenitor cells; Tau accumulation; Learning and memory	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; CONTROLLED CORTICAL IMPACT; AMYLOID PRECURSOR PROTEIN; SCHIFF-POSITIVE GRANULES; TS65DN MOUSE; STEM-CELLS; DENTATE GYRUS; ANIMAL-MODEL; HIPPOCAMPAL NEUROGENESIS	Although Down syndrome (DS) is primarily considered as a pediatric disorder, all DS patients incur Alzheimer's disease (AD)-like pathology and about 60% develop an additional AD-like dementia by 30-40 years of age. Cognitive and neuroanatomical changes in DS are least compromised perinatally, indicating there may be an opportunity to modulate their cognitive and neuroanatomical development during aging, preventing or postponing the onset of AD. To this end, neural progenitor cells (NPC) or saline were implanted into the hippocampus of neonatal DS-modeling (trisomic Ts65Dn) mice and non-DS (disomic Ts65Dn) age-matched mice. Twelve months later, implanted and unimplanted mice were assessed for long-term survival of NPC, for cognitive function, hippocampal cell density, and the presence of extracellular tau accumulation. Implantation of NPC in trisomic mice improved learning and memory as assessed by conditioned taste aversion testing, but not on the novel object recognition task. Trisomic mice given saline control injections improved performance on both cognitive tasks compared to unimplanted trisomic mice. In contrast, disomic mice, implanted with either saline or NPC, were impaired in both tasks. Long-term surviving NPC were found in 7 out of 11 disomic brains and 4 out of 5 trisomic brains, with an average survival rate of 3.1% and 5.9% respectively. Extracellular tau aggregations were elevated in trisomic mice, but implantation with NPC was associated with significantly fewer aggregations. This was also seen in disomic mice. Saline injections significantly elevated tau presence in both karyotypes. Based on these results, we conclude that the modest effects of a few surviving NPC cannot be distinguished from those induced by the implant procedure. However, the changes prompted by neonatal treatment were detectable in aged animals. Collectively, our data are consistent with the hypothesis that neonatal therapeutic intervention in DS has the potential to exert positive lasting effects in the later stages of life but that NPC or the implantation approach may not be the most effective strategy and alternative stem cell types or delivery systems merit further investigation. (C) 2012 Elsevier Inc. All rights reserved.	[Rachubinski, Angela L.; Maclean, Kenneth N.; Evans, Jeffrey R.; Bjugstad, Kimberly B.] Univ Colorado Denver, Dept Pediat, Sch Med, Aurora, CO 80045 USA; [Maclean, Kenneth N.; Evans, Jeffrey R.; Bjugstad, Kimberly B.] Univ Colorado Denver, Colorado Intellectual & Dev Disabil Res Ctr IDDRC, Aurora, CO USA		Bjugstad, KB (corresponding author), Univ Colorado Denver, Dept Pediat, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA.	kimberly.bjugstad@ucdenver.edu		Bjugstad, Kimberly/0000-0002-0473-5413	Charles J. Epstein Research Award through the National Down Syndrome Society, an NIH Ruth L. Kirschstein National Research Service Award (NRSA) [F31 NS060517]; Anna and John J. Sie Foundation; Linda Crnic Institute for Down Syndrome, NIH/NCRR Colorado CTSI Grant [TL1 RR025778]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [RO1 HD045224]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045224] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1RR025778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS060517] Funding Source: NIH RePORTER	The authors thank Edward Calvin for his microscopy assistance. Funding for this project was provided in part by a Charles J. Epstein Research Award through the National Down Syndrome Society, an NIH Ruth L. Kirschstein National Research Service Award (NRSA) F31 NS060517, the Anna and John J. Sie Foundation, the Linda Crnic Institute for Down Syndrome, NIH/NCRR Colorado CTSI Grant Number TL1 RR025778, and NICHD funding RO1 HD045224 (to KNM). Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	Aldridge K, 2007, AM J MED GENET A, V143A, P1060, DOI 10.1002/ajmg.a.31721; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; An JH, 2009, J PROTEOME RES, V8, P2873, DOI 10.1021/pr900020q; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Bianchi P, 2010, J NEUROSCI, V30, P8769, DOI 10.1523/JNEUROSCI.0534-10.2010; Bimonte-Nelson HA, 2003, BEHAV BRAIN RES, V139, P47, DOI 10.1016/S0166-4328(02)00082-7; Bjugstad KB, 2008, EXP NEUROL, V211, P362, DOI 10.1016/j.expneurol.2008.01.025; Bosch M, 2004, EXP NEUROL, V190, P42, DOI 10.1016/j.expneurol.2004.06.027; Bouab M, 2011, NEUROSCIENCE, V173, P135, DOI 10.1016/j.neuroscience.2010.11.032; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Chakrabarti L, 2011, DEV NEUROSCI-BASEL, V33, P428, DOI 10.1159/000329423; Choi JHK, 2009, J NEUROCHEM, V110, P1818, DOI 10.1111/j.1471-4159.2009.06277.x; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Contestabile A, 2009, BRAIN PATHOL, V19, P224, DOI 10.1111/j.1750-3639.2008.00168.x; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; Demas GE, 1996, BEHAV BRAIN RES, V82, P85, DOI 10.1016/S0166-4328(97)81111-4; Dimayuga FO, 2007, J NEUROIMMUNOL, V182, P89, DOI 10.1016/j.jneuroim.2006.10.003; Doehner J, 2010, J ALZHEIMERS DIS, V19, P1339, DOI 10.3233/JAD-2010-1333; Ebert AD, 2010, EXP NEUROL, V224, P155, DOI 10.1016/j.expneurol.2010.03.005; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Granholm ACE, 2002, PHYSIOL BEHAV, V77, P371, DOI 10.1016/S0031-9384(02)00884-3; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hunter CL, 2004, NEUROBIOL AGING, V25, P873, DOI 10.1016/j.neurobiolaging.2003.10.010; Hunter CL, 2003, NEUROSCI RES, V45, P437, DOI 10.1016/S0168-0102(03)00005-1; Hunter CL, 2003, BEHAV BRAIN RES, V138, P121, DOI 10.1016/S0166-4328(02)00275-9; Hyde LA, 2002, BRAIN RES, V945, P26, DOI 10.1016/S0006-8993(02)02500-3; Jing M, 2009, BRAIN RES, V1295, P203, DOI 10.1016/j.brainres.2009.07.079; Johnson V.E., 2011, BRAIN PATHOL; JUCKER M, 1994, NEUROSCIENCE, V60, P875, DOI 10.1016/0306-4522(94)90269-0; JUCKER M, 1994, MOL NEUROBIOL, V9, P125, DOI 10.1007/BF02816112; Jucker M., 1994, AGING CLOCK PINEAL G; Kazma M, 2010, J NEUROSCI RES, V88, P315, DOI 10.1002/jnr.22193; Kern DS, 2011, CELL TRANSPLANT, V20, P371, DOI 10.3727/096368910X528085; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Knuesel I, 2009, NEUROBIOL AGING, V30, P697, DOI 10.1016/j.neurobiolaging.2007.08.011; Kondoh T, 2011, INT J PSYCHIAT MED, V41, P71, DOI 10.2190/PM.41.1.g; Kuo H, 1996, NEUROSCIENCE, V74, P733, DOI 10.1016/0306-4522(96)00169-8; Kurt MA, 2004, BRAIN RES, V1022, P101, DOI 10.1016/j.brainres.2004.06.075; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; Landt J, 2011, ARCH NEUROL-CHICAGO, V68, P890, DOI 10.1001/archneurol.2011.36; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Llorens-Martin MV, 2010, NEUROSCIENCE, V171, P1228, DOI 10.1016/j.neuroscience.2010.09.043; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Lockrow J, 2009, EXP NEUROL, V216, P278, DOI 10.1016/j.expneurol.2008.11.021; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lott IT, 2011, AM J MED GENET A, V155A, P1939, DOI 10.1002/ajmg.a.34114; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Madhusudan A, 2009, EUR J NEUROSCI, V30, P1064, DOI 10.1111/j.1460-9568.2009.06884.x; Manich G, 2011, J ALZHEIMERS DIS, V25, P535, DOI 10.3233/JAD-2011-101713; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Mitsuno S, 1999, ACTA NEUROPATHOL, V98, P31, DOI 10.1007/s004010051048; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nelson LD, 2011, ARCH NEUROL-CHICAGO, V68, P768, DOI 10.1001/archneurol.2011.104; PENROSE LS, 1949, J MENT SCI, V95, P685, DOI 10.1192/bjp.95.400.685; Rachubinski AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036082; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Robertson TA, 1998, NEUROSCIENCE, V82, P171; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Rueda N, 2005, NEUROSCI LETT, V380, P197, DOI 10.1016/j.neulet.2005.01.039; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Saenz RB, 1999, AM FAM PHYSICIAN, V59, P381; Schmitz C, 1998, ANAT EMBRYOL, V198, P371, DOI 10.1007/s004290050191; Sebastia J, 2004, EUR J NEUROSCI, V20, P2355, DOI 10.1111/j.1460-9568.2004.03686.x; Shichiri M, 2011, FREE RADICAL BIO MED, V50, P1801, DOI 10.1016/j.freeradbiomed.2011.03.023; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tyler C, 2004, PRIMARY CARE, V31, P627, DOI 10.1016/j.pop.2004.04.006; Van Den Heuvel C., 2007, NEUROTRAUMA NEW INSI; Vukovic J, 2011, NEUROCHEM INT, V59, P341, DOI 10.1016/j.neuint.2011.04.003; Wang YZ, 2011, STEM CELLS, V29, P907, DOI 10.1002/stem.644; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; Yang H, 2011, EXP GERONTOL, V46, P628, DOI 10.1016/j.exger.2010.12.004; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	82	11	11	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565			EXP GERONTOL	Exp. Gerontol.	SEP	2012	47	9					723	733		10.1016/j.exger.2012.06.013			11	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	990VU	WOS:000307660700009	22776132				2022-02-06	
J	Friess, SH; Smith, C; Kilbaugh, TJ; Frangos, SG; Ralston, J; Helfaer, MA; Margulies, SS				Friess, Stuart H.; Smith, Colin; Kilbaugh, Todd J.; Frangos, Suzanne G.; Ralston, Jill; Helfaer, Mark A.; Margulies, Susan S.			Early cerebral perfusion pressure augmentation with phenylephrine after traumatic brain injury may be neuroprotective in a pediatric swine model	CRITICAL CARE MEDICINE			English	Article						cerebral blood flow; cerebral perfusion pressure; pediatric head injury; phenylephrine; neuroprotection; swine	CLOSED-HEAD INJURY; INTRACRANIAL-PRESSURE; NEONATAL PIG; CEREBROVASCULAR RESPONSE; CORTICAL IMPACT; ISCHEMIC-STROKE; AXONAL INJURY; HYPOTENSION; CHILDREN; AUTOREGULATION	Objective: Cerebral perfusion pressure <40 mm Hg following pediatric traumatic brain injury has been associated with increased mortality independent of age, and current guidelines recommend maintaining cerebral perfusion pressure between 40 mm Hg-60 mm Hg. Although adult traumatic brain injury studies have observed an increased risk of complications associated with targeting a cerebral perfusion pressure >70, we hypothesize that targeting a cerebral perfusion pressure of 70 mm Hg with the use of phenylephrine early after injury in the immature brain will be neuroprotective. Design: Animals were randomly assigned to injury with a cerebral perfusion pressure of 70 mm Hg or 40 mm Hg. Diffuse traumatic brain injury was produced by a single rapid rotation of the head in the axial plane. Cerebral microdialysis, brain tissue oxygen, intracranial pressure, and cerebral blood flow were measured 30 min-6 hrs postinjury. One hour after injury, cerebral perfusion pressure was manipulated with the vasoconstrictor phenylephrine. Animals were euthanized 6 hrs posttraumatic brain injury, brains fixed, and stained to assess regions of cell injury and axonal dysfunction. Setting: University center. Subject: Twenty-one 4-wk-old female swine. Measurements and Main Results: Augmentation of cerebral perfusion pressure to 70 mm Hg resulted in no change in axonal dysfunction, but significantly smaller cell injury volumes at 6 hrs postinjury compared to cerebral perfusion pressure 40 (1.1% vs. 7.4%, p < .05). Microdialysis lactate/pyruvate ratios were improved at cerebral perfusion pressure 70 compared to cerebral perfusion pressure 40. Cerebral blood flow was higher in the cerebral perfusion pressure 70 group but did not reach statistical significance. Phenylephrine was well tolerated and there were no observed increases in serum lactate or intracranial pressure in either group. Conclusions: Targeting a cerebral perfusion pressure of 70 mm Hg resulted in a greater reduction in metabolic crisis and cell injury volumes compared to a cerebral perfusion pressure of 40 mm Hg in an immature swine model. Early aggressive cerebral perfusion pressure augmentation to a cerebral perfusion pressure of 70 mm Hg in pediatric traumatic brain injury before severe intracranial hypertension has the potential to be neuroprotective, and further investigations are needed. (Crit Care Med 2012; 40:2400-2406)	[Margulies, Susan S.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Friess, Stuart H.; Kilbaugh, Todd J.; Helfaer, Mark A.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA USA; [Smith, Colin] Western Gen Hosp, Dept Neuropathol, Edinburgh EH4 2XU, Midlothian, Scotland; [Frangos, Suzanne G.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Margulies, SS (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Smith, Colin/0000-0002-4507-5132; Kilbaugh, Todd/0000-0002-4959-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08-NS064051, R01-NS39679]; Endowed Chair in Critical Care Medicine, The Children's Hospital of Philadelphia; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700704B] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545, R01NS039679, K08NS064051] Funding Source: NIH RePORTER	Supported by NIH grant K08-NS064051 (SHF), the Endowed Chair in Critical Care Medicine, The Children's Hospital of Philadelphia (MAH), and NIH grant R01-NS39679 (SSM).	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; Bedforth NM, 2001, BRIT J ANAESTH, V87, P193, DOI 10.1093/bja/87.2.193; Broderick JP, 2002, CIRCULATION, V106, P1736, DOI 10.1161/01.CIR.0000030407.10591.35; Chambers Iain R, 2003, Neurosurg Focus, V15, pE3; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; De Cosmo G, 2005, NEUROL RES, V27, P433, DOI 10.1179/016164105X21724; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Jackson S, 2000, ACTA NEUROCHIR SUPPL, V76, P453; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Llinas RH, 2008, SEMIN NEUROL, V28, P645, DOI 10.1055/s-0028-1105975; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; Nordstrom Carl-Henrik, 2003, Neurosurg Focus, V15, pE5; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rajan V, 1998, BIOL NEONATE, V74, P39, DOI 10.1159/000014009; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Swindle MM., 2007, SWINE LAB SURG ANEST; Winter JD, 2011, PEDIATR RES, V69, P418, DOI 10.1203/PDR.0b013e3182110f7e	40	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2012	40	8					2400	2406		10.1097/CCM.0b013e31825333e6			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	976SM	WOS:000306604900018	22809910	Green Accepted, Green Submitted			2022-02-06	
J	Godoy, DA; Rabinstein, AA; Biestro, A; Ainslie, PN; Di Napoli, M				Godoy, Daniel A.; Rabinstein, Alejandro A.; Biestro, Alberto; Ainslie, Philip N.; Di Napoli, Mario			Effects of Indomethacin Test on Intracranial Pressure and Cerebral Hemodynamics in Patients With Refractory Intracranial Hypertension: A Feasibility Study	NEUROSURGERY			English	Article						Cerebral perfusion pressure; Indomethacin; Intracerebral hemorrhage; Intracranial hypertension; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW-VELOCITY; HEAD-INJURY; ACUTE MANAGEMENT; METABOLISM; PERFUSION; OXYGEN; HYPERVENTILATION; CYCLOOXYGENASE; EXTRACTION	BACKGROUND: Intracranial hypertension is the final pathway of many neurocritical entities, such as spontaneous intracerebral hemorrhage (sICH) and severe traumatic brain injury (sTBI). OBJECTIVE: This study aimed to (1) determine alterations in intracranial pressure (ICP) and cerebral hemodynamics after an indomethacin (INDO) infusion test and the related association with survival in patients with refractory intracranial hypertension (RICH) secondary to sICH or sTBI and (2) assess the safety profile after INDO. METHODS: INDO was administered in a loading dose (0.8 mg/kg/15 min), followed by a 2-hour continuous infusion (0.5 mg/kg/h) in RICH patients with ICP greater than 20 mm Hg who did not respond to first-line therapies. Changes in ICP, cerebral perfusion pressure (CPP), and cerebrovascular variables (assessed by transcranial Doppler and jugular bulb saturation) were observed. Clinical outcome was assessed at 1 and 6 months according to the Glasgow Outcome Scale and correlated with INDO infusion test response. Analysis of INDO safety profile was conducted. RESULTS: Thirteen sICH and 10 sTBI patients were studied. The median GCS score at admission was 6. Within 30 minutes of INDO infusion, ICP decreased (42.0 +/- 13.5 vs 27.70 +/- 12.7mm Hg; Delta%: -48.4%; P < .001), and both CPP (57.7 +/- 4.8 vs 71.9 +/- 7.0 mm Hg; Delta%: +26.0%; P < .001) and middle cerebral artery velocity (35.2 +/- 5.6 vs 42.0 +/- 5.1 cm.s(-1); Delta%: +26.1%; P < .001) increased. The CPP response to a 2-hour INDO infusion test was correlated (R-2 = 0.72, P < .001) with survival. No adverse events were observed after INDO. CONCLUSION: Our findings support the effectiveness and feasibility of an INDO test in decreasing ICP and improving cerebral hemodynamics in surviving RICH patients. Future studies to evaluate different doses, lengths of infusion, and longer term effects are needed.	[Godoy, Daniel A.] Sanatorio Pasteur, Neurocrit Care Unit, Catamarca, Argentina; [Rabinstein, Alejandro A.] Mayo Clin, Neurosci Intens Care Unit, Rochester, MN USA; [Biestro, Alberto] Hosp Clin Montevideo, Intens Treatment Ctr, Montevideo, Uruguay; [Ainslie, Philip N.] Univ British Columbia Okanagan, Fac Hlth & Social Dev, Dept Human Kinet, Kelowna, BC, Canada; [Di Napoli, Mario] San Camillo de Lellis Gen Hosp, Neurol Serv, Rieti, Italy; [Di Napoli, Mario] SMDN Ctr Cardiovasc Med & Cerebrovasc Dis Prevent, Neurol Sect, Laquila, Italy		Godoy, DA (corresponding author), Chacabuco 675, RA-4700 San Fernando Valle Catam, Argentina.	dagodoytorres@yahoo.com.ar; mariodinapoli@katamail.com	Di Napoli, Mario/H-3475-2019; Di Napoli, Mario/J-6418-2014	Di Napoli, Mario/0000-0001-9609-4926; Di Napoli, Mario/0000-0001-9609-4926	Sanatorio Pasteur, Catamarca, Argentina	This work was supported by grants from the Sanatorio Pasteur, Catamarca, Argentina. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	BIESTRO AA, 1995, J NEUROSURG, V83, P627, DOI 10.3171/jns.1995.83.4.0627; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burgess KR, 2010, CHEST, V137, P707, DOI 10.1378/chest.09-1329; Clemmesen JO, 1997, HEPATOLOGY, V26, P1423; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cruz J, 1996, CRIT CARE MED, V24, P953, DOI 10.1097/00003246-199606000-00013; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Dahl B, 1996, ACTA NEUROCHIR, V138, P265, DOI 10.1007/BF01411736; ERIKSSON S, 1983, ACTA PHYSIOL SCAND, V117, P203, DOI 10.1111/j.1748-1716.1983.tb07198.x; Fox JL, 2010, CAN J EMERG MED, V12, P355; Godoy DA, 2005, ACTA ANAESTH SCAND, V49, P1577, DOI 10.1111/j.1399-6576.2005.00885_49_10.x; Harrigan MR, 1997, J NEUROTRAUM, V14, P637, DOI 10.1089/neu.1997.14.637; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Imberti R, 2005, J NEUROSURG, V102, P455, DOI 10.3171/jns.2005.102.3.0455; Jensen K, 1996, J NEUROSURG ANESTH, V8, P111, DOI 10.1097/00008506-199604000-00002; JENSEN K, 1993, ACTA NEUROCHIR, V124, P114, DOI 10.1007/BF01401132; JENSEN K, 1991, ACTA NEUROCHIR, V108, P116, DOI 10.1007/BF01418518; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Marion DW, 2006, NEUROSURGERY, V58, P655; MARKUS HS, 1994, STROKE, V25, P1760, DOI 10.1161/01.STR.25.9.1760; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Minassian AT, 1998, J NEUROSURG, V88, P996, DOI 10.3171/jns.1998.88.6.0996; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PICKARD J, 1980, BRAIN RES, V197, P425, DOI 10.1016/0006-8993(80)91127-0; PICKARD JD, 1977, EUR J PHARMACOL, V43, P343, DOI 10.1016/0014-2999(77)90040-1; Poca MA, 2007, J NEUROSURG, V106, P530, DOI 10.3171/jns.2007.106.4.530; Puppo C, 2007, ACTA NEUROCHIR, V149, P139, DOI 10.1007/s00701-006-1074-0; QUINTANA A, 1988, EUR J PHARMACOL, V149, P385, DOI 10.1016/0014-2999(88)90674-7; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rasmussen M, 2005, ACTA ANAESTH SCAND, V49, P341, DOI 10.1111/j.1399-6576.2005.00647.x; Rasmussen M, 2004, ANESTHESIOLOGY, V101, P872, DOI 10.1097/00000542-200410000-00011; Rasmussen M, 2004, ANAESTHESIA, V59, P229, DOI 10.1111/j.1365-2044.2004.03604.x; Roberts R G, 2002, Crit Care Resusc, V4, P271; Schumann P, 1996, NEUROSCI LETT, V220, P137, DOI 10.1016/S0304-3940(96)13210-9; Slavik RS, 1999, NEUROL RES, V21, P491; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; TEASDALE G, 1974, LANCET, V2, P81; Tofteng F, 2004, J CEREBR BLOOD F MET, V24, P798, DOI 10.1097/01.WCB.0000125648.03213.1D; Upton RN, 2008, CLIN EXP PHARMACOL P, V35, P317, DOI 10.1111/j.1440-1681.2007.04818.x; Valadka A B, 2000, Neurosurg Focus, V9, pe3; Valdueza JM, 1997, AM J NEURORADIOL, V18, P1929; Weigert G, 2008, INVEST OPHTH VIS SCI, V49, P1065, DOI 10.1167/iovs.07-0824; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	54	11	11	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2012	71	2					245	257		10.1227/NEU.0b013e318256b9f5			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	983HB	WOS:000307109301004	22531711				2022-02-06	
J	Marshall, SA; Riechers, RG				Marshall, Scott A.; Riechers, Ronald G., II			Diagnosis and Management of Moderate and Severe Traumatic Brain Injury Sustained in Combat	MILITARY MEDICINE			English	Article							CEREBRAL PERFUSION-PRESSURE; CLOSED-HEAD INJURY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; HYPOTHERMIA; HERNIATION; THERAPY; CARE; LEVETIRACETAM; PROGESTERONE	Traumatic brain injury exists in a spectrum of severity among wounded personnel. The evaluation and clinical presentation, initial management, and treatment interventions to prevent secondary injury processes for combat-associated moderate and severe traumatic brain injury are reviewed. Promising therapies are discussed, and a current review of the literature is provided.	[Marshall, Scott A.] San Antonio Mil Med Ctr, Dept Neurol, Div Crit Care Med, Ft Sam Houston, TX 78234 USA; [Marshall, Scott A.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Riechers, Ronald G., II] Cleveland VA Med Ctr, Polytrauma Team, Cleveland, OH 44106 USA; [Riechers, Ronald G., II] Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA		Marshall, SA (corresponding author), San Antonio Mil Med Ctr, Dept Neurol, Div Crit Care Med, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.						Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; American College of Surgeons, 2004, ADV TRAUM LIF SUPP P; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Brain Trauma Foundation, 2011, ONL TBI GUID; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS21; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Geocadin R., 2004, HDB NEURO CRITICAL C, P73; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Habashi Nader M, 2005, Crit Care Med, V33, pS228, DOI 10.1097/01.CCM.0000155920.11893.37; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jia XF, 2008, RESUSCITATION, V76, P431, DOI 10.1016/j.resuscitation.2007.08.014; Juhasz M, 2010, DIGESTION, V81, P10, DOI 10.1159/000243717; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion D W, 1995, New Horiz, V3, P439; Marion DW, 1998, NEUROL CLIN, V16, P485, DOI 10.1016/S0733-8619(05)70073-6; Marko NF, 2012, AM J RESP CRIT CARE, V185, P467, DOI 10.1164/rccm.201109-1698ED; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MICHELSON AD, 1994, THROMB HAEMOSTASIS, V71, P633; Mossad EB, 2007, SEMIN CARDIOTHORAC V, V11, P34, DOI 10.1177/1089253206297413; Muehlschlegel S, 2009, ARCH NEUROL-CHICAGO, V66, P670, DOI 10.1001/archneurol.2009.33; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Naidech AM, 2005, STROKE, V36, P583, DOI 10.1161/01.STR.0000141936.36596.1e; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Qureshi AI, 2008, NEUROLOGY, V70, P990, DOI 10.1212/01.wnl.0000311290.86780.78; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROPPER AH, 2004, NEUROLOGICAL NEUROSU; Schlifka B, 2010, J TRAUMA, V62, pS103; Schlifka B, 2007, J TRAUMA, V62, pS103, DOI 10.1097/TA.0b013e318065b4e5; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Seinfeld Joshua, 2007, Neurosurgery, V61, pE175; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEASDALE G, 1974, LANCET, V2, P81; Temkin N R, 1995, New Horiz, V3, P518; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Vilela MD, 2008, SURG NEUROL, V69, P293, DOI 10.1016/j.surneu.2007.01.027; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017	71	11	11	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2012	177	8		S	SI		76	85		10.7205/MILMED-D-12-00142			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33OB	WOS:000209027000011	22953444				2022-02-06	
J	Moein, H; Sanati, MA; Fard, SA; Moein, P; Hasheminasab, SM				Moein, Hooshang; Sanati, Mohammad Ali; Fard, Salman Abbasi; Moein, Payam; Hasheminasab, Seyed Mohammad			Outcome of Decompressive Craniectomy in Patients With Severe Head Injury: A Pilot Randomized Clinical Trial	NEUROSURGERY QUARTERLY			English	Article						decompressive craniectomy; GCS; brain injury	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; MANAGEMENT; SECONDARY; CHILDREN; IMPACT; DAMAGE	Background: Head injury is the most important cause of death caused by trauma. Decompressive craniectomy is the best-known way to reduce otherwise intractable intracranial pressure and its complications in traumatic brain injury. Aim: This aim of this study was to evaluate the outcome of patients with decompressive craniectomy after severe traumatic brain injury and compare with a control group. Setting: Al-Zahra and Kashani hospital in Isfahan. Design: Pilot randomized clinical trial. Methods: Twenty patients were entered in this study. Patients were randomly divided into group A and group B. Group A received surgical and conservative treatment and group B underwent conservative treatment alone. Both groups were then followed for 6 months. Both groups' presentation Glasgow Coma Scale and Glasgow Outcome Scale (GOS) were compared. Results: A favorable GOS was achieved in 6 cases (60%) of patients in group A and in 2 cases (20%) in group B. However, the difference was not statistically significant. The death rate was higher in group B, with 3 cases (30%), and only 1 patient (10%) died in group A, but the difference was not significant. Conclusions: Decompressive craniectomy seems to be helpful and may lead to a better GOS achievement and improve the mortality rate among traumatic brain injury patients; however, further investigation will be needed to confirm the results.	[Moein, Hooshang] Al Zahra Hosp, Dept Neurosurg, Esfahan, Iran; [Sanati, Mohammad Ali; Fard, Salman Abbasi; Moein, Payam] Isfahan Univ Med Sci, Dept Neurosurg, Tehran, Iran; [Hasheminasab, Seyed Mohammad] Univ Tehran Med Sci, Fac Med, Tehran, Iran		Fard, SA (corresponding author), Al Zahra Hosp, Dept Neurosurg, Esfahan, Iran.	Dr_abbasi_s@yahoo.com					Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Chen Chun-Chung, 2007, J Chin Med Assoc, V70, P56; DiValvasone S, 2010, CRITICAL CARE S1, V14, P298; Fukai J, 2009, NEUROL MED-CHIR, V49, P22, DOI 10.2176/nmc.49.22; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; JENNETT B, 1975, LANCET, V1, P480; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Toussaint CP, 2008, NEUROSURG QUART, V18, P45, DOI 10.1097/WNQ.0b013e3181642924; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zhao Z, 2007, NEUROCRIT CARE, V7, P263, DOI 10.1007/s12028-007-0074-0; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	27	11	11	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-6438	1534-4916		NEUROSURG QUART	Neurosurg. Q.	AUG	2012	22	3					149	152		10.1097/WNQ.0b013e318240f1e0			4	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	985IN	WOS:000307256700002					2022-02-06	
J	Zakaria, N; Kallakuri, S; Bandaru, S; Cavanaugh, JM				Zakaria, Nisrine; Kallakuri, Srinivasu; Bandaru, Sharath; Cavanaugh, John M.			Temporal assessment of traumatic axonal injury in the rat corpus callosum and optic chiasm	BRAIN RESEARCH			English	Article						Traumatic axonal injury; Corpus callosum; Optic chiasm; Impaired axoplasmic transport; Neurofilament compaction; Impact acceleration model	INTRAAXONAL NEUROFILAMENT COMPACTION; BETA-APP IMMUNOHISTOCHEMISTRY; IMPACT-ACCELERATION INJURY; DIFFUSE BRAIN INJURY; CLOSED-HEAD INJURY; POSTTRAUMATIC HYPOTHERMIA; AXOLEMMAL PERMEABILITY; MEMBRANE-PERMEABILITY; QUANTITATIVE-ANALYSIS; NERVE FIBERS	Impaired axoplasmic transport (IAT) and neurofilament compaction (NFC), two common axonal pathology processes involved in traumatic axonal injury (TAI), have been well characterized. TAI is found clinically and in animal models in brainstem white matter (WM) tracts and in the corpus callosum (CC), optic chiasm (Och), and internal capsule. Previous published quantitative studies of the time course of TAI expression induced by the Marmarou impact acceleration model have been limited to the brainstem. Accordingly, this study assessed the extent of IAT and NFC in the CC and Och at 8 h, 28 h, 3 days and 7 days after traumatic brain injury (TB!) induction by the Marmarou impact acceleration model. IAT peak density was observed at 8 h in the CC and 28 h in the Och post-TBI. NFC peak density was observed at 28 h in both structures. The density of IAT and NFC decreased with increasing survival time in both structures. The NFC density time profile followed a similar trend in both the Och and CC, whereas the IAT density time profile was variable between the Och and CC. Furthermore, a strong linear relationship was observed between IAT and NFC in the CC but not in the Och. These findings highlight the heterogeneity of TAI as evidenced by variable IAT and NFC injury time profiles in each anatomical structure. This variability indicates the requirement of multiple markers for a comprehensive TAI evaluation and multiple targeted treatments for TAI polypathology within its therapeutic window time frame. (c) 2012 Elsevier B.V. All rights reserved.	[Zakaria, Nisrine; Kallakuri, Srinivasu; Bandaru, Sharath; Cavanaugh, John M.] Wayne State Univ, Dept Biomed Engn, Coll Engn, Detroit, MI 48202 USA		Zakaria, N (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 W Hancock, Detroit, MI 48201 USA.	nisrine@wayne.edu; skallakuri@wayne.edu; sharath@wayne.edu; jmc@wayne.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BENNETT M, 1995, IRISH MED J, V88, P59; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 2000, J HISTOCHEM CYTOCHEM, V48, P153; Czeiter E, 2008, J NEUROTRAUM, V25, P205, DOI 10.1089/neu.2007.0331; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; DUVDEVANI R, 1993, J ELECTRON MICROSC, V42, P412; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Hoffman PN., 1995, NEUROSCIENTIST, VVol 1, P76; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Li Y., 2011, STAPP CAR CRASH J, V55, P11; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; MALBOUISSON AMB, 1985, ANAT EMBRYOL, V171, P339, DOI 10.1007/BF00347022; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Pal J, 2006, J NEUROSCI METH, V153, P283, DOI 10.1016/j.jneumeth.2005.11.004; Perunovic B, 2001, J NEUROL SCI, V185, P55, DOI 10.1016/S0022-510X(01)00463-4; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 1999, ACT NEUR S, V73, P15; PRICE RL, 1988, J NEUROCYTOL, V17, P55, DOI 10.1007/BF01735377; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Slazinski T, 1994, J Neurosci Nurs, V26, P151; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; TROJANOWSKI JQ, 1989, AM J PATHOL, V135, P747; WAXMAN SG, 1988, BRAIN RES, V453, P337, DOI 10.1016/0006-8993(88)90174-6; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]	52	11	11	1	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 27	2012	1467						81	90		10.1016/j.brainres.2012.05.046			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	994CT	WOS:000307909200009	22652307				2022-02-06	
J	Kane, MJ; Angoa-Perez, M; Francescutti, DM; Sykes, CE; Briggs, DI; Leung, LY; VandeVord, PJ; Kuhn, DM				Kane, Michael J.; Angoa-Perez, Mariana; Francescutti, Dina M.; Sykes, Catherine E.; Briggs, Denise I.; Leung, Lai Yee; VandeVord, Pamela J.; Kuhn, Donald M.			Altered gene expression in cultured microglia in response to simulated blast overpressure: Possible role of pulse duration	NEUROSCIENCE LETTERS			English	Article						Microglia; Gene expression; Blast; Overpressure; Barochamber; Primary trauma	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; RATS; EXPOSURE; NEUROTOXICITY; ACTIVATION; MECHANISMS; RELEVANCE; STRIATUM; DISEASES	Blast overpressure has long been known to cause barotrauma to air-filled organs such as lung and middle ear. However, experience in Iraq and Afghanistan is revealing that individuals exposed to explosive munitions can also suffer traumatic brain injury (TBI) even in the absence of obvious external injury. The interaction of a blast shock wave with the brain in the intact cranial vault is extremely complex making it difficult to conclude that a blast wave interacts in a direct manner with the brain to cause injury. In an attempt to "isolate" the shock wave and test its primary effects on cells, we exposed cultured microglia to simulated blast overpressure in a barochamber. Overpressures ranging from 15 to 45 psi did not change microglial Cox-2 levels or TNF-alpha secretion nor did they cause cell damage. Microarray analysis revealed increases in expression of a number of microglial genes relating to immune function and inflammatory responses to include Saa3, Irg1, Fas and CxCl10. All changes in gene expression were dependent on pulse duration and were independent of pressure. These results indicate that microglia are mildly activated by blast overpressure and uncover a heretofore undocumented role for pulse duration in this process. Published by Elsevier Ireland Ltd.	[Kane, Michael J.; Angoa-Perez, Mariana; Francescutti, Dina M.; Sykes, Catherine E.; Briggs, Denise I.; Leung, Lai Yee; VandeVord, Pamela J.; Kuhn, Donald M.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA; [Kane, Michael J.; Angoa-Perez, Mariana; Francescutti, Dina M.; Sykes, Catherine E.; Briggs, Denise I.; Kuhn, Donald M.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA; [Leung, Lai Yee; VandeVord, Pamela J.] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA		Kuhn, DM (corresponding author), John D Dingell VAMC, R&D Serv 11R, 4646 John R, Detroit, MI 48201 USA.	donald.kuhn@wayne.edu	Leung, Lai Yee/H-8204-2013	Briggs, Denise/0000-0002-4824-3947	Department of Veterans AffairsUS Department of Veterans Affairs; VA Career Development Award; VA Merit AwardUS Department of Veterans Affairs; VA Research Career Scientist Award; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA017327] Funding Source: NIH RePORTER	This work was supported by funding from the Department of Veterans Affairs, a VA Career Development Award (P.J.V.) and by VA Merit and Research Career Scientist Awards (D.M.K.).	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Lee KYK, 2011, NEUROIMAGE, V54, pS30, DOI 10.1016/j.neuroimage.2010.05.042; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Minghetti L, 2005, BRAIN RES REV, V48, P251, DOI 10.1016/j.brainresrev.2004.12.015; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas D.M., 2005, FASEB J; Thomas DM, 2005, FASEB J, V19, P515, DOI 10.1096/fj.05-4873fje; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906	40	11	11	1	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUL 26	2012	522	1					47	51		10.1016/j.neulet.2012.06.012			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	982IF	WOS:000307035700010	22698585	Green Accepted			2022-02-06	
J	Monsalve, BC; Guitart, MB; Lopez, R; Vilasar, AB; Quemada, JI				Castano Monsalve, Beatriz; Bernabeu Guitart, Montserrat; Lopez, Raquel; Bulbena Vilasar, Antoni; Ignacio Quemada, Jose			Psychopatological evaluation of traumatic brain injury patients with the Neuropsychiatric Inventory	REVISTA DE PSIQUIATRIA Y SALUD MENTAL			Spanish	Article						Traumatic Brain Injury; Neuropsychiatric Inventory; Behavior disorder; Drug abuse; Disability	MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; RATING-SCALE; HEAD-INJURY; SYMPTOMS; PSYCHOPATHOLOGY; DISABILITY; DISORDERS; COMMUNITY; DEMENTIA	Introduction: The Neuropsychiatric Inventory (NPI) is a scale that assesses psychiatric symptoms in patients with neurological disorders, principally dementia. Despite its advantages, there are few published studies in traumatic brain injury (TBI) patients. With the NPI information we are going to describe the psychopatologic disorders in a group of TBI chronic patients and look the possible association with psychiatric history and outcome measures. Method: The NPI was applied to caregivers of 53 patients with severe TBI in chronic phase. We also collected functional and community integration scales. Results: 92.5% of patients had some neuropsychiatric symptom, according to NPI. The most frequents were irritability/lability, apathy and depression/dysphoria. Those patients with drugs abuse history had more psychiatric symptoms. Presence of agitation/aggression, apathy and disinhibition were correlated with more disability. Conclusions: Psychiatric disorders are common between patients with TBI. The NPI is a scale that systematically assesses the behavioral and emotional disorders more common in these patients. Some of the symptoms negatively influence the degree of disability. (C) 2011 SEP y SEPB. Published by Elsevier Espana, S.L. All rights reserved.	[Castano Monsalve, Beatriz; Bernabeu Guitart, Montserrat; Lopez, Raquel; Bulbena Vilasar, Antoni] Univ Autonoma Barcelona, Unidad Dano Cerebral, Inst Guttmann, Hosp Neurorrehabil,Inst Univ, Badalona, Spain; [Ignacio Quemada, Jose] Hosp Aita Menni, Serv Dano Cerebral, Donostia San Sebastian, Spain		Monsalve, BC (corresponding author), Univ Autonoma Barcelona, Unidad Dano Cerebral, Inst Guttmann, Hosp Neurorrehabil,Inst Univ, Badalona, Spain.	bcastano@guttmann.com					Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Castellanos-Pinedo F, 2011, J NEUROPSYCH CLIN N, V23, P340, DOI 10.1176/appi.neuropsych.23.3.340; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; de Sanidad M, 2004, INF PLAN NAC DROG; Diaz-Olavarrieta C, 1999, J NEUROPSYCH CLIN N, V11, P51, DOI 10.1176/jnp.11.1.51; Dimarco, 2002, EURA MEDICOPHYS, V38, P167; Figved N, 2005, ACTA PSYCHIAT SCAND, V112, P463, DOI 10.1111/j.1600-0447.2005.00624.x; Garcia-Alberca JM, 2008, ACTAS ESP PSIQUIATRI, V36, P265; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson DK, 2011, ALZ DIS ASSOC DIS, V25, P326, DOI 10.1097/WAD.0b013e31820d89b6; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Kulisevsky J, 2001, MOVEMENT DISORD, V16, P1098, DOI 10.1002/mds.1225; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Litvan I, 1998, J NEUROL NEUROSUR PS, V65, P717, DOI 10.1136/jnnp.65.5.717; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Manes F, 1999, J NERV MENT DIS, V187, P707, DOI 10.1097/00005053-199912000-00001; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rush BK, 2010, J STROKE CEREBROVASC, V19, P326, DOI 10.1016/j.jstrokecerebrovasdis.2009.09.009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vilalta-Franch J, 1999, REV NEUROLOGIA, V29, P15, DOI 10.33588/rn.2901.99226; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wright J, 2008, DISABILITY RATING SC	27	11	11	0	6	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	1888-9891	1989-4600		REV PSIQUIATR SALUD	Rev. Psiquiatr. Salud Ment.	JUL-SEP	2012	5	3					160	166		10.1016/j.rpsm.2012.02.004			7	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	972CY	WOS:000306255300004	22854610				2022-02-06	
J	Ghai, A; Sangwan, SS; Hooda, S; Kiran, S; Garg, N				Ghai, Anju; Sangwan, Sukhbir Singh; Hooda, Sarla; Kiran, Shashi; Garg, Nidhi			Obturator neurolysis using 65% alcohol for adductor muscle spasticity	SAUDI JOURNAL OF ANAESTHESIA			English	Article						Alcohol; obturator nerve block; spasticity		Spasticity is motor alteration characterized by muscle hypertonia and hyperreflexia. It is an important complication of spinal cord injury, traumatic brain injury, cerebral palsy, and multiple sclerosis. If uncorrected, fibrosis and eventually bony deformity lock the joint into a fixed contracture. Chemical neurolysis using various agents is one of the therapeutic possibilities to alleviate spasticity. We are, hereby, reporting 3 patients in whom 65% alcohol was used as neurolytic agent for the treatment of hip adductor spasticity, and the effect lasted for a variable period.	[Ghai, Anju; Kiran, Shashi; Garg, Nidhi] PGIMS, Dept Anaesthesiol & Crit Care, Rohtak, Haryana, India; [Sangwan, Sukhbir Singh] Pt BD Sharma PGIMS Rohtak, Orthoped & Rehabil, Rohtak, Haryana, India; [Ghai, Anju] PGIMS, 19-9J,Med Campus, Rohtak, Haryana, India		Ghai, A (corresponding author), PGIMS, 19-9J,Med Campus, Rohtak, Haryana, India.	dr.wadhera@yahoo.com		Hooda, Sarla/0000-0002-2937-9830			Akkaya T, 2010, ACTA ANAESTH SCAND, V54, P79, DOI 10.1111/j.1399-6576.2009.02130.x; Barnes MP, 1998, AGE AGEING, V27, P239, DOI 10.1093/ageing/27.2.239; Ganesh Bavikatte, 2009, British Journal of Medical Practitioners, V2, P29; Georgescu VA., 2009, DRUGS AGENTS USED NE; Jain S, 2007, NEURAL BLOCKADE NEUR; Kong KH, 1999, INT J REHABIL RES, V22, P327, DOI 10.1097/00004356-199912000-00011; RAJ PP, 1991, CLIN PRACTICE REGION; Rajendra K, 2008, INDIAN J PHYS MED RE, V19, P13; Viel EJ, 2002, EUR J PAIN-LONDON, V6, P97, DOI 10.1053/eujp.2001.0269; Ward AB, 2002, EUR J NEUROL, V9, P48, DOI 10.1046/j.1468-1331.2002.0090s1048.x	10	11	11	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1658-354X	0975-3125		SAUDI J ANAESTH	Saudi J. Anaesth.	JUL-SEP	2012	6	3					282	284		10.4103/1658-354X.101223			3	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V4N6K	WOS:000219096100019	23162405	gold, Green Published			2022-02-06	
J	Pachalska, M; Kaczmarek, BLJ				Pachalska, Maria; Kaczmarek, Boiydar L. J.			ALEXANDER ROMANOVICH LURIA (1902-1977) AND THE MICROGENETIC APPROACH TO THE DIAGNOSIS AND REHABILITATION OF TBI PATIENTS	ACTA NEUROPSYCHOLOGICA			English	Article						neuropsychology (history); single case study; microgenetic theory	LANGUAGE; BRAIN	Alexander Romanovich Luria (1902-1977), Russian psychologist and neuropsychologist, is recognized throughout the world as one of the most eminent and influential psychologists of the 20th century, who made advances in many areas, including cognitive psychology, the processes of learning and forgetting, mental retardation and neuropsychology. Luria's scientific career was build in "the stages of a journey undertaken" (as the Russian title of Luria's autobiography says): co-working with Lev S. Vygotsky (1896-1934) and the foundation of the cultural-historical school (the 1920s), cross-cultural research, an expedition to Central Asia, and studies on twins (the 1930s), the war and the first works on brain injured patients (the 1940s), research into mentally retarded children, brain injuries and rehabilitation (1950s), the systematic development of neuropsychological research (the 1960s and 70s). The research on the functioning of the brain, touching on learning and forgetting, attention and perception as psychological constructs, was to engage Luria for forty years. Analysis of functional changes resulting from local brain lesions constituted the area of greatest interest. The single-case approach to neurological studies was to be the focus of his last years. In this paper we attempt to show the impact of Luria's approach on the foundations of the microgenetic approach to the diagnosis and rehabilitation of patients with traumatic brain injuries, and espe cially the importance of symptom analysis in single-case studies.	[Pachalska, Maria] Andrzej Fryczmodrzewski Cracow Univ, Herlinga Grudzinskiego 1, Krakow, Poland; [Pachalska, Maria] Ctr Cognit & Commun, New York, NY USA; [Kaczmarek, Boiydar L. J.] Univ Econ & Innovat, Lublin, Poland		Pachalska, M (corresponding author), Andrzej Fryczmodrzewski Cracow Univ, Herlinga Grudzinskiego 1, Krakow, Poland.	neuropsychologia23@o2.pl	Kaczmarek, Bozydar/AAI-3301-2020	Kaczmarek, bozydar/0000-0001-8683-1128			Akhutina T V, 1983, Brain Cogn, V2, P129, DOI 10.1016/0278-2626(83)90003-9; Bein E.S, 1964, AFAZIJA PUTI JEJO PR; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; Brown J., 2003, ACTA NEUROPSYCHOL, V1, P1; Brown J., 2005, PROCESS AUTHENTIC LI; Brown J. W., 2004, ACTA NEUROPSYCHOLOGI, V2, P1; Brown J.W., 2001, NEUROPSYCHOANALYSIS, V3, P61; Brown J.W., 1985, J NEUROLINGUIST, V1, P31; Brown J.W., 2000, MIND NATURE ESSAYS T; Brown J.W., 1986, INTERVENTION STRATEG; Brown J.W, 2002, SELF EMBODYING MIND SELF EMBODYING MIND; Brown J.W., 2010, NEUROPSYCHOLOGICAL F; Brown J. W., 1972, APHASIA APRAXIA AGNO; Brown J.W., 1996, TIME WILL MENTAL PRO; BROWN JW, 1994, DEV PSYCHOPATHOL, V6, P551, DOI 10.1017/S0954579400004685; BROWN JW, 1975, BRAIN LANG, V2, P18, DOI 10.1016/S0093-934X(75)80051-4; BROWN JW, 1988, LIFE MIND SELECTED P; BROWN JW, 1979, NEUROBIOLOGY SOCIAL; BROWN JW, 1983, COGNITION BRAIN THEO, V6, P145; Christensen AL., 1975, LURIAS NEUROPSYCHOLO; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Galkowski T., 1993, DIAGNOZA TERAPIA ZAB; Glozman JM, 1999, NEUROPSYCHOL REV, V9, P23, DOI 10.1023/A:1025638903874; Goldberg E., 2001, EXECUTIVE BRAIN FRON; Herzyk A, 2000, DIAGNOZA NEUROPSYCHO; Herzyk A., 2011, NEUROPSYCHOLOGIA KLI; Herzyk A., 2005, WPROWADZENIE NEUROPS; Herzyk A., 2004, PAMIEC JAWNA NIEJAWN; Herzyk A, 1992, ASYMETRIA INTEGRACJA; Homskaya E., 2001, AR LURIA SCI BIOGRAP; Kaczmarek B.L.J., 2012, CUDOWNE KROSNA UMYSL; Kaczmarek B. L. J., 1984, MOZGOWE MECHANIZMY F; Kaczmarek B.L.J., 2003, CLASSIC CASES NEUROP, V2, P131; Kaczmarek B.L.J., 1995, APHASIOLOGY; Kaczmarek B. L. J., 1987, FRONTAL LOBES REVISI, P225; KACZMAREK BLJ, 1993, DISORDERS EXECUTIVE, P79; KACZMAREK BLJ, 1998, MOZG JEZYK ZACHOWANI; Kadzielawa D, 1983, CZYNNOSC ROZUMIENIA; Kadzielawa D., 2012, ACTA NEUROPSYCHOLOGI, V10; Kadzielawa D., 2000, PSYCHOL PODRECZNIK A, V3, P649; Kadzielawa D., 1997, ZWIAZEK MOZG ZACHOWA, P111; Kadzielawa D., 1996, ZABURZENIA FUNKCJONO, P53; Kadzielawa D., 1986, STUD PSYCHOL, V24, P87; Kadzielawa D, 2003, NEUROPSYCHOLOGICZNE, P17; Kaku Michio, 1994, HYPERSPACE SCI ODYSS; Klimkowski M., 1975, LOGOPEDIA, V12, P25; Klimkowski M, 1976, PAMIEC CZLOWIEKA JEJ; Klimkowski M., 1987, DIAGNOZA NEUROPSYCHO; KOLB B, 2003, FUNDAMENTALS HUMAN N; Kropotov J. D., 2009, QUALITATIVE EEG EVEN; Laaksonen R., 1986, 2 APH REH C JUN 1986; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A.R., 1932, NATURE HUMAN CONFLIC; Luria A.R., 1973, WORKING BRAIN; Luria A. R., 1984, SWIAT UTRACONY ODZYS; Luria A.R., 1959, TRAUMATIC APHASIA; Luria Alexander, 1968, MIND MNEMONIST; LURIA AR, 1958, LANG SPEECH, V1, P14, DOI 10.1177/002383095800100103; Luria AR., 1972, MAN SHATTERED WORLD; Luria AR, 1963, RESTORATION FUNCTION; Luria Karl., 2006, AUTOBIOGRAPHY A LURI; Maruszewski M., 1972, PSYCHOL KLIN, P324; Maruszewski M., 1966, AFAZJA ZAGADNIENIA T; Maruszewski M., 1970, MOWA MAZG ZAGADNIENI; Maruszewski M., 1973, STUD PSYCHOL, V12, P5; Maruszewski M., 1974, CHORY AFAZJA JEGO US; Mecacci L, 2005, CORTEX, V41, P816, DOI 10.1016/S0010-9452(08)70300-9; Pachalska M., 2013, FUNCTIONAL NEUROPHYS; Pachalska M., 2008, REHABILITACJA NEUROP; Pachalska M., 1990, ROCZNIK NAUKOWY AWF, V24, P305; Pachalska M., 1986, WYDAWNICTWO MONOGRAF; Pachalska M., 2012, ENCY HIST PSYCHOL TH, V26, P675, DOI DOI 10.1007/978-1-4419-0463-8_150; Pachalska M., 1999, AFAZJOLOGIA; Pachalska M., 2013, NEUROPSYCHOLOGIA KLI; Pachalska M., 2002, J NEUROPSYCHOANALYSI, V4, P109; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M., 2008, NEUROPSYCHOLOGY PHIL; Pachalska M, 2005, TOZSAMOSC CZLOWIEKA; Pachalska M., 2003, ACTA NEUROPSYCHOLOGI, V1, P194; Pachalska M, 2011, MED SCI MONITOR, V17, pCS120, DOI 10.12659/MSM.881970; PAPATHANASIOU I, 2000, ACQUIRED NEUROGENIC; Peters A., 1984, CEREBRAL CORTEX, V1; Pribram KH, 1973, PSYCHOPHYSIOLOGY FRO; Przesmycka-Kaminska J, 1980, ZABURZENIA POROZUMIE; Przesmycka-Kaminska J, 1990, PSYCHOL OSOBOWA SROD; Przesmycka-Kaminska J, 1994, NEUROPSYCHOLOGIA KLI, P153; PURVES D, 1992, TRENDS NEUROSCI, V15, P362, DOI 10.1016/0166-2236(92)90180-G; Ronning C, 2005, PEDIATR NEUROSURG, V41, P15, DOI 10.1159/000084860; Rosenthal V., 2005, ACTA NEUROPSYCHOLOGI, V3, P282; Rosenthal V, 2004, THEORY DECIS LIB A, V38, P221; Seniow J, 1999, Neurol Neurochir Pol, V33, P1139; Seniow J, 1978, REHABILITACJA CHORYC; Seniow J, 2003, NEUROREHABILITACJA P, P113; Seniow Joanna, 2002, Neurol Neurochir Pol, V36 Suppl 1, P33; TONKONOGY J, 1981, ARCH NEUROL-CHICAGO, V38, P486, DOI 10.1001/archneur.1981.00510080048005; Zeki S., 1993, VISION BRAIN	97	11	12	0	0	MEDSPORTPRESS PUBLISHING HOUSE	WARSAW	UL MARYMONCKA 34 SKR 23, WARSAW, 01813, POLAND	1730-7503	2084-4298		ACTA NEUROPSYCHOL	Acta Neuropsychol.	JUL-SEP	2012	10	3					341	369		10.5604/17307503.1023670			29	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	V1K7W	WOS:000216993900001		Bronze			2022-02-06	
J	Pachalska, M; Manko, G; Chantsoulis, M; Knapik, H; Mirski, A; Mirska, N				Pachalska, Maria; Manko, Grzegorz; Chantsoulis, Marzena; Knapik, Henryk; Mirski, Andrzej; Mirska, Natalia			The quality of life of persons with TBI in the process of a Comprehensive Rehabilitation Program	MEDICAL SCIENCE MONITOR			English	Article						treatment plan; individual needs; effectiveness of rehabilitation	SPINAL-CORD-INJURY; SHORT-TERM; BEHAVIOR; OUTCOMES; CHILDREN	Background: The aim of the research was to evaluate the effectiveness of the phased rehabilitation program in patients after traumatic brain injury, one developed by the authors and controlled by the strategic plan, pertaining to their quality of life compared to patients treated according to a standard, phased rehabilitation program. Material/Methods: The study included 40 patients of post traumatic brain injury treated at the Rehabilitation Clinic of the L. Rydygier Academy of Medical Sciences in Bydgoszcz and the Department of Medical Rehabilitation of the Cracow Rehabilitation Centre. An experimental group included 20 patients rehabilitated by a strategic approach and a control group consisted of 20 patients treated before the introduction of this approach. In assessing the effectiveness of rehabilitation, a structured interview was used with clinical observation and the Battery of Quality of Life Assessment. The study was conducted twice: before and after eight weeks of rehabilitation. Results: The quality of life of people after brain injury is affected by self-service difficulties, difficulties in meeting the physiological needs and loss of psychophysical comfort, decreased mobility, impaired cognitive functions and executive and social functions. There is no consistency between the stated (subjective) level of quality of life of the patient, and the depth of objectively measured disability resulting from the injury sustained. Conclusions: A rehabilitation program controlled by a strategic plan, in collaboration with the patient treated subjectively is more effective in improving the quality of life, since the cooperating patient is more motivated to carry out individually designed goals. A rehabilitation program based on a strategic plan is worthy of recommendation for the treatment and improvement of patients after cranio-cerebral trauma.	[Pachalska, Maria; Mirski, Andrzej; Mirska, Natalia] Andrzej Frycz Modrzewski Cracow Univ, Krakow, Poland; [Pachalska, Maria] Ctr Cognit & Commun, New York, NY USA; [Manko, Grzegorz] Jagiellonian Univ, Dept Ergon & Exercise Physiol, Fac Hlth Sci, Coll Med, Krakow, Poland; [Manko, Grzegorz] Elblag Univ Humanities & Econ, Dept Hlth Sci, Elblag, Poland; [Chantsoulis, Marzena] Acad Phys Educ, Dept Physiotherapy, Wroclaw, Poland; [Chantsoulis, Marzena] Mil Hosp 4, Dept Neurosurg, Wroclaw, Poland; [Knapik, Henryk] Acad Phys Educ, Fac Physiotherapy, Katowice, Poland		Pachalska, M (corresponding author), Andrzej Frycz Modrzewski Cracow Univ, Herlinga Grudzinskiego 1 St, Krakow, Poland.	neuropsychologia23@o2.pl	manko, grzegorz/I-5102-2012; Knapik, Henryk/X-5978-2018	Knapik, Henryk/0000-0003-2009-3788			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Baranowski P, 2000, Ortop Traumatol Rehabil, V2, P31; Bulinski L, 2010, MED SCI MONITOR, V16, pPH14; Bulpitt CJ, 1997, POSTGRAD MED J, V73, P613, DOI 10.1136/pgmj.73.864.613; CLAYTON KS, 1994, ARCH PHYS MED REHAB, V75, P633, DOI 10.1016/0003-9993(94)90184-8; Craig A, 1999, SPINAL CORD, V37, P345, DOI 10.1038/sj.sc.3100829; CURCOLL ML, 1992, PARAPLEGIA, V30, P425, DOI 10.1038/sc.1992.93; DENNIS RE, 1993, EXCEPT CHILDREN, V59, P499, DOI 10.1177/001440299305900603; Firsching R, 1998, SPINAL CORD, V36, P741, DOI 10.1038/sj.sc.3100713; Grady CL, 2002, CAN J PSYCHIAT, V47, P327, DOI 10.1177/070674370204700403; Grochmal-Bach B, 1996, SZTUKA LECZENIA, V2, P95; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; JUDD FK, 1986, PARAPLEGIA, V24, P6, DOI 10.1038/sc.1986.3; Kannisto M, 1998, SPINAL CORD, V36, P193, DOI 10.1038/sj.sc.3100543; Kennedy P, 1999, SPINAL CORD, V37, P136, DOI 10.1038/sj.sc.3100745; MacQueen BD, 2003, ORTOPEDIA TRAUMATOLO, V5, P797; MacQueen BD, 2003, NEUROPSYCHOLOGICZNE, P99; MacQueen BD, 2002, URAZY PNIA MOZGU KOM, P328; Manko G, 2004, OCENA SKUTECZNOSCI S; Pachalska M, 2000, Ortop Traumatol Rehabil, V2, P44; Pachalska M, 2001, Ortop Traumatol Rehabil, V3, P89; Pachalska M, 1998, SKALA OCENY JAKOSCI; Pachalska M., 2008, REHABILITACJA NEUROP; Pachalska M, 1997, VID PRES SESS 28 C I; Pachalska M, 2000, ORTOPEDIA TRAUMATOLO, V3, P34; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M, 2001, ORTOPEDIA TRAUMATOLO, V2, P182; Pruitt SD, 1998, SPINAL CORD, V36, P724, DOI 10.1038/sj.sc.3100649; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rubin KH., 2006, HDB CHILD PSYCHOL, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Sapountzi-Krepia D, 1998, SPINAL CORD, V36, P432, DOI 10.1038/sj.sc.3100641; SINTONEN H, 1993, QUALITY OF LIFE ASSESSMENT : KEY ISSUES IN THE 1990S, P185; Snowdy Jr HA, 1992, CRITICAL CARE CLIN, V3, P449; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; STENSMAN R, 1994, PARAPLEGIA, V32, P416, DOI 10.1038/sc.1994.68; Talar J, 2002, URAZY PNIA MOZGU KOM, P207; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor-Sarno M, 1997, APHASIOLOGY, V11, P665; Vaidyananthan S, 1998, SPINAL CORD, V36, P409, DOI 10.1038/sj.sc.3100573; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	40	11	12	0	12	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	JUL	2012	18	7					CR432	CR442					11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	980HD	WOS:000306883300013		Green Published, Green Submitted			2022-02-06	
J	Walcott, BP; Nahed, BV; Sheth, SA; Yanamadala, V; Caracci, JR; Asaad, WF				Walcott, Brian P.; Nahed, Brian V.; Sheth, Sameer A.; Yanamadala, Vijay; Caracci, James R.; Asaad, Wael F.			Bilateral Hemicraniectomy in Non-Penetrating Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bilateral; craniectomy; brain injury; intensive care unit; trauma	ACUTE SUBDURAL-HEMATOMA; TRANSORBITAL VENTRICULAR PUNCTURE; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; TRANSTENTORIAL HERNIATION; COMPUTERIZED-TOMOGRAPHY; COMATOSE PATIENTS; DURET HEMORRHAGE; MORTALITY; EVACUATION	Traumatic brain injury is a heterogeneous entity that encompasses both surgical and non-surgical conditions. Surgery may be indicated with traumatic lesions such as hemorrhage, fractures, or malignant cerebral edema. However, the neurological exam may be clouded by the effects of medications administered in the field, systemic injuries, and inaccuracies in hyperacute prognostication. Typically, neurological injury is considered irreversible if diffuse loss of grey/white matter differentiation or if brainstem hemorrhage (Duret hemorrhage) exists. We aim to characterize a cohort of patients undergoing bilateral hemicraniectomy for severe traumatic brain injury. A retrospective consecutive cohort of adult patients undergoing craniectomy for trauma was established between the dates of January 2008 and November 2011. The primary outcome of the study was in-hospital mortality. Secondary outcomes were ICU length of stay, surgical complications, and Glasgow Outcome Score at most recent follow-up. During the study period, 210 patients undergoing craniectomy for traumatic mass-occupying lesion (epidural hematoma, subdural hematoma, or parenchymal contusion) were analyzed. Of those, 9 met study criteria. In-hospital mortality was 67% (6 of 9 patients). The average ICU length of stay was 12 days. The GOS score was 3 in surviving patients. Bilateral hemicraniectomy is a heroic intervention for patients with severe TBI, but can be a life-saving procedure.	[Walcott, Brian P.; Nahed, Brian V.; Sheth, Sameer A.; Yanamadala, Vijay; Caracci, James R.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Walcott, Brian P.; Nahed, Brian V.; Sheth, Sameer A.; Yanamadala, Vijay; Caracci, James R.] Harvard Univ, Sch Med, Boston, MA USA; [Asaad, Wael F.] Brown Univ, Sch Med, Dept Neurosurg, Providence, RI 02912 USA		Walcott, BP (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St,White Bldg,Room 502, Boston, MA 02114 USA.	walcott.brian@mgh.harvard.edu	Asaad, Wael/I-8485-2012; Nahed, Brian/E-4239-2014	Asaad, Wael/0000-0003-4406-9096; Nahed, Brian/0000-0001-8537-106X			Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Domenicucci M, 1998, NEUROSURGERY, V42, P51, DOI 10.1097/00006123-199801000-00010; Duhaime AC, 2007, PROG BRAIN RES, V161, P293, DOI 10.1016/S0079-6123(06)61020-0; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; FELL DA, 1975, J NEUROSURG, V42, P37, DOI 10.3171/jns.1975.42.1.0037; Gabl M, 1989, Unfallchirurgie, V15, P273; Galton C, 2011, NEUROCRIT CARE, V14, P354, DOI 10.1007/s12028-011-9525-8; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P233; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Lau D, 2012, J NEUROSURG, V116, P234, DOI 10.3171/2011.7.JNS11396; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Marion DW, 2006, NEUROSURGERY, V58, P655; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; NAVARRO IM, 1981, J NEUROSURG, V54, P273, DOI 10.3171/jns.1981.54.2.0273; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Tubbs RS, 2009, J NEUROSURG, V111, P1191, DOI 10.3171/2009.3.JNS081651; Wan WH, 2008, J CLIN NEUROSCI, V15, P223, DOI 10.1016/j.jocn.2007.05.025; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	36	11	12	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	10					1879	1885		10.1089/neu.2012.2382			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	971YV	WOS:000306244400392	22452418				2022-02-06	
J	Goyagi, T; Horiguchi, T; Nishikawa, T; Tobe, Y; Masaki, Y				Goyagi, Toru; Horiguchi, Takashi; Nishikawa, Toshiaki; Tobe, Yoshitsugu; Masaki, Yoko			Neuroprotective effects of selective beta-1 adrenoceptor antagonists, landiolol and esmolol, on transient forebrain ischemia in rats; a dose-response study	BRAIN RESEARCH			English	Article						Adrenergic beta antagonist; Esmolol; Landiolol; Forebrain ischemia	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; PROVIDES NEUROPROTECTION; BLOCKER EXPOSURE; PROPRANOLOL; POSTTREATMENT; HEMORRHAGE; EXPRESSION; APOPTOSIS; ARREST	Although selective beta-1 adrenoceptor antagonists are known to provide neuroprotective effects after brain ischemia, dose-response relationships of their neuroprotective effects have not been examined. The present study was conducted to evaluate whether the degree of brain protection against transient forebrain ischemia would be influenced by different doses of selective beta-1 adrenoceptor antagonists, esmolol and landiolol, in rats. Adult male S.D. rats received intravenous infusion of saline 0.5 ml/h, esmolol 20, 200, 2000 mu g/kg/min, or landiolol 5, 50, 500 mu g/kg/min. Infusion was initiated 30 min prior to ischemia and continued for 24 h. Ten-minute forebrain ischemia was induced by hemorrhagic hypotension and occlusion of the bilateral carotid arteries. Neurological and histological examinations were performed. Neurological deficit scores at 1,4 and 7 days were lower, and the number of intact neurons in CA1 hippocampal region was larger in the rats treated with esmolol and landiolol after ischemia, compared with saline-treated rats (P<0.05), whereas no difference was found among different doses of esmolol and landiolol. These results suggested that selective beta-1 adrenoceptor antagonists improved neurological and histological outcomes following forebrain ischemia in rats, irrespective of their doses. (C) 2012 Elsevier B.V. All rights reserved.	[Goyagi, Toru; Horiguchi, Takashi; Nishikawa, Toshiaki; Tobe, Yoshitsugu; Masaki, Yoko] Akita Univ, Grad Sch Med, Dept Anesthesia & Intens Care Med, Akita 0108543, Japan		Goyagi, T (corresponding author), Akita Univ, Grad Sch Med, Dept Anesthesia & Intens Care Med, 1-1-1 Hondo, Akita 0108543, Japan.	tgoyagi@doc.med.akita-u.ac.jp	Goyagi, Toru/AAI-2885-2020	Goyagi, Toru/0000-0002-3077-4790			Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Atarashi H, 2000, CLIN PHARMACOL THER, V68, P143, DOI 10.1067/mcp.2000.108733; CAPRARO JA, 1984, STROKE, V15, P486, DOI 10.1161/01.STR.15.3.486; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; DOUGLAS RG, 1989, BRIT J SURG, V76, P115, DOI 10.1002/bjs.1800760205; Goyagi T, 2009, ACTA ANAESTH SCAND, V53, P1176, DOI 10.1111/j.1399-6576.2009.01976.x; Goyagi T, 2006, ANESTH ANALG, V103, P658, DOI 10.1213/01.ane.0000228859.95126.69; Goyagi T, 2011, J NEUROSURG ANESTH, V23, P131, DOI 10.1097/ANA.0b013e31820369c1; Goyagi T, 2010, BRAIN RES, V1343, P213, DOI 10.1016/j.brainres.2010.04.079; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Iwata M, 2010, ANESTH ANALG, V110, P1126, DOI 10.1213/ANE.0b013e3181d278f7; Jetschmann JU, 1997, J NEUROIMMUNOL, V74, P159, DOI 10.1016/S0165-5728(96)00221-4; Johnston I D, 1976, Surg Annu, V8, P91; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Ker K, 2009, CNS NEUROSCI THER, V15, P52, DOI 10.1111/j.1755-5949.2008.00069.x; Kimura-Kurosawa S, 2007, J ANESTH, V21, P480, DOI 10.1007/s00540-007-0558-2; Kitamura A, 1997, EUR J CLIN PHARMACOL, V51, P467, DOI 10.1007/s002280050232; LATCHAW JP, 1985, NEUROSURGERY, V16, P18, DOI 10.1227/00006123-198501000-00005; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Liao XH, 2010, ONCOL REP, V24, P1669, DOI 10.3892/or_00001032; LITTLE JR, 1982, STROKE, V13, P302, DOI 10.1161/01.STR.13.3.302; McNamee EN, 2010, NEUROPHARMACOLOGY, V59, P37, DOI 10.1016/j.neuropharm.2010.03.014; Oberbeck R, 2002, SHOCK, V18, P331, DOI 10.1097/00024382-200210000-00007; QUON CY, 1988, DRUG METAB DISPOS, V16, P425; QUON CY, 1985, DRUG METAB DISPOS, V13, P420; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Savitz SI, 2000, J CEREBR BLOOD F MET, V20, P1197, DOI 10.1097/00004647-200008000-00005; Schedlowski M, 1996, J IMMUNOL, V156, P93; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; STANDEFER M, 1986, NEUROSURGERY, V18, P136, DOI 10.1227/00006123-198602000-00003; Staudt Y, 2003, EUR J PHARMACOL, V466, P1, DOI 10.1016/S0014-2999(03)01431-6; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Trudeau F, 1996, Can J Appl Physiol, V21, P481; Umehara S, 2010, ANESTH ANALG, V110, P1133, DOI 10.1213/ANE.0b013e3181cdb06b; VOLZZANG C, 1994, EUR J CLIN PHARMACOL, V46, P399; Weist D., 1995, CLIN PHARMACOKINET, V28, P190	36	11	13	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 21	2012	1461						96	101		10.1016/j.brainres.2012.04.040			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966EF	WOS:000305819700010	22583856				2022-02-06	
J	Shang, AJ; Liu, KD; Wang, HY; Wang, J; Hang, XY; Yang, Y; Wang, ZF; Zhang, CG; Zhou, DBA				Shang, Aijia; Liu, Kaidong; Wang, Hangyan; Wang, Jing; Hang, Xingyi; Yang, Ying; Wang, Zhongfeng; Zhang, Chenggang; Zhou, Dingbiao			Neuroprotective effects of neuroglobin after mechanical injury	NEUROLOGICAL SCIENCES			English	Article						Neuroglobin; Neurons; Mechanical injury; Neuroprotection	PROTECTS PC12 CELLS; NEURONS	Neuroglobin (NGB) is a recently discovered globin, which is widely expressed in vertebrates central and peripheral nervous systems. Previous studies have shown that NGB is important in protecting neurons from hypoxic/ischemic brain injuries. However, there are no reports on the neuroprotective effects of NGB after mechanical injury. Currently, we showed that the NGB expression level in neurons increased continuously from 2 h after injury, and reached a peak at 16 h (p < 0.01), after which it decreased sharply. NGB that was overexpressed in mechanically injured B104 cells showed significant neuroprotective effects. Lactate dehydrogenase (LDH) activity decreased and cell survival rates increased (p < 0.01, n = 5). In the rat model of focal brain trauma, the NGB expression increased sharply at 1 h, after which it increased continuously until it reached a peak at 6 h, and then gradually decreased (p < 0.01, n = 5). Furthermore, moderate and severe injury resulted in significantly higher NGB levels than did mild injury (p < 0.01, n = 5). Our results indicate that NGB exerts significant neuroprotective effects after mechanical injury, and thus has important implications for the prognosis and cure of traumatic brain injury.	[Shang, Aijia; Liu, Kaidong; Zhou, Dingbiao] Gen Hosp Chinese PLA, Dept Neurosurg, Beijing 100853, Peoples R China; [Wang, Hangyan; Wang, Jing] Gen Hosp Chinese PLA, Dept Pediat, Beijing 100853, Peoples R China; [Hang, Xingyi] Gen Hosp Chinese PLA, Ctr Neuroinformat, Beijing 100853, Peoples R China; [Yang, Ying] Gen Hosp Chinese PLA, Dept Hlth Med, Beijing 100853, Peoples R China; [Wang, Zhongfeng] Fudan Univ, Med Neurobiol State Key Lab, Shanghai 200433, Peoples R China; [Zhang, Chenggang] Beijing Inst Radiat Med, Beijing 100850, Peoples R China		Zhou, DBA (corresponding author), Gen Hosp Chinese PLA, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China.	shangaj@126.com	Zhang, Chenggang/B-1480-2009		National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81071055, 30801249]; Medical Neurobiology of State Key Laboratory [09-08]; Military medicine and public health research project [10BJZ04]	Thanks for the help of data analysis from Sys-Biomics Bioinformatics (Beijing) Co., Ltd. (http://www.sysbiomics.com). This work was supported by National Natural Science Foundation (No. 81071055, No. 30801249); Open project from Medical Neurobiology of State Key Laboratory (No. 09-08); Military medicine and public health research project (No. 10BJZ04).	Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2004, NEWS PHYSIOL SCI, V19, P110, DOI 10.1152/nips.01513.2003; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; Emara M, 2009, MOL ONCOL, V3, P45, DOI 10.1016/j.molonc.2008.11.002; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Garry DJ, 2003, LANCET, V362, P342, DOI 10.1016/S0140-6736(03)14055-X; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hundahl C, 2006, BRAIN RES, V1085, P19, DOI 10.1016/j.brainres.2006.02.040; Jin KL, 2008, NEUROSCI LETT, V430, P135, DOI 10.1016/j.neulet.2007.10.031; Kelsen J, 2008, STROKE, V39, pE177, DOI 10.1161/STROKEAHA.108.526533; Khan AA, 2007, GENE, V398, P172, DOI 10.1016/j.gene.2007.02.044; Li RC, 2008, NEUROBIOL AGING, V29, P1815, DOI 10.1016/j.neurobiolaging.2007.05.001; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Shang AJ, 2006, BRAIN RES, V1078, P219, DOI 10.1016/j.brainres.2006.01.064; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Venis S, 2001, LANCET, V358, P2055, DOI 10.1016/S0140-6736(01)07148-3; Verratti V, 2009, ADV EXP MED BIOL, V648, P191, DOI 10.1007/978-90-481-2259-2_22; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Zhang C G, 2001, Yi Chuan Xue Bao, V28, P997	20	11	18	1	12	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUN	2012	33	3					551	558		10.1007/s10072-011-0772-4			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944ZG	WOS:000304241700007	21915648				2022-02-06	
J	Kallakuri, S; Li, Y; Zhou, RZ; Bandaru, S; Zakaria, N; Zhang, LY; Cavanaugh, JM				Kallakuri, Srinivasu; Li, Yan; Zhou, Runzhou; Bandaru, Sharath; Zakaria, Nisrine; Zhang, Liying; Cavanaugh, John M.			Impaired axoplasmic transport is the dominant injury induced by an impact acceleration injury device: An analysis of traumatic axonal injury in pyramidal tract and corpus callosum of rats	BRAIN RESEARCH			English	Article						Traumatic axonal injury; Head impact acceleration model; Impaired axoplasmic transport; Neurofilament compaction; Corpus callosum; Pyramidal tract	INTRAAXONAL NEUROFILAMENT COMPACTION; DIFFUSE BRAIN INJURY; HEAD IMPACT; POSTTRAUMATIC HYPOTHERMIA; QUANTITATIVE-ANALYSIS; SEX-DIFFERENCES; CYCLOSPORINE-A; SPINAL-CORD; MODEL; BIOMECHANICS	Traumatic axonal injury (TAI) involves neurofilament compaction (NFC) and impaired axoplasmic transport (IAT) in distinct populations of axons. Previous quantification studies of TAI focused on limited areas of pyramidal tract (Py) but not its entire length. Quantification of TAI in corpus callosum (CC) and its comparison to that in Py is also lacking. This study assessed and compared the extent of TAI in the entire Py and CC of rats following TBI. TBI was induced by a modified Marmarou impact acceleration device in 31 adult male Sprague Dawley rats by dropping a 450 gram impactor from either 1.25 m or 2.25 m. Twenty-four hours after TBI, TAI was assessed by beta amyloid precursor protein (beta-APP-IAT) and RMO14 (NFC) immunocytochemistry. TAI density (beta-APP and RMO14 axonal swellings, retraction balls and axonal profiles) was counted from panoramic images of CC and Py. Significantly high TAI was observed in 2.25 m impacted rats. beta-APP immunoreactive axons were significantly higher in number than RMO14 immunoreactive axons in both the structures. TAI density in Py was significantly higher than in CC. Based on our parallel biomechanical studies, it is inferred that TAI in CC may be related to compressive strains and that in Py may be related to tensile strains. Overall, IAT appears to be the dominant injury type induced by this model and injury in Py predominates that in CC. (C) 2012 Elsevier B.V. All rights reserved.	[Kallakuri, Srinivasu; Li, Yan; Zhou, Runzhou; Bandaru, Sharath; Zakaria, Nisrine; Zhang, Liying; Cavanaugh, John M.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA		Zhang, LY (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 W Hancock St, Detroit, MI 48201 USA.	lzhang@wayne.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 EB006508]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB006508] Funding Source: NIH RePORTER	This research was supported by NIH R01 EB006508.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gresle MM, 2006, BRAIN RES, V1110, P13, DOI 10.1016/j.brainres.2006.06.111; HALL GF, 1995, J COMP NEUROL, V353, P38, DOI 10.1002/cne.903530106; HARDING GW, 1985, EXP NEUROL, V87, P503, DOI 10.1016/0014-4886(85)90180-3; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; LEE VMY, 1987, J NEUROSCI, V7, P3474; LEENEN LPH, 1985, BRAIN RES, V359, P65, DOI 10.1016/0006-8993(85)91413-1; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; MACK CM, 1995, BRAIN RES, V697, P152, DOI 10.1016/0006-8993(95)00804-Y; Maier B, 2007, SHOCK, V27, P610, DOI 10.1097/shk.0b013e31802f9eaf; MALBOUISSON AMB, 1985, ANAT EMBRYOL, V171, P339, DOI 10.1007/BF00347022; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; MCLEAN AJ, 1995, J NEUROTRAUM, V12, P621, DOI 10.1089/neu.1995.12.621; Menon DK, 2002, CLIN SCI, V103, p399S, DOI 10.1042/CS103S399S; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; PRICE RL, 1988, J NEUROCYTOL, V17, P55, DOI 10.1007/BF01735377; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; SMITH M, 2003, TRAUMA, V5, P227; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; SZARO BG, 1990, J COMP NEUROL, V302, P220, DOI 10.1002/cne.903020204; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Yoganandan N., 2003, P ADV AUT MED, V47, P62; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhang L., 2010, J NEUROTRAUMA A, VA18, P41; Zhang L., 2011, J NEUROTRAUM, V28, P346; Zhang L., IMPROVED HEAD UNPUB; Zhang LY, 2011, J NEUROSCI METH, V198, P93, DOI 10.1016/j.jneumeth.2011.03.024; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	56	11	12	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAY 3	2012	1452						29	38		10.1016/j.brainres.2012.02.065			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	945MZ	WOS:000304279900004	22472596				2022-02-06	
J	Azar, TA; Sharp, JL; Lawson, DM				Azar, Toni A.; Sharp, Jody L.; Lawson, David M.			Effects of Cage Enrichment on Heart Rate, Blood Pressure, and Activity of Female Sprague-Dawley and Spontaneously Hypertensive Rats at Rest and after Acute Challenges	JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; STRESS-LIKE RESPONSES; ENVIRONMENTAL ENRICHMENT; COGNITIVE DEFICITS; COMMON PROCEDURES; ADULT RATS; INTERVENTION; PERFORMANCE; EXERCISE; IMPACT	Here we sought to determine whether a nonsocial cage enrichment program, identical to one we previously used with male rats, was effective in reducing heart rate or systolic blood pressure (SBP) in female Sprague Dawley rats and spontaneously hypertensive rats (SHR). Young adult rats, each instrumented with a radiotelemetry pressure transmitter, were housed individually under enriched or nonenriched conditions. Heart rate and SBP were monitored at 5- and 1-min intervals, respectively, when the rats were undisturbed or after several different types of experimental manipulations some of which are considered stressful. Cage enrichment did not significantly alter heart rate or SBP of undisturbed rats in either strain at any time during the day or night. However, activity of female SHR was increased in the afternoon and at night under enriched conditions compared with nonenriched conditions. The enrichment program did not significantly reduce heart rate or SBP responses to most acute manipulations in either strain. However, cage enrichment increased the responses to some procedures (Sprague-Dawley: handling, 1-h restraint; SHR: subcutaneous injection, tail-vein injection, handling). We conclude that a nonsocial cage enrichment program did not reduce physiologic indicators of stress in female Sprague Dawley rats or SHR.	[Azar, Toni A.; Sharp, Jody L.; Lawson, David M.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA		Lawson, DM (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.	dlawson@med.wayne.edu					Abou-Ismail UA, 2011, LAB ANIM-UK, V45, P145, DOI 10.1258/la.2011.010149; Azar T, 2011, J AM ASSOC LAB ANIM, V50, P175; Azar TA, 2008, J AM ASSOC LAB ANIM, V47, P25; Beale KEL, 2011, OBESITY, V19, P1715, DOI 10.1038/oby.2010.331; Bell JA, 2009, DEV PSYCHOBIOL, V51, P564, DOI 10.1002/dev.20394; Belz EE, 2003, PHARMACOL BIOCHEM BE, V76, P481, DOI 10.1016/j.pbb.2003.09.005; Brillaud E, 2005, BRAIN RES, V1054, P174, DOI 10.1016/j.brainres.2005.06.069; BROWN KJ, 1995, PHYSIOL BEHAV, V58, P1085, DOI 10.1016/0031-9384(95)02043-8; Del Arco A, 2007, BEHAV BRAIN RES, V176, P267, DOI 10.1016/j.bbr.2006.10.006; Elliott BM, 2005, BEHAV BRAIN RES, V165, P187, DOI 10.1016/j.bbr.2005.06.025; Gelfo F, 2011, NEUROREHAB NEURAL RE, V25, P243, DOI 10.1177/1545968310380926; GENTILE AM, 1987, BEHAV NEURAL BIOL, V47, P321, DOI 10.1016/S0163-1047(87)90435-3; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Grace L, 2009, METAB BRAIN DIS, V24, P643, DOI 10.1007/s11011-009-9162-5; Khabour OF, 2010, HIPPOCAMPUS, V20, P637, DOI 10.1002/hipo.20657; KLEIN SL, 1994, PHYSIOL BEHAV, V56, P291, DOI 10.1016/0031-9384(94)90197-X; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Nyhuis TJ, 2010, BRAIN RES, V1362, P68, DOI 10.1016/j.brainres.2010.09.038; Paban V, 2005, NEUROSCIENCE, V132, P13, DOI 10.1016/j.neuroscience.2004.11.024; Pamplona FA, 2009, PROG NEURO-PSYCHOPH, V33, P1153, DOI 10.1016/j.pnpbp.2009.06.012; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Pham TM, 1999, BEHAV BRAIN RES, V103, P63, DOI 10.1016/S0166-4328(99)00019-4; Saland SK, 2011, PHARMACOL BIOCHEM BE, V98, P455, DOI 10.1016/j.pbb.2011.02.014; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Sharp J, 2005, CONTEMP TOP LAB ANIM, V44, P32; Sharp J, 2003, CONTEMP TOP LAB ANIM, V42, P9; Sharp J, 2002, CONTEMP TOP LAB ANIM, V41, P8; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Woodcock EA, 2000, NEUROBIOL LEARN MEM, V73, P1, DOI 10.1006/nlme.1999.3911	31	11	11	0	11	AMER ASSOC LABORATORY ANIMAL SCIENCE	MEMPHIS	9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA	1559-6109			J AM ASSOC LAB ANIM	J. Amer. Assoc. Lab. Anim. Sci.	MAY	2012	51	3					339	344					6	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	978UX	WOS:000306772400010	22776192				2022-02-06	
J	Howard, CJ				Howard, Christopher J.			Neurobiological Correlates of Partner Abusive Men: Equifinality in Perpetrators of Intimate Partner Violence	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						intimate partner violence; neurophysiology; neurobiology; childhood physical abuse	POSTTRAUMATIC-STRESS-DISORDER; COMPUTERIZED COGNITIVE REHABILITATION; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTERGENERATIONAL TRANSMISSION; DOMESTIC VIOLENCE; SELECT GROUP; NEUROFEEDBACK; CHILDREN; BEHAVIOR	This theoretical review integrates findings from functional imaging, counseling effectiveness program evaluation, and childhood physical abuse to inform current assessment and intervention practices with partner abusive men. Understanding how to adequately assess traumatic brain injury, trauma symptomatology, and concomitant deficits in conflict regulation strategies will be elucidated. Particular emphasis on executive functioning, verbal deficits, impulsivity and an integrative biopsychosocial model including the roles of quantitative electroencephalography, the hypothalamus-pituitary-adrenal axis, sympathetic nervous system, and serotonergic system will be presented, enriching current conceptualization and treatment of partner abusive men.	Antioch Univ, Dept Clin Psychol, Santa Barbara, CA 93101 USA		Howard, CJ (corresponding author), Antioch Univ, Dept Clin Psychol, 801 Garden St, Santa Barbara, CA 93101 USA.	choward@antioch.edu					Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Babcock JC, 2005, J ABNORM PSYCHOL, V114, P444, DOI 10.1037/0021-843X.114.3.444; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; BARLOW D, 2001, CLIN HDB PSYCHOL DIS; Beach SRH, 2010, J FAM PSYCHOL, V24, P12, DOI 10.1037/a0018074; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beutler L. E, REV INT PSI IN PRESS; BLACK DA, 1999, PARTNER CHILD ABUSE; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; Briere J., 1995, TRAUMA SYMPTOM INVEN; Cicchetti D, 2002, J CONSULT CLIN PSYCH, V70, P6, DOI 10.1037//0022-006X.70.1.6; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cohen R A, 1999, Violence Vict, V14, P397; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dunn, 2007, J NEUROTHERAPY, V10, P3; Ehrensaft MK, 2003, J CONSULT CLIN PSYCH, V71, P741, DOI 10.1037/0022-006X.71.4.741; Fallon J. H, OHIO STATE J CRIMINA, V3, P341; Fang XM, 2008, J FAM VIOLENCE, V23, P303, DOI 10.1007/s10896-008-9152-0; Foa E. B., 2000, J TRAUMA STRESS, V13, P4; George DT, 2000, BIOL PSYCHIAT, V47, P804, DOI 10.1016/S0006-3223(99)00300-5; George DT, 2004, PSYCHIAT RES-NEUROIM, V130, P11, DOI 10.1016/S0925-4927(03)00105-7; Hammond DC, 2005, CHILD ADOL PSYCH CL, V14, P105, DOI 10.1016/j.chc.2004.07.008; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hebben N., 2002, ESSENTIALS NEUROPSYC; Hibbeln JR, 2004, BIOL PSYCHIAT, V56, P895, DOI 10.1016/j.biopsych.2004.08.021; IBRIC VL, 2009, J NEUROTHER, V13, P156, DOI DOI 10.1080/10874200903118378; ISNR Comprehensive Neurofeedback Bibliography compiled by Harold Burke at EEG, ISNR COMPREHENSIVE N; Kalat J. W., 2007, BIOL PSYCHOL, V10th; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kendall-Tackett K. A., 2010, PSYCHONEUROIMMUNOLOG; Kendall-Tackett K, 2009, PSYCHOL TRAUMA-US, V1, P35, DOI 10.1037/a0015128; Koenen KC, 2003, DEV PSYCHOPATHOL, V15, P297, DOI 10.1017/S0954579403000166; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kropotov J. D., 2009, QUANTITATIVE EEG EVE; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Leppamaki S, 2002, J AFFECT DISORDERS, V72, P139, DOI 10.1016/S0165-0327(01)00417-7; Lucas J.A., 2006, CLIN NEUROPSYCHOLOGY, V2nd ed., P351; Magdol L, 1998, J ABNORM PSYCHOL, V107, P375, DOI 10.1037/0021-843X.107.3.375; Manchester D, 2001, BRAIN DAM B, P157; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; Masterpasqua F, 2003, PROF PSYCHOL-RES PR, V34, P652, DOI 10.1037/0735-7028.34.6.652; McGrath J, 1997, NEUROPSYCHOL REHABIL, V7, P231, DOI 10.1080/713755532; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; McNeil J E, 1996, Cogn Neuropsychiatry, V1, P239, DOI 10.1080/135468096396532; Metzger LJ, 2004, J ABNORM PSYCHOL, V113, P324, DOI 10.1037/0021-843X.113.2.324; Middelboe T., 1992, European Psychiatry, V7, P183; Moore TM, 2002, AGGRESSIVE BEHAV, V28, P299, DOI 10.1002/ab.90027; Mulvihill D, 2005, Compr Child Adoles N, V28, P115, DOI 10.1080/01460860590950890; Orr S. P., 2004, ASSESSING PSYCHOL TR, V289; Paul RH, 2005, INT J NEUROSCI, V115, P1549, DOI 10.1080/00207450590957890; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Raine A, 2002, J ABNORM CHILD PSYCH, V30, P311, DOI 10.1023/A:1015754122318; Resick P.A., 2001, STRESS TRAUMA; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; SNYDER PJ, 2006, CLIN NEUROPSYCHOLOGY; Sokhadze Tato M., 2007, Journal of Neurotherapy, V11, P13, DOI 10.1300/J184v11n02_03; Southwick S. M., 2003, PTSD RES Q, V14, P1; Stith SM, 2000, J MARRIAGE FAM, V62, P640, DOI 10.1111/j.1741-3737.2000.00640.x; Straus M. A., 1995, REVISED CONFLICT TAC; Susman EJ, 2006, NEUROSCI BIOBEHAV R, V30, P376, DOI 10.1016/j.neubiorev.2005.08.002; Thatcher R.W., 2010, J NEUROTHER, V14, P122; Thompson, 2003, NEUROFEEDBACK BOOK I; Thornton KE, 2005, CHILD ADOL PSYCH CL, V14, P137, DOI 10.1016/j.chc.2004.07.001; Tombaugh T.N., 1996, TEST MEMORY MALINGER; U.S. Department of Health and Human Services Administration for Children and Families, 2005, CHILD MALTR 2003; US Department of Veterans Affairs, PTSD CHILDR AD; Vasterling J., 2005, NEUROPSYCHOLOGY PTSD; Watts-English T, 2006, J SOC ISSUES, V62, P717, DOI 10.1111/j.1540-4560.2006.00484.x; Weathers FW, 1991, PTSD CHECKLIST CIVIL; Wechsler D., 1995, WECHSLER ADULT INTEL; Yucha C., 2008, EVIDENCE BASED PRACT	80	11	12	0	26	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma	MAY	2012	4	3					330	337		10.1037/a0024229			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	941JI	WOS:000303959100011					2022-02-06	
J	Gunther, M; Al Nimer, F; Gahm, C; Piehl, F; Mathiesen, T				Guenther, Mattias; Al Nimer, Faiez; Gahm, Caroline; Piehl, Fredrik; Mathiesen, Tiit			iNOS-mediated secondary inflammatory response differs between rat strains following experimental brain contusion	ACTA NEUROCHIRURGICA			English	Article						Neurotrauma; Neuroinflammation; TBI; Nitric oxide synthase; Peroxynitrite; Manganese superoxide dismutase; Dark Agouti; Piebald Virol Glaxo	NITRIC-OXIDE SYNTHASE; SPINAL-CORD INJURY; NON-MHC GENES; OXIDATIVE STRESS; PEROXYNITRITE; EXPRESSION; NEURODEGENERATION; NEUROPROTECTION; DEGENERATION; ACTIVATION	Nitric oxide is a key mediator of post-traumatic inflammation in the brain. We examined the expressions of iNOS, nNOS, and eNOS in inbred DA and PVGa rat strains where DA is susceptible to autoimmune neuroinflammation and PVGa-resistant. Parietal contusions using a weight drop model were produced in five rats per genotype. After 24 h, the brains were removed and analyzed using a range of immunohistochemical methods. PVGa presented significantly increased iNOS expression in infiltrating inflammatory cells in the perilesional area compared to DA (p < 0.05). The amount of w3/13-positive infiltrating inflammatory cells did not differ between strains. eNOS and nNOS expression did not differ between strains. iNOS-positive cells coexpressed neuronal (NeuN), macrophage (ED-1), and leucocyte (w3/13) markers. MnSOD was significantly increased in PVGa (p < 0.05). 3-Nitrotyrosine, a measure of peroxynitrite levels, and fluoro-jade stained neuronal degeneration, did not differ between strains. Two inbred rat strains with genetically determined differences in susceptibility to develop autoimmune disease displayed different levels of the inflammatory and anti-inflammatory mediators iNOS and MnSOD, indicating genetic regulation. Interestingly, the increased levels of iNOS did not lead to elevated expression of the neuronal cell-death marker fluoro-jade. The increased iNOS expression was correlated with increased expression of superoxide scavenger MnSOD. Excessive peroxynitrite formation was probably prevented by limitation of available superoxide. Subsequently, the higher expression of potentially deleterious iNOS in PVGa did not result in increased neuronal death.	[Guenther, Mattias; Al Nimer, Faiez; Gahm, Caroline; Piehl, Fredrik; Mathiesen, Tiit] Karolinska Inst, Dept Clin Neurosci, Sect Neurosurg & Neuroimmunol, SE-17176 Stockholm, Sweden		Gunther, M (corresponding author), Karolinska Inst, Dept Clin Neurosci, Sect Neurosurg & Neuroimmunol, SE-17176 Stockholm, Sweden.	mattias.gunther@ki.se	Piehl, Fredrik/E-3451-2013; Nimer, Faiez Al/ABB-9465-2020; , Mattias/A-4442-2013; mathiesen, tiit/ABC-3627-2021	, Mattias/0000-0003-2372-6114; Piehl, Fredrik/0000-0001-8329-5219; Al Nimer, Faiez/0000-0003-0937-5995; Mathiesen, Tiit/0000-0001-9463-1919			Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Al Nimer F, 2011, BRAIN BEHAV IMMUN, V25, P981, DOI 10.1016/j.bbi.2010.10.017; Arteel GE, 1999, FEBS LETT, V445, P226, DOI 10.1016/S0014-5793(99)00073-3; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; BRADEN AWH, 1958, FERTIL STERIL, V9, P243; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Inman D, 2002, J COMP NEUROL, V451, P225, DOI 10.1002/cne.10340; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Keller JN, 1998, J NEUROSCI, V18, P687; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Li L, 2007, BRAIN RES, V1159, P8, DOI 10.1016/j.brainres.2007.04.066; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Lorentzen JC, 1997, J NEUROIMMUNOL, V80, P31, DOI 10.1016/S0165-5728(97)00131-8; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lundberg C, 2001, J COMP NEUROL, V431, P75; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Noack H, 1998, GLIA, V23, P285, DOI 10.1002/(SICI)1098-1136(199808)23:4<285::AID-GLIA1>3.0.CO;2-2; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Ste-Marie L, 2001, BRAIN RES, V918, P10, DOI 10.1016/S0006-8993(01)02903-1; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; WILSON DB, 1965, J EXP MED, V122, P143, DOI 10.1084/jem.122.1.143	47	11	11	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2012	154	4					689	697		10.1007/s00701-012-1297-1			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	912IA	WOS:000301788900019	22362050				2022-02-06	
J	Meng, X; Browne, K; Huang, SM; Cullen, DK; Tofighi, MR; Rosen, A				Meng, X.; Browne, K.; Huang, S. M.; Cullen, D. K.; Tofighi, M. R.; Rosen, A.			Dynamic study of wireless intracranial pressure monitoring of rotational head injury in swine model	ELECTRONICS LETTERS			English	Article							SCALP	For what is believed to be for the first time, the dynamic study of wireless intracranial pressure measurements in a swine model of traumatic brain injury is described. This achieves an extremely important milestone, since the measurements demonstrate the system's robustness, and the feasibility of acquiring wireless readings of the intracranial pressure resulting from non-impact rotational head injury in swine. The fully implanted device uses a capacitive pressure sensor modulating an RF oscillator, coupled to a planar inverted-F antenna. The results match well those obtained from a standard fibre-optic based (tethered) commercial intracranial pressure monitor, as well as published literature data, and may enable a future trend in the use of implantable wireless systems for research or clinical diagnoses.	[Meng, X.; Huang, S. M.; Rosen, A.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Browne, K.; Cullen, D. K.] Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Tofighi, M. R.] Penn State Univ, Capital Coll, Middletown, PA 17057 USA		Meng, X (corresponding author), Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA.	xm26@drexel.edu	Huang, Shimin/X-6369-2019				Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Tofighi MR, 2006, ELECTRON LETT, V42, P148, DOI 10.1049/el:20063658	3	11	11	0	8	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	0013-5194			ELECTRON LETT	Electron. Lett.	MAR 29	2012	48	7					363	U92		10.1049/el.2012.0281			2	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	917NB	WOS:000302183300010					2022-02-06	
J	Bramlett, HM; Dietrich, WD				Bramlett, Helen M.; Dietrich, W. Dalton			The Effects of Posttraumatic Hypothermia on Diffuse Axonal Injury Following Parasagittal Fluid Percussion Brain Injury in Rats	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article							AMYLOID PRECURSOR PROTEIN; GLOBAL FOREBRAIN ISCHEMIA; TERM MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; POSTISCHEMIC HYPOTHERMIA; HEAD-INJURY; DAMAGE; MODEL; CONSEQUENCES; COMBINATION	Previous investigations have demonstrated the beneficial effects of mild hypothermia following different types of traumatic brain injury (TBI). In some models, early cooling following TBI has been shown to reduce the frequency of axonal damage, a major consequence of head injury. The purpose of this study was to evaluate the effects of post-traumatic hypothermia in a model that has been shown to be sensitive to temperature manipulations in the early injury setting. Animals underwent moderate parasagittal fluid percussion (FP) brain injury and were then either randomized into normothermic or hypothermic groups. In the hypothermic groups, brain temperature was reduced to either 30 degrees C or 33 degrees C 5 minutes after trauma and maintained for a 3-hour period. Normothermic or sham-operated animals were held under normal temperature conditions. At 3 days after TBI, animals were perfusion-fixed for a quantitative assessment of beta amyloid precursor protein (beta-APP) immunohistochemistry and silver staining. Traumatic injury led to a significant increase in the frequency of beta-APP immunoreactive profiles within both the corpus callosum, external capsule, and the internal capsule. While early cooling revealed a trend for protection, no significant differences were shown between normothermic and hypothermic animals in terms of the frequency of injured axons at 3 days post-trauma. These results emphasize that axonal pathology is a major consequence of brain injury using this particular model. It is concluded that longer periods of post-traumatic hypothermia may be required to chronically protect axon populations undergoing a progressive injury.	[Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA		Bramlett, HM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14th Terrace,LPLC 3-18, Miami, FL 33136 USA.	hbramlett@miami.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS030291, NS042133]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042133, P50NS030291] Funding Source: NIH RePORTER	The authors wish to thank Jeremy Lytle for editorial support. This study was supported by NIH Grants NS030291 and NS042133.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; DIETRICH WD, 1995, J CEREBR BLOOD F MET, V15, P960, DOI 10.1038/jcbfm.1995.122; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Langlois J.A., 2004, TRAUMATIC BRAIN INJU, P1; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SEVIER AC, 1965, J NEUROPATH EXP NEUR, V24, P130, DOI 10.1097/00005072-196501000-00012; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Staunton M, 2000, ANESTHESIOLOGY, V92, P125, DOI 10.1097/00000542-200001000-00023; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; Yokobori S, 2011, THER HYPOTHERMIA TEM, V1, P185, DOI 10.1089/ther.2011.0012	60	11	11	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	MAR 1	2012	2	1					14	23		10.1089/ther.2012.0002			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V38PJ	WOS:000209355000006	23420536	Green Accepted, Green Published			2022-02-06	
J	Kostka, T; Furgal, W; Gawronski, W; Bugajski, A; Czamara, A; Klukowski, K; Krysztofiak, H; Lewicki, R; Szygula, Z; Tomaszewski, W; Trzaska, T; Widuchowski, J; Ziemba, A; Jegier, A				Kostka, Tomasz; Furgal, Witold; Gawronski, Wojciech; Bugajski, Andrzej; Czamara, Andrzej; Klukowski, Krzysztof; Krysztofiak, Hubert; Lewicki, Romuald; Szygula, Zbigniew; Tomaszewski, Wieslaw; Trzaska, Tadeusz; Widuchowski, Jerzy; Ziemba, Andrzej; Jegier, Anna		Polish Soc Sports Med	Recommendations of the Polish Society of Sports Medicine on age criteria while qualifying children and youth for participation in various sports	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; RISK-FACTORS; INJURY RATES; BRAIN-INJURY; CONCUSSION; HEAD; EPIDEMIOLOGY; BOXERS		[Kostka, Tomasz] Med Univ Lodz, Fac Hlth Sci, Polish Soc Sports Med, PL-90647 Lodz, Poland; [Furgal, Witold] MEDIVITSPORT Hlth Ctr, Tarnobrzeg, Poland; [Gawronski, Wojciech; Szygula, Zbigniew] Univ Sch Phys Educ, Dept Sports Med, Krakow, Poland; [Bugajski, Andrzej; Czamara, Andrzej; Tomaszewski, Wieslaw] Coll Physiotherapy, Wroclaw, Poland; [Klukowski, Krzysztof] Univ Phys Educ, Chair Physiotherapy, Warsaw, Poland; [Krysztofiak, Hubert] Natl Ctr Sports Med, Warsaw, Poland; [Lewicki, Romuald] Inst Med Educ, Kielce, Poland; [Trzaska, Tadeusz] Univ Phys Educ, Dept Traumatol Sports, Poznan, Poland; [Widuchowski, Jerzy] Ctr Arthroscopy & Knee Surg, Piekary Slaskie, Poland; [Ziemba, Andrzej] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Appl Physiol, Warsaw, Poland; [Jegier, Anna] Med Univ Lodz, Dept Sports Med, Lodz, Poland		Kostka, T (corresponding author), Med Univ Lodz, Fac Hlth Sci, Polish Soc Sports Med, Pl Hallera 1, PL-90647 Lodz, Poland.	tomaszkostka@wp.pl	Czamara, Andrzej/N-2597-2018; Krysztofiak, Hubert/L-8083-2019; Gawronski, Wojciech/AAM-4585-2020	Czamara, Andrzej/0000-0002-2713-5090; Krysztofiak, Hubert/0000-0003-4567-1433; Kostka, Tomasz/0000-0003-0437-650X; Szygula, Zbigniew/0000-0002-6685-6579; Ziemba, Andrzej/0000-0002-1987-3050			Adesunkanmi ARK, 1998, J TRAUMA, V44, P506, DOI 10.1097/00005373-199803000-00015; Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; Anderson SJ, 2000, PEDIATRICS, V106, P154, DOI 10.1542/peds.106.1.154; [Anonymous], 2009, SPR ZAKR KON BAD LEK; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Blanpain R, 2002, LEGAL STATUS SPORTSM; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Caine D, 2006, CLIN J SPORT MED, V16, P500, DOI 10.1097/01.jsm.0000251181.36582.a0; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; David P., 2005, HUMAN RIGHTS YOUTH S; European Commission, 2007, STUD TRAIN YOUNG SPO; European Commission, 2009, WHIT PAP SPORT; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Frisch A, 2009, BRIT MED BULL, V92, P95, DOI 10.1093/bmb/ldp034; Furgal W, 2005, MEDYCYNA SPORTOWA, P747; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Knowles SB, 2010, BRIT J SPORT MED, V44, P38, DOI 10.1136/bjsm.2009.065763; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Maffulli N, 2010, BRIT J SPORT MED, V44, P21, DOI 10.1136/bjsm.2009.069526; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McGuine T, 2006, CLIN J SPORT MED, V16, P488, DOI 10.1097/01.jsm.0000248848.62368.43; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michell LJ, 1998, B WORLD HEALTH ORGAN, V76, P445; Morrison AB, 2011, BRIT J SPORT MED, V45, DOI 10.1136/bjsm.2006.034827; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Steffen K, 2010, BRIT J SPORT MED, V44, P485, DOI 10.1136/bjsm.2010.073833; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Washington RL, 2001, PEDIATRICS, V107, P1459; Wingfield K, 2004, CLIN J SPORT MED, V14, P109, DOI 10.1097/00042752-200405000-00002; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321; Zazryn TR, 2008, NEUROL CLIN, V26, P257, DOI 10.1016/j.ncl.2007.11.004; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582	40	11	11	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAR	2012	46	3					159	162		10.1136/bjsports-2011-090043			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	894WL	WOS:000300458100003	21948125	Bronze, Green Published			2022-02-06	
J	Lu, J; Marmarou, A; Lapane, KL				Lu, Juan; Marmarou, Anthony; Lapane, Kate L.		IMPACT Investigators	Impact of GOS Misclassification on Ordinal Outcome Analysis of Traumatic Brain Injury Clinical Trials	JOURNAL OF NEUROTRAUMA			English	Article						clinical trials; Glasgow Outcome Scale; misclassification; probability sensitivity analysis	SEVERE HEAD-INJURY; GLASGOW; SCALE; MULTICENTER; EXPERIENCE	This study extends our previous investigation regarding the effect of nondifferential dichotomous Glasgow Outcome Scale (GOS) misclassification in traumatic brain injury (TBI) clinical trials to the effect of GOS misclassification on ordinal analysis in TBI clinical trials. The impact of GOS misclassification and ordinal outcome analysis was explored via probabilistic sensitivity analyses using TBI patient datasets from the IMPACT database (n = 9205). Three patterns of misclassification were explored given the pre-specified misclassification distributions. For the random pattern, we specified a trapezoidal distribution (minimum: 80%, mode: 85%, and 95%, maximum: 100%) for both sensitivity and specificity; for the upward pattern, the same trapezoidal distribution for sensitivity but with a perfect specificity; and for the downward pattern, the same trapezoidal distribution for specificity but with a perfect sensitivity. The conventional 95% confidence intervals and simulation intervals, which accounts for the misclassification and random errors together, were reported. The results showed that given the specified misclassification distributions, the misclassification with a random or upward pattern would have caused a slightly underestimated outcome in the observed data. However, the misclassification with a downward pattern would have resulted in an inflated estimation. Thus the sensitivity analysis suggests that the nondifferential misclassification can cause uncertainties on the primary outcome estimation in TBI trials. However, such an effect is likely to be small when ordinal analysis is applied, compared with the impact of dichotomous GOS misclassifications. The result underlines that the ordinal GOS analysis may gain from both statistical efficiency, as suggested by several recent studies, and a relatively smaller impact from misclassification as compared with conventional binary GOS analysis.	[Lu, Juan] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Dept Neurosurg, Richmond, VA 23298 USA		Lu, J (corresponding author), Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Dept Neurosurg, POB 980212, Richmond, VA 23298 USA.	jlu1@vcu.edu		Lu, Juan/0000-0002-5389-7603	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 4269]; National Institutes of Health through the University Center for Translation ScienceUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1UL1RR031990-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031990] Funding Source: NIH RePORTER	Grant support was provided by the National Institutes of Health (NS 4269), and the National Institutes of Health through the University Center for Translation Science (grant 1UL1RR031990-01).	Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Bath PMW, 2008, STROKE, V39, P2817, DOI 10.1161/STROKEAHA.107.509893; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Fox MP, 2005, INT J EPIDEMIOL, V34, P1370, DOI 10.1093/ije/dyi184; JENNETT B, 1975, LANCET, V1, P480; Lash TL, 2003, EPIDEMIOLOGY, V14, P451, DOI 10.1097/01.EDE.0000071419.41011.cf; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Marmarou A., 2001, HEAD TRAUMA BASIC PR, P15; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; WHITEHEAD J, 1993, STAT MED, V12, P2257, DOI 10.1002/sim.4780122404; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910	20	11	11	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	5					719	726		10.1089/neu.2010.1746			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	907TZ	WOS:000301442900002	21815785	Green Published			2022-02-06	
J	Nelson, DV; Esty, ML				Nelson, David V.; Esty, Mary Lee			Neurotherapy of Traumatic Brain Injury/Posttraumatic Stress Symptoms in OEF/OIF Veterans	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							INJURY; IRAQ; DISORDER; OUTCOMES	The Flexyx Neurotherapy System (FNS), a novel variant of EEG biofeedback, was adapted for intervention with seven treatment-refractory Afghanistan/Iraq war veterans, and brought about significant decreases in bothersome neurobehavioral and posttraumatic stress symptoms. FNS may help ameliorate mixed trauma spectrum syndromes. (The Journal of Neuropsychiatry and Clinical Neurosciences 2012; 24:237-240)	[Nelson, David V.; Esty, Mary Lee] Sam Houston State Univ, Dept Psychol & Philosophy, Huntsville, TX 77341 USA; [Nelson, David V.; Esty, Mary Lee] Brain Wellness & Biofeedback Ctr Washington, Bethesda, MD USA		Nelson, DV (corresponding author), Sam Houston State Univ, Dept Psychol & Philosophy, Box 2447, Huntsville, TX 77341 USA.	nelsondv@shsu.edu					Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Mueller HH, 2001, J CLIN PSYCHOL, V57, P933, DOI 10.1002/jclp.1060; Ochs L, 2006, J NEUROTHER, V10, P5, DOI DOI 10.1300/J184V10N02_02; Ochs L, 1930, FLEXYX NEUROTHERAPY, P1997; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8	15	11	12	0	8	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2012	24	2					237	240		10.1176/appi.neuropsych.11020041			4	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	972MN	WOS:000306281300112	22772672				2022-02-06	
J	Hoshizaki, B; Vassilyadi, M; Post, A; Oeur, A				Hoshizaki, Blaine; Vassilyadi, Michael; Post, Andrew; Oeur, Anna			Performance analysis of winter activity protection headgear for young children Laboratory investigation	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric head injury; helmet; traumatic brain injury; concussion	CHILDHOOD SLEDDING INJURIES; UNITED-STATES; ACCIDENTS	Object. The purpose of this study was to evaluate how currently used helmets would perform for winter play activities, such as tobogganing. In Canada and northern parts of the US, the advent of winter is followed by an increase in visits to hospital emergency departments by young children presenting with head injuries resulting from winter activities. Sliding, skating, skiing, and snowboarding all involve risks of head injury from situations such as falling on ice or sliding into stationary objects. This study compared the protective characteristics of helmets used by young children (<7 years of age) participating in winter recreational activities. Methods. Ice hockey, alpine ski, and bicycling helmets were impacted at 2.0, 4.0, 6.0, and 8.0 m/second at the front and side impact location by using a monorail drop rig. Results. The results for the front impact showed that the ice hockey helmet protected the child significantly better at 2 and 4 m/second when considering both linear and angular peak acceleration. The bicycle helmet performed significantly better than the other 2 helmets at 8 m/second for the front location and only angularly for the side impacts. Conclusions. Depending on the impact velocity of the hazard, the type of helmet significantly affected the risk of brain injury. (http://thejns.org/doi/abs/10.3171/2011.11.PEDS11299)	[Hoshizaki, Blaine; Post, Andrew; Oeur, Anna] Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON, Canada; [Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada		Hoshizaki, B (corresponding author), 200 Lees Ave,Room A-106, Ottawa, ON K1S 5S9, Canada.	thoshiza@uottawa.ca		Post, Andrew/0000-0002-5960-5552	ThinkFirst Canada	This research was funded by ThinkFirst Canada, as represented by Dr. Vassilyadi, a co-author on this paper.	American Society for Testing and Materials, 2006, F1045 06 STAND PERF, DOI [10.1520/F1045-06, DOI 10.1520/F1045-06]; American Society of Testing and Materials, 2006, F2040 11 STAND SPEC, DOI [10.1520/F2040-11, DOI 10.1520/F2040-11]; Bernardo L M, 1998, J Trauma Nurs, V5, P34; BJORNSTIG U, 1986, SCAND J SOC MED, V14, P83; Canadian Standards Association, 2009, Z26209 CAN STAND ASS; Canadian Standards Association, 2007, CAN CSA Z263 1 07 RE; Canadian Standards Association, 1996, CAN CSA D113 2 M89 C; Cimpello LB, 2009, J TRAUMA, V66, pS23, DOI 10.1097/TA.0b013e318160f856; Corra Stefano, 2007, J Trauma Manag Outcomes, V1, P5, DOI 10.1186/1752-2897-1-5; Dershewitz R, 1990, PEDIATR FORUM, V144, P1070; European Committee for Standardization, 1997, 1080 EN EUR COMM STA; GENNARELLI TA, 1971, 15TH P STAPP CAR CRA, P797; Gimbel GM, 2008, EUR J SPORT SCI, V8, P341, DOI 10.1080/17461390802438763; Hackam DJ, 1999, J PEDIATR SURG, V34, P65, DOI 10.1016/S0022-3468(99)90230-0; HEDGES JR, 1980, ANN EMERG MED, V9, P131, DOI 10.1016/S0196-0644(80)80267-8; Holbourn AHS, 1943, LANCET, V2, P438; KIM PCW, 1995, J PEDIATR SURG, V30, P1135, DOI 10.1016/0022-3468(95)90005-5; Lee F, 1999, Inj Prev, V5, P198; Major CP, 1999, SOUTHERN MED J, V92, P193, DOI 10.1097/00007611-199902000-00006; MANARY MJ, 1993, PEDIATR EMERG CARE, V9, P155, DOI 10.1097/00006565-199306000-00011; Mertz H.J., 1997, 41 STAPP CAR CRASH C; Noffsinger Dana, 2008, J Trauma Nurs, V15, P58, DOI 10.1097/01.JTN.0000327328.60405.f9; Ortega HW, 2005, PEDIATR EMERG CARE, V21, P839, DOI 10.1097/01.pec.0000190233.27857.6a; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Sallee D, 2000, Alaska Med, V42, P37; Shorter NA, 1999, AM J EMERG MED, V17, P32, DOI 10.1016/S0735-6757(99)90010-4; Skarbek-Borowska S, 2006, ACAD EMERG MED, V13, P181, DOI 10.1111/j.1553-2712.2006.tb01669.x; SLOAN JP, 1985, BRIT MED J, V290, P821, DOI 10.1136/bmj.290.6471.821; Snell Memorial Foundation, 1998, 1998 STAND PROT HEAD; Snell Memorial Foundation, 2000, 1995 STAND PROT HEAD; Verrees M, 2004, PEDIATR NEUROSURG, V40, P2, DOI 10.1159/000076570; WYNNE AD, 1994, J TRAUMA, V37, P820, DOI 10.1097/00005373-199411000-00019; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	34	11	11	1	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	FEB	2012	9	2					133	138		10.3171/2011.11.PEDS11299			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	882SC	WOS:000299583200005	22295916				2022-02-06	
J	Shi, W; Gong, PP; Fan, J; Yan, YH; Ni, LC; Wu, XH; Cui, G; Wu, XM; Gu, XX; Chen, J				Shi, Wei; Gong, Peipei; Fan, Jian; Yan, Yao Hua; Ni, Lanchun; Wu, Xiaohong; Cui, Gang; Wu, Xinmin; Gu, Xingxing; Chen, Jian			The expression pattern of ADP-ribosyltransferase 3 in rat traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						ART3; Traumatic brain injury; Apoptosis; GAP43; Neurons; Rat	DIFFUSE AXONAL INJURY; GLIAL PROLIFERATION; RIBOSYLATION; NEUROGENESIS; SUBSTRATE; APOPTOSIS; TOXIN; NEUROPROTECTION; MECHANISMS; INHIBITION	Mammalian ecto ADP-ribosyltransferases (ARTs) can regulate the biological functions of various types of cells by catalyzing the transfer of single ADP-ribose moiety from NAD(+) to a specific amino acid in a target protein. ART3 is a member of the known ART family which is involved in cell division, DNA-repair and the regulation of the inflammatory response. To elucidate the expression, cellular localization and possible functions of ART3 in central nervous system (CNS) lesion and repair, we performed an acute traumatic brain injury model in adult rats. Western blot analysis showed that the expression of ART3 in ipsilateral brain cortex increased, then reached a peak at day 3 after traumatic brain injury (TBI), and gradually declined during the following days. But in the contralateral brain cortex, no obvious alterations were observed. Immunohistochemistry revealed the highly significant accumulation of ART3 at the ipsilateral brain in comparison to contralateral cerebral cortex. Double immunofluorescence labeling suggested that ART3 was localized mainly in the plasmalemma of neurons, but not in astrocytes or microglias within 3 mm from the lesion site at day 3 post-injury. In addition, we detected the expression profiles of caspase-3 and growth associated protein 43 (GAP-43) whose changes were correlated with the expression profiles of ART3 in this TBI model. Besides, co-localization of ART3/active caspase-3 and ART3/GAP43 were detected in NeuN-positive cells, respectively. Moreover, Pheochromocytoma (PC12) cells were treated with H2O2 to establish an apoptosis model. The results showed that the expression of ART3 was increased in the concentration and time dependence way. To further examine the involvement of ART3 in apoptosis of PC12, 3-Methoxybenzamide was used in flow cytometry analysis of apoptotic cells stained with Annexin V and PI. The experimental group in which 3-Methoxybenzamide used had a relative low level of apoptotic index compared with the untreated group. Together with previous reports, we hypothesize that ART3 may play important roles in CNS pathophysiology after TBI and further research is needed to have a good understanding of its function and mechanism.	[Shi, Wei; Gong, Peipei; Yan, Yao Hua; Ni, Lanchun; Wu, Xiaohong; Cui, Gang; Wu, Xinmin; Gu, Xingxing; Chen, Jian] Nantong Univ, Dept Neurosurg, Surg Comprehens Lab, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China; [Fan, Jian] Nantong Univ, Dept Neurosurg, Affiliated Qidong People Hosp, Nantong 226200, Jiangsu, Peoples R China		Chen, J (corresponding author), Nantong Univ, Dept Neurosurg, Surg Comprehens Lab, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.	chenjian1107@126.com	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870320, 31070723, 81070275, 81171139, 81172879]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009161, BK2010169]; Nature Science Foundation of China Ministry of Health [2010-2-025]; Key Project Nature Science Foundation of Jiangsu Colleges and Universities [11KJA310002]; Nature Science Foundation of Jiangsu Colleges and Universities [09KJB320011]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 30870320, No. 31070723, No. 81070275, No. 81171139 and No. 81172879); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009161 and No. BK2010169); Nature Science Foundation of China Ministry of Health (2010-2-025); Key Project Nature Science Foundation of Jiangsu Colleges and Universities (No. 11KJA310002); Nature Science Foundation of Jiangsu Colleges and Universities Grant (09KJB320011); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Adriouch S, 2001, J IMMUNOL, V167, P196, DOI 10.4049/jimmunol.167.1.196; Balducci E, 2007, FEBS LETT, V581, P4199, DOI 10.1016/j.febslet.2007.07.061; BENOWITZ LI, 1991, PROG BRAIN RES, V89, P69; Braren R, 1998, BIOCHEM J, V336, P561, DOI 10.1042/bj3360561; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; COGGINS PJ, 1993, FEBS LETT, V335, P109, DOI 10.1016/0014-5793(93)80450-9; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; DELOULME JC, 1990, J CELL BIOL, V111, P1559, DOI 10.1083/jcb.111.4.1559; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; DUMAN RS, 1991, J NEUROCHEM, V57, P2124, DOI 10.1111/j.1471-4159.1991.tb06431.x; Emery DL, 2000, J COMP NEUROL, V424, P521; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Friednich M, 2006, BBA-GENE STRUCT EXPR, V1759, P270, DOI 10.1016/j.bbaexp.2006.06.004; Friedrich M, 2006, ASIAN J ANDROL, V8, P281, DOI 10.1111/j.1745-7262.2006.00125.x; Grahnert A, 2002, BIOCHEM J, V362, P717, DOI 10.1042/0264-6021:3620717; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Hong SY, 2009, PURINERG SIGNAL, V5, P369, DOI 10.1007/s11302-009-9162-2; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Koch-Nolte F, 1997, GENOMICS, V55, P130; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Levy I, 1996, FEBS LETT, V382, P276, DOI 10.1016/0014-5793(96)00183-4; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Lodhi IJ, 2001, ARCH BIOCHEM BIOPHYS, V387, P66, DOI 10.1006/abbi.2000.2215; LOGAN A, 1992, J NEUROSCI, V12, P3828; LUDDEN PW, 1994, MOL CELL BIOCHEM, V138, P123, DOI 10.1007/BF00928453; Moss J, 1990, SCIENCE, V250, P841; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; SCHUMAN EM, 1994, P NATL ACAD SCI USA, V91, P11958, DOI 10.1073/pnas.91.25.11958; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	45	11	12	1	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	FEB	2012	43	1					37	47		10.1007/s10735-011-9366-y			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	880AL	WOS:000299376400005	22037978				2022-02-06	
J	Bailie, JM; King, LC; Kinney, D; Nitch, SR				Bailie, Jason M.; King, Loren C.; Kinney, Dominique; Nitch, Stephen R.			The Relationship Between Self-Reported Neuropsychological Risk Factors and RBANS Test Performance Among Forensically Committed Psychiatric Inpatients	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						developmental delays; psychiatric patients; RBANS; state psychiatric hospitals	TRAUMATIC BRAIN-INJURY; REPEATABLE BATTERY; BASE RATES; NEUROCOGNITIVE DEFICITS; SCREENING-TEST; SCHIZOPHRENIA; PREVALENCE; VALIDITY; RELIABILITY; SENSITIVITY	Patients who are committed to a psychiatric inpatient hospital are at increased risk for neuropsychological compromise. This study investigated a large (n = 260) and diverse sample of patients at a forensic state psychiatric hospital. A substantial proportion (35.8%) of the sample performed two standard deviations below the normative mean on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). In addition, 65% of the participants reported a history of developmental delays, less than 12 years of education, or past learning difficulties. Participants who reported these developmental and academic problems performed worse on the RBANS compared with those without such a history. Additionally, the more developmental/educational risk factors a participant reported, the more likely they were to be impaired on the RBANS. Half of the sample reported a history of at least one neurological risk factor (e.g., history of head injury with loss of consciousness). However, in this sample, a history of neurological risk factors did not influence overall performance on the RBANS and did not increase the likelihood of impairment. These results speak to the relevance of neuropsychological services at state psychiatric hospitals and provide some evidence that a history of developmental or academic problems may help identify psychiatric patients with neuropsychological compromise.	[Bailie, Jason M.; King, Loren C.; Kinney, Dominique; Nitch, Stephen R.] Patton State Hosp, Dept Psychol, Patton, CA 92369 USA		Bailie, JM (corresponding author), Patton State Hosp, Dept Psychol, 3102 E Highland Ave, Patton, CA 92369 USA.	bailiejm@gmail.com		Bailie, Jason/0000-0002-5831-2360			Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Baune BT, 2010, PSYCHIAT RES, V176, P183, DOI 10.1016/j.psychres.2008.12.001; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; Denney RL, 2000, J HEAD TRAUMA REHAB, V15, P804, DOI 10.1097/00001199-200004000-00005; Department of Mental Health, 2012, HIST POP DAT; Dickerson F, 2004, PSYCHIAT RES, V129, P45, DOI 10.1016/j.psychres.2004.07.002; Duff K, 2008, ARCH CLIN NEUROPSYCH, V23, P603, DOI 10.1016/j.acn.2008.06.004; Duff K, 2010, ARCH CLIN NEUROPSYCH, V25, P429, DOI 10.1093/arclin/acq045; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 1996, AM J PSYCHIAT, V153, P321; Hancock M, 2010, AGGRESSIVE BEHAV, V36, P338, DOI 10.1002/ab.20353; Hobart MP, 1999, AM J PSYCHIAT, V156, P1951; IVERSON GL, 1993, CRIM JUSTICE BEHAV, V20, P347, DOI 10.1177/0093854893020004003; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P31, DOI 10.1080/09084280802644128; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kurtz MM, 2011, CLIN PSYCHOL REV, V31, P663, DOI 10.1016/j.cpr.2011.02.008; MARTELL DA, 1992, LAW HUMAN BEHAV, V16, P313, DOI 10.1007/BF01044772; McEvoy JP, 1996, SCHIZOPHRENIA BULL, V22, P635, DOI 10.1093/schbul/22.4.635; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Murrey GJ, 2004, REHABIL PSYCHOL, V49, P259, DOI 10.1037/0090-5550.49.3.259; Niemi LT, 2003, SCHIZOPHR RES, V60, P239, DOI 10.1016/S0920-9964(02)00234-7; Pachet AK, 2007, CLIN NEUROPSYCHOL, V21, P286, DOI 10.1080/13854040500376823; Randolph C., 1998, REPEATABLE BATTERY A; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Sreenivasan S, 1997, INT J LAW PSYCHIAT, V20, P279, DOI 10.1016/S0160-2527(97)00008-3	33	11	11	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2012	19	4					279	286		10.1080/09084282.2012.670146			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	022WG	WOS:000309994300006	23373640				2022-02-06	
J	Brown, CVR; Sowery, L; Curry, E; Valadka, AB; Glover, CS; Grabarkewitz, K; Green, T; Hail, S; Admire, J				Brown, Carlos V. R.; Sowery, Lauren; Curry, Eardie; Valadka, Alex B.; Glover, Cynthia S.; Grabarkewitz, Kim; Green, Terry; Hail, Steve; Admire, John			Recombinant Factor VIIa to Correct Coagulopathy in Patients with Traumatic Brain Injury Presenting to Outlying Facilities Before Transfer to the Regional Trauma Center	AMERICAN SURGEON			English	Article								Timely correction of coagulopathy in patients with traumatic brain injury (TBI) improves mortality. Recombinant, activated factor VII (VIIa) has been identified as an effective method to correct coagulopathy in patients with TBI. We performed a retrospective study (January 1, 2008-December 31, 2009) of all patients with TBI and coagulopathy (international normalized ratio (INR) > 1.5) transferred to our Level I trauma center. Twenty-three patients with coagulopathy and TBI were transferred to our trauma center, 100 per cent sustained a fall, and 100 per cent were taking warfarin at the time of injury. Ten patients received VIIa to correct coagulopathy before transfer, whereas 13 did not. The purpose of this study was to compare outcomes in patients who received VIIa with those who did not. When comparing the VIIa group with the no-VIIa group there was no difference in age, gender, Glasgow Coma Scale score, injury severity score, transfer time, or INR at outlying facility. Both groups received one unit of plasma before arrival at our trauma center; patients in the VIIa group received a single 1.2 mg dose of VIIa at the outlying facility. Upon arrival to our trauma center the VIIa group had a lower INR (1.0 vs 3.0, P = 0.02) and lower mortality (0% vs 39%, P = 0.03). In coagulopathic patients with TBI presenting to outlying institutions with limited resources to quickly provide plasma, VIIa efficiently corrects coagulopathy before transfer to definitive care at the regional trauma center. More rapid correction of coagulopathy with VIIa in this patient population may improve mortality.	[Brown, Carlos V. R.; Sowery, Lauren; Curry, Eardie; Valadka, Alex B.; Admire, John] Univ Texas Southwestern Austin, Univ Med Ctr Brackenridge, Austin, TX USA; [Glover, Cynthia S.] Seton Highland Lakes Med Ctr, Burnet, TX USA; [Grabarkewitz, Kim] Seton Edgar B Davis Hosp, Luling, TX USA; [Green, Terry] Seton Southwest Healthcare Ctr, Austin, TX USA; [Hail, Steve] Seton Med Ctr Williamson, Round Rock, TX USA		Brown, CVR (corresponding author), Univ Med Ctr Brackenridge, Trauma Serv, 601 East 15th St, Austin, TX 78701 USA.	CVRBrown@seton.org					Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; Brown CVR, 2010, J TRAUMA, V68, P348, DOI 10.1097/TA.0b013e3181bbfb6b; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Meyer J., 2001, AGE 2000 CENSUS 2000; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a	9	11	12	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JAN	2012	78	1					57	60					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	V32LQ	WOS:000208953100035	22273315				2022-02-06	
J	Cotton, GS				Cotton, Glen			Occupational Identity Disruption After Traumatic Brain Injury: An Approach to Occupational Therapy Evaluation and Treatment	OCCUPATIONAL THERAPY IN HEALTH CARE			English	Article						Adaptation; disruption; identity; occupation; traumatic brain injury		People with traumatic brain injury (TBI) represent a significant population for occupational therapy practitioners. The long-term physical, cognitive, behavioral, and psychosocial symptoms of TBI can contribute to the experience of occupational identity disruption and affect participation outcomes in community living. Although occupational therapy scholars have studied the topic of identity, there appears to be a gap in the education and research literature regarding the topic of post-TBI occupational identity disruption. This article describes theoretical perspectives on identity, summarizes evidence regarding post-TBI identity disruption and the transition process, and examines the role of occupational therapy in evaluating and treating identity disruption.	[Cotton, Glen] Univ Illinois, Dept Occupat Therapy, 1919 W Taylor St,MC 811, Chicago, IL 60612 USA		Cotton, GS (corresponding author), Univ Illinois, Dept Occupat Therapy, 1919 W Taylor St,MC 811, Chicago, IL 60612 USA.	gcotto2@uic.edu					American Occupational Therapy Association, 2008, AM J OCCUP THER, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.62.6.625]; Brain Injury Association of America, 2012, AB BRAIN INJ; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US C; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Christiansen CH, 1999, AM J OCCUP THER, V53, P547, DOI 10.5014/ajot.53.6.547; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Erikson E. H., 1963, CHILDHOOD SOC; Faul M, 2010, TRAUMATIC BRAIN INJU; Gillen G., 2009, COGNITIVE PERCEPTUAL; Golisz K., 2009, OCCUPATIONAL THERAPY; Griffith Jennifer, 2007, Can J Occup Ther, V74, P78; HOWIE L, 2004, THE AMERICAN JOURNAL, V58, P446; Kielhofner G, 2001, AM J OCCUP THER, V55, P260, DOI 10.5014/ajot.55.3.260; Kielhofner G., 2008, MODEL HUMAN OCCUPATI; Kielhofner G., 2004, USERS MANUAL OCCUPAT; Kielhofner G., 2009, CONCEPTUAL FDN OCCUP; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Kroger J., 2008, BLACKWELL HDB ADOLES, P205; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Marcia J., 2002, IDENTITY, V2, P7, DOI [10.1207/S1532706XID0201_02, DOI 10.1207/S1532706XID0201_02]; McDevitt T.M., 2007, CHILD DEV ED; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Pollock N., 2005, CANADIAN OCCUPATIONA; Rudman DL, 2002, J OCCUP SCI, V9, P12, DOI DOI 10.1080/14427591.2002.9686489; Tasker SL., 2003, ILLN CRISES LOSS, V11, P337, DOI DOI 10.1177/1054137303256585; Unruh Anita M, 2004, Can J Occup Ther, V71, P290; *US DEP JUST, 2008, AM DIS ACT QUEST ANS	36	11	11	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0738-0577	1541-3098		OCCUP THER HEALTH CA	Occup. Ther. Health Care		2012	26	4					270	282		10.3109/07380577.2012.726759			13	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V61BW	WOS:000210874700006	23899201				2022-02-06	
J	Edmed, SL; Sullivan, KA				Edmed, Shannon L.; Sullivan, Karen A.			Base Rates of Postconcussion Syndrome by Method of Symptom Report	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						assessment; base rates; mild traumatic brain injury; postconcussion syndrome	POST-CONCUSSION SYMPTOMS; TRAUMATIC BRAIN-INJURY; PEOPLE; INTERVIEW; CRITERIA	This study compared the base rate of postconcussion syndrome (PCS) symptoms using three different assessment methods in a nonclinical sample. Seventy-three university students with no history of brain injury or neurological disease reported symptoms experienced during the previous 2 weeks in response to an open-ended question, a structured interview (simulated), and the British Columbia Postconcussion Symptom Inventory (BC-PSI). Statistically significant differences (all p < .001, d = 1.80-3.93, large effect sizes) were found between the number of symptoms reported on all assessment methods, such that participants reported the most PCS symptoms on the BC-PSI (M = 9.45, SD = 2.52), followed by the structured interview (M = 5.58, SD = 2.02), and the open-ended question (M = 1.86, SD = 1.00). Further, 100%, 92.1%, and 25.4% of the sample reported three or more ICD-10 Category C PCS symptoms on the BC-PSI, structured interview, and open-ended question, respectively. Findings suggest that method of assessment influences PCS base rates, such that symptom elicitation decreases relative to the reduction in prompting associated with each assessment method. Therefore, different diagnostic conclusions may be drawn depending on method of assessment used. Clinicians need to consider how their chosen assessment method may be influencing the symptoms reported by their patients.	[Edmed, Shannon L.; Sullivan, Karen A.] Queensland Univ Technol, Sch Psychol & Counseling, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia; [Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counseling, Clin Neuropsychol Res Grp, Victoria Pk Rd,O Block,B Wing,Room 523, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au		Edmed, Shannon/0000-0001-5550-9371	School of Psychology and Counseling, Queensland University of Technology	This study was supported in part by a research funding allocation to Miss Shannon Edmed, and allocation to support manuscript completion to Associate Professor Karen Sullivan by the School of Psychology and Counseling, Queensland University of Technology. The research protocol was assessed and approved by The Queensland University of Technology Human Research Ethics Committee (QUT Ref no: 1000000311) and by occupational workplace health and safety officers.	Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gouvier WD, 1998, CRIT ISS NE, P55; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Lovibond P.F., 1995, MANUAL DESPRESSION A; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stapleton E, 2008, J LARYNGOL OTOL, V122, P139, DOI 10.1017/S0022215107009073; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	25	11	11	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2012	19	3					164	170		10.1080/09084282.2011.643961			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	994RU	WOS:000307949900002	23373602				2022-02-06	
J	Gonen-Yaacovi, G; Burgess, PW				Gonen-Yaacovi, Gil; Burgess, Paul W.			PROSPECTIVE MEMORY: THE FUTURE FOR FUTURE INTENTIONS	PSYCHOLOGICA BELGICA			English	Article							TRAUMATIC BRAIN-INJURY; AGE-RELATED DIFFERENCES; RETROSPECTIVE-MEMORY; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; COMPLEX INTENTIONS; MULTIPLE PROCESSES; ONGOING ACTIVITIES; YOUNG-ADULTS; EVENT	Prospective memory is the ability to remember to execute future intentions and thoughts. It is probably the newest established field of memory research. We provide a selective review of work conducted in the last two decades with respect to the following issues: (1) the different types and characteristics of prospective tasks, (2) the theoretical models of the cognitive processes supporting prospective memory, (3) prospective memory performance in younger and older adults and (4) the findings from neuropsychological and neuroimaging studies. The findings indicate an extraordinarily fast progress in our understanding of the behaviour and the brain regions that are involved in this important ability, and suggest at least two possible emerging areas of enquiry for future research: a link with the closely related field of prospection (i.e., thinking about the future), and "expectation prospective memory" (triggering of behaviour in the absence of awareness depending on contingencies learnt from the environment).	[Gonen-Yaacovi, Gil; Burgess, Paul W.] UCL, Inst Cognit Neurosci, London WC1N 3AR, England		Burgess, PW (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	p.bur-gess@ucl.ac.uk	Burgess, Paul W/A-1811-2010				Aberle I, 2010, DEV PSYCHOL, V46, P1444, DOI 10.1037/a0020718; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Altgassen M, 2008, J CLIN EXP NEUROPSYC, V30, P777, DOI 10.1080/13803390701779552; Altgassen M, 2007, J INT NEUROPSYCH SOC, V13, P888, DOI 10.1017/S1355617707071068; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Baddeley A. D., 1984, EVERYDAY MEMORY ACTI, P1; Bailey PE, 2010, Q J EXP PSYCHOL, V63, P646, DOI 10.1080/17470210903521797; Benoit R.G., 2011, CEREBRAL CORTEX; Bisiacchi PS, 2009, NEUROPSYCHOLOGIA, V47, P1362, DOI 10.1016/j.neuropsychologia.2009.01.034; Blais C, 2012, Q J EXP PSYCHOL, V65, P268, DOI 10.1080/17470211003775234; Block RA, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P25, DOI 10.1142/9789812707123_0002; Boyer P, 2008, TRENDS COGN SCI, V12, P219, DOI 10.1016/j.tics.2008.03.003; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; BRANDIMONTE MA, 1996, PROSPECTIVE MEMORY T; Brandimonte MA, 2011, MEMORY, V19, P56, DOI 10.1080/09658211.2010.535657; Brewer GA, 2010, MEM COGNITION, V38, P304, DOI 10.3758/MC.38.3.304; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Burgess P.W., 2011, NEUROPSYCHOLOGIA, V49, P2185; Burgess P. W., 2008, PROSPECTIVE MEMORY C, P233; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Cherry KE, 1999, PSYCHOL AGING, V14, P60, DOI 10.1037/0882-7974.14.1.60; Cherry KE, 2001, MEMORY, V9, P177, DOI 10.1080/09658210143000092; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Cook GI, 2007, PSYCHON B REV, V14, P101, DOI 10.3758/BF03194035; Cook GI, 2005, APPL COGNITIVE PSYCH, V19, P345, DOI 10.1002/acp.1082; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; d'Ydewalle G, 2001, AM J PSYCHOL, V114, P411, DOI 10.2307/1423688; d'Ydewalle G, 1999, EUR J COGN PSYCHOL, V11, P219, DOI 10.1080/713752309; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; DEVOLDER PA, 1990, PSYCHOL AGING, V5, P291, DOI 10.1037/0882-7974.5.2.291; Einstein, 2007, PROSPECTIVE MEMORY O; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 1997, PSYCHOL AGING, V12, P479, DOI 10.1037/0882-7974.12.3.479; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 1999, BRIT J PSYCHOL, V90, P9, DOI 10.1348/000712699161233; Ellis J., 1998, ADHERENCE TREATMENT, P113; Eschen A, 2007, INT J PSYCHOPHYSIOL, V64, P259, DOI 10.1016/j.ijpsycho.2006.09.005; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Gilbert SJ, 2011, J NEUROSCI, V31, P2888, DOI 10.1523/JNEUROSCI.5336-10.2011; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; Graf P, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P1, DOI 10.1142/9789812707123_0001; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guynn MJ, 2007, PSYCHON B REV, V14, P484, DOI 10.3758/BF03194094; Guynn MJ, 1998, MEM COGNITION, V26, P287, DOI 10.3758/BF03201140; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; Hashimoto T, 2011, NEUROIMAGE, V54, P645, DOI 10.1016/j.neuroimage.2010.07.047; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Hicks JL, 2000, J EXP PSYCHOL LEARN, V26, P1160, DOI 10.1037/0278-7393.26.5.1160; Jones CRG, 2011, J AUTISM DEV DISORD, V41, P455, DOI 10.1007/s10803-010-1067-y; Katai S, 2003, J NEUROL NEUROSUR PS, V74, P704, DOI 10.1136/jnnp.74.6.704; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M, 2005, J NEUROL NEUROSUR PS, V76, P1501, DOI 10.1136/jnnp.2004.051268; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2001, MEMORY, V9, P1, DOI 10.1080/09658210042000003; Kliegel M, 2004, MEMORY, V12, P553, DOI 10.1080/09658210344000099; Kliegel M, 2003, INT J PSYCHOL, V38, P193, DOI 10.1080/00207590344000114; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Kondel TK, 2002, BRAIN COGNITION, V48, P405, DOI 10.1006/brcg.2001.1387; Kumar D, 2005, J CLIN EXP NEUROPSYC, V27, P867, DOI 10.1080/13803390490919100; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T; Kvavilashvili L, 2009, MEMORY, V17, P180, DOI 10.1080/09658210802194366; Lee E, 2010, ARCH CLIN NEUROPSYCH, V25, P640, DOI 10.1093/arclin/acq061; Levy R. L., 1984, EVERYDAY MEMORY ACTI, P93; Leynes PA, 2003, CONSCIOUS COGN, V12, P1, DOI 10.1016/S1053-8100(02)00002-8; LINTON M, 1978, PRACTICAL ASPECTS ME; Loft S, 2007, MEM COGNITION, V35, P263, DOI 10.3758/BF03193447; LOFTUS EF, 1971, PSYCHON SCI, V23, P315, DOI 10.3758/BF03336128; Mantyla T, 1993, Memory, V1, P203, DOI 10.1080/09658219308258233; Marsh R.L., 2006, MEM COGNITION, V29, P861; Marsh RL, 2007, AGING NEUROPSYCHOL C, V14, P168, DOI 10.1080/138255891007074; Marsh RL, 2005, J EXP PSYCHOL LEARN, V31, P68, DOI 10.1037/0278-7393.31.1.68; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; Marsh RL, 2002, PSYCHON B REV, V9, P604, DOI 10.3758/BF03196319; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Maylor E. A., 1996, PROSPECTIVE MEMORY T, P173; Maylor E. A., 1993, ADULT INFORMATION PR, P529; Maylor EA, 1998, AGING NEUROPSYCHOL C, V5, P107, DOI 10.1076/anec.5.2.107.599; Maylor EA, 2002, MEM COGNITION, V30, P871, DOI 10.3758/BF03195773; McCauley S.R., 2011, J CLIN EXPT NEUROPSY; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCauley SR, 2010, J INT NEUROPSYCH SOC, V16, P335, DOI 10.1017/S135561770999138X; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel M. A., 2008, PROSPECTIVE MEMORY C, P141; McDaniel MA, 1998, MEM COGNITION, V26, P121, DOI 10.3758/BF03211375; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; MEACHAM JA, 1977, J PSYCHOL, V97, P191, DOI 10.1080/00223980.1977.9923962; Meacham JA, 1975, MEMORY OBSERVED, P327; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Moscovitch M, 1982, AGING COGNITIVE PROC, P55; Moscovitch Morris, 1994, P269; Neisser U., 1982, MEMORY OBSERVED REME, P327; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Okuda J, 2011, NEUROPSYCHOLOGIA, V49, P2258, DOI 10.1016/j.neuropsychologia.2011.02.005; Palmer HM, 2000, BRAIN COGNITION, V44, P103; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; PATTON GW, 1993, EXP AGING RES, V19, P165, DOI 10.1080/03610739308253929; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Potvin MJ, 2011, BRAIN INJURY, V25, P192, DOI 10.3109/02699052.2010.541896; Racsmany M, 2011, J CLIN EXP NEUROPSYC, V33, P85, DOI 10.1080/13803395.2010.493147; Rajendran G., 2010, J AUTISM DEV DISORDE; Reese CM, 2002, AGING NEUROPSYCHOL C, V9, P98, DOI 10.1076/anec.9.2.98.9546; Rendell P. G., 1993, AUSTR J AGEING, V12, P11, DOI DOI 10.1111/J.1741-6612.1993.TB00578.X; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P736, DOI 10.1037/a0018971; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P190, DOI 10.1037/a0017732; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith R.E, 2008, PROSPECTIVE MEMORY C, P42; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Smith RE, 2006, J EXP PSYCHOL LEARN, V32, P623, DOI 10.1037/0278-7393.32.3.623; Smith RE, 2010, J EXP PSYCHOL LEARN, V36, P1089, DOI 10.1037/a0019183; Smith RE, 2010, DEV PSYCHOL, V46, P230, DOI 10.1037/a0017100; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Umeda S, 2011, NEUROPSYCHOLOGIA, V49, P2178, DOI 10.1016/j.neuropsychologia.2011.03.036; Vogels WWA, 2002, BRAIN COGNITION, V49, P341, DOI 10.1006/brcg.2001.1504; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Weiler JA, 2010, BEHAV BRAIN RES, V212, P196, DOI 10.1016/j.bbr.2010.04.013; West R, 2006, NEUROPSYCHOLOGIA, V44, P197, DOI 10.1016/j.neuropsychologia.2005.05.003; West R, 1999, PSYCHOL AGING, V14, P264, DOI 10.1037/0882-7974.14.2.264; West R, 2005, PSYCHON B REV, V12, P502, DOI 10.3758/BF03193795; West R, 2003, PSYCHOL AGING, V18, P461, DOI 10.1037/0882-7974.18.3.461; West R, 2003, PSYCHOPHYSIOLOGY, V40, P260, DOI 10.1111/1469-8986.00028; West R, 2001, COGNITIVE BRAIN RES, V12, P1, DOI 10.1016/S0926-6410(01)00014-3; West R, 2001, PSYCHOL AGING, V16, P682, DOI 10.1037//0882-7974.16.4.682; West R. L., 1988, PRACTICAL ASPECTS ME, V2, P119; West R, 2007, MEM COGNITION, V35, P1034, DOI 10.3758/BF03193476; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; West R, 2007, INT J PSYCHOPHYSIOL, V64, P269, DOI 10.1016/j.ijpsycho.2006.09.006; West R, 2007, INT J PSYCHOPHYSIOL, V64, P215, DOI 10.1016/j.ijpsycho.2006.09.004; West R, 2004, COGN AFFECT BEHAV NE, V4, P354, DOI 10.3758/CABN.4.3.354; West R, 2011, NEUROPSYCHOLOGIA, V49, P2233, DOI 10.1016/j.neuropsychologia.2010.12.028; West R, 2002, COGN AFFECT BEHAV NE, V2, P162, DOI 10.3758/CABN.2.2.162; Wilkins A. J., 1978, PRACTICAL ASPECTS ME, P27; Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278; Zimmermann TD, 2006, Q J EXP PSYCHOL, V59, P2040, DOI 10.1080/17470210600917835; Zinke K, 2010, CHILD NEUROPSYCHOL, V16, P338, DOI 10.1080/09297041003631451; Zollig J, 2010, CORTEX, V46, P575, DOI 10.1016/j.cortex.2009.09.010	169	11	11	0	36	UBIQUITY PRESS LTD	LONDON	2N, 6 OSBORNE ST, LONDON, E1 6TD, ENGLAND	0033-2879			PSYCHOL BELG	Psychol. Belg.		2012	52	2-3			SI		173	204					32	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	004XN	WOS:000308714900006					2022-02-06	
J	Haar, CV; Emery, MA; Hoane, MR				Haar, Cole Vonder; Emery, Michael A.; Hoane, Michael R.			Chronic folic acid administration confers no treatment effects in either a high or low dose following unilateral controlled cortical impact injury in the rat	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Vitamin-therapy; traumatic brain injury; neurotoxicity; therapeutic; recovery of function	TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; FLUID PERCUSSION INJURY; NICOTINAMIDE TREATMENT; CONTUSION INJURY; SUPPLEMENTATION; EXPRESSION; FOLATE; DAMAGE; NEUROPROTECTION	Purpose: Traumatic brain injury (TBI) is a major health concern today and effective treatments must be developed in order to combat the numerous TBIs that occur each year. Multiple b-vitamins have been shown to have neuroprotective effects, however, folic acid (B-9) has not been widely studied. The current study examined two different doses in a rodent model of controlled cortical impact (CCI) TBI. Methods: Sham procedures or a unilateral parietal controlled cortical impact injury was induced. Rats were administered either vehicle or folic acid in an 80 mu g/kg or 800 mu g/kg dose. Rats were tested on the bilateral tactile adhesive removal task, rotarod task and the Morris water maze. Brains were examined to determine lesion size and neuronal loss. Results: Neither of the folic acid-treated groups showed improvement on any behavioral task or anatomical measure post-CCI and the high dose group had increased neuronal loss compared to the vehicle. Administration of the high dose in sham animals resulted in some behavioral dysfunction and significant neuronal loss. Conclusions: The results from this study suggest that folic acid may not represent an effective avenue for treatment and that higher doses may actually be detrimental following TBI.	[Haar, Cole Vonder; Emery, Michael A.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrated Res Cognit & Neural Sci, MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Vonder Haar, Cole/0000-0001-7949-2068; Hoane, Michael/0000-0001-7779-2657; Emery, Michael/0000-0002-8587-4115	ARRA from NINDS [NS045647]; Southern Illinois University's Center for Integrated Research in Cognitive and Neural Sciences; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS045647]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647] Funding Source: NIH RePORTER	Thanks to Derrick Haan for his assistance with behavioral tasks and to Lynn Moore for her help with histological analyses. This project was funded by ARRA funds from NINDS NS045647 and Southern Illinois University's Center for Integrated Research in Cognitive and Neural Sciences. Funded by NINDS NS045647.	Achon M, 2000, BRIT J NUTR, V83, P177, DOI 10.1017/S0007114500000222; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; CDC, 2010, INJ PREV CONTR TRAUM; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Fenech M, 2001, MUTAT RES-FUND MOL M, V475, P57, DOI 10.1016/S0027-5107(01)00079-3; Fioravanti M, 1997, ARCH GERONTOL GERIAT, V26, P1, DOI 10.1016/S0167-4943(97)00028-9; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2005, J NEUROTRAUM, V22, P1112, DOI 10.1089/neu.2005.22.1112; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Iskandar BJ, 2004, ANN NEUROL, V56, P221, DOI 10.1002/ana.20174; Kelly PJ, 2003, STROKE, V34, pE51, DOI 10.1161/01.STR.0000071109.23410.AB; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; MOSER E, 1993, J NEUROSCI, V13, P3916; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sommer BR, 2003, J GERIATR PSYCH NEUR, V16, P156, DOI 10.1177/0891988703256052; Sunder-Plassmann G, 2000, J AM SOC NEPHROL, V11, P1106, DOI 10.1681/ASN.V1161106; Vogel T, 2009, INT J CLIN PRACT, V63, P1061, DOI 10.1111/j.1742-1241.2009.02026.x	36	11	11	1	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	4					291	302		10.3233/RNN-2012-110196			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	973OA	WOS:000306368300003	22572023				2022-02-06	
J	Jiang, JD; Bu, XY; Liu, M; Cheng, PX				Jiang, Jindou; Bu, Xingyao; Liu, Meng; Cheng, Peixun			Transplantation of autologous bone marrow-derived mesenchymal stem cells for traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						angiogenesis; neurogenesis; neurotrophic factors; bone marrow-derived mesenchymal stem cells; traumatic brain injury; stem cell transplantation; neural regeneration	STROMAL CELLS; NEUROTROPHIC FACTOR; CEREBRAL-ISCHEMIA; HEAD-INJURY; NEUROGENESIS; RAT; GROWTH; MICE; PROLIFERATION; DIFFERENTIATE	Results from the present study demonstrated that transplantation of autologous bone marrow-derived mesenchymal stem cells into the lesion site in rat brain significantly ameliorated brain tissue pathological changes and brain edema, attenuated glial cell proliferation, and increased brain-derived neurotrophic factor expression. In addition, the number of cells double-labeled for 5-bromodeoxyuridine/glial fibrillary acidic protein and cells expressing nestin increased. Finally, blood vessels were newly generated, and the rats exhibited improved motor and cognitive functions. These results suggested that transplantation of autologous bone marrow-derived mesenchymal stem cells promoted brain remodeling and improved neurological functions following traumatic brain injury.	[Jiang, Jindou] So Med Univ, Dept Plast & Cosmet Surg, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China; [Bu, Xingyao; Liu, Meng; Cheng, Peixun] Henan Prov Peoples Hosp, Dept Neurosurg, Zhengzhou 450003, Henan Province, Peoples R China		Bu, XY (corresponding author), Henan Prov Peoples Hosp, Dept Neurosurg, Zhengzhou 450003, Henan Province, Peoples R China.	buxingyao@126.com			Science and Technology Tackle Program of Henan Province [0424420054]	This work was financially supported by the Science and Technology Tackle Program of Henan Province, No. 0424420054.	Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; BOULTON RA, 1995, CLIN SCI, V88, P119, DOI 10.1042/cs0880119; Bu XY, 2004, LAB INVEST, V84, P667, DOI 10.1038/labinvest.3700089; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hsi ED, 2001, ARCH PATHOL LAB MED, V125, P289; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Tsyb AF, 2007, B EXP BIOL MED+, V143, P539, DOI 10.1007/s10517-007-0174-z; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; WANG YC, 2005, ZHONGGUO XINGWEI YIX, V14, P69; Whetton AD, 1999, TRENDS CELL BIOL, V9, P233, DOI 10.1016/S0962-8924(99)01559-7; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zhang F, 2009, ZHONGHUA SHIYONG ZHE, V23, P240; Zhang SX, 2009, ZHONGHUA LINCHUANG Y, V3, P771	30	11	12	2	13	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2012	7	1					46	53		10.3969/j.issn.1673-5374.2012.01.008			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	887GN	WOS:000299915000009	25806058				2022-02-06	
J	Viano, DC; Hamberger, A; Bolouri, H; Saljo, A				Viano, David C.; Hamberger, Anders; Bolouri, Hayde; Saljo, Annette			Evaluation of Three Animal Models for Concussion and Serious Brain Injury	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Brain injury; Head impact; Traumatic brain injury; Animal models	EXPERIMENTAL HEAD-INJURY; CONTROLLED CORTICAL IMPACT; PROFESSIONAL FOOTBALL; CEREBRAL CIRCULATION; AXONAL INJURY; ROTATIONAL ACCELERATION; PERCUSSION CONCUSSION; RAT-BRAIN; TRAUMA; MORPHOLOGY	Three animal models were evaluated in this study involving head impacts of the rat, including the Marmarou drop-weight and two momentum-exchange techniques. In series 1, 36 Wistar rats were hit on the side of the free-moving head using Marmarou's 450 g impact mass at 4.4, 5.4, and 6.3 m/s. Head acceleration was measured and injuries were observed. The 6.3-m/s side impact resulted in no deaths, no skull fractures, infrequent contusions, and some injuries consistent with diffuse axonal injury. In series 2, 57 Marmarou drop-weight tests were conducted to study head biomechanical responses. Marmarou's technique involves a head impact followed by prolonged loading into a foam pad under the animal. Based on the literature, the 2 m (6.3 m/s) Marmarou drop causes death, skull fracture, brain and spinal cord contusions, and diffuse axonal injury. These injuries are more severe than that occurring with impact of similar mass and velocity to the free-moving head. Impacts to the free-moving head provide more realistic animal models to study concussion and severe brain injury.	[Viano, David C.] ProBiomechanics LLC, Bloomfield Hills, MI 48304 USA; [Hamberger, Anders; Bolouri, Hayde; Saljo, Annette] Univ Gothenburg, Dept Anat & Cell Biol, S-40530 Gothenburg, Sweden		Viano, DC (corresponding author), ProBiomechanics LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.	dviano@comcast.net			National Football League; NFL Charities; NFL Players Association; League	Funding for this research was provided by the National Football League and NFL Charities, which is funded by the NFL Players Association and the League. The authors gratefully appreciate their support.	Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Chou CC, 1974, SAE T, P398; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1961, ARCH NEUROL-CHICAGO, V5, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ellingson Benjamin M., 2005, V41, P86; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; Gurdjian ES, 1975, IMPACT HEAD INJURY M; Gurgjian E. S., 1954, NEUROLOGY, V4, P674; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LINDGREN S, 1967, J TRAUM, V7, P493, DOI 10.1097/00005373-196707000-00001; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P511, DOI 10.1016/0013-4694(55)90077-8; MEYER JS, 1956, ELECTROEN CLIN NEURO, V8, P107, DOI 10.1016/0013-4694(56)90037-2; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; Ommaya AK, 1967, 11 STAPP CAR CRASH C, P73; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tornheim P A, 1976, Surg Neurol, V5, P171; TORNHEIM PA, 1983, J NEUROSURG, V59, P431, DOI 10.3171/jns.1983.59.3.0431; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; VIANO DC, 1988, J BIOMECH, V21, P387, DOI 10.1016/0021-9290(88)90145-5; VIANO DC, 1999, CRASH PREV INJ CONTR, V1, P35; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69	53	11	12	2	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		213	226		10.1007/s10439-011-0386-2			14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895HJ	WOS:000300486700019	22012080				2022-02-06	
J	Wilde, EA; Hunter, JV; Bigler, ED				Wilde, Elisabeth A.; Hunter, Jill V.; Bigler, Erin D.			A primer of neuroimaging analysis in neurorehabilitation outcome research	NEUROREHABILITATION			English	Article						Neuroimaging primer and analysis; neurorehabilitation; diffusion tensor imaging (DTI); magnetic resonance imaging (MRI); computed tomography (CT)	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; COMMON DATA ELEMENTS; COGNITIVE IMPAIRMENT; CEREBRAL ATROPHY; CHILDREN; TOMOGRAPHY; MORPHOLOGY; RECOVERY; STROKE	Although most neurological patients that enter a rehabilitation treatment program have had either a computed tomography (CT) or magnetic resonance imaging (MRI) scan, the utilization of neuroimaging in rehabilitation has been limited. However, a number of new MRI methods for image analysis hold great promise to better inform the neurorehabilitation clinician. The current review provides a foundation in neuroimaging fundamentals for neurorehabilitation specialists and examines the progress in using such techniques as quantitative MRI analyses, diffusion tensor imaging (DTI) and functional MRI to better understand the neurologically impaired patient.	[Wilde, Elisabeth A.; Hunter, Jill V.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Wilde, Elisabeth A.; Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA		Wilde, EA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1709 Dryden Rd,Ste 1200, Houston, TX 77030 USA.	ewilde@bcm.edu					Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Atlas SW, 2002, MAGNETIC RESONANCE I; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P441, DOI 10.1037/10361-021; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bigler ED, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00228; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Ciumas C, 2008, CURR OPIN NEUROL, V21, P431, DOI 10.1097/WCO.0b013e3283056a3c; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Delano-Wood L, 2009, J INT NEUROPSYCH SOC, V15, P906, DOI 10.1017/S1355617709990257; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Finger S., 1994, OOF NEUROSCIENCE; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Gasparetto EL, 2011, NEUROIMAG CLIN N AM, V21, P115, DOI 10.1016/j.nic.2011.02.003; Gauthier LV, 2012, STROKE, V43, P453, DOI 10.1161/STROKEAHA.111.633255; Gibson E, 2010, J MAGN RESON IMAGING, V31, P1311, DOI 10.1002/jmri.22004; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haller Sven, 2009, Top Magn Reson Imaging, V20, P301, DOI 10.1097/RMR.0b013e318207a5a9; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Jang SH, 2011, NEUROREHABILITATION, V28, P345, DOI 10.3233/NRE-2011-0662; Jirsa VK, 2010, ARCH ITAL BIOL, V148, P189; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kononen M, 2012, EUR J NEUROL, V19, P578, DOI 10.1111/j.1468-1331.2011.03572.x; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025930; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lotze M, 2012, NEUROREHAB NEURAL RE, V26, P594, DOI 10.1177/1545968311427706; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Reed BR, 2004, ARCH NEUROL-CHICAGO, V61, P1545, DOI 10.1001/archneur.61.10.1545; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Robinson RJ, 2011, J NEUROIMAGING, V21, pE189, DOI 10.1111/j.1552-6569.2010.00516.x; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schiff ND, 2006, J HEAD TRAUMA REHAB, V21, P388, DOI 10.1097/00001199-200609000-00003; Seitz RJ, 2010, J MAGN RESON IMAGING, V32, P756, DOI 10.1002/jmri.22315; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Stroman PW, 2012, CLIN NEUROL NEUROSUR, V114, P460, DOI 10.1016/j.clineuro.2012.01.003; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Takao H, 2010, NEURORADIOLOGY, V52, P691, DOI 10.1007/s00234-010-0715-4; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Wang LE, 2012, HUM BRAIN MAPP, V33, P2941, DOI 10.1002/hbm.21417; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023	62	11	11	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	3					227	243		10.3233/NRE-2012-0793			17	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	028QC	WOS:000310436200002	23093452				2022-02-06	
J	Sifri, ZC; Nyak, N; Homnick, AT; Mohr, AA; Yonclas, P; Livingston, DH				Sifri, Ziad C.; Nyak, Natasha; Homnick, Adena T.; Mohr, Alicia A.; Yonclas, Peter; Livingston, David H.			Utility of Repeat Head Computed Tomography in Patients With an Abnormal Neurologic Examination After Minimal Head Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Minimal head injury; Repeat head computed tomography; Neurosurgical intervention; Intracranial bleed; Neurological deterioration	TRAUMATIC BRAIN-INJURY; CT; ADMISSION; MODERATE; MILD; MANAGEMENT	Background: Previous studies proposed that repeat head computed tomography (RHCT) is of no value in patients with a minimal head injury (MHI) and normal neurologic examination (NE). The goal of our study was to investigate the value of RHCT in patients with MHI with an abnormal NE. Methods: A retrospective chart review of adult patients presenting to a Level I trauma center from July 2002 to December 2006 with MHI was performed. Demographics, injury severity, and HCT findings were collected. Patients with an abnormal NE at the time of RHCT were divided into three subgroups: acute deterioration NE (AD-NE), persistently abnormal NE (PANE), and unknown NE (U-NE). Changes in the management and outcomes after RHCT were compared. Results: One hundred seven patients had a MHI with an abnormal NE. Of those, seven (6.5%) had a change in management after RHCT. At the time of RHCT, 68 patients (63%) had a PA-NE, 21 AD-NE, and 18 U-NE. Six patients (29%) with AD-NE, 1 patient (6%) with an U-NE, and no patients with PA-NE required changes in management after RHCT. Compared with a RHCT, NE had higher positive and negative predictive values in determining the need for management changes. Conclusions: Of all patients with MHI with an abnormal NE at the time of RHCT, 63% had a PA-NE. Although a RHCT is beneficial to patients with an acutely deteriorating or U-NE, it appears to be of little value in patients with a PA-NE. Compared with RHCT, serial NE may be a stronger predictor for the need for intervention in patients with MHI.	[Sifri, Ziad C.] UMDNJ NJMS, Div Trauma & Crit Care, Dept Surg, New Jersey Trauma Ctr, Newark, NJ 07101 USA		Sifri, ZC (corresponding author), UMDNJ NJMS, Div Trauma & Crit Care, Dept Surg, New Jersey Trauma Ctr, 150 Bergen St,M232, Newark, NJ 07101 USA.	sifrizi@umdnj.edu	Mohr, Alicia M/E-3016-2015	Mohr, Alicia/0000-0003-1732-1313			Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Faul M, 2010, TRAUMATIC BRAIN INJU; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Homnick AT, 2009, AAST ANN C PITTSB PA; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; LeTarte P, 2000, TRAUMA, P397; Levin HS, 1996, NEUROTRAUMA, P749; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Shackford SR, 2004, J TRAUMA, V56, P480; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sinson G, 2001, J TRAUMA, V51, P875; Stearley H E, 1998, Am J Crit Care, V7, P282; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	24	11	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1605	1610		10.1097/TA.0b013e31822b3728			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	869RT	WOS:000298616400028	21857258				2022-02-06	
J	Konno, T; Hata, S; Hamada, Y; Horikoshi-Sakuraba, Y; Nakaya, T; Saito, Y; Yamamoto, T; Yamamoto, T; Maeda, M; Ikeuchi, T; Gandy, S; Akatsu, H; Suzuki, T				Konno, Tomoko; Hata, Saori; Hamada, Yukiko; Horikoshi-Sakuraba, Yuko; Nakaya, Tadashi; Saito, Yuhki; Yamamoto, Tohru; Yamamoto, Takayuki; Maeda, Masahiro; Ikeuchi, Takeshi; Gandy, Sam; Akatsu, Hiroyasu; Suzuki, Toshiharu		Japanese Alzheimers Dis	Coordinated increase of gamma-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer's disease patients: quantitative analysis of p3-Alc alpha with a new ELISA system	MOLECULAR NEURODEGENERATION			English	Article							TRAUMATIC BRAIN-INJURY; AMYLOID-BETA; APOLIPOPROTEIN-E; ASSOCIATION; ESTROGEN; PEPTIDE; GENE; NEURODEGENERATION; DEGRADATION; METABOLISM	Background: Aggregatable amyloid beta-peptide (A beta) and non-aggregatable p3-Alc alpha are metabolic products of the gamma-secretase cleavage of amyloid beta-protein precursor (APP) and Alcadein alpha (Alc alpha), respectively. Familial AD (FAD)-linked mutations in the presenilin 1 or 2 (PS1 or PS2) component of gamma-secretase can cause alternative intramembranous processing of APP and Alc alpha, leading to a coordinated generation of variants of both A beta and p3-Alc alpha. Variant Alc alpha peptides have been observed in the cerebrospinal fluid (CSF) of patients with mild cognitive impairment and sporadic Alzheimer's disease (AD). Since, like APP, Alc alpha is largely expressed in brain, one might predict that alternative processing of Alca would be reflected in body fluids of some AD patients. These patients with misprocessing of multiple gamma-secretase substrates might define an endophenotype of p3-Alc alpha, in whom AD is due either to dysfunction of gamma-secretase or to a disorder of the clearance of hydrophobic peptides such as those derived from transmembrane domains. Results: We developed a simple procedure for extraction of p3-Alc alpha from plasma and for analyzing this extract in a sensitive, p3-Alc alpha-specific sandwich enzyme-linked immunosorbent assay (ELISA) system. Plasma p3-Alca levels and A beta 40 levels were examined in sporadic AD subjects from two independent Japanese cohorts. In some of these patients, levels of plasma p3-Alc alpha were significantly higher, and were accompanied by parallel changes in A beta 40 levels. This AD-related difference was more marked in female subjects, but this phenomenon was not observed in subjects with frontotemporal lobar degeneration (FTLD). Conclusion: Reagents and procedures have been established that enable extraction of p3-Alc alpha from plasma and for quantification of plasma p3-Alc alpha levels by ELISA. Some populations of AD subjects apparently show increased levels of both p3-Alc alpha and A beta 40. Quantification of p3-Alc alpha level may be useful as a readily accessible biomarker for a population of sporadic AD patients in which disease pathogenesis is associated with either dysfunction of gamma-secretase or with a disorder of the clearance of transmembrane domain-derived peptides.	[Konno, Tomoko; Hata, Saori; Nakaya, Tadashi; Saito, Yuhki; Yamamoto, Tohru; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Sapporo, Hokkaido 0600812, Japan; [Hamada, Yukiko; Horikoshi-Sakuraba, Yuko; Maeda, Masahiro] Immunobiol Labs Co Ltd IBL, Fujioka 3750005, Japan; [Yamamoto, Takayuki; Akatsu, Hiroyasu] Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi 4418124, Japan; [Ikeuchi, Takeshi] Niigata Univ, Brain Res Inst, Dept Mol Neurosci, Niigata 9518585, Japan; [Gandy, Sam] Alzheimers Dis Res Ctr, Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Gandy, Sam] Alzheimers Dis Res Ctr, Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Gandy, Sam] James J Peters Vet Adm Med Ctr, Bronx, NY 10468 USA		Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Hata, Saori/A-3829-2012; Iwata, Atsushi/AAH-8924-2019; Hata, Saori/AAP-9634-2020; Yamamoto, Tohru/A-3801-2012; Suzuki, Toshiharu/B-5342-2013	Iwata, Atsushi/0000-0001-7308-5314; Yamamoto, Tohru/0000-0002-1652-0233; Hata, Saori/0000-0003-4723-5993	Ministry of Education, Culture, Sports, Science and Technology (MEXT)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Ministry of Health, Labor and Welfare (MHLW)Ministry of Health, Labour and Welfare, Japan; New Energy and Industrial Technology Development Organization (NEDO) in JapanNew Energy and Industrial Technology Development Organization (NEDO); NIA Alzheimer's Disease Research Center [P50 05138]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23390017, 22590055] Funding Source: KAKEN	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), a grant from the Ministry of Health, Labor and Welfare (MHLW), and a grant from the New Energy and Industrial Technology Development Organization (NEDO) in Japan. S.G. was supported by the NIA Alzheimer's Disease Research Center grant P50 05138 to Mary Sano.	Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Frankfort SV, 2008, CURR CLIN PHARMACOL, V3, P123, DOI 10.2174/157488408784293723; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hata S, 2011, ANN NEUROL, V69, P1026, DOI 10.1002/ana.22343; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Melchor JP, 2003, J NEUROSCI, V23, P8867; Melchor JP, 2003, J MOL NEUROSCI, V20, P287, DOI 10.1385/JMN:20:3:287; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nord LC, 2010, NEURODEGENER DIS, V7, P349, DOI 10.1159/000282279; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharman MJ, 2010, J ALZHEIMERS DIS, V21, P403, DOI 10.3233/JAD-2010-100141; Shaw LM, 2011, ACTA NEUROPATHOL, V121, P597, DOI 10.1007/s00401-011-0808-0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yaffe K, 2011, JAMA-J AM MED ASSOC, V305, P261, DOI 10.1001/jama.2010.1995; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026; Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X; Zheng H, 2002, J NEUROCHEM, V80, P191, DOI 10.1046/j.0022-3042.2001.00690.x	32	11	11	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1750-1326			MOL NEURODEGENER	Mol. Neurodegener.	NOV 8	2011	6								76	10.1186/1750-1326-6-76			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864NT	WOS:000298247600001	22067061	gold, Green Published			2022-02-06	
J	Maestas, KL; Benge, JF; Pastorek, NJ; LeMaire, A; Darrow, R				Maestas, Kacey Little; Benge, Jared F.; Pastorek, Nicholas J.; LeMaire, Ashley; Darrow, Rachel			Factor Structure of Posttraumatic Stress Disorder Symptoms in OEF/OIF Veterans Presenting to a Polytrauma Clinic	REHABILITATION PSYCHOLOGY			English	Article						factor analysis; posttraumatic stress; veterans; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONFIRMATORY FACTOR-ANALYSIS; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MEASUREMENT INVARIANCE; WAR VETERANS; CHRONIC PAIN; CHECKLIST; COMBAT; IRAQ; AFGHANISTAN	Objective: A significant number of Operation Iraqi Freedom/Operation Enduring Freedom (OEF/OIF) veterans are returning from deployment and presenting to Veterans Health Administration (VHA) polytrauma clinics with elevated rates of posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI). Inherent to the accurate assessment and treatment of this diagnostically complex group of veterans is the assumption that the construct of PTSD is the same in this population as in other trauma groups. To our knowledge, no previous study has examined the structure of PTSD in this relevant and fast-growing population of treatment-seeking OEF/OIF veterans. Evidence suggests that the latent structure of PTSD symptoms is best represented by a four-factor model, rather than the three-factor model found in the current DSM-IV-TR. Thus, we examined the three and four-factor models using the PTSD Check List-Civilian (PCL-C) in a sample of treatment-seeking OEF/OIF veterans seen through a VHA polytrauma clinic. Method: A chart review was conducted for OEF/OIF veterans (N = 361) seen through a VHA outpatient polytrauma clinic from September 2007 through August 2008. Participants completed the PCL-C as part of a comprehensive polytrauma evaluation. Results: Confirmatory factor analyses showed that the DSM-IV-TR three-factor model did not fit the data well. A direct comparison showed that the four-factor model provided a superior fit relative to the three-factor model. Conclusion: Results extend the generalizability of the four-factor model to OEF/OIF veterans presenting to Veterans Health Administration (VHA) polytrauma clinics.	[Maestas, Kacey Little] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Maestas, Kacey Little; Pastorek, Nicholas J.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Benge, Jared F.; Pastorek, Nicholas J.] Jack C Montgomery VA Med Ctr, Rehabil Care Line, Muskogee, OK USA; [LeMaire, Ashley] Mem Hosp Gulfport, Dept Neurosci & Rehabil, Gulfport, MS USA; [Darrow, Rachel] Ralph H Johnson VA Med Ctr, Mental Hlth Care Line, Charleston, SC USA		Pastorek, NJ (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd,RCL 117, Houston, TX 77030 USA.	nicholas.pastorek@va.gov		Benge, Jared/0000-0001-6201-3278; Pastorek, Nicholas/0000-0002-9290-380X			Amdur RL, 2001, J ANXIETY DISORD, V15, P345, DOI 10.1016/S0887-6185(01)00068-8; American Psychiatric Association, 2001, DSM 5 DEV WEBS; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arbuckle J., 2008, AMOS 17 USERS GUIDE; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; Baschnagel JS, 2005, J TRAUMA STRESS, V18, P677, DOI 10.1002/jts.20076; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Breslau N, 2005, ARCH GEN PSYCHIAT, V62, P1343, DOI 10.1001/archpsyc.62.12.1343; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Department of Veterans Affairs and Department of Defense Management of Post-Traumatic Stress Working Group, 2010, VA DOD CLIN PRACT GU; DuHamel KN, 2004, PSYCHOL ASSESSMENT, V16, P255, DOI 10.1037/1040-3590.16.3.255; Felmingham KL, 2002, PSYCHIAT RES, V109, P171, DOI 10.1016/S0165-1781(02)00003-3; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P1044, DOI 10.1097/PHM.0b013e3181c1ef29; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Lintz B. T., 1992, CLIN PSYCHOL REV, V12, P417, DOI [10.1016/0272-7358(92)90125-R, DOI 10.1016/0272-7358(92)90125-R]; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mansfield AJ, 2010, J TRAUMA STRESS, V23, P91, DOI 10.1002/jts.20492; Marshall GN, 2004, J TRAUMA STRESS, V17, P223, DOI 10.1023/B:JOTS.0000029265.56982.86; McDonald SD, 2008, J TRAUMA STRESS, V21, P309, DOI 10.1002/jts.20344; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Miller MW, 2010, J TRAUMA STRESS, V23, P631, DOI 10.1002/jts.20559; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Palmieri PA, 2005, J TRAUMA STRESS, V18, P657, DOI 10.1002/jts.20074; Schinka JA, 2007, J TRAUMA STRESS, V20, P281, DOI 10.1002/jts.20202; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shevlin M, 2009, J ANXIETY DISORD, V23, P995, DOI 10.1016/j.janxdis.2009.07.001; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor S, 1998, J ABNORM PSYCHOL, V107, P154, DOI 10.1037/0021-843X.107.1.154; Taylor S, 2003, J CONSULT CLIN PSYCH, V71, P330, DOI 10.1037/0022-006X.71.2.330; Taylor S, 2001, J CONSULT CLIN PSYCH, V69, P541, DOI 10.1037//0022-006X.69.3.541; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F.W., 1993, ANN CONV INT SOC TRA	51	11	10	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2011	56	4					366	373		10.1037/a0025447			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	862AQ	WOS:000298062600010	21928917				2022-02-06	
J	Soustiel, JF; Vlodavsky, E; Milman, F; Gavish, M; Zaaroor, M				Soustiel, Jean F.; Vlodavsky, Eugene; Milman, Felix; Gavish, Moshe; Zaaroor, Menashe			Improvement of Cerebral Metabolism Mediated by Ro5-4864 is Associated with Relief of Intracranial Pressure and Mitochondrial Protective Effect in Experimental Brain Injury	PHARMACEUTICAL RESEARCH			English	Article						18 kDa translocator protein; intracranial pressure; microdialysis; mitochondria; traumatic brain injury	PERIPHERAL BENZODIAZEPINE-RECEPTOR; HYPERBARIC-OXYGEN THERAPY; SEVERE HEAD-INJURY; BLOOD-FLOW; RAT MODEL; MICRODIALYSIS; ISCHEMIA; DAMAGE; REDUCTION; VOLUME	To investigate the possible impact of reduction of mitochondrial membrane permeabilization by modulation of the 18 kDa translocator protein mediated by Ro5-4864 over post-traumatic cerebral edema and metabolic crisis. Cerebral microdialysis and intracranial pressure (ICP) monitoring were performed in Sprague-Dawley rats treated by intraperitoneal injection of either dimethylsulfoxide (vehicle) or Ro5-4864 following cortical contusion and further correlated with quantitative assessment of mitochondrial damage, water content in the injured tissue, modified neurological severity score, and lesion size. Ro5-4864 resulted in a profound decrease in ICP that correlated with improved cerebral metabolism characterized by significantly higher glucose and pyruvate and lower lactate concentrations in the pericontusional area in comparison with vehicle-treated animals. Reduced ICP correlated with reduced water content in the injured tissue; improved metabolism was associated with reduced mitochondrial damage evidenced by electron microscopy. Both effects were associated with a profound and significant reduction in glycerol release and lesion size, and correlated with improved neurological recovery. The present study shows that Ro5-4864 has a favorable effect on the fate of injured brain, presumably mediated by improvement of metabolism. It further suggests that improvement of metabolism may contribute to ICP relief.	[Soustiel, Jean F.] Rambam Med Ctr, Dept Neurosurg, IL-31096 Haifa, Israel; [Soustiel, Jean F.; Milman, Felix; Zaaroor, Menashe] Technion Israel Inst Technol, Fac Med, Acute Brain Injury Res Lab, Haifa, Israel; [Vlodavsky, Eugene] Technion Israel Inst Technol, Fac Med, Inst Pathol, Rambam Med Ctr, Haifa, Israel; [Gavish, Moshe] Technion Israel Inst Technol, Fac Med, Dept Mol Pharmacol, Haifa, Israel		Soustiel, JF (corresponding author), Rambam Med Ctr, Dept Neurosurg, POB 9602, IL-31096 Haifa, Israel.	j_soustiel@rambam.health.gov.il					BAZAN NG, 1970, LIFE SCI, V9, P501, DOI 10.1016/0024-3205(70)90205-5; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; CHAN PH, 1983, BRAIN RES, V277, P329, DOI 10.1016/0006-8993(83)90941-1; Chieregato A, 2007, INTENS CARE MED, V33, P856, DOI 10.1007/s00134-007-0604-4; Decaudin D, 2004, ANTI-CANCER DRUG, V15, P737, DOI 10.1097/00001813-200409000-00001; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; GERCKEN G, 1973, PFLUG ARCH EUR J PHY, V344, P207, DOI 10.1007/BF00588461; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; LANGEMANN H, 1995, CLIN NEUROL NEUROSUR, V97, P149, DOI 10.1016/0303-8467(94)00067-G; LEES GJ, 1992, J NEUROL SCI, V108, P221, DOI 10.1016/0022-510X(92)90055-P; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27; Nakamoto Y, 1996, BRAIN RES, V717, P91, DOI 10.1016/0006-8993(96)00033-9; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Shiotani T, 2000, BRAIN RES, V859, P255, DOI 10.1016/S0006-8993(00)01971-5; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Soustiel JF, 2010, NEUROTHERAPEUTICS, V7, P13, DOI 10.1016/j.nurt.2009.11.001; Soustiel JF, 2008, EXP NEUROL, V214, P201, DOI 10.1016/j.expneurol.2008.08.008; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Valtysson J, 1998, ACTA NEUROCHIR, V140, P387, DOI 10.1007/s007010050113; Veiga S, 2005, J NEUROSCI RES, V80, P129, DOI 10.1002/jnr.20430; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	39	11	12	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741	1573-904X		PHARM RES-DORDR	Pharm. Res.	NOV	2011	28	11					2945	2953		10.1007/s11095-011-0463-0			9	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	830ZF	WOS:000295697700025	21584844				2022-02-06	
J	D'Onofrio, PM; Thayapararajah, M; Lysko, MD; Magharious, M; Spratt, SK; Lee, G; Ando, D; Surosky, R; Fehlings, MG; Koeberle, PD				D'Onofrio, Philippe M.; Thayapararajah, Mahinthan; Lysko, Meghan D.; Magharious, Mark; Spratt, S. Kaye; Lee, Gary; Ando, Dale; Surosky, Richard; Fehlings, Michael G.; Koeberle, Paulo D.			Gene Therapy for Traumatic Central Nervous System Injury and Stroke Using an Engineered Zinc Finger Protein that Upregulates VEGF-A	JOURNAL OF NEUROTRAUMA			English	Article						CNS; ischemia; retinal ganglion cell; trauma; VEGF	ENDOTHELIAL GROWTH-FACTOR; RETINAL GANGLION-CELLS; PUPILLARY LIGHT REFLEX; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTION FACTOR; IN-VIVO; HINDLIMB ISCHEMIA; NITRIC-OXIDE; AXONAL REGENERATION; BRAIN-INJURY	Recent studies have identified anti-apoptotic functions for vascular endothelial growth factor (VEGF) in the central nervous system (CNS). However, VEGF therapy has been hampered by a tendency to promote vascular permeability, edema, and inflammation. Recently, engineered zinc finger proteins (ZFPs) that upregulate multiple forms of VEGF in their natural biological ratios, have been developed to overcome these negative side effects. We used retinal trauma and ischemia models, and a cortical pial strip ischemia model to determine if VEGF upregulating ZFPs are neuroprotective in the adult CNS. Optic nerve transection and ophthalmic artery ligation lead to the apoptotic degeneration of retinal ganglion cells (RGCs) and are, respectively, two highly reproducible models for CNS trauma or ischemia. Adeno-associated vectors (AAV) vectors encoding VEGF-ZFPs (AAV-VEGF-ZFP) significantly increased RGC survival by similar to twofold at 14 days after optic nerve transection or ophthalmic artery ligation. Furthermore, AAV-VEGF-ZFP enhanced recovery of the pupillary light reflex. RECA-1 immunostaining demonstrated no appreciable differences between retinas treated with AAV-VEGF-ZFP and controls, suggesting that AAV-VEGF-ZFP treatment did not affect retinal vasculature. Following pial strip of the forelimb motor cortex, brains treated with an adenovirus encoding VEGF ZFPs (AdV-ZFP) showed higher neuronal survival, accelerated wound contraction, and reduced lesion volume between 1 and 6 weeks after injury. Behavioral testing using the cylinder test for vertical exploration showed that AdV-VEGF-ZFP treatment enhanced contralateral forelimb function within the first 2 weeks after injury. Our results indicate that VEGF ZFP therapy is neuroprotective following traumatic injury or stroke in the adult mammalian CNS.	[Koeberle, Paulo D.] Univ Toronto, Div Anat, Dept Surg, Toronto, ON M5S 1A8, Canada; [Magharious, Mark; Koeberle, Paulo D.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A8, Canada; [Spratt, S. Kaye; Lee, Gary; Ando, Dale; Surosky, Richard] Sangamo Biosci, Dept Therapeut Dev, Port Richmond, CA USA		Koeberle, PD (corresponding author), Univ Toronto, Div Anat, Dept Surg, MSB 1186,1 Kings Coll, Toronto, ON M5S 1A8, Canada.	paulo.koeberle@utoronto.ca		Fehlings, Michael/0000-0002-5722-6364			Ahmad S, 2006, CIRC RES, V99, P715, DOI 10.1161/01.RES.0000243989.46006.b9; Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Baumgartner I, 2000, ANN INTERN MED, V132, P880, DOI 10.7326/0003-4819-132-11-200006060-00005; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Borlongan CV, 2006, CAN MED ASSOC J, V174, P954, DOI 10.1503/cmaj.060199; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Dai QS, 2004, CIRCULATION, V110, P2467, DOI 10.1161/01.CIR.0000145139.53840.49; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373, DOI 10.2174/1389203054546334; Fu CY, 2007, J HUAZHONG UNIV SCI, V27, P186, DOI 10.1007/s11596-007-0221-z; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Guy J, 1999, ARCH OPHTHALMOL-CHIC, V117, P929; Hata Y, 2008, BRIT J OPHTHALMOL, V92, P1540, DOI 10.1136/bjo.2008.141002; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kaur C, 2009, INVEST OPHTH VIS SCI, V50, P5364, DOI 10.1167/iovs.09-3552; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; KLOOSTER J, 1995, BRAIN RES, V688, P34, DOI 10.1016/0006-8993(95)00497-E; Koeberle PD, 2008, CELL DEATH DIFFER, V15, P471, DOI 10.1038/sj.cdd.4402281; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Lafuente MP, 2002, NEUROSCIENCE, V109, P157, DOI 10.1016/S0306-4522(01)00458-4; Li YJ, 2007, DIABETES, V56, P656, DOI 10.2337/db06-0999; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; McCarran WJ, 2007, J NEUROSCI, V27, P4220, DOI 10.1523/JNEUROSCI.5542-06.2007; Nakazawa T, 2002, INVEST OPHTH VIS SCI, V43, P3319; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Norrby K, 2002, APMIS, V110, P355, DOI 10.1034/j.1600-0463.2002.100501.x; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Pernet V, 2005, J NEUROCHEM, V93, P72, DOI 10.1111/j.1471-4159.2005.03002.x; Price SA, 2006, DIABETES, V55, P1847, DOI 10.2337/db05-1060; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; RADEL JD, 1995, NEUROSCIENCE, V68, P893, DOI 10.1016/0306-4522(95)00191-K; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Ramanathan MD, 2003, EXP BIOL MED, V228, P697, DOI 10.1177/153537020322800608; Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795; Sapieha PS, 2006, J NEUROSCI RES, V83, P985, DOI 10.1002/jnr.20803; Schreiber RC, 2002, J NEUROBIOL, V53, P68, DOI 10.1002/neu.10093; Sivakumar V, 2008, BRAIN PATHOL, V18, P71, DOI 10.1111/j.1750-3639.2007.00104.x; Skoff RP, 2007, NEUROCHEM RES, V32, P331, DOI 10.1007/s11064-006-9188-6; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Witmer AN, 2004, J HISTOCHEM CYTOCHEM, V52, P39, DOI 10.1177/002215540405200105; Witmer AN, 2002, INVEST OPHTH VIS SCI, V43, P849; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396; Xie DH, 2006, J VASC SURG, V44, P166, DOI 10.1016/j.jvs.2006.03.024; Yang JJ, 2000, CURR EYE RES, V21, P981, DOI 10.1076/ceyr.21.6.981.6991; Young MJ, 1998, BRAIN RES, V787, P191, DOI 10.1016/S0006-8993(97)01473-X; YOUNG MJ, 1994, NEUROSCIENCE, V62, P481, DOI 10.1016/0306-4522(94)90381-6; Yu J, 2006, FASEB J, V20, P479, DOI 10.1096/fj.04-3670fje; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200; Zhou J, 2004, CANCER RES, V64, P9041, DOI 10.1158/0008-5472.CAN-04-1437; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	60	11	12	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1863	1879		10.1089/neu.2011.1896			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000017	21902538				2022-02-06	
J	Kangas, M; Williams, JR; Smee, RI				Kangas, Maria; Williams, Janet R.; Smee, Robert I.			Benefit Finding in Adults Treated for Benign Meningioma Brain Tumours: Relations with Psychosocial Wellbeing	BRAIN IMPAIRMENT			English	Article						brain tumour; meningioma; benefit finding; psychosocial wellbeing; intrusions; avoidance	POSTTRAUMATIC GROWTH; BREAST-CANCER; INJURY; DEPRESSION; ADJUSTMENT; WOMEN; HEAD	Introduction: Research has indicated that individuals may report benefit finding (BF) as a result of experiencing potentially life-threatening traumatic events, such as being diagnosed with cancer or sustaining an acquired brain injury (ABI). No study to date has examined the incidence and correlates of BF in adult brain tumour samples. The present study aimed to investigate the association between BF and demographic and psychosocial variables in adults treated for a benign meningioma. Method: Seventy participants aged 36 to 87 years completed questionnaires that assessed perceived BF resulting from one's meningioma experience, intrusion and avoidance symptoms, emotional wellbeing and perceived quality of social support. Results: 39% of the sample had been diagnosed with their tumour within a 2-year period prior to assessment ('early' meningioma subgroup), while the remaining 61% of participants had been diagnosed with their tumour for more than 2 years ('late' meningioma subgroup). Almost two thirds (63%) of the sample reported deriving a moderate amount of BF due to their meningioma experience; although different psychological variables were found to be associated with BF according to group status. Whereas greater BF was found to be significantly associated with elevated depressive symptoms in the 'early' subsample, elevated BF was significantly positively correlated with intrusions and avoidance symptoms in the 'late' subsample. Conclusions: The findings indicate that BF may co-occur in context of both adaptive and positive illusory processes, which is consistent with the Janus-Face model of growth following adversity. The findings also support the use of psychosocial interventions to facilitate psychosocial adjustment following health crises.	[Kangas, Maria] Macquarie Univ, Ctr Emot Hlth, Dept Psychol, Sydney, NSW 2109, Australia; [Williams, Janet R.; Smee, Robert I.] Prince Wales Hosp, Prince Wales Canc Ctr, Sydney, NSW, Australia; [Smee, Robert I.] Prince Wales Private Hosp, Sydney, NSW, Australia		Kangas, M (corresponding author), Macquarie Univ, Ctr Emot Hlth, Dept Psychol, Sydney, NSW 2109, Australia.	maria.kangas@mq.edu.au	McLean, Emma/F-4616-2012	Kangas, Maria/0000-0001-8693-2949	Macquarie University	This study was partially supported by a research grant from Macquarie University awarded to Dr Kangas.	Andrykowski M.A., 2010, PSYCHO-ONCOLOGY, P348, DOI DOI 10.1093/MED/9780195367430.003.0047; Antoni MH, 2001, HEALTH PSYCHOL, V20, P20, DOI 10.1037/0278-6133.20.1.20; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Cahill S. P., 2007, HDB PTSD SCI PRACTIC, P55; Calhoun, 1995, TRAUMA TRANSFORMATIO; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Carver CS, 2004, HEALTH PSYCHOL, V23, P595, DOI 10.1037/0278-6133.23.6.595; De Monte F., 1995, BRAIN TUMOURS, P375; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Harrington S, 2008, J PSYCHOSOC ONCOL, V26, P43, DOI 10.1080/07347330802115848; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Helgeson VS, 1996, HEALTH PSYCHOL, V15, P135, DOI 10.1037/0278-6133.15.2.135; Horowitz MJ, 1986, STRESS RESPONSE SYND; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P763, DOI 10.1037/0022-006X.73.4.763; Kangas M, 2002, CLIN PSYCHOL REV, V22, P499, DOI 10.1016/S0272-7358(01)00118-0; Keane T., 1997, ASSESSING PSYCHOL TR; Kinsinger DP, 2006, PSYCHO-ONCOL, V15, P954, DOI 10.1002/pon.1028; Lechner S.C., 2009, OXFORD HDB POSITIVE, P633; Lechner SC, 2003, PSYCHO-ONCOL, V12, P491, DOI 10.1002/pon.671; Lundgren T, 2008, J BEHAV MED, V31, P225, DOI 10.1007/s10865-008-9151-x; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; McNair D. M, 1971, MANUAL PROFILE MOOD; O'Rance L., 2007, DISABILITY AUSTR ACQ; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Pringle AM, 1999, BRIT J NEUROSURG, V13, P46, DOI 10.1080/02688699944177; Sawyer A, 2010, CLIN PSYCHOL REV, V30, P436, DOI 10.1016/j.cpr.2010.02.004; Schulz U, 2004, SOC SCI MED, V59, P653, DOI 10.1016/j.socscimed.2003.11.019; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedstone JE, 2003, CLIN PSYCHOL REV, V23, P409, DOI 10.1016/S0272-7358(03)00031-X; Tomich PL, 2004, HEALTH PSYCHOL, V23, P16, DOI 10.1037/0278-6133.23.1.16; Updegraff J. A., 2000, LOSS TRAUMA GEN CLOS, P3; Urcuyo KR, 2005, PSYCHOL HEALTH, V20, P175, DOI 10.1080/08870440512331317634; van Nieuwenhuizen D, 2007, J NEURO-ONCOL, V84, P271, DOI 10.1007/s11060-007-9366-7; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	39	11	12	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2011	12	2			SI		105	116					12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	837BH	WOS:000296165600004					2022-02-06	
J	Takase, K; Mizuochi, J				Takase, Katsumi; Mizuochi, Jun			Irreducible dislocation of the radial head with undisplaced olecranon fracture in a child: a case report	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						annular ligament; irreducible reduction; Monteggia fracture; olecranon fracture; radial head	ANTERIOR DISLOCATION; MONTEGGIA FRACTURE; ELBOW; NECK	Irreducible isolated dislocation of the radial head is a rare injury. In this study, we describe a patient with irreducible dislocation of the radial head associated with an undisplaced fracture of the olecranon. A 6-year-old girl fell down while walking and suffered injury to the posterior aspect of the proximal ulnar shaft with the right elbow in a slightly flexed position. Plain radiographs of the elbow revealed an anterior-medial dislocation of the radial head and an undisplaced fracture of the olecranon. However, the attempted closed reduction was not successful. An open reduction was then performed through a lateral approach. The radial head was found to be protruding through a buttonhole tear of the anterior joint capsule, causing the joint to become interposed between the articular surfaces of the joint, precluding closed reduction. Once the interposed capsule was extricated from the joint, the radial head could be easily reduced. At this point, no tear of the annular ligament was observed. Six months after the surgery, the patient was able to use her elbow fully and without pain. The range of motion was 0-140 degrees for both extension and flexion and 90 degrees for pronation and supination. Plain radiographs revealed a united bone of the olecranon and good reduction of the radial head. The radial head pushed through the tear of the anterior joint capsule. This buttonhole effect on the radial head prevented closed reduction of the radial head. J Pediatr Orthop B 20:345-348 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Takase, Katsumi] Tokyo Med Univ, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1600023, Japan		Takase, K (corresponding author), Tokyo Med Univ, Dept Orthoped Surg, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	k-takase@muf.biglobe.ne.jp					HAMILTON W, 1973, CLIN ORTHOP RELAT R, P94; HUME AC, 1957, J BONE JOINT SURG BR, V39, P508, DOI 10.1302/0301-620X.39B3.508; KAMALI M, 1974, J BONE JOINT SURG AM, VA 56, P841, DOI 10.2106/00004623-197456040-00026; KONG KC, 1993, ARCH ORTHOP TRAUM SU, V112, P304, DOI 10.1007/BF00452972; LLOYDROBERTS GC, 1977, J BONE JOINT SURG BR, V59, P402, DOI 10.1302/0301-620X.59B4.925049; NEVIASER RJ, 1971, CLIN ORTHOP RELAT R, P72; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; Ruchelsman DE, 2005, J ORTHOP TRAUMA, V19, P425; TRIANTAFYLLOU SJ, 1992, CLIN ORTHOP RELAT R, P153; WATSON JAS, 1994, INJURY, V25, P325, DOI 10.1016/0020-1383(94)90246-1; WILEY JJ, 1974, J BONE JOINT SURG BR, VB 56, P501, DOI 10.1302/0301-620X.56B3.501; Yoshihara Y, 2002, J TRAUMA, V53, P984, DOI 10.1097/00005373-200211000-00028	12	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1060-152X			J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	SEP	2011	20	5					345	348		10.1097/BPB.0b013e32834534cb			4	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	803NP	WOS:000293588300015	21460738				2022-02-06	
J	Matsukawa, H; Shinoda, M; Fujii, M; Takahashi, O; Yamamoto, D; Murakata, A; Ishikawa, R				Matsukawa, Hidetoshi; Shinoda, Masaki; Fujii, Motoharu; Takahashi, Osamu; Yamamoto, Daisuke; Murakata, Atsushi; Ishikawa, Ryoichi			Genu of corpus callosum in diffuse axonal injury induces a worse 1-year outcome in patients with traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Corpus callosum; Diffuse axonal injury; Genu; Traumatic brain injury	HEAD-INJURY; COGNITIVE IMPAIRMENT; ATROPHY; LEUKOARAIOSIS; MILD; DIAGNOSIS; FEATURES; MODERATE; LESIONS; GAIT	Previous studies have shown a relationship between diffuse axonal injury (DAI) and unfavorable clinical outcome in patients with traumatic brain injury (TBI), but it remains unclear whether the type of DAI lesion influences outcome after TBI. The aim of the present study was to investigate whether 1-year outcome after TBI differed between patients with different types of lesions. A retrospective, single-institution study involving 261 patients with TBI was carried out between April 2003 and December 2009. Outcome was measured using the Glasgow Outcome Scale (GOS) 1 year after TBI. DAI lesions occurred in the lobar region, corpus callosum (CC), and brainstem. CC lesions were subdivided into three types: genu, body, and splenium. Univariate and multivariate logistic regression analyses were performed to evaluate the relationships between clinical characteristics and outcome for each type of DAI lesion and each type of CC lesion in patients with TBI. Sixty-nine patients had DAI lesions: 34 in the lobar region, 30 in the CC, and five in the brainstem. Of the 30 patients with CC lesions, ten each were found in the genu, body, and splenium. Each DAI, CC, and genu lesion was significantly associated with unfavorable outcome 1 year after TBI by multivariate analysis using variables that were significantly associated with unfavorable outcome as determined by univariate analysis after adjustment for age. CC lesions, especially those in the genu, were related to unfavorable 1-year outcome in patients with TBI.	[Matsukawa, Hidetoshi; Shinoda, Masaki; Fujii, Motoharu; Yamamoto, Daisuke; Murakata, Atsushi; Ishikawa, Ryoichi] St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, Tokyo 1048560, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Dept Clin Epidemiol, Chuo Ku, Tokyo 1048560, Japan		Matsukawa, H (corresponding author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	mahide@luke.or.jp			General Insurance Association of Japan	This study was supported by a medical research grant on traffic accident from The General Insurance Association of Japan 2010.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bhadelia RA, 2009, STROKE, V40, P3816, DOI 10.1161/STROKEAHA.109.564765; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Caille S, 2005, NEUROSURGERY, V57, P50, DOI 10.1227/01.NEU.0000163089.31657.08; Gallo A, 2005, ARCH NEUROL-CHICAGO, V62, P803, DOI 10.1001/archneur.62.5.803; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gorrie C, 2001, J NEUROTRAUM, V18, P849, DOI 10.1089/089771501750451776; Guttmann CRG, 2000, NEUROLOGY, V54, P1277, DOI 10.1212/WNL.54.6.1277; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1975, LANCET, V7905, P480; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Moretti M, 2005, NEUROL SCI, V26, P61, DOI 10.1007/s10072-005-0437-2; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Pandya D., 2009, FIBER PATHWAYS BRAIN; PANDYA DN, 1971, BRAIN RES, V32, P31, DOI 10.1016/0006-8993(71)90153-3; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Ryberg C, 2007, NEUROBIOL AGING, V28, P955, DOI 10.1016/j.neurobiolaging.2006.04.008; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; YAMANOUCHI H, 1990, J NEUROL, V237, P39, DOI 10.1007/BF00319666; YAMAUCHI H, 1994, STROKE, V25, P1788, DOI 10.1161/01.STR.25.9.1788; Yamauchi H, 2000, STROKE, V31, P1515, DOI 10.1161/01.STR.31.7.1515	36	11	11	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	AUG	2011	153	8					1687	1694		10.1007/s00701-011-1002-9			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	794TU	WOS:000292925000020	21479582				2022-02-06	
J	Ng, Y; Chin, KJ; Kwek, TK				Shin Yi Ng; Chin, Ki Jinn; Kwek, Tong Kiat			Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case series	INTENSIVE CARE MEDICINE			English	Article						Thiopentone; Barbiturate coma; Refractory; intracranial hypertension; Dyskalaemia	TRAUMATIC BRAIN-INJURY; REBOUND HYPERKALEMIA; PLASMA POTASSIUM; HYPOKALEMIA	There have been case reports of hypokalaemia and hyperkalaemia on induction and cessation of thiopentone barbiturate coma for refractory intracranial hypertension, respectively. However, the incidence and characteristics are not well described. We performed a retrospective review of all patients who received thiopentone barbiturate therapy for refractory intracranial hypertension during an 18-month period from January 2004 to June 2005 in our neurosurgical intensive care unit (ICU). During this time period, 47 patients received thiopentone barbiturate therapy for refractory intracranial hypertension. Forty-two (89.4%) patients developed hypokalaemia after induction of barbiturate therapy. The median time to onset of hypokalaemia was 11 (6-23) h and time to nadir of serum potassium levels was 25 (15-41) h. Sixteen (34%) patients developed hyperkalaemia on weaning of barbiturate therapy. The peak serum potassium levels developed 31 (28-56) h after cessation. All patients who developed hyperkalaemia had been hypokalaemic previously. The mean potassium replaced during hypokalaemia was higher in patients who developed hyperkalaemia compared to those who did not (230 +/- A 135 vs. 66 +/- A 70, p < 0.001). Hypokalaemia and hyperkalaemia are frequently associated with induction and cessation of thiopentone barbiturate coma. Serum potassium levels must be monitored vigilantly. Patients who develop hypokalaemia and receive large potassium replacement may be at greater risk of hyperkalaemia on cessation.	[Shin Yi Ng] Singapore Gen Hosp, Dept Anaesthesiol, Singapore 169608, Singapore; [Chin, Ki Jinn] Univ Toronto, Toronto Western Hosp, Dept Anesthesia, Toronto, ON M5T 2S8, Canada; [Kwek, Tong Kiat] Tan Tock Seng Hosp, Dept Anaesthesiol, Singapore 308433, Singapore		Ng, Y (corresponding author), Singapore Gen Hosp, Dept Anaesthesiol, Outram Rd, Singapore 169608, Singapore.	ng.shin.yi@sgh.com.sg	Chin, Ki Jinn/ABA-9450-2021				Beal AL, 2002, SHOCK, V18, P107, DOI 10.1097/00024382-200208000-00002; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cairns CJS, 2002, INTENS CARE MED, V28, P1357, DOI 10.1007/s00134-002-1399-y; Carlsson C, 1975, Acta Anaesthesiol Scand Suppl, V57, P1; Friederich P, 1999, ANESTHESIOLOGY, V91, P1853, DOI 10.1097/00000542-199912000-00040; Jung JY, 2009, CLIN NEPHROL, V71, P333; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Neil MJE, 2009, ANESTH ANALG, V108, P1867, DOI 10.1213/ane.0b013e3181a16418; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; POMERANZ S, 1989, ACTA NEUROCHIR, V97, P62, DOI 10.1007/BF01577741; ROBSON WL, 1981, CAN ANAESTH SOC J, V28, P210, DOI 10.1007/BF03005502; SCHAEFER M, 1995, INTENS CARE MED, V21, P235, DOI 10.1007/BF01701479; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Seo W, 2010, J NEUROSCI NURS, V42, P201, DOI 10.1097/JNN.0b013e3181e26b4a; TROUWBORST A, 1984, INJURY, V15, P293, DOI 10.1016/0020-1383(84)90048-2	16	11	11	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	AUG	2011	37	8					1285	1289		10.1007/s00134-011-2240-2			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	793IW	WOS:000292815000008	21567112				2022-02-06	
J	Stuart, RM; Claassen, J; Schmidt, M; Helbok, R; Kurtz, P; Fernandez, L; Lee, K; Badjatia, N; Mayer, SA; Lavine, S; Connolly, ES				Stuart, Robert Morgan; Claassen, Jan; Schmidt, Michael; Helbok, Raimund; Kurtz, Pedro; Fernandez, Luis; Lee, Kiwon; Badjatia, Neeraj; Mayer, Stephan A.; Lavine, Sean; Connolly, E. Sander			Multimodality Neuromonitoring and Decompressive Hemicraniectomy After Subarachnoid Hemorrhage	NEUROCRITICAL CARE			English	Article						Intracranial monitoring; Multimodality brain monitoring; Decompressive craniectomy; Microdialysis; Brain oxygen	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; CRANIECTOMY; MICRODIALYSIS; INFARCTION; VASOSPASM; PRESSURE	We report the case of a young woman with delayed cerebral infarction and intracranial hypertension following subarachnoid hemorrhage requiring hemicraniectomy, who underwent multimodality neuromonitoring of the contralateral hemisphere before and after craniectomy. Intracranial hypertension was preceded by signs of ischemia and impaired brain metabolism diagnosed through cerebral microdialysis and PbtO2 monitoring, as well as a decrease in cerebral perfusion pressure (CPP) to < 40 mmHg despite increasing vasopressor requirements. We describe how a comprehensive multimodality neuromonitoring approach was utilized to inform the decision to perform an early decompressive hemicraniectomy. Post-operatively, CPP and intracranial pressure (ICP) normalized, and the patient was weaned off all pressors within hours. The modified Rankin score at 3 and 12 months was 5. Delayed rescue hemicraniectomy can be life-saving after poor grade SAH. The role of multimodality brain monitoring for determining the optimal timing of hemicraniectomy deserves further study.	[Stuart, Robert Morgan] Columbia Presbyterian Med Ctr, Neurol Inst New York, Dept Neurosurg, New York, NY 10032 USA; [Claassen, Jan; Schmidt, Michael; Helbok, Raimund; Kurtz, Pedro; Fernandez, Luis; Lee, Kiwon; Badjatia, Neeraj; Mayer, Stephan A.] Columbia Univ Coll Phys & Surg, Dept Neurol, Div Crit Care Neurol, New York, NY 10032 USA; [Stuart, Robert Morgan; Lavine, Sean; Connolly, E. Sander] Columbia Univ Coll Phys & Surg, Dept Neurol Surg, New York, NY 10032 USA		Stuart, RM (corresponding author), Columbia Presbyterian Med Ctr, Neurol Inst New York, Dept Neurosurg, 710 W 168th St, New York, NY 10032 USA.	rms2130@columbia.edu	Claassen, Jan/AAA-5451-2020; Badjatia, Neeraj/AAS-4855-2021; Helbok, Raimund/AAA-8361-2021	Badjatia, Neeraj/0000-0003-1509-9034	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Wellcome TrustWellcome TrustEuropean Commission; Howard Hughes Medical Institute (HHMI)Howard Hughes Medical Institute	This work was not funded by the National Institute of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI) or any other institution requiring open access.	Bardt TF, 1998, ACT NEUR S, V71, P153; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Berger C, 1999, STROKE, V30, P460, DOI 10.1161/01.STR.30.2.460; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Kirkness CJ, 2009, CRIT CARE MED, V37, P371, DOI 10.1097/CCM.0b013e3181930eff; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Shimoda M, 2001, NEUROSURGERY, V49, P1341, DOI 10.1097/00006123-200112000-00010; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Strege RJ, 2003, NEUROL RES, V25, P510, DOI 10.1179/016164103101201742; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Ushewokunze S, 2009, CHILD NERV SYST, V25, P341, DOI 10.1007/s00381-008-0752-z; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	23	11	11	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2011	15	1					146	150		10.1007/s12028-009-9264-2			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	789XI	WOS:000292552100023	19669604				2022-02-06	
J	Geeraerts, T; Coles, JP; Aigbirhio, FI; Pickard, JD; Menon, DK; Fryer, TD; Hong, YT				Geeraerts, Thomas; Coles, Jonathan P.; Aigbirhio, Franklin I.; Pickard, John D.; Menon, David K.; Fryer, Tim D.; Hong, Young T.			Validation of reference tissue modelling for [C-11]flumazenil positron emission tomography following head injury	ANNALS OF NUCLEAR MEDICINE			English	Article						[C-11]Flumazenil; Kinetic modelling; Positron emission tomography (PET); Reference tissue; Traumatic brain injury (TBI)	TRAUMATIC BRAIN-INJURY; ARTERIAL INPUT FUNCTION; C-11 FLUMAZENIL; DIFFUSION-TENSOR; CEREBRAL-ISCHEMIA; PET; RECEPTOR; BINDING; LIGAND; PARAMETERS	[C-11]Flumazenil ([C-11]FMZ) positron emission tomography (PET) can be used as a measure of neuronal loss. The purpose of this study was to validate reference tissue kinetic modelling of [C-11]FMZ PET within a group of patients with head injury. Following earlier studies, the pons was used as the reference region. PET scans were performed on 16 controls and 11 patients at least 6 months following injury, each of whom also had arterial blood sampling to provide whole blood and metabolite-corrected plasma input functions. Regional non-displaceable binding potentials (BPND) were calculated from five reference tissue models and compared to BPND from arterial input models. For the patients, the regions included a peri-lesional region of interest (ROI). Total distribution volume of the pons was not significantly different between control and patient groups (P = 0.24). BPND from all the reference tissue approaches correlated well with BPND from the plasma input models for both controls (r (2) = 0.98-1.00; P < 0.001) and patients (r (2) = 0.99-1.00; P < 0.001). For the peri-lesional regions (n = 11 ROI values), the correlation was also high (r (2) = 0.91). These results indicate that reference tissue modelling with the pons as the reference region is valid for [C-11]FMZ PET in head-injured patients at 6 months following injury within both normal appearing and peri-lesional brain regions.	[Coles, Jonathan P.] Addenbrookes Hosp, Univ Dept Anaesthesia, Cambridge CB2 2QQ, England; [Geeraerts, Thomas; Coles, Jonathan P.; Menon, David K.] Univ Cambridge, Univ Div Anaesthesia, Cambridge, England; [Coles, Jonathan P.; Aigbirhio, Franklin I.; Pickard, John D.; Menon, David K.; Fryer, Tim D.; Hong, Young T.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Pickard, John D.] Univ Cambridge, Acad Neurosurg Unit, Cambridge, England; [Geeraerts, Thomas] Univ Paris Sud, Ctr Hosp Univ Bicetre, AP HP, Dept Anesthesie Reanimat Chirurg, F-94275 Le Kremlin Bicetre, France		Coles, JP (corresponding author), Addenbrookes Hosp, Univ Dept Anaesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England.	jpc44@wbic.cam.ac.uk		Coles, Jonathan/0000-0003-4013-679X	Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); UK Government; Royal College of Anaesthetists/British Journal of Anaesthesia; Cambridge National Institute for Health Research (NIHR) Biomedical Research CentreNational Institute for Health Research (NIHR); Societe Francaise d'Anesthesie et de Reanimation; Jounees d'enseignement post-universitaire; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390, G0001237] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390, G0600986] Funding Source: UKRI	We wish to thank the Wolfson Brain Imaging Centre radiochemistry and scanning staff for their assistance with data acquisition. These studies were supported by the Medical Research Council (UK), a Technology Foresight from the UK Government, a Royal College of Anaesthetists/British Journal of Anaesthesia project grant and the Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre. Dr. Geeraerts was funded from the Societe Francaise d'Anesthesie et de Reanimation and from the Jounees d'enseignement post-universitaire. No potential conflicts of interest were disclosed.	Baron JC, 2001, BRAIN, V124, P2, DOI 10.1093/brain/124.1.2; Barre L, 1991, Int J Rad Appl Instrum A, V42, P435, DOI 10.1016/0883-2889(91)90102-7; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Cleij MC, 2007, J LABELLED COMPD RAD, V50, P19, DOI 10.1002/jlcr.1152; Coles JP, 2009, J CEREBR BLOOD F MET, V29, P965, DOI 10.1038/jcbfm.2009.22; DELFORGE J, 1995, J CEREBR BLOOD F MET, V15, P284, DOI 10.1038/jcbfm.1995.34; Folkersma H, 2009, J NUCL MED, V50, P1975, DOI 10.2967/jnumed.109.067512; Guadagno JV, 2008, BRAIN, V131, P2666, DOI 10.1093/brain/awn175; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Gunn RN, 1998, NEUROIMAGE, V8, P426, DOI 10.1006/nimg.1998.0379; Hammers A, 2008, J CEREBR BLOOD F MET, V28, P207, DOI 10.1038/sj.jcbfm.9600515; Heiss W.D., 1997, STROKE, V28, P2051; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 1997, STROKE, V28, P2045, DOI 10.1161/01.STR.28.10.2045; Heiss WD, 2001, BRAIN, V124, P20, DOI 10.1093/brain/124.1.20; HUME SP, 1992, SYNAPSE, V12, P47, DOI 10.1002/syn.890120106; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; KINAHAN PE, 1989, IEEE T NUCL SCI, V36, P964, DOI 10.1109/23.34585; Klumpers UMH, 2008, J CEREBR BLOOD F MET, V28, P579, DOI 10.1038/sj.jcbfm.9600554; KOEPPE RA, 1991, J CEREBR BLOOD F MET, V11, P735, DOI 10.1038/jcbfm.1991.130; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Miederer I, 2009, EUR J NUCL MED MOL I, V36, P659, DOI 10.1007/s00259-008-0990-z; Millet P, 2002, NEUROIMAGE, V17, P928, DOI 10.1006/nimg.2002.1233; Okazawa H, 2004, J COMPUT ASSIST TOMO, V28, P428, DOI 10.1097/00004728-200405000-00021; SETTE G, 1993, STROKE, V24, P2046, DOI 10.1161/01.STR.24.12.2046; SETTE G, 1993, STROKE, V24, P2057; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; TEASDALE G, 1974, LANCET, V2, P81; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34	36	11	11	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187			ANN NUCL MED	Ann. Nucl. Med.	JUL	2011	25	6					396	405		10.1007/s12149-011-0480-4			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	790RG	WOS:000292606300002	21461598	Green Submitted			2022-02-06	
J	Honeybul, S; Ho, KM; Lind, CRP; Gillett, GR				Honeybul, Stephen; Ho, Kwok M.; Lind, Christopher R. P.; Gillett, Grant R.			Decompressive Craniectomy for Diffuse Cerebral Swelling After Trauma: Long-Term Outcome and Ethical Considerations	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Decompressive craniectomy; Outcome; Neurotrauma; Ethics	BRAIN-INJURY; SURGICAL DECOMPRESSION; ARTERY INFARCTION; MULTICENTER; SURGERY; VALIDATION; RECOVERY; TRIAL; SCALE	Background: There is currently much interest in the use of decompressive for the management of diffuse cerebral swelling after trauma. Although the use of the procedure may improve survival, some of those survivors may be left severely disabled. The aim of this study was to see whether severe disability can be predicted and discuss the difficult ethical issue that this raises. Methods: This was a retrospective cohort subgroup analysis of those patients with severe head injury in Western Australia between 2004 and 2008 who had had a decompressive craniectomy for intractably raised intracranial pressure despite maximal medical management. Results: Among a total of 1,786 adult neurotrauma patients admitted between 2004 and 2008, 74 patients required a bifrontal decompressive craniectomy for intractably raised intracranial pressure. After the application of Corticosteroid Randomization After Significant Head Injury (CRASH) trial collaborators' prediction model, predicted and observed outcomes were compared. The mean timing and median timing of surgery were 42 hours and 30 hours after hospital admission, respectively. The timing of decompressive craniectomy was inversely correlated to the severity of the head injury (Spearman's correlation coefficient = -0.251, p = 0.031). At 18-month follow-up, 16 patients were deceased, 3 were in a persistent vegetative state, and 10 were severely disabled. In contrast to these unfavorable outcomes, 35 patients had a good outcome and 10 were moderately disabled at 18 months. The discrimination of the CRASH prediction model was excellent (area under receiver-operating characteristic curve, 0.905; 95% confidence interval, 0.829-0.982; p = 0.001). Conclusion: Our data provide some evidence that the CRASH prediction model may help clinicians and families to make informed decision about the benefits and risks of decompressive craniectomy for diffuse cerebral swelling.	[Honeybul, Stephen; Lind, Christopher R. P.] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; Royal Perth Hosp, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Lind, Christopher R. P.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Lind, Christopher/K-3629-2012; Ho, Kwok M./E-3546-2010	Lind, Christopher/0000-0001-9991-1725; Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; BLAKE R, 2007, DAY D HERBERT WOKE; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Fins JJ, 2009, ANN NY ACAD SCI, V1157, P131, DOI 10.1111/j.1749-6632.2009.04473.x; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gillett G, 2001, NEW ZEAL MED J, V114, P188; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hall K, 1992, NEUROREHABILITATION, V2, P98, DOI DOI 10.3233/NRE-1992-2410; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2009, J CLIN NEUROSCI, V16, P727, DOI 10.1016/j.jocn.2008.06.015; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kobylarz E, 2004, ARCH NEUROL-CHICAGO, V61, P1357, DOI 10.1001/archneur.61.9.1357; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Meier U, 2005, ACT NEUR S, V95, P55; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; SCHIFF ND, 2003, CEREBRUM, V5, P7; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	37	11	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					128	132		10.1097/TA.0b013e3182117b6c			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	790RR	WOS:000292607400032	21460742				2022-02-06	
J	Mattio, M; Ceaglio, N; Oggero, M; Perotti, N; Amadeo, I; Orozco, G; Forno, G; Kratje, R; Etcheverrigaray, M				Mattio, Monica; Ceaglio, Natalia; Oggero, Marcos; Perotti, Norma; Amadeo, Ignacio; Orozco, Gustavo; Forno, Guillermina; Kratje, Ricardo; Etcheverrigaray, Marina			Isolation and Characterization of a Subset of Erythropoietin Glycoforms with Cytoprotective but Minimal Erythropoietic Activity	BIOTECHNOLOGY PROGRESS			English	Article						erythropoietin; isoforms; cytoprotection	RECOMBINANT-HUMAN-ERYTHROPOIETIN; MICE OVEREXPRESSING ERYTHROPOIETIN; BLOOD-BRAIN-BARRIER; CELL-DEATH; IN-VITRO; GM-CSF; RECEPTOR; GLYCOSYLATION; ESTABLISHMENT; CIRCULATION	Although historically used for the treatment of anemia, erythropoietin (EPO) has emerged as a neurotrophic and neuroprotective agent in different conditions of neuronal damage (traumatic brain injury, ischemia, spinal cord compression, peripheral neuropathy, retinal damage, epilepsy, Parkinson's Disease, among others). Nonetheless, EPO's therapeutic application is limited due to its hematological side-effects. With the aim of obtaining EPO derivatives resembling the hormone isolated from cells and tissues of neural origin, a novel combination of less acidic EPO glycoforms-designated as neuroepoetin (rhNEPO)- was purified to homogeneity from the supernatant of a CHO-producing cell line by a four-step chromatographic procedure. This simple and single process allowed us to prepare two EPO derivatives with distinct therapeutic expectations: the hematopoietic version and a minimally hematopoietic, but mainly in vitro cytoprotective, alternative. Further biological characterization showed that the in vivo erythropoietic activity of rhNEPO was 25-times lower than that of rhEPO. Interestingly, using different in vitro cytoprotective assays we found that this molecule exerts cytoprotection equivalent to, or better than, that of rhEPO in cells of neural phenotype. Furthermore, despite its shorter plasma half-life, rhNEPO was rapidly absorbed and promptly detected in the cerebrospinal fluid after intravenous administration in rats (5 min postinjection, in comparison with 30 min for rhEPO). Therefore, our results support the study of neuroepoetin as a potential drug for the treatment of neurological diseases, combining high cytoprotective activity with reduced hematological side-effects. (C) 2011 American Institute of Chemical Engineers Biotechnol. Prog., 27: 1018-1028, 2011	[Oggero, Marcos] Univ Nacl Litoral, Cell Culture Lab, Fac Bioquim & Ciencias Biol, Sch Biochem & Biol Sci, Santa Fe, Argentina; [Amadeo, Ignacio; Orozco, Gustavo; Forno, Guillermina] Zelltek SA, RN PTLC 168, RA-3000 Paraje El Pozo, Santa Fe, Argentina		Oggero, M (corresponding author), Univ Nacl Litoral, Cell Culture Lab, Fac Bioquim & Ciencias Biol, Sch Biochem & Biol Sci, Ciudad Univ,CC 242,S3000ZAA, Santa Fe, Argentina.	moggero@fbcb.unl.edu.ar		Ceaglio, Natalia/0000-0003-2798-4532; Oggero, Marcos/0000-0002-9234-9511	Universidad Nacional del Litoral [5/38, 356.698]; Zelltek SA; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	The authors thank Alejandro Raimondi for his kind cooperation in CZE experiments, Francisco Godoy for his valuable help in artwork preparation and Gisela Leal for meticulously proofreading the manuscript. This work was supported by the following Argentine institutions: Universidad Nacional del Litoral (CAI+D 2006 No. 5/38; SAT No. 356.698), Zelltek SA and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET).	Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; *COUNC EUR, 2008, EUR PHARM, P1813; Darling RJ, 2002, BIOCHEMISTRY-US, V41, P14524, DOI 10.1021/bi0265022; Egrie JC, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_3.3; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fisher JW, 2003, EXP BIOL MED, V228, P1; FUKUDA MN, 1989, BLOOD, V73, P84; GOOCHE CF, 1992, BIOTECHNOLOGY, V9, P1347; Haviv R, 1997, J NEUROSCI RES, V50, P69, DOI 10.1002/(SICI)1097-4547(19971001)50:1<69::AID-JNR8>3.0.CO;2-J; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; KOMATSU N, 1993, BLOOD, V82, P456; Konstantinopoulos PA, 2007, BBA-REV CANCER, V1776, P1, DOI 10.1016/j.bbcan.2007.07.002; KRATJE RB, 1992, BIOTECHNOL BIOENG, V39, P233, DOI 10.1002/bit.260390216; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li G, 2008, NEUROSCI LETT, V442, P143, DOI 10.1016/j.neulet.2008.07.007; LIM VS, 1991, AM J KIDNEY DIS, V18, P34; Llop E, 2008, ANAL BIOCHEM, V383, P243, DOI 10.1016/j.ab.2008.08.027; MASUDA S, 1994, J BIOL CHEM, V269, P19488; Mennini T, 2006, MOL MED, V12, P153, DOI 10.2119/2006-00045.Mennini; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Shargel L, 2005, APPL BIOPHARMACEUTIC, V5th; Stohlawetz PJ, 2000, BLOOD, V95, P2983, DOI 10.1182/blood.V95.9.2983.009k27_2983_2989; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; TAKEUCHI M, 1990, J BIOL CHEM, V265, P12127; TSUDA E, 1990, EUR J BIOCHEM, V188, P405, DOI 10.1111/j.1432-1033.1990.tb15417.x; Wagner KF, 2001, BLOOD, V97, P536, DOI 10.1182/blood.V97.2.536; WASLEY LC, 1991, BLOOD, V77, P2642; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Xenocostas A, 2005, EUR J CLIN PHARMACOL, V61, P189, DOI 10.1007/s00228-005-0896-7; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x	42	11	11	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	8756-7938			BIOTECHNOL PROGR	Biotechnol. Prog.	JUL-AUG	2011	27	4					1018	1028		10.1002/btpr.633			11	Biotechnology & Applied Microbiology; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Food Science & Technology	810EG	WOS:000294107600013	21608141				2022-02-06	
J	Tiemessen, CAM; Hoedemaekers, CWE; van Iersel, FM; Rosken, GHJ; van der Hoeven, J; Biessels, GJ; Slooter, AJC				Tiemessen, Charlotte A. M.; Hoedemaekers, Cornelia W. E.; van Iersel, Freya M.; Rosken, Gerrit H. J.; van der Hoeven, Johannes; Biessels, Geert-Jan; Slooter, Arjen J. C.			Intensive Insulin Therapy Increases the Risk of Hypoglycemia in Neurocritical Care Patients	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						intensive insulin therapy; effects; protocol; neurocritical care patients; intensive care; hypoglycemia	CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GLUCOSE CONTROL; STRESS HYPERGLYCEMIA; STROKE; MICRODIALYSIS; MANAGEMENT; INFARCTION; BENEFITS	Background: Intensive insulin therapy protocols are widely used in intensive care medicine. A disadvantage of these protocols may be the occurrence of hypoglycemic episodes. Neurocritical care patients are particularly vulnerable to the effects of hypoglycemia. We aimed to study the risk of hypoglycemia in neurocritical care patients in relation to intensive insulin therapy. Methods: To determine the effects of 2 different intensive insulin therapy protocols on glucose levels and hypoglycemia incidence, we collected data before and after implementation of the protocols in 2 university hospitals. The risk of hypoglycemia (blood glucose level below 3.0 mmol/L) was studied retrospectively with logistic regression analyses. Results: In hospital A, data were obtained on 152 patients before implementation of the protocol and on 649 patients after implementation of the protocol. In hospital B, data were obtained on 111 patients before implementation of the protocol and on 118 patients thereafter. Implementation of intensive insulin therapy protocols increased the time spent in the desired blood glucose range of 4.6 to 6.0 mmol/L in both hospitals, but increased the risk of hypoglycemia: the absolute risk of hypoglycemia during intensive care unit admission increased in hospital A from 14.5% to 20.3% (adjusted odds ratio = 1.3; 95% confidence interval: 0.8-2.3) and in hospital B from 3.6% to 29.7% (adjusted odds ratio = 28.6; 95% confidence interval: 5.9-138.9). Conclusions: Implementation of intensive insulin therapy protocols in neurocritical care patients not only seems to increase the time spent in the desired blood glucose range, but also seems to increase the risk of hypoglycemia. The risk of hypoglycemia strongly depends on characteristics of the intensive insulin therapy protocol.	[Slooter, Arjen J. C.] Univ Med Ctr, Dept Intens Care Med, UMC Utrecht, NL-3508 GA Utrecht, Netherlands; [Biessels, Geert-Jan] Univ Med Ctr, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3508 GA Utrecht, Netherlands; [Tiemessen, Charlotte A. M.; Hoedemaekers, Cornelia W. E.; van Iersel, Freya M.; Rosken, Gerrit H. J.; van der Hoeven, Johannes] St Radboud Univ, Med Ctr, Dept Intens Care, Nijmegen, Netherlands		Slooter, AJC (corresponding author), Univ Med Ctr, Dept Intens Care Med, UMC Utrecht, POB 85500,Room F-06-149, NL-3508 GA Utrecht, Netherlands.	A.Slooter-3@umcutrecht.nl	Hoedemaekers, C.W.E./L-4375-2015; van der Hoeven, J.G./H-8048-2014				Badjatia N, 2005, CRIT CARE MED, V33, P1603, DOI 10.1097/01.CCM.0000168054.60538.2B; Bellomo R, 2009, MAYO CLIN PROC, V84, P400, DOI 10.1016/S0025-6196(11)60557-0; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta F, 2009, J NEUROSURG ANESTH, V21, P2, DOI 10.1097/ANA.0b013e31818f8a5c; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Juvela S, 2005, J NEUROSURG, V102, P998, DOI 10.3171/jns.2005.102.6.0998; Kanji S, 2010, NEUROCRIT CARE, V12, P43, DOI 10.1007/s12028-009-9275-z; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Lewis KS, 2004, ANN PHARMACOTHER, V38, P1243, DOI 10.1345/aph.1D211; Li PA, 2001, BRAIN RES, V912, P203, DOI 10.1016/S0006-8993(01)02724-X; MELAMED E, 1976, J NEUROL SCI, V29, P267, DOI 10.1016/0022-510X(76)90176-3; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Oksanen T, 2007, INTENS CARE MED, V33, P2093, DOI 10.1007/s00134-007-0876-8; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Stead LG, 2009, NEUROCRIT CARE, V10, P181, DOI 10.1007/s12028-008-9080-0; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF	28	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2011	23	3					206	214		10.1097/ANA.0b013e31821aa6f2			9	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	774YY	WOS:000291423900008	21593693				2022-02-06	
J	Tang, HL; Sun, HP; Wu, X; Sha, HY; Feng, XY; Zhu, JH				Tang Hai-liang; Sun Hua-ping; Wu Xing; Sha Hong-ying; Feng Xiao-yuan; Zhu Jian-hong			Detection of neural stem cells function in rats with traumatic brain injury by manganese-enhanced magnetic resonance imaging	CHINESE MEDICAL JOURNAL			English	Article						manganese-enhanced magnetic resonance imaging; neural stem cells; traumatic brain injury; superparamagnetic iron oxide particles	IN-VIVO; ACTIVATION	Background Previously we had successfully tracked adult human neural stem cells (NSCs) labeled with superparamagnetic iron oxide particles (SPIOs) in host human brain after transplantation in vivo non-invasively by magnetic resonance imaging (MRI). However, the function of the transplanted NSCs could not be evaluated by the method. In the study, we applied manganese-enhanced MRI (ME-MRI) to detect NSCs function after implantation in brain of rats with traumatic brain injury (TBI) in vivo. Methods Totally 40 TBI rats were randomly divided into 4 groups with 10 rats in each group. In group 1, the TBI rats did not receive NSCs transplantation. MnCl2 center dot 4H(2)O was intravenously injected, hyperosmolar mannitol was delivered to disrupt rightside blood brain barrier, and its contralateral forepaw was electrically stimulated. In group 2, the TBI rats received NSCs (labeled with SPIO) transplantation, and the ME-MRI procedure was same to group 1. In group 3, the TBI rats received NSCs (labeled with SPIO) transplantation, and the ME-MRI procedure was same to group 1, but diltiazem was introduced during the electrical stimulation period. In group 4, the TBI rats received phosphate buffered saline (PBS) injection, and the ME-MRI procedure was same to group 1. Results Hyperintense signals were detected by ME-MRI in the cortex areas associated with somatosensory in TBI rats of group 2. These signals, which could not be induced in TBI rats of groups 1 and 4, disappeared when diltiazem was introduced in TBI rats of group 3. Conclusion In this initial study, we mapped implanted NSCs activity and its functional participation within local brain area in TBI rats by ME-MRI technique, paving the way for further pre-clinical research. Chin Med J 2011;124(12):1848-1853	[Tang Hai-liang; Wu Xing; Zhu Jian-hong] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China; [Sun Hua-ping; Feng Xiao-yuan] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200040, Peoples R China; [Sha Hong-ying; Zhu Jian-hong] Fudan Univ, Natl Key Lab Med Neurobiol, Inst Brain Sci, Shanghai Med Coll, Shanghai 200032, Peoples R China		Zhu, JH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China.	jzhu@fudan.edu.cn			Major State Basic Research ProgramNational Basic Research Program of China [2010CB945500, 2009CB941100, 2007CB947902]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [90919002, 30870805]; Shanghai Committee of Science and TechnologyShanghai Science & Technology Committee [08dj140053, 2007Y39]; Fudan University	This work was supported by grants from the Major State Basic Research Program (No. 2010CB945500, No. 2009CB941100 and No. 2007CB947902), the National Natural Science Foundation of China (No. 90919002 and No. 30870805), Shanghai Committee of Science and Technology (No. 08dj140053 and No. 2007Y39) and Postgraduate's Research Program of Fudan University (2010).	Bonny JM, 2008, NEUROIMAGE, V40, P1542, DOI 10.1016/j.neuroimage.2008.01.050; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; Lee JH, 2004, CURR PHARM BIOTECHNO, V5, P529, DOI 10.2174/1389201043376607; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Lu HB, 2007, P NATL ACAD SCI USA, V104, P2489, DOI 10.1073/pnas.0606983104; Massaad CA, 2011, METHODS MOL BIOL, V711, P145, DOI 10.1007/978-1-61737-992-5_7; Matsuda K, 2010, NEUROIMAGE, V50, P366, DOI 10.1016/j.neuroimage.2010.01.008; Modo M, 2005, MOL IMAGING, V4, P143; Olanow CW, 1996, NEUROLOGY, V46, P492, DOI 10.1212/WNL.46.2.492; PAXINOS G, 2007, RAT BRAIN STEREOTAXI, P41; Schlorf T, 2011, INT J MOL SCI, V12, P12, DOI 10.3390/ijms12010012; Simmons JM, 2008, J NEUROSCI, V28, P7637, DOI 10.1523/JNEUROSCI.1488-08.2008; Zhu J, 2005, CURR DRUG TARGETS, V6, P97, DOI 10.2174/1389450053345055; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	17	11	11	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JUN 20	2011	124	12					1848	1853		10.3760/cma.j.issn.0366-6999.2011.12.016			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787AX	WOS:000292350100016	21740844				2022-02-06	
J	Brandstack, N; Kurki, T; Hiekkanen, H; Tenovuo, O				Brandstack, N.; Kurki, T.; Hiekkanen, H.; Tenovuo, O.			Diffusivity of Normal-Appearing Tissue in Acute Traumatic Brain Injury	CLINICAL NEURORADIOLOGY			English	Article						Traumatic brain injury; Diffusion weighted MRI; Magnetic resonance imaging; Glasgow coma scale; Glasgow outcome scale	CLOSED-HEAD INJURY; AXONAL INJURY; EDEMA; COEFFICIENT; MRI; SCALE	Apparent diffusion coefficient (ADC) values derived from diffusion-weighted magnetic resonance imaging (MRI) can provide information about traumatic changes not visible in conventional MRI. The ADC values in acute traumatic brain injury (TBI) were measured and correlated with initial severity and outcome scores. In this study 22 unselected patients were studied 1 week (mean 7 +/- 2 days) after TBI of variable severity. In conventional MRI 7 patients were without visible findings, 15 showed cortical contusions or traumatic axonal injury and 14 healthy subjects served as controls. The ADC values were measured from 46 brain regions away from the visible traumatic changes and compared between the groups. Regional ADC values and the number of abnormal regions were correlated with the Glasgow coma scale (GCS) on arrival in hospital and the Glasgow outcome scale (extended version, GOS-E) at 1 year after injury. The ADC values of TBI patients with and without visible lesions did not show any differences but both groups differed significantly from the controls in several cortical and deep brain regions. Increased ADC values were common in TBI groups but decreased ADC values were relatively uncommon. The regional ADC values and the number of abnormal regions did not correlate with either GCS or GOS-E scores. Increased diffusion in normal appearing brain tissue is a common finding 1 week after TBI in patients with and without visible lesions in conventional MRI. More investigations are needed to evaluate how these findings could be used for clinical applications.	[Brandstack, N.] Helsinki Univ Hosp, Dept Radiol, Helsinki 00029, Finland; [Kurki, T.] Turku Univ Hosp, Dept Radiol, Turku 20521, Finland; [Hiekkanen, H.; Tenovuo, O.] Turku Univ Hosp, Dept Neurol, Turku 20521, Finland		Brandstack, N (corresponding author), Helsinki Univ Hosp, Dept Radiol, POB 340, Helsinki 00029, Finland.	nimabr@utu.fi		Kurki, Timo/0000-0001-5532-3534			Ahlhelm F, 2004, MED SCI MONITOR, V10, pMT121; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Cellerini M, 1997, ACTA ANAT, V158, P215; CURNES JT, 1988, AM J NEURORADIOL, V9, P1061; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Engelter ST, 2000, AM J ROENTGENOL, V175, P425, DOI 10.2214/ajr.175.2.1750425; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kinoshita T, 2005, EUR J RADIOL, V56, P5, DOI 10.1016/j.ejrad.2005.04.001; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou A, 2003, ACT NEUR S, V86, P7; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schaefer PW, 1997, STROKE, V28, P1082, DOI 10.1161/01.STR.28.5.1082; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Tench CR, 2002, MAGN RESON MED, V47, P967, DOI 10.1002/mrm.10144	32	11	12	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.	JUN	2011	21	2					75	82		10.1007/s00062-011-0058-5			8	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	798UI	WOS:000293237300004	21394634				2022-02-06	
J	Carrera, E; Steiner, LA; Castellani, G; Smielewski, P; Zweifel, C; Haubrich, C; Pickard, JD; Menon, DK; Czosnyka, M				Carrera, Emmanuel; Steiner, Luzius A.; Castellani, Gianluca; Smielewski, Peter; Zweifel, Christian; Haubrich, Christina; Pickard, John D.; Menon, David K.; Czosnyka, Marek			Changes in Cerebral Compartmental Compliances during Mild Hypocapnia in Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; brain trauma; cerebrospinal fluid; CBF autoregulation	BLOOD-FLOW VELOCITY; CEREBROSPINAL-FLUID SYSTEM; INTRACRANIAL-PRESSURE; HEAD-INJURY; MODERATE HYPERVENTILATION; DOPPLER ULTRASOUND; CARBON-DIOXIDE; PULSE PRESSURE; HUMANS; AUTOREGULATION	The benefit of induced hyperventilation for intracranial pressure (ICP) control after severe traumatic brain injury (TBI) is controversial. In this study, we investigated the impact of early and sustained hyperventilation on compliances of the cerebral arteries and of the cerebrospinal (CSF) compartment during mild hyperventilation in severe TBI patients. We included 27 severe TBI patients (mean 39.5 +/- 3.4 years, 6 women) in whom an increase in ventilation (20% increase in respiratory minute volume) was performed during 50 min as part of a standard clinical CO(2) reactivity test. Using a new mathematical model, cerebral arterial compliance (Ca) and CSF compartment compliance (Ci) were calculated based on the analysis of ICP, arterial blood pressure, and cerebral blood flow velocity waveforms. Hyperventilation initially induced a reduction in ICP (17.5 +/- 6.6 vs. 13.9 +/- 6.2 mmHg; p < 0.001), which correlated with an increase in Ci (r(2) = 0.213; p = 0.015). Concomitantly, the reduction in cerebral blood flow velocities (CBFV, 74.6 +/- 27.0 vs. 62.9 +/- 22.9 cm/sec; p < 0.001) marginally correlated with the reduction in Ca (r(2) = 0.209; p = 0.017). During sustained hyperventilation, ICP increased (13.9 +/- 6.2 vs. 15.3 +/- 6.4 mmHg; p < 0.001), which correlated with a reduction in Ci (r(2) = 0.297; p = 0.003), but no significant changes in Ca were found during that period. The early reduction in Ca persisted irrespective of the duration of hyperventilation, which may contribute to the lack of clinical benefit of hyperventilation after TBI. Further studies are needed to determine whether monitoring of arterial and CSF compartment compliances may detect and prevent an adverse ischemic event during hyperventilation.	[Carrera, Emmanuel; Castellani, Gianluca; Smielewski, Peter; Zweifel, Christian; Haubrich, Christina; Pickard, John D.; Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Acad Neurosurg Unit, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Cambridge CB2 2QQ, England; [Steiner, Luzius A.] Univ Hosp, Dept Anaesthesia, Lausanne, Switzerland		Carrera, E (corresponding author), Univ Cambridge, Dept Clin Neurosci, Acad Neurosurg Unit, Addenbrookes Hosp, Level 4,A Block, Cambridge CB2 2QQ, England.	emmanuel.carrera@chuv.ch	Steiner, Luzius/C-9836-2011; Steiner, Luzius/J-1987-2019	Carrera, Emmanuel/0000-0003-0045-5382; Smielewski, Peter/0000-0001-5096-3938	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [PASSMP3-124262, PBBSP3-125550]; National Institute of Health Research, United KingdomNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G0600986, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390, G0001237] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	This work was supported by the Swiss National Science Foundation (PASSMP3-124262 to E. C., and PBBSP3-125550 to C.Z.) and the National Institute of Health Research, United Kingdom.	AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Alperin N, 2005, J MAGN RESON IMAGING, V22, P591, DOI 10.1002/jmri.20427; ATKINSON JLD, 1990, BRAIN RES, V517, P333, DOI 10.1016/0006-8993(90)91046-J; AVEZAAT CJ, 1984, CEREBROSPINAL FLUID, P57; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; BRADAC GB, 1976, NEURORADIOLOGY, V10, P257, DOI 10.1007/BF00327574; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; CARRERA E, 2010, J NEUROIMAG IN PRESS; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; COLD GE, 1981, ACTA ANAESTH SCAND, V25, P397, DOI 10.1111/j.1399-6576.1981.tb01673.x; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; ERIKSSON S, 1983, ACTA PHYSIOL SCAND, V117, P203, DOI 10.1111/j.1748-1716.1983.tb07198.x; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Huber P, 1967, Invest Radiol, V2, P17, DOI 10.1097/00004424-196701000-00016; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; KITAZONO T, 1995, STROKE, V26, P1713, DOI 10.1161/01.STR.26.9.1713; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; PETRUK KC, 1974, STROKE, V5, P230, DOI 10.1161/01.STR.5.2.230; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Poulin MJ, 1996, STROKE, V27, P2244, DOI 10.1161/01.STR.27.12.2244; REIVICH M, 1964, AM J PHYSIOL, V206, P25, DOI 10.1152/ajplegacy.1964.206.1.25; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Smielewski P, 2005, ACT NEUR S, V95, P43; Steiner LA, 2005, ACTA NEUROCHIR SUPPL, V95, P17; Steiner LA, 2004, INTENS CARE MED, V30, P2180, DOI 10.1007/s00134-004-2463-6; Tain RW, 2009, IEEE T BIO-MED ENG, V56, P544, DOI 10.1109/TBME.2008.2006010; Valdueza JM, 1997, AM J NEURORADIOL, V18, P1929; Wilkinson IB, 2001, J PHYSIOL-LONDON, V530, P541, DOI 10.1111/j.1469-7793.2001.0541k.x; YURA T, 1995, NEPHRON, V71, P168, DOI 10.1159/000188707	35	11	11	1	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2011	28	6					889	896		10.1089/neu.2010.1377			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	788PT	WOS:000292457600004	21204704	Green Published			2022-02-06	
J	van Heugten, CM; Geurtsen, GJ; Derksen, RE; Martina, JD; Geurts, ACH; Evers, SMAA				van Heugten, Caroline M.; Geurtsen, Gert J.; Derksen, R. Elze; Martina, Juan D.; Geurts, Alexander C. H.; Evers, Silvia M. A. A.			INTERVENTION AND SOCIETAL COSTS OF RESIDENTIAL COMMUNITY REINTEGRATION FOR PATIENTS WITH ACQUIRED BRAIN INJURY: A COST-ANALYSIS OF THE BRAIN INTEGRATION PROGRAMME	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injuries; cost-analysis; rehabilitation; residential treatment; outcome	REHABILITATION PROGRAMS; EVALUATE; OUTCOMES	Objective: The objective of this study was to examine the intervention costs of a residential community reintegration programme for patients with acquired brain injury and to compare the societal costs before and after treatment. Methods: A cost-analysis was performed identifying costs of healthcare, informal care, and productivity losses. The costs in the year before the Brain Integration Programme (BIN) were compared with the costs in the year after the BIN using the following cost categories: care consumption, caregiver support, productivity losses. Dutch guidelines were used for cost valuation. Results: Thirty-three cases participated (72% response). Mean age was 29.8 years, 59% traumatic brain injury. The BIN costs were (sic)68,400. The informal care and productivity losses reduced significantly after BIN (p < 0.05), while healthcare consumption increased significantly (p < 0.05). The societal costs per patient were (sic)48,449. After BIN these costs were (sic)39,773; a significant reduction (p < 0.05). Assuming a stable situation the break-even point is after 8 years. Conclusion: The reduction in societal costs after the BIP advocates the allocation of resources and, from an economic perspective, favours reimbursement of the BIP costs by healthcare insurance companies. However, this cost-analysis is limited as it does not relate costs to clinical effectiveness.	[van Heugten, Caroline M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Geurtsen, Gert J.; Derksen, R. Elze; Martina, Juan D.] Rehabil Med Ctr Groot Klimmendaal, Dept Acquired Brain Injury, Arnhem, Netherlands; [Derksen, R. Elze] Univ Appl Sci, Zwolle, Netherlands; [Geurts, Alexander C. H.] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil Med, NL-6525 ED Nijmegen, Netherlands; [Evers, Silvia M. A. A.] Maastricht Univ, Sch Publ Hlth & Primary Care Caphri, Maastricht, Netherlands		Geurtsen, GJ (corresponding author), Rehabil Ctr Groot Klimmendaal, Dept Acquired Brain Injury, POB 9044, NL-6800 GG Arnhem, Netherlands.	Herendubbel@yahoo.com	Geurts, Alexander/H-8032-2014; Evers, Silvia MAA/K-9720-2015; Evers, Silvia/ABG-2128-2020	Geurts, Alexander/0000-0001-7478-1119; Evers, Silvia MAA/0000-0003-1026-570X; Evers, Silvia/0000-0003-1026-570X; Geurtsen, G.J./0000-0002-2508-340X	Johanna Child Fund; BIO Children Rehabilitation Fund	This study was funded by the Johanna Child Fund and the BIO Children Rehabilitation Fund.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cooney F, 2010, J REHABIL MED, V42, P284, DOI 10.2340/16501977-0532; Drummond M., 2005, METHODS EC EVALUATIO; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Geurtsen GJ, 2008, BRAIN INJURY, V22, P545, DOI 10.1080/02699050802132479; Geurtsen GJ, 2011, ARCH PHYS MED REHAB, V92, P696, DOI 10.1016/j.apmr.2010.12.022; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Knies S, 2010, PHARMACOECONOMICS EU, V1, P20; Koopmanschap M, 2005, PHARMACOECONOMICS, V23, P47, DOI 10.2165/00019053-200523010-00004; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Koopmanschap MA, 2008, PHARMACOECONOMICS, V26, P269, DOI 10.2165/00019053-200826040-00001; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; McLaughlin Ann Marie, 1993, Brain Injury, V7, P71, DOI 10.3109/02699059309008158; Oostenbrink J, 2004, MANUAL COST RES METH; Oostenbrink JB, 2002, PHARMACOECONOMICS, V20, P443, DOI 10.2165/00019053-200220070-00002; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408	21	11	11	0	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JUN	2011	43	7					647	652		10.2340/16501977-0818			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	787IF	WOS:000292369100011	21667010	Green Submitted, gold, Green Published			2022-02-06	
J	Watts, DD; Gibbons, S; Kurzweil, D				Watts, Dorraine D.; Gibbons, Susanne; Kurzweil, Dina			Mild Traumatic Brain Injury: A Survey of Perceived Knowledge and Learning Preferences of Military and Civilian Nurses	JOURNAL OF NEUROSCIENCE NURSING			English	Article							FOOTBALL PLAYERS; EPIDEMIOLOGY; CONCUSSION; COLLEGIATE; MODEL; IRAQ	Early case recognition and intervention by nurses for patients with mild traumatic brain injury (mTBI) can significantly improve outcomes for civilian and military patients. The "Concussion/mTBI Learning Needs Assessment for Registered Nurses Survey" was developed to evaluate bedside nurses' knowledge related to the assessment and care of patients with mTBI as well as their preferences for learning in order to develop a targeted curriculum. An anonymous, self-administered, Web-based survey was available from February to August 2009. A series of invitational e-mails were sent to nurses at a convenience sample of civilian, federal, and military institutions. A total of 1,224 nurses meeting the inclusion criteria of being bedside care providers and nonadvanced practice responded and were included in the analysis (civilian, n = 731; military, n = 494). Most respondents (91.3%) considered knowledge of mTBI to be important or very important to their practice, and 44.5% saw mTBI patients at least monthly. Despite this perception of importance and exposure to the patients, nurses' self-reported knowledge levels were very low. Overall, 39.8% expressed a high knowledge level (score of 4 [a lot] or 5 [expert] on a 1-5 scale) of the causes of mTBI. Fewer than 25% expressed high knowledge level in the skills needed for the identification and assessment of mTBI patients, and less than 15% had high knowledge in the treatment and prognosis of these patients. The nurses' preferred learning method was shadowing another provider (37%), but the most often used method was Internet searches (80.3%). There was minimal difference between military and civilian nurses. Although nurses recognize the importance of familiarity with mTBI for their practice and most clearly self-identify knowledge deficits in all aspects of care of the mTBI patients, a broad but succinct curriculum for the nonadvanced practice bedside nurse could provide a cost-effective, quickly accessible way to provide the needed education.	[Watts, Dorraine D.] St Petersburg Coll, Coll Nursing, St Petersburg, FL 33701 USA; [Gibbons, Susanne] Uniformed Serv Univ Hlth Sci, Grad Sch Nursing, Bethesda, MD 20814 USA; [Kurzweil, Dina] Uniformed Serv Univ Hlth Sci, Educ & Technol Innovat Support Off, Bethesda, MD 20814 USA		Watts, DD (corresponding author), St Petersburg Coll, Coll Nursing, St Petersburg, FL 33701 USA.	watts.deedee@spcollege.edu			Office of Naval ResearchOffice of Naval Research [N00014-07-1-1070]	This project was funded in part by the Office of Naval Research award N00014-07-1-1070 as part of the Nursing Telehealth Applications Initiative. The views expressed in this manuscript are those of the authors and do not reflect the official policy or position of the Uniformed Services University, the Department of Defense, or the United States Government. The authors thank the following people for their assistance with the review and/or implementation of this survey: Commander Susan Galloway, NC, USN; Nancy Gardetto, MS, ARNP; Janet Grady, DrPH, RN; Captain Gwen Hosey, MS, ARNP, USPHS; Julie LaZarre-Miller, MS, ARNP; Joseph Lopreiato, MD, CAPT, USN, (Ret.); Gilbert Muniz, PhD, RN, PNP; and Judith Wilber, BA.	Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CASSIDY JD, 2004, J REHABILITATION MED, V36, P1651; Centers for Disease Control Prevention, 2004, HEADS FACTS PHYS MIL; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; GARDETTO N, 2009, FEDERAL PRACTITIONER, V26, P40; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Helmick KM, 2007, FEDERAL PRACTITIONER, V24, P58; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy JE, 2006, MIL MED, V171, P516, DOI 10.7205/MILMED.171.6.516; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Picard M, 1991, HELPS BRAIN INJURY S; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; STETLER CB, 1994, NURS OUTLOOK, V42, P15, DOI 10.1016/0029-6554(94)90067-1; Stetler CB, 2001, NURS OUTLOOK, V49, P272, DOI 10.1067/mno.2001.120517; 2007, ARMY TIMES      0411	26	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2011	43	3					122	129		10.1097/JNN.0b013e3182135af6			8	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	762JV	WOS:000290473400004	21796028				2022-02-06	
J	Gabbe, BJ; Lyons, RA; Lecky, FE; Bouamra, O; Woodford, M; Coats, TJ; Cameron, PA				Gabbe, Belinda J.; Lyons, Ronan A.; Lecky, Fiona E.; Bouamra, Omar; Woodford, Maralyn; Coats, Timothy J.; Cameron, Peter A.			Comparison of Mortality Following Hospitalisation for Isolated Head Injury in England and Wales, and Victoria, Australia	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MAJOR TRAUMA; SYSTEM; CARE; REGISTRY; QUALITY; MANAGEMENT; SURVIVAL; OUTCOMES; TRENDS	Background: Traumatic brain injury (TBI) remains a leading cause of death and disability. The National Institute for Health and Clinical Excellence (NICE) guidelines recommend transfer of severe TBI cases to neurosurgical centres, irrespective of the need for neurosurgery. This observational study investigated the risk-adjusted mortality of isolated TBI admissions in England/Wales, and Victoria, Australia, and the impact of neurosurgical centre management on outcomes. Methods: Isolated TBI admissions (> 15 years, July 2005-June 2006) were extracted from the hospital discharge datasets for both jurisdictions. Severe isolated TBI (AIS severity >3) admissions were provided by the Trauma Audit and Research Network (TARN) and Victorian State Trauma Registry (VSTR) for England/Wales, and Victoria, respectively. Multivariable logistic regression was used to compare risk-adjusted mortality between jurisdictions. Findings: Mortality was 12% (749/6256) in England/Wales and 9% (91/1048) in Victoria for isolated TBI admissions. Adjusted odds of death in England/Wales were higher compared to Victoria overall (OR 2.0, 95% CI: 1.6, 2.5), and for cases <65 years (OR 2.36, 95% CI: 1.51, 3.69). For severe TBI, mortality was 23% (133/575) for TARN and 20% (68/346) for VSTR, with 72% of TARN and 86% of VSTR cases managed at a neurosurgical centre. The adjusted mortality odds for severe TBI cases in TARN were higher compared to the VSTR (OR 1.45, 95% CI: 0.96, 2.19), but particularly for cases <65 years (OR 2.04, 95% CI: 1.07, 3.90). Neurosurgical centre management modified the effect overall (OR 1.12, 95% CI: 0.73, 1.74) and for cases <65 years (OR 1.53, 95% CI: 0.77, 3.03). Conclusion: The risk-adjusted odds of mortality for all isolated TBI admissions, and severe TBI cases, were higher in England/Wales when compared to Victoria. The lower percentage of cases managed at neurosurgical centres in England and Wales was an explanatory factor, supporting the changes made to the NICE guidelines.	[Gabbe, Belinda J.; Cameron, Peter A.] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia; [Gabbe, Belinda J.; Cameron, Peter A.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Lyons, Ronan A.] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Lecky, Fiona E.; Bouamra, Omar; Woodford, Maralyn; Coats, Timothy J.] Univ Manchester, Salford Royal Hosp, Manchester Acad Hlth Sci Ctr,Sch Community Based, Trauma Audit & Res Network,Hlth Sci Res Grp, Salford, Lancs, England; [Lecky, Fiona E.] Salford Royal Hosp, Dept Emergency Med, Salford, Lancs, England; [Coats, Timothy J.] Leicester Royal Infirm, Dept Accid & Emergency, Leicester, Leics, England; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia		Gabbe, BJ (corresponding author), Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia.	belinda.gabbe@monash.edu	Coats, Timothy/AAW-1254-2021; Lyons, Ronan/G-7741-2012	Coats, Timothy/0000-0003-2736-2784; Lyons, Ronan/0000-0001-5225-000X; Cameron, Peter/0000-0002-1443-557X; Gabbe, Belinda/0000-0001-7096-7688	Department of Human Services (Victoria); Transport Accident Commission (TAC) Health Research; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	The VSTR is a Department of Human Services (Victoria) and Transport Accident Commission (TAC) Health Research funded and approved initiative. Dr. Belinda Gabbe and Prof. Peter Cameron were supported by a Career Development Award and a Practitioner Fellowship, respectively, from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cameron PA, 2006, INJURY, V37, P1178, DOI 10.1016/j.injury.2006.07.015; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Coats TJ, 1999, J ACCID EMERG MED, V16, P182; Esposito Thomas J, 2006, Adv Surg, V40, P213, DOI 10.1016/j.yasu.2006.06.002; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lee A, 2003, INJURY, V34, P815, DOI 10.1016/S0020-1383(02)00395-9; MacLeod JBA, 2004, AM SURGEON, V70, P805; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; O'Reilly GM, 2010, ACAD EMERG MED, V17, P1122, DOI 10.1111/j.1553-2712.2010.00887.x; Papa L, 2006, J TRAUMA, V61, P261, DOI 10.1097/01.ta.0000221789.53864.ba; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Yeung JHH, 2008, INJURY, V39, P1034, DOI 10.1016/j.injury.2008.03.017	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20545	10.1371/journal.pone.0020545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	WOS:000291097600093	21655237	gold, Green Accepted, Green Published, Green Submitted			2022-02-06	
J	Rickels, E; von Wild, K; Wenzlaff, P				Rickels, E.; von Wild, K.; Wenzlaff, P.			Treatment of traumatic brain injury in Germany	UNFALLCHIRURG			German	Article						Traumatic brain Injury (TBI); Epidemiology; Clinical pathway; Quality management; Subjective sequelae	MINOR HEAD-INJURY; EPIDEMIOLOGY; POPULATION; RULE; US	The relationship between severe, moderate and mild traumatic brain injury (TBI) as well as the course of treatment and quality management, were studied in a 1-year prospective study in regions of Hannover and Munster Germany. A total of 6,783 patients were documented at the initial examination (58.4% male, 28.1% children < 16 years old) and 63.5% participated in the follow-up survey 1 year after the accident. Of these TBI patients 5,220 (73%) were admitted to hospital for clinical treatment but only 258 (< 4%) received inpatient rehabilitation. The incidence of TBI was 332/100,000 inhabitants and according to the Glasgow Coma Scale (GCS) brain injury was mild in 90.9%, severe in 5.2% and moderate in 3.9%. The main cause of injury was a fall (52.5%) followed by a traffic accident (26.3%). In-hospital mortality was 1%. Only 56% of TBI patients were neurological examined and 63% were examined in hospital within the first hour after the accident. An immediate x-ray of the skull with a doubtful evidential value was made in 82%. Of the participants 35.9% were still receiving medical treatment 1 year after the accident although the majority only suffered mild TBI. An overabundance of severe socioeconomic consequences, e.g. loss of job, accommodation, family, were also found following only mild TBI.	[Rickels, E.] Allgemeines Krankenhaus Celle, Bereich Neurochirurg, D-29223 Celle, Germany; [von Wild, K.] Univ Munster, Fak Med, Cerebprotect Forderverein eV, Munster, Germany; [Wenzlaff, P.] Arztekammer Niedersachsen, Zentrum Qualitat & Management Gesundheitswesen, Hannover, Germany		Rickels, E (corresponding author), Allgemeines Krankenhaus Celle, Bereich Neurochirurg, Siemenspl 4, D-29223 Celle, Germany.	emrickels@t-online.de					Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; *CDC, 2003, TRAUM BRAIN INJ US R; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; RICKELS E, 2006, SCHADEL HIRNVERLETZU; SARWADEI F, 2002, J NEUROSURG SCI, V46, P111; Schootman M, 2000, BRAIN INJURY, V14, P373; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; WEIMAR C, 2003, DTSCH ARZTEBL, V100	17	11	11	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	MAY	2011	114	5					417	423		10.1007/s00113-010-1872-y			7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	762OZ	WOS:000290490600010	21461785				2022-02-06	
J	Rekha, J; Veena, LR; Prem, N; Kalaivani, P; Choudhury, R; Alladi, PA; Agrahari, M; Raju, TR; Kutty, BM				Rekha, J.; Veena, L. R.; Prem, Neethi; Kalaivani, P.; Choudhury, Rupam; Alladi, Phalguni Anand; Agrahari, Maulishree; Raju, T. R.; Kutty, Bindu M.			NIH-3T3 fibroblast transplants enhance host regeneration and improve spatial learning in ventral subicular lesioned rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						CNS insult; Cognitive impairment; Fibroblast transplants; Trophic support; Host regeneration; Behavioural recovery	NERVE GROWTH-FACTOR; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; RADIAL MAZE PERFORMANCE; CA1 PYRAMIDAL CELLS; SPINAL-CORD-INJURY; ENTORHINAL CORTEX; ENRICHED ENVIRONMENT; ADULT-RATS; CHOLINE-ACETYLTRANSFERASE	Transplants, besides providing neural replacement, also stimulate host regeneration, which could serve as a powerful means to establish functional recovery in CNS insults. Earlier, we have reported the H3-GFP transplant mediated recovery of cognitive functions in the ventral subicular lesioned rats. In the present study, we demonstrate the efficacy of a non-neural fibroblast transplants in mediating host regeneration and functional recovery in ventral subicular lesioned rats. Adult male Wistar rats were lesioned with ibotenic acid in the ventral subiculum (VSL) and were transplanted with NIH-3T3 fibroblast cells into CA1 region of the hippocampus. Ventral subicular lesioning impaired the spatial task performances in rats and produced considerable degree of dendritic atrophy of the hippocampal pyramidal neurons. Two months following transplantation, the transplants were seen in the dentate gyrus and expressed BDNF and bFGF. Further, the VSL rats with fibroblast transplants showed enhanced expression of BDNF in the hippocampus and enhanced dendritic branching and increased spine density in the CA1 hippocampal pyramidal neurons. Transplantation of fibroblast cells also helped to establish functional recovery and the rats with transplants showed enhanced spatial learning performances. We attribute the recovery of cognitive functions to the graft mediated host regeneration, although the mechanisms of functional recovery remain to be elucidated. (C) 2010 Elsevier B.V. All rights reserved.	[Rekha, J.; Veena, L. R.; Prem, Neethi; Kalaivani, P.; Alladi, Phalguni Anand; Raju, T. R.; Kutty, Bindu M.] NIMHANS Deemed Univ, Natl Inst Mental Hlth & Neuro Sci, Dept Neurophysiol, Bangalore 560029, Karnataka, India; [Agrahari, Maulishree] PES Inst Technol, Dept Biotechnol, Bangalore 560085, Karnataka, India; [Choudhury, Rupam] TIFR, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India		Kutty, BM (corresponding author), NIMHANS Deemed Univ, Natl Inst Mental Hlth & Neuro Sci, Dept Neurophysiol, Bangalore 560029, Karnataka, India.	bindu.nimhans@gmail.com	Alladi, Phalguni/AAY-6912-2020	Alladi, Phalguni/0000-0002-2876-3478	Department of Biotechnology (DBT), New DelhiDepartment of Biotechnology (DBT) India [BT/PR 6567/Med/14/849/2005]	The study was funded by the Department of Biotechnology (DBT), New Delhi, (project No. BT/PR 6567/Med/14/849/2005). We acknowledge with thanks the support provided by Dr. M.M. Panicker, Associate Professor, NCBS-TIFR, GKVK Campus, Bangalore 560065, during the study and also for suggesting the use of NIH-3T3 fibroblast cell lines.	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Barde YA, 1987, PROG BRAIN RES <D>, V71, P185; BERGER TW, 1980, BRAIN RES, V183, P265, DOI 10.1016/0006-8993(80)90463-1; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Bindu B, 2005, BRAIN RES, V1063, P121, DOI 10.1016/j.brainres.2005.09.044; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Brodhun M, 2004, EXP TOXICOL PATHOL, V56, P103, DOI 10.1016/j.etp.2004.04.004; CHO YH, 1995, NEUROBIOL LEARN MEM, V64, P285, DOI 10.1006/nlme.1995.0011; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; DAVIES DC, 1992, ACTA NEUROPATHOL, V83, P510, DOI 10.1007/BF00310028; DEKKER AJ, 1994, NEUROSCIENCE, V60, P299, DOI 10.1016/0306-4522(94)90244-5; Devi L, 2003, BRAIN RES, V960, P9, DOI 10.1016/S0006-8993(02)03699-5; Dhanushkodi A, 2007, BEHAV NEUROSCI, V121, P491, DOI 10.1037/0735-7044.121.3.491; Dickinson-Anson H, 2003, MOL THER, V8, P51, DOI 10.1016/S1525-0016(03)00145-X; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; FISHER LJ, 1993, J NEUROCHEM, V61, P1323, DOI 10.1111/j.1471-4159.1993.tb13625.x; Floresco SB, 1996, BEHAV BRAIN RES, V81, P163, DOI 10.1016/S0166-4328(96)00058-7; Galani R, 1997, NEUROBIOL LEARN MEM, V67, P43, DOI 10.1006/nlme.1996.3745; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; GOODLETT CR, 1989, BEHAV BRAIN RES, V32, P63, DOI 10.1016/S0166-4328(89)80072-5; Govindaiah, 1997, BRAIN RES, V745, P121, DOI 10.1016/S0006-8993(96)01135-3; Herzog CD, 2002, NEUROSCIENCE, V113, P569, DOI 10.1016/S0306-4522(02)00203-8; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hodges H, 2000, NEUROSCIENCE, V101, P945, DOI 10.1016/S0306-4522(00)00408-5; JARRARD LE, 1978, J COMP PHYSIOL PSYCH, V92, P1119, DOI 10.1037/h0077516; JARRARD LE, 1984, PHARMACOL BIOCHEM BE, V21, P273, DOI 10.1016/0091-3057(84)90226-0; Jin Y, 2002, EXP NEUROL, V177, P265, DOI 10.1006/exnr.2002.7980; Kerr DA, 2003, J NEUROSCI, V23, P5131; Kim D, 2001, NEUROREHAB NEURAL RE, V15, P141, DOI 10.1177/154596830101500207; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; Laxmi TR, 1999, BRAIN RES, V816, P245, DOI 10.1016/S0006-8993(98)01187-1; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; LeviMontalcini R, 1996, TRENDS NEUROSCI, V19, P514, DOI 10.1016/S0166-2236(96)10058-8; Li N, 2007, BIOCHEM BIOPH RES CO, V356, P561, DOI 10.1016/j.bbrc.2007.03.013; LINDSAY RM, 1984, NEUROSCIENCE, V12, P45, DOI 10.1016/0306-4522(84)90136-2; Liu W G, 1999, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V13, P291; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Modo M, 2002, STROKE, V33, P2270, DOI 10.1161/01.STR.0000027693.50675.C5; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nutan K S, 1998, Indian J Physiol Pharmacol, V42, P460; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; Oswald CJP, 2000, BEHAV NEUROSCI, V114, P211, DOI 10.1037/0735-7044.114.1.211; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Pizzo DP, 2004, MOL BRAIN RES, V126, P1, DOI 10.1016/j.molbrainres.2004.03.006; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rao BSS, 2001, NEUROSCIENCE, V102, P319, DOI 10.1016/S0306-4522(00)00462-0; Rao MS, 2006, NEUROBIOL DIS, V21, P276, DOI 10.1016/j.nbd.2005.07.009; Rekha J, 2009, BEHAV NEUROSCI, V123, P1197, DOI 10.1037/a0017655; Scholl DA, 1956, ORG CEREBRAL CORTEX; SEGAL RA, 1995, J NEUROSCI, V15, P4970; SHARP PE, 1990, J NEUROSCI, V10, P3093; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sinden JD, 1997, NEUROSCIENCE, V81, P599, DOI 10.1016/S0306-4522(97)00330-8; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Sunanda Rao MS, 1995, BRAIN RES, V694, P312, DOI DOI 10.1016/0006-8993(95)00822-8.PUBMED:8974660; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; Tobias CA, 2001, J NEUROTRAUM, V18, P287, DOI 10.1089/08977150151070937; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Toda H, 2001, NEUROSCI LETT, V316, P9, DOI 10.1016/S0304-3940(01)02331-X; TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; VOLPE BT, 1989, STROKE, V20, P1700, DOI 10.1161/01.STR.20.12.1700; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; YEE BK, 1994, J NEUROSCI, V14, P3766; Yuan QJ, 2000, NEUROREPORT, V11, P2237, DOI 10.1097/00001756-200007140-00035; Yuen EC, 1996, ANN NEUROL, V40, P346, DOI 10.1002/ana.410400304; Zaman V, 2003, HIPPOCAMPUS, V13, P618, DOI 10.1002/hipo.10091	82	11	13	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	APR 15	2011	218	2					315	324		10.1016/j.bbr.2010.11.020			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	730OF	WOS:000288042600008	21074573				2022-02-06	
J	Berry, C; Ley, EJ; Mirocha, J; Margulies, DR; Tillou, A; Salim, A				Berry, Cherisse; Ley, Eric J.; Mirocha, James; Margulies, Daniel R.; Tillou, Areti; Salim, Ali			Do pregnant women have improved outcomes after traumatic brain injury?	AMERICAN JOURNAL OF SURGERY			English	Article						Traumatic brain injury; Sex; Pregnant; Outcome; Mortality	GENDER-DIFFERENCE; DIMORPHISM; OBESITY; IMPACT	BACKGROUND: Pregnant women, who have significantly elevated levels of estrogen and progesterone, might benefit from the neuroprotective effect of steroid hormones. METHODS: Pregnant patients were identified and compared with their nonpregnant counterparts with respect to demographics and outcome. \ RESULTS: Of the 18,800 female, moderate to severe TBI patients, 71 were pregnant. Similar mortalities were noted in pregnant and nonpregnant TBI patients (9.9% vs 9.3%, P = .84). Adjusting for confounding variables, pregnant TBI patients had a trend toward increased mortality (adjusted odds ratio [AOR] = 2.2; 95% confidence interval [CI], .9-5.1; P = .07). In patients aged 15 to 47 years (n = 8,854), similar mortalities were noted in pregnant and nonpregnant TBI patients (9.9% vs 6.8%, P = .34). After adjusting for risk factors, again there was a trend toward increased mortality in the pregnant TBI group (AOR = 2.0; 95% CI, .8-4.6; P = .12). CONCLUSIONS: Pregnant patients with moderate to severe TBI show no statistically significant difference in mortality compared with their nonpregnant counterparts. (C) 2011 Elsevier Inc. All rights reserved.	[Berry, Cherisse; Ley, Eric J.; Mirocha, James; Margulies, Daniel R.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Tillou, Areti] Univ Calif Los Angeles, Div Trauma, Los Angeles, CA USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215NT, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020				Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Bernasconi D, 1996, METABOLISM, V45, P72, DOI 10.1016/S0026-0495(96)90202-4; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; KIRSCHNER MA, 1990, J CLIN ENDOCR METAB, V70, P473, DOI 10.1210/jcem-70-2-473; Kondo Y, 1997, NEUROSCI LETT, V238, P45, DOI 10.1016/S0304-3940(97)00847-1; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Phelan HA, 2007, J TRAUMA, V63, P1127, DOI 10.1097/TA.0b013e318154c1b8; Rogers E, 2006, J HEAD TRAUMA REHAB, V21, P279, DOI 10.1097/00001199-200605000-00008; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; SAMOJLIK E, 1984, J CLIN ENDOCR METAB, V59, P949, DOI 10.1210/jcem-59-5-949; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10	18	11	11	0	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	APR	2011	201	4					429	432		10.1016/j.amjsurg.2010.10.008			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	747HU	WOS:000289311700002	21421094				2022-02-06	
J	Fernandes, CA; Fievez, L; Ucakar, B; Neyrinck, AM; Fillee, C; Huaux, F; Delzenne, NM; Bureau, F; Vanbever, R				Fernandes, Claudia A.; Fievez, Laurence; Ucakar, Bernard; Neyrinck, Audrey M.; Fillee, Catherine; Huaux, Francois; Delzenne, Nathalie M.; Bureau, Fabrice; Vanbever, Rita			Nicotinamide enhances apoptosis of G(M)-CSF-treated neutrophils and attenuates endotoxin-induced airway inflammation in mice	AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY			English	Article						lipopolysaccharide; lung inflammation; pulmonary drug delivery; neutrophil recruitment	COLONY-STIMULATING FACTOR; ACUTE LUNG INJURY; NF-KAPPA-B; RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; POLY(ADP-RIBOSE) POLYMERASE; IN-VIVO; LEUKEMIA-CELLS; INHIBITION; RESOLUTION	Fernandes CA, Fievez L, Ucakar B, Neyrinck AM, Fillee C, Huaux F, Delzenne NM, Bureau F, Vanbever R. Nicotinamide enhances apoptosis of G(M)-CSF-treated neutrophils and attenuates endotoxin-induced airway inflammation in mice. Am J Physiol Lung Cell Mol Physiol 300: L354-L361, 2011. First published December 3, 2010; doi:10.1152/ajplung.00198.2010.-Neutrophils constitute the first line of host defense against invading microorganisms. Yet their removal from the inflammatory environment is fundamental for injury restraint and resolution of inflammation. Nicotinamide, a component of vitamin B-3, is known to modulate cell survival. In this study, we assessed the influence of nicotinamide on neutrophil apoptosis, both in vitro and in vivo in a mouse model of endotoxin-induced lung inflammation. In vitro, nicotinamide promoted apoptosis of human blood neutrophils in a dose-dependent manner in the presence of the apoptosis inhibitors granulocyte colony-stimulating factor and granulocyte/ macrophage colony-stimulating factor. The highest concentration of nicotinamide completely neutralized the pro-survival effect of granulocyte (macrophage) colony-stimulating factor. Nicotinamide proapoptotic effect was associated with enhanced caspase-3 activity. In addition, nicotinamide slightly reduced neutrophil chemotaxis in vitro. In vivo, pulmonary nicotinamide delivery decreased the levels of cellular and biochemical inflammation markers and increased the percentage of apoptotic neutrophils in bronchoalveolar lavages. Our findings suggest that nicotinamide is an apoptotic stimulus for neutrophils, thereby contributing to the resolution of neutrophilic inflammation in the lungs.	[Fernandes, Claudia A.; Ucakar, Bernard; Vanbever, Rita] Catholic Univ Louvain, Unite Pharm Galen, LDRI, B-1200 Brussels, Belgium; [Fievez, Laurence; Bureau, Fabrice] Univ Liege, Lab Cellular & Mol Physiol, GIGA Res, Liege, Belgium; [Neyrinck, Audrey M.; Delzenne, Nathalie M.] Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Huaux, Francois] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium		Vanbever, R (corresponding author), Catholic Univ Louvain, Unite Pharm Galen, LDRI, Ave E Mounier,73 UCL 73-20, B-1200 Brussels, Belgium.	rita.vanbever@uclouvain.be	Neyrinck, Audrey/AAE-7929-2019; Delzenne, Nathalie/AAC-4628-2019	Neyrinck, Audrey/0000-0002-9435-3338; Delzenne, Nathalie/0000-0003-2115-6082	Reseaux programme of the Walloon Region (Belgium) [415695]; Universite Catholique de Louvain; Fonds National de la Recherche Scientifique (FNRS, Belgium)Fonds de la Recherche Scientifique - FNRS	This work was supported by the Reseaux programme of the Walloon Region (Grant 415695; Belgium), by a Patrimoine research grant from the Universite Catholique de Louvain, and by the Fonds National de la Recherche Scientifique (FNRS, Belgium). R. Vanbever is Maitre de Recherches of the FNRS.	Allport JR, 1996, BRIT J CLIN PHARMACO, V42, P99, DOI 10.1046/j.1365-2125.1996.37014.x; Beneke S, 2007, NUCLEIC ACIDS RES, V35, P7456, DOI 10.1093/nar/gkm735; BHATIA M, 1995, BIOCHEM J, V308, P131, DOI 10.1042/bj3080131; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P271, DOI 10.2174/156720205774322584; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Conese Massimo, 2003, J Cyst Fibros, V2, P129, DOI 10.1016/S1569-1993(03)00063-8; Corhay JL, 2009, CHEST, V136, P1047, DOI 10.1378/chest.08-2782; Cowburn AS, 2008, CHEST, V134, P606, DOI 10.1378/chest.08-0422; COX G, 1995, AM J RESP CELL MOL, V12, P232, DOI 10.1165/ajrcmb.12.2.7865221; Crowley CL, 2000, CELL DEATH DIFFER, V7, P314, DOI 10.1038/sj.cdd.4400658; Fernandes CA, 2009, EXPERT OPIN DRUG DEL, V6, P1231, DOI 10.1517/17425240903241788; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Fudala R, 2008, CLIN SCI, V114, P403, DOI 10.1042/CS20070272; Fukuzawa M, 1997, IMMUNOL LETT, V59, P7, DOI 10.1016/S0165-2478(97)00088-6; Hallett JM, 2008, TRENDS PHARMACOL SCI, V29, P250, DOI 10.1016/j.tips.2008.03.002; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hussain N, 1998, AM J RESP CELL MOL, V19, P867, DOI 10.1165/ajrcmb.19.6.3118; IJICHI H, 1966, J BIOL CHEM, V241, P3701; Jung-Hynes B, 2009, J BIOL CHEM, V284, P3823, DOI 10.1074/jbc.M807869200; Jung-Hynes B, 2009, CELL CYCLE, V8, P1478, DOI 10.4161/cc.8.10.8408; Kao SJ, 2007, J CARDIOVASC PHARM, V50, P333, DOI 10.1097/FJC.0b013e3180cbd18a; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Minne A, 2007, IMMUNOLOGY, V122, P316, DOI 10.1111/j.1365-2567.2007.02641.x; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Patton JS, 2004, CLIN PHARMACOKINET, V43, P781, DOI 10.2165/00003088-200443120-00002; PELLATDECEUNYNCK C, 1994, BIOCHEM J, V297, P53, DOI 10.1042/bj2970053; Puneet P, 2005, AM J PHYSIOL-LUNG C, V288, pL3, DOI 10.1152/ajplung.00405.2003; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Saldeen J, 2003, MOL CELL BIOCHEM, V243, P113, DOI 10.1023/A:1021651811345; Sousa LP, 2010, J LEUKOCYTE BIOL, V87, P895, DOI 10.1189/jlb.0809540; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Taylor DM, 2008, CELL MOL LIFE SCI, V65, P4000, DOI 10.1007/s00018-008-8357-y; Traister A, 2005, SCAND J GASTROENTERO, V40, P1226, DOI 10.1080/00365520510023341; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; van Raam BJ, 2008, BLOOD, V112, P2046, DOI 10.1182/blood-2008-04-149575; Wampfler J, 2009, BRIT J HAEMATOL, V146, P337, DOI 10.1111/j.1365-2141.2009.07749.x	44	11	11	0	6	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1040-0605			AM J PHYSIOL-LUNG C	Am. J. Physiol.-Lung Cell. Mol. Physiol.	MAR	2011	300	3					L354	L361		10.1152/ajplung.00198.2010			8	Physiology; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Respiratory System	728ZX	WOS:000287915100005	21131399				2022-02-06	
J	Wani, AA; Ramzan, AU; Malik, NK; Qayoom, A; Nizami, FA; Kirmani, AR; Wan, MA				Wani, Abrar A.; Ramzan, Altaf U.; Malik, Nayil K.; Qayoom, Abdul; Nizami, Furqan A.; Kirmani, Altaf R.; Wan, M. Afzal			Missile injury to the pediatric brain in conflict zones Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						penetrating missile injury; pediatric brain injury; conflict	SEVERE HEAD-INJURY; CRANIOCEREBRAL GUNSHOT WOUNDS; TRAUMATIC EXTRADURAL HEMATOMAS; OPERATION-IRAQI-FREEDOM; GLASGOW-COMA-SCALE; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL HYPERTENSION; BLAST INJURIES; EXPERIENCE; CHILDREN	Object. This study was conducted both prospectively and retrospectively at one center over a period of 8 years. The population consisted of all patients with both an age 18 years or younger and a diagnosed penetrating missile injury (PMI) during the study interval. The authors analyzed factors determining outcome and demographic trends in this population, and they compared them with those in the more developed world Methods. Fifty-one patients were the victims of armed conflict, although no one was directly a party to any battle. This mechanism of injury is in strong opposition to data in the literature from developed countries, in which most missile injuries are the result of suicide or homicide or are even sports related. Moreover, all previous studies on the pediatric population have considered only injuries from gunshots, but authors of the current study have included injuries from other penetrating missiles as well. Results. On cross tabulation analysis using the chi-square test, the factors shown to correlate with outcome included the Glasgow Coma Scale (GCS) score, pupillary abnormalities, patient age, hemodynamic status, and bi-hemispheric damage. On multinomial regression analysis, the two strongest predictors of death were GCS score and pupillary abnormalities. The GCS score and hemodynamic status were the strongest predictors of disability. Conclusions. There was no difference in the prognostic factors for PMI between developing or more developed countries. Glasgow Coma Scale score, pupillary abnormalities, and hemodynamic status were the strongest predictors of outcome. In conflict zones in developing countries the victims were mostly innocent bystanders, whereas in the more developed countries homicides and suicides were the leading etiological factors. (DOI: 10.317112010.12.PEDSIO241 )	[Wani, Abrar A.; Ramzan, Altaf U.; Malik, Nayil K.; Qayoom, Abdul; Nizami, Furqan A.; Kirmani, Altaf R.; Wan, M. Afzal] Sherikashmir Inst Med Sci, Dept Neurosurg, Srinagar, JK, India		Wani, AA (corresponding author), Sherikashmir Inst Med Sci, Dept Neurosurg, Srinagar, JK, India.	abrarwani@rediffmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARLOW B, 1982, J PEDIATR SURG, V17, P927, DOI 10.1016/S0022-3468(82)80469-7; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chambers LW, 2005, ARCH SURG-CHICAGO, V140, P26, DOI 10.1001/archsurg.140.1.26; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Comninos S C, 1979, Acta Neurochir Suppl (Wien), V28, P144; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DHELLEMMES P, 1985, J NEUROSURG, V62, P861, DOI 10.3171/jns.1985.62.6.0861; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Gutierrez FA, 1981, CONCEPTS PEDIAT NEUR, P188; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P199, DOI 10.1007/BF01808959; HUBSCHMANN O, 1979, J TRAUMA, V19, P6, DOI 10.1097/00005373-197901000-00002; Humphreys RP, 1983, CONCEPTS PEDIATRIC N, V3, P191; Jagannathan J, 2007, J NEUROSURG, V106, pA761; Jandial R, 2008, NEUROSURGERY, V62, P472, DOI 10.1227/01.neu.0000316015.05550.7a; JENNETT B, 1976, LANCET, V1, P1031; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; Kluger Y, 2003, ISRAEL MED ASSOC J, V5, P235; KRIEGER D, 1993, CRIT CARE MED, V21, P1944, DOI 10.1097/00003246-199312000-00024; Kunze E, 1998, ACT NEUR S, V71, P16; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; LEVY ML, 1993, NEUROSURGERY, V33, P1018; Liebenberg WA, 2005, NEUROSURGERY, V57, P293, DOI 10.1227/01.NEU.0000166662.77797.EC; LILLARD PL, 1978, SURG NEUROL, V9, P79; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAYER T, 1982, CLIN PEDIATR, V21, P391, DOI 10.1177/000992288202100701; MAZZA C, 1982, ACTA NEUROCHIR, V65, P67, DOI 10.1007/BF01405443; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MINER ME, 1986, NEUROSURGERY, V19, P952, DOI 10.1227/00006123-198612000-00009; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Peleg K, 2003, AM J EMERG MED, V21, P258, DOI 10.1016/S0735-6757(03)00043-3; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RAIMONDI AJ, 1970, J NEUROSURG, V32, P647, DOI 10.3171/jns.1970.32.6.0647; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rodoplu Ulkumen, 2004, Prehosp Disaster Med, V19, P133; ROPPER AH, 1990, NEUROLOGY, V40, P1707; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SHERMAN WD, 1980, WESTERN J MED, V132, P99; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P161; ZUCCARELLO M, 1985, CHILD NERV SYST, V1, P158, DOI 10.1007/BF00735731	54	11	11	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2011	7	3					276	281		10.3171/2010.12.PEDS10241			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	725WE	WOS:000287676800013	21361767				2022-02-06	
J	Edmonds, RD; Cuschieri, J; Minei, JP; Rosengart, MR; Maier, RV; Harbrecht, BG; Billiar, TR; Peitzman, AB; Moore, EE; Sperry, JL				Edmonds, Rebecca D.; Cuschieri, Joseph; Minei, Joseph P.; Rosengart, Matthew R.; Maier, Ronald V.; Harbrecht, Brian G.; Billiar, Timothy R.; Peitzman, Andrew B.; Moore, Ernest E.; Sperry, Jason L.		Inflammation Host Response Injury	Body Adipose Content is Independently Associated With a Higher Risk of Organ Failure and Nosocomial Infection in the Nonobese Patient Postinjury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	40th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 07, 2010	Telluride, CO	Western Trauma Assoc			STANDARD OPERATING PROCEDURES; SCALE COLLABORATIVE PROJECT; ORIENTED RESEARCH CORE; NECROSIS-FACTOR-ALPHA; CLINICAL CARE; HOST RESPONSE; BLUNT TRAUMA; MASS-INDEX; OBESITY; INJURY	Objective: Obesity defined by a body mass index (BMI) > 30 kg/m(2) is associated with increased morbidity and mortality following trauma. Evidence suggests that obesity represents a state of chronic inflammation and that the adipose tissue content may affect the intensity and resolution of inflammatory response. We sought to avoid the confounding effects attributable to obesity and determine the association of BMI and outcomes following injury in nonobese patients. Methods: Data were obtained from a multicenter prospective cohort study evaluating outcomes in blunt-injured adults with hemorrhagic shock. Only patients with a BMI >= 18.5 and <30 were analyzed. Those with isolated traumatic brain injury and cervical cord injury and those who survived <24 hours were excluded. Logistic regression was used to evaluate the effects of BMI on mortality, multiple organ failure (MOF, multiple organs dysfunction score [MODS] <5), and nosocomial infection (NI) after adjusting for differences in demographics, injury severity, early resuscitation needs, shock parameters, and comorbidities. Results: Overall mortality, MOF, and NI rates for the study cohort (n = 820) were 13%, 37%, and 46%, respectively. Median Injury Severity Score was 33 (interquartile range, 22-41). Median BMI for the study cohort was 25 (interquartile range, 23-27). As BMI increased, maximum organ dysfunction scores also significantly increased for cardiac, respiratory, and renal systems. Logistic regression revealed no significant association with mortality (odds ratio [OR] = 0.95; 95% confidence interval [CI], 0.9-1.0); however, BMI was independently associated with a higher risk of MOF (OR = 1.09; 95% CI, 1.02-1.06) and NI (OR = 1.07; 95% CI, 1.01-1.13). For every single-point increase in BMI, the risk of MOF and NI increase by 9% and 7%, respectively. Conclusion: The risk of MOF and NI increases as BMI increases in the nonobese injured patient. These results suggest that body adipose content may be associated with the magnitude of or extent of the inflammatory response postinjury. Further studies are needed to elucidate the mechanism responsible for this association.	[Edmonds, Rebecca D.; Rosengart, Matthew R.; Billiar, Timothy R.; Peitzman, Andrew B.; Sperry, Jason L.] Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, Pittsburgh, PA 15213 USA; [Cuschieri, Joseph; Maier, Ronald V.] Harborview Med Ctr, Div Gen Surg & Trauma, Washington, DC USA; [Cuschieri, Joseph; Maier, Ronald V.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burn, Dallas, TX 75390 USA; [Harbrecht, Brian G.] Univ Louisville, Dept Surg, Div Gen Surg & Trauma, Louisville, KY 40292 USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Moore, Ernest E.] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80262 USA		Sperry, JL (corresponding author), Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, 200 Lothrop St, Pittsburgh, PA 15213 USA.	sperryjl@upmc.edu			NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR024154] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54 GM062119-1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM062119] Funding Source: NIH RePORTER		Alban RF, 2006, AM SURGEON, V72, P966; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; Bochicchio GV, 2006, J AM COLL SURGEONS, V203, P533, DOI 10.1016/j.jamcollsurg.2006.07.001; Brandt C A, 2003, AMIA Annu Symp Proc, P794; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Byrnes MC, 2005, J TRAUMA, V58, P232, DOI 10.1097/01.TA.0000152081.67588.10; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Ciesla DJ, 2006, J AM COLL SURGEONS, V203, P539, DOI 10.1016/j.jamcollsurg.2006.06.029; Davenport DL, 2009, J VASC SURG, V49, P140, DOI 10.1016/j.jvs.2008.08.052; Diaz JJ, 2009, J TRAUMA, V66, P226, DOI 10.1097/TA.0b013e31815eb776; Duane TM, 2006, J TRAUMA, V61, P1218, DOI 10.1097/01.ta.0000241022.43088.e1; Falagas ME, 2009, OBES REV, V10, P280, DOI 10.1111/j.1467-789X.2008.00546.x; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Harbrecht BG, 2007, J TRAUMA, V63, P703, DOI 10.1097/TA.0b013e31811eadea; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Maier RV, 2005, J TRAUMA, V59, P762, DOI 10.1097/01.ta.0000177656.85206.cd; MANSHIP L, 1984, AM SURGEON, V50, P94; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Marshall JC, 1999, EUR J SURG, V163, P62; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moore FA, 2006, J TRAUMA, V61, P82, DOI 10.1097/01.ta.0000225933.08478.65; Mullen JT, 2009, ANN SURG, V250, P166, DOI 10.1097/SLA.0b013e3181ad8935; Nathens AB, 2005, J TRAUMA, V59, P764, DOI 10.1097/01.ta.0000177759.17704.35; Nathens AB, 1996, WORLD J SURG, V20, P386, DOI 10.1007/s002689900061; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; ROUMEN RMH, 1995, CRIT CARE MED, V23, P474, DOI 10.1097/00003246-199503000-00010; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; West MA, 2006, J TRAUMA, V61, P436, DOI 10.1097/01.ta.0000232517.83039.c4; Winfield RD, 2010, CRIT CARE MED, V38, P51, DOI 10.1097/CCM.0b013e3181b08089	38	11	11	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2011	70	2					292	298		10.1097/TA.0b013e31820b5f69			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	719FV	WOS:000287187700009	21307724				2022-02-06	
J	Heltemes, KJ; Dougherty, AL; MacGregor, AJ; Galameau, MR				Heltemes, Kevin J.; Dougherty, Amber L.; MacGregor, Andrew J.; Galameau, Michael R.			Inpatient Hospitalizations of U.S. Military Personnel Medically Evacuated From Iraq and Afghanistan With Combat-Related Traumatic Brain Injury	MILITARY MEDICINE			English	Article							NECK INJURIES; DEPRESSION; FREEDOM; HEAD; WAR	Traumatic brain injury (TBI) has been called the signature wound of Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF). The aim of the present study was to describe and assess the incidence of inpatient hospitalizations of U.S. military personnel who were medically evacuated from OIF and OEF with combat-related TBI. Inpatient medical records from 2003 to 2008 were used to determine incident episodes of TBI requiring hospitalization in Landstuhl or CONUS Regional Medical Centers. Denominator data for calculating incidence rates were available from the Defense Manpower Data Center. During the study period, 1,213 U.S. military personnel from OIF and OEF were hospitalized with combat-related TBI. Of these, the largest proportion (40.9%) occurred in 2007. The rate of inpatient hospitalization with TBI was 10.4 per 10,000 troop strength (95% confidence interval: 9.9, 10.9). Future research should examine the incidence of TBI in-theater and include an analysis by injury severity.	[Heltemes, Kevin J.; Dougherty, Amber L.; MacGregor, Andrew J.; Galameau, Michael R.] USN, Hlth Res Ctr, San Diego, CA 92106 USA		Heltemes, KJ (corresponding author), USN, Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.			MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery, Washington, DC under Work Unit [60808]	We thank Science Applications International Corporation for its contributions to this work. This work was supported by the U.S. Navy Bureau of Medicine and Surgery, Washington, DC, under Work Unit No. 60808.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; *EMEDICINE, CLASS COMPL TRAUM BR; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Lauder TD, 2000, AM J PREV MED, V18, P118, DOI 10.1016/S0749-3797(99)00174-9; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; *MAYO CLIN, DEPR; *MAYO CLIN, HYDR; *MAYO CLIN, DYSPH; *MAYO CLIN, EP; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; REISTER FA, 1973, BATTLE CASUALTIES ME, pCH3; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; THOMPSON K, 2001, N C MED J, V62, P381; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Zouris JM, 2008, MIL MED, V173, P247, DOI 10.7205/MILMED.173.3.247; Zouris JM, 2006, MIL MED, V171, P246, DOI 10.7205/MILMED.171.3.246	27	11	11	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2011	176	2					132	135		10.7205/MILMED-D-09-00238			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825BL	WOS:000295245800005	21366072	Bronze			2022-02-06	
J	Huh, JW; Widing, AG; Raghupathi, R				Huh, Jimmy W.; Widing, Ashley G.; Raghupathi, Ramesh			Differential Effects of Injury Severity on Cognition and Cellular Pathology after Contusive Brain Trauma in the Immature Rat	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; caspases; children; cognition; contusion; infants; neurodegeneration; traumatic axonal injury; traumatic brain injury	CONTROLLED CORTICAL IMPACT; LATERAL FLUID PERCUSSION; MORRIS WATER MAZE; AXONAL INJURY; HEAD-INJURY; SPINAL-CORD; COMA SCALE; MEMORY DEFICITS; YOUNG-CHILDREN; NEURONAL LOSS	Although diffuse brain damage has been suggested to be the predominant predictor of neurological morbidity following closed head injury in infants and children, the presence of contusions also predicts long-term neurobehavioral dysfunction. Contusive brain trauma in the 17-day-old rat resulted in neurodegeneration and caspase activation in the cortex at 1 day, and in the thalamus at 3 days post-injury, and to a greater extent following a deeper impact. Cortical tissue loss in the 4-mm impact group was significantly greater than that in the 3-mm impact group (p<0.05), and exhibited a time-dependent increase over the first 3 weeks post-injury. Traumatic axonal injury was observed in the white matter tracts below the site of impact at 1 day, and in the corpus callosum at 3 days, to a greater extent following 4-mm impact. In contrast, cellular caspase-3 activation in these white matter tracts was only observed at 24 h post-injury and was not affected by impact depth. Similarly, neurodegeneration and caspase activation in the hippocampus was restricted to the dentate gyrus and occurred to a similar extent in both injured groups. Only the 4-mm impact group exhibited learning deficits in the first week (p<0.0001) that was sustained until the third week post-injury (p<0.0001), while deficits in the 3-mm impact group were seen only at 3 weeks post-injury (p<0.02). These observations demonstrate that increasing severity of injury in immature animals does not uniformly increase the extent of cellular damage, and that the progression of tissue damage and behavioral deficits varies as a function of injury severity.	[Widing, Ashley G.; Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; [Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA		Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	rramesh@drexelmed.edu	Raghupathi, Ramesh/AAX-5538-2021		National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08-NS053651, R01-HD061963]; VA merit review grantUS Department of Veterans Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS053651] Funding Source: NIH RePORTER	These studies were supported in part by National Institute of Neurological Disorders and Stroke grants K08-NS053651 and R01-HD061963, and a VA merit review grant.	Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2000, BRAIN INJURY, V14, P679; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Huh JW, 2006, DEV NEUROSCI-BASEL, V28, P466, DOI 10.1159/000094172; IIZUKA H, 1990, STROKE, V21, P790, DOI 10.1161/01.STR.21.5.790; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Nottingham SA, 2003, J COMP NEUROL, V464, P463, DOI 10.1002/cne.10806; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Rasband WS, 2007, IMAGE J; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TEASDALE G, 1974, LANCET, V2, P81; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	66	11	14	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2011	28	2					245	257		10.1089/neu.2010.1639			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	719UE	WOS:000287234700008	21091272	Green Published			2022-02-06	
J	Keightley, M; Kendall, V; Jang, SH; Parker, C; Agnihotri, S; Colantonio, A; Minore, B; Katt, M; Cameron, A; White, R; Longboat-White, C; Bellavance, A				Keightley, Michelle; Kendall, Victoria; Jang, Shu-Hyun; Parker, Cindy; Agnihotri, Sabrina; Colantonio, Angela; Minore, Bruce; Katt, Mae; Cameron, Anita; White, Randy; Longboat-White, Claudine; Bellavance, Alice			From health care to home community: An Aboriginal community-based ABI transition strategy	BRAIN INJURY			English	Article						Acquired brain injury; Aboriginal health; transition; framework analysis	TRAUMATIC BRAIN-INJURY; ETHNIC DISPARITIES; REHABILITATION; OUTCOMES	Primary objective: To explore the barriers and enablers surrounding the transition from health care to home community settings for Aboriginal clients recovering from acquired brain injuries (ABI) in northwestern Ontario. Research design: Participatory research design using qualitative methods. Methods: Focus groups conducted with clients with ABI, their caregivers and hospital and community health-care workers. The Framework Method of analysis was used to uncover emerging themes. Findings: Six main categories emerged: ABI diagnosis accuracy, acute service delivery and hospital care, transition from hospital to homecare services, transition from hospital to community services, participant suggestions to improve service delivery and transition, and views on traditional healing methods during recovery. Discussion: A lack of awareness, education and resources were acknowledged as key challenges to successful transitioning by clients and healthcare providers. Geographical isolation of the communities was highlighted as a barrier to accessibility of services and programmes, but the community was also regarded as an important source of social support. The development of educational and screening tools and needs assessments of remote communities were identified to be strategies that may improve transitions. Conclusions: Findings demonstrate that the structure of rehabilitation and discharge processes for Aboriginal clients living on reserves or in remote communities are of great concern and warrants further research.	[Keightley, Michelle] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Keightley, Michelle; Agnihotri, Sabrina; Colantonio, Angela] Univ Toronto, Dept Psychol, Toronto, ON M5G 1V7, Canada; [Keightley, Michelle; Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON, Canada; [Keightley, Michelle] Bloorview Kids Rehab, Toronto, ON, Canada; [Minore, Bruce; Katt, Mae] Lakehead Univ, Ctr Rural & No Hlth Res, Thunder Bay, ON P7B 5E1, Canada; [Cameron, Anita; White, Randy; Longboat-White, Claudine] Washagamis Bay First Nation, Wassay Gezhig Na Nahn Dah We Igamig, Keewatin, ON, Canada; [Bellavance, Alice] Brain Injury Serv No Ontario, Thunder Bay, ON, Canada		Keightley, M (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Grad Dept Rehabil Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	michelle.keightley@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Ontario Neurotrauma Foundation; Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario	The authors gratefully acknowledge the Ontario Neurotrauma Foundation who provided financial support for the research project. We recognize the support of the University of Toronto, Toronto Rehabilitation Institute Foundation and a grant from the Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute.	Blackmer J, 1999, BRAIN INJURY, V13, P627; Bolch Denise, 2005, Aust J Rural Health, V13, P91, DOI 10.1111/j.1440-1854.2005.00660.x; CLOSSON T, 2005, INTEGRATED SERVICE P; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dean S, 2000, PSYCHOL REP, V86, P653, DOI 10.2466/pr0.2000.86.2.653; Dickson G, 2001, Health Care Women Int, V22, P471, DOI 10.1080/073993301317094290; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; GAGE M, 1996, AM J OCCUPATIONAL TH, V51, P96; Green LW, 1995, STUDY PARTICIPATORY; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Keightley ML, 2009, BRAIN INJURY, V23, P250, DOI 10.1080/02699050902748331; Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655; *N W MENT HLTH IMP, 2002, REG MENT HLTH SYST N; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; *ONT BRAIN INJ ASS, 2010, WHAT IS BRAIN INJ; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; *QSR, 2002, QSR N6 SOFTW VERS 6; Ritchie J., 2003, QUALITATIVE RES PRAC; Ritchie J., 2002, ANAL QUALITATIVE DAT, P305, DOI 10.4135/9781412986274; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shafi S, 2008, ARCH SURG-CHICAGO, V143, P1057, DOI 10.1001/archsurg.143.11.1057; *STAND SEN COMM SO, 2006, OUT SHAD LAST HIGHL; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Swallow V, 2003, J CLIN NURS, V12, P610, DOI 10.1046/j.1365-2702.2003.00728.x; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; TURNER BJ, 2008, DISABILITY REHABILIT, V23, P250; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Young TK, 2003, BMJ-BRIT MED J, V327, P419, DOI 10.1136/bmj.327.7412.419	30	11	12	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2011	25	2					142	152		10.3109/02699052.2010.541898			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JJ	WOS:000288101800002	21219087				2022-02-06	
J	Gonzalez-Mao, MC; Reparaz-Andrade, A; Del Campo-Perez, V; Alvarez-Garcia, E; Vara-Perez, C; Andrade-Olivie, MA				Gonzalez-Mao, M. C.; Reparaz-Andrade, A.; Del Campo-Perez, V.; Alvarez-Garcia, E.; Vara-Perez, C.; Andrade-Olivie, M. A.			Model Predicting Survival/Exitus After Traumatic Brain Injury: Biomarker S100B 24H	CLINICAL LABORATORY			English	Article						Traumatic Brain Injury (TBI); biomarkers; S100B; GOS; GCS; model predicting; positive prediction value (PPV); negative prediction value (NPV)	SEVERE HEAD-INJURY; SERUM S100B; METHODOLOGICAL FEATURES; OUTCOME PREDICTION; S-100B PROTEIN; MARKER; VALIDATION; DIAGNOSIS; AMNESIA; DAMAGE	Background: The enigma of Traumatic Brain Injury (TBI), reflected in recent scientific literature, is its uncertain consequences, variability of the final prognosis with apparently similar TBI, necessity for peripheral biomarkers, and more specific predictive models. Objectives: To study the relationship between serum S100B and survival in TBI patients in various serious situations; the S100B level in patients without traumatic pathology or associated tumour, subjected to stressful situations such as neurological intensive care unit (NICU) stay; the possible overestimation caused by extracerebral liberation in TBI patients and associated polytraumatism; the predictive cutoffs to determine the most sensitive and specific chronology; and achieve a predictive prognostic model. Methods: Patients admitted to the NICU within 6 hours after TBI were selected. We measured: a) clinical: exitus yes/no; age and gender, traumatic mechanism, polytraumatism yes/no, GCS score, unconsciousness duration, amnesia duration, neurological focality, and surgical interventions; b) radiological: CT scan for radiological lesions; c) biochemical: serum SB100B at 6, 24, 48 and 72 hours after TBI and drug abuse detected in the urine; d) COS on hospital discharge. Results: N: 149 TBI patients, independent of polytraumatism, mean serum S100B at 6, 24, 48, and 72 hours: 2.1, 1.3, 1.2, and 0.6 mu g/L, respectively; N: 124 without associated polytraumatism, S100B at 6, 24, 48, and 72 hours: 2.0, 1.4, 1.3, and 0.6 mu g/L; N: 50 control I S100B 24 hours: 0.17 mu g/L (0.04 - 0.56) and 25 healthy subjects S100B 0.057 mu g/L (0.02-0.094). Conclusions: Significantly higher S100B levels are observed on exitus, with excellent TBI prognosis and evolution performance. Hospital stay in the NICU produces significant increases in S100B compared to healthy subjects, without invalidating it as a biomarker. Polytraumatism associated to TBI does not significantly alter S100B levels. S100B at 24 hours >= 0.90 mu g/L appears to predict unfavourable TBI evolution with a NPV: 94.2 % and PPV: 54.9 %. We propose a predictive model when we associate S100B at 24 hours with amnesia duration over 30 minutes with a NPV of 85.5 % and a PPV of 83.3 %. (Clin. Lab. 2011;57:587-597)	[Gonzalez-Mao, M. C.; Reparaz-Andrade, A.; Alvarez-Garcia, E.; Andrade-Olivie, M. A.] Univ Hosp Complex Vigo CHUVI, Dept Clin Chem, Vigo, Spain; [Vara-Perez, C.] Univ Hosp Complex Vigo CHUVI, Intens Care Unit, Vigo, Spain		Gonzalez-Mao, MC (corresponding author), Argazada 25 Samil Vigo, Vigo, Spain.	Maria.carmen.gonzalez.mao@sergas.es	Reparaz-Andrade, Alfredo/AAB-7976-2021; Gonzalez Mao, Maria Carmen/T-5403-2017; Badia, M. Amelia Cibeira/C-4308-2015	Reparaz-Andrade, Alfredo/0000-0001-5682-9457; Gonzalez Mao, Maria Carmen/0000-0003-3890-6118; Badia, M. Amelia Cibeira/0000-0001-6016-5374	Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission; European Regional Development Fund (FEDER)European Commission; Health Research Fund (FIS)Instituto de Salud Carlos III [PI08/90342]	This article has been financed by Instituto de Salud Carlos III, Health Research Fund (FIS) code PI08/90342 and cofinanced by the European Regional Development Fund (FEDER).	Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Boto GR, 2006, NEUROCIRUGIA, V17, P215; Boto GR, 2004, NEUROCIRUGIA, V15, P233; BRAAKMAN R, 1992, ACTA NEUROCHIR, V116, P161, DOI 10.1007/BF01540870; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Enochsson L, 2005, EUR J NEUROL, V12, P445, DOI 10.1111/j.1468-1331.2005.00996.x; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gazzolo D, 2010, CLIN CHEM LAB MED, V48, P1363, DOI 10.1515/CCLM.2010.262; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Hayes RL, 2009, METHODS MOL BIOL, V566, P303, DOI 10.1007/978-1-59745-562-6_20; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hu Dian-lei, 2004, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V16, P221; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Leite MC, 2008, J NEUROSCI METH, V169, P93, DOI 10.1016/j.jneumeth.2007.11.021; MAO MCG, 2009, CLIN CHEM S, V55, pA200; Margis R, 2004, BRAIN RES, V1028, P213, DOI 10.1016/j.brainres.2004.09.013; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martenson ED, 2001, J CLIN ONCOL, V19, P824, DOI 10.1200/JCO.2001.19.3.824; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Netto CBO, 2006, ARCH MED RES, V37, P683, DOI 10.1016/j.arcmed.2005.11.005; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Saenger AK, 2010, CLIN CHEM, V56, P21, DOI 10.1373/clinchem.2009.133801; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Snyder-Ramos SA, 2003, RESTOR NEUROL NEUROS, V21, P123; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC	35	11	12	0	5	CLIN LAB PUBL	HEIDELBERG	IM BREITSPIEL 15, HEIDELBERG, D-69126, GERMANY	1433-6510			CLIN LAB	Clin. Lab.		2011	57	7-8					587	597					11	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	825DL	WOS:000295251000016	21888023				2022-02-06	
J	Jaderstad, J; Jaderstad, LM; Herlenius, E				Jaderstad, Johan; Jaderstad, Linda Maria; Herlenius, Eric			Dynamic changes in connexin expression following engraftment of neural stem cells to striatal tissue	EXPERIMENTAL CELL RESEARCH			English	Article						Neural stem cells; CNS; Engraftment; Gap junctions; Striatum; Interactions; Rescue; Organotypic culture	GAP JUNCTIONAL COMMUNICATION; HUMAN NEURODEGENERATIVE DISORDERS; IMPLANTATION MOUSE EMBRYO; SPINAL-CORD-INJURY; NERVOUS-SYSTEM; DIFFERENTIAL EXPRESSION; ORGANOTYPIC CULTURES; ISCHEMIC BRAIN; THERAPY; NEURONS	Gap-junctional intercellular communication between grafted neural stem cells (NSCs) and host cells seem to be essential for many of the beneficial effects associated with NSC engraftment Utilizing murine NSCs (mNSCs) grafted Into an organotypic ex vivo model system for striatal tissue we examined the prerequisites for formation of gap-junctional couplings between graft and host cells at different time points following implantation We utilized flow cytometry (to quantify the proportion of connexin (Cx) 26 and 43 expressing cells) immunohistochemistry (for localization of the gap-junctional proteins in graft and host cells) dye-transfer studies with and without pharmacological gap-junctional blockers (assaying the functionality of the formed gap-junctional couplings) and proliferation assays (to estimate the role of gap junctions for NSC well-being) to this end Immunohistochemical staining and dye-transfer studies revealed that the NSCs already form functional gap junctions prior to engraftment thereby creating a substrate for subsequent graft and host communication The expression of Cx43 by grafted NSCs was decreased by neurotrophin-3 overexpression in NSCs and culturing of grafted tissue in serum-free Neurobasal B27 medium Cx43 expression in NSC-derived cells also changed significantly following engraftment In host cells the expression of Cx43 peaked following traumatic stimulation and then declined within two weeks suggesting a window of opportunity for successful host cell rescue by NSC engraftment Further investigation of the dynamic changes in gap junction expression in graft and host cells and the associated variations in intercellular communication between implanted and endogenous cells might help to understand and control the early positive and negative effects evident following neural stem cell transplantation and thereby optimize the outcome of future clinical NSC transplantation therapies (C) 2010 Elsevier Inc All rights reserved	[Jaderstad, Johan; Jaderstad, Linda Maria; Herlenius, Eric] Karolinska Inst, Neonatal Res Unit, Dept Womens & Childrens Hlth, Astrid Lindgren Childrens Hosp, S-17176 Stockholm, Sweden		Jaderstad, J (corresponding author), Karolinska Inst, Neonatal Res Unit, Dept Womens & Childrens Hlth, Astrid Lindgren Childrens Hosp, Q2 07, S-17176 Stockholm, Sweden.		Herlenius, Eric/B-7260-2008	Herlenius, Eric/0000-0002-6859-0620; Ringstedt, Thomas/0000-0003-0294-9351	Swedish Research CouncilSwedish Research CouncilEuropean Commission [04-5718, 06-5898, 09-3724]; Stockholm County CouncilStockholm County Council; Karolinska InstitutetKarolinska Institutet; M&M Wallenberg Freemason Children s House Swedish Medical Association; National Heart FoundationNational Heart Foundation of Australia; Lung Foundation	This study is supported by the Swedish Research Council (04-5718 and 06-5898 and 09-3724) the Stockholm County Council and Karolinska Institutet as well as by grants from the M&M Wallenberg Freemason Children s House Swedish Medical Association and National Heart and Lung Foundations We also thank Ruth Detlofsson for skilful technical assistance Hjalmar Brismar and Evan Snyder for advice and Evan Snyder Mark Tuszynski and Paul Lu for the NSC clones	Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Elias LAB, 2008, TRENDS NEUROSCI, V31, P243, DOI 10.1016/j.tins.2008.02.007; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; GAHWILER BH, 1981, JAMA-J AM MED ASSOC, V245, P1858, DOI 10.1001/jama.245.18.1858; Hanstein R, 2009, MOL ENDOCRINOL, V23, P1479, DOI 10.1210/me.2009-0022; HOSSAIN MZ, 1994, GLIA, V10, P250, DOI 10.1002/glia.440100404; Jaderstad J, 2006, EXP NEUROL, V198, P572, DOI 10.1016/j.expneurol.2006.02.050; Jaderstad J, 2003, PEDIATR RES, V54, P594; Jaderstad J, 2010, P NATL ACAD SCI USA, V107, P5184, DOI 10.1073/pnas.0915134107; KALIMI GH, 1988, J CELL BIOL, V107, P241, DOI 10.1083/jcb.107.1.241; Khan Z, 2007, EXP CELL RES, V313, P2958, DOI 10.1016/j.yexcr.2007.05.004; Kim BG, 2007, CELL TRANSPLANT, V16, P355, DOI 10.3727/000000007783464885; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; Leung DSY, 2002, INT J DEV NEUROSCI, V20, P63, DOI 10.1016/S0736-5748(01)00056-9; Li JX, 2006, J NEUROSCI, V26, P7839, DOI 10.1523/JNEUROSCI.1624-06.2006; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; LO CW, 1979, CELL, V18, P411, DOI 10.1016/0092-8674(79)90060-6; LO CW, 1979, CELL, V18, P399, DOI 10.1016/0092-8674(79)90059-X; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Madhavan L, 2005, ANN NY ACAD SCI, V1049, P185, DOI 10.1196/annals.1334.017; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Montoro RJ, 2004, BRAIN RES REV, V47, P216, DOI 10.1016/j.brainresrev.2004.06.009; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Nagy JI, 1996, BRAIN RES, V717, P173, DOI 10.1016/0006-8993(95)01526-4; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Nakase T, 2003, CELL COMMUN ADHES, V10, P413, DOI 10.1080/714040461; Nakase T, 2006, GLIA, V54, P369, DOI 10.1002/glia.20399; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Pitts JD, 1998, BIOESSAYS, V20, P1047, DOI 10.1002/(SICI)1521-1878(199812)20:12<1047::AID-BIES11>3.0.CO;2-0; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Rouach N, 2002, BIOL CELL, V94, P457, DOI 10.1016/S0248-4900(02)00016-3; Rozental R, 2000, BRAIN RES REV, V32, P11, DOI 10.1016/S0165-0173(99)00095-8; Rufer M, 1996, J NEUROSCI RES, V46, P606, DOI 10.1002/(SICI)1097-4547(19961201)46:5<606::AID-JNR9>3.3.CO;2-2; Siushansian R, 2001, J COMP NEUROL, V440, P387, DOI 10.1002/cne.1392; Snyder EY, 2004, J NEUROSCI RES, V76, P157, DOI 10.1002/jnr.20033; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Trosko JE, 2000, METHODS, V20, P245, DOI 10.1006/meth.1999.0941; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; Vis JC, 1998, CELL BIOL INT, V22, P837, DOI 10.1006/cbir.1998.0388; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; Worsdorfer P, 2008, STEM CELLS, V26, P431, DOI 10.1634/stemcells.2007-0482	54	11	11	0	9	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827			EXP CELL RES	Exp. Cell Res.	JAN 1	2011	317	1					70	81		10.1016/j.yexcr.2010.07.011			12	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	691IZ	WOS:000285074800007	20654614				2022-02-06	
J	Lancioni, GE; O'Reilly, MF; Singh, NN; Oliva, D				Lancioni, Giulio E.; O'Reilly, Mark F.; Singh, Nirbhay N.; Oliva, Doretta			Enabling two women with blindness and additional disabilities to make phone calls independently via a computer-aided telephone system	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Blindness; computer-aided telephone; microswitches; motor disabilities	TRAUMATIC BRAIN-INJURY; INTELLECTUAL DISABILITIES; MULTIPLE DISABILITIES; VOCATIONAL-REHABILITATION; PHYSICAL-DISABILITIES; VISUAL IMPAIRMENTS; LEISURE ACTIVITIES; SOCIAL VALIDATION; PEOPLE; INDIVIDUALS	Objective: To assess whether two women with blindness and additional disabilities could make independent phone calls through a computer-aided telephone system. Method: For each participant, the study involved an ABAB design, in which the A represented baseline phases and the B represented intervention phases with the special telephone system (involving among others a net-book computer with specific software, a global system for mobile communication modem and a microswitch). Results: Both participants learned to use the system and made phone calls independently to a variety of partners such as family members, friends and staff personnel. Conclusion: The system assessed in this study might represent a useful means for enabling persons with blindness and additional disabilities to manage phone calls on their own.	[Lancioni, Giulio E.] Univ Bari, Dept Psychol, I-70100 Bari, Italy; [O'Reilly, Mark F.] Univ Texas Austin, Meadows Ctr Preventing Educ Risk, Austin, TX 78712 USA; [Singh, Nirbhay N.] Amer Hlth & Wellness Inst, Verona, VA USA; [Oliva, Doretta] Lega F DOro Res Ctr, Osimo, Italy		Lancioni, GE (corresponding author), Univ Bari, Dept Psychol, Via Quintino Sella 268, I-70100 Bari, Italy.	g.lancioni@psico.uniba.it	Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; Lancioni, Giulio/0000-0002-6515-5690			Bache J, 2008, NEUROREHABILITATION, V23, P343; Baker PMA, 2008, ASSIST TECHNOL, V20, P149, DOI 10.1080/10400435.2008.10131942; Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Callahan K, 2008, J AUTISM DEV DISORD, V38, P678, DOI 10.1007/s10803-007-0434-9; Cavenaugh BS, 2006, J VISUAL IMPAIR BLIN, V100, P425; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Durando J, 2008, J VISUAL IMPAIR BLIN, V102, P40, DOI 10.1177/0145482X0810200105; Fichten CS, 2009, J VISUAL IMPAIR BLIN, V103, P543, DOI 10.1177/0145482X0910300905; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Huo XL, 2008, IEEE T NEUR SYS REH, V16, P497, DOI 10.1109/TNSRE.2008.2003375; Jessup GM, 2010, J VISUAL IMPAIR BLIN, V104, P419, DOI 10.1177/0145482X1010400705; Johnson KL, 2009, DISABIL REHABIL-ASSI, V4, P1, DOI 10.1080/17483100802239648; Kim J, 2010, IEEE ENG MED BIO, P5250, DOI 10.1109/IEMBS.2010.5626294; LANCIONI GE, 2011, CLIN CASE STUDIES, P79, DOI DOI 10.1177/1534650110395380; Lancioni G, 2011, DEV NEUROREHABIL, V14, P8, DOI 10.3109/17518423.2010.519760; Lancioni GE, 2006, J DEV PHYS DISABIL, V18, P383, DOI 10.1007/s10882-006-9024-6; Lim L., 2000, INT J DISABIL DEV ED, V47, P77; Madar T, 2007, ADV MENTAL HLTH INTE, V1, P29; Manley K, 2008, J BEHAV EDUC, V17, P221, DOI 10.1007/s10864-008-9065-2; Mesterman R, 2010, J CHILD NEUROL, V25, P36, DOI 10.1177/0883073809336677; Miltenberger R.G., 2007, BEHAV MODIFICATION P; Bryen DN, 2007, INTELLECT DEV DISAB, V45, P1, DOI 10.1352/1934-9556(2007)45[1:CPUBAW]2.0.CO;2; Nguyen T., 2008, TECHNOL DISABIL, V20, P225; Nguyen T, 2007, ASSIST TECHNOL, V19, P78, DOI 10.1080/10400435.2007.10131867; Patterson I, 2009, LEISURE STUD, V28, P387, DOI 10.1080/02614360903071688; Peterson JJ, 2009, J APPL RES INTELLECT, V22, P487, DOI 10.1111/j.1468-3148.2009.00500.x; Sesto Mary E, 2008, Universal Access in the Information Society, V7, P25, DOI 10.1007/s10209-007-0099-3; Sohlberg MM, 2005, APHASIOLOGY, V19, P651, DOI 10.1080/02687030544000100; Solish A, 2010, J APPL RES INTELLECT, V23, P226, DOI 10.1111/j.1468-3148.2009.00525.x; Stock SE, 2008, J INTELL DISABIL RES, V52, P1155, DOI 10.1111/j.1365-2788.2008.01099.x; Su CY, 2008, J INTELL DISABIL RES, V52, P18, DOI 10.1111/j.1365-2788.2007.00969.x; Sundqvist A, 2010, AUGMENT ALTERN COMM, V26, P255, DOI 10.3109/07434618.2010.528796; Sung YT, 2010, J COMPUT ASSIST LEAR, V26, P106, DOI [10.1111/J.1365-2729.2010.00345.x, 10.1111/j.1365-2729.2010.00345.x]; Tomasik M, 2007, J VISUAL IMPAIR BLIN, V101, P657, DOI 10.1177/0145482X0710101012; Trelease RB, 2008, ANAT SCI EDUC, V1, P233, DOI 10.1002/ase.58; Trief E, 2010, J VISUAL IMPAIR BLIN, V104, P499, DOI 10.1177/0145482X1010400806; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105; Yang CH, 2008, MATH COMPUT MODEL, V47, P318, DOI 10.1016/j.mcm.2007.01.012	38	11	11	1	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1751-8423			DEV NEUROREHABIL	Dev. Neurorehabil.		2011	14	5					283	289		10.3109/17518423.2011.586372			7	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	827XY	WOS:000295464800004	21870952				2022-02-06	
J	Medaglia, JD; Ramanathan, DM; Venkatesan, UM; Hillary, FG				Medaglia, John D.; Ramanathan, Deepa M.; Venkatesan, Umesh M.; Hillary, Frank G.			The challenge of non-ergodicity in network neuroscience	NETWORK-COMPUTATION IN NEURAL SYSTEMS			English	Article						functional neuroimaging; traumatic brain injury; network modeling; neuroscience		Ergodicity can be assumed when the structure of data is consistent across individuals and time. Neural network approaches do not frequently test for ergodicity in data which holds important consequences for data integration and intepretation. To demonstrate this problem, we present several network models in healthy and clinical samples where there exists considerable heterogeneity across individuals. We offer suggestions for the analysis, interpretation, and reporting of neural network data. The goal is to arrive at an understanding of the sources of non-ergodicity and approaches for valid network modeling in neuroscience.	[Medaglia, John D.; Ramanathan, Deepa M.; Venkatesan, Umesh M.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Hillary, Frank G.] Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 223 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Ramanathan-Elion, Deepa/0000-0001-7723-7346			Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Gates KM, 2011, NEUROIMAGE, V54, P1151, DOI 10.1016/j.neuroimage.2010.08.051; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Kim J, 2007, HUM BRAIN MAPP, V28, P85, DOI 10.1002/hbm.20259; Lamiell JT, 1998, THEOR PSYCHOL, V8, P23, DOI 10.1177/0959354398081002; Molenaar PCM., 2004, MEASUREMENT, V2, P201, DOI [10.1207/s15366359mea0204_1, DOI 10.1207/S15366359MEA0204_1]; Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 2001, PSYCHOL AGING, V16, P371, DOI 10.1037//0882-7974.16.3.371; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163	15	11	11	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0954-898X	1361-6536		NETWORK-COMP NEURAL	Netw.-Comput. Neural Syst.		2011	22	1-4					148	153		10.3109/09638237.2011.639604			6	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Engineering; Neurosciences & Neurology	857XF	WOS:000297757300009	22149675				2022-02-06	
J	Wang, HP; Yu, XJ; Xu, GH; Xu, GT; Gao, GS; Xu, XH				Wang, Haipeng; Yu, Xiaojun; Xu, Guohui; Xu, Guangtao; Gao, Guishan; Xu, Xiaohu			Alcoholism and Traumatic Subarachnoid Hemorrhage: An Experimental Study on Vascular Morphology and Biomechanics	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic subarachnoid hemorrhage (TSAH); Vascular biomechanics; Rat model of alcoholism; Strike model; Forensic pathology	PERCUSSION BRAIN-INJURY; RAT AORTA; VERTEBRAL ARTERY; CONSUMPTION; MECHANISMS; COLLAGEN; ELASTIN; TISSUE; DEATH	Background: Traumatic subarachnoid hemorrhage (TSAH) related to alcohol abuse is a notable risk factor. Here, we investigated the vascular morphology and biomechanics of TSAH in rat models of acute alcoholic intoxication and chronic alcoholism rats to explore the possible mechanisms of TSAH. Methods: Sixty male Sprague-Dawley rats were divided into acute alcoholic intoxication and chronic alcoholism groups. Edible spirituous liquor (56% vol/vol) was intragastrically given (15 mL/kg) once to the rats in the acute group, and given twice daily (8 mL/kg for 2 weeks and 12 mL/kg for another 2 weeks) to rats in the chronic group. A self-made instrument was used to inflict head injury. Whole brain, arterial blood, and thoracic aorta of rats were sampled for morphologic and biomechanical examination. Results: Compared with the acute alcoholic rats, the chronic alcoholic rats showed significant morphologic and biomechanical changes: (1) decreased body weight (p < 0.05), (2) higher morbidity and mortality from TSAH (p < 0.01), (3) greater mean thickness of vascular wall of subarachnoid small arteries and each layer thickness of thoracic aorta (p < 0.05), (4) decreased failure load and corresponding extensibility (60 kPa and limit load) of thoracic aorta, and (5) increased elastic modulus (30 kPa, range in physiologic stress) (p < 0.05). Conclusions: Chronic alcoholism can induce the morphologic and biomechanical changes in cerebral vessels and thoracic aorta. The synergistic effect of alcohol abuse and minor blow may be one of the mechanisms of TSAH. High blood pressure from long-term alcohol abuse is also a notable factor.	[Wang, Haipeng; Yu, Xiaojun; Xu, Guohui; Xu, Guangtao; Gao, Guishan; Xu, Xiaohu] Shantou Univ, Coll Med, Dept Forens Med, Shantou City, Guangdong, Peoples R China; [Wang, Haipeng] Beihua Univ, Basic Med Coll, Dept Forens Med, Jilin, Jilin Prov, Peoples R China		Yu, XJ (corresponding author), Shantou Univ, Coll Med, Dept Forens Med, Shantou City, Guangdong, Peoples R China.	cnxjyu@yahoo.com.cn	Xu, Guangtao/L-8929-2017	Xu, Guangtao/0000-0001-5846-9280	National Natural Science Foundation Council of ChinaNational Natural Science Foundation of China (NSFC) [30772458]	Source of support: National Natural Science Foundation Council of China (No. 30772458).	ANDREASSEN TT, 1987, ACTA ENDOCRINOL-COP, V115, P338, DOI 10.1530/acta.0.1150338; Assoul N, 2008, J BIOMECH, V41, P2227, DOI 10.1016/j.jbiomech.2008.04.017; Baglietto L, 2006, ALCOHOL ALCOHOLISM, V41, P664, DOI 10.1093/alcalc/agl087; BARBOUR RL, 1993, ALCOHOL CLIN EXP RES, V17, P1319, DOI 10.1111/j.1530-0277.1993.tb05248.x; BRUEL A, 1991, ACTA ENDOCRINOL-COP, V125, P49, DOI 10.1530/acta.0.1250049; Cerqueira Nereide Freire, 2005, Acta Cir. Bras., V20, P213, DOI 10.1590/S0102-86502005000300004; CHAN TCK, 1985, HYPERTENSION, V7, P519, DOI 10.1161/01.HYP.7.4.519; Daula M, 2006, AM J FOREN MED PATH, V27, P355, DOI 10.1097/01.paf.0000233554.79665.0c; DECK JHN, 1986, ARCH PATHOL LAB MED, V110, P489; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; FACTOR M, 1976, AM HEART J, V92, P561; FARAG AM, 1988, FORENSIC SCI INT, V38, P275, DOI 10.1016/0379-0738(88)90173-9; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gdovinova Z, 2001, ALCOHOL ALCOHOLISM, V36, P346, DOI 10.1093/alcalc/36.4.346; Gray JT, 1999, FORENSIC SCI INT, V105, P13, DOI 10.1016/S0379-0738(99)00113-9; HARLAND WA, 1983, J CLIN PATHOL, V36, P1335, DOI 10.1136/jcp.36.12.1335; Hillbom M, 1998, NOVART FDN SYMP, V216, P193; JOHN JH, 2004, BIOCHEM BIOPH RES CO, V323, P361; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V370, P44, DOI 10.1016/j.bbrc.2008.03.005; Liu Z. R., 1996, NEW ADV BIOMECHANICS, P188; Mayhan WG, 1996, ALCOHOL CLIN EXP RES, V20, P538, DOI 10.1111/j.1530-0277.1996.tb01089.x; Mizutani K, 1999, J HYPERTENS, V17, P481, DOI 10.1097/00004872-199917040-00005; OXLUND H, 1980, ACTA ENDOCRINOL-COP, V94, P132, DOI 10.1530/acta.0.0940132; Partridge CR, 1999, LIFE SCI, V65, P1395, DOI 10.1016/S0024-3205(99)00381-1; PLANT JR, 1993, AM J FOREN MED PATH, V14, P61, DOI 10.1097/00000433-199303000-00015; Sampei K, 1996, NEURORADIOLOGY, V38, P291; SANTI FP, 1993, STUDY THORACIC AORTA; Sarphie TG, 1996, ALCOHOL CLIN EXP RES, V20, P973, DOI 10.1111/j.1530-0277.1996.tb01933.x; SIMONSEN J, 1963, J Forensic Sci, V8, P97; SIMONSEN J, 1984, FORENSIC SCI INT, V24, P57, DOI 10.1016/0379-0738(84)90152-X; Simonsen J, 1967, J Forensic Med, V14, P146; SOHAL RS, 1969, CARDIOVASC RES, V3, P369, DOI 10.1093/cvr/3.3.369; Vorp DA, 2003, ANN THORAC SURG, V75, P1210, DOI 10.1016/S0003-4975(02)04711-2; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; WILSON JS, 1982, ALCOHOL CLIN EXP RES, V6, P117, DOI 10.1111/j.1530-0277.1982.tb05389.x	35	11	14	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2011	70	1					E6	E12		10.1097/TA.0b013e3181cda3b9			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	707WD	WOS:000286320300002	21217473				2022-02-06	
J	Zhou, H; Chen, Q; Kong, DL; Guo, JA; Wang, QA; Yu, SY				Zhou, Hao; Chen, Qing; Kong, Dan Li; Guo, Jiang; Wang, Qian; Yu, Shou Yi			Effect of Resveratrol on Gliotransmitter Levels and p38 Activities in Cultured Astrocytes	NEUROCHEMICAL RESEARCH			English	Article						Resveratrol; Amino acid; p38 MAPK; Astrocyte; Stretch injury	D-SERINE; GLUTAMATE TRANSPORTERS; NMDA RECEPTORS; GLIAL-CELLS; BRAIN; RELEASE; NEURONS; NEUROTOXICITY; ACTIVATION; GLYCINE	Accumulating evidence suggests that resveratrol may have beneficial effects against traumatic brain injury. However, its effect on the regulation of extracellular levels of gliotransmitter and on the activation of p38 MAPK in astrocytes is still unknown. We have examined whether resveratrol regulates extracellular levels of gliotransmitter as well as the activation of p38 MAPK in cultured astrocytes before and after stretch injury. The extracellular levels of glutamate, D-/L-serine and D-serine were apparently reduced by 100 mu M resveratrol in control astrocyte cultures. The dramatic increase of glutamate and D-serine release induced by stretch injury was also clearly inhibited by resveratrol. Resveratrol mediates this response by reduction of release through inhibition of extracellular calcium influx and increment of gliotransmitter uptake through enhancement of amino acid transporter expressed in the membrane of astrocyte. In addition, resveratrol definitely reduced the activation of p38 MAPK in cultured astrocytes following stretch injury. AMPA receptor is involved in the activation of p38 following injury. Conversely, the levels of glutamine and glycine were not obviously affected by resveratrol before and after injury. Intracellular levels of glutamate and D-serine are not apparently changed by stretch injury. Collectively, our data suggest that resveratrol might play an important role in protection of the nervous system after injury by decreasing the extracellular levels of gliotransmitter and inhibiting activation of p38 MAPK following injury.	[Chen, Qing; Kong, Dan Li; Guo, Jiang; Yu, Shou Yi] So Med Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Hao; Wang, Qian] So Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China		Yu, SY (corresponding author), So Med Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.	zw7980@fimmu.com			Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University	We would like to thank Zhiye Zhuang for manuscript review and technical support in cell cultures. This work was supported by Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University.	Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Ban JY, 2008, J PHARMACOL SCI, V106, P68, DOI 10.1254/jphs.FP0071206; Brown DR, 1999, MOL CELL NEUROSCI, V13, P379, DOI 10.1006/mcne.1999.0751; CHAPARRO HV, 2008, INT J DEV NEUROSCI, V26, P487; Chen CJ, 2000, J NEUROCHEM, V75, P1557, DOI 10.1046/j.1471-4159.2000.0751557.x; Eaton MJ, 2007, J PAIN, V8, P33, DOI 10.1016/j.jpain.2006.05.013; FABRICIO MB, 2007, PHYTOCHEMISTRY, V68, P1992; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Jakab M, 2008, CELL PHYSIOL BIOCHEM, V22, P567, DOI 10.1159/000185541; JIONG C, 2004, J BIOL CHEM, V279, P35903; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; MARCO V, 2000, NEUROSCI LETT, V281, P123; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; Mokni M, 2007, NEUROCHEM RES, V32, P981, DOI 10.1007/s11064-006-9255-z; Montal M, 1998, BBA-BIOENERGETICS, V1366, P113, DOI 10.1016/S0005-2728(98)00124-8; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; OLIET SH, 2008, NEUROSCIENCE, V19; Ou HC, 2006, CLIN CHIM ACTA, V364, P196, DOI 10.1016/j.cccn.2005.06.018; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Verleysdonk S, 1999, GLIA, V27, P239, DOI 10.1002/(SICI)1098-1136(199909)27:3<239::AID-GLIA5>3.0.CO;2-K; de Almeida LMV, 2007, CELL MOL NEUROBIOL, V27, P661, DOI 10.1007/s10571-007-9152-2; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	32	11	13	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JAN	2011	36	1					17	26		10.1007/s11064-010-0254-8			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	711KA	WOS:000286589000003	20842424				2022-02-06	
J	de Liano, BGG; Umilta, C; Stablum, F; Tebaldi, F; Cantagallo, A				Gil-Gomez de Liano, Beatriz; Umilta, Carlo; Stablum, Franca; Tebaldi, Francesca; Cantagallo, Anna			Attentional distractor interference may be diminished by concurrent working memory load in normal participants and traumatic brain injury patients	BRAIN AND COGNITION			English	Article						Selective attention; Working memory load; Distractor processing; Traumatic brain injury patients	CLOSED-HEAD INJURY; SELECTIVE ATTENTION; VISUAL-SEARCH; COGNITIVE CONTROL; TASK; DEFICITS; REHABILITATION; INHIBITION; PARADIGM	A reduction in congruency effects under working memory (WM) load has been previously described using different attentional paradigms (e.g., Kim, Kim, & Chun, 2005; Smilek, Enns, Eastwood, & Merikle, 2006). One hypothesis is that different types of WM load have different effects on attentional selection, depending on whether a specific memory load demands resources in common with target or distractor processing. In particular, if information in WM is related to the distractors in the selective attention task, there is a reduction in distraction (Kim et al., 2005). However, although previous results seem to point to a decrease in interference under high WM load conditions (Kim et al., 2005), the lack of a neutral baseline for the congruency effects makes it difficult to differentiate between a decrease in interference or in facilitation. In the present work we included neutral trials in the task introduced by Kim et al. (2005) and tested normal participants and traumatic brain injury patients. Results support a reduction in the processing of distractors under WM load, at least for incongruent trials in both groups. Theoretical as well as applied implications are discussed. (C) 2010 Elsevier Inc. All rights reserved.	[Gil-Gomez de Liano, Beatriz] Autonomous Univ Madrid, Fac Psicol, Dept Social Psychol & Methodol, E-28049 Madrid, Spain; [Umilta, Carlo; Stablum, Franca] Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy; [Tebaldi, Francesca; Cantagallo, Anna] Hosp Ferrara, Dept Neurosci Rehabil, Ferrara, Italy; [Tebaldi, Francesca; Cantagallo, Anna] Univ Ferrara, I-44100 Ferrara, Italy		de Liano, BGG (corresponding author), Autonomous Univ Madrid, Fac Psicol, Dept Social Psychol & Methodol, C Ivan Pavlov,6 Carretera Colmenar,Km 15,Campus C, E-28049 Madrid, Spain.	bgil.gomezdelianno@uam.es	de Liano, Beatriz Gil-Gomez/L-1715-2014	de Liano, Beatriz Gil-Gomez/0000-0002-7823-4486; Stablum, Franca/0000-0003-0123-5090			Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Burgess P., 1997, METHODOLOGY FRONTAL, P81; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Dell'Acqua R, 2003, EXP BRAIN RES, V152, P29, DOI 10.1007/s00221-003-1512-7; de Liano BGG, 2011, PSICOLOGICA, V32, P13; de Liano BGG, 2010, PSICOTHEMA, V22, P725; Hester R, 2005, MEM COGNITION, V33, P221, DOI 10.3758/BF03195311; HOLZMAN PS, 1994, ARCH GEN PSYCHIAT, V51, P952; JENNETT B, 1975, LANCET, V1, P480; KIM MS, 2006, J VISION, V6, pA125; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Park S, 2007, J EXP PSYCHOL HUMAN, V33, P1062, DOI 10.1037/0096-1523.33.5.1062; Perlstein WM, 1998, NEUROPSYCHOLOGY, V12, P414, DOI 10.1037/0894-4105.12.3.414; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PERSLTEIN WM, 2006, NEUROPSYCHOLOGIA, V44, P260; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD JL, 2000, NEUROPSYCHOLOGICAL A, P355; Posner M I, 1989, J Cogn Neurosci, V1, P50, DOI 10.1162/jocn.1989.1.1.50; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1982, PHILOS T ROY SOC B, V298, P187, DOI 10.1098/rstb.1982.0081; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI., 1994, IMAGES MIND; RABBITT PM, 1997, METHODOLOGY FRONTAL, P81; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Rissman J, 2009, NEUROPSYCHOLOGIA, V47, P1637, DOI 10.1016/j.neuropsychologia.2009.01.036; Sandson J, 1988, COGNITIVE APPROACHES; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Smilek D, 2006, VIS COGN, V14, P543, DOI 10.1080/13506280500193487; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; Stablum F, 2007, NEUROPSYCHOL REHABIL, V17, P1, DOI 10.1080/13506280500411111; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE JD, 1993, EUR J COGN PSYCHOL, V5, P417, DOI 10.1080/09541449308520128; Townsend J.T., 1983, STOCHASTIC MODELLING; Umilta C, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P37; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339	48	11	11	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	DEC	2010	74	3					298	305		10.1016/j.bandc.2010.08.009			8	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	679SY	WOS:000284182300015	20846773				2022-02-06	
J	Lewiecki, EM				Lewiecki, E. Michael			Clinical use of denosumab for the treatment for postmenopausal osteoporosis	CURRENT MEDICAL RESEARCH AND OPINION			English	Article						Denosumab; FREEDOM; Osteoporosis; Postmenopausal; Safety; Treatment	BONE-MINERAL DENSITY; VERTEBRAL FRACTURE RISK; RANDOMIZED-TRIAL; NONVERTEBRAL FRACTURES; STRONTIUM RANELATE; ZOLEDRONIC ACID; WOMEN; ALENDRONATE; RISEDRONATE; PREVENTION	Denosumab is a fully human monoclonal antibody with high affinity and specificity for human receptor activator of nuclear factor kappa B ligand (RANKL), the principal regulator of osteoclastic bone resorption. By binding to RANKL, denosumab prevents it from binding to its receptor on the cell surface of pre-osteoclasts and mature osteoclasts, thereby reducing the formation, activity, and survival of osteoclasts and inhibiting osteoclastic bone resorption. In a large, randomized, placebo-controlled clinical trial in postmenopausal women with osteoporosis, denosumab 60 mg administered subcutaneously every 6 months reduced levels of bone turnover markers, increased bone mineral density, and reduced the risk of vertebral fractures, hip fractures, and non-vertebral fractures. There was no significant difference between denosumab and placebo in the overall risk of adverse events or serious adverse events. Denosumab was associated with a significant increase in the risk of eczema and cellulitis, and a significant decrease in the risk of falling and concussions. Denosumab recently received regulatory approval for the treatment of postmenopausal women with osteoporosis at high risk for fracture, with no dose adjustment in patients with renal impairment. Denosumab is a new therapeutic option to reduce fracture risk in women with postmenopausal osteoporosis, especially for those with impaired renal function or with intolerance or poor response to oral therapy.	New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM 87106 USA		Lewiecki, EM (corresponding author), New Mexico Clin Res & Osteoporosis Ctr, 300 Oak St NE, Albuquerque, NM 87106 USA.	LEWIECKI@aol.com	Lewiecki, E. Michael/B-3706-2018	Lewiecki, E. Michael/0000-0003-2026-9587	AmgenAmgen; MerckMerck & Company; Eli LillyEli Lilly; NovartisNovartis; Warner Chilcott; GenentechRoche HoldingGenentech	E.M.L. has disclosed that he has received grant/research support from Amgen, Merck, Eli Lilly, Novartis, Warner Chilcott, and Genentech. He has served as a consultant, advisory board member, speakers' bureau participant, or given presentations at sponsored speaking events for Amgen, Eli Lilly, Novartis, and Genentech.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/jbmr.080901, 10.1359/JBMR.0809010]; Caro JJ, 2004, OSTEOPOROSIS INT, V15, P1003, DOI 10.1007/s00198-004-1652-z; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Chesnut CH, 2000, AM J MED, V109, P267, DOI 10.1016/S0002-9343(00)00490-3; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; FERRARILACRAZ S, 2010, OSTEOPOROS INT; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Hiligsmann M, 2010, BONE, V47, P34, DOI 10.1016/j.bone.2010.03.009; Kendler DL, 2010, J BONE MINER RES, V25, P72, DOI 10.1359/jbmr.090716; KENDLER DL, 2010, OSTEOPOROS INT; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lindsay R, 1997, OSTEOPOROSIS INT, V7, P1; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; McCombs JS, 2004, MATURITAS, V48, P271, DOI 10.1016/j.maturitas.2004.02.005; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Prolia, 2010, PROL PACK INS, P2010; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Reid IR, 2010, J BONE MINER RES, V25, P2256, DOI 10.1002/jbmr.149; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Silverman SL, 2008, J BONE MINER RES, V23, P1923, DOI 10.1359/JBMR.080710; Stolina M, 2005, ARTHRITIS RHEUM-US, V52, pS708; Stolina M, 2007, J IMMUNOL, V179, P7497, DOI 10.4049/jimmunol.179.11.7497; U.S. Department of Health and Human Services, 2004, BON HLTH OST REP SUR; van Staa T, 1997, AM J MED, V103, P462, DOI 10.1016/S0002-9343(97)00242-8; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Yood RA, 2003, OSTEOPOROSIS INT, V14, P965, DOI 10.1007/s00198-003-1502-4	43	11	12	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0300-7995	1473-4877		CURR MED RES OPIN	Curr. Med. Res. Opin.	DEC	2010	26	12					2807	2812		10.1185/03007995.2010.533651			6	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	680GI	WOS:000284220000012	21050058				2022-02-06	
J	Ponsford, J; Olver, J; Ponsford, M; Schonberger, M				Ponsford, Jennie; Olver, John; Ponsford, Michael; Schoenberger, Michael			Two-Year Outcome Following Traumatic Brain Injury and Rehabilitation: A Comparison of Patients From Metropolitan Melbourne and Those Residing in Regional Victoria	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; outcomes; rural health	SICKNESS IMPACT PROFILE; STRUCTURED INTERVIEWS; HEAD-INJURY; DISORDERS; DEPRESSION; EXPERIENCE; DIZZINESS; VALIDITY; ANXIETY; PEOPLE	Background and Objective: Victoria's trauma management system provides acute care and rehabilitation following traumatic brain injury (TBI), with care of more complex injuries generally provided in specialist centres in metropolitan Melbourne. Little is known about how the outcomes of TBI survivors living in metropolitan Melbourne compare to those who reside in regional Victoria once they return to their community, where support services may be less available. The aim of the present study was to compare, in TBI individuals who have been treated at an inner-city rehabilitation centre in Melbourne, the long-term outcomes of those who live in metropolitan Melbourne (termed 'Metro') with those who reside in regional Victoria, termed 'Regional: Design and participants: Comparative study with quantitative outcome measures. A total of 959 patients, of whom 645 were designated 'metro' and 314 'regional', were followed-up routinely at 2 years post-injury. Outcome measures: Structured Outcome Questionnaire, Glasgow Outcome Scale - Extended, Sickness Impact Profile, Craig Handicap Assessment and Reporting Technique, Hospital Anxiety and Depression Scale, Alcohol Use Disorders Identification Test and Drug Abuse Screening Test. Results: Few differences in outcomes were found between groups. However, after controlling for group differences in age and injury severity, some non-significant trends were suggestive of better outcomes in terms of less social isolation and anxiety and fewer dysexecutive behaviours in regional dwellers. Conclusions: These findings suggest that outcomes in patients from regional areas are at least as good as those from metropolitan Melbourne.	[Ponsford, Jennie; Schoenberger, Michael] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Ponsford, Jennie; Schoenberger, Michael] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton Campus Bldg 17,Wellington Rd, Clayton, Vic 3800, Australia.	Jennie.Ponsford@monash.edu		Olver, John/0000-0001-7069-1191	Victorian Neurotrauma Initiative; Transport Accident Commission	This study was supported by the Victorian Neurotrauma Initiative and the Transport Accident Commission.	BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; Brown AW, 2005, J NEUROTRAUM, V22, P1503; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; Gontkovsky ST, 2006, BRAIN INJURY, V20, P701, DOI 10.1080/02699050600744103; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Parsons L, 2008, AUST OCCUP THER J, V55, P231, DOI 10.1111/j.1440-1630.2008.00753.x; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHONBERGER M, PSYCHIAT RE IN PRESS; Schootman M, 1999, BRAIN INJURY, V13, P995; Snaith R., 1983, HOSP ANXIETY DEPRESS; Staab JP, 2007, ARCH OTOLARYNGOL, V133, P170, DOI 10.1001/archotol.133.2.170; Staab JP, 2003, LARYNGOSCOPE, V113, P1714, DOI 10.1097/00005537-200310000-00010; TEMKIN N, 1988, J CLIN EPIDEMIOL, V41, P47, DOI 10.1016/0895-4356(88)90008-X; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	31	11	11	1	7	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2010	11	3					253	261		10.1375/brim.11.3.253			9	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	710VJ	WOS:000286544800001					2022-02-06	
J	Travis, R; Sturmey, P				Travis, Robert; Sturmey, Peter			FUNCTIONAL ANALYSIS AND TREATMENT OF THE DELUSIONAL STATEMENTS OF A MAN WITH MULTIPLE DISABILITIES A FOUR-YEAR FOLLOW-UP	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						delusional statements; differential reinforcement of alternative behavior extinction; functional analysis; long-term follow up; traumatic brain injury	SPEECH	Although delusional statements in people with intellectual disabilities and traumatic brain injury can be treated using behavioral interventions none have demonstrated long-term treatment effects In the current study, a functional analysis demonstrated that delusional statements were maintained by attention Differential reinforcement of alternative behavior and extinction of delusional statements resulted in near elimination of delusional statements and an increase in nondelusional statements Follow-up at 6 months 1 2 and 4 years indicated that treatment gains were maintained with continued staff training	CUNY, Queens Coll, New York, NY 10021 USA; CUNY, Grad Ctr, New York, NY 10021 USA		Travis, R (corresponding author), LITU, Tacon Dev Disabil Serv Off, 26 Ctr Circle, Wassaic, NY 12592 USA.		Sturmey, Peter/AAV-3949-2021				Carr JE, 1999, BEHAV INTERVENT, V14, P37, DOI 10.1002/(SICI)1099-078X(199901/03)14:1<37::AID-BIN28>3.0.CO;2-Z; DeLeon IG, 2003, J APPL BEHAV ANAL, V36, P101, DOI 10.1901/jaba.2003.36-101; Dixon MR, 2001, J APPL BEHAV ANAL, V34, P361, DOI 10.1901/jaba.2001.34-361; DURAND VM, 1987, J AUTISM DEV DISORD, V17, P17, DOI 10.1007/BF01487257; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; Rehfeldt RA, 2003, J APPL BEHAV ANAL, V36, P259, DOI 10.1901/jaba.2003.36-259; Travis R, 2008, J MENT HEALTH RES IN, V1, P19, DOI 10.1080/19315860701686963; Wilder D A, 2007, FUNCTIONAL ANAL CLIN, P283, DOI [10.1016/B978-012372544-8/50016-1, DOI 10.1016/B978-012372544-8/50016-1]	8	11	11	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8855	1938-3703		J APPL BEHAV ANAL	J. Appl. Behav. Anal.	WIN	2010	43	4					745	749		10.1901/jaba.2010.43-745			5	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	696JJ	WOS:000285437400019	21541160	Green Published, Bronze			2022-02-06	
J	Morrow, SE; Pearson, M				Morrow, Stephen E.; Pearson, Matthew			Management Strategies for Severe Closed Head Injuries in Children	SEMINARS IN PEDIATRIC SURGERY			English	Article						Severe brain injury; Pediatric; Head trauma; Intracranial pressure; Hypertonic saline; Decompressive craniectomy; Hypothermia	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL HYPERTENSION; THERAPEUTIC HYPOTHERMIA; COMPUTED-TOMOGRAPHY; CONTROLLED-TRIAL; MODERATE; CRANIOPLASTY; OXYGENATION	Brain injuries represent the most common cause of mortality and long-term morbidity from trauma in children. The management of closed head injuries focuses on prevention of secondary injury by optimizing the delivery of oxygen and nutrients to the injured brain while minimizing neuronal metabolic demand. Despite the known differences between the immature and mature brain, treatments used in head-injured children are mainly extrapolated from those employed in adults due to the paucity of class one and two studies focused on the pediatric age group. Therapies intended to minimize secondary brain injury, such as cerebrospinal fluid drainage, hypertonic saline infusion, barbiturate coma induction, brain cooling, and decompressive craniectomy, vary widely in their clinical application among practitioners and trauma centers and have unclear indications, benefits, and long-term consequences. Prospective studies on brain injury management in children are needed to develop treatment strategies that optimize outcomes. (C) 2010 Elsevier Inc. All rights reserved.	[Morrow, Stephen E.] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp, Dept Pediat Surg, Nashville, TN USA; [Pearson, Matthew] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp, Dept Neurosurg, Nashville, TN USA		Morrow, SE (corresponding author), 2200 Childrens Way,Suite 7100, Nashville, TN 37232 USA.	stephen.morrow@vanderbilt.edu	Pearson, Matthew/AAR-7763-2020				Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Becker S, 1999, EUR J PEDIATR, V158, pS197, DOI 10.1007/PL00014355; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Carney NA, 2003, PEDIATR CRIT CARE ME, V4, P1; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; EISENBERG HM, 1980, NEUROSURGERY, V7, P598; FANCONI S, 1988, INTENS CARE MED, V14, P163; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; GERIACH R, 2009, PEDIATR EMERG CARE, V25, P164; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; GRANDE PO, 2004, YB INTENSIVE CARE EM, P215; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Ikonomidou C, 2001, BIOCHEM PHARMACOL, V62, P401, DOI 10.1016/S0006-2952(01)00696-7; Inamasu J, 2010, J TRAUMA, V68, P183, DOI 10.1097/TA.0b013e3181c45384; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Madikians A, 2009, CURR TREAT OPTION NE, V11, P393, DOI 10.1007/s11940-009-0044-2; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; NODBY HK, 1984, NEUROCHIRURGIA, V72, P157; Philip S, 2009, CRIT CARE MED, V37, P2973, DOI 10.1097/CCM.0b013e3181a963f6; PLATT JH, 1984, NEUROSURGERY, V15, P427; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	43	11	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1055-8586	1532-9453		SEMIN PEDIATR SURG	Semin. Pediatr. Surg.	NOV	2010	19	4					279	285		10.1053/j.sempedsurg.2010.07.001			7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	665IL	WOS:000283028500007	20889084				2022-02-06	
J	Portaccio, E; Goretti, B; Zipoli, V; Hakiki, B; Giannini, M; Pasto, L; Razzolini, L; Amato, MP				Portaccio, Emilio; Goretti, Benedetta; Zipoli, Valentina; Hakiki, Bahia; Giannini, Marta; Pasto, Luisa; Razzolini, Lorenzo; Amato, Maria Pia			Cognitive rehabilitation in children and adolescents with multiple sclerosis	NEUROLOGICAL SCIENCES			English	Article						Multiple sclerosis; Cognitive impairment; Cognitive rehabilitation	TRAUMATIC BRAIN-INJURY; REMEDIATION; CHILDHOOD; PROGRAM; MEMORY; TRIAL	Cognitive impairment can be detected in a sizeable proportion of pediatric multiple sclerosis (MS) patients. It involves memory, complex attention, information processing speed, executive functions, linguistic abilities, and intelligent quotient. It has a great impact on school, everyday and social activities, and significantly progresses overtime in the great majority of the subjects. These findings highlight the importance of a comprehensive and systematic assessment of MS-related cognitive difficulties in pediatric cases. Moreover, despite the acknowledged relevance of cognitive impairment in this age range, specific interventions for pediatric MS are lacking. As for rehabilitative strategies, there is some evidence of efficacy in other diseases, in particular brain trauma, tumor, and stroke. The development of effective rehabilitative strategies tailored to the needs of young MS patients is a priority for future research in the field.	[Portaccio, Emilio; Goretti, Benedetta; Zipoli, Valentina; Hakiki, Bahia; Giannini, Marta; Pasto, Luisa; Razzolini, Lorenzo; Amato, Maria Pia] Univ Florence, Dept Neurol, I-50134 Florence, Italy		Portaccio, E (corresponding author), Univ Florence, Dept Neurol, Viale Morgagni 85, I-50134 Florence, Italy.	portilio@tin.it	Amato, Maria Pia/AAC-5940-2022; amato, Maria Pia/AAL-5998-2020; Hakiki, Bahia/AAB-8461-2022	amato, Maria Pia/0000-0003-3325-3760; Hakiki, Bahia/0000-0001-8540-7405; Portaccio, Emilio/0000-0002-9662-1762			Amato MP, 2008, NEUROLOGY, V70, P1891, DOI 10.1212/01.wnl.0000312276.23177.fa; Amato Maria Pia, 2008, Expert Rev Neurother, V8, P1585, DOI 10.1586/14737175.8.10.1585; AMATO MP, 2010, NEUROLOGY IN PRESS; Baddeley A.D., 1986, WORKING MEMORY; Banwell B, 2007, LANCET NEUROL, V6, P887, DOI 10.1016/S1474-4422(07)70242-9; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Franzen KM, 1996, CHILD NEUROPSYCHOL, V2, P176, DOI 10.1080/09297049608402250; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Portaccio E, 2009, MULT SCLER J, V15, P620, DOI 10.1177/1352458508101950; RAOSM, 1986, J CLIN EXP NEUROPSYC, V8, P503; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Yerys BE, 2003, J PEDIAT HEMATOL ONC, V25, P495, DOI 10.1097/00043426-200306000-00014	18	11	12	0	9	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	NOV	2010	31			2			275	278		10.1007/s10072-010-0377-3			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	687LA	WOS:000284778800015	20635109				2022-02-06	
J	Ma, CY; Xue, YJ; Li, M; Zhang, Y; Li, GZ				Ma Chi-yuan; Xue Ya-jun; Li Ming; Zhang Yang; Li Guang-zhao			Sodium valproate for prevention of early posttraumatic seizures	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Valproic acid; Seizures; Brain injuries		Objective: To assess the preventive effect of sodium valproate on early posttraumatic seizures in traumatic brain injury (TBI) patients. Methods: The retrospective study was based on 159 patients with TBI treated at Department of Neurosurgery, Nanjing General Hospital of Nanjing Command enrolled between January 1, 2008 and December 31, 2009. The in-hospital section of the retrospectively collected database includes information on age, sex, initial Glasgow Coma Score (GCS), results of CT scanning, operation, usage of sodium valproate, seizures in the first week after injury and outcome. Results: Seven patients (4.4%) showed early posttraumatic seizures. Although the incidence was zero in patients who received sodium valproate treatment, the difference between the treatment and control groups was not statistically significant. Of the 87 severe TBI patients (GCS 3-8), 6 patients in the control group (6.9%) suffered from early seizures during the first week after TBI and no patient who received preventive therapy suffered from seizures. The difference between the treatment and the control groups was still not statistically significant. Of the 72 mild and moderate TBI patients (GCS 9-15), only 1 patient in the control group suffered from seizures and no patient in the treatment group suffered. Conclusions: Although the results suggest that the study is not sufficiently powerful to detect a clinically important difference in the seizure rates between the treatment and control groups, sodium valproate is effective in decreasing the risk of early posttraumatic seizures in severe TBI patients. Further prospective studies are recommended.	[Ma Chi-yuan; Xue Ya-jun; Zhang Yang; Li Guang-zhao] Nanjing Gen Hosp Nanjing Command, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Li Ming] Maanshan Peoples Hosp, Dept Neurosurg, Maanshan 246000, Jiangsu, Peoples R China		Ma, CY (corresponding author), Nanjing Gen Hosp Nanjing Command, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.	machiyuan@msn.com					Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Agrawal Amit, 2008, J Pak Med Assoc, V58, P471; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Barry Elizabeth, 1997, Epilepsia, V38, P49; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; De Santis A, 1979, J Neurosurg Sci, V23, P207; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jawahar G, 1985, J Indian Med Assoc, V83, P199; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; YOUNG B, 1975, Surgical Neurology, V4, P339	17	11	13	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2010	13	5					293	296		10.3760/cma.j.issn.1008-1275.2010.05.008			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1AS	WOS:000441916900008	20880456				2022-02-06	
J	Bhullar, IS; Roberts, EE; Brown, L; Lipe, H				Bhullar, Indermeet S.; Roberts, Eric E.; Brown, Lianne; Lipe, Heidi			The Effect of Age on Blunt Traumatic Brain-Injured Patients	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting and Postgraduate Course Program of the Southeastern-Surgical-Congress	FEB 20-23, 2010	Savannah, GA				ELDERLY-PATIENTS; MORTALITY; WORSE	An increasing number of super geriatric (age older than 80 years) patients are being hospitalized with traumatic brain injury (TBI). Although geriatric (age older than 65 years) patients have been reported to have a worse functional outcome compared with younger patients who present with the same or less severe degree of TBI; the mortality for the super geriatric (age older than 80 years) remains to be determined. Knowledge of their hospital mortality may help improve clinical decision-making protocols and resource use. A retrospective chart review of patients who sustained TBI after blunt trauma was performed over a 3-year period (June 2005 to June 2008) at a Level II trauma center. Mortality was calculated for various age groupings and data analyzed using analysis of variance test and chi(2) test. We hypothesized that mortality would increase significantly with increasing age from the geriatric to the super geriatric group. A total of 2369 patients were evaluated with 744 pediatric patients in Group I (age younger than 17 years), 1297 adult patients in Group II (age 17-64 years), 185 geriatric patients in Group III (age 65-80 years), and 143 super geriatric patients in Group IV (age older than 80 years). The respective mortalities for each group were as follows: Group I (6%), Group 11 (9%), Group III (21%), and Group IV (6%). There was no significant difference in the Injury Severity Score for the four groups. In comparing Group III with Groups I and II, we found a significant increase in mortality with increasing age as reported in the literature (21 vs 6%, P = 0.01 and 21 vs 9%, P = 0.04). However, in comparing Group IV with the other three groups, there was no significant difference in mortality. There was a trend toward decrease in mortality from age Group III to IV (21 vs 6%, P = 0.09), which is of unclear etiology and warrants further study. In patients with blunt TBI, there is no significant difference in mortality between the super geriatric age group (age older than 80 years) and the younger pediatric, adult, and geriatric age groups. Resource use therefore should not be limited to patients older than 80 years with TBI.	[Bhullar, Indermeet S.] Univ Florida, Shands Hosp, Div Acute Care Surg, Dept Surg, Jacksonville, FL 32209 USA; [Roberts, Eric E.] Lake Erie Coll Osteopath Med, Erie, PA USA; [Brown, Lianne; Lipe, Heidi] Sacred Heart Hosp, Dept Acute Care Surg, Pensacola, FL USA		Bhullar, IS (corresponding author), Univ Florida, Shands Hosp, Div Acute Care Surg, Dept Surg, 655 W 8 St, Jacksonville, FL 32209 USA.	Indermeet.Bhullar@jax.ufl.edu					AMACHER AL, 1987, NEUROSURGERY, V20, P954; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; KRAUS JF, 1993, HEAD INJURY; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; *US BUR CENS, 2000, CENS 2000; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	9	11	11	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	SEP	2010	76	9					966	968					3	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	643LD	WOS:000281297000010	20836344				2022-02-06	
J	Gobbel, GT; Kondziolka, D; Fellows-Mayle, W; Uram, M				Gobbel, Glenn T.; Kondziolka, Douglas; Fellows-Mayle, Wendy; Uram, Martin			Cellular transplantation for the nervous system: impact of time after preparation on cell viability and survival Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						cell transplantation; brain; stroke; Parkinson disease	MARROW STROMAL CELLS; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; FUNCTIONAL RECOVERY; DOPAMINE NEURONS; RAT MODEL; STROKE; THERAPY	Object. Cell transplantation has shown promise for the treatment of various neurological disorders, but the factors that influence cell survival and integration following transplantation are poorly understood. In fact, little is known regarding how simple but potentially critical variables, including the method of cellular preparation and administration, might affect transplant success. The goal of the present study was to determine the impact of time between tissue preparation and implantation on cellular viability. Time can vary with cell preparation, delivery to the operating room, and surgical technique. This study was also designed to evaluate the sensitivity of various methods of assessing implant viability. Methods. Cell lines of neural progenitor cells and bone marrow stromal cells were generated from healthy adult mice. On the day of experimentation, the cells were collected, suspended in a balanced salt solution, and sequentially assessed for viability for up to 3.5 hours based on their appearance under phase-contrast microscopy, their ability to retain a fluorescent dye, and their attachment to a cultivation surface for 24 hours. Results. When viability was measured based on the ability of cells to retain a fluorescent dye, there was a decrease in viability of 10-15% each hour. Based on the ability of the cells to attach to a culture surface and grow for 24 hours, viability decreased more rapidly at approximately 20% per hour. In addition, only about one-third of the cells judged viable based on phase-contrast microscopy or acute dye retention were found to be viable based on plating, and only 10% of the cells initially judged as viable were still capable of survival after 3 hours in suspension. Conclusions. The authors' results indicate that that there can be significant losses in viability between preparation and implantation and that more sophisticated methods of evaluation, such as the ability of cells to attach to a substrate and grow, may be required to detect decreases in viability. The time between preparation and implantation will be an important factor in clinical trial design. (DOI: 10.3171/2009.10.JNS09252)	[Gobbel, Glenn T.] Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, Pittsburgh, PA 15213 USA; [Gobbel, Glenn T.; Kondziolka, Douglas] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Uram, Martin] MEDRAD Inc, Indianola, PA USA		Gobbel, GT (corresponding author), Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	gobbelg@upmc.edu			MEDRAD, Inc.; NASANational Aeronautics & Space Administration (NASA) [NNJ06HE87G]	The work in this study was supported by a grant from MEDRAD, Inc., to Glenn T. Gobbel based on work supported by NASA under award No. NNJ06HE87G.	Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Braak H, 2008, NAT MED, V14, P483, DOI 10.1038/nm0508-483; Fink JS, 2000, CELL TRANSPLANT, V9, P273, DOI 10.1177/096368970000900212; Franklin RJM, 1997, J ANAT, V190, P23, DOI 10.1046/j.1469-7580.1997.19010023.x; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freeman TB, 2000, P NATL ACAD SCI USA, V97, P13877, DOI 10.1073/pnas.97.25.13877; Freshney R, 1994, CULTURE ANIMAL CELLS, V3rd, P71; Gobbel GT, 2003, BRAIN RES, V980, P221, DOI 10.1016/S0006-8993(03)02977-9; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; MADRAZO I, 1995, NEUROL RES, V17, P312, DOI 10.1080/01616412.1995.11740334; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Marchionini DM, 2004, CELL TRANSPLANT, V13, P273, DOI 10.3727/000000004783983972; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; Niranjan A, 2007, J NEUROSURG, V107, P383, DOI 10.3171/JNS-07/08/0383; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Philpott LM, 1997, CELL TRANSPLANT, V6, P203, DOI 10.1016/S0963-6897(97)00028-6; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Stilley CS, 2004, NEUROLOGY, V63, P1320, DOI 10.1212/01.WNL.0000140700.44904.53; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Terpstra BT, 2007, J NEUROSCI METH, V166, P13, DOI 10.1016/j.jneumeth.2007.06.022; Thompson TP, 1999, NEUROSURGERY, V45, P741, DOI 10.1097/00006123-199910000-00001; VIDAIR CA, 1993, INT J RADIAT BIOL, V63, P589, DOI 10.1080/09553009314450771; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhou YF, 2006, CANCER RES, V66, P10849, DOI 10.1158/0008-5472.CAN-06-2146	36	11	11	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2010	113	3					666	672		10.3171/2009.10.JNS09252			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	641FV	WOS:000281111100034	19911893				2022-02-06	
J	Noonan, VK; Kopec, JA; Noreau, L; Singer, J; Masse, LC; Zhang, HB; Dvorak, MF				Noonan, Vanessa K.; Kopec, Jacek A.; Noreau, Luc; Singer, Joel; Masse, Louise C.; Zhang, Hongbin; Dvorak, Marcel F.			COMPARING THE VALIDITY OF FIVE PARTICIPATION INSTRUMENTS IN PERSONS WITH SPINAL CONDITIONS	JOURNAL OF REHABILITATION MEDICINE			English	Article						consumer participation; World Health Organization; rehabilitation; questionnaires; disability evaluation	TRAUMATIC BRAIN-INJURY; CORD-INJURY; DISABILITY; QUALITY; IMPACT; RELIABILITY; VALIDATION; AUTONOMY; CRITERIA; INDEX	Objective: To evaluate and compare the construct validity of 5 participation instruments developed using the International Classification of Functioning, Disability and Health (ICF). Methods: A total of 545 subjects diagnosed and treated for a spinal condition at an acute hospital were followed-up and consented to complete a questionnaire. Subjects completed 5 participation instruments (Impact on Participation and Autonomy (IPA), Keele Assessment of,Participation (KAP), Participation Measure-Post Acute Care (PM-PAC), Participation Objective Participation Subjective (POPS), World Health Organization Disability Assessment Schedule II (WHODAS II)). In addition, each subject completed a health status instrument and a quality of life instrument. The dimensionality, convergent/discriminant validity and known-group validity of the participation instruments were assessed. Results: A confirmatory factor analysis of the facture structure for the IPA and PM-PAC demonstrated adequate model fit. For convergent/discriminant validity, correlations were generally higher among similar domains of the WHODAS II, IPA, KAP and PM-PAC, and as expected the lowest correlations were observed with the objective domains of the POPS. Most instruments demonstrated known-group validity. Conclusion: Differences in the construct validity evidence of the POPS compared with the other 4 instruments were noted. To date, there is no gold standard for measuring participation, and clinicians and researchers should consider the type of information required prior to selecting an instrument.	[Noonan, Vanessa K.; Zhang, Hongbin; Dvorak, Marcel F.] Univ British Columbia, Dept Orthopaed, Div Spine, Vancouver, BC V5Z 1M9, Canada; [Noonan, Vanessa K.; Kopec, Jacek A.; Singer, Joel] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Kopec, Jacek A.] Arthrit Res Ctr Canada, Vancouver, BC, Canada; [Noreau, Luc] Univ Laval, Rehabil Dept, Quebec City, PQ, Canada; [Noreau, Luc] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Singer, Joel] Univ British Columbia, Canadian HIV Trials Network, Vancouver, BC V5Z 1M9, Canada; [Masse, Louise C.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada		Noonan, VK (corresponding author), Univ British Columbia, Dept Orthopaed, Div Spine, Vancouver, BC V5Z 1M9, Canada.	Vanessa.Noonan@vch.ca		Masse, Louise/0000-0003-2483-8791	Paetzold Chair in Spinal Cord Injury Clinical Research; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	We would like to thank the staff at the Vancouver Spine Research Office for their assistance with this study. Also, we would like to acknowledge the funding we received from the Paetzold Chair in Spinal Cord Injury Clinical Research. VKN's research is supported by a Fellowship from the Canadian Institutes of Health Research.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Brown TA., 2015, CONFIRMATORY FACTOR, V2; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cardol M, 2001, ARCH PHYS MED REHAB, V82, P210, DOI 10.1053/apmr.2001.18218; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; FEINSTEIN AR, 1987, J CHRON DIS, V40, P635, DOI 10.1016/0021-9681(87)90027-0; FERRANS CE, 1985, ADV NURS SCI, V8, P15, DOI 10.1097/00012272-198510000-00005; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Gandek B, 2007, AM J PHYS MED REHAB, V86, P57, DOI 10.1097/01.PHM.0000233200.43822.21; Graves, 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Hoenig H, 1999, SPINE, V24, P539, DOI 10.1097/00007632-199903150-00007; Hoenig H, 1998, ARCH PHYS MED REHAB, V79, P378, DOI 10.1016/S0003-9993(98)90137-X; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joreskog K. G., 1993, TESTING STRUCTURAL E, P294, DOI DOI 10.1093/SF/73.3.1161; &Machin D., 2000, QUALITY LIFE ASSESSM; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; MUTHEN B, 1985, BRIT J MATH STAT PSY, V38, P171, DOI 10.1111/j.2044-8317.1985.tb00832.x; Noonan VK, 2010, J REHABIL MED, V42, P735, DOI 10.2340/16501977-0583; Noonan VK, 2009, DISABIL REHABIL, V31, P1883, DOI 10.1080/09638280902846947; Rochette A, 2006, DISABIL REHABIL, V28, P1231, DOI 10.1080/09638280600554827; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Sibley A, 2006, CLIN REHABIL, V20, P793, DOI 10.1177/0269215506070808; Statistics Canada, 2007, 2006 CENS DICT; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; *WHO, WHODAS 2; Wilkie R, 2005, QUAL LIFE RES, V14, P1889, DOI 10.1007/s11136-005-4325-2; World Health Organization, 2007, INT CLASS FUNCT DIS	35	11	11	0	10	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2010	42	8					724	734		10.2340/16501977-0584			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	651KQ	WOS:000281927000005	20809054	Green Published, gold			2022-02-06	
J	Agrawal, S; Hulme, SL; Hayward, R; Brierley, J				Agrawal, Shruti; Hulme, Sara-Louise; Hayward, Richard; Brierley, Joe			A Portable CT Scanner in the Pediatric Intensive Care Unit Decreases Transfer-Associated Adverse Events and Staff Disruption	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Pediatrics; Trauma; Head injury; Neurosurgery; Portable CT imaging	INTRAHOSPITAL TRANSPORT; SECONDARY INSULTS	Introduction: Computerized tomography (CT) is an important diagnostic tool in the management of critically ill children, especially those with neurosurgical problems such as traumatic brain injury. Traditionally, such scans require transfer to the radiology department (RD) at times of extreme physiological instability, such as incipient cerebral herniation, and exposes children with actual, or potential, spinal injuries to the risks of transfer. Moving children from pediatric intensive care (PIC), often overnight, also depletes units of senior staff. Portable CT (PCT) scanning offers a solution to this problem, and we assessed patient stability and staff time occupied during urgent CT scans before and after the introduction of a PCT scanner (CereTom (R)) in a regional neurosurgical pediatric intensive care unit (PICU). Materials and Methods: Prospective observational study of ventilated children in the PICU requiring urgent CT of the head to limit secondary brain injury. Data was collected for three months prior to, and for the same period after, the introduction of PCT on a questionnaire designed to assess physiological variables, PICU interventions, and staff time, which was completed immediately post scanning. Results: Eight children had urgent CT head scan in the RD during the first 3 months and ten PCT in the second 6 months. The patients transferred to the RD required medical intervention because of cardio-respiratory instability or fluctuating intracranial pressure in nearly every patient and clearly increased the strain on staff resources. None of those patients undergoing PCT had untoward events and staff resources were far less impacted upon. Discussion: PCT scanning is safe for unstable neurosurgical patients who need urgent diagnostic head CT, reducing the risks associated with transfer and the depletion of staff provision to the other children in the PICU. While this study did not specifically address image quality, all images were diagnostic regarding the indication for scanning.	[Agrawal, Shruti; Hulme, Sara-Louise; Brierley, Joe] Inst Child Hlth, Paediat & Neonatal Intens Care Unit, London WC1N 3JH, England; [Agrawal, Shruti; Hulme, Sara-Louise; Hayward, Richard; Brierley, Joe] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Hayward, Richard] Inst Child Hlth, Dept Paediat Neurosurg, London WC1N 3JH, England		Agrawal, S (corresponding author), Inst Child Hlth, Paediat & Neonatal Intens Care Unit, London WC1N 3JH, England.	agraws1@gosh.nhs.uk		Brierley, Joe/0000-0003-0919-6882			ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Bekar A, 1998, NEUROSURG REV, V21, P98, DOI 10.1007/BF02389312; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Butler WE, 1998, NEUROSURGERY, V42, P1304, DOI 10.1097/00006123-199806000-00064; Gunnarsson T, 2000, J NEUROSURG, V93, P432, DOI 10.3171/jns.2000.93.3.0432; Gwinn R, 2000, PEDIATR NEUROSURG, V32, P37, DOI 10.1159/000028895; Hertzog J H, 2001, Pediatr Crit Care Med, V2, P346, DOI 10.1097/00130478-200110000-00012; MARMAROU A, 1991, J NEUROSURG, V75, P559; Masaryk Thomas, 2008, Radiol Manage, V30, P50; Matson MB, 1999, BRIT J RADIOL, V72, P631, DOI 10.1259/bjr.72.859.10624318; McCunn M, 2000, CRIT CARE MED, V28, P3808, DOI 10.1097/00003246-200012000-00008; Papson JPN, 2007, ACAD EMERG MED, V14, P574, DOI 10.1197/j.aem.2007.02.034; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Truog RD, 2006, CRIT CARE MED, V34, P958, DOI 10.1097/01.CCM.0000206116.10417.D9; WALLEN E, 1995, CRIT CARE MED, V23, P1588, DOI 10.1097/00003246-199509000-00020	15	11	11	0	3	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	1863-9933			EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2010	36	4					346	352		10.1007/s00068-009-9127-8			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	639AP	WOS:000280943500008	26816039				2022-02-06	
J	Wendell, LC; Khan, A; Raser, J; Lang, SS; Malhotra, N; Kofke, WA; LeRoux, P; Park, S; Levine, JM				Wendell, Linda C.; Khan, Amir; Raser, Jonathan; Lang, Shih-Shan; Malhotra, Neil; Kofke, W. Andrew; LeRoux, Peter; Park, Soojin; Levine, Joshua M.			Successful Management of Refractory Intracranial Hypertension from Acute Hyperammonemic Encephalopathy in a Woman with Ornithine Transcarbamylase Deficiency	NEUROCRITICAL CARE			English	Article						Hyperammonemia; Ornithine transcarbamylase deficiency; Intracranial hypertension; Hypothermia; Craniectomy	TRAUMATIC BRAIN-INJURY; CEREBRAL EDEMA; PATIENT	Ornithine transcarbamylase deficiency (OTCD) is the most common of the urea cycle disorders and results in an accumulation of ammonia and its metabolites. Excess ammonia in the brain is metabolized to glutamine, which increases intracellular osmolarity and contributes to cytotoxic edema. We report a case of a woman heterozygous for OTCD who developed acute hyperammonemic encephalopathy and increased intracranial pressure (ICP). Despite hemodialysis, protein restriction, and administration of pharmacologic nitrogen scavengers, she developed progressive cerebral edema and increased ICP that was refractory to maximal medical management. She underwent a bifrontal decompressive craniectomy resulting in resolution of her intracranial hypertension. Aggressive multimodality management of the patient coupled with bifrontal decompressive hemicraniectomy was a life-saving measure, offering the patient a reasonable outcome. At 6 month follow-up she had moderate disability on the Glasgow Outcome Score associated with cognitive difficulties.	[Wendell, Linda C.; Khan, Amir; Raser, Jonathan; Park, Soojin; Levine, Joshua M.] Hosp Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Lang, Shih-Shan; Malhotra, Neil; LeRoux, Peter; Park, Soojin; Levine, Joshua M.] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Kofke, W. Andrew; Park, Soojin; Levine, Joshua M.] Hosp Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA		Wendell, LC (corresponding author), Hosp Univ Penn, Dept Neurol, 3400 Spruce St, Philadelphia, PA 19104 USA.	linda.wendell@uphs.upenn.edu; joshua.levine@uphs.upenn.edu					associated, 2001, METABOLIC MOL BASIS, V2, P1909; Berry GT, 1999, ARCH NEUROL-CHICAGO, V56, P481, DOI 10.1001/archneur.56.4.481; BOURRIER P, 1988, PRESSE MED, V17, P2063; Clay AS, 2007, CHEST, V132, P1368, DOI 10.1378/chest.06-2940; CUEVA W, 2009, 7 ANN NEUR CAR SOC M; Gordon N, 2003, EUR J PAEDIATR NEURO, V7, P115, DOI 10.1016/S1090-3798(03)00040-0; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Jacob S, 2009, NEUROCRIT CARE, V11, P242, DOI 10.1007/s12028-009-9266-0; Kleppe Soledad, 2003, Curr Treat Options Neurol, V5, P309, DOI 10.1007/s11940-003-0037-5; MURRAY RK, 2003, LANGE MED BOOK, V10, P693; Panlaqui OM, 2008, INTENS CARE MED, V34, P1922, DOI 10.1007/s00134-008-1217-2; Summar ML, 2005, CRIT CARE CLIN, V21, pS1, DOI 10.1016/j.ccc.2005.05.002; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021	16	11	11	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2010	13	1					113	117		10.1007/s12028-010-9361-2			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	620NF	WOS:000279505900019	20422467				2022-02-06	
J	Dar, DE; Soustiel, JF; Zaaroor, M; Brotfain, EM; Leibowitz, A; Shapira, Y; Semenikhina, L; Solopov, A; Krausz, MM				Dar, Dalit E.; Soustiel, Jean F.; Zaaroor, Menashe; Brotfain, Evgeni M.; Leibowitz, Akiva; Shapira, Yoram; Semenikhina, Leubov; Solopov, Anna; Krausz, Michael M.			MODERATE RINGER'S LACTATE SOLUTION RESUSCITATION YIELDS BEST NEUROLOGICAL OUTCOME IN CONTROLLED HEMORRHAGIC SHOCK COMBINED WITH BRAIN INJURY IN RATS	SHOCK			English	Article						Traumatic brain injury; hemorrhagic shock; Ringer's lactate solution; resuscitation; fluid therapy	CEREBRAL OXYGEN DELIVERY; FLUID RESUSCITATION; HEAD-INJURY; HYPOTENSION; HYPOXIA; SALINE; DAMAGE; MODEL; MULTICENTER; REDUCTION	Anesthetized rats were assigned to sham; brain injury (BI); controlled hemorrhagic shock (CHS); BI combined with CHS (combined injury [CI]); and CI groups resuscitated with 2.5 mL/kg Ringer's lactate solution (RL-2.5), 10 mL/kg RL (RL-10), or 40 mL/kg RL (RL-40). Brain injury was induced by applying 400 millibar negative pressure for 10 s through a hollow screw inserted into a 4.5-mm burr hole drilled into the left parietal region of the skull. Five minutes after BI, 30% of circulating blood volume was withdrawn for 10 min to induce CHS. One hour of fluid resuscitation commenced 20 min posthemorrhage. MAP, lactate, and base excess levels were significantly improved in the RL-40 group compared with all other hemorrhaged groups. The hematocrit level 1 h after resuscitation began was significantly lower in the RL-40 group (27.6% +/- 0.57%) than in all other groups. The RL-40 group had the worst neurological severity score 24 h postsurgery. MAP, lactate, and base excess levels were not significantly improved in the RL-2.5 group, however, the number of surviving neuronal cells in the perilesional brain region was significantly higher than in the CI or RL-40 groups. MAP, lactate, and base excess levels were significantly improved in the RL-10 group (P < 0.05). Mobility and the number of surviving neurons in the perilesional region of the brain were significantly better in the RL-10 group than in the CI or RL-40 groups (P < 0.05). Although massive fluid resuscitation yields preferable hemodynamic and metabolic outcomes, neurological outcomes are better after moderate fluid resuscitation for BI combined with controlled hemorrhagic shock.	[Krausz, Michael M.] Rambam Hlth Care Ctr, Dept Surg A, IL-31096 Haifa, Israel; [Krausz, Michael M.] Rambam Hlth Care Ctr, Lab Shock & Trauma Res, IL-31096 Haifa, Israel; [Soustiel, Jean F.; Zaaroor, Menashe] Dept Neurosurg, Haifa, Israel; [Brotfain, Evgeni M.; Leibowitz, Akiva; Shapira, Yoram] Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol, IL-84105 Beer Sheva, Israel; [Solopov, Anna] Carmel Hosp, Dept Anesthesiol, Haifa, Israel; Technion Israel Inst Technol, Haifa, Israel		Krausz, MM (corresponding author), Rambam Hlth Care Ctr, Dept Surg A, POB 9602,Rambam Hlth Care Campus, IL-31096 Haifa, Israel.	m_krausz@rambam.health.gov.il	Leibowitz, Akiva/F-1397-2012	Leibowitz, Akiva/0000-0003-4244-1915	Israeli Defense Forces	This study was funded in part by a grant from the Medical Unit Fund of the Israeli Defense Forces.	*AM COLL SURG COMM, 1997, ADV TRAUM LIF SUPP D, P21; BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; FALK JL, 1995, CRIT CARE MED, V23, P4, DOI 10.1097/00003246-199501000-00003; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; GROSS D, 1988, J TRAUMA, V28, P751, DOI 10.1097/00005373-198806000-00005; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Krausz MM, 2003, J TRAUMA, V55, P62, DOI 10.1097/01.TA.0000074110.77122.46; KRAUSZ MM, 1991, CIRC SHOCK, V35, P9; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; PROUGH DS, 1997, J TRAUMA, V42, P10; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; York J, 2000, J TRAUMA, V48, P376, DOI 10.1097/00005373-200003000-00002; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; YUAN XQ, 1993, J NEUROTRAUM, V10, P307, DOI 10.1089/neu.1993.10.307; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	37	11	12	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUL	2010	34	1					75	82		10.1097/SHK.0b013e3181ce2cbc			8	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	613ZQ	WOS:000279024500013	20551780				2022-02-06	
J	Forbes, JA; Reig, AS; Tomycz, LD; Tulipan, N				Forbes, Jonathan A.; Reig, Adam S.; Tomycz, Luke D.; Tulipan, Noel			Intracranial hypertension caused by a depressed skull fracture resulting in superior sagittal sinus thrombosis in a pediatric patient: treatment with ventriculoperitoneal shunt insertion Case report	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						sagittal sinus thrombosis; depressed skull fracture; ventriculoperitoneal shunt	OF-THE-LITERATURE; CRANIAL FRACTURE; VENOUS SINUS; OCCLUSION; PRESSURE; STENOSIS; INJURY	Object. Intracranial hypertension resulting from compression of the superior sagittal sinus (SSS) by an overlying depressed calvarial fracture is a rare condition. Primary surgical treatment for the symptomatic patient in this setting traditionally involves elevation of the fracture, which often carries significant associated morbidity. Methods. The authors report a case involving a 6-year-old boy who suffered a closed, depressed, parietooccipital fracture as the result of an unhelmeted all-terrain vehicle accident. This fracture caused compression and subsequent thrombosis of the SSS, which resulted in CSF malabsorption and progressive intracranial hypertension. Initially headache free following the injury, he had developed severe and unremitting headaches by postinjury Day 7. A CT angiography study of the head obtained at this time exhibited thrombosis of the SSS underlying the depressed calvarial fracture. Subsequent lumbar puncture demonstrated markedly elevated intrathecal pressures. Large volumes of CSF were removed, with temporary improvement in symptoms. After medical management with anticoagulation failed, the decision was made to proceed with image-guided ventriculoperitoneal shunt insertion. Results. The patient's headaches resolved immediately following the procedure, and anticoagulation therapy was reinstituted. Follow-up images obtained 4 months after the injury demonstrated evidence of resolution of the depressed fracture, with recanalization of the SSS. The anticoagulation therapy was then discontinued. To the authors' knowledge, this report is the first description of ventriculoperitoneal shunt insertion as the primary treatment of this infrequent condition. Conclusions. This report demonstrates that select patients with this presentation can undergo CSF diversion in lieu of elevation of the depressed skull fracture a surgical procedure shown to be associated with increased risks when the depressed fracture overlies the posterior SSS. The literature on this topic is reviewed and management of this condition is discussed. (DOI: 10.3171/2010.3.PEDS09441)	[Forbes, Jonathan A.; Reig, Adam S.; Tomycz, Luke D.; Tulipan, Noel] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA		Tulipan, N (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, 9226 Doctors Off Tower, Nashville, TN 37232 USA.	noel.tulipan@vanderbilt.edu					Binder DK, 2004, NEUROSURGERY, V55, P986, DOI 10.1227/01.NEU.0000137329.13981.01; Bishop FS, 2009, J NEUROSURG, V111, P17, DOI 10.3171/2009.2.JNS08491; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; Donovan DJ, 2005, SURG NEUROL, V63, P380, DOI 10.1016/j.surneu.2004.06.020; Drake JM, 2009, CHILD NERV SYST, V25, P467, DOI 10.1007/s00381-008-0761-y; DUPLESSIS JJ, 1993, J TRAUMA, V34, P290, DOI 10.1097/00005373-199302000-00021; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MEIER U, 1992, ACTA NEUROCHIR, V119, P91, DOI 10.1007/BF01541788; Meltzer H, 2000, J TRAUMA, V49, P981, DOI 10.1097/00005373-200011000-00035; Ozer FD, 2005, J EMERG MED, V29, P137, DOI 10.1016/j.jemermed.2005.03.006; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; Uzan M, 1998, J NEUROSURG, V88, P598, DOI 10.3171/jns.1998.88.3.0598; vandenBrink WA, 1996, NEUROSURGERY, V38, P1044, DOI 10.1097/00006123-199605000-00039; Vender JR, 2005, J NEUROSURG, V103, P458, DOI 10.3171/ped.2005.103.5.0458; Yokota H, 2006, J NEUROSURG, V104, P849, DOI 10.3171/jns.2006.104.5.849	16	11	12	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2010	6	1					23	28		10.3171/2010.3.PEDS09441			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	615BV	WOS:000279107100004	20593983				2022-02-06	
J	Larsson, J; Esbjornsson, E; Bjorkdahl, A; Morberg, I; Nilsson, M; Sunnerhagen, KS				Larsson, Jerry; Esbjornsson, Eva; Bjorkdahl, Ann; Morberg, Ingrid; Nilsson, Michael; Sunnerhagen, Katharina S.			Sick leave after traumatic brain injury The person or the diagnosis - Which has greater impact?	SCANDINAVIAN JOURNAL OF PUBLIC HEALTH			English	Article						Brain injury; compensation; employment; prediction; rehabilitation; sick leave; socioeconomic factors; work	REACTION LEVEL SCALE; RETURN; WORK; EMPLOYMENT; MODERATE; PREDICTORS	Purpose: The aim of this study was to describe if and when a sample of traumatic brain injury (TBI) patients could finish their time of sick leave during a 4-year follow up and to explore which factors that influenced the time for sick leave. Materials and methods: All persons, 1999-2002, between 18 and 64 years of age (250 in total), admitted to the emergency room and diagnosed according to ICD 10 as S062 and S063, were included. Demographic data were gathered from medical charts and data concerning sick leave 1 year before trauma and 4 years after trauma, were collected from the Swedish social insurance system. To explore predictors of sick leave, two logistic regressions were performed. Results: The sample (mean age 39.68) consisted of 78% men. More than half of the accidents were due to fall. In the sample, 28% was on sick leave on the day of trauma and 96% of these were still on sick leave 4 years after trauma, compared with 39% in the group not on sick leave on the day of TBI. Sick leave at the day for trauma was found to be a predictor for sick leave 4 years after trauma for the whole group (p = 0.000) together with Glasgow Coma Scale (GCS) (p = 0.002) and length of stay (p = 0.049). In the logistic regression with only the group not on sick leave, the only significant variable was GCS (p = 0.003). Conclusion: The findings support the necessity to consider premorbid and social factors in the TBI rehabilitation.	[Larsson, Jerry; Esbjornsson, Eva; Bjorkdahl, Ann; Morberg, Ingrid; Nilsson, Michael; Sunnerhagen, Katharina S.] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, SE-41345 Gothenburg, Sweden; [Sunnerhagen, Katharina S.] Univ Oslo, Sunnaas Rehabil Hosp, N-0316 Oslo, Norway; [Sunnerhagen, Katharina S.] Univ Oslo, Fac Med, N-0316 Oslo, Norway		Larsson, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Dubbsgatan 14, SE-41345 Gothenburg, Sweden.	jerry.larsson@vgregion.se	Bjorkdahl, Ann/ABD-6197-2021; Sunnerhagen, Katharina Stibrant/AAE-2405-2020; NILSSON, MICHAEL/ABE-7821-2020	Bjorkdahl, Ann/0000-0002-2194-6773; Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; NILSSON, MICHAEL/0000-0002-8826-1621	AFA; Handicap Research Committee in Vastra Gotaland; Willhelm and Martina Lundgren Foundation; FoU in Gothenburg and Southern Bohuslan	This study was based on data from the Sahlgrenska University Hospital and Swedish Social Insurance. The study was supported in part by grants from AFA, the Handicap Research Committee in Vastra Gotaland, the Willhelm and Martina Lundgren Foundation, and the FoU in Gothenburg and Southern Bohuslan.	Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	27	11	11	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1403-4948	1651-1905		SCAND J PUBLIC HEALT	Scand. J. Public Health	JUL	2010	38	5					541	547		10.1177/1403494810371143			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	614NA	WOS:000279064900013	20484307				2022-02-06	
J	Lindsey, KA; Brown, RO; Maish, GO; Croce, MA; Minard, G; Dickerson, RN				Lindsey, Kimberly A.; Brown, Rex O.; Maish, George O., III; Croce, Martin A.; Minard, Gayle; Dickerson, Roland N.			Influence of traumatic brain injury on potassium and phosphorus homeostasis in critically ill multiple trauma patients	NUTRITION			English	Article						Potassium; Phosphorus; Head injury; Enteral nutrition; Critical care; Nutritional support	SPECIALIZED NUTRITIONAL SUPPORT; SEVERE HEAD-INJURY; SEVERE HYPOPHOSPHATEMIA; PARENTERAL-NUTRITION; BARBITURATE THERAPY; ENERGY-EXPENDITURE; HYPOKALEMIA; CALCIUM; REPLACEMENT; EXCRETION	Objective: The intent of this study was to ascertain whether multiple trauma patients with traumatic brain injury (TBI) had lower serum concentrations of potassium and phosphorus and required more aggressive supplementation than multiple trauma patients without TBI. Methods: Ventilator-dependent adult patients without renal impairment who were admitted to the trauma intensive care unit or neurosurgical intensive care unit and who received enteral nutrition were evaluated for the first 14 d after hospital admission. Patients were grouped according to the presence or absence of TBI. Target serum concentrations for potassium and phosphorus were 4 mEq/L and 4 mg/dL, respectively. Electrolyte repletion therapy was given according to the nutritional support service guidelines. Results: Fifty trauma patients (25 with and without TBI) were studied. Daily serum potassium concentrations were consistently lower for those with TBI (P <= 0.001), whereas the mean net potassium intake was greater (1.3 +/- 0.5 versus 0.7 +/- 0.3 mEq.kg(-1).d-1, respectively, P <= 0.001). Serial serum phosphorus concentrations were similar between groups (P = NS) except for a significantly lower serum phosphorus concentration for trauma patients with TBI on day 3 after hospital admission (2.5 +/- 0.5 versus 2.9 +/- 0.7 mg/dL, respectively, P <= 0.05). However, the mean net phosphorus intake was significantly greater for trauma patients with TBI (0.65 +/- 0.25 versus 0.45 +/- 0.17 mmol.kg(-1).d(-1), P <= 0.001). Conclusion: Potassium and phosphorus requirements are greater for multiple trauma patients with TBI compared with those without TBI. (C) 2010 Elsevier Inc. All rights reserved.	[Lindsey, Kimberly A.; Brown, Rex O.; Dickerson, Roland N.] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA; [Lindsey, Kimberly A.] Union Univ, Sch Pharm, Jackson, TN 38305 USA; [Maish, George O., III; Croce, Martin A.; Minard, Gayle] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA		Dickerson, RN (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA.	rdickerson@utmem.edu		Dickerson, Roland/0000-0002-2086-6317			AGARWAL R, 1994, GASTROENTEROLOGY, V107, P548, DOI 10.1016/0016-5085(94)90184-8; AUBIER M, 1985, NEW ENGL J MED, V313, P420, DOI 10.1056/NEJM198508153130705; Barak V, 1998, AM J MED, V104, P40, DOI 10.1016/S0002-9343(97)00275-1; BLISS DZ, 1992, AM J CLIN NUTR, V55, P753, DOI 10.1093/ajcn/55.3.753; BODY JJ, 1983, J CLIN INVEST, V71, P572, DOI 10.1172/JCI110802; BOHANNON NJV, 1989, ARCH INTERN MED, V149, P1423, DOI 10.1001/archinte.149.6.1423; Brown KA, 2006, JPEN-PARENTER ENTER, V30, P209, DOI 10.1177/0148607106030003209; BURNELL JM, 1956, J CLIN INVEST, V35, P935, DOI 10.1172/JCI103352; Choban Patricia S, 2005, Nutr Clin Pract, V20, P480, DOI 10.1177/0115426505020004480; CLARK CL, 1995, CRIT CARE MED, V23, P1504, DOI 10.1097/00003246-199509000-00010; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; DAILY WH, 1990, CRIT CARE MED, V18, P1210, DOI 10.1097/00003246-199011000-00004; DAVIES CL, 1984, J TRAUMA, V24, P99, DOI 10.1097/00005373-198402000-00002; DEMPSEY DT, 1985, SURG GYNECOL OBSTET, V160, P128; DICKERSON RN, 1986, AM J CLIN NUTR, V44, P747, DOI 10.1093/ajcn/44.6.747; Dickerson RN, 2004, JPEN-PARENTER ENTER, V28, P124, DOI 10.1177/0148607104028002124; Dickerson RN, 2002, JPEN-PARENTER ENTER, V26, P17, DOI 10.1177/014860710202600117; Dickerson RN, 2002, NUTRITION, V18, P241, DOI 10.1016/S0899-9007(01)00793-6; Dickerson RN, 2001, JPEN-PARENTER ENTER, V25, P152, DOI 10.1177/0148607101025003152; Dickerson RN, 2008, NUTRITION, V24, P536, DOI 10.1016/j.nut.2008.02.008; Dickerson RN, 2007, JPEN-PARENTER ENTER, V31, P228, DOI 10.1177/0148607107031003228; Dickerson RN, 2007, NUTRITION, V23, P9, DOI 10.1016/j.nut.2006.10.001; FINSTERER U, 1983, SCAND J CLIN LAB INV, V43, P117; FRIED RC, 1989, J TRAUMA, V29, P1558, DOI 10.1097/00005373-198911000-00017; GADISSEUX P, 1985, NEUROSURGERY, V17, P35, DOI 10.1227/00006123-198507000-00006; GUENTER PA, 1991, JPEN-PARENTER ENTER, V15, P277, DOI 10.1177/0148607191015003277; HALEVY J, 1988, ARCH INTERN MED, V148, P153, DOI 10.1001/archinte.148.1.153; HAYEK ME, 1989, ARCH SURG-CHICAGO, V124, P1325; Heaney RP, 2002, J AM COLL NUTR, V21, P239, DOI 10.1080/07315724.2002.10719216; KAUSTE A, 1983, ACTA CHIR SCAND, V149, P229; KUROKAWA K, 1985, FLUID ELECTROLYTE AC, P625; Lazar L, 1997, J PEDIATR SURG, V32, P88, DOI 10.1016/S0022-3468(97)90102-0; LIAW KY, 1985, JPEN-PARENTER ENTER, V9, P28, DOI 10.1177/014860718500900128; MacDonald JS, 2003, J TRAUMA, V54, P197, DOI 10.1097/00005373-200301000-00028; Marik PE, 1996, ARCH SURG-CHICAGO, V131, P1043, DOI 10.1001/archsurg.1996.01430220037007; MOSTELLAR ME, 1964, J CLIN INVEST, V43, P138, DOI 10.1172/JCI104888; PAMPOLINI M, 1988, J TRAUMA, V28, P526, DOI 10.1097/00005373-198804000-00020; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; POMERANZ S, 1989, ACTA NEUROCHIR, V97, P62, DOI 10.1007/BF01577741; RAKHIT A, 1987, PHARMACEUT RES, V4, P531, DOI 10.1023/A:1016496026017; REID JL, 1986, AM J CARDIOL, V57, pF23, DOI 10.1016/0002-9149(86)90884-2; Sacks G S, 1994, Nutr Clin Pract, V9, P105, DOI 10.1177/0115426594009003105; Sacks GS, 1997, NUTRITION, V13, P303; SCHAEFER M, 1995, INTENS CARE MED, V21, P235, DOI 10.1007/BF01701479; SHIN B, 1986, ANESTHESIOLOGY, V65, P90, DOI 10.1097/00000542-198607000-00018; SILVIS SE, 1972, GASTROENTEROLOGY, V62, P513; SINGHAL PC, 1992, AM J MED, V92, P458, DOI 10.1016/0002-9343(92)90740-3; SMITH JS, 1978, SURG GYNECOL OBSTET, V147, P18; SPENCER H, 1984, AM J CLIN NUTR, V40, P1213, DOI 10.1093/ajcn/40.6.1213; TROUWBORST A, 1984, INJURY, V15, P293, DOI 10.1016/0020-1383(84)90048-2; Tse HF, 2000, AM J MED, V109, P599, DOI 10.1016/S0002-9343(00)00590-8; VANEK VW, 1994, SOUTHERN MED J, V87, P41, DOI 10.1097/00007611-199401000-00010; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; WEINSIER RL, 1981, AM J CLIN NUTR, V34, P393; WHANG R, 1992, ARCH INTERN MED, V152, P40, DOI 10.1001/archinte.152.1.40; ZAZZO JF, 1995, INTENS CARE MED, V21, P826, DOI 10.1007/BF01700966	57	11	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JUL-AUG	2010	26	7-8					784	790		10.1016/j.nut.2009.08.013			7	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	619UF	WOS:000279455100017	20018481				2022-02-06	
J	Xin, ZL; Wu, XK; Xu, JR; Li, X				Xin, Zhao-liang; Wu, Xiao-kang; Xu, Jian-rong; Li, Xi			Arachnoid cell involvement in the mechanism of coagulation-initiated inflammation in the subarachnoid space after subarachnoid hemorrhage	JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B			English	Article						Arachnoid cells; Cell culture; Human leukocyte antigen-DR (HLA-DR); Soluble interleukin-2 receptor (sIL-2r)	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; CEREBRAL VASOSPASM; DENDRITIC CELLS; MONOCLONAL-ANTIBODY; CHOROID-PLEXUS; TISSUE FACTOR; MACROPHAGES; ARTERY; MODEL	To assess if arachnoid cells have the capability to present antigen and activate T-lymphocytes after stimulation by bloody cerebrospinal fluid (CSF), and to illuminate the mechanism of coagulation-initiated inflammation in the subarachnoid space after subarachnoid hemorrhage (SAH). Arachnoid cells were cultured, characterized, and examined by immunofluorescence for the basal expression of human leukocyte antigen-DR (HLA-DR). Expression of HLA-DR, after co-culturing arachnoid cells in vitro with bloody CSF, was investigated by immunofluorescence and flow cytometry (FCM). The variation of arachnoid cells' ultrastructure was observed by transmission electron microscope (TEM). Arachnoid cells were co-cultured with peripheral blood mononuclear cells (PBMCs). The content of soluble interleukin-2 receptor (sIL-2r) in culture medium was detected by enzyme-linked immunosorbent assay (ELISA). (1) Arachnoid cells were successfully cultured for many passages. The immunofluorescent staining was positive for HLA-DR in over 95% of the human arachnoid cells. The punctate HLA-DR was distributed in cytoplasm and not in the karyon. (2) After co-culturing arachnoid cells in vitro with bloody CSF, numerous particles with strong fluorescence appeared in the cytoplasm on Day 6. On Day 8, the quantity of particles and fluorescent intensity were maximal. FCM showed that the percentage of HLA-DR expressing cells was (2.5 +/- 0.4)% at the first 5 d, increasing to (60.8 +/- 3.6)% on Day 7. (3) After co-culturing arachnoid cells in vitro with bloody CSF, many lysosome and secondary lysosome particles were present in the cytoplasm. Hyperplasia of rough endoplasmic reticulum and enlarged cysts were observed, with numerous phagocytizing vesicles also observed at the edge of the arachnoid cells. (4) Arachnoid cells stimulated by bloody CSF were co-cultured in vitro with PBMCs. The content of sIL-2r in the culture medium, having been maintained at around 1.30 ng/ml during the first 3 d, had increased by Day 4. The content of sIL-2r peaked 7.53 ng/ml on Day 7 and then reduced gradually. (1) Basic HLA-DR expression is present in arachnoid cells. (2) After stimulation by bloody CSF, arachnoid cells have the potential to serve as antigen presenting cells (APCs) and the ability to activate T-lymphocytes, indicating that arachnoid cells are involved in the mechanism of coagulation-initiated inflammation in the subarachnoid space after SAH.	[Xin, Zhao-liang; Li, Xi] Zhejiang Med Coll, Dept Neurosurg, Hangzhou 310053, Zhejiang, Peoples R China; [Wu, Xiao-kang] Shanghai Tenth Peoples Hosp, Dept Neurosurg, Shanghai 200072, Peoples R China; [Xu, Jian-rong] Yiwu Cent Hosp, Dept Neurosurg, Yiwu 322000, Peoples R China		Xin, ZL (corresponding author), Zhejiang Med Coll, Dept Neurosurg, Hangzhou 310053, Zhejiang, Peoples R China.	wxk555@sohu.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30370497]; Science and Technology Research Program of Zhejiang Province, China [2007-C-33039]	Project supported by the National Natural Science Foundation of China (No. 30370497) and the Science and Technology Research Program of Zhejiang Province, China (No. 2007-C-33039)	Ahn YM, 2002, NEUROSURGERY, V50, P843, DOI 10.1097/00006123-200204000-00029; AKOPOV SE, 1992, EXPERIENTIA, V48, P34, DOI 10.1007/BF01923601; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Aydin MD, 2005, INT J NEUROSCI, V115, P1595, DOI 10.1080/00207450590958079; Bernstein JJ, 1996, INT J DEV NEUROSCI, V14, P681, DOI 10.1016/0736-5748(95)00096-8; Chrapusta SJ, 2000, SCAND J IMMUNOL, V51, P400; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Clatterbuck RE, 2002, J NEUROSURG, V97, P676, DOI 10.3171/jns.2002.97.3.0676; Cunningham MA, 1999, BLOOD, V94, P3413, DOI 10.1182/blood.V94.10.3413.422k24_3413_3420; Eddleman CS, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2008.11.FOCUS08278; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; FRANK E, 1995, SPINE, V20, P2093, DOI 10.1097/00007632-199510000-00004; FRANK EH, 1983, EXP CELL RES, V146, P371, DOI 10.1016/0014-4827(83)90138-6; Gomis P, 2005, J NEUROSURG, V102, P715, DOI 10.3171/jns.2005.102.4.0715; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Iuliano BA, 2004, J NEUROSURG, V100, P287, DOI 10.3171/jns.2004.100.2.0287; JACKOWSKI A, 1990, J CEREBR BLOOD F MET, V10, P835, DOI 10.1038/jcbfm.1990.140; Jin HL, 2006, INT IMMUNOL, V18, P565, DOI 10.1093/intimm/dxh398; Kim KY, 2002, NEUROREPORT, V13, P849, DOI 10.1097/00001756-200205070-00022; KUBOTA T, 1993, STROKE, V24, P1993, DOI 10.1161/01.STR.24.12.1993; Kwon KY, 2001, J KOREAN MED SCI, V16, P774, DOI 10.3346/jkms.2001.16.6.774; Lan W, 2005, ANESTH ANALG, V100, P409, DOI 10.1213/01.ANE.0000142113.39092.87; Massicotte EM, 1999, J NEUROSURG, V91, P80, DOI 10.3171/jns.1999.91.1.0080; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; Mathiesen T, 1996, BRIT J NEUROSURG, V10, P89, DOI 10.1080/02688699650040584; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; McMenamin PG, 2003, CELL TISSUE RES, V313, P259, DOI 10.1007/s00441-003-0779-0; MOTOHASHI O, 1995, NEUROSCI LETT, V190, P105, DOI 10.1016/0304-3940(95)11513-V; MOTOHASHI O, 1995, ACTA NEUROCHIR, V136, P88, DOI 10.1007/BF01411441; MURPHY M, 1991, J NEUROSCI RES, V30, P475, DOI 10.1002/jnr.490300304; Muth H, 2005, THROMB HAEMOSTASIS, V94, P1028, DOI 10.1160/TH05-01-0002; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Ogihara K, 2001, BRAIN RES, V889, P89, DOI 10.1016/S0006-8993(00)03120-6; Pradilla G, 2004, J NEUROSURG, V101, P88, DOI 10.3171/jns.2004.101.1.0088; Prignano F, 1998, INT J DERMATOL, V37, P116, DOI 10.1046/j.1365-4362.1998.00116.x; Raymackers J, 2000, ELECTROPHORESIS, V21, P2266, DOI 10.1002/1522-2683(20000601)21:11<2266::AID-ELPS2266>3.0.CO;2-Z; Recinos PF, 2006, SURG NEUROL, V66, P463, DOI 10.1016/j.surneu.2006.04.010; Sanchez CM, 2004, NEUROLOGIA, V19, P44; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; Todo K, 2008, STROKE, V39, P1875, DOI 10.1161/STROKEAHA.107.503433; Wada Hiromi, 2002, J Atheroscler Thromb, V9, P224; Wang L, 2005, ANN CLIN LAB SCI, V35, P79; Zubkov AY, 2002, NEUROSCI LETT, V326, P137, DOI 10.1016/S0304-3940(02)00188-X	45	11	12	1	7	ZHEJIANG UNIV	HANGZHOU	EDITORIAL BOARD, 20 YUGU RD, HANGZHOU, 310027, PEOPLES R CHINA	1673-1581	1862-1783		J ZHEJIANG UNIV-SC B	J. Zhejiang Univ.-SCI. B	JUL	2010	11	7					516	523		10.1631/jzus.B1000099			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Research & Experimental Medicine	620NB	WOS:000279505500007	20593517	Green Published			2022-02-06	
J	Barnard, AM; Nelson, NG; Xiang, HY; McKenzie, LB				Barnard, Alison M.; Nelson, Nicolas G.; Xiang, Huiyun; McKenzie, Lara B.			Pediatric Mobility Aid-Related Injuries Treated in US Emergency Departments From 1991 to 2008	PEDIATRICS			English	Article						mobility aid; injury; National Electronic Injury Surveillance System; emergency department; wheelchair; walker; crutches	WHEELCHAIR-RELATED ACCIDENTS; UNITED-STATES; WALKERS; CANES; FALLS; CONSEQUENCES; CHILDREN; ADULTS; USERS	OBJECTIVES: Although mobility aids such as crutches, walkers, and wheelchairs are typically beneficial, they can be associated with injury. The objective of this study was to describe the incidence, patterns, and trends of pediatric mobility aid-related injuries to children and adolescents who were aged <= 19 years and treated in US emergency departments between 1991 and 2008. METHODS: A retrospective analysis was conducted by using data from the National Electronic Injury Surveillance System database for children and adolescents who were aged <= 19 years. Sample weights were used to calculate national estimates of mobility aid-related injuries on the basis of 2301 actual cases. RESULTS: An estimated 63 309 cases of children and adolescents who were aged <= 19 years were treated in US emergency departments for mobility aid-related injuries. Approximately 70% of mobility aid-related injuries occurred while patients were using wheelchairs. Children who were aged 2 to 10 years were more likely to sustain injuries while using walkers and wheelchairs, injure their heads, and sustain traumatic brain injuries. Children who were aged 11 to 19 years were more likely to sustain injuries while using crutches, injure their lower extremities, and sustain sprains and strains. Injuries involving wheelchairs were more likely to be traumatic brain injuries and result in hospitalization. Injuries involving crutches were more likely to involve misuse and be triggered by stairs or curbs. CONCLUSIONS: Injuries related to crutches, walkers, and wheelchairs have distinct injury patterns, mechanisms of injury, and trigger factors. Injury patterns between younger and older children were different. Additional research is needed to identify effective injury prevention strategies for the pediatric population. Pediatrics 2010; 125: 1200-1207	[Barnard, Alison M.; Nelson, Nicolas G.; Xiang, Huiyun; McKenzie, Lara B.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Xiang, Huiyun; McKenzie, Lara B.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA		McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	lara.mckenzie@nationwidechildrens.org	McKenzie, Lara/C-5122-2012	McKenzie, Lara/0000-0003-2889-0001			Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Bateni H, 2004, GAIT POSTURE, V20, P74, DOI 10.1016/S0966-6362(03)00098-5; Berg K, 2002, AM J PUBLIC HEALTH, V92, P48, DOI 10.2105/AJPH.92.1.48; CALDER CJ, 1990, AM J PHYS MED REHAB, V69, P184, DOI 10.1097/00002060-199008000-00003; CHARRON PM, 1995, AM J PHYS MED REHAB, V74, P237, DOI 10.1097/00002060-199505000-00011; Day C, 2008, PEDIATRICS, V122, pE388, DOI 10.1542/peds.2008-0024; DEAN E, 1993, PHYS THER, V73, P494, DOI 10.1093/ptj/73.8.494; DEAN E, 1993, PHYS THER, V73, P502, DOI 10.1093/ptj/73.8.502; Gaal RP, 1997, J REHABIL RES DEV, V34, P58; Hefflin BJ, 2004, AM J PREV MED, V27, P246, DOI 10.1016/j.amepre.2004.04.005; Johnson KL, 2007, AM J PUBLIC HEALTH, V97, P330, DOI 10.2105/AJPH.2004.050955; JOYCE BM, 1991, AM FAM PHYSICIAN, V43, P535; Kaye HS, 2000, MOBILITY DEVICE USE; KIRBY RL, 1995, AM J PHYS MED REHAB, V74, P308, DOI 10.1097/00002060-199507000-00009; KIRBY RL, 1994, AM J PHYS MED REHAB, V73, P319, DOI 10.1097/00002060-199409000-00004; LOVE C, 2001, J ORTHOP NURS, V5, P45; Mann W.C., 1995, PHYS OCCUP THERAPY G, V13, P1; McFall B, 2004, Ulster Med J, V73, P50; Palisano RJ, 2003, DEV MED CHILD NEUROL, V45, P113, DOI 10.1017/S0012162203000215; Randazzo C, 2009, ACAD EMERG MED, V16, P235, DOI 10.1111/j.1553-2712.2009.00352.x; Russell J N, 1997, Adv Data, P1; Sinclair SA, 2008, AM J PUBLIC HEALTH, V98, P1510, DOI 10.2105/AJPH.2006.097097; Stevens JA, 2009, J AM GERIATR SOC, V57, P1464, DOI 10.1111/j.1532-5415.2009.02365.x; UMMAT S, 1994, AM J PHYS MED REHAB, V73, P163, DOI 10.1097/00002060-199406000-00004; *US BUR CENS, POP EST; *US CONS PROD SAF, 2001, NAT EL INJ SURV SYST; Venkatanarasimha N, 2009, J ORTHOP TRAUMATOL, V10, P155, DOI 10.1007/s10195-009-0057-3; Xiang H, 2006, INJURY PREV, V12, P8, DOI 10.1136/ip.2005.010033	28	11	10	0	8	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	2010	125	6					1200	1207		10.1542/peds.2009-3286			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	604GX	WOS:000278268600014	20498179				2022-02-06	
J	Conner, KA; Williams, LE; McKenzie, LB; Shields, BJ; Fernandez, SA; Smith, GA				Conner, Kristen A.; Williams, Lindsay E.; McKenzie, Lara B.; Shields, Brenda J.; Fernandez, Soledad A.; Smith, Gary A.			Pediatric Pedestrian Injuries and Associated Hospital Resource Utilization in the United States, 2003	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Pedestrian; Injuries; Hospital charges; Length of stay; Pediatrics	POSTTRAUMATIC-STRESS-DISORDER; TRAFFIC ACCIDENTS; CHILDREN; PREVENTION; AGE; EPIDEMIOLOGY; VEHICLES; PATTERNS; TRAUMA; RISK	Background: The objective was to calculate national estimates of pedestrian-related hospitalizations and associated use of healthcare resources among children <= 19 years of age and to explore the effects of sociodemographic, hospital-related factors, and injury severity on total charges and lengths of stay (LOS) in the United States. Methods: Data from the 2003 Healthcare Cost and Utilization Project Kids' Inpatient Database were used. The sample included patients <= 19 years hospitalized with pedestrian-related injuries, from 3,438 hospitals in 36 states. National estimates of pedestrian-associated hospitalizations, rates, resource use, injury severity, and demographics were calculated. Potentially significant covariate associations were studied using hospital charges and LOS. Results: In 2003, 9,172 pedestrian-associated hospitalizations occurred among children <= 19 years in the United States, resulting in $290.8 million (standard deviation [SD] = $23.6 million) in inpatient charges and 44,895 (SD = 2,964) days of hospitalization. Mean (SD) hospital charges and LOS were $32,059 ($74,778) days and 4.9 (10.9) days, respectively. Thirty-six percent of patients suffered a traumatic brain injury, and 21% sustained severe injury with an injury severity scale score >= 16. A traffic-related event was the cause of 92.7% of hospitalizations. Older age, higher injury severity, urban and Western hospital location, children's hospital type, and longer LOS were significantly associated with higher total hospital charges. Older age and higher injury severity were significantly associated with longer LOS. Conclusion: Pediatric pedestrian injuries contribute substantially to the healthcare resource burden in the United States, accounting for similar to 45,000 days of hospitalization and >$290 million in inpatient charges annually.	[Conner, Kristen A.; Williams, Lindsay E.; McKenzie, Lara B.; Shields, Brenda J.; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Williams, Lindsay E.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Fernandez, Soledad A.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org	McKenzie, Lara/C-5122-2012	McKenzie, Lara/0000-0003-2889-0001			AGRAN P, 1991, PEDIATRICS, V87, P70; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; BRISON RJ, 1988, AM J PUBLIC HEALTH, V78, P793, DOI 10.2105/AJPH.78.7.793; Calhoun AD, 1998, ACAD EMERG MED, V5, P685, DOI 10.1111/j.1553-2712.1998.tb02486.x; CDC Injury Research Agenda, 2002, CDC INJ RES AG; *CDCP, UN PED NONF INJ RAT; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P144; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2005, WEB BAS INJ STAT QUE; Chakravarthy B, 2007, PEDIATR EMERG CARE, V23, P738, DOI 10.1097/PEC.0b013e318156acea; Crandall JR, 2002, BRIT MED J, V324, P1145, DOI 10.1136/bmj.324.7346.1145; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; Demetriades D, 2004, J AM COLL SURGEONS, V199, P382, DOI 10.1016/j.jamcollsurg.2004.03.027; DERLET R W, 1989, Journal of Emergency Medicine, V7, P5; Di Scala C, 2001, Annu Proc Assoc Adv Automot Med, V45, P241; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; DiGuiseppi C, 1997, BRIT MED J, V314, P710, DOI 10.1136/bmj.314.7082.710; DiMaggio C, 2002, ACAD EMERG MED, V9, P54; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; Elvik R, 2001, ACCIDENT ANAL PREV, V33, P327, DOI 10.1016/S0001-4575(00)00046-4; GARDNER R, 2007, ARCH PEDIAT ADOLESC, V161, P1; *HEALTHC COST UT P, 2003, DESCR DAT EL KIDS IN; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2003, HEALTHC COST UT PROJ; Henary Basem Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P105; Ivarsson B Johan, 2006, Traffic Inj Prev, V7, P290, DOI 10.1080/15389580600652283; *J HOPK U TRI AN I, 2002, ICDMAP90 J HOPK U TR; JOLY MF, 1991, SOC SCI MED, V33, P765, DOI 10.1016/0277-9536(91)90375-M; KING WD, 1992, PEDIATR EMERG CARE, V8, P221, DOI 10.1097/00006565-199208000-00013; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; MACKAY M, 1994, INJURY, V25, P615, DOI 10.1016/0020-1383(94)90037-X; MALEK M, 1990, ACCIDENT ANAL PREV, V22, P301, DOI 10.1016/0001-4575(90)90046-N; Miller Ted R, 2004, Annu Proc Assoc Adv Automot Med, V48, P265; Nadler EP, 2001, PEDIATRICS, V108, P326, DOI 10.1542/peds.108.2.326; Nance ML, 2004, PEDIATR EMERG CARE, V20, P569, DOI 10.1097/01.pec.0000139736.00850.da; *NAT ASS CHILDR HO, MEMBERSH CRIT; *NAT HIGHW TRAFF A, 2006, 801818 DOT HS NAT HI; Posner JC, 2002, INJURY PREV, V8, P231, DOI 10.1136/ip.8.3.231; RIVARA FP, 1985, PEDIATRICS, V76, P375; RIVARA FP, 1990, AM J DIS CHILD, V144, P692, DOI 10.1001/archpedi.1990.02150300090023; RIVARA FP, 1991, PEDIATRICS, V88, P770; *SAS I INC, 2004, SAS SYST WIND COMP P; Silen ML, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e7; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; *STATACORP LP, 2003, STAT STAT SOFTW COMP; Turner Cathy, 2004, Inj Control Saf Promot, V11, P231, DOI 10.1080/156609704/233/289751; *US BUR CENS, 2000 CENS TOT POP SE; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Wazana A, 1997, Inj Prev, V3, P295, DOI 10.1136/ip.3.4.295; WINN DG, 1991, PEDIATRICS, V88, P776; RECOMMENDED FRAMEWOR; BEST PRACTICES SKILL	51	11	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2010	68	6					1406	1412		10.1097/TA.0b013e3181b28b05			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	610ES	WOS:000278714600026	20093987				2022-02-06	
J	Huttemann, M; Nantwi, KD; Lee, I; Liu, J; Mohiuddin, S; Petrov, T				Huettemann, Maik; Nantwi, Kwaku D.; Lee, Icksoo; Liu, Jenney; Mohiuddin, Syed; Petrov, Theodor			Theophylline treatment improves mitochondrial function after upper cervical spinal cord hemisection	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord injury; Respiratory function; Cytochrome c oxidase; Mitochondria; Oxidative phosphorylation; Energy	CYTOCHROME-C-OXIDASE; CROSSED PHRENIC PHENOMENON; TRAUMATIC BRAIN-INJURY; OXIDATIVE-PHOSPHORYLATION; ADULT-RATS; TYROSINE PHOSPHORYLATION; SYSTEMIC THEOPHYLLINE; MESSENGER-RNA; SUBUNIT-I; RECOVERY	The importance of mitochondria in spinal cord injury has mainly been attributed to their participation in apoptosis at the site of injury. But another aspect of mitochondrial function is the generation of more than 90% of cellular energy in the form of ATP, mediated by the oxidative phosphorylation (OxPhos) process. Cytochrome c oxidase (CcO) is a central OxPhos component and changes in its activity reflect changes in energy demand. A recent study suggests that respiratory muscle function in chronic obstructive pulmonary disease (COPD) patients is compromised via alterations in mitochondrial function. In an animal model of cervical spinal cord hemisection (C2HS) respiratory dysfunction, we have shown that theophylline improves respiratory function. In the present study, we tested the hypothesis that theophylline improves respiratory function at the cellular level via improved mitochondrial function in the C2HS model. We demonstrate that CcO activity was significantly (33%) increased in the spinal cord adjacent to the site of injury (C3-C5), and that administration of theophylline (20 mg/kg 3x daily orally) after C2HS leads to an even more pronounced increase in CcO activity of 62% compared to sham-operated animals. These results are paralleled by a significant increase in cellular ATP levels (51% in the hemidiaphragm ipsilateral to the hemisection). We conclude that C2HS increases energy demand and activates mitochondrial respiration, and that theophylline treatment improves energy levels through activation of the mitochondrial OxPhos process to provide energy for tissue repair and functional recovery after paralysis in the C2HS model. Published by Elsevier Inc.	[Nantwi, Kwaku D.; Mohiuddin, Syed; Petrov, Theodor] Wayne State Univ, Dept Anat & Cell Biol, Sch Med, Detroit, MI 48201 USA; [Huettemann, Maik; Lee, Icksoo; Liu, Jenney] Wayne State Univ, Ctr Mol Med & Genet, Sch Med, Detroit, MI 48201 USA		Nantwi, KD (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, Sch Med, 540 E Canfield Ave, Detroit, MI 48201 USA.	knantwi@med.wayne.edu		Huttemann, Maik/0000-0001-6310-7081	Center for Molecular Medicine and Genetics; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [35766]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD035766] Funding Source: NIH RePORTER	This work was supported by the Center for Molecular Medicine and Genetics (MH) and NIH grant 35766 (KDN). We thank Dr. Jeffrey Doan (Center for Molecular Medicine and Genetics) for comments on the manuscript.	Acsadi G, 2009, J NEUROSCI RES, V87, P2748, DOI 10.1002/jnr.22106; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brambilla G, 1996, J Neurosurg Sci, V40, P213; Dalmonte ME, 2009, J BIOL CHEM, V284, P32331, DOI 10.1074/jbc.M109.050146; Exline MC, 2008, FRONT BIOSCI-LANDMRK, V13, P5030; Fuller DD, 2008, EXP NEUROL, V211, P97, DOI 10.1016/j.expneurol.2008.01.013; Fuller DD, 2006, J APPL PHYSIOL, V100, P800, DOI 10.1152/japplphysiol.00960.2005; Golder FJ, 2001, J APPL PHYSIOL, V91, P2451, DOI 10.1152/jappl.2001.91.6.2451; GOODNOUGH J, 1980, SURG NEUROL, V13, P273; Goshgarian HG, 2003, J APPL PHYSIOL, V94, P795, DOI 10.1152/japplphysiol.00847.2002; GOSHGARIAN HG, 1991, EXP NEUROL, V111, P135, DOI 10.1016/0014-4886(91)90061-G; Horner PJ, 1996, J COMP NEUROL, V364, P690, DOI 10.1002/(SICI)1096-9861(19960122)364:4<690::AID-CNE7>3.0.CO;2-Z; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; ITO T, 1978, J NEUROSURG, V48, P434, DOI 10.3171/jns.1978.48.3.0434; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; LIOU WW, 1994, EXP NEUROL, V127, P145, DOI 10.1006/exnr.1994.1088; Liu YY, 2001, NEUROREPORT, V12, P3239, DOI 10.1097/00001756-200110290-00019; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; MORENO DE, 1992, EXP NEUROL, V116, P219, DOI 10.1016/0014-4886(92)90001-7; Nantwi KD, 1998, NEUROPHARMACOLOGY, V37, P113, DOI 10.1016/S0028-3908(97)00190-1; Nantwi KD, 2003, EXP NEUROL, V182, P232, DOI 10.1016/S0014-4886(03)00109-2; Nantwi KD, 1998, BRAIN RES, V789, P126, DOI 10.1016/S0006-8993(98)00024-9; Nantwi KD, 1996, EXP NEUROL, V140, P53, DOI 10.1006/exnr.1996.0114; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Wu KLH, 2007, J NEUROCHEM, V101, P1552, DOI 10.1111/j.1471-4159.2006.04445.x	35	11	11	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2010	223	2			SI		523	528		10.1016/j.expneurol.2010.01.020			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597GD	WOS:000277743700032	20144890	Green Accepted			2022-02-06	
J	McCauley, SR; Wilde, EA; Kelly, TM; Weyand, AM; Yallampalli, R; Waldron, EJ; Pedroza, C; Schnelle, KP; Boake, C; Levin, HS; Moretti, P				McCauley, Stephen R.; Wilde, Elisabeth A.; Kelly, Tara M.; Weyand, Annie M.; Yallampalli, Ragini; Waldron, Eric J.; Pedroza, Claudia; Schnelle, Kathleen P.; Boake, Corwin; Levin, Harvey S.; Moretti, Paolo			The Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI): II. Reliability and Convergent Validity	JOURNAL OF NEUROTRAUMA			English	Article						convergent validity; Neurological Outcome Scale for Traumatic Brain Injury; outcome; reliability; traumatic brain injury	FUNCTIONAL INDEPENDENCE MEASURE; DISABILITY RATING-SCALE; NIH STROKE SCALE; CLOSED-HEAD INJURY; INTERRATER RELIABILITY; RECOVERY; PREDICTOR	A standardized measure of neurological dysfunction specifically designed for TBI currently does not exist and the lack of assessment of this domain represents a substantial gap. To address this, the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) was developed for TBI outcomes research through the addition to and modification of items specifically relevant to patients with TBI, based on the National Institutes of Health Stroke Scale. In a sample of 50 participants (mean age = 33.3 years, SD = 12.9) <= 18 months (mean = 3.1, SD = 3.2) following moderate (n = 8) to severe (n = 42) TBI, internal consistency of the NOS-TBI was high (Cronbach's alpha = 0.942). Test-retest reliability also was high (rho = 0.97, p < 0.0001), and individual item kappas between independent raters were excellent, ranging from 0.83 to 1.0. Overall inter-rater agreement between independent raters (Kendall's coefficient of concordance) for the NOS-TBI total score was excellent (W = 0.995). Convergent validity was demonstrated through significant Spearman rank-order correlations between the NOS-TBI and the concurrently administered Disability Rating Scale (rho = 0.75, p < 0.0001), Rancho Los Amigos Scale (rho = -0.60, p < 0.0001), Supervision Rating Scale (rho = 0.59, p < 0.0001), and the FIM (TM) (rho = -0.68, p < 0.0001). These results suggest that the NOS-TBI is a reliable and valid measure of neurological functioning in patients with moderate to severe TBI.	[McCauley, Stephen R.] Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; Kelly, Tara M.; Schnelle, Kathleen P.; Boake, Corwin; Levin, Harvey S.] Univ Texas Houston Med Sch, Houston, TX USA; [Wilde, Elisabeth A.; Moretti, Paolo] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Yallampalli, Ragini; Waldron, Eric J.] Univ Houston Univ Pk, Houston, TX USA; [Pedroza, Claudia] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Moretti, Paolo] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA		McCauley, SR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	mccauley@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	National Institutes of Health/National Institute of Neurological Disease and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 43353]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS043353] Funding Source: NIH RePORTER	We would like to extend our gratitude to the participants and their families, whose cooperation and patience helped make this study possible. This study was supported in part by grant NS 43353 from the National Institutes of Health/National Institute of Neurological Disease and Stroke, to Guy L. Clifton, Principal Investigator. The information in this article and the article itself has never previously been published either electronically or in print. None of the authors have any financial or other relationships that could be construed as a conflict of interest with respect to the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	American Educational Research Association American Psychological Association National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Fleiss J.L., 1981, STAT METHODS RATES P; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hagen C, 1979, REHABILITATION HEAD; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Josephson SA, 2006, CEREBROVASC DIS, V22, P389, DOI 10.1159/000094857; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kendall M.G., 1962, RANK CORRELATION MET; LANDIS JR, 1977, BIOMETRICS, V33, P174; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McCauley SR, 2001, J INT NEUROPSYCH SOC, V7, P457, DOI 10.1017/S1355617701744025; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Powers D W, 2001, Emerg Med Serv, V30, P52; PULLICINO P, 1992, STROKE, V23, P919, DOI 10.1161/str.23.6.919a; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RASCH G, 1966, BRIT J MATH STAT PSY, V19, P49, DOI 10.1111/j.2044-8317.1966.tb00354.x; *SAS I INC, 2008, STAT AN SOFTW WIND; Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02; Spilker J, 1997, J Neurosci Nurs, V29, P384; Sun TK, 2006, INT J NURS STUD, V43, P457, DOI 10.1016/j.ijnurstu.2005.07.004; TEASDALE G, 1974, LANCET, V2, P81; Urbina S, 1997, PSYCHOL TESTING; Von Eye A, 2005, ANAL RATER AGREEMENT; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wright BD., 1982, RATING SCALE ANAL	37	11	11	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2010	27	6					991	997		10.1089/neu.2009.1195			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	612VO	WOS:000278933300003	20210595	Green Published			2022-02-06	
J	Olson, DM; Bader, MK; Dennis, C; Mahanes, D; Riemen, K				Olson, DaiWai M.; Bader, Mary Kay; Dennis, Christina; Mahanes, Dea; Riemen, Kristina			Multicenter Pilot Study: Safety of Automated Chest Percussion in Patients at Risk for Intracranial Hypertension	JOURNAL OF NEUROSCIENCE NURSING			English	Article							TRAUMATIC BRAIN-INJURY; PRESSURE; MANAGEMENT; PREVENTION	In the critical care setting, the focus of care during the first few weeks following acute brain injury is prevention of secondary brain injury by optimizing cerebral perfusion. Ensuring adequate oxygenation and perfusion of cerebral tissues requires attention to all of the body systems. Chest percussion therapy (CPT) promotes pulmonary hygiene and optimizes gas exchange by opening the alveoli. However, many patients with brain injury have intracranial pressure (ICP) monitoring, and conventional wisdom supports limiting activities such as CPT that may stimulate the patient and increase ICP. The purpose of this study was to explore the effects of CPT on ICP. Thirty participants were enrolled over a 6-month period. Data were collected at 1-minute intervals for 1 hour. Each patient was randomized to receive automated CPT (using specialty beds) for 10 minutes, starting at 10, 20, 30, or 40 minutes into the hour. There were no differences in mean ICP values before, during, or after CPT. This study provides evidence that it is safe to perform CPT in patients with ICP monitoring in situ.	[Olson, DaiWai M.; Riemen, Kristina] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Bader, Mary Kay] Mission Hosp, Mission Viejo, CA USA; [Dennis, Christina] WakeMed Hlth & Hosp, Raleigh, NC USA; [Mahanes, Dea] Univ Virginia Hlth Syst, Charlottesville, VA USA		Olson, DM (corresponding author), Duke Univ, Med Ctr, Durham, NC 27706 USA.	Olson006@mc.duke.edu		Olson, DaiWai/0000-0002-9280-078X			AANN, 2004, AANN COR CURR NEUR N; Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bader Mary Kay, 2003, Crit Care Nurse, V23, P29; Bader MK, 2003, CRIT CARE NURSE, V23, P40; Bader MK, 2003, CRIT CARE NURSE, V23, P29; *BRAIN INJ ASS AM, 2005, BRAIN INJ; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Branson RD, 2007, RESP CARE, V52, P1328; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS; *CDC, 2009, CTR DIS CONTR PREV F; Dennis L J, 2001, Neurol India, V49 Suppl 1, pS37; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Grap Mary Jo, 2004, Crit Care Nurs Clin North Am, V16, P349, DOI 10.1016/j.ccell.2004.03.005; Greenberg MS, 2001, HDB NEUROSURGERY; HAMMON WE, 1993, CHEST, V103, P1409, DOI 10.1378/chest.103.5.1409; Hess D R, 2001, Respir Care, V46, P1276; Hickey JV, 2009, BIOL RES NURS, V11, P174, DOI 10.1177/1099800409332902; Hickey JV, 2009, CLIN PRACTICE NEUROL, P270; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kaynar AM, 2007, RESP CARE, V52, P1687; Littell RC, 1998, J ANIM SCI, V76, P1216; Littlejohns L, 2005, AACN ADV CRIT CARE, V16, P501, DOI 10.1097/00044067-200510000-00007; Littlejohns Linda R, 2003, Crit Care Nurse, V23, P17; Littlejohns LR, 2003, CRIT CARE NURSE, V23, P6; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; March K, 2000, Crit Care Nurs Clin North Am, V12, P429; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marino PL, 2007, ICU BOOK, V3th; Marion Donald W, 2002, Curr Opin Crit Care, V8, P111, DOI 10.1097/00075198-200204000-00004; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Ntoumenopoulos G, 2002, INTENS CARE MED, V28, P850, DOI 10.1007/s00134-002-1342-2; Olson DM, 2007, NEUROCRIT CARE, V6, P100, DOI 10.1007/s12028-007-0015-y; Olson DaiWai M, 2003, Crit Care Nurse, V23, P45; Olson DM, 2009, AM J CRIT CARE, V18, P330, DOI 10.4037/ajcc2009523; Olson DM., 2007, CRITICAL CARE NURSIN, P359; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Shahlaie K, 2009, NEUROCRIT CARE, V10, P61, DOI 10.1007/s12028-008-9138-z; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Vadeboncoeur TF, 2006, J EMERG MED, V30, P131, DOI 10.1016/j.jemermed.2005.04.019; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Yanko J R, 2001, Crit Care Nurs Q, V23, P1; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	50	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2010	42	3					119	127		10.1097/JNN.0b013e3181d4a3aa			9	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	602OV	WOS:000278149600002	20550071				2022-02-06	
J	Xu, M; Su, W; Xu, QP; Huang, WD				Xu Miao; Su Wei; Xu Qiu-ping; Huang Wei-dong			Effect of Xingnaojing injection on cerebral edema and blood-brain barrier in rats following traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Medicine, Chinese traditional; Brain injuries; Brain edema; Blood-brain barrier		Objective: To explore the effects of Xingnaojing injection on cerebral edema and blood-brain barrier (BBB) in rats following traumatic brain injury (TBI). Methods: A total of 108 adult male Sprague-Dawley rats were used as subjects and randomly assigned to three groups: sham-operation, TBI and Xingnaojing injection groups (10 ml kg(-1)d(-1), intraperitoneal injection). TBI in rats was set up by the improved device of Feeney's weight-dropping model with the impact of 600 gcm. Brain water content and BBB permeability expressed as Evans blue content were measured at 1, 3, 5 and 7 days after surgery. Results: In sham-operation group, brain water content and Evans blue content in brain tissue were 78.97%+/- 1.22 % and 5.13 mu g +/- 0.71 mu g. Following TBI, water content in brain tissue was increased significantly at 1, 3, 5 and 7 days (83.49%+/- 0.54%, 82.74%+/- 0.72%, 80.22%+/- 0.68%, 79.21%+/- 0.60%), being significantly higher than that in sham operation group (P<0.05). Evans blue content was increased in TBI group (16.54 mu g +/- 0.60 mu g, 14.92 mu g +/- 0.71 mu g, 12.44 mu g +/- 0.92 mu g, 10.14 mu g +/- 0.52 mu g) as compared with sham-operation group(P<0.05). After treatment with Xingnaojing injection, brain water content decreased as compared with TBI group(81.91%+/- 1.04%, 80.38%+/- 0.72%, 79.54%+/- 0.58%, 78.60%+/- 0.77%, P<0.05). Xingnaojing injection also reduced the leakage of BBB as compared with TBI group (15.11 mu g +/- 0.63 mu g, 13.62 mu g +/- 0.85 mu g, 10.06 mu g +/- 0.67 mu g, 9.54 mu g +/- 0.41 mu g, P<0.05). Conclusion: Xingnaojing injection could alleviate cerebral edema following TBI via reducing permeability of BBB.	[Xu Miao; Su Wei; Xu Qiu-ping] Zhejiang Univ, Med Coll, Sir Run Run Shaw Hosp, Dept Crit Care Med, Hangzhou 310016, Zhejiang, Peoples R China; [Huang Wei-dong] Zhejiang Univ, Affiliated Hosp 1, Med Coll, Dept Emergency Med, Hangzhou 310016, Zhejiang, Peoples R China		Xu, M (corresponding author), Zhejiang Univ, Med Coll, Sir Run Run Shaw Hosp, Dept Crit Care Med, Hangzhou 310016, Zhejiang, Peoples R China.	HZ6372@hotmail.com			Science and Technology Department of Zhejiang Province [2008C33042]; Medical College of Zhejiang University [2007N30]; Administration Bureau of Traditional Chinese Medicine of Zhejiang Province [2006C053]	This study was supported by the Science and Technology Department of Zhejiang Province (No. 2008C33042), Medical College of Zhejiang University (No. 2007N30) and Administration Bureau of Traditional Chinese Medicine of Zhejiang Province (No. 2006C053).	Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Huang WJ, 2005, CHIN J CLIN PHARM TH, V10, P1171; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Shen SY, 2004, CHIN J CLIN REHABILI, V8, P686; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; [吴旭 Wu Xu], 2005, [中国法医学杂志, Chinese Journal of Forensic Medicine], V20, P1; Xu Miao, 2007, Chin J Traumatol, V10, P90; [杨光田 Yang Guangtian], 2006, [中国药学杂志, Chinese Pharmaceutical Journal], V41, P1142; Zhang HB, 2006, J ZHEJIANG U TRADIT, V30, P233	10	11	16	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	JUN	2010	13	3					158	162		10.3760/cma.j.issn.1008-1275.2010.03.005			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF0ZE	WOS:000441901200006	20515593				2022-02-06	
J	Agarwalla, PK; Dunn, GP; Laws, ER				Agarwalla, Pankaj K.; Dunn, Gavin P.; Laws, Edward R.			An historical context of modern principles in the management of intracranial injury from projectiles	NEUROSURGICAL FOCUS			English	Article						military; traumatic brain injury; neurosurgical history; projectile injury	PENETRATING CRANIOCEREBRAL INJURIES; GUNSHOT WOUNDS; BONE FRAGMENTS; MISSILE WOUNDS; HEAD WOUNDS; FOLLOW-UP; BRAIN; VIETNAM; WAR; NEUROSURGERY	The contemporary management of projectile head injuries owes much to the lessons neurosurgeons have distilled from their experiences in war. Through early investigation and an increasingly detailed account of wartime clinical experience, neurosurgeons-including the field's early giants-began to gain a greater understanding not only of intracranial missile pathophysiology but also of appropriate management. In this paper, the authors trace the development of the principles of managing intracranial projectile injury from the Crimean War in the 19th century through the Vietnam War to provide a context that frames a summary of today's core management principles. (DOI: 10.3171/2010.2.FOCUS1038)	[Laws, Edward R.] Harvard Univ, Sch Med, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA 02115 USA; [Agarwalla, Pankaj K.; Dunn, Gavin P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA		Laws, ER (corresponding author), Harvard Univ, Sch Med, Dept Neurosurg, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	elaws@partners.org					ABBOTT K H, 1946, Mil Surg, V98, P469; Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; Ascroft PB, 1943, LANCET, V2, P211; Ascroft Peter B., 1944, ARCH NEUROL AND PSYCHIAT, V51, P295; BARNETT JC, 1955, J NEUROSURG, V12, P34, DOI 10.3171/jns.1955.12.1.0034; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bliss M., 2005, HARVEY CUSHING LIFE; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; Cairns H, 1944, BMJ-BRIT MED J, V1944, P33; Cairns H, 1944, BRIT J SURG, V32, P199, DOI 10.1002/bjs.18003212539; CAIRNS H, 1947, BRIT J SURG        S, V1, P9; CAIRNS H, 1947, BR J SURG WAR SURG S, V1, P198; CAMPBELL EH, 1945, ANN SURG, V122, P375, DOI 10.1097/00000658-194509000-00004; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CAREY ME, 1982, ACTA CHIR SCAND, P351; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; CAREY ME, 2004, YOUMANS NEUROLOGICAL, V4, P5523; Cushing H, 1918, BRIT J SURG, V5, P558; Cushing H, 1918, Br Med J, V1, P221; Cybulski GR, 2008, NEUROSURGERY, V63, P808, DOI 10.1227/01.NEU.0000325732.58528.86; DAGI TF, 1997, HIST NEUROSURGERY; ECKER AD, 1946, J NEUROSURG, V3, P1, DOI 10.3171/jns.1946.3.1.0001; ECKER AD, 1945, J NEUROSURG, V2, P384, DOI 10.3171/jns.1945.2.5.0384; Eden K, 1943, LANCET, V2, P689; ERICKSON TC, 1946, JAMA-J AM MED ASSOC, V132, P561, DOI 10.1001/jama.1946.02870450015004; FACKLER ML, 1988, JAMA-J AM MED ASSOC, V259, P2730, DOI 10.1001/jama.259.18.2730; FINLAYSON AI, 1945, B US ARMY MED DEP, V87, P61; FORMENTO F, 1990, NOTES OBSERVATIONS A; Fulton J.F., 1946, HARVEY CUSHING BIOGR; GAYNOR WC, 1945, ANN SURG, V122, P12; Gray HMW, 1916, BRIT MED J, V1916, P261, DOI 10.1136/bmj.1.2877.261; GROFF RA, 1946, AM J SURG, V72, P434, DOI 10.1016/0002-9610(46)90333-9; GRUNNAGLE JF, 1945, WAR MED, V8, P376; HAMMON WM, 1971, J NEUROSURG, V34, P142, DOI 10.3171/jns.1971.34.2part1.0142; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HANIGAN WC, 1994, BRIT J NEUROSURG, V8, P279, DOI 10.3109/02688699409029615; Hanigan WC, 2003, NEUROSURGERY, V53, P713, DOI 10.1227/01.NEU.0000079626.37622.6A; HANIGAN WC, 1988, NEUROSURGERY, V23, P283, DOI 10.1227/00006123-198809000-00001; HAYNES WG, 1945, J NEUROSURG, V2, P463, DOI 10.3171/jns.1945.2.6.0463; HAYNES WG, 1945, J NEUROSURG, V2, P365, DOI 10.3171/jns.1945.2.5.0365; HAYNES WG, 1945, J NEUROSURG, V2, P469, DOI 10.3171/jns.1945.2.6.0469; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; Horrax G, 1919, BRIT J SURG, V7, P10, DOI 10.1002/bjs.1800072504; Horsley V., 1894, NATURE, V50, P104; HORSLEY V, 1915, BRIT MED J, V20, P321; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; Kelly PJ, 2003, NEUROSURGERY, V52, P927, DOI 10.1227/01.NEU.0000053179.51319.D0; KRAMER SP, 1897, PHILOS T ROY SOC LON, V188, P223; LEWIN W, 1956, BRIT J SURG, V43, P628, DOI 10.1002/bjs.18004318216; Macleod George H. B., 1858, NOTES SURG WAR CRIME; MALTBY GL, 1946, J NEUROSURG, V3, P239, DOI 10.3171/jns.1946.3.3.0239; MARTIN J, 1946, J NEUROSURG, V3, P58, DOI 10.3171/jns.1946.3.1.0058; MATSON DD, 1946, J NEUROSURG, V3, P46, DOI 10.3171/jns.1946.3.1.0046; MEIROWSKY AM, 1953, J NEUROSURG, V10, P496, DOI 10.3171/jns.1953.10.5.0496; MEIROWSKY AM, 1982, J NEUROSURG, V57, P617, DOI 10.3171/jns.1982.57.5.0617; MEIROWSKY AM, 1953, ANN SURG, V138, P178, DOI 10.1097/00000658-195308000-00003; MEIROWSKY AM, 1953, J NEUROSURG, V10, P373, DOI 10.3171/jns.1953.10.4.0373; Mitchell S., 1872, INJURIES NERVES THEI; Mitchell SW., 1864, GUNSHOT WOUNDS OTHER; POPP AJ, 1995, J NEUROSURG, V83, P174, DOI 10.3171/jns.1995.83.1.0174; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; RISH BL, 1980, J NEUROSURG, V53, P772, DOI 10.3171/jns.1980.53.6.0772; ROWE SN, 1945, J NEUROSURG, V2, P391, DOI 10.3171/jns.1945.2.5.0391; RUSSELL WR, 1952, J NEUROL NEUROSUR PS, V15, P93, DOI 10.1136/jnnp.15.2.93; RUSSELL WR, 1947, BRIT J SURG S, V1, P252; Schurr PH, 2005, J ROY SOC MED, V98, P423, DOI 10.1258/jrsm.98.9.423; SCHWARTZ HG, 1945, ANN SURG, V121, P129; SHEARBURN EW, 1946, AM J SURG, V72, P441, DOI 10.1016/0002-9610(46)90334-0; SLEMON HV, 1945, J NEUROSURG, V2, P332, DOI 10.3171/jns.1945.2.4.0332; SMALL JM, 1947, BR J SURG S, V1, P6274; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; Stromeyer GFL, 1862, GUNSHOT FRACTURES; *USA, 1965, NEUR SURG TRAUM; WALKER AE, 1959, J NEUROSURG, V16, P600, DOI 10.3171/jns.1959.16.6.0600; WALKER AE, 1946, SCIENCE, V103, P116, DOI 10.1126/science.103.2665.116; WALLACE PB, 1960, ANN SURG, V151, P174, DOI 10.1097/00000658-196002000-00004; WANNAMAKER GT, 1958, J NEUROSURG, V15, P512, DOI 10.3171/jns.1958.15.5.0512; WANNAMAKER GT, 1954, J NEUROSURG, V11, P151, DOI 10.3171/jns.1954.11.2.0151; 1944, J NEUROSURG, V1, P1	80	11	11	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2010	28	5							E23	10.3171/2010.2.FOCUS1038			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	589ZU	WOS:000277193600023	20568940				2022-02-06	
J	Bergman, K; Bay, E				Bergman, Karen; Bay, Esther			MILD TRAUMATIC BRAIN INJURY/CONCUSSION: A REVIEW FOR ED NURSES	JOURNAL OF EMERGENCY NURSING			English	Article							POST-CONCUSSION SYMPTOMS; RANDOMIZED-TRIAL; EARLY PREDICTORS; FOLLOW-UP; INJURY; REHABILITATION; INTERVENTION; COMPLAINTS; IDENTIFICATION; ASSOCIATION		[Bergman, Karen] Bronson Hosp, Kalamazoo, MI USA; [Bergman, Karen; Bay, Esther] Michigan State Univ, E Lansing, MI 48824 USA		Bergman, K (corresponding author), 601 John St, Kalamazoo, MI 49007 USA.	bergmank@bronsonhg.org					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Armes J, 2007, CANCER-AM CANCER SOC, V110, P1385, DOI 10.1002/cncr.22923; BAY E, W J NURS RE IN PRESS; BAY E, 2006, CARE MANAGE J, V7, P9; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Bronfort G., 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001878.PUB2; Centers for Disease Control and Prevention, TRAUM BRAIN INJ; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gioia G, ACUTE CONCUSSION EVA; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; JAGODA A, 2008, J EMERG NURS, V35, pE5; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Nicholson K, 2004, J HEAD TRAUMA REHAB, V19, P2, DOI 10.1097/00001199-200401000-00002; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sikorskii A, 2006, J PAIN SYMPTOM MANAG, V32, P129, DOI 10.1016/j.jpainsymman.2006.02.013; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	57	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	MAY	2010	36	3					221	230		10.1016/j.jen.2009.07.001			10	Emergency Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Nursing	605KF	WOS:000278345800010	20457317				2022-02-06	
J	Sabini, RC; Reddy, CC				Sabini, Rosanna C.; Reddy, Cara Camiolo			Concussion Management and Treatment Considerations in the Adolescent Population	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; adolescents; sports; diagnosis; management; traumatic brain injury	SPORTS-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; BASE-LINE; COLLEGIATE; SYMPTOMS; EPIDEMIOLOGY	Over the past decade, significant advances have been made in understanding concussions. Information regarding proper identification, pathophysiology, risks, outcomes, and management protocols has shifted the treatment paradigm from a generalized grading system to an individualized approach. Early identification and timely management of a concussion is necessary to ensure that patients minimize persistent post-concussive symptoms affecting the physical, behavioral, emotional, and cognitive domains. Adolescents are particularly vulnerable to concussions, having greater susceptibility and more prolonged recovery aft er sustaining an injury. This article aims to inform clinicians on how to improve symptom relief and functional outcomes for adolescent patients with concussion via immediate intervention, neuropsychological management, and pharmacological treatment.	[Sabini, Rosanna C.; Reddy, Cara Camiolo] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15219 USA		Sabini, RC (corresponding author), Univ Pittsburgh, Med Ctr, 1400 Locust St,Suite 7203, Pittsburgh, PA 15219 USA.	dr.sabini@gmail.com		Sabini, Rosanna/0000-0002-9273-3855			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Bruce JM, 2004, NEUROLOGY, V63, P1516; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; ELLEMBERG D, J NEUROTRAUMA; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maroon Joseph C, 2002, Clin Neurosurg, V49, P319; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Swartz EE, 2009, PHYSICIAN SPORTSMED, V37, P20, DOI 10.3810/psm.2009.12.1738; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; YARNELL PR, 1970, LANCET, V1, P863; 2009, REPORT TRENDS PARTIC	56	11	11	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	APR	2010	38	1					139	146		10.3810/psm.2010.04.1771			8	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	766SO	WOS:000290807000015	20424411				2022-02-06	
J	Docherty, E; Hassan, A; Burke, D				Docherty, Elizabeth; Hassan, Abu; Burke, Derek			Things that go bump ... bump ... bump: an analysis of injuries from falling down stairs in children based at Sheffield Children's Hospital	EMERGENCY MEDICINE JOURNAL			English	Article								Background Falls down stairs are a common presentation to the paediatric emergency department. The pattern of injury associated with this mechanism of injury has not been described for the UK population. A retrospective analysis of attendances to the Emergency Department of Sheffield Children's Hospital was carried out. Results Overall 90% (216/239) of patients sustained one or more injuries; 69% (165/239) sustained minor head and facial injuries; 12% (29/239) sustained minor soft tissue injuries of other regions; 10% (23/239) had limb fractures, of which 60% (14/23) were of the upper limb (nine clavicle fractures, one supracondylar fracture of the elbow and four wrist fractures) and 40% (9/23) were of the lower limb (four femoral fractures and five tibial fractures). Two per cent (5/239) had skull fractures (all were in the group of children dropped while being carried on the stairs). Injuries to more than one body part occurred in only 3% (8/239) of cases. Discussion The results suggest that children who fall down the stairs are mainly toddlers and in general sustain only minor injuries, the commonest being a minor head injury. Severe truncal and extremity injuries or injuries involving multiple body regions should provoke further questioning looking for evidence of non-accidental injury. There is no correlation between the number of stairs fallen down and the likelihood or severity of injury. Conclusion Infants who fall down stairs with their carer or are dropped while being carried down stairs require an especially close evaluation.	[Docherty, Elizabeth] Sheffield Childrens Hosp, Emergency Dept, Sheffield S10 2TH, S Yorkshire, England; [Docherty, Elizabeth; Hassan, Abu] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England		Docherty, E (corresponding author), Sheffield Childrens Hosp, Emergency Dept, Sheffield S10 2TH, S Yorkshire, England.	ebdocherty@gmail.com					BARLOW B, 1983, J PEDIATR SURG, V18, P509, DOI 10.1016/S0022-3468(83)80210-3; CASEY R, 1986, PEDIATRICS, V78, P497; CHIAVIELLO CT, 1994, PEDIATRICS, V94, P679; JOFFE M, 1988, PEDIATRICS, V82, P457	4	11	11	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	MAR	2010	27	3					207	208		10.1136/emj.2008.069179			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	571VA	WOS:000275782800018	20304888				2022-02-06	
J	Keel, MJB; Bastian, JD; Buchler, L; Siebenrock, KA				Keel, M. J. B.; Bastian, J. D.; Buechler, L.; Siebenrock, K. A.			Surgical dislocation of the hip for a locked traumatic posterior dislocation with associated femoral neck and acetabular fractures	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							HEAD; OSTEOTOMY; REPLACEMENT; REDUCTION; ARTHRITIS	Traumatic posterior dislocation of the hip associated with a fracture of the posterior acetabular wall and of the neck of the femur is a rare injury. A 29-year-old man presented at a level 1 trauma centre with a locked posterior dislocation of the right hip, with fractures of the femoral neck and the posterior wall of the acetabulum after a bicycle accident. An attempted closed reduction had failed. This case report describes in detail the surgical management and the clinical and radiological outcome. Open reduction and fixation with preservation of the intact retinaculum was undertaken within five hours of injury with surgical dislocation of the hip and a trochanteric osteotomy. Two years after operation the function of the injured hip was good. Plain radiographs and MR scans showed early signs of osteoarthritis with some loss of joint space but no evidence of avascular necrosis. The patient had begun skiing and hiking again. The combination of fractures of the neck of the femur and of the posterior wall of the acetabulum hampers closed reduction of a posterior dislocation of the hip. Surgical dislocation of the hip with trochanteric flip osteotomy allows controlled open reduction of the fractures, with inspection of the hip joint and preservation of the vascular supply.	[Keel, M. J. B.; Bastian, J. D.; Buechler, L.; Siebenrock, K. A.] Univ Bern, CH-3010 Bern, Switzerland		Bastian, JD (corresponding author), Univ Bern, Inselspital, Dept Orthopaed Surg, Freiburgstr 3, CH-3010 Bern, Switzerland.	johannesbastian@gmx.de		Buchler, Lorenz/0000-0002-6779-6432; Siebenrock, Klaus Arno/0000-0003-3627-4313			Bastian JD, 2009, CLIN ORTHOP RELAT R, V467, P732, DOI 10.1007/s11999-008-0649-x; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; CANALE ST, 1979, J BONE JOINT SURG AM, V61, P7, DOI 10.2106/00004623-197961010-00003; EPSTEIN HC, 1974, J BONE JOINT SURG AM, VA 56, P1103, DOI 10.2106/00004623-197456060-00001; EPSTEIN HC, 1973, CLIN ORTHOP RELAT R, V92, P116; ERB RE, 1995, AM J ROENTGENOL, V165, P1215, DOI 10.2214/ajr.165.5.7572506; Ertel, 2005, EUR J TRAUMA, V31, P138, DOI DOI 10.1007/S00068-005-1403-7; Espinosa N, 2006, J BONE JOINT SURG AM, V88A, P925, DOI 10.2106/JBJS.E.00290; Espinosa Norman, 2007, J Bone Joint Surg Am, V89 Suppl 2 Pt.1, P36, DOI 10.2106/JBJS.F.01123; Ferguson SJ, 2003, J BIOMECH, V36, P171, DOI 10.1016/S0021-9290(02)00365-2; FICAT P, 1973, REV CHIR ORTHOP, V59, P26; FRANKEL A, 1993, CLIN ORTHOP RELAT R, P209; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; HADDAD RJ, 1990, J BONE JOINT SURG BR, V72, P2, DOI 10.1302/0301-620X.72B1.2298788; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Henle P, 2007, INJURY, V38, P478, DOI 10.1016/j.injury.2007.01.023; HOUGAARD K, 1986, ARCH ORTHOP TRAUM SU, V106, P32, DOI 10.1007/BF00435649; HUNTER G A, 1969, Journal of Bone and Joint Surgery British Volume, V51, P38; KIM YT, 1995, CLIN ORTHOP RELAT R, V320, P187; PATERSON I, 1957, J BONE JOINT SURG BR, V39, P306, DOI 10.1302/0301-620X.39B2.306; RITTER MA, 1981, CLIN ORTHOP RELAT R, V159, P177; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; Schneeberger A G, 1997, Oper Orthop Traumatol, V9, P1, DOI 10.1007/s00064-006-0001-0; Siebenrock KA, 2002, J ORTHOP TRAUMA, V16, P543, DOI 10.1097/00005131-200209000-00002; Siebenrock KA, 1998, J ORTHOP TRAUMA, V12, P387, DOI 10.1097/00005131-199808000-00004; SLATIS P, 1974, INJURY, V5, P188, DOI 10.1016/S0020-1383(74)80003-3; STEWART MJ, 1954, J BONE JOINT SURG AM, V36-A, P315, DOI 10.2106/00004623-195436020-00010; Tannast M, 2009, INJURY, V40, P1118, DOI 10.1016/j.injury.2009.06.166; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; Tonnis D, 1999, J BONE JOINT SURG AM, V81A, P1747; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yue JJ, 1996, J ORTHOP TRAUMA, V10, P447, DOI 10.1097/00005131-199610000-00001; Zahiri CA, 1998, J ARTHROPLASTY, V13, P890, DOI 10.1016/S0883-5403(98)90195-4	35	11	13	0	3	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X	2044-5377		J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	MAR	2010	92B	3					442	446		10.1302/0301-620X.92B3.23016			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	561UW	WOS:000275006000020	20190319	Bronze			2022-02-06	
J	Yang, YM; Lai, H; Tao, CY; Yang, H				Yang, Yuming; Lai, Hua; Tao, Chunyan; Yang, Hua			Correlation of luminescent properties of ZnO and Eu doped ZnO nanorods	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							ZINC-OXIDE NANOWIRES; HYDROTHERMAL GROWTH; NANOSTRUCTURES; PHOTOLUMINESCENCE; PERFORMANCE; MORPHOLOGY; ARRAYS	ZnO and ZnO:Eu nanorods were originally synthesized by concussion method. The nanorods present a wurtzite nanostructure with dispersive distribution morphology. The average diameter and length of the nanorods are about 80 nm and 2 mu m, respectively. The best concussion time, concussion frequency, the function of HMT and the growth mechanism are presented in this paper. This method is simple, economical, and environmentally mild. We believe other kinds of ZnO nanostructures could be obtained by this method when appropriate agents are added. However, because of the different chemical properties between trivalent RE ions and the cations of ZnO, it is rather difficult to incorporate RE ions into the lattice of semiconductors effectively via a wet chemical method. Based on our experiments, the sample of ZnO : Eu-1%(3+) is single-phase and its PL signal is stronger than other single-phase ZnO : Eu-X(3+) samples. So 1% content of Eu3+ was chosen as the best doping concentration.	[Yang, Yuming; Lai, Hua; Yang, Hua] Jilin Univ, Coll Chem, Changchun 130012, Peoples R China; [Tao, Chunyan] Jilin Univ, Key Lab Supramol Struct & Mat, Minist Educ, Changchun 130012, Peoples R China		Yang, H (corresponding author), Jilin Univ, Coll Chem, Changchun 130012, Peoples R China.	huayang86@sina.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC)	This work is supported by National Natural Science Foundation of China (NSFC).	AHUJA IS, 1982, J MOL STRUCT, V81, P229, DOI 10.1016/0022-2860(82)85335-0; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Chang YC, 2007, J PHYS CHEM C, V111, P1268, DOI 10.1021/jp066786q; Destaillats H, 2001, IND ENG CHEM RES, V40, P3855, DOI 10.1021/ie010110u; Fan Z., 2004, ADV MATER, V15, P838; Geng J, 2006, J PHYS CHEM B, V110, P13777, DOI 10.1021/jp057562v; Gou XL, 2008, J MATER CHEM, V18, P965, DOI 10.1039/b716745h; Guo M, 2005, J SOLID STATE CHEM, V178, P3210, DOI 10.1016/j.jssc.2005.07.013; Guo M, 2005, J SOLID STATE CHEM, V178, P1864, DOI 10.1016/j.jssc.2005.03.031; Hartanto AB, 2004, APPL PHYS A-MATER, V78, P299, DOI 10.1007/s00339-003-2286-2; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H; JIE J, 2005, SYNTHESIS OPTICAL PR, DOI DOI 10.1063/1.1854737; Johnson JC, 2003, J PHYS CHEM B, V107, P8816, DOI 10.1021/jp034482n; Kind H, 2002, ADV MATER, V14, P158, DOI 10.1002/1521-4095(20020116)14:2<158::AID-ADMA158>3.0.CO;2-W; Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p; Kong YC, 2001, APPL PHYS LETT, V78, P407, DOI 10.1063/1.1342050; Lao JY, 2002, NANO LETT, V2, P1287, DOI 10.1021/nl025753t; Lao JY, 2003, NANO LETT, V3, P235, DOI 10.1021/nl025884u; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Li SY, 2004, J APPL PHYS, V95, P3711, DOI 10.1063/1.1655685; Li YB, 2002, APPL PHYS LETT, V81, P144, DOI 10.1063/1.1492008; Liu B, 2003, J AM CHEM SOC, V125, P4430, DOI 10.1021/ja0299452; MASON TJ, 1999, SONOCHEMISTRY, P16; PAN ZW, 1947, SCIENCE, V291, P2001; Park JH, 2004, J MATER CHEM, V14, P35, DOI 10.1039/b312821k; Park WI, 2003, APPL PHYS LETT, V82, P964, DOI 10.1063/1.1544437; Pol VG, 2002, CHEM MATER, V14, P3920, DOI 10.1021/cm0203464; SUSLICK KS, 1986, J AM CHEM SOC, V108, P5641, DOI 10.1021/ja00278a055; Wang Z, 2004, LANGMUIR, V20, P3441, DOI 10.1021/la036098n; Williams TM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2236211; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Xing YJ, 2004, SOLID STATE COMMUN, V129, P671, DOI 10.1016/j.ssc.2003.11.049; Xu LF, 2007, J PHYS CHEM C, V111, P11560, DOI 10.1021/jp071536a; Yan HQ, 2003, ADV MATER, V15, P402, DOI 10.1002/adma.200390091; Yan HQ, 2003, ADV MATER, V15, P1907, DOI 10.1002/adma.200305490; Yang J, 2006, J NANOSCI NANOTECHNO, V6, P2196, DOI 10.1166/jnn.2006.363; Yao BD, 2002, APPL PHYS LETT, V81, P757, DOI 10.1063/1.1495878; Yu WD, 2004, APPL PHYS LETT, V84, P2658, DOI 10.1063/1.1695097; Zhang J, 2002, CHEM MATER, V14, P4172, DOI 10.1021/cm020077h	40	11	11	0	15	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	FEB	2010	21	2					173	178		10.1007/s10854-009-9889-0			6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science; Physics	545RE	WOS:000273753300012					2022-02-06	
J	Bjorkdahl, A				Bjorkdahl, Ann			The return to work after a neuropsychological programme and prognostic factors for success	BRAIN INJURY			English	Article						Brain injury; longitudinal; awareness; cognition; pre-morbid occupation	TRAUMATIC BRAIN-INJURY; MILIEU-BASED NEUROREHABILITATION; ACUTE PREDICTORS; SELF-AWARENESS; REHABILITATION; STROKE; EMPLOYMENT; OUTCOMES; INTERVENTION; PERSPECTIVES	Introduction: Several factors influence the return to work (RTW) after brain injury (BI). The aims of the study were to follow-up the RTW after a vocational neuropsychological programme for individuals with a brain injury and to explore factors predicting RTW. The hypothesis was that as self-awareness was already addressed in the programme, severity of injury would have a greater impact on RTW. Method: Sixty-five of 72 persons (median age 27) who had attended the programme 1998-2003 were interviewed about their occupation at 1, 2, 3 and 5 years after the programme. A logistic regression was made with the variables concerning process skill, somatic problems and irritability, the digit symbol coding and pre-morbid occupation to explore predictors of RTW. Results: The main cause was TBI (44.6%). Before injury 77% were employed or studied and after the injury 80% did not have any occupation. After 5 years 40% had returned to work. The only significant variable in the regression was the pre-morbid occupation. Discussion: The study stresses the difficulty to know the key elements involved in RTW which confirms the need for rehabilitation to focus on several factors in different contexts in order to affect the outcome.	[Bjorkdahl, Ann] Bracke Diakoni Fdn, Res Unit, S-41804 Gothenburg, Sweden; [Bjorkdahl, Ann] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden		Bjorkdahl, A (corresponding author), Bracke Diakoni Fdn, Res Unit, Box 210 62, S-41804 Gothenburg, Sweden.	ann.bjorkdahl@brackediakoni.se	Bjorkdahl, Ann/ABD-6197-2021	Bjorkdahl, Ann/0000-0002-2194-6773			BERNSTEIN JH, 1996, DEV SCORING SYSTEM R; BERNTORP E, 1995, HAEMOPHILIA, V1, P3, DOI 10.1111/j.1365-2516.1995.tb00103.x; Bjorkdahl Ann, 2004, J Stroke Cerebrovasc Dis, V13, P122, DOI 10.1016/j.jstrokecerebrovasdis.2004.04.004; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN EC, 1958, J CONSULT PSYCHOL, V22, P469, DOI 10.1037/h0039980; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.534487, 10.1161/STROKEAHA.108.535088]; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; FISHER AG, 1993, AM J OCCUP THER, V47, P319, DOI 10.5014/ajot.47.4.319; Fleming J, 1999, BRAIN INJURY, V13, P417; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Hamsher K., 1989, MULTILINGUAL APHASIA; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Hashimoto K, 2006, J REHABIL MED, V38, P20, DOI 10.1080/16501970510038473; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Leung K L, 2005, Work, V25, P333; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P351, DOI 10.33588/rn.3204.2000456; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Possl O, 2001, BRAIN INJURY, V15, P15; Saeki S, 2000, DISABIL REHABIL, V22, P578, DOI 10.1080/09638280050138241; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schmidt M., 1996, REY AUDITORY VERBAL; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Watanabe TK, 2003, ARCH PHYS MED REHAB, V84, pS23, DOI 10.1053/apmr.2003.50054; Wechsler, 1997, WECHSLER ADULT INTEL; Wolfenden B, 2009, INT J REHABIL RES, V32, P93, DOI 10.1097/MRR.0b013e328325a358; World Health Organization, 2007, INT CLASS FUNCT DIS; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	49	11	14	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	9					1061	1069		10.3109/02699052.2010.494588			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	636RH	WOS:000280756700002	20597634				2022-02-06	
J	Chan, RCK; Qing, YH; Wu, QP; Shum, D				Chan, Raymond C. K.; Qing, Yonghong; Wu, Qiuping; Shum, David			Prospective memory in healthy Chinese people: The latent structure of the Comprehensive Assessment of Prospective Memory Questionnaire	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Prospective memory; Activities of daily living; Normal aging; Chinese	TRAUMATIC BRAIN-INJURY; RETROSPECTIVE MEMORY; NORMATIVE DATA; ADULTS	This study aimed to examine the latent structure of the Chinese version of the Comprehensive Assessment of Prospective Memory (CAPM) using confirmatory factor analysis. A total of 264 healthy Chinese participants (118 men and 146 women) took part in the study and their ages ranged from 17 to 90 years. There was no gender effect upon the frequency of prospective memory (PM) forgetting but age and education were found to be correlated significantly with these frequencies in the current sample. Results of the study also showed that the model with the best fit had a tripartite structure which consisted of a general memory factor (with all items loading on it) plus a basic activities of daily living as well as an instrumental activities of daily living factor. Furthermore, this tripartite model was robust across subgroups with respect to gender, education, and age. These findings provide support for the construct validity of the original CAPM and demonstrate its utility in another culture.	[Chan, Raymond C. K.] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Chan, Raymond C. K.] Chinese Acad Sci, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [Qing, Yonghong] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Qiuping] Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Hong Kong, Peoples R China; [Shum, David] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Shum, David] Griffith Univ, Griffith Inst Hlth & Med Res, Brisbane, Qld 4111, Australia		Chan, RCK (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, 4A Datun Rd, Beijing 100101, Peoples R China.	rckchan@psych.ac.cn	Shum, David/A-3914-2008; Chan, Raymond CK/B-6717-2009	Shum, David/0000-0002-4810-9262; Chan, Raymond CK/0000-0002-3414-450X	Project-Oriented Hundred Talents Programme [O7CX031003]; Chinese Academy of SciencesChinese Academy of Sciences [KSCX2-YW-R-131]	This study was supported partially by the Project-Oriented Hundred Talents Programme (O7CX031003) and the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-YW-R-131) to Raymond Chan.	Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Brown M.W., 1993, SOCIOL METHOD RES, P136; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chan RCK, 2008, J NEUROL NEUROSUR PS, V79, P86, DOI 10.1136/jnnp.2007.117184; CHAN RCK, 2009, PROSPECTIVE RE UNPUB; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; Crawford JR, 2006, BRIT J CLIN PSYCHOL, V45, P83, DOI 10.1348/014466505X28748; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; GLISKY EL, 1996, PROSPECTIVE MEMORY T, P249; GRAF P, 2002, LIFESPAN DEV HUMAN M, P235; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Long, 1996, ECOLOGICAL VALIDITY, P15; Maylor E. A., 1996, PROSPECTIVE MEMORY T, P173; Maylor EA, 2002, MEM COGNITION, V30, P871, DOI 10.3758/BF03195773; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Zhao, 1989, SHANGHAI ARCH PSYCHI, V7, P108	21	11	12	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	3					459	470	PII 919212199	10.1080/09602010903425710			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	598RZ	WOS:000277857200007	20155572				2022-02-06	
J	Dagher, JH; Habra, N; Lamoureux, J; de Guise, E; Feyz, M				Dagher, Jehane H.; Habra, Natalie; Lamoureux, Julie; de Guise, Elaine; Feyz, Mitra			Global outcome in acute phase of treatment following moderate-to-severe traumatic brain injury from motor vehicle collisions vs assaults	BRAIN INJURY			English	Article						Traumatic brain injury; motor vehicle collision; assaults; violence; acute care	HEAD-INJURY; MORTALITY; INTOXICATION; ETIOLOGY; VIOLENCE; ABUSE	Primary objective: To compare socio-demographic, medical characteristics and acute outcomes between patients with traumatic brain injuries (TBIs) from motor vehicle collision (MVC) or assault in an acute care setting. Research design: This descriptive, comparative retrospective cohort study included 415 patients with moderate and severe TBI secondary to an assault (n = 91) vs a motor vehicle collision (n = 324). Methods and procedures: Outcome measures were length of stay (LOS) in the intensive care unit and in hospital, Extended Glasgow Outcome Scale (GOS-E), FIM (R) instrument ('FIM')dagger and discharge destination. Main outcomes and results: Patients with TBI from MVC had a higher percentage of polytrauma, higher injury severity scores, required more orthopaedic surgeries and thoracic drain insertions. Patients with TBI from assault were more often non-Caucasian, young single men, less educated with higher unemployment rates and criminal records, with a history of alcohol and drug abuse and were more often intoxicated on admission. There was no significant group difference in the LOS and FIM ratings, but patients with assault-related TBI were more often discharged home and had a more favourable GOS-E. Conclusion: Variables such as injury severity, age, level of intoxication on admission and presence of surgeries should be considered when determining acute outcome.	[Dagher, Jehane H.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Phys Med & Rehabil Dept, Montreal, PQ H3G 1A4, Canada; [Dagher, Jehane H.; Habra, Natalie] Univ Montreal, Phys Med & Rehabil Dept, Inst Readaptat Gingras Lindsay Montreal, Montreal, PQ, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [de Guise, Elaine; Feyz, Mitra] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Neurol & Neurosurg Dept, Montreal, PQ H3G 1A4, Canada		Dagher, JH (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Phys Med & Rehabil Dept, Room D13-124,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	drdagher@hotmail.com		Lamoureux, Julie/0000-0002-4986-2504			Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN H, 1975, J NERV MENT DIS, V167, P675; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Schopp LH, 2006, J HEAD TRAUMA REHAB, V21, P213, DOI 10.1097/00001199-200605000-00002; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	21	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	12					1389	1398		10.3109/02699052.2010.523042			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	667NR	WOS:000283200800002	20887096				2022-02-06	
J	Duja, CM; Berna, C; Kremer, S; Geronimus, C; Kopferschmitt, J; Bilbault, P				Duja, Corina M.; Berna, Christophe; Kremer, Stephane; Geronimus, Claude; Kopferschmitt, Jacques; Bilbault, Pascal			Confusion after spine injury: cerebral fat embolism after traumatic rupture of a Tarlov cyst: Case report	BMC EMERGENCY MEDICINE			English	Article								Background: Acute low back pain is a very common symptom and reason for many medical consultations. In some unusual circumstances it could be linked to a rare aetiology. Case presentation: We report a 70-year-old man with an 8-month history of left posterior thigh and leg pain who had sudden confusion after a fall from standing. It was due to cerebral fat embolism suspected by computed tomography scan, later confirmed by brain magnetic resonance imaging (MRI). A spinal MRI scan was then performed and revealed a sacral fracture which drained into an unknown perineurial cyst (Tarlov cyst). Under medical observation the patient fully recovered within three weeks. Conclusions: Sacral perineurial cysts are rare, however they remain a potential cause of lumbosacral radiculopathy.	[Duja, Corina M.; Berna, Christophe; Geronimus, Claude; Kopferschmitt, Jacques; Bilbault, Pascal] Hop Hautepierre, Div Emergency & Intens Care, Fac Med, Strasbourg, France; [Kremer, Stephane] Hop Hautepierre, Dept Neuroradiol, Fac Med, Strasbourg, France		Bilbault, P (corresponding author), Hop Hautepierre, Div Emergency & Intens Care, Fac Med, Strasbourg, France.	pascal.bilbault@chru-strasbourg.fr					Acosta F.L., 2003, NEUROSURG FOCUS, V15, P1, DOI 10.3171/foc.2003.15.2.15; Aydin MD, 2005, CLIN NEUROPATHOL, V24, P86; BOLLAR A, 1989, NEUROCHIRURGIA, V32, P123; Caspar W, 2003, SURG NEUROL, V59, P101, DOI 10.1016/S0090-3019(02)00981-3; Guo DS, 2007, NEUROSURGERY, V60, P1059, DOI 10.1227/01.NEU.0000255457.12978.78; GURD AR, 1974, J BONE JOINT SURG BR, VB 56, P408, DOI 10.1302/0301-620X.56B3.408; John-Kalarickal JM, 2007, PITUITARY, V10, P103, DOI 10.1007/s11102-007-0017-y; Parizel PM, 2001, STROKE, V32, P2942, DOI 10.1161/str.32.12.2942; PAULSEN RD, 1994, AM J NEURORADIOL, V15, P293; Richard AD, 2001, NEW ENGL J MED, V344, P363; RODZIEWICZ GS, 1984, SURG NEUROL, V22, P50, DOI 10.1016/0090-3019(84)90228-3; TARLOV IM, 1948, JAMA-J AM MED ASSOC, V138, P740, DOI 10.1001/jama.1948.02900100020005; Tarlov IM, 1938, ARCH NEURO PSYCHIATR, V40, P1067, DOI 10.1001/archneurpsyc.1938.02270120017001; Taviloglu K, 2007, SURG TODAY, V37, P5, DOI 10.1007/s00595-006-3307-5; Voyadzis JM, 2001, J NEUROSURG, V95, P25, DOI 10.3171/spi.2001.95.1.0025	15	11	12	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.		2010	10								18	10.1186/1471-227X-10-18			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V55BG	WOS:000210467500018	20712856	gold, Green Published			2022-02-06	
J	Huebinger, RM; Gomez, R; Mcgee, D; Chang, LY; Bender, JE; O'Keeffe, T; Burris, AM; Friese, SM; Purdue, GF; Hunt, JL; Arnoldo, BD; Horton, JW; Barber, RC				Huebinger, Ryan M.; Gomez, Ruben; McGee, Daphne; Chang, Ling-Yu; Bender, Jessica E.; O'Keeffe, Terence; Burris, Agnes M.; Friese, Susan M.; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Horton, Jureta W.; Barber, Robert C.			ASSOCIATION OF MITOCHONDRIAL ALLELE 4216C WITH INCREASED RISK FOR SEPSIS-RELATED ORGAN DYSFUNCTION AND SHOCK AFTER BURN INJURY	SHOCK			English	Article						Mitochondrial electron transport chain; mitochondrial DNA polymorphism; genetic association; complex I	PARKINSONS-DISEASE; POLYMORPHISMS; MORTALITY; GENOME; EPIDEMIOLOGY; NETWORKS; VARIANT; DEATH	Impaired mitochondrial activity has been linked to increased risk for clinical complications after injury. Furthermore, variant mitochondrial alleles have been identified and are thought to result in decreased mitochondrial activity. These include a nonsynonymous mitochondrial polymorphism (T4216C) in the nicotinamide adenine dinucleotide dehydrogenase 1 gene (ND1), encoding a key member of complex I within the electron transport chain, which is found almost exclusively among Caucasians. We hypothesized that burn patients carrying ND1 4216C are less able to generate the cellular energy necessary for an effective immune response and are at increased risk for infectious complications. The association between 4216C and outcome after burn injury was evaluated in a cohort of 175 Caucasian patients admitted to the Parkland Hospital with burns covering greater than or equal to 15% of their total body surface area or greater than or equal to 5% full-thickness burns under an institutional review board-approved protocol. To remove confounding unrelated to burn injury, individuals were excluded if they presented with significant non-burn-related trauma (Injury Severity Score >= 16), traumatic or anoxic brain injury, spinal cord injury, were HIV/AIDS positive, had active malignancy, or survived less than 48 h postadmission. Within this cohort of patients, carriage of the 4216C allele was significantly associated by unadjusted analysis with increased risk for sepsis-related organ dysfunction or septic shock (P = 0.011). After adjustment for full-thickness burn size, inhalation injury, age, and sex, carriage of the 4216C allele was associated with complicated sepsis (adjusted odds ratio = 3.7; 95% confidence interval, 1.5-9.1; P = 0.005), relative to carriers of the T allele.	[Huebinger, Ryan M.; Chang, Ling-Yu; Burris, Agnes M.; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Horton, Jureta W.; Barber, Robert C.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Gomez, Ruben] Detroit Med Ctr, Dept Surg, Detroit, MI USA; [McGee, Daphne] Baylor Univ, Waco, TX 76798 USA; [Bender, Jessica E.; O'Keeffe, Terence; Friese, Susan M.] Arizona Hlth Sci Ctr, Dept Surg, Tucson, AZ 85724 USA		Barber, RC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	robert.barber@utsouthwestern.edu			National Institutes of Health/US National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM057054-09, 5P50 GM21681-42, 5T32 GM00859313]; UT Southwestern Medical Center Department of Surgery Critical Care Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM057054, P50GM021681] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health/US National Institute of General Medical Sciences (grant no. R01-GM057054-09 to J.W.H. and grant nos. 5P50 GM21681-42 and 5T32 GM00859313) and the UT Southwestern Medical Center Department of Surgery Critical Care Fellowship.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Barber RC, 2007, J BURN CARE RES, V28, P205, DOI 10.1097/BCR.0B013E318031A1BF; Bloemsma GC, 2008, BURNS, V34, P1103, DOI 10.1016/j.burns.2008.02.010; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Canter JA, 2007, ANN SURG, V246, P406, DOI 10.1097/SLA.0b013e3181469955; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Gomez R, 2009, J TRAUMA, V66, P850, DOI 10.1097/TA.0b013e3181991ac8; Hofmann S, 1997, AM J HUM GENET, V60, P1539; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016; Ioannidis JPA, 2005, AM J EPIDEMIOL, V162, P302, DOI 10.1093/aje/kwi201; KARTER M, 2008, FIRE LOSS US 2007; Kudsk K A, 1994, Nutr Clin Pract, V9, P165, DOI 10.1177/0115426594009005165; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McDaniel DO, 2007, J TRAUMA, V63, P147, DOI 10.1097/TA.0b013e31806bf0ab; MERRELL SW, 1989, J TRAUMA, V29, P1362, DOI 10.1097/00005373-198910000-00012; Militsa B, 2001, Neurol India, V49 Suppl 1, pS75; Miller SF, 2006, J BURN CARE RES, V27, P411, DOI 10.1097/01.BCR.0000226260.17523.22; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Sigalet DL, 2004, CAN J SURG, V47, P109; Svistunenko DA, 2006, BBA-BIOENERGETICS, V1757, P262, DOI 10.1016/j.bbabio.2006.03.007; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Velez DR, 2008, MITOCHONDRION, V8, P130, DOI 10.1016/j.mito.2007.10.007	31	11	12	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JAN	2010	33	1					19	23		10.1097/SHK.0b013e3181a99508			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	535LQ	WOS:000272970200005	19487983				2022-02-06	
J	Makdissi, M				Makdissi, Michael			Sports related concussion Management in general practice	AUSTRALIAN FAMILY PHYSICIAN			English	Article						wounds and injuries; athletic injuries; brain concussion	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; HEAD-INJURY; AGREEMENT STATEMENT; ENCEPHALOPATHY; EPIDEMIOLOGY; IMPAIRMENT; SYMPTOMS; RECOVERY; SEQUELAE	Background Concussive injuries are common in many sports and recreational activities, especially those involving body contact, collisions or high speed. Over the past 8 years, international experts met on three occasions to address key issues in the understanding and management of concussion in sport; most recently in Zurich in November 2008. The consensus statement produced from this meeting provides an outline of up-to-date knowledge and best practice management guidelines on concussion in sport. Objective The aim of this article is to provide an overview of the key concepts from the Zurich consensus statement, including an understanding of concussion and an outline of potential risks and recommended management as applicable to the general practice setting. Discussion Concussion is thought to reflect a functional injury to the brain. Clinical features are typically short lived and resolve spontaneously, with the majority of affected individuals recovering within 10-14 days. However, complications can occur including prolonged symptoms or cognitive deficit, depression, and cumulative deterioration in brain function. The potential for adverse outcomes and the absence of direct measures of recovery following a concussive injury, make decisions regarding return to play a challenge. Clinical management includes confirming the diagnosis, differentiating concussion from structural head injury, estimating the severity of injury, and determining when the patient can return safely to competition. Players should return to play in a graded fashion after clinical features have resolved and cognitive function has returned to 'normal' on neuropsychological testing.	[Makdissi, Michael] Australasian Coll Sports Phys, Melbourne, Vic, Australia; [Makdissi, Michael] Olymp Pk Sports Med Ctr, Melbourne, Vic, Australia		Makdissi, M (corresponding author), Australasian Coll Sports Phys, Melbourne, Vic, Australia.	makdissi@unimelb.edu.au		makdissi, michael/0000-0003-0334-7133			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chadwick D, 1997, BRIT MED J, V314, P1283; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 1998, PHYSICIAN SPORTSMED, V26, P25, DOI 10.3810/psm.1998.02.928; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; WESCHLER D, 1981, WESCHLER ADULT INTEL; WRIGHTSON P, 1983, PAT MANAGEMENT, V3, P79	52	11	11	0	3	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	0300-8495			AUST FAM PHYSICIAN	Aust. Fam. Physician	JAN-FEB	2010	39	1-2					12	17					6	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552KW	WOS:000274289900005	20369128				2022-02-06	
J	Alhajj, M; Nelson, NG; McKenzie, LB				Alhajj, Maya; Nelson, Nicolas G.; McKenzie, Lara B.			Hot Tub, Whirlpool, and Spa-Related Injuries in the US, 1990-2007	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							CHILDREN	Background: Recreational use of hot tubs, whirlpools, and spas has increased within the past 3 decades. Injuries due to hot tubs, whirlpools, and spas can affect people of all ages and can result in serious disabilities. Purpose: This Study examines nonfatal hot tub, whirlpool, and spa-related injuries oil a national level. Methods: The National Electronic Injury Surveillance System database was used to examine cases of nonfatal hot tub, whirlpool, and spa-related injuries treated in U.S. emergency departments from January 1, 1990, through December 31, 2007. Analysis was conducted from November 2008 to March 2009. Results: An estimated 81,597 patients, aged <1-102 years, were treated in U.S. emergency departments for hot tub, whirlpool, and spa-related injuries, with the number increasing 160% over the 18-year study period (p<0.001). Nearly 73% of injuries occurred in patients aged >= 17 years. Lacerations were the most common diagnosis (27.8%) and accounted for 58% of all head injuries. Slips and falls were the most common mechanism Of injury (47.6%); were more likely to result in an injury, to the trunk than other body parts (OR=2.49, 95% CI=1.83, 3.39); and were more likely to result in concussions and fractures/dislocations than any other diagnosis (OR=7.813, 95% CI=2.194, 27.823 and OR=3.017, 95% CI=2.057, 4.425, respectively). Conclusions: Given the increase in hot tub, whirlpool, and spa ownership and the 160% increase in injuries during the study period, more research is needed to identify the cause of the increase in hot tub, whirlpool, and spa-related injuries and what injury-prevention Solutions and policies may be appropriate. (Am J Prev Med 2009;37(6):531-536) (C) 2009 American Journal of Preventive Medicine	[Alhajj, Maya; Nelson, Nicolas G.; McKenzie, Lara B.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [McKenzie, Lara B.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA		McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	lara.mckenzie@nationwidechildrens.org	McKenzie, Lara/C-5122-2012	McKenzie, Lara/0000-0003-2889-0001			*ASS POOL SPA PROF, 2006, SENS WAY ENJ YOUR SP, P22; *ASTM INT, 2003, 01003 ASTM INT; Blum C, 2000, Inj Prev, V6, P288, DOI 10.1136/ip.6.4.288; Galbreath RW, 1999, J SAFETY RES, V30, P7, DOI 10.1016/S0022-4375(98)00057-7; Hartman TE, 2007, AM J ROENTGENOL, V188, P1050, DOI 10.2214/AJR.06.0546; Mao SJ, 2009, PEDIATRICS, V124, P541, DOI 10.1542/peds.2008-2489; PRESS E, 1991, AM J PUBLIC HEALTH, V81, P1034, DOI 10.2105/AJPH.81.8.1034; RINKE CM, 1983, JAMA-J AM MED ASSOC, V250, P2031, DOI 10.1001/jama.250.15.2031; Schroeder T., 2001, NEISS SAMPLE DESIGN; SHINABERGER CS, 1990, AM J PUBLIC HEALTH, V80, P613, DOI 10.2105/AJPH.80.5.613; Spencer SR, 2005, CLIN PEDIATR, V44, P311, DOI 10.1177/000992280504400405; SPITALNY KC, 1984, AM J PUBLIC HEALTH, V74, P725, DOI 10.2105/AJPH.74.7.725; TURNER J, 2004, CRIT CARE NURSE, V23, P191; U. S. Consumer Product Safety Commission, 2000, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1982, CHILDR DROWN MOR AR; 2000, MMWR MORB MORTAL WKL, V49, P1087	16	11	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	DEC	2009	37	6					531	536		10.1016/j.amepre.2009.08.024			6	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	532SJ	WOS:000272769700010	19944920				2022-02-06	
J	Czeiter, E; Buki, A; Bukovics, P; Farkas, O; Pai, J; Kovesdi, E; Doczi, T; Sandor, J				Czeiter, Endre; Buki, Andras; Bukovics, Peter; Farkas, Orsolya; Pai, Jozsef; Kovesdi, Erzsebet; Doczi, Tamas; Sandor, Janos			Calpain Inhibition Reduces Axolemmal Leakage in Traumatic Axonal Injury	MOLECULES			English	Article						calpain; MDL-28170; traumatic axonal injury; traumatic brain injury	SPECTRIN BREAKDOWN PRODUCTS; FOCAL CEREBRAL-ISCHEMIA; BRAIN-INJURY; CEREBROSPINAL-FLUID; SPINAL-CORD; HEAD-INJURY; PERMEABILITY; PROTEOLYSIS; RAT; ACTIVATION	Calcium-induced, calpain- mediated proteolysis (CMSP) has recently been implicated to the pathogenesis of diffuse (traumatic) axonal injury (TAI). Some studies suggested that subaxolemmal CMSP may contribute to axolemmal permeability (AP) alterations observed in TAI. Seeking direct evidence for this premise we investigated whether subaxolemmal CMSP may contribute to axolemmal permeability alterations (APA) and pre-injury calpain- inhibition could reduce AP in a rat model of TAI. Horseradish peroxidase (HRP, a tracer that accumulates in axons with APA) was administered one hour prior to injury into the lateral ventricle; 30 min preinjury a single tail vein bolus injection of 30 mg/kg MDL-28170 (a calpain inhibitor) or its vehicle was applied in Wistar rats exposed to impact acceleration brain injury. Histological detection of traumatically injured axonal segments accumulating HRP and statistical analysis revealed that pre-injury administration of the calpain inhibitor MDL-28170 significantly reduced the average length of HRP-labeled axonal segments. The axono-protective effect of pre-injury calpain inhibition recently demonstrated with classical immunohistochemical markers of TAI was further corroborated in this experiment; significant reduction of the length of labeled axons in the drug-treated rats implicate CMSP in the progression of altered AP in TAI.	[Czeiter, Endre; Buki, Andras; Bukovics, Peter; Farkas, Orsolya; Pai, Jozsef; Kovesdi, Erzsebet; Doczi, Tamas] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Sandor, Janos] Univ Pecs, Inst Appl Hlth Sci, Dept Publ Hlth, Pecs, Hungary		Buki, A (corresponding author), Univ Pecs, Dept Neurosurg, Pecs, Hungary.	endre.czeiter@aok.pte.hu; 2saturn@gmail.com; janos.sandor@etk.pte.hu	Czeiter, Endre/B-1404-2009; Bukovics, Peter/A-6019-2009; Buki, Andras/B-1960-2010; Doczi, Tamas/C-5750-2009	Pal, Jozsef/0000-0001-6468-6409	Aventis Pharmaceuticals [MDL-28170]; Hungarian Science Founds [OTKA T048724, OTKA PD 72240]; Bekesy Scholarship of the Hungarian Academy of Sciences	The authors thank the Aventis Pharmaceuticals for the kind donation of the MDL-28170 and Csabane Andok, Andrasne Nodor and Jozsef Nyiradi for their technical assistance. This study was supported by the Hungarian Science Founds (OTKA T048724; OTKA PD 72240) and the Bekesy Scholarship of the Hungarian Academy of Sciences.	Banik NL, 1998, ANN NY ACAD SCI, V844, P131, DOI 10.1111/j.1749-6632.1998.tb08228.x; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cardali S, 2006, J Neurosurg Sci, V50, P25; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Couto LA, 2004, J NEUROSCI RES, V77, P410, DOI 10.1002/jnr.20170; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; Lee KS, 1997, ANN NY ACAD SCI, V825, P95, DOI 10.1111/j.1749-6632.1997.tb48419.x; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Povlishock JT, 2001, HEAD TRAUMA, P281; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Zhang SX, 2003, J NEUROTRAUM, V20, P59, DOI 10.1089/08977150360517182	28	11	12	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	DEC	2009	14	12					5115	5123		10.3390/molecules14125115			9	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	536KL	WOS:000273043200020	20032879	Green Published, Green Submitted, gold			2022-02-06	
J	Ylioja, SG; Baird, AD; Podell, K				Ylioja, Shelley G.; Baird, Anne D.; Podell, Kenneth			Developing a Spatial Analogue of the Reliable Digit Span	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity testing; Traumatic brain injury; Forensic neuropsychology	MALINGERED NEUROCOGNITIVE DYSFUNCTION; ADULT INTELLIGENCE SCALE; SYMPTOM VALIDITY TEST; NEUROPSYCHOLOGICAL TESTS; CLASSIFICATION ACCURACY; III DIGIT; MEMORY; PERFORMANCE; SPECIFICITY; SENSITIVITY	It is recommended that performance validity be assessed in all neuropsychological cases involving external incentive. The present study sought to develop an embedded performance validity measure based on the Spatial Span task of the Wechsler Memory Scale-III in a sample of litigating persistent postconcussion complainants. The Reliable Spatial Span (RSS) calculation had specificity, sensitivity, and predictive power values within the range of other embedded measures. This finding suggests that RSS is able to distinguish between persistent postconcussion complainants demonstrating valid and invalid performance. Other calculations involving Spatial Span scores had lower classification accuracy. Reliable Digit Span (RDS) classification accuracy within the present sample was lower than that of previous research, as well as of RSS. Potential reasons for lack of RDS replication are discussed, along with the potential use of RSS as an embedded validity performance indicator.	[Baird, Anne D.; Podell, Kenneth] Henry Ford Hlth Syst, Div Neuropsychol, Detroit, MI 48202 USA; [Ylioja, Shelley G.; Baird, Anne D.; Podell, Kenneth] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada		Podell, K (corresponding author), Henry Ford Hlth Syst, Div Neuropsychol, 1 Ford Pl 1E, Detroit, MI 48202 USA.	kpodell1@hfhs.org			National Sciences and Engineering Research Council of Canada.Natural Sciences and Engineering Research Council of Canada (NSERC)	This research was supported by a Canada Graduate Scholarship Master's awarded to the first author by the National Sciences and Engineering Research Council of Canada.	Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Darke S., 1988, COGNITION EMOTION, V2, P145, DOI [DOI 10.1080/02699938808408071, 10.1080/02699938808408071]; Delis D.C., 2000, CALIFORNIA VERBAL LE; Duncan SA, 2002, ASSESSMENT, V9, P56, DOI 10.1177/1073191102009001007; Etherton J, 2005, ASSESSMENT, V12, P130, DOI 10.1177/1073191105274859; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 1996, WORD MEMORY TEST USE; GREENE RL, 1998, MMPI 2 ADULT INTERPR; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hester RL, 2004, J INT NEUROPSYCH SOC, V10, P475, DOI 10.1017/S1355617704104037; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Mammarella IC, 2005, COGN NEUROPSYCHOL, V22, P1055, DOI 10.1080/02643290442000509; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Matthews CG., 1964, INSTRUCTION MANUAL A; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; MOREY LC, 1996, PERSONALITY ASSESSME; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Reitan R, 1985, HALSTEAD REITAN NEUR; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; Ruff RM, 1988, RUFF FIGURAL FLUENCY; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smyth MM, 1996, Q J EXP PSYCHOL-A, V49, P159, DOI 10.1080/713755615; Spreen E., 2006, COMPENDIUM NEUROPSYC, P1; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Szmalec A, 2005, MEM COGNITION, V33, P531, DOI 10.3758/BF03193069; The Psychological Corporation, 1997, WAIS III WMS III TEC; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vandierendonck A, 2004, BRIT J PSYCHOL, V95, P57, DOI 10.1348/000712604322779460; Vandierendonck A, 1998, EUR J COGN PSYCHOL, V10, P413, DOI 10.1080/713752284; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Wilde N, 2002, CLIN NEUROPSYCHOL, V16, P322, DOI 10.1076/clin.16.3.322.13858; Wilkinson G., 1993, WIDE RANGE ACHIEVEME, V3	57	11	11	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2009	24	8					729	739		10.1093/arclin/acp078			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	524VO	WOS:000272172700002	19854719				2022-02-06	
J	Jones, HA				Jones, Helen A.			Arterial transducer placement and cerebral perfusion pressure monitoring: a discussion	NURSING IN CRITICAL CARE			English	Article						Head injuries; Intensive care nursing; Monitoring	CRITICAL CLOSING PRESSURE; INTRACRANIAL-PRESSURE; HEAD-INJURY; HYPERTENSION; CIRCULATION; REACTIVITY; FLOW	Aim: To discuss existing disparity of practice and clinical implications of measuring cerebral perfusion pressure (CPP) from differing reference points thus highlighting the need for standardized benchmarks. Background: When managing traumatic brain injury (TBI), the arterial transducer level is a key to an accurate CPP reading; however, there is a lack of national standards about where to zero arterial transducers when monitoring CPP. Methods: A systematized search using the Cochrane library database, Pubmed database, Medline, British Library on line, CINAHL and PROQUEST using key search terms was used to identify articles that could form a basis for a discussion. Papers published between 2000 and 2008 were included. Papers that did not discuss arterial transducer level placement and CPP were excluded. The Brian Trauma Guidelines 2007 were scrutinized for recommendations. Results: Of 57 empirical studies accessed, none reported or explored the placement of the arterial transducer during CPP measurement. Conflicting opinions were identified within the literature and there were no recommendations made for practice within the Brain Trauma Foundation Guidelines 2007. Discussion: At the present time, there is insufficient evidence for recommending standard placement for mean arterial pressure (MAP) measurements for patients with TBI. There are implications to consider as the treatment prescribed will differ depending on where the arterial transducer is placed because the MAP and CPP displayed will fall by 15 mm Hg at a head elevation of 30 degrees. This poses a number of questions: is the CPP underestimated with the arterial transducer placed at head level? Is the CPP overestimated if the transducer is placed at mid axilla level? Recommendations: Further research is recommended. However, studies would be difficult to power as head-injured patients constitute a heterogeneous population. Professional consensus should be applied and standardized benchmarks agreed.	[Jones, Helen A.] Walton Ctr Neurol & Neurosurg NHS Trust, Liverpool 97AL, Merseyside, England		Jones, HA (corresponding author), Walton Ctr Neurol & Neurosurg NHS Trust, Lower Lane, Liverpool 97AL, Merseyside, England.	helen.jones@thewaltoncentre.nhs.uk					BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, DOI DOI 10.1089/NEU.9987; *BRAINIT GROUP, 2008, HYDR PRESS CALC CPP; Buhre W, 2003, BRIT J ANAESTH, V90, P291, DOI 10.1093/bja/aeg073; BULLOCK J, 2001, PHYSIOLOGY; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Farrar JK, 1973, STROKE, V4, P795, DOI 10.1161/01.STR.4.5.795; Hicks JW, 2005, AM J PHYSIOL-REG I, V289, pR629, DOI 10.1152/ajpregu.00810.2004; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; INGRAM M, 2006, CRITICAL CARE PHI S1, V10, P450; JONES H, 2008, BACCN C JUN 2008; LOBATO EB, 2007, COMPLICATIONS ANAEST, P849; MATTA BF, 2000, TXB NEUROANAESTHESIA, P101; McCann YG, 2001, CHEST, V120, P1322, DOI 10.1378/chest.120.4.1322; MUNIS J, 2008, APSF NEWSL, V22, P82; Munis JR, 2000, J NEUROSURG ANESTH, V12, P290, DOI 10.1097/00008506-200007000-00029; NORDSTROM CH, 2003, NEUROSURG FOCUS, V15; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; PRANEVICIUS M, 2008, ANESTHESIA PATIENT S, V23, P21; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Thees C, 2002, ANESTHESIOLOGY, V96, P595, DOI 10.1097/00000542-200203000-00014; Tortora G.j., 2000, PRINCIPLES ANATOMY P; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002	23	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1362-1017	1478-5153		NURS CRIT CARE	Nurs. Crit. Care	NOV-DEC	2009	14	6					303	310		10.1111/j.1478-5153.2009.00352.x			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	V18IH	WOS:000207998000005	19840277				2022-02-06	
J	Mazzola, RF; Mazzola, IC				Mazzola, Riccardo F.; Mazzola, Isabella C.			Treatise on Skull Fractures by Berengario Da Carpi (1460-1530)	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						History; skull fractures; history of surgical instruments; history of plastic surgery		Jacopo Berengario was born in Carpi, a medieval city close to Modena (northern Italy), circa 1460. He Studied medicine at Bologna University and, in 1489, graduated in philosophy and medicine. He was appointed lecturer in anatomy and surgery at the same University, a position that lie maintained for 24 years. Between 1514 and 1523, Berengario published some important anatomic and surgical works, which gave considerable fame to him. Commentaria... supra Anatomiam Mundini (Commentary... on the Anatomy of Mondino), published in 1521, constitutes the first example of an illustrated anatomic textbook ever printed. The anatomic illustrations were intended for explaining the text. Artistically speaking, the plates are typical examples of the Renaissance period and worthy of the greatest consideration. De Fractura Calvae sive Cranei (On Fracture of the Calvaria or Cranium), published in Bologna in 15 18, is the first treatise devoted to head injuries ever printed. It is a landmark in the development of cranial surgery that went through numerous editions. The text was prepared in 2 months and dedicated to Lorenzo de' Medici, Duke of Urbino, who experienced a skull injury in the occipital region. Berengario wanted to demonstrate to other physicians his knowledge of anatomy and his expertise on the brain and head traumas. The book includes the illustration of an entire surgical kit or a corpus instrumentorum for performing cranial operations, which appeared for the first time in a printed book. However, Berengario's highly commendable aim was to indicate to the reader the step-by-step procedure of craniotomy for management of skull fractures along with the sequential use of the previously presented instruments.	[Mazzola, Riccardo F.] Univ Milan, Fdn Osped Maggiore Policlin Regina Elena & Mangia, Dipartimento Sci Chirurg Specialist, IRCCS, I-20122 Milan, Italy; [Mazzola, Isabella C.] Rhein Westfal TH Aachen, Univ Hosp, Dept Plast Surg, Aachen, Germany		Mazzola, RF (corresponding author), Univ Milan, Via Marchiondi 7, I-20122 Milan, Italy.	riccardo.mazzola@fastwebnet.it					CELLINI B, 1728, VITA LUI MEDESIMO SC, P32; CHOULANT L, 1920, HIST BIBLIO ANATOMIC, P136; DECARPI JB, 1990, FRACTURES SKULL CRAN, pR21; FORNI GC, 1948, INSEGNAMENTO CHIRURG, P62; FRENCH R, 1999, DISSECTION VIVISECTI, P91; GURLT E, 1898, GESCH CHIRURG IHRER, V1, P961; MAJNO G, 1975, HEALING HAND MAN WOU, V94, P166; MEDICI M, 1857, COMPENDIO STORICO SC, P54; Putti Vittoro, 1937, BERENGARIO CARPI SAG; VASARI G, 1568, VITE PIU ECCELLENT 3, V1, P83	10	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275			J CRANIOFAC SURG	J. Craniofac. Surg.	NOV	2009	20	6					1981	1984		10.1097/SCS.0b013e3181bd2ddc			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	526SL	WOS:000272313600007	19881381				2022-02-06	
J	Flohe, S; Nast-Kolb, D				Flohe, S.; Nast-Kolb, D.			Surgical management of life-threatening injuries	UNFALLCHIRURG			German	Article						Emergency room management; Advanced trauma life support (ATLS (R)); Emergency interventions; Fatal trias	EMERGENCY-DEPARTMENT THORACOTOMY; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; ABDOMINAL EXSANGUINATION; STILL USEFUL; COAGULOPATHY; CRANIOTOMY; SURVIVAL; PACKING	Life-threatening situations after multiple trauma which then require interruption of the diagnostic algorithm and immediate surgical treatment after admission are a challenge for the multidisciplinary trauma team. Emergency surgery after trauma may be necessary for the abdomen, the pelvis, the chest as well as the head. Therefore, several disciplines may be involved. Damage control surgery is the leading surgical strategy in emergency surgery in unstable trauma patients. The main aspects of damage control surgery are outlined in this article. The goal of damage control surgery is to gain control of bleeding as soon as possible without additional surgical trauma. Packing plays a central role in damage control surgery of the abdomen and the pelvis. Surgical decision-making occurs under unfavorable circumstances and extreme time pressure. However, surgical interventions in the shock room rarely occur in the German health system. Therefore, indications and decision-making processes of these challenging situations have to be practiced with standardized algorithms. The "Definitive Surgical Trauma Care" (DSTC)courses may contribute to a straightforward performance in an emergency operation.	[Flohe, S.] Univ Klinikum Dusseldorf, Klin Unfall & Handchirurg, D-40225 Dusseldorf, Germany; [Nast-Kolb, D.] Univ Klinikum Essen, Unfallchirurg Klin, Essen, Germany		Flohe, S (corresponding author), Univ Klinikum Dusseldorf, Klin Unfall & Handchirurg, Moorenstr 5, D-40225 Dusseldorf, Germany.	Sascha.Flohe@med.uni-duesseldorf.de		Flohe, Sascha/0000-0002-8033-1242; Shahid, Sana/0000-0002-7492-1537			Ali J, 2008, CAN J SURG, V51, P185; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Bulinski P, 2003, J TRAUMA, V54, P161, DOI 10.1097/00005373-200301000-00020; Cothren CC, 2007, J TRAUMA, V62, P834, DOI 10.1097/TA.0b013e31803c7632; Degiannis E, 2006, WORLD J SURG, V30, P1258, DOI 10.1007/s00268-005-0463-5; Doll D, 2006, UNFALLCHIRURG, V109, P898, DOI 10.1007/s00113-006-1096-3; FELICIANO DV, 1981, J TRAUMA, V21, P285, DOI 10.1097/00005373-198104000-00005; Hall BL, 2005, J TRAUMA, V59, P773, DOI 10.1097/01.ta.0000177457.45246.8e; Heinzelmann M, 2004, UNFALLCHIRURG, V107, P871, DOI 10.1007/s00113-004-0846-3; Ivatury RR, 2008, J TRAUMA, V64, P7; Jacobs L M, 2001, Conn Med, V65, P265; Matthes G, 2006, UNFALLCHIRURG, V109, P437, DOI 10.1007/s00113-006-1065-x; Moore EE, 1996, AM J SURG, V172, P405, DOI 10.1016/S0002-9610(96)00216-4; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Osborn PM, 2009, INJURY, V40, P54, DOI 10.1016/j.injury.2008.08.038; Pitts LH, 1998, J TRAUMA, V44, P989; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; SCHEIN M, 1986, BRIT J SURG, V73, P369, DOI 10.1002/bjs.1800730514; Seamon MJ, 2008, J TRAUMA, V64, P1, DOI 10.1097/TA.0b013e3181606125; Soreide K, 2007, INJURY, V38, P34, DOI 10.1016/j.injury.2006.06.125; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TOMINAGA GT, 1993, AM SURGEON, V59, P834	24	11	11	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	OCT	2009	112	10					854	859		10.1007/s00113-009-1680-4			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	505DG	WOS:000270668300004	19756452				2022-02-06	
J	Caeyenberghs, K; van Roon, D; van Aken, K; De Cock, P; Linden, CV; Swinnen, SP; Smits-Engelsman, BCM				Caeyenberghs, Karen; van Roon, Dominique; van Aken, Katrijn; De Cock, Paul; Linden, Catharine Vander; Swinnen, Stephan P.; Smits-Engelsman, Bouwien C. M.			Static and Dynamic Visuomotor Task Performance in Children With Acquired Brain Injury: Predictive Control Deficits Under Increased Temporal Pressure	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; anticipation; brain damage; children; eye-hand coordination; manual pursuit; motor control	MOVEMENT ASSESSMENT BATTERY; CLOSED-HEAD INJURY; MOTOR-PERFORMANCE; MANUAL TRACKING; RELIABILITY; RECOVERY; DISORDERS; VALIDITY; MODERATE; IMAGERY	Objective: To compare performance of children with acquired brain injury (AB I) on static versus dynamic visuornotor tasks with that of control children. Participants: Twenty-eight children with ABI and 28 normal age- and gender-matched controls (aged 6-16 years). Main Measures: Two visuornotor tasks on a digitizing tablet: (1) a static motor task requiring tracing of a flower figure and (2) a dynamic task consisting of tracking an accelerating dot presented on a monitor. Results: Children with ABI performed worse than the control group only during the dynamic tracking task; the duration within the target was shorter, the distance between the centers of cursor and target was larger, and the number of velocity peaks per centimeter and the number of stops (ie, the number of submovements) were higher than those of the control group. Rather than resulting from movement execution problems, this might be due to less adequate processing of fast incoming sensory information, resulting in a decreased ability to anticipate the movement of the target (predictive control). Conclusion: Deficits in eye-hand coordination require careful attention, even in the postinjury chronic phase.	[Caeyenberghs, Karen; Smits-Engelsman, Bouwien C. M.] Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Dept Biomed Kinesiol, B-3001 Louvain, Belgium; [van Aken, Katrijn] Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, B-3001 Louvain, Belgium; [De Cock, Paul] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Paediat, B-3001 Louvain, Belgium; [Linden, Catharine Vander] Ghent Univ Hosp, Child Rehabil Ctr, Dept Phys Med & Rehabil, B-9000 Ghent, Belgium; [Smits-Engelsman, Bouwien C. M.] Univ Profess, Breda, Netherlands		Smits-Engelsman, BCM (corresponding author), Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Dept Biomed Kinesiol, Tervuursevest 101, B-3001 Louvain, Belgium.	bouwiensmits@hotmail.com		Caeyenberghs, Karen/0000-0001-7009-6843	Research Foundation-FlandersFWO [7.0004.05, GP.026.06N]; Katholieke Universiteit LeuvenKU Leuven [F/06/024]	The support for this study was provided through a grant from the Research Program of the Research Foundation-Flanders (FWO, Levenslijn # 7.0004.05). D. van Roon was funded by a visiting postdoctoral fellowship of the Research Foundation-Flanders (FWO, GP.026.06N) and the Research Fund of Katholieke Universiteit Leuven (F/06/024). K. Caeyenbergbs was funded by a PhD fellowsbip of the Research Foundation-Flanders (FWO).	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Caeyenberghs K, 2009, BRAIN COGNITION, V69, P154, DOI 10.1016/j.bandc.2008.07.001; Caeyenberghs K, 2009, DEVELOPMENTAL SCI, V12, P474, DOI 10.1111/j.1467-7687.2008.00803.x; CAIRNEY J, 2008, HUM MOVEMENT SCI, P15; Carey JR, 1998, ARCH PHYS MED REHAB, V79, P435, DOI 10.1016/S0003-9993(98)90146-0; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Croce RV, 2001, PERCEPT MOTOR SKILL, V93, P275, DOI 10.2466/pms.2001.93.1.275; de Vries S, 2007, J REHABIL MED, V39, P5, DOI 10.2340/16501977-0020; DeJong WP, 1996, HANDWRITING AND DRAWING RESEARCH, P429; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Foulder-Hughes L., 2003, BRIT J OCCUPATIONAL, V66, P9; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; He BJ, 2007, CURR OPIN NEUROL, V20, P655, DOI 10.1097/WCO.0b013e3282f1c720; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; MIALL RC, 1985, NEUROSCIENCE, V16, P511, DOI 10.1016/0306-4522(85)90189-7; MOUNOUD P, 1985, J EXP CHILD PSYCHOL, V40, P115, DOI 10.1016/0022-0965(85)90068-2; Smits-Engelsman BC, 1998, MOVEMENT ASSESSMENT; Smits-Engelsman BCM, 1998, HUM MOVEMENT SCI, V17, P699, DOI 10.1016/S0167-9457(98)00019-0; Smits-Engelsman BCM, 2001, HUM MOVEMENT SCI, V20, P161, DOI 10.1016/S0167-9457(01)00033-1; Smits-Engelsman BCM, 2008, PHYS THER, V88, P286, DOI 10.2522/ptj.20070068; Sugden, 1992, MOVEMENT ASSESSMENT; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; van Hartingsveldt Margo J, 2005, Occup Ther Int, V12, P1, DOI 10.1002/oti.11; van Roon D, 2008, CHILD DEV, V79, P852, DOI 10.1111/j.1467-8624.2008.01163.x; Van Waelvelde H, 2007, CLIN REHABIL, V21, P465, DOI 10.1177/0269215507074052; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilson BN, 2000, AM J OCCUP THER, V54, P484, DOI 10.5014/ajot.54.5.484; Wilson PH, 2002, J CHILD NEUROL, V17, P491, DOI 10.1177/088307380201700704; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	41	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2009	24	5					363	373		10.1097/HTR.0b013e3181af0810			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	509WG	WOS:000271049300007	19858970				2022-02-06	
J	Medina, AC				Carolina Medina, Aida			Functional Appliance Treatment for Bilateral Condylar Fracture in a Pediatric Patient	PEDIATRIC DENTISTRY			English	Article						CONDYLAR FRACTURE; MANDIBULAR FRACTURE; CONSERVATIVE TREATMENT; FUNCTIONAL ORTHODONTIC APPLIANCE; HEAD TRAUMA	FOLLOW-UP; MAXILLOFACIAL FRACTURES; OPEN REDUCTION; CHILDREN; INJURIES	Trauma to the mandible may cause condylar fracture (CF). The prevalence of CF in children is low and treatment must focus on possible long-term effects on the growing facial skeleton and soft tissues. Consequences may include functional disturbances, facial asymmetry, mandibular retrusion, temporomandibular joint dysfunction and ankylosis. Conservative treatment, including close observation, soft diet, physiotherapy, and functional appliances, is advised in most cases. The purpose of this report was to describe the case of a pediatric female patient with bilateral condylar fracture. Treatment consisted of physiotherapy and hybrid functional appliances. Satisfactory remodeling of both condyles occurred and normal occlusion and jaw movements were obtained. Close monitoring will continue throughout the 6-year follow-up period and completion of growth. The conservative treatment approach proved successful in this case. (Pediatr Dent 2009;31:432-7) Received June 8, 2008 / Last Revision August 23, 2008 / Revision Accepted August 27 2008	Cent Univ Venezuela, Dept Pediat Dent, Caracas, Venezuela		Medina, AC (corresponding author), Cent Univ Venezuela, Dept Pediat Dent, Caracas, Venezuela.	caromemo@gmail.com	Medina, Aida Carolina/AAN-9227-2020	Medina, Aida Carolina/0000-0002-0465-4410	CDCH-UCV (Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela) [ICC 10-056-2007]	Presentation of preliminary results of this case at the 21<SUP>st</SUP> IAPD Congress, Hong Kong 2007, was made possible by the CDCH-UCV (Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela) grant no. ICC 10-056-2007.	AMARATUNGA NADA, 1992, J DENT CHILD, V59, P111; Chacon GE, 2003, J ORAL MAXIL SURG, V61, P668, DOI 10.1053/joms.2003.50134; Chatzistavrou Evangelia K, 2007, World J Orthod, V8, P241; Choi J, 2005, INT J ORAL MAX SURG, V34, P851, DOI 10.1016/j.ijom.2005.04.005; Crean S T, 2000, Int J Paediatr Dent, V10, P229, DOI 10.1046/j.1365-263x.2000.00196.x; DeFabianis P, 2001, J Clin Pediatr Dent, V26, P29; DeFabianis P, 2001, J Clin Pediatr Dent, V25, P203; Defabianis P, 2004, J OROFAC PAIN, V18, P253; Defabianis Patrizia, 2003, J Clin Pediatr Dent, V27, P191; Defabianis Patrizia, 2003, J Clin Pediatr Dent, V27, P297; Defabianis Patrizia, 2002, J Clin Pediatr Dent, V26, P243; Deleyiannis FWB, 2006, ANN PLAS SURG, V57, P495, DOI 10.1097/01.sap.0000226943.79337.bf; Dimitroulis G, 1997, AUST DENT J, V42, P367, DOI 10.1111/j.1834-7819.1997.tb06079.x; Ellis E, 2005, J ORAL MAXIL SURG, V63, P115, DOI 10.1016/j.joms.2004.02.019; Gerhard S, 2007, INT J ORAL MAX SURG, V36, P214, DOI 10.1016/j.ijom.2006.09.013; GIRTHOFER C, 2002, J OROFAC ORTHOP, V63, P429; Guven O, 2001, J CRANIO MAXILL SURG, V29, P232, DOI 10.1054/jcms.2001.0228; HOTZ RP, 1978, AM J ORTHOD DENTOFAC, V73, P365, DOI 10.1016/0002-9416(78)90169-0; Iida S, 2002, J CRANIO MAXILL SURG, V30, P237, DOI 10.1054/jcms.2002.0295; KAHL B, 1995, DENTOMAXILLOFAC RAD, V24, P37, DOI 10.1259/dmfr.24.1.8593906; Kahl-Nieke B, 1999, J Orofac Orthop, V60, P24, DOI 10.1007/BF01358713; Kahl-Nieke B, 1998, J Orofac Orthop, V59, P150, DOI 10.1007/BF01317176; KLAMMT G, 1969, Fortschritte der Kieferorthopaedie, V30, P305, DOI 10.1007/BF02286281; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P153, DOI 10.1016/S0300-9785(77)80048-3; NORHOLT SE, 1993, J ORAL MAXIL SURG, V51, P1302, DOI 10.1016/S0278-2391(10)80132-6; Ogunlewe MO, 2006, INT J PAEDIATR DENT, V16, P358, DOI 10.1111/j.1365-263X.2006.00757.x; PROFFIT WR, 1980, AM J ORTHOD DENTOFAC, V78, P1, DOI 10.1016/0002-9416(80)90037-8; Ramirez Yanez GO, 2002, WORLD J ORTHOD, V3, P349; Schoen R, 2005, BRIT J ORAL MAX SURG, V43, P258, DOI 10.1016/j.bjoms.2004.11.005; Strobl H, 1999, INT J ORAL MAX SURG, V28, P95; Thoren H, 2001, J ORAL MAXIL SURG, V59, P768, DOI 10.1053/joms.2001.23369; VIG PS, 1986, AM J ORTHOD DENTOFAC, V90, P273, DOI 10.1016/0889-5406(86)90084-3; Yamashiro T, 1998, ANGLE ORTHOD, V68, P85	34	11	13	0	6	AMER ACAD PEDIATRIC DENTISTRY	CHICAGO	211 E CHICAGO AVENUE SUITE 1036, CHICAGO, IL 60611-2616 USA	0164-1263	1942-5473		PEDIATR DENT	Pediatr. Dent.	SEP-OCT	2009	31	5					432	437					6	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	668SI	WOS:000283289700012	19947140				2022-02-06	
J	Gagnon, I; Swaine, B; Forget, R				Gagnon, Isabelle; Swaine, Bonnie; Forget, Robert			Using Activity Diaries to Measure Children's and Adolescents' Compliance With Activity Restrictions After Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						education; measures; traumatic brain injury	PHYSICAL-ACTIVITY QUESTIONNAIRE; ENERGY-EXPENDITURE; TIME; VALIDATION; CONCUSSION; PATTERNS; GENDER	Purpose: To examine the extent to which children and adolescents with a mild traumatic brain injury (MTBI) comply with the activity restrictions received upon discharge from a pediatric trauma center. Participants: Thirty-four children with MTBI (aged 8-16 years) and 34 control children matched for age, sex, and premorbid level of physical activity. Main Measure: Activity diary documenting the exact level of activity during 3 consecutive days during the 1st, 4th, and 12th week post-MTBI (corresponding time intervals for controls) and the Physical Activity Questionnaire. Results: Fifteen pairs of children (MTBI + control) completed the diaries for all 3 assessment times (77% participation rate among consecutive admissions and 44% compliance rate with diary completion). Although some children engaged in activities before the end of the 4-week restriction period, the majority of the children followed the recommendations they received. Children with MTBI maintained a lower level of energy expenditure at the 1- and 4-week evaluations than did the noninjured children, but not at the 12-week evaluation. Conclusion: Children with MTBI usually comply with the activity restrictions they receive upon discharge from the hospital.	[Gagnon, Isabelle] McGill Univ, Montreal Childrens Hosp, Phys Therapy Dept, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Gagnon, Isabelle] Univ Montreal, Hlth Adm, Fac Med, Montreal, PQ H3C 3J7, Canada; [Gagnon, Isabelle] Univ Montreal, Grp Rech Interdisciplinaire Sante, Fac Med, Montreal, PQ H3C 3J7, Canada; [Swaine, Bonnie; Forget, Robert] Univ Montreal, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Fac Med, Site Inst Readaptat Montreal, Montreal, PQ H3C 3J7, Canada; [Gagnon, Isabelle; Swaine, Bonnie; Forget, Robert] Univ Montreal, Sch Rehabil, Fac Med, Montreal, PQ H3C 3J7, Canada		Gagnon, I (corresponding author), McGill Univ, Montreal Childrens Hosp, Phys Therapy Dept, Ctr Hlth, D-292,2300 Tupper, Montreal, PQ H3H 1P3, Canada.	Isabelle.gagnon6@sympatico.ca		Gagnon, Isabelle/0000-0003-2043-1644			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Bergman DA, 1999, PEDIATRICS, V104, P1407; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Bratteby LE, 1997, EUR J CLIN NUTR, V51, P585, DOI 10.1038/sj.ejcn.1600449; *CAN PED SOC, 2006, PEDIAT CHILD HLTH, V11, P420; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P45; COLLINS MW, 2007, BRAIN INJURY MED PRI; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Fox KR, 2000, P NUTR SOC, V59, P497, DOI 10.1017/S0029665100000720; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jacelon CS, 2005, QUAL HEALTH RES, V15, P991, DOI 10.1177/1049732305278603; *JACKS SPORTS MED, 2005, NE FLA MED, P44; Jago R, 2005, AM J PREV MED, V28, P447, DOI 10.1016/j.amepre.2005.02.007; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P342, DOI 10.1123/pes.9.4.342; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Mayo-Wilson E, 2007, AM J PUBLIC HEALTH, V97, P630, DOI 10.2105/AJPH.2006.094169; Ministere de la sante et des services sociaux du Quebec & Societe d'assurance automobile du Quebec, 2005, OR MIN TRAUM CRAN LE; NOLAND M, 1990, RES Q EXERCISE SPORT, V61, P146, DOI 10.1080/02701367.1990.10608668; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Rossi P. H., 2004, EVALUATION SYSTEMATI; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SALLIS JF, 1988, AM J EPIDEMIOL, V127, P933, DOI 10.1093/oxfordjournals.aje.a114896; SARIS WHM, 1985, ACTA PAEDIATR SCAND, P37; Selvadurai HC, 2004, ARCH DIS CHILD, V89, P928, DOI 10.1136/adc.2003.034249; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; SWAINE B, 2000, ARCH PHYS MED REHAB, V81, P1617; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Swaine BR, 2001, J HEAD TRAUMA REHAB, V16, P292, DOI 10.1097/00001199-200106000-00008; TELAMA R, 1985, ACTA PAEDIATR SCAND, P169; Wickel EE, 2006, MED SCI SPORT EXER, V38, P373, DOI 10.1249/01.mss.0000183344.46077.bb	36	11	11	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2009	24	5					355	362		10.1097/HTR.0b013e3181b97a4e			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	509WG	WOS:000271049300006	19858969				2022-02-06	
J	Fletcher, JJ; Bergman, K; Feucht, EC; Blostein, P				Fletcher, Jeffrey J.; Bergman, Karen; Feucht, Eric C.; Blostein, Paul			Continuous Renal Replacement Therapy for Refractory Intracranial Hypertension	NEUROCRITICAL CARE			English	Article						Continuous renal replacement therapy; Traumatic brain injury; Hemofiltration; Hypervolemia; Intracranial hypertension	CONTINUOUS VENOVENOUS HEMOFILTRATION; CEREBRAL EDEMA; BRAIN WATER; PRESSURE; HEMODIALYSIS; FLUID; MANAGEMENT; DIALYSIS; FAILURE; UREMIA	Little is known about the effects of hemodialysis on the injured brain, however; concern exists over the use of intermittent hemodialysis in patients with acute brain injury (ABI) due to its hemodynamic effects and increased intracranial pressure (ICP) associated with therapy. Continuous renal replacement therapy (CRRT) has become the preferred method of renal support in these patients though there is limited data to support its safety. Furthermore, exacerbations of cerebral edema have been reported. CRRT is an option for the treatment of hypervolemia and in theory may improve intracranial compliance. We report the case of a poly-trauma patient with severe traumatic brain injury (TBI) in which CRRT was implemented solely for refractory intracranial hypertension. A 28-year-old male was involved in a high-speed motor vehicle collision suffering a severe TBI and polytrauma. He required significant volume resuscitation. Intensive care unit course was complicated by shock, acute respiratory distress syndrome, ventilator associated pneumonia, and development of intracranial hypertension (IH). Data were collected by retrospective chart review. Continuous hemofiltration was initiated for IH refractory to medical therapy. Within hours of initiation increase, ICP improved and normalized. Hemofiltration was safely discontinued after 48 h. Modified Rankin Score was 2 at 90 days. Though unproven, CRRT may be beneficial in patients with IH due to gentle removal of fluid, solutes, and inflammatory cytokines. Given the limited data on safety of CRRT in patients with ABI, we encourage further reports.	[Fletcher, Jeffrey J.; Bergman, Karen; Feucht, Eric C.; Blostein, Paul] Bronson Methodist Hosp, Dept Neurol Neurocrit Care, Kalamazoo, MI 49007 USA; [Fletcher, Jeffrey J.; Bergman, Karen; Feucht, Eric C.; Blostein, Paul] Bronson Methodist Hosp, Dept Crit Care Med & Trauma Crit Care, Kalamazoo, MI 49007 USA		Fletcher, JJ (corresponding author), Bronson Methodist Hosp, Dept Neurol Neurocrit Care, 601 John St,Suite M-124, Kalamazoo, MI 49007 USA.	fletchej@bronsonhg.org					ARIEFF AI, 1973, KIDNEY INT, V4, P177, DOI 10.1038/ki.1973.100; ARIEFF AI, 1976, J CLIN INVEST, V58, P306, DOI 10.1172/JCI108473; BELLOMO R, 1993, CRIT CARE MED, V21, P522, DOI 10.1097/00003246-199304000-00011; BERTRAND YM, 1983, INTENS CARE MED, V9, P321, DOI 10.1007/BF01692550; Caruso DM, 1998, J NEUROSURG, V89, P649, DOI 10.3171/jns.1998.89.4.0649; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; DAVENPORT A, 1989, AM J KIDNEY DIS, V14, P516, DOI 10.1016/S0272-6386(89)80153-2; Davenport A, 1999, KIDNEY INT, V56, pS62, DOI 10.1046/j.1523-1755.56.s.72.3.x; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; DAVENPORT A, 1990, NEPHROL DIAL TRANSPL, V5, P192, DOI 10.1093/ndt/5.3.192; DAVENPORT A, 1991, CONTRIB NEPHROL, V93, P225; DAVENPORT A, 1987, BRIT MED J, V295, P1098; Davenport A, 2007, CONTRIB NEPHROL, V156, P333, DOI 10.1159/000102124; Galons JP, 1996, J CLIN INVEST, V98, P750, DOI 10.1172/JCI118847; Ghahramani N, 2008, NEPHROLOGY, V13, P570, DOI 10.1111/j.1440-1797.2008.00966.x; Goldsmith DJA, 1997, CLIN SCI, V93, P593, DOI 10.1042/cs0930593; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Rabindranath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003773.pub3; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; SCHETZ M, 1997, CURR OPIN CRIT CARE, V3, P434; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; SCHMOKER JD, 1992, J TRAUMA, V33, P476, DOI 10.1097/00005373-199209000-00024; SHENKIN HA, 1968, J NEUROSURG, V28, P417, DOI 10.3171/jns.1968.28.5.0417; SHENKIN HA, 1976, J NEUROSURG, V45, P432, DOI 10.3171/jns.1976.45.4.0432; Silver SM, 1996, AM J KIDNEY DIS, V28, P1, DOI 10.1016/S0272-6386(96)90124-9; Silver SM, 1995, J AM SOC NEPHROL, V6, P1600; TRACHTMAN H, 1993, J AM SOC NEPHROL, V3, P1913	28	11	13	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2009	11	1					101	105		10.1007/s12028-009-9197-9			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	468AU	WOS:000267786400019	19267223				2022-02-06	
J	van Hensbroek, PB; Mulder, S; Luitse, JSK; van Ooijen, MR; Goslings, JC				van Hensbroek, P. Boele; Mulder, S.; Luitse, J. S. K.; van Ooijen, M. R.; Goslings, J. C.			Staircase falls: High-risk groups and injury characteristics in 464 patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Staircase falls; Injury characteristics; High-risk groups; Young children; Senior citizens	CHILDREN; ACCIDENTS; SLIP; TRIP; AGE	Introduction: Few data are available about the epidemiology and injury characteristics in staircase falls. The available literature mainly concerns children and autopsy studies. Objective: To describe the epidemiology and injury characteristics of staircase falls, and to identify high-risk groups for these falls. Methods: All patients who reported to an academic Accident & Emergency (A&E) department in 2005 after a staircase fall were selected in the Dutch Injury Surveillance System These data were linked to the hospital Trauma Registry database. Results: Four hundred and sixty-four patients (42% male, p = 0.001), with a median age of 35 years were included. Children under five suffered significantly more head injuries. Male patients showed significantly more thoracic injuries than female patients. Spinal column fractures were only seen in patients over 25 years of age. Older patients tended to accumulate more rib fractures and lower extremity fractures and were admitted more frequently than the younger patients. Sixty-one patients (13%) required admission. Two patients, both with severe traumatic brain injury TBI), died. National data on staircase falls were comparable with our hospital data. However, in comparison to the national population data, senior citizens in this study had an incidence that was markedly higher than in the younger patients. Conclusion: Injuries due to staircase falls occur in all age groups, however, children under five years are relatively over-represented with higher rates of head injury. Senior citizens showed a markedly higher incidence than younger patients. Most injuries occur to the distal extremities and are relatively mild. (C) 2009 Elsevier Ltd. All rights reserved.	[van Hensbroek, P. Boele; Luitse, J. S. K.; van Ooijen, M. R.; Goslings, J. C.] Acad Med Ctr, Trauma Unit, Dept Surg, NL-1100 DD Amsterdam, Netherlands; [Mulder, S.] Consumer Safety Inst, Amsterdam, Netherlands		van Hensbroek, PB (corresponding author), Acad Med Ctr, Trauma Unit, Dept Surg, G4-134,Meibergdreef 9,POB 22660, NL-1100 DD Amsterdam, Netherlands.	p.boelevanhensbroek@amc.nl					Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Albrecht-Anoschenko J, 2005, ZBL NEUROCHIR, V66, P59, DOI 10.1055/s-2005-836487; Cayless SM, 2001, APPL ERGON, V32, P155, DOI 10.1016/S0003-6870(00)00052-1; Chang LT, 2007, J TRAUMA, V63, P70, DOI 10.1097/01.ta.0000219142.15584.b8; CHIAVIELLO CT, 1994, PEDIATRICS, V94, P679; DAWODU ST, 2007, TRAUMATIC BRAIN INJU; *DEP TRAD IND METR, 2007, AV SLIPS TRIPS BROK; Hamel KA, 2005, GAIT POSTURE, V21, P135, DOI 10.1016/j.gaitpost.2004.01.006; Hamel KA, 2004, J AM GERIATR SOC, V52, P563, DOI 10.1111/j.1532-5415.2004.52162.x; Huntimer CM, 2000, PEDIATRICS, V106, P301, DOI 10.1542/peds.106.2.301; JOFFE M, 1988, PEDIATRICS, V82, P457; McGeehan J, 2006, PEDIATRICS, V118, pE279, DOI 10.1542/peds.2005-1822; MOSENTHAL AC, 1995, J TRAUMA, V38, P753, DOI 10.1097/00005373-199505000-00013; *STAT NETH, 2008, POP BAS FIG; Trokel M, 2006, PEDIATR EMERG CARE, V22, P700, DOI 10.1097/01.pec.0000238734.76413.d0; Wyatt JP, 1999, INJURY, V30, P31, DOI 10.1016/S0020-1383(98)00191-0	16	11	11	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	AUG	2009	40	8					884	889		10.1016/j.injury.2009.01.105			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	483FU	WOS:000268948800020	19486973				2022-02-06	
J	Hill, PS; Ngo, AD; Khuong, TA; Dao, HL; Hoang, HM; Trinh, HT; Nguyen, LTN; Nguyen, PH				Hill, Peter S.; Ngo, Anh D.; Khuong, Tuan A.; Dao, Huong L.; Hoang, Hanh M.; Trinh, Hang T.; Nguyen, Lien T. N.; Nguyen, Phong H.			Mandatory helmet legislation and the print media in Viet Nam	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Viet Nam; Motorcycles; Helmets; Print media; Policy; Prevention	MASS-MEDIA; HEALTH; POLICY	With motorcycle ownership high and rising in Viet Nam, and motorcycle riders vulnerable to both fatal and non-fatal injury, the re-introduction of mandatory helmet legislation in 2007 has been a priority for the Vietnamese government. The paper uses a qualitative analysis of web-based versions of the eight most popular newspapers in Viet Nam to track reporting over four phases of the implementation of the legislation, identifying codes and constructing the dominant themes of the media coverage. The study documents the justification and promotion of the legislation, and the mechanisms for preparing for its implementation at a national and local level, developing solutions and encouraging the replication of successful strategies. It records opposition and obstacles to helmet use, and concerns raised around the quality of helmets purchased. In return, the press notes the response of the market in innovative solutions to these problems. With the successful implementation of the legislation, the functions of the print media in promulgating and promoting the legislation, together with the reporting of ongoing resistance to the process, serve to enable a dialogue between the State and population around expressed concerns. In highlighting quality control of helmets as a key issue, the media have identified a potential ongoing role in monitoring the state's initiative in reducing the road toll from traumatic brain injury in motorcyclists. (C) 2009 Elsevier Ltd. All rights reserved.	[Hill, Peter S.; Ngo, Anh D.; Khuong, Tuan A.] Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia; [Hoang, Hanh M.; Trinh, Hang T.; Nguyen, Lien T. N.; Nguyen, Phong H.] Hlth Strategy & Policy Inst, Hanoi, Vietnam; [Dao, Huong L.] Viet Nam Off, World Bank, Hanoi, Vietnam		Hill, PS (corresponding author), Univ Queensland, Sch Populat Hlth, Herston Rd, Herston, Qld 4006, Australia.	peter.hill@sph.uq.edu.au; n.anh@sph.uq.edu.au; khuonganhtuan@hspi.org.vn; hdao1@worldbank.org; hoangmyhanh@hspi.org.vn; namedmoon@yahoo.com; namlien71@yahoo.com; phong_the_great@yahoo.com	Hill, Peter/F-2768-2010; Hill, Peter Stewart/AAL-8053-2020	Hill, Peter/0000-0001-7091-5108; Hill, Peter Stewart/0000-0001-7091-5108			*A FFORD ASS, 2008, VIET NAM 2007 RETR C; *AQDAS, ATL QUAL DAT AN SOFT; *AS INJ PREV FDN, 2008, CEL UN GET WORD OUT; Blows S, 2005, INJURY PREV, V11, P304, DOI 10.1136/ip.2005.0086680; BUSE K, 2005, MAKING HLTH POLICY, P75; CHAPMAN S, 1994, FIGHT PUBLIC HLTH PR; CHAPMAN S, 1998, HDB PUBLIC HLTH METH, P483; CHINH ND, 2008, ABSTR REP 2 AS PAC C, P97; CONWAY T, 2004, 241 OVERS DEV I; CRAFT G, 2008, LESSONS HELMET WEARI; DAN CAN, 2007, CHRISTMAS GOD FATHER; DAN CAN, 2008, WHEN HEAD PROTECTOR; DAN CAN, 2007, NO EXCEPTION THOSE W; DAN N, 2007, HO CHI MINH CITY; DAN N, 2007, SAFETY HELMETS WHICH; DAN N, 2007, DECEMBER 15 THERE WI; DAN N, 2007, HANOI DA NANG ENCOUR; DAN N, 2007, STRICTLY PUNISH MOTO; DAN N, 2007, MANAGEMENT SAFETY HE; DAN N, 2007, WEAR SAFETY HELMET M; DAN N, 2007, MOBILIZE RESOURCES F; *DHYTCC, 2003, BAO CAO KET QUA NGHI; DONG L, 2007, TPHCM PRESENTING 200; DONG L, 2007, VIETNAM LABOUR UNION; DONG L, 2007, HEAT HELMETS; DONG L, 2007, POLICE ROAD REMIND P; Elder RW, 2004, AM J PREV MED, V27, P57, DOI 10.1016/j.amepre.2004.03.002; *GOV VIET NAM, 2007, 322007NQCP GOV VIET; HANH HTM, 2008, VIETNAM COST EFFECT, V6, P17; HARRABIN R, 2003, HLTH NEWS RISK REPOR; Hung DV, 2006, INJURY PREV, V12, P409, DOI 10.1136/ip.2006.012724; Hung DV, 2008, ACCIDENT ANAL PREV, V40, P1627, DOI 10.1016/j.aap.2008.05.002; HUYEN NTT, 2008, MINISTRY HLTH NEWSLE, P20; Kerkvliet B. J. T., 2001, SOJURN: Journal of Social Issues in Southeast Asia, V16, P238, DOI 10.1355/SJ16-2D; Khan H, 2008, EJC SUPPL, V6, P137, DOI 10.1016/S1359-6349(08)71702-6; Khng, 2001, SOJOURN, V16, P213; LIU BC, 2008, HELMETS PREVENTING I, P4333, DOI DOI 10.1002/14651858.CD004333.PUB3; MART D, 1998, MASS MEDIA VIETNAM P, V25, P20; MCDONNELL MB, 2008, INJURY PREVENTION RO; McKay MP, 2004, ANN EMERG MED, V44, P155, DOI 10.1016/jannemergmed.2004.05.009; *MIN TRANSP, 2001, 082001TTBGTVT MIN TR; *MIN TRANSP, 2000, 3122000TTBGTVT MIN T; *MIN TRANSP, 2003, 012003TTBGTVT MIN TR; NIEN T, 2007, 1 DAY IMPLEMENTING H; NIEN T, 2007, 1 DAY IMPLEMENTING D; NIEN T, 2007, 3 DAY FOLLOWING ENFO; NIEN T, 2007, HCM CITY STEPS INSPE; NIEN T, 2008, DONT JUST BECAUSE WE; NIEN T, 2007, COLLABORATION CONTRO; NIEN T, 2007, UNIQUE CHRISTMAS TRE; NIEN T, 2007, HANOI FULL HELMETS A; Nolen Sixten, 2002, Inj Control Saf Promot, V9, P89, DOI 10.1076/icsp.9.2.89.8695; OTTEN AL, 1992, HEALTH AFFAIR, V11, P111, DOI 10.1377/hlthaff.11.4.111; Paalman M, 1997, HEALTH POLICY PLANN, V12, P86, DOI 10.1093/heapol/12.1.86; Peden M., 2004, WORLD REPORT ROAD TR; PHONG SG, 2007, 2 DAY LAW COMES INTO; PHONG SG, 2007, G CRAFT WEARS SAFETY; PHONG SG, 2007, MOTOR RIDERS VOLUNTA; PHONG SG, 2007, SURVIVED THANKS WEAR; PHONG SG, 2007, MORE THAN 60 SAMPLES; PHONG SG, 2007, SAFETY MARKET HCM CI; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; SHELOV SP, 1995, PEDIATR ANN, V24, P419, DOI 10.3928/0090-4481-19950801-09; Stead M, 2005, HEALTH EDUC RES, V20, P36, DOI 10.1093/her/cyg093; THAI NT, 2008, MINISTRY HLTH NEWSLE, P18; TRE T, 2007, 10000 HELMETS GIVEN; TRE T, 2007, SOME WEAR SOME DONT; TRE T, 2007, ANNOUNCEMENT LIST SA; TRE T, 2007, MORE FREE HELMETS XE; TRE T, 2007, GENUINE FAKE HELMETS; TRE T, 2007, BOOMING LIVE OFF SER; TRE T, 2007, HELMETS MUST CONTAIN; TRE T, 2007, THOUGHTS HELMET; TRE T, 2007, HANOI POLICE ROLE MO; TRE T, 2007, INSIDER; TRE T, 2007, G CRAFT WEARS SAFETY; TRE T, 2007, FAKE HELMET FELL GRO; TRE T, 2007, DONT LET CASE SPEND; TRE T, 2007, PROBLEMS ARISING HEL; TRE T, 2007, HANOI MORE THAN 80 H; Truitt A, 2008, AM ETHNOL, V35, P3, DOI 10.1111/j.1548-1425.2008.00002.x; *VIETN, 2007, INC WEAR HELM MAN AD; *VIETN, 2007, AG HELM AG STRAIGHT; *VIETN, 2007, WEAR HELM LOOK IT EC; *VNEXPRESS, 2007, YOUNG GIRLS SAF HELM; *VNEXPRESS, 2007, BOOM SERV HELM; *VNEXPRESS, 2007, DISC WEAR HELM; *VNEXPRESS, 2007, 20 HELM SAMPLE DO NO; *VNEXPRESS, 2007, HAN SIGN COMM; *VNEXPRESS, 2007, SAF HELM AR DANG CHI; WALLACK L, 1994, J PUBLIC HEALTH POL, V15, P420, DOI 10.2307/3343024; WILSON BJ, 2007, J NUTR EDUC BEHAV, V8, P201; Witter S, 1996, INT J HEALTH PLAN M, V11, P159; 2008, GLOBAL ROAD SAFETY P	94	11	12	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2009	41	4					789	797		10.1016/j.aap.2009.04.001			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	471QC	WOS:000268072200016	19540968				2022-02-06	
J	Knight, RG; O'Hagan, K				Knight, Robert G.; O'Hagan, Kimberley			Autobiographical memory in long-term survivors of severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Remote memory; Retrograde amnesia; Autobiographical memory; Social deficits; Semantic memory	CLOSED-HEAD INJURY; EPISODIC MEMORY; COGNITIVE NEUROSCIENCE; SEMANTIC MEMORY; RETROGRADE; REMOTE; RECOLLECTION; SENSE; SELF	The aim of this study was to examine the ability of persons who had sustained a severe traumatic brain injury (TBI) at least 6 years previously to recall memories associated with famous names. Each of 19 persons with TBI was matched with a healthy control of the same age, gender, and occupational-educational background. A list of 115 names of famous people was compiled, 25 of whom came to prominence in each decade from 1960 to 1999, and 15 in the period 2000 to 2005. Participants were first asked whether they recognized each name as being of a famous person and to state the reason for the individual's fame. For those names they correctly identified, they were asked to recall a memory associated with the person; each memory produced was categorized as a context-specific memory or a general memory. The ability to recognize and identify famous names was well preserved in the TBI group; however, they showed a consistent impairment in the ability to recall specific episodic memories acquired before and after the date of the TBI. This inability to generate personal and specific information is likely to have an impact on the ability of the person with TBI to participate in interpersonal interactions and problem solve in complex social situations.	[Knight, Robert G.; O'Hagan, Kimberley] Univ Otago, Dept Psychol, Dunedin 9013, New Zealand		Knight, RG (corresponding author), Univ Otago, Dept Psychol, Box 56, Dunedin 9013, New Zealand.	rknight@psy.otago.ac.nz			University of Otago	This study was supported by a University of Otago research grant.	ALBERT MS, 1981, ARCH NEUROL-CHICAGO, V38, P495, DOI 10.1001/archneur.1981.00510080057008; Berry E, 2007, NEUROPSYCHOL REHABIL, V17, P582, DOI 10.1080/09602010601029780; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fujii T., 2000, HDB NEUROPSYCHOLOGY, P223; Gilboa A, 2006, HIPPOCAMPUS, V16, P966, DOI 10.1002/hipo.20226; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Jennett B, 1981, MANAGEMENT HEAD INJU; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; KNOWLTON BJ, 1995, J EXP PSYCHOL LEARN, V21, P699, DOI 10.1037/0278-7393.21.3.699; Knowlton BJ, 1998, ACTA PSYCHOL, V98, P253, DOI 10.1016/S0001-6918(97)00045-0; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; KOPELMAN MD, 1989, NEUROPSYCHOLOGIA, V27, P437, DOI 10.1016/0028-3932(89)90050-X; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Piolino P, 2005, COGN NEUROPSYCHOL, V22, P1005, DOI 10.1080/02643290442000428; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; RENDLE V, 2005, BRAIN IMPAIRMENT, V6, P90; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SQUIRE LR, 1975, J EXP PSYCHOL-HUM L, V104, P50; Steinvorth S, 2005, NEUROPSYCHOLOGIA, V43, P479, DOI 10.1016/j.neuropsychologia.2005.01.001; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Westmacott R, 2004, COGN NEUROPSYCHOL, V21, P353, DOI 10.1080/02643290342000375; Westmacott R, 2004, NEUROPSYCHOLOGIA, V42, P25, DOI 10.1016/S0028-3932(03)00147-7; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	33	11	11	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	2009	31	5					575	583		10.1080/13803390802363710			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	473YT	WOS:000268249200007	18972310				2022-02-06	
J	Wang, ZT; Deng, QJ; Zhang, XH; Zhang, JN				Wang, Zhitao; Deng, Quanjun; Zhang, Xiaohui; Zhang, Jianning			Treatment of Injured Neurons with Bone Marrow Stem Cells Cotransfected by hTERT and Ad-BDNF In Vitro	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Bone marrow stromal cells; Brain-derived neurotrophic factor; Human telomerase reverse transcriptase; Traumatic brain injury	STROMAL CELLS; GENE-EXPRESSION; SPINAL-CORD; RAT; DIFFERENTIATE; TRANSPLANTATION; MYOCARDIUM; TELOMERASE; FOREBRAIN; INDUCTION	The purpose of this paper is to study the anti-injury effect of bone marrow stromal cells (BMSCs) transfected by human telomerase reverse transcriptase (hTERT) and adenovirous brain-derived neurotrophic factor (Ad-BDNF) in injured neurons. Rat injured neurons were induced in vitro and then cocultured with rBMSCs transfected by hTERT and Ad-BDNF. The anti-injury effect of rBMSCs transfected by hTERT and Ad-BDNF was detected by Western blot for neural apoptosis gene MAP2 and NF-kappa B and lactic dehydrogenase released by injured neurons. Our data demonstrated that graft rBMSCs transfected by hTERT and Ad-BDNF could increase the expression of BDNF in injured neurons and alleviate apoptosis of the injured neurons. According to these data, BDNF-BMSCs demonstrate a tendency to be protection against neuronal death caused by apoptosis which would last a long time after neural injury. The data also show the potential of BDNF-BMSCs as a promising therapeutic strategy that warrants further investigation in patients with traumatic brain injury.	[Wang, Zhitao; Deng, Quanjun; Zhang, Xiaohui; Zhang, Jianning] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [3067210]; Technology Development Project of Tianjin [5YFJZJC01400]	This research was supported by a grant from the National Nature Science Foundation of China (3067210) and a grant from the Technology Development Project of Tianjin (5YFJZJC01400).	Akiyama Y, 2002, J NEUROSCI, V22, P6623; Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; ANDERSON WF, 1994, HUM GENE THER, V5, P755, DOI 10.1089/hum.1994.5.6-755; Black IB, 2001, BLOOD CELL MOL DIS, V27, P632, DOI 10.1006/bcmd.2001.0423; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.0299.x, 10.1111/j.1582-4934.2008.00299.x]; Brandoli C, 1998, J NEUROSCI, V18, P7953; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Imabayashi H, 2003, EXP CELL RES, V288, P35, DOI 10.1016/S0014-4827(03)00130-7; Kim BJ, 2002, NEUROREPORT, V13, P1185, DOI 10.1097/00001756-200207020-00023; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kobune M, 2003, EXP HEMATOL, V31, P715, DOI 10.1016/S0301-472X(03)00177-2; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; McIntosh TK, 1996, LAB INVEST, V74, P315; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Orlic D, 2003, ANN NY ACAD SCI, V996, P152, DOI 10.1111/j.1749-6632.2003.tb03243.x; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Smith DH, 1999, J NEUROSCI, V19, P4263; Song S, 2004, EXP NEUROL, V185, P191, DOI 10.1016/j.expneurol.2003.09.003; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vacanti V, 2005, J CELL PHYSIOL, V205, P194, DOI 10.1002/jcp.20376; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Yaghoobi MM, 2005, NEUROSCI LETT, V390, P81, DOI 10.1016/j.neulet.2005.08.011; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859	42	11	12	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JUL	2009	38	3					265	272		10.1007/s12031-009-9208-5			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	458NX	WOS:000267031900006	19459071				2022-02-06	
J	Yang, YG; Jiang, DM; Quan, ZX; Ou, YS				Yang, Y-G; Jiang, D-M; Quan, Z-X; Ou, Y-S			Insulin with Chondroitinase ABC Treats the Rat Model of Acute Spinal Cord Injury	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						INSULIN; CHONDROITINASE ABC; ACUTE SPINAL CORD INJURY; RAT MODEL; AXON REGROWTH; GROWTH ASSOCIATED PROTEIN 43	AXONAL REGENERATION; GROWTH; RECOVERY; PROTEOGLYCANS; HEMISECTION; EXPRESSION; PREVENTION; OUTGROWTH; NEURONS; CNS	Traumatic brain injury is often associated with acute spinal cord injury (ASCI). Insulin and chondroitinase ABC (ChABC) are both therapeutically effective, but the combined therapeutic effect of insulin and ChABC is still not clear. A combination of insulin and ChABC were used to treat a rat model of ASCI. This combination therapy prevented neuronal cell death by improving motor function, increasing cell growth and inhibiting cell apoptosis in ASCI rats. Expression of growth-associated protein 43, a marker of axonal re-growth, increased after combined treatment with insulin and ChABC. These results may provide a basis for a future method of treating ASCI.	[Yang, Y-G; Jiang, D-M; Quan, Z-X; Ou, Y-S] Chongqing Med Univ, Dept Orthopaed, Affiliated Hosp 1, Chongqing 400016, Peoples R China		Jiang, DM (corresponding author), Chongqing Med Univ, Dept Orthopaed, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	dmjiang2009@yahoo.cn		ou, yunsheng/0000-0001-8578-3523			Aarts LHJ, 1998, ADV EXP MED BIOL, V446, P85; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brange J, 1993, Pharm Biotechnol, V5, P315; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; Chen CH, 2005, J CELL BIOCHEM, V94, P684, DOI 10.1002/jcb.20341; Chen HY, 2005, J NEUROCYTOL, V34, P37, DOI 10.1007/s11068-005-5046-8; Colberg SR, 2007, CURR DIABETES REV, V3, P176; Costacou T, 2003, ANNU REV NUTR, V23, P147, DOI 10.1146/annurev.nutr.23.011702.073027; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Filbin MT, 2000, CURR BIOL, V10, pR100, DOI 10.1016/S0960-9822(00)00302-X; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Hsu JYC, 2005, J NEUROSCI RES, V82, P472, DOI 10.1002/jnr.20662; Huang WC, 2006, BIOCHEM BIOPH RES CO, V349, P963, DOI 10.1016/j.bbrc.2006.08.136; Ikegami T, 2005, EUR J NEUROSCI, V22, P3036, DOI 10.1111/j.1460-9568.2005.04492.x; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; Li GL, 1996, ACTA NEUROPATHOL, V92, P19, DOI 10.1007/s004010050484; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nihal M, 2005, INT J CANCER, V114, P513, DOI 10.1002/ijc.20785; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rouleau P, 2007, J NEUROTRAUM, V24, P367, DOI 10.1089/neu.2006.0117; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; TENCER AF, 1985, SPINE, V10, P586, DOI 10.1097/00007632-198507000-00014; Tom VJ, 2008, EXP NEUROL, V211, P315, DOI 10.1016/j.expneurol.2008.01.021; Wenner P, 1999, J NEUROSCI, V19, P7557, DOI 10.1523/JNEUROSCI.19-17-07557.1999; Wu XH, 2007, J NEUROTRAUM, V24, P1502, DOI 10.1089/neu.2006.0228; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3; Zhao YH, 2007, NEUROSCI LETT, V429, P49, DOI 10.1016/j.neulet.2007.09.076	32	11	11	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	JUL-AUG	2009	37	4					1097	1107		10.1177/147323000903700414			11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	509RQ	WOS:000271036300014	19761692	Green Published, Bronze			2022-02-06	
J	Ferguson, SD; Coccaro, EF				Ferguson, Sherise D.; Coccaro, Emil F.			HISTORY OF MILD TO MODERATE TRAUMATIC BRAIN INJURY AND AGGRESSION IN PHYSICALLY HEALTHY PARTICIPANTS WITH AND WITHOUT PERSONALITY DISORDER	JOURNAL OF PERSONALITY DISORDERS			English	Article							BLUNT HEAD-INJURY; BEHAVIOR; AGITATION; RELATIVES; CHILDREN; SCALE	We tested the hypothesis that history of mild to moderate traumatic brain injury (TBI) is associated with higher scores on psychometrically valid measures of aggression and impulsivity in both normal control (NC), and personality disordered (PD), participants. Participants were 458 research volunteers in whom history of mild TBI and measures of both aggression and impulsivity were collected. Aggression, but not impulsivity, scores were elevated as a function of TBI and PD status; there was no interaction between mild TBI and subject group. These data suggest that lifetime history of mild TBI is associated with history of aggression regardless of history of psychiatric disorder.	[Coccaro, Emil F.] Univ Chicago, Clin Neurosci & Psychopharmacol Res Unit, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA		Coccaro, EF (corresponding author), Univ Chicago, Clin Neurosci & Psychopharmacol Res Unit, Dept Psychiat & Behav Neurosci, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ecoccaro@yoda.bsd.uchicago.edu			NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH46948, K02MH00951] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH046948, K02MH000951] Funding Source: NIH RePORTER		American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bunce SC, 2005, J PSYCHIATR RES, V39, P421, DOI 10.1016/j.jpsychires.2004.09.005; COCCARO EF, 1989, ARCH GEN PSYCHIAT, V46, P587; Coccaro EF, 1996, ARCH GEN PSYCHIAT, V53, P531; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; COCCARO EF, 2003, AGGRESSION PSYCHIAT, P149; *DEP DEF VET HEAD, 1999, BRAIN INJ YOU; Diaz F G, 1995, Med Law, V14, P131; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Eysenck HJ, 1975, MANUAL EYSENCK PERSO; First M., 1997, STRUCTURED CLIN INTE; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Kim E, 2002, NEUROREHABILITATION, V17, P297; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pfohl B., 1995, STRUCTURED CLIN INTE; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; VIRKKUNEN M, 1977, DIS NERV SYST, V38, P907; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	30	11	11	1	5	GUILFORD PUBLICATIONS INC	NEW YORK	370 SEVENTH AVE, SUITE 1200, NEW YORK, NY 10001-1020 USA	0885-579X	1943-2763		J PERS DISORD	J. Pers. Disord.	JUN	2009	23	3					230	239		10.1521/pedi.2009.23.3.230			10	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	459NC	WOS:000267108600002	19538079				2022-02-06	
J	Sugarman, J; Sitlani, C; Andrusiek, D; Aufderheide, T; Bulger, EM; Davis, DP; Hoyt, DB; Idris, A; Kerby, JD; Powell, J; Schmidt, T; Slutsky, AS; Sopko, G; Stephens, S; Williams, C; Nichol, G				Sugarman, Jeremy; Sitlani, Colleen; Andrusiek, Dug; Aufderheide, Tom; Bulger, Eileen M.; Davis, Daniel P.; Hoyt, David B.; Idris, Ahamed; Kerby, Jeffrey D.; Powell, Judy; Schmidt, Terri; Slutsky, Arthur S.; Sopko, George; Stephens, Shannon; Williams, Carolyn; Nichol, Graham		Resuscitation Outcomes Consortium	Is the enrollment of racial and ethnic minorities in research in the emergency setting equitable?	RESUSCITATION			English	Article						Research in the emergency setting; Exemption from consent; Research ethics; Subject selection; Clinical trials; Trauma; Race and ethnicity	AFRICAN-AMERICANS; RESUSCITATION; OUTCOMES; TRAUMA; IMPLEMENTATION; EPIDEMIOLOGY; WILLINGNESS; PARTICIPATE; TUSKEGEE; CONSENT	Background: Concerns have been raised about the enrollment of racial and ethnic minorities in research in the emergency setting when it is not possible to obtain informed consent. However, there is a paucity of data related to the validity of such claims. Methods: Retrospective comparison of registry enrollment (4/1/2006-3/31/2007) and trial enrollment (4/1/2007-3/31/2008) from three sites in the Resuscitation Outcomes Consortium. Subjects compared met the following Criteria: (I) shock, defined by blunt or penetrating force to the body with either systolic blood pressure (SBP) <= 70 mmHg or SBP 71-90 mmHg and heart rate >= 108 beats/min and/or (2) traumatic brain injury (TBI), defined by blunt force to the head with out-of-hospital Glasgow Coma Score <= 8. Results: Overall, compared to a registry there were no differences in the percent of racial or ethnic groups enrolled in the clinical trial [odds ratio (OR) for Blacks versus Whites: 0.87, 95% confidence interval (Cl) 0.65-1.16, p = .34; OR for Hispanics versus Whites 1.04; 95% CI 0.72-1.49, p =.85]. However, Blacks were less likely than Whites to be enrolled in the TBI cohort [OR 0.58 (0.34-0.97), p =.04]. Conclusions: Despite some discordance in subgroups, there was no overall difference in the racial and ethnic distribution of subjects enrolled in a multi-center clinical trial of severe trauma compared to a registry accounting for study entry criteria. These findings help address justice concerns about enrollment of racial and ethnic minorities in trauma research performed using an exception from informed consent under emergency circumstances. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA; [Sugarman, Jeremy] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Sitlani, Colleen; Powell, Judy; Nichol, Graham] Univ Washington, Dept Biostat, Resuscitat Outcomes Consortium Clin Trial Ctr, Seattle, WA 98195 USA; [Andrusiek, Dug] Univ British Columbia, Program Med, Emergency & Hlth Serv Commiss, Vancouver, BC V5Z 1M9, Canada; [Andrusiek, Dug] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Aufderheide, Tom] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Bulger, Eileen M.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Davis, Daniel P.] Univ Calif San Diego, Dept Emergency Med, La Jolla, CA 92093 USA; [Hoyt, David B.] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA; [Idris, Ahamed] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Kerby, Jeffrey D.] Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA; [Schmidt, Terri] Oregon Hlth & Sci Univ, Sch Med, Dept Emergency Med, Portland, OR 97201 USA; [Schmidt, Terri] Oregon Hlth & Sci Univ, Sch Med, Ctr Eth Hlth Care, Portland, OR 97201 USA; [Slutsky, Arthur S.] Univ Toronto, Toronto, CA USA; [Slutsky, Arthur S.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, CA USA; [Sopko, George] NHLBI, Div Cardiovasc Dis, NIH, Bethesda, MD 20892 USA; [Stephens, Shannon; Williams, Carolyn] Univ Alabama Birmingham, Dept Emergency Med, Alabama Resuscitat Ctr, Birmingham, AL USA; [Nichol, Graham] Univ Washington, Dept Med, Harborview Ctr Prehosp Emergency Care, Seattle, WA USA		Sugarman, J (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Hampton House 351,624 N Broadway, Baltimore, MD 21205 USA.	jsugarml@jhm1.edu	Nichol, Graham/Z-4996-2019; Slutsky, Arthur/M-3325-2019	Stephens, Shannon/0000-0001-5898-5170; Sugarman, Jeremy/0000-0001-7022-8332; Idris, Ahamed/0000-0001-7113-6499	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077865, U01HL077873, U01HL077881, U01HL077871, U01HL077908, U01HL077887, U01HL077885, U01HL077863, U01HL077866, U01HL077867, U01HL077872] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL077866, HL077872, U01 HL077908, U01 HL077872, U01 HL077867, HL077885, U01 HL077863, HL077908, HL077881, HL077871, HL077873, U01 HL077881, HL077887, 5U01 HL077863, U01 HL077863-05, HL077865, HL077867, U01 HL077885, U01 HL077866] Funding Source: Medline		Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; Clifton GL, 2002, J NEUROTRAUM, V19, P1121, DOI 10.1089/08977150260337930; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Dickert N, 2005, AM J PUBLIC HEALTH, V95, P1123, DOI 10.2105/AJPH.2004.058933; Dula A, 1997, HASTINGS CENT REP, V27, P11, DOI 10.2307/3528020; Freimuth VS, 2001, SOC SCI MED, V52, P797, DOI 10.1016/S0277-9536(00)00178-7; GAMBLE VN, 1993, AM J PREV MED, V9, P35, DOI 10.1016/S0749-3797(18)30664-0; Guinan M E, 1993, Ann Epidemiol, V3, P193; Harris Y, 1996, J NATL MED ASSOC, V88, P630; Holloway KFC, 2006, AM J BIOETHICS, V6, P7, DOI 10.1080/15265160600685556; Jones J., 1993, BAD BLOOD TUSKEGEE S; KAHN JP, 1998, CONSENT SEEKING JUST; Karmali S, 2005, CAN MED ASSOC J, V172, P1007, DOI 10.1503/cmaj.1040432; KING PA, 1998, CONSENT SEEKING JUST; Lyn-Sue J, 2006, J NATL MED ASSOC, V98, P1940; NEAVLING S, 2007, BLOOD EXPT DISPROPOR; NeSmith EG, 2006, J NURS SCHOLARSHIP, V38, P241, DOI 10.1111/j.1547-5069.2006.00109.x; Newgard CD, 2008, RESUSCITATION, V78, P170, DOI 10.1016/j.resuscitation.2008.01.029; Nichol G, 2006, RESUSCITATION, V70, P360, DOI 10.1016/j.resuscitation.2006.01.020; NIH, 2017, NIH POLICY GUIDELINE; Pickle K, 2002, J HEALTH COMMUN, V7, P427, DOI 10.1080/10810730290001792; POTTER M, 2005, SAN DIEGO READE 0728; Sen Biswas M, 2007, CLIN TRIALS, V4, P258, DOI 10.1177/1740774507079434; Shavers VL, 2001, CANCER, V91, P233, DOI 10.1002/1097-0142(20010101)91:1+<233::AID-CNCR10>3.0.CO;2-8; Shavers VL, 2000, J NATL MED ASSOC, V92, P563; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; 2003, PROTECTION HUMAN 46	29	11	11	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	JUN	2009	80	6					644	649		10.1016/j.resuscitation.2009.03.015			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine	459ID	WOS:000267094100008	19395144	Green Accepted			2022-02-06	
J	Zeng, Q; Burdet, E; Teo, CL				Zeng, Qiang; Burdet, Etienne; Teo, Chee Leong			Evaluation of a Collaborative Wheelchair System in Cerebral Palsy and Traumatic Brain Injury Users	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						Robotic wheelchair; Path guidance; Human-machine interaction; Cerebral palsy; Traumatic brain injury	SMART WHEELCHAIRS	Objective. This article describes the evaluation of the Collaborative Wheelchair Assistant (CWA), a robotic wheelchair that lets the user control the speed and provides guiding assistance along virtual paths programmed in software. Methods. Three people with cerebral palsy and 2 with traumatic brain injury, who had been ruled out as candidates for independent mobility, were recruited. These subjects were first trained to use the CWA with and without path guidance before completing a navigation task. Results. All subjects were able, after a few training sessions, to drive the wheelchair with path guidance safely and efficiently in an environment with obstacles and narrow passageways. The CWA enabled the subjects to drastically reduce their effort and intervention level without compromising performance. Conclusions. The results suggest that the CWA can provide driving assistance adapted to various disabilities. It could be used as a safe mobility device for some subjects who could eventually control a normal powered wheelchair after training and provide a way to increase the mobility of subjects with larger motor control or cognitive deficiencies.	[Teo, Chee Leong] Natl Univ Singapore, Dept Mech Engn, Singapore 119260, Singapore; Univ London Imperial Coll Sci Technol & Med, London, England		Teo, CL (corresponding author), Natl Univ Singapore, Dept Mech Engn, Singapore 119260, Singapore.	e.burdet@imperial.ac.uk; mpeteocl@nus.edu.sg	Ang, Marcelo H/B-4469-2010	Ang, Marcelo H/0000-0001-8277-6408; Burdet, Etienne/0000-0002-2123-0185	Singapore Society for Physical Disability (SPD); National University of SingaporeNational University of Singapore	The experiments were performed at the Singapore Society for Physical Disability (SPD) and National University of Singapore. We thank Tan Chuanhoh and other staff from the SPD for their active collaboration on the CWA project.	Boy ES, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P1511, DOI 10.1109/IRDS.2002.1043969; Elble RJ, 1990, TREMOR; KUMAR V, 1999, WILEY ENCY ELECT ELE; LONG B, 2006, IEEE INT C ROB AUT I; Miller D. P., 1995, Autonomous Robots, V2, P77, DOI 10.1007/BF00735440; NISBET P, 1996, TECHNOL DISABIL, V5, P49; Rebsamen B, 2007, IEEE INTELL SYST, V22, P18, DOI 10.1109/MIS.2007.26; Simpson RC, 2005, J REHABIL RES DEV, V42, P423, DOI 10.1682/JRRD.2004.08.0101; SIMPSON RC, 1999, 6 IEEE INT C REH ROB; ZENG Q, 2008, THESIS NATL U SINGAP; ZENG Q, 2008, DISABIL REH IN PRESS; Zeng Q, 2008, IEEE T NEUR SYS REH, V16, P161, DOI 10.1109/TNSRE.2008.917288	12	11	11	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUN	2009	23	5					494	504		10.1177/1545968308323692			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	450JP	WOS:000266397100011	19074687	Green Published			2022-02-06	
J	Petrov, T				Petrov, Theodor			Amelioration of hypoperfusion after traumatic brain injury by in vivo endothelin-1 knockout	CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Article						microcirculation; laser Doppler flowmetry; morphometry; immunocytochemistry	VASCULAR SMOOTH-MUSCLE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; RECEPTOR ANTAGONIST; GENE-EXPRESSION; BLOOD-FLOW; SIGNALING PATHWAYS; CEREBRAL-ISCHEMIA; CARDIAC-ARREST; RAT MODEL; CELLS	Endothelin 1 (ET-1) is one of the most powerful vasoconstrictors in the brain. Its expression is upregulated after traumatic brain injury (TBI) and is a major factor in the ensuing hypoperfusion. Attenuation of ET-1 effects has been mainly achieved by blockade of its receptors. The result of a direct blockade of ET-1 mRNA synthesis is not known. We used the Marmarou's model to inflict injury to male Sprague-Dawley rats injected with antisense ET-1 oligodeoxynucleotides (ODNs) before injury. Laser Doppler flowmetry in noninjured rats (2 groups, i.e., untreated and animals that received cODNs) revealed a constant cerebral blood flow of approximately 14 mL.min(-1).100 g(-1), whereas the values from injured animals pretreated with control ODNs (cODNs) or from animals subjected to TBI alone were approximately 8.0 mL.min(-1).100 g(-1) during the 18-48 h time period post-TBI. After antisense ET-1 ODNs pretreatment, however, cerebral blood flow in injured animals was approximately 17 mL.min(-1).100 g(-1) during the 6-48 h time period. Antisense ET-1 ODNs-treated animals also had 19%-29% larger microvessel cross-sectional area and approximately one-third less ET-1 immunoreactivity in the 50-75% range after injury than did cODNs-treated animals after TBI. The results indicate that this direct in vivo approach is an effective therapeutic intervention for the restoration of cerebral blood flow after TBI.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Petrov, T (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.	tpetrov@med.wayne.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS39860]; Department of Neurological Surgery, Wayne State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grant NS39860 awarded to T. P. The author thanks Dr. H. K. Park, Department of Neurological Surgery, Wayne State University, for contributing to this study by providing technical assistance in the LDF recordings.	Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Barman SA, 2005, LUNG, V183, P425, DOI 10.1007/s00408-005-2554-3; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen P, 2001, J NEUROIMMUNOL, V116, P62, DOI 10.1016/S0165-5728(01)00280-6; Chen Y, 2003, AM J PHYSIOL-CELL PH, V284, pC243, DOI 10.1152/ajpcell.00305.2002; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; FLORY CM, 1993, LAB INVEST, V69, P396; FRANK HJL, 1993, ENDOCRINOLOGY, V133, P1092, DOI 10.1210/en.133.3.1092; FUXE K, 1992, EXP BRAIN RES, V88, P131, DOI 10.1007/BF02259134; Greenwood K, 2000, PEDIATR RES, V48, P346, DOI 10.1203/00006450-200009000-00014; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hickey RW, 2003, CRIT CARE MED, V31, P531, DOI 10.1097/01.CCM.0000050323.84293.11; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Kawaguchi Chikako, 2002, Pathophysiology, V8, P249, DOI 10.1016/S0928-4680(02)00014-7; Kreipke CW, 2007, NEUROL RES, V29, P604, DOI 10.1179/016164107X166317; Krep H, 2000, CRIT CARE MED, V28, P2873, DOI 10.1097/00003246-200008000-00031; Kwok CF, 2007, AM J PHYSIOL-ENDOC M, V292, pE648, DOI 10.1152/ajpendo.00084.2006; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; Milan J, 2006, AM J PHYSIOL-CELL PH, V291, pC155, DOI 10.1152/ajpcell.00239.2005; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; ODONNELL ME, 1995, AM J PHYSIOL-CELL PH, V268, pC747, DOI 10.1152/ajpcell.1995.268.3.C747; PARK HK, 1999, J MENTAL HLTH, V3, P32; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Shin TK, 2001, NEUROREPORT, V12, P1465, DOI 10.1097/00001756-200105250-00034; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; SZYMKOWSKI DE, 2002, DRUG DISCOV TODAY, V7, P107, DOI DOI 10.1016/S1359-6446(01)02123-7; Takahashi A, 1997, ACTA NEUROPATHOL, V93, P354, DOI 10.1007/s004010050627; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Touzani O, 1997, J CEREBR BLOOD F MET, V17, P1157, DOI 10.1097/00004647-199711000-00004; Yunoki M, 2003, SURG NEUROL, V59, P156, DOI 10.1016/S0090-3019(02)01040-6	41	11	11	0	0	NATL RESEARCH COUNCIL CANADA-N R C RESEARCH PRESS	OTTAWA	BUILDING M 55, OTTAWA, ON K1A 0R6, CANADA	0008-4212			CAN J PHYSIOL PHARM	Can. J. Physiol. Pharmacol.	MAY	2009	87	5					379	386		10.1139/Y09-022			8	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	450ZX	WOS:000266441600007	19448736				2022-02-06	
J	Carrai, R; Grippo, A; Fossi, S; Campolo, MC; Lanzo, G; Pinto, F; Amantini, A				Carrai, R.; Grippo, A.; Fossi, S.; Campolo, M. C.; Lanzo, G.; Pinto, F.; Amantini, A.			Transient post-traumatic locked-in syndrome: A case report and a literature review	NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY			English	Article						Locked-in syndrome; Head trauma; EEG; Somatosensory evoked potentials; Event related potentials; P300	EVOKED-POTENTIALS; VEGETATIVE STATE; HEAD; CONSCIOUSNESS; TOMOGRAPHY; PARADIGM; COMA	Introduction.-Post-traumatic locked-in syndrome may be particularly difficult to recognize, especially when it follows a state of coma and presents the clinical feature of a "total" locked-in syndrome. Patient and methods.-A 56-year-old male with a closed head injury was admitted in intensive care unit (ICU) with GCS = 4 (V1, M2, E1). Computed tomography (CT) scan disclosed a limited subarachnoid haemorrhage in the sylvian region without any brain oedema or ventricular shift. The GCS did not change until day 6. At the same time EEG showed a reactivity to acoustic stimuli consisting in the paradoxical appearance of a posterior rhythm in alpha range (10-12c/s), blocked by passive eye opening. Early cortical components (N20-P25) of somatosensory evoked potentials were normal on both hemispheres; middle components were also clearly evident. Magnetic resonance imaging of the brain showed both diffuse and midbrain axonal injuries, particularly in a strategic lesion involving both cerebral peduncles. Event related potentials showed N2 and P3 components to stimulation by rare tones. Conclusions.-A comprehensive multimodal neurophysiological approach, using the more informative tests and the proper time of recording, should be included in protocols for patients with severe head trauma, in order to establish the actual patient's clinical state and to avoid that a locked-in syndrome state be mistaken for prolonged coma, vegetative state, minimally conscious state or akinetic mutism. Neurophysiological evaluation before discharge from ICU can be a baseline evaluation useful for the follow-up of low-responsive patients in the neuro-rehabilitation unit. (C) 2008 Elsevier Masson SAS. All rights reserved.	[Carrai, R.; Grippo, A.; Fossi, S.; Lanzo, G.; Pinto, F.; Amantini, A.] Azienda Osped Univ Careggi, DAI Sci Neurol, SOD Neurofisiopatol, Florence, Italy; [Carrai, R.] Fond Don C Gnocchi ONLUS IRCCS Pozzolat, UO Riabilitaz Resp, Florence, Italy; [Grippo, A.] Fond Don C Gnocchi ONLUS IRCCS Pozzolat, UO Riabilitaz Neurol, Florence, Italy; [Campolo, M. C.] Azienda Osped Univ Carregi, SOD Rianimaz 2, Florence, Italy		Carrai, R (corresponding author), Azienda Osped Univ Careggi, DAI Sci Neurol, SOD Neurofisiopatol, Viale Morgagni 85, Florence, Italy.	riccadoc@hotmail.com; agrippo@unifi.it; selvaggiafossi@libero.it; mcampolo@hotmail.com; giovanni.lanzo@virgilio.it; neurofp@neurounifi.it; amantini@unifi.it	Viani, Rafael/V-1196-2018; grippo, antonello/AAP-6926-2020; Pinto, Fausto/G-9363-2015	Pinto, Fausto/0000-0002-8034-4529; Grippo, Antonello/0000-0002-9997-8564			ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; BASSETTI C, 1994, J NEUROL NEUROSUR PS, V57, P1403, DOI 10.1136/jnnp.57.11.1403; BRITT RH, 1977, ANN NEUROL, V1, P590, DOI 10.1002/ana.410010614; CHANG B, 1979, EUR NEUROL, V18, P391, DOI 10.1159/000115110; CHERINGTON M, 1976, NEUROLOGY, V26, P180, DOI 10.1212/WNL.26.2.180; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Dumas A., 1910, COUNT MONTE CRISTO, VTwo; Fins JJ, 2007, CURR OPIN NEUROL, V20, P650, DOI 10.1097/WCO.0b013e3282f11f6d; FORTI A, 1982, ANN NEUROL, V12, P393, DOI 10.1002/ana.410120413; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; Guerit JM, 2005, NEUROPSYCHOL REHABIL, V15, P357, DOI 10.1080/09602010443000560; Gutling E, 1996, NEUROLOGY, V46, P1092, DOI 10.1212/WNL.46.4.1092; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; JACOME DE, 1990, CLIN ELECTROENCEPHAL, V21, P31, DOI 10.1177/155005949002100112; KEANE JR, 1986, NEUROLOGY, V36, P80, DOI 10.1212/WNL.36.1.80; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Leon-Carrion J, 2002, BRAIN INJURY, V16, P571, DOI 10.1080/02699050110119781; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MARTIVILALTA JL, 1977, LANCET, V31, P1351; MURPHY MJ, 1979, J NEUROL NEUROSUR PS, V42, P1062, DOI 10.1136/jnnp.42.11.1062; Onofrj M, 1997, J NEUROL NEUROSUR PS, V63, P759, DOI 10.1136/jnnp.63.6.759; ORESTEIN M, 1990, CAHIERS ANESTH, V38, P87; Owen AM, 2007, CURR OPIN NEUROL, V20, P632, DOI 10.1097/WCO.0b013e3282f15669; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758; PINTO F, 1990, ACTA ANAESTH SCAND, V34, P389, DOI 10.1111/j.1399-6576.1990.tb03108.x; Plum F., 1983, DIAGNOSIS STUPOR COM; POLICH J, 1989, ELECTROEN CLIN NEURO, V74, P312, DOI 10.1016/0168-5597(89)90061-0; Sloan TB, 2002, J CLIN NEUROPHYSIOL, V19, P430, DOI 10.1097/00004691-200210000-00006; Stevens RD, 2006, CRIT CARE MED, V34, P31, DOI 10.1097/01.CCM.0000194534.42661.9F; Zakaria T, 2006, NEUROLOGY, V67, P1889, DOI 10.1212/01.wnl.0000229160.49552.b0; ZAMPELLA EJ, 1988, NEUROSURGERY, V22, P591, DOI 10.1227/00006123-198803000-00027	33	11	12	1	4	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0987-7053	1769-7131		NEUROPHYSIOL CLIN	Neurophysiol. Clin.-Clin. Neurophysiol.	APR	2009	39	2					95	100		10.1016/j.neucli.2008.11.003			6	Clinical Neurology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	457UO	WOS:000266959500004	19467439				2022-02-06	
J	Rando, K; Zunini, G; Negroto, A				Rando, K.; Zunini, G.; Negroto, A.			Intraoperative hyponatremia during craniofacial surgery	PEDIATRIC ANESTHESIA			English	Article						craniofacial surgery; hyponatremia; mannitol; complications	SALT-WASTING SYNDROME; ANTIDIURETIC-HORMONE SECRETION; TRAUMATIC BRAIN-INJURY; HOSPITALIZED CHILDREN; NATRIURETIC-PEPTIDE; MANAGEMENT; PATIENT; WATER	Hyponatremia is an important cause of morbidity in some groups of hospitalized children. Our aim is to describe the incidence and severity of intraoperative hyponatremia in children undergoing craniofacial surgery, and determine the associated risk factors. A descriptive retrospective study of children who underwent primary craniofacial surgery between March 1994 and February 2008 was performed. All administered fluids contained a minimum sodium concentration of 140 mmol.l(-1). Hyponatremia was classified as follows: severe <= 125 mmol.l(-1); moderate 126-130 mmol.l(-1); and, mild 131-134 mmol.l(-1). Hundred and seven cases are reported. Severe, moderate and mild intraoperative hyponatremia occurred in 14 (13%), 21 (19%) and 23 (22%) children respectively. Mannitol was given to 31 (29%) children, but was not associated with the development of hyponatremia. Neither the type nor duration of surgery, type of fluid replacement nor hourly urinary output, was associated with development of hyponatremia. Most episodes of significant intraoperative hyponatremia (44%) were detected between the 2nd and the 4th hour of surgery. There were no identified neurological sequelae (e.g. coma, neurological deficit) attributable to the hyponatremia. Despite strict avoidance of low sodium solutions (< 140 mmol.l(-1)), hyponatremia occurs frequently in children undergoing craniofacial surgery in our practice; and is unrelated to the administration of mannitol. Although the mechanisms are yet to be determined, anesthesiologists should be aware of this issue and be prepared to monitor and treat this potentially serious complication.	Univ Hosp, Natl Craniofacial Surg Unit, Montevideo, Uruguay; Univ Hosp, Dept Anesthesia, Montevideo, Uruguay		Rando, K (corresponding author), Guadalupe 1578, Montevideo 11800, Uruguay.	karina.rando@gmail.com					Adrogue HJ, 2005, AM J NEPHROL, V25, P240, DOI 10.1159/000086019; Ausman JI, 2008, SURG NEUROL, V69, P221, DOI 10.1016/j.surneu.2007.12.013; Bohn D, 2005, QJM-INT J MED, V98, P691, DOI 10.1093/qjmed/hci101; Byeon JH, 2005, J KOREAN MED SCI, V20, P866, DOI 10.3346/jkms.2005.20.5.866; Guerrero R, 2007, EUR J ENDOCRINOL, V156, P611, DOI 10.1530/EJE-06-0659; Halperin ML, 1998, FLUID ELECTROLYTE AC; HOLLIDAY MA, 1957, PEDIATRICS, V19, P823; Hoorn EJ, 2004, PEDIATRICS, V113, P1279, DOI 10.1542/peds.113.5.1279; Jimenez R, 2006, PEDIATR NEUROL, V35, P261, DOI 10.1016/j.pediatrneurol.2006.05.004; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Levine JP, 2001, PLAST RECONSTR SURG, V108, P1501, DOI 10.1097/00006534-200111000-00009; Lieh-Lai MW, 1999, CRIT CARE MED, V27, P622, DOI 10.1097/00003246-199903000-00046; Lu DC, 2008, SURG NEUROL, V69, P226, DOI 10.1016/j.surneu.2007.02.051; MILLER R, 2005, MILLER ANESTHESIA, P1104; Nakajima K, 2005, INT J CARDIOL, V104, P332, DOI 10.1016/j.ijcard.2004.12.020; Palmer BF, 2000, NEPHROL DIAL TRANSPL, V15, P262, DOI 10.1093/ndt/15.2.262; Porzio P, 2000, CRIT CARE MED, V28, P1905, DOI 10.1097/00003246-200006000-00037; Sata A, 2006, NEUROENDOCRINOLOGY, V83, P117, DOI 10.1159/000094725; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Singh S, 2002, CRIT CARE MED, V30, P2575, DOI 10.1097/00003246-200211000-00028; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; WATTAD A, 1992, CLIN PEDIATR, V31, P153, DOI 10.1177/000992289203100305; Yun JJ, 2008, INTERN MED J, V38, P74, DOI 10.1111/j.1445-5994.2007.01561.x	23	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1155-5645	1460-9592		PEDIATR ANESTH	Pediatr. Anesth.	APR	2009	19	4					358	363		10.1111/j.1460-9592.2009.02928.x			6	Anesthesiology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Pediatrics	418RK	WOS:000264165900010	19236596				2022-02-06	
J	Tango, HK; Schmidt, AP; Mizumoto, N; Lacava, M; Auler, JOC				Tango, Humberto K.; Schmidt, Andre P.; Mizumoto, Nelson; Lacava, Marcelo; Auler, Jose O. C., Jr.			Low Hematocrit Levels Increase Intracranial Pressure in an Animal Model of Cryogenic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Normovolemic hemodilution; Traumatic brain injury; Cerebral perfusion pressure; Intracranial pressure	ACUTE NORMOVOLEMIC HEMODILUTION; EXPERIMENTAL CEREBRAL EDEMA; ACUTE ISCHEMIC STROKE; FLUID RESUSCITATION; HEMORRHAGIC-SHOCK; BLOOD-FLOW; REPLACEMENT; THERAPY; RABBITS; VOLUME	Background: Brain injury is responsible for significant morbidity and mortality in trauma patients, but controversy still exists over optimal fluid management for these patients. This study aimed to investigate the effects of acute hemodilution with hydroxyethyl starch (HES) or lactated Ringer's solution (LR) in intracranial pressure (ICP) and cerebral perfusion pressure (CPP) in dogs submitted to a cryogenic brain injury model. Methods: Design-Prospective laboratory animal study. Setting-Research laboratory in a teaching hospital. Subjects-Thirty-five male mongrel dogs. Interventions-Animals were enrolled to five groups: control, hemodilution with LR or HES 6% to an hematocrit target of 27% or 35%. Results: ICP and CPP levels were measured after cryogenic brain injury. Hemodilution promotes an increment of ICP levels, which decreases CPP when hematocrit target was estimated in 27.% after hemodilution. However, no differences were observed regarding crystalloid or colloid solution used for hemodilution in ICP and CPP levels. Conclusions: Hemodilution to a low hematocrit level increases ICP and decreases CPP scores in dogs submitted to a cryogenic brain injury. These results suggest that excessive hemodilution to a hematocrit below 30% should be avoided in traumatic brain injury patients.	[Tango, Humberto K.; Schmidt, Andre P.; Mizumoto, Nelson; Lacava, Marcelo; Auler, Jose O. C., Jr.] Univ Sao Paulo, Sch Med, Dept Anesthesia, Lab Med Invest LIM Anestesiol 08, Sao Paulo, Brazil		Auler, JOC (corresponding author), Av Dr Eneas Carvalho Aguiar,44,2 Andar,Bloco 1, BR-05403000 Sao Paulo, Brazil.	auler@incor.usp.br	Auler, Jose Otavio Costa/C-4492-2017; Schmidt, Andre P/E-4652-2012	Auler, Jose Otavio Costa/0000-0002-3919-1743; 	FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Supported by the Brazilian funding agency FAPESP.	ALBRIGHT AL, 1982, ACTA NEUROCHIR, V60, P257, DOI 10.1007/BF01406311; Asplund K., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000103; Bak Z, 2000, ANESTHESIOLOGY, V92, P1250, DOI 10.1097/00000542-200005000-00012; Bendo A A, 1993, Acta Anaesthesiol Belg, V44, P103; Biboulet P, 1996, BRIT J ANAESTH, V76, P81, DOI 10.1093/bja/76.1.81; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; Ginsberg MD, 2006, STROKE, V37, P2100, DOI 10.1161/01.STR.0000231388.72646.05; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; GRANDE PO, 1997, ACTA ANAESTH SCAND, V42, pS23; GROSS JB, 1983, ANESTHESIOLOGY, V58, P277, DOI 10.1097/00000542-198303000-00016; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Hlatky R., 2003, NEUROSURG FOCUS, V14, P1; Homi HM, 2004, ANESTH ANALG, V99, P974, DOI 10.1213/01.ane.0000131504.90754.d0; James HE, 2006, ACT NEUR S, V96, P125; Jones SB, 2004, J CLIN ANESTH, V16, P11, DOI 10.1016/j.jclinane.2003.03.003; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P571, DOI 10.1097/00000542-198910000-00016; KOROSUE K, 1992, STROKE, V23, P1487, DOI 10.1161/01.STR.23.10.1487; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Otsuki DA, 2006, ARTIF ORGANS, V30, P458, DOI 10.1111/j.1525-1594.2006.00242.x; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Reasoner DK, 1996, ANESTH ANALG, V82, P61, DOI 10.1097/00000539-199601000-00011; Rudolf J, 2002, CEREBROVASC DIS, V14, P33, DOI 10.1159/000063721; TODD MM, 1994, AM J PHYSIOL-HEART C, V267, pH2025, DOI 10.1152/ajpheart.1994.267.5.H2025; TU YK, 2002, AM J PHYSIOL-HEART C, V282, pH832; York J, 2000, J TRAUMA, V48, P376, DOI 10.1097/00005373-200003000-00002; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023	31	11	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2009	66	3					720	726		10.1097/TA.0b013e3181719b35			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	419ZU	WOS:000264259000022	19276744				2022-02-06	
J	Ouellet, MC; Sirois, MJ; Lavoie, A				Ouellet, Marie-Christine; Sirois, Marie-Josee; Lavoie, Andre			PERCEIVED MENTAL HEALTH AND NEEDS FOR MENTAL HEALTH SERVICES FOLLOWING TRAUMA WITH AND WITHOUT BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						multiple trauma; brain injuries; mental health services; health services accessibility	QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; STRESS-DISORDER; DEPRESSION; REHABILITATION; OUTCOMES; ANXIETY; SF-36; RATES	Objectives: To compare self-reported mental health in trauma survivors with and without brain injury; to describe factors associated with lower mental health; and to compare needs in terms of mental health services and perceived access limitations to such services. Design: Cross-sectional community survey. Patients: A total of 405 trauma survivors (239 with traumatic brain injury and 166 without) interviewed 2-4 years post-injury. Methods: Short Form-12 mental health scales and a survey measuring perceived needs for mental health services, and access limitations. Results: Injury survivors with and without traumatic brain injury are similarly affected on subjective reports of global mental health, vitality, role changes, and social functioning except for cognitive complaints. Variables associated with lower mental health in trauma survivors include younger age, being a woman, shorter time since injury, higher pain, lower social support, and presence of cognitive problems. Although individuals with traumatic brain injury report slightly more mental health problems and more need for mental health services, proportionally to their needs, more individuals without traumatic brain injury report access limitations to mental health services. Conclusion: Mental health problems affect important proportions of trauma survivors, either with or without traumatic brain injury. More effort should be made to facilitate access to mental health services for all trauma survivors.	[Ouellet, Marie-Christine; Sirois, Marie-Josee; Lavoie, Andre] CHAUQ, Ctr Rech, Quebec City, PQ, Canada; [Ouellet, Marie-Christine] McGill Univ, Dept Surg, Quebec City, PQ, Canada; [Sirois, Marie-Josee] Univ Quebec Trois Rivieres, Programme Ergotherapie, Quebec City, PQ, Canada		Ouellet, MC (corresponding author), CHA, Hop Enfant Jesus, CHAUQ, Ctr Rech, Pavillon Notre Dame,Local H-044,1401 18E Rue, Quebec City, PQ G1J 1Z4, Canada.	marie-christine.ouellet@mail.mcgill.ca		Sirois, Marie-josee/0000-0001-9775-6960; Ouellet, Marie-Christine/0000-0003-3477-1893	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP-62873]; Fonds de la Recherche en Sante du Quebec (FRSQ)Fonds de la Recherche en Sante du Quebec [3255]; Fondation de l'Hopital de l'Enfant-Jesus	Preparation of this article was supported by the Canadian Institutes for Health Research (CIHR, grants no. MOP-62873), by the Fonds de la Recherche en Sante du Quebec (FRSQ, grant no. 3255), and by a scholarship awarded to the first author by the Fondation de l'Hopital de l'Enfant-Jesus.	*AM ASS ADV AUT ME, 1990, ABBR INJ SCAL; Andersson AL, 1997, INJURY, V28, P539, DOI 10.1016/S0020-1383(97)00083-1; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Daveluy C., 2001, ENQUETE SOCIALE SANT; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; Ham OK, 2008, PUBLIC HEALTH NURS, V25, P37, DOI 10.1111/j.1525-1446.2008.00678.x; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; KREUTZER JS, 2003, BRAIN INJURY, V15, P563; LeBlanc M, 2007, J PSYCHOSOM RES, V63, P157, DOI 10.1016/j.jpsychores.2007.03.004; LEVASSEUR M, 2001, PROBLEMES SANTE; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Mason S, 2002, EMERG MED J, V19, P400, DOI 10.1136/emj.19.5.400; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McCarthy ML, 2003, J BONE JOINT SURG AM, V85A, P1689, DOI 10.2106/00004623-200309000-00006; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Piccinelli M, 1999, J PSYCHOSOM RES, V46, P455, DOI 10.1016/S0022-3999(98)00126-3; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Richmond TS, 2000, J TRAUMA STRESS, V13, P681, DOI 10.1023/A:1007866318207; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SHEPHERD JP, 1990, BRIT MED J, V301, P849, DOI 10.1136/bmj.301.6756.849; SIROIS M, AM J PHYS M IN PRESS; Sirois MJ, 2007, AM J PHYS MED REHAB, V86, P563, DOI 10.1097/PHM.0b013e31806e84d2; Tabachnik B.G., 1996, USING MULTIVARIATE S, V3rd ed.; Wallace CA, 2000, BRAIN INJURY, V14, P549; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; Ware J.E., 2002, SCORE VERSION 2 SF 1; WARE JE, 1995, INT J TECHNOL ASSESS, V11, P525, DOI 10.1017/S0266462300008710; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001	39	11	11	1	6	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	FEB	2009	41	3					179	186		10.2340/16501977-0306			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	416PD	WOS:000264017100012	19229452	gold, Green Submitted			2022-02-06	
J	Allen, DN; Haderlie, M; Kazakov, D; Mayfield, J				Allen, Daniel N.; Haderlie, Michael; Kazakov, Dmitriy; Mayfield, Joan			CONSTRUCT AND CRITERION VALIDITY OF THE COMPREHENSIVE TRAIL MAKING TEST IN CHILDREN AND ADOLESCENTS WITH TRAUMATIC BRAIN INJURY	CHILD NEUROPSYCHOLOGY			English	Article						Children; Adolescents; Trail Making Test; Traumatic brain injury; Validity	SERIAL ASSESSMENT; CATEGORY TEST; MAKING TEST; WAIS-R; SCHIZOPHRENIA; VARIANTS; DAMAGE	The current study examined the construct and criterion validity of the Comprehensive Trail Making Test (CTMT) when used to evaluate children and adolescents with traumatic brain injury (TBI). Participants included 100 children and adolescents, 50 who had sustained TBI and 50 normal comparisons (NC). Analyses indicated that the CTMT factor scores were significantly correlated with tests of perceptual organizational ability, processing speed, and motor function and provided support for its construct validity. Additionally, correlations between the various CTMT scores suggested that a different pattern of associations was present in the TBI group compared to the NC group. Finally, the TBI group performed significantly worse (p < .001) on all of the CTMT scores, including each of the five CTMT trails as well as the factor and composite index scores. Results support the construct and criterion validity of the CTMT when used to assess children and adolescents with TBI.	[Allen, Daniel N.; Haderlie, Michael; Kazakov, Dmitriy] Univ Nevada Las Vegas, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada Las Vegas, 4505 Maryland Pkwy,Box 455030, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 1998, SCHIZOPHR RES, V34, P87, DOI 10.1016/S0920-9964(98)00090-5; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Army Individual Test Battery, 1944, MAN DIR SCOR; Atkinson TM, 2008, J PSYCHOEDUC ASSESS, V26, P42, DOI 10.1177/0734282907301592; Buck KK, 2008, J CLIN EXP NEUROPSYC, V30, P312, DOI 10.1080/13803390701390483; Conners C. K., 2000, CONTINUOUS PERFORMAN; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; GASS CS, 1990, PSYCHOL REP, V67, P569; GOLDSTEIN G, 1966, PERCEPT MOTOR SKILL, V22, P347, DOI 10.2466/pms.1966.22.2.347; LEITER RG, 1949, PSYCHOL SERVICE CTR, V1, P139; Leiter RG., 1949, PSYCHOL SERVICE CTR, V1, P11; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Partington J, 1949, PSYCHOL SERVICE CTR, V1, P46; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; REITAN RM, 1992, HALSTEADREITAN NEURO; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Reynolds C. R., 2002, DEV TEST VISUAL PERC; Smith SR, 2008, CLIN NEUROPSYCHOL, V22, P507, DOI 10.1080/13854040701399269; TEASDALE G, 1974, LANCET, V2, P81; Ward LC, 2000, ASSESSMENT, V7, P79, DOI 10.1177/107319110000700107; WATSON N, 1949, PSYCHOL SERVICE CTR, V1, P49; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Woodcock R., 2001, EXAMINERS MANUAL WOO; [No title captured]	31	11	11	0	10	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.		2009	15	6					543	553		10.1080/09297040902748234			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	520IE	WOS:000271836400003	19319747				2022-02-06	
J	Catroppa, C; Anderson, V; Muscara, F				Catroppa, Cathy; Anderson, Vicki; Muscara, Frank			Rehabilitation of executive skills post-childhood traumatic brain injury (TBI): A pilot intervention study	DEVELOPMENTAL NEUROREHABILITATION			English	Article						intervention; childhood; executive skills; brain injury	HEAD-INJURY; RECOVERY; CHILDREN; REMEDIATION; ADOLESCENCE; KNOWLEDGE; DEFICITS; ABILITY; IMPACT	Background: Following TBI in childhood it is common for deficits to be seen in higher order skills, such as executive functions, both in the acute and longer-term post-injury. Despite this, very little evaluative research has been conducted with children post-TBI, particularly in the area of EF. Methods: The current study aimed to develop and implement a pilot intervention programme for adolescent/young adults (n = 3), in the chronic phase of recovery, when EF skills are no longer in a rapid state of development. Results and conclusions: Study results highlight the importance and need for accurate and relevant outcome measures that capture subtle as well as more obvious changes following intervention.	[Catroppa, Cathy; Anderson, Vicki; Muscara, Frank] Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki; Muscara, Frank] Univ Melbourne, Melbourne, Vic 3010, Australia		Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson P, 2001, CLIN NEUROPSYCHOL, V15, P81, DOI 10.1076/clin.15.1.81.1905; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; CHALMERS D, 1993, INT J BEHAV DEV, V16, P191, DOI 10.1177/016502549301600206; CICERONE K, 1990, NEUROPSYCHOLOGY EVER, P71; Cronin AF, 2001, AM J OCCUP THER, V55, P377, DOI 10.5014/ajot.55.4.377; CROWLEY JA, 1991, J PEDIATR PSYCHOL, V16, P611, DOI 10.1093/jpepsy/16.5.611; DAVIS MJ, 2005, J DENT CHILDREN, V62, P93; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; DENNIS M, 1989, CLIN NEUROPSYCHOLOGY, P495; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Garth J, 1997, Pediatr Rehabil, V1, P99; Gioia GA IP, 2000, BEHAV RATING INVENTO; GLANG A, 1992, J HEAD TRAUMA REHAB, V7, P93; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Kazdin A. E., 1984, BEHAV MODIFICATION A; Kelly T., 2000, CLIN NEUROPSYCHOL, V1, P38; KOLB B, 1996, FUNDAMENTALS HUMAN N; KOLB B, 1999, COGNITIVE NEUROREHAB; Lashley K., 1929, BRAIN MECH INTELLIGE; Laurence S., 1978, RECOVERY BRAIN DAMAG, P369; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Luria AR, 1963, RESTORATION FUNCTION; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; Mottram Lisa, 2004, Pediatr Rehabil, V7, P133, DOI 10.1080/1363849042000202286; NEIMEIER P, 2005, NEUROPSYCHOL REHABIL, V15, P129; Pentland L, 1998, NEUROPSYCHOL REHABIL, V8, P301, DOI 10.1080/713755572; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rosenblueth, 1949, SUPERSENSITIVITY DEN; ROTHI LJ, 1983, J CLIN NEUROPSYCHOL, V5, P73, DOI 10.1080/01688638308401152; RUFF R M, 1990, Brain Injury, V4, P339, DOI 10.3109/02699059009026187; Selznick L, 2000, BEHAV INTERVENT, V15, P243, DOI 10.1002/1099-078X(200007/09)15:3<243::AID-BIN59>3.3.CO;2-T; STERLING L, 1994, STUDENTS AC IN PRESS; Stuss D. T., 1994, BRAIN INJURY REHABIL, P212; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; THOMPSON J, 1995, J INT NEUROPSYCH SOC, P1; THOMSON JB, 2000, NEUROPSYCHOLOGICAL M, P233; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477	56	11	11	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2009	12	5					361	369		10.3109/17518420903087335			9	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	V15FS	WOS:000207788500011	20477565				2022-02-06	
J	Galvin, J; Mandalis, A				Galvin, Jane; Mandalis, Anna			Executive skills and their functional implications: Approaches to rehabilitation after childhood TBI	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Rehabilitation; brain injury; paediatric; outcomes	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL SUPPORTS; SCHOOL-AGE-CHILDREN; YOUNG-CHILDREN; SHORT-TERM; SOCIAL-PARTICIPATION; ACADEMIC PLACEMENT; NEEDS SCALE; OUTCOMES; ADOLESCENTS	Background: It is widely acknowledged that children recover differently from adults following traumatic brain injury. The impact of neurological injury in the context of developing skills and changing expectations of behaviour requires a developmental approach to rehabilitation that considers children's abilities across home, school and community environments. Methods: This article aims to provide an overview of the impact of executive deficits on everyday functioning and to review information about intervention strategies that support long term development of skills. Results and conclusions: While individual disciplines are not directly referred to in this paper, input from a comprehensive and co-ordinated interdisciplinary team is crucial to understanding and reducing the impact of executive deficits on functional performance.	[Galvin, Jane] Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Melbourne, Vic, Australia; [Galvin, Jane; Mandalis, Anna] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Galvin, Jane] La Trobe Univ, Sch Occupat Therapy, Bundoora, Vic, Australia; [Mandalis, Anna] Sydney Childrens Hosp, Dept Psychol, Randwick, NSW, Australia		Galvin, J (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	jane.galvin@mcri.edu.au					Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ANDERSON VA, 2007, DEV NEUROREHABIL, V10, P269; *AUSTR I HLTH WELF, 2003, AUSTR US GUID VERS 1; Bates G, 2006, DEV MED CHILD NEUROL, V48, P697, DOI 10.1017/S0012162206001472; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BLOSSER JL, 1994, ED DIMENSIONS ACQUIR, P413; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Carlson PM, 2006, BRAIN INJURY, V20, P1111, DOI 10.1080/02699050600955337; CATROPPA C, 2008, J PEDIATR PSYCHOL, V33, P1; De Luca CR, 2010, STUD NEUROPSYCHOL NE, P23; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; DUNN W, 1994, AM J OCCUP THER, V48, P595, DOI 10.5014/ajot.48.7.595; Eslinger P. J, 1996, ATTENTION MEMORY EXE, P367; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Garth J, 1997, Pediatr Rehabil, V1, P99; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; King Gillian A., 1999, Physical and Occupational Therapy in Pediatrics, V19, P5; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Law Mary, 1998, Physical and Occupational Therapy in Pediatrics, V18, P83, DOI 10.1300/J006v18n01_06; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Murphy NA, 2008, PEDIATRICS, V121, P1057, DOI 10.1542/peds.2008-0566; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Polatajko Helene J., 2001, Physical and Occupational Therapy in Pediatrics, V20, P107, DOI 10.1300/J006v20n02_07; Pollock N., 2005, CANADIAN OCCUPATIONA; Rosenbaum P., 1998, PHYS OCCUP THER PEDI, V18, P1, DOI [DOI 10.1080/J006v18n01_01, 10.1080/J006v18n01_01]; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Sohlberg MM, 1998, APHASIOLOGY, V12, P1047, DOI 10.1080/02687039808249469; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Soo C, 2008, DEV NEUROREHABIL, V11, P204, DOI 10.1080/17518420802259498; Steenbeek D, 2008, CHILD CARE HLTH DEV, V34, P521, DOI 10.1111/j.1365-2214.2008.00841.x; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; YLVISAKER M, 1994, ED DIMENSIONS ACQUIR, P121; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	59	11	11	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2009	12	5					352	360		10.3109/17518420903087293			9	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	V15FS	WOS:000207788500010	20477564				2022-02-06	
J	Gilkey, SL; Carey, J; Wade, SL				Gilkey, So'Nia L.; Carey, JoAnne; Wade, Shari L.			Families in Crisis: Considerations for the Use of Web-Based Treatment Models in Family Therapy	FAMILIES IN SOCIETY-THE JOURNAL OF CONTEMPORARY SOCIAL SERVICES			English	Article							PROBLEM-SOLVING INTERVENTION; ONLINE THERAPY; CHILDREN; CAREGIVERS; EFFICACY; ISSUES; WORK	Psychological interventions have typically utilized the traditional face-to-face office visit with clients. Although this strategy has proven to be effective (Simpson, Bell, Knox, & Mitchell, 2005), an emerging trend is to offer alternative approaches to therapeutic interventions (Schmidt, 1998). The current study considers the merits and shortcomings of Web-based interventions via synchronous videoconferencing (SVC) with families of children with a traumatic brain injury. Recent research suggests that family therapy offered via SVC has the potential for the delivery of family-based therapy. When using SVC, client readiness to address issues coupled with patience with the imperfection of the technology proved to be important factors. Other factors included the diagnosis and readiness to address identified problems in the context of SVC.	[Gilkey, So'Nia L.] Tulane Univ, Sch Social Work, New Orleans, LA 70118 USA; [Carey, JoAnne] Cincinnati Childrens Hosp, Med Ctr, Dept Behav Med & Clin Psychol, Cincinnati, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp, Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH USA		Gilkey, SL (corresponding author), 6823 St Charles Ave, New Orleans, LA 70118 USA.	sgilkey@tulane.edu					Carey JC, 2008, CYBERPSYCHOL BEHAV, V11, P188, DOI 10.1089/cpb.2007.0025; Castelnuovo G, 2003, CYBERPSYCHOL BEHAV, V6, P375, DOI 10.1089/109493103322278754; Cohen G. E., 1998, Computers in Human Services, V15, P13; Cook JE, 2002, CYBERPSYCHOL BEHAV, V5, P95, DOI 10.1089/109493102753770480; Cullen KW, 2008, AM J HEALTH BEHAV, V32, P40; DAVID H, 2003, J TECHNOLOGY HUMAN S, V21, P17; DAY SX, 2000, CYBERCOUNSELING CYBE; DONGIER M, 1986, CAN J PSYCHIAT, V31, P32, DOI 10.1177/070674378603100107; Drotar D, 2006, CHILD HEALTH CARE, V35, P91, DOI 10.1207/s15326888chc3501_8; FEINCHEL M, 2002, MYTHS REALITIES ONLI; Finn J, 2002, J SOC WORK EDUC, V38, P403, DOI 10.1080/10437797.2002.10779107; Glueckauf RL, 2002, REHABIL PSYCHOL, V47, P49, DOI 10.1037/0090-5550.47.1.49; GLUECKAUF RL, 2001, NIDRR ATA TEL STAT S; Glueckauf RL, 2007, CLIN GERONTOLOGIST, V31, P21, DOI 10.1300/J018v31n01_03; GROHOL JM, 1999, BEST PRACTICES E THE; Jones WP, 2002, J EMPLOYMENT COUNS, V39, P127, DOI 10.1002/j.2161-1920.2002.tb00844.x; Kanani K, 2003, FAM SOC-J CONTEMP H, V84, P155, DOI 10.1606/1044-3894.98; KING SA, 1998, BRIT J GUID COUNS, V26, P43, DOI DOI 10.1080/03069889808253837; Klein B, 2001, BEHAV COGN PSYCHOTH, V29, P113, DOI 10.1017/S1352465801001138; Lange A, 2001, J BEHAV THER EXP PSY, V32, P73, DOI 10.1016/S0005-7916(01)00023-4; Marziali E, 2006, GERONTOLOGIST, V46, P398, DOI 10.1093/geront/46.3.398; MCFADDEN J, 2000, J TECHNOLOGY COUNSEL, V1; Nezu AM, 1998, HELPING CANC PATIENT; ORAVEC JA, 2000, J MENTAL HLTH, V9, P212; Robin AL, 1989, NEGOTIATING PARENT A; Robinson P, 2003, EUR EAT DISORD REV, V11, P210, DOI 10.1002/erv.516; Robson D., 2000, COUNS PSYCHOL, V13, P249, DOI DOI 10.1080/09515070010037911; Rochlen AB, 2004, J CLIN PSYCHOL, V60, P269, DOI 10.1002/jclp.10263; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; SANTHIVEERAN J, 2004, J FAMILY SOCIAL WORK, V8, P37, DOI DOI 10.1300/J039V08N03_03; Schmidt JJ, 1998, J COUNS DEV, V76, P483, DOI 10.1002/j.1556-6676.1998.tb02708.x; Simpson S, 2005, CLIN PSYCHOL PSYCHOT, V12, P156, DOI 10.1002/cpp.436; Simpson S, 2006, EUR EAT DISORD REV, V14, P226, DOI 10.1002/erv.686; Skinner A, 2004, AM BEHAV SCI, V48, P434, DOI 10.1177/0002764204270280; STOFLE GS, 2001, CHOOSING ONLINE THER; Suler JR, 2000, CYBERPSYCHOL BEHAV, V3, P151, DOI 10.1089/109493100315996; SUSSMAN RJ, 2000, COUNSELING INTERNET; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Wade SL, 2006, J CONSULT CLIN PSYCH, V51, P178; York G., 2006, J MENTAL HLTH COUNSE, V28, P69, DOI [DOI 10.17744/MEHC.28.1.F0H37DJRW89NV6VB, 10.17744/mehc.28.1.f0h37djrw89nv6vb]; Young KS, 2005, CYBERPSYCHOL BEHAV, V8, P172, DOI 10.1089/cpb.2005.8.172; ZIMMER E, 1997, VILLAGE VOICE    MAY, P31	45	11	11	0	11	ALLIANCE CHILDREN & FAMILIES	MILWAUKEE	11700 WEST LAKE PARK DRIVE, MILWAUKEE, WI 53224 USA	1044-3894	1945-1350		FAM SOC	Fam. Soc.	JAN-MAR	2009	90	1					37	45		10.1606/1044-3894.3843			9	Family Studies; Social Work	Social Science Citation Index (SSCI)	Family Studies; Social Work	515EU	WOS:000271451100006					2022-02-06	
J	Homaifar, BY; Harwood, JE; Wagner, TH; Brenner, LA				Homaifar, Beeta Y.; Harwood, Jeri E.; Wagner, Todd H.; Brenner, Lisa A.			Description of outpatient utilization and costs in group of veterans with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						aging; costs; Department of Veterans Affairs; healthcare; nonacute care; outpatient services; rehabilitation; traumatic brain injury; utilization; veterans	MULTICENTER ANALYSIS; CARE; REHABILITATION; HEALTH; MANAGEMENT; MILITARY; MEDICINE; OUTCOMES; SYSTEMS; CHARGES	In an attempt to increase Understanding regarding the nonacute healthcare needs of veterans with traumatic brain injury (TBI), we examined the outpatient utilization and cost patterns of 72 patients with TBI who were at least 4 years postinjury. We selected participants from a clinical database of veterans receiving care at a western Department of Veterans Affairs (VA) medical center. We extracted data from national utilization databases maintained by the VA and examined data from primary care and internal medicine, psychiatry and substance use, rehabilitation, and other services (e.g., ancillary, diagnostic, prosthetic, dental, nursing home, and home care). We extracted data For fiscal years 2002 to 2007. In addition to descriptive statistics, we modeled visits per year as a function of time since injury. The data show that this sample of patients with TBI consistently used a wide array Of Outpatient services over time with considerable variation in cost. Further study regarding economic aspects of care for patients with TBI is warranted.	[Homaifar, Beeta Y.; Brenner, Lisa A.] Dept Vet Affairs Vet Integrated Serv Network 19, Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Homaifar, Beeta Y.; Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA; [Harwood, Jeri E.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO USA; [Harwood, Jeri E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Wagner, Todd H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Wagner, Todd H.] Stanford Univ, Stanford, CA 94305 USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA		Homaifar, BY (corresponding author), VA VISN 19, Mental Illness Res Educ & Clin Ctr, 1055 Clermont St, Denver, CO 80220 USA.	beeta.homaifar1@va.gov	Brenner, Lisa A./AAG-2442-2019	Wagner, Todd/0000-0001-7625-3504	VA Veterans Integrated Service Network 19 Mental Illness Research, Education and Clinical Center	This work was supported by the VA Veterans Integrated Service Network 19 Mental Illness Research, Education and Clinical Center.	Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Cote Murray J, 2007, Health Care Manag Sci, V10, P253, DOI 10.1007/s10729-007-9018-7; *DEP VET AFF, 2004, VETEESA138 SP DEP VE; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Felicetti T, 2005, PROF CASE MANAG, V10, P264; Girard P, 2007, J REHABIL RES DEV, V44, P1017, DOI 10.1682/JRRD.2006.12.0174; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; Liang H, 2003, BIOSTATISTICS, V4, P297, DOI 10.1093/biostatistics/4.2.297; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Phibbs CS, 2003, MED CARE RES REV, V60, p54S, DOI 10.1177/1077558703256725; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; Thurman DJ., 1995, GUIDELINES SURVEILLA; United States Department of Labor, CONS PRIC IND; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000; Yu W, 2003, MED CARE RES REV, V60, p40S, DOI 10.1177/1077558703256724	23	11	12	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2009	46	8					1003	1010		10.1682/JRRD.2008.12.0166			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	550YO	WOS:000274171000003	20157857	Bronze			2022-02-06	
J	Hoshida, S; Hatano, M; Furukawa, M; Ito, M				Hoshida, Shigeru; Hatano, Miyako; Furukawa, Mitsuru; Ito, Makoto			Neuroprotective effects of vitamin E on adult rat motor neurones following facial nerve avulsion	ACTA OTO-LARYNGOLOGICA			English	Article						Facial nerve avulsion; -tocopherol nicotinate; retrograde degeneration; facial motor nucleus (FMN); 4-hydroxynonenal	CEREBRAL-ISCHEMIA; NITRIC-OXIDE; DOUBLE-BLIND; CELL-DEATH; MOTONEURONS; INJURY; EXPRESSION; APOPTOSIS; BRAIN; TJ-23	Conclusion. The present study demonstrates the neuroprotective effect of vitamin E after peripheral facial nerve injury. Antioxidants may have therapeutic potential in traumatic facial nerve dysfunction resulting from traumatic temporal bone injury and ear surgery. Objective. We investigated the possible neuroprotective effect of vitamin E on the facial motor nucleus (FMN) motor neurones after peripheral nerve avulsion. Methods. In 36 adult rats, the right facial nerve was avulsed from the stylomastoid foramen. Following nerve avulsion, immunohistochemistry was used to investigate the effects of vitamin E on 4-hydroxynonenal (HNE) activity. FMN motor neurones and glial cells were counted bilaterally in sections stained with cresyl violet. Results. Rats administered vitamin E exhibited clear suppression of injury-induced neuronal HNE expression in the ipsilateral FMN as compared to non-treated controls. Following nerve avulsion, the number of surviving motor neurones in the ipsilateral FMN was significantly greater among vitamin E-treated rats than non-treated controls.	[Hoshida, Shigeru; Hatano, Miyako; Furukawa, Mitsuru; Ito, Makoto] Kanazawa Univ, Grad Sch Med Sci, Div Neurosci, Dept Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan		Ito, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Div Neurosci, Dept Otolaryngol Head & Neck Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	makoto@med.kanazawa-u.ac.jp			Ministry of Education, Science, Sports and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19591961]	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (#19591961).	Bartels M, 2004, CLIN NUTR, V23, P1360, DOI 10.1016/j.clnu.2004.05.003; Chaudhary G, 2003, FUND CLIN PHARMACOL, V17, P703, DOI 10.1046/j.0767-3981.2003.00209.x; Hayden KM, 2007, AM J MED, V120, P180, DOI 10.1016/j.amjmed.2006.03.039; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; Ikeda T, 2002, NEUROSCI LETT, V329, P33, DOI 10.1016/S0304-3940(02)00573-6; Ito M, 2007, OTOLARYNG HEAD NECK, V136, P225, DOI 10.1016/j.otohns.2006.08.012; Itoh T, 1996, AM J CHINESE MED, V24, P205, DOI 10.1142/S0192415X9600027X; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Maclusky NJ, 2003, NEUROSCIENCE, V118, P741, DOI 10.1016/S0306-4522(02)00940-5; Mattsson P, 1999, BRAIN RES BULL, V49, P333, DOI 10.1016/S0361-9230(98)00178-6; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Qin FZ, 2006, FREE RADICAL BIO MED, V40, P1827, DOI 10.1016/j.freeradbiomed.2006.01.019; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rossiter JP, 1996, EXP NEUROL, V138, P33, DOI 10.1006/exnr.1996.0044; RUAN RS, 1995, BRAIN RES, V698, P163, DOI 10.1016/0006-8993(95)00887-V; Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006; Uchiyama K, 2004, CLIN EXP PHARMACOL P, V31, P226, DOI 10.1111/j.1440-1681.2004.03981.x; Ueda Y, 1996, NEUROCHEM RES, V21, P909, DOI 10.1007/BF02532340; WU WT, 1993, EXP NEUROL, V120, P153, DOI 10.1006/exnr.1993.1050	19	11	12	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.		2009	129	3					330	336	PII 901462640	10.1080/00016480802210431			7	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	410CH	WOS:000263553200016	18720077				2022-02-06	
J	McDonald, S; Bornhofen, C; Hunt, C				McDonald, Skye; Bornhofen, Cristina; Hunt, Christopher			Addressing deficits in emotion recognition after severe traumatic brain injury: The role of focused attention and mimicry	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Rehabilitation; Emotion; Social perception; Attention	FACIAL AFFECT RECOGNITION; CLOSED-HEAD INJURY; PERCEPTION DEFICITS; SOCIAL-PERCEPTION; SELECTIVE ATTENTION; EXPRESSION; SCHIZOPHRENIA; BEHAVIOR; INTELLIGENCE; PLASTICITY	Deficits in emotion perception are prevalent in people with severe traumatic brain injury (TBI) and are an important target for remediation. Preliminary work has indicated that emotion perception can improve with treatment but there is a dearth of studies examining the efficacy of specific techniques. In this study we examined two remediation strategies: (1) focusing attention on relevant aspects of the facial expression, and (2) mimicking the facial expression. Twenty-two people with chronic, severe brain injuries and 32 people matched on basic demographic variables were asked to label six basic emotions spontaneously followed by either a Focus or Mimic instructional strategy. Contrary to expectations, the TBI group was not poorer than the control group in the Spontaneous condition. Consequently, the effects of Focus vs. Mimic were examined for participants who had average scores or less in the Spontaneous condition (n = 14 and 20, respectively). The poorer performing control group was found to benefit from repeated exposure regardless of remediation strategy. The TBI group did not. Over and above repeated exposure, the Focus instruction assisted control participants but lead to poorer performance in those with TBI. The Mimic strategy resulted in little improvement for either group. Those who benefited least from the Focus strategies in the TBI group were those with poor abstract reasoning and flexibility. There was no such association in the control group and no associations between cognitive abilities and changes in scores using the Mimic strategy in either group.	[McDonald, Skye; Bornhofen, Cristina; Hunt, Christopher] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094; Hunt, Christopher/0000-0001-5648-1139	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; University of New South Wales	This project was funded by the National Health and Medical Research Council of Australia and the University of New South Wales. We would like to thank Zoe Hill, Broke Adams and Corrine Restuccio for their assistance with data collection. We are indebted to the people with traumatic brain injury and others from the community who volunteered to take part in this study.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 1996, J NEUROSCI, V16, P7678; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; BENTON AL, 1978, FACIAL RECOGNITION T; Benton AL, 1994, MULTILINGUAL APHASIA; BOICE R, 1983, PSYCHOL BULL, V93, P3, DOI 10.1037/0033-2909.93.1.3; Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BURGESS PW, 1997, HAYLINGS BRIXTON TES; Combs DR, 2006, SCHIZOPHR RES, V87, P340, DOI 10.1016/j.schres.2006.05.003; Cornelissen K, 2003, J COGNITIVE NEUROSCI, V15, P444, DOI 10.1162/089892903321593153; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Davies M, 1998, J PERS SOC PSYCHOL, V75, P989, DOI 10.1037/0022-3514.75.4.989; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Ekman P., 1976, PICTURES FACIAL AFFE; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hess U, 1998, COGNITION EMOTION, V12, P509, DOI 10.1080/026999398379547; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kee KS, 2003, SCHIZOPHRENIA BULL, V29, P487, DOI 10.1093/oxfordjournals.schbul.a007021; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Martin RA, 1996, J RES PERS, V30, P290, DOI 10.1006/jrpe.1996.0019; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; McHugo GJ, 1996, MOTIV EMOTION, V20, P85, DOI 10.1007/BF02253867; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Penn DL, 2000, SCHIZOPHR RES, V46, P217, DOI 10.1016/S0920-9964(00)00005-0; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pleger B, 2003, NEUROSCI LETT, V335, P192, DOI 10.1016/S0304-3940(02)01153-9; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Reitan RM, 1992, TRAIL MAKING TEST; Ries M, 2005, NEUROPSYCHOLOGY, V19, P476, DOI 10.1037/0894-4105.19.4.476; Roberts RD, 2006, EMOTION, V6, P663, DOI 10.1037/1528-3542.6.4.663; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Russell TA, 2006, BRIT J CLIN PSYCHOL, V45, P579, DOI 10.1348/014466505X90866; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Silver H, 2004, PSYCHIAT RES, V128, P147, DOI 10.1016/j.psychres.2004.06.002; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Weiss EM, 2006, AGGRESSIVE BEHAV, V32, P187, DOI 10.1002/ab.20120	59	11	12	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2009	19	3					321	339	PII 909314286	10.1080/09602010802193989			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	435UO	WOS:000265369000001	19274576				2022-02-06	
J	Meyers, JE; Rohling, ML				Meyers, John E.; Rohling, Martin L.			CT and MRI Correlations with Neuropsychological Tests	APPLIED NEUROPSYCHOLOGY			English	Article						MNB; MRI; Meyers Neuropsychological Battery; neuropsychology	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SHORT BATTERY; INTELLIGENCE; PERFORMANCE; WAIS; VALIDATION; LOCALIZATION; DEFICITS; APHASIA	This study consisted of 124 brain-injured participants who were administered the Meyers Neuropsychological Battery (MNB) and (Meyers, 2003); the MNB contains commonly used neuropsychological instruments. These individuals had defined lesions on CT/MRI studies. The current study examined the performance of more modern versions of older tests and some newer neuropsychological tests to determine their sensitivity to lesion location as identified in the brain scans. The results showed 84% concordance with previously hypothesized localization results. Tables of sensitivity to various localizations were constructed along with functional maps for the various tests. These data will assist the clinician in assessing consistency ill cognitive impairment across test performance. Newer versions of tests seem to perform as well or better than their previous versions for localization; although localization is not the main purpose of modern neuropsychological assessment, the current data do indicate that the modern versions of neuropsychological tests do perform generally as expected. Memory tests were found to be the most sensitive to injury regardless of the location of injury.	[Meyers, John E.] Meyers Neuropsychol Serv, Mililani, HI 96789 USA; [Rohling, Martin L.] Univ S Alabama, Dept Psychol, Mobile, AL 36688 USA		Meyers, JE (corresponding author), Meyers Neuropsychol Serv, 94-553 Alapoai St 162, Mililani, HI 96789 USA.	jmeyersneuro@yahoo.com					BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A. L., 1959, RIGHT LEFT DISCRIMIN; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BLACK FW, 1986, J CLIN PSYCHOL, V42, P770, DOI 10.1002/1097-4679(198609)42:5<770::AID-JCLP2270420516>3.0.CO;2-P; BLACK FW, 1976, CORTEX, V12, P212, DOI 10.1016/S0010-9452(76)80002-0; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; Brandt J., 1985, ANN NY ACAD SCI, V44, P502; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CHASE TN, 1984, ARCH NEUROL-CHICAGO, V41, P1244, DOI 10.1001/archneur.1984.04050230026012; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DeFilippis N., 1997, BOOKLET CATEGORY TES, V2nd; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GOLDBERG E, 1994, J COGNITIVE NEUROSCI, V6, P276, DOI 10.1162/jocn.1994.6.3.276; GOLDSTEIN G, 1983, REHABILITATION BRAIN; Goodglass H, 1983, ASSESSMENT APHASIA R; GREENLIEF CL, 1985, J INT NEUROPSYCH SOC, V4, P595; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Halstead W.C., 1947, BRAIN INTELLIGENCE; Hamsher K., 1989, MULTILINGUAL APHASIA; Hardcastle VG, 2002, PHILOS SCI, V69, pS72, DOI 10.1086/341769; Heaton R. K., 2004, REVISED COMPREHENSIV; HOM J, 1984, J CLIN NEUROPSYCHOL, V6, P309, DOI 10.1080/01688638408401221; Howieson D. B., 2004, NEUROPSYCHOLOGICAL A, P286; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kaplan E, 1983, BOSTON NAMING TEST; Kertesz A, 1994, LOCALIZATION NEUROIM, P1; KING MC, 1981, J CLIN PSYCHOL, V37, P400, DOI 10.1002/1097-4679(198104)37:2<400::AID-JCLP2270370233>3.0.CO;2-B; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P139, DOI 10.1076/1385-4046(200002)14:1;1-8;FT139; Leonberger FT, 1992, NEUROPSYCHOLOGY, V6, P239, DOI DOI 10.1037/0894-4105.6.3.239; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Luria A. R., 1966, HUMAN BRAIN PSYCHOL; MARGOLIN DI, 1990, J CLIN EXP NEUROPSYC, V12, P597, DOI 10.1080/01688639008401004; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; MCFIE J, 1975, ASSESSMENT ORGANIC I; Meyers J., 1995, REY COMPLEX FIGURE R; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; MEYERS JE, 2003, MEYERS NEUROPSYCHOLO; MICELI G, 1981, Journal of Clinical Neuropsychology, V3, P53, DOI 10.1080/01688638108403113; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Newcombe F., 1969, MISSILE WOUNDS BRAIN; PHILLIPS CG, 1984, BRAIN, V107, P328, DOI 10.1093/brain/107.1.328; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; RAMIER AM, 1970, REV NEUROL, V123, P17; REITAN R, 1986, TRAUMATIC BRAIN INJU, V2; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R. M., 1986, TRAUMATIC BRAIN INJU, VI; REY A, 1964, EXAMIN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roberts M A, 1994, Appl Neuropsychol, V1, P45, DOI 10.1207/s15324826an0101&2_9; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Rothi L J, 1991, Clin Commun Disord, V1, P7; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; RUSSELL EW, 1987, NEUROPSYCHOLOGY, V1, P2; Scheres A, 2004, ARCH CLIN NEUROPSYCH, V19, P569, DOI 10.1016/j.acn.2003.08.005; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; SKLAR M, 1963, J SPEECH HEAR RES, V6, P84, DOI 10.1044/jshr.0601.84; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STORANDT M, 1986, HDB CLIN MEMORY ASSE; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; TULSKY DS, 2003, CLIN INTERPRETATION; Volbrecht ME, 2000, ARCH CLIN NEUROPSYCH, V15, P251, DOI 10.1016/S0887-6177(99)00016-5; WANG PL, 1987, FRONTAL LOBES REVISI; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Wechsler D., 1981, WAIS R MANUAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	80	11	11	0	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2009	16	4					237	253		10.1080/09084280903098752			17	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	539ZD	WOS:000273298100001	20183179				2022-02-06	
B	Owen, AM; Schiff, ND; Laureys, S		Laureys, S; Tononi, G		Owen, Adrian M.; Schiff, Nicholas D.; Laureys, Steven			The Assessment of Conscious Awareness in the Vegetative State	NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY			English	Article; Book Chapter							CEREBRAL-BLOOD-FLOW; EMISSION TOMOGRAPHY DATA; TRAUMATIC BRAIN INJURY; GLUCOSE-METABOLISM; NEURONAL-ACTIVITY; PERSISTENT; RECOVERY; PET; CONNECTIVITY; DIAGNOSIS	The assessment of patients in the vegetative state is extremely complex and depends frequently on subjective interpretations of the observed spontaneous and volitional behaviour. In recent years, a number of studies have demonstrated an important role for functional neuroimaging in the identification of residual cognitive function, and even conscious awareness, in some patients fulfilling the clinical criteria for vegetative state. Such studies, when successful, may be particularly useful where there is concern about the accuracy of the diagnosis and the possibility that residual cognitive function has remained undetected. However, use of these techniques in severely brain-injured persons is methodologically complex and requires careful quantitative analysis and interpretation. In addition, ethical frameworks to guide research in these patients urgently need to be developed to accommodate these emerging technologies.	[Owen, Adrian M.] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England; [Owen, Adrian M.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Schiff, Nicholas D.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; [Laureys, Steven] Univ Hosp CHU, Dept Neurol, Liege, Belgium; [Laureys, Steven] Univ Liege, Cyclotron Res Ctr, Belgian Natl Funds Sci Res, Liege, Belgium		Owen, AM (corresponding author), Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England.	adrian.owen@mrc-cbu.cam.ac.uk; nds2001@med.cornell.edu; steven.laureys@ulg.ac.be	Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Laureys, Steven/0000-0002-3096-3807			AGARDH CD, 1983, ANN NEUROL, V14, P482, DOI 10.1002/ana.410140414; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; Bates D, 2005, NEUROPSYCHOL REHABIL, V15, P175, DOI 10.1080/09602010443000399; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Beuthien-Baumann B, 2003, NUCL MED COMMUN, V24, P643, DOI 10.1097/00006231-200306000-00005; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; deJong BM, 1997, CLIN NEUROL NEUROSUR, V99, P213, DOI 10.1016/S0303-8467(97)00024-3; DEVOLDER AG, 1990, ARCH NEUROL-CHICAGO, V47, P197, DOI 10.1001/archneur.1990.00530020103022; Edgren E, 2003, RESUSCITATION, V57, P161, DOI 10.1016/S0300-9572(03)00004-2; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gsell W, 2000, J CHEM NEUROANAT, V20, P215, DOI 10.1016/S0891-0618(00)00095-8; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hamzei F, 2003, NEUROIMAGE, V20, P1393, DOI 10.1016/S1053-8119(03)00384-7; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HERSCOVITCH P, 1986, J CEREBR BLOOD F MET, V6, P120, DOI 10.1038/jcbfm.1986.14; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 2002, VEGETATIVE STATE MED; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2000, PHYSL IMAGING BRAIN, P329; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Momose T, 1989, Radiat Med, V7, P243; Owen AM, 2007, SCIENCE, V315, DOI 10.1126/science.1135583; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2005, NEUROPSYCHOL REHABIL, V15, P290, DOI 10.1080/09602010443000579; Owen AM, 2005, PROG BRAIN RES, V150, P457, DOI 10.1016/S0079-6123(05)50032-3; Owen AM, 2002, NEUROCASE, V8, P394, DOI 10.1076/neur.8.4.394.16184; Rossini PM, 2004, BRAIN, V127, P99, DOI 10.1093/brain/awh012; *ROYAL COLL PHYS, 2003, VEG STAT GUID DIAGN; Rudolf J, 2002, EUR J NEUROL, V9, P671, DOI 10.1046/j.1468-1331.2002.00468.x; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; Rudolf J, 1999, J NEUROSURG ANESTH, V11, P17, DOI 10.1097/00008506-199901000-00004; Sakatani K, 2003, ACT NEUR S, V87, P59; Schiff N, 1999, J COGNITIVE NEUROSCI, V11, P650, DOI 10.1162/089892999563715; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; TURKSTRA LS, 1995, BRAIN INJURY, V9, P61, DOI 10.3109/02699059509004573; VIDEEN TO, 1988, J CEREBR BLOOD F MET, V8, P662, DOI 10.1038/jcbfm.1988.113; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841; Wilson BA, 2001, BRAIN INJURY, V15, P1083, DOI 10.1080/02699050110082197; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	54	11	12	0	0	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-08-092102-0; 978-0-12-374168-4				2009							163	172		10.1016/B978-0-12-374168-4.00013-7			10	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BEI12	WOS:000316668600015		Green Submitted			2022-02-06	
J	Willemse-van Son, AHP; Ribbers, GM; Stam, HJ; van den Bos, GAM				Willemse-van Son, Agnes H. P.; Ribbers, Gerard M.; Stam, Henk J.; van den Bos, Geertrudis A. M.			IS THERE EQUITY IN LONG-TERM HEALTHCARE UTILIZATION AFTER TRAUMATIC BRAIN INJURY?	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; craniocerebral trauma; healthcare utilization; healthcare quality; healthcare access; healthcare evaluation	SICKNESS IMPACT PROFILE; SHORT GENERIC VERSION; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; MEDICAL-CARE; EPIDEMIOLOGY; DISABILITY; OUTCOMES; STROKE; LOCUS	Objective: To quantify the long-term use of various types of healthcare services in patients with traumatic brain injury and to estimate the relative contribution of predisposing characteristics, enabling factors and health-related needs to determine whether there is equity in healthcare utilization. Design: Cross-sectional study. Patients: Seventy-nine non-institutionalized moderate to severe patients with traumatic brain injury (age range 16-67 years). Methods: Healthcare use was measured at 3-5 years post-injury. The relative contribution of predisposing characteristics, enabling factors, and health-related needs to the utilization of various types of care was analysed using logistic regression to determine whether there was equity in healthcare utilization. Results: At least one healthcare service was used by 68% of the patients. Health-related needs explained most of the utilization. However, predisposing characteristics were also related to the use of other medical care and supportive care. Patients with a high internal locus of control were more likely to be users of supportive care, and patients with a high locus of control with the physician were more likely to visit medical specialists. Conclusion: The results suggest that most of our patients who needed care, received care. However, inequity could not be ruled out completely as predisposing characteristics also contributed to some types of healthcare utilization.	[Willemse-van Son, Agnes H. P.; Ribbers, Gerard M.; Stam, Henk J.] Erasmus MC, Dept Rehabil Med, NL-3000 CA Rotterdam, Netherlands; [Ribbers, Gerard M.] Rijndam Rehabil Ctr, Rotterdam, Netherlands; [van den Bos, Geertrudis A. M.] Univ Amsterdam, Acad Med Ctr, Dept Social Med, NL-1105 AZ Amsterdam, Netherlands		Willemse-van Son, AHP (corresponding author), Erasmus MC, Dept Rehabil Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.vanson-willemse@erasmusmc.nl	Ribbers, Gerard/N-3623-2019; Ribbers, Gerard M/C-1454-2014	Ribbers, Gerard M/0000-0002-6114-349X	Netherlands Organisation for Health Research and DevelopmentNetherlands Organization for Health Research and Development [1435.0020]	This study was performed as part of the "Long-term prognosis of functional outcome in neurological disorders", supervised by the Department of Rehabilitation Medicine of the VU Medical Centre, Amsterdam, and supported by the Netherlands Organisation for Health Research and Development (project: 1435.0020).	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andersen Ronald., 1968, BEHAV MODEL FAMILIES; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; *CENTR BUR STAT, 1981, US MED SERV; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; deBoer AGEM, 1997, HEALTH POLICY, V42, P101, DOI 10.1016/S0168-8510(97)00062-6; DEBRUIN AF, 1994, J CLIN EPIDEMIOL, V47, P863, DOI 10.1016/0895-4356(94)90189-9; DEBRUIN AF, 1994, J CLIN EPIDEMIOL, V47, P407, DOI 10.1016/0895-4356(94)90162-7; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Geyh S, 2007, QUAL LIFE RES, V16, P833, DOI 10.1007/s11136-007-9174-8; Goldsteen R L, 1994, J Aging Health, V6, P314, DOI 10.1177/089826439400600303; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Holman H, 2000, BRIT MED J, V320, P526, DOI 10.1136/bmj.320.7234.526; Jacobi CE, 2003, ARTHRIT RHEUM-ARTHR, V49, P567, DOI 10.1002/art.11200; Jacobi CE, 2001, ARTHRIT RHEUM-ARTHR, V45, P324, DOI 10.1002/1529-0131(200108)45:4<324::AID-ART344>3.0.CO;2-1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MAELAND JG, 1989, SCAND J SOC MED, V17, P93, DOI 10.1177/140349488901700114; Michie S, 2003, PATIENT EDUC COUNS, V51, P197, DOI 10.1016/S0738-3991(02)00194-5; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; van den Bos GAM, 2002, J EPIDEMIOL COMMUN H, V56, P943, DOI 10.1136/jech.56.12.943; van den Bos GAM, 1999, QUAL HEALTH CARE, V8, P247, DOI 10.1136/qshc.8.4.247; Van Sonderen E., 1993, MEASURING SOCIAL SUP; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298; VANBALEN HGG, 1992, MENSEN MET TRAUMATIS; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; Von Korff M, 2002, BRIT MED J, V325, P92, DOI 10.1136/bmj.325.7355.92; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; WALLSTON KA, 1991, HEALTH EDUC RES, V6, P251, DOI 10.1093/her/6.2.251; WHO, 2002, INT CLASS FUNCT DIS; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103	38	11	11	0	6	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JAN	2009	41	1					59	65		10.2340/16501977-0294			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	416PB	WOS:000264016900009	19197571	gold, Green Submitted			2022-02-06	
J	Yang, XY; Yang, SY; Wang, J; Zhang, XM; Wang, C; Hong, GL				Yang, Xinyu; Yang, Shuyuan; Wang, Jie; Zhang, Xuemin; Wang, Chen; Hong, Guoliang			Expressive proteomics profile changes of injured human brain cortex due to acute brain trauma	BRAIN INJURY			English	Article						Traumatic brain injury; proteomics; human; cortex	INTEGRIN-LINKED KINASE; CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE BRAIN; GROWTH-FACTOR; 2-DIMENSIONAL ELECTROPHORESIS; MASS-SPECTROMETRY; NEURONAL INJURY; CEREBRAL-CORTEX; PROTEINS; CELLS	Objective: To find the expressive proteomics changes in damaged human brain cortex after traumatic brain injury (TBI). Method: By rapid high-throughput and precise proteomic techniques, the traumatic injured human frontal cortexes were compared with non-trauma controls. Results: On 2-DE PAGE, 138 protein spots were found significantly different on expressive level of quantitative mature. Most of these proteins expressed in a fluctuant fashion within 18 hours after trauma, with mean levels lower than control. Eighty-two protein spots were identified by MALDI-MS TOF, which were products of 71 proteins and could be grouped into 10 categories based on possible functions: cytoskeleton (n = 10), metabolism (n = 13), electron transport (n = 8), signalling transduction (n = 4), stress response (n = 6), protein synthesis and turnover (n = 8), transporter (n = 5), cell cycle (n = 1), other (n = 8) and unknown (n = 9). Conclusion: After traumatic brain injury, there are significant proteins expressing changes in damaged brain tissue. These proteins may play a critical role in TBI. Although some of these proteins functions are not fully understood, they may become novel biomarkers and novel therapy targets in the future.	[Yang, Xinyu; Yang, Shuyuan; Wang, Chen; Hong, Guoliang] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Wang, Jie; Zhang, Xuemin] Acad Mil Med Sci, Natl Ctr Biomed Anal, Beijing, Peoples R China		Yang, SY (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China.	paradiseyang@gmail.com			National Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30271331]	This work was supported by the National Science Foundation of China (NSFC), ( No. 30271331).	Abdullaev Y, 2005, NAT NEUROSCI, V8, P1424, DOI 10.1038/nn1105-1424; Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Bajo M, 2002, PROTEOMICS, V2, P1539, DOI 10.1002/1615-9861(200211)2:11<1539::AID-PROT1539>3.0.CO;2-C; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; BERNANOVAGIORGI.S, 2002, PROTEOMICS, V2, P534; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buono P, 1997, BIOCHEM J, V323, P245, DOI 10.1042/bj3230245; Butterfield DA, 2004, BRAIN RES, V1000, P1, DOI 10.1016/j.brainres.2003.12.012; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen W, 2002, NEUROCHEM RES, V27, P871, DOI 10.1023/A:1020383313177; Chin LS, 1999, MOL BRAIN RES, V67, P239, DOI 10.1016/S0169-328X(99)00066-2; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Davidsson P, 2002, MOL BRAIN RES, V109, P128, DOI 10.1016/S0169-328X(02)00549-1; Davidsson P, 2001, PROTEOMICS, V1, P444; Ekegren T, 2006, J PROTEOME RES, V5, P2364, DOI 10.1021/pr060237f; Eun JP, 2004, EXP MOL MED, V36, P185, DOI 10.1038/emm.2004.26; Fei Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-96; Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Fountoulakis M, 2002, PROTEOMICS, V2, P1547, DOI 10.1002/1615-9861(200211)2:11<1547::AID-PROT1547>3.0.CO;2-M; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hanai N, 2004, FEBS LETT, V568, P83, DOI 10.1016/j.febslet.2004.05.030; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Hoffrogge R, 2006, NEURODEGENER DIS, V3, P112, DOI 10.1159/000092102; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Kaneko Y, 2004, J CELL SCI, V117, P407, DOI 10.1242/jcs.00871; Kartmann B, 2001, J CELL SCI, V114, P839; Kim SI, 2004, NEUROCHEM RES, V29, P1317, DOI 10.1023/B:NERE.0000023618.35579.7c; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; LEE JM, 2005, J NEUROSCI, V25, P6449; Leypoldt F, 2002, NEUROSCI LETT, V324, P37, DOI 10.1016/S0304-3940(02)00170-2; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Loan T, 1999, NUTRITION, V15, P809; Lubec G, 2003, PROG NEUROBIOL, V69, P193, DOI 10.1016/S0301-0082(03)00036-4; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marion Donald W, 2006, Prog Neurol Surg, V19, P171, DOI 10.1159/000095191; Maurer Martin H, 2003, Proteome Sci, V1, P4, DOI 10.1186/1477-5956-1-4; Mills J, 2003, J NEUROSCI, V23, P1638; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Patel K, 2002, PROTEOMICS, V2, P1464, DOI 10.1002/1615-9861(200210)2:10<1464::AID-PROT1464>3.0.CO;2-9; Peyrl A, 2003, PROTEOMICS, V3, P1781, DOI 10.1002/pmic.200300460; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Poona HF, 2005, NEUROCHEM INT, V46, P159, DOI 10.1016/j.neuint.2004.07.008; Renault F, 2003, BIOCHEM PHARMACOL, V66, P1581, DOI 10.1016/S0006-2952(03)00514-8; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; Vanrobaeys F, 2005, J PROTEOME RES, V4, P2283, DOI 10.1021/pr050205c; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Yamaji R, 2004, ARCH BIOCHEM BIOPHYS, V423, P332, DOI 10.1016/j.abb.2004.01.003; Yang JW, 2005, J PROTEOME RES, V4, P768, DOI 10.1021/pr049774v; Yoganathan N, 2002, PHARMACOL THERAPEUT, V93, P233, DOI 10.1016/S0163-7258(02)00192-4	57	11	13	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	10					830	840	PII 914074702	10.1080/02699050903196670			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	485SP	WOS:000269144600007	19697172				2022-02-06	
J	Frasier, LD				Frasier, Lori D.			Abusive Head Trauma in Infants and Young Children: A Unique Contributor to Developmental Disabilities	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Abusive head trauma; Inflicted neurotrauma; Shaken baby svndrome; Shaken impact syndrome; Battered ohild syndrome; Child abuse; Developmental disabilities	SHAKEN-BABY-SYNDROME; PERMANENT BRAIN-DAMAGE; AGE-RELATED INCIDENCE; RETINAL HEMORRHAGES; VITREOUS HEMORRHAGES; SUBDURAL-HEMATOMA; INJURY; MANIFESTATIONS; NEUROPATHOLOGY; CONSEQUENCES	Abusive head trauma in infants and young children is the leading cause of death and disability from child abuse. This article discusses the history, epidemiology, clinical aspects, developmental outcomes, and associated injuries of this unique contributor to developmental disabilities. Prevention of abusive injuries and prevention of child abuse and neglect are also discussed.	Univ Utah, Sch Med, Ctr Safe & Healthy Families, Primary Childrens Med Ctr, Salt Lake City, UT 84113 USA		Frasier, LD (corresponding author), Univ Utah, Sch Med, Ctr Safe & Healthy Families, Primary Childrens Med Ctr, 100 N Med Dr,Suite 3400, Salt Lake City, UT 84113 USA.	Lori.frasier@imail.org					Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Becker JC, 1998, CHILD ABUSE NEGLECT, V22, P931, DOI 10.1016/S0145-2134(98)00069-6; Berger RP, 2004, CHILD ABUSE NEGLECT, V28, P739, DOI 10.1016/j.chiabu.2004.01.007; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; Bourgeois M, 2008, CHILD NERV SYST, V24, P169, DOI 10.1007/s00381-007-0493-4; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; ELDER JE, 1991, J PAEDIATR CHILD H, V27, P286, DOI 10.1111/j.1440-1754.1991.tb02539.x; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Francis PJ, 2004, EUR J PEDIATR, V163, P420, DOI 10.1007/s00431-004-1440-y; FRASIER L, 2006, ABUSIVE HEAD TRAUMA, V1; FRIENDLY D S, 1971, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V75, P318; Frikke M, 2004, PEDIATRICS, V114, P1131, DOI 10.1542/peds.2004-1491; Ganesh A, 2004, OPHTHALMOLOGY, V111, P1428, DOI 10.1016/j.ophtha.2003.10.028; GAYNON MW, 1988, AM J OPHTHALMOL, V106, P423, DOI 10.1016/0002-9394(88)90877-X; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GELLES RJ, 1996, DISCIPLINING CHILDRE; Ghatan S, 2002, NEUROSURG CLIN N AM, V13, P227, DOI 10.1016/S1042-3680(01)00002-X; GIANGIACOMO J, 1988, OPHTHALMOLOGY, V95, P295; GIANGIACOMO J, 1985, Journal of Pediatric Ophthalmology and Strabismus, V22, P234; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; GREENWALD MJ, 1986, OPHTHALMOLOGY, V93, P618; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Han D P, 1990, J Pediatr Ophthalmol Strabismus, V27, P299; HANSEN KK, 1994, ARCH PEDIAT ADOL MED, V148, P1345, DOI 10.1001/archpedi.1994.02170120107021; HARCOURT B, 1971, BMJ-BRIT MED J, V3, P398, DOI 10.1136/bmj.3.5771.398; HARLEY RD, 1980, J PEDIAT OPHTH STRAB, V17, P5; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Keenan H, 2001, N C Med J, V62, P340; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kivlin J D, 1999, Trans Am Ophthalmol Soc, V97, P545; Kivlin JD, 2001, CURR OPIN OPHTHALMOL, V12, P158, DOI 10.1097/00055735-200106000-00002; KLEINMAN P, 1998, DIAGNOSTIC IMAGING C, V1; KLEINMAN PK, 1992, RADIOLOGY, V185, P119, DOI 10.1148/radiology.185.1.1523293; Krugman SD, 2000, PEDIATR EMERG CARE, V16, P432, DOI 10.1097/00006565-200012000-00016; Landry SH, 2004, DEV NEUROPSYCHOL, V26, P707, DOI 10.1207/s15326942dn2603_4; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Levin A V, 1991, Pediatr Emerg Care, V7, P129, DOI 10.1097/00006565-199104000-00028; Levine LM, 2003, PEDIATR CLIN N AM, V50, P137, DOI 10.1016/S0031-3955(02)00109-8; Lo T Y M, 2003, Pediatr Rehabil, V6, P47, DOI 10.1080/1363849031000109516; Lynch RE, 2000, J PEDIATR-US, V136, P565, DOI 10.1016/S0022-3476(00)90031-3; Marshman WE, 1999, J AAPOS, V3, P255, DOI 10.1016/S1091-8531(99)70013-3; Matthews GP, 1996, J PEDIATR OPHTHALMOL, V33, P260, DOI 10.3928/0191-3913-19960701-13; Mierisch RF, 2004, PEDIATR EMERG CARE, V20, P118, DOI 10.1097/01.pec.0000113883.10140.c2; Morad Y, 2004, J AAPOS, V8, P521, DOI 10.1016/j.jaapos.2004.07.009; MUSHIN A, 1971, BRIT J OPHTHALMOL, V55, P343, DOI 10.1136/bjo.55.5.343; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; Pounder DJ, 1997, AM J FOREN MED PATH, V18, P321, DOI 10.1097/00000433-199712000-00001; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Rutty GN, 1999, AM J FOREN MED PATH, V20, P48, DOI 10.1097/00000433-199903000-00012; Salehi-Had H, 2006, PEDIATRICS, V117, pE1039, DOI 10.1542/peds.2005-0811; Showers J, 1992, Child Today, V21, P34; SILVERMAN FN, 1953, AM J ROENTGENOL, V69, P413; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STARLING SP, 1995, PEDIATRICS, V95, P259; Taylor D, 1999, EYE, V13, P3; Theodore AD, 2006, CHILD ABUSE NEGLECT, V30, P1353, DOI 10.1016/j.chiabu.2006.05.010; Trenchs V, 2007, PEDIATR NEUROSURG, V43, P352, DOI 10.1159/000106382; Vasconcelos MM, 1999, PEDIATR NEUROL, V20, P289, DOI 10.1016/S0887-8994(98)00153-2; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; WEISSGOLD DJ, 1995, SURV OPHTHALMOL, V39, P509; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037; 2004, NATL CHILD ABUSE NEG	81	11	13	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	DEC	2008	55	6					1269	+		10.1016/j.pcl.2008.08.003			18	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	390QA	WOS:000262177600003	19041457				2022-02-06	
J	Brenner, LA; Harwood, JEE; Homaifar, BY; Cawthra, E; Waldman, J; Adler, LE				Brenner, Lisa A.; Harwood, Jeri E. E.; Homaifar, Beeta Y.; Cawthra, Ellen; Waldman, Jeffrey; Adler, Lawrence E.			Psychiatric Hospitalization and Veterans With Traumatic Brain Injury: A Retrospective Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol; drug; psychiatric hospitalization; substance abuse; traumatic brain injury	MULTICENTER ANALYSIS; DRUG-USE; PREVALENCE; SUICIDE; ALCOHOL; POPULATION; DISORDERS	To determine risk factors for psychiatric hospitalization after traumatic brain injury (TBI) in veterans. Subjects and procedures: Medical records of 96 veteran, with histories of TBI (17 mild, 33 moderate, and 46 severe) were reviewed for information concerning psychiatric history, including hospitalization and substance misuse. Results: Subjects with a history of problematic drug and alcohol use had a significantly higher probability of psychiatric hospitalization than those without such a history. Gender, age, problematic alcohol use without problematic drug use, injury severity, time since injury, years of follow-up, and a history of psychiatric symptoms (including those attributed to general medical conditions) were not identified as significant risk factors. Ninety-one veterans (95%) had a history of psychiatric difficulty. In addition, the probability of post-TBI problematic drug and alcohol use, given a pre-TBI history of such use, was significantly higher than the probability given no history. Conclusions: Veterans with problematic drug and alcohol use are at increased risk for psychiatric hospitalization after TBI. In addition, the likelihood of problematic post-TBI drug and alcohol use was significantly greater for those with a preinjury history. Ninety-five percent of veterans in the current sample endorsed lifetime histories of psychiatric difficulty. These findings highlight the need for evidence-based means of psychiatric and/or substance abuse treatment of those with a history of TBI.	[Brenner, Lisa A.; Harwood, Jeri E. E.; Homaifar, Beeta Y.; Cawthra, Ellen; Waldman, Jeffrey; Adler, Lawrence E.] UCD, Sch Med, VA VISN 19 Mental Illness Res Educ & Clin Ctr, Aurora, CO USA; [Brenner, Lisa A.; Homaifar, Beeta Y.; Adler, Lawrence E.] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Phys Med & Rehabil, Aurora, CO USA; [Harwood, Jeri E. E.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA		Adler, LE (corresponding author), VA VISN 19 MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	Lisa.Brenner@va.gov	Brenner, Lisa A./AAG-2442-2019		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [50878-09] Funding Source: Medline		Ahmed I, 1998, Semin Clin Neuropsychiatry, V3, P23; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Brenner LA, 2007, J HEAD TRAUMA REHAB, V22, P56, DOI 10.1097/00001199-200701000-00007; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; *DEP VET AFF, 2004, VETEESA138 DEP VET A; Hazlett SB, 2004, ACAD EMERG MED, V11, P193, DOI 10.1111/j.1553-2712.2004.tb01434.x; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Institute of Medicine, 1990, BROAD BAS TREATM ALC; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; SCHLENGER WE, 1992, J TRAUMA STRESS, V5, P333, DOI 10.1002/jts.2490050303; Schnyder U, 1997, GEN HOSP PSYCHIAT, V19, P119, DOI 10.1016/S0163-8343(96)00169-7; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thurman DJ., 1995, GUIDELINES SURVEILLA; Way BB, 2001, PSYCHIATR SERV, V52, P214, DOI 10.1176/appi.ps.52.2.214; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000	23	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2008	23	6					401	406		10.1097/01.HTR.0000341436.59627.a5			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	379WZ	WOS:000261428300006	19033833				2022-02-06	
J	Cox, CD; West, EJ; Liu, MC; Wang, KKW; Hayes, RL; Lyeth, BG				Cox, Christopher D.; West, Eric J.; Liu, Ming Cheng; Wang, Kevin K. W.; Hayes, Ronald L.; Lyeth, Bruce G.			Dicyclomine, an M1 Muscarinic Antagonist, Reduces Biomarker Levels, But Not Neuronal Degeneration, in Fluid Percussion Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						CSF; dicyclomine; immunohistochemistry; spectrin; TBI	LONG-TERM POTENTIATION; ALPHA-II-SPECTRIN; CHOLINERGIC RECEPTOR-BINDING; SIGNAL-TRANSDUCTION PATHWAY; PHOSPHATIDYLINOSITOL BISPHOSPHATE; BEHAVIORAL DEFICITS; BREAKDOWN PRODUCTS; PHOSPHOINOSITIDE TURNOVER; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE	Recent studies indicate that alpha II-spectrin breakdown products (SBDPs) have utility as biological markers of traumatic brain injury (TBI). However, the utility of SBDP biomarkers for detecting effects of therapeutic interventions has not been explored. Acetylcholine plays a role in pathological neuronal excitation and TBI-induced muscarinic cholinergic receptor activation may contribute to excitotoxic processes. In experiment I, regional and temporal changes in calpain-mediated alpha-spectrin degradation were evaluated at 3, 12, 24, and 48 h using immunostaining for 145-kDa SBDP. Immunostaining of SBDP-145 was only evident in the hemisphere ipsilateral to TBI and was generally limited to the cortex except at 24 h when immunostaining was also prominent in the dentate gyrus and striatum. In Experiment II, cerebral spinal fluid (CSF) samples were analyzed for various SBDPs 24 h after moderate lateral fluid percussion TBI. Rats were administered either dicyclomine (5 mg/kg i.p.) or saline vehicle (n=8 per group) 5 min prior to injury. Injury produced significant increases (p< 0.001) of 300%, 230%, and >1000% in SBDP-150, -145, and -120, respectively in vehicle-treated rats compared to sham. Dicyclomine treatment produced decreases of 38% (p=0.077), 37% (p=0.028), and 63% (p=0.051) in SBDP-150, -145, and -120, respectively, compared to vehicle-treated injury. Following CSF extraction, coronal brain sections were processed for detecting degenerating neurons using Fluoro-Jade histofluorescence. Stereological techniques were used to quantify neuronal degeneration in the dorsal hippocampus CA2/3 region and in the parietal cortex. No significant differences were detected in numbers of degenerating neurons in the dorsal CA2/3 hippocampus or the parietal cortex between saline and dicyclomine treatment groups. The percent weight loss following TBI was significantly reduced by dicyclomine treatment. These data provide additional evidence that, as TBI biomarkers, SBDPs are able to detect a therapeutic intervention even in the absence of changes in neuronal cell degeneration measured by Fluoro-jade.	[Cox, Christopher D.; West, Eric J.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Liu, Ming Cheng; Wang, Kevin K. W.; Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL USA; [Wang, Kevin K. W.; Hayes, Ronald L.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Wang, Kevin K. W.; Hayes, Ronald L.] Univ Florida, Dept Anesthesiol, Gainesville, FL USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1515 Newton Court,1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Wang, Kevin/0000-0002-9343-6473; Cox, Christopher/0000-0001-9986-1561; Lyeth, Bruce/0000-0003-4811-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS29995, NS45136, NS051431, NS049175]; DoDUnited States Department of Defense [DAMD17-03-1-0772, DAMD17-03-1-0066]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051431, R01NS045136, R01NS049175, R01NS029995] Funding Source: NIH RePORTER	This research was supported by NIH NS29995, NS45136 (to B.G.L.); DoD DAMD17-03-1-0772, DAMD17-03-1-0066, NIH NS051431 (to R.L.H.); and NIH NS049175 (to K.K.W.W.).	Amaral David G., 1995, P443; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; BURGARD EC, 1990, NEUROSCI LETT, V116, P34, DOI 10.1016/0304-3940(90)90382-J; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DELAHUNTY TM, 1995, NEUROCHEM RES, V20, P405; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DHILLON HS, 1995, BRAIN RES, V698, P100, DOI 10.1016/0006-8993(95)00840-M; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DOODS HN, 1987, J PHARMACOL EXP THER, V242, P257; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; GALLO MP, 1993, J PHYSIOL-LONDON, V471, P41, DOI 10.1113/jphysiol.1993.sp019890; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; HABER B, 1980, NEUROBIOLOGY CEREBRO, V1, P345; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HEPPNER F, 1958, Monatsschr Unfallheilkd Versicherungsmed, V61, P257; Jenkner FL, 1954, NERVENARZT, V25, P77; JENKNER FL, 1955, ELECTROEN CLIN NEURO, V7, P303, DOI 10.1016/0013-4694(55)90044-4; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; Jiang ZW, 2000, BRAIN RES, V852, P37, DOI 10.1016/S0006-8993(99)02230-1; JOHNSON GVW, 1989, BIOCHEM BIOPH RES CO, V163, P1505, DOI 10.1016/0006-291X(89)91150-9; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; KUMAGAE Y, 1991, J NEUROCHEM, V56, P1169, DOI 10.1111/j.1471-4159.1991.tb11407.x; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; Lyeth BG, 1996, BRAIN RES, V742, P63, DOI 10.1016/S0006-8993(96)01002-5; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; OLNEY JW, 1983, NATURE, V301, P520, DOI 10.1038/301520a0; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; PRASAD MR, 1994, J NEUROCHEM, V63, P773; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; REEVES TM, 1995, EXP BRAIN RES, V106, P248; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Sharma VK, 1996, CIRC RES, V79, P86, DOI 10.1161/01.RES.79.1.86; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; TURSKI WA, 1983, EXPERIENTIA, V39, P1408, DOI 10.1007/BF01990130; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG KKW, 2002, METH NE FRO NEUROSCI, P181; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	73	11	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2008	25	11					1355	1365		10.1089/neu.2008.0671			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	384BP	WOS:000261718900008	19061379	Green Accepted, Green Published			2022-02-06	
J	Lee, HO; Koh, EJ; Oh, YM; Park, SS; Kwon, KH; Choi, HY				Lee, Hai-Ong; Koh, Eun-Jeong; Oh, Young-Min; Park, Seung-Soo; Kwon, Ki-Hun; Choi, Ha-Young			Effect of Vagus Nerve Stimulation in Post-Traumatic Epilepsy and Failed Epilepsy Surgery : Preliminary Report	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Vagus nerve; Electric stimulation; Epilepsy; Post-traumatic	TERM-FOLLOW-UP; LONG-TERM; REFRACTORY EPILEPSY; DEVICE PARAMETERS; PARTIAL SEIZURES; THERAPY	Objective : Vagus nerve stimulation (VNS) has been used in epilepsy patients refractory to standard medical treatments and unsuitable candidates for resective or disconnective surgery. In this study, we investigated the efficacy of VNS to patients who had refractory result to epilepsy surgery and patients with post-traumatic epilepsy. Methods : We analyzed the effect of VNS in 11 patients who had undergone previous epilepsy surgery and patients with intractable post-traumatic epilepsy associated with brain injury. All patients underwent VNS implantation between October 2005 and December 2006. Results : We evaluated seizure frequency before and after implantation of VNS and maximum follow up period was 24 months. In the first 6 months, 11 patients showed an average of 74.3% seizure reduction. After 12 months, 10 patients showed 85.2% seizure reduction. Eighteen months after implantation, 9 patients showed 92.4% seizure reduction and 7 patients showed 97.2% seizure reduction after 24 months. Six patients were seizure-free at this time. Conclusion : We conclude that the VNS is a helpful treatment modality in patients with surgically refractory epilepsy and in patients with post-traumatic epilepsy due to severe brain injury.	[Lee, Hai-Ong; Koh, Eun-Jeong; Oh, Young-Min; Park, Seung-Soo; Kwon, Ki-Hun; Choi, Ha-Young] Chonbuk Natl Univ, Med Sch Hosp, Dept Neurosurg, Res Inst Clin Med, Jeonju 561712, South Korea		Koh, EJ (corresponding author), Chonbuk Natl Univ, Med Sch Hosp, Dept Neurosurg, Res Inst Clin Med, 634-18 Geumam Dong, Jeonju 561712, South Korea.	kohejns@chonbuk.ac.kr					Ardesch JJ, 2007, SEIZURE-EUR J EPILEP, V16, P579, DOI 10.1016/j.seizure.2007.04.005; Ben Renfroe J, 2002, NEUROLOGY, V59, pS26, DOI 10.1212/WNL.59.6_suppl_4.S26; DeGiorgio CM, 2001, EPILEPSIA, V42, P1017, DOI 10.1046/j.1528-1157.2001.0420081017.x; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; GEORGE R, 1994, EPILEPSIA, V35, P637, DOI 10.1111/j.1528-1157.1994.tb02484.x; Heck C, 2002, NEUROLOGY, V59, pS31, DOI 10.1212/WNL.59.6_suppl_4.S31; HOLDER LK, 1992, PACE, V15, P1557, DOI 10.1111/j.1540-8159.1992.tb02934.x; Morris GL, 1999, NEUROLOGY, V53, P1731, DOI 10.1212/WNL.53.8.1731; Morrow JI, 2000, SEIZURE-EUR J EPILEP, V9, P442, DOI 10.1053/seiz.2000.0417; Schachter SC, 2002, NEUROLOGY, V59, pS15, DOI 10.1212/WNL.59.6_suppl_4.S15; Spanaki MV, 2004, SEIZURE-EUR J EPILEP, V13, P587, DOI 10.1016/j.seizure.2004.01.009; Uthman BM, 2004, NEUROLOGY, V63, P1124, DOI 10.1212/01.WNL.0000138499.87068.C0; You SJ, 2007, J KOREAN MED SCI, V22, P442, DOI 10.3346/jkms.2007.22.3.442	13	11	11	0	0	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	OCT	2008	44	4					196	198		10.3340/jkns.2008.44.4.196			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	367OO	WOS:000260561500003	19096676	Green Published, gold			2022-02-06	
J	Luukinen, H; Jokelainen, J; Kervinen, K; Kesaniemi, YA; Winqvist, S; Hillbom, M				Luukinen, H.; Jokelainen, J.; Kervinen, K.; Kesaniemi, Y. A.; Winqvist, S.; Hillbom, M.			Risk of dementia associated with the ApoE epsilon 4 allele and falls causing head injury without explicit traumatic brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						ageing; ApoE epsilon 4; dementia; fall accident; head injury	APOLIPOPROTEIN-E EPSILON-4; ALZHEIMERS-DISEASE; OLDER-ADULTS; POPULATION; PEOPLE; AGE	Objectives - Severe head injury (HI) and the apolipoprotein E (ApoE) epsilon 4 allele are risk factors for dementia. The corresponding effect of falls causing HI without explicit traumatic brain injury (TBI) in association with the ApoE epsilon 4 is not known. Materials and methods - Altogether 134 persons aged 70 years or older constituted a retrospective population sample, who scored >= 26 in the MiniMental State Examination (MMSE) test at baseline and were clinically examined for dementia 9 years afterward. Fall-related HI causing superficial laceration or bruises or wounds that require suturing were prospectively recorded during the 9-year follow-up. We used Cox regression with age at the diagnosis of dementia as a dependent variable. Results - Twenty-eight (21%) subjects had falls causing HI without explicit TBI, the ApoE epsilon 4 allele was seen in 44 (33%), and clinical dementia was diagnosed in 25 (19%). Adjusted for the baseline MMSE score, sex and educational status, the hazard ratio for subsequent dementia in subjects having falls with HI without explicit TBI and the ApoE epsilon 4 allele as compared with those who do not possess these characteristics was 2.70 (95% confidence interval, 1.02-7.16). Conclusions - According to the results of this small retrospective study, falls with HI without explicit TBI in connection with the ApoE epsilon 4 allele is associated with subsequent dementia among older adults.	[Luukinen, H.; Jokelainen, J.] Univ Oulu, Oulu Univ Hosp, Unit Gen Practice, Dept Publ Hlth Sci & Gen Practice, FIN-90014 Oulu, Finland; [Kervinen, K.; Kesaniemi, Y. A.] Univ Oulu, Dept Internal Med, FIN-90014 Oulu, Finland; [Kervinen, K.; Kesaniemi, Y. A.] Univ Oulu, Bioctr, FIN-90014 Oulu, Finland; [Winqvist, S.; Hillbom, M.] Univ Hosp Oulu, Dept Neurol, Oulu, Finland		Luukinen, H (corresponding author), Univ Oulu, Oulu Univ Hosp, Unit Gen Practice, Dept Publ Hlth Sci & Gen Practice, PB 5000, FIN-90014 Oulu, Finland.	heikki.luukinen@oulu.fi		Jokelainen, Jari/0000-0003-4629-0560			Aevarsson O, 1997, Int Psychogeriatr, V9, P11; *AM PSYCH ASS, 1994, DSM4 AM PSCYH ASS; Commenges D, 1998, STAT MED, V17, P1973, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; EHNHOLM C, 1986, J LIPID RES, V27, P227; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Juva K, 2000, INT PSYCHOGERIATR, V12, P379, DOI 10.1017/S1041610200006487; Katzman R, 1996, NEUROLOGY, V46, P889; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; LUUKINEN H, 1994, J CLIN EPIDEMIOL, V47, P843, DOI 10.1016/0895-4356(94)90187-2; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAZZUCCHI A, 1992, J NEUROL, V239, P256; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	31	11	11	0	2	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	SEP	2008	118	3					153	158		10.1111/j.1600-0404.2008.00994.x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	336PC	WOS:000258376100003	18307571				2022-02-06	
J	Siddharthan, K; Scott, S; Bass, E; Nelson, A				Siddharthan, Kris; Scott, Steven; Bass, Elizabeth; Nelson, Audrey			Rehabilitation outcomes for veterans with polytrauma treated at the Tampa VA	REHABILITATION NURSING			English	Article						combat polytrauma; health outcomes; rehabilitation; Veterans Administration	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; IDENTIFICATION; DEPRESSION; SURVIVAL	Returning soldiers from Iraq and Afghanistan who have sustained polytrauma have a combination of complex physical and mental morbidities that require extensive therapy and rehabilitation. This study examined the effect of rehabilitation on 116 polytrauma patients with service-connected injuries treated at the Tampa VA; improvements in functional and cognitive abilities were measured using the Functional Independence Measure (FIM (TM)) scores and healthcare costs for rehabilitation treatment were also assessed. Intensive rehabilitation therapy increased functional ability in this cohort with an average improvement in total FIM scores of 23 points, Total inpatient costs for these patients exceeded $4 million in approximately 3 years. Rehabilitation nurses face challenges providing quality care to this target patient population, including characterizing war-related polytrauma, providing surveillance, coordinating care, synchronizing care for patients with multiple injuries, and conducting evidence-based pain management.	[Siddharthan, Kris] James A Haley Vet Adm Med Ctr, Patient Safety Ctr Inquiry VISN8, Tampa, FL 33612 USA; [Scott, Steven] James A Haley Vet Adm Med Ctr, Level Polytrauma Ctr 1, Tampa, FL 33612 USA; [Bass, Elizabeth; Nelson, Audrey] James A Haley Vet Adm Med Ctr, Patient Safety Ctr Inquiry, Tampa, FL 33612 USA; [Bass, Elizabeth] Univ S Florida, Sch Aging Studies, Tampa, FL 33620 USA; [Nelson, Audrey] Univ S Florida, Coll Nursing, Tampa, FL 33620 USA		Siddharthan, K (corresponding author), James A Haley Vet Adm Med Ctr, Patient Safety Ctr Inquiry VISN8, Tampa, FL 33612 USA.	kris.siddharthan@med.va.gov					Aziz Mohamed A, 2004, J Psychiatr Pract, V10, P307, DOI 10.1097/00131746-200409000-00004; BINGHAM RL, 1990, J GEN INTERN MED, V5, P342, DOI 10.1007/BF02600403; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cambron JA, 2004, J MANIP PHYSIOL THER, V27, P299, DOI 10.1016/j.jmpt.2004.04.003; Centers for Disease Control (CDC), 1986, COMPR PLAN EP SURV; Corson K, 2004, AM J MANAG CARE, V10, P839; *DEF VET BRAIN INJ, BLAST INJ; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; GIBBS N, 2005, TIME, V167, P50; GRANGER CV, 1996, PHYSICAL MED REHABIL, P247; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Kennedy BM, 2005, ETHNIC DIS, V15, P373; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Pobereskin LH, 2001, J NEUROSURG, V95, P555, DOI 10.3171/jns.2001.95.4.0555; Powell S, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-11; Scott SG, 2005, FEDERAL PRACTITIONER, V22, P67; Sheeran T, 2002, J CONSULT CLIN PSYCH, V70, P961, DOI 10.1037//0022-006X.70.4.000; Sheeran T, 2002, PSYCHIAT RES, V109, P51, DOI 10.1016/S0165-1781(01)00364-X; Starr AJ, 2004, J BONE JOINT SURG AM, V86A, P1115, DOI 10.2106/00004623-200406000-00001; *US DEP DEF, 2008, OP IR FREED OP END; vanderFeltzCornelis CM, 1997, INT J PSYCHIAT MED, V27, P1; ZITTER M, 1997, DIS MANAGEMENT SYSTE, P1	25	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	SEP-OCT	2008	33	5					221	225		10.1002/j.2048-7940.2008.tb00231.x			5	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	343JK	WOS:000258849200007	18767404				2022-02-06	
J	Garcia-Molina, A; Rajo, PR; Gomez, PV; Plaja, CJI; Roig-Rovira, T				Garcia-Molina, Alberto; Rodriguez Rajo, Pablo; Vendrell Gomez, Pere; Junque i Plaja, Carme; Roig-Rovira, Teresa			Orbitofrontal dysfunction in multiple sclerosis: Iowa Gambling Task	PSICOTHEMA			Spanish	Article; Proceedings Paper	18th Technical Congress of the Institute-Guttmann	2006	Barcelona, SPAIN	Inst Guttmann			SOMATIC MARKER HYPOTHESIS; DECISION-MAKING PROCESSES; HUMAN PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE DAMAGE; COGNITIVE DYSFUNCTION; NEUROPSYCHOLOGY; PERFORMANCE; IMPAIRMENT	Cognitive dysfunction has been widely studied in multiple sclerosis (MS), however decision-making has been less investigated. The current study examined the decision-making processes of patients with multiple sclerosis (MS) using a computerized version of the Iowa Gambling Task (IGT). This task was applied to 18 patients with clinically diagnosed MS and 18 healthy control subjects matched for age, sex, and years of education. The results showed that IGT scores differ significantly between patients with MS and the healthy control subjects: the patients with MS made significantly less advantageous decisions than the controls in the IGT. Possible causes of impaired decision-making in multiple sclerosis are discussed.	[Garcia-Molina, Alberto; Rodriguez Rajo, Pablo; Roig-Rovira, Teresa] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Vendrell Gomez, Pere; Junque i Plaja, Carme] Univ Barcelona, E-08007 Barcelona, Spain		Plaja, CJI (corresponding author), Inst Univ Neurorehabil Guttmann, Badalona 08916, Spain.	agarciam.investigacio@guttmann.com	Vendrell, Pere/B-4392-2011	Vendrell, Pere/0000-0001-8918-5440			Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Arango-Lasprilla JC, 2007, PSICOTHEMA, V19, P1; Beatty W W, 1996, J Int Neuropsychol Soc, V2, P134; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Birnboim S, 2004, MULT SCLER J, V10, P67, DOI 10.1191/1352458504ms980oa; Brassington JC, 1998, NEUROPSYCHOL REV, V8, P43, DOI 10.1023/A:1025621700003; Calabrese P, 2006, J NEUROL, V253, P10, DOI 10.1007/s00415-006-1103-1; Cavedini P, 2002, NEUROPSYCHOLOGIA, V40, P205, DOI 10.1016/S0028-3932(01)00077-X; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Damasio A., 1994, DESCARTES ERROR EMOT; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Garcia-Molina A, 2007, NEUROLOGIA, V22, P206; GRIGSBY J, 1993, ARCH PHYS MED REHAB, V74, P1350, DOI 10.1016/0003-9993(93)90091-N; Kleeberg J, 2004, ANN NEUROL, V56, P787, DOI 10.1002/ana.20277; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Nagy H, 2006, J INT NEUROPSYCH SOC, V12, P559, DOI 10.1017/S1355617706060644; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Ritter LM, 2004, SCHIZOPHR RES, V68, P65, DOI 10.1016/S0920-9964(03)00086-0; Rolania OS, 2006, PSICOTHEMA, V18, P84; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Simon VM, 1997, PSICOTHEMA, V9, P365; Stablum F, 2004, BRAIN COGNITION, V56, P328, DOI 10.1016/j.bandc.2004.08.048	32	11	12	0	3	COLEGIO OFICIAL DE PSICOLOGOS DE ASTURIAS	OVIEDO	ILDEFONSO S. DEL RIO, 4-1 B, 33001 OVIEDO, SPAIN	0214-9915	1886-144X		PSICOTHEMA	Psicothema	AUG	2008	20	3					445	449					5	Psychology, Multidisciplinary	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	326NG	WOS:000257665600017	18674441				2022-02-06	
J	Mathioudakis, N; Salvatori, R				Mathioudakis, Nestoras; Salvatori, Roberto			Adult-onset growth hormone deficiency: causes, complications and treatment options	CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY			English	Article						adult-onset growth hormone deficiency; growth hormone deficiency in adults; growth hormone replacement therapy	TRAUMATIC BRAIN-INJURY; GH REPLACEMENT THERAPY; QUALITY-OF-LIFE; RADIOLOGICAL SPINAL DEFORMITIES; AMYOTROPHIC-LATERAL-SCLEROSIS; BONE-MINERAL DENSITY; CARDIOVASCULAR RISK; FACTOR-I; HYPOPITUITARY PATIENTS; SUBSTITUTION THERAPY	Purpose of review Description of the progresses related to the complications and treatment of adult-onset growth hormone deficiency. Recent findings Growth hormone deficiency in adults has gained attention as a clinical syndrome associated with increased morbidity and possibly mortality. Many studies have been conducted on the consequences of growth hormone deficiency and of its replacement, supporting its use in appropriate patients. Early studies were characterized by a high incidence of side effects due to a lack of pilot data to guide appropriate dosing. Given the wide variability in individual responsiveness to growth hormone therapy based on age, sex, and body composition, recent work has been dedicated to understanding which patients derive benefit from therapy, minimizing side effects, and ensuring cost-effectiveness. Summary Long-term prospective trials have shown that growth hormone replacement therapy results in improvements in body composition, dyslipidemia, bone mineral density, and quality of life. The effects on endpoints such as cardiovascular morbidity and mortality and fractures are, however, not fully proven. Randomized trials that compare homogenous groups of growth hormone deficiency patients are still needed. Given the high cost of treatment, dynamic testing for growth hormone deficiency should only be performed in patients in whom there is high clinical suspicion, and therapy should be limited to those with biochemically proven growth hormone deficiency.	[Mathioudakis, Nestoras; Salvatori, Roberto] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD USA		Salvatori, R (corresponding author), Johns Hopkins Sch Med, Div Endocrinol & Metab, 1830 E Monument St,Suite 333, Baltimore, MD 21287 USA.	salvator@jhmi.edu	Mathioudakis, Nestoras/AAP-4595-2020	Mathioudakis, Nestoras/0000-0002-0210-655X			Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; Agha A, 2005, J CLIN ENDOCR METAB, V90, P6355, DOI 10.1210/jc.2005-1525; Andreassen M, 2007, CLIN ENDOCRINOL, V67, P909, DOI 10.1111/j.1365-2265.2007.02986.x; Arwert LI, 2006, NEUROENDOCRINOLOGY, V83, P12, DOI 10.1159/000093337; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Behan LA, 2007, HORM RES, V68, P18, DOI 10.1159/000110466; Bidlingmaier M, 2006, J CLIN ENDOCR METAB, V91, P2926, DOI 10.1210/jc.2006-0514; Blackman MR, 2007, NEW ENGL J MED, V357, P2397, DOI 10.1056/NEJMe0707201; Bollerslev J, 2006, EUR J ENDOCRINOL, V154, P537, DOI 10.1530/eje.1.02125; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Buchfelder M, 2007, EUR J ENDOCRINOL, V157, P149, DOI 10.1530/EJE-07-0164; Burger Albert G, 2006, Endocr Pract, V12, P682; Chihara K, 2006, CURR MED RES OPIN, V22, P1973, DOI 10.1185/030079906X132460; Climent V, 2007, CURR MED CHEM, V14, P1399, DOI 10.2174/092986707780831195; Devin JK, 2007, J CLIN ENDOCR METAB, V92, P3633, DOI 10.1210/jc.2007-0609; Falutz J, 2007, NEW ENGL J MED, V357, P2359, DOI 10.1056/NEJMoa072375; Gelato M, 2007, CLIN THER, V29, P2269, DOI 10.1016/j.clinthera.2007.11.004; Giannoulis MG, 2006, J CLIN ENDOCR METAB, V91, P477, DOI 10.1210/jc.2005-0957; Gilchrist FJ, 2002, CLIN ENDOCRINOL, V57, P363, DOI 10.1046/j.1365-2265.2002.01608.x; Gomez JM, 2006, CLIN ENDOCRINOL, V64, P632, DOI 10.1111/j.1365-2265.2006.02518.x; Gotherstrom G, 2007, J CLIN ENDOCR METAB, V92, P1442, DOI 10.1210/jc.2006-1487; Hartman ML, 2008, J CLIN ENDOCR METAB, V93, P125, DOI 10.1210/jc.2007-1430; Higham CE, 2007, PITUITARY, V10, P159, DOI 10.1007/s11102-007-0027-9; Hitz MF, 2006, CLIN ENDOCRINOL, V65, P783, DOI 10.1111/j.1365-2265.2006.02667.x; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Holmer H, 2007, J BONE MINER RES, V22, P1842, DOI 10.1359/JBMR.070811; Holmer H, 2007, J CLIN ENDOCR METAB, V92, P3560, DOI 10.1210/jc.2007-0458; Khosla S, 2007, NEW ENGL J MED, V356, P2293, DOI 10.1056/NEJMcp070341; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Koranyi J, 2001, J CLIN ENDOCR METAB, V86, P4693, DOI 10.1210/jc.86.10.4693; Leonsson M, 2003, CLIN ENDOCRINOL, V59, P242, DOI 10.1046/j.1365-2265.2003.01832.x; Li GL, 2008, J CLIN ENDOCR METAB, V93, P1379, DOI 10.1210/jc.2007-2021; Lichtenwalner RJ, 2006, J NEUROSCI RES, V83, P199, DOI 10.1002/jnr.20719; Maison P, 2007, DIABETIC MED, V24, P1012, DOI 10.1111/j.1464-5491.2007.02195.x; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Gomez JM, 2007, CURR NEUROVASC RES, V4, P55; Mazziotti G, 2006, J BONE MINER RES, V21, P520, DOI 10.1359/JBMR.060112; Mazziotti G, 2008, PITUITARY, V11, P55, DOI 10.1007/s11102-007-0069-z; McMillan CV, 2003, CLIN ENDOCRINOL, V59, P467, DOI 10.1046/j.1365-2265.2003.01870.x; Mesa J, 2003, MED CLIN-BARCELONA, V120, P41, DOI 10.1157/13042257; Miljic Dragana, 2006, Hormones (Athens), V5, P187; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Monson JP, 2007, CLIN ENDOCRINOL, V67, P623, DOI 10.1111/j.1365-2265.2007.02935.x; Morselli LL, 2007, J ENDOCRINOL INVEST, V30, P767, DOI 10.1007/BF03350815; Morselli LL, 2006, CLIN ENDOCRINOL, V65, P385, DOI 10.1111/j.1365-2265.2006.02609.x; Nilsson AG, 2007, GROWTH HORM IGF RES, V17, P441, DOI 10.1016/j.ghir.2007.05.005; Oflaz H, 2007, CLIN ENDOCRINOL, V66, P524, DOI 10.1111/j.1365-2265.2007.02767.x; Oliveira JLM, 2007, J CLIN ENDOCR METAB, V92, P4664, DOI 10.1210/jc.2007-1636; Randeva HS, 2004, CIRCULATION, V109, P2405, DOI 10.1161/01.CIR.0000129763.51060.77; Rizzo M, 2007, INT J CLIN PRACT, V61, P1949, DOI 10.1111/j.1742-1241.2007.01596.x; Rizzo M, 2008, GROWTH HORM IGF RES, V18, P264, DOI 10.1016/j.ghir.2007.10.003; Rizzo M, 2007, EUR J ENDOCRINOL, V156, P361, DOI 10.1530/EJE-06-0652; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Sathiavageeswaran M, 2007, EUR J ENDOCRINOL, V156, P439, DOI 10.1530/eje.1.02346; SCACCHI M, 2008, CLIN ENDOCRINOL OXF; Scacchi M, 2007, CLIN ENDOCRINOL, V67, P790, DOI 10.1111/j.1365-2265.2007.02965.x; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Seeman E, 2008, J BONE MINER METAB, V26, P1, DOI 10.1007/s00774-007-0793-5; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; Shechter M, 2007, GROWTH HORM IGF RES, V17, P165, DOI 10.1016/j.ghir.2007.01.009; Snyder PJ, 2007, J BONE MINER RES, V22, P762, DOI 10.1359/JBMR.070205; STANLEY TL, 2008, PITUITARY; Stochholm K, 2007, EUR J ENDOCRINOL, V157, P9, DOI 10.1530/EJE-07-0013; Stochholm K, 2007, HORM RES, V68, P173, DOI 10.1159/000110618; Stochholm K, 2006, EUR J ENDOCRINOL, V155, P61, DOI 10.1530/eje.1.02191; Svensson J, 2007, GROWTH HORM IGF RES, V17, P67, DOI 10.1016/j.ghir.2006.11.002; Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Urushihara H, 2007, EUR J ENDOCRINOL, V156, P637, DOI 10.1530/EJE-07-0016; van der Klaauw AA, 2007, EUR J ENDOCRINOL, V156, P455, DOI 10.1530/EJE-06-0699	72	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1752-296X	1752-2978		CURR OPIN ENDOCRINOL	Curr. Opin. Endocrinol. Diabetes Obes.	AUG	2008	15	4					352	358		10.1097/MED.0b013e3282ffd97d			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	V14SV	WOS:000207755000008	18594276				2022-02-06	
J	Sun, XC; Jiang, Y				Sun Xiao-chuan; Jiang Yong			Genetic susceptibility to traumatic brain injury and apolipoprotein E gene	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Brain injuries; Genetic predisposition to disease; Genes		Traumatic brain injury (TBI) is defined as an injury caused by a blow or jolt to the head or a penetrating head injury that disrupts the normal function of the brain. It is a common emergency and severe case in neurosurgery field. Nowadays, there are more and more evidences showing that TBI, which is apparently similar in pathology and severity in the acute stage, may have different outcomes. The known prognostic factors (such as age, severity of injury and treatments, etc.) explain only part of this variability and the concept of genetic susceptibility of traumatic brain injury has already been accepted by more and more people. It is now demonstrated that genetic polymorphism may play a key role in the susceptibility to TBI, even outcome following TBI. Although there are many genes that may involved in pathophysiological processes influencing TBI, apolipoprotein E gene has become one of the most extensive studied genes in neurotrauma and neurodegenerative disease and seems to take an important part in the neural responses to TBI. In this article, we will review the current understanding of the genetic susceptibility of TBI and the advancements regarding the impact of apolipoprotein E genotype on the severity and/or outcome following TBI.	[Sun Xiao-chuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Jiang Yong] Luzhou Med Coll, Affiliated Hosp 1, Dept Neurosurg, Luzhou 646000, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China.	sunxch1445@gmail.com		sun, xiao chuan/0000-0001-6992-332X			Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Cantallops I, 2000, HIPPOCAMPUS, V10, P269, DOI 10.1002/1098-1063(2000)10:3<269::AID-HIPO7>3.0.CO;2-R; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; DAS HK, 1985, J BIOL CHEM, V260, P6240; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Feng G, 2001, CHIN J TRAUMA, V17, P301; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; [GU Yi 顾奕], 2007, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V33, P385; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; [江涌 Jiang Yong], 2005, [中华创伤杂志, Chinese Journal of Traumatology], V21, P520; Kraus J, 2000, HEAD INJURY, P1; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; MAHLEY RW, 1984, J LIPID RES, V25, P1277; MARTINS RN, 1995, NEUROREPORT, V6, P1513, DOI 10.1097/00001756-199507310-00012; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McCarron MO, 2003, ACTA NEUROL SCAND, V107, P106, DOI 10.1034/j.1600-0404.2003.01365.x; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; Merched A, 1997, J NEUROL SCI, V145, P33, DOI 10.1016/S0022-510X(96)00234-1; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OLAISEN B, 1982, HUM GENET, V62, P233, DOI 10.1007/BF00333526; PAIK YK, 1985, P NATL ACAD SCI USA, V82, P3445, DOI 10.1073/pnas.82.10.3445; Pang Y, 2006, NEUROSCIENCE, V141, P745, DOI 10.1016/j.neuroscience.2006.04.007; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RALL SC, 1982, J BIOL CHEM, V257, P4171; Schauwecker PE, 2003, EPILEPSY RES, V55, P201, DOI 10.1016/S0920-1211(03)00115-3; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Wang JG, 2007, CHIN J NEUROMED, V6, P362; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; Xiao ZJ, 2004, CHIN J NEUROSCI, V20, P376; Xu Z, 2006, CHIN MED J COMMUN, V20, P177; Yang Xiao-feng, 2006, Chin J Traumatol, V9, P276; Zhou LF, 2005, CLIN J NEUROSURG DIS, V4, P193; 江涌, 2005, [中华创伤杂志, Chinese Journal of Traumatology], V21, P154	47	11	14	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	AUG	2008	11	4					247	252		10.1016/S1008-1275(08)60051-6			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF0VT	WOS:000441869500011	18667124	hybrid			2022-02-06	
J	Ding, MC; Lo, EH; Stanley, GB				Ding, M. C.; Lo, E. H.; Stanley, G. B.			Sustained focal cortical compression reduces electrically-induced seizure threshold	NEUROSCIENCE			English	Article						traumatic brain injury; spreading depression; excitation and inhibition	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; IN-VITRO; RAT; IMPACT; MODEL; ISCHEMIA; INSULTS; NEURONS; VULNERABILITY	Brain injury can often result in the subsequent appearance of seizures, suggesting an alteration in neural excitability associated with the balance between neuronal excitation and inhibition. The process by which this occurs has yet to be fully elucidated. The specific nature of the changes in excitation and inhibition is still unclear, as is the process by which the seizures appear following injury. In this study, we investigated the effects of focal cortical compression on electrically-induced localized seizure threshold in rats. Male Long Evans rats were implanted with stimulating screw electrodes in their motor cortices above the regions controlling forelimb movement. Initial seizure threshold was determined in the animals using a ramped electrical stimulation procedure prior to any compression. Following initial threshold determination, animals underwent sustained cortical compression and then following a 24 h recovery period had their seizure thresholds tested again with electrical stimulation. Reliability of threshold measurements was confirmed through repeated measurements of seizure threshold. Localized seizure threshold was significantly lowered following sustained cortical compression as compared with control cases. Taken together, the results here suggest a change in global brain excitability following localized, focal compression. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.	[Stanley, G. B.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Ding, M. C.; Stanley, G. B.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ding, M. C.; Stanley, G. B.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lo, E. H.] Harvard Univ, Sch Med, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Stanley, G. B.] Emory Univ, Atlanta, GA 30332 USA		Stanley, GB (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.	garrett.stanley@bme.gatech.edu		Stanley, Garrett/0000-0003-2039-7706; Ding, Ming-Chieh/0000-0002-2278-5326	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048285] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS048285-04, R01NS48285, R01 NS048285] Funding Source: Medline		Adamo PF, 2005, J AM ANIM HOSP ASSOC, V41, P400, DOI 10.5326/0410400; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bough KJ, 2003, EPILEPSIA, V44, P752, DOI 10.1046/j.1528-1157.2003.55502.x; Chen JR, 2004, J NEUROTRAUM, V21, P1640, DOI 10.1089/0897715042441729; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Glass TF, 2004, NEUROBIOL DIS, V17, P378, DOI 10.1016/j.nbd.2004.07.017; Krupp E, 1998, J PHARMACOL EXP THER, V285, P1137; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; LOSCHER W, 1985, J PHARMACOL EXP THER, V233, P204; Luszczki JJ, 2007, NEUROSCI LETT, V421, P87, DOI 10.1016/j.neulet.2007.05.028; Maeda M, 1998, ACT NEUR S, V71, P293; Marino R, 2006, NEUROLOGY, V67, P1165, DOI 10.1212/01.wnl.0000238081.35281.b5; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Nguyen SM, 2007, J NEUROSCI METH, V161, P281, DOI 10.1016/j.jneumeth.2006.10.026; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; Reinert M, 2000, Neurosurg Focus, V8, pe10; Salci K, 2006, NEUROSURGERY, V59, P367, DOI 10.1227/01.NEU.0000222648.61065.38; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; VOSKUYL RA, 1989, EPILEPSY RES, V3, P120, DOI 10.1016/0920-1211(89)90039-9; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; Yang HY, 2006, BEHAV BRAIN RES, V172, P80, DOI 10.1016/j.bbr.2006.04.023	26	11	11	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	JUN 23	2008	154	2					551	555		10.1016/j.neuroscience.2008.03.088			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	319OB	WOS:000257172200015	18495350	Green Accepted, Green Submitted			2022-02-06	
J	Prigatano, GP; Gray, JA				Prigatano, George P.; Gray, Jennifer A.			Predictors of performance on three developmentally sensitive neuropsychological tests in children with and without traumatic brain injury	BRAIN INJURY			English	Article						normal functioning school age children; traumatic brain injury; developmentally sensitive neuropsychological tests; predictors of performance	ACADEMIC-ACHIEVEMENT; COGNITIVE RESERVE; RECOVERY; SEVERITY; SKILLS; AGE	Objective: To determine the effect of age and vocabulary as predictors of performance on neuropsychological tests in children with and without traumatic brain injury (TBI). Setting and participants: In the first study, 213 school-age children were evaluated in their public school environment. In the second study, 65 children with a history of TBI were examined in a medical centre. Major outcome measures: Age of the child and two estimates of intellectual functioning (Vocabulary and Block Design) were used to predict performance on the Barrow Neurological Institute Screen for Higher Cerebral Functions in School-Age Children (BNIS-C), a verbal fluency task and the Halstead Finger Tapping Test (HFTT). Results: In study 1, the exact age of the child was the strongest predictor of performance (e.g. 47.5% of the variability on the BNIS-C) in normal school-age children. Vocabulary level accounted for less than 10% of the variability across the three measures. In children with TBI (study 2; n = 65) age effects remained strong, but a greater vocabulary effect was observed on two of the three measures (i.e. 29.2% on the BNIS-C and 18.8% on verbal fluency). Conclusions: While age is an important predictor of neuropsychological test performance in children, post-injury vocabulary level appears to be an important moderator variable.	[Prigatano, George P.; Gray, Jennifer A.] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 222 W Thomas Rd,Suite 315, Phoenix, AZ 85013 USA.	gprigat@chw.edu					Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Belsky J, 2004, HARVARD EDUC REV, V74, P1; Biemiller A, 2006, J EDUC PSYCHOL, V98, P44, DOI 10.1037/0022-0663.98.1.44; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; DONDERS J, 1998, HDB PEDIAT PSYCHOL P, V2, P166; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Fuld PA, 1981, FULD OBJECT MEMORY E; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Keppel G., 1989, DATA ANAL RES DESIGN; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Miller AL, 2005, SOC DEV, V14, P637, DOI 10.1111/j.1467-9507.2005.00321.x; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2008, J INT NEUROPSYCH SOC, V14, P143, DOI 10.1017/S1355617708080089; Prigatano GP, 2007, DEV NEUROPSYCHOL, V32, P757, DOI 10.1080/87565640701539469; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; PRIGATANO GP, CHILD NEURO IN PRESS; PRIGATANO GP, 2005, BNI SCREEN HIGHER CE; PRIGATANO GP, 2005, BNI Q, V21, P4; PRIGATANO GP, 2004, COMMUNITY SCH REINTE, P151; Reitan RM., 1955, MANUAL ADM NEUROPSYC; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RIVARA JMB, 1994, 4 C INT ASS STUD TRA; SPSS Inc, 1998, SPSS BAS 8 0 WIND US; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TEASDALE G, 1981, MANAGEMENT HEAD INJU; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2003, WISC 4 WECHSLER INTE; Wechsler D., 1991, WISC 3 WECHSLER INTE; YEATES KO, 2000, CLOSED HEAD INJURY P, P92	39	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2008	22	6					491	500		10.1080/02699050802084902			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	316TW	WOS:000256973600006	18465390				2022-02-06	
J	Schultz, IZ; Stewart, AM				Schultz, Izabela Z.; Stewart, Alison M.			Disentangling the Disability Quagmire in Psychological Injury and Law	PSYCHOLOGICAL INJURY & LAW			English	Article						Psychological injury; Psychological impairment; Models of disability; Forensic model; Biopsychosocial model	RETURN-TO-WORK; TRAUMATIC BRAIN-INJURY; LOW-BACK-PAIN; OCCUPATIONAL DISABILITY; RECOVERY EXPECTATIONS; MUSCULOSKELETAL PAIN; COST-EFFECTIVENESS; ACUTE PREDICTORS; PRODUCTIVE WORK; MENTAL-ILLNESS	This paper aims to critically analyze the evolution of six models of conceptualization, determination, and prediction of occupational disability relevant in the medicolegal context of psychological injury. The six models are the (a) biomedical, (b) forensic, (c) psychosocial, (d) ecological, (e) economic, and (f) biopsychosocial. We will discuss the key commonalities and differences among the models, including disciplinary tradition, research paradigm, recognition of person-environment interaction, key tenets, and implications for practice and research in psychological injury. The paper will highlight and discuss psychosocial issues, often underemphasized in forensic psychological practice, including: (a) balanced assessment of primary, secondary, and tertiary gains and losses, (b) self-perception, (c) disability identity, (d) beliefs and expectations, (e) coping, (f) adaptation and positive growth, (g) social stigma and social reactions to disability, including disability harassment, and (h) recognition of system-based environmental influences and demands. We will provide a special focus on the current state of the science and practice of prediction of disability, of particular interest to researchers and clinicians involved in clinical and occupational prognostication in psychological injuries. Finally, we will draw conclusions and recommendations for future research and best practices in the psychological injury area using a cross-diagnostic, dynamic, functionally based, and integrated biopsychosocial and forensic model of disability.	[Schultz, Izabela Z.; Stewart, Alison M.] Univ British Columbia, Dept Educ & Counselling Psychol & Special Educ, Vancouver, BC V6T 1Z4, Canada		Schultz, IZ (corresponding author), Univ British Columbia, Dept Educ & Counselling Psychol & Special Educ, Vancouver, BC V6T 1Z4, Canada.	ischultz@telus.net					American Educational Research Association American Psychological Association National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Amick BC, 2000, J OCCUP REHABIL, V10, P21, DOI 10.1023/A:1009437728024; Arbisi PA, 2004, ARCH CLIN NEUROPSYCH, V19, P341, DOI 10.1016/j.acn.2003.12.003; Atkins R., 2002, BR J THER REHABIL, V9, P92; BAGBY RM, 2006, MMPI 2 PRACTITIONERS, P39, DOI DOI 10.1037/11287-003; Baldwin ML, 1996, AM J IND MED, V29, P632; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A, 1986, SOCIAL FDN THOUGHT A; BARIL R, 2000, R238 IRSST; Bishop M, 2007, PSYCHOL SOCIAL IMPAC, P230; Bowman ML, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P315, DOI 10.1007/0-387-28919-4_17; Brines J, 1999, AAOHN J, V47, P365; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; BRUYERE SM, 1991, REHABIL COUNS BULL, V34, P227; BURTON AK, 1995, SPINE, V20, P722, DOI 10.1097/00007632-199503150-00014; BURTON AK, 2006, POWER BELIEF PSYCHOS, P161; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Butcher J. N., 2008, PSYCHOL INJ IN PRESS; BUTLER RJ, 1995, IND LABOR RELAT REV, V48, P452, DOI 10.2307/2524774; CHIRIKOS TN, 1985, REV ECON STAT, V67, P61, DOI 10.2307/1928435; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cole DC, 2002, CAN MED ASSOC J, V166, P749; Corrigan PW, 2007, REHABIL PSYCHOL, V52, P451, DOI 10.1037/0090-5550.52.4.451; Crook J, 2002, J OCCUP REHABIL, V12, P277, DOI 10.1023/A:1020278708861; Crowther RE, 2001, BMJ-BRIT MED J, V322, P204, DOI 10.1136/bmj.322.7280.204; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; den Boer JJ, 2006, PAIN, V126, P72, DOI 10.1016/j.pain.2006.06.010; Dersh J, 2004, J OCCUP REHABIL, V14, P267, DOI 10.1023/B:JOOR.0000047429.73907.fa; DERSH J, 2005, PRACTICAL PAIN MANAG, P13; Drake RE, 2003, CURR OPIN PSYCHIATR, V16, P451, DOI 10.1097/01.yco.0000079209.36371.84; Dunn DS, 2005, REHABIL PSYCHOL, V50, P305, DOI 10.1037/0090-5550.50.3.305; Durand Marie-Jose, 2001, Work, V17, P57; Elliot T. R., 2005, HDB POSITIVE PSYCHOL, P687; Ferrari R., 2006, POWER BELIEF PSYCHOS, P69; Feuerstein M, 1991, J Occup Rehabil, V1, P185, DOI 10.1007/BF01073455; FISHBAIN DA, 1994, CLIN J PAIN, V10, P28, DOI 10.1097/00002508-199403000-00006; Fitzgerald L. F, 2003, PSYCHOL INJURIES TRI; Franche RL, 2005, J OCCUP REHABIL, V15, P525, DOI 10.1007/s10926-005-8032-1; Franche RL, 2002, J OCCUP REHABIL, V12, P233, DOI 10.1023/A:1020270407044; Friesen Margaret N., 2001, Work, V17, P11; Garb H. N., 1998, STUDYING CLIN JUDGME; Garb HN, 2000, PSYCHOL ASSESSMENT, V12, P31, DOI 10.1037/1040-3590.12.1.31; Gatchel RJ, 2003, J OCCUP REHABIL, V13, P1, DOI 10.1023/A:1021823505774; Gatchel Robert J., 1996, P33; Gill CJ, 2003, AM PSYCHOL, V58, P305, DOI 10.1037/0003-066X.58.4.305; Gnam WH, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P371, DOI 10.1007/0-387-28919-4_20; GOLDING SL, 1991, LAW HUMAN BEHAV, V15, P655; Graffam J., 2002, J VOCATIONAL REHABIL, V17, P175; Green-McKenzie J, 1998, J OCCUP ENVIRON MED, V40, P568, DOI 10.1097/00043764-199806000-00010; GREENWOOD R, 1987, J REHABIL, V53, P37; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P337, DOI 10.1016/j.acn.2003.12.005; GROTHMARNAT G, 2003, HDB PSYCHOL ASSESSME; Guite JW, 2007, J PAIN, V8, P379, DOI 10.1016/j.jpain.2006.10.006; Hadjistavropoulos T., 2001, CONSULTING PSYCHOL J, V53, P52; Haldorsen EMH, 1998, SPINE, V23, P1202, DOI 10.1097/00007632-199806010-00004; Halligan PW, 2006, POWER BELIEF, pxi; Harder HG., 2005, COMPREHENSIVE DISABI; Harnois G., 2000, MENTAL HLTH WORK IMP; Haslam C, 2005, J AFFECT DISORDERS, V88, P209, DOI 10.1016/j.jad.2005.07.009; Heinemann A. W., 1995, PSYCHOL ASSESSMENT M, P39, DOI [10.1037/10175-001, DOI 10.1037/10175-001]; Helmes E, 2007, CLIN J PAIN, V23, P53, DOI 10.1097/01.ajp.0000210942.81310.ed; Holzberg Emily, 2001, Work, V16, P245; Hunt DG, 2002, SPINE, V27, P2715, DOI 10.1097/00007632-200212010-00011; Hunt H. A, 1993, STAFF WORKING PAPERS, V93-18; HUNT HA, 1993, 93004 UPJ I EMPL RES; Iverson GL, 2002, PSYCHOL REP, V90, P131, DOI 10.2466/PR0.90.1.131-136; Iverson Grant L, 2007, Pain Pract, V7, P94, DOI 10.1111/j.1533-2500.2007.00116.x; Jensen MP, 2004, PAIN, V111, P84, DOI 10.1016/j.pain.2004.06.003; Jensen MP, 1999, PAIN, V81, P95, DOI 10.1016/S0304-3959(99)00005-6; Johnson LM, 2006, HEALTH PSYCHOL, V25, P696, DOI 10.1037/0278-6133.25.6.696; Jones M, 2002, MANUAL THER, V7, P2, DOI 10.1054/math.2001.0426; Karjalainen K, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002193; Kates Nick, 2004, Healthc Pap, V5, P68; Katz I., 1988, ATTITUDES PERSONS DI, P47; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Koch WJ, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P333, DOI 10.1007/0-387-28919-4_18; KRAUSE N, 1994, SPINE, V19, P1011, DOI 10.1097/00007632-199405000-00002; Krause N, 2001, AM J IND MED, V40, P464, DOI 10.1002/ajim.1116; Krause N, 2001, AM J IND MED, V40, P374, DOI 10.1002/ajim.1112; Krupa T, 2004, PSYCHIATR REHABIL J, V28, P8, DOI 10.2975/28.2004.8.15; Kusznir A., 2001, 2 ANN NAT S NAT I DI; Kwan O, 2001, MED HYPOTHESES, V57, P459, DOI 10.1054/mehy.2001.1360; Lanyon R. I., 1997, PERSONALITY ASSESSME; Leeman G., 2000, J WORKERS COMPENSATI, V9, P25; LEIBOWITZ G, 1991, J DEV PHYS DISABIL, V3, P201; Linton SJ, 2005, CLIN J PAIN, V21, P109, DOI 10.1097/00002508-200503000-00001; Linton SJ, 2005, J OCCUP REHABIL, V15, P459, DOI 10.1007/s10926-005-8028-x; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Linton SJ, 2001, J OCCUP REHABIL, V11, P53, DOI 10.1023/A:1016656225318; LINTON SJ, 1995, SCAND J REHABIL MED, P67; Livneh H, 1988, J APPL REHABILITATIO, V19, P13; LoBianco AF, 2007, J APPL SOC PSYCHOL, V37, P1, DOI 10.1111/j.0021-9029.2007.00143.x; Loisel P, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P479, DOI 10.1007/0-387-28919-4_26; Loisel P, 2005, J OCCUP REHABIL, V15, P507, DOI 10.1007/s10926-005-8031-2; Loisel P, 2002, OCCUP ENVIRON MED, V59, P807, DOI 10.1136/oem.59.12.807; Loisel P, 2001, DIS MANAG HEALTH OUT, V9, P351, DOI 10.2165/00115677-200109070-00001; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; Main C.J., 2000, PAIN MANAGEMENT INTE; Main CJ, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P387, DOI 10.1007/0-387-28919-4_21; Marhold C, 2001, PAIN, V91, P155, DOI 10.1016/S0304-3959(00)00431-0; Massaro J., 2003, J VOCAT REHABIL, V18, P15; Matthews LR, 2005, INT J PSYCHOL, V40, P339, DOI 10.1080/00207590444000320; McCarthy M, 1998, DISABIL SOC, V13, P557, DOI 10.1080/09687599826605; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MCFARLIN DB, 1991, EMPLOYEE RESPONSIBIL, V0004, P00107; Melhorn JM, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P7, DOI 10.1007/0-387-28919-4_1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Morris D. B., 1998, ILLNESS CULTURE POST; Olkin R, 2003, AM PSYCHOL, V58, P296, DOI 10.1037/0003-066X.58.4.296; Olkin R., 1999, WHAT PSYCHOTHERAPIST; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pergola T, 1999, AAOHN J, V47, P397; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE133, DOI 10.1097/00007632-200203010-00020; POLATIN PB, 1993, SPINE, V18, P66, DOI 10.1097/00007632-199301000-00011; Pransky G, 2005, J OCCUP REHABIL, V15, P453, DOI 10.1007/s10926-005-8027-y; Pransky GS, 2004, DISABIL REHABIL, V26, P625, DOI 10.1080/09638280410001672517; Ruff R. M., 2008, PSYCHOL INJ IN PRESS; Salazar M K, 1999, AAOHN J, V47, P416; SANDSTROM J, 1986, SCAND J REHABIL MED, V18, P29; Sbordone RJ, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P343, DOI 10.1007/0-387-28919-4_19; Schultz I. Z., 2007, BEST EVIDENCE INFORM; Schultz I. Z., 2003, PSYCHOL INJURIES TRI; Schultz IZ, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P523; Schultz IZ, 2004, PAIN, V107, P77, DOI 10.1016/j.pain.2003.09.019; Schultz IZ, 2002, SPINE, V27, P2720, DOI 10.1097/00007632-200212010-00012; Schultz IZ, 2000, J OCCUP REHABIL, V10, P271, DOI 10.1023/A:1009484416267; Schultz IZ, 2007, J OCCUP REHABIL, V17, P327, DOI 10.1007/s10926-007-9071-6; Shaw W S, 2001, AAOHN J, V49, P378; Sherman JJ, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P193; Shrey D.E., 1995, PRINCIPLES PRACTICES, P3; SHREY DE, 1995, PRINCIPLES PRACTICES; Sims D. C., 2007, FLORIDA JUSTICE ASS, V520, P56; Smart J., 2001, DISABILITY SOC INDIV; Standing Senate Committee on Social Affairs Science and Technology, 2004, MENT HLTH MENT DIS A, P1; Steenstra IA, 2006, J OCCUP REHABIL, V16, P557, DOI 10.1007/s10926-006-9053-0; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Stowell AW, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P117, DOI 10.1007/0-387-28919-4_6; Sullivan MJL, 2006, PAIN, V123, P37, DOI 10.1016/j.pain.2006.02.007; Sullivan MJL, 2005, J OCCUP REHABIL, V15, P475, DOI 10.1007/s10926-005-8029-9; SZYMANSKI EM, 1994, J REHABIL, V60, P12; Tate DG, 2003, AM PSYCHOL, V58, P289, DOI 10.1037/0003-066X.58.4.289; Tsai J H, 1999, AAOHN J, V47, P405; Turk DC, 2002, PSYCHOL APPROACHES P, P3; Turk DC., 2002, PSYCHOL APPROACHES P, V2nd; Turk Dennis C., 1996, P3; Turner JA, 2006, SPINE, V31, P682, DOI 10.1097/01.brs.0000202762.88787.af; Turner RJ, 2006, REHABIL PSYCHOL, V51, P214, DOI 10.1037/0090-5550.51.3.214; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Waddell G., 2003, SCREENING IDENTIFY P; WEBER MARK C., 2007, DISABILITY HARASSMEN; Wegener S. T., 2006, AM PSYCH S 3134 AM P; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 2007, INT CLASS FUNCT DIS; Wunderlich GS, 2002, DYNAMICS DISABILITY; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0; Young G., 2006, PSYCHOL KNOWLEDGE CO; Young G, 2008, PSYCHOL INJ LAW, V1, P7, DOI 10.1007/s12207-008-9004-5; [No title captured]	162	11	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2008	1	2					103	121		10.1007/s12207-008-9007-2			19	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3UT	WOS:000415439700004					2022-02-06	
J	Kokiko-Cochran, ON; Michaels, MP; Hamm, RJ				Kokiko-Cochran, Olga N.; Michaels, Maria P.; Hamm, Robert J.			Delayed glucose treatment improves cognitive function following fluid-percussion injury	NEUROSCIENCE LETTERS			English	Article						traumatic brain injury; brain injury; cognitive recovery; glucose; rat	TRAUMATIC BRAIN-INJURY; CORTICAL IMPACT INJURY; METABOLIC DEPRESSION; CEREBRAL CONCUSSION; CONTUSION VOLUME; BLOOD-GLUCOSE; RATS; MEMORY; HYPERGLYCEMIA; INCREASES	Experimental traumatic brain injury (TBI) results in marked neurochemical and metabolic changes. Research has demonstrated that after the initial insult the brain undergoes an immediate state of hypermetabolism followed by a sustained period of hypometabolism. The altered extra- and intracellular environment can compromise neuronal performance and limit functional recovery. If brain metabolism is depressed chronically after TBI, then interventions that are designed to increase metabolism may be beneficial to outcome. Glucose treatment has been shown to improve cognition in many populations, particularly those with cognitive deficits. The following experiments examined the effects of delayed postinjury glucose supplementation on cognitive function following TBI. Male Sprague-Dawley rats received either sham or lateral fluid-percussion (LFP) injury. Cognitive functioning was assessed with the Morris water maze (MWM) on postinjury days 11-15. In the first experiment, saline or 100 mg/kg glucose was administered 10 min before cognition assessment. Injured animals treated with glucose displayed significantly shorter latencies to reach the goal platform compared to injured saline-treated animals. Glucose had no effect on sham-injured rats. In the second experiment, injured rats were given daily injections of saline of 100 mg/kg glucose for 10 days beginning 24 h after injury. Rats were then tested in he MWM on days 11 -15 without glucose or saline treatment. In this experiment, glucose treatment did not affect MWM performance. These data provide evidence that the chronic energy supplementation after TBI improves outcome when administered shortly before cognitive assessment. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Kokiko-Cochran, Olga N.; Michaels, Maria P.; Hamm, Robert J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Kokiko-Cochran, ON (corresponding author), Virginia Commonwealth Univ, Dept Psychol, Box 842018,808 W Franklin St, Richmond, VA 23284 USA.	kokikoon@vcu.edu					Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bergui M, 1997, J NEUROSURG, V87, P803; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; CRAFT S, 1994, PSYCHOBIOLOGY, V22, P95; CRAFT S, 1992, J CLIN EXP NEUROPSYC, V14, P253, DOI 10.1080/01688639208402827; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; FERNSTROM JD, 1971, SCIENCE, V174, P414; Flint RW, 1997, DEV PSYCHOBIOL, V31, P207, DOI 10.1002/(SICI)1098-2302(199711)31:3&lt;207::AID-DEV5&gt;3.0.CO;2-W; Fucetola R, 1999, PSYCHIAT RES, V88, P1, DOI 10.1016/S0165-1781(99)00063-3; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GOLD PE, 1995, AM J CLIN NUTR, V61, p987S, DOI 10.1093/ajcn/61.4.987S; GOLD PE, 1991, NEUR CONT B, V6, P391; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hilton G, 1994, Orthop Nurs, V13, P25, DOI 10.1097/00006416-199407000-00006; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Korol DL, 1998, AM J CLIN NUTR, V67, p764S, DOI 10.1093/ajcn/67.4.764S; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Manning CA, 1997, PSYCHOBIOLOGY, V25, P103; Manning CA, 1998, NEUROPSYCHOLOGY, V12, P479, DOI 10.1037/0894-4105.12.3.479; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Messier C, 1996, BEHAV BRAIN RES, V75, P1, DOI 10.1016/0166-4328(95)00153-0; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; SARA SJ, 1988, NEUROBIOL AGING, V9, P31; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STONE WS, 1990, PSYCHOBIOLOGY, V18, P227; STONE WS, 1988, BEHAV NEURAL BIOL, V50, P325, DOI 10.1016/S0163-1047(88)91018-7; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; WHITE NM, 1991, NEUR CONT B, V6, P421; WHITE NM, 1986, LIFE SCI, V38, P2255, DOI 10.1016/0024-3205(86)90578-3; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	47	11	11	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAY 2	2008	436	1					27	30		10.1016/j.neulet.2008.02.046			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	298OG	WOS:000255696400006	18355962				2022-02-06	
J	Breed, S; Sacks, A; Ashman, TA; Gordon, WA; Dahlman, K; Spielman, L				Breed, Sabrina; Sacks, Amanda; Ashman, Teresa A.; Gordon, Wayne A.; Dahlman, Karen; Spielman, Lisa			Cognitive functioning among individuals with traumatic brain injury, Alzheimer's disease, and no cognitive impairments	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Alzheimer's disease; cognitive functioning; traumatic brain injury	CLOSED-HEAD-INJURY; OLDER ADULTS; MEMORY; MILD; PERFORMANCE; DEMENTIA; DEFICITS; REHABILITATION; DECLINE; PEOPLE	Objective: To compare patterns of cognitive functioning in older adults with traumatic brain injury (TBI), Alzheimer's disease (AD), and no neurological disorder (ND). Design: Group comparison. Setting: Outpatient setting of a large urban tertiary care medical center. Participants: Older adults: 56 with TBI, 64 with AD, and 50 with neurological disorder. Intervention(s): None. Results: Older adults with AD and TBI had lower scores in most areas of cognitive functioning examined than the individuals with neurological disorder. Individuals with AD had lower scores in memory, processing speed, and verbal fluency than did individuals with TBI. Specifically, individuals with AD did not retain learned information over time. Conclusion(s): Cognitive impairments were present in older adults with AD and TBI. However, individuals with TBI were better able to learn and retain new information than were individuals with AD.	[Breed, Sabrina; Sacks, Amanda; Ashman, Teresa A.; Gordon, Wayne A.; Spielman, Lisa] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; [Dahlman, Karen] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA		Breed, S (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, 1450 Madison Ave,Box 1674, New York, NY 10029 USA.		Ashman, Teresa/B-1621-2013				ABRAMS GM, 2003, ENCY NEUROLOGICAL SC, P740; Albert MS, 2001, J INT NEUROPSYCH SOC, V7, P631, DOI 10.1017/S1355617701755105; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; BAUM KM, 1996, CLIN NEUROPSYCHOL, V340; BECKER JT, 1988, J CLIN EXP NEUROPSYC, V10, P739, DOI 10.1080/01688638808402811; BENTONA H, 1989, MULTILIGUAL APHASIA; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Brooker AE, 1997, PERCEPT MOTOR SKILL, V84, P131; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Clare L, 2004, NEUROPSYCHOL REHABIL, V14, P385, DOI 10.1080/09602010443000074; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; DEBETTIGNLES BH, 1997, NEUROPSYCHOLOGY HDB, V11, P173; Delazer M, 2003, NEUROPSYCHOLOGIA, V41, P1593, DOI 10.1016/S0028-3932(03)00116-7; ELLIS G L, 1990, Emergency Medicine Clinics of North America, V8, P281; FELDMAN RG, 1963, ARCH INTERN MED, V112, P966, DOI 10.1001/archinte.1963.03860060178020; FIELDS RB, 1997, HDB NEUROPSYCHOLOGY, P280; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GERBERLING JL, 2003, REP C MILD TRAUM BRA; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goldstein FC, 1996, NEUROPSYCHOLOGY, V10, P147; Gorus E, 2006, INT PSYCHOGERIATR, V18, P539, DOI 10.1017/S1041610205002723; GRADY CL, 1988, J CLIN EXP NEUROPSYC, V10, P576, DOI 10.1080/01688638808402796; Greenaway MC, 2006, COGN BEHAV NEUROL, V19, P79, DOI 10.1097/01.wnn.0000208290.57370.a3; HERLITZ A, 1991, J CLIN EXP NEUROPSYC, V13, P559, DOI 10.1080/01688639108401071; Horikawa E, 2005, INTERNAL MED, V44, P717, DOI 10.2169/internalmedicine.44.717; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; LANGLOIS JA, 1997, MMWR-MORBID MORTAL W, V52, P1; LARRABEE GJ, 1993, J CLIN EXP NEUROPSYC, V15, P701, DOI 10.1080/01688639308402590; LEZAK M, 2004, NEUROPSYCOLOGICAL AS; Lezak MD, 2004, NEUROPSYCHOLOGICAL A; LOCASCIO JJ, 1995, ARCH NEUROL-CHICAGO, V52, P1087, DOI 10.1001/archneur.1995.00540350081020; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Meeter M, 2006, J CLIN EXP NEUROPSYC, V28, P914, DOI 10.1080/13803390591001043; Millis SR, 2003, AM J PHYS MED REHAB, V82, pS32, DOI 10.1097/01.PHM.0000087007.19214.32; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MITRUSHINA M, 1994, J CLIN PSYCHOL, V50, P246, DOI 10.1002/1097-4679(199403)50:2<246::AID-JCLP2270500216>3.0.CO;2-L; MORROW LA, 1992, NEUROPSYCHOLOGIA, V30, P911, DOI 10.1016/0028-3932(92)90035-K; NEBES RD, 1993, CORTEX, V29, P77, DOI 10.1016/S0010-9452(13)80213-4; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; PETERSEN RC, 1994, NEUROLOGY, V44, P867, DOI 10.1212/WNL.44.5.867; Rasmusson DX, 1996, BRAIN COGNITION, V31, P133, DOI 10.1006/brcg.1996.0038; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; REITAN RM, 1985, HALSTEAD REITAN NEUR, P77; RICHARDSON JTE, 1984, CORTEX, V20, P413, DOI 10.1016/S0010-9452(84)80009-X; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; Sheridan PL, 2007, DEMENT GERIATR COGN, V24, P125, DOI 10.1159/000105126; Traynelis V C, 1991, Clin Geriatr Med, V7, P583; Tulsky D., 1997, WAIS 3 WMS 3 TECHNIC; TULSKY DS, 1997, WMS 3 ADM SCORING MA; Unverzagt FW, 2007, J INT NEUROPSYCH SOC, V13, P953, DOI 10.1017/S1355617707071512; WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016; Yaari R, 2007, SEMIN NEUROL, V27, P32, DOI 10.1055/s-2006-956753; ZEC RF, 1991, CLIN NEUROPSYCHOL, V5, P257	64	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2008	23	3					149	157		10.1097/01.HTR.0000319931.76966.ff			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	309XN	WOS:000256493600003	18520427				2022-02-06	
J	Espinosa-Aguilar, A; Reyes-Morales, H; Huerta-Posada, CE; de Leon, ILP; Lopez-Lopez, F; Mejia-Hernandez, M; Mondragon-Martinez, MA; Calderon-Tellez, LM; Amezcua-Cuevas, RL; Rebollar-Gonzalez, JA				Espinosa-Aguilar, Amilcar; Reyes-Morales, Hortensia; Huerta-Posada, Carlos E.; Limon-Perez de Leon, Itzcoatl; Lopez-Lopez, Fernando; Mejia-Hernandez, Margarita; Mondragon-Martinez, Maria A.; Calderon-Tellez, Ligia M.; Amezcua-Cuevas, Rosa L.; Rebollar-Gonzalez, Jorge A.			Design and validation of a critical pathway for hospital management of patients with severe traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						severe traumatic brain injury; critical pathways; health care process; nosocomial infections	CEREBRAL PERFUSION-PRESSURE; COMA SCALE SCORE; BLOOD-FLOW; HYPERVENTILATION; HYPOTHERMIA; STAY; CARE	Background: Critical pathways for the management of patients with severe traumatic brain injury (STBI) may contribute to reducing the incidence of hospital complications, length of hospitalization stay, and cost of care. Such pathways have previously been developed for departments with significant resource availability. In Mexico, STBI is the most important cause of complications and length of stay in neurotrauma services at public hospitals. Although current treatment is designed basically in accordance with the Brain Trauma Foundation guidelines, shortfalls in the availability of local resources make it difficult to comply with these standards, and no critical pathway is available that accords with the resources of public hospitals. The purpose of the present study was to design and to validate a critical pathway for managing STBI patients that would be suitable for implementation in neurotrauma departments of middle-income level countries. Methods: The study comprised two phases: design (through literature review and design plan) and validation (content, construct, and appearance) of the critical pathway. Results: The validated critical pathway for managing STBI patients entails four sequential subprocesses summarizing the hospital's care procedures, and includes three components: (1) nodes and criteria (in some cases, indicators are also included); (2) health team members in charge of the patient; (3) maximum estimated time for compliance with recommendations. Conclusions: This validated critical pathway is based on the current scientific evidence and accords with the availability of resources of middle-income countries.	[Reyes-Morales, Hortensia] Mexican Inst Social Secur, Natl Med Ctr Century 21, Epidemiol & Hlth Serv Res Unity, Mexico City, DF, Mexico; [Reyes-Morales, Hortensia] Mexican Inst Social Secur, Natl Med Ctr Century 21, Epidemiol & Hlth Serv Res Unity, Mexico City, DF, Mexico		Espinosa-Aguilar, A (corresponding author), Mollendo 617, Mexico City 07300, DF, Mexico.	amilcar.espinosa@imss.gob.mx					Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; ALDERSON P, 2006, COCHRANE DB SYST REV, P4; ALDERSON P, 2000, COCHRANE DB SYST REV, V2; *AM COLL SURG, 2004, ADV TRAUM LIF SUPP, P157; Andrews PJD, 2005, BRIT J ANAESTH, V94, P330, DOI 10.1093/bja/aei025; Barbaccia J J, 2001, Curr Opin Anaesthesiol, V14, P227, DOI 10.1097/00001503-200104000-00016; BECKER D, 1989, TXB HEAD INJURY; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Chesnut RM, 1997, J TRAUMA, V42, pS19, DOI 10.1097/00005373-199705001-00004; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; ESPINOSAAGUILAR A, 2001, BOOK MEM 12 WORLD C; Gastmeier P, 2002, INFECT CONT HOSP EP, V23, P91, DOI 10.1086/502013; Higgins TL, 2003, CRIT CARE MED, V31, P45, DOI 10.1097/00003246-200301000-00007; Hoff JT, 1996, J TRAUMA, V40, P1048, DOI 10.1097/00005373-199606000-00037; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kavanagh RJ, 2001, BRIT J ANAESTH, V86, P110, DOI 10.1093/bja/86.1.110; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; MASS A, 2002, INT C REC ADV NEUR I; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; NARAYAN R, 1996, J NEUROTRAUMA; National Health and Medical Research Council, 1999, GUID DEV IMPL EV CLI; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; NUNNALLY J, 1991, PSYCHOMETRIC THEORY, P99; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; PEARSON SD, 1995, ANN INTERN MED, V123, P941, DOI 10.7326/0003-4819-123-12-199512150-00008; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; Sprouse M W, 1995, J Healthc Qual, V17, P40; Stricker KH, 2005, ACTA ANAESTH SCAND, V49, P975, DOI 10.1111/j.1399-6576.2005.00702.x; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TER A, 2002, CRIT CARE MED VOLUME, V30, P1616; Thal SC, 2005, CURR OPIN ANESTHESIO, V18, P490, DOI 10.1097/01.aco.0000182561.32680.30; THOMAS S, 2001, ANN EMERG MED, V38, pS4; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; World Bank, 2006, WORLD BANK ANN REP 2; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906	45	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2008	64	5					1327	1341		10.1097/TA.0b013e3181469ebe			15	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	301SH	WOS:000255915400032	18469658				2022-02-06	
J	Durmaz, R; Ozkara, E; Kanbak, G; Arslan, OC; Dokumacioglu, A; Kartkaya, K; Atasoy, MA				Durmaz, Ramazan; Ozkara, Emre; Kanbak, Guengoer; Arslan, Okan Can; Dokumacioglu, Ali; Kartkaya, Kazim; Atasoy, Metin Ant			Nitric oxide level and adenosine deaminase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage	TURKISH NEUROSURGERY			English	Article						adenosine deaminase activity; cerebrospinal fluid; nitric oxide; subarachnoid hemorrhage; vasospasm	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; IN-VIVO; VASOSPASM; SYNTHASE; RAT; MICRODIALYSIS; HYPOXANTHINE; METABOLITES; INHIBITION	OBJECTIVE: Adenosine and nitric oxide (NO) are known as vasodilatators. We investigated adenosine deaminase (ADA) activity and NO concentration in the cerebrospinal fluid (CSF) of patients with subarachnoid hemorrhage (SAH). METHODS: Forty patients with SAH and 10 controls were included in the study. Nitrate level and ADA activity were measured in CSF. SAH patients were grouped according to the presence of angiographic vasospasm, Hunt and Hess grading, Glasgow Coma Scale (GCS) and Fisher Grade (FG). RESULTS: The level of NO markers in SAH patients decreased when compared to that in the control group (p<0.05). However, NO markers in patients with vasospasm was higher than in that of patients without vasospasm (p<0.05). ADA activity increased in patients with SAH (p<0.01) and also patients with angiographic vasospasm (p<0.05). ADA activity in the poor-grade SAH group was higher than that in the good-grade SAH group. The group with the lower GCS showed increased ADA activity compared to those with a higher GCS score (p<0.01). Furthermore, patients with FG 4 had a higher level of ADA activity compared to FG 1 and 2 and FG 3 (p<0.001 and p<0.01, respectively). CONCLUSION: Decreased NO level may participate in the early development of vasospasm. However, the increased level of ADA activity in the SAH patients with the poor clinical and consciousness level may have resulted from the ischemic cerebral insult.	[Durmaz, Ramazan; Ozkara, Emre; Atasoy, Metin Ant] Eskisehir Osmangazi Univ, Sch Med, Dept Neurosurg, TR-26480 Eskisehir, Turkey; [Kanbak, Guengoer; Arslan, Okan Can; Dokumacioglu, Ali; Kartkaya, Kazim] Eskisehir Osmangazi Univ, Sch Med, Dept Biochem, TR-26480 Eskisehir, Turkey		Durmaz, R (corresponding author), Eskisehir Osmangazi Univ, Sch Med, Dept Neurosurg, TR-26040 Eskisehir, Turkey.	rdurmaz@ogu.edu.tr		Arslan, Okan Can/0000-0002-9784-2663			AFSHAR JKB, 1995, J NEUROSURG, V83, P118, DOI 10.3171/jns.1995.83.1.0118; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Brundege J M, 1997, Adv Pharmacol, V39, P353, DOI 10.1016/S1054-3589(08)60076-9; Chiang MF, 2006, ACTA NEUROCHIR, V148, P615, DOI 10.1007/s00701-006-0771-z; Choi SH, 2002, CLIN NEUROL NEUROSUR, V104, P10, DOI 10.1016/S0303-8467(01)00159-7; CLOWER BR, 1994, ANAT REC, V240, P104, DOI 10.1002/ar.1092400110; CORTAS NK, 1990, CLIN CHEM, V36, P1440; DEMENDONCA A, 1995, NEUROREPORT, V6, P1097, DOI 10.1097/00001756-199505300-00006; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; HAGBERG H, 1987, J NEUROCHEM, V49, P227, DOI 10.1111/j.1471-4159.1987.tb03419.x; HANKIEWICZ J, 1972, ENZYMOLOGIA, V43, P385; Hino A, 1996, NEUROSURGERY, V39, P562, DOI 10.1097/00006123-199609000-00026; HONGO K, 1988, J NEUROSURG, V69, P247, DOI 10.3171/jns.1988.69.2.0247; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Iuliano BA, 2004, J NEUROSURG, V100, P287, DOI 10.3171/jns.2004.100.2.0287; Jung CS, 2007, J NEUROSURG, V107, P945, DOI 10.3171/JNS-07/11/0945; KADER A, 1993, STROKE, V24, P1709, DOI 10.1161/01.STR.24.11.1709; KAPLAN NO, 1955, METHOD ENZYMOL, V2, P473, DOI 10.1016/S0076-6879(55)02233-7; Kobayashi T, 1998, BRAIN RES, V787, P211, DOI 10.1016/S0006-8993(97)01481-9; Lin CL, 2006, FREE RADICAL BIO MED, V40, P1466, DOI 10.1016/j.freeradbiomed.2005.12.019; Marten-Lobenhoffer J, 2007, J NEUROSCI METH, V164, P155, DOI 10.1016/j.jneumeth.2007.04.005; MORIMOTO K, 1991, Neurologia Medico-Chirurgica, V31, P129, DOI 10.2176/nmc.31.129; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; NAKAGOMI T, 1987, STROKE, V18, P482, DOI 10.1161/01.STR.18.2.482; Ng WH, 2001, NEUROSURGERY, V49, P622, DOI 10.1097/00006123-200109000-00016; Pearson T, 2003, J CELL MOL MED, V7, P362, DOI 10.1111/j.1582-4934.2003.tb00239.x; Pluta RM, 2005, J NEUROSURG, V103, P731, DOI 10.3171/jns.2005.103.4.0731; Pluta RM, 1996, J NEUROSURG, V84, P648, DOI 10.3171/jns.1996.84.4.0648; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Sasaki T, 2001, Keio J Med, V50, P182; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Suzuki Y, 1997, NEUROSURGERY, V41, P807, DOI 10.1097/00006123-199710000-00008; TEASDALE G, 1974, LANCET, V2, P81; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; VONHOLST H, 1985, ACTA NEUROCHIR, V77, P52, DOI 10.1007/BF01402306; Widenka DC, 1999, J NEUROSURG, V90, P1098, DOI 10.3171/jns.1999.90.6.1098; WINN HR, 1979, CIRC RES, V45, P486, DOI 10.1161/01.RES.45.4.486; Woszczyk A, 2003, ACTA NEUROCHIR, V145, P257, DOI 10.1007/s00701-003-0004-7; Zhu DY, 2002, LIFE SCI, V71, P1985, DOI 10.1016/S0024-3205(02)01970-7; Zubkov AY, 2000, SURG NEUROL, V53, P260, DOI 10.1016/S0090-3019(99)00187-1; Zubkov AY, 2002, NEUROSCI LETT, V326, P137, DOI 10.1016/S0304-3940(02)00188-X	46	11	12	0	4	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	APR	2008	18	2					157	164					8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	330MG	WOS:000257945100007	18597230				2022-02-06	
J	Yetiser, S; Kahraman, E				Yetiser, Sertac; Kahraman, Erkan			An analysis of time-dependent changes of neurotrophic factors (BDNF, CNTF) in traumatic facial nerve injury of a nerve-cut and nerve-crush model in rats	OTOLOGY & NEUROTOLOGY			English	Article; Proceedings Paper	26th Politzer-Society Meeting	OCT 13-16, 2007	Cleveland, OH	Politzer Soc		brain-derived neurotrophic factor; ciliary neurotrophic factor; traumatic facial injury	MESSENGER-RNA; FACTOR PREVENTS; SCIATIC-NERVE; MOTOR NEURONS; ADULT-RAT; MOTONEURONS; REGENERATION; BRAIN; EXPRESSION; AXOTOMY	Hypothesis: To investigate neurotrophic changes in the injured facial nerve in rats. Background: Time-dependent follow-up of brain-derived neurotropbic factor (BDNF) and ciliary neurotrophic factor (CNTF) concentrations in a standardized nerve-cut and nerve-crush trauma model could present valuable information about estimation of the extent of the injury. Methods: Ninety Wistar rats were grouped into permanent (transection: nerve-cut) and transient (compression: nerve-crush) nerve injury and analyzed for neurotrophic changes at Week I and after 1, 3, and 6 months. Ten undissected rats served as controls. Permanent injury was accomplished with a 5-mm transection. To model transient injury, the facial nerve was pressed by vascular clamps for 40 minutes. Rat BDNF and CNTF enzyme-linked immunosorbent assay kits were used to perform histochemical analysis of blood samples. Measurements were compared with variance analysis and Student's t tests. Results: BDNF levels in nerve-injured preparations from both groups at consecutive intervals were not significant from those of controls, except for transient increases in the first week. When BDNF levels in nerve-cut and nerve-crush groups were compared at each interval separately, differences were insignificant (p > 0.05). CNTF levels at consecutive intervals were significant from that of control rats in both groups. When CN0054F levels in nerve-cut and nerve-crush groups were compared at each interval separately, differences were significant (p = 0.023, p = 0.001, p = 0.043, and p = 0.023). Conclusion: Elevated levels of BDNF in the first week after nerve injury do not differentiate the severity of the facial nerve injury. However, diminished CNTF levels in the nerve-crush group were significant when compared with that of nerve-cut group. This finding suggests the possibility that CNTF levels can distinguish whether the facial nerve is interrupted after trauma. Further experimental studies should investigate the indicative role of CNTF levels as a marker of nerve disruption in the clinical setting.	[Yetiser, Sertac; Kahraman, Erkan] Gulhane Mil Med Acad, Dept ORL & HNS, TR-06018 Ankara, Turkey		Yetiser, S (corresponding author), Gulhane Mil Med Acad, Dept ORL & HNS, TR-06018 Ankara, Turkey.	syetiser@yahoo.com	KAHRAMAN, MEHMET ERKAN/AAW-1049-2021				Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; KIEFER R, 1995, INT J DEV NEUROSCI, V13, P331; Kobayashi NR, 1996, EUR J NEUROSCI, V8, P1018, DOI 10.1111/j.1460-9568.1996.tb01588.x; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; LOWRIE MB, 1992, TRENDS NEUROSCI, V15, P80, DOI 10.1016/0166-2236(92)90014-Y; MANTHORPE M, 1986, BRAIN RES, V367, P282, DOI 10.1016/0006-8993(86)91603-3; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; SAIKA T, 1991, MOL BRAIN RES, V9, P157, DOI 10.1016/0169-328X(91)90142-K; Sendtner M, 1997, J NEUROSCI, V17, P6999; SENDTNER M, 1992, J CELL BIOL, V118, P139, DOI 10.1083/jcb.118.1.139; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; Serpe CJ, 2005, BRAIN BEHAV IMMUN, V19, P173, DOI 10.1016/j.bbi.2004.07.005; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; Tong JXX, 1997, J NEUROCYTOL, V26, P339, DOI 10.1023/A:1018508819191; ULENKATE HJLM, 1994, ACTA NEUROPATHOL, V88, P558; Walter M A, 1993, Facial Plast Surg, V9, P68, DOI 10.1055/s-2008-1064597; Watabe K, 2005, NEUROPATHOLOGY, V25, P371, DOI 10.1111/j.1440-1789.2005.00609.x; Watabe K, 2001, Hum Cell, V14, P7; WU W, 1993, DEV BIOL, V158, P456, DOI 10.1006/dbio.1993.1203	24	11	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1531-7129			OTOL NEUROTOL	Otol. Neurotol.	APR	2008	29	3					392	396		10.1097/MAO.0b013e318161ab3e			5	Clinical Neurology; Otorhinolaryngology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	288IW	WOS:000254980800023	18494143				2022-02-06	
J	Guven, M; Eren, A; Kadioglu, B; Yavuz, U; Kilincoglu, V; Ozkan, K				Guven, Melih; Eren, Abdullah; Kadioglu, Baris; Yavuz, Umut; Kilincoglu, Volkan; Ozkan, Korhan			The results of treatment in pediatric Monteggia equivalent lesions	ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA			Turkish	Article						child; dislocations/therapy; fracture fixation, internal; Monteggia's fracture/therapy; radius fractures/therapy	FRACTURE-DISLOCATIONS; CHILDREN; CHILDHOOD; FOREARM	Objectives: We evaluated the results of conservative and surgical treatment of pediatric Monteggia equivalent lesions. Methods: The study included 13 children (3 females, 10 males; mean age 8 years; range 4 to 13 years) who underwent treatment for Monteggia equivalent lesions. Seven patients (53.9%) had Bado type I and six patients (46.2%) had type 3 equivalent lesions. Two patients with type 3 equivalent lesions also had a lateral humeral condyle fracture. On presentation, one patient (7.7%) had radial nerve palsy. Primarily, closed reduction was attempted in all the patients except for one patient who underwent urgent debridement and irrigation for an open fracture-dislocation. Reduction was successful in eight patients (61.5%). Upon failure of closed reduction, four patients (30.8%) underwent surgery within the first 24 hours of injury. Functional assessment was made according to the Reckling's criteria. The mean follow-up period was 4.1 years (range 2 to 7 years). Results: None of the patients had nonunion. Conservative treatment did not result in loss of reduction of the radius head or limitation in the range of motion of the elbow joint. Except for the patient with an open fracture-dislocation leading to a poor functional result, the results were good in all the patients receiving conservative or surgical treatment. One patient (7.7%) treated conservatively developed cubitus varus (5 degrees) and posterior angulation (20 degrees) of the ulnar fracture line. One patient treated surgically had limitation of supination (10 degrees) without limitation of flexion or extension of the elbow joint. Accompanying radial nerve palsy in this patient disappeared in the postoperative third month. Conclusion: Closed reduction is the first choice of treatment in pediatric Monteggia equivalent lesions. Surgical treatment becomes necessary if closed reduction fails.	[Guven, Melih] Abant Izzet Baysal Univ, Tip Fak, Ortopedi & Travmatol Anabilim Dali, Istanbul, Turkey		Guven, M (corresponding author), Abant Izzet Baysal Univ, Tip Fak Hastanesi, Ortopedi & Travmatol Anabilim Dali, TR-14280 Bolu, Turkey.	maguven2000@gmail.com					Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Bhandari N, 1996, J BONE JOINT SURG AM, V78A, P1252, DOI 10.2106/00004623-199608000-00017; Biyani A, 2000, Am J Orthop (Belle Mead NJ), V29, P115; BOYD HB, 1969, CLIN ORTHOP RELAT R, P94; BRYAN RS, 1971, J TRAUM, V11, P992, DOI 10.1097/00005373-197112000-00002; Caterini R, 2002, J PEDIATR ORTHOP B, V11, P320, DOI 10.1097/00009957-200210000-00010; Eglseder WA, 2006, SOUTH MED J, V99, P723, DOI 10.1097/01.smj.0000224749.40702.32; Faundez AA, 2003, J BONE JOINT SURG BR, V85B, P584, DOI 10.1302/0301-620X.85B4.13204; Givon U, 1997, CLIN ORTHOP RELAT R, P208; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; Hung SC, 2003, ARCH ORTHOP TRAUM SU, V123, P311, DOI 10.1007/s00402-003-0526-8; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; MULLICK S, 1977, J BONE JOINT SURG AM, V59, P543, DOI 10.2106/00004623-197759040-00024; OLNEY BW, 1989, J PEDIATR ORTHOPED, V9, P219; PAPAVASILIOU VA, 1988, CLIN ORTHOP RELAT R, P230; RAVESSOUD FA, 1985, J PEDIATR ORTHOPED, V5, P364, DOI 10.1097/01241398-198505000-00023; RECKLING FW, 1982, J BONE JOINT SURG AM, V64, P857, DOI 10.2106/00004623-198264060-00007; Ruchelsman DE, 2005, J ORTHOP TRAUMA, V19, P425; TOMPKINS DG, 1971, J BONE JOINT SURG AM, VA 53, P1109, DOI 10.2106/00004623-197153060-00007; WILEY JJ, 1985, J BONE JOINT SURG BR, V67, P728, DOI 10.1302/0301-620X.67B5.4055870	20	11	14	0	1	TURKISH ASSOC ORTHOPAEDICS TRAUMATOLOGY	ISTANBUL	SEHREMINI MAH KOYUNCU SK CIGDEM APT NO 4 D 5 FATIH, ISTANBUL, 00000, TURKEY	1017-995X			ACTA ORTHOP TRAUMATO	Acta Orthop. Traumatol. Turc.	MAR-APR	2008	42	2					90	96					7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	343EE	WOS:000258834800005	18552529				2022-02-06	
J	Hoizey, G; Canas, F; Binet, L; Kaltenbach, ML; Jeunehomme, G; Bernard, MH; Lamiable, D				Hoizey, Guillaume; Canas, Frederic; Binet, Laurent; Kaltenbach, Matthieu L.; Jeunehomme, Gerard; Bernard, Marie-Helene; Lamiable, Denis			Thiodicarb and methomyl tissue distribution in a fatal multiple compounds poisoning	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; thiodicarb; methomyl; fatal poisoning; tissue distribution; liquid chromatography ion trap mass spectrometry	CARBAMATE	Thiodicarb is a nonsystemic carbamate insecticide whose acetylcholinesterase activity is related to its main methomyl degradation product. A 40-year-old woman was found dead in her car. Empty packages of medicines and an open bottle of Larvin(R) containing thiodicarb were found near her body. No signs of violence nor traumatic injuries were noticed upon autopsy, and police investigations strongly suggested a suicide. Systematic toxicological analysis performed on postmortem specimens revealed the presence of various sedatives, hypnotics, and antipsychotic drugs in blood, urine, and gastric content. Some of the compounds identified were determined at blood concentrations well above the known therapeutic concentrations: zolpidem (2.87 mg/L), bromazepam (2.39 mg/L), nordazepam (4.21 mg/L), and levopremazine (0.64 mg/L). Specific analysis of thiodicarb and of its methomyl metabolite was then performed on all fluids and tissues collected during autopsy by liquid chromatography ion trap tandem mass spectrometry (LC-MS-MS). The anticholinesterase capacity of blood, urine, and gastric content collected at autopsy was 83%, 82%, and 32%, respectively (normal value: 0%). The presence of thiodicarb in the bottle found near the body corroborates the hypothesis of an intake of that compound. Although thiodicarb was only detected in gastric content (24.3 mg/L), its methomyl metabolite was quantified in most postmortem tissues and fluids: gastric content (19.9 mg/L), peripheral blood (0.7 mg/L), urine (8.5 mg/L), bile (2.7 mg/L), liver (0.7 mg/kg), kidney (1.7 mg/kg), lung (1.5 mg/kg), brain (9.3 mg/kg), and heart (3.6 mg/kg).	[Hoizey, Guillaume; Binet, Laurent; Lamiable, Denis] CHU Reims, Hosp Maison Blanche, Lab Pharmacol & Toxicol, F-51092 Reims, France; [Kaltenbach, Matthieu L.] UFR Pharm, Lab Pharmacol & Pharmacocinet, Reims, France		Hoizey, G (corresponding author), CHU Reims, Hosp Maison Blanche, Lab Pharmacol & Toxicol, 45 Rue Cognacq Jay, F-51092 Reims, France.	ghoizey@chu-reims.fr					ALAWADI AH, 2001, B INT ASS FORENSIC T, V31, P6; BISMUTH C, 2000, TOXICOLOGIE CLIN, P516; DRUMMER OH, 1997, 35 ANN M PAD IT 24 2; *INT ASS FOR TOX, 2006, TIAFT REF BLOOD LIST; MAHIEU P, 1982, J TOXICOL-CLIN TOXIC, V19, P425, DOI 10.3109/15563658208992497; MIYAZAKI T, 1989, FORENSIC SCI INT, V42, P263, DOI 10.1016/0379-0738(89)90094-7; Moriya F, 2005, FORENSIC SCI INT, V149, P167, DOI 10.1016/j.forsciint.2004.06.013; Moriya F, 1999, J FORENSIC SCI, V44, P1131; Peters FT, 2007, FORENSIC SCI INT, V165, P216, DOI 10.1016/j.forsciint.2006.05.021; Tsatsakis AM, 1998, SCI JUSTICE, V38, P282; Tsatsakis AM, 1996, SCI JUSTICE, V36, P41, DOI 10.1016/S1355-0306(96)72553-4	11	11	12	2	12	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-1198			J FORENSIC SCI	J. Forensic Sci.	MAR	2008	53	2					499	502		10.1111/j.1556-4029.2008.00676.x			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	278SF	WOS:000254305900041	18366586				2022-02-06	
J	Morais, DF; Spotti, AR; Tognola, WA; Gaia, FFP; Andrade, AF				Morais, Dionei F.; Spotti, Antonio R.; Tognola, Waldir A.; Gaia, Felipe F. P.; Andrade, Almir F.			Clinical application of magnetic resonance in acute traumatic brain injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						magnetic resonance imaging; traumatic brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; IMAGING FINDINGS; CORPUS-CALLOSUM; MR; CT; TOMOGRAPHY; FEATURES; LESIONS	Purpose: To evaluate the clinical applications of magnetic resonance imaging (MRI) in patients with acute traumatic brain injury (TBI): to identify the type, quantity, severity; and improvement clinical-radiological correlation. Method: Assessment of 55 patients who were imaged using CT and MRI, 34 (61.8%) males and 21 (38.2%) females, with acute (0 to 5 days) and closed TBI. Results: Statistical significant differences (McNemar test): ocurred fractures were detected by CT in 29.1% and by MRI in 3.6% of the patients; subdural hematoma by CT in 10.9% and MRI in 36.4%; diffuse axonal injury (DAI) by CT in 1.8% and MRI in 50.9%; cortical contusions by CT in 9.1% and MRI in 41.8%; subarachnoid hemorrhage by CT in 18.2% and MRI in 41.8%. Conclusion: MRI was superior to the CT in the identification of DAI, subarachnoid hemorrhage, cortical contusions, and acute subdural hematoma; however it was inferior in diagnosing fractures. The detection of DAI was associated with the severity of acute TBI.	Fac Med Sao Jose do Rio Preto, Dept Ciencias Neurol, Sao Jose Do Rio Preto, SP, Brazil; [Morais, Dionei F.; Gaia, Felipe F. P.] Hosp Base, Serv Neurocirurg, Sao Jose Do Rio Preto, SP, Brazil; [Spotti, Antonio R.; Tognola, Waldir A.] FAMERP, Dept Ciencias Neurol, Sao Jose Do Rio Preto, SP, Brazil; [Andrade, Almir F.] HC FMUSP, Dept Neurocirurg Emergencia, Sao Paulo, Brazil		Morais, DF (corresponding author), Avenida Jose Munia 4850, BR-15090500 Sao Jose Dos Campos, Brazil.	centro@cerebroecoluna.com.br		Gaia, Felipe/0000-0003-3457-3053			ANDRADE AF, 2006, SURG NEUROL, V65, P10; ANDRADE AF, 2004, THESIS SAO PAULO; Braga FT, 2003, AM J NEURORADIOL, V24, P1863; *COM TRAUM COL AM, 1997, SUP AV VID TRAUM SAV; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; GEAN AD, TRAUMATIC BRAIN LESI; Gennarelli TA, 1993, HEAD INJURY, P137; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1994, RADIOLOGY, V191, P1; GENTRY LR, 2002, MAGNETIC RESONANCE I, P1059; Gentry LR, 1991, NEUROIMAG CLIN N AM, V1, P411; GUSMAO SN, 2000, NEUROTRAUMATOLOGIA, P170; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kraus J, 1996, NEUROTRAUMA, P13; Lee Bruce, 2005, NeuroRx, V2, P372; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MACPHERSON BCM, 1990, CLIN RADIOL, V42, P321, DOI 10.1016/S0009-9260(05)82145-2; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Osborn AG, 2004, DIAGNOSTIC IMAGING B; OSBORN AG, 1999, DIAGNOSTICO NEURORRA, P199; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; ROCHA AJ, 2006, J COMPUT ASSIST TOMO, V2, P295; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; TEASDALE G, 1974, LANCET, V2, P81; Tokutomi T, 1997, ACT NEUR S, V70, P80; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Zar J.H., 2013, BIOSTATISTICAL ANAL BIOSTATISTICAL ANAL; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687	36	11	12	0	7	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2008	66	1					53	58		10.1590/S0004-282X2008000100013			6	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	282PQ	WOS:000254580100013	18392415	gold, Green Published, Green Submitted			2022-02-06	
J	Youngblut, JM; Brooten, D				Youngblut, JoAnne M.; Brooten, Dorothy			Mother's mental health, mother-child relationship, and family functioning 3 months after a preschooler's head injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head injury; family functioning; parent mental health; preschool children	TRAUMATIC BRAIN-INJURY; PREDICTORS; ATTENTION; RECOVERY; DISTRESS; BURDEN	Objective: Investigate mothers' mental health, mother-child relationship, and family functioning 3 months after preschool children's head trauma and hospital discharge. Design: Prospective survey. Setting: Seven hospitals; families' homes. Participants: Eighty mothers of children (ages 3-6) with head trauma. Measures: Perceived injury severity, Mental Health Inventory, Parental Stressor Scale taken in pediatric intensive care unit 24 to 48 hours after admission; Mental Health Inventory, Parenting Stress Index, FACES II, Multidimensional Scale of Perceived Social Support taken at 3 months postdischarge. Results: Injury severity had negative effects on mothers' mental health at 3 months after discharge, but not on the mother-child relationship and the family's functioning. Mothers' baseline mental health and ongoing support had positive effects on mother-child relationship and family adaptability. Conclusions: Mothers with greater stress and poorer mental health during their child's hospitalization may be at risk for negative mother-child and family outcomes. Interventions that decrease parents' stress during hospitalization and promote ongoing social support after discharge may diminish this risk.	[Youngblut, JoAnne M.; Brooten, Dorothy] Florida Int Univ, Coll Nursing & Hlth Sci, Miami, FL 33199 USA		Youngblut, JM (corresponding author), Florida Int Univ, Coll Nursing & Hlth Sci, 11200 SW 8th St,Room 485, Miami, FL 33199 USA.	youngblu@fiu.edu; drjmy3@aolcom.com			NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR004430] Funding Source: NIH RePORTER; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR04430, R01 NR004430, R01 NR004430-06] Funding Source: Medline		Abidin R., 1990, PARENTING STRESS IND; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; BERENBAUM J, 1992, J PEDIATR PSYCHOL, V17, P359, DOI 10.1093/jpepsy/17.3.359; BOARD RM, 1994, PARENTAL CARE THEIR; Carter M C, 1989, Matern Child Nurs J, V18, P187; CARTER MC, 1983, PARENTAL STRESSOR SC; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; GREEN M, 1964, PEDIATRICS, V34, P58; Guerra H L, 1997, Rev Panam Salud Publica, V2, P115, DOI 10.1590/S1020-49891997000800004; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; MAX J, 1998, CHILD ADOL PSYCH CL, V37, P83; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McCubbin M., 1993, FAMILIES HLTH ILLNES, P21, DOI 10.4135/9781452274720.n8; MCKINNEY B, 1984, TEST CRITIQUES, P504; Melnyk BM, 1997, RES NURS HEALTH, V20, P3; Olson D. H., 1989, CIRCUMPLEX MODEL SYS, P7; Olson DH, 1983, MARRIAGE FAMILY ASSE, P299; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; STRUSS D, 2004, BRAIN COGNITION, V55, P69; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; VEIT CT, 1983, J CONSULT CLIN PSYCH, V51, P730, DOI 10.1037/0022-006X.51.5.730; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Youngblut J M, 1995, Issues Compr Pediatr Nurs, V18, P11, DOI 10.3109/01460869509080954; Youngblut J M, 1991, AACN Clin Issues Crit Care Nurs, V2, P329; Youngblut JM, 2006, J PEDIATR PSYCHOL, V31, P608, DOI 10.1093/jpepsy/jsj066; Youngblut JoAnne M, 2005, Pediatr Crit Care Med, V6, P550, DOI 10.1097/01.PCC.0000163283.27419.E9; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	34	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2008	23	2					92	102		10.1097/01.HTR.0000314528.85758.30			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	280KW	WOS:000254426700004	18362763	Green Submitted, Green Accepted			2022-02-06	
J	Battistone, M; Woltz, D; Clark, E				Battistone, Melanie; Woltz, Dan; Clark, Elaine			Processing speed deficits associated with traumatic brain injury: Processing inefficiency or cautiousness?	APPLIED NEUROPSYCHOLOGY			English	Article						processing speed; speed-accuracy trade-off; traumatic brain injury; volition	CLOSED-HEAD-INJURY; ATTENTIONAL DEFICITS; SELF-REGULATION; INFORMATION; PERFORMANCE; REHABILITATION; ADOLESCENTS; IMPAIRMENT; RECOVERY; SLOWNESS	This study used speed-accuracy trade-off (SAT) methodology to test competing explanations for processing speed deficits due to traumatic brain injury (TBI): fixed limited capacity and volition. Twenty TBI participants and 20 comparison participants performed a visual scanning task with processing times controlled by the experimenter using a response deadline procedure. Results of the study demonstrated marked differences in SAT functions between the two groups. Participants who had TBIs were significantly slower on information accrual across processing deadlines (supporting a fixed limit explanation), but when early responding was allowed they chose to hold off responding despite being no more accurate in their responses with the additional time (a finding supporting a volitional explanation). Results of the study are discussed in terms of a resource allocation model that incorporates the influences of both processing capacity and volitional processes for individuals who suffer from brain injuries.	[Battistone, Melanie; Woltz, Dan; Clark, Elaine] Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA		Woltz, D (corresponding author), Univ Utah, Dept Educ Psychol, 1705 E Central Campus Dr,Rm 327, Salt Lake City, UT 84112 USA.	Dan.Woltz@ed.utah.edu					Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; DiPace E, 1995, J CLIN EXP NEUROPSYC, V17, P878; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; GRONWALL D, 1974, LANCET, V2, P605; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; KANFER R, 1989, ABILITIES, MOTIVATION, AND METHODOLOGY, P375; KANFER R, 1989, J APPL PSYCHOL, V74, P657, DOI 10.1037/0021-9010.74.4.657; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; LOHMAN DF, 1989, ABILITIES, MOTIVATION, AND METHODOLOGY, P119; Long CJ, 1992, HDB HEAD TRAUMA ACUT, P107; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; Miller E, 1970, Cortex, V6, P121; Murdock B, 1982, HDB RES METHODS HUMA, P1; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SAMPSON H, 1956, CAN J PSYCHOLOGY, V10, P219, DOI 10.1037/h0083679; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stuart RB, 1977, BEHAV SELF MANAGEMEN, P1; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; [No title captured]; [No title captured]	35	11	11	0	5	LAWRENCE ERLBAUM ASSOC INC-TAYLOR & FRANCIS	PHILADELPHIA	325 CHESTNUT STREET, STE 800, PHILADELPHIA, PA 19106 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2008	15	1					69	78		10.1080/09084280801917863			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	287KZ	WOS:000254917300009	18443943				2022-02-06	
J	Cook, LG; Chapman, SB; Levin, HS				Cook, Lori G.; Chapman, Sandra B.; Levin, Harvey S.			Self-regulation abilities in children with severe traumatic brain injury: A preliminary investigation of naturalistic action	NEUROREHABILITATION			English	Article						Brain injury; children; executive function; self-regulation; supervisory attention; top-down processing; naturalistic action; script	CLOSED-HEAD INJURY; EXECUTIVE FUNCTION; ACADEMIC-ACHIEVEMENT; WORKING-MEMORY; FRONTAL-LOBE; ADOLESCENTS; LONDON; TOWER; CHILDHOOD; LESIONS	Research suggests that the occurrence of a traumatic brain injury (TBI) in childhood may disrupt self-regulation abilities, putting children at risk for difficulty on everyday tasks requiring self-regulation throughout their development. In the current exploratory study, a novel age-appropriate task assessed the ability to perform three familiar tasks using real objects while adhering to specific rules. Performance of children (ages 8-16) with severe TBI (n = 11) on the naturalistic task was compared to that of typically developing children (n = 21), including measures of the amount/types of errors and number of broken rules. The children with TBI exhibited significantly increased use of distractor objects in place of target objects as compared to the non-injured children. Additionally, children with TBI demonstrated trends of increased breaking of rules during the task and failure to include necessary steps. The preliminary results support the theory that children with severe TBI possess inefficient supervisory processes of self-regulation, corresponding to a decreased ability to carry out goal-based top-down processing. They may instead exhibit a bias towards a bottom-up approach, depending primarily on environmental cues such as the objects present to guide their actions, thus impeding self-regulation abilities.	[Cook, Lori G.; Chapman, Sandra B.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr Brain Hlth, Dallas, TX 75235 USA; [Levin, Harvey S.] Baylor Coll Med, Houston, TX 77030 USA		Cook, LG (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Ctr Brain Hlth, 2200 W Mockingbird Ln, Dallas, TX 75235 USA.	lori.cook@utdallas.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2R01 NS 21889-16] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V., 1999, PEDIAT REHAB, V3, P137; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Buxbaum LJ, 1998, COGNITIVE NEUROPSYCH, V15, P617, DOI 10.1080/026432998381032; Buxbaum LJ, 1997, COGNITIVE NEUROPSYCH, V14, P219, DOI 10.1080/026432997381565; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Newell A., 1972, HUMAN PROBLEM SOLVIN; Norman D.A., 1986, ADV RES THEOR, P1; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; Raizner RD, 2002, DEV NEUROPSYCHOL, V21, P1, DOI 10.1207/S15326942DN2101_1; Schwartz M. F., 1997, APRAXIA NEUROPSYCHOL, P269; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Sohlberg MM, 1998, APHASIOLOGY, V12, P1047, DOI 10.1080/02687039808249469; TEASDALE G, 1974, LANCET, V2, P81; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Wehmeyer M. L., 1998, TEACHING SELF DETERM; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891; [No title captured], DOI DOI 10.1080/13854048708520056	42	11	11	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2008	23	6					467	475					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	391CI	WOS:000262210200003	19127000				2022-02-06	
J	Frost, FS; Mukkamala, S; Covington, E				Frost, Frederick S.; Mukkamala, Sridevi; Covington, Edward			Self-inflicted finger injury in individuals with spinal cord injury: An analysis of 5 cases	JOURNAL OF SPINAL CORD MEDICINE			English	Article						spinal cord injuries; tetraplegia; pain; obsessive-compulsive disorder; nail biting; autoamputation; autophagia; self-injurious behavior, traumatic brain injury	SENSORY DEPRIVATION; MANIFEST ANXIETY; BEHAVIOR; MUTILATION; OSTEOMYELITIS; ONYCHOPHAGIA; PAIN	Objective: To describe the occurrence of finger autophagia in 5 persons with traumatic spinal cord injury and to present a discussion of putative causes and potential treatments. Background: Minor self-mutilating actions, such as nail biting and hair pulling, are common in humans and usually benign. In some circumstances, these behaviors are associated with obsessive-compulsive personality traits. In humans, self-injurious biting behaviors are well described in the setting of mental retardation and psychosis and in persons with Lesch-Nyhan syndrome. Rare cases of human autophagia in persons with intact cognition have been reported, most commonly in the setting of acquired nervous system lesions. After spinal cord injury, it has been suggested that this behavior constitutes a human variant of animal autotomy and a response to neuropathic pain. Design: Case presentation narrative. Main Outcome Measures: Photographic and radiological study, administration of Yale-Brown Obsessive-Compulsive Scale (YBOCS). Findings: In 5 patients with complete tetraplegia, pain in the hands was present in only one instance. The severity of autoamputation varied from minor to extreme. In all cases, damage was confined to analgesic body parts. In 3 cases, autophagia behavior was discovered in progress. Treatments included pharmacotherapy, counseling, and behavioral therapy, with mixed results. All patients were intelligent, willing to discuss their issues, and able to identify conditions of stress and isolation in their lives. Mild preinjury obsessive-compulsive behaviors, such as nail biting, were universal. On the YBOCS, only 1 patient scored in a range indicative of mild obsessive-compulsive symptomatology. Conclusions: This group exhibited heterogeneous medical, social, and cultural characteristics. A link between pain and self-injurious behavior could not be demonstrated. This behavior may be viewed as an extreme variant of nail biting, with potential ominous complications. Treatment strategies have been employed with mixed results.	[Frost, Frederick S.; Mukkamala, Sridevi; Covington, Edward] Cleveland Clin, Dept Rehabil Med, Cleveland, OH 44195 USA		Frost, FS (corresponding author), Cleveland Clin, Dept Rehabil Med, Desk C15,9500 Euclid Ave, Cleveland, OH 44195 USA.	frostf@ccf.org	Yang, Bangxiang/G-2510-2014				ADEY WR, 1968, ARCH NEURAL, V19, P277; Bryce T N, 2000, Phys Med Rehabil Clin N Am, V11, P157; BUCHER BD, 1968, BEHAV RES THER, V6, P389, DOI 10.1016/0005-7967(68)90072-7; Cavaggioni G, 2003, Eat Weight Disord, V8, P62; Coppola R J, 1975, J Am Osteopath Assoc, V74, P555; CROSS HA, 1965, J EXP RES PERS, V1, P39; Crossman MW, 1996, SPINAL CORD, V34, P573, DOI 10.1038/sc.1996.102; DAHLIN PA, 1985, PARAPLEGIA, V23, P306, DOI 10.1038/sc.1985.48; DAVIDSON AM, 1980, BEHAV RES THER, V18, P1, DOI 10.1016/0005-7967(80)90063-7; DEARDOFF PA, 1974, J CLIN PSYCHOL, V30, P378, DOI 10.1002/1097-4679(197407)30:3<378::AID-JCLP2270300348>3.0.CO;2-0; Ellerbroek W C, 1978, J Am Soc Psychosom Dent Med, V25, P7; Frost FS, 2000, PHYS MED REHABILITAT, P1230; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; HODES R, 1962, ELECTROEN CLIN NEURO, V14, P220, DOI 10.1016/0013-4694(62)90032-9; JONES IH, 1978, ACTA PSYCHIAT SCAND, V58, P40, DOI 10.1111/j.1600-0447.1978.tb06918.x; KAHAN J, 1984, SUICIDE LIFE-THREAT, V14, P17; KLATTE KM, 1981, PSYCHOL REP, V48, P82, DOI 10.2466/pr0.1981.48.1.82; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; Krishnan K R, 1992, J Am Paraplegia Soc, V15, P60; LEONARD HL, 1991, ARCH GEN PSYCHIAT, V48, P821; LUISELLI JK, 1989, BEHAV MODIF, V13, P65, DOI 10.1177/01454455890131004; Mailis A, 1996, PAIN, V64, P569, DOI 10.1016/0304-3959(95)00173-5; Manavbasi I, 2000, PLAST RECONSTR SURG, V106, P519, DOI 10.1097/00006534-200008000-00068; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; MARMOLYA G, 1989, SPINE, V14, P137, DOI 10.1097/00007632-198901000-00033; McCaffery M, 1999, PAIN CLIN MANUAL, P63; Morley DS, 2000, INT J NEUROSCI, V103, P139, DOI 10.3109/00207450009003260; Parrott HJ, 2001, INT J CLIN PRACT, V55, P317; PENNINGTON LA, 1945, AM J PSYCHIAT, V102, P241, DOI 10.1176/ajp.102.2.241; RICHARDS JS, 1980, PAIN, V8, P355, DOI 10.1016/0304-3959(80)90079-2; RICHARDS JS, 1986, ARCH PHYS MED REHAB, V67, P115; RICHARDS JS, 1982, ARCH PHYS MED REHAB, V63, P195; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; RINCOVER A, 1986, PSYCHIAT CLIN N AM, V9, P755; RONCHESE F, 1951, AMA ARCH DERM SYPH, V63, P565, DOI 10.1001/archderm.1951.01570050023003; ROSENTHAL TL, 1978, BEHAV RES THER, V16, P421, DOI 10.1016/0005-7967(78)90013-X; SINGER P, 1988, CUTIS, V42, P191; Taylor Steven, 2003, Cognitive Behaviour Therapy, V32, P13, DOI 10.1080/16506070310003639; TOSTI A, 1994, ACTA DERM-VENEREOL, V74, P206; Twohig MP, 2003, J CLIN PSYCHIAT, V64, P40, DOI 10.4088/JCP.v64n0109; Velazquez L, 2000, J AM ACAD CHILD PSY, V39, P812, DOI 10.1097/00004583-200007000-00009; Vogel LC, 2002, SPINAL CORD, V40, P666, DOI 10.1038/sj.sc.3101377; Wadden P, 1999, CAN J PSYCHIAT, V44, P709; WAISMAN M, 1965, POSTGRAD MED, V38, P620, DOI 10.1080/00325481.1965.11696846; WALDMAN BA, 1990, PEDIATR DERMATOL, V7, P189, DOI 10.1111/j.1525-1470.1990.tb00279.x; WALKER BA, 1977, J NERV MENT DIS, V164, P64, DOI 10.1097/00005053-197701000-00011; Wells JH, 1998, AUST NZ J PSYCHIAT, V32, P534, DOI 10.1046/j.1440-1614.1998.00448.x; WESTLING L, 1988, CRANIO, V6, P182, DOI 10.1080/08869634.1988.11678237	48	11	13	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.		2008	31	1					109	116		10.1080/10790268.2008.11753991			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	305FO	WOS:000256163400018	18533422	Green Published			2022-02-06	
J	Hachiya, NS; Kozuka, Y; Kaneko, K				Hachiya, Naomi S.; Kozuka, Yoshimichi; Kaneko, Kiyotoshi			Mechanical stress and formation of protein aggregates in neurodegenerative disorders	MEDICAL HYPOTHESES			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRINUCLEOTIDE CAG REPEAT; TRAUMATIC BRAIN-INJURY; HUNTINGTONS-DISEASE; PROFESSIONAL FOOTBALL; ALZHEIMERS-DISEASE; RISK; AGE; EXPANSION; SYNUCLEIN	Misfolded protein aggregates and inclusion bodies have been associated with various protein conformation disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and prion diseases including bovine spongiform encephalopathy (BSE). Models have been proposed as plausible explanations for the extension and progression of protein aggregates; however, little is known about the initiation process of protein aggregation, particularly in sporadic neurodegenerative diseases. Epidemiological data have suggested a tight association between sporadic neurodegenerative diseases and history of mechanical stresses such as trauma, head injury, and occupational exposures, including professional soccer and boxer's brain that carries histological hallmarks of AD/PD. Here, we propose that mechanical stress is an environmental factor that provokes a disturbance in cellular quality control systems and molecular chaperones that target misfolded proteins. This subsequently initiates protein aggregation and results in sporadic neurodegenerative disorders. Further, continuous and repetitive exposure to environmental mechanical stress, mostly in an unrecognized manner, is inevitable in daily life and thus, it functions as a potential driving force for protein aggregation. In this regard, a recent identification of the fact that an intracellular mechanosensor actually exists may support our notion. Reduction in the mechanical stress in combination with other conventional aspects should facilitate the development of rational therapeutics for these neurodegenerative disorders. (C) 2007 Elsevier Ltd. All rights reserved.	[Hachiya, Naomi S.; Kozuka, Yoshimichi; Kaneko, Kiyotoshi] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan		Kaneko, K (corresponding author), Tokyo Med Univ, Dept Neurophysiol, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	k-kaneko@tokyo-med.ac.jp					ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; DAVANIPOUR Z, 1985, NEUROLOGY, V35, P1483, DOI 10.1212/WNL.35.10.1483; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Goodwin Linda, 2006, J Insur Med, V38, P300; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Lutz Richard E, 2007, Semin Pediatr Neurol, V14, P26, DOI 10.1016/j.spen.2006.11.006; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Piazza O, 2004, CURR MED RES OPIN, V20, P505, DOI 10.1185/030079904125003296; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Squitieri F, 2006, EUR J NEUROL, V13, P408, DOI 10.1111/j.1468-1331.2006.01264.x; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; UITTI RJ, 1993, EUR NEUROL, V33, P6, DOI 10.1159/000118533; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Vanacore N, 2006, PARKINSONISM RELAT D, V12, P327, DOI 10.1016/j.parkreldis.2005.11.007; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9	29	11	11	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses		2008	70	5					1034	1037		10.1016/j.mehy.2007.06.043			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	295BU	WOS:000255450800026	17910993				2022-02-06	
J	Hough, MS				Hough, Monica Strauss			Word retrieval failure episodes after traumatic brain injury	APHASIOLOGY			English	Article							VERBAL IMPAIRMENT; ORGANIZATION; TONGUE; YOUNG; TIP	Background/Aims: The purpose of this investigation was to examine patterns of episodes of word retrieval failure in a group of adults who suffered traumatic brain injury (TBI). The Test of Adolescent/Adult Word Finding (German, 1990) was administered to 20 adults who experienced TBI as the result of motor vehicle accident. The tool provides extensive naming opportunities, varied naming tasks, and frequency of occurrence of stimulus items does not change throughout each task. Methods Procedures: Episodes of word retrieval failures were investigated relative to the occurrence of 1, 2, 3, and 4-plus consecutive word retrieval failures on the TAWF for participants who exhibited a word retrieval deficit (standard score below 85). Fourteen of the 20 participants had standard scores below this normal range. These participants were classified according to the three patterns (Fleeting, Clustered, Extended) developed by Hough (2007) regarding episodes of word retrieval failure. Main Contribution/Conclusions: Results revealed that most TBI participants who demonstrated a word retrieval deficit displayed primarily a Fleeting pattern (10) relative to word retrieval failure. A few participants exhibited an Extended retrieval pattern (4). Pattern of retrieval failure appeared to be related to severity of word retrieval deficit.	E Carolina Univ, Greenville, NC 27858 USA		Hough, MS (corresponding author), E Carolina Univ, Greenville, NC 27858 USA.	houghm@ecu.edu					ADAMOVICH B, 2005, APHASIA RELATED NEUR, P225; Adamovich B. B., 1992, SCALES COGNITIVE ABI; ADAMOVICH BB, 1990, FOLIA PHONIATR, V42, P11, DOI 10.1159/000266015; *AM SPEECH LANG HE, 1996, AM SPEECH HEAR ASS D, V4, P333; BARROW IM, 2003, J TRAUMA, V54, P1; Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; Burke DM, 1997, PHILOS T R SOC B, V352, P1845, DOI 10.1098/rstb.1997.0170; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Burke DM, 2000, DEBATES PSYCHOL, P204; BURKE DM, 2004, CURRENT DIRECTIONS P, V13, P20; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CAPRUSO DX, 2000, HEAD INJURY; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Caramazza A, 1998, NEUROCASE, V4, P265, DOI 10.1080/13554799808410627; CHIALANT D, 2002, HDB ADULT LANGUAGE D, P123; Dell GS, 1999, COGNITIVE SCI, V23, P517; German D. J., 1990, TEST ADOLESCENT ADUL; GILLIS R, 1996, TRAUMATIC BRAIN INJU; Goodglass Harold, 1993, UNDERSTANDING APHASI; GROHER ME, 1990, REHABILITATION ADULT, P148; Hagen C, 1981, TOP LANG DIS, V1, P73; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hough MS, 1997, BRAIN INJURY, V11, P801; Hough MS, 2006, J MED SPEECH-LANG PA, V14, P33; HOUGH MS, J MED SPEEC IN PRESS; Humphreys GW, 1999, PSYCHOL RES-PSYCH FO, V62, P118, DOI 10.1007/s004260050046; HUMPHREYS GW, 1988, COGNITIVE NEUROPSYCH, V5, P67, DOI 10.1080/02643298808252927; Kaplan E., 2001, ASSESSMENT APHASIA R; KENNEDY M, 1991, COMMUNICATION DISORD; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Rastle KG, 1996, J MEM LANG, V35, P586, DOI 10.1006/jmla.1996.0031; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Schuell H., 1974, APHASIA THEORY THERA; STEMBERGER JP, 2003, ENCY COGNITIVE SCI, P492; STEMBERGER JP, 1985, PROGR PSYCHOL LANGUA; YLSIVAKER M, 2001, LANGUAGE INTERVENTIO, P745; [No title captured]	42	11	11	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2008	22	6					644	654		10.1080/02687030701541024			11	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	318JH	WOS:000257086900004					2022-02-06	
J	Jacobs, ML; Donders, J				Jacobs, Monica L.; Donders, Jacobus			Performance discrepancies on the California Verbal Learning Test - Second Edition (CVLT-II) after traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						learning; memory; traumatic brain injury	RECALL DISCRIMINABILITY; MEMORY; INDEXES; UTILITY	One hundred fourteen patients with traumatic brain injury (TBI), selected from a 5-year series of consecutive rehabilitation referrals, completed the California Verbal Learning Test-Second Edition (CVLT-II) within 1 year after injury. Various performance contrasts (i.e., proactive interference, retroactive interference, rapid forgetting, and retrieval problems) were evaluated. Initial analyses revealed higher rates of rapid forgetting in the TBI group as compared to the standardization sample. Follow-up analyses between those patients with and without unusual degrees of rapid forgetting did not reveal any significant differences between these groups on demographic or neurological variables (p>0.10 for all variables). It is concluded that performance discrepancies on the CVLT-II should never be used in isolation to determine the presence or absence of acquired cerebral or memory impairment. However, regardless of the cause, such discrepancies may still be relevant for clinical treatment recommendations. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Jacobs, Monica L.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy S E, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Brooks BL, 2006, CLIN NEUROPSYCHOL, V20, P230, DOI 10.1080/13854040590947461; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELIS DC, 2000, CVLT 2 COMPREHENSIVE; Delis DC, 1987, CALIFORNIA VERBAL LE; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; Donders J, 2006, PSYCHOL ASSESSMENT, V18, P458, DOI 10.1037/1040-3590.18.4.458; Fiszdon JM, 2006, PSYCHIAT RES, V143, P159, DOI 10.1016/j.psychres.2005.09.012; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; McDonald CR, 2001, ARCH CLIN NEUROPSYCH, V16, P571, DOI 10.1016/S0887-6177(00)00068-8; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Smith RM, 2006, COGN BEHAV NEUROL, V19, P157, DOI 10.1097/01.wnn.0000213909.41901.cc; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	19	11	11	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2008	23	1					113	118		10.1016/j.acn.2007.09.003			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	259ET	WOS:000252922600009	17959354	Bronze			2022-02-06	
J	Leon-Carrion, J; Martin-Rodriguez, JF; Damas-Lopez, J; Martin, JMBY; Dominguez-Morales, MDR				Leon-Carrion, Jose; Martin-Rodriguez, Juan Francisco; Damas-Lopez, Jesus; Martin, Juan Manuel Barroso Y.; Dominguez-Morales, Maria Del Rosario			A QEEG index of level of functional dependence for people sustaining acquired brain injury: The Seville Independence Index (SINDI)	BRAIN INJURY			English	Article; Proceedings Paper	Annual Meeting Society-of-Applied-Neuroscience	SEP 13-19, 2006	Swansea, WALES	Soc Appl Neurosci		traumatic brain injury; stroke; functional independence; QEEG; neuropsychological assessment; forensic assessment	EEG COHERENCE; MRI; ELECTROENCEPHALOGRAPHY; RELIABILITY; STABILITY; MODEL; SCALE; POWER	Primary objective: To find an easy-to-use, valid and reliable tool for evaluating the level of functional dependence of an individual with brain damage who seeks a diagnosis of his/her functional dependence in daily activities. Methods: Eighty-one patients with acquired brain injury (ABI) in post-acute phase, 40 traumatic brain injury (TBI) and 41 cerebral vascular accident (CVA), were assessed using quantitative electroencephalography (QEEG) and grouped according to the FIM + FAM scale. Discriminant analysis was performed on QEEG variables to obtain a discriminant function with the best discriminative capacity between functionality groups. Results: Discriminant analysis showed classification accuracy of 100% in the training set sample and 75% in an external cross-validation sample; 100% sensitivity and 100% specificity were reached. Coherence measures were the most numerous variables in the function. Conclusions: These results point out that the discriminant function may be a useful tool in objective evaluations of patients seeking a diagnosis of their level of dependence and that it could be included in current functionality assessment protocols.	[Leon-Carrion, Jose; Martin-Rodriguez, Juan Francisco; Martin, Juan Manuel Barroso Y.] Univ Seville, Sch Psychol, Dept Expt Psychol, Human Neuropsychol Lab, Seville 41018, Spain; [Leon-Carrion, Jose; Martin-Rodriguez, Juan Francisco; Damas-Lopez, Jesus; Dominguez-Morales, Maria Del Rosario] Ctr Brain Injury Rehabil CRECER, Seville, Spain		Leon-Carrion, J (corresponding author), Univ Seville, Sch Psychol, Dept Expt Psychol, Human Neuropsychol Lab, C Camilo Jose Cela S-N, Seville 41018, Spain.	leoncarrion@us.es	Barroso y Martin, Juan Manuel/AAB-9758-2020	Martin Rodriguez, Juan Francisco/0000-0003-1392-8775			Arruda JE, 1996, INT J PSYCHOPHYSIOL, V23, P63, DOI 10.1016/0167-8760(96)00032-3; Broicolo A, 1973, J NEUROSURG SCI, V17, P278; CorsiCabrera M, 1997, ELECTROEN CLIN NEURO, V102, P248, DOI 10.1016/S0013-4694(96)95179-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DOODS TA, 1993, ARCH PHYS MED REHAB, V74, P531; Finnigan SP, 2004, STROKE, V35, P899, DOI 10.1161/01.STR.0000122622.73916.d2; Fuster JM, 2006, INT J PSYCHOPHYSIOL, V60, P125, DOI 10.1016/j.ijpsycho.2005.12.015; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hebb Donald O., 1949, ORG BEHAV, p[63, 70]; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; JENNETT B, 1975, LANCET, V1, P480; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LEONCARRION J, CLIN NEUROPHYSIOLOGY; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lubar JF, 1997, APPL PSYCHOPHYS BIOF, V22, P111, DOI 10.1023/A:1026276228832; LUND TR, 1995, PSYCHOPHYSIOLOGY, V32, P66, DOI 10.1111/j.1469-8986.1995.tb03407.x; Luria A. R., 1966, HUMAN BRAIN PSYCHOL; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Neumann N, 2004, BRAIN RES PROTOC, V14, P25, DOI 10.1016/j.brainresprot.2004.09.001; RUIJS MBM, 1994, NEUROPEDIATRICS, V25, P73, DOI 10.1055/s-2008-1071589; Srivastava G, 2005, NEUROIMAGE, V24, P50, DOI 10.1016/j.neuroimage.2004.09.041; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thornton K, 2003, ARCH CLIN NEUROPSYCH, V18, P363, DOI 10.1016/S0887-6177(02)00139-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	34	11	12	0	12	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	1					61	74		10.1080/02699050701824143			14	Neurosciences; Rehabilitation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	250QF	WOS:000252314400008	18183510				2022-02-06	
J	Morris, SL; Dodd, KJ; Morris, ME				Morris, Susan L.; Dodd, Karen J.; Morris, Meg E.			Reliability of dynamometry to quantify isometric strength following traumatic brain injury	BRAIN INJURY			English	Article						Reliability and validity; traumatic brain injury	HAND-HELD DYNAMOMETRY; TREADMILL WALKING; MUSCLE STRENGTH; STROKE PATIENTS; DISABILITY	Objective: To investigate the within-session reliability and test-re-test reliability of hand-held dynamometry (HHD) to quantify strength in hip flexors, quadriceps, plantarflexors and triceps brachii following traumatic brain injury (TBI). Design: Within-session reliability was examined across six consecutive trials of HHD. Test-re-test reliability was examined between two sessions separated by 7 days. Setting: Private physical therapy practice, Melbourne, Australia. Participants: Ten adults with TBI with a mean age of 32.5 years (range = 19-63, SD = 12.8) and mean time after injury of 12.2 years (range = 2.3-26, SD = 8.6). Main outcome measures: Isometric strength measured by HHD. Results: Test-re-test reliability of HHD following TBI was good when repeated tests occurred within a single session. Within a session, the first trial was the most variable out of the six examined. Of the four muscles examined, re-test measures of strength for the quadriceps, plantarflexors and triceps were the most reliable. For the hip flexors an increase greater than 3.1 kg (28%) was needed before real change could be detected. Test-re-test reliability was higher for muscles tested on the more affected side (ICC(2,1) = 0.55-0.93) than muscles tested on the less affected side (ICC(2,1) = 0.09-0.86). Conclusions: To gain a representative measure of isometric strength using HHD in a single session, three trials are recommended. The first is for familiarization and trials 2 and 3 are averaged to provide a typical measure of isometric muscle strength. Further research needs to occur but alternative methods to quantify muscle strength might be needed if repeated measures are to be performed over a 7-day interval.	[Morris, Susan L.] Private Neurol Physiotherapy Practice, Melbourne, Vic, Australia; [Morris, Susan L.; Dodd, Karen J.] La Trobe Univ, Musculoskeletal Res Ctr, Melbourne, Vic, Australia; [Morris, Susan L.; Dodd, Karen J.] La Trobe Univ, Sch Physiotherapy, Melbourne, Vic, Australia; [Morris, Meg E.] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic 3010, Australia		Morris, SL (corresponding author), POB 308, Warrandyte, Vic 3113, Australia.	sjaj@people.net.au		Morris, Meg/0000-0002-0114-4175	La Trobe University	This research was partially supported by a Faculty Research Grant, Faculty of Health Sciences, La Trobe University.; I certify that all financial and material support for this research and work are clearly identified in the title page attached to the manuscript.	*ACSM, 2000, ACSM GUID EX TEST PR; AGRE JC, 1987, ARCH PHYS MED REHAB, V68, P454; Altman D.G., 1990, PRACTICAL STAT MED R; ANDREWS AW, 1991, J HUM MUSCLE PERFORM, V1, P35; Badics E, 2002, NEUROREHABILITATION, V17, P211; Bohannon RW, 1997, J NEUROL REHABIL, V11, P115; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; BOHANNON RW, 1987, CLIN BIOMECH, V2, P74, DOI 10.1016/0268-0033(87)90131-8; BOHANNON RW, 1990, CLIN PHYS PHYSIOL M, V11, P217, DOI 10.1088/0143-0815/11/3/004; Bohannon RW, 1987, CLIN REHABIL, V1, P5; Canning CG, 2004, CLIN REHABIL, V18, P300, DOI 10.1191/0269215504cr715oa; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P322, DOI 10.1053/apmr.2002.29622; Giuliani C, 1995, NEUROLOGY REPORT, V19, P29; GOLDIE PA, 1990, PHYS THER, V70, P234, DOI 10.1093/ptj/70.4.234; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Matsas A, 2000, GAIT POSTURE, V11, P46, DOI 10.1016/S0966-6362(99)00048-X; Mercier C, 2004, CLIN REHABIL, V18, P215, DOI 10.1191/0269215504cr724oa; Merlini L, 2002, MUSCLE NERVE, V26, P64, DOI 10.1002/mus.10166; MYSIW W J, 1990, Brain Injury, V4, P247, DOI 10.3109/02699059009026174; OLNEY SJ, 1991, ARCH PHYS MED REHAB, V72, P309; Pallant J., 2001, SPSS SURVIVAL MANUAL; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; RICHARDSON J, 1997, PHYSIOTHERAPY THEORY, V79, P369; Richardson Julie, 1998, Physiotherapy Theory and Practice, V14, P49, DOI 10.3109/09593989809070043; RIDDLE DL, 1989, PHYS THER, V69, P182, DOI 10.1093/ptj/69.3.182; Shepherd Roberta B., 2001, Neural Plasticity, V8, P121, DOI 10.1155/NP.2001.121; STRATFORD P W, 1992, Physiotherapy Canada, V44, P14; STUBERG WA, 1988, PHYS THER, V68, P977, DOI 10.1093/ptj/68.6.977; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Wass E, 2005, GAIT POSTURE, V21, P72, DOI 10.1016/j.gaitpost.2004.01.003; Weiss A, 2000, AM J PHYS MED REHAB, V79, P369, DOI 10.1097/00002060-200007000-00009; WHITELY J, 1962, RES QUART, V34, P248; WIKHOLM J B, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P191; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	35	11	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	13-14					1030	1037	PII 907311794	10.1080/02699050802533775			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	389ZM	WOS:000262134100007	19117182				2022-02-06	
J	Pasternak, JJ; Hertzfeldt, DN; Stanger, SR; Walter, KR; Werts, TD; Marienau, MES; Lanier, WL				Pasternak, Jeffrey J.; Hertzfeldt, Dana N.; Stanger, Sharm R.; Walter, Kirsten R.; Werts, Travis D.; Marienau, Mary E. S.; Lanier, William L.			Disseminated intravascular coagulation after craniotomy	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						disseminated intravascular coagulation; crarnotomy; bleeding; traumatic head injury	AUTOLOGOUS BLOOD-TRANSFUSION; MODEL	Disseminated intravascular coagulation (DIC) is reported in neurosuraical patients; however, the incidence of DIC after craniotomy procedures is unknown. Using a surgical database, we identified 3164 patients who underwent primary craniotomy at Mayo Clinic Rochester between January 1, 2000 and December 31, 2004. Potential cases of DIC in this population were identified using 3 search triggers, patients: (1) in whom the diagnosis of DIC was noted on their hospital discharge summary, (2) who received red blood cell-free blood products, or (3) in whom a blood fibrinogen or d-dimer concentration was assessed. Using criteria based on laboratory values, we estimated the incidence of DIC developing within 72 hours of primary craniotomy to be between 13 and 44 per 10,000 patients. Despite a low incidence of DIC, the associated mortality rate was 43% to 75%. Traumatic head injury was a significant risk factor for the development of DIC [odds ratio of trauma was in the range of 16 (95% confidence interval (Cl) = 5.3-49) to 29 (Cl = 4.0-204)]. Autologous salvaged blood was administered intraoperatively to 44 patients, and I of these developed DIC. Although this small sample of patients receiving salvaged blood requires caution in interpreting the results, the risk of DIC seemed to be greater with salvaged blood than without [odds ratio 24 (Cl = 2.5-237)]. In children, 2 of 3 patients who developed DIC had congenital malformations of the brain. Findings from this study suggest that DIC is rare after craniotomy, but is often associated with mortality.	[Pasternak, Jeffrey J.] Mayo Clin, Dept Anesthesiol, Coll Med, Rochester, MN 55905 USA; Mayo Clin, Dept Anesthesiol, Sch Hlth Related Sci, Rochester, MN 55905 USA		Pasternak, JJ (corresponding author), Mayo Clin, Dept Anesthesiol, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	pasternak.jeffrey@mayo.edu					Amanor-Boadu S D, 2002, Afr J Med Med Sci, V31, P79; Cataldi S, 1997, NEUROSURGERY, V40, P765, DOI 10.1097/00006123-199704000-00021; CLARK JA, 1980, J NEUROSURG, V52, P266, DOI 10.3171/jns.1980.52.2.0266; GREENBERG RS, 1993, MED EPIDEMIOLOGY, P139; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; Kinasewitz GT, 2005, CRIT CARE MED, V33, P2214, DOI 10.1097/01.CCM.0000181296.53204.DE; Levi M, 2005, CRIT CARE CLIN, V21, P449, DOI 10.1016/j.ccc.2005.02.001; Pathak A, 2005, Neurol India, V53, P178; PATTISAPU JV, 1990, NEUROSURGERY, V27, P549, DOI 10.1227/00006123-199010000-00008; SAWAYA R, 1983, NEUROSURGERY, V12, P580, DOI 10.1227/00006123-198305000-00020; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Uemura T, 2001, J CRANIOFAC SURG, V12, P479, DOI 10.1097/00001665-200109000-00015	12	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2008	20	1					15	20		10.1097/ANA.0b013e318155b1c4			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	247VB	WOS:000252109600003	18157020				2022-02-06	
J	van de Nes, JAP; Bajanowski, T; Trubner, K				van de Nes, J. A. P.; Bajanowski, T.; Truebner, K.			Fibromuscular dysplasia of the basilar artery: An unusual case with medico-legal implications	FORENSIC SCIENCE INTERNATIONAL			English	Article						fibromuscular dysplasia; histopathology; occipital condyle fracture; traffic accident; traumatic subarachnoid hemorrhage	TRAUMATIC SUBARACHNOID HEMORRHAGE; SUDDEN NATURAL DEATH; OF-THE-LITERATURE; AUTOPSY VERIFICATION; DISEASE; INJURIES; BRAIN; WHEEL	A 28-year-old male car driver was reported to suddenly loose the control over his vehicle, to hit the right and middle crash barrier, and to be unconscious as the car came to a halt in a position at right angles to the road. The car was hit in its left side by an automobile with high velocity, and the 28-year-old driver died. Examination of the brain revealed a massive isolated basal subarachnoid hemorrhage and a complete tearing of the basilar artery. A macroscopically detectable aneurysm was not found. However, histological examination of the large arteries at the base of the brain showed (i) fibromuscular dysplasia (FMD) mostly involving the basilar artery (ii) with a ruptured micro-aneurysm in its upper third part. The observations of the eye witnesses that the driver initially lost control over his car were judged in favour of the accused to be due to that rupture of the micro-aneurysm, while complete transverse tearing of the basilar artery occurred during the car crash due to hyperextension and rotation of his neck. Intracranial FMD is a rare cause in the differential diagnosis of isolated basal subarachnoid hemorrhage. The medico-legal implications of this entity are described in the presented case. (C) 2007 Elsevier Ireland Ltd. All rights reserved.	Univ Hosp Essen, Dept Pathol & Neuropathol, D-45122 Essen, Germany; Univ Hosp Essen, Dept Legal Med, Essen, Germany		van de Nes, JAP (corresponding author), Univ Hosp Essen, Dept Pathol & Neuropathol, Hufelandstr 55, D-45122 Essen, Germany.	johannes.van.de.nes@uni-essen.de					ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; Arunodaya GR, 1997, NEUROLOGY, V48, P1605, DOI 10.1212/WNL.48.6.1605; Aulino JM, 2005, EMERG RADIOL, V11, P342, DOI 10.1007/s10140-005-0425-0; Black M, 2002, J CLIN PATHOL, V55, P44, DOI 10.1136/jcp.55.1.44; Bunai Y, 2000, AM J FOREN MED PATH, V21, P343, DOI 10.1097/00000433-200012000-00009; Buttner A, 1999, FORENSIC SCI INT, V103, P101, DOI 10.1016/S0379-0738(99)00063-8; CONTOSTAVLOS DL, 1995, FORENSIC SCI INT, V73, P61, DOI 10.1016/0379-0738(95)01700-3; DOWLING G, 1988, AM J FOREN MED PATH, V9, P23, DOI 10.1097/00000433-198803000-00007; Eachempati SR, 1998, J TRAUMA, V44, P406, DOI 10.1097/00005373-199802000-00035; FURIE DM, 1995, AM J ROENTGENOL, V164, P1205; Gray JT, 1999, FORENSIC SCI INT, V105, P13, DOI 10.1016/S0379-0738(99)00113-9; HARRISON EG, 1971, MAYO CLIN PROC, V46, P161; HEGEDUS K, 1984, ARCH NEUROL-CHICAGO, V41, P440, DOI 10.1001/archneur.1984.04050160106024; HILL LD, 1965, ARCH SURG-CHICAGO, V90, P585; Hiraiwa K, 2005, NEUROL MED-CHIR, V45, P549, DOI 10.2176/nmc.45.549; HIRSCH CS, 1975, HUM PATHOL, V6, P749, DOI 10.1016/S0046-8177(75)80084-0; HOUSER OW, 1971, RADIOLOGY, V101, P606; KRAULAND W, 1981, Z RECHTSMED, V87, P1; LUSCHER TF, 1987, MAYO CLIN PROC, V62, P931; LUSCHER TF, 1986, NEPHRON, V44, P109, DOI 10.1159/000184059; METTINGER KL, 1982, STROKE, V13, P53, DOI 10.1161/01.STR.13.1.53; METTINGER KL, 1982, STROKE, V13, P46, DOI 10.1161/01.STR.13.1.46; OSTROM M, 1987, J FORENSIC SCI, V32, P988; RINALDI I, 1976, STROKE, V7, P511, DOI 10.1161/01.STR.7.5.511; Sato Y, 1997, AM J FOREN MED PATH, V18, P129, DOI 10.1097/00000433-199706000-00004; SCHMIDT P, 1990, FORENSIC SCI INT, V48, P155, DOI 10.1016/0379-0738(90)90108-B; SIMONSEN J, 1984, FORENSIC SCI INT, V24, P57, DOI 10.1016/0379-0738(84)90152-X; Slovut DP, 2004, NEW ENGL J MED, V350, P1862, DOI 10.1056/NEJMra032393; STANLEY JC, 1975, ARCH SURG-CHICAGO, V110, P561; TATSUNO Y, 1974, ARCH PATHOL, V97, P211	30	11	12	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	DEC 20	2007	173	2-3					188	192		10.1016/j.forsciint.2007.02.016			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	233FO	WOS:000251076000018	17383130				2022-02-06	
J	Brinar, VV; Habek, M; Ozretic, D; Djakovic, V; Matijevic, V				Brinar, Vesna V.; Habek, Mario; Ozretic, David; Djakovic, Visnja; Matijevic, Vesna			Isolated nontraumatic abducens nerve palsy	ACTA NEUROLOGICA BELGICA			English	Article						abducens nerve; palsy; traumatic; nontraumatic	NASOPHARYNGEAL CARCINOMA; PETROUS APICITIS; PARALYSIS; PROGNOSIS	Introduction : Abducens nerve palsy (ANP) is the most common isolated palsy. The injury of the abducens nerve can occur anywhere along its long course, so differential diagnosis of ANP occasionally demands thorough investigation to find the proper cause. Patients : Ten patients with isolated ANP are presented. The causes included nasopharyngeal carcinoma, diabetes, cholesteatoma of the inner ear, carotid-cavernous fistula, subarachnoid bleeding, hydrocephalus, toxic ANP, multiple sclerosis, clinically isolated syndrome suggestive of multiple sclerosis, and Tolosa-Hunt syndrome. Discussion : Based on the cases presented and review of the literature, we argue that every patient with isolated nontraumatic ANP requires brain MRI as an initial diagnostic tool. If this finding remains inconclusive, additional tests including angiography and CSF examination should be performed.	Univ Zagreb, Zagreb Univ Hosp Ctr, Univ Dept Neurol, HR-10000 Zagreb, Croatia; [Ozretic, David] Univ Zagreb, Zagreb Sch Med, Dept Radiol, Zagreb, Croatia; [Ozretic, David] Univ Zagreb, Univ Hosp Ctr, Zagreb, Croatia; [Brinar, Vesna V.; Habek, Mario; Djakovic, Visnja; Matijevic, Vesna] Univ Zagreb, Zagreb Sch Med, Univ Dept Neurol, Referral Ctr Demyelinating Dis Cent Nervous Syst, Zagreb, Croatia		Habek, M (corresponding author), Univ Zagreb, Zagreb Univ Hosp Ctr, Univ Dept Neurol, Kispaticeva 12, HR-10000 Zagreb, Croatia.	mhabek@mef.hr					Alioglu Z, 1999, J NEURORADIOLOGY, V26, P68; Atilla H, 2000, ACTA NEUROL BELG, V100, P246; Barr D, 2000, J NEUROL, V247, P701, DOI 10.1007/s004150070114; Bendszus M, 2001, NEURORADIOLOGY, V43, P742, DOI 10.1007/s002340100572; Chan JW, 2003, NEUROLOGY, V61, P1417, DOI 10.1212/01.WNL.0000090567.33686.A3; CHOLE RA, 1983, ANN OTO RHINOL LARYN, V92, P544, DOI 10.1177/000348948309200603; Durkin SR, 2006, OPHTHALMOLOGY, V113, P2108, DOI 10.1016/j.ophtha.2006.06.026; Holmes J M, 1998, J AAPOS, V2, P265, DOI 10.1016/S1091-8531(98)90081-7; Holmes JM, 2001, OPHTHALMOLOGY, V108, P1457, DOI 10.1016/S0161-6420(01)00633-9; Ilhan O, 2002, EUR J OPHTHALMOL, V12, P55, DOI 10.1177/112067210201200111; Iwasaki M, 2006, SURG NEUROL, V65, P516, DOI 10.1016/j.surneu.2005.06.044; Kawase Takeshi, 1996, Neurologia Medico-Chirurgica, V36, P1, DOI 10.2176/nmc.36.1; KEANE JR, 1976, ARCH NEUROL-CHICAGO, V33, P681, DOI 10.1001/archneur.1976.00500100015007; Lee MS, 1999, PEDIATR NEUROL, V20, P49, DOI 10.1016/S0887-8994(98)00090-3; Mak W, 1999, CLIN NEUROL NEUROSUR, V101, P111, DOI 10.1016/S0303-8467(99)00006-2; Malloy Kelly A, 2007, Optometry, V78, P55, DOI 10.1016/j.optm.2006.08.015; Marzo S J, 2001, Ear Nose Throat J, V80, P869; Paik JW, 2004, EUR NEUROL, V52, P254, DOI 10.1159/000082373; Patel SV, 2004, OPHTHALMOLOGY, V111, P369, DOI 10.1016/j.ophtha.2003.05.024; Peters GB, 2002, OPHTHALMOLOGY, V109, P1925, DOI 10.1016/S0161-6420(02)01226-5; Price T, 2002, J LARYNGOL OTOL, V116, P726, DOI 10.1258/002221502760238055; RICHARDS BW, 1992, AM J OPHTHALMOL, V113, P489, DOI 10.1016/S0002-9394(14)74718-X	22	11	12	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	DEC	2007	107	4					126	130					5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281RL	WOS:000254516300008	18416288				2022-02-06	
J	Fins, JJ; Shapiro, ZE				Fins, Joseph J.; Shapiro, Zachary E.			Neuroimaging and neuroethics: clinical and policy considerations	CURRENT OPINION IN NEUROLOGY			English	Article						anoxic brain injury; diffusion tensor imaging; functional MRI; minimally conscious state; traumatic brain injury; vegetative state	MINIMALLY CONSCIOUS STATE; PERSISTENT VEGETATIVE STATE; LATE RECOVERY; DISORDERS; DIAGNOSIS	Purpose of review Neuroimaging is providing a window on severe brain injury and mechanisms of recovery in patients with consciousness disorders. This brief essay will consider the ethical implications of these developments for clinical diagnosis, emerging therapeutics and health policy. Recent findings Over the past year, functional imaging has led to two dramatic findings with the potential to alter how clinicians categorize severe brain injury and understand mechanisms of recovery. One paper reported a neuroimaging response in a patient who was behaviorally in the vegetative state. Another described structural changes in a patient with late emergence from the minimally conscious state. Summary Research into functional imaging and disorders of consciousness have the potential to elucidate mechanisms of brain recovery and refine their diagnostic nosology. These distinctions are becoming increasingly important given the potential of emerging therapeutic approaches to the minimally conscious state. Despite this promise the refinement of descriptive categories such as the vegetative and minimally conscious states is not without some degree of peril. Investigators and clinicians need to appreciate the uncertainty that will be engendered as diagnostic categories are redrawn and resist the premature dissemination of neuroimaging technology before its ethical implications for clinical practice are well understood.	New York Prebyterian Weill Cornell Med Ctr, Profess Med & Profeess Publ Hlth, Div Med Eth, New York, NY 10021 USA; Brown Univ, Providence, RI 02912 USA		Fins, JJ (corresponding author), New York Prebyterian Weill Cornell Med Ctr, Profess Med & Profeess Publ Hlth, Div Med Eth, 435 E 70th Str, Suite 4-J, New York, NY 10021 USA.	jjfins@med.cornell.edu		Fins, Joseph/0000-0002-7221-0053			Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annas George J, 1996, Duquesne Law Rev, V34, P875; [Anonymous], 1968, JAMA, V205, P337; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Berube J, 2006, MOHONK REPORT REPORT; Cantor NL, 2001, J LAW MED ETHICS, V29, P182; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; CRANFORD RE, 1994, J AM GERIATR SOC, V42, P894, DOI 10.1111/j.1532-5415.1994.tb06567.x; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Fins JJ, 2005, PROG BRAIN RES, V150, P565, DOI 10.1016/S0079-6123(05)50040-2; Fins JJ, 2005, AM J BIOETHICS, V5, P56, DOI 10.1080/15265160590960951; Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.2307/3527759; FINS JJ, 2006, PALLATIVE ETHICS CAR; FINS JJ, 2004, SUPPORT PALL CARE, V4, P169; Fins JJ, 2006, HASTINGS CENT REP, V36, P8, DOI 10.1353/hcr.2006.0094; Fins JJ, 2007, AM J BIOETHICS, V7, P51, DOI 10.1080/15265160601064231; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hirsch J, 2005, PROG BRAIN RES, V150, P25, DOI 10.1016/S0079-61239(05)50003-7; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 2002, VEG STAT; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Menon DK, 1998, LANCET, V352, P1148, DOI 10.1016/S0140-6736(05)79795-6; Naccache L, 2006, SCIENCE, V313, P1395, DOI 10.1126/science.1132881; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1981, DEF DEATH MED LEG ET; Schiff N, 1999, J COGNITIVE NEUROSCI, V11, P650, DOI 10.1162/089892999563715; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; SCHIFF ND, 2003, CEREBRUM, V5, P7; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wilson FC, 2002, NEUROREHABILITATION, V17, P231	39	11	11	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2007	20	6					650	654		10.1097/WCO.0b013e3282f11f6d			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	235BU	WOS:000251209300008	17992084				2022-02-06	
J	Fujimoto, C; Ito, K; Takano, S; Karino, S; Iwasaki, S				Fujimoto, Chisato; Ito, Ken; Takano, Shingo; Karino, Shotaro; Iwasaki, Shinichi			Successful cochlear implantation in a patient with bilateral progressive sensorineural hearing loss after traumatic subarachnoid Hemorrhage and brain contusion	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article						bilateral progressive sensorineural hearing loss; brain contusion; cochlear implantation; head trauma; subarachnoid hemorrhage	CENTRAL-NERVOUS-SYSTEM; SUPERFICIAL SIDEROSIS; INTRACRANIAL HYPOTENSION	Objectives: We address the proper indications for cochlear implantation for profound deafness with possible retrocochlear involvement by reporting successful implantation in a patient with traumatic subarachnoid hemorrhage and brain contusion. Methods: We present a patient (55-year-old man) who had bilateral progressive sensorineural hearing loss after traumatic subarachnoid hemorrhage and brain contusion. Preoperative imaging and functional studies were done, as well as routine tests, to evaluate the possible performance of the cochlear implant. Results: Sensorineural hearing loss developed promptly after head trauma with progressive deterioration. The cause of progressive sensorineural hearing loss remained unknown. Distortion product otoacoustic emissions demonstrated bilateral inner ear (outer hair cell) damage. Highly impaired speech discrimination despite less marked pure tone average elevation and a focal lesion in the left middle temporal gyrus suggested the possibility of coexisting retrocochlear lesions. After thorough discussion of the possible outcomes, cochlear implantation was successfully performed 25 months after the trauma. The patient became able to use a telephone. Conclusions: We advocate that profound bilateral sensorineural hearing loss caused by traumatic head injury, even with possible involvement of central auditory pathways, should not be regarded as a contraindication to cochlear implantation, as long as bilateral inner ear dysfunction is clearly demonstrated and there is no obvious evidence of central deafness.	[Fujimoto, Chisato; Ito, Ken; Takano, Shingo; Karino, Shotaro; Iwasaki, Shinichi] Univ Tokyo, Fac Med, Dept Otolaryngol, Tokyo, Japan		Ito, K (corresponding author), Univ Tokyo, Fac Med, Dept Otolaryngol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Bergemalm PO, 2003, ACTA OTO-LARYNGOL, V123, P836, DOI 10.1080/00016480310002474; COLIGADO EJ, 1993, ARCH PHYS MED REHAB, V74, P653, DOI 10.1016/0003-9993(93)90166-8; Dhooge IJM, 2002, OTOL NEUROTOL, V23, P468, DOI 10.1097/00129492-200207000-00013; FEARNLEY JM, 1995, BRAIN, V118, P1051, DOI 10.1093/brain/118.4.1051; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; JERGER J, 1960, J SPEECH HEAR RES, V3, P275, DOI 10.1044/jshr.0303.275; Kale SU, 2003, OTOL NEUROTOL, V24, P90, DOI 10.1097/00129492-200301000-00019; Maas S, 1996, J LARYNGOL OTOL, V110, P881, DOI 10.1017/S0022215100135236; Moore A, 1999, J LARYNGOL OTOL, V113, P34, DOI 10.1017/S0022215100146079; Nikolopoulos TP, 2004, INT J PEDIATR OTORHI, V68, P127, DOI 10.1016/j.ijporl.2003.09.019; Portier F, 2002, ANN OTO RHINOL LARYN, V111, P817, DOI 10.1177/000348940211100910; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Vibert D, 2004, AM J OTOLARYNG, V25, P142, DOI 10.1016/j.amjoto.2003.10.001; Weekamp HH, 2003, OTOL NEUROTOL, V24, P738, DOI 10.1097/00129492-200309000-00008	14	11	11	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-4894	1943-572X		ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.	DEC	2007	116	12					897	901		10.1177/000348940711601205			5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	243VI	WOS:000251825000007	18217508				2022-02-06	
J	Galanaud, D; Naccache, L; Puybasset, L				Galanaud, Damien; Naccache, Lionel; Puybasset, Louis			Exploring impaired consciousness: the MRI approach	CURRENT OPINION IN NEUROLOGY			English	Article						brain; functional MRI; imaging-traumatic; injury-anoxia; spectroscopy-diffusion; tensor	MAGNETIC-RESONANCE; OWN NAME; ARCHITECTURE; AWARENESS; RECOVERY; PATIENT	Purpose of review To summarize the application of advanced MRI sequences such as magnetic resonance spectroscopy, diffusion tensor imaging and functional MRI for the evaluation of patients with altered consciousness. Recent findings Magnetic resonance spectroscopy, volumetry and diffusion tensor imaging have shown promising results in the evaluation of traumatic or anoxo-ischaemic brain lesions and can detect damage of the brainstem, basal ganglia and white matter tracts not visible on conventional sequences. A diffusion tensor imaging study has raised the possibility of detecting ongoing axonal regrowth many years after the initial injury in minimally conscious patients. Functional MRI studies have shown that a high level of brain activities, such as recognizing one's own name or imagining playing tennis, can be preserved in vegetative patients. Summary The development of quantitative imaging could lead to a more objective evaluation of the extent of destruction or preservation of critical brain areas at the acute phase of brain injury, which could be integrated in multi-parametric decisional strategies for these patients. Functional imaging could help define borders between the various levels of altered consciousness and detect the presence of cryptic residual functions in vegetative or minimally conscious patients. This approach could eventually help determine the neurological outcome and make individual blueprints of the preserved brain activities in severely brain injured patients.	Univ Paris 06, Pitie Salpetriere Hosp, Dept Neuroradiol, Paris, France; Univ Paris 06, Pitie Salpetriere Hosp, Dept Clin Neurophysiol, Paris, France; Univ Paris 06, Pitie Salpetriere Hosp, Dept Neurosurg Intens Care Unit, Paris, France		Galanaud, D (corresponding author), Univ Paris 06, Pitie Salpetriere Hosp, APHP, Dept Neuroradiol, 47 Blvd Hop, F-75013 Paris, France.	galanaud@dat.org		naccache, lionel/0000-0002-2874-1009			Ammermann H, 2007, J NEUROL SCI, V260, P65, DOI 10.1016/j.jns.2007.03.026; Bernat JL, 2007, NEUROLOGY, V68, P885, DOI 10.1212/01.wnl.0000258973.95355.68; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Gasser T, 2005, NEUROSURGERY, V57, P94, DOI 10.1227/01.NEU.0000163488.91335.C5; Hopkin M, 2006, NATURE, V443, P132, DOI 10.1038/443132b; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Marcar VL, 2006, AM J NEURORADIOL, V27, P799; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Naccache L, 2006, SCIENCE, V313, P1395, DOI 10.1126/science.1132881; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Siva N, 2006, LANCET NEUROL, V5, P906, DOI 10.1016/S1474-4422(06)70592-0; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wang SM, 2007, ANESTH ANALG, V105, P499, DOI 10.1213/01.ane.0000270216.71234.f5; 2006, NATURE, V443, P121	24	11	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2007	20	6					627	631		10.1097/WCO.0b013e3282f169ec			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	235BU	WOS:000251209300004	17992080				2022-02-06	
J	Is, M; Coskun, A; Sanus, GZ; Tanriverdi, T; Kafadar, AM; Hanimoglu, H; Tanriover, N; Gezen, F; Uzan, M				Is, Merih; Coskun, Abdurrahman; Sanus, Galip Zihni; Tanriverdi, Taner; Kafadar, Ali Metin; Hanimoglu, Hakan; Tanriover, Necmettin; Gezen, Ferruh; Uzan, Mustafa			High-sensitivity C-reactive protein levels in cerebrospinal fluid and serum in severe head injury: Relationship to tumor necrosis factor-alpha and interleukin-6	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						hsCRP; IL-6; inflammation; severe head injury; TNF-alpha	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CENTRAL-NERVOUS-SYSTEM; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RISK MARKER; TNF-ALPHA; CYTOKINES; MEDIATOR; IL-6	Recent studies have demonstrated the role of high-sensitivity C-reactive protein (hsCRP) in inflammatory diseases; however, it is unclear whether this molecule has a role after severe head injury (SHI). Our aim was to evaluate the levels of hsCRP in both cerebrospinal fluid (CSF) and serum from patients after SHI. The study focused on 11 patients with SHI and evaluated CSF and serum levels of hsCRP, tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in a 10-day period following the head trauma. The values were compared with those from nine control patients, who had normal pressure hydrocephalus. In the CSF and serum of the patients after SHI HsCRP was found to be significantly higher, at all times, than in the controls; TNF-alpha and IL-6 levels were also higher in these patients. However, hsCRP levels did not correlate with either TNF-alpha or IL-6. TNF-alpha and IL-6 increased during the period immediately following the SHI and intrathecal levels were always higher than those of the serum. This study demonstrates for the first time that hsCRP reaches high levels in both CSF and serum in patients with SHI, and it may therefore be used as an inflammatory index. This finding suggests a need for further studies in this area, which are larger in scope than the present study. (c) 2007 Elsevier Ltd. All rights reserved.	[Is, Merih; Gezen, Ferruh] Abant Izzet Baysal Univ, Duzce Med Fac, Dept Neurosurg, Duzce, Turkey; [Coskun, Abdurrahman] Abant Izzet Baysal Univ, Duzce Med Fac, Dept Clin Biochem, Duzce, Turkey; [Sanus, Galip Zihni; Tanriverdi, Taner; Kafadar, Ali Metin; Hanimoglu, Hakan; Tanriover, Necmettin; Uzan, Mustafa] Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey		Tanriverdi, T (corresponding author), PK 5 Cerrahpasa, TR-34301 Istanbul, Turkey.	tanerato2000@yahoo.com	Coskun, Abdurrahman/C-3906-2015; Uzan, Mustafa/D-6571-2019; Tanriverdi, Taner/C-9003-2019; Sanus, Galip Zihni/D-6715-2019; Kafadar, Ali/AAH-9387-2019; Ulu, Mustafa Onur/D-6484-2019; Tanriover, Necmettin/AAD-3212-2020	Coskun, Abdurrahman/0000-0002-1273-0604; Kafadar, Ali/0000-0002-3312-3192; Ulu, Mustafa Onur/0000-0002-6256-0869; Uzan, Mustafa/0000-0001-7214-380X; Sanus, Galip Zihni/0000-0001-6539-7254; Tanriover, Necmettin/0000-0001-7628-9443			Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Bickel C, 2002, AM J CARDIOL, V89, P901, DOI 10.1016/S0002-9149(02)02236-1; Blake GJ, 2003, AM J PHYSIOL-REG I, V285, pR1250, DOI 10.1152/ajpregu.00227.2003; Byl Baudouin, 1997, Clin Microbiol Infect, V3, P306, DOI 10.1111/j.1469-0691.1997.tb00618.x; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Chang CY, 2005, NUTRITION, V21, P987, DOI 10.1016/j.nut.2005.02.010; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; GANAPATHI MK, 1991, J IMMUNOL, V147, P1261; Gerdes LU, 1998, SCAND J CLIN LAB INV, V58, P383, DOI 10.1080/00365519850186364; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hans VHJ, 1999, NEUROREPORT, V10, P409; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hoshi T, 2005, STROKE, V36, P768, DOI 10.1161/01.STR.0000158915.28329.51; JENNETT B, 1993, J NEUROL NEUROSUR PS, V60, P5; Jialal I, 2004, HYPERTENSION, V44, P6, DOI 10.1161/01.HYP.0000130484.20501.df; Jialal I, 2001, Am J Clin Pathol, V116 Suppl, pS108; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Libby Peter, 2004, Am J Med, V116 Suppl 6A, p9S; MACKIEWICZ A, 1991, J IMMUNOL, V146, P3032; Marquardt L, 2005, J NEUROL SCI, V236, P65, DOI 10.1016/j.jns.2005.05.006; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Tamam Y, 2005, TOHOKU J EXP MED, V206, P91, DOI 10.1620/tjem.206.91; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Vainas T, 2005, J VASC SURG, V42, P243, DOI 10.1016/j.jvs.2005.03.060; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	37	11	12	0	4	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2007	14	12					1163	1171		10.1016/j.jocn.2006.05.020			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241HK	WOS:000251647300005	17884503				2022-02-06	
J	Mueller, CA; Schluesener, HJ; Fauser, U; Conrad, S; Schwab, JM				Mueller, C. A.; Schluesener, H. J.; Fauser, U.; Conrad, S.; Schwab, J. M.			Lesional expression of the endogenous angiogenesis inhibitor endostatin/collagen XVIII following traumatic brain injury (TBI)	EXPERIMENTAL NEUROLOGY			English	Article						CNS injury; vascular remodelling; antiangiogenesis	ENDOTHELIAL GROWTH-FACTOR; SPINAL-CORD-INJURY; INFLAMMATORY RESPONSE; MICROGLIAL CELLS; RAT-BRAIN; VASCULAR ARCHITECTURE; CEREBRAL-ISCHEMIA; BARRIER BREAKDOWN; COLLAGEN-XVIII; ALPHA-1 CHAIN	We have analysed the expression of the endogenous angiogenesis inhibitor endostatin/collagen XVIII following stab wound injury and observed a highly significant (p < 0.0001) lesional accumulation confined to areas of pan-necrotic injury and developing secondary damage. Maximal cell numbers were detected at Day 14, declining until Day 21 after injury. Further, endostatin/collagen XVIII+ monocytic cells accumulated in Virchow-Robin spaces where they formed cell clusters. Besides being prevailingly localised to ED1(+) activated microglia/macrophages, endostatin/collagen XVIII expression was also detected by subendothelial surrounding vessels in the lesioned area. Late and prolonged accumulation of endostatin/collagen XVIII+ microglia/macrophages and increased numbers of endostatin/collagen XVIII+ subendothelial cells/vessels in areas of vascular pruning and regression, point to a role in the termination of the transient angiogenic response, linked to a "late" inflammatory milieu. (c) 2007 Elsevier Inc. All rights reserved.	[Mueller, C. A.] Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; [Mueller, C. A.; Schluesener, H. J.; Fauser, U.; Conrad, S.; Schwab, J. M.] Univ Tubingen, Sch Med, Inst Brain Res, D-72076 Tubingen, Germany; [Conrad, S.] Univ Tubingen, Sch Med, Div Tissue Engn, Inst Anat, Tubingen, Germany; [Schwab, J. M.] Humboldt Univ, Charite Med Sch, Dept Neurol & Experimental Neurol, D-10117 Berlin, Germany		Mueller, CA (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	Christian-Andreas.Mueller@ukb.uni-bonn.de		Schwab, Jan/0000-0001-6784-4919			BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Berger AC, 2000, J SURG RES, V91, P26, DOI 10.1006/jsre.2000.5890; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P627, DOI 10.1007/s004010000232; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bloch W, 2000, FASEB J, V14, P2373; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; COFFEY PJ, 1990, NEUROSCIENCE, V35, P121, DOI 10.1016/0306-4522(90)90126-O; Deininger MH, 2006, J NEUROTRAUM, V23, P1103, DOI 10.1089/neu.2006.23.1103; Dong SC, 2003, J BIOL CHEM, V278, P1700, DOI 10.1074/jbc.M209276200; DSOUZA S, 1995, J NEUROSCI, V15, P7293; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gerlach C, 1997, LAB INVEST, V77, P697; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Hajitou A, 2002, FASEB J, V16, P1802, DOI 10.1096/fj.02-0109fje; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hirji N, 1998, J IMMUNOL, V160, P6004; Hsu CY, 1996, NEUROTRAUMA, P1433; ImperatoKalmar EL, 1997, EXP NEUROL, V145, P322, DOI 10.1006/exnr.1997.6449; Jander S, 1998, EUR J NEUROSCI, V10, P680, DOI 10.1046/j.1460-9568.1998.00078.x; Karumanchi SA, 2001, MOL CELL, V7, P811, DOI 10.1016/S1097-2765(01)00225-8; Kato H, 2000, BRAIN PATHOL, V10, P137; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Ma L, 2002, P NATL ACAD SCI USA, V99, P13243, DOI 10.1073/pnas.202392199; MAMEROS AG, 2001, MATRIX BIOL, V20, P337; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McIntosh TK, 1996, LAB INVEST, V74, P315; MonteroMenei CN, 1996, BRAIN RES, V724, P55, DOI 10.1016/0006-8993(96)00268-5; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nag S, 2005, LAB INVEST, V85, P1189, DOI 10.1038/labinvest.3700325; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; OH SP, 1994, GENOMICS, V19, P494, DOI 10.1006/geno.1994.1098; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Popovich PG, 2003, EXP NEUROL, V182, P275, DOI 10.1016/S0014-4886(03)00120-1; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; Rehn M, 1996, GENOMICS, V32, P436, DOI 10.1006/geno.1996.0139; REHN M, 1994, J BIOL CHEM, V269, P13929; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Schluesener HJ, 1996, J NEUROSCI RES, V44, P606; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Schmidt A, 2004, DEV DYNAM, V230, P468, DOI 10.1002/dvdy.20072; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; Strik HM, 2001, CANCER, V91, P1013, DOI 10.1002/1097-0142(20010301)91:5<1013::AID-CNCR1092>3.0.CO;2-Q; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Takahashi K, 2003, FASEB J, V17, P896, DOI 10.1096/fj.02-0824fje; Wenzel D, 2006, CIRC RES, V98, P1203, DOI 10.1161/01.RES.0000219899.93384.ed	67	11	13	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2007	208	2					228	237		10.1016/j.expneurol.2007.07.020			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241OP	WOS:000251666000007	17942095				2022-02-06	
J	Fei, Z; Zhang, X; Bai, HM; Jiang, XF; Li, X; Zhang, W; Hu, W				Fei, Zhou; Zhang, Xiang; Bai, Hong-Min; Jiang, Xiao-Fan; Li, Xia; Zhang, Wei; Hu, Wei			Posttraumatic secondary brain insults exacerbates neuronal injury by altering metabotropic glutamate receptors	BMC NEUROSCIENCE			English	Article							SEVERE HEAD-INJURY; EXCITATORY AMINO-ACIDS; CORTICAL IMPACT INJURY; GROUP-II; EXPRESSION PATTERNS; PROGNOSTIC VALUE; RODENT MODEL; RATS; HYPOTENSION; ACTIVATION	Background: Our previous studies indicated that metabotropic glutamate receptors (mGluRs) are deeply involved in the secondary processes after diffuse brain injury (DBI). In the present study, we used a rodent DBI model to determine whether hypotension exacerbates neuronal injury as a secondary brain insult (SBI) after traumatic brain injury (TBI) by changing the expression of metabotropic glutamate receptors ( mGluRs) in the cerebral cortex. Results: Three hundred and eleven male Sprague-Dawley rats were randomly assigned into five groups: normal control, sham-operated control, SBI alone, DBI alone, or DBI with SBI. DBI was produced in rats by Marmarou's methods and the SBI model was produced by hypotension. The alteration of neuronal expression of mGluRs after DBI and DBI coupled with SBI was observed by hybridization in situ at different time points in the experiment. We found a higher mortality and neurological severity score (NSS) for rats in the DBI with SBI group compared with those in the DBI alone group. Although there was a significant rise in the expression of group I and group III mGluRs (except mGluR6) and a decrease in the expression of group II mGluRs after DBI (P < 0.05), the changes were more severe when DBI was coupled with SBI (P < 0.05). The expression of group I mGluRs peaked at 24 hours, while the expression of the group III mGluRs peaked at 6 hours after injuries, which may reflect a self-protection first mechanism of the damaged neurons. Moreover, the overall neuro-harmful effects of mGluRs on neurons were seemly associated with higher mortality and NSS in the DBI with SBI group. Conclusion: The results suggest posttraumatic SBI may exacerbate neuronal injury or brain injury by altering expression of mGluRs, and more emphasis should therefore be put on the prevention and treatment of SBI.	[Fei, Zhou; Zhang, Xiang; Jiang, Xiao-Fan; Li, Xia; Zhang, Wei; Hu, Wei] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China; [Bai, Hong-Min] Guang Zhou liuhuaqiao Hosp, Dept Neurosurg, Guangzhou 510010, Peoples R China		Zhang, X (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn; sjwk3bq@fmmu.edu.cn; baihmfmmu@163.com; jiangxf@fmmu.edu.cn; sjwklixia@sina.com; zhangwei@fmmu.edu.cn; huwei116@fmmu.edu.cn					Alagarsamy S, 2001, CURR OPIN NEUROBIOL, V11, P357, DOI 10.1016/S0959-4388(00)00219-1; Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Beaumont A, 2002, ACT NEUR S, V81, P217; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COKER L H, 1989, Anesthesiology (Hagerstown), V71, pA108, DOI 10.1097/00000542-198909001-00108; DeWitt D S, 1995, New Horiz, V3, P376; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fei Z, 2005, ACTA NEUROCHIR SUPPL, V95, P265; Fei Z, 2005, NEUROSCI LETT, V380, P280, DOI 10.1016/j.neulet.2005.01.063; Fei Z, 2003, J CLIN NEUROSCI, V10, P684, DOI 10.1016/j.jocn.2003.04.001; Ferraguti F, 2001, EXP BRAIN RES, V137, P1, DOI 10.1007/s002210000633; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Gong QZ, 1999, J NEUROTRAUM, V16, P893, DOI 10.1089/neu.1999.16.893; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Huang WD, 2005, NEUROSCI LETT, V389, P46, DOI 10.1016/j.neulet.2005.07.014; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; IVERSEN L, 1994, J NEUROCHEM, V63, P625; Jones Suzanne R., 1993, Endangered Species Update, V10, P1; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCDONALD JW, 1993, J NEUROSCI, V13, P4445; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Movsesyan VA, 2006, J NEUROTRAUM, V23, P117, DOI 10.1089/neu.2006.23.117; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Stefani A, 1998, EXP BRAIN RES, V119, P237, DOI 10.1007/s002210050337; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Zhou F, 2001, J CLIN NEUROSCI, V8, P561, DOI 10.1054/jocn.2001.0980; Zwienenberg M, 2001, NEUROSURGERY, V48, P1119, DOI 10.1097/00006123-200105000-00031	43	11	20	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	NOV 17	2007	8								96	10.1186/1471-2202-8-96			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	266UK	WOS:000253462400001	18021417	gold, Green Published			2022-02-06	
J	Dettmer, JL; Daunhauer, L; Detmar-Hanna, D; Sample, PL				Dettmer, Judy L.; Daunhauer, Lisa; Detmar-Hanna, Donna; Sample, Pat L.			Putting brain injury on the radar: Exploratory reliability and validity analyses of the Screening Tool for Identification of Acquired Brain Injury in School-Aged Children	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; identification; screening tool; special education; tool validity and reliability; traumatic brain injury	HEAD-INJURY; SYMPTOMS; CARE	Purpose: This study explored the reliability and validity of the Screening Tool for the Identification of Acquired Brain Injury in School-Aged Children (STI). Methods: Parents and teachers of students (K-12) from 3 different groups (students with known acquired brain injuries, students with special education needs, and typical students) rated their students' behaviors, symptoms, and injuries using the STI. Results: Test-retest and internal consistency analyses indicated acceptable reliability. Additionally, the 3 activities used to determine test validity all yielded positive results. Discussion: The STI indicates sensitivity to learning challenges; however, further research is needed to develop instrument specificity. We also introduce the idea of using tools, such as the STI for the purpose of an "educational identification" for students who are in need of immediate support, and for whom no formal medical diagnosis yet exists.	Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; Colorado State Univ, Ctr Community Partnerships, Ft Collins, CO 80523 USA		Sample, PL (corresponding author), Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA.	psample@cahs.colostate.edu					Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Dise-Lewis J. E., 2002, BRAIN STARS BRAIN IN; Glang A, 2004, NEUROREHABILITATION, V19, P219; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GORDON WS, 2006, TBI RES REV POLICY P, V2, P1; HIBBARD M, 2001, STUDENTS TRAUMATIC B; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Keyser-Marcus L., 2002, TEACHING EXCEPTIONAL, V34, P62; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LASH M, 2002, BRAIN INJ SOURCE, V6, P20; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Sample PL, 2007, SUBST USE MISUSE, V42, P705, DOI 10.1080/10826080701202536; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Savage RC, 2001, NEUROREHABILITATION, V16, P49; SAVAGE RC, 2007, CHILDREN ADOLESCENTS; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; *US DEP ED, IND DIS ED ACT IDE B; *US DEP HHS CDCP N, 1999, TRAUM BRAIN INJ US R; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; 2006, FED REG 2, V71, P46539	23	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2007	22	6					339	349		10.1097/01.HTR.0000300229.13490.c7			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	234RN	WOS:000251181500004	18025966				2022-02-06	
J	Reichard, AA; Langlois, JA; Sample, PL; Wald, MM; Pickelsimer, EE				Reichard, Audrey A.; Langlois, Jean A.; Sample, Pat L.; Wald, Marlena M.; Pickelsimer, E. Elisabeth			Violence, abuse, and neglect among people with traumatic brain injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						abuse; disability; neglect; prevention; qualitative research; traumatic brain injury; violence; victimization	PERSONAL ASSISTANCE PROVIDERS; SEXUAL-ABUSE; DEVELOPMENTAL-DISABILITIES; PHYSICAL-DISABILITIES; LEARNING-DISABILITIES; WOMEN; ADULTS	Background: Violence, abuse, and neglect (VAN) among people with physical and other disabilities has been reported; however, little is known about VAN experiences among people with traumatic brain injuries (TBI). Methods: Nine people who reported experiencing VAN post-TBI were interviewed for this phenomenological study. The data were analyzed to understand VAN as experienced by those with TBI. Results: Participants detailed many VAN experiences along with contributing factors, barriers in obtaining help, and recommendations for improving preventive and assistance services. Conclusions: Greater efforts are needed to identify and prevent VAN among people with TBI. Services following VAN must be improved.	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Response, Atlanta, GA USA; Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; Lockheed Martin Corp, Atlanta, GA USA; Med Univ S Carolina, Div Epidemiol, Charleston, SC 29425 USA		Reichard, AA (corresponding author), NIOSH, Ctr Dis Control & Prevent, Div Safety Res, 1095 Willowdale Rd,MS H1808, Morgantown, WV 26505 USA.	AReichard@cdc.gov					BEAIL N, 1995, J INTELL DISABIL RES, V39, P382, DOI 10.1111/j.1365-2788.1995.tb00542.x; BROWN H, 1994, CHILD ABUSE REV, V3, P26, DOI DOI 10.1002/CAR.2380030106; Chang JC, 2003, J WOMENS HEALTH, V12, P699, DOI 10.1089/154099903322404348; CHRISTOFFEL T, 2006, INJURY PREVENTION PU; Cramer E. P., 2003, J HUMAN BEHAV SOCIAL, V7, P183, DOI DOI 10.1300/J137V07N03_11; Curry MA, 2001, VIOLENCE AGAINST WOM, V7, P60, DOI 10.1177/10778010122182307; CURRY MA, 2003, J AGGRESS MALTREAT T, V8, P123, DOI DOI 10.1300/J146v08n07_06; FUREY EM, 1994, SEX DISABIL, V12, P285, DOI 10.1007/BF02575320; KEATING KA, 1998, ADV SPECIAL ED, P279; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marley JA, 2001, SOC WORK, V46, P115, DOI 10.1093/sw/46.2.115; McFarlane J, 2001, J WOMEN HEALTH GEN-B, V10, P861, DOI 10.1089/152460901753285750; Milberger Sharon, 2003, Violence Vict, V18, P581, DOI 10.1891/vivi.2003.18.5.581; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; Nosek MA, 2004, FAM COMMUNITY HEALTH, V27, P6, DOI 10.1097/00003727-200401000-00003; Nosek MA, 2003, SOC SCI MED, V56, P1737, DOI 10.1016/S0277-9536(02)00169-7; Nosek MA, 2001, VIOLENCE AGAINST WOM, V7, P477, DOI 10.1177/10778010122182569; NOSEK MA, 2002, PREV INT VIOL CHILDR; Oktay JS, 2004, HEALTH SOC WORK, V29, P177, DOI 10.1093/hsw/29.3.177; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Petersilia JR, 2001, CRIM JUSTICE BEHAV, V28, P655, DOI 10.1177/009385480102800601; Rizzo Matthew, 1996, P1; Rosenberg M., 1991, VIOLENCE AM PUBLIC H, P14; Saxton M, 2001, VIOLENCE AGAINST WOM, V7, P393, DOI 10.1177/10778010122182523; *SCI SOFTW DEV, 1997, ATL TI COMP PROGR VE; Seidman I., 1998, INTERVIEWING QUALITA, V2nd; Sequeira H, 2003, BRIT J PSYCHIAT, V183, P451, DOI 10.1192/bjp.183.5.451; Sequeira H, 2001, VIOLENCE AGAINST WOM, V7, P462, DOI 10.1177/10778010122182550; Sobsey D., 1991, SEXUALITY DISABILITY, V9, P243, DOI DOI 10.1007/BF01102395; Sobsey D., 1994, VIOLENCE ABUSE LIVES; *STAT U NEW YORK U, 2002, CALL ACT END CRIM VI; Stromsness M. M., 1993, WOMEN THER, V14, P139, DOI DOI 10.1300/J015V14N03_14; Swedlund NP, 2000, J REHABIL, V66, P57; THURMAN D, 2001, HEAD TRAUMA BASIC PR; *US DEP COMM EC ST, 2003, DIS STAT 2000; *US DEP HHS, 1999, NIH CONS STAT REH PE, P5; *US DEP HHS CDCP N, 2005, FACTS TRAUM BRAIN IN; *US DEP JUST OFF J, 1998, WORK VICT CRIM DIS; Van Manen M., 1990, RES LIVED EXPERIENCE; Verdugo MA, 1997, AGGRESS VIOLENT BEH, V2, P143, DOI 10.1016/S1359-1789(96)00020-1; Watson-Armstrong L.A., 1994, J APPL REHABIL COUS, V25, P36; Welner SL, 2000, SEX TRANSM DIS, V27, P272, DOI 10.1097/00007435-200005000-00007; WHO, 2002, WORLD REP VIOL HLTH; Young M.E, 1997, J DISABIL POLICY STU, V8, P157, DOI [10.1177/104420739700800208, DOI 10.1177/104420739700800208]; Young ME, 1997, ARCH PHYS MED REHAB, V78, pS34, DOI 10.1016/S0003-9993(97)90219-7; [No title captured], DOI DOI 10.1111/J.1468-3148.1993.TB00053.X; [No title captured]	48	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2007	22	6					390	402		10.1097/01.HTR.0000300234.36361.b1			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	234RN	WOS:000251181500009	18025971				2022-02-06	
J	Reid-Arndt, SA; Schopp, L; Brenneke, L; Johnstone, B; Poole, AD				Reid-Arndt, Stephanie A.; Schopp, Laura; Brenneke, Lori; Johnstone, Brick; Poole, A. Diane			Evaluation of the traumatic brain injury early referral programme in Missouri	BRAIN INJURY			English	Article						traumatic brain injury; community integration; outcome; functional status; employment; case management	FAMILY; NEEDS	Purpose: Missouri's traumatic brain injury (TBI) early referral programme connects individuals with TBI to state services in the acute stages of recovery. This study evaluated the impact of this programme on service utilization and functional outcomes. Method: Sixty-seven individuals in the Early Referral (ER) programme were compared with 31 individuals who received services later in their recovery (controls) in terms of their functioning upon programme enrollment and programme services received. Telephone surveys were then completed with 29 ER and 22 later-referred controls assessing social/emotional and vocational functioning, as well as satisfaction with programme services. Results: The ER group had greater functional limitations than controls upon enrollment. Despite this, at follow-up the ER group evidenced significantly better social integration, emotional well-being and vocational functioning than the control group. Individuals in the ER group did not require/receive more programme resources to achieve these better outcomes. Across both groups, 91% reported feeling the programme is valuable for individuals with TBI. Conclusions: Missouri's TBI early referral programme provides efficacious and cost-effective targeted support for individuals with TBI. Contact with clients and their families during or shortly after acute rehabilitation appears to be associated with better functional outcomes without an increase in the level of services rendered.	[Reid-Arndt, Stephanie A.; Schopp, Laura; Johnstone, Brick] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65212 USA; [Brenneke, Lori; Poole, A. Diane] Missouri Dept Hlth & Senior Serv, Div Community & Publ Hlth Special Hlth Care Needs, Jefferson, AR USA		Reid-Arndt, SA (corresponding author), Univ Missouri, Dept Hlth Psychol, 1 Hosp Dr,DC 116-88, Columbia, MO 65212 USA.	reidarndts@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649			BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Cusick CP, 2003, BRAIN INJURY, V17, P931, DOI 10.1080/0269905031000110391; ENGLANDER J, 1999, REHABILITATION ADULT, P354; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fitzsimmons RD, 2003, BRAIN INJURY, V17, P947, DOI 10.1080/0269905031000110409; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; MCKINLAY W, 1999, REHABILITATION ADULT, P74; McNeny R., 1999, REHABILITATION ADULT, P242; MICHAUD LJ, 1999, REHABILITATION ADULT, P345; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	17	11	11	0	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2007	21	12					1295	1302		10.1080/02699050701721802			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	249HP	WOS:000252219200008	17963093				2022-02-06	
J	Ibrahim, MI; Abdullah, M; Naing, L; Abdullah, JM; Idris, Z; Aljunid, SM				Ibrahim, Mohd Ismail; Abdullah, Mazlan; Naing, Lin; Abdullah, Jafri Malin; Idris, Zamzuri; Aljunid, Syed Mohamed			Cost effectiveness analysis of using multiple neuromodalities in treating severe traumatic brain injury in a developing country like Malaysia	ASIAN JOURNAL OF SURGERY			English	Article						cost-effectiveness; economic evaluation; multiple neuromonitoring; severe traumatic brain injury		OBJECTIVE: The aim of this study was to determine the cost-effectiveness of using baseline neuromonitoring (BNM) compared with multimodality monitoring (M3) for severe traumatic brain injury (TBI). METHODS: Sixty-two patients with severe TBI underwent a prospective observational study where they were divided into two groups of patients receiving treatment with M3 (32 patients) and BNM (30 patients). The macro and micro costings were performed on each patient. The Barthel Index score after 1 year was used as an outcome measurement tool for both groups. The cost-effectiveness (CE) ratio was calculated using the Poisson regression model. RESULTS: The costs of equipment and consumables between the groups was statistically significant (p < 0.001) after correcting for age and severity of injury. Other cost categories were not significantly different. The crude CE ratios were 168.66 (95% CI: 168.32, 169.03) and 144.16 (95% CI: 143.87, 144.45) for BNM and M3 respectively. The two crude CE ratios were significantly different (p < 0.001). It was calculated by controlling or adjusting age, gender, Glasgow Coma Score, Marshall's classification at admission and type of injury. The adjusted CE ratios were 171.32 (95% CI: 170.97,171.68) and 141.50 (95% CI: 141.26, 141.79) for BNM and M3, respectively. The two adjusted CE ratios were significantly different (p < 0.001). CONCLUSION: The application of M3 for severe TBI was more cost-effective than BNM. All calculations were made at 3.8 Malaysian Ringgit (MYR) to the United States dollar (USD).	Univ Sains Malaysia, Hosp Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia; Univ Sains Malaysia, Sch Med Sci, Dept Community Med, Kubang Kerian 16150, Kelantan, Malaysia; Natl Univ, Fac Med, Dept Community Hlth, Bangi, Malaysia		Abdullah, JM (corresponding author), Univ Sains Malaysia, Hosp Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Univ Sains Malaysia Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	deptneurosciencesppspusm@yahoo.com	Abdullah, Mazlan/AAD-9128-2019; Ibrahim, Mohd Ismail/C-8347-2016; Aljunid, Syed/J-6009-2014; Abdullah, J/C-2828-2011; Idris, Zamzuri/AAB-6764-2022	Ibrahim, Mohd Ismail/0000-0002-5470-4180; Aljunid, Syed/0000-0002-0380-1335; Abdullah, J/0000-0002-0258-7410; Idris, Zamzuri/0000-0002-9470-0571			AHMAD TJ, 2002, NCD MALAYSIA, V2, P29; ASHELY MJ, 1990, J INSURANCE MED, V22, P230; ASHLEY MJ, 1990, J INSURANCE MED, V22, P156; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; Cormio M, 2001, J NEUROSURG ANESTH, V13, P250, DOI 10.1097/00008506-200107000-00014; Hlatky Roman, 2002, Curr Opin Anaesthesiol, V15, P489, DOI 10.1097/00001503-200210000-00003; KELVIN KWY, 2002, ACCIDENT ANAL PREV, V4, P12; Kirkpatrick PJ, 1996, NEUROSURGERY, V39, P714, DOI 10.1097/00006123-199610000-00013; LOEWEN SC, 1989, PHYS THER, V69, P780; Macmillan CSA, 2000, INTENS CARE MED, V26, P1028, DOI 10.1007/s001340051315; MAHONEY F I, 1965, Md State Med J, V14, P61; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; Merican M I, 2004, Med J Malaysia, V59, P84; Miller J D, 1994, Neurosurg Clin N Am, V5, P661; Miller JI, 1998, ACT NEUR S, V71, P82; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; Murray A, 1998, ACCIDENT ANAL PREV, V30, P169, DOI 10.1016/S0001-4575(97)00088-2; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; MURRAY CJL, 1999, GLOBAL BURDEN DIS IN, V1, P29; Neter John, 2004, APPL LINEAR STAT MOD; NEWLON PG, 1984, J TRAUMA, V24, P61, DOI 10.1097/00005373-198401000-00010; RUWAIDA I, 2003, NEUROSURG FOCUS, V15, P1; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; Tan H, 2001, Chin J Traumatol, V4, P156; Vigue B, 1999, INTENS CARE MED, V25, P1477, DOI 10.1007/s001340051107; Waran V, 2000, BRIT J NEUROSURG, V14, P469; White H, 2002, CAN J ANAESTH, V49, P623, DOI 10.1007/BF03017393	29	11	11	0	0	ELSEVIER SINGAPORE PTE LTD	SINGAPORE	3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE	1015-9584	0219-3108		ASIAN J SURG	Asian J. Surg.	OCT	2007	30	4					261	266		10.1016/S1015-9584(08)60036-6			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	227WX	WOS:000250689600006	17962129	Bronze			2022-02-06	
J	Morgan, AT; Liegeois, F; Occomore, L				Morgan, A. T.; Liegeois, F.; Occomore, L.			Electropalatography treatment for articulation impairment in children with dysarthria post-traumatic brain injury	BRAIN INJURY			English	Article						speech; brain injury; paediatric; dysarthria; electropalatography; intervention	PALATE CONTACT; EPG; REMEDIATION; ADOLESCENTS; CHILDHOOD; SPEAKERS	Primary objective: Dysarthria with severe articulatory impairment is a common and debilitating sequelae following severe traumatic brain injury ( TBI). Eectropalatography ( EPG) is an instrumental treatment technique allowing visual feedback of tongue to palate movement during real time articulation. The present study investigated the effectiveness of EPG in treating the articulatory component of dysarthria post-TBI. Study design/ methods: The articulatory component of dysarthria post-TBI was treated once per week with EPG over a 10-week period in three adolescents ( aged 14 years 10 months-15 years 1 month). A multiple case series ABA treatment design was used. Perceptual ( articulation, intelligibility) and EPG ( spatial, durational) assessments were conducted pre- and post-treatment to determine outcome. Results/ discussion: Perceptual improvement was noted for phoneme precision and length. Spatial EPG measures confirmed increased precision of phoneme production. No clear pattern of change for phoneme duration occurred. Intelligibility increased at word and sentence level, with little change reported in everyday speech intelligibility. Conclusion: This preliminary study indicates that EPG treatment may be effective for improving speech at the isolated phoneme, word or sentence level of articulation. These preliminary results are encouraging, being the first study to report speech changes post-treatment in participants with severe TBI and persistent dysarthria. Further research is required, however, in order to understand the regenerative capacity of articulatory function post-brain injury and to determine optimal treatment parameters for achieving generalization of therapy to everyday connected speech.	UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, London, England; Childrens Trust Paediat Rehabil Ctr, Surrey, England		Morgan, AT (corresponding author), Murdoch Childrens Res Inst, 50 Flemington Rd, Melbourne, Vic 3052, Australia.	angela.morgan@mcri.edu.au	Occomore-Kent, Louise/AAI-9298-2021; Liegeois, Frederique/A-6351-2009; Morgan, Angela/J-5235-2017	Occomore-Kent, Louise/0000-0002-6212-5461; Morgan, Angela/0000-0003-1147-7405; Liegeois, Frederique/0000-0002-8640-6217			BARRY RM, 1989, CLIN LINGUIST PHONET, V3, P81, DOI 10.3109/02699208908985273; Brown J.R., 1975, MOTOR SPEECH DISORDE; BYRD D, 1995, J SPEECH HEAR RES, V38, P821, DOI 10.1044/jshr.3804.821; Cahill LM, 2005, BRAIN INJURY, V19, P41, DOI 10.1080/02699050410001719961; CAHILL LM, 2002, J MED SPEECH-LANG PA, V8, P347; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Cheng HY, 2007, J SPEECH LANG HEAR R, V50, P375, DOI 10.1044/1092-4388(2007/027); COSTEFF H, 1985, SCAND J REHABIL MED, P10; Dagenais P.A., 1994, AM J SPEECH-LANG PAT, V3, P67, DOI [10.1044/1058-0360.0303.67, DOI 10.1044/1058-0360.0303.67]; DAGENAIS PA, 1994, J PHONETICS, V22, P225, DOI 10.1016/S0095-4470(19)30202-5; DAGENAIS PA, 1995, J COMMUN DISORD, V28, P303, DOI 10.1016/0021-9924(95)00059-1; DENT H, 1995, EUR J DISORDER COMM, V30, P264; DENT H, 1992, INTERDISCIPLINARY PE, P211; Duffy, 2005, MOTOR SPEECH DISORDE; FARNETANI E, 1991, QUADERNI CTR STUDIO, V10, P117; Gibbon FE, 2003, CLIN LINGUIST PHONET, V17, P365, DOI 10.1080/0269920031000079976; Goldman R., 2000, GOLDMAN FRISTOE TEST; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2003, J MED SPEECH-LANG PA, V11, P115; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; Hartelius L, 2005, J MED SPEECH-LANG PA, V13, P189; HOWARD S, 1995, EUR J DISORDER COMM, V30, P246; Ladefoged P., 2001, COURSE PHONETICS, V4th ed.; McAuliffe M J, 2001, Logoped Phoniatr Vocol, V26, P165, DOI 10.1080/14015430152928357; McAuliffe MJ, 2003, CLIN LINGUIST PHONET, V17, P43, DOI 10.1080/0269920021000066846; MORGANBARRY RA, 1995, EUR J DISORDER COMM, V30, P256; Rosenbeck JC, 1991, CLIN MANAGEMENT NEUR, P97; Stierwalt JAG, 1996, DISORDERS MOTOR SPEE, P241; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Theodoros DG, 2001, TRAUMATIC BRAIN INJU, P155; TITZE IR, 1993, J SPEECH HEAR RES, V36, P1177, DOI 10.1044/jshr.3606.1177; van Mourik M, 1997, PEDIATR NEUROL, V17, P299; VOGEL M, 1983, FOLIA PHONIATR, V35, P294, DOI 10.1159/000265705; WELLS JC, 1997, WHAT ESTUARY ENGLISH, V3, P46; Weschler D., 1999, WESCHLER ABBREVIATED; Wilcox K., 1999, CHILDRENS SPEECH INT; WOOD S, 1999, ACQUIRED NEUROGENIC, P203; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; Yorkston K. M., 1996, AM J SPEECH-LANG PAT, V5, P55, DOI [10.1044/1058-0360.0501.55, DOI 10.1044/1058-0360.0501.55]; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; ZIEGLER W, 1989, APHASIOLOGY, V3, P449, DOI 10.1080/02687038908249006	44	11	11	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2007	21	11					1183	1193		10.1080/02699050701649573			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222WX	WOS:000250329900010	17896211				2022-02-06	
J	Tessier, C; Weill-Chounlamountry, A; Michelot, N; Pradat-Diehl, P				Tessier, Catherine; Weill-Chounlamountry, Agnes; Michelot, Nadine; Pradat-Diehl, Pascale			Rehabilitation of word deafness due to auditory analysis disorder	BRAIN INJURY			English	Article						aphasia; cognitive rehabilitation; traumatic brain injury; stroke; disability	SUBCORTICAL LESIONS; APHASIA; COMPREHENSION; RECOGNITION; MODULARITY; ERRORLESS; THERAPY; NEGLECT; PATIENT; STROKE	Background: Word deafness refers to an inability to understand spoken words despite intact hearing. In a cognitive approach, word deafness could be explained by a deficiency at the lower perceptive level of the auditory process. The impairment of the auditory analysis system would explain a disorder of identification of speech sounds. Only few studies addressed rehabilitation of central auditory processing and have described therapy focused on phoneme discrimination. Objective: To determine whether a specific auditory analysis rehabilitation addressing phoneme discrimination and phoneme recognition may improve oral comprehension and communication. Method: A single-case experimental design was used in a 65 year-old woman, with word deafness consecutive to a cerebral infarction which occurred 10 months before. Verbal naming, written expression and written comprehension were normal. Verbal comprehension, repetition and phoneme discrimination and recognition were impaired. In terms of cognitive model of auditory processing, the patient showed impairment of the auditory analysis system affecting verbal comprehension. A computerized rehabilitation of auditory analysis system was carried out in two consecutive tasks: phoneme discrimination and phoneme recognition. Errorless learning therapy was used, with a difficulty hierarchy practised from the easier to the most difficult phoneme and systematic visual cues which were progressively delayed and suppressed. This study tested the efficacy and the specificity of this therapy on the addressed tasks ( phoneme discrimination and recognition), related tasks ( oral comprehension and repetition), independent tasks ( recognition of environmental sounds) and daily life ( questionnaire). Results: The phoneme discrimination and recognition impairment was stable over 4 months before therapy. After therapy, phoneme discrimination ( p< 0.001) and phoneme recognition ( p< 0.0001) were improved. The improvement was specific to verbal sounds recognition, while non-verbal sounds recognition was unchanged. An improvement occurred for repetition ( p< 0.05) and oral comprehension ( p< 0.01). The communication disability decreased ( p< 0.05). Conclusion: In a case of word deafness, this study demonstrates not only the efficacy of a specific phoneme processing therapy but also its efficacy in the improvement of higher level of cognitive treatment such as oral comprehension and its transfer in daily life. The role of errorless therapy using systematic visual cues and difficulty hierarchy must be underlined.	Grp Hop Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, Paris, France; UPMC, INSERM, U731, F-75013 Paris, France		Pradat-Diehl, P (corresponding author), Pr Perrigot Hop Salpetriere, Serv Med Phys & Readaptat, 47-83 Blvd Hop, F-75651 Paris, France.	pascale.pradat@psl.aphp.fr	Weill-Chounlamountry, Agnes/D-2870-2011	Weill-Chounlamountry, Agnes/0000-0001-6844-5979			AUERBACH SH, 1982, BRAIN, V105, P271, DOI 10.1093/brain/105.2.271; BADDELEY A, 1993, NEUROPSYCHOL REHABIL, V3, P235, DOI 10.1080/09602019308401438; Baddeley A.D., 1986, WORKING MEMORY; BEHRMANN M, 1995, NEUROPSYCHOL REHABIL, V5, P149, DOI 10.1080/09602019508520179; BLUMSTEIN SE, 1977, NEUROPSYCHOLOGIA, V15, P19, DOI 10.1016/0028-3932(77)90111-7; CARAMAZZA A, 1993, NEUROPSYCHOL REHABIL, V3, P217, DOI 10.1080/09602019308401437; DARRIGRAND B, 2000, APHASIE REEDUCATION, P88; DARRIGRAND B, 2000, ECHELLE COMMUNICATIO; DUCARNE B, 1992, GLOSSA, V30, P10; DUCARNE B, 1989, EXAMEN APHASIE; DUCARNE B, 1986, REEDUCATION SEMIOLOG; ELLIS AW, 1994, COGNITIVE NEUROPSYCH, P287; EUSTACHE F, 1993, REV NEUROPSYCHOL, V3, P353; FILLINGHAM J, 2006, NEUROPSYCHOLGICAL RE, V16, P29; Fillingham JK, 2003, NEUROPSYCHOL REHABIL, V13, P337, DOI 10.1080/09602010343000020; FRANKLIN S, 1989, APHASIOLOGY, V3, P189, DOI 10.1080/02687038908248991; GLISKY EL, 1995, NEUROPSYCHOL REHABIL, V5, P299, DOI 10.1080/09602019508401474; Griffiths TD, 1999, NEUROCASE, V5, P365, DOI 10.1080/13554799908402733; Griffiths TD, 2002, CURR OPIN NEUROL, V15, P31, DOI 10.1097/00019052-200202000-00006; Jacquemot C., 2002, CORTEX, V38, P869, DOI DOI 10.1016/S0010-9452(08)70059-5; Komatsu S, 2000, NEUROPSYCHOL REHABIL, V10, P113, DOI 10.1080/096020100389200; LADAVAS E, 1994, COGN NEUROPSYCHOL, V11, P75, DOI 10.1080/02643299408251967; LECOURS AR, 1979, REEDUCATION TROUBLES, P578; Maneta A, 2001, INT J LANG COMM DIS, V36, P91, DOI 10.1080/13682820150217581; Martin P, 2006, BRAIN LANG, V97, P214, DOI 10.1016/j.bandl.2005.10.009; Martin RC, 1999, BRAIN LANG, V70, P437, DOI 10.1006/brln.1999.2184; MITCHUM CC, 1995, NEUROPSYCHOL REHABIL, V5, P1, DOI 10.1080/09602019508520173; Morris J, 1996, APHASIOLOGY, V10, P137, DOI 10.1080/02687039608248402; Musiek Frank E, 2004, J Am Acad Audiol, V15, P133, DOI 10.3766/jaaa.15.2.4; Pedersen PM, 2004, CEREBROVASC DIS, V17, P35, DOI 10.1159/000073896; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; Pinard M, 2002, NEUROCASE, V8, P40, DOI 10.1076/neur.8.1.40.16243; Polster MR, 1998, CORTEX, V34, P47, DOI 10.1016/S0010-9452(08)70736-6; PRAAMSTRA P, 1991, BRAIN, V114, P1197, DOI 10.1093/brain/114.3.1197; PRADATDIEHL P, 1998, SYNDROMES NEGLIGENCE, P235; Riley GA, 2000, NEUROPSYCHOL REHABIL, V10, P133, DOI 10.1080/096020100389219; ROBERTSON IH, 1990, ARCH PHYS MED REHAB, V71, P663; Robey RR, 1998, J SPEECH LANG HEAR R, V41, P172, DOI 10.1044/jslhr.4101.172; SHINDO M, 1991, BRAIN LANG, V40, P301; Shivashankar N, 2001, CLIN NEUROL NEUROSUR, V103, P201, DOI 10.1016/S0303-8467(01)00136-6; Tanaka Y, 2002, CORTEX, V38, P69, DOI 10.1016/S0010-9452(08)70639-7; TESSIER C, 2000, ENTRETIENS ORTHOPHON, P39; Vitte E, 2002, NEUROLOGY, V58, P970, DOI 10.1212/WNL.58.6.970; Wee J, 1999, ARCH PHYS MED REHAB, V80, P1106, DOI 10.1016/S0003-9993(99)90069-2; WILSON BA, 1993, NEUROPSYCHOL REHABIL, V3, P1; Wirkowski E, 2006, J EMERG MED, V30, P53, DOI 10.1016/j.jemermed.2005.03.016	46	11	14	2	35	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2007	21	11					1165	1174		10.1080/02699050701559186			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222WX	WOS:000250329900008	17852097				2022-02-06	
J	Aloni, R; Keren, O; Katz, S				Aloni, R.; Keren, O.; Katz, S.			Sex therapy surrogate partners for individuals with very limited functional ability following traumatic brain injury	SEXUALITY AND DISABILITY			English	Article						Traumatic brain injury; sex rehabilitation; sex therapy; surrogate partner	FAMILY; DAMAGE	The use of surrogate sex therapists for survivors after Traumatic Brain Injury (TBI) who have Very Limited Functional Ability (VLFA) is discussed. It includes the rationale of using surrogate therapy with this population as well as some of the professional and ethical issues that such therapy can evoke. It is suggested that surrogate therapy can provide satisfaction and positive experiences to the restricted lives of some of the VLFA-TBI survivors. The use of surrogate therapy is viewed as a part of the integral rehabilitation process aimed at improving the quality of life and the fulfillment of basic human intimacy needs. Often requiring help in this important area of life, they are not always able to initiate and control emotional behaviors to promote healthy sexual relationship and activity. Surrogate therapy is an activity that can help survivors with TBI monitor and initiate feelings, reactions and motivation in intimate relationships, as well as provide a certain amount of control over their lives. A case study is presented to illustrate the process of sex therapy with a surrogate partner for a VLFA-TBI survivor.	Sexual Private Clin, Tel Aviv, Israel; Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel		Keren, O (corresponding author), Rehabil Pediat Ctr, POB 9117, IL-91090 Jerusalem, Israel.	ofkeren@internet-zahav.net					ALONI R, 2003, SEXUALITY DIFFICULTI, P14; APFELBAUM B, 1977, J SEX RES, V13, P234; COLE M, 1985, BRIT J PSYCHIAT, V147, P337, DOI 10.1192/bjp.147.4.337; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; Griffith ER, 1993, SEXUALITY PERSON TRA; Groswasser Z, 1998, J HEAD TRAUMA REHAB, V13, P69, DOI 10.1097/00001199-199802000-00009; JOHNSON W, 1981, SEXUAL ED COUNSELING, P244; Katz DI, 2007, BRAIN INJURY MED PRI, P3; KEREN O, 2000, SISTEMA NERVOSO, V1, P23; Kothari S., 2007, BRAIN INJURY MED PRI, P169; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Masters W., 1970, HUMAN SEXUAL INADEQU; Oksenberg A, 2000, SLEEP, V23, P953; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; SANDEL ME, 2007, BRAIN INJURY MED, V37, P673; Strauss D, 1991, SEX DISABIL, V9, P49; TEASDALE G, 1974, LANCET, V2, P81; WRIGHT G, 1988, TOTAL REHABILITATION; [No title captured]	22	11	11	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0146-1044			SEX DISABIL	Sex. Disabil.	SEP	2007	25	3					125	134		10.1007/s11195-007-9047-7			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	207SM	WOS:000249271400004					2022-02-06	
J	Bansal, V; Fortlage, D; Lee, JG; Hill, LL; Potenza, B; Coimbra, R				Bansal, Vishal; Fortlage, Dale; Lee, Jeanne G.; Hill, Linda L.; Potenza, Bruce; Coimbra, Raul			Significant injury in cruise ship passengers - A case series	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							EPIDEMIOLOGY; FALLS; RISK	Background: The attention placed on cruise ship infectious epidemics has helped create important preventive strategies in improving food handling, sanitation, and overall cruise ship medical care. However, the incidence of serious injury in cruise ship passengers has never been fully described. In 2006, there was an increase in the number of cruise ship passengers receiving medical care at a Level I trauma center. This report provides a case series analysis of eight patients identified as suffering from significant cruise ship-related injuries. Methods: A retrospective, descriptive study design was used. Data on trauma patients transported directly from cruise ships and admitted to a university Level I trauma center in 2003-2006 were reviewed. Results: A total of 2132 patients were admitted as major trauma resuscitations in 2006. Eight were identified as being injured on a major cruise ship compared to an average of 1.7 patients/year in the preceding 3 years. All but one patient was female. Three patients had significant medical comorbidities. All eight patients suffered injuries from falls, five of which were in stairwells. Concussions were the most common injury. Five patients were discharged to home, two to extended rehabilitation facilities, and one died. Conclusions: In this case series, falls were the sole cause of major injury among cruise ship passengers. Improved surveillance and characterization of injuries among cruise ship passengers is needed to inform safety policies and develop programs to prevent passenger injury.	Univ Calif San Diego, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Family & Preventat Med, La Jolla, CA 92093 USA		Coimbra, R (corresponding author), Univ Calif San Diego, Div Trauma Surg Crit Care & Burns, 200 W Arbor Dr 8896, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			*AM COLL EM PHYS, 1996, ANN EMERG MED, V27, P846; Cramer EH, 2006, AM J PREV MED, V30, P252, DOI 10.1016/j.amepre.2005.10.027; DIGIOVANNA T, 1992, ANN EMERG MED, V21, P1476, DOI 10.1016/S0196-0644(05)80065-4; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kennedy RL, 2002, J TRAUMA, V52, P660, DOI 10.1097/00005373-200204000-00008; Koo D, 1996, JAMA-J AM MED ASSOC, V275, P545, DOI 10.1001/jama.275.7.545; Marshall SW, 2005, AM J PREV MED, V28, P95, DOI 10.1016/j.amepre.2004.09.015; Peake DE, 1999, ANN EMERG MED, V33, P67, DOI 10.1016/S0196-0644(99)70419-1; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; SMOCK WS, 1995, J TRAUMA, V38, P489, DOI 10.1097/00005373-199504000-00004	10	11	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	SEP	2007	33	3					219	221		10.1016/j.amepre.2007.05.004			3	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	210JO	WOS:000249452700009	17826583				2022-02-06	
J	Silverberg, ND; Hanks, RA; Mckay, C				Silverberg, Noah D.; Hanks, Robin A.; Mckay, Cherisse			Cognitive estimation in traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						neuropsychological tests; neurobehavioral manifestations; head injuries; closed head injuries; penetrating; cognition; judgment	TESTS	The present study explores the construct and ecological validity of the Biber Cognitive Estimation Test (BCET) in a traumatic brain injury (TBI) sample. Participants completed the BCET in the course of a neuropsychological evaluation at 1-15 years after injury. BCET scores correlated moderately with other standard measures of executive functioning, and contrary to our hypotheses, at least as high with neuropsychological tests with minimal demands on executive functioning. Moreover, partialing out the portion of BCET variance not attributable to executive functioning markedly attenuated the former correlations. With respect to ecological validity, BCET scores did not predict concurrent functional status, as measured by the Disability Rating Scale. By comparison, standard measures of executive functioning strongly correlated with each other, correlated less strongly with nonexecutive functioning measures, and predicted functional status. In conclusion, unlike standard measures of executive functioning, the BCET demonstrated poor construct and ecological validity in TBI patients.	Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; Inst Rehabil, Dept Rehabil Psychol & Neuropsychol, Detroit, MI USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA		Silverberg, ND (corresponding author), Univ Windsor, Dept Psychol, 173 Chrysler Hall S,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	noahsilverberg@hotmail.com					AXELROD BN, 1994, ASSESSMENT, V0001, P00269, DOI DOI 10.1177/107319119400100307; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Brand M, 2003, NEUROPSYCHOLOGIA, V41, P575, DOI 10.1016/S0028-3932(02)00183-5; Bullard SE, 2004, ARCH CLIN NEUROPSYCH, V19, P835, DOI 10.1016/j.acn.2003.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Delis DC., 2001, DELIS KAPLAN EXECUTI; DELIS DC, 2000, CALIFORNIA VERBAL LE; Denckla MB, 1996, DEV NEUROPSYCHOL, V12, P5, DOI 10.1080/87565649609540637; Gillespie DC, 2002, J CLIN EXP NEUROPSYC, V24, P286, DOI 10.1076/jcen.24.3.286.988; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Heaton PDRK., 1993, WISCONSIN CARD SORTI; JACKSON CT, 2002, VALIDATION BIBER COG; Liss M, 2000, J AUTISM DEV DISORD, V30, P613, DOI 10.1023/A:1005699713072; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; *PSYCH CORP, 1997, WECHSL AD INT SCAL; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R, 1985, HALSTEAD REITAN NEUR; SHALLICE T, 1978, CORTEX, V14, P293; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; SHRETLAN DJ, 1992, J CLIN EXP NEUROPSYC, V14, P77	20	11	11	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2007	13	5					898	902		10.1017/S1355617707071135			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	205UQ	WOS:000249140500018	17697421				2022-02-06	
J	Fearing, MA; Bigler, ED; Norton, M; Tschanz, JA; Hulette, C; Leslie, C; Welsh-Bohmer, K				Fearing, Michael A.; Bigler, Erin D.; Norton, Maria; Tschanz, Jo Ann; Hulette, Christine; Leslie, Carol; Welsh-Bohmer, Kathleen		Cache Country Investigators	Autopsy-confirmed Alzheimer's disease versus clinically diagnosed Alzheimer's disease in the Cache County Study on Memory and Aging: A comparison of quantitative MRI and neuropsychological findings	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; MINI-MENTAL-STATE; APOLIPOPROTEIN-E GENOTYPE; HIPPOCAMPAL VOLUME; VASCULAR DEMENTIA; AD; CERAD; QUESTIONNAIRE; RELIABILITY; PROGRESSION	Atrophy of specific, regional, and generalized brain structures occurs as a result of the Alzheimer's disease (AD) process. Comparing AD patients with histopathological confirmation of the disease at autopsy to those without autopsy but who were clinically diagnosed using the same antemortem criteria will provide further evidence of the utility and accuracy of neuropsychological assessments at the time of diagnosis, as well as the efficacy of quantitative magnetic resonance imaging (qMRI) in demonstrating gross neuropathological changes associated with the disease. The Cache County Study of Aging provides a unique opportunity to determine how closely AD subjects with only the clinical diagnosis match similarly diagnosed AD subjects but with postmortem confirmation of the disease. qMRI volumes of various brain structures, as well as neuropsychological outcome measures from an expanded battery, were obtained in 31 autopsy-confirmed AD subjects and 45 clinically diagnosed AD subjects. Of the various qMRI variables examined, only total temporal lobe volume was different, where those with postmortem confirmation had reduced volume. No significant differences between the two groups were found with any of the neuropsychological outcome measures. These findings confirm the similarity in neuroimaging and neuropsychological assessment findings between those with just the clinical diagnosis of AD and those with an autopsy-confirmed diagnosis in the moderate-to-severe stage of the disease at the time of diagnosis.	Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; Utah State Univ, Logan, UT 84322 USA; Duke Univ, Med Ctr, Durham, NC USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1190D SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu	Norton, Maria C/E-6994-2013; Tschanz, JoAnn T./E-5986-2010; Welsh-Bohmer, Kathleen/AAA-3178-2020	Pieper, Carl/0000-0003-4809-1725	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG011380] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG011380, AG-11380] Funding Source: Medline		American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; BENTON AL, 1969, J NEUROL SCI, V9, P39, DOI 10.1016/0022-510X(69)90057-4; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Hayden KM, 2005, J AM GERIATR SOC, V53, P935, DOI 10.1111/j.1532-5415.2005.53301.x; Heyman A, 1999, NEUROLOGY, V52, P1839, DOI 10.1212/WNL.52.9.1839; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; LEITE AJB, 2004, TOP MAGN RESON IMAG, V15, P369, DOI DOI 10.1097/01.RMR.0000168070.90113.DC; Lewis H, 2006, NEUROPATH APPL NEURO, V32, P103, DOI 10.1111/j.1365-2990.2006.00696.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Miyasaka T, 2005, J NEUROPATH EXP NEUR, V64, P665, DOI 10.1097/01.jnen.0000173890.79058.1d; Mori E, 1997, AM J PSYCHIAT, V154, P18, DOI 10.1176/ajp.154.1.18; Norton MC, 1999, NEUROPSY NEUROPSY BE, V12, P270; PLASSMAN BL, IN PRESS ALZHEIMER D; Price CC, 2005, NEUROLOGY, V65, P376, DOI 10.1212/01.WNL.0000168877.06011.15; Salmon DP, 2002, NEUROLOGY, V59, P1022, DOI 10.1212/WNL.59.7.1022; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stoub TR, 2005, NEUROLOGY, V64, P1520, DOI 10.1212/01.WNL.0000160089.43264.1A; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; THAL DR, 2004, SCI AGING KNOWLEDGE, V23, P26; Tschanz JT, 2000, NEUROLOGY, V54, P1290, DOI 10.1212/WNL.54.6.1290; WELSH KA, 1994, ARCH CLIN NEUROPSYCH, V9, P395, DOI 10.1016/0887-6177(94)90003-5; Xu Y, 2000, NEUROLOGY, V54, P1760, DOI 10.1212/WNL.54.9.1760; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416	39	11	11	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	2007	29	5					553	560		10.1080/13803390600826579			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	185RJ	WOS:000247727800010	17564920				2022-02-06	
J	Kaindl, AM; Zabel, C; Stefovska, V; Lehnert, R; Sifringer, M; Klose, J; Ikonomidou, C				Kaindl, Angela M.; Zabel, Claus; Stefovska, Vanya; Lehnert, Ron; Sifringer, Marco; Klose, Joachim; Ikonomidou, Chrysanthy			Subacute proteome changes following traumatic injury of the developing brain: Implications for a dysregulation of neuronal migration and neurite arborization	PROTEOMICS CLINICAL APPLICATIONS			English	Article						axon arborization; brain proteome; brain trauma; developing brain; neurodegeneration	CENTRAL-NERVOUS-SYSTEM; DEVELOPING RAT-BRAIN; OXIDATIVE STRESS; APOPTOTIC NEURODEGENERATION; MICROGLIAL CELLS; MAMMALIAN-CELLS; DEFICIENT MICE; HEAD TRAUMA; PROTEINS; IDENTIFICATION	Traumatic brain injury (TBI) is a major cause of morbidity and mortality among children and adolescents. To gain insight into developmental events influenced by TBI, we analyzed subacute mouse brain proteome changes in a percussion head trauma model at P7 ipsi- and contralateral to the site of injury. The comparison of brain proteomes of trauma mice and controls revealed reproducible changes in the intensity of 28 proteins (30 protein spots) in response to trauma. The changes detected suggest that TBI leads to apoptosis, inflammation, and oxidative stress. These changes were consistent with our results of histological and biochemical evaluation of the brains which revealed widespread apoptotic neurodegeneration, microglia activation, and increased levels of protein carbonyls. Furthermore, we detected changes in proteins involved in neuronal migration as well as axonal and dendritic growth and guidance, suggesting interference of trauma with these developmental events.	Univ Med Berlin, Dept Pediat Neurol, Berlin, Germany; Univ Med Berlin, Inst Human Genet, Berlin, Germany; Tech Univ Dresden, Univ Childrens Hosp, Dept Pediat Neurol, D-8027 Dresden, Germany		Kaindl, AM (corresponding author), Univ Med Sch, Dept Pediat Neurol, Augustenburger Pl 1, D-13353 Berlin, Germany.	angela.kaindl@charite.de		Kaindl, Angela/0000-0001-9454-206X			Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Bittigau P, 2003, NEUROTOX RES, V5, P475, DOI 10.1007/BF03033158; Bittigau P, 1998, RESTOR NEUROL NEUROS, V13, P11; BOYA J, 1991, ACTA ANAT, V140, P250; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Das KC, 2004, ANTIOXID REDOX SIGN, V6, P177, DOI 10.1089/152308604771978480; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DOBBING J, 1974, PEDIATRICS, V53, P2; ESIRI MM, 1991, J CLIN PATHOL, V44, P102, DOI 10.1136/jcp.44.2.102; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Felderhoff-Mueser Ursula, 2000, Current Opinion in Neurology, V13, P141, DOI 10.1097/00019052-200004000-00005; Fetler L, 2005, SCIENCE, V309, P392, DOI 10.1126/science.1114852; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Ivacko JA, 1996, PEDIATR RES, V39, P39, DOI 10.1203/00006450-199601000-00006; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kaindl AM, 2006, CELL DEATH DIFFER, V13, P1097, DOI 10.1038/sj.cdd.4401796; Klose J, 1999, METH MOL B, V112, P147; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Lagercrantz H, 2001, ACTA PAEDIATR, V90, P707; LENN NJ, 1987, PEDIATR NEUROSCI, V13, P176, DOI 10.1159/000120326; MALORNI W, 1991, CHEM-BIOL INTERACT, V80, P217, DOI 10.1016/0009-2797(91)90026-4; Norton WT, 1999, NEUROCHEM RES, V24, P213, DOI 10.1023/A:1022505903312; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Penkowa M, 1999, J NEUROSCI, V19, P2535; Plaisant F, 2003, FREE RADICAL BIO MED, V34, P862, DOI 10.1016/S0891-5849(02)01440-5; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Potts Mathew B, 2006, NeuroRx, V3, P143; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.3.CO;2-S; Rezaie P, 1997, DEV BRAIN RES, V104, P175; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suzuki Y, 2003, J NEUROCHEM, V86, P1042, DOI 10.1046/j.1471-4159.2003.01920.x; Swann JW, 2000, MENT RETARD DEV D R, V6, P258, DOI 10.1002/1098-2779(2000)6:4<258::AID-MRDD5>3.0.CO;2-H; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Zabel C, 2006, J PROTEOME RES, V5, P1948, DOI 10.1021/pr0601077	44	11	12	0	1	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-8346	1862-8354		PROTEOM CLIN APPL	Proteom. Clin. Appl.	JUL	2007	1	7					640	649		10.1002/prca.200600696			10	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	192KH	WOS:000248199900003	21136719				2022-02-06	
J	Kocaaga, Z; Bal, S; Gurgan, A				Kocaaga, Zehra; Bal, Serpil; Gurgan, Alev			Hemiplegia and heterotopic ossification on the non-paretic extremity: A case report	JOURNAL OF REHABILITATION MEDICINE			English	Article						hemiplegia; stroke; heterotopic ossification	CORD-INJURED PATIENTS; MYOSITIS-OSSIFICANS; BONE-FORMATION	Heterotopic ossification is the formation of new bone in an abnormal location. It is usually seen following central nervous system disorders, including spinal cord injury, traumatic brain injury, encephalitis, and burn and trauma. Heterotopic ossification in post-stroke hemiplegia is rare; the reported incidence is 0.5-1.2%. It usually occurs on the paretic side of hemiplegic patients. We present here a case of post-stroke hemiplegia with heterotopic ossification in the non-paretic limb.	Ataturk Res & Educ Hosp, Dept Phys Med & Rehabil, Izmir, Turkey		Kocaaga, Z (corresponding author), Izmir Ataturk Egitim ve Arastirma Hastanesi, Fizik Tedavi ve Rehabil Klin 2, TR-35280 Izmir, Turkey.	zehrakocaaga@hotmail.com					ACKERMAN LV, 1958, J BONE JOINT SURG AM, V40, P279, DOI 10.2106/00004623-195840020-00004; Bosse A, 1997, Veroff Pathol, V146, P1; Chua KSG, 2003, BRAIN INJURY, V17, P535, DOI 10.1080/0269905021000010104; FURMAN R, 1970, J BONE JOINT SURG AM, VA 52, P1131, DOI 10.2106/00004623-197052060-00005; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P303; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GARLAND DE, 1992, ORTHOPAEDIC REHABILI, P453; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; Lotta S, 2001, SPINAL CORD, V39, P595, DOI 10.1038/sj.sc.3101134; MICHELSSON JE, 1983, CLIN ORTHOP RELAT R, P265; MICHELSSON JE, 1980, J BONE JOINT SURG AM, V62, P811, DOI 10.2106/00004623-198062050-00017; SNOECX M, 1995, PARAPLEGIA, V33, P464, DOI 10.1038/sc.1995.101; STOVER SL, 1975, ARCH PHYS MED REHAB, V56, P199; Stover SL, 1986, MANAGEMENT SPINAL CO, P284; VARGHESE G, 1992, PHYS MED REH CLIN N, V3, P407; Warren S B, 1990, Orthop Rev, V19, P603; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; WHYTE J, 2005, PHYS MED REHABILIATI, V2, P1677; Zeilig G, 2006, ARCH PHYS MED REHAB, V87, P92, DOI 10.1016/j.apmr.2005.07.308	21	11	11	0	0	TAYLOR & FRANCIS AS	OSLO	PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY	1650-1977			J REHABIL MED	J. Rehabil. Med.	JUL	2007	39	6					500	502		10.2340/16501977-0086			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	192TR	WOS:000248226400011	17624486	Green Submitted, gold			2022-02-06	
J	Mehta, S				Mehta, Sanjay			Neuroimaging for paediatric minor closed head injuries	PAEDIATRICS & CHILD HEALTH			English	Article						clinical decision rules; computed tomography; minor head injuries; neuroimaging	DECISION RULE; COMPUTED-TOMOGRAPHY; CHILDREN; TRAUMA; RISK	It is clear that paediatric minor head injuries are common and that most cases may be observed without neuroimaging. However, with easier access to computed tomography scans, there has been an increase in its use. In the present article, clinical decision rules for neuroimaging of paediatric minor head injuries, such as the Child and Adolescent Trial for Cardiovascular Health (CATCH) study, will be discussed. Risk factors that should trigger concern are persistently low Glasgow coma scale, suspected open or basilar skull fracture, worsening headache, irritability, large and boggy scalp hematomas and dangerous mechanism of injury. An update on recent recommendations and evidence-based changes are provided.	Hosp Sick Children, Dept Pediat, Div Pediat Emergency Med, Toronto, ON M5G 2L3, Canada		Mehta, S (corresponding author), Hosp Sick Children, Dept Pediat, Div Pediat Emergency Med, 1220-525 Univ Ave, Toronto, ON M5G 2L3, Canada.	sanjay.mehta@sickkids.ca					Bergman DA, 1999, PEDIATRICS, V104, P1407; Da Dalt L, 2007, J PEDIATR-US, V150, P274, DOI 10.1016/j.jpeds.2006.11.060; Dayan PS, 2007, ACAD EMERG MED, V14, P978, DOI 10.1197/j.aem.2007.06.033; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gerein RB, 2006, ACAD EMERG MED, V13, P653, DOI 10.1197/j.aem.2005.12.025; Greenes DS, 2003, ANN EMERG MED, V42, P515, DOI 10.1067/S0196-0644(03)00631-0; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; *PUBL HLTH AG CAN, CHIRRP CAN HOSP INJ; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Thomas KE, 2006, PEDIATR RADIOL, V36, P823, DOI 10.1007/s00247-006-0170-x	12	11	11	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	JUL-AUG	2007	12	6					482	484		10.1093/pch/12.6.482			3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	281QC	WOS:000254512500011	19030413	Bronze, Green Published			2022-02-06	
J	Reiter, PD; Valuck, RJ; Taylor, RS				Reiter, Pamela D.; Valuck, Robert J.; Taylor, Rustorl S.			Evaluation of off-label recombinant activated factor VII for multiple indications in children	CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS			English	Article						NovoSeven; recombinant activated factor VII; bleeding; child	GLANZMANN THROMBASTHENIA; CARDIAC-SURGERY; COAGULOPATHY; TRANSFUSION; INFECTIONS; MANAGEMENT; HEMORRHAGE	Despite a paucity of safety and efficacy data, the use of recombinant activated factor VII in children for off-label indications has now surpassed its use in hemophilia. A retrospective chart review was conducted of 46 subjects (age, 6.7 +/- 6 years; weight, 26 20 kg) who received recombinant activated factor VII for nonhemophiliac indications between January 1, 2004, and September 1, 2005. Indications for use included prevention (n = 6) or treatment (n = 40) of bleeding due to general surgery, hepatic failure, gastrointestinal bleeding, severe traumatic brain injury, bone marrow transplant, cardiac, acetaminophen overdose, and multiorgan system failure. Decreases in prothrombin time, partial thromboplastin time, and international normalized ratio were observed. No inappropriate thrombotic events were noted. Administration of recombinant activated factor VII was associated with a reduction in coagulation markers without obvious adverse thrombotic events at cost of $4189 per dose. These findings should be confirmed in a prospective trial.	Childrens Hosp, Pediat ICU & Trauma, Denver, CO 80218 USA; Univ Colorado, Denver, CO 80262 USA; Sch Pharm, Hlth Sci Ctr, Denver, CO 80262 USA; Christus Santa Rosa Hosp, Dept Pharm, San Antonio, TX USA		Reiter, PD (corresponding author), Ctr Pediat Med, Dept Pharm, PharmD 1056 E 19th Ave,Campus Box 375, Denver, CO 80218 USA.	reiter.pam@tchden.org					Almeida AM, 2003, BRIT J HAEMATOL, V121, P477, DOI 10.1046/j.1365-2141.2003.04286.x; Blatt J, 2001, BONE MARROW TRANSPL, V28, P405, DOI 10.1038/sj.bmt.1703157; Brown JB, 2003, J PEDIATR GASTR NUTR, V37, P268, DOI 10.1097/00005176-200309000-00013; Cetin H, 2006, BLOOD COAGUL FIBRIN, V17, P213, DOI 10.1097/01.mbc.0000220245.20036.2d; Chuansumrit A, 2004, BLOOD COAGUL FIBRIN, V15, P335, DOI 10.1097/00001721-200406000-00008; CULIC S, 2006, PEDIATR BLOOD C 0302; Dodd RY, 2003, NEW ENGL J MED, V349, P1205, DOI 10.1056/NEJMp038138; Egan JR, 2004, INTENS CARE MED, V30, P682, DOI 10.1007/s00134-003-2108-1; Hennewig U, 2005, KLIN PADIATR, V217, P365, DOI 10.1055/s-2005-872523; Kalicinski P, 2005, PEDIATR TRANSPLANT, V9, P299, DOI 10.1111/j.1399-3046.2005.00309.x; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Pychynska-Pokorska Magdalena, 2004, Pediatr Crit Care Med, V5, P246, DOI 10.1097/01.PCC.0000123546.78900.67; Ratko T., 2005, P T, V30, P644; Razon Y, 2005, PEDIATR ANESTH, V15, P235, DOI 10.1111/j.1460-9592.2005.01429.x; Stein DM, 2005, J TRAUMA, V59, P609, DOI 10.1097/01.ta.0000177655.67763.df; Tancabelic J, 2004, PEDIATR BLOOD CANCER, V43, P170, DOI 10.1002/pbc.20078; Taylor RW, 2006, CRIT CARE MED, V34, P2302, DOI 10.1097/01.CCM.0000234034.51040.7F; Tobias JD, 2003, SOUTH MED J, V96, P12, DOI 10.1097/01.SMJ.0000047629.79538.82; Tobias Joseph D, 2003, Pediatr Crit Care Med, V4, P49, DOI 10.1097/00130478-200301000-00009; Veldman A, 2002, INTENS CARE MED, V28, P1635, DOI 10.1007/s00134-002-1489-x; Yilmaz BT, 2005, PEDIATR CARDIOL, V26, P843, DOI 10.1007/s00246-004-0919-7	22	11	11	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1076-0296			CLIN APPL THROMB-HEM	Clin. Appl. Thromb.-Hemost.	JUL	2007	13	3					233	240		10.1177/1076029607302402			8	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	184XG	WOS:000247675300001	17636185	Bronze			2022-02-06	
J	Yi, JH; Herrero, R; Chen, G; Hazell, AS				Yi, Jae-Hyuk; Herrero, Raquel; Chen, Gang; Hazell, Alan S.			Glutamate transporter EAAT4 is increased in hippocampal astrocytes following lateral fluid-percussion injury in the rat	BRAIN RESEARCH			English	Article						traumatic brain injury; glutamate transporter; EAAT4; excitotoxicity; astrocyte; fluid-percussion; brain trauma	PURKINJE-CELL VULNERABILITY; TRAUMATIC BRAIN-INJURY; GATED CHLORIDE CHANNEL; EXPRESSION; GLT-1; LOCALIZATION; CEREBELLUM; PROTEINS; GLAST; MILD	Functional impairment of glutamate transporters contributes to excitotoxic damage and exacerbation of injury in certain neurodegenerative disorders. Several high-affinity sodium-dependent glutamate transporters have been cloned thus far. Of these, EAAT4 is abundantly expressed in Purkinje cells of the cerebellum in rats. However, little is currently known regarding levels of EAAT4 following traumatic brain injury (TBI). In this study, EAAT4 changes were examined for up to 7 days after moderate fluid-percussion by immunoblotting and immunohistochemistry. TBI caused a 20% and 25% increase in EAAT4 levels in the injured hippocampus at day 3 and day 7 following the insult. Immunohistochemical analysis revealed this increase to be localized in cells exhibiting morphological characteristics of astrocytes. In addition, increased EAAT4 immunoreactivity was observed in astrocytes in the ipsilateral cortex and cerebellum at day 3 post-injury that persisted up to 7 days after the insult. Given the reported novel characteristics of chloride conductance displayed by this transporter, our findings of increased EAAT4 levels suggest this protein may play an important role in the pathophysiology of TBI. (C) 2007 Elsevier B.V. All rights reserved.	Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada		Hazell, AS (corresponding author), CHUM, Hop St Luc, NeuroRescu Lab, 1058 St Denis, Montreal, PQ H2X 3J4, Canada.	alan.stewart.hazell@umontreal.ca		Herrero, Raquel/0000-0001-8789-0904			Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Hazell AS, 2001, J NEUROCHEM, V78, P560, DOI 10.1046/j.1471-4159.2001.00436.x; Hu WH, 2003, GLIA, V44, P13, DOI 10.1002/glia.10268; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lin CLG, 1998, MOL BRAIN RES, V63, P174, DOI 10.1016/S0169-328X(98)00256-3; Nagao S, 1997, NEUROSCIENCE, V78, P929; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Ward MM, 2004, CELL TISSUE RES, V315, P305, DOI 10.1007/s00441-003-0849-3; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; [No title captured]	23	11	12	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 18	2007	1154						200	205		10.1016/j.brainres.2007.04.011			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	187OK	WOS:000247857400022	17490622				2022-02-06	
J	Lupi, A; Bertagnoni, G; Salgarello, M; Orsolon, P; Malfatti, V; Zanco, P				Lupi, Andrea; Bertagnoni, Giannettore; Salgarello, Matteo; Orsolon, Piergiuseppe; Malfatti, Veronica; Zanco, Pierluigi			Cerebellar vermis relative hypermetabolism: An almost constant PET finding in an injured brain	CLINICAL NUCLEAR MEDICINE			English	Article						brain FDG metabolism; subcortical structures activation; brain trauma	COGNITIVE EVOKED-POTENTIALS; PERSISTENT VEGETATIVE STATE; HEAD-INJURY; COMA; METABOLISM; PERFUSION; RECOVERY; SPECT	Cortical alterations of brain metabolism, as seen in PET, obviously depend on the nature of the damage (either mechanical, toxic, anoxic, or other). However, some subcortical abnormalities seem to occur rather frequently regardless of the extension, position and cause of the damage. In particular, relative cerebellar vermis activation seems to be frequently encountered. The aim of this work was to determine the incidence of this pattern in a heterogeneous population of brain trauma, and to compare it on a quantitative basis with a group of age-sex matched controls. The case records of this study consist of 58 consecutive patients, 44 males, 14 females, age 14-69 (median 34) 44 traumatic, 8 anoxic, 4 vascular and 2 toxic injuries. In the trauma group, the visualization of the cerebellar vermis was readily appreciable as a consistent majority of cases. In particular, the mean vermis/cerebellum ratio (calculated by appropriate ROI positioning) was 1.26 +/- 0.17 SD (range 0.92-1.82); in the control group the same parameters showed much less dispersion: average 0.92 +/- 0.06, range 0.80-1.10 (P < 0.005). If, on the basis of the normal group data, a cut-off value of 1 is accepted for the v/c ratio, it is noted that 54/57 trauma patients (95%) showed a ratio above this value. In conclusion, a hypermetabolic cerebellar vermis is a common finding in a damaged brain, regardless of the nature of the trauma (probably due to the relative preservation compared with other structures of alternative metabolic pathways), and seems to be the hallmark of the injured brain.	Opsed S Bortolo, Div Nucl Med, I-36100 Vicenza, Italy; Opsed S Bortolo, Div Phys Med, I-36100 Vicenza, Italy		Lupi, A (corresponding author), Opsed S Bortolo, Div Nucl Med, Via M Rodolfi, I-36100 Vicenza, Italy.	andrea.lupi@ulssvicenza.it	Lupi, Andrea/AAI-8661-2020				Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; Beuthien-Baumann B, 2003, NUCL MED COMMUN, V24, P643, DOI 10.1097/00006231-200306000-00005; Bonito V, 2002, NEUROL SCI, V23, P131, DOI 10.1007/s100720200040; Claeys KG, 2003, NEUROIMAGE, V20, P840, DOI 10.1016/S1053-8119(03)00366-5; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; GORDON E, 1995, J NEUROSURG ANESTH, V7, P235, DOI 10.1097/00008506-199510000-00001; Guerit JM, 1997, ACTA NEUROL BELG, V97, P214; Guerit JM, 2000, ACTA NEUROL BELG, V100, P229; Hattori N, 2004, J NUCL MED, V45, P775; Hattori N, 2003, J NUCL MED, V44, P1709; Holguin JA, 2003, REV NEUROLOGIA, V37, P259; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Laureys S, 2004, NEUROREHABILITATION, V19, P335; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Matsumura M, 2004, BRAIN RES BULL, V63, P471, DOI 10.1016/j.brainresbull.2004.04.008; McLean SAM, 1999, J CLIN PATHOL, V52, P490, DOI 10.1136/jcp.52.7.490; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; Palma V, 1989, Acta Neurol (Napoli), V11, P259; Pissiota A, 2002, EUR ARCH PSY CLIN N, V252, P68, DOI 10.1007/s004060200014; Plum F, 1975, Ciba Found Symp, P121; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Snedecor GW., 1989, STAT METHODS, V8th; *SPSS INC STAFF, 1993, SPSS PC PLUS GUID DA; Van Mier HI, 2002, ANN NY ACAD SCI, V978, P334	30	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	JUN	2007	32	6					445	451		10.1097/RLU.0b013e3180537621			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	172FM	WOS:000246789500004	17515750				2022-02-06	
J	Garcia-Molina, A; Roig-Rovira, T; Ensenat-Cantallops, A; Sanchez-Carrion, R; Pico-Azanza, N; Pena-Casanova, J				Garcia-Molina, A.; Roig-Rovira, T.; Ensenat-Cantallops, A.; Sanchez-Carrion, R.; Pico-Azanza, N.; Pena-Casanova, J.			Examination of decision-making processes in patients with traumatic brain injury	NEUROLOGIA			Spanish	Article						traumatic brain injury; decision-making; gambling task; behaviour; knowledge	SOMATIC MARKER HYPOTHESIS; PREFRONTAL CORTEX; GAMBLING TASK; EMOTION; DAMAGE; EPIDEMIOLOGY; PERFORMANCE; DYSFUNCTION; DEFICIT	Introduction. Patients with. moderate or severe traumatic brain injury (TBI) may show impairment in decision-making processes. The Iowa Gambling Task (IGT) has become a widely used neuropsychological research tool to investigate decision-making by simulating real-life decision-making in terms of uncertainty, reward, and punishment. Objective. Investigate decision-making in patients with moderate or severe TBI during performance of the IGT, and study patient's conscious knowledge of the task's reinforcement contingencies (:reward/punishment schedule). Patients and methods. Forty patients with moderate or severe TBI and 30 healthy volunteers participated in the study. Decision-making was evaluated using a computerized version of the IGT. After completing the task, the participants' knowledge of the task was tested. Results. The TBI group had worse performance on the IGT than the control group. They chose more unfavorable cards of the deck than the favorable ones. IGT score differences were observed among TBI patients in relation to level of knowledge of the task. The patients with knowledge of the task's reinforcement contingencies showed better performance, while the patients with scarce knowledge presented worse performance. Conclusions. These results suggest that there is a direct relationship between the knowledge that patients with moderate and serious TBI have regarding the TBI reinforcement contingencies and their performance in the task.	Guttmann UAB, Inst Univ Neurorrehabil, E-08916 Badalona, Barcelona, Spain; Hosp del Mar, IMAS, Secc Neurol Conducta & Demencias, Barcelona, Spain		Roig-Rovira, T (corresponding author), Guttmann UAB, Inst Univ Neurorrehabil, Cami Can Rutin S-N, E-08916 Badalona, Barcelona, Spain.	troig@guttmann.com					Bark R, 2005, PSYCHIAT RES, V134, P131, DOI 10.1016/j.psychres.2004.04.013; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benson D.F., 1986, FRONTAL LOBES; Bowman CH, 2005, BRAIN COGNITION, V57, P21, DOI 10.1016/j.bandc.2004.08.015; Cavedini P, 2002, NEUROPSYCHOLOGIA, V40, P205, DOI 10.1016/S0028-3932(01)00077-X; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Damasio A., 1994, DESCARTES ERROR EMOT; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Damasio AR, 2003, SER AFFECTIVE SCI, P66; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JUNQUE C, 1998, TRAUMATISMOS CRANEOE; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Mesulam M.-M., 2000, PRINC BEHAV COGN NEU, V2, P1, DOI [DOI 10.1017/9781108164320.002, 10.1017/9781108164320.002]; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Ritter LM, 2004, SCHIZOPHR RES, V68, P65, DOI 10.1016/S0920-9964(03)00086-0; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; SHOLBERG MM, 2001, COGNITIVE REHABILITA; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wilson B, 1999, CASE STUDIES NEUROPS; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124; [No title captured]	38	11	12	1	8	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0213-4853	1578-1968		NEUROLOGIA	Neurologia	MAY	2007	22	4					206	212					7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	179DJ	WOS:000247269200002	17492514				2022-02-06	
J	Cummings, JL				Cummings, Jeffrey L.			Involuntary emotional expression disorder: Definition, diagnosis, and measurement scales	CNS SPECTRUMS			English	Article							TRAUMATIC BRAIN-INJURY; PSEUDOBULBAR AFFECT; MULTIPLE-SCLEROSIS; PATHOLOGICAL LAUGHTER; AFFECTIVE LABILITY; NITROUS-OXIDE; PREVALENCE; STROKE; PALSY	Involuntary emotional expression disorder (IEED) is a syndrome in which emotional or affective motor control becomes dysregulated as a result of brain damage from neurological disease or as a result of brain injury. A debilitating disorder with persistent symptoms, IEED has a significant impact upon the lives of patients and caregivers, but is often overlooked or misdiagnosed. IEED is a clinically well-defined disorder, and specific criteria may be used when making a diagnosis. It must be distinguished from depression or other psychological and neurological conditions. Several assessment scales have been validated for use in IEED, in order to evaluate the baseline severity and to track the course of the disorder and response to treatment.	Univ Calif Los Angeles, Alzheimers Dis Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Deane F Johnson Ctr Neurotherapeut, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Cummings, JL (corresponding author), Univ Calif Los Angeles, Alzheimers Dis Ctr, 10911 Weyburn Ave, Los Angeles, CA 90095 USA.	jcummings@mednet.ucla.edu					Adams RD, 1997, PRINCIPLES NEUROLOGY, V6th; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Arciniegas DB, 2005, CNS SPECTRUMS, V10, P1, DOI 10.1017/S1092852900026602; BERKOVIC SF, 1999, MOVEMENT DISORDERS N; BESSON G, 1991, ARCH NEUROL-CHICAGO, V48, P501, DOI 10.1001/archneur.1991.00530170061021; Bleuler E, 1950, DEMENTIA PRAECOX; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Dark FL, 1996, AUST NZ J PSYCHIAT, V30, P472, DOI 10.3109/00048679609065020; Darwin C., 1965, EXPRESS EMOT MAN; DEFENDORF AR, 1904, CLIN PSYCHIAT TXB AB; DUCHOWNY MS, 1983, HDB HUMAN RES, V2; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; Finger S, 1998, ARCH NEUROL-CHICAGO, V55, P241, DOI 10.1001/archneur.55.2.241; GOPINATH SP, 1993, CLIN PEDIATR, V32, P126, DOI 10.1177/000992289303200215; Green, 1998, Semin Clin Neuropsychiatry, V3, P195; GREEN RL, 1987, AM J PSYCHIAT, V144, P442; HARRIS L, 1974, J PSYCHEDEL DRUG, V6, P29, DOI 10.1080/02791072.1974.10471502; HARVEY PD, 1989, J CLIN PSYCHOL, V45, P786, DOI 10.1002/1097-4679(198909)45:5<786::AID-JCLP2270450515>3.0.CO;2-P; Haupt M, 1996, Int Psychogeriatr, V8 Suppl 3, P409; James W., 1890, PRINCIPLES PSYCHOL; James William, 1882, MIND, V7, P186; JAY V, 1991, NEUROLOGY, V41, P416, DOI 10.1212/WNL.41.3.416; Kim JS, 2002, NEUROLOGY, V58, P1106, DOI 10.1212/WNL.58.7.1106; LADER M, 1987, TXB MED TREATMENT, P285; Langworthy OR, 1940, ARCH INTERN MED, V65, P106, DOI 10.1001/archinte.1940.00190070116008; Lauterbach EC, 1997, J NEUROPSYCH CLIN N, V9, P259; LIEBERMAN A, 1977, ARCH NEUROL-CHICAGO, V34, P717, DOI 10.1001/archneur.1977.00500230087017; Mendez MF, 2005, J NEUROPSYCH CLIN N, V17, P429, DOI 10.1176/appi.neuropsych.17.3.429; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; Newsom-Davis IC, 1999, J NEUROL SCI, V169, P22, DOI 10.1016/S0022-510X(99)00211-7; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; Paus S, 2005, ARCH NEUROL-CHICAGO, V62, P1312, DOI 10.1001/archneur.62.8.1312; POECK K, 1969, DISORDERS EMOTION, P343; RAULIN JM, 1900, RIRE EXILARANTS; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Sanfilipo MP, 2006, NEUROLOGY, V66, P685, DOI 10.1212/01.wnl.0000201238.93586.d9; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; SETHI PK, 1976, J NEUROL NEUROSUR PS, V39, P823, DOI 10.1136/jnnp.39.9.823; SHAIBANI AT, 1994, NEUROPSY NEUROPSY BE, V7, P243; SIEGEL RK, 1985, J PSYCHOACTIVE DRUGS, V17, P87, DOI 10.1080/02791072.1985.10472327; SLOAN R L, 1992, Brain Injury, V6, P315, DOI 10.3109/02699059209034945; Smith RA, 2004, AMYOTROPH LATERAL SC, V5, P99, DOI 10.1080/17434470410020058; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Stearns FR, 1972, LAUGHING PHYSL PATHO; STEINBERG H, 1956, BRIT J PSYCHOL, V47, P183, DOI 10.1111/j.2044-8295.1956.tb00581.x; Stoll WA, 1947, SCHWEIZ ARCH NEUROL, V60, P279; STRUB AL, 1988, NEUROBEHAVIOURAL DIS; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Tsai WC, 1998, SCAND J REHABIL MED, V30, P145; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; PSEUDOBULBAR AFFECT; LIVING IEED	56	11	12	0	2	M B L COMMUNICATIONS, INC	NEW YORK	333 HUDSON ST, 7TH FLOOR, NEW YORK, NY 10013 USA	1092-8529			CNS SPECTRUMS	CNS Spectr.	APR	2007	12	4		5			11	16					6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	170WT	WOS:000246697600003	17712916				2022-02-06	
J	Driver, SJ				Driver, Simon J.			Psychometric properties and analysis of the physical activity social influence scale for adults with traumatic brain injuries	ADAPTED PHYSICAL ACTIVITY QUARTERLY			English	Article							MULTIDIMENSIONAL SCALE; CAREGIVER BURDEN; SUPPORT; INDIVIDUALS; EFFICACY; PEOPLE; PREDICTORS; BEHAVIORS; NETWORKS; AQUATICS	The study consisted of (a) assessing the validity and reliability of the Social Influence Scale (SIS) for adults with brain injuries and (b) examining the types and sources of social influence and demographic variables that affect participants' physical activity behaviors. Three confirmatory factor analyses, intraclass correlations, and a repeated measures MANOVA were completed on responses from 402 adults with brain injuries. Results provide evidence of the validity and reliability of the SIS, and post hoc analyses revealed that participants reported receiving different types of social influence from family, friends, and caregivers. Findings have implications for specialists and suggestions are provided on ways to enhance the physical activity participation of adults with brain injuries.	Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA		Driver, SJ (corresponding author), Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA.			driver, simon/0000-0003-2356-432X			ARMSTRONG C, 1991, J REHABIL, V57, P15; Bandura A, 1986, SOCIAL FDN THOUGHT A; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Benson D.F., 1986, FRONTAL LOBES; Berkhuysen MA, 1999, PATIENT EDUC COUNS, V38, P21, DOI 10.1016/S0738-3991(98)00115-3; Chogahara M, 1998, J AGING PHYS ACTIV, V6, P1, DOI 10.1123/japa.6.1.1; Chogahara M, 1999, J GERONTOL B-PSYCHOL, V54, pS356, DOI 10.1093/geronb/54B.6.S356; Clarke D E, 1996, J Cardiopulm Rehabil, V16, P372, DOI 10.1097/00008483-199611000-00006; COAKLEY J, 2001, SPORT SOC ISSUES CON; Cohen J., 1988, STAT ANAL BEHAV SCI; Cohen S., 1984, HDB PSYCHOL HLTH, P253; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cutrona CE., 1990, SOCIAL SUPPORT INTER, P319; Cutrona EC., 1987, ADV PERSONAL RELATIO, V1, P37, DOI DOI 10.1037/0882-7974.1.1.47; Driver S, 2006, ADAPT PHYS ACT Q, V23, P148, DOI 10.1123/apaq.23.2.148; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2006, ADAPT PHYS ACT Q, V23, P1; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; DUNCAN TE, 1993, J APPL SOC PSYCHOL, V23, P1498, DOI 10.1111/j.1559-1816.1993.tb01045.x; DUNCAN TE, 1993, J BEHAV MED, V16, P199, DOI 10.1007/BF00844893; Eyler AA, 1999, SOC SCI MED, V49, P781, DOI 10.1016/S0277-9536(99)00137-9; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Harter S., 1987, CONT ISSUES DEV PSYC, P219; Howell DC, 2001, STAT METHODS PSYCHOL; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Joreskog KG, LISREL 8 STRUCTURAL; Karoly, 1991, PSYCHOL ASSESSMENT, V3, P97, DOI [10.1037/1040-3590.3.1.97, DOI 10.1037/1040-3590.3.1.97]; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Leathem J, 1996, BRAIN INJURY, V10, P27; Litwin H, 2003, J AGING PHYS ACTIV, V11, P389, DOI 10.1123/japa.11.3.389; Loehlin JC, 1998, LATENT VARIABLE MODE; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McAuley E, 2000, PREV MED, V31, P608, DOI 10.1006/pmed.2000.0740; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; *NAT ENV PROT COUN, 1999, NIG DEM HLTH SURV, P1; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Potter J. S., 1994, Journal of Leisurability, V21, P34; Rauch RJ, 2001, NEUROREHABILITATION, V16, P11; Resnick Barbara, 2002, Clin Nurs Res, V11, P52, DOI 10.1177/1054773802011001005; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tabachnick B.G., 2001, USING MULTIVARIATE S; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Udry E, 1997, J SPORT EXERCISE PSY, V19, P71, DOI 10.1123/jsep.19.1.71; *US DEP HHS, 2000, HEALTH PEOPL 2010; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Yun J, 2002, ADAPT PHYS ACT Q, V19, P32, DOI 10.1123/apaq.19.1.32; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1037/0033-2909.107.2.238; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	63	11	11	1	7	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0736-5829	1543-2777		ADAPT PHYS ACT Q	Adapt. Phys. Act. Q.	APR	2007	24	2					160	177		10.1123/apaq.24.2.160			18	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	159OU	WOS:000245876500004	17916915				2022-02-06	
J	Edwards, P; Fernandes, J; Roberts, I; Kuppermann, N				Edwards, Phil; Fernandes, Janice; Roberts, Ian; Kuppermann, Nathan			Young men were at risk of becoming lost to follow-up in a cohort of head-injured adults	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						clinical trial; follow-up; traumatic brain injury; loss to follow-up; outcome assessment; risk factors	GLASGOW OUTCOME SCALE; CRASH TRIAL; MRC CRASH; QUESTIONNAIRES; ATTRITION	Objective: This study is to identify predictors of loss to follow-up among adults with head injury. Study Design and Setting: A prospective cohort of 1,857 adults enrolled in the Medical Research Council (MRC) CRASH trial known to be alive 2 weeks after head injury. Six-month follow-up was defined as "overdue" if over 6 months late. Patient information collected at enrollment and after 14 days was used to predict overdue follow-up. A random two-thirds of the cohort was analyzed using logistic regression and binary recursive partitioning. The regression model and decision rule derived by recursive partitioning were evaluated using the remaining third. Results: Overdue follow-up was more likely in patients aged 25-34 years (odds ratio, 1.76; 95% confidence interval [CI] = 1.18-2.62), victims of assault (1.63; 1.09-2.45), patients independent after 2 weeks (1.79; 1.18-2.72) and patients for whom postcodes (2.36; 1.65-3.39), telephone numbers (1.82; 1.19-2.79) or general practitioners (1.67; 1.16-2.39) were unknown. Binary recursive partitioning specifically identified males aged younger than 43 years to be at risk. Conclusion: Successful follow-up in head-injury studies requires patients' postcodes and telephone numbers to be available. Young men remain at risk of becoming lost to follow-up, presenting a challenge for researchers aiming for complete data. (C) 2007 Elsevier Inc. All rights reserved.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, CRASH Trials Coordinating Ctr, London WC1E 7HT, England; Univ Calif Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Dept Paediat, Davis, CA 95616 USA		Edwards, P (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, CRASH Trials Coordinating Ctr, Keppel St, London WC1E 7HT, England.	phil.edwards@LSHTM.ac.uk		Edwards, Phil/0000-0003-4431-8822			ARMSTRONG BK, 1995, MONOGRAPHS EPIDEMIOL, V21, P294; Braet V, 2002, EMERG MED J, V19, P510; BRIEMAN L, 1994, CLASSIFICATION REGRE; Coats TJ, 2005, EMERG MED J, V22, P683, DOI 10.1136/emj.2005.024588; Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P213, DOI 10.1016/S0895-4356(01)00472-3; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Edwards P, 2005, J EPIDEMIOL COMMUN H, V59, P987, DOI 10.1136/jech.2005.034397; Edwards P, 2005, LANCET, V365, P1957; Murray C. J., 1996, GLOBAL HLTH STAT COM; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P79; *STAT CORP, 1999, STATACORP STAT STAT; STEINBERG D, 1997, CART CLASSIFICATION; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0; Weinberger M, 2002, J CLIN EPIDEMIOL, V55, P230, DOI 10.1016/S0895-4356(01)00437-1; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Yates D, 1999, J ACCID EMERG MED, V16, P83	18	11	11	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-4356			J CLIN EPIDEMIOL	J. Clin. Epidemiol.	APR	2007	60	4					417	424		10.1016/j.jclinepi.2006.06.021			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	148SF	WOS:000245094200015	17346617				2022-02-06	
J	Donders, J; Nienhuisi, JB				Donders, Jacobus; Nienhuisi, Jacob B.			Utility of California Verbal Learning Test, Second Edition, recall discriminability indices in the evaluation of traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						assessment; learning; memory; traumatic brain injury; sensitivity; specificity	MEMORY; PERFORMANCE; DEFICITS; DEMENTIA	The performance of 23 patients with moderate-severe traumatic brain injury on the California Verbal Learning Test, Second Edition (CVLT-II; Delis et al., 2000) was compared with that of 23 matched healthy controls to determine whether recall discriminability indices, which take into account both correct target recall and intrusive errors, would provide better diagnostic classification than traditional variables that are based exclusively on correct recall. Patients with traumatic brain injury recalled fewer correct words, and also made more intrusive errors, on CVLT-II short and long delay, free and cued recall trials (p <.02 for all variables after Stepdown Bonferroni correction). However, recall discriminability indices yielded a classification of clinical versus control participants (72%) that was not significantly different from one based on traditional variables (74%). We conclude that CVLT-II recall discriminability indices do not routinely provide an advantage over traditional variables in patients with traumatic brain injury.	Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DELIS D, 1987, CALIFORNIA VERBAL LE; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELIS DC, 2000, CALIFORNIA VERBAL LE; Hamilton JM, 2004, J INT NEUROPSYCH SOC, V10, P689, DOI 10.1017/S1355617704105043; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; [No title captured], DOI DOI 10.1037/1040-3590.3.1.19	14	11	11	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2007	13	2					354	358		10.1017/S1355617707070439			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	144XD	WOS:000244828800018	17286892				2022-02-06	
J	Handel, SF; Ovitt, L; Spiro, JR; Rao, V				Handel, Sharon F.; Ovitt, Linda; Spiro, Jennifer R.; Rao, Vani			Affective disorder and personality change in a patient with traumatic brain injury	PSYCHOSOMATICS			English	Article							PSYCHIATRIC ASPECTS; DEPRESSION; MANAGEMENT		Johns Hosp Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD USA; Johns Hopkins Bayview Med Ctr, Brain Injury Clin, Dept Psychiat, Community Psychiat Program, Baltimore, MD USA		Rao, V (corresponding author), Johns Hopkins Univ Hosp, Dept Psychiat & Behav Sci, Div Geriatr Psychiat & Neuropsychiat, 550 N Broadway, Baltimore, MD 21205 USA.	vrao@jhmi.edu					Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Beresford TP, 2005, BRAIN INJURY, V19, P309, DOI 10.1080/02699050410001720121; Deb S, 1999, AM J PSYCHIAT, V156, P374; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Mustafa B, 2005, J NEUROPSYCH CLIN N, V17, P122, DOI 10.1176/appi.neuropsych.17.1.122; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791	17	11	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	FEB	2007	48	1					67	70		10.1176/appi.psy.48.1.67			4	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	123RN	WOS:000243313300011	17209153				2022-02-06	
J	Hemelsoet, DM; De Bleecker, JL				Hemelsoet, D. M.; De Bleecker, J. L.			Post-traumatic spontaneous recurrent hypothermia: a variant of Shapiro's syndrome	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						hypothermia; post-traumatic; recurrent; Shapiro's syndrome; spontaneous	AGENESIS; HYPERHIDROSIS	A 49-year-old man presented with episodic hypothermia many years after sustaining a contusional brain injury. Brain magnetic resonance imaging demonstrated the destruction of the anterior parts of the corpus callosum without hypothalamic lesions. Nevertheless, delayed hypothalamic dysfunction at the neurotransmitter level is the probable pathophysiological key factor. Clomipramine treatment was beneficial. This case expands the spectrum of Shapiro's syndrome.	Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium		Hemelsoet, DM (corresponding author), Ghent Univ Hosp, Dept Neurol, De Pintelaan 185, B-9000 Ghent, Belgium.	dimitri.hemelsoet@ugent.be	De Bleecker, Jan/B-7785-2013	Hemelsoet, Dimitri/0000-0001-5403-3092			Bosacki C, 2005, REV MED INTERNE, V26, P615, DOI 10.1016/j.revmed.2005.05.005; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Dattani M, 2004, LANCET, V363, P1977, DOI 10.1016/S0140-6736(04)16413-1; GUREWITZ R, 1986, ACTA ENDOCR-COP    S, V279, P468; Klein CJ, 2001, NEUROLOGY, V56, P254, DOI 10.1212/WNL.56.2.254; KLOOS RT, 1995, MEDICINE, V74, P268, DOI 10.1097/00005792-199509000-00004; Mekjavic IB, 2006, J APPL PHYSIOL, V100, P2065, DOI 10.1152/japplphysiol.01118.2005; OBRIEN H, 1982, BRIT J HAEMATOL, V51, P451, DOI 10.1111/j.1365-2141.1982.tb02802.x; Osaka T, 2004, AM J PHYSIOL-REG I, V287, pR306, DOI 10.1152/ajpregu.00003.2004; Segeren CM, 1997, NETH J MED, V50, P29, DOI 10.1016/S0300-2977(96)00071-X; SHAPIRO WR, 1969, BRAIN, V92, P423, DOI 10.1093/brain/92.2.423; Tambasco N, 2005, NEUROLOGY, V65, P124, DOI 10.1212/01.WNL.0000160423.17825.5E	12	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	FEB	2007	14	2					224	227		10.1111/j.1468-1331.2006.01609.x			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128SO	WOS:000243679100026	17250734				2022-02-06	
J	Koshinaga, M; Suma, T; Fukushima, M; Tsuboi, I; Aizawa, S; Katayama, Y				Koshinaga, M.; Suma, T.; Fukushima, M.; Tsuboi, I.; Aizawa, S.; Katayama, Y.			Rapid microglial activation induced by traumatic brain injury is independent of blood brain barrier disruption	HISTOLOGY AND HISTOPATHOLOGY			English	Article						microglia; blood brain barrier; brain injury; CR3	SPREADING DEPRESSION; RAT; CELLS; DAMAGE; ASTROCYTES; EXPRESSION; ISCHEMIA; RELEASE	Following CNS injury, microglia respond and transform into reactive species exhibiting characteristic morphological changes that have been termed "activated" or "ameboid" microglia. In an attempt to establish that microglial reactions induced immediately after injury are caused by intrinsic mechanisms rather than infiltration of blood and its constituents, oxygenized Ringer's solution was perfused into the cerebral circulation of rats so that the circulating blood could be eliminated prior to injury induction. Under artificial respiration, a catheter was inserted from the cardiac apex into the ascending aorta, and oxygenized Ringer's solution was immediately perfused with a pulsatile blood pump, resulting in wash out of the circulating blood from the brain within 1 min. Subsequently, a cortical contusion was induced in the unilateral parietal cortex using a controlled cortical impact (CCI) device. At 5 min following the injury, the brain was fixed by perfusion of fixative through the catheter and removed. Coronal vibratome sections were then processed for CR3 immunohistochemistry to examine the microglial activation. It appeared that microglial activation with both morphological transformation and an increase in CR3 immunoreactivity was induced throughout the hemisphere ipsilateral to the injury side exclusively, even in rats with elimination of circulating blood. The microglial reactions did not differ substantially from those observed in the control rats with extensive BBB disruption. The present results thus provide direct evidence that the microglial activation induced immediately after injury is independent of infiltration of circulating blood induced by concurrent BBB disruption.	Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo 1738610, Japan; Nihon Univ, Sch Med, Dept Anat, Tokyo 1738610, Japan		Koshinaga, M (corresponding author), Nihon Univ, Sch Med, Dept Anat & Neurol Surg, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	koshimo@med.nihon-u.ac.jp					AKIYAMA H, 1988, J NEUROSCI RES, V20, P147, DOI 10.1002/jnr.490200202; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Caggiano AO, 1996, J COMP NEUROL, V369, P93, DOI 10.1002/(SICI)1096-9861(19960520)369:1<93::AID-CNE7>3.0.CO;2-F; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Del Rio-Hortega R., 1965, CYTOLOGY CELLULAR PA, P483; DIXON CE, 1991, J NEUROSCI METH, V39, P253; GEHRMANN J, 1992, J CEREBR BLOOD F MET, V12, P257, DOI 10.1038/jcbfm.1992.36; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1994, NEUROCHEM INT, V25, P227, DOI 10.1016/0197-0186(94)90066-3; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; HOSSMANN KA, 1973, ARCH NEUROL-CHICAGO, V29, P375, DOI 10.1001/archneur.1973.00490300037004; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; KREUTZBERG GW, 1987, ENCY NEUROSCIENCE, P661; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; Maeda T, 1998, J NEUROTRAUM, V15, P655, DOI 10.1089/neu.1998.15.655; MORIOKA T, 1991, J CEREBR BLOOD F MET, V11, P966, DOI 10.1038/jcbfm.1991.162; SHIPLEY MT, 1994, SOC NEUR ABSTR, V365, P4; SUZUMURA A, 1990, J NEUROIMMUNOL, V30, P111, DOI 10.1016/0165-5728(90)90094-4; WALZ W, 1993, J NEUROSCI, V13, P4403	27	11	12	0	0	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	FEB	2007	22	2					129	135					7	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	113CY	WOS:000242576600002	17149685				2022-02-06	
J	Cordeiro, JR; Camelier, A; Oakley, F; Jardim, JR				Cordeiro, Junia R.; Camelier, Aquiles; Oakley, Frances; Jardim, Jose R.			Cross-cultural reproducibility of the Brazilian Portuguese version of the role checklist for persons with chronic obstructive pulmonary disease	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						chronic obstructive pulmonary disease (COPD); culture; role	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; OCCUPATIONAL-THERAPY; TRANSLATION; ADAPTATION; AGREEMENT; PATIENT	OBJECTIVE. This article presents the results of a cross-cultural reproducibility and test-retest reliability study of a Brazilian version of the Role Checklist, in a population with chronic obstructive pulmonary disease (COPD). METHODS. The English version was translated and culturally adapted into Brazilian Portuguese, then administered twice at a 2-week interval to a group of 25 clinically stable individuals with COPD. RESULTS. Cross-cultural adaptation led to adjustments in some terms used in the checklist. Values obtained for kappa suggested mode rate-to-substantial agreement for Part I and Part II. No statistically significant correlations were found between agreement and variables of gender, occupation, marital status, level of education, level of depression, or severity of bronchial obstruction. CONCLUSION. The Brazilian Portuguese version of the Role Checklist was found content valid and reliable for persons with COPD and probably for the Brazilian population in general.	Univ Fed Sao Paulo, Brazil Resp Div, Lar Escola Sao Francisco, BR-04023062 Sao Paulo, Brazil; Univ Fed Sao Paulo, Rehabil Pulm Ctr, Lar Escola Sao Francisco, BR-04023062 Sao Paulo, Brazil; Hosp Israelita Albert Einstein, Occupat Therapy Sect, Sao Paulo, Brazil; NIH, Occupat Therapy Sect, Bethesda, MD 20892 USA		Cordeiro, JR (corresponding author), Univ Fed Sao Paulo, Brazil Resp Div, Lar Escola Sao Francisco, Rua Botucatu 740,3o Andar, BR-04023062 Sao Paulo, Brazil.	juniacordeiro@terra.com.br; joserjardim@yahoo.com.br	Jardim, Jose R/E-3205-2016				BAKER F, 1991, SOC SCI MED, V32, P697, DOI 10.1016/0277-9536(91)90149-7; BARRIS R, 1986, OCCUP THER J RES, V6, P301, DOI 10.1177/153944928600600504; BARRIS R, 1988, OCCUPATIONAL THERAPY, V8, P3; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; BAVARO SM, 1991, AM J OCCUP THER, V45, P456, DOI 10.5014/ajot.45.5.456; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Biaggio AMB., 1979, INVENTARIO ANSIEDADE; BRANHOLM IB, 1994, DISABIL REHABIL, V16, P205; Bussab, 2004, ESTATISTICA BASICA; Camelier A, 2005, RESP MED, V99, P602, DOI 10.1016/j.rmed.2004.09.022; Camelier Aquiles, 2003, J. Pneumologia, V29, P28, DOI 10.1590/S0102-35862003000100007; Chen S, 2003, PERS SOC PSYCHOL B, V29, P1285, DOI 10.1177/0146167203255226; Colon H, 2002, AM J OCCUP THER, V56, P586, DOI 10.5014/ajot.56.5.586; COPPOLA S, 2000, PULMONARY REHABILITA, P213; Crowe TK, 1997, AM J OCCUP THER, V51, P651, DOI 10.5014/ajot.51.8.651; DICKERSON AE, 1995, AM J OCCUP THER, V49, P221, DOI 10.5014/ajot.49.3.221; DUELLMAN MK, 1986, AM J OCCUP THER, V40, P618, DOI 10.5014/ajot.40.9.618; EBB E W, 1989, Occupational Therapy in Mental Health, V9, P53, DOI 10.1300/J004v09n02_03; EGAN M, 1992, OCCUP THER J RES, V12, P342, DOI 10.1177/153944929201200602; ELLIOTT MS, 1987, OCCUP THER J RES, V7, P215, DOI 10.1177/153944928700700403; Fabbri Leonardo, 2004, COPD, V1, P105; Falcao DD, 2003, J RHEUMATOL, V30, P379; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fernandez-Castro J, 2002, PSYCHOL REP, V91, P431, DOI 10.2466/PR0.91.6.431-435; Frosch S, 1997, BRAIN INJURY, V11, P891; *GOLD, 2003, POCK GUID DIAGN TREA; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; GUSICH RL, 1984, OCCUPATIONAL THERAPY, V4, P59; Hachey R, 2001, Can J Occup Ther, V68, P112; Hachey R., 1995, OCCUPATIONAL THERAPY, V2, P190, DOI DOI 10.1002/0TI.V2.3; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; HULLEY SB, 2001, DESIGNING CLIN RES; JACOWAY IS, 1987, OCCUPATIONAL THERAPY, V7, P17; Karpinski A, 2004, PERS SOC PSYCHOL B, V30, P22, DOI 10.1177/0146167203258835; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Kusznir A, 1996, CAN J OCCUP THER, V63, P313; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEDERER J M, 1985, Occupational Therapy in Mental Health, V5, P59, DOI 10.1300/J004v05n02_05; OAKLEY F, 1986, OCCUP THER J RES, V6, P157, DOI 10.1177/153944928600600303; OAKLEY F, 1985, AM J OCCUP THER, V39, P147, DOI 10.5014/ajot.39.3.147; OAKLEY F, 1987, OCCUPATIONAL THERAPY, V7, P215; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; RUST KM, 1987, OCCUPATIONAL THERAPY, V7, P17; SEPIOL JM, 1990, AM J OCCUP THER, V44, P1008, DOI 10.5014/ajot.44.11.1008; SKELTON JA, 1991, MENTAL REPRESENTATIO; SMYNTEK L, 1985, Occupational Therapy in Mental Health, V5, P21, DOI 10.1300/J004v05n01_02; Sousa TC., 2000, J PNEUMOLOGIA, V26, P119, DOI DOI 10.1590/S0102-35862000000300004; SOUZA CB, 2003, PSICOL SAUDE DOENCAS, V4, P149; Velloso M, 2003, CHEST, V123, P1047, DOI 10.1378/chest.123.4.1047; WATSON MA, 1991, PHYS OCCUPATIONAL TH, V10, P27, DOI DOI 10.1080/J148V10N01_03; *WHO, 2004, CHRON OBSTR PULM DIS; Youngstrom MJ, 2002, AM J OCCUP THER, V56, P609	53	11	11	1	4	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2007	61	1					33	40		10.5014/ajot.61.1.33			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	130EM	WOS:000243782300004	17302103				2022-02-06	
B	Donders, J		Hunter, SJ; Donders, J		Donders, Jacobus			Traumatic brain injury	PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE			English	Article; Book Chapter							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; SEROTONIN REUPTAKE INHIBITORS; VERBAL-LEARNING-TEST; LONG-TERM OUTCOMES; EXECUTIVE FUNCTION; PSYCHIATRIC-DISORDERS; FAMILY INTERVENTION; PERSONALITY-CHANGE; CHILDRENS-VERSION										Adelson PD, 2003, CRIT CARE MED, V31, pS418, DOI 10.1097/00003246-200306006-00002; AGRAN PF, 1992, ACCIDENT ANAL PREV, V24, P349, DOI 10.1016/0001-4575(92)90047-M; American Educational Research Association American Psychological Association & American Council on Measurement in Education, 1999, STAND ED PSYCH TESTS; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Benn KM, 2004, BRAIN INJURY, V18, P239, DOI 10.1080/02699050310001617343; Bigler E.D., 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Butler K, 1997, CHILD NEUROPSYCHOL, V3, P98, DOI 10.1080/09297049708401371; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Courtney DB, 2004, CAN J PSYCHIAT, V49, P557, DOI 10.1177/070674370404900807; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Delis DC., 1994, CALIFORNIA VERBAL LE; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Donders J, 1999, DEV NEUROPSYCHOL, V15, P395, DOI 10.1080/87565649909540757; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2001, CHILD NEUROPSYCHOL, V7, P99, DOI 10.1076/chin.7.2.99.3126; Donders J, 1997, Pediatr Rehabil, V1, P179; Donders J, 2000, J HEAD TRAUMA REHAB, V15, P792, DOI 10.1097/00001199-200004000-00004; DONDERS J, 1998, HDB PEDIAT PSYCHOL P, V2, P166; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gil AM, 2003, J SCHOOL PSYCHOL, V41, P337, DOI 10.1016/S0022-4405(03)00085-2; Gioia GA IP, 2000, BEHAV RATING INVENTO; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Green LB, 2004, AM J PHYS MED REHAB, V83, P893, DOI 10.1097/01.PHM.0000143400.15346.C8; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P87, DOI 10.1093/jpepsy/27.1.87; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Kieslich M, 2001, DISABIL REHABIL, V23, P665; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Marshall KW, 1998, AM J NEURORADIOL, V19, P1599; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McMahon MA, 2001, J HEAD TRAUMA REHAB, V16, P587, DOI 10.1097/00001199-200112000-00006; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mottram L, 2005, PSYCHOL ASSESSMENT, V17, P212, DOI 10.1037/1040-3590.17.2.212; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Nybo T, 1999, BRAIN INJURY, V13, P759; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Poussaint TY, 2002, NEUROIMAG CLIN N AM, V12, P271, DOI 10.1016/S1052-5149(02)00005-9; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Swift EE, 2003, J DEV BEHAV PEDIATR, V24, P24, DOI 10.1097/00004703-200302000-00007; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Teplicky R, 2005, ARCH PHYS MED REHAB, V86, P924, DOI 10.1016/j.apmr.2004.07.355; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Verger K, 2001, BRAIN INJURY, V15, P211; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; WAALAND PK, 1993, BRAIN INJURY, V7, P135, DOI 10.3109/02699059309008167; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Weller Elizabeth B, 2005, Curr Psychiatry Rep, V7, P87, DOI 10.1007/s11920-005-0003-x; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wong ICK, 2004, DRUG SAFETY, V27, P991, DOI 10.2165/00002018-200427130-00002; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yeates KO., 2005, WISC 4 CLIN USE INTE, P415, DOI 10.1016/B978-012564931-5/50014-1; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	141	11	11	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-521-87550-9				2007							91	111					21	Clinical Neurology; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BXM34	WOS:000296371600006					2022-02-06	
J	Saltzman-Benaiah, J; Lalonde, CE				Saltzman-Benaiah, Jennifer; Lalonde, Christopher E.			Developing clinically suitable measures of social cognition for children: Initial findings from a normative sample	CLINICAL NEUROPSYCHOLOGIST			English	Article							FRONTOTEMPORAL DEMENTIA; INTERPRETIVE DIVERSITY; LEARNING-DISABILITIES; EXECUTIVE FUNCTION; MIND; RECOGNITION; BELIEFS; ADOLESCENTS; DISTINCTION; PERSPECTIVE	Our understanding of children's social competence has increased tremendously over the past two decades. There is increasing evidence to suggest that social-cognitive impairments are not restricted to children on the autistic spectrum, but rather may be associated with a host of developmental and acquired neurological conditions including learning disabilities, attention deficit disorder, traumatic brain injury, and stroke. Although many investigators have begun to bridge the gap between clinical practice and research by applying experimental tasks to clinical populations, few tools are available for the clinical evaluation of social competence, particularly in children. This study marks a series of first steps in the development of measures suitable for the assessment of children between 6 and 12 years of age. The results of the study provide data for a number of experimental tasks that have been adapted with clinical practice in mind. A discussion of the developmental progressions and the relationships among the measures is also included.	Univ Victoria, Dept Psychol, Victoria, BC V8W 2Y2, Canada		Saltzman-Benaiah, J (corresponding author), Toronto Western Hosp, Tourette Syndrome Neurodev Clin, 3rd Floor W Wing,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	jsaltzma@uhnres.utoronto.ca		Lalonde, Christopher/0000-0002-0446-0464			ADAMS K, 1991, AM J MENT RETARD, V96, P21; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Astington J.W., 1988, DEV THEORIES MIND; Baron-Cohen S. J., 2000, UNDERSTANDING OTHER; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; BROTHERS L, 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Carpendale JI, 1996, CHILD DEV, V67, P1686, DOI 10.2307/1131725; CHANDLER MJ, 1984, INT J BEHAV DEV, V7, P145, DOI 10.1177/016502548400700203; CHANDLER MJ, 1988, DEV THEORIES MIND, P387; Chandok MR, 1996, J PLANT BIOCHEM BIOT, V5, P7, DOI 10.1007/BF03262971; DEMOREST A, 1984, CHILD DEV, V55, P1527, DOI 10.2307/1130022; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GNEPP J, 1986, DEV PSYCHOL, V22, P103, DOI 10.1037/0012-1649.22.1.103; GNEPP J, 1985, CHILD DEV, V56, P1455, DOI 10.1111/j.1467-8624.1985.tb00211.x; Greene RW, 1996, J AM ACAD CHILD PSY, V35, P571, DOI 10.1097/00004583-199605000-00011; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Grezes J, 2004, NEUROIMAGE, V21, P744, DOI 10.1016/S1053-8119(03)00665-7; HALA S, 1991, CHILD DEV, V62, P83, DOI 10.1111/j.1467-8624.1991.tb01516.x; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; HARRIS PL, 1986, CHILD DEV, V57, P895, DOI 10.1111/j.1467-8624.1986.tb00253.x; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; LALONDE CE, 1995, COGNITION EMOTION, V9, P167, DOI 10.1080/02699939508409007; Lalonde CE, 2002, NEW IDEAS PSYCHOL, V20, P163, DOI 10.1016/S0732-118X(02)00007-7; LEEKAM SR, 1991, COGNITION, V40, P203, DOI 10.1016/0010-0277(91)90025-Y; Leekam SR., 1991, NATURAL THEORIES MIN, P159; Matthys W, 1999, J AM ACAD CHILD PSY, V38, P311, DOI 10.1097/00004583-199903000-00019; MCEVOY RE, 1993, J CHILD PSYCHOL PSYC, V34, P563, DOI 10.1111/j.1469-7610.1993.tb01036.x; Milch-Reich S, 1999, CHILD DEV, V70, P413, DOI 10.1111/1467-8624.00030; MOFFATT CW, 1995, EDUC TRAIN MENT RET, V30, P76; MONTGOMERY DE, 1993, DEV PSYCHOL, V29, P337, DOI 10.1037/0012-1649.29.2.337; ONEILL DK, 1991, DEV PSYCHOL, V27, P390, DOI 10.1037/0012-1649.27.3.390; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Pennington, 1991, DEV PSYCHOPATHOL, V3, P137, DOI [10.1017/S0954579400000043, DOI 10.1017/S0954579400000043]; Perner J., 1988, DEV THEORIES MIND, P271; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; Rourke BP, 1996, TOP LANG DISORD, V16, P30, DOI 10.1097/00011363-199602000-00005; SAARNI C, 1984, CHILD DEV, V55, P1504, DOI 10.2307/1130020; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; SODIAN B, 1991, BRIT J DEV PSYCHOL, V9, P173, DOI 10.1111/j.2044-835X.1991.tb00869.x; Sprouse CA, 1998, J NONVERBAL BEHAV, V22, P125, DOI 10.1023/A:1022932315274; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; TAYLOR M, 1991, CHILD DEV, V62, P1334, DOI 10.2307/1130810; Terwogt MM, 2003, NEW IDEAS PSYCHOL, V21, P69, DOI 10.1016/S0732-118X(02)00031-4; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zelazo P. D., 2002, HDB CHILDHOOD COGNIT, P445, DOI DOI 10.1002/9780470996652.CH20; Zeman J, 1996, CHILD DEV, V67, P957, DOI 10.1111/j.1467-8624.1996.tb01776.x; [No title captured]	50	11	11	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2007	21	2					294	317		10.1080/13854040500473760			24	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	158GW	WOS:000245780800007	17455020				2022-02-06	
J	Eberspacher, E; Heimann, K; Hollweck, R; Werner, C; Schneider, G; Engelhard, K				Eberspacher, Eva; Heimann, Kerstin; Hollweck, Regina; Werner, Christian; Schneider, Gerhard; Engelhard, Kristin			The effect of electroencephalogram-targeted high- and low-dose propofol infusion on histopathological damage after traumatic brain injury in the rat	ANESTHESIA AND ANALGESIA			English	Article							CONTROLLED CORTICAL IMPACT; CEREBRAL BLOOD-FLOW; INCOMPLETE ISCHEMIA; ELECTRICAL-ACTIVITY; TEMPORAL PROFILE; ISOFLURANE; HALOTHANE; NEUROPROTECTION; METABOLISM; MODEL	BACKGROUND: Propofol is commonly used to sedate patients after traumatic brain injury. However, the dose-dependent neuroprotective effects of propofol after head trauma are unknown. We compared histopathological damage after 6 h of electroencephalogram-targeted high- and low-dose propofol infusion in rats subjected to controlled cortical impact (CCI). METHODS: Animals were randomly assigned to CCI/propofol with electroencephalogram burst-suppression-ratio 1%-5% (CCI/lowprop), CCI/propofol with burst-suppression-ratio 30%,40% (CCI/highprop), control group CCI/1.0 vol % halothane (CCI/halo), or sham group with halothane anesthesia (SHAM/halo). Brain slices were stained with kresyl violet (K-V) and hematoxyhn/eosin (HIE) to evaluate lesion volume, number of eosinophilic cells, and activation of caspase-3 in the hippocampus. RESULTS: Lesion volume (mm(3)) and number of eosinophilic cells in the hippocampus did not differ significantly [lesion volumes: CCI/lowprop 31.55 +/- 14.66 (KV) and 53.77 +/- 8.62 (HE); CCI/highprop 33.81 +/- 10.57 (KV) and 52.30 +/- 11.55 (HE); CCI/halo 36.42 +/- 17.06 (KV) and 57.95 +/- 8.49 (HE)]. Activation of caspase-3 occurred in the ipsilateral hippocampus in all CCI-groups. CONCLUSION: Despite different levels of cortical neuronal function, there were no relevant differences in the short-term histopathological damage. These results challenge the view that the neuroprotective effect of propofol relates to the suppression of cerebral metabolic demand.	Univ Calif Davis, Vet Med Teaching Hosp, Dept Surg & Radiol Sci, Davis, CA 95616 USA; Tech Univ Munich, Klinikum Isar, Klin Anaesthesiol, D-8000 Munich, Germany; Tech Univ Munich, Klinikum Isar, Dept Med Stat & Epidemiol, D-8000 Munich, Germany; Univ Mainz, Anasthesiol Klin, D-6500 Mainz, Germany		Eberspacher, E (corresponding author), Univ Calif Davis, Vet Med Teaching Hosp, Dept Surg & Radiol Sci, 1 Shields Ave, Davis, CA 95616 USA.	eberspaecher@ucdavis.edu		Schneider, Gerhard/0000-0002-4903-0118			Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bhardwaj A, 2001, STROKE, V32, P1920, DOI 10.1161/01.STR.32.8.1920; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; ENGLELHARD K, 2004, ANESTHESIOLOGY, V99, P1095; FULTON B, 1995, DRUGS, V50, P636, DOI 10.2165/00003495-199550040-00006; HOFFMAN WE, 1990, ANESTHESIOLOGY, V72, P1045, DOI 10.1097/00000542-199006000-00015; Hollrigel GS, 1996, J NEUROPHYSIOL, V76, P2412, DOI 10.1152/jn.1996.76.4.2412; Ito H, 1999, ACTA ANAESTH SCAND, V43, P153, DOI 10.1034/j.1399-6576.1999.430206.x; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Lagerkranser M, 1997, J NEUROSURG ANESTH, V9, P188, DOI 10.1097/00008506-199704000-00015; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; NEWBERG LA, 1983, ANESTHESIOLOGY, V59, P23, DOI 10.1097/00000542-198307000-00005; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Palkovits M., 1988, MAPS GUIDE MICRODISS; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; RIDENOUR TR, 1992, ANESTHESIOLOGY, V76, P807, DOI 10.1097/00000542-199205000-00020; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; TODD MM, 1984, ANESTHESIOLOGY, V60, P276, DOI 10.1097/00000542-198404000-00002; Young Y, 1997, EUR J ANAESTH, V14, P320, DOI 10.1046/j.1365-2346.1997.00130.x	25	11	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	DEC	2006	103	6					1527	1533		10.1213/01.ane.0000247803.30582.2d			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	109DW	WOS:000242289100036	17122234				2022-02-06	
J	Falk, AC; Cederfjall, C; Von Wendt, L; Klang, B				Falk, Ann-Charlotte; Cederfjall, Claes; Von Wendt, Lennart; Klang, Birgitta			Are the symptoms and severity of head injury predictive of clinical findings three months later?	ACTA PAEDIATRICA			English	Article						children; classification; outcome; symptoms; traumatic brain injuries		Aim: To describe symptoms and functional disabilities 3 mo after a minimal, mild or moderate head injury in children, and to analyse relationships between these and initial symptoms and management documented at the time of the injury. Methods: The sample consisted of all children (0 - 15 y) admitted to an emergency department during a 1-mo period with a history of head injury. Data were collected from the medical records at the time of the injury, and questionnaires about symptoms/change and functional problems 3 mo after the injury. Results: Symptoms and functional problems were reported in 35% of the children 3 mo after a head injury. Documented altered consciousness (in children less than 5 y) and disorientation (in children 5 y of age or older) at the emergency department were correlated with changes in behaviour at 3 mo. The initial duration of unconsciousness was not predictive of subsequent behaviour. Conclusion: The difficulties in predicting outcomes in head-injured children, especially younger ones, indicate the need for a follow-up appointment in order to identify children with special needs. Further studies are needed regarding the early signs and symptoms in different age groups.	Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; Helsinki Univ Cent Hosp, Dept Child Neurol, Helsinki, Finland; Danderyd Hosp, Karolinska Inst, Dept Nursing, Danderyd, Sweden		Falk, AC (corresponding author), Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, SE-17177 Solna, Sweden.	ann-charlotte.falk@karolinska.se	Falk, Ann-Charlotte/ABA-1730-2020	Falk, Ann-Charlotte/0000-0003-2246-7894			ANDERSON V, 2001, PEDIAT NEUROSURG, V34; ANDERSON VA, 2005, J NEUROL NEUROSURG P, V76; Bergman DA, 1999, PEDIATRICS, V104, P1407; BROWN L, 2003, AM J EMERG MED, V21; CRAWFORD S, 1996, J NEUROL NEUROSURG P, V60; ELKIND D, BARNS UTVECKLING UPP; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; FALK AC, 2005, CHILDS NERV SYST, V21; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; HAWLEY C, 2003, BRAIN INJURY, V17; HAWLEY C, 2002, BRAIN INJURY, V16; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRAUS JF, TRAUMATIC HEAD INJUR; KRAUS JF, 1987, PEDIATRICS, V779; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; OVERWEGPLANDSOE.W, 1999, EURO J PEDIAT, V158; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; RESCORLA L, 2005, MENT RETARD DEV DISA, V11; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; *SBU, 2000, 153 SBU; TEASDALE G, 1974, LANCET, V2, P81; World Health Organization, 1992, ICD10 WHO	25	11	11	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	DEC	2006	95	12					1533	1539		10.1080/08035250600731957			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	120ZN	WOS:000243125800003	17129958				2022-02-06	
J	Mujuru, P; Singla, L; Helmkamp, J; Bell, J; Hu, W				Mujuru, Priscah; Singla, Lisa; Helmkamp, James; Bell, Jennifer; Hu, Wen			Evaluation of the burden of logging injuries using West Virginia Workers' Compensation claims data from 1996 to 2001	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						occupational injuries; logging injuries; indemnity costs; permanent disability; traumatic brain injuries; injury prevention; workers' compensation; ICD-9 codes	OCCUPATIONAL INJURY; UNITED-STATES; COSTS; ILLNESS; RISK	Background The risks associated with logging are well documented, however little work has been done on estimating the economic impact of injuries among loggers. Methods West Virginia Workers' Compensation claims data for the period 1996-2001 was used to assess the economic burden of logging injuries in the state. Results There were 1,371 claimants during this period with the highest number of claims (39%) in the 25-34 years age category. The total cost of injuries was over $14 million. The most severe injuries, traumatic brain injuries (TBI), thoracic, cervical, and lumbar, resulted in the highest medical costs, indemnity costs and permanent disability. The average medical cost for logging-related to TBI was $198,048 compared to $15,321 for other major industries. Conclusions The magnitude of the economic costs underscores the need for active research of injury prevention among loggers and for greater attention to occupational safety and health programs.	W Virginia Univ, Dept Community Med, Inst Occupat & Environm Hlth, Morgantown, WV 26506 USA; W Virginia Univ, Dept Injury Control, Res Ctr, Morgantown, WV 26506 USA; NIOSH, Div Safety Res, CDCt, Morgantown, WV USA		Mujuru, P (corresponding author), W Virginia Univ, Dept Community Med, Inst Occupat & Environm Hlth, Morgantown, WV 26506 USA.	pmujuru@hsc.wvu.edu			NCIPC CDC HHS [5 R49/CE000345-02] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000345] Funding Source: NIH RePORTER		Bell JL, 2006, J SAFETY RES, V37, P53, DOI 10.1016/j.jsr.2005.10.019; Bell JL, 2003, AM J IND MED, V44, P502, DOI 10.1002/ajim.10307; Boden LI, 2001, AM J IND MED, V40, P398, DOI 10.1002/ajim.10013; *BUR LAB STAT, 2004, NAT CENS FAT OCC INJ; Childs R.A., 2005, W VIRGINIAS FORESTS; EWAN C, 1991, SOCIOL HLTH ILLN, V13, P169; Fischer V, 2005, AM J IND MED, V47, P246, DOI 10.1002/ajim.20133; Fosbroke DE, 1997, AM J IND MED, V31, P459, DOI 10.1002/(SICI)1097-0274(199704)31:4<459::AID-AJIM13>3.0.CO;2-Z; GALIZZI M, 1998, WORKERS STORY RESULT; Glazner JE, 1998, AM J IND MED, V34, P105, DOI 10.1002/(SICI)1097-0274(199808)34:2<105::AID-AJIM2>3.0.CO;2-W; Johnson CM, 2002, AM SURGEON, V68, P573; Leigh JP, 1997, J OCCUP ENVIRON MED, V39, P1170; Leigh JP, 2004, SCAND J WORK ENV HEA, V30, P199, DOI 10.5271/sjweh.780; Leigh JP, 1997, ARCH INTERN MED, V157, P1557, DOI 10.1001/archinte.157.14.1557; Miller TR, 1995, ACCIDENT ANAL PREV, V27, P741, DOI 10.1016/0001-4575(95)00022-4; Morse T F, 1998, Int J Occup Environ Health, V4, P209; MYERS JR, 1994, J SAFETY RES, V25, P97, DOI 10.1016/0022-4375(94)90021-3; *NAT SAF COUNC, 2004, INJURY FACTS; PAULOZZI LJ, 1987, J OCCUP MED, V29, P105; Pransky G, 2000, AM J IND MED, V37, P400, DOI 10.1002/(SICI)1097-0274(200004)37:4<400::AID-AJIM10>3.0.CO;2-C; Schulte PA, 2005, J OCCUP ENVIRON MED, V47, P607, DOI 10.1097/01.jom.0000165086.25595.9d; STRUNIN L, 2000, HUMAN COSTS OCCUPATI; Sygnatur, 1998, COMPENSATION WORKING, V3, P3; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	24	11	11	0	1	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0271-3586			AM J IND MED	Am. J. Ind. Med.	DEC	2006	49	12					1039	1045		10.1002/ajim.20389			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	108ZN	WOS:000242277800007	17096361				2022-02-06	
J	Kumar, V; Naik, RS; Hillert, M; Klein, J				Kumar, Vikas; Naik, Runa S.; Hillert, Markus; Klein, Jochen			Effects of chloride flux modulators in an in vitro model of brain edema formation	BRAIN RESEARCH			English	Article						edema; furosemide; DIDS; niflumic acid; NMDA receptor; oxygen-glucose deprivation	OXYGEN-GLUCOSE-DEPRIVATION; EXCITOTOXIC CELL-DEATH; K+-CL-COTRANSPORTER; HIPPOCAMPAL SLICE; INTRACELLULAR CHLORIDE; NA+; GLUTAMATE; HOMEOSTASIS; INHIBITION; ACTIVATION	Brain edema is a serious consequence of hemispheric stroke and traumatic brain injury and contributes significantly to patient mortality. In the present study, we measured water contents in hippocampal slices as an in vitro model of edema formation. Excitotoxic conditions induced by N-methyl-D-aspartate (NMDA, 300 mu M), as well as ischemia induced by oxygen-glucose deprivation (OGD), caused cellular edema formation as indicated by an increase of slice water contents. In the presence of furosemide, an inhibitor of the Na,K,Cl-cotransporter, NMDA-induced edema were reduced by 64% while OGD-induced edema were unaffected. The same observation, i.e., reduction of excitotoxic edema formation but no effect on ischemia-induced edema, was made with chloride transport inhibitors such as DIDS and niflumic acid. Under ischemic conditions, modulation of GABA(A) receptors by bicuculline, a GABA antagonist, or by diazepam, a CABAergic agonist, did not significantly affect edema formation. Further experiments demonstrated that low chloride conditions prevented NMDA-induced, but not OGD-induced, water influx. Omission of calcium ions had no effect. Our results show that NMDA-induced edema formation is highly dependent on chloride influx as it was prevented by low-chloride conditions and by various compounds that interfere with chloride influx. In contrast, OGD-induced edema observed in brain slices was not affected by modulators of chloride fluxes. The results are discussed with reference to ionic changes occurring during tissue ischemia. (c) 2006 Elsevier B.V. All rights reserved.	Texas Tech Univ, Sch Pharm, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA		Klein, J (corresponding author), Texas Tech Univ, Sch Pharm, Hlth Sci Ctr, Dept Pharmaceut Sci, 1300 Coulter Dr, Amarillo, TX 79106 USA.	jochen.klein@ttuhsc.edu	Klein, Jochen/B-9730-2008	Klein, Jochen/0000-0001-6971-3381	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [R21AT003399] Funding Source: NIH RePORTER		Abbruscato TJ, 2004, J PHARMACOL EXP THER, V310, P459, DOI 10.1124/jpet.104.066274; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Babot Z, 2005, EUR J NEUROSCI, V21, P103, DOI 10.1111/j.1460-9568.2004.03848.x; Beck J, 2003, J NEUROSCI, V23, P5061; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Breder J, 2000, NEUROPHARMACOLOGY, V39, P1779, DOI 10.1016/S0028-3908(00)00027-7; Chen Q, 1999, EXP NEUROL, V160, P215, DOI 10.1006/exnr.1999.7179; CHOI DW, 1987, J NEUROSCI, V7, P369; Czyz A, 2002, J NEUROCHEM, V81, P379, DOI 10.1046/j.1471-4159.2002.00851.x; ERDO SL, 1991, BRAIN RES, V542, P254, DOI 10.1016/0006-8993(91)91575-L; Foroutan S, 2005, AM J PHYSIOL-CELL PH, V289, pC1492, DOI 10.1152/ajpcell.00257.2005; Galeffi F, 2004, J NEUROSCI, V24, P4478, DOI 10.1523/JNEUROSCI.0755-04.2004; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Grondahl TO, 1998, NEUROL RES, V20, P131; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Inglefield JR, 1998, J NEUROCHEM, V71, P1396; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; Klein J, 2003, PHARMACOPSYCHIATRY, V36, pS78; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lodder J, 2006, CEREBROVASC DIS, V21, P120, DOI 10.1159/000090210; Lopachin RM, 2001, NEUROSCIENCE, V103, P971, DOI 10.1016/S0306-4522(01)00035-5; MacGregor DG, 2003, J NEUROCHEM, V85, P1402, DOI 10.1046/j.1471-4159.2003.01772.x; Martinez-Sanchez M, 2004, NEUROSCIENCE, V128, P729, DOI 10.1016/j.neuroscience.2004.06.074; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; OLNEY JW, 1986, NEUROSCI LETT, V65, P65, DOI 10.1016/0304-3940(86)90121-7; Parkerson KA, 2003, AM J PHYSIOL-CELL PH, V284, pC1460, DOI 10.1152/ajpcell.00603.2002; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Ringel F, 2000, J NEUROCHEM, V75, P125, DOI 10.1046/j.1471-4159.2000.0750125.x; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Siklos L, 1997, NEUROSCIENCE, V79, P1013, DOI 10.1016/S0306-4522(97)00031-6; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Steiner T, 2001, NEUROLOGY, V57, pS61, DOI 10.1212/WNL.57.suppl_2.S61; STEMMER JE, 2004, EUR J NEUROSCI, V19, P2915; Sun DD, 1998, AM J PHYSIOL-CELL PH, V275, pC772, DOI 10.1152/ajpcell.1998.275.3.C772; TAKATA M, 1995, INTEGR COMPUT-AID E, V2, P249; UNTERBERGA W, 2004, NEUROSCIENCE, V129, P1019; Weichel O, 1999, N-S ARCH PHARMACOL, V360, P609, DOI 10.1007/s002109900131; Yan YP, 2001, J CEREBR BLOOD F MET, V21, P711, DOI 10.1097/00004647-200106000-00009	46	11	13	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 29	2006	1122						222	229		10.1016/j.brainres.2006.09.012			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114LU	WOS:000242668500027	17014830	Green Accepted			2022-02-06	
J	Yao, XL; Liu, J; Lee, E; Ling, GSF; McCabe, JT				Yao, Xiang-Lan; Liu, Jiong; Lee, Eleanor; Ling, Geoffrey S. F.; McCabe, Joseph T.			Cullin 5 gene expression in the rat cerebral cortex and hippocampus following traumatic brain injury (TBI)	NEUROSCIENCE LETTERS			English	Article						cullin-5; E3-ligase; traumatic brain injury; gene expression; protein degradation; proteasome	CENTRAL-NERVOUS-SYSTEM; VASOPRESSIN-ACTIVATED CALCIUM; MESSENGER-RNA; UBIQUITIN LIGASES; FAMILY-MEMBER; CELL-GROWTH; CUL-5 GENE; VACM-1; COMPLEX; DEGRADATION	Cullin-5 (Cul-5), a member of the cullin gene family of scaffold proteins of E3 ubiquitin-ligase complexes, has a role in proteolysis and cell cycle regulation. We recently demonstrated that cul-5 mRNA is ubiquitously expressed in the central nervous system. The present study used quantitative real time polymerase chain reaction and western blotting to measure changes in cul-5 mRNA and Cul-5 protein expression, respectively, in the injured CNS in response to traumatic brain injury (TBI). cul-5 mRNA levels were significantly decreased in the ipsilateral rat cerebral cortex on Days I and 7, but not on Day 3 following TBI. In the ipsilateral hippocampus, cul-5 mRNA was significantly reduced on Day I after TBI. Cul-5 protein levels were significantly decreased in the ipsilateral rat cerebral cortex on Days 1-7 post-TBI while levels were significantly lower in the ipsilateral hippocampus on Days 3-7 post-TBI. Since Cul-5 is ubiquitously expressed in eukaryotic cells and is linked to proteasome-mediated protein degradation, it may have a role in CNS cell fate determination under conditions of traumatic stress. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Uniformed Serv Univ Hlth Sci, F Edmund Herbert Sch Med, Grad Program Neurosci, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, F Edmund Herbert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, F Edmund Herbert Sch Med, Dept Neurol, Bethesda, MD 20814 USA		Yao, XL (corresponding author), Uniformed Serv Univ Hlth Sci, F Edmund Herbert Sch Med, Grad Program Neurosci, 4301 Jones bridge Rd, Bethesda, MD 20814 USA.	XYao@usuhs.mil; JLiu@usuhs.mil; ELee@usuhs.mil; GLing@usuhs.mil; JMcCabe@usuhs.mil	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442			Ayyub C, 2005, DEV DYNAM, V232, P865, DOI 10.1002/dvdy.20322; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Burnatowska-Hledin M, 2000, AM J PHYSIOL-CELL PH, V279, pC266, DOI 10.1152/ajpcell.2000.279.1.C266; Burnatowska-Hledin MA, 2004, BIOCHEM BIOPH RES CO, V319, P817, DOI 10.1016/j.bbrc.2004.05.057; BURNATOWSKAHLEDIN MA, 1995, AM J PHYSIOL-RENAL, V268, pF1198, DOI 10.1152/ajprenal.1995.268.6.F1198; Byrd PJ, 1997, GENOME RES, V7, P71, DOI 10.1101/gr.7.1.71; Ceremuga TE, 2003, NEUROSCI LETT, V345, P121, DOI 10.1016/S0304-3940(03)00298-2; Ceremuga TE, 2003, NEUROSCI RES, V45, P305, DOI 10.1016/S0168-0102(02)00228-6; Ceremuga TE, 2003, NEUROL RES, V25, P211, DOI 10.1179/016164103101201229; Ceremuga TE, 2001, ENDOCR RES, V27, P433, DOI 10.1081/ERC-100107867; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Fay Michael J, 2003, Mol Cancer, V2, P40, DOI 10.1186/1476-4598-2-40; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Hurbin A, 2000, J NEUROENDOCRINOL, V12, P677; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Sartor A, 2006, BIOCHEM BIOPH RES CO, V343, P1086, DOI 10.1016/j.bbrc.2006.02.197; Singhal S, 2003, CANCER BIOL THER, V2, P291, DOI 10.4161/cbt.2.3.399; Van Dort C, 2003, AM J PHYSIOL-CELL PH, V285, pC1386, DOI 10.1152/ajpcell.00338.2002; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	28	11	11	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 27	2006	409	1					65	69		10.1016/j.neulet.2006.09.015			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106LK	WOS:000242101800014	17010517				2022-02-06	
J	Demir, SO; Oktay, F; Uysal, H; Selcuk, B				Demir, Sibel Ozbudak; Oktay, Fuegen; Uysal, Hilmi; Selcuk, Baran			Upper extremity shortness in children with hemiplegic cerebral palsy	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						hemiplegic cerebral palsy; upper extremity shortness	TRAUMATIC BRAIN-INJURY; SPASTIC HEMIPLEGIA; SKELETAL; GROWTH; HANDS	Objective: To evaluate upper extremity shortness in patients with hemiplegic cerebral palsy (HCP) and to investigate the association between extremity shortness, motor level, and muscle tone. Design: Prospective, controlled study. Subjects: Forty-two children with HCP and 29 healthy children. Methods: Radiographs of the involved and the uninvolved humerus, forearm, and hands were obtained with a radiographic ruler placed adjacent to the extremity. The lengths and the diameters of both the diaphyses and metaphyses of the humerus, ulna, radius, and the second and the fifth metacarpal bones were measured in patients and the control group. The discrepancy was calculated as a percentage compared with the normal side. The Ashworth Scale was used in the evaluation of spasticity, and the Brunnstrom recovery staging was used in the motor evaluation. Results: Children with HCP had significant differences in bone lengths and diameters compared with control children. There was no significant correlation between the upper extremity Brunnstrom stagings and the differences of bone length and diameter. A significant correlation was observed between the hand Brunnstrom staging and percentage difference of the bone length and diameter. The spasticity level showed no relation to the differences in bone length and diameter. Conclusions: Children with HCP have significant side-to-side limb-length discrepancy when compared with control children. The discrepancy increases with age. The extent of shortening did not appear to be related to upper extremity function and spasticity. The extremity shortness showed a relation to hand function.	Minist Hlth, Ankara Phys Med Rehabil Educ & Res Hosp, Ankara, Turkey; Akdeniz Univ Fac Med, Antalya, Turkey		Demir, SO (corresponding author), Y Dikmen Mah Turan Gunes bulvari,12 Cadde 11-4,Ay, TR-06450 Ankara, Turkey.	sibiozbudak@hotmail.com	Uysal, Hilmi/C-3651-2016	Uysal, Hilmi/0000-0002-6063-377X			CARTER DR, 1987, J BIOMECH, V20, P1095, DOI 10.1016/0021-9290(87)90027-3; CARTER DR, 1987, CLIN ORTHOP RELAT R, P237; Chenu C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P132; Chung UI, 1998, P NATL ACAD SCI USA, V95, P13030, DOI 10.1073/pnas.95.22.13030; Flett P, 2003, J PAEDIATR CHILD H, V39, P6, DOI 10.1046/j.1440-1754.2003.00082.x; Goldstein Murray, 2001, Developmental Medicine and Child Neurology, V43, P563, DOI 10.1017/S0012162201001025; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kong CK, 1999, DEV MED CHILD NEUROL, V41, P758, DOI 10.1017/S0012162299001528; Lin PP, 1996, DEV MED CHILD NEUROL, V38, P782; McDaid PJ, 2002, J PEDIATR ORTHOPED, V22, P364; Pellegrino L, 1998, CARING FOR CHILDREN WITH CEREBRAL PALSY, P3; STEMPIEN LM, 1996, PHYS MED REHABILITAT, P1191; STEVENSON RD, 1995, DEV MED CHILD NEUROL, V37, P124; STRECKER TR, 1983, TERATOLOGY, V27, P159, DOI 10.1002/tera.1420270204; TACHDJIAN MO, 1958, J BONE JOINT SURG AM, V40, P85, DOI 10.2106/00004623-195840010-00008; TIZARD JPM, 1954, JAMA-J AM MED ASSOC, V155, P628, DOI 10.1001/jama.1954.03690250008003; Uvebrant P, 1988, Acta Paediatr Scand Suppl, V345, P1; VANHEEST AE, 1993, J HAND SURG-AM, V18A, P278, DOI 10.1016/0363-5023(93)90361-6; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620	20	11	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798			J PEDIATR ORTHOPED	J. Pediatr. Orthop.	NOV-DEC	2006	26	6					764	768		10.1097/01.bpo.0000235393.34289.82			5	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	157CB	WOS:000245695100014	17065942				2022-02-06	
J	Pryor, J; Shi, R				Pryor, J.; Shi, R.			Electrophysiological changes in isolated spinal cord white matter in response to oxygen deprivation	SPINAL CORD			English	Article						axons; spinal cord injury; in vitro; sucrose gap recording; membrane; neurotrauma; afterpotential	AORTIC-ANEURYSM REPAIR; RAT OPTIC-NERVE; MYELINATED AXONS; DEPOLARIZING AFTERPOTENTIALS; ISCHEMIC-INJURY; BRAIN INJURY; IN-VITRO; CALCIUM; CONDUCTION; GLUCOSE	Study design: In vitro studies using isolated guinea pig spinal cord white matter. Objectives: To determine whether lack of oxygen can cause irreversible impairment of electrical impulse conduction. Setting: Department of Basic Medical Sciences, Purdue University, West Lafayette, Indiana, USA. Methods: The hypoxic injury was induced by reducing the oxygen tension of the perfused solution by 80%. Compound action potentials (CAPs) were monitored before, during, and after oxygen deprivation. Results: We have found that 60 min of hypoxia reduced the conduction to 30% of preinjury level and recovered to approximately 60% of the preinjury level upon reoxygenation. Larger axons appeared to be more vulnerable to oxygen deprivation. We noted a significant decrease and recovery of the depolarizing afterpotential (DAP). Likewise, there was a delay and recovery of absolute and relative refractory period. Concomitantly, the ability of axons to follow repetitive stimuli was suppressed following oxygen deprivation but recovered upon reoxygenation. Conclusion: Following 60 min of oxygen deprivation and 30 min of reoxygenation, mammalian spinal cord white matter can partially recover electrical impulse conduction. However, within the same period, cords gained a complete recovery of other electrical properties, such as the depression of DAP, the delaying of refractory period, and the decreased ability to respond to repetitive stimuli. Compared to previous findings when both oxygen and glucose were deprived, we conclude that glucose plays a relatively minor role during the acute stage of oxygen deprivation in mammalian spinal cord white matter.	Purdue Univ, Dept Vet Med Sci, Ctr Paralysis Res, Inst Appl Neurol, W Lafayette, IN 47907 USA		Shi, R (corresponding author), Purdue Univ, Dept Vet Med Sci, Ctr Paralysis Res, Inst Appl Neurol, W Lafayette, IN 47907 USA.						Agrawal SK, 1996, J NEUROSCI, V16, P545; ALLEN BT, 1995, VASCULAR SURG THEORY, P1402; BARRETT EF, 1982, J PHYSIOL-LONDON, V323, P117, DOI 10.1113/jphysiol.1982.sp014064; BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0; BLIGHT AR, 1985, NEUROSCIENCE, V15, P1, DOI 10.1016/0306-4522(85)90118-6; BORGENS RB, 2003, ADV ANAT EMBRYOL CEL, V171, pR1; Coselli JS, 1997, ANN THORAC SURG, V63, P28, DOI 10.1016/S0003-4975(96)01029-6; FRIEDMAN A, 1992, NEUROSCI LETT, V135, P13, DOI 10.1016/0304-3940(92)90125-Q; GORDON TR, 1990, NEUROSCIENCE, V37, P829, DOI 10.1016/0306-4522(90)90112-H; GORDON TR, 1989, BRAIN RES, V502, P252, DOI 10.1016/0006-8993(89)90620-3; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; KAJI R, 1989, NEUROLOGY, V39, P1364, DOI 10.1212/WNL.39.10.1364; Kanellopoulos GK, 1997, STROKE, V28, P2532, DOI 10.1161/01.STR.28.12.2532; KOJIMA M, 1986, EUR J PHARMACOL, V122, P65, DOI 10.1016/0014-2999(86)90159-7; Lang-Lazdunski L, 2000, EUR J CARDIO-THORAC, V18, P174, DOI 10.1016/S1010-7940(00)00430-9; LasserRoss N, 1997, J NEUROPHYSIOL, V78, P825, DOI 10.1152/jn.1997.78.2.825; LEBLANC MH, 1994, STROKE, V25, P1443, DOI 10.1161/01.STR.25.7.1443; Lemon N, 2000, J NEUROPHYSIOL, V84, P1519, DOI 10.1152/jn.2000.84.3.1519; LOPANTSEV VE, 1990, NEUROSCIENCE, V38, P137, DOI 10.1016/0306-4522(90)90380-M; Peasley MA, 2002, AM J PHYSIOL-CELL PH, V283, pC980, DOI 10.1152/ajpcell.00591.2001; Safi HJ, 1998, ANN THORAC SURG, V66, P1204, DOI 10.1016/S0003-4975(98)00781-4; Sala F, 1999, ANN NY ACAD SCI, V890, P133, DOI 10.1111/j.1749-6632.1999.tb07989.x; SANDLER AN, 1976, J NEUROSURG, V45, P638, DOI 10.3171/jns.1976.45.6.0638; SATRAN R, 1988, Stroke, V19, P529; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763, DOI 10.1152/jn.2000.84.4.1763; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; Stys PK, 1998, NEUROSCIENCE, V82, P21; STYS PK, 1991, BRAIN RES, V546, P18, DOI 10.1016/0006-8993(91)91154-S; SUAREZKURTZ G, 1979, J PHYSIOL-LONDON, V286, P317, DOI 10.1113/jphysiol.1979.sp012621; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TEREK RM, 1987, AM J PHYSIOL, V252, pH645, DOI 10.1152/ajpheart.1987.252.3.H645; Wass CT, 1996, MAYO CLIN PROC, V71, P801; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; WITTE OW, 1994, EPILEPSY RES, V18, P43, DOI 10.1016/0920-1211(94)90032-9; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86; YOUNG W, 1985, CENTRAL NERVOUS SYST, P463; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zareie M, 2003, NEPHROL DIAL TRANSPL, V18, P2629, DOI 10.1093/ndt/gfg356; ZHANG L, 1993, J NEUROPHYSIOL, V70, P223, DOI 10.1152/jn.1993.70.1.223	44	11	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	NOV	2006	44	11					653	661		10.1038/sj.sc.3101901			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	103KS	WOS:000241884700002	16432530	Bronze			2022-02-06	
J	Reid, SM; Lanigan, A; Reddihough, DS				Reid, Susan M.; Lanigan, Anna; Reddihough, Dinah S.			Post-neonatally acquired cerebral palsy in Victoria, Australia, 1970-1999	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						brain injury; cerebral palsy; child; incidence; registries	RISK-FACTORS; PREVALENCE; ORIGIN	Aim: To use the information from a population-based cerebral palsy register to describe post-neonatally acquired cerebral palsy, to determine trends over time and relate any aetiological trends to community preventative measures. Methods: Data on cases of post-neonatally acquired cerebral palsy, between the birth years 1970 and 1999, were generated from the Victorian Cerebral Palsy Register. Distributions, rates and trends over time were calculated for the entire cohort and for subgroups according to gender, age at acquisition, aetiology, gestation at delivery, birthweight, maternal age at delivery and parity. Results: 339 cases were found with post-neonatally acquired cerebral palsy, accounting for 10.7% of all cerebral palsy and giving an overall rate of 1.98/10 000 live births. There was a statistically significant fall in the overall rate of post-neonatally acquired cerebral palsy (P = 0.001) over the study period. Significant falls were seen in post-neonatal cerebral palsy due to infection, traumatic head injury and hypoxia and other acute encephalopathies, but not cerebrovascular accidents. Conclusion: A large proportion of post-neonatally acquired cerebral palsy is preventable. While the reported decline in cases in Victoria is encouraging, it will be important to monitor these trends over time, and continue public health measures to further reduce preventable causes.	Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia		Reid, SM (corresponding author), Royal Childrens Hosp, Dept Child Dev & Rehabil, Flemington Rd, Parkville, Vic 3052, Australia.	sue.reid@mcri.edu.au		Reid, Sue/0000-0001-9415-5246			ARENS LJ, 1989, DEV MED CHILD NEUROL, V31, P246; Badawi N, 1998, DEV MED CHILD NEUROL, V40, P520; BLAIR E, 1982, DEV MED CHILD NEUROL, V24, P575; Cans C, 2004, PAEDIATR PERINAT EP, V18, P214, DOI 10.1111/j.1365-3016.2004.00559.x; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; *CONS COUNC OBST P, 2003, ANN REP YEAR 2001 IN; Corben B, 2000, INJURY REDUCTION MEA; Diamantopoulou K., 2002, 187 MON U ACC RES CT; Grimwood K, 1996, J PAEDIATR CHILD H, V32, P457, DOI 10.1111/j.1440-1754.1996.tb00949.x; Hagberg B, 1996, ACTA PAEDIATR, V85, P954, DOI 10.1111/j.1651-2227.1996.tb14193.x; HENDERSON M, 1999, INJURY ISSUES MONITO, V16, P9; Laisram Nonica, 1992, Indian Journal of Pediatrics, V59, P723, DOI 10.1007/BF02859408; Li L., 1998, HYDROLOGY-BASEL, P1, DOI [10.19797/j.cnki.1000-0852.1998.06.001, DOI 10.19797/J.CNKI.1000-0852.1998.06.001]; MOLLER JN, 1997, AUST INJ PREV B, P1; Murphy C. C., 1993, J PEDIATR, V123, pS13; MUTCH L, 1992, DEV MED CHILD NEUROL, V34, P547; Oxley JA, 2001, 178 MON U ACC RES CT; PAINE M, 2001, ASSESSMENT CHILD RES; PHAROAH POD, 1989, ARCH DIS CHILD, V64, P1013, DOI 10.1136/adc.64.7.1013; Stanley F, 2000, CLIN DEV MED, V151; *TAC, 2002, TACS ROAD SAF CAMP; *VICROADS, 2002, WALK SAF PED PROGR	22	11	12	1	3	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1034-4810			J PAEDIATR CHILD H	J. Paediatr. Child Health	OCT	2006	42	10					606	611		10.1111/j.1440-1754.2006.00936.x			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	081BK	WOS:000240292000008	16972967				2022-02-06	
J	Stubbe, HD; Greiner, C; Westphal, M; Rickert, CH; Van Aken, H; Eichel, V; Wassmann, H; Daudel, F; Hinder, F				Stubbe, Henning D.; Greiner, Christoph; Westphal, Martin; Rickert, Christian H.; Van Aken, Hugo; Eichel, Vera; Wassmann, Hansdetlef; Daudel, Fritz; Hinder, Frank			Cerebral response to norepinephrine compared with fluid resuscitation in ovine traumatic brain injury and systemic inflammation	CRITICAL CARE MEDICINE			English	Article						head injury; endotoxemia; intracranial pressure; cerebral blood flow; fluid resuscitation; vasopressor therapy; cerebral perfusion	INTERNAL CAROTID-ARTERY; BLOOD-FLOW; NITRIC-OXIDE; PERFUSION-PRESSURE; HEAD-INJURY; MANAGEMENT; SEPSIS; ENDOTOXEMIA; DOPAMINE; VOLUME	Objective. Traumatic brain injury is frequently accompanied by a systemic inflammatory response. Systemic inflammation was associated with cerebral hyperperfusion uncoupled to global oxygen metabolism in ovine head trauma. The present study investigated the cerebral effects of cerebral perfusion pressure (CPP) management performed by either fluid resuscitation or vasopressor treatment of low CPP induced by systemic inflammation. Design: Nonrandomized experimental study. Setting: University hospital laboratory. Subjects. A total of 12 adult sheep. Interventions, Measurements, and Main Results: Sheep were anesthetized and ventilated throughout the experimental period (13 hrs). After baseline measurements (hour 0), blunt head trauma was induced by a nonpenetrating stunner. After postinjury measurements (hour 2), all animals received continuous endotoxin infusion. At hour 10, one group (n = 6) was infused with hydroxyethyl starch until CPP reached 60-70 mm Hg. A second group (n = 6) received norepinephrine for CPP elevation. In the norepinephrine group, blood was isovolemically exchanged by hydroxyethyl starch to achieve comparable hematocrit levels. Head trauma increased intracranial pressure and decreased brain tissue oxygen tension. Endotoxemia induced a hyperdynamic cardiovascular response with increased internal carotid blood flow in the presence of systemic hypotension and decreased CPP. Hydroxyethyl starch infusion further increased internal carotid blood flow from (mean +/- SD) 247 +/- 26 (hour 10) to 342 +/- 42 mL/min (hour 13) and intracranial pressure from 20 +/- 4 (hour 10) to a maximum of 25 +/- 3 mm Hg (hour 12) but did not significantly affect brain tissue oxygen tension, sinus venous oxygen saturation and oxygen extraction fraction. Norepinephrine increased internal carotid blood flow from 268 +/- 19 to 342 +/- 58 mL/min and intracranial pressure from 22 +/- 11 to 24 +/- 11 mm Hg (hour 10 vs. hour 13) but significantly increased sinus venous oxygen saturation from 49 +/- 4 (hour 10) to a maximum of 59 +/- 6 mm Hg (hour 12) and decreased oxygen extraction fraction. The increase in brain tissue oxygen tension during norepinephrine treatment was not significant. Conclusion: We conclude that despite identical carotid blood flows, only CPP management with norepinephrine reduced the cerebral oxygen deficit in this model.	Univ Klinikum Munster, Klin & Poliklin Anasthesiol & Operat Intens Med, Munster, Germany; Univ Klinikum Munster, Klin & Poliklin Neurochirurg, Munster, Germany; Univ Klinikum Munster, Inst Neuropathol, Gerhard Domagk Inst Pathol, Munster, Germany; Inselspital Bern, Klin Intens Med, D-3010 Bern, Germany		Stubbe, HD (corresponding author), Univ Klinikum Munster, Klin & Poliklin Anasthesiol & Operat Intens Med, Munster, Germany.						Booke M, 1995, Prog Clin Biol Res, V392, P393; Booke M, 2003, ANESTH ANALG, V96, P1122, DOI 10.1213/01.ANE.0000052516.86497.B6; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Dal Nogare A R, 1991, Am J Med Sci, V302, P50; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hinder F, 2003, CRIT CARE MED, V31, P903, DOI 10.1097/01.CCM.0000050289.15988.67; Hinder F, 1999, AM J RESP CRIT CARE, V159, P252, DOI 10.1164/ajrccm.159.1.9806024; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kroppenstedt SN, 2002, ACT NEUR S, V81, P225; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Meadow W, 1999, PEDIATR RES, V45, P324, DOI 10.1203/00006450-199903000-00006; Muckart DJJ, 1997, CRIT CARE MED, V25, P1789, DOI 10.1097/00003246-199711000-00014; Myburgh JA, 1998, ACT NEUR S, V71, P19; Parratt JR, 1998, J ANTIMICROB CHEMOTH, V41, P31, DOI 10.1093/jac/41.suppl_1.31; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Stubbe HD, 2004, J CEREBR BLOOD F MET, V24, P1400, DOI 10.1097/01.WCB.0000141516.61418.82; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Tian J, 2004, ANESTH ANALG, V98, P768; TODD MM, 1993, ANESTHESIOLOGY, V78, P945, DOI 10.1097/00000542-199305000-00020; TRABER DL, 1988, AM J PHYSIOL, V254, pH833, DOI 10.1152/ajpheart.1988.254.5.H833; York J, 2000, J TRAUMA, V48, P376, DOI 10.1097/00005373-200003000-00002	27	11	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2006	34	10					2651	2657		10.1097/01.CCM.0000239196.17999.B7			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088EZ	WOS:000240795700021	16932232				2022-02-06	
J	Bathen, TF; Sjobakk, TE; Skranes, J; Brubakk, AM; Vik, T; Martinussen, M; Myhr, GE; Gribbestad, IS; Axelson, D				Bathen, Tone F.; Sjoebakk, Torill E.; Skranes, Jon; Brubakk, Ann-Mari; Vik, Torstein; Martinussen, Marit; Myhr, Gunnar E.; Gribbestad, Ingrid S.; Axelson, David			Cerebral metabolite differences in adolescents with low birth weight: assessment with in vivo proton MR spectroscopy	PEDIATRIC RADIOLOGY			English	Article						very low birth weight; in vivo proton MRS; probabilistic neural network; partial least squares regression discriminant analysis; adolescents; brain metabolites	MAGNETIC-RESONANCE-SPECTROSCOPY; FOR-GESTATIONAL-AGE; NEURAL-NETWORK ANALYSES; TRAUMATIC BRAIN-INJURY; PEAK ALIGNMENT; NMR SIGNALS; CHILDREN; INFANTS; DISEASE; H-1-MRS	Background: Children with very low birth weight (VLBW) have a significantly increased risk of later neurodevelopmental problems, while infants born small for gestational age (SGA) at term are also at some risk of developing neurological impairment. Objective: To investigate possible brain metabolite differences in adolescents with VLBW, SGA at term and controls by proton in vivo magnetic resonance spectroscopy (MRS) at 1.5 T. Materials and methods: MR spectra were acquired from volumes localized in the left frontal lobe, containing mainly white matter (54 subjects). Peak areas of N-acetyl aspartate (NAA), choline (Cho) and creatine (Cr) were determined, and the peak area ratio of NAA to Cr, total Cho to Cr, or NAA to Cho calculated. Probabilistic neural network (PNN) analysis was performed utilizing the chemical shift region containing resonances from NAA, Cho and Cr as inputs. Results: No significant difference in the peak area ratios could be found using the Kruskal-Wallis test. By application of PNN, a correct classification of 52 of the 54 adolescents with a sensitivity and specificity exceeding 93% for all groups was achieved. Conclusion: Small, yet systematic, differences in brain metabolite distribution among the groups were confirmed by PNN analysis.	Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, MTFS, N-7489 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Neurosci, MTFS, N-7489 Trondheim, Norway; Norwegian Univ Sci & Technol, St Olavs Hosp HF, Dept Lab Med Childrens & Womens Hlth, N-7006 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practise, MTFS, N-7489 Trondheim, Norway; St Olavs Univ Hosp, Dept Radiol, N-7006 Trondheim, Norway; MRi Consulting, Kingston, ON, Canada		Bathen, TF (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, MTFS, N-7489 Trondheim, Norway.	tone.f.bathen@ntnu.no	Martinussen, Marit/AAE-8135-2021	Martinussen, Marit/0000-0002-7090-4326			ARNOLD DL, 2005, MR SPECTROSCOPY CLIN, P139; Axelson D, 2002, J MAGN RESON IMAGING, V16, P13, DOI 10.1002/jmri.10125; Bakken IJ, 1999, EPILEPSY RES, V35, P245, DOI 10.1016/S0920-1211(99)00019-4; Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1399; Cady EB, 1996, MAGN RESON MED, V36, P878, DOI 10.1002/mrm.1910360610; Despagne F, 1998, ANALYST, V123, p157R; Evensen KAI, 2004, ARCH DIS CHILD-FETAL, V89, pF451, DOI 10.1136/adc.2003.037788; Filippi CG, 2002, AM J NEURORADIOL, V23, P882; FORD CC, 1992, NEUROLOGY, V42, P1408, DOI 10.1212/WNL.42.7.1408; Forshed J, 2003, ANAL CHIM ACTA, V487, P189, DOI 10.1016/S0003-2670(03)00570-1; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Hollo O, 2002, ARCH PEDIAT ADOL MED, V156, P179, DOI 10.1001/archpedi.156.2.179; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Horska A, 2002, J MAGN RESON IMAGING, V15, P137, DOI 10.1002/jmri.10057; Imamura Keiko, 2003, Magn Reson Med Sci, V2, P117, DOI 10.2463/mrms.2.117; Indredavik MS, 2004, ARCH DIS CHILD-FETAL, V89, pF445, DOI 10.1136/adc.2003.038943; Kadota T, 2001, AM J NEURORADIOL, V22, P128; Kemsley EK, 1996, CHEMOMETR INTELL LAB, V33, P47, DOI 10.1016/0169-7439(95)00090-9; KIMURA H, 1995, RADIOLOGY, V194, P483, DOI 10.1148/radiology.194.2.7529934; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Kutschera J, 2002, Z GEBURTSH NEONATOL, V206, P65, DOI 10.1055/s-2002-30139; Lee GC, 2004, ANAL CHIM ACTA, V513, P413, DOI 10.1016/j.aca.2004.02.068; LUCASIUS CB, 1993, CHEMOMETR INTELL LAB, V19, P1, DOI 10.1016/0169-7439(93)80079-W; MEYER B, 1991, SCIENCE, V251, P542, DOI 10.1126/science.1990429; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Moore GJ, 1998, PEDIATR RADIOL, V28, P805, DOI 10.1007/s002470050470; Nagy Z, 2003, PEDIATR RES, V54, P672, DOI 10.1203/01.PDR.0000084083.71422.16; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Preul MC, 1996, NAT MED, V2, P323, DOI 10.1038/nm0396-323; Shu SK, 1997, PEDIATR NEUROL, V17, P309, DOI 10.1016/S0887-8994(97)00140-9; Skranes JS, 2005, PEDIATR RADIOL, V35, P758, DOI 10.1007/s00247-005-1446-2; Skranes JS, 1998, PEDIATR RADIOL, V28, P471, DOI 10.1007/s002470050387; SKRANES JS, 1993, NEUROPEDIATRICS, V24, P256, DOI 10.1055/s-2008-1071553; Smith LM, 2001, PEDIATRICS, V107, P227, DOI 10.1542/peds.107.2.227; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; TOFT PB, 1994, JMRI-J MAGN RESON IM, V4, P1, DOI 10.1002/jmri.1880040102; Usenius JP, 1996, NEUROREPORT, V7, P1597, DOI 10.1097/00001756-199607080-00013; Yeo RA, 2000, DEV NEUROPSYCHOL, V17, P143, DOI 10.1207/S15326942DN1702_01; Zimmerman RA, 1997, AM J NEURORADIOL, V18, P1872	40	11	11	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	AUG	2006	36	8					802	809		10.1007/s00247-006-0159-5			8	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	068GZ	WOS:000239362400007	16703344				2022-02-06	
J	Briassoulis, G; Mavrikiou, M; Margeli, A; Lazaropoulou, C; Natsi, L; Papassotiriou, I; Hatzis, T				Briassoulis, George; Mavrikiou, Maria; Margeli, Alexandra; Lazaropoulou, Christina; Natsi, Labrini; Papassotiriou, Ioannis; Hatzis, Tasos			Circulating levels of KL-6 in acute respiratory distress syndrome sepsis or traumatic brain injury in critically ill children	PEDIATRIC PULMONOLOGY			English	Article						acute respiratory distress syndrome; critically ill children; KL-6; sepsis; traumatic brain injury	ACUTE LUNG INJURY; PULMONARY ALVEOLAR PROTEINOSIS; HUMAN MUC1 MUCIN; SERUM KL-6; CONSENSUS CONFERENCE; CLINICAL-OUTCOMES; DISEASE-ACTIVITY; PLASMA; FLUID; DEFINITIONS	KL-6 is a high molecular weight glycoprotein that is expressed on the apical borders of normal secretary alveolar epithelial cells. The aim of our study was to elucidate the potential role of circulating levels of KL-6, related to C-reacting protein (CRP), disease severity (PRISM, TISS), length of stay (LOS) or mechanical ventilation (LOMV), and outcome, in children with acute respiratory distress syndrome (ARDS), sepsis, or traumatic brain injury (TBI). KL-6 concentrations were monitored using solid phase sandwich enzyme-linked immunosorbent assay in plasma of nine patients with ARDS and compared to nine patients with TBI, nine with sepsis, and nine ventilated patients with cancer of matched illness severity on days 1, 3, 5, 7, and 10. Initial respiratory/ventilatory parameters (oxygenation index, plateau pressures) were recorded for ARDS patients. Patients with ARDS had higher early plasma levels of KL-6 (956 +/- 400 U/ml), as compared to patients with TBI (169 +/- 9 U/ml), sepsis (282 +/- 81 U/ml), and ventilated controls (255 +/- 40 U/ml). Significant correlations were demonstrated between plasma KL-6 concentration and oxygenation index, PaO2: FiO(2) ratio, LOS and LOMV, but not with CRP or PRISM. Only in patients with ARDS, plasma KL-6 levels were higher in non-survivors than survivors (P< 0.03). Plasma KL-6 levels have possible prognostic significance and may provide a useful marker for ARDS in critically ill children.	Univ Hosp Heraklion, Pediat Intens Care Unit, Iraklion 71110, Crete, Greece; Aghia Sophia Childrens Hosp, Dept Clin Biochem, Athens, Greece		Briassoulis, G (corresponding author), Univ Hosp Heraklion, Pediat Intens Care Unit, POB 1352, Iraklion 71110, Crete, Greece.	ggbriass@otenet.gr					Agouridakis P, 2002, RESPIR RES, V3, DOI 10.1186/rr193; Ashida T, 2001, INT J HEMATOL, V74, P464, DOI 10.1007/BF02982094; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brower RG, 2004, NEW ENGL J MED, V351, P327; Curley MAQ, 2005, JAMA-J AM MED ASSOC, V294, P229, DOI 10.1001/jama.294.2.229; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; Flori Heidi R, 2003, Pediatr Crit Care Med, V4, P315, DOI 10.1097/01.PCC.0000074583.27727.8E; Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; HAMADA H, 1992, CHEST, V101, P858, DOI 10.1378/chest.101.3.858; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hirasawa Y, 1997, AM J RESP CELL MOL, V17, P501, DOI 10.1165/ajrcmb.17.4.2253; Inoue Y, 2006, RESPIROLOGY, V11, pS55, DOI 10.1111/j.1440-1843.2006.00810.x; Inoue Y, 1997, AM J RESP CRIT CARE, V156, P109, DOI 10.1164/ajrccm.156.1.9612043; Ishizaka A, 2004, AM J PHYSIOL-LUNG C, V286, pL1088, DOI 10.1152/ajplung.00420.2002; Kashiwabara K, 2006, CHEST, V129, P402, DOI 10.1378/chest.129.2.402; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; Kobayashi J, 1996, CHEST, V109, P1276, DOI 10.1378/chest.109.5.1276; KOBAYASHI J, 1995, CHEST, V108, P311, DOI 10.1378/chest.108.2.311; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; KOHNO N, 1993, AM REV RESPIR DIS, V148, P637, DOI 10.1164/ajrccm/148.3.637; Kuwano K, 2002, RESPIROLOGY, V7, P15, DOI 10.1046/j.1440-1843.2002.00369.x; Ohshimo S, 2005, BIOCHEM BIOPH RES CO, V338, P1845, DOI 10.1016/j.bbrc.2005.10.144; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Sato H, 2004, EUR RESPIR J, V23, P142, DOI 10.1183/09031936.03.00070303; Selman M, 2003, AM J RESP CELL MOL, V29, pS93; Takahashi T, 1998, AM J RESP CRIT CARE, V158, P1294, DOI 10.1164/ajrccm.158.4.9712003; Thammasitboon Satid, 2005, Pediatr Crit Care Med, V6, P340; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680, DOI 10.1164/ajrccm.158.5.9803115; Zhao X, 2005, LUNG, V183, P87, DOI 10.1007/s00408-004-2522-3	32	11	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-6863	1099-0496		PEDIATR PULM	Pediatr. Pulmonol.	AUG	2006	41	8					790	795		10.1002/ppul.20465			6	Pediatrics; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Respiratory System	067AF	WOS:000239271600014	16779848				2022-02-06	
J	Zhao, WZ; Wu, CY; Yin, K; Young, TY; Ginsberg, MD				Zhao, Weizhao; Wu, Chunyan; Yin, Kai; Young, Tzay Y.; Ginsberg, Myron D.			Pixel-based statistical analysis by a 3D clustering approach: Application to autoradiographic images	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						autoradiographic images; traumatic brain injury; statistical analysis; image processing	CEREBRAL-ARTERY OCCLUSION; GLUCOSE-UTILIZATION; BLOOD-FLOW; QUANTITATIVE AUTORADIOGRAPHY; PROBABILISTIC ATLAS; PARAMETRIC MAPS; BRAIN RESPONSES; PET IMAGES; ACTIVATION; RATS	Statistical analysis of medical images in experimental laboratories plays an important role in confirming scientific findings and in guiding potential clinical applications. In experimental neuroscience studies, autoradiographic images taken under differing physiological or pathological conditions from replicate animals are often compared in order to detect any significant change in glucose utilization or blood flow and to localize these changes. For these comparisons to be valid and informative, proper statistical procedures are in order. Conventional methods include statistic parametric mapping (SPM) analysis, non-parametric analysis and cluster- analysis. Each method of comparison has a specific purpose. This paper describes an approach that combines these conventional methods and presents a non-parametric statistical procedure based on cluster- analysis for localizing significant differences in autoradiographic data sets. By thresholding cluster sizes rather than pixel values to reject false positives, this approach enhances statistical power. By re-shuffling the data sets to produce the null distribution of a cluster size statistic, the test makes few assumptions as to the statistical properties of the SPM, and thus it is valid under a broad range of conditions. The designed method was tested on autoradiographic images of rats subjected to moderate traumatic brain injury (TBI). Different methods were also performed on the same data sets. Comparison among these methods shows that this method is suitable for the statistical analysis of autoradiographic images. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA; Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA; Univ Miami, Sch Med, Dept Neurol, Cerebral Vasc Dis Res Ctr, Miami, FL 33101 USA		Zhao, WZ (corresponding author), Univ Miami, Dept Biomed Engn, POB 248294, Coral Gables, FL 33124 USA.	w.zhao1@miami.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2P50NS05820] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS005820] Funding Source: NIH RePORTER		Back T, 1998, NEUROL RES, V20, P643; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; BROWN LG, 1992, ACM COMPUT SURV, V24, P325, DOI DOI 10.1145/146370.146374; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Cheng RCH, 2001, WSC'01: PROCEEDINGS OF THE 2001 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P179, DOI 10.1109/WSC.2001.977264; Dinov ID, 2000, J COMPUT ASSIST TOMO, V24, P128, DOI 10.1097/00004728-200001000-00024; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FOX PT, 1988, J CEREBR BLOOD F MET, V8, P642, DOI 10.1038/jcbfm.1988.111; FOX PT, 1991, J CEREBR BLOOD F MET, V11, pA79, DOI 10.1038/jcbfm.1991.41; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; FRISTON KJ, 1995, J CEREBR BLOOD F MET, V15, P361, DOI 10.1038/jcbfm.1995.45; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GHATAN PH, 1995, NEUROIMAGE, V2, P112, DOI 10.1006/nimg.1995.1014; Ginsberg MD, 2003, ANN NEUROL, V54, P330, DOI 10.1002/ana.10659; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; HIBBARD LS, 1984, AM J PHYSIOL, V247, pE412, DOI 10.1152/ajpendo.1984.247.3.E412; HIBBARD LS, 1987, SCIENCE, V236, P1641, DOI 10.1126/science.3603004; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Huh PW, 2000, J NEUROSURG, V92, P91, DOI 10.3171/jns.2000.92.1.0091; Iwi G, 1999, PHYS MED BIOL, V44, pN55, DOI 10.1088/0031-9155/44/4/021; Kannurpatti SS, 2004, J CEREBR BLOOD F MET, V24, P703, DOI 10.1097/01.WCB.0000121232.04853.46; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McColl J H, 1994, Stat Methods Med Res, V3, P63, DOI 10.1177/096228029400300105; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; POLINE JB, 1995, J COMPUT ASSIST TOMO, V19, P788, DOI 10.1097/00004728-199509000-00017; Rangarajan A, 1997, Med Image Anal, V1, P379; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Royackkers N, 1999, NEUROIMAGE, V10, P625, DOI 10.1006/nimg.1999.0512; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; SMITH CB, 1988, P NATL ACAD SCI USA, V85, P9341, DOI 10.1073/pnas.85.23.9341; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Thompson P M, 1997, Med Image Anal, V1, P271; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; VOTAW JR, 1995, J CEREBR BLOOD F MET, V15, P492, DOI 10.1038/jcbfm.1995.61; Woods R. E, 2002, DIGITAL IMAGE PROCES; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; ZHAO WZ, 1995, J CEREBR BLOOD F MET, V15, P552, DOI 10.1038/jcbfm.1995.69; Zhao WZ, 1997, J CEREBR BLOOD F MET, V17, P1281, DOI 10.1097/00004647-199712000-00003; ZHAO WZ, 1993, IEEE T MED IMAGING, V12, P782, DOI 10.1109/42.251130; Zilles K, 1985, CORTEX RAT; [No title captured]	46	11	11	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	JUL	2006	83	1					18	28		10.1016/j.cmpb.2006.05.005			11	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	067ZY	WOS:000239342500003	16828919				2022-02-06	
J	Cao, R; Hasuo, H; Ooba, S; Akasu, T; Zhang, X				Cao, Ruifeng; Hasuo, Hiroshi; Ooba, Satomi; Akasu, Takashi; Zhang, Xiang			Facilitation of glutamatergic synaptic transmission in hippocampal CA1 area of rats with traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						traumatic brain injury; hippocampal CA1; intracellular recording; excitability; synaptic transmission; glutamate release	PAIRED-PULSE FACILITATION; LONG-TERM POTENTIATION; POSTTRAUMATIC EPILEPSY; HYPEREXCITABILITY; SYNAPSES; RELEASE; DEPRESSION; RECEPTORS; RECOVERY; NEURONS	We investigated the effects of traumatic brain injury (TBI) on the glutamatergic synaptic transmission in the hippocampal CA1 area. A moderate impact (3.8-4.8 atm) was applied onto the left parietal cerebral cortex by a fluid percussion injury (FPI) device. Conventional intracellular recordings were made from hippocampal CA1 pyramidal neurons in vitro. Electrophysiological properties of these neurons were compared between three groups (control, FPI-ipsilateral, and FPI-contralateral). The excitability of postsynaptic membrane of CA1 pyramidal neurons was not altered by the moderate FPI; however, the evoked glutamatergic excitatory synaptic transmission in the pyramidal neurons of post-FPI-CA1 was enhanced. Paired-pulse facilitation (PPF) was significantly suppressed in both the FPI-ipsilateral and FPI-contralateral groups and the frequencies of mEPSPs in neurons from the bilateral FPI groups were greater than the frequency in the control group. These results suggest that the glutamatergic synaptic transmission in the hipppocampal CA1 area is facilitated through presynaptic mechanisms after TBI. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Fourth Mil Med Univ, Xijing Hosp, Neurosurg Inst PLA, Dept Neurosurg, Xian 710032, Peoples R China; Kurume Univ, Sch Med, Dept Physiol, Kurume, Fukuoka 8300011, Japan; Kurume Univ, Open Res Ctr, Cognit & Mol Res Inst Brain Dis, Kurume, Fukuoka 8300011, Japan		Hasuo, H (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Neurosurg Inst PLA, Dept Neurosurg, 15 W Changle Rd, Xian 710032, Peoples R China.	xzhang@fmmu.edu.cn	Cao, Ruifeng/P-3819-2019; Cao, Ruifeng/K-8894-2013; Cao, Ruifeng/E-8496-2011	Cao, Ruifeng/0000-0001-5105-7726; 			Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Knoblach SM, 2000, NEUROSCI LETT, V289, P5, DOI 10.1016/S0304-3940(00)01263-5; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Patel DR, 1997, EUR J PHARMACOL, V332, P143, DOI 10.1016/S0014-2999(97)01077-7; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; SCHWARTZKROIN PA, 1978, BRAIN RES, V147, P117, DOI 10.1016/0006-8993(78)90776-X; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Takeya M, 2003, NEUROSCI LETT, V344, P153, DOI 10.1016/S0304-3940(03)00357-4; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Toth Z, 1997, J NEUROSCI, V17, P8106; Zhang DQ, 1999, NEUROSCI LETT, V272, P57, DOI 10.1016/S0304-3940(99)00455-3	30	11	13	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 19	2006	401	1-2					136	141		10.1016/j.neulet.2006.03.005			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	050JB	WOS:000238082400027	16574323				2022-02-06	
J	Kennedy, JE; Lumpkin, RJ; Grissom, JR				Kennedy, JE; Lumpkin, RJ; Grissom, JR			A survey of mild traumatic brain injury treatment in the emergency room and primary care medical clinics	MILITARY MEDICINE			English	Article; Proceedings Paper	27th Annual Williamsburg Traumatic Brain Injury Rehabilitation Conference	JUN 06-08, 2003	Williamsburg, VA				HEAD-INJURY; RISK-FACTORS; MANAGEMENT; VALIDATION; DIAGNOSIS; PROPOSAL; US	This study surveyed health care providers about their evaluation and treatment of mild traumatic brain injury (TBI) in adults. We presented two vignettes describing mild TBI cases to staff in the emergency department (N = 22) and primary care clinics (N = 16) at Wilford Hall Air Force Medical Center and asked how they would evaluate and treat these patients. Most providers said they would assess visual changes, nausea[vomiting, headache, and neck pain. More emergency department personnel than primary care clinic providers would make referrals to different specialties, whereas more primary care clinic providers would schedule a follow-up appointment. Neither group of providers mentioned assessing common postconcussive symptoms of fatigue, emotional changes, and problems sleeping. Comparing findings to current literature suggest that added focus on emotional, cognitive and psychosocial factors, and education of the patient and family could improve early identification of mild TBI patients at risk for poor recovery.	Wilford Hall USAF Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX 78227 USA; Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Kennedy, JE (corresponding author), Wilford Hall USAF Med Ctr, Def & Vet Brain Injury Ctr, POB 27376, San Antonio, TX 78227 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; Centers for Disease Control and Prevention and National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; *CTR DIS CONTR PRE, 2001, INJ FACT BOOK 2001 2; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; KAY T, 1992, PHYSICAL MED REHABIL, V6, P109; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schootman M, 2000, BRAIN INJURY, V14, P373; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609	23	11	11	0	2	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	JUN	2006	171	6					516	521		10.7205/MILMED.171.6.516			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058IH	WOS:000238658200017	16808133	Bronze			2022-02-06	
J	Pape, TLB; Lundgren, S; Heinemann, AW; Guernon, A; Giobbie-Hurder, A; Wang, J; Roth, H; Blahnik, M; Williams, V				Pape, Theresa Louise-Bender; Lundgren, Sandra; Heinemann, Allen W.; Guernon, Ann; Giobbie-Hurder, Anita; Wang, Jia; Roth, Heidi; Blahnik, Melanie; Williams, Vanessa			Establishing a prognosis for functional outcome during coma recovery	BRAIN INJURY			English	Article						coma; unconsciousness; prognostication; functional outcomes	TRAUMATIC BRAIN-INJURY; CRAIG HANDICAP ASSESSMENT; EFFECTS REGRESSION-ANALYSIS; DISABILITY RATING-SCALE; COMMUNITY INTEGRATION; LIFE SATISFACTION; PATIENT HEALTH; REHABILITATION; VALIDITY; RELIABILITY	Primary objective: One of the most challenging tasks for clinicians caring for survivors of severe brain injury (BI) is establishing a prognosis, for long-term functional outcome, while the patient is unconscious. The objective of this article is to report findings regarding the prediction of functional outcomes 1-year after severe BI using data available when the patient is unconscious. Research design: Longitudinal prognostication study. Methods and procedures: Persons unconscious after severe BI who present to inpatient (IP) rehabilitation hospitals in the Midwestern US are enrolled in an ongoing study. Each subject is followed for 1-year and the final outcome interview includes similar to 70 questions; 32 of these questions are from the Craig Handicap Assessment and Reporting Technique (CHART). A sample of 63 persons was abstracted from the study database to examine the predictability of 42 independent variables and 16 dichotomous outcomes. Main outcomes and results: Twelve of the 16 dichotomous outcomes were found to be significantly predictable (p < 0.05). These involve activity, participation, environment and quality of life outcomes. Ten predictors were found to be significant (p < 0.05): aetiology (Closed Head Injury vs. Other BI), presence of urinary tract infection (UTI), seizure, hypertension during IP rehabilitation, veteran benefit eligibility, health insurance, marital status at injury, whether or not recovery of consciousness occurred within 1 year, the number of days between injury and admission to acute rehabilitation and the average length of IP rehabilitation stay. Eight of the 10 variables are available early after injury or when the patient is unconscious.	Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Res Serv, Hines, IL 60141 USA; Marianjay Rehabil Hosp, Wheaton, IL USA; Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; VA Med Ctr, Mental & Behav Hlth Patient Serv Line MC 116 B, Minneapolis, MN USA; VA Med Ctr, Def & Vet Brain Injury Ctr, Minneapolis, MN USA; Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; Edward Hines Jr VA Hosp, VA Cooperat Studies Program Coordinating Ctr, Hines, IL USA; Rehabil Inst Chicago, Traumat Brain Injury Program, Chicago, IL 60611 USA		Pape, TLB (corresponding author), Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Res Serv, POB 5000,M-C 15H, Hines, IL 60141 USA.	theresa.pape@va.gov	Giobbie-Hurder, Anita/AAU-6193-2021; Heinemann, Allen W/K-6283-2012; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W/0000-0003-2782-7326; Heinemann, Allen W./0000-0003-2782-7326; Bender Pape, Theresa/0000-0001-7738-5963			Alderson AL, 2002, J HEAD TRAUMA REHAB, V17, P210, DOI 10.1097/00001199-200206000-00003; Anderson Caroline J, 2002, J Spinal Cord Med, V25, P184; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CORWIN B, 1996, J PHYS MED REHABILIT, V75, P105; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; GIACINO J, 1992, JFK COMA RECOVERY SC; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005; Hahn EA, 2003, ARCH PHYS MED REHAB, V84, pS35, DOI 10.1053/apmr.2003.50245; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hanson CS, 2001, AM J OCCUP THER, V55, P332, DOI 10.5014/ajot.55.3.332; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hedeker D, 1996, COMPUT METH PROG BIO, V49, P229, DOI 10.1016/0169-2607(96)01723-3; Hedeker D, 2000, STAT METHODS MED RES, V9, P161, DOI 10.1191/096228000667253473; Henderson V W, 1987, Bull Clin Neurosci, V52, P47; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JENNETT B, 1975, LANCET, V1, P480; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; PAPE T, 1999, THESIS U ILLINOIS CH; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Pape TLB, 2004, J REHABIL RES DEV, V41, P155, DOI 10.1682/JRRD.2004.02.0155; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENTHAL M, 1999, FUNCTIONAL CONSEQUEN; ROTHMAN ML, 1991, MED CARE, V29, P115, DOI 10.1097/00005650-199102000-00004; SEGAL ME, 1995, AM J PHYS MED REHAB, V74, P276, DOI 10.1097/00002060-199507000-00004; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tyler EJ, 2002, ARCH PHYS MED REHAB, V83, P236, DOI 10.1053/apmr.2002.27466; Vogel LC, 1998, ARCH PHYS MED REHAB, V79, P1496, DOI 10.1016/S0003-9993(98)90409-9; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whyte J, 2003, AM J PHYS MED REHAB, V82, pS16, DOI 10.1097/01.PHM.0000086992.95121.C2; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; World Health Organization, 2002, COMM LANG FUNCT DIS; Wright BD., 1982, RATING SCALE ANAL; Zafonte RD, 1996, NEUROREHABILITATION, V6, P19, DOI 10.3233/NRE-1996-6104; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	49	11	11	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2006	20	7					743	758		10.1080/02699050600676933			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	062LV	WOS:000238947200009	16809207				2022-02-06	
J	Wong, VCN; Sun, JG; Yeung, DWC				Wong, Virginia C. N.; Sun, Jie-Guang; Yeung, David W. C.			Pilot study of efficacy of tongue and body acupuncture in children with visual impairment	JOURNAL OF CHILD NEUROLOGY			English	Article; Proceedings Paper	5th Congress of the European-Paediatric-Neurology-Society	OCT 25, 2003	Taormina, ITALY	European Paediat Neurol Soc			POSITRON-EMISSION-TOMOGRAPHY; PROGNOSTIC VALUE; NEUROSCIENCE; ETIOLOGY	We studied the efficacy of tongue and body acupuncture in affecting visual recovery in children with central and peripheral visual disorders. Twelve children (five boys, seven girls) (age range 18 months to 14.5 years) with visual disorder with static functional visual ability for at least 12 months were recruited for the study. The causes of cortical visual impairment (10) included severe perinatal asphyxia (4), postencephalitis (1), traumatic brain injury (1), hydrocephalus (1), and increased intracranial pressure (3). Peripheral causes (2) were due to congenital optic atrophy. We used the following assessment tools: clinical visual improvement, defined as improvement of vision by one grade in one or both eyes with measurement of visual acuity; the functional visual outcome scale of 0 to 5, with positive outcome defined as improvement in one level on a functional scale; visual evoked potential, with positive improvement defined as 10% improvement in P100 latency of one or both eyes; [F-18]-fluorodeoxyglucose (FDG) positron emission tomography (PET) of the brain, with positive improvement defined as a 10% increase in glucose metabolism in one or both occipital lobes; and the Clinical Global Impression Scale (parental report). Tongue and body acupuncture consisted of 60 sessions, with 5 sessions per week. Four children showed clinical or functional improvement (33%). Of nine children with abnormal visual evoked potentials, five had improvement (56%). Of seven children who underwent PET, six had improvement in glucose metabolism in the visual cortex (86%). Seven parents (58%) reported improvement (three children had 75% improvement; four children had 25% improvement). There was a significant correlation between the interval of onset of visual impairment and starting treatment with clinical or functional outcome, with a longer interval resulting in a better outcome (P =.0282). However, there was no correlation between cause, severity, or clinical or functional visual outcome with improvement in the visual evoked potential or PET We demonstrated that tongue and body acupuncture can improve the visual status of children with visual disorders, both peripheral and central in origin. As children with chronic visual impairment also showed some visual recovery, more studies should be done to assess the full potential of acupuncture as an adjunct to Western medicine in neuroplasticity.	Univ Hong Kong, Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; Int Tongue Acupuncture Res Clin, Hong Kong, Hong Kong, Peoples R China; Hong Kong Sanatorium & Hosp, Dept Nucl Med & Positron Emiss Tomog, Hong Kong, Hong Kong, Peoples R China		Wong, VCN (corresponding author), Univ Hong Kong, Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	vcnwong@hkucc.hku.hk					Chen W, 1998, NEUROREPORT, V9, P3669, DOI 10.1097/00001756-199811160-00019; Clarke MP, 1997, EYE, V11, P398, DOI 10.1038/eye.1997.84; Cynader M, 2000, SCIENCE, V287, P1943, DOI 10.1126/science.287.5460.1943; Dutton G, 1996, EYE, V10, P302, DOI 10.1038/eye.1996.64; Huo R, 1999, BRIT J OPHTHALMOL, V83, P670, DOI 10.1136/bjo.83.6.670; Kiyosawa M, 1996, GRAEF ARCH CLIN EXP, V234, P110, DOI 10.1007/BF00695250; National Institute of Mental Health, 1985, PSYCHOPHARMACOL BULL, V21, P839; Pallagrosi M, 1993, Ann Ist Super Sanita, V29, P163; PHELPS ME, 1985, SCIENCE, V228, P799, DOI 10.1126/science.2860723; Pomeranz B, 1998, BASICS ACUPUNCTURE, P6; SANNITA WG, 1995, NEUROPSYCHOBIOLOGY, V32, P208, DOI 10.1159/000119237; Schiller PH, 1996, BEHAV BRAIN RES, V76, P21, DOI 10.1016/0166-4328(95)00186-7; Sun JG, 2004, J NEUROL NEUROSUR PS, V75, P1054, DOI 10.1136/jnnp.2003.021485; SUN JG, 2000, 5 WORLD C AC WFAS NO; SUN JG, 2000, 13 ANN SCI M HONG KO; TAYLOR MJ, 1991, PEDIATR NEUROL, V7, P111, DOI 10.1016/0887-8994(91)90006-7; TAYLOR MJ, 1992, J CLIN NEUROPHYSIOL, V9, P357, DOI 10.1097/00004691-199207010-00004; WHITING S, 1985, DEV MED CHILD NEUROL, V27, P730; Wong V, 2002, PEDIATR NEUROL, V27, P78, DOI 10.1016/S0887-8994(02)00410-1; Wong V, 2001, PEDIATR NEUROL, V25, P47, DOI 10.1016/S0887-8994(01)00292-2; WONG V, 2000, 5 WORLD C AC WFAS NO; WONG V, 2002, BRAIN DEV, V24, P372; WONG V, 1999, P 2 S WORLD ASS CHIN; WONG V, 2003, P INT C NEUR REC ADV; Wong V, 2001, J NEUROL SCI S1, V187, pS329; WONG V, 2000, P 5 WORLD C AC WFAS; WONG V, 2001, EUR J NEUROL, V5, P189; WONG V, 2000, INT HEALTHC C HEALTC; WONG V, 2001, J NEUROL SCI S1, V187, pS254; WONG V, 1999, P 6 AS OC C CHILD NE; Wong V, 2002, BRAIN DEV, V24, P319; WONG V, 2002, AUTISM ASPERGERS SEP, P18; WONG V, 2003, P 11 AS C PAED NOV 7; WONG V, 2001, 23 INT C PED SEPT 9, P31; WONG V, 1999, EUR J PAEDIATR NEURO, V3, P198; WONG V, 1999, P 9 NAT CHILD NEUR C; WONG VCN, 1991, PEDIATR NEUROL, V7, P178, DOI 10.1016/0887-8994(91)90081-U; Wong VCN, 2006, J CHILD NEUROL, V21, P455, DOI 10.1177/08830738060210061001; YEUNG D, 2002, P ANN SCI M NUCL MED; Yeung D, 2002, BRAIN DEV, V24, P320	40	11	12	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2006	21	6					462	473		10.1177/08830738060210061201			12	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics	069SW	WOS:000239469500005	16948929				2022-02-06	
J	Martinez-Vargas, M; Gonzalez-Rivera, R; Soto-Nunez, M; Cisneros-Martinez, M; Huerta-Saquero, A; Morales-Gomez, J; Molina-Guarneros, J; Navarro, L				Martinez-Vargas, Marina; Gonzalez-Rivera, Ruben; Soto-Nunez, Maribel; Cisneros-Martinez, Marina; Huerta-Saquero, Alejandro; Morales-Gomez, Julio; Molina-Guarneros, Juan; Navarro, Luz			Recovery after a traumatic brain injury depends on diurnal variations - Effect of cystatin C	NEUROSCIENCE LETTERS			English	Article						cathepsins; circadian rhythm; brain vulnerability; neuroprotection	CATHEPSIN; MECHANISMS; ISCHEMIA; DEATH; RATS	Many studies indicate that the hour of the day at which the onset of stroke Occurs is very important in patient recovery. Furthermore, multiple studies have been conducted which show that ischemia in rats produces different magnitudes of injury depending on the hour of the day at which it was induced. Using a traumatic brain injury (TBI) model, we analyzed the effect of the time of day on the recovery of rats and obtained a higher survival rate if TBI was induced at 01:00 h as compared with TBI induced at 13:00 h. We also analyzed the effect of the protease inhibitor cystatin C (CC) on the recovery of rats from TBI and found that it increased mortality and bleeding, and that these effects were more pronounced at 13:00 h. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Univ Nacl Autonoma Mexico, Dept Fisiol, Fac Med, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Dept Farmacol, Fac Med, Mexico City 04510, DF, Mexico		Navarro, L (corresponding author), Univ Nacl Autonoma Mexico, Dept Fisiol, Fac Med, Apdo Postal 70-250, Mexico City 04510, DF, Mexico.	lnavarro@servidor.unam.mx	Navarro, Luz/Q-9086-2019; Huerta-Saquero, Alejandro/P-3499-2019; Navarro, Luz/A-4983-2013; Saquero, Alejandro Huerta/E-2734-2016; MOLINA-GUARNEROS, JUAN A/A-3357-2016	Huerta-Saquero, Alejandro/0000-0002-0156-6773; Saquero, Alejandro Huerta/0000-0002-0156-6773; MARTINEZ-VARGAS, MARINA/0000-0002-3729-2161; MOLINA GUARNEROS, JUAN ARCADIO/0000-0002-1946-0408			GONZALEZRIVERA R, 2003, SOC NEUR 33 ANN M NE; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; MARKS N, 1986, ARCH BIOCHEM BIOPHYS, V249, P489, DOI 10.1016/0003-9861(86)90026-3; MARLER J, 1993, CIRCADIAN RHYTHMS CA, P163; Nagai A., 2002, ANN NY ACAD SCI, V977, P321; Olsson T, 2004, NEUROSCIENCE, V128, P65, DOI 10.1016/j.neuroscience.2004.06.024; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; PAXINOS, 1998, RAT BRAIN STEREOTAXI; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; SOULBAN G, 1989, LIFE SCI, V45, P2485, DOI 10.1016/0024-3205(89)90015-5; TORNER JC, 1999, TRAUMATIC BRAIN INJU, P9; Ucar T, 2005, ACTA NEUROL SCAND, V112, P163, DOI 10.1111/j.1600-0404.2005.00463.x; Verma A, 2000, J HEAD TRAUMA REHAB, V15, P1149, DOI 10.1097/00001199-200010000-00008; Vinall PE, 2000, J NEUROSURG, V93, P82, DOI 10.3171/jns.2000.93.1.0082; WURTMAN RJ, 1964, SCIENCE, V143, P1328, DOI 10.1126/science.143.3612.1328; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yoshida M, 2002, ACTA NEUROPATHOL, V104, P267, DOI 10.1007/s00401-002-0554-4	18	11	12	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 29	2006	400	1-2					21	24		10.1016/j.neulet.2006.02.010			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	046XB	WOS:000237843300005	16519999				2022-02-06	
J	Ringel, F; Baethmann, A; Plesnila, N				Ringel, F; Baethmann, A; Plesnila, N			Lactacidosis-induced glial cell swelling depends on extracellular Ca2+	NEUROSCIENCE LETTERS			English	Article						cell volume regulation; acidosis-induced cell swelling; cytotoxic brain edema; calcium; glial cells	C6 GLIOMA-CELLS; VOLUME REGULATION; INTRACELLULAR PH; INVITRO MODEL; BRAIN EDEMA; LACTIC-ACID; ACIDIFICATION; COTRANSPORT; ASTROCYTES; MECHANISMS	Cerebral tissue acidosis following ischemia or traumatic brain injury contributes to cytotoxic brain edema formation. In vitro lactacidosis induces swelling of glial cells by intracellular Na+- and Cl--accumulation by the Na+/H+-antiporter, Cl-/HCO3--antiporters and the Na+-K+-2Cl(-) cotransport. The present study aimed to elucidate whether mechanisms of lactacidosis-induced glial swelling are dependent on intra-or extracellular Ca2+-ions. Therefore, C6 glioma cells were exposed to a lactacidosis of pH 6.2 in standard or calcium-free medium and following intracellular calcium chelation. Cell volume and intracellular pH were assessed by flow cytometry. Lactacidosis of pH 6.2 induced a prompt and sustained swelling of suspended C6 glioma cells reaching a maximum of 128% within 60 min. Omission of Ca2+ from the suspension medium strongly attenuated cell swelling while chelation of intracellular Ca2+ had no effects. Intracellular acidosis was not affected by either treatment. The present data show a strong dependency of lactacidosis-induced glial swelling upon extracellular Ca2+ while intracellular acidosis is not affected by omission of [Ca2+](e). Therefore, our data suggest that the Na+-K+-2Cl(-)-cotransporter, the only so far known transporter involved in cell volume regulation but not in pH(i) regulation during lactacidosis, is activated in a [Ca2+](e)-dependent manner. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Munich, Ctr Med, Walter Brendel Ctr Expt Med, Lab Expt Neurosurg, Munich, Germany		Ringel, F (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	florian.ringel@ukb.uni-bonn.de	Plesnila, Nikolaus/T-7522-2019; Ringel, Florian/E-4933-2014				BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; CHASSANDE O, 1988, EUR J BIOCHEM, V171, P425, DOI 10.1111/j.1432-1033.1988.tb13807.x; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; GOLDMAN SA, 1989, J CEREBR BLOOD F MET, V9, P471, DOI 10.1038/jcbfm.1989.70; JAKUBOVICZ DE, 1987, BRAIN RES, V435, P138, DOI 10.1016/0006-8993(87)91594-0; JAKUBOVICZ DE, 1989, BRAIN RES, V485, P215, DOI 10.1016/0006-8993(89)90564-7; KACHEL V, 1976, J HISTOCHEM CYTOCHEM, V24, P211, DOI 10.1177/24.1.1254918; KEMPSKI O, 1987, STROKE, V18, P623, DOI 10.1161/01.STR.18.3.623; KEMPSKI O, 1988, STROKE, V19, P385, DOI 10.1161/01.STR.19.3.385; KEMPSKI O, 1983, BRAIN RES, V279, P217, DOI 10.1016/0006-8993(83)90180-4; KIMELBERG HK, 1987, J PHYSIOL-PARIS, V82, P294; MARMAROU A, 1992, J NEUROTRAUM, V9, P551; Mongin AA, 1996, BBA-BIOMEMBRANES, V1285, P229, DOI 10.1016/S0005-2736(96)00165-4; MONGIN AA, 1994, BRAIN RES, V655, P110, DOI 10.1016/0006-8993(94)91603-9; Morihata H, 2000, J NEUROSCI, V20, P7220; Nabekura T, 2003, GLIA, V41, P247, DOI 10.1002/glia.10190; Pasantes-Morales H, 2000, NEUROCHEM RES, V25, P1301, DOI 10.1023/A:1007652330703; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; Pringle AK, 2004, CELL CALCIUM, V36, P235, DOI 10.1016/j.ceca.2004.02.014; Ringel F, 2000, J NEUROCHEM, V75, P125, DOI 10.1046/j.1471-4159.2000.0750125.x; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; STAUB F, 1993, J NEUROL SCI, V119, P79, DOI 10.1016/0022-510X(93)90194-4; STAUB F, 1994, J CEREBR BLOOD F MET, V14, P1030, DOI 10.1038/jcbfm.1994.135; STAUB F, 1990, J CEREBR BLOOD F MET, V10, P866, DOI 10.1038/jcbfm.1990.143; STRUPP M, 1993, GLIA, V9, P136, DOI 10.1002/glia.440090207; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012	26	11	12	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAY 8	2006	398	3					306	309		10.1016/j.neulet.2006.01.012			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	041DQ	WOS:000237434000029	16469448				2022-02-06	
J	Radulovic, D; Janosevic, V; Djurovic, B; Slavik, E				Radulovic, D.; Janosevic, V.; Djurovic, B.; Slavik, E.			Traumatic delayed epidural hematoma	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						head injury; delayed epidural hematoma; neurological observation; computerized tomography	MILD HEAD-INJURY; EXTRADURAL HEMATOMA; ONSET	Object: Traumatic delayed epidural hematoma (DEH) can be defined as a hematoma that is insignificant or not present on the initial computerized tomography (CT) scan made after trauma but subsequent CT scan shows sizeable epidural bleeding. During a 3-year period we have treated a total of 96 epidural hematomas, eight (8.3%) of which had a delayed onset. Case Report: We present here an analysis of the eight patients with traumatic DEH which had a significant mass effect in all patients and required surgical evacuation. In three patients with mild head injury (GCS > 12) neurological deterioration indicated the necessity of repeating the CT scan and preceded the detection of DEH. In only one case of the five patients with moderate (8 < GCS < 13) and severe head injury (GCS < 9) was neurological deterioration the precursor of the DEH. All patients were immediately operated on after diagnosis. Postoperative outcome was favorable in all cases. Conclusions: DEHs are highly unpredictable and continue to cause diagnostic difficulty. Close observation for signs of clinical deterioration and repeat CT scan are the most important factors for early detection of DEH. Early diagnosis and prompt operation offers excellent results for DEHs.	Clin Ctr Serbia, Inst Neurosurg, Belgrade 11000, Serbia Monteneg		Radulovic, D (corresponding author), Clin Ctr Serbia, Inst Neurosurg, Visegradska 26, Belgrade 11000, Serbia Monteneg.	rd@yubc.net					Alappat JP, 2002, NEUROL INDIA, V50, P313; ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; BUCCI MN, 1986, NEUROSURGERY, V19, P65, DOI 10.1227/00006123-198607000-00009; DIROCCO A, 1991, NEURORADIOLOGY, V33, P253, DOI 10.1007/BF00588229; DOMENICUCCI M, 1995, NEUROSURG REV, V18, P109, DOI 10.1007/BF00417668; Ferrera PC, 1997, AM J EMERG MED, V15, P76, DOI 10.1016/S0735-6757(97)90055-3; FUKAMACHI A, 1984, COMPUT RADIOL, V8, P197, DOI 10.1016/0730-4862(84)90123-9; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; Inamasu J, 2001, AM J EMERG MED, V19, P324, DOI 10.1053/ajem.2001.24480; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; POON WS, 1992, NEUROSURGERY, V30, P681; Riesgo P, 1997, SURG NEUROL, V48, P226, DOI 10.1016/S0090-3019(97)00194-8; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8	14	11	12	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.	MAY	2006	67	2					76	80		10.1055/s-2006-933359			5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	042WL	WOS:000237561200003	16673239				2022-02-06	
J	Barus, D; Kozin, SH				Barus, Diane; Kozin, Scott H.			The evaluation and treatment of elbow dysfunction secondary to spasticity and paralysis	JOURNAL OF HAND THERAPY			English	Article							TO-TRICEPS TRANSFER; SPINAL-CORD INJURY; BOTULINUM TOXIN; TETRAPLEGIA; BICEPS	An integrated pharmaceutical, surgical, and therapeutic approach is described for the management of patients with spasticity and paralysis of the elbow due to central nervous system injury The patient populations considered in this article include those with cerebral palsy, traumatic brain injury, and spinal cord injuries. Therapy evaluations and techniques and pharmacologic interventions to prevent loss of elbow motion are presented. Surgical techniques such as tendon lengthening, joint releases, and/or tendon transfer and postoperative therapy guidelines to restore loss of elbow motion are reviewed. Outcomes of this team approach in one clinical setting are presented.	Shriners Hosp Children, Philadelphia, PA 19140 USA; Temple Univ, Dept Orthopaed Surg, Philadelphia, PA 19122 USA		Kozin, SH (corresponding author), Shriners Hosp Children, 3551 N Broad St, Philadelphia, PA 19140 USA.	skozin@shrinenet.org					APPLE DF, 1996, CHILD SPINAL CORD IN, P269; BLACKMORE SM, REHABILITATION HAND, P1779; Cup EHC, 2003, CLIN REHABIL, V17, P402, DOI 10.1191/0269215503cr635oa; Dunkerley AL, 2000, SPINAL CORD, V38, P435, DOI 10.1038/sj.sc.3101025; Flowers K R, 1994, J Hand Ther, V7, P150; GRIFFITH AJ, REHABILITATION HAND, P1245; HAMBLETON P, 1993, J MED MICROBIOL, V39, P243, DOI 10.1099/00222615-39-4-243; HANSON RW, 1976, ARCH PHYS MED REHAB, V57, P291; House J H, 1976, J Hand Surg Am, V1, P152; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; KOZIN SH, 2002, J AM SOC SURG HAND, V3, P141; Kuz JE, 1999, J HAND SURG-AM, V24A, P161; Law M, 1990, Can J Occup Ther, V57, P82; Law M, 1994, Can J Occup Ther, V61, P191; MACDERMID JC, REHABILITATION HAND, P285; MCCLURE PW, 1994, PHYS THER, V74, P1101, DOI 10.1093/ptj/74.12.1101; MORREY BF, 1990, J BONE JOINT SURG AM, V72A, P601, DOI 10.2106/00004623-199072040-00019; Mulcahey MJ, 1999, J PEDIATR ORTHOPED, V19, P319, DOI 10.1097/00004694-199905000-00008; Mulcahey MJ, 2003, J HAND SURG-AM, V28A, P964, DOI 10.1016/S0363-5023(03)00485-4; PELJOVICH AE, REHABILITATION HAND, P854; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Revol M, 1999, J HAND SURG-BRIT EUR, V24B, P235, DOI 10.1054/jhsb.1998.0184; Sewell L., 2001, BRIT J OCCUP THER, V64, P305, DOI [10.1177/030802260106400607, DOI 10.1177/030802260106400607]; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; Vogel L, 1997, DEV MED CHILD NEUROL, V39, P202	25	11	11	0	1	HANLEY & BELFUS-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0894-1130			J HAND THER	J. Hand Ther.	APR-JUN	2006	19	2					192	205		10.1197/j.jht.2006.02.012			14	Orthopedics; Rehabilitation; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Surgery	101RZ	WOS:000241759500012	16713867				2022-02-06	
J	Pace, MC; Cicciarella, G; Barbato, E; Maisto, M; Passavanti, MB; Gazzerro, G; Barbarisi, M; Aurilio, C				Pace, M. C.; Cicciarella, G.; Barbato, E.; Maisto, M.; Passavanti, M. B.; Gazzerro, G.; Barbarisi, M.; Aurilio, C.			Severe traumatic brain injury: management and prognosis	MINERVA ANESTESIOLOGICA			English	Article						traumatic brain injury, therapy; vital functions; functional recovery; survival	SCORE	Aim. The aim of the study is to assess the efficacy of early treatment in severe traumatic brain injury by evaluating patients' survival and functional recovery. Methods. We subdivided 184 patients into 2 groups (Group A: patients admitted to hospital within the first hour of injury; Group B: patients admitted after the first hour of injury). In order to maintain the mean arteial pressure (MAP) >90 with cerebral perfusion pressure (CPP) >70 mmHg, we used plasma expanders; in 76 patients with MAP >90 mmHg, we administered dopamine, and in 5 cases noradrenaline. in 157 patients we used mechanical ventilation (MV). For orotracheal intubation and sedation/analgesia, we administered: propofol (a bolus of 2 mg/kg+1 mg/kg/h)+midazolam (0-03 mg/kg/h) + cisatracurium besilate (0.2 mg/kg) in 113 patients, or thiopentone sodium (a bolus of 4 mg/kg + 1-2 mg/kg/h)+cisatracurium besilate (0.2 mg/kg) in 44 patients with endocranial hypertension without bleeding and convulsions. After muscle relaxation we administered remifentanyl (0.075 mu g/kg/min). Surgical decompression was performed in 57 cases. Data were analysed with Student's t-test. Results. The number of deaths was significantly lower in Group A (P<0.05): 9 patients from Group A and 21 patients from Group B died within 24 h (P<0.05), while 15 patients from Group A and 16 patients from Group B died after the first 24 h period. After the recovery of critical life functions, 53 patients from Group A and 34 patients from Group B were transferred to a medical ward (P<0.0001), while 15 patients from Group A and 21 patients from Group B were transferred to a rehabilitation facility (P<0.05). Conclusion. Prevention, early treatment of complications and maintenance of homeostasis lead to a better prognosis in terms of survival, functional recovery and to a reduction in economic and social costs.	Univ Naples 2, Dept Anesthesiol Surg & Emergency Sci, Naples, Italy		Pace, MC (corresponding author), Via Eldorado 13, Naples, Italy.	caterina.pace@libero.it	Pace, Maria Caterina/L-5452-2016	Pace, Maria Caterina/0000-0002-9352-4780; Passavanti, Maria Beatrice/0000-0002-9659-0847			*AM ASS NEUR SURG, 2000, MAN PROGN SEV BRAIN; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Beretta L, 1999, Minerva Anestesiol, V65, P159; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CANCELLOTTI C, 1999, ESIA ONLINE J ANESTH, V4; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iacono L A, 2000, J Neurosci Nurs, V32, P54; Natalini E, 2002, Ann Ital Chir, V73, P105; OWEN A, 1998, MONITORAGGIO AREA CR; Procaccio F, 1999, Minerva Anestesiol, V65, P147; Toschlog EA, 2003, AM SURGEON, V69, P491; Vigue B, 2003, NEUROCHIRURGIE, V49, P583; Yang Zhen-jiu, 2004, Chin J Traumatol, V7, P49; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; 2000, NEUROTRAUMA CONTROL	20	11	13	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	APR	2006	72	4					235	242					8	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	103KQ	WOS:000241884500007	16570035				2022-02-06	
J	Marchio, PS; Previgliano, IJ; Goldini, CE; Murillo-Cabezas, F				Marchio, PS; Previgliano, IJ; Goldini, CE; Murillo-Cabezas, F			Head injury in Buenos Aires city: a prospective, population based, epidemiologic study	NEUROCIRUGIA			Spanish	Article						traumatic brain injury; head injury; epidemiology; incidence; risk factors	TRAUMATIC BRAIN-INJURY; SAN-DIEGO-COUNTY	Objective. The aim of the study is to present head injury (HI) epidemiology in a population of Buenos Aires that represents almost all socioeconomic sectors. Material and method. Prospective, population based study, approved by the Ethic, Education and Research Committees as part of a neurotrauma program. Results. HI incidence was 322/100000 inhabitants, of them mild HI accounted for 93%, moderate HI 4% and severe HI 3%. Average age was greater in women than in men (49 vs. 38 yo, p 0,01). Taking into account population under and over 40 years we found several differences: the relative risk (RR) for any kind of HI was 1,97 (CI 95% 1,77 - 2,19, p < 0,01, and the RR for motor vehicle (MV) related HI was 2,53 (CI 95% 2,03 - 3,17, p < 0,01). Male drivers had a higher RR (16,76 CI 95% 5,35 - 52,50, p < 0,01) regardless age. Assaults were also significantly higher in people under 40 yo (RR 2,11 IC 95% 1,46 - 3,03, p < 0,01) increased in young males. Self altitude falls were more frequent in population over 40 yo (RR 4,35 CI 95% 2,61 - 4,16, p < 0,01) and in women at any age (RR 3,15 CI 95% 2,57 - 3,87, p < 0,01). Pedestrian accidents were also more common in population over 40 yo (RR 1,84 CI 95% 1,41 -2,41 p < 0,01). We did not found any other differences concerning the remaining trauma mechanisms. Conclusions. HI incidence in Buenos Aires is similar to other printed series, but moderate and severe HI and mortality rates are below that ones. Motor vehicle accidents are the leading HI cause, especially in the young male population, while self altitude fall and pedestrian accidents are prevalent in women and people over 40 yo.	Hosp Gen Agudos JA Fernandez, Area Emergencia & Terapia Intens, Buenos Aires, DF, Argentina; Hosp Univ Virgen Rocio, Serv Cuidados Criticos & Urgencias, Seville, Spain		Previgliano, IJ (corresponding author), Virrey Loreto 2676 7 CP 1426, Buenos Aires, DF, Argentina.		Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016				Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BARQUERO AV, 1992, EUR J EPIDEMIOL, P832; Bastida JL, 2004, J TRAUMA, V56, P883, DOI 10.1097/01.TA.0000069207.43004.A5; *BRAIN TRAUM FDN, 2000, MAN PROGN SEV TRAU 2, P27; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Marshall LF, 1991, J NEUROSURG S, V75, P14; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Meerhoff S R, 2000, Ned Tijdschr Geneeskd, V144, P1915; MINER MG, 1998, SALUD PUBLICA; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Raja IA, 2001, WORLD J SURG, V25, P1230; Servadei F, 2002, NEUROEPIDEMIOLOGY, V21, P297, DOI 10.1159/000065523; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; TIRET L, 1986, INT J EPIDEMIOL, V19, P133; Torner James C., 1996, P19; TORNER JC, 1989, EPIDEMIOLOGY CLOSED; Wallace G L, 1993, Hawaii Med J, V52, P234	24	11	13	0	7	SOCIEDAD LUSO-ESPANOLA NEUROCIRUGIA	SANTANDER	C/O J M IZQUIERDO HOSPITAL VALDECILLA, 39908 SANTANDER, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	FEB	2006	17	1					14	22					9	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	038HK	WOS:000237209700003	16565777				2022-02-06	
J	Urdzikova, L; Vanicky, I				Urdzikova, L; Vanicky, I			Post-traumatic moderate systemic hyperthermia worsens behavioural outcome after spinal cord injury in the rat	SPINAL CORD			English	Article						hyperthermia; hypothermia; temperature; spinal cord injury; rat	BRAIN TEMPERATURE; ANOXIC INJURY; HEAD-INJURY; HYPOTHERMIA; TRAUMA; STROKE; FEVER; MECHANISMS; PYREXIA	Study design: A standardized rat model of compression spinal cord injury (SCI) was used to test the effect of transient systemic hyperthermia on long-term behavioural and morphometric outcomes. Objective: To determine the effect of hyperthermia on the development of spinal cord lesion after SCI. Setting: Institute of Neurobiology, Slovak Republic. Methods: Male Wistar rats ( n = 30) weighing between 300 and 330 g were used in the study. After incomplete spinal injury performed by balloon compression at the Th8 - Th9 spinal level, rats were randomly divided into two groups. Rats in the treatment group were maintained hyperthermic for 3 h ( rectal temperature at 40.5 +/- 0.5 degrees C), immediately after SCI; rats from the control group received exactly the same procedure except that their rectal temperature was maintained at 37 +/- 0.5 degrees C. Results: The 3 h of post-traumatic hyperthermic treatment worsened behavioural outcome after SCI. Morphometric analysis showed that hyperthermia had a deleterious effect on white and grey matter, but the results did not reach statistical significance. Conclusion: These results indicate that systemic hyperthermia exacerbates secondary processes in the lesion and significantly worsens behavioural outcome after traumatic SCI in the rat. Sponsorship: Grant VEGA 2/3216/24.	Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia		Urdzikova, L (corresponding author), Slovak Acad Sci, Inst Neurobiol, Soltesovej 4-6, Kosice 04001, Slovakia.		Vanicky, Ivo/ABB-2298-2021	Machova Urdzikova, Lucia/0000-0001-7622-5837			BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BERALDO PSS, 1993, PARAPLEGIA, V31, P186, DOI 10.1038/sc.1993.35; Boysen G, 2001, STROKE, V32, P413, DOI 10.1161/01.STR.32.2.413; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHILDERS MK, 1994, BRAIN INJURY, V8, P335, DOI 10.3109/02699059409150984; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Colachis SC, 2002, AM J PHYS MED REHAB, V81, P232, DOI 10.1097/00002060-200203000-00013; COLACHIS SC, 1995, AM J PHYS MED REHAB, V74, P114; Corbett D, 2000, BRAIN PATHOL, V10, P145; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; ESSIET A, 1992, PARAPLEGIA, V30, P339, DOI 10.1038/sc.1992.79; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Inamasu J, 2003, J NEUROL SCI, V209, P55, DOI 10.1016/S0022-510X(02)00463-X; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liu XZ, 1997, J NEUROSCI, V17, P5395; MASUHR F, 1999, THROMB HAEMOSTASIS, V1, P85; MICHENFELDER JD, 1991, ANESTHESIOLOGY, V75, P130, DOI 10.1097/00000542-199107000-00021; Ondrejcak T, 2004, BRAIN RES, V995, P267, DOI 10.1016/j.brainres.2003.10.009; RANSOM BR, 1990, STROKE, V21, P52; Rosenberg LJ, 1997, J NEUROTRAUM, V14, P823, DOI 10.1089/neu.1997.14.823; SCHMIDT KD, 1992, MAYO CLIN PROC, V67, P469, DOI 10.1016/S0025-6196(12)60394-2; Sharma HS, 2002, AMINO ACIDS, V23, P247, DOI 10.1007/s00726-001-0136-0; Shibuya S, 2004, SPINAL CORD, V42, P29, DOI 10.1038/sj.sc.3101516; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stallman J S, 1993, J Am Paraplegia Soc, V16, P157; STYS PK, 1992, J CEREBR BLOOD F MET, V12, P977, DOI 10.1038/jcbfm.1992.135; STYS PK, 1992, J NEUROSCI, V12, P430; SUGARMAN B, 1982, JAMA-J AM MED ASSOC, V248, P66, DOI 10.1001/jama.248.1.66; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Tuzgen S, 1998, SPINAL CORD, V36, P654, DOI 10.1038/sj.sc.3100660; Vanicky I, 2002, NEUROSCI RES COMMUN, V31, P183, DOI 10.1002/nrc.10051; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Winkler T, 2002, AMINO ACIDS, V23, P273, DOI 10.1007/s00726-001-0138-y; Yamamoto K, 1998, NEUROREPORT, V9, P1655, DOI 10.1097/00001756-199805110-00072; Yu CG, 2001, NEUROSURGERY, V49, P152, DOI 10.1097/00006123-200107000-00023	41	11	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	FEB	2006	44	2					113	119		10.1038/sj.sc.3101792			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	008VK	WOS:000235068600007	16130024	Bronze			2022-02-06	
J	Mayzler, O; Leon, A; Eilig, I; Fuxman, Y; Benifla, M; Freixo, PC; Gurevich, B; Agassi, R; Artru, AA; Shapria, Y				Mayzler, O; Leon, A; Eilig, I; Fuxman, Y; Benifla, M; Freixo, PC; Gurevich, B; Agassi, R; Artru, AA; Shapria, Y			The effect of hypertonic (3%) saline with and without furosemide on plasma osmolality, sodium concentration, and brain water content after closed head trauma in rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral edema; diuretic; hyperosmolar therapy	ELEVATED INTRACRANIAL-PRESSURE; CEREBRAL BLOOD-FLOW; HEMORRHAGIC-SHOCK; CEREBROSPINAL-FLUID; INJURY; MANNITOL; RESUSCITATION; EDEMA; MODEL; HYPERTENSION	Adding furosemide (F) to mannitol causes a greater decrease of brain volume, intracranial pressure, and brain water content (BW) as compared with mannitol alone. We examined whether adding F to hypertonic saline (HS) causes less increase of BW early after closed head trauma (CHT) as compared with HS alone. With institutional approval, 125 rats underwent sham surgery or CHT and then immediately received no treatment, HS (1.2 g/kg, 3% solution), or HS + F (2 mg/kg), In groups 1-10 (n = 8/group), the percent BW content was determined at 30, 60, or 120 minutes. In groups 11-14 (n = 8/group), physiologic values were determined at 0, 30, 60, and 120 minutes. At 120 minutes, the increase of BW caused by CHT (sham = 78.9 +/- 0.6% and CHT = 81.5 +/- 2.2%, mean +/- SD) was prevented by HS + F (78.0 +/- 0.8%) but not by HS (80.7 +/- 2.2%). Both HS and HS + F similarly increased plasma osmotality and sodium concentration. Post-CHT hypotension and acidosis (30 and 60 minutes) and decrease of hemoglobin concentration (120 minutes) were less with HS + F than with HS. We conclude that adding F to HS decreases BW without causing more increase of osmolality and Na than that caused by HS alone.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Soroka Med Ctr, Dept Surg, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; Soroka Med Ctr, Div Anesthesiol, IL-84101 Beer Sheva, Israel; Barzilay Med Ctr, Dept Surg, Askelon, Israel; Soroka Med Ctr, Dept Neurosurg, IL-84101 Beer Sheva, Israel		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, 356540, Seattle, WA 98195 USA.	artruaa@u.washington.edu					BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; BERGER S, 1994, ACTA NEUROCHIR, P494; DAUTERMANN C, 1992, ADV EXP MED BIOL, V317, P731; Dixon CE, 1996, NEUROTRAUMA, P1337; Eilig I, 2001, ANESTH ANALG, V92, P669, DOI 10.1213/00000539-200103000-00023; FOXWORTHY JC, 1990, J NEUROSURG ANESTH, V2, P256, DOI 10.1097/00008506-199012000-00002; GUNNAR W, 1988, SURGERY, V103, P398; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Ichai C, 1997, ANN FR ANESTH, V16, P435, DOI 10.1016/S0750-7658(97)81476-1; JACKSON EK, 2001, GOODMAN GILMANS PHAR, P757; LORENZO AV, 1986, Z KINDERCHIR, V41, P10; MELBY JM, 1982, CAN J PHYSIOL PHARM, V60, P405, DOI 10.1139/y82-059; MILHORAT TH, 2001, ANESTHESIA NEUROSURG, P115; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NELSON GIC, 1983, EUR HEART J, V4, P706, DOI 10.1093/oxfordjournals.eurheartj.a061382; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; POLLAY M, 1983, J NEUROSURG, V59, P945, DOI 10.3171/jns.1983.59.6.0945; Prandota Joseph, 2002, Am J Ther, V9, P317, DOI 10.1097/00045391-200207000-00009; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; RAGAISIS V, 2002, MEDICINA B AIRES, V39, P243; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Saltarini M, 2002, Eur J Emerg Med, V9, P262, DOI 10.1097/00063110-200209000-00011; SCHELLER MS, 1991, J NEUROSURG ANESTH, V3, P291, DOI 10.1097/00008506-199112000-00009; SCHETTINI A, 1982, J NEUROSURG, V56, P679, DOI 10.3171/jns.1982.56.5.0679; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; Thenuwara K, 2002, ANESTHESIOLOGY, V96, P416, DOI 10.1097/00000542-200202000-00029; TOMITA H, 1994, ACTA NEUROCHIR, P547; TORNHEIM PA, 1979, NEUROSURGERY, V4, P48, DOI 10.1227/00006123-197901000-00009; Toung TJK, 2002, J NEUROSURG ANESTH, V14, P187, DOI 10.1097/00008506-200207000-00003; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; WILKINSON HA, 1983, NEUROSURGERY, V12, P405, DOI 10.1227/00006123-198304000-00006; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	39	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2006	18	1					24	31		10.1097/01.ana.0000188358.41284.cb			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	000YF	WOS:000234497700005	16369137				2022-02-06	
J	Shiozaki, T				Shiozaki, T			Hypertension and head injury	CURRENT HYPERTENSION REPORTS			English	Article							CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; BLOOD-FLOW; AUTOREGULATION; MANAGEMENT	Systemic hypertension and tachycardia are often observed in the acute phase of traumatic brain injury. What causes systemic hypertension after head injury? Is systemic hypertension somehow beneficial to the injured brain? Are vasoclilating drugs the first choice for treatment of systemic hypertension after traumatic brain injury? The occurrence of a hyperadrenergic state, the effects of systemic hypertension on the injured brain, the ideal blood pressure, and the management of systemic hypertension after traumatic brain injury are reviewed herein.	Osaka Univ, Sch Med, Dept Traumatol, Suita, Osaka 5650871, Japan		Shiozaki, T (corresponding author), Osaka Univ, Sch Med, Dept Traumatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	shiozaki@hp-emerg.med.osaka-u.ac.jp					Black HR, 1997, ARCH INTERN MED, V157, P2413; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; DELANEY KA, 2000, HEAD INJURY, P41; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gravenstein D, 2004, TXB NEUROINTENSIVE C, P695; GUYTON AC, 2000, TXB MED PHYSL, V10, P697; HAYASHI M, 1988, STROKE, V19, P314, DOI 10.1161/01.STR.19.3.314; Herregods L, 1988, Anaesthesia, V43 Suppl, P107, DOI 10.1111/j.1365-2044.1988.tb09089.x; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kelly DF, 1996, NEUROTRAUMA, P71; Lemke Denise M, 2004, J Neurosci Nurs, V36, P4; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SANDEL ME, 1986, ARCH PHYS MED REHAB, V67, P469; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; SHIOZAKI T, 1993, J NEUROSURG, V78, P501, DOI 10.3171/jns.1993.78.3.0501; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; SUMAS M, 1996, NEUROTRAUMA, P313; WORTSMAN J, 1980, JAMA-J AM MED ASSOC, V243, P1459, DOI 10.1001/jama.243.14.1459	27	11	11	1	4	CURRENT SCIENCE INC	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1522-6417			CURR HYPERTENS REP	Curr. Hypertens. Rep.	DEC	2005	7	6					450	453		10.1007/s11906-005-0040-1			4	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	003SW	WOS:000234702900010	16386201				2022-02-06	
J	Westcott, MC; Alfano, DP				Westcott, MC; Alfano, DP			The symptom checklist-90-revised and mild traumatic brain injury	BRAIN INJURY			English	Article						neuropsychological assessment; mild traumatic brain injury; symptom checklist-90-revised	MINOR HEAD-INJURY; CHRONIC PAIN; SCL-90-R; WHIPLASH; PERSONALITY; DEPRESSION; DISABILITY; MMPI	Objective: Assessment of emotional functioning is a critical aspect of the clinical neuropsychological evaluation of individuals following mild traumatic brain injury (MTBI). The objective of this study was to examine the utility of the Symptom Checklist-90-Revised as a brief tool for assessing psychological and symptomatic distress following MTBI. Method: A contrasted groups approach, involving three clinical groups (MTBI, Whiplash Associated Disorder, Type I Diabetes) and a non-clinical control group, was used in this study. Results: The group with MTBI scored significantly higher on the majority of primary symptom dimensions and global distress indices of the SCL-90-R compared to both the diabetes and non-clinical control groups. Analysis of individual cases further revealed that 68.2% of the participants in the group with MTBI were classified as positive cases, a rate significantly higher than that of the diabetes and non-clinical control groups. The group with MTBI did not differ significantly from the group of individuals with whiplash associated disorder with respect to elevation of primary symptom dimensions or global distress indices, or the number of cases classified as positive. Conclusion: The results of this study suggest that the SCL-90-R has considerable utility as a general measure of psychological and symptomatic distress following MTBI.	Univ Regina, Dept Psychol, Regina, SK S4S 0A2, Canada; Univ Calgary, Dept Appl Psychol, Calgary, AB, Canada		Alfano, DP (corresponding author), Univ Regina, Dept Psychol, Regina, SK S4S 0A2, Canada.	dennis.alfano@uregina.ca					Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; Alfano DP, 1999, ARCH CLIN NEUROPSYCH, V14, P780; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BURKE J M, 1990, Brain Injury, V4, P223, DOI 10.3109/02699059009026171; CARPENTER KM, 1995, J CLIN PSYCHOL, V51, P383, DOI 10.1002/1097-4679(199505)51:3<383::AID-JCLP2270510310>3.0.CO;2-Q; Cripe LI, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P291; Fabiano RJ, 1998, J REHABIL, V64, P9; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kaplan CP, 1998, BRAIN INJURY, V12, P199, DOI 10.1080/026990598122674; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kellett SC, 1999, J APPL RES INTELLECT, V12, P323, DOI 10.1111/j.1468-3148.1999.tb00088.x; KINNEY RK, 1991, SPINE, V16, P940, DOI 10.1097/00007632-199108000-00013; MOBAYED M, 1990, J AFFECT DISORDERS, V19, P237, DOI 10.1016/0165-0327(90)90100-M; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Morgan CD, 1998, ASSESSMENT, V5, P197, DOI 10.1177/107319119800500210; Nemeth AJ, 1996, ARCH CLIN NEUROPSYCH, V11, P677, DOI 10.1016/S0887-6177(96)80004-7; Peebles JE, 2001, SPINE, V26, P766, DOI 10.1097/00007632-200104010-00014; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rauter UK, 1996, J CLIN PSYCHOL, V52, P625; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schmitz N, 2000, PSYCHOL REP, V86, P263, DOI 10.2466/PR0.86.1.263-274; Stovner LJ, 1996, SPINE, V21, P2735, DOI 10.1097/00007632-199612010-00006; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; Vassend O, 1999, BEHAV RES THER, V37, P685, DOI 10.1016/S0005-7967(98)00182-X; Wallis BJ, 1996, SPINE, V21, P804, DOI 10.1097/00007632-199604010-00006; WILKINSON DG, 1981, BRIT J PSYCHIAT, V138, P1, DOI 10.1192/bjp.138.1.1; [No title captured]; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1177/014662167700100306; [No title captured]	34	11	11	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	14					1261	1267		10.1080/02699050500150104			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	983ZF	WOS:000233270200010	16286342				2022-02-06	
J	Davies, R; Mcmillan, TM				Davies, R; Mcmillan, TM			Opinion about post-concussion syndrome in health professionals	BRAIN INJURY			English	Article							HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; FOLLOW-UP; DISABILITY	Objective: To compare opinion about post-concussion syndrome (PCS) in accident and emergency doctors, clinical neuropsychologists and neurosurgeons. Method: A UK postal survey was sent to all accident and emergency doctors, neurosurgeons and clinical neuropsychologists listed by their professional bodies. Predictions of symptom complaint were made from a vignette about minor traumatic brain injury and a questionnaire about PCS-symptoms, cause, recovery and treatment. Results: All professional groups named headache, attention and memory difficulties as most common symptoms. Clinical neuropsychologists listed more symptoms at recall, more often achieved 'caseness' (Diagnostic and Statistical Manual-IV or International Classification of Diseases-10 criteria) and were more optimistic about treatment effectiveness. Neurosurgeons were more pessimistic about recovery. Organic factors were most frequently cited as the main cause of PCS, followed by emotional factors and then compensation factors. Conclusions: There was fair consistency between professional groups regarding PCS. Differences may reflect differing clinical roles between the professions, in terms of early care and late rehabilitation. The usefulness of the concept of PCS is discussed. All groups and particularly those working in acute settings may benefit from further information about minor brain injury including the effectiveness of psychological interventions.	Univ Glasgow, Gartnavel Royal Hosp, Glasgow G12 0XH, Lanark, Scotland		Mcmillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	t.m.mcmillan@clinmed.gla.ac.uk					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; AUERBACH AH, 1967, DIS NERV SYST, V28, P110; Bazarian J, 2000, BRAIN INJURY, V14, P285; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Burges C, 2001, BRIT J CLIN PSYCHOL, V40, P209, DOI 10.1348/014466501163544; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; MACKENZIE JA, 2004, UNPUB KNOWLEDGE POST; McMillan T, 2003, STUD NEUROPSYCHOL DE, P271; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; *NAT I CLIN EXC, 2003, N0235 NICE; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; *ROYAL COLL SURG E, 1999, REP WORK PART MAN PE; *SCOTT INT GUID NE, 2001, EARL MAN PEOPL HEAD; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; World Health Organization, 1992, ICD 10 ICD 10 CLASS	31	11	12	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2005	19	11					941	947		10.1080/02699050400000565			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983YY	WOS:000233269500009	16299935				2022-02-06	
J	Dawson, DR; Markowitz, M; Stuss, DT				Dawson, DR; Markowitz, M; Stuss, DT			Community integration status 4 years after traumatic brain injury - Participant-proxy agreement	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community integration; Katz Adjustment Scale; level of agreement; measurement; traumatic brain injury	KATZ ADJUSTMENT SCALE; ACUTE PREDICTORS; SOCIAL-BEHAVIOR; RELIABILITY; CONCORDANCE; RECOVERY; VALIDITY; OUTCOMES; RATINGS; FAMILY	objectives: To measure the level of agreement on community integration outcomes 4 years after traumatic brain injury (TBI) in relation to injury severity, proxy-participant relationship, and type of question. Participants: Thirty-one survivors of TBI (14 with mild TBI and 17 with moderate-severe TBI) and 31 significant other proxies. Measures: General and leisure activity scales of the Katz Adjustment Scale (KAS). Results: Agreement was highest between proxies and participants with mild versus moderate-severe TBIs, between Spouse proxies and TBI participants compared to nonspouse proxies and on the more objective subscales (frequency of participation) compared to the expectation and satisfaction scales regardless of injury severity or proxy-participant relationship. Conclusions: For research purposes, proxy data are acceptable but clinicians should assess outcomes and set goals with input from both persons with TBIs and their proxies.	Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Occupat Therapy, Toronto, ON, Canada; Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON, Canada		Dawson, DR (corresponding author), Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	ddawson@klaru-baycrest.on.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121			Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; BASSETT SS, 1990, PSYCHOL AGING, V5, P127, DOI 10.1037/0882-7974.5.1.127; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; FABIANO RJ, 1992, REHABIL PSYCHOL, V37, P75, DOI 10.1037/h0079096; Feinstein AR, 1987, CLINIMETRICS; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Law M., 1987, CAN J OCCUP THER, V54, P133, DOI [DOI 10.1177/000841748705400308, 10.1177/000841748705400308]; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, pL1067; McDowell I., 1996, MEASURING HLTH GUIDE; Ocampo S, 1997, OCCUP THER INT, V4, P161; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Stuss DT, 2000, NEUROLOGY, V54, P1337, DOI 10.1212/WNL.54.6.1337; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; World Health Organization, INT CLASS FUNCT DIS	28	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2005	20	5					426	435		10.1097/00001199-200509000-00004			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	965NO	WOS:000231957600005	16170251				2022-02-06	
J	Faraji, M; Ashrafzadeh, F				Faraji, M; Ashrafzadeh, F			Penetrating head injuries in children	NEUROSURGERY QUARTERLY			English	Article						air gun pellet; children; penetrating head injury	INTERNAL CAROTID-ARTERY; CRANIOCEREBRAL MISSILE WOUNDS; CIVILIAN GUNSHOT WOUNDS; GUN PELLET INJURIES; TRAUMATIC ANEURYSMS; LEBANESE CONFLICT; BRAIN; VIETNAM; MANAGEMENT; CHILDHOOD	Head trauma is exceedingly common in children but rarely presents as a penetrating injury to the skull. Early recognition and correct management of the possible complications of penetrating head injuries (PHIs) is important and may prevent a poor outcome. The authors' experience with 14 cases of PHIs in children referred to the Department of Neurosurgery during the last 20 years is presented. The characteristic findings on physical examination and imaging studies performed in these cases are described. All cases occurred in children in the first decade of life. There were 10 boys and 4 girls. A damaged globe that had to be exenterated was the earliest complication (1 case), followed by cerebrospinal fluid leakage (3 cases) and diabetes insipidus (1 case). Objects were removed in 11 cases. In addition to plain radiographs, computed tomography scanning and angiography were used as diagnostic procedures. The present series of patients is one of the largest collections of PHIs in children younger than 10 years of age reported in the literature. The need for prompt extrication of these objects and the possible complications of such injuries have been reviewed.	Mashhad Univ Med Sci, Dept Neurosurg, Mashhad 9176653347, Iran; Mashhad Univ Med Sci, Dept Neurol, Mashhad 9176653347, Iran		Faraji, M (corresponding author), Mashhad Univ Med Sci, Dept Neurosurg, 48 Mollasadra 4 Ave,Ahmadabad BLVD, Mashhad 9176653347, Iran.	Farajirad@yahoo.com					Amirjamshidi A, 1997, SURG NEUROL, V47, P331, DOI 10.1016/S0090-3019(96)00357-6; ARABI B, 1988, NEUROSURGERY, V22, P1056; BISHOP EJ, 1967, NEUROSURGERY TRAUMA, P203; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; CAREY ME, 1972, SURG GYNECOL OBSTETR, V135, P386; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CHAPMAN PH, 1985, CONCEPTS PEDIAT NEUR, V5, P1; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DUJOVNY M, 1975, J TRAUMA, V15, P981, DOI 10.1097/00005373-197511000-00007; EICHLER A, 1996, J NEUROSURG, V31, P72; FURLOW LT, 1974, J NEUROSURGY, V4, P380; GRAHAM TW, 1994, NEUROSURGERY, V27, P696; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; HUBSCHMANN O, 1979, J TRAUMA, V19, P6, DOI 10.1097/00005373-197901000-00002; KIRKPATRICK JB, 1978, J NEUROSURG, V49, P185, DOI 10.3171/jns.1978.49.2.0185; Koestler J, 2001, J EMERG MED, V21, P145, DOI 10.1016/S0736-4679(01)00363-8; KOJIMA T, 1987, NEUROSURGERY, V20, P322, DOI 10.1227/00006123-198702000-00022; MALTBY GL, 1946, J NEUROSURG, V3, P239, DOI 10.3171/jns.1946.3.3.0239; Martinez-Lage JF, 2001, PEDIATR SURG INT, V17, P657, DOI 10.1007/s003830100018; MEIROWSKY AM, 1981, J NEUROSURG, V54, P44, DOI 10.3171/jns.1981.54.1.0044; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; PENCEK TL, 1986, J NEUROSURG, V64, P813, DOI 10.3171/jns.1986.64.5.0813; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; RAHIMIZADEH A, 1987, ACTA NEUROCHIR, V84, P93, DOI 10.1007/BF01418831; RAHMAT H, 1984, J NEUROSURG, V60, P630, DOI 10.3171/jns.1984.60.3.0630; RAINMOND AJ, 1970, J NEUROSURG, V32, P647; RICH NM, 1980, AM J SURG, V139, P414, DOI 10.1016/0002-9610(80)90304-9; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; SADAR ES, 1973, SURG GYNECOL OBSTET, V137, P59; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007; TEAL JS, 1973, J NEUROSURG, V38, P568, DOI 10.3171/jns.1973.38.5.0568; VAQUERO J, 1982, NEURORADIOLOGY, V23, P161; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	38	11	11	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-6438			NEUROSURG QUART	Neurosurg. Q.	SEP	2005	15	3					160	163		10.1097/01.wnq.0000176390.07352.4d			4	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	961VK	WOS:000231689700004					2022-02-06	
J	Seledtsov, VI; Rabinovich, SS; Parlyuk, OV; Kafanova, MY; Astrakov, SV; Seledtsova, GV; Samarin, DM; Poveschenko, OV				Seledtsov, VI; Rabinovich, SS; Parlyuk, OV; Kafanova, MY; Astrakov, SV; Seledtsova, GV; Samarin, DM; Poveschenko, OV			Cell transplantation therapy in reanimating severely head-injured patients	BIOMEDICINE & PHARMACOTHERAPY			English	Article						cell transplantation; brain injury; coma	SPINAL-CORD-INJURY; STEM-CELLS; ASTROCYTES; DIFFERENTIATE; CONTUSION; RAT	The results of controlled, retrospective clinical investigation of applying cell transplantation (CT) therapy in 38 severely head-injured patients are presented. The patients initially were in state of coma (Glasgow coma scale score 3-7), owing to their traumatic brain injuries. Cells prepared from fetal nervous and hematopoietic tissues were grafted subarachnoidally via lumbar puncture. The control group consisted of 38 patients and was clinically comparable with the trial one. From the results obtained it appears that CT treatment promoted both wakening consciousness of the patients and their following neurological rehabilitation. A death-rate in the trial and control group was 5% (two cases) and 45% (17 cases), respectively. According to a Glasgow scale, favorable (good + satisfactory) outcomes of a disease were noted in 33 (87%) cell-grafted and only in 15 (39%) control patients. Statistical analysis revealed that CT treatment generally improved the outcomes by 2.5-fold. No serious complications of CT therapy were noted. The results point out a possible rationality of applying CT therapy in severely head-injured patients as early as within acute period of a disease. (c) 2005 Elsevier SAS. All rights reserved.	Russian Acad Med Sci, Inst Clin Immunol, Immunohematol Dept, Novosibirsk 630099, Russia; Novosibirsk State Med Acad, Novosibirsk, Russia; 34 Municipal Clin Hosp, Novosibirsk, Russia		Seledtsov, VI (corresponding author), Russian Acad Med Sci, Inst Clin Immunol, Immunohematol Dept, 14 Yadrintsevskaya St, Novosibirsk 630099, Russia.	vs@online.nsk.su	Seledtsova, Galina/B-1085-2014	Seledtsova, Galina/0000-0001-8072-6255; Seledtsov, Victor/0000-0002-4746-8853			Azanchi R, 2004, J NEUROTRAUM, V21, P775, DOI 10.1089/0897715041269696; Cova L, 2004, STEM CELLS DEV, V13, P121, DOI 10.1089/154732804773099326; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; FAVCETT JW, 1998, SPINAL CORD, V36, P811; Golfier F, 1999, BONE MARROW TRANSPL, V24, P451, DOI 10.1038/sj.bmt.1701940; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; Hao HN, 2003, J HEMATOTH STEM CELL, V12, P23, DOI 10.1089/152581603321210109; HATTON JD, 1992, GLIA, V5, P251, DOI 10.1002/glia.440050403; LACHAPELLE F, 1989, ACTA CYTOBIOL MORPHO, V1, P24; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; MOISEEV AY, 1998, B EXP BIOL MED S1, V126, P129; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; NGUYEN HM, 1990, J CELL BIOL, V111, P490; Rabinovich SS, 2003, BIOMED PHARMACOTHER, V57, P428, DOI 10.1016/j.biopha.2003.05.001; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; SELEDTSOV VI, 1995, IMMUNOBIOLOGY, V192, P205, DOI 10.1016/S0171-2985(11)80098-7; SELEDTSOV VI, 2005, IN PRESS CELL TECHNO; SMITH GM, 1991, BRAIN RES, V543, P111, DOI 10.1016/0006-8993(91)91054-5; Wu SF, 2002, NEUROSCI LETT, V318, P81, DOI 10.1016/S0304-3940(01)02488-0	19	11	13	0	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	AUG	2005	59	7					415	420		10.1016/j.biopha.2005.01.012			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	967BM	WOS:000232066500012	16084057				2022-02-06	
J	Dolberg, OT; Barkai, G; Gross, Y; Schreiber, S				Dolberg, OT; Barkai, G; Gross, Y; Schreiber, S			Differential effects of topiramate in patients with traumatic brain injury and obesity - a case series	PSYCHOPHARMACOLOGY			English	Article						binge eating disorder; obesity; PTSD; post traumatic stress disorder; topiramate; traumatic brain injury; TBI; weight gain; epilepsy; side effects	BINGE-EATING DISORDER; WEIGHT-GAIN; MOOD; MONOTHERAPY; MANAGEMENT	Topiramate is an antiepileptic drug known to have effects on weight. In order to use this as a tool to treat eating disorders, it is useful to examine whether these effects can be predicted in certain patients. To report the effects of topiramate, initiated for the treatment of epilepsy, on top of ongoing treatment, on eating patterns and weight of 17 patients with traumatic brain injury (TBI) with post-traumatic epilepsy and weight gain of various etiologies. Patients were followed up according to their usual treatment plan. Topiramate was added on top of current and stable treatment. Dose was titrated based on the patients' neurological status. Patients were asked to report side effects. No other changes were made. Of the 17 patients included, one patient dropped out. Six patients with binge eating disorder (BED) demonstrated the most pronounced effects, with marked attenuation of binges and normalizing body mass index. Less noticeable were the effects in patients with mood disorders. Topiramate was ineffective in patients whose overweight was a side effect of their medication. Side effects were rated as mild and included somnolence, paresthesias, mild cognitive disturbances and some gastrointestinal disturbances. In this report of the actual effects of topiramate in a clinical setting on weight and eating habits of 17 patients with TBI and obesity of various etiologies, topiramate seemed to be a safe intervention. Topiramate appeared to be differentially effective, with particular effects on primary pathological eating patterns.	Tel Aviv Univ, Sourasky Med Ctr, Dept Psychiat, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, Dept Psychiat, Tel Aviv, Israel; Neuropsychiat Unit Treatment & Rehabil, Tel Aviv, Israel; Bar Ilan Univ, Dept Psychol, Givat Shemuel, Israel		Dolberg, OT (corresponding author), Lundbeck Israel Ltd, POB 3088, IL-49130 Petah Tiqwa, Israel.	orna@lundbeck.com	Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693			Appolinario JC, 2002, CAN J PSYCHIAT, V47, P271, DOI 10.1177/070674370204700309; Birt Julie, 2003, Ann Clin Psychiatry, V15, P49, DOI 10.1023/A:1023280610379; Bray GA, 2003, OBES RES, V11, P722, DOI 10.1038/oby.2003.102; Calabrese JR, 2001, J CLIN PSYCHOPHARM, V21, P340, DOI 10.1097/00004714-200106000-00015; Carpenter LL, 2002, J AFFECT DISORDERS, V69, P251, DOI 10.1016/S0165-0327(01)00337-8; Chengappa KNR, 2001, EUR PSYCHIAT, V16, P186, DOI 10.1016/S0924-9338(01)00562-4; Chengappa KNR, 2001, BIPOLAR DISORD, V3, P215, DOI 10.1034/j.1399-5618.2001.30501.x; Colom F, 2001, J CLIN PSYCHIAT, V62, P475, DOI 10.4088/JCP.v62n0612c; Dursun SM, 2000, CAN J PSYCHIAT, V45, P198; Dursun SM, 2001, CAN J PSYCHIAT, V46, P287, DOI 10.1177/070674370104600316; Erfurth A, 2000, NEUROPSYCHOBIOLOGY, V42, P50, DOI 10.1159/000054854; Gordon A, 1999, AM J PSYCHIAT, V156, P968; Lessig MC, 2001, J AM ACAD CHILD PSY, V40, P1364, DOI 10.1097/00004583-200112000-00003; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Shapira NA, 2000, J CLIN PSYCHIAT, V61, P368, DOI 10.4088/JCP.v61n0508; Van Ameringen M, 2002, J CLIN PSYCHIAT, V63, P981, DOI 10.4088/JCP.v63n1104; Wallace SJ, 2001, BRAIN DEV-JPN, V23, P277, DOI 10.1016/S0387-7604(01)00230-3; Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X; Werneke U, 2002, INT CLIN PSYCHOPHARM, V17, P145, DOI 10.1097/00004850-200207000-00001; Young WB, 2002, CEPHALALGIA, V22, P659, DOI 10.1046/j.1468-2982.2002.00380.x	20	11	11	1	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUN	2005	179	4					838	845		10.1007/s00213-004-2117-y			8	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	924ZZ	WOS:000229022600013	15619108				2022-02-06	
J	Grill, E; Harder, M; Fischbacher, L; Boldt, C; Mittrach, R; Stucki, G				Grill, E; Harder, M; Fischbacher, L; Boldt, C; Mittrach, R; Stucki, G			Identification of relevant ICF categories by patients in early post-acute rehabilitation facilities	PHYSIKALISCHE MEDIZIN REHABILITATIONSMEDIZIN KURORTMEDIZIN			English	Article						rehabilitation; outcome assessment; cross sectional studies; post-acute rehabilitation; ICF; ICF core set	TRAUMATIC BRAIN INJURY; STROKE	Purpose: To describe functioning and health of patients in early post-acute rehabilitation facilities and to identify the most common problems using the International Classification of Functioning, Disability and Health (ICF). Material and method: Crosssectional survey in a convenience sample of patients requiring rehabilitation in early post-acute rehabilitation facilities. The second level categories of the ICF were used to collect information on patients' problems. For the ICF components Body Functions, Body Structures and Activities and Participation absolute and relative frequencies of impairments or limitations in the study population were reported. For the component Environmental Factors absolute and relative frequencies of perceived barriers or facilitators were reported. Results: The mean age in the sample of 174 patients was 59.8 years. 37% of the patients were female. 85 categories (35%) had a prevalence of 30% and above. The 85 categories included 25 categories (32%) of Body Functions, 10 categories (33%) of Body Structures, 30 categories (41%) of Activities and Participation and 20 (39%) categories of Environmental Factors. The most common categories belonged to the chapters Movement related functions and Mobility. Conclusion: This study is a first step towards the development of ICF Core Sets for patients in early post-acute rehabilitation facilities.	Univ Munich, Dept Phys Med & Rehabil, D-81377 Munich, Germany; Univ Munich, Inst Hlth & Rehabil Sci, WHO FIC Collaborating Ctr DIMDI, ICF Res Branch, D-81377 Munich, Germany; Community Hosp Bogenhausen, Dept Phys Med & Rehabil, Munich, Germany		Stucki, G (corresponding author), Univ Munich, Dept Phys Med & Rehabil, Marchioninistr 15, D-81377 Munich, Germany.	gerold.stucki@med.uni-muenchen.de	Grill, Eva/AAF-8104-2020; Grill, Eva/D-1875-2010	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984			*ACCP AACVPR PULM, 1997, J CARDIOPULM REHABIL, V17, P371; BOLDT C, 2005, IN PRESS DISABIL REH; Collin C, 1988, Int Disabil Stud, V10, P61; GRESHAM GE, 1980, ARCH PHYS MED REHAB, V61, P355; GRILL E, 2005, IN PRESS DISABIL REH; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Grissom SP, 2001, AM J PHYS MED REHAB, V80, P798, DOI 10.1097/00002060-200111000-00002; Karner AM, 2004, J ADV NURS, V46, P204, DOI 10.1111/j.1365-2648.2003.02980.x; Kelly-Hayes M, 1998, STROKE, V29, P1274, DOI 10.1161/01.STR.29.6.1274; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; LOEWEN SC, 1990, STROKE, V21, P78, DOI 10.1161/01.STR.21.1.78; Mant J, 2000, LANCET, V356, P808, DOI 10.1016/S0140-6736(00)02655-6; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Mukand JA, 2001, AM J PHYS MED REHAB, V80, P346, DOI 10.1097/00002060-200105000-00005; Pashkow P, 1995, J Cardiopulm Rehabil, V15, P394, DOI 10.1097/00008483-199511000-00001; Prosiegel M., 1996, NEUROL REHABIL, V1, P7; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; ROY CW, 1988, INT J REHABIL RES, V11, P67, DOI 10.1097/00004356-198803000-00010; STIERJARMER M, 2005, IN PRESS DISABIL REH; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2002, PHYS MED REHAB KUROR, V12, P146, DOI 10.1055/s-2002-32718; STUCKI G, 2005, IN PRESS DISABIL REH	22	11	11	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0940-6689	1439-085X		PHYS MED REHAB KUROR	Physik. Med. Rehabilitationsmed. Kurort.	JUN	2005	15	3					168	173		10.1055/s-2004-834778			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	942AE	WOS:000230254500003					2022-02-06	
J	Cheng, HY; Goozee, JV; Murdoch, BE				Cheng, HY; Goozee, JV; Murdoch, BE			Analysis of articulatory dynamics in dysarthria following brain injury in childhood using electromagnetic articulography and electropalatography	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							CLOSED-HEAD INJURY; SPEECH DISORDERS; CHILDREN; EPG; SPEAKERS; ALVEOLAR; CONTACT; VELAR; MOTOR	Two physiological assessments, electromagnetic articulography (EMA) and electropalatography (EPG), were used simultaneously to investigate the articulatory dynamics in an 18-year-old male with dysarthria 9 years following traumatic brain injury (TBI). Eight words consisting of /t, s, integral, k/ in word initial and word final positions were produced up to 10 times. A nonneurologically impaired male served as a control subject. Six parameters were analyzed using EMA: velocity, acceleration, deceleration, distance, duration, and motion path of tongue movements. Using EPG, the pattern and amount of tongue-to-palate contact and the duration of the closure/constriction phase of each consonant produced were assessed. Timing disturbances in the TBI speaker's speech were highlighted in perceptual assessments in the form of prolonged phonemes and a reduced speech rate. EMA analysis revealed that the approach and release phase durations of the consonant productions were within normal limits. Kinematic strategies such as decreased velocity and decreased distances traveled by the tongue, however, may have counterbalanced each other to produce these appropriate results. EPG examination revealed significantly longer closure/constriction phase periods, which may have contributed to the prolonged phonemes and reduced speech rate observed. The implications of these findings for the development of treatment programs for dysarthria subsequent to TBI will be highlighted.	Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia		Cheng, HY (corresponding author), Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia.	y.cheng@shrs.uq.edu.au	Murdoch, Bruce E/C-1397-2012				ADAMS SG, 1993, J SPEECH HEAR RES, V36, P41, DOI 10.1044/jshr.3601.41; Annegers J. F., 1983, PEDIATRIC HEAD TRAUM, P1; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Brown J.R., 1975, MOTOR SPEECH DISORDE; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; CAHILL LM, 2001, TRAUMATIC BRAIN INJU, P121; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; DAGENAIS PA, 1994, J PHONETICS, V22, P225, DOI 10.1016/S0095-4470(19)30202-5; Duffy JR., 2020, MOTOR SPEECH DISORDE; Ellis L, 2002, J PHONETICS, V30, P373, DOI 10.1006/jpho.2001.0162; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; Enderby P, 1983, FRENCHAY DYSARTHRIA; Fitzpatrick L, 2002, J PHONETICS, V30, P397, DOI 10.1006/jpho.2001.0158; GIBBON F, 1990, BRIT J DISORD COMMUN, V25, P329; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; HIROSE H, 1986, FOLIA PHONIATR, V38, P61, DOI 10.1159/000265824; HOOLE P, 1993, LANG SPEECH, V36, P235, DOI 10.1177/002383099303600307; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; Krakow RA, 1999, J PHONETICS, V27, P23, DOI 10.1006/jpho.1999.0089; Kuehn D. P., 1976, J PHONETICS, V4, P303, DOI 10.1016/S0095-4470(19)31257-4; MANUEL SY, 2002, AM SPEECH LANG HEAR; MANUEL SY, 1998, J ACOUSTICAL SOC S1, V84, pS84; Marslen-Wilson William D., 1980, SPOKEN LANGUAGE GENE, P39, DOI 10.1007/978-94-009-9091-3_2; Murdoch B. E., 1990, ACQUIRED SPEECH LANG; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; OSTRY DJ, 1985, J ACOUST SOC AM, V77, P640, DOI 10.1121/1.391882; SCOTT D, 2002, UNPUB EPGLAB MANUAL; Sosin DM, 1996, BRAIN INJURY, V10, P47; Theodoros D G, 1998, Pediatr Rehabil, V2, P107; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, p[53, 75]; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; WEISMER G, 1991, DYSARTHRIA APRAXIA S; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; [No title captured]	39	11	11	0	12	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2005	13	1					15	35					21	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	914WM	WOS:000228258700004					2022-02-06	
B	Elovic, EP; Dobrovic, NM; Fellus, JL		DeLuca, J		Elovic, Elie P.; Dobrovic, Nino M.; Fellus, Jonathan L.			Fatigue after Traumatic Brain Injury	FATIGUE AS A WINDOW TO THE BRAIN	Issues in Clinical and Cognitive Neuropsychology		English	Article; Book Chapter							GROWTH-HORMONE DEFICIENCY; ANTERIOR-PITUITARY DYSFUNCTION; PLACEBO-CONTROLLED TRIAL; HEAD-INJURY; DOUBLE-BLIND; MULTIPLE-SCLEROSIS; POSTTRAUMATIC SEIZURES; SLEEP DISTURBANCE; HYPOPITUITARISM; PERFORMANCE		[Elovic, Elie P.] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Elovic, Elie P.] Kessler Med Rehabil Res & Educ Corp, Traumat Brain Injury Res, W Orange, NJ USA; [Fellus, Jonathan L.] Kessler Inst Rehabil, Brain Injury Serv, W Orange, NJ USA		Elovic, EP (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, 185 S Orange Ave, Newark, NJ 07103 USA.						Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Blomstrand E, 2001, AMINO ACIDS, V20, P25, DOI 10.1007/s007260170063; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; BLOMSTRAND E, 1991, ACTA PHYSIOL SCAND, V143, P225, DOI 10.1111/j.1748-1716.1991.tb09225.x; Breitbart W, 2001, ARCH INTERN MED, V161, P411, DOI 10.1001/archinte.161.3.411; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Busek P, 2000, Sb Lek, V101, P233; Carpenter MB., 1985, CORE TEXT NEUROANATO, V3rd ed.; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; COHEN RA, 1989, ARCH NEUROL-CHICAGO, V46, P676, DOI 10.1001/archneur.1989.00520420096030; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Dwyer D, 2000, ACTA PHYSIOL SCAND, V170, P211, DOI 10.1046/j.1365-201x.2000.00774.x; EDWARDS OM, 1986, MEDICINE, V65, P281; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P184, DOI 10.1097/00001199-200403000-00010; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P541, DOI 10.1097/00001199-200311000-00008; EMONSON DL, 1995, SPACE ENV MED, V66, P260; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Heilman KM, 2003, CLIN NEUROPSYCHOLOGY; HILLARY F, 2003, AM J PHYS MED REHABI, V82, P240; Hillier SL, 1997, BRAIN INJURY, V11, P661; JORGENSEN JOL, 1994, EUR J ENDOCRINOL, V130, P224, DOI 10.1530/eje.0.1300224; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Krupp, 2003, FATIGUE; Krupp LB, 1996, CURR OPIN NEUROL, V9, P456, DOI 10.1097/00019052-199612000-00011; KRUPP LB, 1995, NEUROLOGY, V45, P1956, DOI 10.1212/WNL.45.11.1956; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Larsen P, 2003, WILLIAMS TXB ENDOCRI; LEZAK MD, 1978, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Newman CB, 1998, ENDOCRINOLOGIST, V8, P178, DOI 10.1097/00019616-199805000-00009; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; Rammohan KW, 2002, J NEUROL NEUROSUR PS, V72, P179, DOI 10.1136/jnnp.72.2.179; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Rosenthal M, 1999, REHABILITATION ADULT; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Simpson H, 2002, GROWTH HORM IGF RES, V12, P1, DOI 10.1054/ghir.2001.0263; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Wagner GJ, 2000, J CLIN PSYCHIAT, V61, P436, DOI 10.4088/JCP.v61n0608; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Wesensten NJ, 2002, PSYCHOPHARMACOLOGY, V159, P238, DOI 10.1007/s002130100916	59	11	11	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142 USA			978-0-262-25135-8	ISS CLIN COGN NEUROP			2005							89	105					17	Neurosciences; Psychiatry; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychiatry; Psychology	BPS59	WOS:000279778900008					2022-02-06	
J	Komiyama, M; Yoshimura, M; Honnda, Y; Matsusaka, Y; Yasui, T				Komiyama, M; Yoshimura, M; Honnda, Y; Matsusaka, Y; Yasui, T			Acute basilar artery dissection treated by emergency stenting in a 13-year-old boy	PEDIATRIC NEUROSURGERY			English	Article						basilar artery dissection; brain stem; cerebral infarction; stenting	VERTEBROBASILAR DISSECTION; VERTEBRAL ARTERY; CHILDHOOD; ANEURYSMS; CHILDREN; STROKE; INJURY; FLOW	We report a 13-year-old boy who presented with acute basilar artery occlusion due to traumatic arterial dissection. Because a grave prognosis was expected if left untreated, and the chance of neurological recovery was believed to be unlikely but not zero, given that emergency stenting for the dissection was performed within 6 h of ictus. Recanalization of the basilar artery with stent placement did not change the poor prognosis in this patient because there was extension of dissection into the posterior cerebral arteries. Copyright (c) 2005 S. Karger AG, Basel.	Osaka City Gen Hosp, Dept Neurosurg, Osaka 5340021, Japan		Komiyama, M (corresponding author), Osaka City Gen Hosp, Dept Neurosurg, 2-13-22,Miyakojima Hondohri, Osaka 5340021, Japan.	komiyama@japan-mail.com		komiyama, masaki/0000-0003-0998-6315			AminHanjani S, 1997, ACTA NEUROCHIR, V139, P44, DOI 10.1007/BF01850867; BERGER MS, 1984, J NEUROSURG, V61, P882, DOI 10.3171/jns.1984.61.5.0882; CAPLAN LR, 1988, NEUROLOGY, V38, P868, DOI 10.1212/WNL.38.6.868; Chabrier S, 2000, J CHILD NEUROL, V15, P290, DOI 10.1177/088307380001500504; Chung YS, 2002, NEUROL RES, V24, P129, DOI 10.1179/016164102101199666; deVeber G, 2003, SEMIN THROMB HEMOST, V29, P567; JAMES CA, 1995, AM J NEURORADIOL, V16, P1689; Kieslich M, 2002, J NEUROL NEUROSUR PS, V73, P13, DOI 10.1136/jnnp.73.1.13; KURIHARA S, 2002, CLIN NEUROL, V42, P970; Lotze TE, 2000, J CHILD NEUROL, V15, P694, DOI 10.1177/088307380001501011; MANZ HJ, 1983, J NEUROL, V230, P25, DOI 10.1007/BF00313594; Marietta M, 2002, CLIN APPL THROMB-HEM, V8, P179, DOI 10.1177/107602960200800215; MOSCOW NP, 1973, AM J ROENTGENOL, V119, P597, DOI 10.2214/ajr.119.3.597; Nakatomi H, 1999, ACTA NEUROCHIR, V141, P99, DOI 10.1007/s007010050272; POZZATI E, 1995, NEUROSURGERY, V36, P254, DOI 10.1227/00006123-199502000-00003; Roach, 2000, Curr Treat Options Neurol, V2, P295, DOI 10.1007/s11940-000-0047-5; Schols G, 1999, NEUROPEDIATRICS, V30, P328, DOI 10.1055/s-2007-973514; Willing SJ, 2003, AM J NEURORADIOL, V24, P985	18	11	11	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2005	41	6					318	322		10.1159/000088734			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	985GC	WOS:000233363900005	16293951				2022-02-06	
J	McGwin, G; Taylor, AJ; MacLennan, PA; Rue, LW				McGwin, G; Taylor, AJ; MacLennan, PA; Rue, LW			Unusual job activities as a risk factor for occupational injuries	OCCUPATIONAL MEDICINE-OXFORD			English	Article							CASE-CROSSOVER; HAND INJURY	Background Based upon our clinical observation, many job-related injuries occur as a consequence of workers performing a task or engaging in an activity for which they have not been trained. Methods A case-crossover study was used to evaluate unusual job tasks, unusual tools and unusual work locations as triggers for occupational injuries. Data on work activities on the day of the injury and 7 days prior to injury were collected via in-person interview. Results All the 33 subjects enrolled were male, 23 were white and 10 were black, with a mean age of 34.9 years. The most common mechanisms of injury were falls and burns. The most common injuries were fractures and closed head injuries. Unusual job tasks [odds ratio (OR) 27.0, 95% confidence interval (CI) 3.1-235.3] and unusual tools (OR 13.3, 95% CI 1.4-125.4) were associated with the injury. Conclusions Workers should be extra cautious and they should be provided with training for new tasks and new tools.	Univ Alabama, Ctr Injury Sci, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Dept Surg, Div Gen Surg,Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA; Univ Alabama, Sch Publ Hlth, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA		McGwin, G (corresponding author), Univ Alabama, Ctr Injury Sci, 120 Kracke Bldg,1922 7th Ave S, Birmingham, AL 35294 USA.	mcgwin@uab.edu					HERTZ RP, 1986, J OCCUP ENVIRON MED, V28, P36, DOI 10.1097/00043764-198601000-00010; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Redelmeier DA, 1997, J CLIN EPIDEMIOL, V50, P1281, DOI 10.1016/S0895-4356(97)00196-0; SAARI J, 1981, SCAND J WORK ENV HEA, V7, P97; SOROCK G, 2001, INJ PREV S1, V7, P38; Sorock GS, 2004, OCCUP ENVIRON MED, V61, P305, DOI 10.1136/oem.2002.004028; Sorock GS, 2001, AM J IND MED, V39, P171, DOI 10.1002/1097-0274(200102)39:2<171::AID-AJIM1004>3.0.CO;2-0	7	11	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0962-7480			OCCUP MED-OXFORD	Occup. Med.-Oxf.	JAN	2005	55	1					66	68		10.1093/occmed/kqi020			3	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	899GK	WOS:000227132700013	15699094	Bronze			2022-02-06	
J	Kim, EH; Kim, TS; Sun, W; Kim, DS; Chung, HS; Kim, DK; Park, SH; Kim, F				Kim, EH; Kim, TS; Sun, W; Kim, DS; Chung, HS; Kim, DK; Park, SH; Kim, F			Differential regulation of metallothionein-I and metallothionein-II mRNA expression in the rat brain following traumatic brain injury	MOLECULES AND CELLS			English	Article						glial cells; metallothioneins; neurons; rat brain; traumatic brain injury	REGIONAL PATTERNS; NEURONAL INJURY; MOUSE; CNS; GENES	In this study, we investigated the expression of metallothionein (MT)-I and MT-II in the rat brain following traumatic brain injury (TBI). In the early stage, significant induction of MT-I and MT-II were observed in various regions including ventricle walls, pia mater, and dentate gyrus. At 12-24 h after TBI, strong induction of MT-I mRNA was observed in cerebral cortical layer II/III, amygdala, and piriform cortex where neurons reside. On the other hand, MT-II appeared to be expressed mainly in glial cells localized in the cerebral cortex and hippocampal formation. Three days after TBI, MTs were observed in the vimentin-positive astrocytes in the penumbra as revealed by double immunohistochemistry. The differences in expression of MT-I and MT-II in different brain regions and cell types (neuron vs. glial cells) suggests that multiple regulatory mechanisms are involved in the control of MT expression following brain injury.	Korea Univ, Dept Anat, Coll Med, Seoul 136705, South Korea; Natl Inst Hlth, Div Brain Dis, Dept Biomed Sci, Seoul 122701, South Korea; Catholic Univ, Uijongbu St Marys Hosp, Coll Med, Dept Neurosurg, Kyonggi Do 480130, South Korea; Yonsei Univ, Coll Med, Dept Emergency Med, Seoul 120752, South Korea		Kim, F (corresponding author), Korea Univ, Dept Anat, Coll Med, Seoul 136705, South Korea.	kimhyun@korea.ac.kr					Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; CHOUDHURI S, 1995, TOXICOL APPL PHARM, V131, P144, DOI 10.1006/taap.1995.1056; Chung RS, 2003, J NEUROSCI, V23, P3336; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dincer Z, 1999, J COMP PATHOL, V120, P29, DOI 10.1053/jcpa.1998.0254; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Hernandez J, 1998, NEUROCHEM INT, V32, P369, DOI 10.1016/S0197-0186(97)00096-X; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Kim D, 2003, NEUROREPORT, V14, P679, DOI 10.1097/00001756-200304150-00004; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 1999, J NEUROSCI, V19, P2535; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Soares HD, 1995, J NEUROSCI, V15, P8223; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; YAGLE MK, 1985, MOL CELL BIOL, V5, P291, DOI 10.1128/MCB.5.2.291	20	11	11	0	5	SPRINGER SINGAPORE PTE LTD	SINGAPORE	#04-01 CENCON I, 1 TANNERY RD, SINGAPORE 347719, SINGAPORE	1016-8478			MOL CELLS	Mol. Cells	DEC 31	2004	18	3					326	331					6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	883VA	WOS:000226042600008	15650329				2022-02-06	
J	Heim, C; Schoettker, R; Spahn, DR				Heim, C; Schoettker, R; Spahn, DR			Glasgow coma scale in traumatic brain injury	ANAESTHESIST			German	Article						Glasgow Coma Scale; coma; traumatic brain injury; sum score; pseudoscore; Glasgow Coma Score	SEVERE HEAD-INJURY; PRACTICAL SCALE; SEVERITY SCORE; MOTOR SCORE; MORTALITY; PREDICTION; PROGNOSIS; SYSTEMS; ABILITY; APACHE	Even 30 years after its first publication the Glasgow Coma Scale (GCS) is still used worldwide to describe and assess coma. The GCS consists of three components, the ocular, motor and verbal response to standardized stimulation, and is used as a severity of illness indicator for coma of various origins. The GCS facilitates information transfer and monitoring changes in coma. In addition, it is used as a triage tool in patients with traumatic brain injury. Its prognostic value regarding the outcome after a traumatic brain injury still lacks evidence. One of the main problems is the evaluation of the GCS in sedated, paralysed and/or intubated patients. A multitude of pseudoscores exists but a universal definition has yet to be defined.	CHU Vaudois, Dept Anesthesia, CH-1011 Lausanne, Switzerland		Heim, C (corresponding author), CHU Vaudois, Dept Anesthesia, Rue Bugnon, CH-1011 Lausanne, Switzerland.	Catherine.Heim@hospvd.ch		Schoettker, Patrick/0000-0001-5370-048X			Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Chen LM, 1999, CRIT CARE MED, V27, P1999, DOI 10.1097/00003246-199909000-00046; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Diringer MN, 1997, ARCH NEUROL-CHICAGO, V54, P606, DOI 10.1001/archneur.1997.00550170078017; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; JAGGER J, 1983, LANCET, V2, P97; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; KOZIOL JA, 1990, J NEUROL, V237, P461, DOI 10.1007/BF00314762; Kuhls DA, 2002, J AM COLL SURGEONS, V194, P695, DOI 10.1016/S1072-7515(02)01211-5; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; Lucke JF, 1996, ANN EMERG MED, V28, P408, DOI 10.1016/S0196-0644(96)70006-9; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Nolan JP, 1997, BRIT J ANAESTH, V79, P226, DOI 10.1093/bja/79.2.226; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; SACCO RL, 1990, ARCH NEUROL-CHICAGO, V47, P1181, DOI 10.1001/archneur.1990.00530110035013; SEGATORE M, 1992, HEART LUNG, V21, P548; Senkowski CK, 1999, J AM COLL SURGEONS, V189, P491, DOI 10.1016/S1072-7515(99)00190-8; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1976, BRIT J ANAESTH, V48, P761, DOI 10.1093/bja/48.8.761; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1975, Nurs Times, V71, P972; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Vassar MJ, 1999, J TRAUMA, V47, P324, DOI 10.1097/00005373-199908000-00017	39	11	14	3	10	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0003-2417			ANAESTHESIST	Anaesthesist	DEC	2004	53	12					1245	1255		10.1007/s00101-004-0777-y			11	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	882ET	WOS:000225922500015	15597166				2022-02-06	
J	Nakamura, T; Miyamoto, O; Auer, RN; Nagao, S; Itano, T				Nakamura, T; Miyamoto, O; Auer, RN; Nagao, S; Itano, T			Delayed precursor cell markers expression in hippocampus following cold-induced cortical injury in mice	JOURNAL OF NEUROTRAUMA			English	Article						3CB2; cold-induced brain injury; mice; migration; nestin; remodeling	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; SPINAL-CORD-INJURY; NEURAL STEM-CELLS; REACTIVE ASTROCYTES; ADULT-RAT; INTERMEDIATE FILAMENT; SUBVENTRICULAR ZONE	The purpose of this study was to examine the possibility of neuronal remodeling and repair after cold-induced brain injury using immunoassay of nestin and 3CB2 (potential precursor cell markers). Male ddN strain mice were subjected to cold-induced cortical injury. Animals were divided into the following six groups: (1) 1 day after injury, (2) 1 week after injury, (3) 2 weeks after injury, (4) 1 month after injury, (5) sham controls, and (6) normal controls. Western blot analysis (n = 3 in each group) and histological examination (n = 5 in each group) were performed. At 1 day and 1 week after injury, TUNEL-positive cells were observed, while immunoreactivity of nestin and 3CB2 was absent. At 1 month after injury, expression of both nestin and 3CB2 was observed in the ipsilateral hippocampus. Nestin was expressed in GFAP- or 3CB2-positive astrocytes at 1 month after injury, and nestin expression with TUC-4 (immature neuron marker) was present in the hippocampal cell layer. The findings demonstrate delayed nestin expression in both glia and neuron-like cells after brain injury. The present study suggests that the delayed nestin expression in glia and neuron-like cells might be part of the adaptation to injury.	Kagawa Univ, Fac Med, Dept Neurol Surg, Miki, Kagawa 7610793, Japan; Kagawa Univ, Fac Med, Dept Neurobiol, Miki, Kagawa 7610793, Japan; Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; Univ Calgary, Dept Pathol & Lab Med & Clin Neurosci, Calgary, AB T2N 1N4, Canada		Nakamura, T (corresponding author), Kagawa Univ, Fac Med, Dept Neurol Surg, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	neuron@kms.ac.jp	Auer, Roland/F-6661-2017	Auer, Roland/0000-0001-9044-3419; Nakamura, Takehiro/0000-0002-4105-5767			Alves JAJ, 2002, J NEUROBIOL, V52, P251, DOI 10.1002/neu.10087; Bagum MA, 2001, ACTA MED OKAYAMA, V55, P19; BARRES BA, 1991, J NEUROSCI, V11, P3685; Brook GA, 1999, NEUROREPORT, V10, P1007, DOI 10.1097/00001756-199904060-00021; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; Chanas-Sacre G, 2000, J NEUROSCI RES, V61, P357, DOI 10.1002/1097-4547(20000815)61:4<357::AID-JNR1>3.0.CO;2-7; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doyle KL, 2001, J COMP NEUROL, V437, P186, DOI 10.1002/cne.1278; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Galvin KA, 2003, NEUROSCIENCE, V118, P1023, DOI 10.1016/S0306-4522(03)00066-6; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kuroda T, 2002, J CHEM NEUROANAT, V24, P137, DOI 10.1016/S0891-0618(02)00042-X; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; MASON HA, 2001, J COMP NEUROL, V405, P508; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1998, BRAIN RES, V466, P183; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1016/S0378-1097(00)00262-7; Momma S, 2000, CURR OPIN NEUROBIOL, V10, P45, DOI 10.1016/S0959-4388(99)00056-2; Nakamura T, 1999, ACTA NEUROCHIR, V141, P407, DOI 10.1007/s007010050317; Nakamura T, 1999, ICRAN 99: INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN NEUROTRAUMATOLOGY, P187; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Parnavelas JG, 2001, NEURON, V31, P881, DOI 10.1016/S0896-6273(01)00437-8; Perry G, 2001, AM J PATHOL, V158, P1, DOI 10.1016/S0002-9440(10)63936-3; Prada FA, 1995, GLIA, V15, P389, DOI 10.1002/glia.440150404; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; Shibuya S, 2003, GLIA, V42, P172, DOI 10.1002/glia.10203; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; SUZUKI M, 1991, ACTA NEUROPATHOL, V82, P93, DOI 10.1007/BF00293950; TAKAMIYA Y, 1988, DEV BRAIN RES, V38, P201, DOI 10.1016/0165-3806(88)90045-4; Wei LC, 2002, DEV BRAIN RES, V139, P9, DOI 10.1016/S0165-3806(02)00509-6; Xu RX, 1998, NEUROSURGERY, V43, P107, DOI 10.1097/00006123-199807000-00070; Yang HY, 1997, EXP NEUROL, V146, P199, DOI 10.1006/exnr.1997.6518	43	11	11	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2004	21	12					1747	1755		10.1089/neu.2004.21.1747			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	877FY	WOS:000225554400006	15684766	Green Submitted			2022-02-06	
J	Orient-Lopez, F; Sevilla-Hernandez, E; Guevara-Espinosa, D; Terre-Boliart, R; Ramon-Rona, S; Bernabeu-Guitart, M				Orient-Lopez, F; Sevilla-Hernandez, E; Guevara-Espinosa, D; Terre-Boliart, R; Ramon-Rona, S; Bernabeu-Guitart, M			Functional outcome at discharge of patients with severe traumatic brain injury admitted to a brain damage unit	REVISTA DE NEUROLOGIA			Spanish	Article						functional independence; post-traumatic amnesia; prognosis; rehabilitation; reintegration; traumatic brain injury	AMANTADINE; REHABILITATION; POSTDISCHARGE; IMPAIRMENTS	Introduction. Severe traumatic brain injuries (TBI) are linked to high morbidity and mortality rates and have important individual and social costs, not only because of the high incidence of deaths they cause but also owing to the large number of individuals who are left with some kind of disability. Aims. The purpose of this study was to analyse the epidemiological, clinical, functional and rehabilitational aspects of patients with severe TBI admitted to a brain damage unit for neurorehabilitation therapy with special emphasis on the functional outcome at discharge. Patients and methods. We carried out a descriptive study of patients suffering from TBI admitted to the Brain Damage Unit of the Institut Guttmann hospital between January 2000 and June 2002. We analysed epidemiological (age, sex, cause of the TBI), clinical (aetiology, initial Glasgow Coma Scale -GCS-, motor deficit, type of injury, duration of post-traumatic amnesia), functional (Glasgow Outcome Scale -GOS-, Level of Cognitive Functioning Scale -LCFS- and Disability Rating Scale -DRS-) variables, in addition to patients' destination on discharge. Results. Of a total of 174 hospitalised patients, 88.52% were cases of serious TBI, 80% of which involved males, with a mean age of 29.72 years (standard deviation: 12.63), and an average of 99.28 days' hospitalisation (standard deviation: 60.72). Road accidents were the chief cause of the TBI (78%). The most frequent neurological injuries were parenchymatous (68.05%), followed by subarachnoid haemorrhages (40.58%). 87.58% of the patients presented TBI-related complications. Functional improvement at discharge was statistically significant (p < 0.001) as regards the GOS, LCFS and DSR scales, and 87.5% of the patients were able to reintegrate into their home life. Conclusions. Despite the severity of the sequelae left by serious TBI, the functional outcome at discharge, associated with the high rate of reintegration into home life, justifies admission of these patients to a brain damage unit for neurorehabilitation therapy.	Hosp Neurorehabil, Inst Guttman, Unidad Dano Cerebral, E-08916 Badalona, Barcelona, Spain; Hosp Morales Meseguer, Serv Rehabil & Med Fis, Murcia, Spain		Orient-Lopez, F (corresponding author), Hosp Neurorehabil, Inst Guttman, Unidad Dano Cerebral, Cami Can Ruti S-N, E-08916 Badalona, Barcelona, Spain.	metges@guttmann.com					Annoni J M, 1992, Disabil Rehabil, V14, P23; *APANEFA, 2002, B INF APANEFA, V3, P4; BORI I, 2002, REHABILITACION, V36, P318; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Garcia-Pena M, 2004, REV NEUROLOGIA, V38, P775, DOI 10.33588/rn.3808.2003567; Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JENNETT B, 1975, LANCET, V1, P480; JOHNSTON MV, 1992, ARCH PHYS MED REHAB, V73, pS3; Junque C, 1999, REV NEUROLOGIA, V28, P423, DOI 10.33588/rn.2804.98420; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; Leon-Carrion J, 2001, REV NEUROLOGIA, V33, P377, DOI 10.33588/rn.3304.2000196; LEONCARRION J, 1998, NOTICIAS MED, V3686, P32; LEVIN HS, 1975, J NERV MENT DIS, V11, P675; MALKMUS D, 1974, RANCHO LEVELS COGNIT; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; Mazaux JM, 2002, ACT NEUR S, V79, P49; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MUNOZ CJM, 2002, EVALUACION INTEGRACI; Munoz-Cespedes JM, 2004, REV NEUROLOGIA, V38, P852, DOI 10.33588/rn.3809.2003446; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P351, DOI 10.33588/rn.3204.2000456; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Novack TA, 2000, BRAIN INJURY, V14, P987; Orient-Lopez F, 2002, REV NEUROLOGIA, V35, P362, DOI 10.33588/rn.3504.2001457; Perea MV, 1999, REV NEUROLOGIA, V29, P1099, DOI 10.33588/rn.2912.99373; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAO N, 1986, ARCH PHYS MED REHAB, V67, P759, DOI 10.1016/0003-9993(86)90011-0; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SAAD K, 2002, BRAIN INJURY, V16, P537; Suarez JI, 2001, REV NEUROLOGIA, V32, P289, DOI 10.33588/rn.3203.2000518; TEASDALE G, 1974, LANCET, V73, P68; TERRE R, 2002, REHABILITACION, V36, P13; TICO N, 1998, REHABILITACION, V32, P39	41	11	14	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	NOV 16	2004	39	10					901	906		10.33588/rn.3910.2004302			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874OY	WOS:000225360900001	15573302				2022-02-06	
J	Tellisi, NK; Abusitta, GR; Fernandes, RJ				Tellisi, NK; Abusitta, GR; Fernandes, RJ			Bilateral posterior fracture dislocation of the shoulders following seizure	SAUDI MEDICAL JOURNAL			English	Article							PROXIMAL HUMERAL FRACTURES	Bilateral posterior fracture dislocation is a rare injury known to be associated with seizures. Convulsion was found to be the cause of fracture dislocation in 78% of the cases reported. The mechanism of injury was described by Shaw in 1971. The management depends largely on the severity of the injury. In many cases reported, the fracture was a large compression defect in the anteromedial aspect of the articular surface of the humeral head. It has been suggested that for defects that involve less than 20% of the articular surface closed reduction can be attempted. Rush nail or percutaneous K wires can be used to maintain reduction. Open reduction is necessary for defects that are involving 20-40% of the surface. The aim in these cases is to reconstruct the proximal humerus if possible by the use of internal fixation. If reconstruction is not feasible, a modified McLaughlin procedure can be used to prevent chronic instability of the shoulder. This procedure involves re-implanting the subscapularis tendon into the defect. Reconstructing fractures that involve more than 40% of the articular surface or 4-part fracture is not usually successful. These fractures are associated with a high the risk of avascular necrosis. Hemi-arthroplasty or total shoulder replacement is generally regarded as better option as they offer rapid recovery and eliminate the possibility of multiple procedures if fixation fails.	Good Hope Hosp, Dept Orthoped & Trauma, Birmingham, W Midlands, England		Tellisi, NK (corresponding author), 28 Warwick Rd, Birmingham B73 6ST, W Midlands, England.	Tellisi@totalise.co.uk					AUFRANC GP, 1966, JAMA-J AM MED ASSOC, V195, P1140; DIN KM, 1983, J BONE JOINT SURG BR, V65, P176, DOI 10.1302/0301-620X.65B2.6826625; GRISTINA AG, 1987, CONT ORTHOP, V15, P61; HAWKINS R, 1987, J BONE JOINT SURG, V69, P18; Honner R, 1969, Aust N Z J Surg, V38, P269; JALOVAARA P, 1988, ACTA ORTHOP SCAND, V59, P603; LINDHOLM TS, 1980, ACTA ORTHOP SCAND, V51, P485, DOI 10.3109/17453678008990828; Martens C, 1995, Acta Orthop Belg, V61, P249; MCLAUGHLIN HL, 1952, J BONE JOINT SURG AM, V34-A, P584, DOI 10.2106/00004623-195234030-00011; MILLS KLG, 1974, INJURY, V6, P39, DOI 10.1016/0020-1383(74)90169-7; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; NICOLA FG, 1981, J BONE JOINT SURG AM, V63, P1175, DOI 10.2106/00004623-198163070-00018; PAGE AE, 1995, J ORTHOP TRAUMA, V9, P526, DOI 10.1097/00005131-199509060-00012; PARRISH GA, 1985, ANN EMERG MED, V14, P264, DOI 10.1016/S0196-0644(85)80453-4; PEAR BL, 1970, NEW ENGL J MED, V283, P135, DOI 10.1056/NEJM197007162830307; PRILLAMAN HA, 1969, J BONE JOINT SURG AM, VA 51, P1627, DOI 10.2106/00004623-196951080-00012; SHAW JL, 1971, J BONE JOINT SURG AM, VA 53, P1437, DOI 10.2106/00004623-197153070-00023; SHEPHARD E, 1960, J BONE JOINT SURG BR, V42, P728; WILSON JC, 1949, J BONE JOINT SURG AM, V31-A, P160, DOI 10.2106/00004623-194931010-00018	20	11	11	0	0	SAUDI MED J	RIYADH	ARMED FORCES HOSPITAL, PO BOX 7897,, RIYADH 11159, SAUDI ARABIA	0379-5284			SAUDI MED J	Saudi Med. J.	NOV	2004	25	11					1727	1729					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	882EJ	WOS:000225921400039	15573213				2022-02-06	
J	Hu, DZ; Zhou, LF; Zhu, JH				Hu, DZ; Zhou, LF; Zhu, JH			Marrow stromal cells administrated intracisternally to rats after traumatic brain injury migrate into the brain and improve neurological function	CHINESE MEDICAL JOURNAL			English	Article						brain injuries; transplantation; stromal cells; bone marrow; Cisterna magna	ADULT RATS; MOTOR		Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China		Hu, DZ (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China.	hudezhi1972@msn.com					Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Bjorklund A, 2000, NAT NEUROSCI, V3, P537; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; FANG JM, 1995, INT J DEV BIOL, V39, P519; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; HEALTON EB, 1982, NEUROLOGY, V32, P776, DOI 10.1212/WNL.32.7.776; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998	14	11	11	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	OCT	2004	117	10					1576	1578					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866QH	WOS:000224787500027	15498388				2022-02-06	
J	Noppens, R; Brambrink, AM				Noppens, R; Brambrink, AM			Traumatic brain injury in children - clinical implications	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	4th International Congress of Pathophysiology	JUN 29-JUL 05, 2002	BUDAPEST, HUNGARY				SEVERE HEAD-INJURY; CEREBRAL BLOOD-FLOW; INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; HYPERTONIC SALINE; THERAPEUTIC HYPOTHERMIA; CRANIOCEREBRAL TRAUMA; INTENSIVE-CARE; CARDIAC-ARREST; PRESSURE	Traumatic brain injury (TBI) is the leading cause of death in childhood; however only very few studies focusing on the specific pathophysiology and treatment have been published to date. Head trauma is more likely in young children than in adults given the same deceleration of the body due to their large and heavy heads and weak cervical ligaments and muscles. Resulting brain injury is more severe due to their thin, pliable skulls and the yet unfused sutures. Accordingly, children below the age of 4 years have lower chances of a full recovery after severe TBI, although in,general, neurologic recovery after severe brain injury in children is better than in adults. The time course of brain injury can be divided into two steps: primary and secondary injury. Primary brain injury exclusively results from the initial impact. In contrast, adverse physiologic conditions during recovery after head trauma may account for additional brain damage, which is then referred to as secondary brain injury. As primary brain injury can only be influenced by preventive measures, all therapeutic efforts during the post-injury period focus on the reduction of secondary injury to the traumatized brain. Several mechanisms have been identified to be involved in the development of post-traumatic secondary brain injury, which render the rationale for the key treatment strategies. Three evidence based measures are of critical importance to prevent or minimize secondary brain injury: (1) avoid hypoxemia, (2) avoid post-traumatic arterial hypotension, and (3) refer the traumatized child to an experienced trauma team at a center that provides the availability of special equipment, e.g. for surgical procedures and airway management, for this age group. For several other therapeutical means, e.g. hypothermia or specific surgical interventions, clinical evidence to date is insufficient to allow recommendation as rescue treatment for children at risk of severe neurological sequelae following TBI. This review discusses the clinical implication of pathophysiologic mechanisms of TBI in the developing brain according to the recent literature and current guidelines. It follows the clinical approach to a head injured child, that can be divided into three phases, i.e. initial assessment and stabilization, followed by first tier, and if necessary second tier therapeutic interventions to assure adequate oxygenation and perfusion of the brain. (C) 2004 Elsevier GmbH. All rights reserved.	Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA		Brambrink, AM (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, 3181 SW Sam Jackson Pk Rd,Mail Code UHS-2, Portland, OR 97239 USA.	brambrin@ohsu.edu					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS9; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS34; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS60; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS38; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Bauer R, 1999, EXP TOXICOL PATHOL, V51, P143, DOI 10.1016/S0940-2993(99)80088-8; Baughman Verna L, 2002, Anesthesiol Clin North Am, V20, P315, DOI 10.1016/S0889-8537(01)00004-9; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Brambrink AM, 1999, EXP TOXICOL PATHOL, V51, P151, DOI 10.1016/S0940-2993(99)80089-X; Brambrink AM, 1999, J CEREBR BLOOD F MET, V19, P927, DOI 10.1097/00004647-199908000-00012; BRAMBRINK AM, 2002, NOTFALL RETTUNGSMED, V5, P332; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOUX M, 1986, ADV NEUROTRAUMATOLOG, P210; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; CRAMER KE, 1995, CLIN ORTHOP RELAT R, P125; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Ergun A, 2003, SPINAL CORD, V41, P249, DOI 10.1038/sj.sc.3101442; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; FANCONI S, 1988, INTENS CARE MED, V14, P163; FELDMANN M, 2002, NOTFALL RETTUNGSMED, V5, P360; GAAB MR, 1990, ACT NEUR S, V51, P326; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; GUYER B, 1990, AM J DIS CHILD, V144, P649, DOI 10.1001/archpedi.1990.02150300047016; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; HENDRICK EB, 1959, AMA ARCH SURG, P17; Herrera EJ, 2000, CHILD NERV SYST, V16, P585, DOI 10.1007/s003810000340; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Hutchinson PJA, 2002, ACT NEUR S, V81, P359; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KALKUM M, 2002, NOTFALL RETTUNGSMED, V5, P345; KASPERK R, 1991, Aktuelle Traumatologie, V21, P1; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; KELLER MS, 1995, J PEDIATR SURG, V30, P221, DOI 10.1016/0022-3468(95)90564-2; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Loop T, 2003, ANESTHESIOLOGY, V99, P360, DOI 10.1097/00000542-200308000-00017; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAIERHAUFF K, 1993, UNFALLCHIRURG, V96, P604; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; MERTEN DF, 1983, PEDIATR ANN, V12, P882, DOI 10.3928/0090-4481-19831201-06; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NOPPENS R, 2002, J NEUROSURG ANESTHES, V14, P337; NOPPENS R, 2002, ZENTRALB KINDERCHIR, V11, P121; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Park CO, 1998, YONSEI MED J, V39, P395, DOI 10.3349/ymj.1998.39.5.395; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; REHNCRONA S, 1981, BRAIN FAILURE RESUSC, P11; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Schindler MB, 1996, INTENS CARE MED, V22, P486, DOI 10.1007/BF01712173; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; SELDEN PD, 2003, PEDIATR CRIT CARE ME, V4, pS53; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Skellett S, 2002, BRIT MED J, V324, P591, DOI 10.1136/bmj.324.7337.591; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; TASKER TC, 1996, HDB ADV PEDIAT LIFE, P217; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; ZIMMERMAN RA, 1981, J NEURORADIOLOGY, V8, P257	97	11	11	0	5	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	OCT	2004	56	1-2					113	125		10.1016/j.etp.2004.04.005			13	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	872QF	WOS:000225221900014	15581282				2022-02-06	
J	Turner, RJ; Van den Heuvel, C; Vink, R				Turner, RJ; Van den Heuvel, C; Vink, R			Amiloride increases neuronal damage after traumatic brain injury in rats	JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION			English	Article						apoptosis; brain Mg; traumatic brain injury; hemorrhage; Mg treatment; amiloride; Na+/Mg2+ antiport		Objective: It is well known that traumatic brain injury (TBI) decreases brain free magnesium (Mg) concentration, and that administration of Mg salts after TBI restores concentration of Mg in brain and improves functional outcome. In the presence of hemorrhage, administration of Mg salts exacerbates the injury process and worsens outcome. An alternative to administration of Mg salts may be to prevent cellular loss of Mg with use of amiloride, which inhibits the Na+/Mg2+ exchange. Methods: In the present study, male, adult Sprague-Dawley rats were injured using the impact acceleration model of diffuse TBI and administered either 100 mols/kg i.v. amiloride, or an equal volume of 50% DMSO/saline, 30 minutes (min) after injury. Results: Amiloride did not improve functional outcome (motor or cognitive outcome) after TBI relative to vehicle treated controls. Histologically, treatment with amiloride significantly increased hippocampal caspase-3 expression (apoptosis), axonal swellings in the medulla and the degree of dark cell change (cell stress) in the cortex. Phosphorus NMR demonstrated that amiloride did not increase free Mg concentration after injury. Conclusions; Thus, amiloride is ineffective in preventing Mg loss after TBI when administered 30 min after trauma. Moreover, by administering amiloride after the TBI-related Mg decline has already been initiated, it may exacerbate injury by, in part by inhibiting Na+/Mg2+ antiport and preventing entry of Mg back into the cell, and also by inhibiting other Na+ linked transporters.	Univ Adelaide, Dept Pathol, Adelaide, SA, Australia		Vink, R (corresponding author), Univ Adelaide, Dept Pathol, GPO Box 498, Adelaide, SA, Australia.	robert.vink@adetaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Turner, Renee/0000-0003-4278-8302			ANDREEVA N, 1992, NEUROSCIENCE, V49, P175, DOI 10.1016/0306-4522(92)90085-G; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; GUNTHER T, 1985, BIOCHEM BIOPH RES CO, V130, P540, DOI 10.1016/0006-291X(85)90450-4; Gunzel D, 1996, J PHYSIOL-LONDON, V491, P595, DOI 10.1113/jphysiol.1996.sp021242; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heath DL, 2001, J NEUROTRAUM, V18, P465, DOI 10.1089/089771501750171074; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x	12	11	12	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0731-5724	1541-1087		J AM COLL NUTR	J. Am. Coll. Nutr.	OCT	2004	23	5					534S	537S		10.1080/07315724.2004.10719397			4	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	863AF	WOS:000224531900018	15466959				2022-02-06	
J	Bedell, EA; DeWitt, DS; Uchida, T; Prough, DS				Bedell, EA; DeWitt, DS; Uchida, T; Prough, DS			Cerebral pressure autoregulation is intact and is not influenced by hypothermia after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebral blood flow; fluid percussion injury; hypothermia; laboratory animal models; laser Doppler flowmetry; traumatic brain injury	LASER-DOPPLER FLOWMETRY; SEVERE HEAD-INJURY; BLOOD-FLOW; MODERATE HYPOTHERMIA; CEREBROVASCULAR RESPONSES; CORTICAL IMPACT; L-ARGININE; HYPOPERFUSION; HYPOTENSION; ISCHEMIA	In head-injured patients and experimental traumatic brain injury (TBI), important cerebrovascular abnormalities include decreases in cerebral blood flow (CBF) and impairment of cerebral pressure autoregulation. We evaluated CBF and pressure autoregulation after fluid percussion injury (FPI) and hypothermia in rats with the hypothesis that hypothermia would ameliorate changes in posttraumatic CBF. Male Sprague-Dawley rats, intubated and mechanically ventilated, were prepared for parasaggital FPI (1.8 atm) and laser Doppler CBF flow (LDF) measurement. The abdominal aorta was cannulated for rapid removal and reinfusion of blood. Baseline autoregulatory testing in all groups consisted of LDF measurements at normothermia and a mean arterial pressure (MAP) of 100 mm Hg, followed by randomly ordered changes of MAP to 80, 60, and 40 mm Hg. Animals were then randomized to one of five groups: normothermic control without FPI; normothermia with FPI; hypothermic control (32degreesC) without FPI; hypothermia initiated before FPI; and hypothermia initiated immediately after FPI injury. For each group, a complete, randomly ordered autoregulatory sequence was performed at 30 and 60 min after FPI or sham TBI. In a second study, rats were prepared identically, maintained at normothermic temperatures and autoregulation was tested before and after TBI using a set of randomly ordered levels of hypotension or using progressive reductions in MAP (i.e., 80, 60, 40 mm Hg) with the hypothesis that the technical manner and timing of decreasing of the blood pressure would effect CBF after TBI. Due to high acute mortality, the group in which hypothermia was induced before FPI was excluded from the analysis. At baseline, autoregulation was similar in all groups. There was no change in CBF or autoregulation in the normothermic control group at 30 and 60 min. In the other groups at 30 and 60 min, there was a similar, statistically significant decrease in absolute CBF (i.e., a decrease of 27-57% of baseline values), but pressure autoregulation was intact except at the lowest blood pressure tested at 60 min, where there was a slight improvement in the hypothermic group. Thus, in these experiments, absolute CBF decreased with hypothermia and FPI, while neither hypothermia nor FPI significantly altered autoregulation. In the second study, autoregulatory function was not different before TBI when comparing random and sequential blood pressure changes, but, when comparing the groups after TBI at the 60 mm Hg blood pressure level, CBF was significantly lower in the sequential group than in the random order group. This suggests that the mechanism of creating hypotension, whether random or sequential, significantly affects the measurement of CBF and autoregulation after TBI in rats.	Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Off Biostat, Galveston, TX 77555 USA		Prough, DS (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	dsprough@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X			Bedell EA, 1998, J NEUROTRAUM, V15, P985, DOI 10.1089/neu.1998.15.985; BLAUTH CI, 1988, J THORAC CARDIOV SUR, V95, P668; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DeWitt D S, 1995, New Horiz, V3, P376; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GROEGER JS, 1992, CRIT CARE MED, V20, P846, DOI 10.1097/00003246-199206000-00024; Irikura K, 1998, J CEREBR BLOOD F MET, V18, P1294, DOI 10.1097/00004647-199812000-00003; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Niwa K, 2002, AM J PHYSIOL-HEART C, V283, pH315, DOI 10.1152/ajpheart.00022.2002; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; VERHAEGEN MJJ, 1993, STROKE, V24, P407, DOI 10.1161/01.STR.24.3.407; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	37	11	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2004	21	9					1212	1222					11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	855HC	WOS:000223962900010	15453991				2022-02-06	
J	Laatsch, L; Little, D; Thulborn, K				Laatsch, L; Little, D; Thulborn, K			Changes in fMRI following cognitive rehabilitation in severe traumatic brain injury: A case study	REHABILITATION PSYCHOLOGY			English	Article							TEST-RETEST; ACTIVATION	Objective: To illustrate the relationship between changes in neuropsychological testing and changes in functional magnetic resonance imaging (fMRI) before and after cognitive rehabilitation therapy (CRT). Study Design: Single case study. Setting: Outpatient treatment center. Participant: A woman with history of severe traumatic brain injury (TBI) 16 years before study. Intervention: Individualized CRT using a developmental metacognitive model. Main Outcome Measures: Neuropsychological tests and fMRI imaging performed during an eye movement task and a reading comprehension task. Results: Improvements on some neuropsychological test scores (>1 SD) and changes in the magnitude and distribution of the blood oxygen level dependent (BOLD) response as a function of task performance on both fMRI tasks. Conclusions: Individuals with severe TBI many years postinjury can demonstrate improvements in neuropsychological testing following CRT. Behavioral improvements can be related to changes in brain activity using fMRI.	Univ Illinois, Coll Med, Dept Neurol & Rehabil, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Magnet Resonance Res, Chicago, IL 60612 USA		Laatsch, L (corresponding author), Univ Illinois, Coll Med, Dept Neurol & Rehabil, 912 S Wood St,M-C, Chicago, IL 60612 USA.	llaatsch@uic.edu	Thulborn, Keith Raymond/D-9183-2015	Thulborn, Keith Raymond/0000-0001-6197-4296			BOLGER JF, 1980, CLIN NEUROPSYCHOLOGY, V4, P66; BRACY O, 1985, SOFT TOOLS COGNITIVE; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Christensen C K, 1987, J Diabet Complications, V1, P45, DOI 10.1016/S0891-6632(87)80079-X; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; *EXP SOFTW, 1997, CROSSW MOR; GIANUTSOS R, 1991, Brain Injury, V5, P353, DOI 10.3109/02699059109008108; GIANUTSOS R, 1984, COGNITIVE REHABILITA; GLADSOJO J, 1999, NORMS LETT CATEGORY; Heaton RK, 1991, COMPREHENSIVE NORMS; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kiehl KA, 2003, HUM BRAIN MAPP, V18, P42, DOI 10.1002/hbm.10074; Laatsch L, 2000, NEUROREHABILITATION, V15, P189; LEWIS R, 1995, DIGIIT VIGILANCE TES; Luna B, 1998, CEREB CORTEX, V8, P40, DOI 10.1093/cercor/8.1.40; Luria A. R., 1981, WORKING BRAIN; Mather N., 2001, WOODCOCK JOHNSON 3 T; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MENZEL K, 1995, DEV STANDARDIZATION; Meyers JE., 1995, REY COMPLEX FIGURE T; Nybakken GE, 2002, NEURORADIOLOGY, V44, P403, DOI 10.1007/s00234-001-0722-6; PARENTE R., 1996, RETRAINING COGNITION; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Reitan R, 1985, HALSTEAD REITAN NEUR; SEYMOUR D, 1983, VISUAL THINKING CARD; STETSON E, 1989, STETSON SPELLING PRO; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; THULBORN KR, 2001, CURRENT PROTOCOLS MR; Wilkinson, 1984, WIDE RANGE ACHIEVEME	33	11	11	0	5	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2004	49	3					262	267		10.1037/0090-5550.49.3.262			6	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	847BX	WOS:000223364900011					2022-02-06	
J	Langeluddecke, PM; Lucas, SK				Langeluddecke, PM; Lucas, SK			Evaluation of two methods for estimating premorbid intelligence on the WAIS-III in a clinical sample	CLINICAL NEUROPSYCHOLOGIST			English	Article							DEMOGRAPHIC-VARIABLES; COMBINED PERFORMANCE; BRAIN-INJURY; R IQ; REGRESSION; ACCURACY; VALIDATION; DECLINE; ABILITY; UTILITY	Two methods of predicting premorbid WAIS-III Full Scale IQ, namely a demographic measure (DP IQ) and the Oklahoma Premorbid Intelligence Estimate-3 (OPIE-3), were assessed in three traumatic brain injury (TBI) groups of varying injury severity and normal controls. On the DP IQ, average scores were in keeping with the general population mean across all groups but range was severely restricted. OPIE-3 IQ scores were not subject to severe range restriction and were comparable with the general population mean in the control and least severely brain injured group. They were significantly lower relative to controls in the severe and extremely severe TBI groups, with differences averaging around 7 and 10 points, respectively. OPIE-3 (Best) proved particularly robust in more severely injured subjects. Effect sizes for the combined TBI sample relative to controls were greatest for OPIE-3 measures that included two non-verbal subtests and were least for that involving vocabulary only. Implications of the findings for clinical practice and further research are discussed.	Westmead Hosp, Dept Psychol Med, Westmead, NSW 2145, Australia		Langeluddecke, PM (corresponding author), Suite 1003,37 Bligh St, Sydney, NSW 2000, Australia.	langeluddecke@bigpond.com					ALEKOUMBIDES A, 1987, INT J CLIN NEUROPSYC, V9, P11; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Basso MR, 2002, CLIN NEUROPSYCHOL, V16, P57, DOI 10.1076/clin.16.1.57.8329; Basso MR, 2000, CLIN NEUROPSYCHOL, V14, P325, DOI 10.1076/1385-4046(200008)14:3;1-P;FT325; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; EPPINGER MG, 1987, J CONSULT CLIN PSYCH, V55, P86, DOI 10.1037/0022-006X.55.1.86; Griffin SL, 2002, ARCH CLIN NEUROPSYCH, V17, P497, DOI 10.1016/S0887-6177(01)00136-6; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Powell BD, 2003, ARCH CLIN NEUROPSYCH, V18, P277, DOI 10.1016/S0887-6177(02)00135-X; Psychological Corporation, 2001, MAN WECHSL TEST AD R; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; SILVERSTEIN AB, 1987, J CLIN PSYCHOL, V43, P493, DOI 10.1002/1097-4679(198709)43:5<493::AID-JCLP2270430511>3.0.CO;2-V; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SWEET JJ, 1990, PSYCHOL ASSESSMENT J, V2, P41; Taylor KI, 1996, J CLIN EXP NEUROPSYC, V18, P883, DOI 10.1080/01688639608408309; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tulsky D., 2003, CLIN INTERPRETATION, P43, DOI DOI 10.1016/B978-012703570-3/50006-7; TULSKY DS, 2003, CLIN INTERPRETATION; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; [No title captured]	37	11	11	0	5	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG	2004	18	3					423	432		10.1080/1385404049052422			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	875QP	WOS:000225437100008	15739813				2022-02-06	
J	Newman, MB; Emerich, DF; Borlongan, CV; Sanberg, CD; Sanberg, PR				Newman, MB; Emerich, DF; Borlongan, CV; Sanberg, CD; Sanberg, PR			Use of human umbilical cord blood (HUCB) cells to repair the damaged brain	CURRENT NEUROVASCULAR RESEARCH			English	Article						human umbilical cord blood cells; neurodegeneration; neural stem cells; cell replacement; traumatic brain injury; spinal cord injury; ALS; transplantation; neural and neuronal phenotypes; immunocytochemistry; stroke; ischemia; middle cerebral artery occlusion (MCAO); and behavior	HEMATOPOIETIC STEM-CELLS; VERSUS-HOST-DISEASE; HIGH-EFFICIENCY RECOVERY; BONE-MARROW; PERIPHERAL-BLOOD; DIFFERENTIATION ABILITY; RETROVIRUS RECEPTOR; REGULATORY FUNCTION; RECOMBINANT HUMAN; INTERFERON-GAMMA	Neurodegenerative diseases as well as acute center nervous system (CNS) injuries remains a problematic and frustrating area of medicine in terms of treatments and cures, which is mostly due to the complex circuitry of the CNS along with our limited knowledge. therapeutically, the last two and a half decades have offered new hope for those suffering from neurodegenerative diseases or in juries with advent of new drug discoveries and Cellular therapies. Cell transplantation is a compelling and potential treatment for certain neurological and neurodegenerative diseases as well as for acute injuries to the spinal cord and brain. The hematopoietic system offers an alternative source of cells that is easily obtainable, abundant, and reliable when compared to cells obtained from fetal or embryonic origins. Human umbilical cord blood (HUCB) cells have been used clinically for over ten years to treat both malignant and non-malignant diseases. With in the last five years these cells have been used pre-clinically in animal models of brain and spinal cord injuries, in which functional recovery have been shown. This paper reviews the advantages, utilization, and progress of HUCB cells in the field of cellular transplantation and repair.	Univ S Florida, Coll Med MDC 78, Ctr Excellence Aging & Brain Repair, Dept Neurosurg, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Psychol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pharmacol, Tampa, FL 33612 USA; Saneron CCEL Therapeut Inc, Tampa, FL 33637 USA; Med Coll Georgia, Res & Affiliat Serv Line, Dept Neurol, Inst Mol Med & Genet,Sch Grad Studies, Augusta, GA 30912 USA; Augusta Vet Adm Med Ctr, Augusta, GA 30912 USA		Sanberg, PR (corresponding author), Univ S Florida, Coll Med MDC 78, Ctr Excellence Aging & Brain Repair, Dept Neurosurg, Tampa, FL 33612 USA.	psanberg@hsc.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782			BECK R, 1994, IMMUNOL CELL BIOL, V72, P440, DOI 10.1038/icb.1994.65; Bicknese AR, 2002, CELL TRANSPLANT, V11, P261; Broxmeyer H E, 1993, J Hematother, V2, P197, DOI 10.1089/scd.1.1993.2.197; Broxmeyer H E, 1996, Cancer Treat Res, V84, P139; BROXMEYER HE, 1992, P NATL ACAD SCI USA, V89, P4109, DOI 10.1073/pnas.89.9.4109; Broxmeyer HE, 1997, CLIN EXP IMMUNOL, V107, P45; Broxmeyer HE, 2003, P NATL ACAD SCI USA, V100, P645, DOI 10.1073/pnas.0237086100; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; BROXMEYER HE, 1995, IMMUNOL INVEST, V24, P391, DOI 10.3109/08820139509062787; BROXMEYER HE, 1991, BLOOD CELLS, V17, P313; BROXMEYER HE, 2000, CORD BLOOD CHARACTER; BROXMEYER HE, 1998, CELLULAR CHARACTERIS; Buzanska L, 2003, J NEUROCHEM, V85, P33; Buzanska L, 2002, J CELL SCI, V115, P2131; Cardoso A A, 1993, J Hematother, V2, P275, DOI 10.1089/scd.1.1993.2.275; CARDOSO AA, 1993, P NATL ACAD SCI USA, V90, P8707, DOI 10.1073/pnas.90.18.8707; Cohen I, 1999, INT J COMPUT VISION, V33, P29, DOI 10.1023/A:1008161130332; Ende N, 2000, LIFE SCI, V67, P53, DOI 10.1016/S0024-3205(00)00602-0; Ende Norman, 2002, Journal of Medicine (Westbury), V33, P173; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P231; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P241; Fallen PR, 2000, CORD BLOOD CHARACTER, P39; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Gluckman E, 1999, Cancer Treat Res, V101, P79; Gluckman E, 1999, BEST PRACT RES CL HA, V12, P279, DOI 10.1053/beha.1999.0023; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; Gluckman E, 2001, TRANSFUS CLIN BIOL, V8, P146, DOI 10.1016/S1246-7820(01)00132-X; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Ha Y, 2001, NEUROREPORT, V12, P3523, DOI 10.1097/00001756-200111160-00030; HAN P, 1995, BRIT J HAEMATOL, V89, P733; HOWS JM, 1992, BONE MARROW TRANSPL, V9, P105; *INCFH NAT CTR FAR, 2002, NAT VIT STAT REP; Kempuraj D, 1999, BLOOD, V93, P3338, DOI 10.1182/blood.V93.10.3338.410k05_3338_3346; KINNIBURGH D, 1993, BONE MARROW TRANSPL, V12, P489; Kosaras B, 2003, EXP NEUROL, V181, P96; Laughlin MJ, 2001, NEW ENGL J MED, V344, P1815, DOI 10.1056/NEJM200106143442402; Lobel DA, 2003, EXP NEUROL, V181, P97; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu L, 1996, CRIT REV ONCOL HEMAT, V22, P61, DOI 10.1016/1040-8428(96)88370-3; Mayani H, 1998, STEM CELLS, V16, P153, DOI 10.1002/stem.160153; Metcalf D, 1984, CLONAL CULTURE HEMOP; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; MIYAWAKI T, 1981, IMMUNOL REV, V57, P61, DOI 10.1111/j.1600-065X.1981.tb00442.x; NAGAOKI T, 1981, J IMMUNOL, V126, P2015; Newman MB, 2003, NEURAL STEM CELLS: DEVELOPMENT AND TRANSPLANTATION, P379; NEWMAN MB, 2003, TIME DEPENDENT FACTO; NONOYAMA S, 1995, J CLIN INVEST, V95, P66, DOI 10.1172/JCI117677; Orlic D, 1999, LEUKEMIA, V13, pS52, DOI 10.1038/sj.leu.2401287; Orlic D, 1996, P NATL ACAD SCI USA, V93, P11097, DOI 10.1073/pnas.93.20.11097; Orlic D, 1999, ANN NY ACAD SCI, V872, P115, DOI 10.1111/j.1749-6632.1999.tb08458.x; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PEREZCRUZ I, 2000, CORD BLOOD CHARACTER; Potgens AJG, 2001, PLACENTA, V22, P639, DOI 10.1053/plac.2001.0701; Rabian-Herzog C, 1993, J Hematother, V2, P255, DOI 10.1089/scd.1.1993.2.255; Rappold I, 1997, BLOOD, V90, P111; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Rocha V, 2001, BLOOD, V97, P2962, DOI 10.1182/blood.V97.10.2962; Sakabe H, 1998, LEUKEMIA, V12, P728, DOI 10.1038/sj.leu.2401001; Sanberg PR, 2002, NEUROTOX RES, V4, P95, DOI 10.1080/10298420290015917; Sanchez-Ramos JR, 2001, EXP NEUROL, V171, P109, DOI 10.1006/exnr.2001.7748; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Thomson BG, 2000, BLOOD, V96, P2703; TRAYCOFF CM, 1994, EXP HEMATOL, V22, P215; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; UENO Y, 1985, J IMMUNOL, V135, P180; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; WAGNER JE, 1992, BLOOD, V79, P1874; WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1; Wenger DA, 2000, MOL GENET METAB, V70, P1, DOI 10.1006/mgme.2000.2990; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; WILSON CB, 1986, J CLIN INVEST, V77, P860, DOI 10.1172/JCI112383; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zigova T, 2002, CELL TRANSPLANT, V11, P265	77	11	12	0	2	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	JUL	2004	1	3					269	281		10.2174/1567202043362261			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902LD	WOS:000227357700010	16181077				2022-02-06	
J	Opel, DJ; Lundin, DA; Stevenson, KL; Klein, EJ				Opel, DJ; Lundin, DA; Stevenson, KL; Klein, EJ			Glass foreign body in the spinal canal of a child - Case report and review of the literature	PEDIATRIC EMERGENCY CARE			English	Article						foreign bodies; plain radiograph; glass-inflicted laceration	SOFT-TISSUE; PENETRATING INJURIES; BODIES; FRAGMENT; ULTRASONOGRAPHY; LACERATIONS; RADIOGRAPHS; TOMOGRAPHY; DIAGNOSIS; WOUNDS	Retained foreign bodies pose a risk to the patient from the perspective of potential morbidity. We describe a previously healthy 8-year-old boy with head and back trauma from a glass picture frame that fell off the wall. He sustained a closed head injury and a back laceration several centimeters lateral to the spine. A persistent drainage from the back laceration contained glucose and protein levels consistent with cerebral spinal fluid. A foreign body was easily visible on subsequent plain radiograph. The glass foreign body was removed by neurosurgeons after computed tomography and magnetic resonance imaging clarified the exact location of the glass fragment. Physicians should have a low threshold for obtaining plain radiographs in patients with glass foreign bodies and consider that projectiles may rest some distance from the laceration site.	Childrens Hosp & Med Ctr, Seattle, WA 98105 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurosurg, Seattle, WA 98195 USA		Klein, EJ (corresponding author), Childrens Hosp & Med Ctr, 4800 Sand Point Way NE Mail Stop 5D-1, Seattle, WA 98105 USA.	eileen.klein@seattlechildrens.org					Adornato D C Jr, 1972, Int Surg, V57, P147; *AM COLL EM PHYS, 1999, ANN EMERG MED, V33, P612; ANDERSON MA, 1982, AM J SURG, V144, P63, DOI 10.1016/0002-9610(82)90603-1; AVNER JR, 1992, AM J DIS CHILD, V146, P600, DOI 10.1001/archpedi.1992.02160170080020; BAGHAI P, 1982, NEUROSURGERY, V11, P419, DOI 10.1227/00006123-198209000-00014; BAKER MD, 1990, AM J DIS CHILD, V144, P87, DOI 10.1001/archpedi.1990.02150250097042; BLYME PJH, 1990, ARCH ORTHOP TRAUM SU, V110, P24, DOI 10.1007/BF00431361; BODNE D, 1988, J COMPUT ASSIST TOMO, V12, P608, DOI 10.1097/00004728-198807000-00013; Boyse TD, 2001, RADIOGRAPHICS, V21, P1251, DOI 10.1148/radiographics.21.5.g01se271251; COURTER BJ, 1990, ANN EMERG MED, V19, P997, DOI 10.1016/S0196-0644(05)82562-4; CRIADO E, 1990, SOUTHERN MED J, V83, P332, DOI 10.1097/00007611-199003000-00020; DELACEY G, 1985, BRIT J RADIOL, V58, P27, DOI 10.1259/0007-1285-58-685-27; FELMAN AH, 1969, RADIOLOGY, V92, P1529, DOI 10.1148/92.7.1529; FORDHAM SD, 1976, SOUTHERN MED J, V69, P1484, DOI 10.1097/00007611-197611000-00028; GINSBURG MJ, 1990, ANN EMERG MED, V19, P701, DOI 10.1016/S0196-0644(05)82483-7; Graham DD, 2002, J EMERG MED, V22, P75, DOI 10.1016/S0736-4679(01)00440-1; GRON P, 1986, INJURY, V17, P404, DOI 10.1016/0020-1383(86)90081-1; Heary RF, 1996, ORTHOP CLIN N AM, V27, P69; HUMPHREY G, 1993, INJURY, V24, P493, DOI 10.1016/0020-1383(93)90159-4; JONES FD, 1981, J NEUROSURG, V55, P979, DOI 10.3171/jns.1981.55.6.0979; KEANE JR, 1993, NEUROSURGERY, V33, P274, DOI 10.1227/00006123-199308000-00014; Kulkarni AV, 2000, J EMERG MED, V18, P209, DOI 10.1016/S0736-4679(99)00196-1; Lammers Richard L., 1992, Emergency Medicine Clinics of North America, V10, P767; Lipschitz R, 1967, Paraplegia, V5, P75; MONTANO JB, 1992, ANN EMERG MED, V21, P1360, DOI 10.1016/S0196-0644(05)81902-X; ODRISCOLL SW, 1988, CAN MED ASSOC J, V139, P643; REID I, 1989, IRISH J MED SCI, V158, P280, DOI 10.1007/BF02942071; Silvestro C, 2001, SPINE, V26, P578, DOI 10.1097/00007632-200103010-00025; Steele MT, 1998, AM J EMERG MED, V16, P627, DOI 10.1016/S0735-6757(98)90161-9; Tomaras CR, 1997, NEUROSURGERY, V40, P1291, DOI 10.1097/00006123-199706000-00034; TOPLIFF E, 1931, CMAJ, P836; Yanay O, 2001, PEDIATR EMERG CARE, V17, P354, DOI 10.1097/00006565-200110000-00009	32	11	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUL	2004	20	7					468	472		10.1097/01.pec.0000136894.91647.6f			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	838DU	WOS:000222694500013	15232251				2022-02-06	
J	Dawes, H; Collett, J; Ramsbottom, R; Howells, K; Sackley, C; Wade, D				Dawes, H; Collett, J; Ramsbottom, R; Howells, K; Sackley, C; Wade, D			Measuring oxygen cost during level walking in individuals with acquired brain injury in the clinical setting	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						oxygen consumption brain injury; test re-test; level walking	ENERGY-EXPENDITURE; CONSUMPTION; VARIABILITY; KNEE	This study examined the test-retest reliability of oxygen cost (ml.kg(-1).min(-1)) during level walking in individuals with acquired brain injury (ABI). Ten individuals with ABI (5 men, 5 women) (Traumatic brain injury, 1, central pontine myelinolysis, 1, stroke 8) and 21 healthy controls (11 men, 10 women). Measurements of gross and net (walking minus resting) oxygen consumption (ml.kg(-1).min(-1)), and oxygen cost (ml.kg(-1).m(-1)) during level walking at self-selected speeds. Measurements were taken on two occasions within one week. Oxygen cost was significantly lower (p < 0.05) in individuals with ABI on the second test versus the first test. Percentage variability in oxygen cost from test to re-test ranged from 14.7 to 17.3% in the control group and from 17.4 to 20.8% in the brain injury group. Clinical populations may demonstrate a significant decrease in oxygen cost between testing occasions. Individuals require at least one period of familiarisation if oxygen cost is used as an outcome measure during level walking in clinical groups. The amount of familiarisation has yet to be investigated in individuals with ABI.	Oxford Brookes Univ, Sch Biol & Mol Sci, Movement Sci Grp, Oxford OX3 ODB, England; Oxford Brookes Univ, Sch Biol & Mol Sci, Exercise Sci Grp, Oxford OX3 ODB, England; Univ Birmingham, Sch Hlth Sci, Birmingham, W Midlands, England; Nuffield Orthopaed Ctr, Oxford Ctr Enablement, Oxford OX3 7LD, England		Dawes, H (corresponding author), Oxford Brookes Univ, Sch Biol & Mol Sci, Movement Sci Grp, Gipsy Lane, Oxford OX3 ODB, England.	hdawes@brookes.ac.uk		sackley, catherine/0000-0002-8580-6622; Wade, Derick/0000-0002-1188-8442; , Johnny/0000-0003-4138-2589; Dawes, Helen/0000-0002-2933-5213			[Anonymous], 1996, BRIT MED J, V313, P1448; ASTRAND I, 1960, ACTA PHYSL SCAND, V49, P61; Baker R, 2001, GAIT POSTURE, V13, P202, DOI 10.1016/S0966-6362(00)00104-1; Bernardi M, 1999, J ELECTROMYOGR KINES, V9, P149, DOI 10.1016/S1050-6411(98)00046-7; Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654; Bowen TR, 1998, J PEDIATR ORTHOPED, V18, P738, DOI 10.1097/00004694-199811000-00008; Boyd R, 1999, DEV MED CHILD NEUROL, V41, P676, DOI 10.1017/S0012162299001395; Corcoran P J, 1970, Arch Phys Med Rehabil, V51, P69; da Cunha IT, 2003, J REHABIL RES DEV, V40, P19, DOI 10.1682/JRRD.2003.01.0019; DAWES H, 2001, THESIS U E LONDON LO, P259; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Hanada E, 2001, ARCH PHYS MED REHAB, V82, P1251, DOI 10.1053/apmr.2001.24902; Inman V. T., 1981, HUMAN WALKING; Kerrigan DC, 2001, J REHABIL RES DEV, V38, pIX; LINNARSSON D, 1989, CLIN PHYSIOL, V9, P1, DOI 10.1111/j.1475-097X.1989.tb00950.x; MATTSSON E, 1990, SCAND J REHABIL MED, V22, P51; MATTSSON E, 1990, SCAND J REHABIL MED, V22, P55; MUNRO B, 1993, CORRELATION STAT MET; RALSTON HJ, 1965, ERGONOMICS S, P53; RIEPER H, 1993, BRIT J NUTR, V69, P29, DOI 10.1079/BJN19930006; WATERS RL, 1988, J ORTHOPAED RES, V6, P215, DOI 10.1002/jor.1100060208; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Wergel-Kolmert U, 1999, CLIN PHYSIOL, V19, P161, DOI 10.1046/j.1365-2281.1999.00160.x; Zamparo P., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P348; Zamparo P, 1998, SCAND J MED SCI SPOR, V8, P222	25	11	12	0	2	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	JUN	2004	3	2					76	82					7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	915AV	WOS:000228270900004	24482582				2022-02-06	
J	Stoffel, M; Blau, C; Reinl, H; Breidt, J; Gersonde, K; Baethmann, A; Plesnila, N				Stoffel, M; Blau, C; Reinl, H; Breidt, J; Gersonde, K; Baethmann, A; Plesnila, N			Identification of brain tissue necrosis by MRI: Validation by histomorphometry	JOURNAL OF NEUROTRAUMA			English	Article						cerebral contusion; cold lesion; histology; lesion growth; MRI; rat; traumatic brain injury	CEREBRAL-ISCHEMIA; SECONDARY EXPANSION; COLD INJURY; EDEMA; LESION; RATS; MODELS; MICE	The volume of an experimental necrotic lesion of the cortex expands up to 400% of its initial size within the first 24 h after the insult. Lesion expansion, a clinically well known phenomenon, is often accompanied by perifocal brain edema and consequently difficult to image and to analyze by magnetic resonance imaging (MRI). Therefore we aimed to validate a T-2-weighted spin echo sequence upon its ability to distinguish necrotic from edematous brain tissue. Male Sprague-Dawley rats (n = 5 per group) were subjected to a cortical freezing lesion leading to immediate tissue necrosis with subsequent perifocal vasogenic brain edema. Immediately and 4, 12, and 24 h after the lesion the maximal area of necrosis was quantified longitudinally by coronal T2-weighted spin echo MRI-scans. After the last scan, animals were sacrificed for direct comparison of the lesion area obtained by MRI and histomorphometry. In parallel groups of animals, lesion expansion was quantified by histology. The acquired T-2-maps clearly distinguish the cortical necrosis from perifocal edema and healthy brain. Focal freezing led to a cortical lesion of 5.24 +/- 0.36 mm(2) immediately after trauma (0 h; 100%) which expanded progressively to a maximum of 6.82 +/- 0.34 mm(2) after 24 h (131%; *p < 0.01 vs. 0 h). Lesion expansion quantified by histology was almost identical (132% within 24 h). Histological assessment resulted in smaller absolute lesion areas compared to MRI, most likely due to shrinking during tissue processing (4.72 +/- 0.26 mm(2) vs. 6.82 +/- 0.34 mm(2),p < 0.01). The current study shows that necrotic brain tissue can be distinguished from surrounding brain edema by T-2-mapping. The technique is sensitive enough to detect small changes in necrosis expansion in vivo as validated by histology. The presented technique may be a useful future tool for the non-invasive identification of necrotic brain tissue following brain injury (e.g., from trauma or ischemia).	Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Munich, Klinikum Grosshadern, Inst Surg Res, D-8000 Munich, Germany; Fraunhofer Inst Biomed Tech, St Ingbert, Germany		Stoffel, M (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	michael.stoffel@ukb.uni-bonn.de	Plesnila, Nikolaus/T-7522-2019				BENVENISTE H, 1991, STROKE, V22, P259, DOI 10.1161/01.STR.22.2.259; DIEMER NH, 1982, CRC CR REV TOXICOL, V10, P215, DOI 10.3109/10408448209037456; EKE A, 1990, STROKE, V21, P299, DOI 10.1161/01.STR.21.2.299; EKE A, 1989, LAB INVEST, V61, P243; ERISKAT J, 1994, ACTA NEUROCHIR, P425; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Kamada Kyousuke, 1995, Neurologia Medico-Chirurgica, V35, P1, DOI 10.2176/nmc.35.1; KATO H, 1986, J CEREBR BLOOD F MET, V6, P212, DOI 10.1038/jcbfm.1986.34; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; NARUSE S, 1986, Magnetic Resonance Imaging, V4, P293, DOI 10.1016/0730-725X(86)91039-8; Plesnila N, 2003, NEUROSCI LETT, V345, P85, DOI 10.1016/S0304-3940(03)00396-3; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; SCHNEIDER GH, 1994, ACTA NEUROCHIR, P437; Steinbach JP, 1999, NEUROPATH APPL NEURO, V25, P468; Stoffel M, 2002, J NEUROTRAUM, V19, P467, DOI 10.1089/08977150252932415; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; Stowell RE, 1941, STAIN TECHNOL, V16, P67, DOI 10.3109/10520294109106200; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; Venkatesan, 1999, MAGNETIC RESONANCE I; WYRWICH W, 1997, THESIS LUDWIG MAXIMI	23	11	11	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2004	21	6					733	740		10.1089/0897715041269678			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	836EG	WOS:000222537600009	15253801				2022-02-06	
J	Valach, L; Selz, B; Signer, S				Valach, L; Selz, B; Signer, S			Length of stay in the rehabilitation center, the admission functional independence measure and the functional independence measure gain	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						length of stay; functional independence measure; decision to discharge	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; MEDICAL REHABILITATION; STROKE REHABILITATION; CLASSIFICATION-SYSTEM; DISCHARGE DESTINATION; POSTSTROKE DEPRESSION; RESOURCE UTILIZATION; CASE-MIX; OUTCOMES		Univ Zurich, Rehabil Ctr, Buerger Hosp Solothum, CH-8006 Zurich, Switzerland; Univ Zurich, Fac Philosophy, CH-8006 Zurich, Switzerland		Valach, L (corresponding author), Univ Zurich, Klin Schloessli, CH-8618 Oetwil Am See, Switzerland.	ladislav.valach@schloessli.ch	valach, ladislav k/D-9250-2016	valach, ladislav k/0000-0002-1017-9329			ALEXANDER MP, 1994, STROKE, V25, P128, DOI 10.1161/01.STR.25.1.128; Andrews AW, 2001, NEUROREHAB NEURAL RE, V15, P93, DOI 10.1177/154596830101500202; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Diller Leonard, 1995, Top Stroke Rehabil, V2, P44; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Eilertsen TB, 1998, MED CARE, V36, P695, DOI 10.1097/00005650-199805000-00009; GALSKI T, 1993, STROKE, V24, P1794, DOI 10.1161/01.STR.24.12.1794; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; Gillen R, 1999, J Stroke Cerebrovasc Dis, V8, P300, DOI 10.1016/S1052-3057(99)80004-4; Gordon WA, 1997, ARCH PHYS MED REHAB, V78, P658, DOI 10.1016/S0003-9993(97)90433-0; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Grimby G, 1996, SCAND J REHABIL MED, V28, P51; HAMILITON BB, 1994, PHYS THER, V74, P494, DOI 10.1093/ptj/74.5.494; Harvey RL, 1998, ARCH PHYS MED REHAB, V79, P1349, DOI 10.1016/S0003-9993(98)90226-X; Hosking SG, 1996, NEUROPSYCHOL REV, V6, P107, DOI 10.1007/BF01874894; Mills TL, 2002, J NATL MED ASSOC, V94, P846; Oczkowski WJ, 1997, ARCH PHYS MED REHAB, V78, P340, DOI 10.1016/S0003-9993(97)90222-7; Reker DM, 1998, ARCH PHYS MED REHAB, V79, P751, DOI 10.1016/S0003-9993(98)90351-3; Ring H, 1997, ARCH PHYS MED REHAB, V78, P630, DOI 10.1016/S0003-9993(97)90429-9; Sandstrom R, 1998, ARCH PHYS MED REHAB, V79, P762, DOI 10.1016/S0003-9993(98)90353-7; Spencer KA, 1997, PSYCHOL BULL, V122, P132; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; Stineman MG, 1998, ARCH PHYS MED REHAB, V79, P241, DOI 10.1016/S0003-9993(98)90001-6; Stineman MG, 1997, HEALTH SERV RES, V32, P529; Stineman MG, 1996, AM J PHYS MED REHAB, V75, P68, DOI 10.1097/00002060-199601000-00018; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Unsworth CA, 2001, INT J REHABIL RES, V24, P103; Ween JE, 2000, NEUROREHAB NEURAL RE, V14, P229, DOI 10.1177/154596830001400309; Ween JE, 1996, NEUROLOGY, V47, P659, DOI 10.1212/WNL.47.3.659	30	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2004	27	2					135	143		10.1097/01.mrr.0000131577.55940.80			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	839PH	WOS:000222796500007	15167111				2022-02-06	
J	Xiao-Sheng, H; Xiang, Z; Zhou, F; Luo-An, F; Shuang, W				Xiao-Sheng, H; Xiang, Z; Zhou, F; Luo-An, F; Shuang, W			Calcium overloading in traumatic axonal injury by lateral head rotation: a morphological evidence in rat model	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						calcium overloading; traumatic axonal injury; rat	MYELINATED NERVE-FIBERS; EXPERIMENTAL BRAIN-INJURY; ATPASE ACTIVITY; OPTIC-NERVE; LOCALIZATION; PATHOGENESIS; PROTEOLYSIS; MECHANISMS; PATHOLOGY; BREAKDOWN	The study investigated morphologically axonal calcium overloading and its relationship with axonal structural changes. Twelve SD rats were divided into an injury and a sham group. The rat model of traumatic axonal injury (TAI) by lateral head rotation was produced. The oxalate-pyroantimonate technique for calcium localization was used to process the rat's medulla oblongata tissues with thin sections observed electron-microscopically for axonal structure and calcium precipitates on it. The axonal damage in medulla oblongata appeared at 2 h postinjury, gradually became diffuse and severe, and continued to exist at 24 hours. At 2 hours, calcium precipitates were deposited on separated lamellae and axolemma, but were rarely distributed in the axoplasm. At 6 hours, calcium precipitates occurred on separated lamellae and axolemma in much higher density, but on axoplasm in extremely small amounts. Some axons, though lacking structural changes of the myelin sheath, sequestered plenty of calcium deposits on their swollen mitochondria. At 24 hours, damaged axons presented with much more severe lamellae separation and calcium deposits. Axonal calcium overloading developed in rat TAI model using lateral head rotation. This was significantly related to structural damage in the axons. These findings suggest the feasibility of using calcium antagonists in cope the management of human DAI in its very early stage. (C) 2004 Elsevier Ltd. All rights reserved.	Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China		Xiao-Sheng, H (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, 15 W Chang Le Rd, Xian 710032, Shaanxi, Peoples R China.	xiaohe@pub.xaonline.com					ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BENNETT M, 1995, IRISH MED J, V88, P59; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BORGERS M, 1977, LAB INVEST, V37, P1; BORGERS M, 1981, ACTA HISTOCHEM, P327; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; KAMAKURA K, 1983, J NEUROCHEM, V40, P908, DOI 10.1111/j.1471-4159.1983.tb08072.x; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; MATA M, 1986, J NEUROBIOL, V17, P449, DOI 10.1002/neu.480170508; MATA M, 1987, HISTOCHEMISTRY, V87, P339, DOI 10.1007/BF00492588; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; MAXWELL WL, 1991, J ANAT, V176, P71; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McIntosh TK, 1997, NEUROSCIENTIST, V3, P169, DOI 10.1177/107385849700300310; OBERC MA, 1977, LAB INVEST, V36, P566; OCHS S, 1990, NEUROSCIENCE, V36, P553, DOI 10.1016/0306-4522(90)90445-A; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SLANZINSKI T, 1994, J NEUROSCI NURS, V26, P151; WADE CR, 1980, J ANAT, V130, P641; YAMAKI T, 1992, ACTA NEUROCHIR, V119, P153, DOI 10.1007/BF01541800	34	11	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2004	11	4					402	407		10.1016/j.jocn.2004.01.001			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	818DW	WOS:000221226800014	15080957				2022-02-06	
J	Tortosa, JG; Martinez-Lage, JF; Poza, M				Tortosa, JG; Martinez-Lage, JF; Poza, M			Bitemporal head crush injuries: clinical and radiological features of a distinctive type of head injury	JOURNAL OF NEUROSURGERY			English	Article						skull injury; skull base; otorrhagia; epistaxis; sixth cranial nerve; seventh cranial nerve; nerve injury; diabetes insipidus; pneumocephalus	TRIGEMINO-ABDUCENS SYNKINESIS; PITUITARY GLAND; ANTERIOR LOBE; CONCUSSION; FRACTURES; CHILDREN; NERVE; STALK	Object. Most craniocerebral injuries are caused by mechanisms of acceleration and/or deceleration. Traumatic injuries following progressive compression to the head are certainly Unusual. The authors reviewed clinical and radiological features in a series of patients who had sustained a special type of cranial crush injury produced by the bilateral application of rather static forces to the temporal region. Their aim was to define the characteristic clinical features in this group of patients and to assess the mechanisms involved in the production of the cranial injuries and those of the associated cerebral and endocrine lesions found in this peculiar type of head injury. Methods. Clinical records of 11 patients were analyzed with regard to the state of consciousness, cranial nerve involvement, findings on neuroimaging studies, endocrine symptoms, and outcome. Furthermore, an experimental model of bitemporal crush injury was developed by compressing a dried skull with a carpenter's vice. Seven of the 11 patients were 16 years old or younger. All patients presented with a characteristic clinical Picture consisting of no loss of consciousness (six patients), epistaxis (nine patients), otorrhagia (11 patients), peripheral paralysis of the sixth and/or seventh cranial nerves (10 patients), hearing loss (five patients), skull base fractures (11 patients), pneumocephalus (11 patients), and diabetes insipidus (seven patients). Ten patients survived the injury and most recovered neurological function. Conclusions. Static forces applied to the head in a transverse axis produce fractures in the skull base that cross the midline structures without producing significant cerebral damage. Stretching of cranial nerves at the skull base explains the nearly universal finding of paralysis of these structures, whereas an increase in the vertical diameter of the skull accounts for the Occurrence of diabetes insipidus in the presence of an intact function of the anterior pituitary lobe. The association of clinical, endocrine, and neuroimaging findings encountered in this peculiar type of head injury supports the idea that this Subset of injured patients has a distinctive clinical condition, namely the syndrome of bitemporal crush injury to the head.	Virgen Arrixaca Univ Hosp, Reg Serv Neurosurg, E-30120 Murcia, Spain		Tortosa, JG (corresponding author), Virgen Arrixaca Univ Hosp, Reg Serv Neurosurg, E-30120 Murcia, Spain.	jtortosa@arrixaca.huva.es					ADAMS JH, 1966, J NEUROL NEUROSUR PS, V29, P545, DOI 10.1136/jnnp.29.6.545; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Ceballos R, 1966, Ala J Med Sci, V3, P185; CROMPTON MR, 1975, HDB CLIN NEUROLOGY, V23, P465; DANIEL PM, 1959, LANCET, V2, P927; DANIEL PM, 1958, LANCET, V1, P1101; DANIEL PM, 1976, GREENFIELDS NEUROPAT, P581; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DUHAIME AC, 1995, NEUROSURGERY, V37, P401, DOI 10.1227/00006123-199509000-00005; GHORAYEB BY, 1987, ARCH OTOLARYNGOL, V113, P749; Gonzalez Tortosa J, 1991, NEUROCIRUGIA, V2, P17; Holbourn AHS, 1943, LANCET, V2, P438; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; JEFFERSON G, 1955, BRIT J SURG, V42, P561, DOI 10.1002/bjs.18004217602; KAWAI K, 1995, J NEUROSURG, V83, P368, DOI 10.3171/jns.1995.83.2.0368; KO KF, 1995, CLIN NEUROL NEUROSUR, V97, P199, DOI 10.1016/0303-8467(95)00027-H; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; MARKHAM JW, 1976, HDB CLIN NEUROLOGY, V24, P201; MCGOVERN ST, 1986, AUST NZ J OPHTHALMOL, V14, P275, DOI 10.1111/j.1442-9071.1986.tb00049.x; MOHANTY S, 1978, NEUROL INDIA, V26, P71; MONNET F, 1984, NEUROENDOCRINOLOGY, V39, P251, DOI 10.1159/000123987; NELSON SK, 1990, J CLIN NEURO-OPHTHAL, V10, P111; PAGE RB, 1977, PITUITARY CURRENT RE, P9; PARKINSON D, 1982, CLIN NEUR, V29, P131; PORTER RJ, 1948, J NEUROL NEUROSUR PS, V11, P258, DOI 10.1136/jnnp.11.4.258; Prasad MR, 1999, J CHILD NEUROL, V14, P496, DOI 10.1177/088307389901400803; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; ROBERTS M, 1976, HDB CLIN NEUROLOGY 2, V24, P59; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; SCHNEIDER RC, 1971, J NEUROSURG, V34, P33, DOI 10.3171/jns.1971.34.1.0033; Shuto T, 1999, No To Shinkei, V51, P615; STEUDEL WI, 1986, ACTA NEUROCHIR, V80, P93, DOI 10.1007/BF01812281; SUMMERS CG, 1979, J NEUROSURG, V50, P508, DOI 10.3171/jns.1979.50.4.0508; Takagi H, 1976, No Shinkei Geka, V4, P963; TOGLIA JU, 1976, HDB CLIN NEUROLOGY, V24, P119; TREIP CS, 1970, J NEUROL NEUROSUR PS, V33, P715, DOI 10.1136/jnnp.33.5.715-a; WOLFF E, 1968, ANATOMY EYE ORBIT IN, P529; XUEREB GP, 1954, Q J EXP PHYSIOL CMS, V39, P199, DOI 10.1113/expphysiol.1954.sp001072; [No title captured]	40	11	11	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2004	100	4					645	651		10.3171/jns.2004.100.4.0645			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	806NP	WOS:000220440900015	15070119				2022-02-06	
J	Olvey, SE; Knox, T; Cohn, KA				Olvey, SE; Knox, T; Cohn, KA			The development of a method to measure head acceleration and motion in high-impact crashes	NEUROSURGERY			English	Article						ear accelerometers; head impact analysis; high-velocity traumatic brain injury; measured head accelerations	INJURY	OBJECTIVE: To establish a mechanism to obtain precise measurements of the accelerations of the head in the high-speed racing environment and during crash impacts. The long-term goal is to apply this system to the assessment of head injury in automobile racing drivers and then in participants in other helmeted sports. METHODS: A multidisciplinary team conceptualized, designed, and successfully tested a triaxial accelerometer system capable of measuring head acceleration and motion in high-impact crashes. The system has been implemented successfully in the professional racing environment. RESULTS: Accurate and reproducible data have been obtained from the accelerometer system in tests on manikins and cadavers and in actual racing events. The system has been implemented in two professional racing series in 2003. Information gained from the accelerometer system is currently being entered into a database. Eventually, the data should aid in the development of improved cockpit head protection in racing cars. Improved helmet design not only in motor sports but also in other helmeted sports should benefit from the data collected. These data will also aid the development of improved head injury protection in military aircraft and passenger vehicles. CONCLUSION: Although there has been a significant decrease in the overall rate of injury during the past 25 years, head injury remains a serious safety concern in motor sports and the greatest cause of death. Sports-related head injuries are also of great concern because repeated mild head injury has become an important health issue with potential long-term disability. True human tolerance to brain injury has yet to be established. Our scientific knowledge of brain injury is currently based on results derived from manikin, cadaver, and human volunteer testing, along with animal and computer models. The racing environment represents a venue to ethically measure and evaluate the forces involved in human brain injury.	Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; USAF, Res Lab, Biodynam & Accelerat Branch, Wright Patterson AFB, OH 45433 USA; Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA		Olvey, SE (corresponding author), Univ Miami, Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace,D4-6, Miami, FL 33136 USA.	solvey@med.miami.edu					CHENG LY, 1990, VEHICLE CRASHWORTHIN, P141; Clarke KS, 1998, CLIN SPORT MED, V17, P1, DOI 10.1016/S0278-5919(05)70056-9; Gennarelli T. A., 1987, HEAD INJURY, P108; HANDMAN D, 2000, SAE 2000 WORLD C DET; KNOX T, 2003, RES TECHN ORG APPL V; Kraus JF, 1993, HEAD INJURY, P1; LEE MC, 1987, P 31 STAPP CAR CRASH; Melvin J. W., 1998, P 42 STAPP CAR CRASH; Mendis K, 1992, THESIS OHIO STATE U; *NAT CTR INJ PREV, 2004, NCIPC; Olvey S.E., 1998, SPORTS NEUROLOGY, P317; PLUCHE R, 1985, HEAD INJURY PREVENTI, P235; RUAN JS, 1994, P 38 STAPP CAR CRASH; SHUGAR TA, 1975, J ENG MECH DIV-ASCE, V101, P223; TRAMMELL TR, 1990, 34 ANN P ASS ADV AUT, P329; Ueno K., 1989, CRASH WORTHINESS OCC, P123	16	11	12	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	2004	54	3					672	677		10.1227/01.NEU.0000108782.68099.29			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	802FN	WOS:000220149500043	15028143				2022-02-06	
J	Moore, BA; Donders, J; Thompson, EH				Moore, BA; Donders, J; Thompson, EH			Validity of the Children's Category Test-Level 1 after pediatric traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						neuropsychology; traumatic brain injury; assessment	HEAD-INJURY; STANDARDIZATION SAMPLE; LATENT STRUCTURE	The performance of 38 5-8-year-old children with traumatic brain injury (TBI) on the Children's Category Test-Level 1 (CCT-1; Boll, 1993) was investigated in order to examine the criterion validity of the component subtests. Only subtests III and V varied in a consistent and meaningful manner with levels of injury severity and post-injury psychometric intelligence. In contrast, 21% of the sample performed at chance level on subtest IV, a task that did not demonstrate any criterion validity. It is concluded that when a substantial proportion of the total errors (e.g., greater than or equal to50%) on the CCT-1 pertain to items from subtest IV, interpretation of the composite summary T score may not be valid. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Mary Free Bed Hosp, Grand Rapids, MI 49503 USA; Adler Sch Profess Psychol, Chicago, IL 60601 USA		Donders, J (corresponding author), Mary Free Bed Hosp, 235 Wealthy SE, Grand Rapids, MI 49503 USA.						BOLL T, 1993, CHILDRENS CATEGORY T; Culbertson WC., 2001, TOWER LONDON DREXEL; DALBY R, 1991, DEV NEUROPSYCHOL, V7, P39; DELIS D, 1994, CALIFORNIA VERBAL LE; Donders J, 1998, CHILD NEUROPSYCHOL, V4, P178; Donders J, 1999, J CLIN EXP NEUROPSYC, V21, P279; Donders J, 1995, CHILD NEUROPSYCHOL, V1, P19, DOI 10.1080/09297049508401339; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Gutentag SS, 1998, ASSESSMENT, V5, P263, DOI 10.1177/107319119800500306; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kizilbash A., 2001, PEDIAT REHABILITATIO, V4, P71; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; Murphy K. R., 1998, STAT POWER ANAL SIMP; Nesbit-Greene K, 2002, J CLIN EXP NEUROPSYC, V24, P194, DOI 10.1076/jcen.24.2.194.996; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; TEASDALE G, 1974, LANCET, V2, P81; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Woodward H, 1998, APPL NEUROPSYCHOL, V5, P113, DOI 10.1207/s15324826an0503_1	21	11	11	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2004	19	1					1	9	PII S0887-6177(02)00171-3	10.1016/S0887-6177(02)00171-3			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	759MB	WOS:000187740500001	14670375				2022-02-06	
J	Anderson, GD; Temkin, NR; Chandler, WL; Winn, HR				Anderson, GD; Temkin, NR; Chandler, WL; Winn, HR			Effect of valproate on hemostatic function in patients with traumatic brain injury	EPILEPSY RESEARCH			English	Article						valproate; coagulation; neurotrauma; brain injury	SODIUM VALPROATE; BLOOD-LOSS; ACID; CHILDREN; THERAPY; THROMBOCYTOPENIA	Objectives: To evaluate whether valproate (VPA) resulted in laboratory or clinical evidence of a change in bleeding-related measures associated with VPA therapy in patients sustaining a traumatic brain injury. Methods: Fibrinogen, platelet count and clot elastic shear modulus using the Thrombelastographo (TEGO) coagulation analyzer were measured at baseline, 4, 14, 30, and 180 days post-injury. Clinically significant events, defined as the trigger for requiring a transfusion, were identified and evaluated as to possible treatment effects. Results: Compared to baseline, the platelet count in the VPA groups was decreased on day 4, increased by 100% on day 14, and returned to baseline levels by day 30. Fibrinogen was significantly increased by day 4 and returned to baseline by day 30. The platelet count was correlated with an increase in the maximum amplitude or width of the TEG(R) tracing; a measure of strength of the clot, suggesting that valproate did not alter the clot strength contributed by platelets. None of the clinical events requiring transfusions appeared to be treatment related. Conclusions: No serious hemostatic adverse events occurred in the trauma patients receiving VPA or phenytoin that could be attributed to treatment. (C) 2003 Elsevier B.V. All rights reserved.	Univ Washington, Dept Pharm, Seattle, WA 98195 USA; Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Mt Sinai Sch Med, New York, NY 10029 USA		Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Box 357630, Seattle, WA 98195 USA.	gaila@u.wahington.edu; temkin@u.washington.edu; wic@u.washington.edu; rwinn0l@msnyuhealth.org			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS19643] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER		Allarakhia IN, 1996, PEDIATR NEUROL, V14, P303, DOI 10.1016/0887-8994(96)00052-5; Anderson GD, 1997, J NEUROSURG, V87, P252, DOI 10.3171/jns.1997.87.2.0252; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARR RD, 1982, ARCH DIS CHILD, V57, P681, DOI 10.1136/adc.57.9.681; Bourgeois BFD, 2001, PEDIATRIC EPILEPSY: DIAGNOSIS AND THERAPY, SECOND EDITION, P433; Bowbrick VA, 2003, CLIN APPL THROMB-HEM, V9, P137, DOI 10.1177/107602960300900208; Chambers HG, 1999, J PEDIATR ORTHOPED, V19, P792, DOI 10.1097/00004694-199911000-00018; Chandler WL, 1995, SEMIN THROMB HEMOST, V21, P1; Chandler WL, 2001, BLOOD COAGUL FIBRIN, V12, P101, DOI 10.1097/00001721-200103000-00003; COULTER DL, 1980, JAMA-J AM MED ASSOC, V244, P785; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; GANICK DJ, 1990, AM J PEDIAT HEMATOL, V12, P80; GIDAL B, 1994, NEUROLOGY, V44, P1418, DOI 10.1212/WNL.44.8.1418; Hauser E, 1996, BRAIN DEV-JPN, V18, P105, DOI 10.1016/0387-7604(95)00139-5; HOFFMAN LM, 1982, CAN MED ASSOC J, V126, P358; JAEKEN J, 1979, ARCH DIS CHILD, V54, P986, DOI 10.1136/adc.54.12.986; JEAVONS PM, 1974, BRIT MED J, V2, P584, DOI 10.1136/bmj.2.5919.584; KAYA IS, 1991, LANCET, V337, P1227, DOI 10.1016/0140-6736(91)92902-E; Kis B, 1999, EPILEPSIA, V40, P307, DOI 10.1111/j.1528-1157.1999.tb00709.x; KISHI T, 1994, ARCH DIS CHILD, V71, P153, DOI 10.1136/adc.71.2.153; KREUZ W, 1992, EPILEPSIA, V33, P178, DOI 10.1111/j.1528-1157.1992.tb02303.x; LOISEAU P, 1981, EPILEPSIA, V22, P141, DOI 10.1111/j.1528-1157.1981.tb04094.x; MACDOUGALL LG, 1982, JAMA-J AM MED ASSOC, V247, P53; MAJER RV, 1987, LANCET, V2, P740; MALLETT SV, 1992, BRIT J ANAESTH, V69, P307, DOI 10.1093/bja/69.3.307; MALLETT SV, 1991, LANCET, V338, P765, DOI 10.1016/0140-6736(91)91495-G; NEOPHYTIDES AN, 1979, ANN NEUROL, V5, P389, DOI 10.1002/ana.410050414; NUTT JG, 1978, LANCET, V2, P636; OZKARA C, 1993, ACTA NEUROL SCAND, V88, P210; RANGANATHAN C, 1993, J EPILEPSY, V6, P142, DOI 10.1016/S0896-6974(05)80081-7; RAWORTH RE, 1978, LANCET, V1, P670; RICHARDSON SGN, 1976, BRIT MED J, V1, P221, DOI 10.1136/bmj.1.6003.221-c; ROGERS FB, 1995, SURG CLIN N AM, V75, P279, DOI 10.1016/S0039-6109(16)46588-6; SANDLER RM, 1978, BRIT MED J, V2, P1683, DOI 10.1136/bmj.2.6153.1683; SMITH FR, 1980, ANN NEUROL, V8, P197, DOI 10.1002/ana.410080213; SYMON DNK, 1983, ARCH DIS CHILD, V58, P235, DOI 10.1136/adc.58.3.235; Tanindi S, 1996, THROMB RES, V81, P471, DOI 10.1016/0049-3848(96)00019-9; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; TETZLAFF JE, 1991, CAN J ANAESTH, V38, P222, DOI 10.1007/BF03008150; Trannel TJ, 2001, AM J PSYCHIAT, V158, P128, DOI 10.1176/appi.ajp.158.1.128; VANVOSS H, 1976, BRIT MED J, V2, P179; Verrotti A, 1999, PEDIATR NEUROL, V21, P611, DOI 10.1016/S0887-8994(99)00060-0; Ward MM, 1996, EPILEPSIA, V37, P98, DOI 10.1111/j.1528-1157.1996.tb00519.x; WINFIELD DA, 1976, BRIT MED J, V2, P981, DOI 10.1136/bmj.2.6042.981; Winter SL, 1996, PEDIATR NEUROL, V15, P19, DOI 10.1016/0887-8994(96)00124-5; Zeller JA, 1999, EPILEPSIA, V40, P186, DOI 10.1111/j.1528-1157.1999.tb02073.x	47	11	12	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	DEC	2003	57	2-3					111	119		10.1016/j.eplepsyres.2003.11.001			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	774RF	WOS:000188997100003	15013052				2022-02-06	
J	Prigatano, GP; Borgaro, S; Caples, H				Prigatano, GP; Borgaro, S; Caples, H			Non-pharmacological management of psychiatric disturbances after traumatic brain injury	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							CLOSED HEAD-INJURY; REHABILITATION; BEHAVIOR; DAMAGE	Persons who suffer traumatic brain injury (TBI) often demonstrate a variety of psychiatric and neuropsychiatric disturbances. Some of those disturbances may be managed by non-pharmacological methods. The methods draw heavily on established principles of psychotherapy and behavioral modification. However, the unique problems imposed by neurocognitive deficits must be factored into any form of non-pharmacological intervention with this patient group. A simple model consolidates information about the important ingredients in the non-pharmacological management of psychiatric disturbances in TBI patients.	St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychoil, Div Neurol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychoil, Div Neurol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	gprigat@chw.edu					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ayllon T., 1968, TOKEN EC; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; CHRISTENSEN AL, 2000, INT HDB NEUROPSYCHOL; Christensen AL, 1994, BRAIN INJURY NEUROPS; Ducharme JM, 2000, CLIN PSYCHOL REV, V20, P405, DOI 10.1016/S0272-7358(98)00102-0; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; EAMES P, 1988, J HEAD TRAUMA REHAB, V3, P1; ESSLINGER PJ, 2002, NEUROPSYCHOLOGICAL I; FINN SE, 1996, USING MMPI 2 THERAPE; Frank J. D., 1984, MASTER LECT SERIES, V1, P5; Freud S., 1924, GEN INTRO PSYCHOANAL; GOLDSTEIN FC, 1995, HDB MEMORY DISORDERS, P187; GOLDSTEIN K, 1942, AFTER EFFECTS BRAIN; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Grattan LM, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P266; Guthrie ER, 1939, PSYCHOL REV, V46, P480, DOI 10.1037/h0058583; HOWARD ME, 1988, J HEAD TRAUMA REHAB, V3, P14; IWATA BA, 1990, J APPL BEHAV ANAL, V23, P11, DOI 10.1901/jaba.1990.23-11; Jehkonen M, 2000, ACTA NEUROL SCAND, V102, P378, DOI 10.1034/j.1600-0404.2000.102006378.x; JUNG CG, 1957, PRACTICE PSYCHOTHERA; Kalff Dora, 1980, SANDPLAY PSYCHOTHERA; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Klonoff PS, 1989, J HEAD TRAUMA REHAB, V4, P37; Laatsch L, 1999, PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADULTS WITH BRAIN INJURY OR STROKE: A CLINICIAN'S TREATMENT RESOURCE, P131; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; Mateer C. A., 1999, REHABILITATION ADULT, P254; Meyer A, 1904, AM J INSANITY, V60, P373, DOI 10.1176/ajp.60.3.373; Miller, 1950, PERSONALITY PSYCHOTH; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PACE GM, 1993, STAFF DEV CLIN INTER, P105; Pedersen PM, 1996, J NEUROL REHABIL, V10, P243; Pepping M, 2003, NEURO S B C, P313; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Prigatano GP, 1986, CLIN NEUROPSYCHOLOGY, P135; PRIGATANO GP, 2003, OXFORD HDB CLIN NEUR; Prigatano GP, 1994, BRAIN INJURY NEUROPS, P173; Prigatano GP, 1999, REHABILITATION ADULT, P271; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Schilder P, 1934, AM J PSYCHIAT, V91, P155, DOI 10.1176/ajp.91.1.155; Sherer M, 2003, NEURO S B C, P39; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHERER M, IN PRESS ARCH PHYSIC; Skinner BF, 1938, BEHAV ORGANISMS; SLIFER KJ, 1993, ARCH PHYS MED REHAB, V74, P810, DOI 10.1016/0003-9993(93)90006-V; Thorndike EL, 1932, FUNDAMENTALS LEARNIN; TOLMAN EC, 1949, PSYCHOL REV, V56, P144, DOI 10.1037/h0055304; VONSTEINBUCHEL NV, 1992, NEUROPSYCHOLOGICAL R; WOOD RL, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P153; WOOD RL, 1992, NEUROPSYCHOL REHABIL, P51; ZENICUS A, 1989, BRAIN INJURY, V3, P67	56	11	13	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	NOV	2003	15	4					371	379		10.1080/09540260310001606755			9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	739UD	WOS:000186364100009	15276958				2022-02-06	
J	Ross, SR; Krukowski, RA; Putnam, SH; Adams, KM				Ross, SR; Krukowski, RA; Putnam, SH; Adams, KM			The memory assessment scales in the detection of incomplete effort in mild head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							ADULT INTELLIGENCE SCALE; TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; WMS-R; COGNITIVE IMPAIRMENT; MALINGERING TOMM; RECOGNITION TEST; TESTS; VALIDATION; DEFICITS	Despite differences in the constructs measured, the Memory Assessment Scales (MAS) remain an alternative to the Wechsler Memory Scales (WMS) as a broad-band instrument for assessing multiple aspects of attention and memory. Although a number of studies have examined indices of the WMS as indicators of malingering, few studies have similarly investigated the MAS. In this study, we examined the degree to which the MAS was effective in detecting incomplete effort in a clinical sample of patients referred for neuropsychological evaluation after mild head injury. Included in the sample were 21 financially compensable (FC) participants with alleged mild head injury and 21 participants who were not involved in litigation and suffered more serious head injuries. Examination of the four MAS domain indices indicated that Short-Term Memory was most useful at identifying incomplete effort. We also examined subscales of the MAS. Consistent with previous findings, brief tests such as Verbal and Visual Span had high rates of diagnostic sensitivity and specificity. Although tests based on a forced-choice recognition paradigm (e.g., Immediate and Delayed Visual Recognition) predicted group membership above chance levels, they failed to significantly add to prediction above Verbal and Visual Span subtests.	DePauw Univ, Dept Psychol, Greencastle, IN 46135 USA; Univ Vermont, Burlington, VT USA; Wayne State Univ, Sch Med, Detroit, MI USA; VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Univ Michigan, Ann Arbor, MI 48109 USA		Ross, SR (corresponding author), DePauw Univ, Dept Psychol, Greencastle, IN 46135 USA.	srross@depauw.edu	Krukowski, Rebecca/AAS-4304-2020	Krukowski, Rebecca/0000-0001-9193-2783			Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; FAHRMEIR L, 1994, MULTIVARIATE STAT MO; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Golden CJ, 1999, ARCH CLIN NEUROPSYCH, V14, P265, DOI 10.1016/S0887-6177(98)00017-1; Gontkovsky ST, 2000, PSYCHOL REP, V87, P512, DOI 10.2466/PR0.87.6.512-514; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HILSABECK RC, 1996, ASSESSMENT, V3, P417; HISCOCK CK, 1994, J PSYCHOPATHOL BEHAV, V16, P95, DOI 10.1007/BF02232721; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; IVERSON GL, 2001, AM J FORENSIC PSYCH, V19, P5; Johnson JL, 1997, ARCH CLIN NEUROPSYCH, V12, P231, DOI 10.1016/S0887-6177(96)00040-6; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Menard S., 2002, APPL LOGISTIC REGRES, V2nd; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Rawling P, 1990, NEUROPSYCHOLOGY, V4, P223, DOI 10.1037/0894-4105.4.4.223; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; ROSS SR, IN PRESS J CLIN EXPT; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; VANZOMEREN AH, 1990, HDB CLIN NEUROLOGY, V13, P397; Warrington E, 1984, RECOGNITION MEMORY T, V1; WILLIAMS MJ, 1991, MEMORY ASSESSMENT SC; ZIELINSKI JJ, 1993, PROF PSYCHOL-RES PR, V24, P353, DOI 10.1037/0735-7028.24.3.353; [No title captured]	48	11	11	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	2003	17	4					581	591		10.1076/clin.17.4.581.27940			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	776XV	WOS:000189145400014	15168922				2022-02-06	
J	Millis, SR				Millis, SR			Emerging standards in statistical practice - Implications for clinical trials in rehabilitation medicine	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article; Proceedings Paper	Clinical Trials in Medical Rehabilitation Conference	NOV 01-02, 2002	PARSIPPANY, NJ			clinical trials; statistics; rehabilitation	PERFORMING MULTIPLE TESTS; TRAUMATIC BRAIN-INJURY; SINGLE EXPERIMENT; ERROR	This article discusses selected issues in statistical practice that occur during the conduct of clinical trials in medical rehabilitation: (1) supplementing null hypothesis statistical testing and P values, (2) determining. sample size and statistical power, (3) handling missing data, and (4) dealing with multiplicity (i.e., multiple endpoints, multiple statistical comparisons, and repeated measurements). Suggested strategies to address these issues are offered in light of the International Conference on Harmonisation guideline "Statistical Principles for Clinical Trials".	Kessler Med Rehabil Res & Educ Corp, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA		Millis, SR (corresponding author), Kessler Med Rehabil Res & Educ Corp, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.						Allison PD, 2001, MISSING DATA; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOHAYCHUK W, 1999, CONDUCTING GCP COMPL; CARVER RP, 1978, HARVARD EDUC REV, V48, P378, DOI 10.17763/haer.48.3.t490261645281841; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Dupont WD, 2002, STAT MODELING BIOMED; Everitt B., 1998, CAMBRIDGE DICT STAT; Everitt B., 2003, MODERN MED STAT; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; HULLY SB, 2001, DESIGNING CLIN RES; Keselman HJ, 1999, PSYCHOL METHODS, V4, P58, DOI 10.1037/1082-989X.4.1.58; Kirk RE, 1996, EDUC PSYCHOL MEAS, V56, P746, DOI 10.1177/0013164496056005002; Matthews JNS, 1996, BRIT MED J, V313, P808; MULAIK SA, 1997, MULTIVAR APPL SER, P65; Mullner M, 2002, ANN INTERN MED, V136, P122, DOI 10.7326/0003-4819-136-2-200201150-00009; OBRIEN PC, 1988, MAYO CLIN PROC, V63, P816, DOI 10.1016/S0025-6196(12)62363-5; OBRIEN PC, 1988, MAYO CLIN PROC, V63, P813, DOI 10.1016/S0025-6196(12)62362-3; Phillips A, 2000, DRUG INF J, V34, P337, DOI 10.1177/009286150003400202; Phillips A, 2003, STAT MED, V22, P1, DOI 10.1002/sim.1328; Ramsey PH, 2002, PSYCHOL METHODS, V7, P504, DOI 10.1037//1082-989X.7.4.504; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SALSBURY D, 2001, LADY TASTING TEA; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Senn S, 2000, STAT MED, V19, P861, DOI 10.1002/(SICI)1097-0258(20000330)19:6<861::AID-SIM407>3.0.CO;2-F; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; van Belle G., 2002, STAT RULES THUMB; Williams VSL, 1999, J EDUC BEHAV STAT, V24, P42, DOI 10.3102/10769986024001042	27	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	OCT	2003	82	10		S			S32	S37		10.1097/01.PHM.0000087007.19214.32			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	724YP	WOS:000185516100007	14502037				2022-02-06	
J	Philip, S; Armstead, WM				Philip, S; Armstead, WM			Differential role of PTK, ERK and p38 MAPK in superoxide impairment of NMDA cerebrovasodilation	BRAIN RESEARCH			English	Article						cerebral circulation; excitatory amino acid; oxygen free radical; signal transduction	ACTIVATED PROTEIN-KINASE; CEREBRAL ARTERIOLAR DILATION; HYPOXIC-ISCHEMIC IMPAIRMENT; NOC/OFQ-INDUCED IMPAIRMENT; BRAIN-INJURY; NITRIC-OXIDE; INDUCED CONTRACTION; TYROSINE KINASE; PIAL ARTERY; RAT-BRAIN	Previous studies in piglets have shown that the generation of oxygen free radicals (O-2(-)) following traumatic brain injury and hypoxia/ischemia contribute to the reversal of N-methyl-D-aspartate (NMDA)-induced pial artery dilation to vasoconstriction. This study determined the contribution of protein tyrosine kinase (PTK) and mitogen-activated protein (MAPK) activation to impairment of NMDA cerebrovasodilation by O-2(-) in piglets equipped with a closed window. Exposure of the cerebral cortex to a xanthine oxidase O-2(-) generating system (OX) reversed NMDA (10(-8), 10(-6) M) dilation to vasoconstriction but such impairment was partially prevented by the PTK inhibitor, genistein, the MAPK (ERK isoform) inhibitor, U0126, and the MAPK (p38 isoform) inhibitor, SB203580 (9 +/- 1 and 15 +/- 1 vs. - 1 +/- 1 and - 1 +/- 1 vs. 5 +/- 1 and 9 +/- 1 % for sham control, OX and OX in the presence of genistein, respectively). However, the p38 MAPK inhibitor, SB203580, prevented NMDA dilator impairment significantly less than the ERK MAPK inhibitor, U0126. Similar results were obtained for glutamate. These data show that PTK and MAPK activation by the presence of O-2(-) contributes to the impairment of NMDA dilation. Furthermore, these data indicate a differential role for ERK and p38 MAPK activation in impairment of NMDA dilation by O-2(-) in the brain. (C) 2003 Elsevier B.V. All rights reserved.	Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia, 3400 Spruce St, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu					Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2002, PEDIATR RES, V51, P586, DOI 10.1203/00006450-200205000-00007; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 2001, J NEUROTRAUM, V18, P615, DOI 10.1089/089771501750291855; Armstead WM, 2000, BRAIN RES, V868, P48, DOI 10.1016/S0006-8993(00)02262-9; Armstead WM, 2000, AM J PHYSIOL-HEART C, V279, pH2678, DOI 10.1152/ajpheart.2000.279.6.H2678; ARMSTEAD WM, 2000, AM J PHYSIOL, pH2188; Bari F, 1998, BRAIN RES, V780, P237, DOI 10.1016/S0006-8993(97)01196-7; Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H; BECKMAN JS, 1994, ANN NY ACAD SCI, V738, P69; Bolla M, 2002, J VASC RES, V39, P353, DOI 10.1159/000065547; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Busija DW, 1996, AM J PHYSIOL-HEART C, V270, pH1225, DOI 10.1152/ajpheart.1996.270.4.H1225; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; FARACI FM, 1993, CIRC RES, V72, P476, DOI 10.1161/01.RES.72.2.476; Hayashi T, 2000, NEUROSCI LETT, V284, P195, DOI 10.1016/S0304-3940(00)01024-7; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1089, DOI 10.1097/00004647-200007000-00008; Jagolino AL, 2003, AM J PHYSIOL-HEART C, V284, pH101, DOI 10.1152/ajpheart.00457.2002; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; Kim CJ, 1998, J NEUROSURG, V89, P289, DOI 10.3171/jns.1998.89.2.0289; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; Kulkarni M, 2000, STROKE, V31, P1990, DOI 10.1161/01.STR.31.8.1990; Laher I, 2001, J CEREBR BLOOD F MET, V21, P887, DOI 10.1097/00004647-200108000-00001; LEFFLER CW, 1990, AM J PHYSIOL, V259, pH1230, DOI 10.1152/ajpheart.1990.259.4.H1230; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; McKeon RJ, 1997, EXP NEUROL, V148, P558, DOI 10.1006/exnr.1997.6698; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; NAMURA S, 1999, P NATL ACAD SCI USA, V98, P11568; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Philip S, 2003, NEUROREPORT, V14, P201, DOI 10.1097/00001756-200302100-00008; ROSS J, IN PRESS AM J PHYSL; Shin HK, 2002, J CEREBR BLOOD F MET, V22, P869, DOI 10.1097/00004647-200207000-00012; Veltkamp R, 1999, STROKE, V30, P148, DOI 10.1161/01.STR.30.1.148; WATSON DB, 1984, J NEUROCHEM, V41, P268; WEI EP, 1985, AM J PHYSIOL, V248, pH157, DOI 10.1152/ajpheart.1985.248.2.H157; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781	40	11	11	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 25	2003	979	1-2					98	103		10.1016/S0006-8993(03)02879-8			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705LT	WOS:000184397100013	12850576				2022-02-06	
J	Alves, OL; Bullock, R				Alves, OL; Bullock, R			"Basal durotomy" to prevent massive intra-operative traumatic brain swelling	ACTA NEUROCHIRURGICA			English	Article						basal durotomy; intra-operative brain swelling; traumatic brain injury		Objective. Massive intraoperative swelling (IOS) is a potential complication of intracranial surgery for traumatic hematomas. We present a novel design of dural opening to minimize the risks of IOS. Methods. Over the last eight years, we have used and evaluated a "reversed U-shaped" durotomy incision, which leaves the dura intact in the parasagittal region. Accordingly, the dura should be opened initially over the fronto-basal eminence of the frontal lobe anterior to the middle meningeal artery and sylvian region. The incision is then carried across the middle meningeal into the temporal region. Additional slit incisions may be made, as needed, around the circumference of the craniotomy in order to obtain sufficient access to remove a subdural hematoma. Results. We have employed this technique in 220 trauma craniotomies without any case of uncontrolled IOS. In all patients a complete dural closure was obtained. Conclusion. When IOS is suspected, basal durotomy proved to be an excellent technique to prevent it, without compromising the total evacuation of the traumatic intracranial hematoma.	Ctr Hosp Vila Nova Gaia, Serv Neurocirurgia, P-4050583 Oporto, Portugal; Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA		Alves, OL (corresponding author), Ctr Hosp Vila Nova Gaia, Serv Neurocirurgia, Rua Serpa Pinto 172,3 Andar, P-4050583 Oporto, Portugal.	oscar.luis.alves@clix.pt					BULLOCK R, 1990, HDB CLIN NEUROLOGY, V57, P249; Bundgaard H, 1998, ACT NEUR S, V71, P276; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MARMAROU A, 1993, INTRACRANIAL PRESSUR, V8, P5525; MARSHALL LF, 1983, NEUROSURGERY, V13, P412, DOI 10.1227/00006123-198310000-00011; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289	8	11	15	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2003	145	7					583	586		10.1007/s00701-003-0055-9			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	718NX	WOS:000185154200018	12910402				2022-02-06	
J	LoBello, SC; Underhil, AT; Valentine, PV; Stroud, TP; Bartolucci, AA; Fine, PR				LoBello, SC; Underhil, AT; Valentine, PV; Stroud, TP; Bartolucci, AA; Fine, PR			Social integration and life and family satisfaction in survivors of injury at 5 years postinjury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						CHART; disability; family satisfaction; FSS; injury; life satisfaction; LSI-A; social integration	TRAUMATIC BRAIN-INJURIES; SPINAL-CORD INJURY; HANDICAP; IMPAIRMENT; DISABILITY	This study assessed the relationship of social integration (SI) to life satisfaction and family satisfaction among survivors 5 years after injury. Thirty-four matched pairs of injured patients were interviewed by telephone 60 months after initial discharge from the acute care setting. Respondents were matched according to sex, race, education, injury severity, and employment status before comparing high and low socially integrated persons on measures of family and life satisfaction. High and low SI groups were formed based on the Craig Handicap Assessment and Reporting Technique (CHART) SI Scale. The former consisted of patients scoring 100; the latter consisted of patients scoring 50 or less. Analyses of covariance, with age and injury type as covariates, were used to test for group differences. The high and low SI groups differed on both the life and the family satisfaction measures, with the high SI group reporting greater life and family satisfaction.	Auburn Univ, Montgomery, AL 36117 USA; Univ Alabama Birmingham, Sch Med, Injury Control Res Ctr, Birmingham, AL USA; Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL USA		LoBello, SC (corresponding author), POB 244023, Montgomery, AL 36124 USA.	lobello@strudel.aum.edu			ODCDC CDC HHS [R49/CCR403641] Funding Source: Medline		ADAMS DL, 1969, J GERONTOL, V24, P470, DOI 10.1093/geronj/24.4.470; AMERIKANER M, 1994, J COUNS DEV, V72, P614, DOI 10.1002/j.1556-6676.1994.tb01691.x; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Carruth AK, 1997, NURS RES, V46, P93, DOI 10.1097/00006199-199703000-00006; COLLETTE J, 1984, J GERONTOL, V39, P243, DOI 10.1093/geronj/39.2.243; *COMM INJ SCAL AM, 1985, ABBR INJ SCAL 1985 R; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; KENNEDY GE, 1989, PERCEPT MOTOR SKILL, V68, P129, DOI 10.2466/pms.1989.68.1.129; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; LOHMANN N, 1977, J GERONTOL, V32, P73, DOI 10.1093/geronj/32.1.73; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; NOREAU L, 1995, SPORTS MED, V20, P226, DOI 10.2165/00007256-199520040-00003; OLSON DH, 1982, FAMILY SATISFACTION; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; RAO VN, 1982, INT J AGING HUM DEV, V14, P55, DOI 10.2190/DWM4-E05K-CNTD-XNAA; VIITANEN M, 1988, SCAND J REHABIL MED, V20, P17; Vogel LC, 1998, ARCH PHYS MED REHAB, V79, P1496, DOI 10.1016/S0003-9993(98)90409-9; Wallace KA, 2002, EDUC PSYCHOL MEAS, V62, P674, DOI 10.1177/001316402128775085; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	26	11	13	0	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.	JUL-AUG	2003	40	4					293	299		10.1682/JRRD.2003.07.0293			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	712CU	WOS:000184779800002	15074440	Bronze, Green Submitted			2022-02-06	
J	Chua, KSG; Kong, KH				Chua, KSG; Kong, KH			Acquired heterotopic ossification in the settings of cerebral anoxia and alternative therapy: two cases	BRAIN INJURY			English	Article								Acquired Heterotopic Ossification (HO) has been well described in the literature as a recognized complication following spinal cord injury, traumatic brain injury and joint arthroplasty. Commonly, large proximal limb joints are affected. The underlying mechanisms for ectopic bone formation remain poorly elucidated. Post-stroke hemiplegia as a cause of neurogenic HO is rare, and no published reports of HO occurring after anoxic brain injury in adults have been documented. This study reports two unusual cases of acquired HO: (1) Polyarticular HO involving the ankle joint in a 24-year-old Chinese female who suffered severe anoxic encephalopathy following near drowning which resulted in persistent vegetative state; and (2) Elbow HO in chronic post-stroke hemiplegia occurring as a complication of alternative therapy following repeated forceful manipulation by a traditional practitioner in a 46 year-old male.	Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 569766, Singapore		Chua, KSG (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17,Ang Mo Kio Ave 9, Singapore 569766, Singapore.	karen_chua@ttsh.com.sg					BARON M, 1983, J RHEUMATOL, V10, P961; BOHANNON RW, 1987, PHYS THER, V67, P216; Condon F, 1998, J SPINAL DISORD, V11, P448; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Hagan C., 1982, COGNITIVE REHABILITA, P131; HAJEK VE, 1987, ARCH PHYS MED REHAB, V68, P313; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Kimura Masahiko, 1995, No To Hattatsu, V27, P487; MICHELSSON J, 1993, CLIN ORTHOP RELAT R, V176, P265; SHAH S, 1999, CLIN REHABIL, V13, P141; Stover SL, 1986, MANAGEMENT SPINAL CO, P284; Subbarao J V, 1999, J Spinal Cord Med, V22, P273; SUBBARAO JV, 1990, AM J PHYS MED REHAB, V69, P88, DOI 10.1097/00002060-199004000-00008; Taly AB, 2001, NEUROL INDIA, V49, P37	15	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2003	17	6					535	544		10.1080/0269905021000010104			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	672GG	WOS:000182512400007	12745708				2022-02-06	
J	Petrov, T; Rafols, JA; Alousi, SS; Kupsky, WJ; Johnson, R; Shah, J; Shah, A; Watson, C				Petrov, T; Rafols, JA; Alousi, SS; Kupsky, WJ; Johnson, R; Shah, J; Shah, A; Watson, C			Cellular compartmentalization of phosphorylated eIF2 alpha and neuronal NOS in human temporal lobe epilepsy with hippocampal sclerosis	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						hippocampus; neurons; glia; immunocytochemistry; NADPH-D	BRAIN ISCHEMIA; NADPH-DIAPHORASE; SYNAPTIC REORGANIZATION; FEBRILE CONVULSIONS; MESIAL STRUCTURES; INTERNEURON LOSS; GRADING SYSTEM; IMMUNOREACTIVITY; REPERFUSION; LOCALIZATION	Hippocampal sclerosis (HS) is the most common neuropathologic finding in patients with medically refractory temporal lobe epilepsy (TLE). The mechanisms resulting in neuronal injury and cell loss in HS are incompletely understood, but inhibition of protein synthesis may play a pivotal role in these processes. This study examined the relationships between two molecules known to be involved in reduced protein synthesis in animals subjected to traumatic brain injury. Translational initiation of protein synthesis is inhibited when 2alpha (eIF2alpha) is phosphorylated. Recently, nitric oxide (NO) has been shown to reduce protein synthesis by inducing phosphorylation of eIF2alpha. We performed immunocytochemistry for eIF2alpha(P) and histochemistry (NADPH-D reaction) for nitric oxide synthase (NOS) to determine the distribution of these molecules in hippocampi removed from patients undergoing anterior temporal lobectomy (ATL) for medically intractable TLE due to HS. The greatest number of eIF2alpha(P) positive cells was in the CA1 sector of the hippocampus, followed by the hilus of the dentate gyrus. NADPH-D positive neurons were observed most often in the hilus. Labeling in both instances involved neuronal cell body cytoplasm and varicose processes. Combination of both staining procedures revealed close relationships between differentially labeled neurons within the hilus. The results suggest that NO participates in the phosphorylation of eIF2alpha since we demonstrated that nNOS processes are closely related to eIF2alpha(P) positive cells. This may occur through activation of kinases such as PERK, which was recently revealed. In human, TLE protein synthesis inhibition may occur at the translational level since the eIF2alpha(P) labeling is cytoplasmic. Protein synthesis inhibition may contribute to neuronal cell injury and death in HS. (C) 2003 Elsevier Science B.V All rights reserved.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA		Petrov, T (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.	tpetrov@med.wayne.edu		Shah, Aashit/0000-0001-7370-3004	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 39860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		Atkins CM, 1999, J NEUROSCI, V19, P7241, DOI 10.1523/JNEUROSCI.19-17-07241.1999; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Babb TL, 1987, SURGICAL TREATMENT E, P511; Bruton C., 1988, NEUROPATHOLOGY TEMPO; CENDES F, 1993, ANN NEUROL, V34, P795, DOI 10.1002/ana.410340607; CENDES F, 1993, NEUROLOGY, V43, P1083, DOI 10.1212/WNL.43.6.1083; Davies KG, 1996, EPILEPSY RES, V24, P119, DOI 10.1016/0920-1211(96)00008-3; de Lanerolle NC, 1998, EUR J NEUROSCI, V10, P1687, DOI 10.1046/j.1460-9568.1998.00171.x; DeGracia DJ, 1997, J CEREBR BLOOD F MET, V17, P1291, DOI 10.1097/00004647-199712000-00004; DELANEROLLE NC, 1988, EPILEPSIA, V29, P674; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Downen M, 1999, J NEUROPATH EXP NEUR, V58, P12, DOI 10.1097/00005072-199901000-00002; Doyle CA, 1997, NEUROSCIENCE, V76, P387, DOI 10.1016/S0306-4522(96)00297-7; FALCONER MA, 1964, ARCH NEUROL-CHICAGO, V10, P233, DOI 10.1001/archneur.1964.00460150003001; FALCONER MA, 1959, BRAIN, V82, P483, DOI 10.1093/brain/82.4.483; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Goldstein EN, 1999, ACTA NEUROPATHOL, V98, P493, DOI 10.1007/s004010051115; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; HOUSER CR, 1990, J NEUROSCI, V10, P267; Jhamandas JH, 1996, NEUROREPORT, V7, P2843, DOI 10.1097/00001756-199611250-00006; JOHANSEN FF, 1987, ACTA NEUROPATHOL, V73, P110, DOI 10.1007/BF00693775; Kim YM, 1998, MOL MED, V4, P179, DOI 10.1007/BF03401915; Kumar R, 2001, J NEUROCHEM, V77, P1418, DOI 10.1046/j.1471-4159.2001.00387.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; MATHERN GW, 1995, J NEUROSURG, V82, P211, DOI 10.3171/jns.1995.82.2.0211; Mathern GW, 1998, J NEUROPATH EXP NEUR, V57, P615, DOI 10.1097/00005072-199806000-00008; MATHERN GW, 1995, J NEUROSCI, V15, P3990; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; McNaught KSP, 1998, J NEUROCHEM, V70, P1541; Norris PJ, 1996, MOL BRAIN RES, V41, P36, DOI 10.1016/0169-328X(96)00064-2; PETROV T, 1995, NEUROPHARMACOLOGY, V34, P509, DOI 10.1016/0028-3908(95)00002-N; Petrov T, 2001, J NEUROTRAUM, V18, P799, DOI 10.1089/089771501316919166; Rafols J. A., 2001, Society for Neuroscience Abstracts, V27, P568; RAFOLS JA, 1995, ACTA NEUROPATHOL, V90, P17; RAFOLS JA, 1999, J CEREB BLOOD FLO S1, V19, pS511; ROBBINS RJ, 1991, ANN NEUROL, V29, P325, DOI 10.1002/ana.410290316; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; SAGAR HJ, 1987, ANN NEUROL, V22, P334, DOI 10.1002/ana.410220309; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Tasch E, 1999, ANN NEUROL, V45, P568, DOI 10.1002/1531-8249(199905)45:5<568::AID-ANA4>3.0.CO;2-P; Theodore WH, 1999, NEUROLOGY, V52, P132, DOI 10.1212/WNL.52.1.132; TRENERRY MR, 1993, EPILEPSY RES, V15, P247, DOI 10.1016/0920-1211(93)90062-C; UNDERWOOD BD, IN PRESS J NEUROTRAU; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Watson C, 1996, J EPILEPSY, V9, P56, DOI 10.1016/0896-6974(95)00060-7; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521, DOI 10.1001/archneur.1997.00550240071015; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P67, DOI 10.1001/archneur.1997.00550130049015; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; WYLER AR, 1992, J EPILEPSY, V5, P220, DOI 10.1016/S0896-6974(05)80120-3; Yasuda H, 2001, EPILEPSIA, V42, P13, DOI 10.1046/j.1528-1157.2001.083032.x	55	11	11	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAY 15	2003	209	1-2					31	39		10.1016/S0022-510X(02)00461-6			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672VN	WOS:000182543800006	12686399				2022-02-06	
J	Hart, T; Bogner, JA; Whyte, J; Polansky, M				Hart, T; Bogner, JA; Whyte, J; Polansky, M			Attribution of blame in accidental and violence-related traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article; Proceedings Paper	29th Annual Meeting of the International-Neuropsychological-Society	FEB 14-17, 2001	CHICAGO, ILLINOIS	Int Neuropsychol Soc			DISABILITY RATING-SCALE; SPINAL-CORD INJURY; HEAD-INJURY; SELF-BLAME; ADJUSTMENT	Objective: To study reliability and validity of blame attribution following acute moderate to severe traumatic brain injury (TBI) caused by violence versus accident. Study Design: Prospective study with test-retest component, comparing groups with violent versus accidental injuries as determined by self-report and chart review. Participants: Fifty-seven persons in acute rehabilitation for moderate to severe TBI. Measure: Eight-item Blame Attribution Questionnaire. Results: Blame attribution was reliable, even for participants with severe TBI. Violence and accident groups apportioned different amounts of blame to other people; concern with cause of injury and degree of self-blame showed less striking differences. Conclusions: Blame of others, which may increase risk of adverse psychological outcome, is strongest in those with violence-related TBI. Self-blame is not as strongly related to external circumstances and could signal a constructive coping mechanism.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Med Coll Penn & Hahnemann Univ, Sch Publ Hlth, Philadelphia, PA USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.		Bogner, Jennifer/E-2773-2011	Whyte, John/0000-0002-4381-1474			ATHELSTAN GT, 1979, REHABIL COUNS BULL, V22, P311; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; BULMAN RJ, 1977, J PERS SOC PSYCHOL, V35, P351, DOI 10.1037/0022-3514.35.5.351; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; Delahanty DL, 1997, J CONSULT CLIN PSYCH, V65, P560, DOI 10.1037/0022-006X.65.4.560; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Hagen C., 1972, LEVELS COGNITIVE FUN; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; HEINEMANN AW, 1988, REHABIL PSYCHOL, V33, P195, DOI 10.1037//0090-5550.33.4.195; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REIDY K, 1994, ARCH PHYS MED REHAB, V75, P837, DOI 10.1016/0003-9993(94)90106-6; SCHULZ R, 1985, J PERS SOC PSYCHOL, V48, P1162, DOI 10.1037/0022-3514.48.5.1162; SHOLOMSKAS DE, 1990, J APPL SOC PSYCHOL, V20, P548, DOI 10.1111/j.1559-1816.1990.tb00427.x; VANDENBOUT J, 1988, J CLIN PSYCHOL, V44, P17, DOI 10.1002/1097-4679(198801)44:1<17::AID-JCLP2270440104>3.0.CO;2-J; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774	17	11	11	0	5	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2003	48	2					86	92		10.1037/0090-5550.48.2.86			7	Psychology, Clinical; Rehabilitation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology; Rehabilitation	674FV	WOS:000182627500003					2022-02-06	
J	Little, DC; Vermillion, JM; Dikis, EJ; Little, RJ; Custer, MD; Cooney, DR				Little, DC; Vermillion, JM; Dikis, EJ; Little, RJ; Custer, MD; Cooney, DR			Life on the farm - Children at risk	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	34th Annual Meeting of the Canadian-Association-of-Paediatric-Surgeons	SEP 19-22, 2002	VANCOUVER, CANADA	Canadian Assoc Paediat Surgeons		farm injuries; agricultural injuries	UNITED-STATES; INJURIES; ACCIDENTS; ADOLESCENTS; DEATHS	Background: More than 1 million children live, play, and work on farms, surrounded by animals and machinery. This symbiotic relationship between work and home exposes children to unique risks. Methods: Children presenting with a farm-related injury (November 1994 to August 2001, 82 months) were included. Trauma registry parameters included injury severity score (ISS); Glascow Coma Scale (GCS); time to presentation; season and day of injury; emergency room, intensive care unit, and total length of stay type; and mechanism of injury; and operations. Results: A total of 1,832 pediatric trauma patients were evaluated. Ninety-four children were identified with farm-related injuries. Mean age was 10.75 years. Mean ISS was 7.38. Three children died. Four children wore protective equipment. Forty-four percent of injuries occurred during summer, 31% during spring, and 55% on weekends. Average time to initial presentation was 39 minutes. A total of 177 minutes elapsed before transfer to regional trauma center. Seventy-two children required admission. LOS was 0 to 28 days, mean, 2.76 days. Twenty-six children (28%) required operations. Injuries included dislocations/fractures (52%), lacerations/avulsions (38%), concussions (31%), contusions (30%), and burns (14%). Mechanism included animals (41%), falls (34%), motor vehicles (28%), all-terrain vehicles (20%), and firearms (4%). Conclusions: Farm injuries occur most commonly during weekends, summer, and spring months, resulting in significant morbidity. Most injuries required hospitalization. Unless unstable, initial transfer to a regional pediatric trauma center should result in the most cost-effective, prompt, and highest quality of care.	Texas A&M Univ Syst, Hlth Sci Ctr, Scott & White Mem Hosp, Temple, TX USA; Scott Sherwood & Brindley Fdn, Temple, TX USA		Little, DC (corresponding author), Dept Gen Surg, 2401 S 31st, Temple, TX 76508 USA.						*AM AC PED COMM AC, 1998, PEDIATRICS, V81, P902; BUSHY A, 1991, RURAL NURSING, V1; Byard RW, 1999, AM J FOREN MED PATH, V20, P73, DOI 10.1097/00000433-199903000-00018; CAMERON D, 1992, BRIT MED J, V305, P23, DOI 10.1136/bmj.305.6844.23; CASTILLO DN, 1994, AM J PUBLIC HEALTH, V84, P646, DOI 10.2105/AJPH.84.4.646; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P57; COGBILL TH, 1985, PEDIATRICS, V76, P562; *DEP LAB, 1990, CHILD LAB B, V102; DOLAN MA, 1989, PEDIATRICS, V84, P694; DOYLE Y, 1989, J SOC OCCUP MED, V39, P35; DUNN KA, 1993, AM J DIS CHILD, V147, P1044, DOI 10.1001/archpedi.1993.02160340030008; Gerberich SG, 1993, REGIONAL RURAL INJUR; GERBERICH SG, 1991, OLMSTED AGR TRAUMA S; Lee TY, 1996, J OCCUP ENVIRON MED, V38, P782, DOI 10.1097/00043764-199608000-00014; Meiers S, 2001, J PEDIATR SURG, V36, P726, DOI 10.1053/jpsu.2001.22946; MERCHANT JA, 1991, OCCUP MED, V6, P529; *NAT I OCC SAF HLT, 1996, NIOSH FACTS AGR SAF; *NAT SAF COUNC, 1996, ACC FACTS; *NAT SAF COUNC, 1991, ACC FACTS; *NAT SAF COUNC, 1994, ACC FACTS; PICKETT W, 1995, ACCIDENT ANAL PREV, V27, P425, DOI 10.1016/0001-4575(94)00080-6; PURSCHWITZ MA, 1990, AM J IND MED, V18, P179, DOI 10.1002/ajim.4700180210; Reed D. B., 1998, Journal of Agricultural Safety and Health, P129; Rivara F P, 1997, Inj Prev, V3, P190, DOI 10.1136/ip.3.3.190; RIVARA FP, 1985, PEDIATRICS, V76, P567; SWANSON JA, 1987, AM J DIS CHILD, V141, P1276, DOI 10.1001/archpedi.1987.04460120038029; TEVIS C, 1992, CHILDH AGR INJ PREV; Zietlow SP, 1999, AM SURGEON, V65, P693	28	11	11	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAY	2003	38	5					804	807		10.1016/jpsu.2003.50171			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Surgery	676EK	WOS:000182738300035	12720198				2022-02-06	
J	Valentin, A; Lang, T; Karnik, R; Ammerer, HP; Ploder, J; Slany, J				Valentin, A; Lang, T; Karnik, R; Ammerer, HP; Ploder, J; Slany, J			Intracranial pressure monitoring and case mix-adjusted mortality in intracranial hemorrhage	CRITICAL CARE MEDICINE			English	Article						intracranial hemorrhage; intracranial pressure; intracranial pressure/diagnosis; outcome assessment; hospital mortality; risk adjustment	TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; CARE; MANAGEMENT; PERFORMANCE; PREDICTION; GUIDELINES; QUALITY; MODELS; SCORE	Objective: Intracranial pressure (ICP) monitoring is frequently used in intensive care treatment of patients with intracranial hemorrhage. Data demonstrating an improved outcome from this intervention are lacking. We analyzed standardized mortality ratios in patients with and without ICP monitoring to determine its efficacy. Design; A nonrandomized study of case records of consecutively admitted intensive care unit (ICU) patients with intracranial hemorrhage. Setting: General and medical ICU of a 900-bed tertiary-care hospital. Patients: A total of 225 patients with intracranial hemorrhage (mainly nontraumatic) admitted consecutively between April 1997 and March 2000. Measurements: Simplified Acute Physiology Score (SAPS) II, diagnosis, age, sex, use of ICP monitoring, and in-hospital mortality rates were collected from the hospital's ICU database. Expected mortality was provided by means of SAPS II. Standardized mortality ratios were calculated and compared in 119 patients with ICP monitoring and 106 patients without ICP monitoring. Main Results: The case mix-adjusted hospital mortality in the group with ICP monitoring was in the expected range (standardized mortality ratio, 1.09 [95% confidence interval (Cl), 0.87-1.31]). Patients without ICP monitoring had a significantly higher standardized mortality ratio than expected (1.26 [95% Cl, 1.06-1.46]). Conclusions: A beneficial effect of ICP monitoring in patients with intracranial hemorrhage may be reflected in an improved standardized mortality ratio.	Univ Vienna, Dept Med 2, A-1010 Vienna, Austria; Univ Vienna, Dept Neurosurg, A-1010 Vienna, Austria; Univ Vienna, KA Rudolfstiftung, A-1010 Vienna, Austria; Univ Vienna, Dept Med Stat, A-1010 Vienna, Austria		Valentin, A (corresponding author), Univ Vienna, Dept Med 2, Garnisongasse 13, A-1010 Vienna, Austria.			Valentin, Andreas/0000-0001-7443-3595			Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Chesnut R M, 1995, New Horiz, V3, P581; HOSMER DW, 1995, STAT MED, V14, P2161, DOI 10.1002/sim.4780141909; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lane PL, 2000, CAN J SURG, V43, P442; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Metnitz PGH, 1999, CRIT CARE MED, V27, P1486, DOI 10.1097/00003246-199908000-00014; Metnitz PGH, 2000, INTENS CARE MED, V26, P1466, DOI 10.1007/s001340000638; Moreno R, 1998, INTENS CARE MED, V24, P40, DOI 10.1007/s001340050513; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825	13	11	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	MAY	2003	31	5					1539	1542		10.1097/01.CCM.0000065270.53951.9E			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	680ME	WOS:000182981300037	12771630				2022-02-06	
J	Ng, KC; Moochhala, SM; Md, S; Yap, EL; Low, SY; Lu, J				Ng, KC; Moochhala, SM; Md, S; Yap, EL; Low, SY; Lu, J			Preservation of neurological functions by nitric oxide synthase inhibitors following hemorrhagic shock	NEUROPHARMACOLOGY			English	Article						iNOS inhibitor; hemorrhagic shock; MABP; neurological functions; rat	TRAUMATIC BRAIN INJURY; CEREBRAL-ISCHEMIA; L-CANAVANINE; L-ARGININE; RAT; AMINOGUANIDINE; RESUSCITATION; DAMAGE; CELLS	Excessive production of nitric oxide (NO) as result of inducible nitric oxide synthase (iNOS) induction has been implicated in the pathophysiology of hemorrhagic shock. Our aim was to study the effect of iNOS inhibitors, L-canavanine (50mg/kg) and N-G-nitro- L-arginine methyl (L-NAME, 10mg/kg) and a resuscitation fluid, lactated Ringer's solution (3 time,, amount of blood lost), on survivability and neurological functions in rodents subjected to hemorrhagic shock. rat,, had significantly higher survival rates (75%) compared to L-NAME-treated rats (44%) and lactated Ringer's solution-treated rats (40%), 72 h following hemorrhagic shock. A marked increase in the neurological performance was observed in rats over the three-day period. Histological examinations also showed a reduction of degenerating neurons in rats when compared to L-NAME, lactated Ringer's solution- or un-treated rats. Mean arterial blood pressure (MABP), nitrate/nitrite level, glutamic oxalacetic transaminase (GOT) level, and blood gases were also significantly improved in L-canavanine-treated rats when compared to those of L-NAME-, lactated Ringer's solution- or un-treated rats. In conclusion. rats were able to improve survivability, attenuate organ damage, and improve neurological outcome when compared to other treatment groups. It is therefore suggest that L-canavanine may be beneficial as a potentially useful therapeutic agent in treating neurological deficit as a result of hemorrhagic shock. (C) 2003 Elsevier Science Ltd. All rights reserved.	NUS, Def Sci & Technol Agcy, Med Res Inst Chem Def, Singapore 117579, Singapore; Natl Univ Singapore, Dept Pharmacol, Singapore 117579, Singapore		Lu, J (corresponding author), NUS, Def Sci & Technol Agcy, Med Res Inst Chem Def, 18 Med Dr,01-06,MD2, Singapore 117579, Singapore.			MOOCHHALA, SHABBIR/0000-0003-4521-3192			Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; Cash D, 2001, BRAIN RES, V905, P91, DOI 10.1016/S0006-8993(01)02508-2; Cobbs CS, 1997, BRAIN RES, V751, P336, DOI 10.1016/S0006-8993(96)01429-1; DALKARA T, 1994, BRAIN PATHOL, V4, P49; DAWSON TM, 1994, J NEUROSCI, V14, P5147; Harbrecht BG, 1997, SHOCK, V8, P415, DOI 10.1097/00024382-199712000-00004; Hua TC, 1999, SHOCK, V11, P51, DOI 10.1097/00024382-199901000-00008; Iadecola C, 1995, AM J PHYSIOL, V268, P286; JANIGRO D, 1994, CIRC RES, V75, P528, DOI 10.1161/01.RES.75.3.528; Kawase M, 1996, BRAIN RES, V738, P319, DOI 10.1016/S0006-8993(96)00924-9; Kilbourn RG, 1997, SHOCK, V7, P235, DOI 10.1097/00024382-199704000-00001; Kline JA, 1999, SHOCK, V12, P454, DOI 10.1097/00024382-199912000-00007; KOBARI M, 1994, BRAIN RES, V667, P255, DOI 10.1016/0006-8993(94)91503-2; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; Liaudet L, 1996, CLIN SCI, V90, P369, DOI 10.1042/cs0900369; MONEADA S, 1991, PHARMACOL REV, V43, P109; ROBERT GK, 1997, SHOCK, V4, P235; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SULLIVAN SJ, 1994, BRAIN INJURY, V8, P613, DOI 10.3109/02699059409151014; SZABO C, 1994, SHOCK, V2, P145, DOI 10.1097/00024382-199408000-00011; Szabo C, 1995, New Horiz, V3, P2; UMANS JG, 1992, EUR J PHARMACOL, V210, P343, DOI 10.1016/0014-2999(92)90425-4; Wei G, 1999, BBA-MOL BASIS DIS, V1455, P23, DOI 10.1016/S0925-4439(99)00051-4; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; Zingarelli B, 1997, EUR J PHARMACOL, V338, P55, DOI 10.1016/S0014-2999(97)01325-3	26	11	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908			NEUROPHARMACOLOGY	Neuropharmacology	FEB	2003	44	2					244	252		10.1016/S0028-3908(02)00368-4			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	647DL	WOS:000181077100011	12623223				2022-02-06	
J	Krieger, D; Hansen, K; McDermott, C; Matthews, R; Mitchell, R; Bollegala, N; Bhalerao, S				Krieger, D; Hansen, K; McDermott, C; Matthews, R; Mitchell, R; Bollegala, N; Bhalerao, S			Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury	NEUROREHABILITATION			English	Article						delirium; brain injury; neuroleptic; loxapine; olanzapine	D-2 RECEPTOR OCCUPANCY; SCHIZOPHRENIA; 5-HT2	The use of typical neuroleptics has always been the mainstay of treatment for delirium following traumatic brain injury (TBI). Given the recent application of atypical neuroleptics to various psychiatric conditions formerly treated with typical neuroleptics, one questions whether this new class of drugs is superior to its predecessor in treating delirium post-TBI. We present a case of one patient with TBI-induced delirium where in fact the use of the typical mid-potency neuroleptic, loxapine, appeared to have a better clinical effect over the atypical neuroleptic, olanzapine.	St Michaels Hosp, Med Psychiat Serv, Toronto, ON M5B 1W8, Canada; Univ Alberta, Sch Med, Edmonton, AB, Canada; Univ Toronto, Sch Med, Toronto, ON, Canada		Bhalerao, S (corresponding author), St Michaels Hosp, Med Psychiat Serv, 30 Bond St,17-046 Victoria Wing, Toronto, ON M5B 1W8, Canada.			McDermott, Colleen/0000-0002-9588-6574			American Psychiatric Association, 1994, DIAGN CRIT DSM 4; FENTON M, 2000, COCHRANE LIB, P3; Flacker JM, 1999, J GERONTOL A-BIOL, V54, pB239, DOI 10.1093/gerona/54.6.B239; Kapur S, 1999, AM J PSYCHIAT, V156, P286; Kapur S, 1997, AM J PSYCHIAT, V154, P1525, DOI 10.1176/ajp.154.11.1525; Kapur S, 1998, AM J PSYCHIAT, V155, P921, DOI 10.1176/ajp.155.7.921; Leshner AI, 1999, AM J PSYCHIAT, V156, P1; O'Keeffe ST, 1999, AGE AGEING, V28, P115, DOI 10.1093/ageing/28.2.115; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; RUMMANS TA, 1995, MAYO CLIN PROC, V70, P989, DOI 10.4065/70.10.989; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; SILVER JM, 1992, NEUROPSYCHIATRIC ASP; Silver JM., 1994, NEUROPSYCHIATRY TRAU	13	11	12	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2003	18	3					205	208					4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	733ZZ	WOS:000186031900004	14530585				2022-02-06	
J	Labi, MLC; Brentjens, M; Coad, ML; Flynn, WJ; Zielezny, M				Labi, MLC; Brentjens, M; Coad, ML; Flynn, WJ; Zielezny, M			Development of a longitudinal study of complications and functional outcomes after traumatic brain injury	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; SECONDARY INSULTS; REHABILITATION; PREVENTION; HYPOTENSION; DEPRESSION; ADULTS; DAMAGE; ABUSE; TBI	Primary objective: To create a longitudinal database of patients with moderate and severe traumatic brain injury. Research design: A prospective study design was used to collect data pertaining to demographics, acute and post-acute management, complications, resource utilization and functional outcomes. Methods and procedures: Data were collected on 233 patients with a Glasgow Coma Score of 12 or less, admitted to a Level 1 Trauma Centre within 24 hours of injury and continued through post-hospitalization follow-up. Main outcomes and results: The mean age was 37.7 years, 70% were males, 54% were motor vehicle related accidents, and 21% died. Of the 185 survivors, 23% were discharged directly home from acute hospital care and 74% required inpatient rehabilitation. At hospital discharge, 76% had Rancho Los Amigos Scores of VII or higher; 81% had no or only mild verbal communication deficits and 79% were able to ambulate. Conclusions: The study indicates that while it is difficult to predict functional outcomes for individual survivors of TBI in the early stages of acute care, they are often better than suspected at the time of injury.	SUNY Buffalo, Sch Biol & Med Sci, Buffalo, NY 14260 USA		Labi, MLC (corresponding author), Geisinger Med Ctr, 2 Rehab Lane, Danville, PA 17821 USA.	labi@acsu.buffalo.edu		Coad, Mary Lou/0000-0002-5791-9240	ODCDC CDC HHS [R04/CCR208541] Funding Source: Medline		Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bryant ET, 1993, J HEAD TRAUMA REHAB, V8, P15; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Davis CH, 1997, AM J PHYS MED REHAB, V76, P213, DOI 10.1097/00002060-199705000-00011; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; DePalma J A, 2001, Crit Care Nurs Q, V23, P42; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; EISENBERG HM, 1987, HEAD INJURY, P20; Eker C, 2000, BRAIN INJURY, V14, P605; ELOVIC E, 1996, MED REHABILITATION T, P1; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Hall KM, 1997, ARCH PHYS MED REHAB, V78, pS5, DOI 10.1016/S0003-9993(97)90149-0; Harris JKJ, 2001, BRAIN INJURY, V15, P223; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hoofien D, 2001, BRAIN INJURY, V15, P189; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1975, LANCET, V1, P480; JOHNSTON MV, 1994, AM J PHYS MED REHAB, V73, P296, DOI 10.1097/00002060-199407000-00014; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kraus Jess F., 1994, P3; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Mazaux JM, 2001, J REHABIL MED, V33, P99; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MERLI GJ, 1993, ARCH PHYS MED REHAB, V74, P1199; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; *NHIF PROF COUNC S, 1988, WHIT PAP; NIKAS D L, 1987, Critical Care Nursing Quarterly, V10, P19; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RIESENBERG D, 1989, JAMA-J AM MED ASSOC, V262, P943, DOI 10.1001/jama.262.7.943; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SAHGAL V, 1989, SCAND J REHABIL MED, V21, P71; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1996, INT TBI C NIAG ON TH; WATANABE TK, 2001, PHYS MED REHABILITAT, V15, P283; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533; [No title captured]	68	11	11	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2003	17	4					265	278		10.1080/0269905021000038410			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	660MP	WOS:000181837200001	12637180				2022-02-06	
J	Love, JM; Greve, KW; Sherwin, E; Mathias, C				Love, JM; Greve, KW; Sherwin, E; Mathias, C			Comparability of the standard WCST and WCST-64 in traumatic brain injury	APPLIED NEUROPSYCHOLOGY			English	Article						Wisconsin Card Sort-64 (Short Form); Wisconsin Card Sort (Standard form); traumatic brain injury	CARD-SORTING-TEST; TEST-PERFORMANCE; SHORT-FORM; SAMPLE	The aim of this study was to investigate the comparability of the Wisconsin Card Sorting Test short form (WCST-64) to the standard form in a clinical population with documented brain pathology: chronic severe traumatic brain injury (TBI). Participants were 61 patients at least I year after severe TBI living at a large residential rehabilitation facility. The WCST was administered in standard fashion with both the standard and 64-card versions scored. All derived scores with norms were examined. Results indicated that the WCST-64 scores were comparable to the standard version, and assigned impairment levels remained relatively stable. These results suggest the WCST-64 is a valid alternative to the standard version in chronic severe TBI.	Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; Georgia So Univ, Dept Psychol, Statesboro, GA 30460 USA		Greve, KW (corresponding author), Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu		Mathias, Charles/0000-0003-1902-673X			*AM PSYCH ASS, 1992, AM PSYCH, V0047, P01597, DOI DOI 10.1037/0003-066X.47.12.1597; Axelrod B, 1992, CLIN NEUROPSYCHOL, P27; Axelrod BN, 1997, ASSESSMENT, V4, P41, DOI 10.1177/107319119700400105; AXELROD BN, 1993, CLIN NEUROPSYCHOL, V7, P205, DOI 10.1080/13854049308401523; BONDI MW, 1993, NEUROPSYCHOLOGY, V7, P205; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; GREVE KW, 1991, GERONTOLOGY GERIATRI, V11, P57, DOI DOI 10.1300/J021v11n04_05; HAALAND KY, 1987, J GERONTOL, V42, P345, DOI 10.1093/geronj/42.3.345; HART R. P., 1988, CLIN NEUROPSYCHOL, V2, P49, DOI DOI 10.1080/13854048808520085; Heaton R., 2000, WISCONSIN CARD SORTI; Heaton R.K., 2000, WCST 64 COMPUTER VER; Heaton RK, 1981, MANUAL WISCONSIN CAR; Heaton RK, 1999, WISCONSIN CARD SORTI; HEATON SK, 1992, J CLIN EXPT NEUROPSY, V14, P63; Heaton SK, 1993, WISCONSIN CARD SORTI; Jenkins R. L., 1978, ALCOHOL TECHNICAL RE, V7, P76; Kirk R. E., 1999, STAT INTRO, V4th; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Osmon DC, 1996, ARCH CLIN NEUROPSYCH, V11, P541, DOI 10.1016/0887-6177(95)00048-8; Paolo AM, 1996, J CLIN EXP NEUROPSYC, V18, P892, DOI 10.1080/01688639608408310; Purdon SE, 2001, J PSYCHIATR NEUROSCI, V26, P253; Ramage A, 1999, BRAIN LANG, V66, P329, DOI 10.1006/brln.1999.2032; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; SILLANPAA MC, 1993, J CLIN EXP NEUROPSYC, V15, P68; Smith-Seemiller L, 1997, CLIN NEUROPSYCHOL, V11, P421, DOI 10.1080/13854049708400472; Stanford MS, 1997, PERS INDIV DIFFER, V23, P961, DOI 10.1016/S0191-8869(97)00120-7; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7	30	11	11	0	0	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2003	10	4					246	251		10.1207/s15324826an1004_7			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	780NT	WOS:000189388100007	14690806				2022-02-06	
J	Ikematsu, K; Tsuda, R; Kondo, T; Nakasono, I				Ikematsu, K; Tsuda, R; Kondo, T; Nakasono, I			The expression of excitatory amino acid transporter 2 in traumatic brain injury	FORENSIC SCIENCE INTERNATIONAL			English	Article						traumatic brain injury; excitatory amino acid transporter 2; human	GLUTAMATE TRANSPORTER; RELEASE; EAAT2	It is well recognized that glutamate is the major excitatory neurotransmitter, which is removed from the synaptic cleft by excitatory amino acid transporter 2 (EAAT2) located on the perisynaptic astrocytes and that neuronal death has been associated with an increased extracellular glutamate concentration. In this study, we have immunohistochemically demonstrated the expression of EAAT2 protein in the human brain after traumatic brain injury (TBI). The EAAT2 expression patterns can be divided into three types: continuous and highly extensive staining (E); continuous but sporadic staining (M); and sporadic pattern staining (S). In six of the nine short survival cases studied (I h to I day), continuous and highly extensive staining for EAAT2 (E type) was observed in the ipsilateral cerebral cortex. On the other hand, we were able to demonstrate weak staining (S and M types) in 5 of the 7 long survival cases (greater than or equal to1 day) and in 12 of the 14 very short survival cases (<1 h) studied. Similar findings were obtained in the contralateral cerebral cortex and also in the ipsilateral hippocampus. In addition, positive staining for glial fibrillary acidic protein was detected around the cerebral contusion, but the EAAT2-positive expression was not observed in the same region for all of the six short and long survival cases ( ! I h) after TBI. These findings clearly showed the differences in EAAT2 expression in the cerebral cortex according to the survival time and severity of cerebral contusion after TBI. Therefore, we emphasized that EAAT2 might play an important role in contributing to extracellular glutamate concentrations and secondary brain injury after TBI.,(C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Nagasaki Univ, Grad Sch Biochem Sci, Course Med & Dent Sci, Dept Translatat Med Sci,Div Forens Pathol & Sci, Nagasaki 8528523, Japan; Kanazawa Univ, Grad Sch Med Sci, Div Environm Sci Forens & Environm Med, Kanazawa, Ishikawa 920, Japan		Ikematsu, K (corresponding author), Nagasaki Univ, Grad Sch Biochem Sci, Course Med & Dent Sci, Dept Translatat Med Sci,Div Forens Pathol & Sci, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.			Kondo, Toshikazu/0000-0002-5059-8309			ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Fray AE, 1998, EUR J NEUROSCI, V10, P2481, DOI 10.1046/j.1460-9568.1998.00273.x; Ikematsu K, 2001, FORENSIC SCI INT, V118, P49, DOI 10.1016/S0379-0738(00)00378-9; KANAI Y, 1994, J BIOL CHEM, V269, P20599; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Shirai Y, 1996, PSYCHIAT CLIN NEUROS, V50, P161, DOI 10.1111/j.1440-1819.1996.tb01682.x; Vemuganti LRR, 1998, J NEUROCHEM, V70, P2020	11	11	14	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	DEC 4	2002	130	2-3					83	89	PII S0379-0738(02)00344-4	10.1016/S0379-0738(02)00344-4			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	625CP	WOS:000179799600002	12477627				2022-02-06	
J	Chute, DL				Chute, DL			Neuropsychological technologies in rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amyotrophic lateral sclerosis; assistive technology; cognitive prosthetics; cognitive rehabilitation; computerized assessment; functional brain imaging; neuropsychology; traumatic brain injury	PSYCHOLOGY; MACINTOSH	Objective: To provide an introduction and a conceptual context for the articles presented in this special edition of the Journal of Head Trauma Rehabilitation on neuropsychological technologies. Summary: Many clinical assessments in neuropsychology are metamorphosing from a psychometric search for a lesion to a functional image of the working brain. Behavioral probes increasingly employ technology to provide more ecologically valid stimuli to elicit diagnostically relevant responses. Intervention strategies include an expanding range of assistive devices and technologically based treatments. The advent of the microprocessor and discipline specific programming have allowed certain aspects of rehabilitation practice to incorporate these new assessment and intervention strategies. For example, the development of neuropsychological technologies has already lead to computer based prosthetics and orthotics, cognitive probes with millisecond accurate links to functional imaging, virtual reality managed ecological assessments, cognitive retraining, assistive devices, and online, and "real-time" database-driven evaluations. Emerging technologies offer the potential for personal, portable, everyday brain imaging and rehabilitation systems. Few psychologists, physiatrists, or allied health professionals are formally trained in technological development. What has emerged thus far is a collection of individual efforts that remain to be integrated into more comprehensive tools for the rehabilitation professions. The selective history of neuropsychological technologies presented here is meant to illustrate past difficulties in the emergence of this sub-specialty and point to new applications and technological integration that may prove fruitful. The convergence of neuroengineering, adaptive assessments, everyday neuroimaging, neuroinformatics, and educational neuroimaging, presage such future developments in neuropsychological technologies.	Drexel Univ, Philadelphia, PA 19104 USA; Med Coll Penn & Hahnemann Univ, Dept Psychol, Philadelphia, PA USA		Chute, DL (corresponding author), Drexel Univ, 3141 Chestnut St, Philadelphia, PA 19104 USA.						BANK B, 1986, BRAIN RES, P390; CHANCE B, 1995, THERAP RES, V16, P107; Chute D. L., 1992, Proceedings of the Johns Hopkins National Search for Computing Applications to Assist Persons with Disabilities (Cat. No.92TH0429-1), P124, DOI 10.1109/CAAPWD.1992.217426; Chute D. L., 1987, ACAD COMP, V2, P40; CHUTE DL, 1993, BEHAV RES METH INSTR, V25, P180, DOI 10.3758/BF03204492; Chute DL, 1996, BEHAV RES METH INSTR, V28, P311, DOI 10.3758/BF03204788; CHUTE DL, 1986, BEHAV RES METH INSTR, V18, P205, DOI 10.3758/BF03201023; CHUTE DL, 1987, BEHAV RES METH INSTR, V19, P2005; CHUTE DL, 2001, INT C TECHN AG; CHUTE DL, 1998, ACTIVITIES HDB TEACH, V4; CHUTE DL, 1995, EXPLORING PSYCHOL DI; Chute DL, 1988, NEUROPSYCHOLOGY, V2, P41, DOI 10.1037//0894-4105.2.1.41; Crook TH, 1988, NEUROPSYCHOLOGY, V2, P1, DOI 10.1037//0894-4105.2.1.1; DANIEL RS, 1972, STUDENTS MANUAL GEN; GUR RC, 1992, ARCH GEN PSYCHIAT, V49, P409; KOFFLER SP, 2001, SLIP TEST NEUROPSYCH; KUTZIK D, 1997, Patent No. 5692215; Lynch WJ, 1988, NEUROPSYCHOLOGY, V2, P111, DOI 10.1037/h0091794; Mihailidis A., 2000, TECHNOLOGY DISABILIT, V13, P23, DOI DOI 10.3233/TAD-2000-13104; MUELLER J, 2000, PSYCHOL EXPT INTERNE; RUFF R, 2001, PRESIDENTIAL ADDRESS; SCHATZ P, 1998, SYLLABUS 98; SCHULTHEISS M, IN PRESS HDB DRIVING; TULSKEY D, 2002, DEV PROGR PSYCHOL IQ; WESTALL RF, 1989, BEHAV RES METH INSTR, V21, P540, DOI 10.3758/BF03202886; ZABEL TA, 2001, DISS ABSTR INT B, V61, P5045	26	11	11	2	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2002	17	5					369	377		10.1097/00001199-200210000-00001			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	610DD	WOS:000178944700001	12802249				2022-02-06	
J	Frontczak-Baniewicz, M; Walski, M				Frontczak-Baniewicz, M; Walski, M			Non-sprouting angiogenesis in neurohypophysis after traumatic injury of the cerebral cortex. Electron-microscopic studies	NEUROENDOCRINOLOGY LETTERS			English	Article						angiogenesis; cerebral cortex; neurohypophysis; perivascular cells	ENDOTHELIAL GROWTH-FACTOR; WOUND-HEALING ANGIOGENESIS; CELL-PROLIFERATION; NITRIC-OXIDE; FACTOR VEGF; MECHANISMS; EXPRESSION; MICROGLIA; PHENOTYPE; HYPOXIA	OBJECTIVES: Angiogenesis comprises two different mechanisms: endothelial sprouting and intussusceptive microvascular growth. The sprouting process is based on endothelial cell migration, proliferation and tube formation. Intussusceptive microvascular growth divides existing vessel lumens by formation and insertion of endothelial columns into the vessel lumen. The morphological features of microvessels of cerebral cortex and neurohypophysis were evaluated in a model of the cerebral traumatic injury. METHOD: The observations were conducted seven days after induction of cortical trauma. Traumatic injury was induced in the fronto-temporal region of cerebral cortex in general anesthesia with 20mg/kg ketamine hydrochloride. RESULTS: Seven days after traumatic brain injury in sections from cerebral cortex and neurohypophysis we can observe morphological features of angiogenesis. Endothelium of the cerebral cortex possesses high endotheliocytes tightly connected and enveloped by amorphous basement membrane-like material. Transcapillary pillars tightly connected with neighbouring endothelial cells split the newly formed vessels and branching takes place. In neurohypophysis we can observe all stages of non-sprouting angiogenesis: proliferation endothelial cells on the inside mother vessel, splitting newly formed blood vessels by transcapillary pillars directed into the vessel lumen, maturation of endothelium and network formation. CONCLUSION: The mechanical injuries directly induced angiogenesis not only in cerebral cortex, but also in neurohypophysis. Our studies show that mechanism of angiogenesis is not the same as observed previously in neurohypophysis after focal cerebral ischemia (Neuroendocrinology Letters 2001; 22: 87-92). This study indicates that mechanism of angiogenesis can depend on kind of induction.	Polish Acad Sci, Med Res Ctr, Lab Cell Ultrastruct, PL-02106 Warsaw, Poland		Frontczak-Baniewicz, M (corresponding author), Polish Acad Sci, Med Res Ctr, Lab Cell Ultrastruct, Pawinskiego St 5, PL-02106 Warsaw, Poland.	gosia@cmdik.pan.pl					ADAIR TH, 1990, AM J PHYSIOL, V259, pR393, DOI 10.1152/ajpregu.1990.259.3.R393; Alexander CM, 1991, CELL BIOL EXTRACELLU, P255; Bar T., 1980, ADV ANATOMY EMBRYOLO, VVolume 59, P1, DOI [10.1007/978-3-642-67432-7, DOI 10.1007/978-3-642-67432-7]; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Carmeliet P, 2000, NATURE, V408, P43, DOI 10.1038/35040684; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cho CH, 2001, J PHYSIOLOGY-PARIS, V95, P253, DOI 10.1016/S0928-4257(01)00034-1; DAmore PA, 1996, CANCER METAST REV, V15, P205, DOI 10.1007/BF00437473; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; FALANGA V, 1993, J DERMATOL SURG ONC, V19, P711, DOI 10.1111/j.1524-4725.1993.tb00414.x; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Frontczak-Baniewicz M, 2001, NEUROENDOCRINOL LETT, V22, P87; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; Goke M, 1998, AM J PHYSIOL-GASTR L, V274, pG809, DOI 10.1152/ajpgi.1998.274.5.G809; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Gu WG, 2001, ACTA NEUROPATHOL, V102, P216; Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hossmann KA, 2001, ACTA NEUROPATHOL, V101, P101; Ichioka S, 1997, J SURG RES, V72, P29, DOI 10.1006/jsre.1997.5170; KNIGHTON DR, 1981, SURGERY, V90, P262; KNIGHTON DR, 1983, SCIENCE, V221, P1283, DOI 10.1126/science.6612342; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; NEHLS V, 1992, CELL TISSUE RES, V270, P469, DOI 10.1007/BF00645048; NEWCOMB PM, 1993, J CELL PHYSIOL, V155, P385, DOI 10.1002/jcp.1041550220; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SCHOR AM, 1992, ANGIOGENESIS KEY PRI, P22; Skalak Thomas C., 1996, Microcirculation (Philadelphia), V3, P143, DOI 10.3109/10739689609148284; Steinbrech DS, 1999, J SURG RES, V84, P127, DOI 10.1006/jsre.1999.5627; Stockhammer G, 2000, NEUROLOGY, V54, P1670, DOI 10.1212/WNL.54.8.1670; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Walski M, 2001, NEUROENDOCRINOL LETT, V22, P19; Walski M, 1999, J BRAIN RES, V39, P455; Ware JA, 1997, NAT MED, V3, P158, DOI 10.1038/nm0297-158	40	11	14	0	2	MAGHIRA & MAAS PUBLICATIONS	MUNSBACH	MAGHIRA & MAAS S A R L, 6C, RUE GABRIEL LIPPMANN, L-5365 MUNSBACH, LUXEMBOURG	0172-780X	2354-4716		NEUROENDOCRINOL LETT	Neuroendocrinol. Lett.	OCT-DEC	2002	23	5-6					396	404	PII NEL235602A02				9	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	632ZQ	WOS:000180255100006	12500160				2022-02-06	
J	Stover, JF; Sakowitz, OW; Thomale, UW; Kroppenstedt, SN; Unterberg, AW				Stover, JF; Sakowitz, OW; Thomale, UW; Kroppenstedt, SN; Unterberg, AW			Norepinephrine-induced hyperglycemia does not increase cortical lactate in brain-injured rats	INTENSIVE CARE MEDICINE			English	Article						catecholamines; blood-brain barrier; glucose; microdialysis; traumatic brain injury	CEREBROSPINAL-FLUID GLUTAMATE; TRANSIENT CEREBRAL-ISCHEMIA; NECROSIS-FACTOR-ALPHA; IMPACT INJURY; GLUCOSE-TRANSPORTER; FOREBRAIN ISCHEMIA; CONTUSION VOLUME; PREISCHEMIC HYPERGLYCEMIA; SECONDARY ISCHEMIA; ENERGY-METABOLISM	Objective: Hyperglycemia aggravates ischemic brain damage. Since catecholamines increase hepatic gluconeogenesis, resulting in hyperglycemia, we investigated whether norepinephrine and dopamine elevate arterial blood glucose, thereby increasing pericontusional cortical glucose and lactate concentrations and brain edema in brain-injured rats. Design: Prospective, randomized, controlled animal study. Subjects: Male Sprague Dawley rats. Interventions: Physiological saline solution, norepinephrine, or dopamine were infused intravenously for 90 min beginning 4.5 h after inducing a focal cortical contusion. Blood glucose, lactate, and pericontusional cortical extracellular glucose and lactate were determined before, during and up to 60 min after the infusion period. Thereafter brains were removed to assess hemispheric water content. Measurements and results: Continuous norepinephrine and dopamine infusion significantly increased pericontusional glucose concentrations, being mostly sustained by norepinephrine (NaCl: 1.3 +/- 0.2, dopamine: 2.7 +/- 0.2, norepinephrine: 4.8 +/- 1.1 mM). While arterial blood glucose was only significantly elevated in norepinephrine-treated rats from 8.6 +/- 0.6 to 12.6 +/- 1.6 mM, the extracellular to blood glucose ratio was significantly increased in dopamine- and norepinephrine-treated rats (0.28 +/- 0.01 and 0.38 +/- 0.05 vs. 0.17 +/- 0.01). Plasma and pericontusional lactate remained unchanged, and brain edema was similar in all groups. Conclusions: Norepinephrine and dopamine significantly increased pericontusional glucose concentrations which did not elevate extracellular lactate and aggravate underlying posttraumatic edema formation. In addition to possibly increased facilitated endothelial glucose transport, the elevated extracellular to blood glucose ratio suggests a passive concentration- and pressure- dependent entry via a damaged blood-brain barrier. This might contribute to the observed reversible increase in extracellular glucose.	Humboldt Univ, Dept Neurosurg, Charite, Virchow Med Ctr, Berlin, Germany		Stover, JF (corresponding author), Univ Penn, Dept Neurosurg, 105 C Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.			Sakowitz, Oliver/0000-0003-3248-6335			Anderson MS, 2001, AM J PHYSIOL-REG I, V281, pR1545, DOI 10.1152/ajpregu.2001.281.5.R1545; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; Dempsey RJ, 1996, NEUROL RES, V18, P546; DIETRICH WD, 1993, STROKE, V24, P111, DOI 10.1161/01.STR.24.1.111; Duelli R, 2000, BRAIN RES, V858, P338, DOI 10.1016/S0006-8993(00)01942-9; Duelli R, 2001, NEUROSCI LETT, V310, P101, DOI 10.1016/S0304-3940(01)02060-2; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FILIPPONI P, 1982, DIABETES METAB, V8, P313; Garcia-Barrado MJ, 1998, J AUTON PHARMACOL, V18, P287, DOI 10.1046/j.1365-2680.1998.18596.x; Gisselsson L, 1999, J CEREBR BLOOD F MET, V19, P288, DOI 10.1097/00004647-199903000-00007; Guyot LL, 2001, NEUROSURGERY, V48, P385, DOI 10.1097/00006123-200102000-00030; HIROSE H, 1992, ACTA ENDOCRINOL-COP, V127, P279, DOI 10.1530/acta.0.1270279; Huang NC, 1996, EXP BRAIN RES, V109, P33; Kawai N, 1998, ACT NEUR S, V71, P219; KECK FS, 1990, DIABETES RES CLIN PR, V8, P155, DOI 10.1016/0168-8227(90)90026-P; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LANG CH, 1994, AM J PHYSIOL, V266, pE863, DOI 10.1152/ajpendo.1994.266.6.E863; Li PA, 1997, BRAIN RES, V753, P133, DOI 10.1016/S0006-8993(97)00005-X; Li PA, 1998, BRAIN RES, V782, P175, DOI 10.1016/S0006-8993(97)01150-5; Li PA, 2000, STROKE, V31, P183, DOI 10.1161/01.STR.31.1.183; Li PA, 1999, FREE RADICAL BIO MED, V27, P1033, DOI 10.1016/S0891-5849(99)00152-5; Li PA, 2001, J CEREBR BLOOD F MET, V21, P568, DOI 10.1097/00004647-200105000-00011; Lin BW, 1998, ACTA NEUROPATHOL, V96, P610, DOI 10.1007/s004010050942; Lin BW, 2000, NEUROSCI LETT, V278, P1, DOI 10.1016/S0304-3940(99)00889-7; Park WS, 2001, BRAIN RES, V901, P102, DOI 10.1016/S0006-8993(01)02295-8; Pellerin L, 1997, GLIA, V21, P74, DOI 10.1002/(SICI)1098-1136(199709)21:1<74::AID-GLIA8>3.0.CO;2-1; PRADO R, 1988, J CEREBR BLOOD F MET, V8, P186, DOI 10.1038/jcbfm.1988.48; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; Salvi S, 2001, CHEST, V119, P1242, DOI 10.1378/chest.119.4.1242; Schurr A, 2002, NEUROCHEM INT, V41, P1, DOI 10.1016/S0197-0186(01)00142-5; Shimizu Y, 1998, BIOCHEM J, V330, P397, DOI 10.1042/bj3300397; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Stover JF, 2001, J NEUROSURG, V94, P782, DOI 10.3171/jns.2001.94.5.0782; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; Stroop R, 1998, ACT NEUR S, V71, P303; Tirone TA, 2001, WORLD J SURG, V25, P461, DOI 10.1007/s002680020338; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; Wei JN, 1997, FREE RADICAL BIO MED, V23, P986, DOI 10.1016/S0891-5849(97)00127-5; YIP PK, 1991, NEUROLOGY, V41, P899, DOI 10.1212/WNL.41.6.899	54	11	11	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	OCT	2002	28	10					1491	1497		10.1007/s00134-002-1431-2			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	641PG	WOS:000180753500019	12373476				2022-02-06	
J	Weitzenkamp, DA; Whiteneck, GG; Lammertse, DP				Weitzenkamp, DA; Whiteneck, GG; Lammertse, DP			Predictors of personal care assistance for people with spinal cord injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						activities of daily living; personal health services; rehabilitation; spinal cord injuries	FUNCTIONAL INDEPENDENCE MEASURE; REHABILITATION OUTCOMES; MEDICAL REHABILITATION; DISABILITY MEASURES; ASSESSMENT SCALES; TRAUMATIC BRAIN; HEALTH; VALIDITY; HANDICAP; COSTS	Objective: To assess the predictors of personal care assistance (PCA) use in people with spinal cord injury (SCI). Design: Cross-sectional. Setting: Follow-up of individuals crossing their 1st, 5th, 10th, 15th, 20th, or 25th anniversary of injury who underwent their initial rehabilitation at a Spinal Cord Injury Model Systems center. Participants: A total of 2154 participants (2547 records) who met the inclusion criteria for the National Spinal Cord Injury Database and had valid values for the main outcome measures. Interventions: Not applicable. Main Outcome Measures: Daily hours of paid, unpaid, and occasional PCA services. Results: Differences in an interval version of the motor portion of the FIM(TM) instrument accounted for 26.3% of the variance in total PCA hours, Model Systems differences accounted for 9.3%, and no other predictor accounted for more than 2.1% of the variance. Conclusion: Activities of daily living functioning, as measured by the motor portion of the FIM, was the strongest predictor of PCA use among people with SCI.	Craig Hosp, Res Dept, Englewood, CO 80110 USA		Weitzenkamp, DA (corresponding author), Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80110 USA.	davidaw@craighospital.org		Lammertse, Daniel/0000-0003-4590-2481			BERKOWITZ M, 1998, SPINAL CORD INJURY A, P87; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BURNS TJ, 1990, ARCH PHYS MED REHAB, V71, P138; Coll JR, 1998, SPINAL CORD, V36, P275, DOI 10.1038/sj.sc.3100497; Cook RD, 2001, TECHNOMETRICS, V43, P443, DOI 10.1198/00401700152672537; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; DEJONG G, 1991, PARAPLEGIA, V29, P373, DOI 10.1038/sc.1991.53; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; FUHRER MJ, 1987, ARCH PHYS MED REHAB, V68, P353; GERHART KA, 1993, ARCH PHYS MED REHAB, V74, P1030, DOI 10.1016/0003-9993(93)90057-H; Go Bette K., 1995, P21; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Graves DE, 1999, ARCH PHYS MED REHAB, V80, P1464, DOI 10.1016/S0003-9993(99)90259-9; GRAVES DE, 1997, J SPINAL CORD MED, V20, P142; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1507, DOI 10.1016/S0003-9993(99)90265-4; Hamilton BB, 1999, ARCH PHYS MED REHAB, V80, P385, DOI 10.1016/S0003-9993(99)90274-5; HARVEY C, 1992, PARAPLEGIA, V30, P834, DOI 10.1038/sc.1992.160; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Hoenig H, 1999, SPINE, V24, P539, DOI 10.1097/00007632-199903150-00007; Holicky R, 1996, Rehabil Nurs, V21, P247; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MattsonPrince J, 1997, SPINAL CORD, V35, P326, DOI 10.1038/sj.sc.3100453; NOSEK MA, 1993, ARCH PHYS MED REHAB, V74, P127; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Shackelford M, 1998, SPINAL CORD, V36, P337, DOI 10.1038/sj.sc.3100510; *STAT U NEW YORK, 1997, GUID UN DAT SET MED; Stover SL, 1999, ARCH PHYS MED REHAB, V80, P1365, DOI 10.1016/S0003-9993(99)90246-0; TATE D, 1994, AM J PHYS MED REHAB, V73, P175, DOI 10.1097/00002060-199406000-00006; TATE DG, 1994, ARCH PHYS MED REHAB, V75, P407, DOI 10.1016/0003-9993(94)90164-3; Whiteneck G, 1999, ARCH PHYS MED REHAB, V80, P1485, DOI 10.1016/S0003-9993(99)90262-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLAN AR, 1978, TECHNOMETRICS, V20, P407, DOI 10.2307/1267640; World Health Organization, 2007, INT CLASS FUNCT DIS; YOUNG MA, 1993, J SPEECH HEAR RES, V36, P644, DOI 10.1044/jshr.3604.644	40	11	11	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2002	83	10					1399	1405		10.1053/apmr.2002.35087			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	600NT	WOS:000178397800013	12370876				2022-02-06	
J	Pointinger, H; Sarahrudi, K; Poeschl, G; Munk, P				Pointinger, H; Sarahrudi, K; Poeschl, G; Munk, P			Electroencephalography in primary diagnosis of mild head trauma	BRAIN INJURY			English	Article							INJURY; EEG	Objective: The aim of this study was to compare the clinical examination and EEG examination regarding their relevance in diagnosing cerebral function changes in early head trauma. Methods: Ninety four male patients who suffered from mild head trauma (GCS 13-15) were assigned into two groups. The first group fulfilled at least one sign of cerebral concussion (amnesia, anisocoria, changes of vigilance or vegetative symptoms such as vomiting), the second group did not. EEG examination was performed in both groups. Results: In the first group, more pathologic EEG records were found. These findings showed a statistical significance (p=0.019). The concussion group showed more focal changes (p=0.283) and specific changes (p=0.317), but they were statistically not significant. Conclusion: EEG can be used for detecting pathologic unspecific alterations with a high accuracy, but is not useful in specifing the findings for an exact diagnosis.	Mil Hosp Vienna, Dept Surg, Vienna, Austria; Mil Hosp Vienna, Dept Anaesthesia & Crit Care Med, Vienna, Austria		Pointinger, H (corresponding author), Maurer Lange Gasse 101, A-1238 Vienna, Austria.						Airoldi L, 1999, J CLIN NEUROPHYSIOL, V16, P456, DOI 10.1097/00004691-199909000-00007; Barth JT, 1996, CLIN ELECTROENCEPHAL, V27, P183; BERNAD PG, 1991, CLIN ELECTROENCEPHAL, V22, P203, DOI 10.1177/155005949102200408; Cheung DS, 1999, EMERG MED CLIN N AM, V17, P9, DOI 10.1016/S0733-8627(05)70044-4; DICHGANS J, 1978, FORTSCHRITTE NEUROLO, V47, P144; DUFFNER F, 1995, ZBL CHIR, V120, P536; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; GROTE EH, 1993, UNFALLCHIRURG, V96, P609; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Kelsch G, 1996, UNFALLCHIRURG, V99, P202; KRUGER J, 1991, NERVENARZT, V62, P226; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; LORENZONI E, 1975, FORTSCHR NEUROL PSYC, V43, P155; LORENZONI E, 1976, J NEUROL, V211, P275, DOI 10.1007/BF00313237; Pfenninger E, 1994, Klin Anasthesiol Intensivther, V46, P229; ROGOZEA R, 1980, ARCH PSYCHIAT NERVEN, V229, P75, DOI 10.1007/BF00343804; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Wocjan J, 1972, Hefte Unfallheilkd, V111, P170	22	11	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2002	16	9					799	805		10.1080/02699050210131911			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	585PD	WOS:000177532800005	12217205				2022-02-06	
J	Koszyca, B; Manavis, J; Cornish, RJ; Blumbergs, PC				Koszyca, B; Manavis, J; Cornish, RJ; Blumbergs, PC			Patterns of immunocytochemical staining for ferritin and transferrin in the human spinal cord following traumatic injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						transferrin; ferritin; spinal cord injury	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL SUPERFICIAL SIDEROSIS; SUBSTANTIA-NIGRA; RAT-BRAIN; IRON UPTAKE; LIPID-PEROXIDATION; PARKINSONS-DISEASE; RELEASE; OLIGODENDROCYTES; LACTOFERRIN	Normally Fe2+ is strictly controlled within the central nervous system (CNS) because of its potential to react with oxygen and form free radicals.(1,2) Traumatic spinal cord injury (TSCI) leads to cell damage and haemorrhage, both of which may increase the pool of free iron.(3) The aim of this study was to examine the response to TSCI of the iron storage protein ferritin (Ft) and the iron transport protein transferrin (Tf). The study found a significant increase in Ft positive cells compared to controls and a significant correlation between the number of Ft positive cells and the severity of injury. Significantly fewer Tf positive cells were seen in the trauma cases compared to the control and there was no relation with the severity of injury. These observations suggest a disturbance in normal iron metabolism within the spinal cord following injury, with possible implications for free radical mediated secondary damage. (C) 2002 Published by Elsevier Science Ltd.	Univ Adelaide, Dept Pathol, Adelaide, SA 5005, Australia; Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5005, Australia		Koszyca, B (corresponding author), Univ Adelaide, Dept Pathol, Adelaide, SA 5005, Australia.						ARUOMA OI, 1987, BIOCHEM J, V241, P273, DOI 10.1042/bj2410273; Beard JL, 1996, NUTR REV, V54, P295, DOI 10.1111/j.1753-4887.1996.tb03794.x; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; BENKOVIC SA, 1993, J COMP NEUROL, V338, P97, DOI 10.1002/cne.903380108; BIENFAIT HF, 1980, BIOCHIM BIOPHYS ACTA, V631, P507, DOI 10.1016/0304-4165(80)90028-8; BOLANN BJ, 1987, BIOCHEM J, V243, P55, DOI 10.1042/bj2430055; Bradbury MWB, 1997, J NEUROCHEM, V69, P443; Burtis CA, 1999, TIETZ TXB CLIN CHEM, P1698; Calingasan NY, 1998, AM J PATHOL, V153, P599, DOI 10.1016/S0002-9440(10)65602-7; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; CONNOR JR, 1995, J NEUROCHEM, V65, P717; Connor JR, 1995, J NEUROL SCI, V134, P33, DOI 10.1016/0022-510X(95)00206-H; CONNOR JR, 1992, ANN NEUROL S, V32, P51; Cook JL, 1998, MOL BRAIN RES, V55, P9, DOI 10.1016/S0169-328X(97)00350-1; DeSilva DM, 1996, PHYSIOL REV, V76, P31, DOI 10.1152/physrev.1996.76.1.31; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; DICKSON PW, 1985, BIOCHEM BIOPH RES CO, V127, P890, DOI 10.1016/S0006-291X(85)80027-9; GERBER MR, 1989, ANN NEUROL, V26, P95, DOI 10.1002/ana.410260115; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; HALLGREN R, 1980, ACTA NEUROL SCAND, V61, P384; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hansen TM, 1999, MOL BRAIN RES, V65, P186, DOI 10.1016/S0169-328X(99)00011-X; HARRIS LR, 1994, BIOCHEM J, V301, P385, DOI 10.1042/bj3010385; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HEALING G, 1990, BIOCHEM PHARMACOL, V39, P1239, DOI 10.1016/0006-2952(90)90269-Q; Hoffman R., 1995, HAEMATOLOGY BASIC PR; KANEKO Y, 1989, ACTA NEUROPATHOL, V79, P129, DOI 10.1007/BF00294369; KOEPPEN AH, 1992, J NEUROL SCI, V112, P38, DOI 10.1016/0022-510X(92)90129-9; KOEPPEN AH, 1991, J NEUROPATH EXP NEUR, V50, P579, DOI 10.1097/00005072-199109000-00005; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; McCord JM, 1998, SEMIN HEMATOL, V35, P5; MONTEIRO HP, 1988, BIOCHEM J, V256, P923, DOI 10.1042/bj2560923; MORRIS CM, 1992, ACTA ANAT, V143, P14; QI Y, 1994, J NEUROCHEM, V63, P1485; REIF DW, 1990, ARCH BIOCHEM BIOPHYS, V283, P537, DOI 10.1016/0003-9861(90)90680-W; Sherwood RA, 1998, ANN CLIN BIOCHEM, V35, P693, DOI 10.1177/000456329803500601; SIRIVECH S, 1974, BIOCHEM J, V143, P311, DOI 10.1042/bj1430311; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; STRYER L, 1995, BIOCHEMISTRY-US, P939; SWAIMAN KF, 1984, ANN NEUROL, V16, P66, DOI 10.1002/ana.410160113; WEAVER J, 1989, BIOCHEM J, V261, P787, DOI 10.1042/bj2610787	44	11	13	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2002	9	3					298	301		10.1054/jocn.2001.0969			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582JR	WOS:000177347600015	12093138				2022-02-06	
J	Rintala, DH; Novy, DM; Garza, HM; Young, ME; High, WM; Chiou-Tan, FY				Rintala, DH; Novy, DM; Garza, HM; Young, ME; High, WM; Chiou-Tan, FY			Psychometric properties of a Spanish-language version of the Community Integration Questionnaire (CIQ)	REHABILITATION PSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; TERM REHABILITATION OUTCOMES; SPINAL-CORD INJURY; QUALITY-OF-LIFE; HEALTH-CARE; DISABILITY; AGREEMENT; HANDICAP; VALIDITY; PAIN	Objective: To develop and test the Psychometric properties of a Spanish version of the Community Integration Questionnaire (CIQ; Willer et al., 1993). Study Design: Descriptive data, comparison of Spanish and English versions, and test-retest comparisons of the Spanish version. Setting: Community in southeastern Texas. Participants: Individuals with spinal cord injury (SCI) or traumatic brain injury (TBI) who speak and read Spanish. Main Measures: CIQ and Craig Handicap Assessment and Reporting Technique. Results: Total score correlations: Spanish-English = .83; test-retest = .85. The internal consistency was .70. The Social Integration subscale was the most problematic. Conclusions: The total score and the Home Integration subscale of the Spanish CIQ have adequate psychometric properties for group research, but further refinement is recommended.	Vet Affairs Ctr Excellence Healthy Aging Disabil, Houston, TX USA; Baylor Coll Med, Houston, TX 77030 USA; Inst Rehabil & Res, Houston, TX USA; Univ Texas, Med Sch, Houston, TX USA; Univ Florida, Gainesville, FL 32611 USA; Harris County Hosp Dist, Houston, TX USA		Rintala, DH (corresponding author), Vet Affairs Ctr Excellence Healthy Aging Disabil, Houston, TX USA.						ABELLOBANFI M, 1994, J RHEUMATOL, V21, P1250; ANUAGA JC, 1991, HISPANIC J BEHAV SCI, V13, P63; Bates MS, 1997, SOC SCI MED, V45, P1433, DOI 10.1016/S0277-9536(97)00068-3; BERKANOVIC E, 1985, SOC SCI MED, V20, P567, DOI 10.1016/0277-9536(85)90395-8; Chapman D.W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI [10.3102/01623737001003071, DOI 10.3102/01623737001003071]; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; DEJONG G, 1987, REHABILITATION OUTCO, P261; Devivo Michael J., 1995, P289; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; EISENBERG MG, 1991, PARAPLEGIA, V29, P514, DOI 10.1038/sc.1991.74; EZZATI TM, 1995, STAT MED, V14, P571, DOI 10.1002/sim.4780140515; FERKETICH S, 1993, RES NURS HEALTH, V16, P227, DOI 10.1002/nur.4770160310; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; FUHRER MJ, 1995, AM J PHYS MED REHAB, V74, P243, DOI 10.1097/00002060-199505000-00013; FUHRER MJ, 1987, REHABILITATION OUTCO, P1; FURINO A, 1991, JAMA-J AM MED ASSOC, V265, P255; GRANGER CV, 1976, ARCH PHYS MED REHAB, V57, P103; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HU DJ, 1986, WESTERN J MED, V144, P490; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; KUSTER AE, 1993, NURS RES, V42, P266; LAMMERTSE DP, 1991, ARCH PHYS MED REHAB, V72, pS309; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEAVITT F, 1994, SPINE, V19, P1048, DOI 10.1097/00007632-199405000-00009; NOSEK MA, 1987, REHABILITATION OUTCO, P71; NOVY DM, 1998, AM TRANSLATOR ASS CH, V27, P25; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Richardson LD, 1999, MT SINAI J MED, V66, P267; ROBERTS RE, 1989, J NERV MENT DIS, V177, P581, DOI 10.1097/00005053-198910000-00001; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; TRIESCHMANN RB, 1978, PARAPLEGIA, V16, P212, DOI 10.1038/sc.1978.37; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; WILLER B, 1993, J HEAD TRAUMA REHAB, V72, P372; World Health Organization, 1980, INT CLASS IMP DIS HA	37	11	11	1	1	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2002	47	2					144	164		10.1037//0090-5550.47.2.144			21	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	550WD	WOS:000175526500002					2022-02-06	
J	Savage, R; Combs, DR; Pinkston, JB; Advokat, C; Gouvier, WD				Savage, R; Combs, DR; Pinkston, JB; Advokat, C; Gouvier, WD			The role of temporal lobe and orbitofrontal cortices in olfactory memory function	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						olfaction; olfactory identification; cerebrovascular accident (CVA); traumatic brain injury (TBI)	DEFICITS; DISEASE; DISCRIMINATION	Differences in verbal and nonverbal olfactory identification and recognition were examined among three groups with brain impairment. A left cerebrovascular accident (LCVA) group, a right CVA (RCVA) group, and a traumatic brain injury (TBI) group were compared with two nonimpaired age-matched comparison groups on olfaction identification and recognition abilities. Odors were presented to the left and right nostrils, which maximized hemispheric differences in olfactory processing. Results showed that persons with LCVA demonstrated the greatest impairment on the verbal identification of odors, while persons with RCVA showed the most impairment on the nonverbal identification of odors. Persons with TBI showed an inconsistent impairment across both verbal and nonverbal odor identification tasks. Odor recognition was impaired in both CVA groups as well. In contrast, persons with TBI performed better on the delayed odor recognition tasks. Results are discussed in relation to hemispheric differences in processing olfactory information. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; Univ Alabama, Birmingham, AL 35294 USA		Gouvier, WD (corresponding author), Louisiana State Univ, Dept Psychol, 236 Audubon Hall, Baton Rouge, LA 70803 USA.						ANDERSEN R, 1978, NEUROPSYCHOLOGIA, V16, P439, DOI 10.1016/0028-3932(78)90067-2; CERMACK L, 1982, HUMAN MEMORY AMNESIA; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1992, J HEAD TRAUMA REHAB, V7, P42; Eichenbaum H, 1998, ANN NY ACAD SCI, V855, P657, DOI 10.1111/j.1749-6632.1998.tb10642.x; GELLERMAN LW, 1933, J GENET PSYCHOL, V4, P207; GORDON HW, 1969, NEUROPSYCHOLOGIA, V7, P111, DOI 10.1016/0028-3932(69)90009-8; GUYTON AC, 1987, BASIC NEUROSCIENCE A, P325; Iversen S D, 1976, Int Rev Neurobiol, V19, P1, DOI 10.1016/S0074-7742(08)60700-X; JONES BP, 1975, NEUROPSYCHOLOGIA, V13, P173, DOI 10.1016/0028-3932(75)90026-3; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; KIRK RE, 1982, EXPT DESIGN, P101; KOLB B, 1985, FUNDAMENTALS HUMAN N, P475; KOPALA L, 1990, SCHIZOPHRENIA BULL, V16, P255, DOI 10.1093/schbul/16.2.255; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MILNER B, 1982, PHILOS T R SOC B, V298, P211, DOI 10.1098/rstb.1982.0083; MISHKIN M, 1987, SCI AM, V256, P80, DOI 10.1038/scientificamerican0687-80; MONTEMURRO DG, 1988, HUMAN BRAIN DISSECTI, P62; Nordin S, 1998, ANN NY ACAD SCI, V855, P686, DOI 10.1111/j.1749-6632.1998.tb10646.x; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; RAUSCH R, 1977, CORTEX, V13, P445, DOI 10.1016/S0010-9452(77)80024-5; REZEK DL, 1987, ARCH NEUROL-CHICAGO, V44, P1030, DOI 10.1001/archneur.1987.00520220036012; SMITH PDC, 1992, PHLEBOLOGY, V7, P1; SQUIRE LR, 1982, ANNU REV NEUROSCI, V5, P51; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; ZATORRE RJ, 1990, PERCEPT PSYCHOPHYS, V47, P526, DOI 10.3758/BF03203105	26	11	11	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2002	17	4					305	318	PII S0887-6177(01)00114-7	10.1016/S0887-6177(01)00114-7			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	556DW	WOS:000175834900001	14589716				2022-02-06	
J	Boyle, GJ; Haines, S				Boyle, GJ; Haines, S			Severe traumatic brain injury: Some effects on family caregivers	PSYCHOLOGICAL REPORTS			English	Article							SEVERE HEAD-INJURY; MOOD STATES; RELATIVES; PROFILE; PATIENT	This study assesses the effects of severe traumatic brain injuries on family members and functioning-a topic of interest for those working with survivors and their families. This issue is receiving increased attention as recent findings suggest that family adjustment influences outcome for brain-injured persons. The Family Environment Scale and the Profile of Mood States were completed by 25 individuals who had a family member with a severe traumatic brain injury, These scales were also completed by a comparison group of 32 individuals who had no brain-injured family member. In terms of family functioning, the findings suggest that, when a family member suffers a severe traumatic brain injury, depression may be elevated, along with a decreased ability to express feelings, decreased time and energy for social and recreational activities, and increased control in comparison to families without a brain-injured member. While this might contribute to family isolation which could last for many years, the overall finding of the present study was that caregiver families were coping adequately.	Bond Univ, Dept Psychol, Southport, Qld 4229, Australia; Univ Queensland, Dept Psychiat, St Lucia, Qld 4067, Australia		Boyle, GJ (corresponding author), Bond Univ, Dept Psychol, Gold Coast, Southport, Qld 4229, Australia.		Boyle, Gregory/E-8127-2010; Boyle, Gregory J./N-9656-2019				ACORN S, 1998, LIVING BRAIN INJURY; Baker J E, 1990, J Neurosci Nurs, V22, P232; Bishop DS, 1988, J HEAD TRAUMA REHAB, V3, P16; BLYTH B, 1981, NEW ZEAL MED J, V93, P267; BOYLE GJ, 1988, J PSYCHOPATHOL BEHAV, V10, P205, DOI 10.1007/BF00962545; BOYLE GJ, 1991, PERS INDIV DIFFER, V12, P291, DOI 10.1016/0191-8869(91)90115-R; BOYLE GJ, 1987, PSYCHOL REP, V60, P343, DOI 10.2466/pr0.1987.60.2.343; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Brooks N, 1984, CLOSED HEAD INJURY P, P123; CALDWELL JR, 1985, TEST CRITIQUES, V11, P263; CATTELL RB, 1982, BRIT J EDUC PSYCHOL, V52, P234, DOI 10.1111/j.2044-8279.1982.tb00831.x; DEPOMPEI R, 1987, COG REHABIL, V5, P6; FISHER JM, 1985, SEMIN NEUROL, V5, P197, DOI 10.1055/s-2008-1041516; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; GODFREY HP, 1995, FAMILY SUPPORT PROGR; GODFREY HPD, 1996, FACILITATING PSYCHOS; HUBERTY CJ, 1989, PSYCHOL BULL, V105, P302, DOI 10.1037/0033-2909.105.2.302; Kaplan SP, 1991, CLIN NEUROPSYCHOL, V5, P360; KENDALL E, 1991, ACQUIRED BRAIN DAMAG; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Maitz E.A., 1990, THESIS TEMPLE U PHIL; MARION DW, 1999, TRAUMATIC BRAIN INJU; MCCLELLAND RJ, 1988, BRIT J PSYCHIAT, V153, P141, DOI 10.1192/bjp.153.2.141; McNair DM, 1971, PROFILE MOOD STATES; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; Moos R., 1994, FAMILY ENV SCALE MAN; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Smith LM, 1995, FAMILY SUPPORT PROGR; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; ZEIGLER EA, 1987, J REHABIL, V53, P50; [No title captured], DOI DOI 10.1097/00001199-198812000-00004; [No title captured]; [No title captured]	39	11	12	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-2941	1558-691X		PSYCHOL REP	Psychol. Rep.	APR	2002	90	2					415	425		10.2466/PR0.90.2.415-425			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	555EK	WOS:000175780600010	12061578				2022-02-06	
J	Ordia, JI; Fischer, E; Adamski, E; Spatz, EL				Ordia, JI; Fischer, E; Adamski, E; Spatz, EL			Continuous intrathecal baclofen infusion delivered by a programmable pump for the treatment of severe spasticity following traumatic brain injury	NEUROMODULATION			English	Article						intrathecal baclofen; programmable pump; spasticity; traumatic brain injury	INTRACTABLE SPASTICITY; SPINAL ORIGIN	The aim of this study was to determine the efficacy and safety of intrathecal baclofen (ITB) delivered by a programmable pump for the chronic treatment of severe spasticity due to traumatic brain injury (TBI). Eight patients with severe spasticity following TBI, refractory to oral baclofen or who experienced intolerable side effects, were screened. The first five patients were enrolled in a research protocol that was approved by the Institutional Review Board for Human Research at Boston University Medical Center. The other three patients were evaluated after the FDA approved the therapy for spasticity of cerebral origin. Results showed that the mean Ashworth score for rigidity in the legs decreased from 4.4 preoperatively to 1.3 (p<0.05) on ITB. In the arms, the Ashworth score decreased from 2.7 to 1.5 (p<0.05). Reduction of spasticity resulted in improved levels of physical activity and locomotion and ease of care. Complications consisted of muscular hypotonia, areflexic bladder and urinary retention, erythema, and breakdown of the skin over the pump. Our results suggest that long-term intrathecal baclofen by an implanted programmable pump is a safe and effective method of treating severe intractable spasticity arising from traumatic brain injury.	Boston Univ, Med Ctr, Dept Neurosurg, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston, MA 02118 USA		Ordia, JI (corresponding author), Boston Univ, Med Ctr, Dept Neurosurg, 720 Harrison Ave, Boston, MA 02118 USA.	jordia@bu.edu					ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; CONCALVES J, 1994, STEREOT FUNCT NEUROS, V62, P108, DOI 10.1159/000098605; Kraft CH, 1968, NONPARAMETRIC INTRO; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Ordia JI, 1996, J NEUROSURG, V85, P452, DOI 10.3171/jns.1996.85.3.0452; PENN RD, 1992, J NEUROSURG, V77, P236, DOI 10.3171/jns.1992.77.2.0236; Rifici C, 1994, Funct Neurol, V9, P29; YARKONY GM, 1987, CLIN ORTHOP RELAT R, P93	11	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	APR	2002	5	2					103	107		10.1046/j.1525-1403.2002.02015.x			5	Medicine, Research & Experimental; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	551CX	WOS:000175542900007	22151849				2022-02-06	
J	Pierce, MC; Bertocci, GE; Berger, R; Vogeley, E				Pierce, MC; Bertocci, GE; Berger, R; Vogeley, E			Injury biomechanics for aiding in the diagnosis of abusive head trauma	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							DIFFUSE AXONAL INJURY; SHAKEN-BABY SYNDROME; CHILD-ABUSE; YOUNG-CHILDREN; BRAIN INJURY; CEREBRAL CONCUSSION; SUBDURAL-HEMATOMA; SKULL FRACTURES; FALLS; INFANTS	The biomechanics of specific head injuries and common mechanisms of injury; such as falls, are addressed in this article. Biomechanical considerations of injury and mechanism to aid in differentiating abusive and accidental head injury is emphasized, and experimental head injury models are reviewed.	Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA		Pierce, MC (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.		Pierce, Mary Clyde/AAQ-3509-2021				ABEL JM, 1978, 22 STAPP CAR CRASH C, V22, P35; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; BARLOW B, 1983, J PEDIATR SURG, V18, P509, DOI 10.1016/S0022-3468(83)80210-3; BARRON KD, 1980, J NEUROPATH EXP NEUR, V39, P340, DOI 10.1097/00005072-198005000-00019; Bertocci GE, 2001, ARCH PEDIAT ADOL MED, V155, P1008, DOI 10.1001/archpedi.155.9.1008; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Cameron CM, 1997, PEDIATR EMERG CARE, V13, P334, DOI 10.1097/00006565-199710000-00009; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; CHIAVIELLO CT, 1994, PEDIATRICS, V94, P679; COANT PN, 1992, PEDIATRICS, V89, P274; De Haven H, 1942, WAR MED, V2, P586; DIMAIO DJ, 1993, FORENSIC PATHOLOGY, P139; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; FOUST D, 1977, 21 STAP CAR CRASH C; GADD CW, 1966, 10 STAPP CAR CRASH C, V10, P164; GALLAGHER SS, 1984, AM J PUBLIC HEALTH, V74, P1340, DOI 10.2105/AJPH.74.12.1340; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1985, NEUROSURGERY, P1531; GENNARELLI TA, 1983, ADV NEUROTRAUMATOLOG, P31; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GOSCH HH, 1970, J TRAUM, V10, P370, DOI 10.1097/00005373-197005000-00002; GOVONS SR, 1972, EXP NEUROL, V34, P121, DOI 10.1016/0014-4886(72)90193-8; Graham D.I., 2000, HEAD INJ, P133; Gurdjian E, 1963, P 7 STAPP CAR CRASH; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; GURDJIAN ES, 1950, RADIOLOGY, V54, P313, DOI 10.1148/54.3.313; HAHN YS, 1983, CHILD BRAIN, V10, P229; HANIGAN WC, 1987, PEDIATRICS, V80, P618; HELFER RE, 1977, PEDIATRICS, V60, P533; HERTZ, 1993, 37 ANN P ASS ADV AUT; HOBBS CJ, 1984, ARCH DIS CHILD, V59, P246, DOI 10.1136/adc.59.3.246; Holbourn AHS, 1943, LANCET, V2, P438; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; JOFFE M, 1988, PEDIATRICS, V82, P457; KLEINMAN PK, 1992, J PEDIATR-US, V121, P737, DOI 10.1016/S0022-3476(05)81904-3; Kleinman PK, 1998, DIAGNOSTIC IMAGING C, P285; Klinich K.D., 1996, TECHNIQUES DEV CHILD; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Labbe J, 2001, PEDIATRICS, V108, P271, DOI 10.1542/peds.108.2.271; Lallier M, 1999, J PEDIATR SURG, V34, P1060, DOI 10.1016/S0022-3468(99)90564-X; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; Le Roux PD, 2000, HEAD INJURY, P175; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LEE MC, 1987, 31 STAPP CAR CRASH C, V31, P67; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; LYONS TJ, 1993, PEDIATRICS, V92, P125; Macgregor D M, 2000, Inj Prev, V6, P291, DOI 10.1136/ip.6.4.291; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Melvin J.W., 1993, ACCIDENTAL INJURY BI, P268; MERTEN DF, 1984, PEDIATR RADIOL, V14, P272, DOI 10.1007/BF01601874; MESERVY CJ, 1987, AM J ROENTGENOL, V149, P173, DOI 10.2214/ajr.149.1.173; NELSON LR, 1979, NEUR ABST, V5, P516; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; OMMAYA A K, 1971, International Journal of Neuroscience, V1, P371, DOI 10.3109/00207457109146986; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1969, LANCET, V2, P237; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1967, 11 STAPP CAR CRASH C; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; PRASAD P, SAE GOV IND IND M EX; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Richter D, 1996, INJURY, V27, P655, DOI 10.1016/S0020-1383(96)00083-6; Sane SM, 2000, PEDIATRICS, V105, P1345; SHATSKY SA, 1974, J NEUROSURG, V41, P523, DOI 10.3171/jns.1974.41.5.0523; Shugerman RP, 1996, PEDIATRICS, V97, P664; SMITH MD, 1975, J TRAUMA, V15, P987, DOI 10.1097/00005373-197511000-00008; Sturtz G, 1980, 24 STAPP CAR CRASH C; Sugar NF, 1999, ARCH PEDIAT ADOL MED, V153, P399, DOI 10.1001/archpedi.153.4.399; Tornheim P A, 1976, Surg Neurol, V5, P171; TORNHEIM PA, 1979, NEUROSURGERY, V4, P48, DOI 10.1227/00006123-197901000-00009; TORNHEIM PA, 1983, J NEUROSURG, V59, P431, DOI 10.3171/jns.1983.59.3.0431; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; WARNER KG, 1986, ANN EMERG MED, V15, P1088, DOI 10.1016/S0196-0644(86)80134-2; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; Willman KY, 1997, CHILD ABUSE NEGLECT, V21, P929, DOI 10.1016/S0145-2134(97)00054-9; Winston, 1998, CHILD MALTREATMENT, V3, P116, DOI [DOI 10.1177/1077559598003002006, 10.1177/1077559598003002006]	95	11	11	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	1042-3680			NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2002	13	2					155	+	PII S1042-3680(01)00006-7	10.1016/S1042-3680(01)00006-7			15	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	573HM	WOS:000176823500003	12391701				2022-02-06	
J	Satoh, JI; Kuroda, Y				Satoh, JI; Kuroda, Y			Cytokines and neurotrophic factors fail to affect Nogo-A mRNA expression in differentiated human neurones: implications for inflammation-related axonal regeneration in the central nervous system	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						cytokines; GAP-43; human neurones; neurotrophic factors; Nogo; Nogo receptor; NTera2	NEURITE GROWTH-INHIBITORS; LINES FOLLOWING INDUCTION; CARCINOMA-CELL-LINE; FUNCTIONAL RECOVERY; GENE-EXPRESSION; PURKINJE-CELLS; ADULT CNS; MYELIN; PROTEIN; EXPOSURE	Nogo is a novel myelin-associated inhibitor of neurite outgrowth which regulates stable neuronal connections during axonal regeneration following injury in the adult mammalian central nervous system (CNS). Because cytokines and neurotrophic factors play a key role in inflammation-related axonal regeneration, we investigated: (i) the constitutive expression of Nogo and the Nogo receptor (NgR) mRNA in human neural cell lines: (ii) Nogo and NgR mRNA levels in the NTera2 human teratocarcinoma cell line during retinoic acid (RA)-induced neuronal differentiation; and (iii) their regulation in NTera2-derived differentiated neurones (NTera2-N) after exposure to a battery of cytokines and growth factors potentially produced by activated glial cells at post-traumatic inflammatory lesions in the CNS. By reverse transcriptase-polymerase chain reaction analysis, the constitutive expression of Nogo-A, the longest isoform of three distinct Nogo transcripts and NgR mRNA was identified in a wide variety of human neural and non-neural cell lines. By Northern blot analysis, the levels of Nogo-A mRNA here elevated markedly in NTera2 cells following RA-induced neuronal differentiation, accompanied by an increased expression of the neurite growth-associated protein GAP-43 mRNA. In contrast, Nogo-A, Nogo-B, NgR and GAP-43 mRNA levels were unaltered in NTera2-N cells by exposure to basic fibroblast growth factor. brain-derived neurotrophic factor, glia-derived neurotrophic factor, tumour necrosis factor-alpha, interleukin-1beta, dibutyryl cyclic AMP or phorbol 12-myristate 13-acetate. These results indicate that both Nogo-A and NgR mRNA are coexpressed in various human cell types, including differentiated neurones, where their expression is unaffected by exposure to a panel of cytokines and neurotrophic factors which might be involved in inflammation-related axonal regeneration in the CNS.	Saga Med Sch, Dept Internal Med, Div Neurol, Saga 8498501, Japan		Satoh, JI (corresponding author), Saga Med Sch, Dept Internal Med, Div Neurol, 5-1-1 Nabeshima, Saga 8498501, Japan.	satoj1@post.saga-med.ac.jp					Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; ANDREWS PW, 1984, LAB INVEST, V50, P147; Bandtlow CE, 2000, GLIA, V29, P175, DOI 10.1002/(SICI)1098-1136(20000115)29:2<175::AID-GLIA11>3.0.CO;2-F; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; Blesch A, 2001, J COMP NEUROL, V436, P399, DOI 10.1002/cne.1076; Bregman BS, 1998, CURR OPIN NEUROBIOL, V8, P800, DOI 10.1016/S0959-4388(98)80124-4; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Brittis PA, 2001, NEURON, V30, P11, DOI 10.1016/S0896-6273(01)00258-6; Brosamle C, 2000, J NEUROSCI, V20, P8061; Buffo A, 1997, J NEUROSCI, V17, P8778; Buffo A, 2000, J NEUROSCI, V20, P2275; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GOODWIN RG, 1996, CYTOKINES CNS, P5; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Houle JD, 1996, RESTOR NEUROL NEUROS, V10, P205, DOI 10.3233/RNN-1996-10403; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; Josephson A, 2001, EXP NEUROL, V169, P319, DOI 10.1006/exnr.2001.7659; KAPFHAMMER JP, 1994, J COMP NEUROL, V340, P194, DOI 10.1002/cne.903400206; KAPFHAMMER JP, 1994, EUR J NEUROSCI, V6, P403, DOI 10.1111/j.1460-9568.1994.tb00283.x; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; LOTAN M, 1994, EXP NEUROL, V126, P284, DOI 10.1006/exnr.1994.1066; Mehler MF, 1997, TRENDS NEUROSCI, V20, P357, DOI 10.1016/S0166-2236(96)01045-4; Morris NJ, 1999, BBA-MOL CELL RES, V1450, P68, DOI 10.1016/S0167-4889(99)00033-6; Olson L, 1997, NAT MED, V3, P1329, DOI 10.1038/nm1297-1329; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Satoh J, 2000, J NEUROSCI METH, V94, P155, DOI 10.1016/S0165-0270(99)00143-0; Satoh J, 1997, NEUROPATHOLOGY, V17, P80, DOI 10.1111/j.1440-1789.1997.tb00018.x; Satoh J, 2000, NEUROPATHOLOGY, V20, P289, DOI 10.1046/j.1440-1789.2000.00349.x; Satoh JI, 1999, NEUROPATH APPL NEURO, V25, P492; Satoh JI, 2001, PARKINSONISM RELAT D, V8, P7, DOI 10.1016/S1353-8020(00)00075-4; Satoh JI, 2001, NEUROPATH APPL NEURO, V27, P95, DOI 10.1046/j.1365-2990.2001.00313.x; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SCHWARTZ M, 1991, BRAIN RES, V545, P334, DOI 10.1016/0006-8993(91)91309-O; SELMAJ KW, 1990, J IMMUNOL, V144, P129; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Tessier-Lavigne M, 2000, SCIENCE, V287, P813, DOI 10.1126/science.287.5454.813; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Z'Graggen WJ, 1998, J NEUROSCI, V18, P4744; Zagrebelsky M, 1998, J NEUROSCI, V18, P7912	50	11	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	APR	2002	28	2					95	106		10.1046/j.1365-2990.2002.00375.x			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	545HQ	WOS:000175211700002	11972796				2022-02-06	
J	Winston, FK; Kallan, MJ; Elliott, MR; Menon, RA; Durbin, DR				Winston, FK; Kallan, MJ; Elliott, MR; Menon, RA; Durbin, DR			Risk of injury to child passengers in compact extended-cab pickup trucks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context An increasing number of compact pickup trucks can accommodate restrained rear occupants. Rear seats in these pickup trucks are exempt from regulatory safety testing though their relative safety has not been determined. Objectives To evaluate the risk of injury to children in compact extended-cab pickup trucks compared with children in other vehicles and to determine if any unique hazards exist. Design Cross-sectional study of children aged 15 years or younger in crashes of insured vehicles, with data collected via insurance claim records and a telephone survey. Setting and Participants Probability sample of 7192 multirow vehicles involved in crashes, with 11335 child occupants, in 3 large US regions from December 1, 1998, to November 30, 2000. Main Outcome Measure Relative risk of injury, defined as concussions and more serious brain injuries, spinal cord injuries, internal organ injuries, extremity fractures, and facial lacerations, estimated by odds ratios (ORs) adjusting for age, restraint use, point of impact, vehicle weight, and crash severity. Results Injuries were reported for 1356 children, representing 1.6% of the population. Children in compact extended-cab pickup trucks were at greater risk of injury than children in other vehicles (adjusted OR, 2.96; 95% confidence interval [CI], 1.68-5.21). Children in the rear seats of compact pickup trucks were at substantially greater risk of injury than rear-seated children in other vehicles (adjusted OR, 4.75; 95% CI, 2.39-9.43). Children seated in the front seat of compact extended-cab pickup trucks were at greater risk of injury than children in the front seats of other vehicles, but this risk was not statistically significant (adjusted OR, 1.70; 95% CI, 0.78-3.69). Conclusions Children in compact extended-cab pickup trucks are not as safe as children in other vehicles, primarily due to the increased relative risk of injury in the back seat. For families with another choice of vehicle, clinicians should advise parents against transporting children in compact pickup trucks. The current exemption for regulatory testing for occupant protection in the rear seats of compact pickup trucks should be reconsidered.	Childrens Hosp Philadelphia, TraumaLink Interdisciplinary Pediat Trauma Res Ct, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Emergency Med, Philadelphia, PA 19104 USA		Winston, FK (corresponding author), Childrens Hosp Philadelphia, TraumaLink Interdisciplinary Pediat Trauma Res Ct, 34th St & Civ Ctr Blvd,3535 TraumaLink,10th Floor, Philadelphia, PA 19104 USA.		Durbin, Dennis/AAD-7829-2022				AGRAN PF, 1990, JAMA-J AM MED ASSOC, V264, P712, DOI 10.1001/jama.264.6.712; *AM AC PED, 2001, INF CHILD RESTR; ANDERSON C, 2000, 44 ANN P ASS ADV AUT; Anderson CL, 2000, ACCIDENT ANAL PREV, V32, P533, DOI 10.1016/S0001-4575(99)00075-5; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Braver E R, 1998, Inj Prev, V4, P181; Bull MJ, 2000, PEDIATRICS, V106, P857; *BUR CENS, 1999, PUBL BUR CENS; Durbin DR, 1999, ARCH PEDIAT ADOL MED, V153, P404; Durbin DR, 2001, ACCIDENT ANAL PREV, V33, P407, DOI 10.1016/S0001-4575(00)00054-3; EDWARDS J, 1997, SOC AUT ENG GOV IND; *INS I HIGHW SAF H, 1999, VINDICATOR 2000; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; *NAT HIGHW TRAFF S, 2001, CHILD SAF SEAT US CH; *NAT INS CRIM BUR, 2000, 2000 PASS VEH ID MAN; WILLIAMS AF, 1977, ACCIDENT ANAL PREV, V9, P69, DOI 10.1016/0001-4575(77)90007-0; Winston FK, 2000, PEDIATRICS, V105, P1179, DOI 10.1542/peds.105.6.1179; Wittenberg E, 1999, PEDIATRICS, V104, P1247, DOI 10.1542/peds.104.6.1247	18	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1147	1152		10.1001/jama.287.9.1147			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527KV	WOS:000174186000030	11879112	Bronze			2022-02-06	
J	Chuang, JI; Chen, ST				Chuang, JI; Chen, ST			Differential expression of Bcl-2 and APP immunoreactivity after intrastriatal injection of MPP+ in the rat	NEUROCHEMISTRY INTERNATIONAL			English	Article						Bcl-2; amyloid precursor protein; glia; neurodegeneration	AMYLOID PRECURSOR PROTEIN; PROTOONCOGENE PROTEINS; NEURONAL DEGENERATION; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; X EXPRESSION; BRAIN INJURY; CELL-DEATH; APOPTOSIS	While there is growing evidence that Bcl-2 proto-oncogene and P-amyloid precursor proteins (APP) are neuroprotective in function, our recent studies have demonstrated that Bcl-2 and APP may be co-expressed and co-regulated in retinal neurons or glia under normal or experimental conditions. Whether Bcl-2 and APP are functionally coupled in other neuronal systems is not clear. This issue was investigated further in the present experiments by examining the expression pattern of two molecules after unilateral intrastriatal injection of 1-methyl-4-phenyl-pyridinium (MPP+), a neurotoxic metabolite that selectively damages dopaminergic neurons. One hour to 2 months after MPPI injection into rat striatum, a significant increase in Bcl-2 expression was observed in distinct populations of neurons, astrocyte-like and OX-42-positive cells not only in traumatic regions but also in remote areas including the ipsilateral cortex and substantia nigra (SN). No detectable change was observed in the striatum, cortex or SN on the contralateral side of the brain. The immunoreactive pattern and time-dependent APP increase was similar to that of Bcl-2 in the severely injured striatum. and cortex. However, an up-regulation of Bcl-2 expression, but not APP, appears in dopaminergic neurons in the ipsilateral SN pars compacta where there was retrograde degeneration. In contrast, APP immunoreactivity was decreased in the hippocampus following intrastriatal injury, whereas, no alteration in Bcl-2 expression was detected. The differential changes in Bcl-2 and APP expression in nigral neurons and some other brain tissues suggest that these proteins may not be co-regulated by a common mechanism, at least in certain neuronal pathways. (C) 2001 Elsevier Science Ltd. All rights reserved.	Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 701, Taiwan; Natl Cheng Kung Univ, Coll Med, Dept Anat, Tainan 701, Taiwan		Chen, ST (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 701, Taiwan.						ACUNACASTROVIEJ.D, 1997, LIFE SCI, V60, P23; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; BANATI RB, 1993, GLIA, V9, P199, DOI 10.1002/glia.440090305; Chen ST, 1999, EXP BRAIN RES, V124, P241, DOI 10.1007/s002210050619; Chen ST, 1998, J NEUROPATH EXP NEUR, V57, P16, DOI 10.1097/00005072-199801000-00003; Chen ST, 1996, J NEUROPATH EXP NEUR, V55, P1073, DOI 10.1097/00005072-199655100-00007; CHEN ST, 1994, NEUROSCI LETT, V172, P11, DOI 10.1016/0304-3940(94)90650-5; Chen ST, 1999, NEUROCHEM INT, V35, P371, DOI 10.1016/S0197-0186(99)00078-9; Chuang JI, 1999, J NEUROCHEM, V73, pS189; Chuang JI, 2001, J CHEM NEUROANAT, V21, P215, DOI 10.1016/S0891-0618(01)00109-0; Fallon J, 1997, EXP NEUROL, V144, P193, DOI 10.1006/exnr.1997.6416; Ferrer I, 1998, EXP BRAIN RES, V121, P167, DOI 10.1007/s002210050448; Furukawa K, 1998, NEUROSCIENCE, V83, P429, DOI 10.1016/S0306-4522(97)00398-9; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GIULIAN D, 1993, GLIA, V7, P102, DOI 10.1002/glia.440070116; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GOEDERT M, 1987, EMBO J, V6, P3627, DOI 10.1002/j.1460-2075.1987.tb02694.x; Goodman Y, 1996, BRAIN RES, V706, P328, DOI 10.1016/0006-8993(95)01367-9; HAAN J, 1990, CLIN NEUROL NEUROSUR, V92, P305, DOI 10.1016/0303-8467(90)90055-A; HIGGINS LS, 1995, P NATL ACAD SCI USA, V92, P4402, DOI 10.1073/pnas.92.10.4402; Hochman A, 1998, J NEUROCHEM, V71, P741; JAVITCH JA, 1983, EUR J PHARMACOL, V90, P461, DOI 10.1016/0014-2999(83)90574-5; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lopez E, 1999, NEUROSCIENCE, V91, P1461, DOI 10.1016/S0306-4522(98)00704-0; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Mogi M, 1996, NEUROSCI LETT, V215, P137, DOI 10.1016/0304-3940(96)12961-X; MUCKE L, 1995, J EXP MED, V181, P1551, DOI 10.1084/jem.181.4.1551; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Offen D, 1998, P NATL ACAD SCI USA, V95, P5789, DOI 10.1073/pnas.95.10.5789; PAXINOS G, 1982, RAT BRAIN STEREOTAIC; Pierce JES, 1996, J NEUROSCI, V16, P1083; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461; SATOU T, 1995, BRAIN RES, V697, P35, DOI 10.1016/0006-8993(95)00748-F; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SIMAN R, 1989, NEURON, V3, P272; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Voehringer DW, 1998, P NATL ACAD SCI USA, V95, P2956, DOI 10.1073/pnas.95.6.2956; WALLACE W, 1993, P NATL ACAD SCI USA, V90, P8712, DOI 10.1073/pnas.90.18.8712	42	11	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186			NEUROCHEM INT	Neurochem. Int.	FEB	2002	40	2					169	179		10.1016/S0197-0186(01)00075-4			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	510ZG	WOS:000173237000008	11738483				2022-02-06	
J	Chang, A; Paratz, J; Rollston, J				Chang, A; Paratz, J; Rollston, J			Ventilatory effects of neurophysiological facilitation and passive movement in patients with neurological injury	AUSTRALIAN JOURNAL OF PHYSIOTHERAPY			English	Article						head injuries; closed; physical stimulation; physical therapy; respiratory mechanics	PULSE OXIMETRY; EXERCISE; THERAPY	Thirteen intubated, high dependency patients with neurological injuries were studied in order to investigate the short term respiratory effects of neurophysiological facilitation and passive movement on tidal volume (V-T), minute ventilation (V-E), respiratory rate (V-R) and oxygen saturation (SpO(2)). The subjects were studied under four conditions: no intervention (control) and during periods of neurophysiological facilitation, passive movement and sensory stimulation. All periods were standardised to three minutes duration and all parameters were recorded before and after each intervention. Neurophysiological facilitation produced significant increases (p < 0.01) in V-E and SpO(2) (p < 0.05) when compared with control values, with an overall mean increase in V-E of 14.6%. Similarly, passive movement increased V-E (p < 0.01) by an average of 9.8% and also increased SpO(2) (p < 0.01). In contrast, sensory stimulation produced significant increases (p < 0.01) in SpO(2) with control levels, with no significant change in V-T or V-E. There was no significant difference in V-R with all treatments. This study provides preliminary evidence of improved short term ventilatory function following neurophysiological facilitation, independent of generalised sensory stimulation, which has not been previously examined in the literature, supporting its use in the management of high dependency neurological patients.	Univ Queensland, Physiotherapy Dept, Brisbane, Qld 4072, Australia; La Trobe Univ, Bundoora, Vic 3083, Australia; Derbyshire Royal Infirm, Derby DE1 2QY, England		Chang, A (corresponding author), Univ Queensland, Physiotherapy Dept, Brisbane, Qld 4072, Australia.	a.chang@shrs.uq.edu.au					Ada L, 1990, KEY ISSUES NEUROLOGI, P249; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; BETHUNE DD, 1975, PHYSIOTHER CAN, V27, P241; Brimioulle S, 1997, PHYS THER, V77, P1682, DOI 10.1093/ptj/77.12.1682; Chen LM, 1998, CRIT CARE MED, V26, P1834, DOI 10.1097/00003246-199811000-00025; Ciesla ND, 1996, PHYS THER, V76, P609, DOI 10.1093/ptj/76.6.609; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; EKLUND G, 1964, J PHYSIOL-LONDON, V171, P139, DOI 10.1113/jphysiol.1964.sp007368; ESCOURROU PJL, 1990, CHEST, V97, P635, DOI 10.1378/chest.97.3.635; Gruen P, 1998, EMERG MED CLIN N AM, V16, P63, DOI 10.1016/S0733-8627(05)70349-7; GUYTON, 1991, TXB MED PHYSL, P525; ISHIDA K, 1994, ACTA PHYSIOL SCAND, V151, P343, DOI 10.1111/j.1748-1716.1994.tb09753.x; ISHIDA K, 1993, EUR J APPL PHYSIOL, V66, P507, DOI 10.1007/BF00634300; NYARWAYA JB, 1994, ANAESTHESIA, V49, P775; PIEPER A, 1963, CEREBRAL FUNCTION IN; Prough DS, 1997, J TRAUMA, V42, pS10, DOI 10.1097/00005373-199705001-00003; Pryor JA., 2002, PHYSIOTHERAPY RESP C, V3, P161; SHERWOOD L, 1993, HUMAN PHYSL CELLS SY, P418	18	11	12	0	1	AUSTRALIAN PHYSIOTHERAPY ASSOC	ST KILDA	LEVEL 3, 201  FITZROY ST, ST KILDA, 3182, AUSTRALIA	0004-9514			AUST J PHYSIOTHER	Aust. J. Physiother.		2002	48	4					305	310		10.1016/S0004-9514(14)60170-7			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	627XA	WOS:000179960600007	12443525	Bronze			2022-02-06	
J	Shafer, LL; McNulty, JA; Young, MRI				Shafer, LL; McNulty, JA; Young, MRI			Brain activation of monocyte lineage cells: Brain-derived soluble factors differentially regulate BV2 microglia and peripheral macrophage immune functions	NEUROIMMUNOMODULATION			English	Article						phagocytosis; MHC II; ANA 1; organotypic; coculture	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC NEURONAL INJURY; IN-VITRO; UP-REGULATION; ANTIGEN PRESENTATION; INTERFERON-GAMMA; NITRIC-OXIDE; BONE-MARROW; PHAGOCYTOSIS; EXPRESSION	Brain injury and subsequent neurodegeneration are often associated with infiltrating leukocytes and the activation of microglia as well as other infiltrating cells. However, the characteristics of activation are poorly understood. The objective of this study was to further the understanding of brain regulation of microglial activation. We used an organotypic coculture paradigm to assess how brain-derived soluble factors modulate microglia and peripheral macrophage activation through microscopy and flow cytometry techniques. In the presence of brain-derived soluble factors, the BV2 microglia cell line increased MHC II and phagocytic receptor (Fcgamma II/III) expression. The increased expression correlated with a functional increase in phagocytic activity, but did not correlate with an increase in allostimulation ability. Furthermore, this interaction was selective to an interaction between brain-derived soluble factor(s) and BV2 microglia, since it was not observed in the ANA1 macrophage cell line or in primary peritoneal macrophages. The results indicated that brain-derived soluble factor(s) modulate microglial activation in a manner that is distinct from the effects on peripheral macrophages. Moreover, our results suggest that inflammatory events associated with some types of brain injury may be induced by the brain without dependence on infiltrating peripheral macrophages or T lymphocytes.	Hines VA Hosp, Res Serv, Hines, IL 60141 USA; Loyola Univ, Med Ctr, Dept Cell Biol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Neurobiol & Anat, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Otolaryngol, Maywood, IL 60153 USA		Young, MRI (corresponding author), Hines VA Hosp, Res Serv, Bldg 1,Rm A319, Hines, IL 60141 USA.	myoung1@lumc.edu			NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA085266, R21CA077208, R55CA078262] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21-CA77208-1, R55-CA78262, R01-CA85266, R01-CA4500] Funding Source: Medline		Acarin L, 1999, NEUROSCIENCE, V89, P549, DOI 10.1016/S0306-4522(98)00331-5; Acarin L, 1996, J COMP NEUROL, V367, P361; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Aloisi F, 2000, J IMMUNOL, V164, P1705, DOI 10.4049/jimmunol.164.4.1705; Aloisi F, 1998, J IMMUNOL, V160, P4671; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Bechmann I, 2000, ANN NY ACAD SCI, V911, P192; BELL MD, 1994, J NEUROCYTOL, V23, P605, DOI 10.1007/BF01191555; Beyer M, 2000, GLIA, V31, P262, DOI 10.1002/1098-1136(200009)31:3<262::AID-GLIA70>3.0.CO;2-2; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brana C, 1999, J NEUROSCI METH, V90, P7, DOI 10.1016/S0165-0270(99)00045-X; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; CASH E, 1993, CELL IMMUNOL, V147, P129, DOI 10.1006/cimm.1993.1053; Chang RCC, 2000, BRAIN RES, V853, P236, DOI 10.1016/S0006-8993(99)02255-6; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; DAS GD, 1976, VIRCHOWS ARCH B, V20, P287; del Zoppo GJ, 2001, ARCH NEUROL-CHICAGO, V58, P669, DOI 10.1001/archneur.58.4.669; Duport S, 1998, P NATL ACAD SCI USA, V95, P1840, DOI 10.1073/pnas.95.4.1840; FREI K, 1987, EUR J IMMUNOL, V17, P1271, DOI 10.1002/eji.1830170909; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Giulian D, 1996, NEUROCHEM INT, V29, P65, DOI 10.1016/0197-0186(95)00140-9; Greenberg S, 2001, J CELL SCI, V114, P1039; Han YF, 2000, NEUROSCI LETT, V288, P95, DOI 10.1016/S0304-3940(00)01198-8; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Iglesias BM, 1997, J NEUROIMMUNOL, V72, P83, DOI 10.1016/S0165-5728(96)00155-5; Jander S, 1996, GLIA, V18, P255, DOI 10.1002/(SICI)1098-1136(199611)18:3<255::AID-GLIA9>3.0.CO;2-Y; Kant A, 1996, LEUKEMIA RES, V20, P93, DOI 10.1016/0145-2126(95)00126-3; Kopec KK, 1998, J NEUROCHEM, V71, P2123; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LASSMANN H, 1991, J NEUROSCI RES, V28, P236, DOI 10.1002/jnr.490280211; Mato M, 1996, P NATL ACAD SCI USA, V93, P3269, DOI 10.1073/pnas.93.8.3269; Matsubara T, 1999, INVEST OPHTH VIS SCI, V40, P3186; MATSUMOTO Y, 1986, J IMMUNOL, V136, P3668; MAUERHOFF T, 1988, J NEUROIMMUNOL, V18, P271, DOI 10.1016/0165-5728(88)90049-5; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MORGENSTERN S, 1965, ANAL BIOCHEM, V13, P149, DOI 10.1016/0003-2697(65)90129-6; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; PAUETTE RL, 1995, MOL IMMUNOL, V32, P841; Perry VH, 1998, J NEUROIMMUNOL, V90, P113; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; RIESKE E, 1989, BRAIN RES, V492, P1, DOI 10.1016/0006-8993(89)90883-4; Sakai M, 2000, BIOCHEM BIOPH RES CO, V278, P79, DOI 10.1006/bbrc.2000.3767; SCHWAB ME, 1990, TRENDS NEUROSCI, V13, P452, DOI 10.1016/0166-2236(90)90098-U; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; SMITH ME, 1993, J NEUROSCI RES, V35, P480, DOI 10.1002/jnr.490350504; Sriram S, 1997, NEUROLOGY, V48, P464, DOI 10.1212/WNL.48.2.464; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sugaya K, 1997, NEUROREPORT, V8, P2241, DOI 10.1097/00001756-199707070-00030; Toku K, 1999, J NEUROSCI RES, V57, P855, DOI 10.1002/(SICI)1097-4547(19990915)57:6<855::AID-JNR11>3.0.CO;2-R; Walker WS, 1999, J NEUROIMMUNOL, V94, P127, DOI 10.1016/S0165-5728(98)00237-9; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Wilson ME, 2000, BRAIN RES, V873, P235, DOI 10.1016/S0006-8993(00)02479-3; WOODROOFE MN, 1986, J NEUROL SCI, V74, P135, DOI 10.1016/0022-510X(86)90100-0; WUCHERPFENNIG KW, 1994, CLIN IMMUNOL IMMUNOP, V72, P293, DOI 10.1006/clin.1994.1145; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029	67	11	12	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2002	10	5					283	294		10.1159/000069972			12	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	681RR	WOS:000183049600004	12759565				2022-02-06	
J	Donders, J				Donders, J			Clinical utility of the category test as a multidimensional instrument	PSYCHOLOGICAL ASSESSMENT			English	Article							NEUROPSYCHOLOGICAL TEST-PERFORMANCE	The construct and criterion validities of the Category Test (CT) were evaluated in 162 participants who had sustained traumatic brain injury and had been screened carefully for confounding factors. Maximum likelihood factor analysis identified 2 latent constructs, consistent with previous research. However, only subtests associated with the Proportional Reasoning factor (Subtexts V and VI) demonstrated consistent criterion validity in terms of sensitivity to injury severity. Performance of Subtext III, associated with the Spatial Positioning factor, was in the range of chance for more than a third of the sample, without any relationship to injury variables. It was concluded that the CT has construct validity as a multidimensional instrument but that only the Proportional Reasoning factor has criterion validity in the evaluation of sequelae of traumatic brain injury.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	idonders@mfbrc.com					Allen DN, 1999, J CLIN EXP NEUROPSYC, V21, P237, DOI 10.1076/jcen.21.2.237.926; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Choca JP, 1997, NEUROPSYCHOL REV, V7, P61, DOI 10.1023/B:NERV.0000005944.98635.16; DEFILIPPIS NA, 1987, BOOKLET CATEGORY TES; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Johnstone B, 1997, PSYCHOL ASSESSMENT, V9, P28, DOI 10.1037/1040-3590.9.1.28; LANDSDELL H, 1977, J CONSULT CLIN PSYCH, V45, P412; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; Reitan RM, 1985, HALSTEADREITAN NEURO; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Vanderploeg RD, 1997, CLIN NEUROPSYCHOL, V11, P210, DOI 10.1080/13854049708407054; Wolfson, 1988, TRAUMATIC BRAIN INJU, VII	15	11	11	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	DEC	2001	13	4					592	594		10.1037/1040-3590.13.4.592			3	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	504GJ	WOS:000172848700016	11793902				2022-02-06	
J	Huisman, TAGM; Hawighorst, H; Benoit, CH; Sorensen, AG				Huisman, TAGM; Hawighorst, H; Benoit, CH; Sorensen, AG			Diffusion weighted magnetic resonance imaging: Ischemic and traumatic injury of the central nervous system	RADIOLOGE			German	Article						diffusion weighted MRI; apparent diffusion coefficient; anisotropic diffusion; anisotropic diffusion; trauma; stroke	RAT SPINAL-CORD; ACUTE STROKE; IN-VIVO; MR; ANISOTROPY	Diffusion weighted magnetic resonance imaging (DWI) represents a recent development that extends imaging from the depiction of the neuroanatomy into the field of functional and physiologic processes. DWI measures a fundamentally different physiologic parameter than conventional MRI. Image contrast is related to differences in the microscopic motion (diffusion) of water molecules within brain tissue rather than a change in total tissue water. Consequently, DWI can reveal pathology where conventional T1- and T2-weighted MR images are negative. DWI has clinically proven its value in the assessment of acute cerebral stroke and trauma by showing cerebral injury early due to ist ability to discriminate between lesions with cytotoxic edema (decreased diffusion) from lesions with vasogenic edema (increased diffusion). Full tensor DWI allows to calculate a variety of functional maps, the most widely used maps include maps of apparent diffusion coefficients and isotropic diffusion. In addition maps of anisotropic diffusion can be calculated which are believed to give information about the integrity and location of fiber tracts. This functional-anatomical information will most probably play an increasingly important role in the early detection of primary and secondary tissue injury from various reasons and could guide and validate current and future neuroprotective treatments.	Massachusetts Gen Hosp, NMR Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Swiss Parapleg Ctr, Inst Radiol, Nottwil, Switzerland		Huisman, TAGM (corresponding author), Massachusetts Gen Hosp, NMR Ctr, Mailingcode 149,2301, Charlestown, MA 02119 USA.						Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; CHIEN D, 1992, AM J NEURORADIOL, V13, P1097; Clark CA, 1999, MAGN RESON MED, V41, P1269, DOI 10.1002/(SICI)1522-2594(199906)41:6<1269::AID-MRM26>3.0.CO;2-2; DOUSSET V, 1997, P AM SOC NEUR TOR; FORD JC, 1994, MAGNET RESON MED, V31, P488, DOI 10.1002/mrm.1910310504; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GEAN AD, 1994, IMAGING HEAD TRAUMA, P217; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Holder CA, 2000, AM J NEURORADIOL, V21, P1799; Inglis BA, 1997, MAGN RESON IMAGING, V15, P441, DOI 10.1016/S0730-725X(96)00242-1; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; MOHR JP, 1995, STROKE, V26, P807, DOI 10.1161/01.STR.26.5.807; NAKADA T, 1994, NEUROREPORT, V5, P2053, DOI 10.1097/00001756-199410270-00016; NOMURA Y, 1994, AM J NEURORADIOL, V15, P231; Provenzale JM, 1999, AM J ROENTGENOL, V173, P1459, DOI 10.2214/ajr.173.6.10584783; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005	18	11	16	0	6	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0033-832X			RADIOLOGE	Radiologe	DEC	2001	41	12					1038	+		10.1007/s001170170003			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	506HQ	WOS:000172964600003	11793928				2022-02-06	
J	Nariai, T; Suzuki, R; Ohta, Y; Ohno, K; Hirakawa, K				Nariai, T; Suzuki, R; Ohta, Y; Ohno, K; Hirakawa, K			Focal cerebral hyperemia in postconcussive amnesia	JOURNAL OF NEUROTRAUMA			English	Article						amnesia; cerebral blood flow; cerebral concussion; head injury; hyperemia, posttraumatic amnesia; xenon CT	MILD HEAD-INJURY; ENHANCED COMPUTED-TOMOGRAPHY; TRAUMATIC BRAIN INJURY; BLOOD-FLOW; RETROGRADE-AMNESIA; WORKING-MEMORY; CT; HIPPOCAMPUS; ACTIVATION; HUMANS	Transient amnesia caused by minor head injury is commonly encountered in daily neurosurgical practice, but the mechanism of such amnesia has not been extensively studied. We measured the regional cerebral blood flow (rCBF) of patients with postconcussive amnesia with Xe/CT CBF to examine whether a focal disturbance of CBF exists. The Xe/CT CBF study was performed in eight patients with closed head injury without organic cerebral lesion while they were suffering from posttraumatic amnesia (concussion group). The time interval between accident and CBF measurement was less than 2 h in three patients, 5-6 h in two, 8-9 h in two, and 18 in one. The results were compared with those of nine normal volunteers and eight other age-matched patients who recovered without any neurological deficit despite the presence of hemorrhagic regions (mild hemorrhage group). The rCBF of the concussion group was significantly elevated in the bilateral mesial temporal cortex in comparison to the normal group. The rCBF in the mild hemorrhage group was lower than that of normal controls in all regions. The analysis of right-left difference in CBF indicated that there was significant asymmetry (right > left) in the frontal and temporal cortex in the concussion group, but not in the normal and mild hemorrhage group. This Xe/CT CBF study in acute stages of cerebral concussion, in which patients were amnestic, detected focal cerebral hyperemia. Such hyperemia in regions closely related to human memory function may be the result of vasoparalysis or the compensatory activation of memory circuits after denervation injury.	Tokyo Med & Dent Univ, Dept Neurosurg, Tokyo, Japan; Showa Univ, Fujigaoka Hosp, Dept Neurosurg, Yokohama, Kanagawa 227, Japan		Nariai, T (corresponding author), Tokyo Med & Dent Univ, Dept Neurosurg, Tokyo, Japan.						ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; BARON JC, 1994, BRAIN, V117, P545, DOI 10.1093/brain/117.3.545; BIESOLD D, 1989, NEUROSCI LETT, V98, P39, DOI 10.1016/0304-3940(89)90370-4; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; CAO WH, 1989, NEUROSCI LETT, V107, P135, DOI 10.1016/0304-3940(89)90805-7; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; FALCONER MA, 1971, EPILEPSIA, V12, P13, DOI 10.1111/j.1528-1157.1971.tb03912.x; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GUR D, 1982, SCIENCE, V215, P1267, DOI 10.1126/science.7058347; Jacobs A, 1996, J NUCL MED, V37, P1605; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KALENDER WA, 1991, J COMPUT ASSIST TOMO, V15, P816, DOI 10.1097/00004728-199109000-00017; KAMEYAMA M, 1983, EXP NEUROL, V79, P329, DOI 10.1016/0014-4886(83)90217-0; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kraus J, 1996, NEUROTRAUMA, P13; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KUSCHINSKY W, 1978, PHYSIOL REV, V58, P656, DOI 10.1152/physrev.1978.58.3.656; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MAEHARA T, 1993, ADV NEUROTRAUMA RES, V5, P83; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; Masdeu J C, 1994, J Neuroimaging, V4, P177; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCBEAN DE, 1990, BRAIN RES, V537, P307, DOI 10.1016/0006-8993(90)90374-K; NARIAI T, 1995, AM J NEURORADIOL, V16, P563; Obrist WD, 1998, J CEREBR BLOOD F MET, V18, P1192, DOI 10.1097/00004647-199811000-00005; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Qian L, 1996, ACTA NEUROCHIR, V138, P90, DOI 10.1007/BF01411731; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Stein S. C., 1996, NEUROTRAUMA, P31; SUZUKI R, 1986, PROG CT, V8, P139; TOUHO H, 1988, RADIOLOGY, V168, P207, DOI 10.1148/radiology.168.1.3380959; Tsuchida E, 1999, J NEUROTRAUM, V16, P595, DOI 10.1089/neu.1999.16.595; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; YONAS H, 1991, J CEREBR BLOOD F MET, V11, P716, DOI 10.1038/jcbfm.1991.128; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	47	11	12	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2001	18	12					1323	1332		10.1089/08977150152725623			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	504RE	WOS:000172869000003	11780863				2022-02-06	
J	Yakubovich, N; Eldstrom, JR; Mathers, DA				Yakubovich, N; Eldstrom, JR; Mathers, DA			Lipopolysaccharide can activate BK channels of arterial smooth muscle in the absence of iNOS expression	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						vascular smooth muscle cell; Ca2+-activated potassium channel; BK channel; lipopolysaccharide; inducible nitric oxide synthase; iNOS knockout mouse	NITRIC-OXIDE SYNTHASE; INDUCIBLE NO SYNTHASE; DEPENDENT PROTEIN-KINASE; MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN INJURY; K-CA CHANNELS; RAT AORTA; POTASSIUM CHANNEL; HIGH-CONDUCTANCE; ENDOTOXIC-SHOCK	The role of inducible nitric oxide synthase (iNOS) in the acute activation of large-conductance, Ca2+-dependent K+ channels (BK channels) by Escherichia coli endotoxin (lipopolysaccharide, LPS) was studied in murine vascular smooth muscle cells. Confocal laser scanning microscopy and patch clamp recordings were utilised. Within 2 h of donor rat sacrifice, iNOS-like immunoreactivity Could be detected in cerebrovascular smooth muscle cells (CVSMCs) enzymatically dispersed from rat cerebral arteries. This staining was absent in cells fixed immediately after donor rat sacrifice. LPS as then applied to the cytoplasmic face of inside-out membrane patches excised from rat CVSMCs within 2-4 h of donor rat sacrifice. It was found that LPS (10-100 mug/ml) rapidly and reversibly increased the open probability of BK channels in these patches. This LPS response was not altered in the presence of the non-isoform specific NOS inhibitor N-omega-nitro-L-arginine. LPS responses were then compared in aortic smooth muscle (ASMC) BK channels derived from wild-type and iNOS-knockout (iNOS-KO) mice. LPS activated BK channels in inside-out patches of ASMC membrane derived from both wild-type and iNOS-knockout mice. These Studies establish that LPS can activate BK channels by a mechanism quite independent of the well-established pathway mediated by iNOS in vascular smooth muscle cells. ((C)) 2001 Elsevier Science B.V. All rights reserved.	Univ British Columbia, Dept Physiol, Vancouver, BC V6T 1Z3, Canada		Mathers, DA (corresponding author), Univ British Columbia, Dept Physiol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.						Alonso MJ, 1998, J AUTON PHARMACOL, V18, P105, DOI 10.1046/j.1365-2680.1998.1820105.x; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Briones AM, 1999, BRIT J PHARMACOL, V126, P111, DOI 10.1038/sj.bjp.0702281; Brophy CM, 2000, AM J PHYSIOL-HEART C, V278, pH991, DOI 10.1152/ajpheart.2000.278.3.H991; Cernadas MR, 1998, CIRC RES, V83, P279, DOI 10.1161/01.RES.83.3.279; Chen SJ, 1999, N-S ARCH PHARMACOL, V359, P493, DOI 10.1007/PL00005381; Chou TC, 1998, HYPERTENSION, V31, P643, DOI 10.1161/01.HYP.31.2.643; Chyu KY, 1999, CIRC RES, V85, P1192; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Das R, 1999, BRIT J PHARMACOL, V128, P493, DOI 10.1038/sj.bjp.0702737; Gunnett CA, 1998, AM J PHYSIOL-HEART C, V275, pH416, DOI 10.1152/ajpheart.1998.275.2.H416; Hall S, 1996, BIOCHEM BIOPH RES CO, V224, P184, DOI 10.1006/bbrc.1996.1005; Hecker M, 1999, GEN PHARMACOL, V32, P9, DOI 10.1016/S0306-3623(98)00082-2; Hoang L, 1998, BBA-BIOMEMBRANES, V1369, P335, DOI 10.1016/S0005-2736(97)00237-X; Hoang LM, 1998, BRIT J PHARMACOL, V123, P5, DOI 10.1038/sj.bjp.0701570; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 1999, J GEN PHYSIOL, V114, P305, DOI 10.1085/jgp.114.2.305; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Ishiwata T, 1997, JPN HEART J, V38, P445; Laporte R, 1997, J VASC RES, V34, P325, DOI 10.1159/000159242; LeCras TD, 1996, AM J PHYSIOL-LUNG C, V270, pL164, DOI 10.1152/ajplung.1996.270.1.L164; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Marin J, 1997, PHARMACOL THERAPEUT, V75, P111, DOI 10.1016/S0163-7258(97)00051-X; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Mertineit C, 2000, CAN J PHYSIOL PHARM, V78, P217, DOI 10.1139/cjpp-78-3-217; MIYOSHI H, 1994, J MOL CELL CARDIOL, V26, P1487, DOI 10.1006/jmcc.1994.1167; Morales E, 1996, J PHYSIOL-LONDON, V495, P701, DOI 10.1113/jphysiol.1996.sp021627; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; Muller B, 2000, PHYSIOL RES, V49, P19; Nicholson SC, 1999, J SURG RES, V86, P198, DOI 10.1006/jsre.1999.5715; Palacios B, 1996, EUR J PHARMACOL, V296, P75, DOI 10.1016/0014-2999(95)00765-2; REES DD, 1990, BIOCHEM BIOPH RES CO, V173, P541, DOI 10.1016/S0006-291X(05)80068-3; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Schwarz PM, 1999, ARTERIOSCL THROM VAS, V19, P2584, DOI 10.1161/01.ATV.19.11.2584; Segal SS, 1999, AM J PHYSIOL-HEART C, V277, pH1167; Senba E, 1997, NEUROSCI RES, V29, P183, DOI 10.1016/S0168-0102(97)00095-3; Sennequier N, 1996, BIOCHEMISTRY-US, V35, P5883, DOI 10.1021/bi952844e; Sherman TS, 1999, AM J PHYSIOL-LUNG C, V276, pL383, DOI 10.1152/ajplung.1999.276.2.L383; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Snetkov VA, 1996, EXP PHYSIOL, V81, P743, DOI 10.1113/expphysiol.1996.sp003973; Taguchi H, 1996, J PHARMACOL EXP THER, V279, P1514; TANIGUCHI J, 1993, PFLUG ARCH EUR J PHY, V423, P167, DOI 10.1007/BF00374390; Thiemermann C, 1997, GEN PHARMACOL-VASC S, V29, P159, DOI 10.1016/S0306-3623(96)00410-7; Trovati M, 1999, DIABETOLOGIA, V42, P831, DOI 10.1007/s001250051234; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang R, 1997, J BIOL CHEM, V272, P8222, DOI 10.1074/jbc.272.13.8222; WANG Y, 1993, J PHYSIOL-LONDON, V462, P529, DOI 10.1113/jphysiol.1993.sp019567; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Yan ZQ, 1999, ARTERIOSCL THROM VAS, V19, P2854, DOI 10.1161/01.ATV.19.12.2854	52	11	12	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736			BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	OCT 1	2001	1514	2					239	252		10.1016/S0005-2736(01)00378-9			14	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	474QG	WOS:000171117900009	11557024	Bronze			2022-02-06	
J	Jacobs, R; Anderson, V; Harvey, AS				Jacobs, R; Anderson, V; Harvey, AS			Neuropsychological profile of a 9-year-old child with subcortical band heterotopia or 'double cortex'	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							DIFFUSE CORTICAL DYSPLASIA; TRAUMATIC BRAIN INJURY; NEURONAL MIGRATION; MALFORMATIONS; DISORDERS; PROTEIN	Subcortical band heterotopia (SBH) or 'double cortex', is a congenital brain abnormality that results from aberrant migration of neurons during development of the cortex. MRI shows a continuous band of heterotopic grey matter located between the cortex and ventricular walls, separated from them by a thin layer of white matter. The condition is quite rare, found predominantly in females, and is occasionally familial with an X-linked dominant inheritance. Current research has focused on genetic and neurological correlates, with cognitive assessment restricted to a global measure of general intellectual functioning. This paper describes in detail the results of a neuropsychological assessment of a 9-year-old female recently diagnosed with SBH. Predominant features were a significantly reduced speed of processing for visuomotor and oral output and reduced immediate registration of information. This difficulty has functional implications affecting skill acquisition, learning in the classroom, and social interaction.	Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Dept Psychol, Melbourne, Vic, Australia; Univ Melbourne, Dept Psychol, Parkville, Vic 3052, Australia		Jacobs, R (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.						Allen KM, 1999, EPILEPSY RES, V36, P143, DOI 10.1016/S0920-1211(99)00048-0; Anderson P, 2001, CLIN NEUROPSYCHOL, V15, P81, DOI 10.1076/clin.15.1.81.1905; ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; ANDERSON V, 1995, NEUROPSYCHOLOGICAL A; BARKOVICH AJ, 1994, ANN NEUROL, V36, P609, DOI 10.1002/ana.410360409; BATTAGLIA GT, 1994, ITAL J NEUROL SCI, V15, P15; BROUWERS P, 1984, J CLIN NEUROPSYCHOL, V6, P325, DOI 10.1080/01688638408401222; DENNEY DR, 1973, DEV PSYCHOL, V9, P275, DOI 10.1037/h0035092; DEVOLDER AG, 1994, PEDIATR NEUROL, V11, P290, DOI 10.1016/0887-8994(94)90003-5; Dobyns WB, 1996, NEUROLOGY, V47, P331, DOI 10.1212/WNL.47.2.331; EVRARD P, 1992, HDB NEUROPSYCHOLOGY, V6, P11; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hannan AJ, 1999, J NEUROSCI RES, V55, P650, DOI 10.1002/(SICI)1097-4547(19990301)55:5<650::AID-JNR12>3.0.CO;2-S; HASHIMOTO R, 1993, BRAIN DEV-JPN, V15, P57, DOI 10.1016/0387-7604(93)90007-U; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; IANNETTI P, 1993, ACTA PAEDIATR, V82, P501; Jastak S., 1994, WIDE RANGE ACHIEVEME; Jozwiak S, 1998, ARCH NEUROL-CHICAGO, V55, P379, DOI 10.1001/archneur.55.3.379; KETONEN L, 1994, J CHILD NEUROL, V9, P384, DOI 10.1177/088307389400900409; KUZNIECKY RI, 1994, EPILIPSIA, V35, P44; Leventer RJ, 1999, NEUROLOGY, V53, P715, DOI 10.1212/WNL.53.4.715; Leventer RJ, 1998, J PAEDIATR CHILD H, V34, P6, DOI 10.1046/j.1440-1754.1998.00143.x; Manly T., 1999, TEST EVERYDAY ATTENT; MIURA K, 1993, BRAIN DEV-JPN, V15, P288, DOI 10.1016/0387-7604(93)90025-4; NORTHAM E, 2001, DEV NEUROPSYCHOLOGY; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; PALMINI A, 1991, NEUROLOGY, V41, P1656, DOI 10.1212/WNL.41.10.1656; PALMINI A, 1993, DEV MED CHILD NEUROL, V35, P331; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; REY A, 1941, ARCH PSYCHOL, V28, P240; RICCI S, 1992, ARCH NEUROL-CHICAGO, V49, P61, DOI 10.1001/archneur.1992.00530250065017; ROSS ME, 1997, HUM MOL GENET, V6, P552; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Weschler D, 1992, WESCHLER INTELLIGENC; WOOD S, 1999, J INT NEUROPSYCH SOC, V5, P274; WRENNALL J, 2001, DEV NEUROPSYCHOLOGY	42	11	11	0	2	CAMBRIDGE UNIV PRESS	PORT CHESTER	110 MIDLAND AVE, PORT CHESTER, NY 10573-9863 USA	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	SEP	2001	43	9					628	633		10.1017/S0012162201001141			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	490MU	WOS:000172056300009	11570633				2022-02-06	
J	Lukas, SE; Kouri, EM; Rhee, C; Madrid, A; Renshaw, PF				Lukas, SE; Kouri, EM; Rhee, C; Madrid, A; Renshaw, PF			Effects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effects	PSYCHOPHARMACOLOGY			English	Article						cocaine; citicoline; pharmacotherapy; subjective effect; plasma level; human subject	TRAUMATIC BRAIN INJURY; CEREBRAL BLOOD-FLOW; CDP-CHOLINE; PERFUSION; HUMANS; TECHNETIUM-99M-HMPAO; VOLUNTEERS; ABUSERS; MEMORY; USERS	Rationale: The majority of pharmacotherapies proposed for cocaine dependence have been marginally effective and frequently have undesirable side effects. We recently demonstrated that short-term treatment with citicoline decreased self-reported desire to use cocaine in crack cocaine users. Objective: The present study was conducted to assess the safety of citicoline in combination with cocaine by investigating whether cocaine-induced cardiovascular and behavioral effects and cocaine plasma levels are altered by citicoline pretreatment. Methods: Eight healthy male and female volunteers who used cocaine on an occasional basis participated in this randomized, placebo-controlled, three-visit study. During all three visits, subjects received an acute intranasal dose of cocaine (0.9 mg/kg) and were continuously monitored for the ensuing 3.5 h. The first visit involved no pretreatment, and visits 2 and 3 were preceded by a 4-day pretreatment period of either citicoline (1 g/day) or placebo. Results: Citicoline pretreatment did not alter the cardiovascular, physiologic, or subjective effects of acute cocaine. Conclusions: Although citicoline did not block the acute subjective effects of cocaine in a laboratory environment, the combined use of citicoline and a moderate dose of intranasal cocaine presented no added risk of cardiovascular effects. Further study is necessary to determine whether this medication (which is currently used to treat strokes) will be a useful adjunct to treat cocaine dependence.	Harvard Univ, Sch Med, McLean Hosp, Behav Psychopharmacol Res Lab, Belmont, MA 02478 USA; Harvard Univ, Sch Med, McLean Hosp, Brain Imaging Ctr, Belmont, MA 02478 USA		Lukas, SE (corresponding author), Harvard Univ, Sch Med, McLean Hosp, Behav Psychopharmacol Res Lab, 115 Mill St, Belmont, MA 02478 USA.		Renshaw, Perry/O-1384-2018		NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA0343, DA11098] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA011098] Funding Source: NIH RePORTER		Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; CHIDA N, 1973, TOHOKU J EXP MED, V111, P41, DOI 10.1620/tjem.111.41; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; CONE EJ, 1994, CLIN CHEM, V40, P1299; CORSO E A, 1982, Clinica Terapeutica, V102, P379; DARAS M, 1996, PUBL US DEP HHS, P43; HOLMAN BL, 1991, J NUCL MED, V32, P1206; Kaufman MJ, 1998, JAMA-J AM MED ASSOC, V279, P376, DOI 10.1001/jama.279.5.376; Kaufman MJ, 1998, PSYCHOPHARMACOLOGY, V138, P76, DOI 10.1007/s002130050647; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kosten T R, 1993, NIDA Res Monogr, V135, P48; Kouri EM, 2000, PSYCHOPHARMACOLOGY, V152, P268, DOI 10.1007/s002130000540; LEVIN JM, 1994, J NUCL MED, V35, P1902; LUKAS SE, 1994, PHARMACOL BIOCHEM BE, V48, P715, DOI 10.1016/0091-3057(94)90338-7; Lukas SE, 1996, PSYCHOPHARMACOLOGY, V125, P346, DOI 10.1007/BF02246017; MANSCHRECK TC, 1990, COMPR PSYCHIAT, V31, P369, DOI 10.1016/0010-440X(90)90045-T; MARTINET M, 1979, ARCH INT PHARMACOD T, V239, P52; Martins N, 1997, IEEE T POWER SYST, V12, P245, DOI 10.1109/59.574945; Mathew RJ, 1996, BIOL PSYCHIAT, V40, P609, DOI 10.1016/0006-3223(95)00033-X; MITTENBERG W, 1993, ARCH CLIN NEUROPSYCH, V8, P447; Moriyama M., 1967, GENDAI NO RINSHO, V1, P114; MYKITA S, 1986, J NEUROCHEM, V47, P223; O'Malley S S, 1990, NIDA Res Monogr, V101, P179; OMALLEY S, 1992, AM J DRUG ALCOHOL AB, V18, P131, DOI 10.3109/00952999208992826; Renshaw PF, 1999, PSYCHOPHARMACOLOGY, V142, P132, DOI 10.1007/s002130050871; SALIGAUT C, 1984, CIRC METAB CERVEAU, V2, P33; SECADES JJ, 1995, METHOD FIND EXP CLIN, V17, P1; Spiers PA, 1996, ARCH NEUROL-CHICAGO, V53, P441, DOI 10.1001/archneur.1996.00550050071026; Spiers PA, 1999, J INT NEUROPSYCH SOC, V5, P260, DOI 10.1017/S1355617799533092; STRICKLAND TL, 1993, J NEUROPSYCH CLIN N, V5, P419; TAZAKI Y, 1988, STROKE, V19, P211, DOI 10.1161/01.STR.19.2.211; TUMEH SS, 1990, RADIOLOGY, V176, P821, DOI 10.1148/radiology.176.3.2389042; VOLKOW ND, 1988, BRIT J PSYCHIAT, V152, P641, DOI 10.1192/bjp.152.5.641; Wallace EA, 1996, PSYCHOPHARMACOLOGY, V128, P17, DOI 10.1007/s002130050104; WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T; Wurtman RJ, 2000, BIOCHEM PHARMACOL, V60, P989, DOI 10.1016/S0006-2952(00)00436-6	36	11	11	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0033-3158			PSYCHOPHARMACOLOGY	Psychopharmacology	SEP	2001	157	2					163	167		10.1007/s002130100824			5	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	476TD	WOS:000171244100006	11594440				2022-02-06	
J	Leon-Carrion, J; Machuca-Murga, F; Murga-Sierra, M; Dominguez-Morales, R				Leon-Carrion, J; Machuca-Murga, F; Murga-Sierra, M; Dominguez-Morales, R			Outcome after an intensive, holistic and multidisciplinar rehabilitation program after traumatic brain injury. Medico-legal values	REVISTA DE NEUROLOGIA			Spanish	Article						brain injury; neuropsychology; rehabilitation		Introduction. This paper was designed to evaluate the integral rehabilitation treatments for patients with traumatic brain injury, data about efficiency of the C.RE.CER.(R) intensive, holistic and multidisciplinar rehabilitation program is given. Patients and methods. The study was done keeping in mind not only the clinical aspects of rehabilitation, but also setting it within the judicial realm in which a great number of brain injury cases are found, mainly when caused by traffic accidents. A sample of 10 severe traumatic brain injury patients was studied, aged between 19 and 39. All the patients were assessed at the beginning and the end of the treatment, using a neuropsychological test battery, meanwhile were treated with the C.RE.CER.(R) intensive, holistic and multidisciplinar rehabilitation program. Results and conclusions. The results show a high efficiency of treatments in the majority of the patients, with reductions of more than 70% in emotional deficits and more than 60% in the global recovery of the patients that carried out the programs. This paper also shows some limitations of the criteria for compensation in Spanish legislation.	Univ Seville, Fac Psicol, E-41009 Seville, Spain; Univ Seville, Fac Med, E-41009 Seville, Spain; Ctr Rehabil Dano Cerebral CRE CER, Seville, Spain			jleon@cica.es	Leon Carrion, Jose/D-5638-2012				Benton AL, 1963, REVISED VISUAL RETEN; CHRISTENSEN AL, 1997, NEUROPSYCHOLOGICAL R; FORASTERO P, 1992, REHABILITACION, V26, P211; Goodglass H, 1986, EVALUACION AFASIA TR; Leon-Carrion J, 1998, NEUROREHABILITATION, V11, P129, DOI 10.1016/S1053-8135(98)00017-1; LEONCARRION J, 1995, BATERIA NEUROPSICOLO; LEONCARRION J, 1994, DANO CEREBRAL GUIA F; LEONCARRION J, 1997, NEUROPSYCHOLOGICAL R; LEONCARRION J, 1998, NOTICIOAS MED, P3686; LEONJIMENEZ F, 1998, REV ESP NEUROPSICOL, V1, P99; PERINO C, 1997, NEUROPSYCHOLOGICAL R	11	11	13	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	AUG 16	2001	33	4					377	383		10.33588/rn.3304.2000196			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478RY	WOS:000171360200016	11588734				2022-02-06	
J	Jacome, DE				Jacome, DE			Blepharoclonus and Arnold-Chiari malformation	ACTA NEUROLOGICA SCANDINAVICA			English	Article						Arnold-Chiari malformation; blepharoclonus; digital dysplasia; dural venous malformation; post-traumatic headache; syrinx	NYSTAGMUS; HEADACHE; BLEPHAROSPASM; HYDROCEPHALUS; MIGRAINE; CLOSURE; REFLEX	Objective - Blepharoclonus (BLC) denotes a large amplitude, involuntary tremors of the orbicularis oculi muscles, observed during gentle closure of the eyelids. BLC may follow major head trauma. Four patients with Arnold-Chiari malformation (ACM) and BLC are described. Materials and methods - The first patient had facial numbness for 5 months; the remaining patients had headaches following minor head or cervical spinal injuries. Brain magnetic resonance imaging (MRI), electroencephalogram (EEG) blink reflexes, mental and facial nerve responses and facial electromyogram (EMG) were performed. Results - All patients exhibited ACM on brain MRI. The first patient had coincidental dural venous malformation, empty-sella turcica and familial digital dysplasia. She exhibited oculopterygoid synkinesis. The last 3 patients had posttraumatic headache; the second and third patients had limited features of Ehlers-Danlos syndrome (EDS). The second patient had cervical spinal fusion and the fourth a cervical syrinx. All the patients had BLC on gentle eyelid closure. Conclusion - BLC is an underdiagnosed neuro-ophthalmological sign of ACM.	Franklin Med Ctr, Dept Med, Greenfield, MA 01301 USA; Dartmouth Hitchcock Med Ctr, Div Neurol, Lebanon, NH 03756 USA		Jacome, DE (corresponding author), 1 Burnham St, Turners Falls, MA 01376 USA.						ARAMIDEH M, 1994, BRAIN, V117, P1457, DOI 10.1093/brain/117.6.1457; BARTON JJS, 1990, ARCH NEUROL-CHICAGO, V47, P357; BEHRMAN S, 1988, MOVEMENT DISORD, V3, P326, DOI 10.1002/mds.870030407; Brodsky MC, 1995, J NEURO-OPHTHALMOL, V15, P236; Carmichael E A, 1925, Br J Ophthalmol, V9, P49, DOI 10.1136/bjo.9.2.49; CIRIGNOTTA F, 1991, EUR NEUROL, V31, P36, DOI 10.1159/000116624; DAROFF RB, 1968, J NEUROL NEUROSUR PS, V31, P362, DOI 10.1136/jnnp.31.4.362; GATTO M, 1990, MOVEMENT DISORD, V5, P310, DOI 10.1002/mds.870050409; GILBERT JN, 1986, NEUROSURGERY, V18, P559, DOI 10.1227/00006123-198605000-00008; Hoban Timothy F., 1997, Neurology, V48, pA401; JACOME DE, 1986, HEADACHE, V26, P515, DOI 10.1111/j.1526-4610.1986.hed2610515.x; Jacome DE, 1997, J NEURO-OPHTHALMOL, V17, P95; Jacome DE, 2000, J NEURO-OPHTHALMOL, V20, P276, DOI 10.1097/00041327-200020040-00016; KASNER SE, 1995, HEADACHE, V35, P557, DOI 10.1111/j.1526-4610.1995.hed3509557.x; KEANE JR, 1978, ANN NEUROL, V3, P243, DOI 10.1002/ana.410030310; KHURANA RK, 1991, HEADACHE, V31, P151, DOI 10.1111/j.1526-4610.1991.hed3103151.x; KIMURA J, 1969, ARCH NEUROL-CHICAGO, V21, P193, DOI 10.1001/archneur.1969.00480140093009; KOSNIK E, 1976, NEUROLOGY, V26, P248, DOI 10.1212/WNL.26.3.248; LARON Z, 1997, HELV PAEDIATR ACTA, V24, P576; LAWDEN MC, 1993, J NEUROL NEUROSUR PS, V56, P708, DOI 10.1136/jnnp.56.6.708; LEWIS JA, 1972, NEUROLOGY, V22, P1145, DOI 10.1212/WNL.22.11.1145; LOEFFLER JD, 1996, ARCH OPHTHALMOL-CHIC, V76, P178; MOSSMAN SS, 1990, ARCH NEUROL-CHICAGO, V47, P357, DOI 10.1001/archneur.1990.00530030139030; MOSTER ML, 1988, ANN NEUROL, V23, P190, DOI 10.1002/ana.410230213; OBESO JA, 1985, NEUROLOGY, V35, P1378, DOI 10.1212/WNL.35.9.1378; PEARCE JMS, 1989, J NEUROL NEUROSUR PS, V52, P907, DOI 10.1136/jnnp.52.7.907; SAFRAN AB, 1983, J CLIN NEURO-OPHTHAL, V3, P133; Thomas P, 1996, NEUROLOGY, V46, P1165, DOI 10.1212/WNL.46.4.1165; TOMITA Y, 1991, BRAIN DEV-JPN, V13, P425, DOI 10.1016/S0387-7604(12)80041-6; VANDENBERGH R, 1992, J NEUROL, V239, P263; VRABEC TR, 1989, ANN NEUROL, V26, P401, DOI 10.1002/ana.410260317; WEINTRAUB MI, 1990, DEV MED CHILD NEUROL, V32, P929; ZAHN JR, 1978, J NEUROL NEUROSUR PS, V41, P617, DOI 10.1136/jnnp.41.7.617	33	11	12	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	AUG	2001	104	2					113	117		10.1034/j.1600-0404.2001.104002113.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459WJ	WOS:000170274200012	11493230				2022-02-06	
J	McHenry, MA				McHenry, MA			Vital capacity following traumatic brain injury	BRAIN INJURY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EXPIRATORY FLOW	This study was designed to describe lung volume subdivisions in individuals with traumatic brain injury. Records were reviewed for 114 consecutive referrals for motor speech evaluations in a community re-entry residential rehabilitation programme. Obtained measures were vital capacity, inspiratory capacity, and expiratory reserve volume at the time of evaluation. Seventy-nine per cent of subjects evidenced at least moderate deficits in expiratory reserve volume, with 60% evidencing severe deficits. Inspiratory capacity was the least affected, with 61% of subjects evidencing values within normal limits. Possible contributors to reduced expiratory reserve volumes include expiratory muscle weakness due to physical inactivity, inability to voluntarily perform the task, or perceived effort.	Transit Learning Ctr, Galveston, TX USA		McHenry, MA (corresponding author), Univ Houston, 4800 Calhoun Blvd, Houston, TX 77204 USA.						Begin P, 1997, AM J RESP CRIT CARE, V156, P133, DOI 10.1164/ajrccm.156.1.9509041; Campbell R S, 1997, Respir Care Clin N Am, V3, P51; Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, 1995, AM J RESP CRIT CARE, V152, P1107, DOI [DOI 10.1164/AJRCCM, 10.1164/ajrccm]; COOPER KR, 1983, CHEST, V81, P29; Faulkner J. A., 1995, THORAX C, P2321; HOIT JD, 1994, J SPEECH HEAR RES, V37, P572, DOI 10.1044/jshr.3703.572; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; MURDOCH BE, 1989, J SPEECH HEAR DISORD, V54, P610, DOI 10.1044/jshd.5404.610; MURDOCH BE, 1993, BRAIN INJURY, V7, P295, DOI 10.3109/02699059309034956; Polkey MI, 1998, AM J RESP CRIT CARE, V158, P734, DOI 10.1164/ajrccm.158.3.9710072; PUTNAM AHB, 1984, DYSARTHRIAS PHYSL AC, P37; Tzelepis GE, 1997, AM J RESP CRIT CARE, V156, P1399, DOI 10.1164/ajrccm.156.5.9702009; Vitacca M, 1997, EUR RESPIR J, V10, P1614, DOI 10.1183/09031936.97.10071614; Wechsler D, 1981, WECHSLER ADULT INTEL; Wiercisiewski DR, 1998, J HEAD TRAUMA REHAB, V13, P28, DOI 10.1097/00001199-199802000-00006; Yorkston K, 1991, COMMUNICATION DISORD, P251	16	11	11	0	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2001	15	8					741	745		10.1080/02699050010013932			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	462ZJ	WOS:000170452100008	11485614				2022-02-06	
J	Rao, WLR; Dogan, A; Bowen, KK; Dempsey, RJ				Rao, WLR; Dogan, A; Bowen, KK; Dempsey, RJ			Ornithine decarboxylase knockdown exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						antisense knockdown; cerebral ischemia; infarct; middle cerebral artery occlusion; neuronal damage; ornithine decarboxylase	GLUTAMATE TRANSPORTER GLT-1; TRANSGENIC MICE; MESSENGER-RNA; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; POLYAMINE METABOLISM; ANTISENSE KNOCKDOWN; ENERGY-METABOLISM; TRAUMATIC INJURY; ARTERY OCCLUSION; INFARCT VOLUME	Transient cerebral ischemia leads to increased expression of ornithine decarboxylase (ODC). Contradicting studies attributed neuroprotective and neurotoxic roles to ODC after ischemia. Using antisense oligonucleotides (ODNs), the current study evaluated the functional role of ODC in the process of neuronal damage after transient focal cerebral ischemia induced by middle cerebral artery occlusion (MCAO) in spontaneously hypertensive rats. Transient MCAO significantly increased the ODC immunoreactive protein levels and catalytic activity in the ipsilateral cortex. which were completely pre-vented by the infusion of antisense ODN specific for ODC. Transient MCAO in rats infused with ODC antisense ODN increased the infarct volume, motor deficits, and mortality compared with the sense or random ODN-infused controls. Results of the current study support a neuroprotective or recovery role, or both, for ODC after transient focal ischemia.	Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA; Univ Wisconsin, Cardiovasc Res Ctr, Madison, WI 53792 USA; William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA		Dempsey, RJ (corresponding author), Univ Wisconsin, Dept Neurol Surg, H4-336 CSC,600 Highland Ave, Madison, WI 53792 USA.		Dogan, Aclan/AAF-8305-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220, R01NS028000] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS31220, NS28000] Funding Source: Medline		ALHONEN L, 1995, INT J CANCER, V63, P402, DOI 10.1002/ijc.2910630317; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Bernstein HG, 1999, PROG NEUROBIOL, V57, P485, DOI 10.1016/S0301-0082(98)00065-3; BOURDIOL F, 1992, BRAIN RES, V596, P183, DOI 10.1016/0006-8993(92)91546-Q; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; DEMPSEY R J, 1988, Neurological Research, V10, P175; DEMPSEY RJ, 1991, J CEREBR BLOOD F MET, V11, P979, DOI 10.1038/jcbfm.1991.164; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; DIENEL GA, 1985, J NEUROCHEM, V44, P600, DOI 10.1111/j.1471-4159.1985.tb05454.x; Dogan A, 1999, J NEUROCHEM, V72, P765, DOI 10.1046/j.1471-4159.1999.0720765.x; DOGAN A, 1998, J NEUROSURG, V88; GILAD GM, 1991, EXP NEUROL, V111, P349, DOI 10.1016/0014-4886(91)90102-I; Harada J, 1997, BRAIN RES, V753, P251, DOI 10.1016/S0006-8993(97)00011-5; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; Johnson TD, 1998, PROG DRUG RES, V50, P193; Kaasinen K, 2000, EUR J NEUROSCI, V12, P540, DOI 10.1046/j.1460-9568.2000.00940.x; KAUPPINEN RA, 1992, J NEUROCHEM, V58, P831, DOI 10.1111/j.1471-4159.1992.tb09332.x; Keinanen R, 1997, NEUROSCI LETT, V239, P69, DOI 10.1016/S0304-3940(97)00890-2; KINDY MS, 1994, J CEREBR BLOOD F MET, V14, P1040, DOI 10.1038/jcbfm.1994.136; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUKKARAINEN J, 1995, EUR J NEUROSCI, V7, P1840, DOI 10.1111/j.1460-9568.1995.tb00704.x; Lukkarinen J, 1997, STROKE, V28, P639, DOI 10.1161/01.STR.28.3.639; Lukkarinen JA, 1999, BRAIN RES, V826, P325, DOI 10.1016/S0006-8993(99)01327-X; Lukkarinen JA, 1998, EUR J NEUROSCI, V10, P2046, DOI 10.1046/j.1460-9568.1998.00216.x; Mehrotra PK, 1998, CONTRACEPTION, V57, P55, DOI 10.1016/S0010-7824(97)00208-4; MUSZYNSKI CA, 1993, J CEREBR BLOOD F MET, V13, P1033, DOI 10.1038/jcbfm.1993.131; Nishioka K, 1995, J CELL BIOCHEM, P87; PASCHEN W, 1988, BRAIN RES, V453, P9, DOI 10.1016/0006-8993(88)90138-2; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746; Pussinen R, 1998, SYNAPSE, V28, P288, DOI 10.1002/(SICI)1098-2396(199804)28:4<288::AID-SYN4>3.0.CO;2-5; Rao AM, 2000, J NEUROCHEM, V74, P1106; RAO AM, 1995, J NEUROCHEM, V65, P2639; Rao VLR, 1998, BRAIN RES, V783, P163, DOI 10.1016/S0006-8993(97)01301-2; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Reeben M, 1996, J NEUROSCI RES, V45, P542, DOI 10.1002/(SICI)1097-4547(19960901)45:5<542::AID-JNR4>3.3.CO;2-R; ROHN G, 1992, EXP NEUROL, V117, P210, DOI 10.1016/0014-4886(92)90129-E; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SEILER N, 1984, NEUROCHEM RES, V9, P871, DOI 10.1007/BF00964520; Seiler N, 2000, NEUROCHEM RES, V25, P471, DOI 10.1023/A:1007508008731; Shyng SL, 1996, P NATL ACAD SCI USA, V93, P12014, DOI 10.1073/pnas.93.21.12014; SLOTKIN TA, 1986, BRAIN RES BULL, V17, P307, DOI 10.1016/0361-9230(86)90236-4; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; WEN L, 1989, J BIOL CHEM, V264, P9016; Zoli M, 1996, MOL BRAIN RES, V38, P122, DOI 10.1016/0169-328X(95)00339-T	51	11	11	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2001	21	8					945	954					10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	459AQ	WOS:000170228000007	11487730				2022-02-06	
J	Barbiro-Micahely, E; Mayevsky, A				Barbiro-Micahely, E; Mayevsky, A			Multiparametric monitoring of brain under elevated intracranial pressure in a rat model	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; cisternal infusion; intracranial hypertension; NADH redox state; rat	LASER-DOPPLER FLOWMETRY; CEREBRAL BLOOD-FLOW; CEREBROSPINAL-FLUID; INTRAOPERATIVE MEASUREMENT; CARBON-MONOXIDE; HEAD-INJURY; AUTOREGULATION; HYPERTENSION; RESPONSES; MICROCIRCULATION	Intracranial hypertension may develop in most patients exposed to traumatic head injury. In many cases, patients enduring elevated intracranial pressure (ICP) will incur morbidity or mortality. Several methods are used in animal models to investigate the influence of ICP elevation on physiological parameters. In this study, we developed a cisterna magna model by adding a mechanism for warming the mock cerebrospinal fluid (CSF) entering the cisterna space to a temperature of 37 degreesC and combined this method for ICP elevation with the multiparametric monitoring system (Multiprobe Assembly [MPA]). Using the MPA, we monitored, for the first time, mitochondrial NADH redox state as well as ionic homeostasis under elevated ICP in a rat model. In addition, we monitored cerebral blood flow (CBF) by laser Doppler flowmetry, ECoG (bipolar electrodes), and surface temperature. Blood pressure was measured in the cannulated femoral artery. The ICP (monitored by Camino probe) was elevated to 50-60 mm Hg for 13-15 min, followed by 2 h of recovery. The results show that CBF was decreased by 90%, while NADH was elevated by 80% as compared to the normoxic levels. Complete depolarization occurred as evidence by the decrease in extracellular Ca2+ and a significant increase in K+. All parameters recovered 10 min after reopening the cannula to the cisterna magna to air pressure. We conclude that ICP elevation through the cisterna magna infusion method, used simultaneously with multiparametric monitoring, supplies reliable information on the brain tissue metabolic state with intracranial hypertension in a rat model.	Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel		Mayevsky, A (corresponding author), Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel.	mayevsa@mail.biu.ac.il					ANDREWS B T, 1988, Neurological Research, V10, P123; ARBIT E, 1989, NEUROSURGERY, V24, P166, DOI 10.1227/00006123-198902000-00003; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; BOTEL C, 1994, J EXP ANIM SCI, V36, P78; BOUMAN HJ, 1979, BRAIN RES BULL, V4, P575, DOI 10.1016/0361-9230(79)90045-5; Bullock MR, 1996, J NEUROTRAUM, V13, P685; DALEY ML, 1995, IEEE T BIO-MED ENG, V42, P420, DOI 10.1109/10.376137; DEARDEN NM, 1984, J NEUROSURG, V60, P123, DOI 10.3171/jns.1984.60.1.0123; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FASANO VA, 1988, ACTA NEUROCHIR, V95, P40, DOI 10.1007/BF01793081; FITCH W, 1977, J NEUROL NEUROSUR PS, V40, P843, DOI 10.1136/jnnp.40.9.843; FRIEDLI CM, 1982, AM J PHYSIOL, V243, pR462, DOI 10.1152/ajpregu.1982.243.3.R462; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; HAUERBERG J, 1994, J CEREBR BLOOD F MET, V14, P519, DOI 10.1038/jcbfm.1994.64; HUDETZ AG, 1995, AM J PHYSIOL-HEART C, V268, pH2202, DOI 10.1152/ajpheart.1995.268.6.H2202; INAO S, 1993, NEUROL RES, V15, P264; JOHNSTON IH, 1973, J NEUROL NEUROSUR PS, V36, P161, DOI 10.1136/jnnp.36.2.161; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; MALKINSON TJ, 1985, BRAIN RES BULL, V15, P321, DOI 10.1016/0361-9230(85)90158-3; MARMAROU A, 1993, HEAD INJURY, P203; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1984, BRAIN RES REV, V7, P49, DOI 10.1016/0165-0173(84)90029-8; MAYEVSKY A, 1982, SCIENCE, V217, P537, DOI 10.1126/science.7201167; MAYEVSKY A, 1995, J APPL PHYSIOL, V78, P1188, DOI 10.1152/jappl.1995.78.3.1188; Mayevsky A, 1999, ACT NEUR S, V75, P63; MAYEVSKY A, 1985, AM J PHYSIOL, V248, pR99, DOI 10.1152/ajpregu.1985.248.1.R99; Mayevsky A, 1998, NEUROL RES, V20, pS76; MAYEVSKY A, 1991, SPIE P, V1431, P303; Meilin S, 1996, J APPL PHYSIOL, V81, P1078, DOI 10.1152/jappl.1996.81.3.1078; MORROW BA, 1990, AM J PHYSIOL, V258, pR1170; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; NITTA M, 1990, ACTA NEUROCHIR, V104, P30, DOI 10.1007/BF01842890; Osbakken M, 1996, J Basic Clin Physiol Pharmacol, V7, P97; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; ROSENBLUM BR, 1987, J NEUROSURG, V66, P396, DOI 10.3171/jns.1987.66.3.0396; SHALIT MN, 1974, J NEUROSURG, V40, P594, DOI 10.3171/jns.1974.40.5.0594; SIESJO BK, 1970, ACTA NEUROL SCAND, V46, P187, DOI 10.1111/j.1600-0404.1970.tb05615.x; SIOUTOS PJ, 1996, NEUROTRAUMA, P503; STERN MD, 1977, AM J PHYSIOL, V232, pH441, DOI 10.1152/ajpheart.1977.232.4.H441; SUNDBARG G, 1987, J NEUROSURG, V67, P841, DOI 10.3171/jns.1987.67.6.0841; SUTTON LN, 1987, J NEUROSURG, V67, P381, DOI 10.3171/jns.1987.67.3.0381; Tsai M L, 1988, Chin J Physiol, V31, P113; VINAS FC, 1995, NEUROL RES, V17, P465, DOI 10.1080/01616412.1995.11740365; Wadhwani K.C., 1990, LASER DOPPLER BLOOD, P265; YAMANE K, 1994, SURG NEUROL, V41, P477, DOI 10.1016/0090-3019(94)90011-6	47	11	11	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2001	18	7					711	725		10.1089/089771501750357654			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	457CK	WOS:000170119400007	11497097				2022-02-06	
J	DeFord, SM; Wilson, MS; Gibson, CJ; Baranova, A; Hamm, RJ				DeFord, SM; Wilson, MS; Gibson, CJ; Baranova, A; Hamm, RJ			Nefiracetam improves Morris water maze performance following traumatic brain injury in rats	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						nefiracetam; brain injury; traumatic brain injury; rats; fluid percussion; Morris water maze; cognitive recovery	FOREBRAIN CHOLINE-ACETYLTRANSFERASE; HEAD-INJURY; ANIRACETAM; ACETYLCHOLINE; IMPAIRMENT; GLUTAMATE; CURRENTS; DM-9384; CHANNEL; MEMORY	Nefiracetam, a pyrrolidone derivative, is a nootropic agent that has facilitated cognitive function in a wide variety of animal models of cognitive dysfunction. The purpose of this study was to investigate the efficacy of the chronic postinjury administration of nefiracetam (DM-9384) in improving cognitive performance following central fluid percussion brain injury in rats. Twenty-four hours following surgical preparation, a sham injury or a moderate fluid percussive injury (2.1 arm) was delivered. Nefiracetam was administered chronically (0 or 9 mg/kg, po, for sham animals and 0, 3, or 9 mg/kg for injured animals) on postinjury days 1-15. Cognitive performance was assessed using the Morris water maze (MWM) on postinjury days 11-15. Chronic administration of 3 and 9 mg/kg nefiracetam attenuated MWM deficits produced by central fluid percussive brain injury. Importantly, the MWM performance of the injured animals treated with 9 mg/kg did not significantly differ from uninjured, sham animals. The 9-mg/kg dose of nefiracetam did not have a positive or negative effect on MWM performance of uninjured animals. The results of the present experiment suggest that a nootropic such as nefiracetam may be an appropriate treatment for trauma-induced cognitive dysfunction. (C) 2001 Elsevier Science Inc. All rights reserved.	Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Hamm, RJ (corresponding author), Virginia Commonwealth Univ, Dept Psychol, POB 842018,808 W Franklin St, Richmond, VA 23284 USA.						ABE E, 1994, J NEURAL TRANSM-GEN, V95, P179, DOI 10.1007/BF01271565; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BRUCE DA, 1984, BRIT MED J, V289, P715, DOI 10.1136/bmj.289.6447.715; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Dixon C. E., 1995, Society for Neuroscience Abstracts, V21, P762; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; FUNK KF, 1984, BIOMED BIOCHIM ACTA, V11, P1301; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hiramatsu M, 1997, BEHAV BRAIN RES, V83, P107, DOI 10.1016/S0166-4328(97)86053-6; HIRAMATSU M, 1992, EUR J PHARMACOL, V216, P279, DOI 10.1016/0014-2999(92)90371-A; ISAACSON JS, 1991, P NATL ACAD SCI USA, V88, P10936, DOI 10.1073/pnas.88.23.10936; ITO I, 1990, J PHYSIOL-LONDON, V424, P533, DOI 10.1113/jphysiol.1990.sp018081; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARCHI M, 1990, EUR J PHARMACOL, V185, P247, DOI 10.1016/0014-2999(90)90650-U; NABESHIMA T, 1994, EUR J PHARMACOL, V255, P57, DOI 10.1016/0014-2999(94)90082-5; Nabeshima Toshitaka, 1994, Drugs of Today, V30, P357; Nishizaki T, 1998, MOL PHARMACOL, V53, P1; Nomura T, 2000, BRAIN RES, V870, P157, DOI 10.1016/S0006-8993(00)02417-3; Oyaizu M, 1999, BRAIN RES, V822, P72, DOI 10.1016/S0006-8993(99)01077-X; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; PIKE BR, 1997, PHARM BIOCH BEHAV, V57, P1; SAKURAI T, 1989, JPN J PHARMACOL, V50, P47, DOI 10.1254/jjp.50.47; SARTER M, 1991, TRENDS PHARMACOL SCI, V12, P456, DOI 10.1016/0165-6147(91)90636-7; SPIGNOLI G, 1987, PHARMACOL BIOCHEM BE, V27, P491, DOI 10.1016/0091-3057(87)90353-4; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Von Monakow C, 1969, BRAIN BEHAVIOR, P27; YOSHII M, 1994, BRAIN RES, V642, P123, DOI 10.1016/0006-8993(94)90913-X; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	35	11	11	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	JUL-AUG	2001	69	3-4					611	616		10.1016/S0091-3057(01)00559-7			6	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	460RP	WOS:000170322600037	11509223				2022-02-06	
J	Duffill, J; Buckley, J; Lang, D; Neil-Dwyer, G; McGinn, F; Wade, D				Duffill, J; Buckley, J; Lang, D; Neil-Dwyer, G; McGinn, F; Wade, D			Prospective study of omental transposition in patients with chronic spinal injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						spinal cord injury; omentum; treatment; outcome	CHRONIC TRAUMATIC PARAPLEGIA; CORD INJURY; MYELO-SYNANGIOSIS; INTACT OMENTUM; BRAIN; VASCULARIZATION; RELIABILITY; MANAGEMENT; INDEX	Objectives-This prospective study was designed to assess the effects of omental transpostion in patients with a chronic spinal injury. Methods-Neurological status was established to be stable and multiple baseline across patient studies were done preoperatively and repeated postoperatively. Assessments included activities of daily living (ADL), functional ability, degree of spasticity, motor power, sensation, pain perception, urodynamic studies, electromyography, sensory evoked potentials (SEPs), and infrared thermography to measure peripheral and general skin vascular responses. Each patient had MRI. Assessments were done at 3, 6, and 12 months after omental transposition in 17 patients. Results-The detailed assessments failed to show significant improvement, although some patients showed minor objective and subjective change in some categories. Neurological deterioration occurred in one patient. There were 20 surgical complications including urinary tract infection, deep vein thrombosis, wound infection, and incisional hernia. Conclusions-Omental transposition has not been shown to improve neurological function in 17 patients with chronic spinal cord injury, and continued use of this operation in this situation is not supported by this study. Further advances in spinal cord repair may utilise the pedicled omental graft to provide an alternative vascular supply, but its current use should be limited to experimental models.	Southampton Univ Hosp Trust, Wessex Neurol Ctr, Dept Neurosurg, Southampton SO16 6YD, Hants, England; Southampton Univ Hosp Trust, Dept Physiotherapy, Southampton SO16 6YD, Hants, England; Southampton Univ Hosp Trust, Dept Gen Surg, Southampton SO16 6YD, Hants, England; Rivermead Rehabil Ctr, Oxford OX1 4XD, England		Neil-Dwyer, G (corresponding author), Southampton Univ Hosp Trust, Wessex Neurol Ctr, Dept Neurosurg, Tremona Rd, Southampton SO16 6YD, Hants, England.	dorothy.lang@btinternet.com		Wade, Derick/0000-0002-1188-8442			ABRAHAM J, 1987, PARAPLEGIA, V25, P44, DOI 10.1038/sc.1987.12; ALDAY ES, 1972, SURG GYNECOL OBSTETR, V135, P103; BJORKLUND A, 1994, NATURE, V367, P112, DOI 10.1038/367112a0; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; CHEN L, 1990, J NEUROSURG, V72, P600, DOI 10.3171/jns.1990.72.4.0600; Clifton GL, 1996, SPINAL CORD, V34, P193, DOI 10.1038/sc.1996.38; CURATI WL, 1992, NEURORADIOLOGY, V35, P30, DOI 10.1007/BF00588274; DELATORRE JC, 1988, NEUROSCI LETT, V94, P269, DOI 10.1016/0304-3940(88)90029-8; DELATORRE JC, 1992, ACTA NEUROCHIR WIEN, V102, P152; DITUNNO JF, 1994, NEW ENGL J MED, V330, P550, DOI 10.1056/NEJM199402243300808; Goldsmith H S, 1987, Br J Neurosurg, V1, P359, DOI 10.3109/02688698709023778; Goldsmith H S, 1987, Br J Neurosurg, V1, P463, DOI 10.3109/02688698708999637; GOLDSMITH HS, 1978, STROKE, V9, P224, DOI 10.1161/01.STR.9.3.224; GOLDSMITH HS, 1984, JAMA-J AM MED ASSOC, V252, P2034, DOI 10.1001/jama.252.15.2034; GOLDSMITH HS, 1986, SURG GYNECOL OBSTET, V162, P579; GOLDSMITH HS, 1986, PARAPLEGIA, V24, P173, DOI 10.1038/sc.1986.23; GOLDSMITH HS, 1994, NEUROL RES, V16, P159; GOLDSMITH HS, 1985, PARAPLEGIA, V23, P100, DOI 10.1038/sc.1985.18; GOLDSMITH HS, 1975, AM J SURG, V129, P262, DOI 10.1016/0002-9610(75)90236-6; GOLDSMITH HS, 1973, ARCH SURG-CHICAGO, V106, P695; GOLDSMITH HS, 1975, AM J SURG, V130, P317, DOI 10.1016/0002-9610(75)90393-1; GRESHAM GE, 1986, PARAPLEGIA, V24, P38, DOI 10.1038/sc.1986.7; GUTTMANN L, 1958, J PHYSIOL-LONDON, V142, P406, DOI 10.1113/jphysiol.1958.sp006026; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; Huskisson EC, 1983, PAIN MEASUREMENT ASS, P33; KHOSLA A, 1995, AM J NEURORADIOL, V16, P275; LUCAS JT, 1979, AM SURGEON, V45, P151; MAHONEY F I, 1965, Md State Med J, V14, P61; MASUMORI Y, 1992, SURG NEUROL, V38, P411, DOI 10.1016/0090-3019(92)90108-Y; PIEPMEIER JM, 1988, J NEUROSURG, V69, P399, DOI 10.3171/jns.1988.69.3.0399; RAFAEL H, 1992, ACTA NEUROCHIR, V114, P145, DOI 10.1007/BF01400604; SHARPLESS JW, 1982, MOSSMANS PROBLEM ORI, P470; SHERMAN RA, 1986, AM J PHYS MED REHAB, V65, P281; TESSLER A, 1991, ANN NEUROL, V29, P115, DOI 10.1002/ana.410290202; WADE D, 1992, MEASUREMENT NEUROLOG, P198; WADE DT, 1992, MEASUREMENT NEUROLOG, P354; Wang DJ, 1996, PARAPLEGIA, V34, P65, DOI 10.1038/sc.1996.13	38	11	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUL	2001	71	1					73	80		10.1136/jnnp.71.1.73			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	445AZ	WOS:000169436500016	11413267	Green Published, Bronze			2022-02-06	
J	Cherner, M; Temkin, NR; Machamer, JE; Dikmen, SS				Cherner, M; Temkin, NR; Machamer, JE; Dikmen, SS			Utility of a composite measure to detect problematic alcohol use in persons with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						alcohol abuse; brain injuries; rehabilitation	SUBSTANCE-ABUSE; HEAD-INJURY; INTOXICATION; SEVERITY; DRINKING; PATTERNS; TRENDS	Objectives: To examine factors complicating the study of alcohol-related effects in traumatic brain injury (TBI) patients and to evaluate a composite measure to categorize such patients according to degree of alcohol-related problems. Design: Inception cohort. Setting: Level I trauma center. Patients: Consecutively hospitalized adult TBI patients (n = 156; 73% men; 87% Caucasian; mean age, 30yr; mean education, 12yr). Selection criteria required objective evidence of brain trauma; minimum survival of 1 month postinjury; age 15 years or older; and English speaking. Main Outcome Measures: An index of problematic drinking based on a measure created by combining blood-alcohol level, quantity-frequency of consumption, and the Short Michigan Alcoholism Screening Test. Preinjury characteristics were obtained through structured interview. Results: Participants with highly problematic drinking showed poorer premorbid psychosocial functioning, including lower educational attainment, greater likelihood of problems with the law, lower perceived social support, and greater prevalence of other substance abuse. Conclusion: The composite index is useful in identifying problematic drinkers among TBI patients. Results have implications for interpreting and planning research on the role of alcohol in TBI outcomes. (C) 2001 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Dikmen, SS (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	dikmen@u.washington.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS005304] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD033677] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [HS05304] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD33677] Funding Source: Medline		ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; ALTERMAN AI, 1985, INT J NEUROSCI, V26, P75, DOI 10.3109/00207458508985606; Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bombardier CH, 1997, REHABIL PSYCHOL, V42, P259; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; CHERPITEL CJ, 1994, ALCOHOL CLIN EXP RES, V18, P679, DOI 10.1111/j.1530-0277.1994.tb00930.x; COHEN J, 1975, APPL MULTIPLE REGRES, V21; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Drubach D A, 1993, Md Med J, V42, P989; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P93; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Li GH, 1997, J TRAUMA, V42, P562, DOI 10.1097/00005373-199703000-00032; LUNA GK, 1984, J TRAUMA, V24, P695, DOI 10.1097/00005373-198408000-00001; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; MIDANIK LT, 1994, AM J PUBLIC HEALTH, V84, P1218, DOI 10.2105/AJPH.84.8.1218; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; *US DEP HHS, 1997, 9 SPEC REP US C ALC; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Wilsnack S C, 1995, Recent Dev Alcohol, V12, P29; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296	44	11	12	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2001	82	6					780	786		10.1053/apmr.2001.23263			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	439KK	WOS:000169115900011	11387583				2022-02-06	
J	McCrory, P				McCrory, P			The nature of concussion: a speculative hypothesis	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							MINOR HEAD-INJURY; SPORT		Univ Melbourne, Ctr Sports Med Res & Educ, Parkville, Vic 3052, Australia; Univ Melbourne, Inst Brain Res, Parkville, Vic 3052, Australia		McCrory, P (corresponding author), Univ Melbourne, Ctr Sports Med Res & Educ, Parkville, Vic 3052, Australia.		McCrory, Paul/Q-8688-2019				BROWN WJ, 1972, AM J PATHOL, V67, P41; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GOLDBERG E, 1982, CORTEX, V18, P459, DOI 10.1016/S0010-9452(82)80042-7; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McCrory PR, 1999, BRIT J SPORT MED, V33, P297; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Povlishock JT, 1996, ACT NEUR S, V66, P81; RHAZES A, 1497, OPERA MEDICA VARIA; Shetter A G, 1979, Adv Neurol, V22, P5	21	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	JUN	2001	35	3					146	147		10.1136/bjsm.35.3.146			2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	440UV	WOS:000169193700006	11375871	Bronze, Green Published			2022-02-06	
J	Wong, PP; Monette, G; Weiner, NI				Wong, PP; Monette, G; Weiner, NI			Mathematical models of cognitive recovery	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; HEAD-INJURY; SEVERITY	Longitudinal psychological test results are used as dependant variables to explore the complex relationship between length of coma, time of testing on the recovery curve, and corresponding cognitive status after traumatic brain injury (TBI). A database containing 319 TBI patients with a broad spectrum of coma duration was used. Statistical analysis of mixed effects modelling was applied to longitudinal WAIS-R (Wechsler Adult Intelligence Scale-Revised) scores to construct two mathematical models (verbal IQ and performance IQ). The models predict the course of recovery (initial cognitive level post-coma, eventual recovery level, and level of cognitive functioning at any point on the recovery curve) when the duration of coma is known. Performance IQ was found to recover at a rate that is almost four times slower than verbal IQ. The results have important clinical rehabilitation implications. This statistical modelling technique also enables the medical researcher to investigate disease progression or recovery using structured assessments, which would normally be part of the routine medical monitoring.	York Univ, Dept Kinesiol & Hlth Sc, Toronto, ON M3J 1P3, Canada		Wong, PP (corresponding author), York Univ, Dept Kinesiol & Hlth Sc, 4700 Keele St, Toronto, ON M3J 1P3, Canada.						ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Annoni J M, 1992, Disabil Rehabil, V14, P23; BATES DM, 1997, MODELLING LONGITUDIN; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BROOKS N, 1984, CLOSED HEAD INJURY P; COHADON F, 1991, J NEUROL SCI, V103, P27; Gil M, 1996, BRAIN INJURY, V10, P39, DOI 10.1080/026990596124700; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KOSTECKIDILLON T, 1999, YORK U I SOCIAL RES, V14, P3; MILLER JD, 1990, REHABILITATION ADULT, P236; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; VILKKI J, 1988, J NEUROL NEUROSUR PS, V51, P1452, DOI 10.1136/jnnp.51.11.1452; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Wong P P, 1993, Leadersh Health Serv, V2, P25; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955; WONG PP, 1994, BRAIN INJURY, V8, P509, DOI 10.3109/02699059409151003	25	11	11	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2001	15	6					519	530		10.1080/02699050010005995			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	439VE	WOS:000169137600005	11394971				2022-02-06	
J	Ashley, MJ; Persel, CS; Clark, MC				Ashley, MJ; Persel, CS; Clark, MC			Validation of an independent living scale for post-acute rehabilitation applications	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; VALIDITY	The Independent Living Scale (ILS) was developed in a post-acute traumatic brain injury (TBI) rehabilitation facility over a 15-year period to assess three main areas: (1) activities of daily living, (2) behaviour, and (3) initiation. The purpose of this study was to examine the psychometric properties of the ILS, including test-retest stability, construct validity, and statistical fit. Statistical analysis was completed on all weekly scores between the years 1986-1995 (n = 5250). A previous study showed ILS inter-rater reliability to be 0.85 and convergent validity 0.82-0.87. This study demonstrated a test-retest stability of 0.72, the Kaiser-Meyer-Olkin Measure of Sampling Adequacy 0.94 (marvelous), and a Bartlett Test of Sphericity result of 'scale items independent'. The ILS was shown to have good construct validity, inter-rater reliability, internal consistency, instrument stability, and convergent validity.	Ctr Neuro Skills, Bakersfield, CA 93306 USA; Kern Reg Ctr Dev Disabled, Bakersfield, CA USA		Ashley, MJ (corresponding author), Ctr Neuro Skills, 2658 Mt Vernon Ave, Bakersfield, CA 93306 USA.						Ciccetti D., 1984, VINELAND ADAPTIVE BE; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; HAGEN C, 1982, COGNITIVE REHABILITA, P131; Hal KM, 1997, J REHABILITATION OUT, V1, P63; KAUFERT JM, 1983, ARCH PHYS MED REHAB, V64, P260; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Nihira K., 1974, AAMD ADAPTIVE BEHAV; PERSEL CS, 1987, 49 ANN ASS AM AC PHY; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; *SPSS INC, 1994, SPSS STAT PROGR SOC; TEASDALE G, 1974, LANCET, V2, P81	13	11	11	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2001	15	5					435	442		10.1080/02699050010005896			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	431TW	WOS:000168648700006	11350657				2022-02-06	
J	Kochanek, PM; Hendrich, KS; Robertson, CL; Williams, DS; Melick, JA; Ho, C; Marion, DW; Jackson, EK				Kochanek, PM; Hendrich, KS; Robertson, CL; Williams, DS; Melick, JA; Ho, C; Marion, DW; Jackson, EK			Assessment of the effect of 2-chloroadenosine in normal rat brain using spin-labeled MRI measurement of perfusion	MAGNETIC RESONANCE IN MEDICINE			English	Article						cerebral blood flow; brain; purine; hyperemia; adenosine	CONTROLLED CORTICAL IMPACT; CEREBRAL BLOOD-FLOW; ADENOSINE RECEPTORS; ISCHEMIC BRAIN; ARTERIAL WATER; INJURY	Adenosine analogs such as 2-chloroadenosine are potent cerebrovasodilators. Spin-labeled MRI was used to investigate the spatial distribution, dose-response, and timing of the effect of 2-chloroadenosine on cerebral blood flow (CBF) after intraparenchymal injection into rat brain. Sprague-Dawley rats (N = 10) were injected with 2-chloroadenosine at doses of 0.3, 6.0, or 12 nmoles, or saline vehicle (2-4 muL) CBF was serially quantified in a slice through the injection site in a circular (3.6 mm diameter) region of interest (ROI) around the injection and in ipsilateral hemispheric ROIs at similar to 90 min and similar to 180 min. Marked 3.17- and 3.93-fold increases in CBF (vs, vehicle) were seen in the circular ROI at similar to 90 min and similar to 180 min after 12-nmol injection, respectively. Similarly, 2.92- and 2.78-fold increases in hemispheric CBF were observed at similar to 90 min and similar to 180 min, respectively, after injection of 12 nmoles, Linear dose-response relationships were observed at both times after injection in both ROIs (all P < 0.01), Spin-labeling MRI assessment revealed that parenchymal injection of 2-chloroadenosine produces potent, dose-dependent, and sustained vasodilation over large areas of brain. This treatment and imaging paradigm should facilitate investigation of the effect of CBF promotion in models of traumatic and ischemic brain injury, (C) 2001 Wiley-Liss, Inc.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15260 USA; Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.		Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021; Ho, Chien/O-6112-2016	Kochanek, Patrick M/0000-0002-2627-913X; Ho, Chien/0000-0002-4094-9232; Jackson, Edwin/0000-0002-8101-6009	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR010962, P41RR003631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R01NS038087, P01NS030318, P20NS030318] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR-10962, RR03631] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 38087, NS 30318] Funding Source: Medline		AbdulGhani AS, 1997, EUR J PHARMACOL, V326, P7, DOI 10.1016/S0014-2999(97)00139-8; BERNE RM, 1974, CIRC RES, V35, P262, DOI 10.1161/01.RES.35.2.262; BRUNS RF, 1986, MOL PHARMACOL, V29, P331; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Coney AM, 1998, J PHYSIOL-LONDON, V509, P507, DOI 10.1111/j.1469-7793.1998.507bn.x; DALY JW, 1981, LIFE SCI, V28, P2083, DOI 10.1016/0024-3205(81)90614-7; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; DORA E, 1984, J CEREBR BLOOD F MET, V4, P447, DOI 10.1038/jcbfm.1984.64; EVANS MC, 1987, NEUROSCI LETT, V83, P287, DOI 10.1016/0304-3940(87)90101-7; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; KALARIA RN, 1986, J CEREBR BLOOD F MET, V6, P463, DOI 10.1038/jcbfm.1986.80; MILLER LP, 1992, J NEUROTRAUM, V9, pS563; SILVA AC, 1995, MAGNET RESON MED, V33, P209, DOI 10.1002/mrm.1910330210; Strupp JP, 1996, NEUROIMAGE, V3, pS607; VANWYLEN DGL, 1989, J CEREBR BLOOD F MET, V9, P556, DOI 10.1038/jcbfm.1989.79; VONLUBITZ DKJ, 1997, PURINERGIC APPROACHE, P449; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; ZHANG WG, 1995, MAGNET RESON MED, V33, P370, DOI 10.1002/mrm.1910330310; ZHANG WG, 1993, MAGNET RESON MED, V29, P416, DOI 10.1002/mrm.1910290323	22	11	12	0	0	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0740-3194			MAGNET RESON MED	Magn. Reson. Med.	MAY	2001	45	5					924	929		10.1002/mrm.1123			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	428CR	WOS:000168444000025	11323821				2022-02-06	
J	Bigler, ED				Bigler, ED			Neuropsychological testing defines the neurobehavioral significance of neuroimaging-identified abnormalities	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; IMAGING GUIDE; ATROPHY; MEMORY	Three cases are presented in patients all of whom sustained focal left frontal traumatic injury to the brain. Although each case was selected because of a neuroimaging-identified frontal lesion, the point is made that the behavioral significance of such lesions is defined by the neuropsychological examination process, and not the specific size, location, or type of lesion. While neuroimaging information is critical to the comprehensive evaluation of the neurologic patient, neuroimaging findings alone have only limited predictive ability with regard to neurobehavioral syndromes. The key role of information from neuropsychological test data, combined with neuroimaging findings to fully evaluate the neurologic patient, is made. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 Kimball Tower, Provo, UT 84602 USA.						Ardaman MF, 1996, INT J NEURORADIOL, V2, P296; Ardaman MF, 1996, INT J NEURORADIOL, V2, P374; Bigler E D, 1991, Arch Clin Neuropsychol, V6, P113, DOI 10.1016/0887-6177(91)90028-8; Bigler E. D., 1989, NEUROPSYCHOLOGICAL F; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 1997, NEUROLOGY, V49, P1180, DOI 10.1212/WNL.49.4.1180-a; BIGLER ED, 1981, PROF PSYCHOL, V12, P195, DOI 10.1037/h0078095; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BIGLER ED, 1996, NEUROIMAGING, V1; BIGLER ED, 1996, NEUROIMAGING, V2; BIGLER ED, 1992, PHYSICAL MED REHABIL, V6, P395; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; FINGER S., 1994, ORIGINS NEUROSCIENCE; Netter F. H., 1953, CIBA COLLECTION MED, V1; REYNOLDS CR, 1994, NEUROLOGY, V47, P592	15	11	11	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2001	16	3					227	236		10.1016/S0887-6177(00)00081-0			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	424VU	WOS:000168255300004	14590175	Bronze			2022-02-06	
J	Coetzer, R; Stein, DJ; Du Toit, PL				Coetzer, R; Stein, DJ; Du Toit, PL			Executive function in traumatic brain injury and obsessive-compulsive disorder: An overlap?	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						brain injury; executive function; obsessive-compulsive disorder	NEUROPSYCHOLOGY	Thirteen individuals with traumatic brain injury, 13 individuals with obsessive-compulsive disorder (OCD) and 10 normal controls were compared on neuropsychological measures of executive function. Individuals with a traumatic brain injury performed significantly poorer than the other two groups on a test measuring visuo-spatial strategy. Although the traumatic brain injury group made more errors on a test of maze learning and the OCD group less than the control group, this did not reach statistical significance. No support for an overlap in executive dysfunction in traumatic brain injury and OCD was found. It may be that the 'error prevention system' in the brain was influenced in a contrasting way by executive dysfunction in these disorders. This difference may reveal itself clinically in impulsivity/perseveration and slowness, respectively. Further studies were needed to test this hypothesis.	Univ Stellenbosch, Sch Med, MRC, Anxiety Disorders Res Unit, ZA-7600 Stellenbosch, South Africa		Coetzer, R (corresponding author), Colwyn Bay Hosp, Brain Injry Serv, Hesketh Rd, Colwyn Bay LL29 3AS, Wales.		Stein, Dan J/A-1752-2008	Stein, Dan J/0000-0001-7218-7810			ABBRUZZESE M, 1995, BRAIN COGNITION, V27, P202, DOI 10.1006/brcg.1995.1017; ALARCON RD, 1994, J NEUROPSYCH CLIN N, V6, P217; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BAXTER LR, 1994, J CLIN PSYCHIAT, V55, P54; Berthier ML, 1996, NEUROLOGY, V47, P353, DOI 10.1212/WNL.47.2.353; Childers MK, 1998, BRAIN INJURY, V12, P613; Coetzer R, 1999, PSYCHIAT CLIN NEUROS, V53, P413, DOI 10.1046/j.1440-1819.1999.00565.x; CORWIN J, 1993, CLIN NEUROPSYCHOL, P4; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P9; COX CS, 1989, OBSESSIVE COMPULSIVE; Deb S, 1999, AM J PSYCHIAT, V156, P374; DIRSON S, 1995, PSYCHOTHER PSYCHOSOM, V63, P22, DOI 10.1159/000288933; *HUM SCI RES COUNC, 1969, S AFR WECHSL AD INT; KEEFE RSE, 1995, AM J PSYCHIAT, V152, P6; LEZAC MD, 1995, NEUROPSYCHOLOGICAL A; LISHMAN WA, 1998, ORGANIC PSYCHIAT PSY; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; OTTO MW, 1992, PSYCHIAT CLIN N AM, V15, P825; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Tallis F, 1997, BRIT J CLIN PSYCHOL, V36, P3, DOI 10.1111/j.2044-8260.1997.tb01226.x; TAMMINGA CA, 2000, AM J PSYCHIAT, V157, P3; Walsh K. W., 1985, UNDERSTANDING BRAIN; Wilson KD, 1998, PSYCHON B REV, V5, P161, DOI 10.3758/BF03212942	24	11	11	0	5	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1323-1316			PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	APR	2001	55	2					83	87		10.1046/j.1440-1819.2001.00792.x			5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	429YD	WOS:000168544800001	11285083				2022-02-06	
J	Vanderploeg, RD; Curtiss, G; Schinka, JA; Lanham, RA				Vanderploeg, RD; Curtiss, G; Schinka, JA; Lanham, RA			Material-specific memory in traumatic brain injury: Differential effects during acquisition, recall, and retention	NEUROPSYCHOLOGY			English	Article; Proceedings Paper	106th Annual Convention of the American-Psychological-Association	AUG 14-18, 1998	SAN FRANCISCO, CA	Amer Psychol Assoc			CONFIRMATORY FACTOR-ANALYSIS; TEMPORAL-LOBE; CONSTRUCT-VALIDITY; NONVERBAL MEMORY; COGNITIVE CHANGE; SCALE; LOBECTOMY; EPILEPSY; IMAGERY; IMPAIRMENT	Material-specific memory refers to the ability to learn and recall new episodic information on the basis of the nature of the stimulus material (e.g., verbal vs. nonverbal-visuospatial). Structural equation modeling was used to analyze data from a sample of patients with traumatic brain injury to compare 3 models of memory functioning: material-specific, material-specific plus general, and general (non-material-specific). The models were examined separately for acquisition, delayed free recall, and retention aspects of memory. Results suggest that, at least in a population with traumatic brain injury, the acquisition of new information takes place in a material-specific memory fashion, delayed free recall involves both material-specific and general (non-material-specific) memory components, but retention relies primarily on general (non-material-specific) memory processes.	James A Haley Vet Affairs Med Ctr, Psychol Serv 116B, Tampa, FL USA; Univ S Florida, Dept Psychiat, Tampa, FL 33620 USA; Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; Vet Head Injury Program, Tampa, FL USA; Def & Vet Headad Injury Program, Minneapolis, MN USA; Minneapolis Vet Affairs Med Ctr, Psychol Serv, Minneapolis, MN USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, 13000 N Bruce B Downs Blvd, Tampa, FL 33612 USA.	rodney.vanderploeg@med.va.gov	Schinka, John/A-2619-2009				ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; ANDERSON JR, 1973, HUMAN ASSOCIATIVE ME; ARBUCKLE JL, 1997, AMOS USERS GUIDE; Barr WB, 1997, BRAIN COGNITION, V35, P26, DOI 10.1006/brcg.1997.0925; Barr WB, 1997, J INT NEUROPSYCH SOC, V3, P435, DOI 10.1017/S1355617797004359; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BOLLER F, 1967, NEUROLOGY, V17, P1052; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; CHELUNE GJ, 1991, NEUROLOGY, V41, P399, DOI 10.1212/WNL.41.3.399; De Renzi E., 1967, CORTEX, V3, P194, DOI [10.1098/rstb.1982.0073, DOI 10.1098/RSTB.1982.0073, 10.1016/S0010-9452(67)80012-1, DOI 10.1016/S0010-9452(67)80012-1]; DELANEY RC, 1980, CORTEX, V16, P103, DOI 10.1016/S0010-9452(80)80026-8; Delis DC, 1987, CALIFORNIA VERBAL LE; Denman S.B, 1984, DENMAN NEUROPSYCHOLO; DERENZI E, 1981, CORTEX, V17, P447, DOI 10.1016/S0010-9452(81)80034-2; DERENZI E, 1966, CORTEX, V2, P322; Ehrlichman H, 1983, Brain Cogn, V2, P55, DOI 10.1016/0278-2626(83)90029-5; ELWOOD R W, 1991, Neuropsychology Review, V2, P179, DOI 10.1007/BF01109053; ELWOOD RW, 1993, J CLIN PSYCHOL, V49, P854, DOI 10.1002/1097-4679(199311)49:6<854::AID-JCLP2270490613>3.0.CO;2-F; ELWOOD RW, 1991, CLIN NEUROPSYCHOL, V5, P329; FELER CA, 1992, HDB HEAD TRAUMA ACUT, P19; Gainotti G, 1994, Int J Neurosci, V78, P9; GLANZER M, 1964, AM J PSYCHOL, V77, P621, DOI 10.2307/1420773; GLOSSER G, 1995, NEUROPSYCHOLOGY, V9, P449, DOI 10.1037/0894-4105.9.4.449; Golden CJ, 1978, STROOP COLOR WORD TE; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Gregg, 1972, COGNITION LEARNING M; Hamsher K., 1989, MULTILINGUAL APHASIA; HEILBRONNER RL, 1992, CLIN NEUROPSYCHOL, V6, P105; HERMANN BP, 1987, EPILEPSIA, V28, P547, DOI 10.1111/j.1528-1157.1987.tb03687.x; J?reskog, 1989, LISREL 7 GUIDE PROGR; JONESGOTMAN M, 1986, NEUROPSYCHOLOGIA, V24, P193, DOI 10.1016/0028-3932(86)90052-7; Kelloway E. K., 1998, USING LISREL STRUCTU; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; LANHAM RA, 1995, J INT NEUROPSYCH SOC, V1, P171; LARRABEE GJ, 1983, J CLIN NEUROPSYCHOL, V5, P159, DOI 10.1080/01688638308401162; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P239, DOI 10.1080/01688638508401257; LARRABEE GJ, 1985, INT J NEUROSCI, V26, P269, DOI 10.3109/00207458508985624; LEE GP, 1989, PSYCHOL ASSESS J CON, V1, P192; LORING DW, 1991, J CLIN EXP NEUROPSYC, V13, P575, DOI 10.1080/01688639108401072; MALEC JF, 1991, PSYCHOL ASSESSMENT J, V3, P82; Martin A, 1999, HIPPOCAMPUS, V9, P62, DOI 10.1002/(SICI)1098-1063(1999)9:1<62::AID-HIPO7>3.0.CO;2-K; MARTIN RC, 1990, CORTEX, V26, P443, DOI 10.1016/S0010-9452(13)80093-7; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MUNGAS D, 1985, EPILEPSIA, V26, P340, DOI 10.1111/j.1528-1157.1985.tb05660.x; NAUGLE RI, 1993, ARCH CLIN NEUROPSYCH, V8, P381, DOI 10.1016/0887-6177(93)90002-I; NOVELLY RA, 1984, ANN NEUROL, V15, P64, DOI 10.1002/ana.410150112; OJEMANN GA, 1985, J NEUROSURG, V62, P101, DOI 10.3171/jns.1985.62.1.0101; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PAIVIO A, 1969, J EXP PSYCHOL, V80, P279, DOI 10.1037/h0027273; PAIVIO A, 1989, I RES BEHAV NEUROSCI, P203; PHILLIPS NA, 1995, J CLIN EXP NEUROPSYC, V17, P713, DOI 10.1080/01688639508405161; *PSYCH CORP, 1997, WAIX 3 WMS 3 TECHN M; PYLYSHYN ZW, 1981, PSYCHOL REV, V88, P16, DOI 10.1037/0033-295X.88.1.16; Raftery AE., 1993, TESTING STRUCTURAL E, P163; Randolph C., 1993, NEUROPSYCHOLOGY, V7, P82, DOI [10.1037/0894-4105.7.1.82, DOI 10.1037/0894-4105.7.1.82]; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roid G. H., 1988, CLIN NEUROPSYCHOL, V2, P116, DOI [DOI 10.1080/13854048808520094, 10.1080/13854048808520094]; ROTH DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; SMITH GE, 1992, J CLIN EXP NEUROPSYC, V14, P211, DOI 10.1080/01688639208402824; SMITH ML, 1989, NEUROPSYCHOLOGIA, V27, P71, DOI 10.1016/0028-3932(89)90091-2; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Snow R E, 1984, ADV PSYCHOL HUMAN IN; Squire L. R., 1983, MEMORY CONSOLIDATION, P185; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; VANDERPLOEG RD, 1997, CLIN NEUROPSYCHOL, V11, P326; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1981, WAIS R MANUAL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WHITEHOUSE PJ, 1981, BRAIN LANG, V14, P315, DOI 10.1016/0093-934X(81)90083-3; WILLIAMS JM, 1992, MEMORY ASSESSMENT SC; Wilson RS, 1996, NEUROPSYCHOLOGY, V10, P459; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534; [No title captured], DOI DOI 10.1080/13854048808520093	79	11	11	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	APR	2001	15	2					174	184		10.1037//0894-4105.15.2.174			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	471UK	WOS:000170946900003	11324861				2022-02-06	
J	Buytaert, KA; Kline, AE; Montanez, S; Likler, E; Millar, CJ; Hernandez, TD				Buytaert, KA; Kline, AE; Montanez, S; Likler, E; Millar, CJ; Hernandez, TD			The temporal patterns of c-Fos and basic fibroblast growth factor expression following a unilateral anteromedial cortex lesion	BRAIN RESEARCH			English	Article						rat; growth factor; cortical injury; recovery of function; somatosensory asymmetry	MESSENGER-RNA EXPRESSION; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; FACTOR BFGF EXPRESSION; TACTILE EXTINCTION; KINDLED SEIZURES; TRANSCRIPTION FACTOR; PRIMARY CULTURES; MOTOR CORTEX; NEURONS	Following a unilateral anteromedial cortex lesion, a critical period of 12 h to 6 days exists during which the recovery process is exquisitely vulnerable to manipulation. Certain anti-convulsant drugs, as well as convulsive seizures impede recovery when administered during, but not after, the critical period. The mechanisms underlying these behavioral phenomena have not been delineated. Thus, the present study was designed to determine potential mechanisms underlying and responsible for the critical period. To this end, we measured the immunoreactivity of two important markers of the post-injury response cascade, c-Fos and bFGF, at designated times after a unilateral anteromedial cortex lesion. These temporal patterns of expression in the perilesional cortex and ipsilateral dorsal striatum were mapped onto functional recovery patterns. Within the critical period, c-Fos was dramatically elevated through 48 h after the lesion. while bFGF peaked later, on day 6. Upregulation of these markers preceded recovery from somatosensory deficits, which was most dramatic after post-operative day 9 and complete by day 23. Early post-lesion expression of c-Fos may contribute to lesion-induced bFGF expression, which through its neurotrophic properties could be responsible for subsequent functional recovery. Gaining a similar understanding of the critical period following human traumatic brain injury could be an important first step toward improved treatment strategies and neurobehavioral outcome. (C) 2001 Elsevier Science B.V. All rights reserved.	Univ Colorado, Dept Psychol, Behav Neurosci Program, Boulder, CO 80309 USA		Hernandez, TD (corresponding author), Univ Colorado, Dept Psychol, Behav Neurosci Program, Campus Box 345, Boulder, CO 80309 USA.	terid@psych.colorado.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30595] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS030595] Funding Source: NIH RePORTER		ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; ANNETT LE, 1992, BRAIN, V115, P825, DOI 10.1093/brain/115.3.825; BARTH TM, 1994, BEHAV NEUROSCI, V108, P818, DOI 10.1037/0735-7044.108.4.818; BARTH TM, 1987, EXP NEUROL, V95, P661, DOI 10.1016/0014-4886(87)90307-4; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Bury SD, 2000, NEUROPHARMACOLOGY, V39, P743, DOI 10.1016/S0028-3908(99)00272-5; Buytaert K. A., 1998, Society for Neuroscience Abstracts, V24, P737; Cao W, 1998, INVEST OPHTH VIS SCI, V39, P565; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; Emoto N, 1989, GROWTH FACTORS, V2, P21, DOI 10.3109/08977198909069078; ENDOH M, 1994, MOL BRAIN RES, V22, P76, DOI 10.1016/0169-328X(94)90034-5; FERHAT L, 1993, J NEUROCHEM, V61, P1105, DOI 10.1111/j.1471-4159.1993.tb03626.x; FINKLESTEIN SP, 1993, STROKE, V24, P1141; FINKLESTEIN SP, 1995, BRAIN ISCHEMIA BASIC, P37; FRAGUNOW M, 1988, EUR J PHARMACOL, V135, P113; FRANK E, 1995, NEUROL RES, V17, P129, DOI 10.1080/01616412.1995.11740300; GINSBERG MD, 1993, ARNMD RES PUBLICATIO, P207; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Grahn RE, 1999, BRAIN RES, V826, P35, DOI 10.1016/S0006-8993(99)01208-1; HAYNES LW, 1988, MOL NEUROBIOL, V2, P263, DOI 10.1007/BF02935635; HEDREEN JC, 1976, NEUROSCI LETT, V4, P1; Hernandez T D, 1990, Restor Neurol Neurosci, V1, P323, DOI 10.3233/RNN-1990-1503; HERNANDEZ TD, 1995, BRAIN RES, V673, P208, DOI 10.1016/0006-8993(94)01415-E; HERNANDEZ TD, 1989, CEREBROVASC DIS, P327; IWATA A, 1997, J NEUROTRAUM, V4, P201; JONES TA, 1994, J NEUROSCI, V14, P2140; KALSBEEK WD, 1980, J NEUROSURG, V53, P519; KAWAMATA T, 1996, J CEREB BLOOD FLOW M, V16, P543; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; Kline AE, 2000, BRAIN RES, V880, P38, DOI 10.1016/S0006-8993(00)02762-1; KOLB B, 1992, ADV EXP MED BIOL, V325, P169; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Lin TN, 1997, MOL BRAIN RES, V49, P255, DOI 10.1016/S0169-328X(97)00152-6; LIU HM, 1994, J NEUROPATH EXP NEUR, V53, P598, DOI 10.1097/00005072-199411000-00007; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; MCGEER PL, 1977, BRAIN RES, V128, P369, DOI 10.1016/0006-8993(77)91003-4; Montanez S, 2000, BRAIN RES, V860, P29, DOI 10.1016/S0006-8993(00)01951-X; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; NIETOSAMPEDRO M, 1985, SYNAPTIC PLASTICITY, P407; NOZAKI K, 1993, J CEREBR BLOOD F MET, V13, P221, DOI 10.1038/jcbfm.1993.27; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PETTMANN B, 1986, NEUROSCI LETT, V68, P175, DOI 10.1016/0304-3940(86)90137-0; Ren JM, 1997, EUR J PHARMACOL, V327, P11, DOI 10.1016/S0014-2999(97)89672-0; ROSE FD, 1987, BEHAV BRAIN RES, V24, P195, DOI 10.1016/0166-4328(87)90057-X; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; RUZDIJIC S, 1993, BRAIN RES, V601, P230, DOI 10.1016/0006-8993(93)91715-5; Schallert T, 1998, RESTORATIVE NEUROLOGY, P91; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SCHWARTZ AS, 1979, BRAIN, V102, P669, DOI 10.1093/brain/102.4.669; Shibata F, 1991, GROWTH FACTORS, V4, P277, DOI 10.3109/08977199109043913; SIMPSON CS, 1994, NEUROSCI LETT, V170, P281, DOI 10.1016/0304-3940(94)90338-7; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; To T., 1994, Society for Neuroscience Abstracts, V20, P1048; WALICKE PA, 1988, J NEUROSCI, V8, P2618	58	11	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 9	2001	894	1					121	130		10.1016/S0006-8993(01)01987-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	411VZ	WOS:000167521100014	11245822				2022-02-06	
J	Davis, AE; Gimenez, AM; Therrien, B				Davis, AE; Gimenez, AM; Therrien, B			Effects of entorhinal cortex lesions on sensory integration and spatial learning	NURSING RESEARCH			English	Article						brain injury; entorhinal cortex; sensory integration; spatial learning	HIPPOCAMPAL-FORMATION; BRAIN INJURY; 2 VERSIONS; PERFORMANCE; RAT; REINNERVATION; DENERVATION; SYSTEM; MONKEY; MAZE	Background: The entorhinal cortex provides sensory information to the hippocampus for memory and learning. Damage to the entorhinal cortex is common in patients who experience traumatic brain injury, stroke, and Alzheimer's disease. Entorhinal damage is assumed to interfere with sensory integration; however, substantive knowledge of behavioral patterns is lacking. Objectives: To describe specific behavioral deficits associated with entorhinal cortex injury related to special senses identification, sensory integration, and spatial learning. Method: Adult male rats received bilateral entorhinal cortex damage (n = 19) or sham surgery (n = 11)with a subset randomized to participate in special senses identification, exploration, and sensory integration testing. Spatial learning was examined using a water maze. Results: Lesion and control animals were similar in special senses identification testing. Sensory integration was markedly impaired in lesion animals over 3 days for all integration tasks; however, travel deficit persisted for 4 days. By day 5 sensory integration ability was equal. Lesion animals were significantly impaired across all days of spatial learning for swim time (p = .0001) and directional heading error (p = .03). Control animals exposed to sensory testing demonstrated significantly more efficient learning (p = .005) on swim days 2 and 3 versus control animals not exposed to sensory testing. Conclusions: Early and prolonged behavioral changes are evident following entorhinal cortex damage including sensory integration deficits and persistent spatial learning impairment.	Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; Clin Puerta Hierro, Madrid, Spain		Davis, AE (corresponding author), Univ Michigan, Sch Nursing, 400 N Ingalls, Ann Arbor, MI 48109 USA.						Braak H, 1996, ACTA NEUROL SCAND, V93, P3; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; *HARC BRAC WORLD, 1966, FUNK WAGN STAND COLL; HEINEMANN U, 1993, HIPPOCAMPUS, V3, P89; HOLDEN JE, 1993, NURS RES, V42, P338; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; LINGENHOHL K, 1991, EXP BRAIN RES, V84, P57; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; Luria AR., 1972, MAN SHATTERED WORLD; NAGAHARA AH, 1995, BEHAV NEUROSCI, V109, P3, DOI 10.1037/0735-7044.109.1.3; OHM TG, 1993, HIPPOCAMPUS, V3, P131; OTTENBACHER K, 1982, AM J OCCUP THER, V36, P571, DOI 10.5014/ajot.36.9.571; Otto T, 1997, NEUROBIOL LEARN MEM, V68, P21, DOI 10.1006/nlme.1997.3778; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; SAUNDERS RC, 1988, J COMP NEUROL, V271, P153, DOI 10.1002/cne.902710202; STEWARD O, 1977, BRAIN RES BULL, V2, P41, DOI 10.1016/0361-9230(77)90023-5; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9	21	11	11	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-6562	1538-9847		NURS RES	Nurs. Res.	MAR-APR	2001	50	2					77	85		10.1097/00006199-200103000-00003			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	453LU	WOS:000169918000003	11302296				2022-02-06	
J	Williams, PJ; Lane, JR; Turkel, CC; Capparelli, EV; Dziewanowska, Z; Fox, AW				Williams, PJ; Lane, JR; Turkel, CC; Capparelli, EV; Dziewanowska, Z; Fox, AW			Dichloroacetate: Population pharmacokinetics with a pharmacodynamic sequential link model	JOURNAL OF CLINICAL PHARMACOLOGY			English	Article							PYRUVATE-DEHYDROGENASE; SODIUM DICHLOROACETATE; LACTIC-ACIDOSIS; BRAIN INJURY; HEAD-INJURY; CEREBRAL-ISCHEMIA; LACTATE; HUMANS; METABOLITES; ACTIVATION	Dichloroacetate (DCA) is a small molecule that reduces ambient concentrations of lactate in man. It was the purpose of this study to develop pharmacokinetic and pharmacodynamic models for determination of a dose for a pivotal Phase III clinical trial of DCA in patients with traumatic brain injury (TBI). Population pharmacokinetic and pharmacodynamic models were developed for DCA using NONMEM(R) software. The pharmacokinetic data were fit to a physiologic two-compartment model, and the pharmacodynamic data were fit to an indirect physiologic response model. Simulations were employed to evaluate various dosing strategies for consideration in a pivotal Phase III clinical trial of DCA. For the pharmacokinetic model, it was discovered that the clearance of DCA decreased on multiple dosing from 4.82 L/h to 1.07 L/h and that the pharmacokinetics and pharmacodynamics in TBI patients could not be predicted from normal volunteers. Population pharmacokinetic modeling and simulation of the expected effects of several dosing strategies were useful procedures for designing a Phase III trial. Journal of Clinical Pharmacology, 2001;41:259-267 (C) 2001 the American College of Clinical Pharmacology.	Univ Pacific, Sch Pharm, Stockton, CA 95211 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Cypros Pharmaceut Corp, Carlsbad, CA USA; Trials Design LLC, La Jolla, CA USA; EBD Grp Inc, Carlsbad, CA USA		Williams, PJ (corresponding author), Trials Design LLC, POB 1918,Verdi Ct, Stockton, CA 95207 USA.						ABEMAYOR E, 1984, J NEUROCHEM, V42, P38, DOI 10.1111/j.1471-4159.1984.tb09694.x; BARSAN WG, 1987, LIFE SCI, V41, P1065, DOI 10.1016/0024-3205(87)90622-9; Beal S., 1989, NONMEM USERS GUIDE 1; Boeckman AJ, 1992, NONMEM USERS GUIDE 4; BREIMER DD, 1977, CLIN PHARMACOKINET, V2, P93, DOI 10.2165/00003088-197702020-00002; CHANG LH, 1992, J CEREBR BLOOD F MET, V12, P1030, DOI 10.1038/jcbfm.1992.140; CHU PI, 1987, THESIS U FLORIDA; CROCKARD HA, 1972, EUR NEUROL, V8, P151, DOI 10.1159/000114569; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193; DIMLICH RVW, 1989, ANN EMERG MED, V18, P1172, DOI 10.1016/S0196-0644(89)80054-X; EVANS OB, 1983, BIOCHEM PHARMACOL, V31, P1324; Fox AW, 1996, J PHARMACOL EXP THER, V279, P686; Goodman JC, 1996, ACT NEUR S, V67, P37; GORDON E, 1971, ACTA ANAESTH SCAND, V15, P209, DOI 10.1111/j.1399-6576.1971.tb05462.x; Henderson GN, 1997, J CLIN PHARMACOL, V37, P416, DOI 10.1002/j.1552-4604.1997.tb04319.x; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; JUSKO WJ, 1994, CLIN PHARMACOL THER, V56, P406, DOI 10.1038/clpt.1994.155; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KING LR, 1974, J NEUROSURG, V40, P617, DOI 10.3171/jns.1974.40.5.0617; Kochanek PM, 1997, ACT NEUR S, V70, P109; LUKAS G, 1980, J PHARM SCI, V69, P419, DOI 10.1002/jps.2600690415; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; SEITZ HD, 1977, ACTA NEUROCHIR, V38, P211, DOI 10.1007/BF01401092; STACPOOLE PW, 1992, NEW ENGL J MED, V327, P1564, DOI 10.1056/NEJM199211263272204; Stacpoole PW, 1998, ENVIRON HEALTH PERSP, V106, P989, DOI 10.1289/ehp.98106s4989; TOMSIG JL, 1991, BRAIN RES, V568, P92, DOI 10.1016/0006-8993(91)91383-C; WELLS PG, 1980, DIABETOLOGIA, V19, P109, DOI 10.1007/BF00421855; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; WHITEHOUSE S, 1973, BIOCHEM J, V134, P651, DOI 10.1042/bj1340651	30	11	13	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0091-2700			J CLIN PHARMACOL	J. Clin. Pharmacol.	MAR	2001	41	3					259	267		10.1177/00912700122010078			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	403MW	WOS:000167047900003	11269566				2022-02-06	
J	Wilson, RF; Dente, C; Tyburski, JG				Wilson, RF; Dente, C; Tyburski, JG			The nutritional management of patients with head injuries	NEUROLOGICAL RESEARCH			English	Article						nutrition; head injuries	TRAUMATIC BRAIN INJURY; GROWTH-FACTOR-I; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ZINC SUPPLEMENTATION; LIPID-PEROXIDATION; ENERGY-EXPENDITURE; CONTROLLED TRIAL; MAGNESIUM; IMMUNE; HYPERALIMENTATION	Severe head injuries tend to be associated with hypermetabolism and hypercatabolism resulting in negative nitrogen balances which may exceed 30 grams day(-1). Enteral feeding should begin as soon as the patient is hemodynamically stable, attempting to reach a non-protein caloric intake of at least 30-35 kcal kg(-1) day(-1) and a protein intake of 2.0-2.5 g kg(-1) day(-1) as soon as possible. With severe head injuries (Glasgow Coma Scale < 8), there is an increased tendency for gastric feeding to regurgitate into the upper airway Keeping the patient upright and checking residuals is import-ant in such patients. Jejunal feedings are less apt to be aspirated. if it is apparent that the gastro-intestinal tract cannot be used to reach the nutritional goals within three days, total parental nutrition is begun within 24-48 h so as to reach these nutrition goals by either one or both routes by the third or fourth day. Blood glucose levels exceeding 150-200 mg dl(-1) tend to increase the severity of the neurologic problems and efforts should be made to prevent hyperglycemia by carefully regulating the glucose and insulin intake. Indirect calormetry to determine the respiratory quotient and resting energy expenditure should be determined twice weekly. To determine N-2 balance, urinary urea nitrogen should be measured in 24-h specimens. These tests should be performed once or twice weekly until it is clear that the nutrition is adequate.	Wayne State Univ, Detroit Receiving Hosp, Dept Surg, Detroit, MI 48201 USA		Wilson, RF (corresponding author), Wayne State Univ, Detroit Receiving Hosp, Dept Surg, 4201 St Antoine,Suite 4V-23, Detroit, MI 48201 USA.						Altmayer T, 1996, ARCH PHYS MED REHAB, V77, P1093, DOI 10.1016/S0003-9993(96)90075-1; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BRAU RH, 1984, NEUROSURGERY, V14, P142, DOI 10.1227/00006123-198402000-00004; BRAUGHLER JM, 1991, CENTRAL NERVOUS SYST, pS1; BUCCI MN, 1988, ACTA NEUROCHIR, V93, P133, DOI 10.1007/BF01402895; Bullock MR, 1996, J NEUROTRAUM, V13, P721; CHIOLERO R, 1989, JPEN-PARENTER ENTER, V13, P5, DOI 10.1177/014860718901300105; CLIFTON CL, 1991, NEUROSURGERY, V8, P10; CLIFTON GL, 1985, J NEUROSURG, V62, P186, DOI 10.3171/jns.1985.62.2.0186; CORTE FD, 1998, CRIT CARE MED, V27, P1419; DALY JM, 1988, ANN SURG, V208, P512, DOI 10.1097/00000658-198810000-00013; DAMELIO LF, 1994, AM SURGEON, V60, P180; De Marinis L, 1999, CLIN ENDOCRINOL, V50, P741; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; GORLIN R, 1988, ARCH INTERN MED, V148, P2043, DOI 10.1001/archinte.148.9.2043; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P91; Harbrecht BG, 1998, AM J SURG, V176, P311, DOI 10.1016/S0002-9610(98)00206-2; Hatton J, 1997, J NEUROSURG, V86, P779, DOI 10.3171/jns.1997.86.5.0779; HATTON J, 1993, J NEUROSURG, V78, pA370; Hill D. B., 1992, Journal of the American College of Nutrition, V11, P630; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; KUDSK KA, 1994, ARCH SURG-CHICAGO, V129, P66; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; MARIE C, 1991, CEREBROVAS BRAIN MET, V3, P29; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MILLER C H, 1991, Neurological Research, V13, P117; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; Ng PCH, 1996, J LAPAROENDOSC SURG, V6, P25, DOI 10.1089/lps.1996.6.25; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; NORTON L, 1970, ARCH SURG-CHICAGO, V101, P200; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; OTT LG, 1988, DRUG INTEL CLIN PHAR, V22, P763, DOI 10.1177/106002808802201004; OTT M, 1994, CRIT CARE MED, V22, P393, DOI 10.1097/00003246-199403000-00007; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; RANSEEN JD, 1990, J CLIN EXP NEUROPSYC, V12, P34; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Ritter AM, 1996, J NEUROTRAUM, V13, P473, DOI 10.1089/neu.1996.13.473; Roberts P R, 1995, New Horiz, V3, P506; ROBERTS PR, 1993, JPEN J PARENTER EN S, V17, P69; RODRIGUEZ DJ, 1995, J SURG RES, V59, P455, DOI 10.1006/jsre.1995.1191; ROSS LH, 1988, PHARM APPROACH CRITI, V3, P818; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; SPAPEN HD, 1995, CRIT CARE MED, V23, P481, DOI 10.1097/00003246-199503000-00011; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Twyman D, 1997, CRIT CARE CLIN, V13, P39, DOI 10.1016/S0749-0704(05)70295-5; TWYMAN D, 1985, JPEN-PARENTER ENTER, V9, P679, DOI 10.1177/0148607185009006679; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; WILLMORE LJ, 1984, EXP NEUROL, V83, P62, DOI 10.1016/0014-4886(84)90046-3; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005; WILSON RF, 1980, CRIT CARE MED, V8, P281, DOI 10.1097/00003246-198005000-00002; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; ZALOGA G, 1992, CRIT CARE MED S, V20, pS94; ZHANG Y, 1993, J CEREB BLOOD FLOW M, V13, P578	65	11	11	2	10	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					121	128		10.1179/016164101101198451			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200003	11320590				2022-02-06	
J	Dell'Acqua, R; Stablum, F; Galbiati, S; Spannocchi, G; Cerri, C				Dell'Acqua, R; Stablum, F; Galbiati, S; Spannocchi, G; Cerri, C			Selective effect of closed-head injury on central resource allocation: evidence from dual-task performance	EXPERIMENTAL BRAIN RESEARCH			English	Article						closed-head injury; PRP paradigm; speed of processing	WORKING-MEMORY; ATTENTIONAL PROCESSES; DEFICITS; INTERFERENCE; IMPAIRMENTS; BOTTLENECK; LOCUS	Two dual-task experiments are reported bearing on the issue of slower processing time for severe chronic closed-head injury (CHI) patients compared to matched controls. In the first experiment, a classical psychological refractory period (PRP) paradigm was employed, in which two sequential stimuli, a pure tone and a colored dot, were presented at variable stimulus onset asynchronies (SOAs), each associated with a distinct task. The task on the tone required a speeded vocal response based on pitch, and the task on the colored dot required a speeded manual response based on color. In the second experiment, either one or three masked letters was presented, followed by a pure tone at variable SOAs. The task on the letters required a delayed report of the letters at the end of each trial. The task on the tone required an immediate manual response based on pitch. In both experiments, both CHI patients and matched controls reported an SOA-locked slowing of the speeded response to the second stimulus, a PRP effect. The PRP effect was more substantial for CHI patients than for matched controls, suggesting that a component of the slower processing time for CHI patients was related to a selective increase in temporal demands for central processing of the stimuli.	Univ Ferrara, Dipartimento Sci Umane, I-44100 Ferrara, Italy; Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, I-35131 Padua, Italy; Osped TRabattoni Ronzoni Seregno, I-20126 Milan, Italy; Univ Milano Bicocca, I-20126 Milan, Italy		Dell'Acqua, R (corresponding author), Univ Ferrara, Dipartimento Sci Umane, 38 Via Savonarola, I-44100 Ferrara, Italy.	dellacqu@psy.unipd.it	Cerri, Cesare/C-4267-2011; Galbiati, Susanna/AAH-6883-2019; Dell'Acqua, Roberto/B-1682-2008	Galbiati, Susanna/0000-0001-7209-4251; Dell'Acqua, Roberto/0000-0002-3393-1907; Stablum, Franca/0000-0003-0123-5090			Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BROULIK PD, 1993, HORM METAB RES, V25, P219, DOI 10.1055/s-2007-1002080; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; DEJONG R, 1993, J EXP PSYCHOL HUMAN, V19, P965, DOI 10.1037/0096-1523.19.5.965; Dell'Acqua R, 2000, MEM COGNITION, V28, P184, DOI 10.3758/BF03213798; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; GENTILINI M, 1989, MILD HEAD INJURY, P163; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; Ivry RB, 1998, J EXP PSYCHOL HUMAN, V24, P463, DOI 10.1037/0096-1523.24.2.463; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jolicoeur P, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P309; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MCCANN RS, 1992, J EXP PSYCHOL HUMAN, V18, P471, DOI 10.1037/0096-1523.18.2.471; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Meyer DE, 1997, PSYCHOL REV, V104, P749, DOI 10.1037/0033-295X.104.4.749; Miller E, 1970, Cortex, V6, P121; NAVEHBENJAMIN M, 1984, J VERB LEARN VERB BE, V23, P494, DOI 10.1016/S0022-5371(84)90318-9; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; OGDEN WC, 1980, J EXP PSYCHOL HUMAN, V6, P355, DOI 10.1037/0096-1523.6.2.355; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PASHLER H, 1994, NEUROREPORT, V5, P2381, DOI 10.1097/00001756-199411000-00042; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Pashler H.E., 1998, PSYCHOL ATTENTION; Pashler HE, 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Schubert T, 1999, J EXP PSYCHOL HUMAN, V25, P408, DOI 10.1037/0096-1523.25.2.408; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SHUM DHK, 1994, J CLIN EXP NEUROPSYC, V16, P547, DOI 10.1080/01688639408402666; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; SPINNLER H, 1987, J NEUROL SCI S, V8; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; STABLUM F, 2000, UNPUB NEUROPSYCHOLOG; Van Selst M, 1997, PROCEEDINGS OF THE NINETEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P787; Van Selst M, 1999, J EXP PSYCHOL HUMAN, V25, P1268, DOI 10.1037/0096-1523.25.5.1268; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANDERLINDEN M, 1992, COGNITIVE NEUROPSYCH, V9, P301, DOI 10.1080/02643299208252063; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; VanSelst M, 1997, COGNITIVE PSYCHOL, V33, P266, DOI 10.1006/cogp.1997.0662; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VANZOMEREN AH, 1994, CLIN NEUROPSCYHOLOGY; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; [No title captured]	53	11	12	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	FEB	2001	136	3					364	378		10.1007/s002210000586			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	403FY	WOS:000167032900009	11243478				2022-02-06	
J	Kolakowsky-Hayner, SA; Kreutzer, JS				Kolakowsky-Hayner, SA; Kreutzer, JS			Pre-injury crime, substance abuse, and neurobehavioural functioning after traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY; ALCOHOL-USE; PATTERNS; MODEL; URBAN	There is limited information regarding the effects of pre-injury history of arrest or history of substance use on neurobehavioural functioning after brain injury. The current study included 211 patients with traumatic brain injury, who were seen for a follow-up neuropsychological evaluation in an outpatient setting. An effort was made to distinguish between (1) patients with a history of pre-injury arrests and patients without a history of pre-injury arrests, (2) patients classified as substance abusers and non-abusers, and (3) patients with and without a history of pre-injury illicit drug use on the basis of demographic characteristics, injury characteristics, and neurobehavioural functioning. Results indicate significant differences between patients with a history of pre-injury arrests and patients without a history of pre-injury arrests in terms of demographic and injury characteristics. Differences were also noted between persons classified as substance abusers and non-abusers in terms of demographic and injury characteristics, and neurobehavioural functioning. Clinical implications and future research are discussed.	Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Kolakowsky-Hayner, SA (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Med Coll Virginia Campus,Box 980542, Richmond, VA 23298 USA.		Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909			Albonetti CA, 1997, SOC PROBL, V44, P124, DOI 10.1525/sp.1997.44.1.03x0216h; Belenko S, 1998, ISSUES SCI TECHNOL, V15, P53; BLANCHARD C, 1999, SPECTRUM-J STATE GOV, V72, P26; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P642; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P130; Claus RE, 1999, ADDICT BEHAV, V24, P471, DOI 10.1016/S0306-4603(98)00106-3; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Drubach D A, 1993, Md Med J, V42, P989; *FED BUR INV US DE, 1998, CRIM US 1998 UN CRIM; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; Garretsen HFL, 1999, ALCOHOL ALCOHOLISM, V34, P733, DOI 10.1093/alcalc/34.5.733; GROSSMAN LS, 1995, PSYCHIATR SERV, V46, P790; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kermani EJ, 1996, AM J DRUG ALCOHOL AB, V22, P1, DOI 10.3109/00952999609001642; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kouri EM, 1997, AM J DRUG ALCOHOL AB, V23, P413, DOI 10.3109/00952999709016886; Kreutzer J., 1987, GEN HLTH HIST QUESTI; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LINDENBAUM GA, 1989, J TRAUMA, V29, P1654, DOI 10.1097/00005373-198912000-00012; Mowbray CT, 1997, AM J DRUG ALCOHOL AB, V23, P309, DOI 10.3109/00952999709040949; *NAT CTR ADD SUBST, 1999, SPECTRUM-J STATE GOV, V72, P8; ORD RA, 1995, J ORAL MAXIL SURG, V53, P514, DOI 10.1016/0278-2391(95)90061-6; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1983, REHABILITATION HEAD; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; SEE RT, 1997, ARCH PHYSICAL MED RE, V78, P1254; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010	33	11	11	0	8	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2001	15	1					53	63		10.1080/02699050150209138			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	384UF	WOS:000165963600006	11201315				2022-02-06	
